(navigation image)
Home American Libraries | Canadian Libraries | Universal Library | Community Texts | Project Gutenberg | Biodiversity Heritage Library | Children's Library | Additional Collections
Search: Advanced Search
Anonymous User (login or join us)
Upload
See other formats

Full text of "Psychopharmacology abstracts"

LIBRARY OF THE 

UNIVERSITY OF ILLINOIS 

AT URBANA-CHAMPAIGN 



PS 







il-iULJ\ iHoLL 



nV 






•/v.K^v 



,. FF-oM UBR^R■^ 



•' • * 



ROOSVlUo^O^'^^- 



• v, •.','■•'■,•, v.' ''. ■.•.SV' 



Wi »vy i< HS, . ,,ai. ii 



mM'^m 



r ii»t * < r. ' t' f l! J 



.X TAtiLt 




,'. 'V*-."-^, ' 



^' fixr''^^ '^ 



THE NATIONAL CLEARINGHOUSE FOR MENTAL HEALTH INFORMATION 



umuiaTive 



PSYCHOPHARAAACOLOGY 

ABSTRACTS 




PSYCHOPHARMACOLOGY ABSTRACTS is a pubUcation of the National Clearinghouse 
for Mental Health Information of the National Institute of Mental Health. It is a 
specialized information medium designed to assist the Institute in meeting its obligation 
to foster and support laboratory and clinical research into the nature and causes of 
mental disorders and methods of treatment and prevention. Specifically, this information 
service is designed to meet the needs of investigators in the field of psychopharmacology 
for rapid and comprehensive information about new developments and research results. 
For information or correspondence with the National Institute of Mental Health 
concerning Psychopharmacology Abstracts, changes of address, or removal of names from 
the mailing list see the inside back cover page. 



The Secretary of Health, Education, and Welfare has determined that the publication of 
this periodical is necessary in the transaction of the public business required by law of this 
Department. Use of funds for printing this periodical has been approved by the Director of 
the Office of Management and Budget through December 31, 1976. 



PS 



NATIONAL CLEARINGHOUSE FOR MENTAL HEALTH INFORMATION 
PSYCHOPHARMACOLOGY ABSTRACTS 



Volume 12 



Cumulative Index 



July 1975 



Page 

Author Index Al 

Subject Index SI 



Carrie Lee Rothgeb,£'rf/f or 

Bette L. Shannon, Managing Editor 



U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE 

Public Health Service 

Alcohol, Drug Abuse and Mental Health Administration 

5600 Fishers Lane 

Rockville, Maryland 20852 



Publication No. (ADM) 75-150 
Printed 1975 



For sale by the Superintendent of Documents, U.S. Government Printmg Office WashmgtonD.C. 20402. 
Subscription price per year in the United States, Canada, and Mexico: $16.90; other countnes, $21 15^ 
Lrcopy $3 70 Index issue $2.25. The Clearinghouse does not seU copies oi Psychopharmacolo^ 
'TfLrPersons wishing to subscribe by the year or to purchase single copies should send theu orders, 
accompanied by check or money order, directly to the Superindendent of Documents. 



U 



AUTHOR INDEX 



(The 6-digit number is the abstract occession number. The next two digits are the issue number,- digits ofter hyphen ore the category number.) 



ABBATIELLO ER 172374 01-04 

ABDALLAH A 192014 04-04 

ABDALLAH AH 171007 01-13, 189613 04-04 

ABET 171282 01-11 

ABEL EL 1 76880 02-03, 186570 03-03, 187928 

04-03 
ABLON SL 181274 02-09 
ABRAMS LS 183899 03-03 
ABRAMS R 170627 01-09 
ABRAMSON DC 174568 01-11 
ABSAVA Gl 183518 03-01, 191122 04-03 
ABUZZAHAB FS 171695 01-09 
ACETO MD 191907 04-14 
ACHEE FM 191300 04-03 
ADACHI K 168302 01-17 
ADAMS MD 191971 04-03 
ADAMS RN 190239 04-08 
ADIKUSUMO A 170753 01-11 
ADKINS EK 186681 03-03 
ADLERM 183897 03-03 
ADLER R 184291 03-14 
ADOLPHE M 188864 04-03 
AFIFI A 183600 03-01 
AFIFI AH 182159 02-03 
AFLALOM 18320103-11 
AGARWAL VK 185035 03-01 
AGHAJANIAN GK 177407 02-12, 182141 02-03, 

188750 04-03, 191931 04-03, 191949 04-03 
AGHJANIAN GK 191948 04-03 
AGIO Y 183794 03-03 
AGRESTI E 182788 03-09 
AHLENIUS S 17161101-04,171614 01-04 
AHTEE L 183606 03-04, 191421 04-03 
AIRAKSINEN MM 171613 01-03 
AJMANI S 175410 02-09 
AKABORI F 176456 02-11 
AKERA T 182184 02-03 
AKISKAL HS 187866 04-11 
AKPINAR S 174131 01-08, 180064 02-10 
AL-BAKERA 187076 03-05 
AL-HACHIM GM 187076 03-05 
AL-KAISI AH 185191 03-14 
ALBANUS L 171632 01-03 
ALBIN MS 188689 04-05 
ALBRIGHT JD 185033 03-04 
ALDERMAN JL 191988 04-03 
ALEKSANDROWICZ MK 183706 03-17 
ALESM 168976 01-14 
ALEXANDER K 169817 01-13, 170838 01-13 
ALEXANDER N 188198 04-03 
ALEXANDER RW 191511 04-13 
ALGER! S 189752 04-03 
ALI 8 169818 01-01, 182727 03-03, 185980 

03-01, 191942 04-03 
ALI N 185005 03-08 
ALIVISATOS SGA 191956 04-03 
ALLEN BS 185927 03-04 
ALLEN C 185927 03-04 
ALLEN CR 167334 01-07 
ALLEN GS 182088 02-03 
ALLIKMETS LK 191783 04-02, 191785 04-02, 

191788 04-04 
ALLSOPJL 187618 04-11 
ALLTOP LB 171500 01-09 
ALMLI CR 168859 01-03 
ALTMAN H 176676 02-17 
ALTSHULER HL 191939 04-04 
ALVES CN 167362 01-04 
ALVIN J 177731 02-03 
AMADUCCI L 168578 01-13 
AMAKUSA T 181378 02-08 
AMAMOTO T 191670 04-09 
AMAN MG 185861 03-14 
AMBANI LM 170662 01-13 
AMERYW 183194 03-09 
AMIELANCZYK W 174784 01-15 
AMIN M 167774 01-09, 168807 01-11, 191138 

04-14 
AMIT Z 183470 03-04, 183790 03-04, 184238 

03-04, 186586 03-04 
AMMAR EM 183600 03-01 
AMMON HPT 168440 01-03 



AMORI T 173548 01-05 

ANAGNOSTE B 182256 03-03 

ANANTH JV 168313 01-08, 168319 01-15, 177676 

02-17, 180243 02-15, 180247 02-15, 192412 

04-17 
ANDEN N 171611 01-04, 171622 01-03, 171623 

01-03, 189571 04-03 
ANDERSON A 189924 04-17 
ANDERSON EG 168436 01-03, 188751 04-03, 

189832 04-03 
ANDERSON PF 180057 02-03 
ANDERSON R 182157 02-03 
ANDERSON RE 185330 03-14 
ANDERSON SW 177674 02-14 
ANDJELKOVIC D 180058 02-03 
ANDO K 182110 02-04 
ANDREANI G 175540 02-11 
ANDREWS CJ 187615 04-11 
ANGEL C 187868 04-04, 190696 04-04 
ANGELETTI PU 177338 02-03 
ANGRISTB 185875 03-11,186744 03-14 
ANGRIST BM 177826 02-13, 191507 04-13 
ANNAU Z 191917 04-04 
ANSELL GB 171971 01-01 
ANTELMAN SM 182212 03-03 
ANTON AH 191920 04-03 
ANTONACCIO MJ 177406 02-03 
ANTONELLI F 168809 01-11 
ANTOPOL W 189582 04-05 
ANUSUYASR 169633 01-11 
AOKI N 182552 03-15 
AONOT 181377 02-15 
APFELBACH R 183863 03-04 
APOSHIAN D 190476 04-03 
APPEL JB 174034 01-04, 185752 03-04 
AQUILONIUS S 171600 01-03, 171606 01-03 
ARA T 176541 02-08 
ARAKI Y 181384 02-04 
ARAT M 174131 01-08 
ARBRUS M 191771 04-03 
ARCHIBALD JL 187940 04-01 
AREVALO L 169467 01-03 
ARIOKA I 176472 02-08 
ARITOME T 171275 01-15 
ARORA RC 191956 04-03 
AROURA S 191997 04-03 
ARRANZ T 183955 03-08 
ARRIGO A 167336 01-13 
ARUSHANYAN EB 183521 03-17 
ASANO Y 184178 03-03 
ASAO Y 1 76472 02-C8 
ASBERG M 192873 04-09 
ASCHKENASE LJ 192565 04-04 
ASHKENAZI R 174319 01-03 
ASHTON H 182763 03-14, 187350 04-13 
ASKEW WE 185582 03-03, 188167 04-03 
ASO S 176727 02-08 
ASPER H 191418 04-03 
ATKINSON M 187565 04-11 
ATKINSON RC 189406 04-14 
ATRENS DM 186164 03-04 
AUCLAIRMC 188864 04-03 
AUDIO-VISUAL SERVICES LH 189297 04-17 
AURES D 189597 04-03 
AUYONG IK 182727 03-03 
AVIS HH 183615 03-14, 190264 04-04 
AXELROD J 170082 01-03. 177128 02-03, 177403 

02-16, 178747 02-03, 181468 02-03, 187397 

04-03 
AYD FJ 188312 04-15, 191044 04-08, 191119 

04-09 
AYUSO GUTIERREZ JL 187536 04-09 
AZARNOFF DL 190258 04-15 

B 

BABBINI M 178756 02-04 
BABOR TF 169084 01-13 
BACHRACH AJ 186630 03-04 
BADER A 186026 03-12 
BAENNINGER R 185463 03-04 
BAER L 169869 01-15 
BAEZ LA 186582 03-03 
BAEZ S 182185 02-03 



BAGADIA VN 172444 01-08, 174588 01-08, 

174589 01-08, 175393 02-1 1, 175460 02-08, 

175967 02-10, 180153 02-08 
BAGCHI SP 184838 03-04 
BAGGIOLINI M 191418 04-03 
BAILEY DN 177394 02-15 
BAILEY DW 185751 03-03 
BAILEY J 192577 04-09 
BAILEY LC 176871 02-16 
BAKER JD 190194 04-11 
BAKER KM 169073 01-01 
BAKER M 185928 03-09 
BAKER TG 191906 04-03 
BAKER WW 167329 01-03,182129 02-03 
BALASSA M 180672 02-11 
BALAZS T 191982 04-15 
BALDAUF A 182900 03-11 
BALDESSARINI RJ 169120 01-03, 191035 04-15 
BALDET M 180723 02-03 
BALDWIN BA 189409 04-04 
BALLINGER BR 185195 03-17 
BALOCH N 189042 04-15 
BALTER MB 177699 02-17,181713 02-17 
BALZAMO E 191629 04-04 
BAMJI AN 191320 04-08 
BAN TA 167774 01-09, 168313 01-08, 168804 

01-16, 168805 01-11, 168806 01-11, 168807 

01-11, 169296 01-09, 170293 01-11, 183360 

03-13, 191138 04-14, 191139 04-17, 192412 

04-17 
BANTS 180243 02-15 
BANCROFT J 190061 04-11 
BANDMAN AL 174257 01-03 
BANDO M 182872 03-03 
BANEN DM 167496 01-11 
BANERJEE SP 191290 04-08 
BANERJEE U 172921 01-04 
BARATTI CM 169467 01-03 
BARCHAS JD 183891 03-03 
BARDAKHCH'YAN EA 183520 03-01 
BARFKNECHT CF 172915 01-03, 177734 02-03, 

188121 04-12 
BARKER JL 168485 01-03, 177976 02-03, 189033 

04-03, 190727 04-03 
BARKER LA 182237 03-04, 192000 04-03 
BARKER LM 190265 04-04 
BARNARD M 182219 03-03 
BARNETT A 182240 03-04 
BARO F 192431 04-08 
BAROFSKY I 182244 03-03 
BARONDES SH 188605 04-04 
BARRACLOUGH BM 17456101-15 
BARRATT E 167334 01-07 
BARRER B 178255 02-08 
BARRETT R 182204 02-03 
BARRETT RJ 179990 02-04, 189521 04-04, 

191914 04-04 
BARRY H 182190 02-04, 182243 03-03, 185748 

03-04, 188228 04-06, 189525 04-04, 191946 

04-03 
BARSUHN C 186578 03-03 
BARTHOLIN! 6 184229 03-03, 186677 03-03, 

189602 04-03 
BARTHWAL JP 183601 03-03 
BARTOLETTI M 178756 02-04 
BARUK H 180724 02-04 
BASKIN SI 182184 02-03 
BATES DE 177671 02-11 
BATTIG K 174043 01-14, 190333 04-04 
BATTISTA AF 191932 04-03 
BAUER RB 189502 04-11 
BAUER W 169462 01-14 
BAUGH EL 171306 01-04 
BAUM M 183470 03-04 
BAUMANN IR 184227 03-03 
BAUMANN P 181471 02-03 
BAUMANN PA 172917 01-03 
BAUMEL IP 182721 03-03 
BAUMGARTEN HG 188287 04-03, 188977 04-03 
BAXTER BL 182215 03-04 
BAXTER JH 189895 0403 
BAYLOR MR 189177 04-02 
BAYOMI SM 183600 03-01 
BAYULKEM F 171121 01-17 



A-1 



: 



Author Index 

BAZHIN EF 181778 02-08 

BAZOAJ 173190 01-11 

BEAHRS JO 184021 03-12 

BEARD JO 187866 04-11 

BEATON JM 187260 04-04, 189519 04-04 

BEATTIE CW 175650 02-03 

BEATTIE lA 182762 03-04 

BEAUBIEN AR 191925 04-03 

BEAVEN MA 189895 04-03 

BECHTEREVANP 178787 02-13 

BECK AT 191857 04-09 

BECK H 168369 01-11, 190095 04-11 

BECKETT AH 183796 03-13, 190902 04-06 

BECKNER JS 191968 04-03, 191970 04-03 

BECKSTEAD HD 192787 04-17 

BEDERKA JP 174606 01-12 

BELANGER PM 183796 03-13 

BELESLIN DB 186640 03-03 

BELGRADE J 187700 04-04 

BELIN M 179988 02-13 

BELKNAP JK 175895 02-03 

BELL DS 186702 03-04 

BELL JA 170874 01-03, 174480 01-12 

BEN-ISHAY D 173256 01-04 

BEN-ZVI Z 187574 04-01 

BENDER DA 191320 04-08 

BENEDITO MAC 184212 03-04 

BENESOVA 192430 04-04 

BENNETT EL 174036 01-03 

BENNETT JL 188750 04-03 

BENTLEY R 172741 01-08 

BENVENUTI P 168578 01-13 

BERARDI AC 183609 03-03 

BERG D 185463 03-04 

BERGER BD 182210 02-04 

BERGER FM 182770 03-17 

BERGNER PE 187255 03-08 

BERGONZI P 186643 03-14 

BERKOWITCH S 183201 03-11 

BERKOWITZ BA 189390 04-03 

BERNARD BK 182241 03-04 

BERNDT S 181467 02-03 

BERNHEIM J 180699 02-14 

BERNSTEIN JG 187257 04-14 

BERNTSON GG 182238 03-04 

BERRY PA 182762 03-04 

BERT J 191629 04-04 

BERTHOD H 183406 03-01 

BERTILSSON L 169074 01-01 

BERTRAND N 189023 04-02 

BESBRIS H 19128104-03 

BESSON MJ 184230 03-03 

BEUMONT PJV 183807 03-10, 184436 03-15, 

184437 03-13 
BEYEL V 1 85877 03-08, 1 87840 04- 1 7 
BEYER EC 181158 02-09 
BHARGAVA HN 182159 02-03, 191769 04-03. 

191985 04-03 
BHARGAVA KP 177021 02-03 
BHASKARAN K 171985 01-08, 180154 02-08 
BHATE S 185005 03-08 
BHATIA SC 174376 01-09 
BHATNAGAR SP 187800 04-03 
BIALERI 177771 02-14 
BIANCHI C 177729 02-13, 186377 03-06 
BIANCHI GN 186584 03-10 
BICKEL MH 192423 04-03 
BIEGER D 177785 02-04 
BIEL JH 174760 01-03, 191499 04-01 
BIENER R 182722 03-13 
BIERWAGEN ME 187573 04-03 
BIGELOW A 181958 02-13 
BIGELOW LB 177669 02-08, 177818 02-08 
BIGELOW VTN 173791 01-04 
BIGGIO G 168748 01-03 
BIGGS JT 191924 04-13 
BILLINGS EG 174566 01-09 
BINAZZI A 168578 01-13 
BINDRA D 182123 02-03 
BIRCHALL PMA 175219 02-13 
BIRCHLERA 188093 04-11 
BIRDSONG JH 184195 03-11 
BISCHOFF S 168750 01-03, 189396 04-03 
BISCOE TJ 188201 04-03 
BISHOP G 174137 01-08 
BISHOP MP 174137 01-08 
BITE A 185933 03-03 
BIXLER EG 172114 01-15 
BJEGOVIC M 170747 01-03 



BJERKE K 172735 01-07 

BJORUM N 172402 01-09 

BLACK WC 188760 04-04 

BLACKWELL B 167341 01-08, 189924 04-17 

BLAIR AW 168523 01-14 

BLAKEMORE C 185008 03-11 

BLAMPIED NM 190334 04-04 

BLANC G 188978 04-03 

BLASIG J 169474 01-03 

BLATCHLEY R 188121 04-12 

BLESSED G 185005 03-08 

BLOOM F 168817 01-03 

BLOOM FE 187132 03-06, 187498 04-04, 187499 

04-04, 191762 04-03 
BLOUNT JF 185034 03-01 
BLOZOVSKI D 169473 01-04 
BLOZOVSKI M 169473 01-04 
BLUM A 185873 03-09 
BLUM JE 179021 02-05 
BLUM K 169782 01-03, 192013 04-05 
BOAL D 191522 04-13 
BOBON DP 172972 01-13,174044 01-11 
BOBON J 174044 01-11. 183189 03-09,183190 

03-07 
BOCK K 180676 02-11 
BOEHMES DH 183602 03-01 
BOELKINS RC 178867 02-04 
BOGETTO F 1 84975 03-03 
BOGGAN W 18389103-03 
BOGGAN WO 1 74034 1 -04, 1 82 1 67 02-03, 

187698 04-04 
BOHUON C 190337 04-03 
BOISSE NR 191953 04-04 
BOISSIERJR 167449 01-03 
BOJANOVSKYJ 18259103-14 
BOLT AG 188770 04-01 
BOND AJ 168831 01-14 
BONDARTCHUK AN 178787 02-13 
BONILLA E 185993 03-03 
BONISCH H 189604 04-03 
BONN JA 182764 03-10 
BOOHER R 187130 03-03 
BOOM AJ 183194 03-09 
BOPP B 174760 01-03 
BORBELY AA 177477 02-04. 184227 03-03 
BORBERG S 185954 03-04 
BORCHARDT RT 190716 04-01. 190717 04-01 
BORDARP 177645 02-16 
BORENSTEIN P 184955 03-17 
BORG S 186565 03-08 
BORGEN LA 182191 02-04. 183788 03-03. 191967 

04-04 
BORGMAN RJ 189177 04-02 
BOROWITZ JL 189583 04-05. 189591 04-03 
BOROWSKI R 184228 03-03 
BORSY J 192416 04-03 
BOSCO JJ 178127 02-17 
BOST R 189072 04-08 
BOSWORTH JE 188404 04-03 
BOTALLAL 188350 04-13 
BOUCSEIN W 184617 03-07 
BOUERI-ATEM S 168923 01-11 
BOULU R 169469 01-04 
BOURDOUXHES 174044 01-11. 183190 03-07 
BOURGEOIS M 176432 02-15 
BOU RGOI N S 1 88 1 64 04-03. 1 88976 04-03 
BOUVET D 183794 03-03 
BOVER CE 182128 02-04 
BOVET D 186590 03-04 
BOWDEN CL 172486 01-10 
BOWERS MB 1 70662 01-13,1 77736 02- 1 3 
BOWMAN RE 192565 04-04 
BOYD EH 186666 03-03 
BOYD ES 186666 03-03 
BOYD R 177318 02-14 
BOYSON S 191771 04-03 
BRADBARD G 185324 03-14 
BRADLEY RJ 187260 04-04 
BRADLEY SG 177834 02-05 
BRAESTRUPC 180059 02-03 
BRAHAMANKAR D 188873 04-03 
BRAHIM D 168923 01-11 
BRAHM E 167774 01-09 
BRAMBILLAF 191190 04-14 
BRANCH B 183324 03-03 
BRANCH BJ 181576 02-03 
BRANCH MN 183890 03-04. 187066 03-04 
BRAND L 182156 02-03 
BRANDAU K 181468 02-03 



Psychophormacology Abstracts 

BRASE DA 184179 03-03 
BRASSEUR R 172978 01-09, 172979 01-09 
BRASTED M 186676 03-03 
BRAUD WG 186583 03-04 
BRAUDE MC 182192 02-04, 188872 04-05, 
189516 04-04, 189588 04-05, 191965 04-03, 
191966 04-04 
BRAUN P 167336 01-13 
BRAUZER B 190195 04-09 
BRAYTENBAH EA 182232 03-03 
BREESE GR 186634 03-04, 186699 03-03, 187696 
04-04, 189515 04-04, 191518 04-03, 191526 
04-03, 191905 04-03, 191955 04-03, 191984 
04-03 
BREITBART H 177835 02-03 
BRENNAN T 181811 02-13, 185083 03-12 
BRESLER DE 185753 03-04 
BREULETM 174044 01-11,183190 03-07 
BREZENOFF HE 182130 02-03 
BRIDGE TP 192229 04-09 
BRIDGER WH 1 78575 02-04, 190266 04-04 
BRIDGERS WF 187260 04-04 
BRIGHT TP 191993 04-05 
BRISTOW RL 182160 02-03 
BRODIE BB 188865 04-05 
BRODIE RE 189564 04-05 
BRODY JA 169376 01-15, 179996 02-13 
BRODY TM 182184 02-03 
BROEKKAMP CLE 174763 01-04. 187666 04-04 
BRONAUGH RL 175232 02-03 
BRONHEIMLA 16777401-09, 19113804-14 
BROOKS E 185324 03-14 
BROVERMAN DM 187149 03-13 
BROWN CC 190146 04-07 
BROWN CR 177320 02-11 
BROWN DJ 191991 04-04, 191993 04-05 
BROWN LE 186666 03-03 
BROWN RA 178255 02-08 
BROWN RM 171612 01-04 
BROWN SS 172397 01-16 
BROWN TS 184834 03-04 
BROWNE IW 181811 02-13 
BRUCKWICK EA 19151104-13 
BRUMLEVE SJ 169818 01-01. 183598 03-02, 

183601 03-03, 191942 04-03 
BRUNNGRABER EG 181815 02-03 
BRUS R 178558 02-03 
BRUUN RD 18843104-11 
BRYANT RW 191768 04-03 
BUCCI L 186590 03-04 
BUCH 192420 04-13 
BUCHANAN DC 1 78638 02-04, 184242 03-04 
BUCHAR E 170072 01-03 
BUCHENAUER D 183894 03-03 
BUCHOWSKA I 174777 01-10 
BUCHSBAUMM 16986101-11 
BUCKHOLTZ N 182229 03-03 
BUCKLEY JP 182243 03-03, 183795 03-03, 

185748 03-04 
BUCKMAN J 189074 04-17 
BUCKNERCK 186633 03-03 
BUENING MK 184180 03-03 
BUHRICH N 182765 03-09 
BUNEGIN L 188689 04-05 
BUNNELL PR 191966 04-04 
BUNNEY BS 191948 04-03 
BUNNEY WE 174479 01-14, 185928 03-09 
BURES J 19141 1 04-03 
BURI P 180700 02-15 
BURKE W 187835 04-03 
BURKHALTERA 188178 04-03 
BURKI HR 191418 04-03 
BURKMAN AM 182131 02-04 
BURKS TF 188202 04-03 
BURNER M 172977 01-11 
BURNS M 189358 04-14 
BUROV YV 183206 03-04 
BURROWS G 187582 04-10 
BURSTEIN S 169067 01-03, 187574 04-01 
BURTON RM 192426 04-03 
BUSH MT 177731 02-03, 177732 02-03, 191057 

04-03 
BUTCHER S 182250 03-03, 189597 04-03 
BUTLER WM 188865 04-05 
BUTTERWORTH AT 1 88584 04-1 1 
BUYNISKI JP 187573 04-03 
BYERS MR 191324 04-03 
BYMASTER FP 191951 04-03 
BYRD LD 183889 03-04 



A-2 



VOLUME 12, AUTHOR INDEX 



Author Index 



CAFFEY EM 171926 01-09, )72831 01-08, 186188 

03-09, 186191 03-09, 189735 04-09 
CAIRNS RB 173039 01-04 
CALDWELL DF 191536 04-13 
CALHOUN W 169782 01-03 
CALLERY PS 175759 02-03, 190718 04-03 
CALOBRISI A 174299 01-09 
CAMPBELL BA 174860 01-04 
CAMPBELL HE 192410 04-17 
CAMPBELL JT 185957 03-04 
CAMPBELL M 175872 02-17 
CANALES ES 175245 02-13 
CANDY J 168832 01-10 
CANFIELD DR 182212 03-03 
CANNON E 173398 01-03 
CANTWELL DP 177778 02-11 
CARDAUNS H 178619 02-05 
CARDELLINI M 180098 02-01 
CARENZI A 191766 04-03 
CARL JL 177135 02-03 
CARLIN AS 184021 03-12 
CARLINI EA 167362 01-04, 169472 01-03, 183609 

03-03 
CARLSON ET 192059 04-17 
CARLSON GP 167361 01-05 
CARLSON HE 186580 03-09 
CARLSSON A 191513 04-03 
CARMAN JS 187985 04-11 
CARNEY J 182195 02-04, 191983 04-04 
CARON LB 183359 03-03 
CARPENTER JF 186638 03-04 
CARPER WR 178812 02-03 
CARR CB 171241 01-14 
CARR PJ 183807 03-10 
CARROLL BJ 191532 04-09 
CARROLL Fl 182156 02-03 
CARSKADON M 171496 01-11 
CARTER SB 168286 01-13 
CASEG 184175 03-10 
CASE WG 172993 01-10 
CASELLI G 175540 02-11 
CASS J 190061 04-11 
CASTAGNOLI N 175759 02-03, 187941 04-01, 

190718 04-03 
CASTAIGNE P 171134 01-13 
CASTELLANO C 185751 03-03, 186705 03-04 
CASTLES TR 182160 02-03 
CASTREN 171613 01-03 
CATE JC 177393 02-15 
CATOVIC S 184200 03-04 
CAVANAGH RL 191906 04-03 
CAVANAUGH GL 185873 03-09 
CAVANAUGH JH 184654 03-13 
CAVERO 1 183795 03-03 
CAVNESS C 189884 04-14 
CEB1R0GLU R 182431 03-11 
CECCHETTI G 188196 04-03, 191422 04-03 
CELY W 174608 01-05, 175238 02-03, 191994 

04-03 
CENTURY B 175859 02-03 
CHABOT D 16861901-15,17751102-11 
CHAN TL 168836 01-08 
CHANALJ 180723 02-03 
CHAND N 177021 02-03 
CHANDRA S 182828 03-02 
CHANG HK 171259 01-04, 173078 01-04 
CHANG LW 186476 03-05, 192565 04-04 
CHANG WK 189178 04-02 
CHANLEY JD 174995 02-09 
CHAPALLAZ S 183786 03-15 
CHAPOUTHIER G 168838 01-04 
CHARALAMPOUS KD 190196 04-09 
CHARLTON CG 191918 04-03 
CHASE TN 169376 01-15, 169377 01-13, 177975 
02-11, 179996 02-13, 186029 03-11, 187985 
04-11, 191524 04-13 
CHATURVEDI AK 183598 03-02 
CHAU-W0N6 M 182127 02-03, 187802 04-03, 

189400 04-03 
CHAUDHARY A 183598 03-02 
CHAUDHRY ZA 170622 01-09 
CHAWLA R 174588 01-08, 175460 02-08 
CHAYKIN LB 167335 01-11 
CHEAH JS 167460 01-13 
CHEN G 186581 03-04 
CHEN SS 187802 04-03 
CHENEY D 188891 04-03 



CHENEY DL 180582 02-03, 182226 03-03, 184553 

03-03, 187526 04-03 
CHENG HC 177734 02-03, 188204 04-03 
CHENG R 185192 03-11 
CHENOWETH MB 182258 03-04 
CHEON YS 180507 02-03 
CHERN1CK WS 191962 04-03 
CHESHER GB 180057 02-03, 189513 04-03 
CHESSEN DH 187837 04-15 
CHIEL H 174764 01-03 
CHIEN C 173006 01-09 
CHIKVA1DZE VN 183142 03-13 
CHIN L 191992 04-03 
CHINS 177674 02-14 
CHINN C 183866 03-03 
CH10DINI PG 188350 04-13 
CH1UEH CC 176874 02-03, 189397 04-03, 191897 

04-03 
CHIURULLA C 186643 03-14 
CHO AK 182203 02-06, 191921 04-03, 191923 

04-03 
CHO DW 176676 02-17 
CHO HY 171259 01-04 
CHO YN 173080 01-15 
CHOEJ 186678 03-03 
CHOI L 189597 04-03 
CHOPDE CT 188873 04-03 
CHOROSH J 168420 01-12 
CHOUINARD G 167343 01-08 
CHOUVET G 179988 02-13 
CHRISTENSEN AV 171607 01-04, 186371 03-04 
CHR1STENSEN HD 182223 03-03 
CHRISTIANSEN C 188889 04-1 1 
CHRISTIANSEN J 183604 03-13 
CHUN RWM 173205 01-11 
CHUNG HR 167773 01-10, 172993 01-10, 185747 

03-09 
C1ANCHETTI C 186643 03-14 
CICCARELLI G 183199 03-11 
CICERO TJ 183895 03-03, 191367 04-04 
C10FAL0 FR 183896 03-03 
CISIN IH 177699 02-17 
CLARE RA 183793 03-13 
CLARIDGE GS 175219 02-13 
CLARK DL 187640 04-04 
CLARK EL 188144 04-10 
CLARK ML 173402 01-08, 174348 01-14, 184177 

03-11 
CLARK SC 187812 04-13 
CLARK WC 177674 02-14 
CLARK WG 183608 03-03, 189587 04-05 
CLARKE CC 183897 03-03 
CLARKE PA 185005 03-08 
CLIFFORD JM 192575 04-13 
CLOUET DH 182228 03-03, 184329 03-03 
COAN M 182239 03-04 
COCCHI D 188200 04-03 
COCHIN J 191996 04-03 
COHEN A 167335 01-11 
COHEN G 182130 02-03, 182150 02-03, 182204 

02-03, 182723 03-03 
COHEN I 186706 03-03 
COHEN J 184238 03-04 
COHEN MJ 181887 02-13, 190308 04-14 
COHEN ML 186693 03-03 
COHENS 177373 02-11 
COHEN SM 187113 03-08 
COHN M 182155 02-03, 183789 03-03 
COHN ML 182155 02-03, 183789 03-03 
COINTY C 189023 04-02 
COLASANTI BK 189407 04-03 
COLBURN RW 181810 02-03 
COLE JO 1 73006 01-09, 1 76673 02-08, 184630 
03-17, 185874 03-10, 190144 04-17, 192066 
04-10 
COLE SO 184839 03-03 
COLEMAN M 188429 04-11 
COLEMAN MP 181392 02-13 
COLLARO J 178946 02-11, 183189 03-09, 183198 

03-11 
COLLINGS VB 176307 02-03 
COLLINS AC 185210 03-10 
COLLINS RJ 191940 04-04 
COLOMBEL M 189517 04-05 
COLONNA L 180725 02-07 
CONSOLO S 185995 03-03, 189893 04-03, 191423 

04-03 
CONSROE PF 187640 04-04, 191992 04-03 
COOK DA 176597 02-17 



COOK MP 189564 04-05 

COOKSON JH 192575 04-13 

COOLS AR 186700 03-04 

COOPER BR 186634 03-04, 189515 04-04, 191518 

04-03, 191526 04-03, 191905 04-03, 191955 

04-03, 191984 04-03 
COOPER CW 186570 03-03 
COOPER SD 192005 04-11 
COOPER TB 187255 03-08 
COPER H 180056 02-05, 184199 03-03, 185931 

03-03, 1 89573 04-04 
COPPEN A 192577 04-09 
CORCORAN ME 183790 03-04, 186586 03-04 
CORKER CS 184437 03-13 
CORNATZER WE 185980 03-01 
CORR PB 174008 01-04 
CORREIA J 182244 03-03 
CORRODI H 189611 04-03 
COSCINA DV 182725 03-03 
COSTA E 170086 01-03, 170755 01-03, 173381 

01-03, 179986 02-03, 180582 02-03, 182344 

03-03, 184553 03-03, 186673 03-03, 187526 

04-03, 187527 04-03, 188891 04-03, 191515 

04-03, 191764 04-03, 191766 04-03, 192335 

04-03 
COSTA M 189027 04-03 
COSTALL B 171305 01-03, 176877 02-04, 185958 

03-04, 186577 03-03 
COTE J 187799 04-03 
COTMAN CW 181406 02-04 
COTT JM 189515 04-04 
COTTEE LJ 187835 04-03 
COTTEREAU M 184962 03-09 
COTTRELL JC 170464 01-05 
COTZIAS GC 189587 04-05 
COUCH JR 191950 04-03 
COURRIERE P 183406 03-01 
COUSENS K 174041 01-14 
COUSSE H 180723 02-03 
C0V1 L 169089 01-10, 171925 01-10, 177671 

02-11 
COWAN N 187380 04-03 
COX T 186637 03-04 
COYLE JT 173380 01-03 
CRAIG CR 189407 04-03 
CRAIG JC 182445 03-01 
CRANE A 192000 04-03 
CRANE GE 171974 01-15,189923 04-13 
CRAVENS J 177716 02-14, 177717 02-14, 177718 

02-14 
CRAWFORD Tl 167338 01-11 
CRAYTON JW 187114 03-09 
CREE JE 171731 01-13 
CREMASCOLI G 188350 04-13 
CRESON D 167334 01-07 
CRISCUOLI PM 168975 01-13 
CROFFORD M 182164 02-03 
CROOK TH 171502 01-09 
CROOKS PA 174828 01-03 
CROSBY DM 192878 04-01 
CROUCHER T 172780 01-03 
CROUGHAN JL 174496 01-12 
CROWLEY HJ 181575 02-03 
CROWN P 169068 01-13 
CROY DJ 176873 02-04 
CSANALOSI I 172993 01-10, 184175 03-10, 

185747 03-09 
CUELLO AC 177131 02-03 
CULLENJ 18181102-13 
CULLEN SC 182159 02-03 
CULVER B 176867 02-06 
CURIO 168923 01-11 
CURRY SH 192871 04-14 
CUSHMAN P 182166 02-13 
CUTLER RWP 189031 04-03 
CYRUS J 191233 04-13 
CZERMACK M 167676 01-08 
CZERWINSKI AW 174348 01-14, 184177 03-11 
CZLONKOWSKI A 170126 01-04, 178757 02-04 



D'ANGELI P 182791 03-09 

DACHARY JM 183124 03-11 

DAFNY N 187362 04-03 

DAHL LK 173256 01-04 

DAHLBERG CC 168420 01-12, 192084 04-15 

DAILEY J 171626 01-03 

DALTON B 191961 04-13 



!l|( :j 



A-3 



Author Index 

DALTON C 181575 02-03 

DALTONWS 191989 04-14 

DALYJW 177252 02-03 

DANDIYA PC 174038 01-04, 174768 01-04, 

182828 03-02 
DANIELS AC 188426 04-03 
DANTZER R 189409 04-04 
DARLEY CF 177720 02-14, 189406 04-14 
DARVAS F 190714 04-01 
DASBERG H 171124 01-10 
DASBERG HH 186184 03-13 
DASILVAJ 187115 03-09 
DATAJB 185979 03-01 
DATTA RK 189582 04-05 
DAVE KP 174589 01-08, 175393 02-11, 175967 

02-10 
DAVID J 187931 04-03 
DAVID RJ 189032 04-03 
DAVID-REMACLE M 186704 03-04 
DAVIDSON ST 177699 02-17 
DAVIESAL 174059 01-08 
DAVIES B 187582 04-10, 192510 04-09 
DAVIESJ 189750 04-03 
DAVIES JA 174829 01-04, 174830 01-04, 186636 

03-04 
DAVIES NH 185330 03-14 
DAVIS DA 1 76863 02-04, 191982 04-15 
DAVIS J 191531 04-09 

DAVIS JM 1 72272 01-11,1 75935 02-1 5, 1 77450 
02-14 184654 03-13, 188542 04-14, 189650 
04-09 191508 04-08,191530 04-09 
DAVIS KH 176747 02-03, 180670 02-01, 182223 

03-03 
DAVIS WM 172454 01-04, 182191 02-04, 183788 

03-03, 191899 04-04 
DAWSON S 173521 01-14, 178578 02-08, 188115 

04-08 
DAWSON V 186613 03-04 
DAY RP 182255 03-03 
DAYKIN S 183790 03-04 
DE ALBURQUERQUE IC 169932 01-06 
DE ALBURQUERQUE MA 169932 01-06 
DE BIASE G 182788 03-09 
DE BOER B 191942 04-03 
DE CHAMPLAIN J 172598 01-05, 187807 04-03 
DE GREGORIO M 168809 01-11 
DE GUZMAN T 191413 04-03 
DE JONG W 188393 04-03 
DE KOROSY F 167448 01-09 
DE L. HORNE DJ 184976 03-14 
DE LA CRUZ A 175245 02-13 
DELEENHEERAP 183599 03-02 
DE MARCHI F 178756 02-04 
DE MELLO DN 188120 04-13 
DESILVAJAF 169817 01-13 
DE SILVA KL 167572 01-15 
DE SOUZA NJ 185978 03-01 
DE WIED D 177836 02-04, 187697 04-04, 188166 

04-04, 188393 04-03 
DEARDORFF CM 185330 03-14 
DEBEROT R 183197 03-11 
DEBUS G 180065 02-14 
DECKERT FW 185866 03-03 
DEEM MA 176238 02-15 
DEFELICE EA 167335 01-11 
DEFEO JJ 182721 03-03 
DEFEUDIS FV 168418 01-03 
DEGIOVANNI A 184961 03-17 
DEGUCHI T 176447 02-08, 177128 02-03 
DEISENHAMMER E 180672 02-1 1 
DEJACO R 180063 02-15 
DEL CARPIO W. J 190670 04-11 
DELAUNAY J 184965 03-07 
DELBARRE B 186576 03-04 
DELERM B 189215 04-04 
DELGADO JMR 183863 03-04 
DELINI-STULA A 192420 04-13 
DELLE M 184243 03-03 
DELNEKY P 182157 02-03 
DELUCA DC 187868 04-04, 190696 04-04 
DEMARSJP 192083 04-10 
DEMBERT ML 181813 02-03 
DEMBIEC D 182150 02-03 
DEMENT WC 171496 01-11 
DEMISCH L 181944 02-03 
DEMISSIANOS HV 176108 02-13 
DEMMELER R 185902 03-03 
OEMPSEY GM 185873 03-09 
DENEAU GA 191939 04-04 



Psychopharmocology Abstracts 



DENIKER P 169945 01-17, 180725 02-07, 184962 

03-09 
DENNIS SG 187701 04-04 
DEQUATTRO V 188198 04-03 
DER-KARABETIAN A 186164 03-04 
DERDA D 188426 04-03 
DERKACH P 177785 02-04 
DEROGATIS LR 169089 01-10, 171925 01-10 
DEROSA ER 171507 01-08 
DESAI PD 185978 03-01 
DESI I 188874 04-05 
DEUTSCH R 174877 01-03 
DEVRED D 1 82902 03-09 
DEWARAJ 181942 02-03 
OEWAR JH 188348 04-09 

DEWEY WL 174607 01-04, 182217 03-04, 191960 
04-03, 191963 04-03, 191968 04-03, 191970 
04-03, 191971 04-03 
DEWS P 181399 02-04 
DEWSBURY DA 168718 01-04 
DHASMANA KM 178557 02-03 
DHAWAN BN 176881 02-03 
DIROSAAE 171794 01-13 
Dl TRAPANI G 182790 0311 
Dl VITTORIO P 168748 01-03 
DIAMANT EY 177835 02-03 
DIBONA GF 184243 03-03 
DICK DAT 187644 04-15 
DICK EG 187644 04-15 
DICK P 169468 01-09, 180700 02-15 
DIEZ-EWALD M 185993 03-03 
DIGENIS GA 190715 04-01 
DIGIACOMO J 169491 01-09 
DIGIACOMO JN 176675 02-14 
DIGREGORIO GJ 191962 04-03 
DIMASCIO A 169087 01-09, 171924 01-10, 

173006 01-09, 174041 01-14, 185898 03-17 
DIMITRIJEVIC M 186640 03-03 
DINGELL JV 192003 04-03 
DINGERDISSEN JJ 192879 04-01 
DINOFF M 183635 03-17 
DINOVO EC 182722 03-13 
DIONISIOA 168809 01-11 
DITMAN KS 177373 02-11 
DITTRICH A 174043 01-14 
DLABAC A 192430 04-04 
DOBOS C 170744 01-11 
DOENICKEA 184618 03-14 
DOGGETT NS 178640 02-03 
DOHADWALLAAN 185978 03-01 
DOHERTYJD 191315 04-03 
DOHI T 188199 04-03 
DOIGMT 171792 01-05,178113 02-09 
DOLFINI M 191422 04-03 
DOM R 192431 04-08 
DOMINO EF 182227 03-03, 186703 03-04, 191935 

04-04 
DONALD JM 185193 03-11 
DONLON PT 177748 02-08, 187869 04-08, 189095 

04-08 
DONNELLY C 191502 04-13 
DORE F 187799 04-03 
DORLEAK 188873 04-03 
DORNBUSH R 169068 01-13 
DORRISRL 181809 02-03 
DOSHI SU 175460 02-08 
DOTEUCHI M 182344 03-03 
DOUMAS BT 190194 04-11 
DOUST JWL 174134 01-08 
DOUVAN I 189178 04-02 
DOWNES K 189855 04-03 
DOWNING RW 171299 01-14, 172993 01-10, 
177376 02-10, 181273 02-10, 189919 04-10 
DOWNS DA 191972 04-04 
DOWSON JH 167359 01-03, 172924 01-03 
DRAFFAN GH 183793 03-13 
DRAGOVICH JA 182133 02-04 
DRAKONTIDES AB 186395 03-14 
DRAWBAUGH RB 180021 02-04, 187699 04-04 
DREESMANN H 171299 01-14 
DREW RT 189600 04-05 
DREW WG 171306 01-04 
DRISCOLL P 190333 04-04 
DUBASTC 183363 03-03 
DUBINSKY B 170162 01-04, 182188 02-04, 

192016 04-04 
DUDDERIDGE HJ 186573 03-04 
DUDLEY AW 186476 03-05 
DUDZINSKI DS 189031 04-03 



DUFFICY RG 169746 01-11 

DUFOUR H 167675 01-09 

DUFRASNE M 178946 02-11,183544 03-17 

DUGGAN AW 188201 04-03 

DUMMER GE 182162 02-03 

DUNLEAVY DLF 183547 03-09 

DUNN WJ 174606 01-12 

DUNNER DL 174093 01-09, 187933 04-13 

DUPEYRON JP 169469 01-04 

DYBING E 179989 02-13 

DYER DC 172915 01-03,182716 03-03 

DYKSTRA LA 185752 03-04 



EADES CG 176312 02-03, 186665 03-03, 191904 

04-03 
EARL J 169462 01-14 
EBARAT 180301 02-11 
EBE M 191613 04-03 
EBERTS FS 191900 04-02 
EBSTEIN R 191932 04-03 
EBSTEIN RP 191510 04-13 
ECKERT H 192425 04-03 
ECKMAN WW 170112 01-06 
ECKMANN F 180070 02-15 
EDEN PL 191943 04-14 
EDMONDS HL 186632 03-03 
EDWARDS C 18829104-03 
EGOROVA NL 183517 03-04 
EHLERS W 192428 04-13, 192429 04-14 
EHRENSING RH 171501 01-09, 189076 04-09 
EHRNEBO M 191444 04-13 
EICHELMAN BS 182441 03-03 
EIDUSON S 191498 04-01 
EILERSMK 189924 04-17 
EISENRINGJJ 169468 01-09 
EISSENBERG EM 173133 01-03 
EKIERT H 174777 01-10 
EKWALLT 17160101-03 
EL-YOUSEFMK 172272 01-11, 177450 02-14, 
188542 04-14, 191508 04-08, 191959 04-15 
ELEFTHERIOU BE 185751 03-03 
ELEK SD 178549 02-11 
ELIASSON M 171617 01-04, 188611 04-04 
ELISEO M 168975 01-13, 168976 01-14 
ELLAMAAAN 191790 04-07 
ELLEN P 167954 01-08 
ELLINWOOD EH 182248 03-03, 1871 16 03-13, 

191505 04-04 
ELLIOTT HW 183899 03-03, 185881 03-14 
ELLIS KO 186638 03-04 
ELLIS MJ 181853 02-14 
ELLISON GD 185753 03-04 
ELONEN E 171629 01-03 
EMMERICH DS 167817 01-08 
ENCINOZAO 189173 04-15 
ENDO T 182106 02-17 
ENGELJ 171611 01-04, 171614 01-04, 185899 

03-03 
ENGELBRECHT J 189395 04-03 
ENGELHARDT DM 1 77754 02-08, 1 77782 02-1 7, 

184174 03-11 
ENGISCH R 169298 01-11 
ENGLEHARDT DM 183275 03-08 
ENGLERT LF 183787 03-03, 187578 04-03 
ENSORCR 18658103-04 
EPLOV L 171627 01-03 
EPPS LD 169070 01-13 
ERANKO L 189027 04-03 
ERANKO 189027 04-03 
ERDMANN E 189567 04-03 
ERENBERG G 190138 04-11 
ERICKSON CK 186375 03-03 
ERIKSSON H 171614 01-04 
ERTELRJ 183795 03-03 
ERVIN G 191955 04-03, 191984 04-03 
ERVIN GN 182136 02-04, 191905 04-03 
ERWINVG 175232 02-03 
ESCHENHOF E 179022 02-13 
ESCOBAR Jl 192065 04-13 
ESCUETAAV 188738 04-05, 189032 04-03 
ESSIEN EE 190902 04-06 
ESTEVEZ VS 187578 04-03 
ESTRADA HR 182890 03-11 
ETEVENON P 167449 01-03 
ETIENNE T 182432 03-10 
ETSURAKU M 176474 02-10 
EUBANKSJD 192013 04-05 



A-4 



VOLUME 12, AUTHOR INDEX 



Author Index 



EUN CS 178109 0217 
EVANS Jl 183490 03-13 
EVANS MA 191990 04-14 
EVENSON RC 176676 02-17 
EVERDS JP 183629 03-08 
EVERITT BS 186584 03-10 
EYMARD P 180722 02-07 



FABER J 192419 04-11 

FAHN S 188560 04-11 

FAHNDRICH C 180056 02-05, 185931 03-03 

FAINGOLD CL 182121 02-03, 191927 04-03 

FALK JL 191768 04-03 

FALK MA 167345 01-10 

FANN WE 184654 03-13, 189403 04-11, 190314 

04-13, 190380 04-11, 191533 04-11, 191978 

04-10, 192227 04-10 
FARAGALLA FF 182171 02-03 
FARBER MG 191993 04-05 
FARKAS I 188874 04-05 
FARNEBO L 182347 03-03 
FAURBYEA 172735 01-07 
FAVAZZAAR 192068 04-11 
FAYEZ MBE 192875 04-12 
FECHTER LD 173136 01-04 
FEDER HH 186686 03-04 
FEDYNSKYJ NM 189589 04-03 
FEINBERG I 189884 04-14 
FEIST HW 184618 03-14 
FEJER D 167585 01-17 
FELOMAN HS 185747 03-09 
FELDMAN RS 185934 03-04 
FELDMAN SM 182185 02-03 
FELIX AM 180097 02-03 
FELLENIUS E 171631 01-03 
FENNESSY MR 186584 03-10 
FENSTERMACHER JD 170112 01-06 
FERGUSON GG 167287 01-03 
FERGUSON MM 172397 01-16 
FERNANDES M 189573 04-04 
FERNANDEZ J 18181 1 02-13, 185083 03-12 
FERNGREN HG 182595 03-11 
FERRARO DP 171886 01-04, 186567 03-04, 

186645 03-04, 189405 04-04, 191375 04-04 
FERRO FM 182791 03-09 
FEURST SI 167339 01-10 
FIBIGER HC 175241 02-03 
FIEVE RR 169494 01-09, 169495 01-09, 174093 

01-09, 182443 03-09 
FIGLER MH 177722 02-04 
FILCZEWSKI M 169471 01-03 
FILE SE 171308 01-04, 189514 04-04, 191211 

04-04 
FINK BR 191324 04-03 
FINK M 169068 01-13 
FINK RD 187866 04-11 
FINN G 176673 02-08 
FINNERTY RJ 185874 03-10, 192066 04-10 
FIRTH H 189043 04-14 
FISCH ML 174071 01-11 
FISCHER E 192521 04-09 
FISCHER I 181811 02-13 
FISCHER JF 186706 03-03 
FISCHER R 189744 04-12, 191936 04-03, 191938 

04-03 
FISCHER-PERROUDON C 187237 03-14 
FISHER AE 182212 03-03 
FISHER BA 191943 04-14 
FJALLAND B 186368 03-04, 186369 03-04, 

186370 03-04 
FLANARY HG 186665 03-03 
FLEISCHMAN RW 188872 04-05 
FLEISHMAN RW 191965 04-03 
FLEISS JL 192084 04-15 
FLEMENBAUM A 167342 01-08, 186745 03-13, 

189775 04-09 
FLENTGE F 171600 01-03 
FLYNN K 190147 04-13 
FONLUPT V 182900 03-11 
FONTANA AE 180139 02-12, 180140 02-12, 

180142 02-12, 180143 02-12, 180144 02-12 
FOPPEN FH 177338 02-03 
FORBIS OL 169457 01-14 
FORCIONE M 185979 03-01 
FORD R8 181158 02-09 
FORD RD 182193 02-04 
FORIST AA 187577 04-01 



FORNEY RB 191989 04-14, 191990 04-14, 191991 

04-04 
FORREST AD 182766 03-10 
FORREST IS 173875 01-03, 175751 02-03 
FORREST JN 169486 01-15 
FORREST WH 177320 02-11 
FOSHEE DP 167954 01-08 
FOSTER FG 171503 01-09 
FOUTS JR 189600 04-05 
FOWLER GW 188424 04-03 
FOX S 173516 01-14 
FRACCHIA J 185877 03-08, 187840 04-17 
FRAIPONT J 178946 02-11 
FRANCK KF 171608 01-04 
FRANCOS 182126 02-03 
FRANCOS E 183196 03-08 
FRANK IM 169070 01-13 
FRANKLIN KBJ 189025 04-04 
FRANKLIN LM 186473 03-15 
FRANTZ AG 191506 04-13 
FRANZ DN 191937 04-03 
ERASER HF 187254 03-15 
FR ATTA W 1 68748 1 -03, 1 885 1 9 04-03 
FRAZER A 174994 02-14 
FREED ME 187940 04-01 
FREEDMAN AM 182741 03-14, 184630 03-17, 

1 89059 04-07 
FREEDMAN DX 174034 01-04, 182167 02-03, 

183891 03-03, 188120 04-13 
FREEDMAN LS 191510 04-13 
FREEDMAN R 187496 04-03 
FREEMAN JJ 174963 01-03 
FREEMESSER GF 190196 04-09 
FREEMON FR 172615 01-11, 187929 04-14 
FREIBERGS V 176963 02-04 
FREIDMAN E 191998 04-03 
FREY H 170073 01-03, 171610 01-03, 172923 

01-03, 181469 02-03 
ERIC 186566 03-16 
FRIED I 171631 01-03 
FRIEDHOFF AJ 184630 03-17 
FRIEDL H 180063 02-15 
FRIEDLER G 191902 04-04 
FRIEDMAN AS 169088 01-09 
FRIEDMAN E 182254 03-03 
FRIEDMAN MA 191963 04-03 
FRIESEN HG 184436 03-15, 184437 03-13, 188428 

04-13, 189076 04-09 
FRIGERIO A 169073 01-01 
FRISTROM S 171613 01-03 
FROHMAN CE 191536 04-13 
FROMENT J 189023 04-02 
FROMMER EA 182428 03-10 
FROST JB 168314 01-11 
FROST M 175725 02-08 
FUCHIMOTO H 177019 02-04, 177020 02-04 
FUENTES JA 191500 04-03 
FUJIMORI K 182093 02-03 
FUJIMOTO A 176564 02-11 
FUJITA S 177569 02-11 
FUJITANI Y 182549 03-03 
FUJIWARA M 182114 02-04 
FUKUDA N 181658 02-02 
FUKUDAT 18984304-03 
FUKUMOTOM 174853 01-16, 181588 02-13, 

181593 02-03 
FULLER RW 183869 03-03, 187831 04-03, 190346 

04-03 
FUNDERBURK WH 182124 02-03, 182125 02-03 
FURUKAWA T 178725 02-03, 182109 02-04 
FUXE K 171605 01-03, 189026 04-03, 189611 

04-03, 191932 04-03 
FYRO B 186565 03-08 



GAB AY S 1 743 1 8 1 -03, 1 9 1 300 04-03 

GABELLA G 191326 04-03 

GAEBELEIN C 167398 01-04 

GAFFNEY D 177318 02-14 

GAFFNEY S 177318 02-14 

GAFFNEY T 177395 02-15 

GAGNON M 183359 03-03 

GAGNON MA 183361 03-09 

GAIARDI M 178756 02-04 

GAINER H 168485 01-03 

GAJWANI AK 180406 02-09 

GALANTER M 173516 01-14, 175003 02-14 

GALE K 192018 04-04 



GALLAGER DAW 172015 01-03 

GALLAGER DW 182140 02-03, 191949 04-03 

GALLANT DM 172749 01-03, 174137 01-08, 

189072 04-08 
GALVAN L 168806 01-11, 191138 04-14, 191139 

04-17 
GAMAIKE N 178053 02-08 
GARATTINI S 179983 02-17, 185995 03-03, 

191422 04-03, 191423 04-03 
GARD H 177395 02-15 
GARDEY-LEVASSORT C 185996 03-03 
GARDJITO SO 176582 02-11 
GARDOSG 176673 02-08 
GARELIS E 176254 02-13 
GARNETT JE 191367 04-04 
GARRETT ER 169673 01-16, 188256 04-01 
GARSKE G 182242 03-04 
GASCO P 182789 03-10 
GASPARI NO AM 1 80 1 44 02- 1 2 
GATTONI RC 167403 01-04 
GAUGER D 182242 03-04 
GAURON EF 192116 04-04 
GAUT ZN 191770 04-13 
GAUTHIERG 188093 04-11 
GAUTHIER P 187807 04-03 
GAUTHIER R 183359 03-03 
GAUTIER J 178187 02-08, 178193 02-11, 188406 

04-03, 191142 04-15 
GAY PE 1 73727 1 -04, 1 84839 03-03 
GAYVL 173257 01-03 
GAZTANAGA P 170627 01-09 
GEHA DG 187837 04-15 
GEIGER PF 167287 01-03 
GELDER MG 183807 03-10, 184436 03-15 
GELLER I 176861 02-04, 176873 02-04 
GENT M 168318 01-09 
GERALD MC 182232 03-03, 187937 04-01 
GERBER CJ 189403 04-11,190314 04-13 
GERBER HR 191920 04-03 
GERBER N 177732 02-03 
GERHARDS HJ 191766 04-03 
GERLACH J 185929 03-11, 190310 04-03 
GERSHON S 168836 01-08, 172485 01-10, 174138 

01-09, 177710 02-15, 177826 02-13, 181957 

02-10, 182254 03-03, 185875 03-11, 186744 

03-14, 186920 03-09, 191507 04-13, 191531 

04-09, 191977 04-04, 191998 04-03 
GERVASI A 184291 03-14 
GESSA GL 168748 01-03,188519 04-03 
GESSNER PK 183897 03-03, 192006 04-03 
GEYER MA 186674 03-03 
GHATE VR 169152 01-11 
GHEZZI D 188196 04-03 
GHOSH JJ 189582 04-05 
GIACHETTI A 182234 03-03 
GIANTURCO D 192229 04-09 
GIANUTSOS G 180021 02-04 
GIBB JW 184180 03-03, 188231 04-03 
GIBBONS JL 182190 02-04 
GIBBS JT 188107 04-09 
GIBSON TP 184243 03-03 
GILBERT MM 169632 01-10 
GILBERT PE 176312 02-03 
GILL EW 172596 01-03, 177333 02-03, 181941 

02-03 
GILLIN JC 173398 01-03, 176480 02-12, 178432 

02-09, 187642 04-14 
GILLIS CN 177332 02-03,182717 03-03 
GILLIS RA 187923 04-03 
OILMAN S 187362 04-03 
GINESTET D 169945 01-17, 180725 02-07, 184962 

03-09 
GINTZLERAR 186698 03-03 
GITTELMAN-KLEIN R 189512 04-15 
GIURGEA C 173495 01-02 
GLASS D 183490 03-13 
GLASSMAN AH 169869 01-15, 172271 01-13, 

192872 04-10 
GLATZEL J 180675 02-08 
GLAUBIGER GA 186029 03-11 
GLENNE PO 171630 01-16 
GLESER GC 181072 02-10 
CLICK SD 177409 02-04, 182208 02-04, 186620 

03-04, 187261 04-04, 192000 04-03 
GLOBUS G 177318 02-14 
GLOOR P 188374 04-03 
GLOW PH 168837 01-04, 181605 02-04 
GLOWINSKI J 183794 03-03, 184230 03-03, 

188164 04-03, 188976 04-03, 188978 04-03 



A-5 



Author Index 

GLUCK JP 186567 03-04, 186645 03-04, 191375 

04-04 
GLUCKMAN Ml 182215 0304 
GODSE DD 182725 03-03 
GOENECHEAS 172397 01-16 
GOETZ P 175043 02-04 
GOGERTYJH 191943 04-14 
GOGOL Z 174777 01-10 
GOGOLAKG 178947 02-03 
GOLD Bl 167326 01-03 
GOLDS 183602 03-01 

GOLDBERG AM 184953 03-04, 191954 04-05 
GOLDBERG DM 191926 04-04 
GOLDBERG H 185898 03-17 
GOLDBERG HL 185874 03-10, 192066 04-10 
GOLDBERG IK 188149 04-17 
GOLDBERG JB 176109 02-14 
GOLDBERG ME 170162 01-04, 171304 01-04, 

182188 02-04 
GOLDBERG SC 184977 03-08 
GOLDBERG SR 191916 04-04, 191926 04-04 
GOLDIN A 179983 02-17 
GOLDMAN H 191936 04-03 
GOLDMAN L 185033 03-04 
GOLDSTEIN A 18216102-03 
GOLDSTEIN BJ 190195 04-09 
GOLDSTEIN L 176864 02-04 
GOLDSTEIN M 182256 03-03, 183891 03-03, 

191510 04-13, 191932 04-03 
GOLLUB LR 181400 02-04, 186376 03-06, 187066 

03-04 
GOLUB M 184371 03-04 
GOMERFE 185955 03-04 
GOMITA Y 1 81 384 02-04, 1 821 1 5 02-04 
GONCZI L 188874 04-05 
GONZALEZ FA 191916 04-04 
GOODELL H 175426 02-11 
GOODMAN FR 172925 01-03 
GOODMAN MN 191771 04-03 
GOODWIN BL 167445 01-03 
GOODWIN OW 182719 03-13 
GOODWIN FK 170079 01-09, 170083 01-03, 
170084 01-09, 170621 01-09, 174094 01-09. 
174329 01-09, 181274 02-09, 181358 02-09, 
183546 03-10, 184160 03-09, 185928 03-09, 
187398 04-13, 187642 04-14 
GOOTMAN PM 182185 02-03 
GORDON PE 167773 01-10 
GORELICK DA 190266 04-04, 191934 04-04 
GORODETZKY CW 187256 03-15 
GORRY T 178502 02-04 
GOTHERT M 188977 04-03 
GOTO A 180986 02-10 
GOTOT 176471 02-11 
GOTTFRIES C 192527 04-11 
GOTTLIEB JS 191536 04-13 
GOTTSCHALK LA 177671 02-11, 181072 02-10, 

182722 03-13, 185881 03-14 
GOUDIE AJ 187925 04-04, 187926 04-04, 190335 

04-04 
GOWARDMAN M 178255 02-08 
GRABOWSKI SW 169634 01-11 
GRAEFF EG 186692 03-04 
GRAF CL 190275 04-04 
GRAHAM DT 186375 03-03 
GRAHAM J 19196104-13 
GRAHAM JM 184235 03-03 
GRAHAM LT 167358 01-03 
GRAM LF 182434 03-09, 183604 03-13, 191026 

04-09 
GRANCHELLI FE 174967 02-01 
GRANT LD 186634 03-04, 187696 04-04 
GRATTAROLA FR 167594 01-10 
GRAVES J 1 78432 02-09 
GRAY D 190265 04-04 
GRAY JA 1 68834 01 -04, 1 86573 03-04 
GREEN DE 17575102-03 
GREEN DO 190242 04-07 
GREEN JR 192391 04-07 
GREEN R 1 78578 02-08, 1 881 1 5 04-08 
GREEN RS 181270 02-14 
GREEN TK 189398 04-03 
GREENBERG D 188114 04-15, 191290 04-08 
GREENBERG I 168230 01-04 
GREENBERG L 191400 04-14 
GREENBERG LM 176238 02-15 
GREENBERG S 189394 04-03, 189395 04-03 
GREENBLATT DJ 192190 04-14 
GREENE C 187812 04-13 



GREENGARD P 191896 04-03 

GREENLAND RD 191957 04-05 

GREENSTEIN S 186620 03-04 

GREENWOOD L 170079 01-09 

GREENWOOD MH 184082 03-14 

GREGER J 174101 01-08 

GRETCHIN VB 178787 02-13 

GREVEN J 184222 03-03 

GREWAL RS 187931 04-03 

GRIFFITH JD 17124101-14 

GRIFFITH RK 187937 04-01 

GRIFFITHS PJ 185992 03-03 

GRIGORJ 181192 02-08 

GRILLY DM 171886 01-04, 189405 04-04 

GROBLEWSKI GE 182239 03-04 

GROFF S 189512 04-15 

GROSS MD 169295 01-11 

GROSSMAN SP 187698 04-04 

GROSSMANN W 172926 01-03, 185901 03-03 

GROSZ HJ 188760 04-04 

GROTH HP 188977 04-03 

GROVE J 183793 03-13 

GROVE RN 191941 04-04 

GROVES PM 185264 03-03 

GRUBB MN 188202 04-03 

GUDELSKY G 192009 04-04 

GUELEN PJR 186184 03-13 

GUERINOT F 190337 04-03 

GUERRA FC 192426 04-03 

GUERRERO-FIGUEROA E 172749 01-03, 177749 

02-03 
GUERRERO-FIGUEROA R 172749 01-03, 174137 

01-08, 177749 02-03 
GUERRINI A 191190 04-14 
GUIBERT S 184965 03-07 

GUIDOTTI A 170086 01-03, 170755 01-03, 170876 
01-03, 173381 01-03, 186675 03-03, 191515 
04-03, 191764 04-03 
GUILLEMIN R 190104 04-13 
GUILLEMINAULT C 171134 01-13, 171496 01-11 
GUILLEMOT J 176963 02-04 
GULATI OD 191933 04-03 
GULDBERG HC 191319 04-03 
GUMULKAW 178757 02-04 
GUPTA ML 17702102-03 
GUPTA TK 17702102-03 
GUTIERROZCO 172916 01-03 
GYLYS JA 191906 04-03 
GYORGY L 185933 03-03 

H 

HAAVIK CO 170163 01-03, 182220 03-03 

HABER B 174319 01-03 

HABER BT 176873 02-04 

HABLITZJJ 177645 02-16 

HACKMAN R 176879 02-04 

HACKMANN E 171307 01-03 

HADFIELD MG 188404 04-03 

HADLEY KW 180670 02-01 

HAEFELY W 179021 02-05, 184197 03-03, 184202 

03-03 
HAEUSLERG 186677 03-03 
HAHN I 181470 02-03 

HAIDER I 176286 02-10, 180146 02-10, 180147 
02-15, 180148 02-15, 180149 02-15, 180152 
02-15 

HAIG JR 190321 04-14 

HAIGLER HJ 177407 02-12, 182141 02-03 

HAILEY DM 17173101-13 

HAIN JD 189074 04-17 

HAKKINEN S 189619 04-14 

HALARISA 188120 04-13 

HALARISAE 182168 02-03 

HALL EH 182763 03-14 

HALLM 172745 01-04 

HALL P 185008 03-11 

HALL R 188348 04-09 

HALMAGYI GM 187618 04-11 

HALMI KA 174132 01-14 

HALPERN B 171122 01-11 

HAM CH 169286 01-10 

HAMADA H 191686 04-08 

HAMILTON LW 167401 01-04 

HAMON M 188164 04-03, 188976 04-03 

HANDS 182574 03-17 

HANABUSAY 178725 02-03 

HANBAUER I 170876 01-03 

HANCOCK JC 191995 04-03 



Psychopharmocology Abstracts 

HANDLEY SL 185750 03-03 

HANE DL 180097 02-03 

HANEDA T 185213 03-08 

HANENSON I 177395 02-15 

HANIN I 180582 02-03, 182226 03-03 

HANLON TE 184653 03-09 

HANO J 167813 0104 

HANSEN CE 187639 04-16, 188832 04-09 

HANSEN S 191331 04-03 

HANSL NR 184581 03-02 

HANSON B 185322 03-10 

HANSOTIA P 172439 01-11 

HARA A 174853 01-16, 181588 02-13, 181593 

02-03, 182555 0303, 182556 03-13 
HARADA K 188450 04-15 
HARBISON RD 189598 04-05 
HARCLERODEJ 181813 02-03 
HARDMAN HF 170163 01-03, 182220 03-03, 

191997 04-03 
HARMS D 183183 03-15 
HARPER MA 172741 01-08 
HARRIS GW 184436 03-15 
HARRIS LS 182153 02-03, 183893 03-04, 186570 
03-03, 187928 04-03, 191960 04-03, 191963 
04-03, 191968 04-03, 191970 04-03, 191971 
04-03 
HARRIS RT 187638 04-04 
HARRISON SD 177334 02-03 
HARTL 180063 02-15 
HARTLEY D 187565 04-11 
HARTMAN ER 189407 04-03 
HARTMAN R 187380 04-03 
HARTMANN E 177716 02-14, 177717 02-14, 

177718 02-14 
HARTMANN EL 181393 02-14 
HARTMANN R 176861 02-04 
HARTMANN RJ 176873 02-04 
HARTMANN W 174101 01-08 
HARTSE KM 191389 04-03 
HARVEY JA 189398 04-03, 191947 04-05 
HARVEY WM 178695 02-17 
HASCHKE RH 191324 04-03 
HASEGAWA N 181771 02-07 
HASH AM 182124 02-03 
HASSELBACH W 184223 03-03 
HATANAKA H 1 78623 02-09 
HATTABJR 167340 01-11 
H ATTORI T 1 76454 02- 1 1 , 1 83228 03-03 
HAUBRICH DR 192001 04-03 
HAVLIK I 170072 01-03 
HAWALDARPP 172439 01-11 
HAWKING F 179983 02-17 
HAYAKAWA J 1 76726 02-08 
HAYES RL 191944 04-04 
HEADLEY PM 188201 04-03 
HEBBARYV 175460 02-08 
HEFFNER TG 187699 04-04 
HEFNER MA 171304 01-04 
HEIBER S 182156 02-03 
HEIKKILA RE 182723 03-03 
HEISE GA 181394 02-14 
HELDMAN J 182178 02-06 
HELLER B 192521 04-09 
HELLING DK 189902 04-15 
HENINGERGR 169486 01-15 
HENOMATSU H 182634 03-02 
HENRIKSSON BG 175884 02-04, 178813 02-04 
HENRY DP 168862 01-05 
HENRY GM 169504 01-09 
HERBACZYNSKA-CEDRO K 172835 01-03 
HERBERG LJ 189025 04-04 
HERMAN ZS 178558 02-03, 186571 03-04, 

190311 04-03 
HERNACKA B 174778 01-09 
HERNDON BL 182187 02-03 
HERNDON JG 185705 03-04 
HERRERO FA 168505 01-15 
HERRING BS 192413 04-03 
HERXHEIMERA 183812 03-15 
HERZ A 169474 01-03 
HESBACHER P 188144 04-10 
HESTER JB 185032 03-01 
HEUBEL F 191607 04-17 
HEYL MG 171792 01-05, 178113 02-09 
HEYMAN lA 189588 04-05, 191966 04-04 
HIBI S 189884 04-14 
HIEP A 181192 02-08 
HIGHMAN B 188865 04-05 
HIGUCHI M 181771 02-07 



A-6 



VOLUME 12, AUTHOR INDEX 



Author Index 



HILDICK-SMITH M 17545902-15 

HILL SY 182719 03-13 

HILLEL J 183361 03-09 

HILTON AM 177392 02-15 

HINOMARCH I 172780 01-03 

HINE 8 191977 04-04 

HINTON J 184438 03-14 

HIRAI T 184314 03-13 

HIRAIWAT 181386 02-04 

HIRATAJ 175069 02-09,181388 02-11 

HIRAYAMA M 1 78224 02-08 

HIRONAKA T 191686 04-08 

HIROSE K 168498 01-05 

HIRSCHHORN ID 191944 04-04 

HIRSH K 183887 03-03 

HITZEMANN RJ 182253 03-04, 186671 03-03, 

189586 04-03 
HO BT 183787 03-03, 187578 04-03, 187932 

04-04, 188167 04-03 
HOG 179985 02-03 
HO IK 182231 03-03, 191898 04-03 
HODGSON JR 182160 02-03 
HODSHON BJ 191921 04-03 
HOEKMAN T 187923 04-03 
HOFFERA 188446 04-11 
HOFFER BJ 187496 04-03, 187498 04-04 
HOFFMAN SP 177754 02-08, 183275 03-08, 

184174 03-11 
HOFFMEISTER F 177719 02-04 
HOFMANN A 189101 04-12 
HOKFELT T 191932 04-03 
HOLCOMB RR 177732 02-03 
HOLDEN EM 169376 01-15, 179996 02-13 
HOLLAND JB 180096 02-03 
HOLLENBECK RA 182234 03-03 
HOLLISTER AS 186699 03-03, 191905 04-03 
HOLLISTER LE 171505 01-08, 174347 01-13, 

175914 02-17, 177720 02-14 
HOLTZMAN SG 168439 01-04, 182859 03-04, 

183892 03-04, 186373 03-04 
HOLZ RW 173380 01-03, 177128 02-03 
HOLZBAUER M 191497 04-03 
HOLZER B 18429103-14 
HOMMA I 191613 04-03 
HONDA 178019 02-15 
HONECKER H 177337 02-03 
HONG SA 171599 01-04 
HONG SY 173078 01-04 
HONIG WMM 174763 01-04 
HONMA K 191685 04-17 
HONTELAS 168805 01-11 
HOOGHE-PETERS EL 167324 01-04 
HOPE A 192425 04-03 
HOPWOOD J 191400 04-14 
HORAKOVA Z 189895 04-03 
HORI N 182092 02-03 
HORIBE M 182108 02-04,192415 04-04 
HORITAA 192018 04-04 
HORN A 190545 04-03 
HORN AS 175233 02-03, 177131 02-03 
HORNBUCKLE PA 176307 02-03 
HORNYKIEWICZ 177785 02-04 
HOULIHAN JP 182524 03-08 
HOUSER FL 171302 01-04 
HOUSER VP 171301 01-02, 171302 01-04, 178720 

02-03, 189381 04-03 
HOWARD JL 187696 04-04 
HOWARD JS 181153 02-08 
HOWARD L 189394 04-03, 189395 04-03 
HOWARD-JONES N 186474 03-17 
HOWES JF 191964 04-03 
HOYT HJ 174348 01-14 
HOZAKI H 185235 03-17 
HRDINA PD 182170 02-03 
HSU LL 180020 02-03 
HSU SY 182232 03-03, 187937 04-01 
HSU W 180064 02-10 
HUANG CC 182143 02-03 
HUANG J 187932 04-04 
HUANG JT 182245 03-03 
HUBER HP 192428 04-13, 192429 04-14 
HUBER JA 190717 04-01 
HUBER W 184177 03-11 
HUDICK JP 182224 03-03 
HUGHES RN 190334 04-04 
HUl FW 182164 02-03 
HUISMAN NG 183194 03-09 
HUMPHRIES J 177318 02-14 
HUNT CA 188256 04-01 



HUNT WA 182348 03-03 
HUNTER KR 168286 01-13 
HUNTER P 188348 04-09 
HURST PM 174210 01-14 
HURWIC MJ 17227101-13 
HUSSAIN MZ 170622 01-09 
HUSTON JP 177477 02-04 
HUSZKA L 174134 01-08 
HVIDBERG EF 188832 04-09 
HYNES MD 180021 02-04 



IDE-JOHANSON L 187700 04-04 

IFFLAND R 178619 02-05 

IGISU H 189843 04-03 

IGUCHI K 180301 02-11 

IIDA N 188517 04-09 

IIDA S 182091 02-03 

IISALO E 184978 03-13 

IIZUKA R 191677 04-17 

IIZUKA Y 168499 01-07 

IKEDA K 181657 02-02 

IKUTA T 174505 01-13 

IKUTOMI H 191593 04-08 

ILIUKHINAVA 178787 02-13 

IMLAH NW 172435 01-08 

INADA H 176468 02-08 

INAMORI J 176472 02-08 

INANAGA K 175550 02-08, 184314 03-13 

INAZU Y 168499 01-07 

INOUE K 176454 02-11 

INOUE T 177336 02-03 

INUI M 175119 02-08 

INUI T 174680 01-08 

INWANG EE 187112 03-03 

lORDANISHVILI GS 183142 03-13 

IRWIN S 190236 04-17, 190237 04-17 

ISENBERG PL 189640 04-17 

ISHIBASHI F 176473 02-10 

ISHIDAM 191723 04-09 

ISHIGANE M 191693 04-17 

ISHIGE K 171246 01-11 

ISHII H 173548 01-05 

ISHII N 170660 01-13 

ISHIKAWA H 174681 01-08 

ISHIKAWA T 176469 02-08 

ISHIYAMA Y 191613 04-03 

ISHIZU H 191670 04-09 

ISOZAKI H 184314 03-13 

ISRAEL Y 192005 04-11 

ISWARIAH V 189673 04-14 

ITIL T 180064 02-10 

ITIL TM 174131 01-08, 181958 02-13, 187115 

03-09 
ITO H 177567 02-09, 184845 03-10 
ITO K 191693 04-17 
ITO M 177837 02-04 
ITO R 181386 02-04, 182634 03-02 
ITO S 1 76542 02- 1 1 , 1 77994 02-08 
ITO Y 1 88934 04-08, 1 9 1 720 04-08 
ITOI K 176471 02-11 
ITSKOVITZ HD 190194 04-11 
IVERSEN L 190545 04-03 
IVERSEN LL 180060 02-03, 189616 04-03 
IVERSEN SD 187420 04-04, 188620 04-04 
IWAJIMA Y 1 76467 02-08 
IWAMOTO N 188517 04-09 
IWAMOTO T 182093 02-03 
IWASAWA K 176467 02-08 
IWASAWA Y 182717 03-03 
IWATA H 182113 02-03 
IWATA N 174603 01-03 
IYER DS 180249 02-10 
IZQUIERDO I 167403 01-04, 168749 01-03, 

186575 03-03, 189608 04-03, 189609 04-03 
IZQUIERDO JA 169467 01-03 
IZUMI K 189843 04-03 



JACK ML 169817 01-13,170838 01-13 

JACKSON B 186636 03-04 

JACKSON DM 180057 02-03, 189513 04-03 

JACKSON FB 172021 01-03 

JACOB JJ 189517 04-05 

JACOBOWITZ DM 182211 03-04, 187380 04-03 

JACOBS LS 175245 02-13 

JACOBSON AF 190195 04-09 



JACOBSON G 191035 04-15 

JACOBY JH 180022 02-03 

JACQUES D 183030 03-11 

JAFFE J 168420 01-12, 177674 02-14, 192084 

04-15 
JAGGER J 188164 04-03 
JAIN PC 176881 02-03 
JAIN RC 168319 01-15 
JAKUBCZAK LF 185955 03-04 
JAKUBOVIC A 183228 03-03, 189590 04-03 
JALANBO H 188200 04-03 
JALFRE M 179021 02-05 
JAMES B 168901 01-14, 169745 01-14 
JAMES NM 168901 01-14, 169745 01-14 
JAMROZIK Z 178558 02-03 
JANDHYALA ML 182243 03-03 
JANIEC W 190311 04-03 
JANKE W 180065 02-14, 184617 03-07 
JANNETTA PJ 188689 04-05 
JANOWSKI DS 191508 04-08 
JANOWSKY D 191530 04-09, 191531 04-09 
JANOWSKY DS 172272 01-11, 177450 02-14, 

184654 03-13, 188542 04-14, 189650 04-09 
JAQUETTE DL 188202 04-03 
JARBE TUC 175884 02-04, 178813 02-04 
JARBOE CH 180096 02-03 
JARVIK LF 181395 02-15, 192084 04-15 
JARVIK ME 181401 02-04 
JASINSKI DR 171241 01-14, 174473 01-13, 

174479 01-14, 182163 02-03 
JATLOW PI 1 77393 02- 1 5, 1 77394 02- 1 5 
JAUCH TE 169462 01-14 
JAVOY F 183794 03-03 
JEFFERSON JW 176674 02-15 
JEND H- 184199 03-03 
JERUSSI TP 177409 02-04 
JESTE DV 174588 01-08 
JEWETT RE 168439 01-04 
JHA BK 171985 01-08, 174851 01-09, 180154 

02-08 
JITSUICHI S 191670 04-09 
JOBE PC 167287 01-03 
JOHANSSON G 180044 02-04 
JOHNSON DAW 173866 01-15, 192513 04-15 
JOHNSON DN 182124 02-03, 182125 02-03 
JOHNSON F 167575 01-10 
JOHNSON G 189793 04-09 
JOHNSON JC 182228 03-03 
JOHNSON RD 167445 01-03 
JONES B 191992 04-03 
JONES BC 187640 04-04 
JONES G 181941 02-03 
JONSSON G 171605 01-03, 189026 04-03 
JONSSON J 171634 01-03, 191921 04-03 
JONSSON M 171632 01-03 
JORI A 188196 04-03, 191422 04-03 
JOSHI PC 169818 01-01, 185980 03-01 
JOST F 187958 04-11 
JOUBERT PH 189606 04-15 
JOUVET M 187237 03-14, 189023 04-02 
JOY RM 181818 02-03, 186632 03-03 
JUGE 188093 04-11 
JULIEN RM 188424 04-03 
JUORIO AV 191326 04-03 
JURNA I 172926 01-03, 185901 03-03 
JUS A 167587 01-15, 178187 02-08, 178193 

02-11, 183693 03-17, 188406 04-03, 191142 

04-15 
JUS K 167587 01-15, 178187 02-08, 178193 

02-11, 183693 03-17, 188406 04-03 



KADZIELAWA K 187075 03-03 

KAHLING J 187805 04-01 

KAHN J 190266 04-04 

KAISER DG 187577 04-01 

KAJFEZ F 187942 04-01 

KAJIYAMA S 180986 02-10 

KALANT H 179985 02-03, 192020 04-03 

KALES A 172114 01-15 

KALES JD 172114 01-15 

KAMANO DK 175877 02-04 

KAMBAROVA DK 178787 02-13 

KAMIOKA T 168499 01-07, 180490 02-02 

KAMIZAKI Y 178623 02-09 

KANEKO T 180102 02-17 

KANEKO Z 175119 02-08 

KANETO H 182103 02-04 



E jl 

II'"!, 11 



A-7 



Author Index 



Psychophormacology Abstracts 






KANTO J 171633 01-03, 184978 03-13 
KAPADIA GJ 170839 01-06, 192875 04-12 
KAPELSKI Z 174778 01-09 
KAPLAN J 173521 01-14, 173522 01-12, 176480 

02-12, 178578 02-08, 188115 04-08 
KAPLAN SA 169817 01-13, 170838 01-13 
KARASUMOTO K 176542 02-11 
KARBOWSKI MJ 182158 02-03 
KARIYA T 178224 02-08 
KARIYAMA N 176454 02-11 
KARLER R 174608 01-05, 175238 02-03, 191994 

04-03 
KARNIK NR 175967 02-10 
KARNIOL IG 169472 01-03 
KARON BP 173534 01-08, 178677 02-17 
KAROUM F 179986 02-03, 192335 04-03 
KARPOWICZ JK 170162 01-04, 192016 04-04 
KARRGW 187812 04-13 
KARU LE 191787 04-02 
KASHIMOTO T 191510 04-13 
KASSIR S 169869 01-15 
KASTIN AJ 171501 01-09, 189076 04-09 
KATIRA MN 180249 02-10 
KATO G 182624 03-11 
KATO I 170638 01-13 
KATO M 178021 02-08 
KATO T 192084 04-15 
KATSUDA N 182092 02-03 
KATZ J 192565 04-04 
KAUCHTSCHISCHWILI GM 167336 01-13 
KAUFMANN JS 184654 03-13 
KAWAHARA R 182550 03-11 
KAWAKAMI K 181771 02-07 
KAWAKAMI T 180102 02-17 
KAWAKITAY 177567 02-09 
KAWAMU RA Y 1 892 1 9 04-03 
KAWANO K 181653 02-06 
KAWANO M 182731 03-10 
KAWANO Y 180490 02-02 
KAWATHEKAR P 169633 01-1 1 
KAY DC 174496 01-12 

KAY NE 192510 04-09 

KAYMAKCALAN S 186585 03-03 

KAZAMA K 178725 02-03 

KAZDOVA E 192430 04-04 

KEATING J 192426 04-03 

KEDZIOR J 174783 01-11 

KEEGAN DL 191192 04-11 

KEHNE CW 176810 02-11 

KEHRW 191513 04-03 

KEIPER CG 190743 04-14 

KELFER DA 186568 03-04 

KELLEY DL 190260 04-04 

KELLNER R 168316 01-10,185210 03-10 

KELLOGG C 187551 04-04 

KELLY D 168832 01-10 

KELLY KA 187129 03-04 

KELLY MG 192589 04-11 

KENNEDY J 191331 04-03 

KENNEDY MJ 177749 02-03 

KENNEY J 189178 04-02 

KEPNER LA 171521 01-04 

KERMANI E 172485 01-10 

KERPEL-FRONIUS S 180591 02-04 

KERTESZ D 167448 01-09 

KETTER KA 184243 03-03 

KETTLER R 186677 03-03 

KHACHATURIAN ZS 191946 04-03 

KHANNAJM 179985 02-03 

KHO TK 180298 02-17 

KHORANAAB 167346 01-10, 186553 03-11 

KHORRAMZADEH E 175282 02-07 

KHOUW V 192005 04-11 

KIDO A 181588 02-13, 181593 02-03, 182555 
03-03, 182556 03-13 

KIDO M 175072 02-17 

KIEV A 178544 02-10 

KILBEY MM 172745 01-04 

KILIAN M 170073 01-03, 181469 02-03 

KILLAM KF 181396 02-04 

KILOH LG 169140 01-15 

KIM ST 171159 01-17 

KIMBALL AP 188167 04-03 

KIMBELL I 171505 01-08 

KIMISHIMA K 181650 02-03, 182549 03-03, 
189209 04-05 

KIMURA H 182154 02-03 

KIMURA K 182094 02-03, 191593 04-08 

KIMURA M 182620 03-09 



KIMURA Y 176448 02-10, 182094 02-03 

KINEMUCHI H 175239 02-03 

KING AR 187697 04-04 

KING LJ 177135 02-03 

KINGSTONE E 184259 03-15 

KINOKUNI Y 178019 02-15 

KIRALY I 192416 04-03 

KIRK L 172735 01-07, 191026 04-09 

KIRKBY RJ 186702 03-04 

KIROV K 186081 03-08 

KIRSHNER N 191512 04-13 

KIRVEN LE 170129 01-11 

KISARA K 182112 02-04 

KIVITY-EPHRAIM S 189174 04-11 

KJELLBERG B 180061 02-04 

KLAIBER EL 187149 03-13 

KLEIN DF 169492 01-15, 189512 04-15 

KLEIN M 168838 01-04 

KLEINROK Z 177721 02-04 

KLERMAN G 169087 01-09 

KLERMAN GL 169748 01-17, 171924 01-10, 

185322 03-10 
KLETT CJ 171926 01-09, 172831 01-08, 186188 

03-09, 189735 04-09 
KLINE NS 167344 01-09, 180297 02-09 
KLINGMAN JD 187677 04-03 
KLINGNER A 167774 01-09, 168807 01-11, 

183360 03-13, 191138 04-14 
KLOTTER J 187839 04-09 
KLUGE H 174101 01-08 
KLUWE S 189573 04-04 
KMIECIAK-KOLADA K 18657103-04 
KNAPP D 177395 02-15 
KNAPP S 175149 02-13, 186674 03-03, 191516 

04-03 
KNEFFEL Z 188874 04-05 
KNOBEL M 168808 01-11 
KNOBLOCH LC 188876 04-05 

KNOTT DH 187866 04-11 
KOBAYASHI I 177569 02-11 

KOBAYASHI K 176564 02-11 

KOBAYASHI M 182105 02-03, 182108 02-04 

KOBAYASHI S 168499 01-07 

KOBAYASHI Y 187149 03-13 

KOBYASHI T 170638 01-13 

KOCH-WESERJ 179987 02-13 

KOCHANSKY GE 169086 01-14 

KOCHAR MS 19019404-11 

KODAMA H 191670 04-09 

KOEPKE HH 169632 01-10 

KOERKER RL 190907 04-03 

KOGANTY RR 190715 04-01 

KOHL H 185978 03-01 

KOHLI RP 186569 03-03 

KOIZUMIS 181377 02-15 

KOJIMA S 188199 04-03 

KOJO J 181653 02-06 

KOKETSU K 182637 03-02 

KOLAKOWSKA T 184437 03-13 

KOLIS SJ 170837 01-03 

KOMISKEY H 186633 03-03 

KONDO H 167919 01-09 

KONERMANN G 185900 03-03 

KONUMA M 182755 03-15 

KOPELL BS 177720 02-14, 185932 03-13 

KOPIN I 191495 04-03 

KOPIN IJ 168862 01-05, 178747 02-03, 179983 
02-17, 181810 02-03, 187397 04-03, 187488 
04-17 

KOPPANYI T 169688 01-05 

KORCZAK-DZIUBA K 19031104-03 

KORDUBA CA 175240 02-03 

KORF J 184652 03-09 

KORN M 172976 01-09 

KORNBLIT G 180123 02-12 

KORNBLIT GA 180142 02-12 

KORNETSKY C 181402 02-04, 184371 03-04, 
190330 04-04, 191975 04-04 

KOROLENKO TA 191121 04-03 

KOSERSKY DS 182221 03-03, 183893 03-04 

KOSHINOY 191625 04-13,191667 04-13 

KOSLOW SH 170747 01-03 

KOSTOWSKI W 1 701 26 01-04, 1 78757 02-04 

KOTIN J 170621 01-09, 183546 03-10, 184160 
03-09, 185928 03-09 

KOTORII M 167921 01-14 

KOTWANI PN 175393 02-11 

KOUROUNAKIS P 183611 03-03 

KOVAC T 187942 04-01 



KOWA Y 182107 02-04 

KOYUNCUOGLU H 187645 04-03 

KOZATO Y 181654 02-04 

KRAGH-SORENSEN P 188832 04-09 

KRAKOWSKI AJ 169298 01-11 

KRAMER JC 172109 01-17 

KRAMER M 16734101-08,177747 02-07 

KRAUSS JA 171007 01-13 

KRAYNACK B 182155 02-03 

KREBS H 168817 01-03, 182123 02-03 

KRENDAL FP 183682 03-03 

KREUTER C 185715 03-14 

KREUZ DS 177403 02-16 

KRIEGLSTEIN G 181470 02-03 

KRIEGLSTEIN J 181470 02-03, 186589 03-06 

KRIP G 187552 04-03 

KRIVOY W 183324 03-03 

KROEGER D 183324 03-03 

KROEGER EA 188915 04-03 

KROP S 191976 04-04 

KRSIAK M 174604 01-04 

KRUEGER GAW 174136 01-09 

KRUK ZL 170177 01-04 

KRUNNFUSZ RW 180739 02-01 

KSIRCJ 186372 03-04 

KUCZENSKI R 167325 01-03 

KUDO Y 177567 02-09, 183195 03-08 

KUDRIN AN 183682 03-03 

KUEHNLEJ 187257 04-14 

KUGLERJ 184618 03-14 

KUHAR MJ 191999 04-03 

KUHN CM 191922 04-03 

KUHN R 182429 03-10 

KUHN V 182429 03-10 

KUIPERS H 183194 03-09 

KULESHA ID 180097 02-03 

KULKARNI AS 189613 04-04 

KULKARNI SK 174038 01-04 

KULKARNI SS 167346 01-10 

KULLBERG MP 187256 03-15 

KULSHRESTHA VK 186569 03-03 

KUMAKURA S 168499 01-07 

KUMASHIRO H 181377 02-15, 181388 02-11 

KUMBAR M 174605 01-12 

KUNIGI T 188893 04-09 

KUPFER DJ 171503 01-09 

KUPIETZ S 177771 02-14 

KURATOMO M 176475 02-09 

KURIOKA Y 171296 01-15, 188838 04-13 

KURLAND AA 176109 02-14, 177319 02-07 

KUROKAWA E 191716 04-09 

KUROMARU S 181590 02-11 

KURTIN SB 169492 01-15 

KURTZ P 188248 04-04 

KURTZ SM 189587 04-05 

KUSCHINSKY K 176746 02-03, 184198 03-03 

KUSHIKU K 178725 02-03 

KUSSIN D 168806 01-11 

KUTSCHERAH 188149 04-17 



LA FLORE JE 175242 02-04 

LABRECQUE G 182227 03-03 

LACNY J 168315 01-11 

LADER M 1 87022 03- 1 7, 1 90336 04- 1 1 

LADER MH 168831 01-14, 184082 03-14, 188887 

04-10 
LADINSKY H 185995 03-03, 189893 04-03, 

191423 04-03 
LAGALI S 169633 01-11 
LAHTI RA 176870 02-03, 186578 03-03, 189584 

04-02 
LAJTHA A 182224 03-03, 191413 04-03 
LAKE CR 189403 04-11, 190314 04-13, 190380 

04-11, 191533 04-11, 192227 04-10 
LAL H 171300 01-04, 180021 02-04, 182230 

03-03, 182721 03-03, 184225 03-03, 190306 

04-03 
LAL S 186587 03-04, 188428 04-13 
LALLEY PM 167329 01-03 
LAMM SS 174071 01-11 
LAMPRECHT F 173520 01-09 
LANDAUER AA 189408 04-14 
LANOIS SC 191762 04-03 
LANDIS WB 167773 01-10 
LANGFELDT T 184979 03-04 
LAO L 177135 02-03 
LAPIERRE YD 183362 03-10, 191 137 04-14 



A-8 



VOLUME 12, AUTHOR INDEX 



Author Index 



LARA PP 172992 01-15 

LAROCHELLE L 177785 02-04 

LARSEN N 187639 04-16, 188832 04-09 

LARSSON K 186683 03-04 

LASSEN JB 171609 01-04, 185959 03-04, 190309 

04-04 
LASTING PG 191776 04-14 
LATIES VG 181403 02-04 
LAUDER J 168817 01-03 
LAVALLEEJ 183362 03-10 
LAVO I N E J R 1 84963 03- 1 4, 1 84964 03-11 
LAWRENCE DK 172596 01-03, 177333 02-03 
LE BRUN Y 191522 04-13 
LE POIDEVIN D 185193 03-11 
LEANDER JD 177410 02-04, 182194 02-04 
LEASK BGS 167445 01-03 
LEBLANC AE 189519 04-04 
LEBLANC J 187799 04-03 
LECHAT P 185996 03-03, 188864 04-03 
LEDNICER D 189584 04-02 
LEECK 173563 01-08 
LEE HK 186744 03-14 
LEEJE 175426 02-11 
LEE JH 187255 03-08 
LEE KH 173080 01-15 
LEE T 187801 04-03, 189401 04-03 
LEE WY 173502 01-08 
LEEDS AA 167706 01-17 
LEEMING EC 181408 02-04 
LEFFJP 172963 01-08 
LEFORT H 176432 02-15 
LEGG NJ 184445 03-10 
LEGROS P 176432 02-15 
LEHMANN HE 16777401-09, 16831301-08, 

168804 01-16, 170293 01-11, 180243 02-15, 

183360 03-13, 191138 0414, 192412 04-17 
LEHTINEN V 184978 03-13 
LEIBOWITZ SF 1 822 1 6 03-03, 1 82238 03-04 
LEITE JR 183609 03-03 
LEITH NJ 18952104-04,191914 04-04 
LELORD G 182432 03-10 
LEMBERGER L 17351601-14, 18181002-03, 

182773 03-17, 191961 04-13, 191989 04-14, 

191990 04-14 
LEMMER B 184232 03-03 
LEON AS 170837 01-03 
LEPORE F 176963 02-04 
LERMAN P 189174 04-11 
LESLIE J 183862 03-04 
LESSER LI 177778 02- n 
LESTER D 177733 02-03 
LETERRIER FR 176703 02-03 
LEUNER H 186025 03-12 
LEVINE EM 191313 04-03 
LEVINE FM 167817 01-08,170744 01-11 
LEVINE J 170292 01-11,181713 02-17 
LEVINE JM 175317 02-04 
LEVINE RR 182715 03-03 
LEVITAN H 189033 04-03 
LEVITT M 187933 04-13 
LEVY JA 191960 04-03 
LEVY RA 189832 04-03 
LEVY RH 185977 03-16, 192391 04-07 
LEVY ST 169486 01-15 
LEVY W 187787 04-15 
LEWJY 191932 04-03 
LEWANDER T 169470 01-13, 171602 01-03, 

191503 04-03 
LEYJP 188976 04-03 
LIBERATORE F 180098 02-01 
LICHTSTEINER M 171307 01-03 
LIDBRINK P 171604 01-03, 182347 03-03, 189026 

04-03, 189611 04-03 
LIDEN S 192527 04-11 
LIEBERMAN A 191522 04-13 
LIEBERMAN AN 188414 04-15 
LIEBLING DS 178575 02-04 
LIMACHER JJ 187806 04-03 
LIN GS 172921 01-04 
LIN R 187576 04-03 
LINDEKE B 182203 02-06, 191921 04-03 
LINDOUIST M 191513 04-03 
LINDSTROM LH 171616 01-04 
LING GM 182170 02-03, 183358 03-03 
LINKOUS P 192231 04-09 
LINNOILA M 184848 03-14, 189619 04-14 
LIPMAN RS 169089 01-10, 170292 01-11, 171925 

01-10 
LIPPA AS 182212 03-03 



UPPERS 189734 04-13 

LIPTON MA 182223 03-03, 191534 04-09 

LISCIANI R 168802 OM 3 

LISO G 180098 02-01 

LISTER RE 182762 03-04 

LITTLE HJ 174828 01-03 

LITTLE MH 174134 01-08 

LITTLETON JM 185992 03-03 

LIUJC 185112 03-03 

LIU RK 169675 01-03 

LIUY 186583 03-04 

LIUZZI A 177338 02-03, 188350 04-13 

LIVINGSTON A 190698 04-04 

LLEWELLYN M 191983 04-04 

LLOYD KG 189602 04-03 

LOBER CW 189425 04-03 

LOCH J 169462 01-14 

LOCKE S 182150 02-03 

LODGE D 188201 04-03 

LOEFFLER U 170840 01-06 

LOFFT JG 192083 04-10 

LOFSTRANDH S 170747 01-03 

LOH H 173872 01-03 

LOH HH 182231 03-03, 182253 03-04, 184179 

03-03, 186670 03-04, 186671 03-03, 189586 

04-03, 191898 04-03 
LONEY J 180992 02-11 
LONG JP 177734 02-03, 188204 04-03 
LOO H 180725 02-07, 184962 03-09 
LOPEC CA 183402 03-13 
LOPES DA SILVA FH 1 881 66 04-04 
LOPEZ-IBOR ALINO JJ 187536 04-09 
LOPEZ-IBOR ALINO JM 183957 03-08 
LORANGER AW 1 75426 02-1 1 
LORENS SA 168835 01-04 
LORENZ RJ 181576 02-03 
LOREZ HP 186677 03-03 
LORKOVIC H 188914 04-03 
LOSEY EG 1 76870 02-03 
LOSKOTA WS 1 89597 04-03 
LOSKUTOVA ZF 191123 04-05 
LOTFY AO 1 75282 02-07 
LOVECKY DV 168718 01-04 
LOVELL RA 182168 02-03 
LOVENBERG W 188287 04-03, 191511 04-13 
LOVSTAD RA 177335 02-13 
LOW GL 168318 01-09 
LOW PA 187618 04-11 
LU LJW 191935 04-04 
LUCAS RW 182214 03-03 
LUCKENS MM 167328 01-03 
LUERS H 184585 03-05 
LUKANINASK 183683 03-08 
LULLMANN-RAUCH R 189605 04-03 
LUNDBORG P 185899 03-03 
LUNDE DT 185932 03-13 
LUNDHOLM B 171606 01-03 
LUNTS LHC 187565 04-11 
LU Rl A J 1 68420 01-12, 1 85600 03- 1 4 
LUTHRA YK 189599 04-03 
LUTTGES MW 1 75230 02-03 
LUTZ MP 186703 03-04 
LUYCKX A 183200 03-15 
LYDELL KW 182192 02-04 
LYDIARD RB 186695 03-03 
LYNN CW 171500 01-09 
LYON M 174035 01-04 
LYTLE LD 180022 02-03, 182246 03-03 



M 



MABRY PD 174860 01-04 
MACCANNELL KL 187812 04-13 
MACDONALD ML 175862 02-17 
MACFARLANE MD 19128104-03 
MACHLEIDT H 187805 04-01 
MACINNES JW 175230 02-03 
MACKAYAVP 171785 01-03 
MACKINNON PCB 184436 03-15 
MACPHAIL RC 173748 01-04, 186376 03-06 
MAEDA H 1 76722 02-08 
MAEDA S 191663 04-09 
MAGNUSSON T 171622 01-03, 189571 04-03 
MAGOUR S 180056 02-05, 185931 03-03 
MAGYAR R 173398 01-03 
MAHIER DH 191959 04-15 
MAHNKE MW 189640 04-17 
MAHUZIER G 184955 03-17 



MAICKEL RP 177334 0203, 182134 02-03, 

187381 04-03, 189589 04-03 
MAITRE L 172917 01-03, 181471 02-03 
MAJIMA T 181378 02-08 
MAJORS LF 192227 04-10 
MAKI E 182111 02-04 
MAKI M 184848 03-14 
MAKIHARA H 178021 02-08 
MAKING K 174855 01-05 
MAKINOSE M 184223 03-03 
MALARKEY WB 191233 04-13 
MALETZKY BM 187839 04-09 
MALICK JB 182240 03-04 
MALING HM 169688 01-05, 188865 04-05 
MALITZ S 177674 02-14,188149 04-17 
MALKIN MD 171506 01-15 
MALLACH HJ 178948 02-06 
MALMNAS CO 171618 01-04 
MALONE MH 167328 01-03 
MALPAS A 184445 03-10 
MALSBURY CW 183790 03-04 
MANDEL LR 191535 04-12 
MANDELBROTE BM 184436 03- 15, 184437 03-13 
MANDELL AJ 175149 02-13, 180020 02-03, 

180047 02-13, 186674 03-03, 191516 04-03 
MANFREDINI G 182789 03-10 
MANHEIMER Dl 177699 02-17, 181713 02-17 
MANIAN AA 182243 03-03, 182444 03-01, 

185748 03-04, 188977 04-03, 189589 0403 
MANIGAULT I 182224 03-03 
MANION AA 191908 04-03 
MANNO BR 182218 03-03 
MANNO JE 182218 03-03 
MANSCHRECK T 191035 04-15 
MANTEGAZZA P 188200 04-03 
MANTILLA-PLATA B 189598 04-05 
MAO CC 191764 04-03 
MARAMIS WF 171150 01-11,176446 02-08 
MARASAJ 181958 02-13 
MARCH J 189884 04-14 
MARCHINI P 180098 02-01 
MARCOTTE DB 167775 01-09 
MARCUS R 190330 04-04, 191975 04-04 
MARCY R 185749 03-06 
MARGETTSG 182768 03-10 
MARGULESAS 182133 02-04 
MARGULES DL 182133 02-04 
MARIAUD J 1 76703 02-03 
MARIGNAN R 180723 02-03 
MARK LC 182156 02-03 
MARKOWITZ RA 191975 04-04 
MARKS JH 168418 01-03 
MARKS V 192577 04-09 
MARQUIS WJ 176869 02-04 
MARRAZZI AS 182121 02-03, 182143 02-03 
MARRIOTT PF 181192 02-08 
MARSH 187877 04-13 

MARSANICO RG 186620 03-04, 187261 04-04 
MARSELLAAJ 190240 04-17 
MARSHALL FN 171007 01-13 
MARSHALL J 184437 03-13 
MARSHALL JM 188915 04-03 
MARSHALL KE 173749 01-04 
MARSHMAN J 179985 02-03 
MARTIN A 182901 03-11 
MARTIN BR 191968 04-03, 191970 04-03 
MARTIN DF 171792 01-05, 178113 02-09,178812 

02-03 
MARTIN ICA 185007 03-09 
MARTIN IL 171971 01-01 
MARTIN JB 188428 04-13 
MARTIN P 192068 04-11 
MARTIN WR 170874 01-03, 174480 01-12, 

174496 01-12, 176312 02-03, 186024 03-12, 

186665 03-03, 187254 03-15, 191904 04-03 
MARTIN YC 180096 02-03, 191499 04-01 
MARTINEZ JB 180123 02-12, 180141 02-12 
MARTINEZ OA 190147 04-13 
MARTIS L 185977 03-16 
MARTZ R 191989 0414, 191990 04-14 
MARUKO K 171246 01-11,181377 02-15 
MASEK K 170072 01-03 
MASKIN MB 168619 01-15.17751102-11 
MASLAND RL 191096 04-13 
MASLIYAH E 186164 03-04 
MASON AS 173433 0111 
MASON P 186681 0303 
MASON ST 187420 04-04 
MASSA A 175628 02-11 



'1 



A-9 



Author Index 

MASSON J 182901 03-n 

AAASSOPUST LC 188689 04-05 

MASTEN LW 188178 04-03 

MASTER RS 167346 01-10 

MASTERSON J 185083 03-12 

MASUDA K 191670 04-09 

MASUDA T 181315 02-16, 182623 03-06 

MASUR J 184212 03-04 

MATHEU H 181811 02-13 

MATHIEU LF 191925 04-03 

MATIN SB 190718 04-03 

MATRIANO D 192000 04-03 

MATSUMOTO K 178623 02-09, 181653 02-06, 

190095 04-11 
MATSUMOTO Y 177190 02-17 
MATSUMURA F 191315 04-03 
MATSUSHITA K 178623 02-09, 181653 02-06 
MATSUZAKI M 191952 04-04 
MATTHEWS JD 182227 03-03 
MATTILA MJ 171629 01-03, 186579 03-03 
MATTIS PA 189587 04-05 
MATZ R 174138 01-09 
MAULE M 182766 03-10 
MAXWELL RA 191978 04-10 
MAYEVSKY A 1 77835 02-03 
MAZURKIEWICZ-KWILECKI IM 169471 01-03 
MAZURSKY MB 183683 03-08 
MCALLISTER DR 190146 04-07 
MCCABE OL 186994 03-08 
MCCARTHY DA 186581 03-04 
MCCARTHY KD 188231 04-03 
MCCLAIN LD 187260 04-04 
MCCLELLAND HA 185005 03-08 
MCCLOSKEY KL 191937 04-03 
MCCLURE DJ 167584 01-13, 168318 01-09 
MCCLURE WO 182772 03-17 
MCCONAHEY OLS 185604 03-14 
MCCOY DJ 191991 04-04 
MCCURDY L 167775 01-09 
MCDOWELL FH 175426 02-11, 188421 04-13 
MCGAUGH JL 169467 01-03, 181404 02-04 
MCGEE JJ 171507 01-08 
MCGEER EG 175241 02-03 
MCGEER PL 183228 03-03, 189590 04-03 
MCGLASHAN T 175332 02-16 
MCGOWAN-SASS BK 1821 19 02-03 
MCGUIRE RA 182246 03-03 
MCGUIRE RJ 185191 03-14 
MCHENRY JT 189502 04-11 
MCHUGH PR 183648 03-09 
MCKEARNEY JW 191767 04-03 
MCKELVEY RK 190743 04-14 
MCKENZIE GM 182128 02-04, 185997 03-04, 
189403 04-11, 190314 04-13, 191517 04-03, 
191533 04-11 
MCKERNAN JB 172017 01-03 
MCKIM WA 168833 01-04 
MCKINNEY AS 184195 03-11 
MCLAUGHLIN JL 192874 04-12, 192878 04-01, 

192879 04-01, 192882 04-01 
MCLELLAN DL 178618 02-11 
MCLENDON D 187638 04-04 
MCMAHON SA 176238 02-15 
MCMASTER SE 191947 04-05 
MCM I LLAN D E 1 774 1 02-04, 1 8 1 405 02-04, 
182194 02-04, 183893 03-04, 187928 04-03 
MCNAIR DM 190305 04-17 
MCPHILLIPSJJ 189177 04-02 
MCQUILLAN LM 183402 03-13 
MEAD PG 1 77533 02-04 
MEADOW R 189778 04-11 
MEDRANO JF 185993 03-03 
MEHARGS 19114104-04 
MEHTA NB 191978 04-10 
MEKHILANE LS 191784 04-02, 191785 04-02, 

191786 04-02, 191788 04-04 
MELGES FT 185330 03-14 
MELIKIAN AP 173875 01-03 
MELISKA CJ 186701 03-03 
MELLERUP ET 174133 01-04 
MELLINGERGD 177699 02-17 
MELLO WF 173032 01-04 
MELTZER HL 182443 03-09 
MELTZER HY 174609 01-14, 187114 03-09, 

191506 04-13 
MENDELS J 169093 01-09, 169491 01-09, 174994 

02-14 
MENDELSON JH 187257 04-14 
MENOLEWICZ J 169494 01-09, 169495 01-09 



MENON MK 183608 03-03, 189587 04-05 

MENON MS 1 74587 01 -08, 1 80248 02-1 5 

MERCURO G 168748 01-03 

MERLIS S 185877 03-08, 187840 04-17 

MERRITT J 169782 01-03 

MERSKEY H 182765 03-09 

MESSIHA FS 184653 03-09, 185998 03-13, 

189210 04-03 
MESSINA C 171794 01-13 
MESTER R 175251 02-17 
METZLERCM 176108 02-13 
MEYER ER 183895 03-03 
MEYER H 172923 01-03 
MEYER J 17173101-13 
MEYERSON BJ 171615 01-04, 171616 01-04, 

171617 01-04, 171618 01-04 
MEYLER L 18381203-15 
MICHAELSON lA 191957 04-05 
MICHANEK A 171617 01-04 
MICHIELS W 180699 02-14 
MICZEK KA 182190 02-04, 189525 04-04 
MIDDAUGH L 182229 03-03 
MIDGLEY AR 173257 01-03 
MIDORIKAWAY 176448 02-10 
MIELKE DH 189072 04-08 
MIHARA M 182552 03-15 
MIKEJIRI K 176471 02-11 
MIKODA R 181654 02-04 
MILES H 187130 03-03 
MILHAUD C 168838 01-04 
MILLENSON JR 183862 03-04 
MILLER CA 191313 04-03 
MILLERE 169220 01-11,184196 03-11 
MILLER EM 174297 01-15, 188561 04-11 
MILLER FP 182242 03-04 
MILLER H 185928 03-09 
MILLER LL 171306 01-04 
MILLER R 190545 04-03 
MILLER RE 175317 02-04 
MILLER RJ 177131 02-03, 180060 02-03, 189616 

04-03 
MILLER RR 192190 04-14 
MILLER WC 167775 01-09 
MILLMAN JE 187350 04-13 
MILLNERJR 188412 04-04 
MILLOY S 182208 02-04 
MILLS PJ 182192 02-04 
MILSTEIN SL 187812 04-13 
MILSTEIN V 191188 04-15 
MILZOFF JR 174964 01-03 
MINSKER El 183683 03-08 
MIRMAN MJ 184175 03-10 
MIRSKY lA 175317 02-04 
MISRA RS 183601 03-03 
MITAT 176468 02-08 
MITCHELL CL 168835 01-04, 181397 02-04, 

187077 03-03 
MITTAG TW 192000 04-03 
MIWAGT 191923 04-03 
MIYADERA T 1 80487 02-01 , 1 80488 02-0 1 , 

180489 02-01, 180490 02-02 
MIYAMOTO K 1 76470 02-08 
MIYAMOTO T 191932 04-03 
MIYAMURAA 170638 01-13 
MIYASHITA S 188450 04-15 
MIZUNO K 177099 02-02 
MOAMAI N 17818902-17 
MOAN E 185877 03-08 
MOCHIZUKI Y 176565 02-09 
MODELL W 176011 02-11 
MODIGH K 168751 01-03, 171623 01-03 
MOGLIA A 167336 01-13 
MOHAN J 188094 04-15 
MOLDOWAN MJ 173601 01-03 
MOLINOFF PB 191509 04-03 
MOLLENAUER S 187703 04-04 
MOLNARGW 186187 03-13 
MONTANINI R 182789 03-10 
MONTEBELLI ML 175540 02-11 
MONTEJO IGLESIAS L 187536 04-09 
MONTEL H 182345 03-03, 189568 04-03, 189569 

04-03 
MONTERO EF 170129 01-11 
MONTGOMERY S 192577 04-09 
MONTI JM 186574 03-11 
MONTI L 186574 03-11 
MOODY JP 187644 04-15 
MOON HS 173502 01-08 
MOON IJ 173078 01-04 



Psychophormacoiogy Abstracts 

MOORE JW 172745 01-04, 185934 03-04 
MOORE KE 176874 02-03, 177840 02-03, 186635 
03-04, 189397 04-03, 191521 04-04, 191897 
04-03, 192012 04-04 
MOORE RA 172834 01-11 
MOORE RH 168130 01-03, 191935 04-04 
MOOSMAYER A 1 78948 0206 
MORACCI FM 180098 02-01 
MORALES F 186574 03-11 
MORALISHVILI E 192084 04-15 
MOREAU D 172980 01-11 
MORGAN JP 185998 03-13 
MORGANDO E 167594 01-10 
MORGENROTH VH 191519 04-03, 191908 04-03 
MORI A 177568 02-08, 188893 04-09, 191716 

04-09 
MORI M 170660 01-13,174603 01-03 
MORIN LP 186686 03-04 
MORISHITA H 178725 02-03 
MORITA K 182113 02-03 
MORMONT C 183190 03-07, 190312 04-14 
MOROJI T 184178 03-03, 191685 04-17 
MOROT-GAUDRY Y 188976 04-03 
MORRIS JB 191857 04-09 
MORRIS LA 192704 04-17 
MORRIS M 172741 01-08 
MORRISON CF 190331 04-04, 190332 04-04 
MORRITT C 186288 03-08 
MORROW CW 186567 03-04 
MORSE WH 191926 04-04 
MORSELLI PL 169073 01-01 
MOSKOWITZ H 189358 04-14, 189359 04-14 
MOSNAIM AD 1 79992 02-03, 187112 03-03 
MOSS J 1 68862 01-05, 1 9 1 495 04-03 
MOTULSKYAG 188826 04-11 
MOUNTFORD D 190260 04-04 
MOUNTJOY CO 188348 04-09 
MOURET J 187237 03-14 
MOUZAS GL 174880 01-17 
MOWAT AP 168526 01-15 
MOWBRAY R 187582 04-10 
MULLEN C 185112 03-03 
MULLER EE 188200 04-03 
MULLER P 187804 04-03 
MULLER PJ 167572 01-15 
MULLER W 189595 04-13 
MULLER-CALGAN H 192424 04-04 
MULLER-LIMMROTH W 179023 02-13 
MUNGAVIN JM 182769 03-10 
MUNKVAD I 186588 03-04 
MUNSON AE 177834 02-05, 191960 04-03 
MUNSON AF 191963 04-03 
MURABAYASHI R 180986 02-10 
MURAD F 182154 02-03 
MURAKAMI T 180986 02-10 
MURAYAMAS 182097 02-03 
MURAZAKI M 176565 02-09 
MURPHREE OD 187868 04-04, 190696 04-04 
MURPHY DL 169504 01-09, 173387 01-03, 
178432 02-09, 185928 03-09, 186580 03-09, 
191502 04-13 
MURPHY JE 182768 03-10 
MURPHY LR 184834 03-04 
MURRAY MAF 184437 03-13 
MUSACCHIO JM 186698 03-03 
MUTALIPASSI LR 171506 01-15 
MYAGI MA 191777 04-07, 191790 04-07 
MYTILINEOU C 182204 02-03 

N 

NADEAU R 172598 01-05 

NADEAU RA 187807 04-03 

NADITCH MP 167832 01-15 

NADLER RD 187935 04-03 

NAESTOFT J 188832 04-09 

NAFTCHI NE 182178 02-06 

NAGAI T 176467 02-08 

NAGAMI GT 182250 03-03 

NAGARAJA J 182870 03-17 

NAGASAKA G 176564 02-11 

NAGASWAMI R 169461 01-11 

NAGASWAMI S 169461 01-11, 188094 04-15 

NAGAWA Y 173548 01-05, 177099 02-02, 18165 

02-04 181657 02-02,181658 02-02 
NAGLE BT 191962 04-03 
NAGY A 183603 03-13 
NAHORSKI SR 188291 04-03 



A-10 



VOLUME 12, AUTHOR INDEX 



Author Index 



NAIR NPV 168805 OMl, 168806 01-11. 191138 

04-14 
NAITO H 182547 03-03 
NAITO Y 182096 02-03 
NAJ L 180123 02-12 



NAKAGUCHI T 
NAKAHARA T 
NAKAHARA Y 
NAKAJIMA H 
NAKAJIMA R 
NAKAMURA M 



1 77097 02-05 
1 78725 02-03 

1 77336 02-03 
170754 01-17 
181654 02-04 

182637 03-02 



NAKANE M 185241 03-14 

NAKANISHI H 182103 02-04 

NAKANO S 182118 02-14 

NAKASHIMA Y 180301 02-11 

NAKAYA K 167917 01-09, 167918 01-09 

NAKAYAMA K 168499 01-07 

NAKAZAWA Y 167921 01-14. 176722 02-08 

NAMBA T 171282 01-11.182624 03-11 

NAMIKI M 181771 02-07 

NANOi DN 175410 02-09 

NANIVADEKAR AS 167346 01-10 

NARAHASHI T 186672 03-03 

NARANJO C 178064 02-12 

NARASIMHACHARI N 187576 04-03 

NARAYANAN HS 183418 03-14 

NASH JB 191969 04-03 

NATHANSON JE 184175 03-10 

NAUMOV NN 183520 03-01 

NAVARATNAM V 174830 01-04 

NAYLORGJ 185193 03-11,187644 04-15 

NAYLOR RJ 171305 01-03, 176877 02-04, 185958 

03-04, 186577 03-03 
NEFF NH 168437 01-03, 176254 02-13, 182718 

03-03. 186668 03-03, 191500 04-03 
NEIBURG HA 174297 01-15 
NEILL DB 187698 04-04 
NELSEN JM 176864 02-04 
NELSON DL 191509 04-03 
NELSON LM 187116 03-13 
NELSON MF 180022 02-03 
NELSON WL 190719 04-02 
NEUBURG J 187119 03-04 
NEUVONEN PJ 1 76879 02-04 
NEVSIMALOVA S 192419 04-1 1 
NEWMARK CS 183635 03-17 
NG LKY 181810 02-03 
NICHOLS A 187113 03-08 
NICHOLS DE 172915 01-03. 173588 01-03. 

177734 02-03 
NICKANDER R 187130 03-03 
NICOLL RA 177976 02-03, 190727 04-03 
NIEBURG HA 169220 01-11 
NIELSEN EB 174035 01-04 
NIELSEN IM 186368 03-04, 186369 03-04, 186370 

03-04, 186371 03-04 
NIELSEN M 171627 01-03, 190310 04-03 
NIEMEGEERS CJE 185961 03-04, 190306 04-03, 

192421 04-04 
NISHI H 182095 02-03 
NISHIDA K 171282 01-11,182624 03-11 
NISHIE K 187575 04-04 
NISHIJIMA Y 174603 01-03 
NISHIKAWA T 188199 04-03 
NISHIKIORI T 178655 02-17 
NISHIMURA K 176472 02-08 
NISHIOKA M 182112 02-04 
NISHIURA N 188517 04-09 
NISHIZAKI H 181386 02-04 
NISHIZONO M 170415 01-11, 177066 02-17, 

180319 02-08 
NITYANAND S 176881 02-03 
NIWAGUCHI T 177336 02-03 
NO Yl 182574 03-17 
NOBLE EP 182722 03-13 
NOGUCHI T 180986 02-10,191716 04-09 
NOMA T 167918 01-09,181388 02-11 
NOMURA J 176454 02-11 
NOMURA M 177097 02-05 
NOMURAS 191670 04-09 
NOON JP 191896 04-03 
NORHEIM G 172398 01-16 
NORRED WP 187575 04-04 
NORRMAN S 171632 01-03 
NORTON S 1 76867 02-06 
NOSE F 183199 03-11 
NOWAKOWSKI H 174783 01-11 
NOYES R 174132 01-14, 185873 03-09 
NOZAWA A 182624 03-11 



NURNBERG FL 175003 02-14 

NUTT JG 174473 01-13, 174479 01-14. 182163 

02-03 
NUTTER R 188107 04-09 
NYBACK HV 191931 04-03 
NYMARK M 186368 03-04 



O'BRIEN A 190718 04-03 

O'BRIEN CP 176675 02-14 

O'BRIEN GS 176677 02-03 

O'BRIEN PMJ 185190 03-11 

O'CONNELL RA 187786 04-15 

O'DEAMH 187939 04-01 

O'LEARYJ 174059 01-08 

O'NEAL EC 192704 04-17 

GATES J A 184654 03-13 

OBE G 184585 03-05 

OBERMAJEROVA H 170072 01-03 

OBOURN R 190241 04-09 

OCHI Y 167919 01-09 

ODLE D 171502 01-09 

ODSTRCHEL G 182186 02-03 

OERIPSANTOSO S 172809 01-17 

OESCH F 182720 03-03 

OFFERMEIERJ 191420 04-03 

OGATA M 167921 01-14, 178019 02-15 

OG AWA H 1 82 1 1 6 02-04, 1 82 1 1 7 02-04 

OGAWA N 168272 01-17,181384 02-04, 182114 

02-04, 182115 02-04, 182118 02-14, 185350 

03-17 
OGLESBY MW 1 76866 02-04, 1 84980 03-04 
OGUCHI T 176565 02-09 
OGURA C 181650 02-03, 182549 03-03 
OGURA M 188450 04-15 
OH D 181957 02-10 
OH JS 171599 01-04 
OH YP 172018 01-03 
OHATA K 182094 02-03 
OHMI S 176472 02-08 
OHMOTO T 190095 04-11 
OHSAWA I 175120 02-09 
OHSHIMA T 168499 01-07 
OHTANI T 183369 03-10 
OHUCHIDA S 175120 02-09 
OIKAWA T 182549 03-03 
OKA M 182089 02-03 
OKADA F 170638 01-13 
OKADA M 1 76889 02-09, 191716 04-09 
OKAMOTO M 191952 04-04, 191953 04-04 
OKAMOTO Y 178019 02-15 
OKLOBDZIJAM 187942 04-01 
OKUBO N 182731 03-10 
OKUMURAY 176470 02-08 
OKUSE S 176473 02-10 
OLDS ME 177837 02-04 
OLGIATI S 174299 01-09 
OLIVERIO A 185751 03-03 
OLIVIER JA 189606 04-15 
OLLERICH DA 176476 02-05 
OLLMANN JE 187937 04-01 
OMAR NM 183600 03-01 
OMENN GS 188826 04-11 
ONDRUSEK G 175895 02-03 
ONO M 176474 02-10 
ONO N 178725 02-03, 182109 02-04 
ORCI L 168440 01-03 
ORCUTTJC 191509 04-03 
ORDONA TT 180992 02-11 
ORDONEZ LA 191771 04-03 
ORELAND L 175239 02-03 
ORGANISCIAK DT 187677 04-03 
ORITA S 1 77097 02-05 
ORKIN LR 182185 02-03 
ORNSTON D 189075 04-13 
ORSULAK P 191523 04-01 
ORTIZ A 185992 03-03 
ORZACK MM 176673 02-08 
ORZECHOWSKI RF 188875 04-05 
OSANIUS 8 171632 01-03 
OSAWA S 191720 04-08 
OSGOOD PP 191964 04-03 
OSHIMA M 175550 02-08 
OSKOUI M 182222 03-03 
OSTAPTZEFF G 184963 03-14, 184964 03-1 1 
OSTAPTZEFF M 184963 03-14, 184964 03-1 1 
OSTERHOLM KC 187572 04-04 
OSTOW M 174495 01-10 



OSTRENGAJA 177396 02-15 

OSWALD I 183547 03-09 

OTA H 1 78053 02-08 

OTA KY 177319 02-07 

OTANI T 182872 03-03 

OTIS LS 175751 02-03 

OTSUKA R 191625 04-13, 191667 04-13 

OTSUKI S 167917 01-09, 167918 01-09, 180301 

02-11 
OU GT 180321 02-17 
OVERALL JE 171505 01-08 
OVERO KF 191026 04-09 
OVERSTREET DH 185265 03-04 
OVERTON DA 169071 01-03 
OWEN CA 1 76936 02-03, 1 85330 03 1 4 
OWEN JE 185957 03-04 



PADJEN A 177976 02-03, 190727 04-03 

PAESALU El 191789 04-03 

PAGE JG 189587 04-05 

PALAZZO G 168801 01-01 

PALFAI T 188248 04-04, 188412 04-04 

PANTELEYEVA GP 183683 03-08 

PANTON Y 189744 04-12 

PAOLINO RM 182241 03-04 

PAPESCHI R 183868 03-03, 186587 03-04, 186588 

03-04 
PARE CM 191496 04-03 
PARE WP 171301 01-02. 178720 02-03 
PAREKH CS 172439 01-11 
PARENT M 174044 01-11.183190 03-07 
PARISH LC 184175 03-10 
PARK CW 171259 01-04. 171599 01-04 
PARK DH 191510 04-13 
PARKS 168836 01-08 
PARKER DC 190104 04-13 
PARKER JM 183363 03-03. 191 141 04-04 
PARKER Z 191192 04-11 
PARMAR SS 169818 01-01. 182727 03-03. 

183598 03-02. 183601 03-03. 185980 03-01, 

191942 04-03 
PARRY HJ 177699 02-17 
PARVEZ H 178815 02-03 
PARVEZ S 178815 02-03 
PATCH VD 169085 01-14 
PATEL G 182721 03-03 
PATHAK D 185210 03-10 
PATLAK CS 170112 01-06 
PATNI SK 174768 01-04 
PATON DM 168747 01-03 
PATON WDM 181941 02-03 
PATRICK GA 172019 01-03. 182153 02-03 
PATTISON JH 171925 01-10 
PAUL AG 192876 04-12 
PAULI Al 174763 01-04 
PAULSON GW 168777 01-13. 191233 04-13 
PAYKEL ES 185322 03-10 
PAZZAGLI A 168578 01-13 
PEARCE J 167572 01-15 
PEARLE DL 187923 04-03 
PEARLMAN S 167382 01-17 
PEARSON E 172485 01-10 
PEDEMONTE WA 1 79992 02-03 
PEDERSEN V 171607 01-04, 186368 03-04 
PEET M 192577 04-09 
PEGRAM GV 187260 04-04 
PEKUNOVA LG 183683 03-08 
PELTON EW 177975 02-11 
PENG T 186678 03-03 
PENN RG 182761 03-17 
PENNINGROTH RP 186780 03-10 
PENSABENE JW 187575 04-04 
PENTIKAINEN P 176879 02-04 
PEREIRA-OGAN JA 167773 01-10, 172993 01-10, 

176107 02-10, 184175 03-10 
PEREL JH 192872 04-10 
PEREL JM 172271 01-13, 187933 04-13 
PEREZ-REYES M 176747 02-03, 182223 03-03, 

188119 04-13 
PERI G 189893 04-03, 191423 04-03 
PERKINS R 184438 03-14 
PERL M 177835 02-03 
PERLOFF MM 176107 02-10,188144 04-10 
PERON-MAGNAN J 176438 02-17 
PERON-MAGNAN P 180725 02-07 
PERRIER C 184177 03-11 
PERRON D 191142 04-15 



A-11 



Author Index 

PERRY KW 187831 04-03 

PERRY TL 191331 04-03 

PERSSON G 17240101-09 

PERT A 190264 04-04 

PERT CB 190476 04-03 

PERTWEE RG 181941 02-03 

PERUZZI G 188200 04-03 

PETERS DAV 181945 02-03 

PETERS MA 182165 02-03, 183894 03-03 

PETERSEN BH 191961 04-13 

PETERSON GR 182225 03-03, 188178 04-03 

PETITJEAN F 189023 04-02 

PETROZZI M. C 190670 04-11 

PETRYSHYN WR 187702 04-04 

PETTIGREW A 191192 04-11 

PFEIFFER E 192229 04-09 

PHILIPPU A 184230 03-03, 185902 03-03 

PHILLIPS J 186584 03-10 

PHILLIPS RN 174961 01-05 

PHILLIS JW 187806 04-03, 191380 04-03 

PHOEBUS E 177318 02-14 

PICCHONI A 191992 04-03 

PICKENS R 185960 03-04 

PIERCE JV 170840 01-06 

PIHLAJAMAKI K 171633 01-03 

PILBRANT A 171630 01-16 

PINARD G 167343 01-08, 183359 03-03, 183361 

03-09 
PINCO R 172109 01-17 
PINDER R 190545 04-03 
PINEAU R 178193 02-11, 188406 04-03 
PINEDA MR 190379 04-09 
PINKEY B 186092 03-15 
PINTO A 171507 01-08 
PINTO F 182790 03-11, 182791 03-09 
PIPPENGERCE 191096 04-13 
PIRCH JH 187572 04-04, 191969 04-03 
PI RES P 178187 02-08, 178193 02-11, 188406 

04-03 
PITTERMAN A 182721 03-03 
PITTMAN KA 17864102-03 
PLANAS P 183955 03-08 
PLENGE P 172402 01-09, 174133 01-04 
PLETSCHERA 184229 03-03 
PLOTNIK R 187703 04-04 
PLOTNIKOFF N 180096 02-03 
PLOTNIKOFF NP 176677 02-03, 187938 04-01 
POCOCK DA 189408 04-14 
PODOSIN RL 177778 02-11 
POHORECKY LA 182238 03-04 
POITOU P 190337 04-03 
POKORNYA 171505 01-08 
POKORNY AD 190381 04-09 
POLC P 179021 02-05 
POLIZOS P 177754 02-08, 183275 03-08, 184174 

03-11 
POLLARD H 168750 01-03, 189396 04-03 
POLLIN W 187113 03-08 
POLVAN 18243103-11 
PONG SF 167358 01-03 
PONZIO F 189752 04-03 
POOLWR 180097 02-03 
POPE FE 168361 01-17 
POPE JH 189514 04-04 
PORRINO U 169086 01-14 
PORTER AL 184380 03-04 
POSCHEL BPH 186581 03-04, 191527 04-04 
POSHIVALOV VP 191120 04-04 
POST RM 170084 01-09, 170621 01-09, 174094 
01-09, 183546 03-10, 184160 03-09, 187398 
04-13, 187642 04-14 
POSTEL J 167676 01-08 
POSTEL M 167676 01-08 
POSTMA E 170837 01-03 
POTKIN SG 192229 04-09 
POTTER WZ 189589 04-03 
POUPIER G 182900 03-11 
POWELL BJ 182719 03-13 
POWER M 185083 03-12 
PRADHAN PV 175967 02-10 
PRADHAN SN 191528 04-04 
PRANGE AJ 171500 01-09, 172992 01-15, 191534 

04-09 
PRASADIO T 176446 02-08, 178038 02-10 
PRECHTL HFR 168523 01-14 
PREPAS S 183608 03-03 
PRESLEY JM 167954 01-08 
PRESS M 177771 02-14 
PRESTON AC 186702 03-04 



PRICE JS 188348 04-09 
PRICE-WILLIAMS D 190240 04-17 
PRIEN R 186189 03-09 

PRIEN RE 169065 01-11, 169090 01-09, 171926 
01-09 172831 01-08, 186188 03-09, 186190 
03-09, 186191 03-09, 189735 04-09, 190381 
04-09 

PRIEST RG 173307 01-16 

PRIJOSEMBODO W 17116101-09 

PROAKIS AG 189583 04-05 

PROTT FW 189408 04-14 

PROUDFIT HK 188751 04-03 

PRUITT DB 188202 04-03 

PRUSOFF B 171924 01-10, 185322 03-10 

PRYOR GT 182192 02-04 

PTITO M 176963 02-04 

PUGLISI CV 169817 01-13 

PUHAKKAP 180047 02-13 

PUIG M 184229 03-03 

PUJOL J 179988 02-13 

PULLIAMAL 187577 04-01 

PULLMAN B 183406 03-01 

PURGYI P 180063 02-15 

PU Rl SK 1 7 1 300 1 -04, 1 82230 03-03, 1 84225 
03-03 



QUENTIN J 182901 03-11 
QUENZERLF 185934 03-04 
QUERMONNE MA 185749 03-06 
QUIMBY KL 192565 04-04 
QUINN PO 185324 03-14 
QUITKIN F 169492 01-15 



RACAGNI G 180582 02-03, 184553 03-03, 187526 

04-03, 188891 04-03 
RADA RT 1 77748 02-08, 187869 04-08 
RADCLIFFE GJ 176868 02-04 
RADLOW RR 174210 01-14 
RADULOVACKI M 181815 02-03 
RAFAELSEN OJ 172402 01-09, 174133 01-04, 

182434 03-09 
RAFALOVICH EG 181778 02-08 
RAFT D 183635 03-17 
RAJAN KS 176763 02-06 
RAKEAV 185927 03-04 

RAMACHANDRAN V 174587 01-08, 180248 02-15 
RAND MJ 182088 02-03 
RANDALL CL 177733 02-03 
RANDALL LO 18277103-17 
RANDRUP A 180061 02-04, 185929 03-11, 

186587 03-04. 186588 03-04, 190310 04-03 
RAO BSS 183418 03-14 
RAO DB 185560 03-15 
RAO GS 170839 01-06 
RAO VA 176881 02-03 
RAPOPORTJL 185324 03-14 
RAPOPORT R 190718 04-03 

RASKIN A 171502 01-09, 171923 01-09 

RAUJH 181270 02-14 

RAYAK 185560 03-15 

RAY I 168317 01-09 

RAY OS 178638 02-04, 184242 03-04, 189521 
04-04 

RAZANIJ 189916 04-10 

READ RC 186187 03-13 

READING HW 181942 02-03 

REATIG N 171502 01-09 

REBEC GV 185264 03-03 

RECH RH 176869 02-04, 187930 04-04, 192009 
04-04 

RECHTSCHAFFEN A 191389 04-03 

REDDY GNN 183418 03-14 

REDFERN PH 174829 01-04, 174830 01-04, 
186636 03-04 

REESJMH 174828 01-03 

REES WL 176926 02-17 

REGINA EG 190743 04-14 

REIDAH 185193 03-11 

REIGLE TG 174962 01-03 

REILLYE 174132 01-14 

REIMER DR 188094 04-15, 190242 04-07 

REINHARDJF 187939 04-01 

REINHOLD K 169474 01-03 

REINIS S 171904 01-03, 171905 01-04 

REINTOFT M 187236 03-11 



Psychopharmacology Abstracts 

REISBY N 185929 03-11 

REISS D 189743 04-14 

REISSM 187255 03-08 

REITZ RH 171007 01-13 

RENAULT P 181879 02-13 

RENAULT PF 188120 04-13 

RESCHKE RW 178545 02-08 

RESNICK 167496 01-11 

RESNICK RB 189059 04-07 

REVUSKY S 178502 02-04 

REYNOLDS CF 171503 01-09 

REYNOLDS EH 184439 03-15 

REYNOLDS R 181853 02-14 

REYNOSO RM 180142 02-12, 180143 02-12 

REYNTJENS A 183194 03-09 

REYNTJENSAM 183191 03-11, 183192 03-11, 

183193 03-11 
RHO KS 171599 01-04 
RICCIARDI F 191190 04-14 
RICCIO DC 167398 01-04 
RICHARDS DW 185725 03-03 
RICHARDSON JS 173520 01-09, 18221 1 03-04, 

187380 04-03 
RICKELS K 167773 01-10, 171299 01-14, 172993 
01-10, 176107 02-10, 177376 02-10, 181273 
02-10, 184175 03-10, 185747 03-09, 188144 
04-10, 189919 04-10 
RICKLESW 169070 01-13 
RICKLES WH 181887 02-13, 190308 04-14 
RIDDLE KD 185324 03-14 
RIDGERSA 168834 01-04 
RIEGER F 176703 02-03 
RIEGLET 191523 04-01 
RIFKINA 169492 01-15 
RIGGI F 191190 04-14 
RIKLAN M 168619 01-15,17751102-11 
RIMON R 1 80046 02-08 
RIMON 4 180047 02-13 
RINGLE DA 182187 02-03 
RITCHIE AC 187565 04-11 
RITTER S 173029 01-03, 182210 02-04 
RIVIERJ 190104 04-13 
ROACH MK 191939 04-04 
ROBB D 184372 03-03 
ROBBINS J 186580 03-09 
ROBBINS T 188620 04-04 
ROBERTS CD 181959 02-14 
ROBERTSON JF 191215 04-15 
ROBICHAUD RC 171304 01-04, 182188 02-04, 

192016 04-04 
ROBIN J 178950 02-11 
ROBIN SS 178127 02-17 
ROBINSON RG 187498 04-04 
ROBINSONS 171124 01-10 
ROBY DM 171007 01-13 
RODBRO P 188889 04-11 
RODDA BE 191989 04-14, 191990 04-14 
RODRIGUES VR 178811 02-10 
ROETS 171260 01-06 
ROENSBERGG 185902 03-03 
ROFFMAN M 191523 04-01 
ROGER B 17643102-11 
ROGERS KJ 18829104-03 
ROGERS ME 187938 04-01 
ROIZEN MF 168862 01-05, 191495 04-03 
ROIZIN L 185112 03-03 
ROMERO RJ 189754 04-12 
ROMI JC 169297 01-07 
ROMMELSPACHER H 1 77337 02-03 
ROOLAYD EA 191790 04-07 
ROSCAM ABBING PJ 170847 01-17 
ROSE WC 1 77834 02-05 
ROSECRANS JA 191944 04-04 
ROSEN AJ 175242 02-04, 186568 03-04 
ROSENBERG CM 189926 04-11 
ROSENBLATT JE 177450 02-14 
ROSENBLATTS 174995 02-09 
ROSENBLUM MP 183602 03-01 
ROSENFELD H 185747 03-09, 188144 04-10 
ROSENK RANTZ H 1 88872 04-05, 1 895 1 6 04-04, 
189588 04-05, 189599 04-03, 191965 04-03, 
191966 04-04 
ROSENTHAL R 177669 02-08 
ROSENTHAL SH 172486 01-10 
ROSENZWEIG MR 1 74036 01 -03 
ROSIER YA 172980 01-11 
ROSSI AM 187257 04-14 
ROSSI GV 167329 01-03 
ROSSI V 188875 04-05 



A-12 



VOLUME 12, AUTHOR INDEX 



Author Index 



ROSSIGNOL P 169469 01-04 

ROSSMAN LG 190104 04-13 

ROTH B 192419 04-11 

ROTH JA 177332 02-03 

ROTH RH 191519 04-03, 191896 04-03, 191908 

04-03, 191931 04-03 
ROTH T 167341 01-08, 177747 02-07 
ROTH W 191957 04-05 
ROTH WT 177720 02-14, 189406 04-14 
ROTHSTEIN E 172275 01-11 
ROWE TC 173158 01-04 
ROWLEY VN 192116 04-04 
ROY A 182898 03-15 
ROY JY 183361 03-09 
RUCH W 191418 04-03 
RUDERMAN NB 191771 04-03 
RUDMAN S 180064 02-10 
RUDZIK AD 185032 03-01 
RUPPJM 178948 02-06 
RUSCH DN 173589 01-01 
RUSSELL A 168837 01-04, 181605 02-04 
RUSSELL RW 181406 02-04 
RUSSELL SC 190379 04-09 
RUSTERHOLZ DB 172915 01-03 
RUTHVEN CRJ 167445 01-03 
RUTLEDGE CO 186669 03-03 
RYBAKOWSKI J 174778 01-09 



SAARIKOSKI S 171613 01-03 

SAARNIVAARA L 186579 03-03 

SAAVEDRA JM 173382 01-03 

SABELLI HC 179992 02-03, 187112 03-03 

SABY J 184955 03-17 

SACCO FA 167575 01-10 

SACHAR EJ 191506 04-13 

SACK RL 170083 01-03, 174329 01-09, 181358 

02-09 
SADOF M 185997 03-04 
SADONO B 174618 01-17 
SAFER D 188567 04-11 

182872 03-03 

1 76468 02-08 

176722 02-08, 178002 02-17 

176468 02-08, 176473 02-10 

182626 03-01 

182624 03-11 
177099 02-02, 181654 02-04 



SAITO H 

SAITO K 

SAITO M 

SAITO N 

SAITO S 

SAITO T 

SAJI Y 

SAKALIS G 168836 01-08, 172485 01-10, 181957 

02-10 
SAKATA T 1 770 1 9 02-04, 1 77020 02-04 
SAKSONOV PP 191123 04-05 
SAKURADAS 182112 02-04 
SAKURAI T 176722 02-08 
SALAN R 176582 02-11 
SALELKAR GK 182829 03-10 
SALETU B 174131 01-08, 181958 02-13, 187115 

03-09 
SALETU M 187115 03-09 
SALKIND MR 182767 03-10 
SALLER R 184232 03-03 
SALMINEN J 184978 03-13 
SALZMAN C 169086 01-14, 187837 04-15, 

189743 04-14 
SAM J 182446 03-01, 187938 04-01 
SAMANIN R 188196 04-03 
SAMARDZIC R 186640 03-03 
SAMEJIMA K 177097 02-05 
SAMESHIMA T 176722 02-08 
SAMOURCM 187939 04-01 
SAMPATH SS 182718 03-03 
SANCILIO FD 185034 03-01 
SANDERS-BUSH E 182140 02-03 
SANDLER M 167445 01-03, 168286 01-13, 191496 

04-03 
SANDQUISTVL 176312 02-03 
SANGIOVANNI F 170627 01-09 
SANKAV DVS 174605 01-12 
SANG I 185182 03-17 
SANG M 1 82 1 05 02-03, 1 82 1 08 02-04 
SANTOS CA 182229 03-03 
SANTOS MR 169297 01-07 
SARA SJ 186704 03-04 
SARAF KR 174588 01-08, 175393 02-11, 175460 

02-08, 189512 04-15 
SARAI K 191670 04-09 
SARANTAKIS D 177836 02-04 
SARBIN TR 173056 01-13 



SARGES R 175762 02-17 

SASAMOTO S 176542 02-11 

SASSE EA 19019404-11 

SATHANANTHAN GL 174138 01-09, 177710 02-15 

SATINDER KP 187702 04-04 

SATO E 185241 03-14 

SATO K 1 76565 02-09 

SATO M 1 82 1 05 02-03, 1 82 1 08 02-04 

SATO Y 177567 02-09 

SATTERFIELD JH 177778 02-11 

SAUL RE 177778 02-11 

SAUL W 188865 04-05 

SAULLE RD 181152 02-14 

SAVAGE C 184653 03-09 

SAVAGE RD 182763 03-14 

SAWA A 191686 04-08 

SAWADA H 174853 01-16, 181588 02-13, 181593 

02-03, 182555 03-03, 182556 03-13 
SAWADA T 182096 02-03 
SAWICKY TE 186701 03-03 
SAYERS AC 185750 03-03 
SCARBORO MB 182193 02-04 
SCATTAREGIA F 182155 02-03 
SCELLES F 184955 03-17 
SCERNI R 182215 03-04 
SCHAEFER GJ 1 78638 02-04, 184242 03-04 
SCHAEFFER JC 182250 03-03 
SCHAEPPI U 189516 04-04 
SCHALCH DS 189076 04-09 
SCHALLEK W 181575 02-03, 182771 03-17 
SCHALLYAV 175245 02-13, 189076 04-09 
SCHANBERG SM 191512 04-13, 191922 04-03 
SCHARER K 17902102-05 
SCHARFM 17211401-15 
SCHEEL-KRUGER J 171627 01-03 
SCHERRER P 182898 03-15, 182899 03-17 
SCHIELE BC 192065 04-13 
SCHILDKRAUT JJ 169091 01-13, 178114 02-09, 

191523 04-01 
SCHINTOMI K 182107 02-04 
SCHLEDE E 184228 03-03 
SCHLOSSER W 182126 02-03, 182771 03-17 
SCHMALTZ G 189215 04-04 
SCHMIDBAUERW 175537 02-17 
SCHMIDT KT 181153 02-08 
SCHMITT H 186576 03-04 
SCHMITT R 167334 01-07 
SCHNEIDER B 176107 02-10 
SCHNEIDER FH 190907 04-03 
SCHNEIDER J 185112 03-03 
SCHNITZERRJ 179983 02-17 
SCHNOLLSH 182186 02-03 
SCHOLES NW 169689 01-03 
SCHOLFIELD CN 191945 04-03 
SCHOLZ SD 173039 01-04 
SCHONERW 189567 04-03 
SCHOU M 167675 01-09, 182433 03-09, 185192 

03-11 
SCHREIBER RA 184235 03-03 
SCHROEDERCS 19032104-14 
SCHROEDER DH 191978 04-10 
SCHROEDER SR 190321 04-14 
SCHUBERT DSP 169635 01-15 
SCHUBERT J 168839 01-03 
SCHUBERTH J 171600 01-03 
SCHULTERBRANDT JG 171502 01-09 
SCHULTES RE 189101 04-12 
SCHULZ R 171610 01-03, 182161 02-03 
SCHULZE G 177337 02-03 
SCHUMPELICK V 178945 02-03 
SCHUSTER CR 181879 02-13, 188120 04-13 
SCHWABE U 181467 02-03 
SCHWARTZ J 168750 01-03, 189396 04-03 
SCHWARTZ JL 177747 02-07 
SCHWARTZ M 170837 01-03, 173398 01-03, 

189075 04-13 
SCHWARTZ NB 175650 02-03 
SCHWARTZBAUM JS 173032 01-04, 187700 

04-04 
SCHWIN R 182719 03-13 
SCOGGINS BA 187582 04-10 
SCOTT DF 184445 03-10 
SCOTT J 191400 04-14 
SCOTT JE 174966 01-15 
SCUDDER CL 188637 04-04 
SEDVALL G 171626 01-03, 186565 03-08, 186566 

03-16 



SEEMAN P 182127 02-03, 187801 04-03, 187802 

04-03, 187803 04-03, 187804 04-03, 187805 

04-01, 189400 04-03, 189401 04-03 
SEEVERS MH 191603 04-16 
SEGAL A 176107 02-10 
SEGAL DS 185264 03-03 
SEGAL M 187499 04-04, 190829 04-03, 191996 

04-03 
SEGAWAY 191670 04-09 
SEHON AH 187129 03-04 
SEIDEN LS 171612 01-04 
SEIFERT J 170072 01-03 
SEIFTER E 182254 03-03 
SEIFTER J 182254 03-03 
SEILER K 184226 03-03 
SEILER N 181944 02-03 
SEISER RL 189381 04-03 
SEKERKE HJ 172272 01-11 
SELBY G 191614 04-11 
SELIGER DL 167415 01-03 
SELIVANOVA AT 183517 03-04 
SELLERS EM 179987 02-13, 192005 04-11 
SELYE H 183611 03-03 
SEMEL C 178578 02-08 
SENAULT B 186374 03-04 
SENGUPTA S 187805 04-01 
SERAFETINIDES EA 173402 01-08, 174135 01-16, 

181918 0213, 184177 03-11 
SERRANO AC 169457 01-14 
SERRANO M 167343 01-08 
SETH SK 187937 04-01 
SETHI ML 170839 01-06 
SETHNA ER 185078 03-10 
SETHNA KJ 175620 02-17 
SETHYVH 188429 04-11 
SETYONEGORO K 180299 02-1 1 
SETYONEGORO RK 170412 01-11, 170753 01-11, 

171162 01-10 
SHAGASS C 169092 01-09 
SHAH BK 167344 01-09 
SHAH LP 172444 01-08, 174588 01-08, 174589 

01-08, 175393 02-11, 175967 02-10, 180153 

02-08 
SHAH NS 191933 04-03 
SHAMBHU MB 190715 04-01 
SHAPIRO AK 188431 04-11 
SHARMA S 180406 02-09, 189359 04-14 
SHARPE LG 191367 04-04 
SHARPLESS NS 176936 02-03 
SHASTRI PC 174589 01-08, 180153 02-08 
SHAVELZON A 180140 02-12 
SHEAR 189358 04-14 
SHEEHAN DV 177681 02-12 
SHEERIN E 170802 01-17 
SHEHORN J 18402103-12 
SHELLENBERGER MK 191988 04-03 
SHELLEY E 169495 01-09 
SHELTON JW 176868 02-04 
SHEPPARD C 185877 03-08, 187840 04-17 
SHEPPARD H 180097 02-03, 181575 02-03 
SHERMAN AD 187077 03-03 
SHERMAN WR 191924 04-13 
SHERWOOD BE 190719 04-02 
SHIBATAY 168302 01-17 
SHIBUYA T 182106 02-17 
SHIELDS WE 189640 04-17 
SHIGEYOSHI T 176473 02-10 
SHIH JC 189597 04-03, 191498 04-01 
SHIH T 191946 04-03 
SHIH TM 182222 03-03 
SHIMAZU Y 178224 02-08 
SHIMIZU H 182099 02-03 
SHIMIZU K 177022 02-03 
SHIMIZU S 182091 02-03 
SHIMURA M 182634 03-02 
SHIN KCL 180507 02-03 
SHINOHARA M 182105 02-03 
SHINTOMI K 183610 03-03 
SHIOZAKI M 176727 02-08 
SHIRRON C 182256 03-03 
SHOJI 181388 02-11 
SHOPSIN B 169094 01-09, 181957 02-10, 186920 

03-09, 191531 04-09 
SHORE PA 181809 02-03, 182234 03-03 
SHOSHKES M 192511 04-13 
SHOSTAK M 173536 01-06 
SHOULSON I 187985 04-11 
SHROFF AP 176871 02-16 
SHROFF PF 177320 02-11 



A-13 



Author Index 



Psychopharmocology Abstracts 



SHULGIN AT 192877 04-12 

SHULMAN RS 185210 03-10 

SHUMWAY J 191967 04-04 

SHUPACK JL 188414 04-15 

SHUSTER L 182225 03-03 

SICHEL J 182900 03-11 

SIEMENS AJ 179985 02-03, 192020 04-03 

SIEROSLAWSKA J 167813 01-04 

SIERRA MR 189754 04-12 

SIGGINS GR 187496 04-03 

SIGWALD J 171134 01-13 

SIKIC B 188120 04-13 

SILBERGELD EK 184953 03-04, 191954 04-05 

SILER TM 190104 04-13 

SUVA D 189597 04-03 

SILVERMAN I 167382 01-17 

SILVESTRINI B 168802 01-13 

SILVESTRINI F 188350 04-13 

SIMEON J 187115 03-09 

SIMON G 188874 04-05 

SIMON JR 191999 04-03 

SIMON M 189597 04-03 

SIMOPOULOS AM 171507 01-08 

SIMPSON FO 183234 03-09 

SIMPSON GM 187255 03-08 

SINGER K 171485 01-17,185192 03-11 

SINGHAN 168320 01-08,191140 04-11 

SINGH GB 17688102-03 

SINGH N 186569 03-03 

SINGHAL BS 172439 01-11 

SINGHAL RL 183358 03-03 

SINNETT ER 178695 02-17 

SINYUKHIN VN 183519 03-03 

SIRCOVICH 171122 01-11 

SIRIS JH 191096 04-13 

SIZARET P 18496103-17 

SJO 188889 04-11 

SJOQUIST B 171626 01-03 

SJOQVIST F 169074 01-01 

SJOSTROM R 169470 01-13 

SKOLNICK P 177252 02-03 

SKOPKOVA H 175047 02-11 

SKORINAJK 186833 03-14 

SKOUSEN WC 192092 04-17 

SLATER IH 190346 04-03 

SLEDGE K 192016 04-04 

SLEDGE KL 171304 01-04 

SLEIGH MJ 188770 04-01 

SLETTEN I 180064 02-10 

SLETTEN IW 176676 02-17 

SLOAN JW 186024 03-12 

SLOBODAW 181959 02-14 

SLOMINSKA-ZUREK J 186571 03-04 

SLOTNICK VB 177319 02-07 

SMALL E 192787 04-17 

SMALL JG 191188 04-15 

SMALLING KF 190196 04-09 

SMART R 167585 01-17 

SMATHERSCC 189856 04-03 

SMEETS RA 189923 04-13 

SMIRNOVA LV 174257 01-03 

SMITH AA 182164 02-03 

SMITH BM 189074 04-17 

SMITH CB 177406 02-03, 182255 03-03 

SMITH D 182156 02-03 

SMITH DC 189075 04-13 

SMITH GM 190743 04-14 

SMITH OP 182136 02-04 

SMITH GR 192231 04-09 

SMITH HJ 187640 04-04 

SMITH JE 171925 01-10 

SMITH JS 169140 01-15 

SMITH ML 187573 04-03 

SMITH RB 188875 04-05 

SMITH RD 186634 03-04 

SMITH SG 172454 01-04, 191899 04-04 

SMITH WM 185727 03-04 

SMITHLOFF BR 183895 03-03 

SMYTH WF 190902 04-06 

SMYTHIESJR 187260 04-04 

SNEED GA 172749 01-03, 177749 02-03 

SNIDER SR 18420103-03 

SNODDY HD 183869 03-03, 190346 04-03 

SNYDER E 187703 04-04 

SNYDER S 188114 04-15 

SNYDER SH 188121 04-12, 190476 04-03, 191290 
04-08 

SOBCHINSKAYA NM 183142 03-13 

SOBOTKA TJ 189564 04-05 



SODERSTEN P 171614 01-04, 186683 03-04, 

186691 03-04 
SOFIA RD 188876 04-05 
SOFRONOV GA 174257 01-03 
SOHEL MS 188873 04-03 
SOHN SS 170464 01-05 
SO KOLA A 178558 02-03 
SOLOMON TA 183795 03-03 
SOLYOM L 184259 03-15 
SOMERVILLE B 187615 04-11 
SOSKIN RA 181461 02-12 
SOUBRIERJ 184959 03-17 
SOURKES TL 188769 04-03 
SOVNER RD 183648 03-09 
SOYKA LF 185866 03-03 
SPARBER SB 168438 01-04, 186695 03-03 
SPARE B 171600 01-03, 171632 01-03 
SPATZ H 192521 04-09 
SPAULDING TC 174607 01-04, 182217 03-04 
SPECTOR S 189390 04-03 
SPEHLMANN R 188426 04-03, 189855 04-03, 

189856 04-03 
SPENCER HW 182727 03-03 
SPERANSKAYA NP 183206 03-04 
SPERO L 187804 04-03 
SPIGUEL RD 172916 01-03 
SPILKER BA 178557 02-03 
SPIRTES MA 1 89072 04-08 
SPITALNIK R 170744 01-11 
SPOHN HE 183629 03-08 
SPRAGUE RL 181853 02-14, 185861 03-14, 

187581 04-14 
SPREAVICE R 191604 04-17 
SPRINCE H 183602 03-01 
SPRING C 191400 04-14 
SPRING GK 191187 04-15 
SQUIRE LR 188605 04-04 
SQUIRES R 171628 01-03 
SRAM RJ 175043 02-04 
SRIMAL RC 176881 02-03 
SRINIWAS P 169633 01-11 

STACK JJ 182430 03-09 

STADLER H 189602 04-03 

STADNICKI SW 189516 04-04 

STAEHELIN M 181471 02-03 

STAHL SM 174609 01-14, 188426 04-03 

STAIMAN A 182127 02-03, 187802 04-03, 187803 
04-03, 189400 04-03 

STALLONE F 169494 01-09, 169495 01-09 

STANCAK A 178817 02-13 

STANCER HC 168312 01-17, 182725 03-03 

STARKE K 182345 03-03, 189568 04-03, 189569 
04-03 

STEELE CA 174137 01-08 

STEENBERG ML 185748 03-04 

STEIN DG 191378 04-04 

STEIN L 173029 01-03, 182210 02-04, 191529 
04-13 

STEINBOOK RM 190195 04-09 

STEINER M 184977 03-08 

STEINKEJ 168440 01-03 

STEINMEYER CH 186780 03-10 

STERANKA LR 179990 02-04 

STERN GM 168286 01-13 

STERN H 178549 02-11 

STERN M 184200 03-04 

STERN P 184200 03-04 

STERNS 189075 04-13 

STERNBACH LH 185034 03-01 

STEVENS BC 169438 01-08 

STEVENSON I 189074 04-17 

STEWART WJ 190334 04-04 

STIKELEATHER RA 171500 01-09 

STILL CN 169286 01-10 

STILLE G 191418 04-03 

STILLMAN R 173516 01-14, 173522 01-12, 
175003 02-14, 176480 02-12 

STITZEL RE 189177 04-02 

STOCK G 189571 04-03 

STOCK R 186589 03-06 

STODDARD DD 178812 02-03 

STOFF DM 1731 62 01 -04, 1 78575 02-04 

STOKES JD 188637 04-04 

STOLK JM 182442 03-05, 183891 03-03 

STONE RA 191512 04-13 

STONE TW 188739 04-03 

STONE WN 181072 02-10 

STORM-MATHISEN J 191319 04-03 

STORY DF 182088 02-03 



STORY NL 186204 03-15 

STOTSKY BA 190144 04-17 

STRADA SJ 171973 01-03 

STRAHILEVITZ M 187129 03-04 

STRASSER H 179023 02-13 

STRAUSS SM 177337 02-03 

STRAW RN 176108 02-13 

STREFFER C 185900 03-03 

STRICKER EM 168484 01-03, 182213 03-03, 

187695 04-03, 191520 04-04 
STROJNY N 169817 01-13 
STRONG KH 189902 04-15 
STULL RE 167287 01-03 
STUMPF C 178947 02-03 
sue 189597 04-03 
SUAREZ EM 190265 04-04 
SUDILOVSKY A 1 82248 03-03, 1 871 1 6 03- 1 3 
SUEHIRO K 182620 03-09 
SUEMITSU S 181388 02-11 
SUETA T 182551 03-10, 182552 03-15 
SUETSUGU T 178021 02-08 
SUGANO H 182620 03-09 
SUGIMURA N 176889 02-09 
SUGIYAMA K 178021 02-08 
SUK JH 182581 03-08 
SULE SM 172444 01-08, 180153 02-08 
SULSER F 171973 01-03, 192003 04-03 
SUM C 182203 02-06 
SUNDWALL A 171600 01-03, 171630 01-16 
SUNJIC V 187942 04-01 
SURIA A 170748 01-03, 182249 03-03, 186673 

03-03 
SUTHERLAND VC 182253 03-04 
SUURHASKO BVA 171624 01-03 
SUWA N 170638 01-13 
SUZUKI J 18177102-07 
SUZUKI T 182097 02-03 
SUZUKI Y 168498 01-05, 177063 02-17, 189587 

04-05 
SVENSSON TH 191948 04-03 
SWANSON WC 189072 04-08 
SWEET RD 175426 02-11, 188421 04-13. 188431 

04-11, 188433 04-03 
SWEETMAN BJ 191057 04-03 
SYMCHOWICZ S 175240 02-03 
SYMESAL 188769 04-03 
SZABO S 183611 03-03 
SZEKELYJI 192416 04-03 



TABAKOFF B 182157 02-03 

TABER CA 168436 01-03 

TABOR RG 192013 04-05 

TACHIBANA H 167921 01-14, 175550 02-08 

TACHIKAWA R 1 80487 02-01 , 1 80488 02-01 . 

180489 02-01 
TADANO T 182112 02-04 
TADOKORO S 1 82 1 1 6 02-04, 1 82 1 1 7 02-04 
TAEN S 1 76889 02-09 
TAGASHIRA E 182104 02-04 
TAGLIAMONTE A 168748 01-03, 188519 04-03 
TAGUCHI K 167917 01-09, 167918 01-09, 180301 

02-11 
TAHAAM 183600 03-01 
TAIT AC 192422 04-09 
TAIT RM 189590 04-03 
TAKAGI H 168499 01-07, 180490 02-02, 182094 

02-03 
TAKAGI M 189209 04-05 
TAKAHASHI H 175119 02-08 
TAKAHASHI R 177567 02-09, 185241 03-14 
TAKAHASHI S 167919 01-09, 170638 01-13, 

174125 01-04 
TAKAHASHI T 191677 04-17 
TAKAHASHI Y 181377 02-15 
TAKAI A 181386 02-04 
TAKAMORI M 170660 01-13 
TAKANO K 1 77097 02-05 
TAKASHINA K 176726 02-08 
TAKASU S 176473 02-10 
TAKAYA Y 171246 01-11 
TAKAYAMA I 182731 03-10 
TAKE Y 181657 02-02. 181658 02-02 
TAKEI H 191716 04-09 
TAKEMURA N 176889 02-09, 191686 04-08 
TAKENOSHITAM 182099 02-03 
TAN T 172114 01-15 



A-14 



VOLUME 12, AUTHOR INDEX 



Author Index 



TAN ABE K 181650 02-03, 182111 02-04, 182549 

03-03, 189209 04-05 
TANABE T 182872 03-03 
TANAKA A 182551 03-10 
TANAKA K 176470 02-08, 180307 02-17, 191686 

04-08 
TANAKA M 184314 03-13 
TANAKA R 178019 02-15 
TANAKA S 174680 01-08 
TANAKA T 1 78053 02-08 
TANASE H 168498 01-05 
TANAYAMA S 181654 02-04 
TANDA M 173548 01-05 
TANDOU OP 170414 01-11 
TANEDA M 176565 02-09 
TANG M 191768 04-03 
TANIMUKAI H 17468001-08, 17511902-08 
TANIWA M 171296 01-15 
TANNHAUSER M 168749 01-03, 183609 03-03, 

189609 04-03 
TANSELLAM 190336 04-11 
TARSY D 169120 01-03 
TARTARAA 167336 01-13 
TARVE US 191789 04-03 
TARVERJJ 189390 04-03 
TASSIN JP 188978 04-03 
TATEBE A 183369 03-10 
TAYLOR AN 181576 02-03, 183324 03-03 
TAYLOR CW 192231 04-09 
TAYLOR D 183787 03-03 
TAYLOR FH 183789 03-03 
TAYLOR IJ 191119 04-09 
TAYLOR M 187925 04-04, 187926 04-04, 190335 

04-04 
TAYLOR MA 170627 01-09 
TAYLOR ML 185979 03-01 
TAYLOR WA 174959 01-03 
TEJAJS 174376 01-09 
TELFORD R 182763 03-14, 187350 04-13 
TELLER DN 191413 04-03 
TEMPESTA E 186643 03-14 
TEMPLE DM 184223 03-03 
TENNANT FS 177452 02-15 
TENNENTG 19006104-11 
TEOH PC 167460 01-13 
TERADA A 180487 02-01, 180488 02-01, 180489 

02-01, 180490 02-02 
TESAROVA 180062 02-10 
TESSEL RE 191915 04-04 
TESSMANN R 180674 02-11 
TESTA G 188374 04-03 
TETREAULT L 167343 01-08, 183359 03-03, 

183361 03-09, 183362 03-10 
THEOBALD W 192420 04-13 
THEORELL K 168523 01-14 
THERES C 172926 01-03, 185901 03-03 
THETFORD PE 183629 03-08 
THIELE W 187959 04-17 
THIELEMANS G 183201 03-11 
THIERRY AM 188978 04-03 
THIESSEN PN 176597 02-17 
THOA NB 178747 02-03, 187397 04-03 
THOMAS E 182154 02-03 
THOMAS JA 183358 03-03 
THOMAS M 182835 03-17, 189059 04-07 
THOMPSON DM 174008 01-04, 177408 02-04 
THOMPSON GR 188872 04-05, 191965 04-03 
THOMPSON H 174138 01-09 
THOMPSON JA 176312 02-03, 186665 03-03 
THOMPSON JH 189597 04-03 
THOMPSON J W 1 82763 03- 1 4, 1 87350 04- 1 3 
THOMPSON WO 186665 03-03. 187254 03-15 
THONG YH 174568 01-11 
THORNBURG JE 177840 02-03, 182209 02-04, 

186635 03-04, 192012 04-04 
THORNER R 177730 02-13 
THORNTON BP 174298 01-11 
THORNTON WE 174298 01-11 
THUT PD 187119 03-04 
TILSON HA 168438 01-04, 176869 02-04, 182251 

03-03, 187930 04-04, 191906 04-03 
TIMIRAS PS 182119 02-03 
TIMMONS MC 176747 02-03, 182223 03-03, 

188119 04-13 
TINKLENBERG JR 177720 02-14, 185330 03-14, 

185932 03-13, 189406 04-14 
TIPTON RK 182134 02-03 
TISSARI AH 171624 01-03 
TISSOT R 169468 01-09 



TITOVA VG 191121 04-03 

TJANDRA J 170412 01-11 

TO DH 180320 02-17 

TOBIAS LL 175862 02-17 

TOBIN T 182184 02-03 

TODRICK A 192422 04-09 

TOGULGAG 191300 04-03 

TOLISG 188428 04-13 

TOLLE R 182591 03-14 

TOMAS D 182435 03-11 

TOMASELLO F 171794 01-13 

TOMASI L 177729 02-13, 186377 03-06 

TOMINAGA H 191723 04-09 

TONAMI M 176470 02-08 

TONGE SR 191383 04-03 

TONGYONK J 172800 01-11 

TORAIWAS 176726 02-08 

TORAN-ALLERAND CD 186033 03-03 

TORMAYA 192000 04-03 

TORRE E 184975 03-03 

TORRE M 184975 03-03 

TORRELIO M 169467 01-03 

TORRIELLI MV 178756 02-04 

TOSELAND PA 183793 03-13 

TOSI EC 167340 01-11 

TOSI GC 167340 01-11 

TOSOVSKYJ 192419 04-11 

TOUYAA HJ 180145 02-12 

TOWNEND RA 185007 03-09 

TRABER DL 167334 01-07 

TRABUCCHI M 180582 02-03, 184553 03-03, 

187526 04-03, 187527 04-03, 188891 04-03 
TRANZERJP 186677 03-03 
TRAPPE B 180048 02-10 
TRAVERS RD 184439 03-15 
TREIBER L 183603 03-13 
TREMBLAY EC 189517 04-05 
TRENCHI HM 186574 03-11 
TRENDELENBURG U 189604 04-03 
TREVOR AJ 186693 03-03 
TROUPIN AS 192391 04-07 
TRUEMAN HR 185194 03-08 
TS'O TOT 182258 03-04, 191974 04-04 
TSCHAKALOFFC 178947 02-03 
TSCHENTSCHER K 181470 02-03 
TSENG L 184179 03-03, 186670 03-04 
TSENG LF 182253 03-04, 186671 03-03 
TSUCHIE F 182103 02-04 
TSUI PT 187129 03-04 
TSUJIMOTOA 188199 04-03 
TSUKAMOTO R 176474 02-10 
TSUTSUI S 17128201-11,18262403-11 
TSUTSULKOVSKAYA MY 183683 03-08 
TUBAS T 191141 04-04 
TUOMISTO J 180055 02-06 
TUPIN JP 189095 04-08 
TURECEK LE 187582 04-10 
TUREK I 184653 03-09, 190146 04-07 
TUREK IS 177670 02-11 
TU RKAN IS SA 1 74608 1 -05, 1 75238 02-03, 

191994 04-03 
TURKERMN 186585 03-03 
TURKERRK 186585 03-03 
TURNBOW M 183894 03-03 
TURNER AJ 189752 04-03 
TURNER CE 180670 02-01 
TWYCROSS RG 191606 04-17 
TYCE GM 176936 02-03 
TYE N 186637 03-04 
TYRER P 168832 01-10 
TYRER PJ 188887 04-10 



U 



UBAGOJG 189754 04-12 

UCHA R 191139 04-17 

UCHIMURAY 176889 02-09 

UDABE RU 168803 01-11, 189331 04-17 

UDESCHINI G 188200 04-03 

UEKI S 181384 02-04, 182095 02-03, 182114 

02-04, 182115 02-04 
UEMURA H 182097 02-03 
UHLENHUTH EH 171507 01-08 
ULIANA R 177671 02-11 
ULIANA RL 185881 03-14 
UNGAR F 191956 04-03 
UNGER S 18812104-12 
UNWIN A 172741 01-08 
URBAN I 188166 04-04 



URCUYO L 185875 03-11 
URETSKY NJ 186694 03-03 
URQUHART N 191331 04-03 
USDIN E 170302 01-06 
USHER DR 183358 03-03 
USHIJIMA I 182109 02-04 
USHI2IMA t 178725 02-03 
USUI H 178021 02-08 
UTSUMI S 182096 02-03 
UYENO ET 182189 02-04 



VAHIA NS 187477 04-09 

VAHIAV 187477 04-09 

VAKHING VA 191786 04-02 

VALENTINE MG 185194 03-08 

VAN DAM DP 187381 04-03 

VAN DEN BRINK EG 191420 04-03 

VAN DER KLEIJN E 186184 03-13 

VAN DER POEL AM 187259 04-04, 187641 04-04 

VAN DER STEEN JA 187835 04-03 

VAN DER WIEL HJ 183194 03-09 

VAN KAMMEN DP 178432 02-09 

VAN LEEUWEN WS 188166 04-04 

VAN LOMMEL R 192431 04-08 

VAN PRAAG HM 169095 01-09, 184652 03-09 

VAN RENYNGHE DE VOXVRIE G 183202 03-09 

VAN ROSSUM JM 174763 01-04, 187666 04-04 

VAN TYLE WK 174960 01-03, 182131 02-04 

VAN WOERT MH 170662 01-13, 188429 04-11 

VANDENBOS GR 173534 01-08, 178677 02-17 

VANDERVORT W 1 76 1 07 02- 1 

VANPUTTEN T 171506 01-15 

VANWERSCH RAP 171521 01-04 

VANWYKE PE 185676 03-14 

VAPAATALO H 1 76879 02-04 

VAQUEZ AJ 187552 04-03 

VARDARIS RM 167398 01-04 

VARGA E 187255 03-08 

VARGAS JR 189076 04-09 

VARMA B 182088 02-03 

VARMA LP 180155 02-14 

VASKO MR 186703 03-04 

VAUGHAN T 173521 01-14, 188115 04-08 

VAUGHAN TB 175003 02-14 

VAZQUEZ AJ 179992 02-03 

VEACH HO 188447 04-11 

VEALS J 1 75240 02-03 

VEAUVY N 182432 03-10 

VELDKAMPW 176108 02-13 

VENABLES PH 183630 03-17 

VENALAINEN E 180047 02-13 

VENCOVSKY E 178029 02-17 

VENTAFRIDDAV 191604 04-17 

VENTOURAS K 180700 0215 

VENTURA DF 182254 03-03 

VENTURA MS 188533 04-17 

VERGARA L 191138 04-14,191139 04-17 

VERMEYLEN J 183201 03-11 

VERNADAKIS A 178814 02-03, 184372 03-03 

VERRIER J 182901 03-11 

VESELL ES 181398 02-13 

VESSMAN J 171630 0116 

VETULANI J 192003 04-03 

VIBALJR 183402 03-13 

VICHAIYA V 183749 03-15 

VICTOR SJ 188287 04-03 

VIDAJA 187939 04-01 

VIGNALOU J 168369 01-11 

VIIK K 182128 02-04 

VILLARREAL JE 182162 02-03 

VILLENEUVE A 167587 01-15, 178187 02-08, 

178193 02-11, 188406 04-03, 19114204-15 
VILLENEUVE R 167587 01-15, 178193 02-11, 

188406 04-03 
VINAR 168800 01-17 
VINDING T 173452 01-17 
VIVONIA CA 189587 04-05 
VOGEL E 184585 03-05 
VOGEL RA 191917 04-04 
VOGEL W 187149 03-13 
VOGEL WH 170464 01-05, 182186 02-03, 183602 

03-01, 186706 03-03 
VOLAVKA J 169068 01-13, 189059 04-07 
VOLICER L 167326 01-03 
VOLLMER RR 183795 03-03 
VOMSCHEIDTJ 175537 02-17 
VON BAHR C 171631 01-03 



A-15 



Author Index 

VON SCHWARTZENFELD I 191411 04-03 
VON VIETINGHOFF-RIESCH F 186164 03-04 
VON ZEPPLIN I 174043 01-14 
VORE M 191057 04-03 
VORONTSOV VA 183520 03-01 
VRBANAC JJ 182251 03-03 
VUGRINCIC C 182157 02-03, 191956 04-03 
VYSOTSKAYA NB 183518 03-01 

W 

WADA T 176473 02-10 

WADDINGHAM S 175895 02-03 

WAGLE GP 187931 04-03 

WAGNER LA 190907 04-03 

WAHLSTROM G 171601 01-03 

WAUiR J 1 77754 02-08, 1 83275 03-08, 1 841 74 

03-11 
WAJDA IJ 182224 03-03 
WAKAMATSU Y 182105 02-03 
WALDECK B 184201 03-03 
W/ALDMEIER PC 172917 01-03 
WALFORD RL 169675 01-03 
WALKER CA 191918 04-03 
WALKER JB 187110 03-03 
WALL EM 1 76747 02-03 
WALL ME 182223 03-03, 1881 19 04-13 
WALLACE JE 169782 01-03, 192013 04-05 
WALLACH M 191977 04-04 
WALLACH MB 191504 04-04 
WALLET 177395 02-15 
WALSH CT 182715 03-03 
WALSH DB 177392 02-15 
WALSH JM 186630 03-04 
WALTER LA 189178 04-02 
WALTERS JR 191519 04-03, 1 9 1 93 1 04-03 
WAMPLER KS 178695 02-17 
WANG H 192229 04-09 
WANGS 180097 02-03 
WANG SC 183887 03-03 
WANG TST 187939 04-01 
WARD J W 1 82 1 24 02-03, 1 82 1 25 02-03 
WARSH JJ 182725 03-03 
WASERPG 184227 03-03 
WASSERMAN 184226 03-03 
WASTERLAIN CG 188433 04-03 
WATANABE E 170638 01-13 
WATANABE S 167917 01-09, 167918 01-09, 

180301 02-11, 182095 02-03 
WATERS W 187638 04-04 
WATKINS JC 189750 04-03 
WATTS G 169138 01-11 
WATTS RD 188584 04-11 
WAUQUIER A 185961 03-04, 190306 04-03 
WAY EL 182159 02-03, 182231 03-03, 184179 
03-03, 188178 04-03, 191769 04-03, 191898 
04-03, 191985 04-03 
WEAVER SS 191939 04-04 
WEBB RW 182134 02-03 
WEBB W 176675 02-14 
WEBER F 189568 04-03, 189569 04-03 
WEBER U 183866 03-03 
WEBSTER CD 189519 04-04, 192413 04-03 
WECKOWICZ TE 188107 04-09 
WEDIG JH 173257 01-03 
WEEKS JR 191940 04-04 
WEI E 173872 01-03 
WEIDNER MF 174210 01-14 
WEINER N 191514 04-06 
WEINFELD RE 169817 01-13, 170838 01-13 
WEINGARTNER H 16950401-09, 17351601-14, 

175003 02-14 
WEINSTEIN B 177836 02-04 
WEISE CC 185747 03-09 
WEISS AA 171124 01-10 
WEISS BL 171503 01-09 
WEISS GB 172925 01-03 
WEISS LR 191976 04-04 
WEISSMAN L 169817 01-13 
WEISSMAN M 171924 01-10 
WEISSMAN MM 185322 03-10 
WELBEL L 174777 01-10 
WELLER M 188348 04-09 
WENDER P 169861 01-11 
WENGER GR 186669 03-03, 191973 04-04 
WERBENEC J 180722 02-07 
WERNER WL 191096 04-13 
WERRY JS 187581 04-14 
WEST AP 189099 04-15 



WEST LG 192882 04-01 

WEST NR 183602 03-01 

WESTFALL TC 186676 03-03 

WESTON MJ 172741 01-08 

WHALEN EM 185747 03-09 

WHALLEY C 179992 02-03 

WH ANGER A 192229 04-09 

WHEELER TJ 190335 04-04 

WHITAKER CA 177720 02-14 

WHITE HD 189613 04-04, 192014 04-04 

WHITEHEAD WE 181879 02-13 

WHITSETT TL 174348 01-14 

WHYTE CR 185190 03-11 

WIBISONO S 180299 02-11 

WICKHAM PE 192575 04-13 

WIECZOREK V 174101 01-08 

WIENER L 188561 04-11 

WIESEL F 186566 03-16 

WIG NN 167346 01-10 

WIJSENBEEK H 184977 03-08 

WILBUR WR 187939 04-01 

WILES DH 184437 03-13 

WILEY RA 181391 02-01 

WILK S 177826 02-13 

WILLIAMS Bl 191969 04-03 

WILLIAMS DA 182244 03-03 

WILLIAMS FM 183793 03-13 

WILLIAMS MA 188865 04-05 

WILLIAMS SE 169140 01-15 

WILLINSKY MD 192413 04-03 

WILLIS D 174135 01-16 

WILLIS JC 174319 01-03 

WILLIS WD 174319 01-03 

WILLSON N 185112 03-03 

WILSON A 191935 04-04 

WILSON IC 171500 01-09, 172992 01-15, 191534 

04-09 
WILSON MC 169028 01-04 
WILSON RD 167334 01-07 
WILSON WA 188738 04-05, 189032 04-03 
WILSON WR 189394 04-03, 189395 04-03 
WINAKTU OA 170413 01-11 
WINBLADH B 171606 01-03 
WINNIK HZ 17112201-11 
WINOCUR G 184838 03-04 
WINSBERG BG 17777102-14 
WINSTEAD DK 189924 04-17 
WINSTON RA 172020 01-03 
WINTER DP 180097 02-03 
WINTER JC 176866 02-04, 184980 03-04, 186667 

03-04, 188229 04-12 
WIRZ-JUSTICE A 171307 01-03 
WISE CD 182210 02-04, 191529 04-13 
WISE JG 191995 04-03 
WISE RA 186613 03-04 
WISNIEWSKI K 187787 04-15 
WITIAK DT 187937 04-01 
WITT PA 181853 02-14 
WITT PN 182193 02-04 
WITTNERWK 185932 03-13 
WODE-HELGODT B 186565 03-08 
WOLCOTT GJ 173205 01-11 
WOLCOTT LJ 185932 03-13 
WOLF HH 181407 02-05 
WOLFF BB 177735 02-06 
WOLGIN DL 173775 01-03 
WOLLERT U 189595 04-13 
WOLTHUISOL 17152101-04 
WONG DT 191951 04-03 
WOODROW K 178578 02-08 
WOODS AC 186029 03-11 
WOODS HF 191497 04-03 
WOODS JH 191915 04-04,191972 04-04 
WOODS JM 191983 04-04 
WOODS P 192577 04-09 
WOODWARD JK 182214 03-03 
WOOLLEY E 17464101-17 
WOOTEN GF 1 78747 02-03, 187397 04-03 
WORKMAN M 176312 02-03 
WORSHAM E 167401 01-04 
WRAY M 167341 01-08 
WRIGHT DC 188226 04-14 
WU SC 174036 01-03 
WU YS 190716 04-01,190717 04-01 
WURSCH MS 175751 02-03 
WURTMAN RJ 174764 01-03, 183797 03-03, 

189399 04-04, 191771 04-03 
WUTTKEW 177719 02-04 



Psychopharmocology Abstracts 

WYATT R 173516 01-14, 173521 01-14, 173522 
01-12, 178432 02-09, 187113 03-08, 192335 
04-03 

WYATT RJ 173398 01-03, 175003 02-14, 176480 
02-12, 187642 04-14, 188115 04-08 



YABE Y 180487 02-01, 180488 02-01, 180489 

02-01 
YAGI G 170637 01-08 
YAGIELA JA 188231 04-03 
YAMADA E 176564 02-11 
YAMAGUCHI N 176475 02-09 
YAMAGUCHI S 186476 03-05 
YAMAKAGE N 176542 02-11 
YAMAKI T 182185 02-03 
YAMAMOTO H 182108 02-04 
Y AMAMOTO I 1 82 1 1 3 02-03, 1 9 1 898 04-03 
YAMAMOTO J 188501 04-07 
YAMAMOTO K 182096 02-03 
YAMAMOTO N 183369 03-10 
YAMAMOTO T 1 8 1 384 02-04, 1 892 1 9 04-03 
YAMAMU RA HI 1 88 1 1 4 04- 1 5, 1 9 1 290 04-08 
YAMAMURA M 182107 02-04, 183610 03-03 
YAMANAKA T 182552 03-15 
YAMASH ITA I 1 70638 1 - 1 3, 1 9 1 665 04-09 
YAMASHITAJ 174855 01-05 
YAMAUCHI I 171245 01-08 
YAMAUCHI Y 182637 03-02 
YAMAURA H 176471 02-11 
YAMAZAKI M 181650 02-03, 182549 03-03, 

1 89209 04-05 
YAMAZAKI Y 182553 03-04, 182554 03-04 
YANAGITAT 174125 01-04, 182110 02-04 
YANAURA S 182104 02-04 
YANG DC 174071 01-11 
YANG H-T 186668 03-03 
YANG HT 168437 01-03, 191500 04-03 
YANNIOTIS G 169468 01-09 
YANO H 181588 02-13, 181593 02-03, 182555 

03-03, 182556 03-13 
YARYURA-TOBIAS JA 192521 04-09 
YASHIMAY 171246 01-11 
YASUHARAM 182547 03-03 
YAUCHI N 178053 02-08 
YEH JZ 186672 03-03 
YEHUDA S 174764 01-03, 183797 03-03, 189399 

04-04 
YELLOWLEY TW 167575 01-10 
YEN F 192084 04-15 
YEN SSC 19010404-13 
YEN-KOO HC 191982 04-15 
YEN-KOO HCY 176863 02-04 
YOKEL RA 185960 03-04, 191919 04-04 
YOKOTAN H 177097 02-05 
YOKOTANI H 173548 01-05 
YOKOYAMA S 167918 01-09 
YOMAIDA I 182872 03-03 
YOO BY 175239 02-03 
YORIOKA N 176564 02-11 
YOSHIDA S 176470 02-08, 178623 02-09 
YOSHIMI T 167919 01-09 
YOSHIMURA M 167919 01-09 
YOSHIMUTAT 182731 03-10 
YOUDIM MBH 191496 04-03, 191497 04-03 
YOUNG J 185008 03-11 
YUJL 16813101-03 
YUNGER LM 191947 04-05 



ZABIKJE 18738104-03 
ZARAMM 172512 01-11 
ZARAGOZA H 172977 01-11 
ZARATEA 175245 02-13 
ZAREMBAAL 189924 04-17 
ZARIFIAN E 184962 03-09 
ZAVATSKY E 182126 02-03 
ZEBROWSKA-LUPINA I 17772102-04 
ZEIDENBERG P 177674 02-14 
ZEMP JW 182229 03-03, 184235 03-03 
ZETLERG 177730 02-13 
ZIEGLGANSBERGER S 169474 01-03 
ZIGMOND MJ 168484 01-03, 182213 03-03, 
187695 04-03, 187699 04-04, 191520 04-04 
ZIGMOND RE 171785 01-03 
ZILM DH 192005 04-11 
ZIMMERMAN-TANSELLA C 190336 04-1 1 



A-16 



VOLUME 12, AUTHOR INDEX 



Author Index 



ZIMMERMANN E 183324 03-03 

ZIMMERMANN R 192065 04-13 

ZIRZOW G 182239 03-04 

ZISKIND D 183470 03-04 

ZIVANOVIC D 182129 02-03 

ZIVKOVIC B 170086 01-03, 170755 01-03, 



173381 01-03, 191515 04-03 
ZMORSKI T 187958 04-11 
ZNANIECKAV 181192 02-08 
ZOCH C 191138 04-14,191139 04-17 
ZOLFAGHARI M 191522 04-13 
ZSIGMOND EK 190147 04-13 



ZUANAZZI GF 183199 03-11 

ZUDOVA Z 175043 02-04 

ZUNG WWK 168419 01-14,175286 02-10, 

192229 04-09 
ZWEIG JS 175759 02-03, 187941 04-01, 190718 

04-03 



■ 'H 



A-17 



SUBJECT INDEX 



(The Subiecl Index is machine generoted. Keywords in the titles of obstrocts oppeor olphobeticolly in the left hand ttiorgin; under each keyword is o list of titles in which the 
keyword appears. The spelling of words in the titles of obstrocts has not been changed; hence, two spellings of the some word moy oppeor in this index - for example, 
BEHAVIOR and BEHAVIOUR J 



ABDOMINAL 

THE EFFECT OF DIAZEPAM ON SOME CARDIOVASCULAR AND 
RESPIRATORY REFLEXES ELICITED BY AFFERENT ABDOMINAL VAGUS 
STIMULATION. 

178945 02-03 
ABERRATION 

EMERGENCY TREATMENT OF AN ACUTE STATE OF MENTAL ABERRATION. 

191723 04-09 
ABILITY 

A ROLE OF THE DIETARY LIPID IN THE ABILITY OF PHENOBARBITAL TO 
STIMULATE DRUG DETOXIFICATION. 

175859 02-03 
ABLATIONS 

EFFECTS OF PSYCHOTROPIC DRUGS ON DISCRIMINATION AVOIDANCE 
CONDITIONING IN RATS WITH OLFACTORY BULB ABLATIONS. 

182115 02-04 
SHIFTING OF THE D-AMPHETAMINE DOSE-RESPONSE CURVE IN RATS 
WITH FRONTAL CORTICAL ABLATIONS. 

187261 04-04 
ABNORMAL 

BEHAVIOURAL STATE CYCLES IN ABNORMAL INFANTS. 

168523 01-14 
THOUGHTS ON TREATMENT BY PRIVATE PHYSICIANS OF ABNORMAL SEX 
DRIVES. 

180674 02-11 
EFFECTS OF PSYCHOTROPIC DRUGS ON ABNORMAL BEHAVIOR INDUCED 
BY DELTA9-TETRAHYDR0CANNABIN0L. 

182114 02-04 
ABNORMAUTIES 

THE ELECTROCARDIOGRAPHIC ABNORMALITIES INDUCED BY 
PSYCHOTROPIC DRUGS. 

170638 01-13 
MUSCLE ABNORMALITIES IN PSYCHOTIC PATIENTS: II. SERUM CPK 
ACTIVITY, FIBER ABNORMALITIES, AND BRANCHING AND SPROUTING 
OF SUBTERMINAL NERVES. 

187114 03-09 
ABNORMALITIES IN TRYPTOPHAN METABOLITES IN SCHIZOPHRENIA. 

191536 04-13 
ABNORMAUTY 

THE ELECTROCARDIOGRAPHIC ABNORMALITY INDUCED BY 
CHLORPROMAZINE. 

171296 01-15 
ABRUPT 

THE ABRUPT WITHDRAWAL OF ANTIPARKINSONIAN DRUGS IN 
SCHIZOPHRENIC PATIENTS. 

185005 03-08 
ABSENCE 

CNS DEPRESSION IN THE ABSENCE OF PROLACTIN RELEASE FOLLOWING 
INTRAARTERIAL INJECTIONS OF SODIUM PENTOTHAL IN THE 
PROESTROUS RAT. 

173257 01-03 
ABSENCE OF DEGENERATION OF ADRENERGIC NEURONS AFTER 
PROLONGED TREATMENT WITH DEBRISOQUIN. 

186677 03-03 
ABSENCE OF REM REBOUND AFTER BARBITURATE WITHDRAWAL. 

189884 04-14 
ABSORPTION 

STUDIES ON METABOLISM OF BROMAZEPAM (III): ABSORPTION, 
EXCRETION, AND METABOLISM OF BROMAZEPAM IN MAN. 

181588 02-13 
DIRECT DETERMINATION OF LITHIUM IN SERUM BY ATOMIC 
ABSORPTION SPECTROSCOPY. 

181653 02-06 
ABSORPTION, DISTRIBUTION, EXCRETION AND METABOLISM OF 
BROMAZEPAM IN RABBIT. 

182555 03-03 
DRUG ABSORPTION IN RATS PRETREATEO WITH ANTIBIOTICS. 

182715 03-03 
THE ABSORPTION AND DISTRIBUTION OF THE NEW ANTIDEPRESSANT 
AZAPHEN IN THE ORGANS. 

183519 03-03 
ABSORPTION AND CLEARANCE OF SECOBARBITAL, HEPTABARBITAL, 
METHAQUALONE, AND ETHINAMATE. 

192575 04-13 
ABSTINENT 

RESPONSE TO INCREMENTAL DOSES OF DITRAN IN ABSTINENT 
ALCOHOLICS AND DRUG USERS. 

185875 03-11 
ABSTRACT 

CLINICAL STUDIES OF ACUTE PSYCHOSIS ON THE BASIS OF CHRONIC 
HYPNOTICA INTOXICATION - AN ABSTRACT REPORT. 

182755 03-15 



ABUSE 

THE ROLE OF RESEARCH IN DRUG ABUSE INTERVENTION: STREET DRUG 
ANALYSES. 

167382 01-17 
ABUSE POTENTIAL OF ETORPHINE (M99) I. SUBJECTIVE EFFECTS AND 
PHYSICAL DEPENDENCE. (UNPUBLISHED PAPER). 

171241 01-14 
USE AND ABUSE OF DRUGS IN PSYCHIATRY. 

175620 02- 17 
COMPLICATIONS OF METHAQUALONE DIPHENHYDRAMINE (MANDRAX) 
ABUSE. 

177452 02- 15 
DRUG ABUSE - OVERDOSE AND RECOVERY. 

180147 02-15 
VALIDITY OF SCREENING METHODS FOR DRUGS OF ABUSE IN 
BIOLOGICAL FLUIDS. II. HEROIN IN PLASMA AND SALIVA. 

187256 03-15 
ACCOUNTING 

PERIPHERAL VERSUS CENTRAL MECHANISMS ACCOUNTING FOR 
ANTIANXIETY EFFECTS OF PROPRANOLOL. 

181072 02-10 
ACCUMULATION 

A CENTRAL EFFECT OF LOCAL ANESTHETICS: PREVENTION AGAINST THE 
ACCUMULATION OF CYCLIC AMP IN BRAIN SLICES. 

182099 02-03 
THE INHIBITION OF (3H) BIOGENIC AMINE ACCUMULATION INTO RAT 
BRAIN TISSUE SLICES BY VARIOUS TRYPTAMINE DERIVATIVES. 

182723 03-03 
ON THE CEREBRAL ACCUMULATION OF KETAMINE AND THE 
RELATIONSHIP BETWEEN METABOLISM OF THE DRUG AND ITS 
PHARMACOLOGICAL EFFECTS. 

186693 03-03 
PLASMA AND CEREBROSPINAL FLUID PROBENECID CONCENTRATIONS AS 
RELATED TO ACCUMULATION OF ACIDIC BIOGENIC AMINE 
METABOLITES IN MAN. 

187933 04-13 
SELECTIVE RESERPINE RESISTANT ACCUMULATION OF CATECHOLAMINES 
IN CENTRAL DOPAMINE NEURONES AFTER DOPA ADMINISTRATION. 

189026 04-03 
EXTRANEURONAL REMOVAL, ACCUMULATION AND 0-METHYLATION OF 
ISOPRENALINE IN THE PERFUSED HEART. 

189604 04-03 
ACEPERONE 

EFFECTS OF PHENOXYBENZAMINE, ACEPERONE AND CLONIDINE ON THE 
LEVEL OF 3-METH0XY-4-HYDR0XYPHENYLGLYC0L, (MOPEG) IN RAT 
BRAIN. 

180059 02-03 
ACET ALDEHYDE 

A COMPARISON OF THE EFFECTS OF CHRONIC ADMINISTRATION OF 
ETHANOL AND ACETALDEHYDE TO MICE: EVIDENCE FOR A ROLE OF 
ACETALOEHYDE IN ETHANOL DEPENDENCE. 

185992 03-03 
ACET AMIDE 

N-(2-DIETHYLAMIN0ETHYL) 2 (P-HYDROXYPHENOXY) ACETAMIDE, A 
METABOLITE OF MEFEXAMIDE IN MAN. 

187577 04-01 
ACETATE 

ALTERATION OF MATERNAL BEHAVIOR IN MICE FOLLOWING 
ADMINISTRATION OF CYPROTERONE ACETATE. 

172374 01-04 
EFFECTS OF CYPROTERONE ACETATE IN THE MALE JAPANESE QUAIL. 

186681 03-03 
ACETIC 

STUDIES ON BENZODIAZEPINOOXAZOLES V. REACTIONS Of 

BENZODIAZEPINOOXAZOLE DERIVATIVES WITH ACETIC ANHYDRIDE. 

180489 02-01 
ACETOPHENONE 

INTERACTION OF SEROTONIN ANTAGONISTS WITH 3,4-DICHL0R0-2-(2- 
IMIDAZOLIN-2-YL-THIO) 2 ACETOPHENONE HYDROBROMIDE (DITA) 
AND D-AMPHETAMINE HYDROBROMIDE (DITA) AND D-AMPHETAMINE 
ON CERTAIN BEHAVIORAL PARAMETERS OF MALE MICE. 

192014 04-04 
ACETYLASE 

EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS. 

169467 01-03 
ACETYLCHOLINE 

EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 



S-1 



Subject Index 



ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 

^'^^^ 169467 01-03 

SYNTHESIS OF ACETYLCHOLINE IN BRAIN NERVE TERMINALS DURING 
CONSCIOUSNESS AND BARBITURATE ANESTHESIA. 

1 71 600 01 -03 
INTERACTION BETWEEN ATROPINE AND OXOTREMORINE ON CORTICAL 
ACETYLCHOLINE AND MOTOR ACTIVITY. 

1 7 1 606 U I -Uo 

THE EFFECT OF PSYCHOTROPIC AGENTS ON SOME ASPECTS OF 

ACETYLCHOLINE METABOLISM IN CAT BRAINS. „,„,„. 

174257 01-03 

ACETYLCHOLINE TURNOVER IN BRAIN OF MICE AND RATS: EFFECTS OF 
VARIOUS DOSE REGIMENS OF MORPHINE. (UNPUBLISHED PAPER). 

180582 02-03 

THE EFFECT OF CATECHOLAMINES, ACETYLCHOLINE AND SEROTONIN ON 
THE MORPHINE TOLERANT LONGITUDINAL MUSCLE STRIP OF THE 

e^'^^^-^'^'^^^^ 18216102-03 

EFFECTS OF NARCOTIC ANALGESICS ON ENZYMES OF ACETYLCHOLINE 
METABOLISM IN CULTURED CHICK BRAIN CELLS. 

182225 03-03 

EFFECT OF ACUTE AND CHRONIC MORPHINE ON SPECIFIC 

RADIOACTIVITIES OF CHOLINE AND ACETYLCHOLINE IN MOUSE BRAIN. 

182226 03-03 
EFFECTS OF MORPHINE, NALORPHINE AND NALOXONE ON RAT BRAIN 

RELEASE OF ACETYLCHOLINE. 

182227 03-03 

EFFECTS OF VARIOUS MORPHINE TREATMENT SCHEDULES ON 
ACETYLCHOLINE TURNOVER RATE IN RAT BRAIN PARTS. 

184553 03-03 

PENTOBARBITAL AND IN VIVO TURNOVER RATE OF ACETYLCHOLINE IN 
MOUSE BRAIN AND IN REGIONS OF RAT BRAIN. (UNPUBLISHED 

'^''^'- ,87526 04-03 

EVIDENCE FOR AN INHIBITORY ROLE FOR ACETYLCHOLINE, 
CATECHOLAMINES, AND SEROTONIN ON THE CEREBRAL CORTEX. 

187552 04-03 
EFFECT OF TETRAHYDROCANNABINOLS ON BRAIN ACETYLCHOLINE. 

188167 04-03 

ACETYLCHOLINE AND DEPRESSION. 

188542 04-14 

THE EFFECTS OF ACETYLCHOLINE AND OF SYNAPTIC STIMULATION ON 
THE SENSORIMOTOR CORTEX OF CATS. I. NEURONAL RESPONSES TO 
STIMULATION OF THE RETICULAR FORMATION. 

1 89855 04-03 
THE EFFECTS OF ACETYLCHOLINE AND OF SYNAPTIC STIMULATION ON 

THE SENSORIMOTOR CORTEX OF CATS. II. COMPARISON OF THE 
NEURONAL RESPONSES TO RETICULAR AND OTHER STIMULI. 

189856 04-03 

EFFECT OF DIAZEPAM ON MOUSE WHOLE BRAIN AND BRAIN AREA 

ACETYLCHOLINE AND CHOLINE LEVELS. 

191423 U4-UJ 

BALANCE BETWEEN ACETYLCHOLINE, SEROTONIN, NOREPINEPHRINE, AND 

DOPAMINE IN SELF-STIMULATION. ^^ 

ROLE OF ACETYLCHOLINE AND DOPAMINE IN MANIC BEHAVIOR. 

191532 04-09 

INFLUENCE OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTS OF 
ELECTRICAL STIMULATION AND MICROINJECTION OF ACETYLCHOLINE, 
SEROTONIN AND NORADRENALINE INTO THE MESENCEPHALON. 

MORPHINE TOLERANCE, DEPENDENCE AND WITHDRAWAL AND BRAIN 
ACETYLCHOLINE. ,91985 04-03 

TETRAHYDROCANNABINOLS: INHIBITION IN ACETYLCHOLINE SYNTHESIS 
IN REGIONAL RAT BRAIN SLICES. ,91998 04-03 

INHIBITION IN VIVO OF ACETYLCHOLINE SYNTHESIS IN MOUSE BRAIN BY 
INHIBITORS OF CHOLINE ACETYLTRANSFERASE. ^^^^^^ ^^^^ 

*"YhANGES IN BRAIN ACETYLCHOLINESTERASE ACTIVITY OF YOUNG RATS 
AFTER CHRONIC TREATMENT WITH TREMORINE. ^_^^^^^ ^^^^ 

ACETYLCHOLINESTERASE INHIBITION AND MYELINOGENESIS IN VITRO. 

186033 03-03 

PHARMACOLOGICAL AND BIOCHEMICAL ACTIONS OF THE HEMOLYTIC 

AGENTS ACETYLPHENYLHYDRAZINE AND PHENYLHYDRAZINE ON 

MONOAMINE OXIDASE IN THE RAT. 

188769 04-03 

CHOLINE ACETYLTRANSFERASE ACTIVITY IN THE CEREBROSPINAL FLUID 
OF PSYCHIATRIC PATIENTS. ,80047 02-13 



Psychopharmacology Abstracts 

REGIONAL AND SUBCELLULAR DISTRIBUTION OF CHOLINE 

ACETYLTRANSFERASE IN THE BRAIN OF NORMAL AND MORPHINE 

TREATED RATS. „„„^ „,, „, 

182224 03-03 

DRUGS, BEHAVIOR AND CHOLINE ACETYLTRANSFERASE. 

182237 03-04 
TRANSSYNAPTIC INDUCTION OF CHOLINE ACETYLTRANSFERASE IN THE 
PREGANGLIONIC NEURON OF THE PERIPHERAL SYMPATHETIC NERVOUS 

''''"^- 182720 03-03 

INHIBITION IN VIVO OF ACETYLCHOLINE SYNTHESIS IN MOUSE BRAIN BY 
INHIBITORS OF CHOLINE ACETYLTRANSFERASE. 

192001 04-03 



ACH 



THE EFFECT OF METHAMPHETAMINE ON BRAIN ACH CONSUMPTION AND 
AGGRESSIVENESS IN MICE STRESSED MILDLY BY LONG-TERM 

'^°^^'°'- 182108 02-04 

EFFECT OF DIVALENT CATIONS ON ACH CONTRACTURES OF 
DEPOLARIZED DENERVATED RAT MUSCLES. 

188914 04-03 



ACID 



POTENTIATION OF THERAPEUTIC EFFECTS OF NICOTINIC ACID BY 
PYRIDOXINE IN CHRONIC SCHIZOPHRENICS. 

168313 01-08 

LYSERGIC ACID DIETHYLAAAIDE (LSD-25) AND GAMMA-AMINOBUTYRIC 
ACID (GABA) INTERACTION ON SPONTANEOUS POTENTIALS AND THE 
EVOKED RESPONSE IN THE AVIAN TECTUM. 

1 69689 U I -Uo 

INFLUENCES OF DRUGS ON THE INCREASES IN BRAIN DOPAMINE 
PRODUCED BY AXOTOMY OF GAMMA-HYDROXYBUTYRIC ACID 

'^^^A'- 171622 01-03 

INFLUENCE OF PHENOBARBITAL AND SEX HORMONES ON ENZYMES IN 
ASCORBIC ACID BIOSYNTHESIS IN MALE AND FEMALE RATS. (PH.D. 

^'^^^^^*^'°^'- 172017 01-03 

POTENTIAL PSYCHOTOMIMETICS: BROMOMETHOXYAMPHETAMINES AND 

STRUCTURAL CONGENERS OF LYSERGIC ACID. (PH.D. DISSERTATION)_^ 

1 73588 01-03 
BEHAVIORAL EFFECTS OF A NEW DOPAMINE-BETA-HYDROXYLASE 

INHIBITOR (FUSARIC ACID) IN MAN. (UNPUBLISHED PAPER 

THE EFFECTS OF AMPHETAMINE, 2-AMINOINDANE AND 2- 
AMINOTETRALIN ON THE CONCENTRATIONS OF WHOLE BRAIN 
NORADRENALINE, DOPAMINE, 5-HYDROXYTRYPTAMINE AND 5- 
HYDROXYINDOLEACETIC ACID IN THE MOUSE. 

1 74828 01 -0*^ 

STUDIES ON ENZYMATIC DEALKYLATION OF D-LYSERGIC ACID 

DIETHYLAMIDE (LSD). ,77336 02-0: 

LYSERGIC ACID DIETHYLAMIDE AND SEROTONIN: A COMPARISON OF 
EFFECTS ON SEROTONERGIC NEURONS AND NEURONS RECEIVING A 
SEROTONERGIC INPUT. ,77407 02-1: 

AMITRIPTYLINE IN MAN: DECREASED FORMATION OF CENTRAL 5- 

HYDROXYINDOLEACETIC ACID. ^^^^^^ ^^^, 

THE EFFECT OF PROBENECID AND LARGE DOSE AMPHETAMINE 
ADMINISTRATION ON CEREBROSPINAL FLUID HOMOVANILLIC ACID. 

1 77826 02-1. 
ACTION OF CONVULSANTS ON ROOT POTENTIALS AND AMINO ACID 
RESPONSES IN ISOLATED FROG SPINAL CORD. (UNPUBLISHED PAPER). 

1 77976 02-0 
NICOTINIC ACID INDUCED SYSTEMIC LUPUS-ERYTHEMATOSUS. 

180243 02-1 
STUDY WITH RADIOTRACERS OF THE DISTRIBUTION OF A NEW 
PSYCHOTROPE IN MICE: L-2-PYRROLIDONE-5-CARBOXYLATE 
DIMETHYLAMINOETHANOL. I. COMPARISON WITH L-GLUTAMIC AND I 
2-PYRROLIDONE-5-CARBOXYLIC ACID. ^^^^^^ ^^ ^ 

INCREASED GASTRIC ACID DURING SHOCK AVOIDANCE IN MAN. 

181 879 02- 1 

COMPARISON OF THE CHRONIC AND ACUTE EFFECTS OF D-LYSERGIC 
ACID DIETHYLAMIDE (LSD) TREATMENT ON RAT BRAIN SEROTONIN 
AND NOREPINEPHRINE. ,8,945 02-C 

A COMPARISON OF EFFECTS OF D-LYSERGIC ACID DIETHYLAMIDE (LSD) 
AND SEROTONIN ON PRE- AND POSTSYNAPTIC CELLS IN THE 
SEROTONIN SYSTEM. ,^^141 02.C 

EFFECT OF GAMMA-AMINOBUTYRIC ACID (GABA) ON MORPHINE 

ANALGESIA, TOLERANCE AND PHYSICAL DEPENDENCE. ^^^^^^ ^^ ^ 

SYNTHESIS OF COMPOUNDS RELATED TO LYSERGIC ACID. 

182445 03-1 



S-2 



VOLUME 12, SUBJECT INDEX 



Subject Index 



EVIDENCE FOR THE ACTION OF D-LYSERGIC ACID DIETHYLAMIDE, 

MESCALINE AND BUFOTENINE ON 5-HYDROXYTRYPTAMINE RECEPTORS 
IN UMBILICAL VASCULATURE. 

182716 0303 
THE ELIMINATION OF 5-HYDROXYINDOLEACETIC ACID FROM 

CEREBROSPINAL FLUID: CHARACTERISTICS OF THE ACID TRANSPORT 
SYSTEM OF THE CHOROID PLEXUS. 

182718 03-03 
NICOTINIC ACID AND CATECHOL-0-METHYLTRANSFERASE ACTIVITY IN 
SCHIZOPHRENIA. 

183360 03-13 
CATALEPSY AND STEREOTYPED BEHAVIOUR IN RATS TREATED 
CHRONICALLY WITH METHADONE: RELATION TO BRAIN 
HOMOVANILLIC ACID CONTENT. 

183606 03-04 
A NOVEL SPASMOLYTIC AND CNS ACTIVE AGENT: 3-{2- 

BENZYLMETHYLAMINOETHYL) BENZOIC ACID METHYL ESTER 
HYDROCHLORIDE. 

184581 03-02 
EFFECT OF LSD-25 AND 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE ON 
RAT BRAIN AND PLATELET SEROTONIN LEVELS. 

184975 03-03 
THE SITE OF ACTION ON THE OPTICAL ISOMERS OF l-METHYL-5-PHENYL- 
5PR0PYL BARBITURIC ACID. 

185901 03-03 
THE EFFECT OF CHLORPROMAZINE ON HOMOVANILLIC ACID LEVELS IN 
CEREBROSPINAL FLUID OF SCHIZOPHRENIC PATIENTS. 

186565 03-08 
MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND ITS 

HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD. 

186566 03-16 
THE EFFECTS OF CHRONIC RESERPINE AND NIALAMIDE TREATMENT ON 

THE FREE AMINO ACID LEVELS OF RAT BRAIN. 

187645 04-03 
METHIOTHEPIN ELEVATION OF 5-HYDROXYINDOLEACETIC ACID LEVELS IN 
VARIOUS ANATOMIC REGIONS OF RAT BRAIN. 

187831 04-03 
MESCALINE INDUCED CHANGES OF BRAIN CORTEX RIBOSOMES: EFFECT 
OF MESCALINE ON THE BINDING OF AMINOACYL TRANSFER 
RIBONUCLEIC ACID TO RIBOSOMES OF BRAIN TISSUE. 

189582 04-05 
THE ROLE OF 6AMMA-AMIN0BUTYRIC ACID AS A MEDIATOR OF 
POSITIVE DORSAL ROOT POTENTIALS. 

189832 04-03 
POTENTIAL INHIBITORS OF S-ADENOSYLMETHIONINE DEPENDENT 
METHYLTRANSFERASES: 1. MODIFICATION OF THE AMINO ACID 
PORTION OF S-ADENOSYLHOMOCYSTEINE. 

190716 04-01 
STUDIES ON CONVULSANTS IN THE ISOLATED FROG SPINAL CORD. I. 
ANTAGONISM OF AMINO ACID RESPONSES, (UNPUBLISHED PAPER) 

190727 04-03 
THE METABOLISM OF l-N-BUTYL-5,5 DIETHYLBARBITURIC ACID (N-N 
BUTYLBARBITAL) IN THE RAT. 

191057 04-03 
EFFECT OF PIRIBEDIL AND ONE OF ITS METABOLITES ON THE 
CONCENTRATION OF HOMOVANILLIC ACID IN THE RAT BRAIN. 

191422 04-03 
DIAZEPAM, CYCLIC NUCLEOTIDES AND AMINO ACID 
NEUROTRANSMITTERS IN RAT CEREBELLUM. (UNPUBLISHED PAPER). 

191764 04-03 
DISCRIMINATIVE CONTROL OF BEHAVIOR BY ELECTRICAL STIMULATION 
OF THE DORSAL RAPHE NUCLEUS: GENERALIZATION TO LYSERGIC 
ACID DIETHYLAMIDE (LSD). 

191944 04-04 
THE EFFECT OF INCREASED GAMMA-AMINOBUTYRIC ACID ON ALPHA- 
METHYLTYROSINE INDUCED DECREASE IN CATECHOLAMINES IN RAT 
BRAIN. 

191988 04-03 
CHROMOSOME EXAMINATIONS AFTER MEDICALLY ADMINISTERED 
LYSERGIC ACID DIETHYLAMIDE AND DEXTROAMPHETAMINE. 

192084 04-15 
ACIDIC 

PLASMA AND CEREBROSPINAL FLUID PROBENECID CONCENTRATIONS AS 
RELATED TO ACCUMULATION OF ACIDIC BIOGENIC AMINE 
METABOLITES IN MAN. 

187933 04-13 
ACIDS 

BRAIN AMINO ACIDS DURING CONVULSIONS. 

177135 02-03 
EFFECTS OF CHLORPROMAZINE AND ACTINOMYCIN D ON UPTAKE AND 
INCORPORATION OF CERTAIN AMINO ACIDS, HYPOXANTHINE AND 
THYMIDINE IN CULTURES OF HUMAN SKIN EPITHELIAL CELLS. 

179989 02-13 
ANALGESICS. I. SELECTED 5-SUBSTITUTED 5-PROPIONOXYBARBITURIC 
ACIDS. 

187939 04-01 



ACOUSTIC 

CENTRAL MONOAMINES AND THE ACOUSTIC STARTLE REACTION IN 
RATS. (PH.D. DISSERTATION). 

173136 01-04 
ACQUISITION 

ACQUISITION AND RETENTION OF AVOIDANCE BEHAVIORS FOLLOWING 
SEPTAL LESIONS OR SCOPOLAMINE INJECTIONS IN RATS. 

' 7401 01-04 
THE EFFECT OF DOPAMINE ANTAGONISTS AND AMANTADINE ON THE 
ACQUISITION OF THE CONDITIONED AVOIDANCE RESPONSE IN RATS 

174829 01-04 
ACQUISITION AND PERFORMANCE OF AN ATTENTION TASK BY RATS 
SUBJECTED TO CHRONIC NICOTINE TREATMENT. 

1 76864 02-04 
REPEATED ACQUISITION OF BEHAVIORAL CHAINS UNDER CHRONIC DRUG 
CONDITIONS. 

I 77408 02-04 
OPEN-FIELD BEHAVIOR AND ACQUISITION OF DISCRIMINATIVE RESPONSE 
CONTROL IN DELTA9-THC TOLERANT RATS. 

178813 02-04 
AN ANALYSIS OF D-AMPHETAMINE PRODUCED FACILITATION OF 
AVOIDANCE ACQUISITION IN RATS AND PERFORMANCE CHANGES 
SUBSEQUENT TO DRUG TERMINATION. 

1 79990 02-04 
THE EFFECT OF AMANTADINE, L-DOPA, (_) AMPHETAMINE AND 
APOMORPHINE ON THE ACQUISITION OF THE CONDITIONED 
AVOIDANCE RESPONSE. 

186636 03-04 
STRUCTURE-ACTIVITY RELATIONS OF SOME INDOLEALKYLAMINES IN 
COMPARISON TO PHENETHYLAMINES ON MOTOR ACTIVITY AND 
ACQUISITION OF AVOIDANCE BEHAVIOR. 

186703 03-04 
EFFECTS OF INTRACISTERNAL 6-HYDROXYDOPAMINE TREATMENT ON 
ACQUISITION AND PERFORMANCE OF RATS IN A DOUBLE T-MAZE. 

187696 04-04 
EFFECTS OF CYCLOHEXIMIDE ON ACQUISITION AND RETENTION OF 
AVOIDANCE LEARNING IN THE RAT: RECOVERY OF MEMORY 

189215 04-04 
AN ANALYSIS OF THE FACILITATION OF AVOIDANCE ACQUISITION BY D 
AMPHETAMINE AND SCOPOLAMINE. 

189521 04-04 
ACRIDAN 

CONFORMATIONAL ANALYSIS OF ACRIDAN DERIVATIVES BY NUCLEAR 
MAGNETIC RESONANCE SPECTROSCOPY. A RELATIONSHIP BETWEEN 
CONFORMATION AND PHARMACOLOGICAL ACTIVITY. 

190715 04-01 
ACROMEGALY 

INHIBITORY EFFECT OF DOPAMINERGIC STIMULATION ON GH RELEASE IN 
ACROMEGALY. 

188350 04-13 
ACTH 

ONTOGENESIS OF CIRCADIAN PITUITARY ADRENAL PERIODICITY IN RATS 
AFFECTED BY NEONATAL TREATMENT WITH ACTH. 

181576 02-03 
FAILURE OF ACTH TO INFLUENCE AVOIDANCE EXTINCTION IN A ONE- 
WAY AVOIDANCE SITUATION. 

183470 03-04 
EFFECT OF VARIOUS STEROIDS AND ACTH ON METHYPRYLON PLASMA 
LEVELS AND SLEEPING TIME IN RATS. 

183611 03-03 
A FREQUENCY SHIFT IN THE HIPPOCAMPAL THETA ACTIVITY: AN 

ELECTRICAL CORRELATE OF CENTRAL ACTION OF ACTH ANALOGUES IN 
THE DOG 

188166 04-04 
ACTING 

TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. (UNPUBLISHED PAPER). 

170876 01-03 
STUDY ON THE PSYCHOPHARMACOLOGICAL ASSAY OF CENTRALLY 
ACTING DRUGS IN RATS. 

171260 01-06 
EFFECTS OF CENTRALLY ACTING DRUGS ON ADENYL CYCLASE ACTIVITY 
AND CYCLIC AMP LEVELS OF MOUSE BRAIN. (PH.D. DISSERTATION). 

172019 01-03 
EFFECTS OF SELECTED CENTRALLY ACTING AGENTS ON ADENYL CYCLASE 
ACTIVITY IN MOUSE BRAIN. 

182153 02-03 
DRUGS ACTING ON THE CENTRAL NERVOUS SYSTEM 

182835 03-17 
THE ISOLATED PERFUSED RAT BRAIN AS A MODEL FOR STUDYING 
DRUGS ACTING ON THE CNS. 

186589 03-06 
A NEW PROLONGED ACTING TYPE OF CHLORPROMAZINE: BEHAVIORAL 
EFFECTS AND PROLONGED ACTIONS ON NERVE MEMBRANES. 

187805 04-01 



S-3 



Subject Index 



Psychopharmacology Abstracts 



rcNTRAl LY ACTING MUSCLE RELAXANTS. ISOMERIC 9,10 

^ SIhydroxyoctahydrophenanthrenes and their carbamate 

ESTERS. 190719 04-02 

BEHAVIORAL EFFECTS OF DIRECT AND INDIRECT ACTING DOPAMINERGIC 

AGONISTS. 191521 04-04 

ACT'NO'J^CIN Q^^2INE AND ACTINOMYCIN D ON UPTAKE AND 

'nCORPORAT ON OF CERTAIN AMINO ACIDS, HYPOXANTHINE AND 

Thymidine IN cultures of human skin epithelial cells^^^ ^^^^ 

^^^'^R^OSTAGLANDINS AND CANNABIS. A POSSIBLE MODE OF ACTION FOR 

THC. 169067 01-03 

FVALUATION OF THE HYPOTHERMIC ACTION OF 

TETRAHYDROCANNABINOLS IN MICE AND SQUIRREL MONK^EYS^^ ^^^^ 

THE EFFECT OF L-TRYPTOPHAN (TP) ON CUTANEOUS C-FIBER (CFR) AND 
POLYSYNAPTIC (PSR) REFLEXES IN ACUTE DECEREBRATE SPINAL CATS 
AND THE Ef Ea OF PRETREATMENT WITH P-CHLOROPHENYLALANINE 

TpCPA) on the action OF TP. (UNPUBLISHED PAPER). ^^^^^^ ^^ ^^ 

IS THERE A RELATIONSHIP BETWEEN THE INVOLVEMENT OF 
EXTRAPYRAMIDAL AND MESOLIMBIC BRAIN AREAS WITH THE 
CATALEPTIC ACTION OF NEUROLEPTIC AGENTS AND THEIR CLINICAL 
ANTIPSYCHOTIC EFFECT? 171305 01-03 

STUDY INTO THE MECHANISM OF THE ANORECTIC ACTION OF 

AMPHETAMINE AND ITS P-CHLORO ANALOGUE. ^^^^^^ ^^^^ 

A DIFFERENTIAL INHIBITORY ACTION OF LSD AND AMPHETAMINE ON 
COPULATORY BEHAVIOR IN THE FEMALE RAT. ^^^^^^ ^^ ^ 

COMPARISON OF TRICYCLIC ANTIDEPRESSANTS AS TO THEIR 

CARDIOTOXIC ACTION IN CONSCIOUS RABBITS. ^^^^^^ ^^^^ 

SEROTONINERGIC MECHANISMS IN THE CENTRAL ACTION OF 

PSYCHOTROPIC DRUGS. (PH.D. DISSERTATION). ^^^^^^ ^^^^ 

STUDY OF THE PSYCHOTROPIC ACTION OF TEGRETOL IN PATIENTS WITH 

EPILEPSY. 172439 01-11 

ON THE MECHANISM OF CENTRAL ACTION OF AMPHETAMINE: THE ROLE 

OF CATECHOLAMINES. 17292101-04 

DEPENDENCE OF ANTICONVULSANT DRUG ACTION ON CENTRAL 

MONOAMINES. 172923 01-03 

SLEEP: A TOOL TO STUDY CHLORPROMAZINES ACTION. (UNPUBLISHED 

PAPER). ,73521 oi-14 

BEHAVIORAL PARAMETERS OF DRUG ACTION: SIGNALED AND RESPONSE 

INDEPENDENT REINFORCEMENT. ^^^^^^ ^^^ 

APOMORPHINE INDUCED BITING AND FIGHTING BEHAVIOUR IN 
RE^ERPINIZED RATS AND AN APPROACH TO THE MECHANISM OF 
ACTION. 174768 01-04 

AMPHETAMINE TRICYCLIC INTERACTIONS; ROLE OF THE „,„,„^^„., 

HYDROXYLATION OF AMPHETAMINE IN ITS CENTRAL AND PERIPHERAL 
MODE OF ACTION. (PH.D. DISSERTATION). ^^^^^^ ^^^^ 

MEASURING THE PHARMACOLOGICAL ACTION OF IMIPRAMINE IN THE 
TREATMENT OF DEPRESSIONS. ^^^^^^ ^2-09 

THE MECHANISM OF ACTION OF THE MONOAMINE OXIDASE INHIBITOR 
PARGYLINE. 175239 02-03 

AfTION OF CONVULSANTS ON ROOT POTENTIALS AND AMINO ACID 

^IsPONSES^IN ISOLATED FROG SPINAL CORD. (UNPUBLISHE^DJ-APER)^^ 

ROLE OF 5-HT IN THE ACTION OF SOME DRUGS AFFECTING 

EXTRAPYRAMIDAL SYSTEM. ^^^^^^ ^2-04 

THF FIRST LONG-ACTING (RETARD) THYMOANALEPTIC OR 
InIiDEPRESSANT: the time-released DIBENZEPINE WITH 
PROLONGED ACTION. ,73,4^ Q2-11 

FURTHER EVIDENCE FOR A ROLE OF 2-PHENYLETHYLAMINE IN THE MODE 
''oJACTfoNOFDELTA9-TETRAHYDROCANNABINOL. ,„,,202-03 

THE MECHANISMS OF ACTION OF HALLUCINOGENS. ^^^^^^ ^^^^ 

A FEW GALENIC METHOD TO PROLONG THE ACTION OF LITHIUM 

SULFATE. 180700 02-15 



CENTRAL NERVOUS ACTION OF BROMAZEPAM, A NEW BENZODIAZEPINE 
DERIVATIVE. 181650 02-03 

INFLUENCES OF LITHIUM ON THE BEHAVIORAL ACTION OF 

METHAMPHETAMINE AND TETRABENAZINE. ^^^^^^ ^^^^ 

STUDIES ON THE ANOREXIGENIC ACTION OF PHENTERMINE. ^^^^^^ ^^^^ 

HYPOTHERMIC ACTION OF DELTA9-TETRAHYDR0CANNABIN0L, ll-OH- 
DELTA9-TETRAHYDR0CANNABIN0L AND 1 1-0H-DELTA8- 

Tetrahydrocannabinol (delta9-thc. ii-oh-delta9-thc and ii- 

0H-DELTA8-THC) IN MICE. ^^2220 03-03 

ACTION OF OPIPRAMOL (G-33040) IN DEPRESSIVE SYNDROMES IN 

CHILDREN AND ADOLESCENTS. ^^^432 03-10 

RUBIDIUM SALTS: BASIC MECHANISMS OF ACTION. ^^^^^ ^^^^ 

CENTRAL NERVOUS ACTION OF FLURAZEPAM, A NEW BENZODIAZEPINE 

DERIVATIVE. 182549 03-03 

cvinFNrF FOR THE ACTION OF D-LYSERGIC ACID DIETHYLAMIDE, 

MESCALINE AND BUFOTENINE ON 5-HYDROXYTRYPTAMINE RECEPTORS 
IN UMBILICAL VASCULATURE. ^^2714 03-03 

MPrwANISMS UNDERLYING POTENTIATION OF BARBITURATE ACTION BY 
SOD^U^nS IN THE MOUSE: THE ROLE OF METHEMOGLOBIN 
INDUCED HYPOXIA. ,g2721 03-03 

a <;^AAl 1 CONTROLLED STUDY TO DETERMINE THE TIME OF ONSET OF 
icTIONToXYPERTS^ ORAL ADMINISTRATION IN NORMAL 
SUBJECTS. 182763 03-14 

THE ACTION OF NEMBUTAL ON THE ULTRA ARCHITECTONICS OF THE 

NEUROHYPOPHYSIS. 183520 03-01 

ANTIPSYCHOTIC ACTION OF NEUROLEPTIC AGENTS AND THE FUNCTION 
OF BASAL GANGLIA (SURVEY OF LITERATURE). ^^^^^^ ^^^^ 

A COMPARATIVE STUDY OF THE ANTIPSYCHOTIC ACTION OF SOME 
NE^mOLEPTlCS BASED ON THE MODEL OF LSD PSYCHOSES.^_^^^ ^^^^ 

SELECTIVE RESPIRATORY STIMULATING ACTION OF DOXAPRAM 

COMPARED TO PENTYLENETETRAZOL. ^^^^^ ^^^^ 

MECHANISM OF ACTION OF SUBSTANCE-P. ^^^^^ ^^^ 

A PRELIMINARY STUDY ON THE ACTION OF THYROTROPINE RELEASING 
HORMONE OR TRH IN DEPRESSIVE STATES. ^^^^^^ ^^^ 

THE ANALYSIS OF THE POTENTIAL ACTION OF A ^EDICATION^^^^ ^^^^ 

THE ACTION OF D-AMPHETAMINE ON SPONTANEOUS ACTIVITY IN THE 
CAUDATE NUCLEUS AND RETICULAR FORMATION OF THE RAT^.^^ ^^^^ 

THE SITE OF ACTION ON THE OPTICAL ISOMERS OF l.METHYL-5-PHENYL- 
5-PROPYL BARBITURIC ACID. ^g^^, ^3 33 

fllNICAL PHARMACOLOGY AS AN APPROACH TO THE STUDY OF 
''biochemical SLEEP MECHANISMS: THE ACTION OF L-DOPA^^^ ^^^^ 

NONCHOLINERGIC MECHANISM OF ACTION OF CHOLINERGIC DRUGS ON 
SQUID AXON MEMBRANES. 186672 03-03 

THE ACTION OF ALPHA-METHYLDOPA IN THE CERVEAU ISOLE 

PREPARATION. 187075 03-03 

COMPARISON OF THE LOCOMOTOR STIMULANT MECHANISMS OF 
Kn OF D-AMPHETAMINE AND D-AMPHETAMINE PLUS L-DOPA: 
POSSIBLE INVOLVEMENT OF SEROTONIN. ^^^^^^ ^^^ 

ALPHA-L-ACETYLMETHADOL AND ITS N-DEMTHYLATED METABOLITES 
HAVE POTENT OPIATE ACTION IN THE GUINEA-PIG ISOLATED^ILRIM^ ^^ 

ONE CASE OF AGRYPNIA (4 MONTHS WITHOUT SLEEP) IN A MORVAN 
° DISUSE FAVORABLE ACTION OF 5-HYDROXYTRYPTOPHAN^^^^^ ^^^^ 

A POSSIBLE MECHANISM FOR THE ANTISCHIZOPHRENIC ACTION OF 
f HLORPROMAZINE INHIBITION OF THE FORMATION OF 
DIMETHnTRYPTAMINE BY CHLORPROMAZINE METABOLITE^S.^^^ ^^^^ 

A CDPOiiFNCY SHIFT IN THE HIPPOCAMPAL THETA ACTIVITY: AN 

EUCTRICaI CORRE^TE Of CENTRAL ACTION OF ACTH ANALOGUES IN 
THE DOG 188166 04-04 

STUDIES ON THE ACTION OF CERTAIN PHARMACOLOGICAL AGENTS ON 
TARDIVE DYSKINESIA AND ON THE RABBIT SYNDROME. ^^^^^ ^^^^ 



S-4 



VOLUME 12, SUBJECT INDEX 



Subject Index 



TREATMENT OF ACTION MYOCLONUS WITH L-5-HYDROXYTRYPTOPHAN. 

I o84zt U4- I I 
FURTHER EVIDENCE FOR A DOPAMINE RECEPTOR STIMULATING ACTION 

OF AN ERGOT ALKALOID. ,88739 04-03 

ANTICONVULSANT ACTION OF VITAMIN-D IN EPILEPTIC PATIENTS? A 

CONTROLLED PILOT STUDY. ,88889 04-11 

INVOLVEMENT OF BRAIN CHOLINERGIC MECHANISMS IN THE ACTION OF 

CHLORPROMAZINE. ^^^g,, ^^ ^3 

MECHANISM OF THE VASOCONSTRICTOR ACTION OF PROSTAGLANDIN B^ 

ENHANCEMENT OF AMPHETAMINE ACTION AFTER INTERRUPTION OF 
ASCENDING SEROTONERGIC PATHWAYS. ^^^^^^ ^^^^ 

THE ACTION OF CHLORPROMAZINE ON EXPLORATION IN PAIRS OF RATS. 

' 189514 04-04 

DOPAMINERGIC INHIBITION OF STRIATAL CHOLINERGIC NEURONS: 
SYNERGISTIC BLOCKING ACTION OF GAMMA-BUTYROLACTONE AND 
NEUROLEPTIC DRUGS. ,89602 04-03 

THE ACTION OF BETA-PHENYL-GABA DERIVATIVES ON NEURONES OF THE 
CAT CEREBRAL CORTEX. ,89750 04-03 

DIPSOGENIC ACTION OF DIAZOXIDE: A PHARMACOLOGIC ANALYSIS. 

191768 04-03 
CORRELATION BETWEEN THE TRANQUILIZING AND SEDATIVE ACTION OF 
NEUROLEPTICS. ANTIDEPRESSANTS AND ANTICHOLINERGIC DRUGS 

THE ACTION OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTOR 
CENTERS OF EMOTIONS IN THE HYPOTHALAMUS. 

191785 04-U.^ 

ACTION OF HALOPERIDOL AND TRIFLUOPERAZINE ON THE MOTOR 
RESPONSES ELICITED BY ELECTRICAL STIMULATION OF THE BRAIN IN 

^'^^^^^^ 191787 04-02 

ADENOSINE ACTION ON SYNAPTIC TRANSMISSION IN BRAIN SLICES. 

191945 04-03 

ANALYSIS OF HYPOTHERMIC ACTION OF DELTA9- 
TETRAHYDROCANNABINOL (DELTA9-THC) IN MICE. 

191997 04-03 

ACTIONS 

PARADOXICAL BLOCKADE BY P-CHLOROPHENYLALANINE OF 5- 

HYDROXYTRYPTOPHAN FACILITATORY ACTIONS ON SPINAL REFLEXES. 

1 68436 01 -03 

QUANTUM CHEMICAL STUDIES ON DRUG ACTIONS: IV. CORRELATION OF 
SUBSTITUENT STRUCTURES AND ANTISEROTONIN ACTIVITY IN 
LYSERGAMIDE SERIES. 174605 01-12 

DISSOCIATIVE CHANGE IN ANTIAGGRESSIVE AND MUSCLE RELAXANT 
ACTIONS OF S-TRIAZOLOBENZODIAZEPINE (D-40TA) BY REPEATED 
ADMINISTRATION AND PHENOBARBITAL PRETREATMENT, AND ITS 
RELATION TO METABOLISM. 181654 02-04 

NEURONE BLOCKING ACTIONS OF ANTIPSYCHOTIC DRUGS. 

1 82 1 2/ 02-UJ 
SEPARATION OF THE DEPENDENCE PRODUCING ACTIONS FROM THE 
DIRECT ACTIONS OF NARCOTICS ON GUINEA-PIG ILEUM. 

182162 02-03 

THE ACTIONS OF SEVERAL PSYCHOACTIVE AGENTS UPON THE 

MUSCARINIC MECHANISMS IN THE SUPERIOR CERVICAL GANGLION OF 

^"^'-'^^ 183866 03-03 

THE POSSIBLE ROLE OF TRYPTAMINE IN BRAIN FUNCTION AND ITS 

RELATIONSHIP TO THE ACTIONS OF LSD-LIKE HALLUCINOGENS. 

186024 03-1 2 
A ROLE FOR THE AMYGDALA IN THE DEVELOPMENT OF THE CATALEPTIC 

AND STEREOTYPIC ACTIONS OF THE NARCOTIC AGONISTS AND 

ANTAGONISTS IN THE RAT. ,86577 03-03 

ON THE BEHAVIORAL AND NEUROCHEMICAL ACTIONS OF 6- 
HYDROXYDOPA AND 5,6 DIHYDROXYTRYPTAMINE IN RATS^ 

187380 04-03 
ACTIONS OF ATROPINE, HEMICHOLINIUM-3, AND PHYSOSTIGMINE ON 
CHLORPROMAZINE INDUCED CHANGES IN RAT BRAIN '^ONOAMINES_^ 

187800 04-UJ 
A NEW PROLONGED ACTING TYPE OF CHLORPROMAZINE: BEHAVIORAL 
EFFECTS AND PROLONGED ACTIONS ON NERVE MEMBRANES. 

187805 04-01 

STEREOSPECIFIC ACTIONS OF DOET (2,5 DIMETHOXY-4- 

ETHYLAMPHETAMINE) IN MAN. 

188121 04-12 

PHARMACOLOGICAL AND BIOCHEMICAL ACTIONS OF THE HEMOLYTIC 

AGENTS ACETYLPHENYLHYDRAZINE AND PHENYLHYDRAZINE ON 

MONOAMINE OXIDASE IN THE RAT. 

188769 04-Uo 



INFLUENCE OF ADRENERGIC BLOCKERS AND ANTILIPEMIC AGENTS ON 
PHARMACODYNAMIC ACTIONS OF MORPHINE IN CARBON 
TETRACHLORIDE TREATED RATS. ,88873 04-03 

THE NERVE IMPULSE BLOCKING ACTIONS OF TRANQUILIZERS AND THE 
BINDING OF NEUROLEPTICS TO SYNAPTOSOME MEMBRANES 

1 89400 04-03 
THE DOPAMINE RELEASING ACTIONS OF NEUROLEPTICS AND ETHANOL. 

189401 04-03 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 

METABOLITE NORFENFLURAMINE: AN EVALUATION OF ITS ROLE IN 
THE ACTIONS OF FENFLURAMINE. ,90335 04-04 

EFFECTS OF VARIOUS DRUGS ON THE ACTIONS OF 5,7 

DIHYDROXYTRYPTAMINE ^^^^^^ ^^^^ 

DIFFERENTIAL INCREASE OF BEHAVIORAL AND EXTRAPYRAMIDAL 
STIMULATING ACTIONS OF NEUROLEPTICS BY ALPHA- 
METHYLTYROSINE PRETREATMENT IN RATS. ,r,n^,^n. n. 

192016 04-04 

*^^'cHANGE OF ESTROGEN ACTIVATED BEHAVIOR BY CYCLOHEXIMIDE IN 

THE FEMALE RAT. ,71615 01-04 

EFFECTS OF LSD AND MONOAMINE SYNTHESIS INHIBITORS ON 

HORMONE ACTIVATED COPULATORY BEHAVIOR IN THE FEMALE RAT. 

18861 1 04-04 

ACTIVATING 

IS OXYPERTINE AN ACTIVATING TRANQUILLIZER? 

I Oi/OJ Uj-UV 

INABILITY TO CONDITION A PERIPHERAL ACTIVATING DRUG^ 

190698 04-04 

ACTIVATION 

SPECIFIC ACTIVATION OF STRIATAL TYROSINE HYDROXYLASE (TH) BY 
NEUROLEPTICS. (UNPUBLISHED PAPER). ^^^^^^ ^^^^ 

ACTIVATION OF COPULATORY BEHAVIOR BY PILOCARPINE AND 
OXOTREMORINE IN THE FEMALE RAT. 

171616 01-04 

MONOAMINES AND COPULATORY ACTIVATION IN THE CASTRATED MALE 
"^^ 171618 01-04 

INHIBITION BY MORPHINE OF REPETITIVE ACTIVATION OF CAT SPINAL 
MOTONEURONES. ,72926 01-03 

DRUG-INDUCED ACTIVATION OF STRIATAL TYROSINE HYDROXYLASE: 
CHANGES IN THE AFFINITY FOR PTERIDINE COFACTORS. (UNPUBLISHED 

^'^''^'"- 173381 01-03 

CHOLINE ACTIVATION OF LITHIUM TRANSPORT ^ ^^^^ ^ ^^^^ 

MARIJUANA DIMINISHES GSR ACTIVATION PEAKING. ^^^^^^ ^^^^ 

DOSE EFFECTS OF METHYLPHENIDATE ON BEHAVIORAL INHIBITION AND 
ACTIVATION IN HYPERACTIVE CHILDREN. (PH.D. DISSERTATION). 

185676 03-14 

CENTRAL HYPOTHERMIA BY 2-DEOXY-D-GLUCOSE: ANTAGONISM BY 
ALPHA-ADRENERGIC ACTIVATION ,88200 04-03 

IN VIVO CHANGES OF CEREBRAL CYCLIC ADENOSINE 3,5 

MONOPHOSPHATE INDUCED BY BIOGENIC AMINES: ASSOCIATION 
WITH PHOSPHORYLASE ACTIVATION. ^^^^^ ^^^^ 

ACTIVATION OF STRIATAL HYDROXYLASE BY HYDROXYLATED 

METABOLITES OF CHLORPROMAZINE. ^^^^^^ ^^^^ 

EFFECTS OF INTRAPERITONEAL AND INTRAVENTRICULAR D- 
AMPHETAMINE ADMINISTRATION ON ACTIVE AVOIDANCE 
PERFORMANCE IN THE RAT ,75242 02-04 

INTERACTION OF THE BEHAVIORALLY ACTIVE DRUG, PHENITRONE, A 
PURPORTED HASHISH AND LSD ANTAGONIST, WITH SEVERAL 
CENTRAL NEUROCHEMICAL SYSTEMS ,82217 03-04 

EFFECTS OF NEONATAL STRYCHNINE ADMINISTRATION ON ACTIVE 

AVOIDANCE IN RATS. ,84242 03-04 

A NOVEL SPASMOLYTIC AND CNS ACTIVE AGENT: 3-(2- 

BENZYLMETHYLAMINOETHYL) BENZOIC ACID METHYL ESTER 
HYDROCHLORIDE. ^^^^g, ^3 ^^ 

PHARMACOLOGICAL DISTINCTIONS BETWEEN ACTIVE AND PASSIVE 
AVOIDANCE MEMORY FORMATION AS SHOWN BY MANIPULATION OF 
BIOGENIC AMINE ACTIVE COMPOUNDS. ^^^^^^ ^^^^ 

LOCALIZED BEHAVIORAL EFFECTS OF VASOPRESSIN ON MAINTENANCE 
OF AN ACTIVE AVOIDANCE RESPONSE IN RATS. 

187697 04-04 



:i -1 



S-5 



Subject Index 



Psychopharmacology Abstracts 



COMPARATIVE EFFECTS OF SOME CNS ACTIVE DRUGS ON LEARNED AND 
UNLEARNED BEHAVIOR IN THE HAMSTER. 

191976 04-04 
ACTIVITIES 

A STUDY OF THE RELATIVE ANTICONVULSANT AND TOXIC ACTIVITIES OF 
DELTA9-TETRAHYDR0CANNABIN0L AND ITS CONGENERS. 

174608 01-05 
A SENSITIVE, SIMPLE METHOD FOR MEASUREMENT OF TYROSINE 

HYDROXYLASE AND TRYPTOPHAN-5-HYDROXYLASE ACTIVITIES. 

182178 02-06 
EFFECTS OF ALKALI METALS ON SPONTANEOUS MOTOR ACTIVITIES OF 
MICE. 

182637 03-02 
CONTROL OF MENTAL ACTIVITIES. 

185235 03-17 
THE EFFECT OF PRETREATMENT WITH IPRONIAZID ON THE BEHAVIORAL 
ACTIVITIES OF BETA-PHENYLETHYLAMINE IN RATS. 

187932 04-04 
ACTIVITY 

EFFECT OF PRENATAL MATERNAL ADMINISTRATION OF D-AMPHETAMINE 
ON RAT OFFSPRING ACTIVITY AND PASSIVE AVOIDANCE LEARNING. 

167415 01-03 
EFFECTS OF ATROPINE ON EXPLORATION, LEARNING AND 
ELECTROCORTICAL ACTIVITY IN THE DEVELOPING RAT. 

169473 01-04 
THE ACTIVITY OF SOME NEUROLEPTIC DRUGS AND AMPHETAMINE IN 
NORMAL AND ISOLATED RATS. 

170126 01-04 
TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. (UNPUBLISHED PAPER). 

170876 01-03 
INTERACTION BETWEEN ATROPINE AND OXOTREMORINE ON CORTICAL 
ACETYLCHOLINE AND MOTOR ACTIVITY. 

171606 01-03 
EFFECTS OF CENTRALLY ACTING DRUGS ON ADENYL CYCLASE ACTIVITY 
AND CYCLIC AMP LEVELS OF MOUSE BRAIN. (PH.D. DISSERTATION). 

172019 01-03 
THE NOOTROPIC APPROACH TO THE PHARMACOLOGY OF THE 
INTEGRATIVE ACTIVITY OF THE BRAIN. 

173495 01-02 
DIURETIC ACTIVITY OF A NEW NARCOTIC ANTAGONIST IN MAN 
(BRIST0L-C0MPOUND-2605). (UNPUBLISHED PAPER). 

174473 01-13 
QUANTUM CHEMICAL STUDIES ON DRUG ACTIONS: IV. CORRELATION OF 
SUBSTITUENT STRUCTURES AND ANTISEROTONIN ACTIVITY IN 
LYSERGAMIDE SERIES. 

174605 01-12 
THE ROLE OF HYDROPHOBICITY IN THE ANTISEROTONIN ACTIVITY OF 

LSD ANALOGS. 

174606 01-12 
PLATELET MONOAMINE OXIDASE ACTIVITY AND SUBSTRATE 

PREFERENCES IN SCHIZOPHRENIC PATIENTS. 

174609 01-14 
THE ANTICONVULSANT ACTIVITY OF CANNABIDIOL AND CANNABINOL. 

175238 02-03 
OBSERVATIONS ON THE THERAPEUTIC ACTIVITY OF CLOPENTHIXOL IN 
PSYCHIATRY. 

175540 02-11 
A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY IN MAN OF 
INTRAVENOUSLY ADMINISTERED DELTA9-TETRAHYDR0CANNABIN0L, 
CANNABINOL, AND CANNABIDIOL. 

176747 02-03 
A STUDY OF ANTIOVULATORY ACTIVITY OF HALOPERIDOL IN RABBITS. 

177021 02-03 
ANTICONVULSIVE ACTIVITY OF 8-CHL0R0-6-PHENYL-4H-S- 

TRIAZOLOBENZODIAZEPINE (D-40TA) AND ITS EFFECT ON LIMBIC 
SYSTEM. 

177099 02-02 
DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: 

ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE 
MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY. 

177131 02-03 
L-DOPA CHLORPROMAZINE ANTAGONISM ON RUNNING ACTIVITY IN 
MICE. 

177785 02-04 
INFLUENCE OF N1-2HYDR0XYETHYL SUBSTITUTION ON CENTRAL 
ACTIVITY OF OXAZEPAM AND LORAZEPAM. 

178756 02-04 
CHANGES IN BRAIN ACETYLCHOLINESTERASE ACTIVITY OF YOUNG RATS 
AFTER CHRONIC TREATMENT WITH TREMORINE. 

178814 02-03 
ANTICONVULSANT ACTIVITY OF CLONAZEPAM AND RO-8-4192 AGAINST 
PENICILLIN AND LIDOCAINE INDUCED SEIZURES. 

178947 02-03 
STIMULATION OF BRAIN AROMATIC ALKYLAMINE N- 

METHYLTRANSFERASE ACTIVITY BY FAD AND METHYLCOBALAMIN. 

180020 02-03 



CHOLINE ACETYLTRANSFERASE ACTIVITY IN THE CEREBROSPINAL FLUID 
OF PSYCHIATRIC PATIENTS. 

180047 02-13 
SYNTHESIS AND ANTIRESERPINE ACTIVITY OF PEPTIDES OF L-DOPA. 

180097 02-03 
EFFECTS OF NEUROLEPTICS AND THYMOLEPTICS ON 

PHOSPHODIESTERASE ACTIVITY AND ON CYCLIC 3,5 AMP LEVELS IN 
RAT BRAIN. 

181467 02-03 
REGIONAL CYCLIC NUCLEOTIDES PHOSPHODIESTERASE ACTIVITY IN CAT 
CENTRAL NERVOUS SYSTEM: EFFECTS OF BENZODIAZEPINES. 

181575 02-03 
METHYLPHENIDATE AND THE ACTIVITY OF HYPERACTIVES IN THE 
INFORMAL SETTING. 

181853 02-14 
EFFECT OF PROCAINE, LIDOCAINE AND PENTOBARBITAL ON ELECTRICAL 
ACTIVITY OF GUINEA-PIG OLFACTORY CORTEX IN VITRO. 

182092 02-03 
MODULATORY EFFECTS OF CORTICOSTEROIDS ON EVOKED ACTIVITY IN 
THE HIPPOCAMPUS AND THALAMUS OF THE RAT. 

182119 02-03 
EFFECTS OF NEUROPHARMACOLOGICAL AGENTS ON HYPOTHALAMIC 
NEURONAL ACTIVITY: A MICROELECTROPHORETIC STUDY. 

182123 02-03 
EFFECTS OF SELECTED CENTRALLY ACTING AGENTS ON ADENYL CYCLASE 
ACTIVITY IN MOUSE BRAIN. 

182153 02-03 
PHARMACOLOGIC ACTIVITY AND BIOTRANSFORMATION OF R. AND S- 
BARBITURATE ENANTIOMERS IN MOUSE AND MAN. 

182156 02-03 
CHROMATIN TEMPLATE ACTIVITY DURING MORPHINE-INDUCED 
ANALGESIA AND THE DEVELOPMENT OF ANALGESIC TOLERANCE. 

182160 02-03 
TOLERANCE TO THE ACTIVITY ENHANCING EFFECTS OF D-AMPHETAMINE. 

182208 02-04 
RELATIVE IMPORTANCE OF DOPAMINERGIC AND NORADRENERGIC 

NEURONAL SYSTEMS FOR THE STIMULATION OF LOCOMOTOR 
ACTIVITY INDUCED BY AMPHETAMINE AND OTHER DRUGS. 

182209 02-04 
ANTIPYRETIC, ANALGESIC AND ANTIINFLAMMATORY ACTIVITY OF 

DELTA9-TETRAHYDR0CANNABIN0L IN THE RAT. 

182221 03-03 
A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY OF DELTA9- 
TETRAHYDROCANNABINOL AND ITS MONOHYDROXYLATED 
METABOLITES IN MAN. 

182223 03-03 
EFFECTS OF METHADONE ON ACTIVITY AND ON BRAIN MONOAMINES IN 
TWO MOUSE STRAINS. 

182229 03-03 
EFFECT OF MORPHINE, HALOPERIDOL, APOMORPHINE AND BENZTROPINE 

ON DOPAMINE TURNOVER IN RAT CORPUS-STRIATUM: EVIDENCE 
SHOWING MORPHINE-INDUCED REDUCTION IN CNS DOPAMINERGIC 
ACTIVITY. 

182230 03-03 
BEHAVIORAL AND PHYSIOLOGICAL ACTIVITY OF DEAMINATED 

METABOLITES OF MESCALINE. 

182244 03-03 
COMPARATIVE EFFECTS OF DL-P-METHOXYAMPHETAMINE AND D- 
AMPHETAMINE ON CENTRAL CATECHOLAMINES AND LOCOMOTOR 
ACTIVITY. 

182253 03-04 
THE INFLUENCE OF NEUROTROPIC DRUGS ON MONOAMINE OXIDASE 
(MAO) AND 5-OXYTRYPTOPHANE DECARBOXYLASE (5-OTD) ACTIVITY 
IN THE BRAIN. 

183142 03-13 
EFFECTS OF CHRONICALLY ADMINISTERED DELTAl- 

TETRAHYDROCANNABINOL OF ADRENAL AND GONADAL ACTIVITY OF 
MALE RATS. 

183358 03-03 
NICOTINIC ACID AND CATECHOL-0-METHYLTRANSFERASE ACTIVITY IN 
SCHIZOPHRENIA. 

183360 03-13 
THE EFFECTS OF PSYCHIC STIMULANTS ON THE ACTIVITY OF POTASSIUM 
AND SODIUM ION STIMULATED ATPASE IN THE MICROSOMAL 
FRACTIONS OF THE BRAIN OF RATS. 

183518 03-01 
SUBSTITUTED PIPERAZINOQUINAZOLONES: RELATIONSHIP BETWEEN 
SELECTIVE INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE 
DEPENDENT OXIDATIONS AND ANTICONVULSANT ACTIVITY. 

183598 03-02 
SUBSTITUTED BENZOXAZOLE/BENZTHIAZOLE-2-THIONES: 

INTERRELATIONSHIP BETWEEN ANTICONVULSANT ACTIVITY AND 
INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT 
OXIDATIONS AND MONOAMINE OXIDASE. 

183601 03-03 
ALPHA-ADRENERGIC BLOCKING AGENTS: ANTINOCICEPTIVE ACTIVITY 
AND ENHANCEMENT OF MORPHINE-INDUCED ANALGESIA. 

183895 03-03 



S-6 



VOLUME 12, SUBJECT INDEX 



Subject Index 



INFLUENCE OF METHAMPHETAMINE AND NEUROLEPTIC DRUGS ON 

TYROSINE HYDROXYLASE ACTIVITY. ,84180 03-03 

nFfREASED EFFECT OF PHENOBARBITAL TREATMENT ON MICROSOMAL 
DRUG METABOLIZING ENZYME ACTIVITY DURING "STATION^^^ ^^^^ 

INDICATIONS AND DOSAGE FOR MAXIMAL ACTIVITY OF ORNITHINE- 
CARBAMYL-TRANSFERASE IN THE PSYCHIATRIC ENVIRONMENT^^ ^^^^ 

QUINAZOLINES AND 1,4 BENZ0DIAZEPINES.64.C0MPARIS0N OF THE 
STEREOCHEMISTRY OF DIAZEPAM WITH THAT OF CLOSE ANALOGS 
WITH MARGINAL BIOLOGICAL ACTIVITY. ^ ^^^^^ ^^^^ 

ANTICONVULSANT ACTIVITY OF SUBSTITUTED 'NDOLEALKYLAWUNES^^ ^^ 

THE ACTION OF D-AMPHETAMINE ON SPONTANEOUS ACTIVITY IN THE 
CAUDATE NUCLEUS AND RETICULAR FORMATION OF THE RAT. 

loj/o4 UJ-Uj 

THE EFFECTS OF CHRONIC TREATMENT WITH D-AMPHETAMINE ON FOOD 
INTAKE BODYWEIGHT, LOCOMOTOR ACTIVITY AND SUBCELLULAR 
DISTRIBUTION OF THE DRUG IN RAT BRAIN. ^^^^^^ ^^^^ 

ON CATALEPSY AND CATATONIA AND THE PREDICTABILITY OF THE 
CATALEPSY TEST FOR NEUROLEPTIC ACTIVITY. ^^^^^^ ^^^^ 

SYNTHESIS AND CNS ACTIVITY OF 3-SUBSTITUTED 7-CHLORO-5- 

PHENYLBENZOTRIAZEPIN-2-ONES. ^^^^^^ ^^^^ 

ANTICONVULSANT ACTIVITY AND INHIBITION OF RESPIRATION IN RAT 
BRAIN HOMOGENATES BY SUBSTITUTED OXADIAZOLES. ^^^^^^ ^^^^ 

A NEW RECORDING APPARATUS FOR MEASUREMENT OF LOCOMOTOR 
ACTIVITY OF MICE. EXPERIMENTAL OBSERVATIONS ON ITS USE. 

186377 Uo-U6 

EFFECTS OF METHAMPHETAMINE, PIPRADROL, AND METHYLPHENIDATE 

ON INSTRUMENTAL CONDITIONING AND SPONTANEOUS MOTOR 

ACTIVITY IN THE IMMATURE RAT. 

186568 03-04 

A COMPARISON OF EFFECTS OF APOMORPHINE AND ET-495 ON 
LOCOMOTOR ACTIVITY AND CIRCLING BEHAVIOUR IN MICE. 

186635 03-04 

SIGNIFICANCE OF DOPAMINE RECEPTOR ACTIVITY IN DL-P- 
METHOXYAMPHETAMINE AND D-AMPHETAMINE-INDUCED 
LOCOMOTOR ACTIVITY. ,86670 03-04 

EFFECTS OF AMPHETAMINES ON REGIONAL TRYPTOPHAN HYDROXYLASE 
ACTIVITY AND SYNAPTOSOMAL CONVERSION OF TRYPTOPHAN TO 5- 
HYDROXYTRYPTAMINE IN RAT BRAIN. 

186674 OJ-OJ 

EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF 
BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM 
RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT^ 

186695 03-03 

COMPARISON OF TYROSINE HYDROXYLASE AND DOPAMINE-BETA- 
HYDROXYLASE INHIBITION WITH THE EFFECTS OF VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS ON D-AMPHETAMINE INDUCED 
MOTOR ACTIVITY. ,86699 03-03 

STRUCTURE-ACTIVITY RELATIONS OF SOME INDOLEALKYLAMINES IN 
COMPARISON TO PHENETHYLAMINES ON MOTOR ACTIVITY AND 
ACQUISITION OF AVOIDANCE BEHAVIOR. ^^^^^^ ^^^^ 

MUSCLE ABNORMALITIES IN PSYCHOTIC PATIENTS: II. SERUM CPK 
ACTIVITY FIBER ABNORMALITIES, AND BRANCHING AND SPROUTING 
OF SUBTERMINAL NERVES. ,87114 03-09 

BLOCKING OF THE EFFECT OF A DELTAl-TETRAHYDROCANNABINOL 
(DELTAl-THC) ON SPONTANEOUS MOTOR ACTIVITY IN THE RAT BY 
IMMUNIZATION WITH A PROTEIN CONJUGATE OF DELTAl-THC^ ^^^^ 

EFFECTS OF LOCUS-COERULEUS STIMULATION ON HIPPOCAMPAL UNIT 
ACTIVITY AND ON BEHAVIOR IN UNRESTRAINED RATS. (UNPUBLISHED 
PAPER). ,87499 04-04 

DELTA9-TETRAHYDR0CANNABIN0L: EFFECTS OF ROUTE OF 

ADMINISTRATION ON ONSET AND DURATION OF ACTIVITY AND 
TOLERANCE DEVELOPMENT. ,87928 04-03 

3-ARYL-3-HYDROXYQUINOLIZIDINES WITH POTENTIAL HYPOTENSIVE, 
ANTIDEPRESSANT, AND ANALGETIC ACTIVITY. ^^_^^^^ ^^^^ 

A FREQUENCY SHIFT IN THE HIPPOCAMPAL THETA ACTIVITY: AN 

ELECTRICAL CORRELATE OF CENTRAL ACTION OF ACTH ANALOGUES IN 

^"^■^O^ 188166 04-04 

EFFECT OF ORAL ADMINISTRATION OF METHADONE ON HEPATIC 

MICROSOMAL MIXED FUNCTION OXIDASE ACTIVITY IN ^ICE^.^^^ ^^^^ 



INTERACTIONS OF CHLORPHENIRAMINE ETHANOL COMBINATIONS: 
ACUTE TOXICITY AND ANTIHISTAMINE ACTIVITY. 

188875 04-05 
SYNTHESIS AND CENTRAL NERVOUS SYSTEM ACTIVITY OF 1,2,3,4- 
TETRAHYDRO-l-AMINO-4-PHENYLNAPHTHALENES. 

189178 04-Oj? 
INTERACTION OF D-AMPHETAMINE WITH CENTRAL NERVOUS SYSTEM 
DEPRESSANTS ON FOOD INTAKE AND SPONTANEOUS MOTOR 
ACTIVITY OF MICE. ,89613 04-04 

EFFECT OF PHENOTHIAZINE NEUROLEPTIC DRUGS AND TRICYCLIC 
ANTIDEPRESSANTS ON PHOSPHODIESTERASE ACTIVITY IN RAT 
CEREBRAL CORTEX. ,9031104-03 

CONFORMATIONAL ANALYSIS OF ACRIOAN DERIVATIVES BY NUCLEAR 
MAGNETIC RESONANCE SPECTROSCOPY. A RELATIONSHIP BETWEEN 
CONFORMATION AND PHARMACOLOGICAL ACTIVITY. 

190715 04-01 
EFFECT OF ATROPINE SULFATE ON THE SLEEP RELATED EEG SPIKE 
ACTIVITY OF THE TORTOISE, GEOCHELONE-CARBONARIA. 

ELECTRODERMAL ACTIVITY IN HYPERACTIVE BOYS WHO ARE 

METHYLPHENIDATE RESPONDERS. ^^^^^^ ^^^^ 

PHYSICOCHEMICAL PROPERTIES, DEVELOPMENT, AND REGULATION OF 
CENTRAL AND PERIPHERAL MONOAMINE OXIDASE ACTIVITY. 

191497 04-03 

HUMAN SERUM DOPAMINE-BETA-HYDROXYLASE: RELATIONSHIP TO 
SYMPATHETIC ACTIVITY IN PHYSIOLOGICAL AND PATHOLOGICAL 

^^'^^^^ 191510 04-13 

AN EVALUATION OF SERUM DOPAMINE-BETA-HYDROXYLASE AS AN 
INDEX OF SYMPATHETIC NERVE ACTIVITY IN MAN. 

191 51 1 04-13 
EFFECTS OF NOMIFENSINE (HOE-984), D-AMPHETAMINE AND 

APOMORPHINE ON MOTOR ACTIVITY, CATECHOLAMINE TURNOVER 
AND CAMP CONCENTRATIONS IN RAT BRAIN. (UNPUBLISHED PAPER)^ 

191766 04-03 
CHANGES IN RHYTHMS OF BIOELECTRICAL ACTIVITY OF THE CEREBRAL 
CORTEX IN HUMANS UNDER THE INFLUENCE OF ETHYMIS(}L 

191790 04-0/ 
NORADRENERGIC NEURONS: EFFECTS OF TRICYCLIC ANTIDEPRESSANTS 
ON SINGLE UNIT ACTIVITY. ,9,93104-03 

THE LOCALIZATION AND CHARACTERIZATION OF ,„,,,,,,. 

PHENYLETHANOLAMINE-N-METHYLTRANSFERASE ACTIVITY IN SPECIFIC 

REGIONS OF THE CNS. ,91932 04-03 

A PREDICTABLE LABORATORY MODEL FOR SEDATIVE/HYPNOTIC 

ACTIVITY IN MAN. ,91943 04-14 

CHLORDIAZEPOXIDE INDUCED BETA SPINDLE ACTIVITY IN RATS. 

19241 6 04-03 

LABORATORY ASSESSMENTS OF ANTIDEPRESSIVE ACTIVITY - THEIR 
VALUE FOR CLINICAL PSYCHIATRY AND THE UNDERSTANDING OF 
DEPRESSION. ,,2422 04-09 

THE EFFECTS OF HOE-36801 ON MUSCLE ACTIVITY AND BLOOD 
PRESSURE ON ATTENTION AND CONCENTRATION, ON TIME 
JUDGMENT AND SUBJECTIVE RESPONSES IN NEUROTICS AND 
NORMALS. ,92429 04-14 

ACUTE 

METIAPINE IN ACUTE SCHIZOPHRENIC PATIENTS. 

167341 Ul-Uo 

EFFECTS OF ACUTE AND CHRONIC ADMINISTRATION OF CANNABIS- 
SATIVA EXTRACT ON THE MOUSE-KILLING BEHAVIOR OF RATS^ 

1 67362 1 -04 

ACUTE DRUG-INDUCED EXTRAPYRAMIDAL SYNDROMES. 

1 67572 1 - 1 J 
ACUTE ADVERSE REACTIONS TO PSYCHOACTIVE DRUGS, DRUG USAGE, 
AND PERSONALITY. (UNPUBLISHED PAPER). ^^^^^^ ^^^^ 

USE OF PSYCHOTHERAPEUTIC DRUGS IN THE ACUTE DETOXIFICATION OF 
^^E^°"^ ^^t^'^^^- ,69746 01.11 

THE EFFECT OF L-TRYPTOPHAN (TP) ON CUTANEOUS C-FIBER (CFR) AND 
POLYSYNAPTIC (PSR) REFLEXES IN ACUTE DECEREBRATE SPINAL CATS 
AND THE EFFECT OF PRETREATMENT WITH P-CHLOROPHENYLALANINE 
(PCPA) ON THE ACTION OF TP. (UNPUBLISHED PAPER). ^^^^_^^ ^^^^ 

ACUTE TOXICITY OF 8-CHL0R0-6-PHENYL-4H-S- „.„„„, ,„r, 

TRIAZOLOBENZODIAZEPINE (D-40TA) IN MICE, RATS, RABBITS AND 

D°^^- 173548 01-05 

ACUTE SCHIZOPHRENIA. ,75725 02-08 



S-7 



Subject Index 

ACUTE CEREBELLAR DISTURBANCE ASSOCIATED WITH DIAZEPAM 
THERAPY - A CASE REPORT AND FURTHER INVESTIGATION. 

177392 02-15 
ACUTE LETHALITY FOR MICE FOLLOWING ADMINISTRATION OF 
CYCLOPHOSPHAMIDE WITH BARBITURATES. 

177834 02-05 
PARENTERAL HALOPERIDOL FOR RAPID CONTROL OF SEVERE, 
DISRUPTIVE SYMPTOMS OF ACUTE SCHIZOPHRENIA. 

178545 02-08 
ACUTE NITRAZEPAM (MOGADON) POISONING: AN 
ELECTROENCEPHALOGRAPHIC STUDY. 

180148 02-15 
ELECTROENCEPHALOGRAPHIC CHANGES IN ACUTE PHENOBARBITONE 

POISONING. 

180149 0215 
THE ELECTROENCEPHALOGRAPHIC CHANGES IN ACUTE BARBITURATE 

POISONING 

180152 02-15 
COMPARISON OF THE CHRONIC AND ACUTE EFFECTS OF D-LYSERGIC 
ACID DIETHYLAMIDE (LSD) TREATMENT ON RAT BRAIN SEROTONIN 
AND NOREPINEPHRINE. 

181945 02-03 
EFFECT OF ACUTE AND CHRONIC MORPHINE ON SPECIFIC 
RADIOACTIVITIES OF CHOLINE AND ACETYLCHOLINE IN MOUSE BRAIN. 

182226 03-03 
STUDIES ON THE EFFECT OF ACUTE AND CHRONIC MORPHINE 
TREATMENT ON CATECHOLAMINE LEVELS AND TURNOVER IN 
DISCRETE BRAIN AREAS OF RATS. 

182228 03-03 
DIAZEPAM TREATMENT FOR ACUTE CONVULSIONS IN CHILDREN- A 
REPORT OF 41 PATIENTS, THREE WITH PLASMA LEVELS. 

182595 03-11 
CLINICAL STUDIES OF ACUTE PSYCHOSIS ON THE BASIS OF CHRONIC 
HYPNOTICA INTOXICATION - AN ABSTRACT REPORT. 

182755 03-15 
ACUTE POISONING BY NITRAZEPAM (MOGADON). 

183786 03-15 
THE EFFECTS OF ACUTE ADMINISTRATION OF PROPRANOLOL AND 
PRACTOLOL ON THE UPTAKE, CONTENT, RELEASE AND TURNOVER OF 
NORADRENALINE IN THE RAT HEART IN VIVO. 

184232 03-03 
ACUTE EFFECTS OF ALCOHOL, DIAZEPAM, THIORIDAZINE, FLUPENTHIXOL 
AND ATROPINE ON PSYCHOMOTOR PERFORMANCE PROFILES. 

184848 03-14 
THE CONCENTRATIONS OF DIAZEPAM AND ITS METABOLITES IN THE 
PLASMA AFTER AN ACUTE AND CHRONIC ADMINISTRATION. 

184978 03-13 
DRUG DOSAGE IN ACUTE PHASE SCHIZOPHRENIA. 

185898 03-17 
PROPRANOLOL AND BEHAVIOR OF ALCOHOL ADDICTS AFTER ACUTE 
ALCOHOL INGESTION. 

187257 04-14 
MESORIDAZINE (TPS-23 SANDOZ) IN ACUTE PSYCHOTIC STATES. 

187958 04-11 
INTERACTIONS OF CHLORPHENIRAMINE ETHANOL COMBINATIONS: 
ACUTE TOXICITY AND ANTIHISTAMINE ACTIVITY. 

188875 04-05 
INFLUENCE ON ACUTE PRETREATMENT WITH DELTA9- 

TETRAHYOROCANNABINOL OF THE LD50 OF VARIOUS SUBSTANCES 
THAT ALTER NEUROHUMORAL TRANSMISSION. 

188876 04-05 
THE ACUTE TOXICITY OF L-DOPA. 

189587 04-05 
THE LACK OF EFFECTS OF PRETREATMENT WITH PHENOBARBITAL AND 
CHLORPROMAZINE ON THE ACUTE TOXICITY OF BENZENE IN RATS. 

189600 04-05 
THE EFFECT OF CHLORPROMAZINE AND STELAZINE ON LYSOSOMES OF 
RAT LIVER DURING ACUTE INTOXICATION. 

191121 04-03 
EMERGENCY TREATMENT OF AN ACUTE STATE OF MENTAL ABERRATION. 

191723 04-09 
SUBCELLULAR LOCALIZATION OF H3-DELTA9-TETRAHYDROCANNABINOL 
IN DOG BRAIN AFTER ACUTE OR CHRONIC ADMINISTRATION. 

191970 04-03 
ADAPTATION 

EFFECT OF 6-HYDROXYDOPAMINE ON DARK ADAPTATION IN THE RAT 
RETINA. 

167358 01-03 
REFLECTION OF SHORT-TERM LIGHT ADAPTATION EFFECT IN THE 
ELECTRORETINOGRAM. 

180591 02-04 
ADAPTATION TO NITROGEN NARCOSIS MANIFESTED BY TIMING 
BEHAVIOR IN THE RAT. 

186630 03-04 
ADDICT 

FATAL INTOXICATION OF A YOUNG DRUG ADDICT WITH DIAZEPAM. 

178619 02-05 



Psychopharmacology Abstracts 



ADDICTING 

STATE-DEPENDENT LEARNING PRODUCED BY ADDICTING DRUGS. 

169071 01-03 
ADDICTION 

AFFECTIVE DISORDERS AND CHEMICAL DEPENDENCE: LITHIUM FOR 
ALCOHOL AND DRUG ADDICTION 

189775 04-09 
ENHANCEMENT OF PENTOBARBITAL AFTER MORPHINE ADDICTION. 

191898 04-03 
ADDICTS 

USE OF PSYCHOTHERAPEUTIC DRUGS IN THE ACUTE DETOXIFICATION OF 
HEROIN ADDICTS. 

169746 01-11 
TESTOSTERONE AND LUTEINIZING HORMONE (LH) IN UNTREATED AND 
METHADONE MAINTAINED NARCOTIC ADDICTS. 

182166 02-13 
PROPRANOLOL AND BEHAVIOR OF ALCOHOL ADDICTS AFTER ACUTE 
ALCOHOL INGESTION. 

187257 04-14 
ADDITIVE 

THE ADDITIVE EFFECTS OF TRANQUILIZERS AND DOPAMINE ON SMOOTH 
MUSCLE. 

187804 04-03 
ADENINE 

SUBSTITUTED PIPERAZINOQUINAZOLONES: RELATIONSHIP BETWEEN 
SELECTIVE INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE 
DEPENDENT OXIDATIONS AND ANTICONVULSANT ACTIVITY. 

183598 03-02 
SUBSTITUTED BENZOXAZOLE/BENZTHIAZOLE-2-THIONES: 

INTERRELATIONSHIP BETWEEN ANTICONVULSANT ACTIVITY AND 
INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT 
OXIDATIONS AND MONOAMINE OXIDASE. 

183601 03-03 
ADENOSINE 

THE ROLE OF CYCLIC 3,5 ADENOSINE MONOPHOSPHATE IN 
NEUROMUSCULAR TRANSMISSION. 

170660 01-13 
TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. (UNPUBLISHED PAPER). 

170876 01-03 
CYCLIC ADENOSINE MONOPHOSPHATE: SELECTIVE INCREASE IN CAUDATE 
NUCLEUS AFTER ADMINISTRATION OF L-DOPA. 

176254 02-13 
NEUROCHEMICAL ROLE OF ADENOSINE 3,5 CYCLIC MONOPHOSPHATE 
AND GUANOSINE 3,5 CYCLIC MONOPHOSPHATE AND THEIR RELATION 
TO NEUROTRANSMITTERS; EFFECT OF TETRAHYDROCANNABINOLS. 
(PH.D. DISSERTATION). 

185582 03-03 
IN VIVO CHANGES OF CEREBRAL CYCLIC ADENOSINE 3.5 
MONOPHOSPHATE INDUCED BY BIOGENIC AMINES: ASSOCIATION 
WITH PHOSPHORYLASE ACTIVATION. 

188291 04-03 
ADENOSINE ACTION ON SYNAPTIC TRANSMISSION IN BRAIN SLICES. 

191945 04-03 
ADENYL 

EFFECTS OF CENTRALLY ACTING DRUGS ON ADENYL CYCLASE ACTIVITY 
AND CYCLIC AMP LEVELS OF MOUSE BRAIN. (PH.D. DISSERTATION). 

172019 01-03 
EFFECTS OF SELECTED CENTRALLY ACTING AGENTS ON ADENYL CYCLASE 
ACTIVITY IN MOUSE BRAIN. 

182153 02-03 
EFFECTS OF DOPAMINE-LIKE DRUGS ON RAT STRIATAL ADENYL CYCLASE 
HAVE IMPLICATIONS FOR CNS DOPAMINE RECEPTOR TOPOGRAPHY. 

190545 04-03 
ADENYLATE 

DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: 

ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE 
MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY. 

177131 02-03 
NOREPINEPHRINE SENSITIVE ADENYLATE CYCLASES IN RAT BRAIN- 
RELATION TO BEHAVIOR AND TYROSINE HYDROXYLASE. 

177252 02-03 
EFFECT OF CHLORPROMAZINE AND SOME OF ITS METABOLITES ON THE 
DOPAMINE SENSITIVE ADENYLATE CYCLASE OF RAT BRAIN STRIATUM. 

180060 02-03 
A ROLE FOR NICOTINIC RECEPTORS IN THE REGULATION OF THE 
ADENYLATE CYCLASE OF ADRENAL MEDULLA. 

186675 03-03 
THE EFFECT OF LITHIUM ON HORMONE SENSITIVE ADENYLATE CYCLASE 
FROM VARIOUS REGIONS OF THE RAT BRAIN. 

187110 03-03 
STIMULATION OF A DOPAMINE SENSITIVE ADENYLATE CYCLASE IN 
HOMOGENATES OF RAT STRIATUM BY A METABOLITE OF PIRIBEDIL 
(ET-495). 

189616 04-03 



S-8 



VOLUME 12, SUBJECT INDEX 



FFFECT OF CHRONIC TREATMENT WITH DESIPRAMINE (DMI) AND 
IPRINDOLE (IP) ON THE NOREPINEPHRINE (NE) SENSITIVE ADENYLATE 
CYCLASE SYSTEM IN SLICES OF THE RAT LIMBIC FOREBRAIN^^^_^ ^^^^ 

*""' AMPHETAMINES: VALUABLE ADJUNCT IN TREATMENT OF 

PARKINSONISM ,69220 01-11 

*°'"t"eATmInT EFFECTS ON THE SOCIAL ADJUSTMENT OF DEPRESSED 

''*^'^'^^^- 185322 03-10 

^''^^An'iMA^MODELS for an ENZYMIC BLOOD-BRAIN BARRIER MECHANISM 
FOR THERAPEUTICALLY ADMINISTERED L-DOPA. ^^^^^^ ^^^^ 

THE EFFECTS OF MESCALINE ADMINISTERED BEFORE OR DURING 
EMBRYOGENESIS UPON THE HATCHABILITY AND BEHAVIOR OF THE 
CHICK. (PH.D. DISSERTATION). ,7379,01-04 

A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY IN MAN OF 
INTRAVENOUSLY ADMINISTERED DELTA9-TETRAHYDR0CANNABIN0L, 
CANNABINOL, AND CANNABIDIOL. 

176747 02-OJ 

BEHAVIOURAL EFFECTS OF YOHIMBINE ADMINISTERED 

INTRAVENTRICULARLY IN THE RAT. ^^^^^^ ^^^^ 

INTERACTION OF CENTRALLY ADMINISTERED OUABAIN WITH AGENTS 
AFFECTING SYMPATHETIC FUNCTION. ,78640 02-03 

THE EFFECTS OF INTRAVENTRICULARLY ADMINISTERED 

CATECHOLAMINES AND SEROTONIN ON THE RESERPINE INDUCED 
SPIKE WAVES RECORDED FROM THE MEDICAL NUCLEUS TRAPEZOIDES 

'^^"^^^^^'^- 182094 02-03 

COMPARISON OF INTRAVENOUSLY ADMINISTERED METHADONE (ME), 
MORPHINE (MO), HEROIN (H) AND PLACEBO (P). 

182163 02-03 

EFFECTS OF CHRONICALLY ADMINISTERED DELTAl- 
TETRAHYDROCANNABINOL OF ADRENAL AND GONADAL ACTIVITY OF 

'^^^E«^^5- 183358 03-03 

THE EFFECT OF PAIN RELIEVING DRUGS ADMINISTERED DURING LABOR 
AND DELIVERY ON THE BEHAVIOR OF THE NEWBORN: A REVIEW. 

183706 03-17- 

THE EFFECT OF ORALLY ADMINISTERED COCAINE ON SLEEP OF 

DEPRESSED PATIENTS. ,87642 04-14 

EFFECTS OF ALPHA-METHYLTYROSINE ON D-AMPHET AMINE INDUCED 
RELEASE OF ENDOGENOUSLY SYNTHESIZED AND EXOGENOUSLY 
ADMINISTERED CATECHOLAMINES FROM THE CAT BRAIN IN VIVO. 

189397 04-03 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) 
ADMINISTERED SUBCUTANEOUSLY TO RABBITS FOR 28 DAYS. 

191965 04-03 
CHROMOSOME EXAMINATIONS AFTER MEDICALLY ADMINISTERED 
LYSERGIC ACID DIETHYLAMIDE AND DEXTROAMPHETAMINE. 

192084 04-15 

ADMINISTRATION 

EFFECTS OF ACUTE AND CHRONIC ADMINISTRATION OF CANNABIS- 
SATIVA EXTRACT ON THE MOUSE-KILLING BEHAVIOR OF RATS. 

167362 01-04 
EFFECT OF PRENATAL MATERNAL ADMINISTRATION OF D-AMPHETAMINE 
ON RAT OFFSPRING ACTIVITY AND PASSIVE AVOIDANCE LEARNING. 

167415 01-03 
A CONTROLLED STUDY OF SINGLE DOSE ADMINISTRATION OF 
IMIPRAMINE PAMOATE IN ENDOGENOUS DEPRESSION. 

1 67775 01 -OV 
GROWTH HORMONE RESPONSES TO ADMINISTRATION OF L-5- 

HYDROXYTRYPTOPHAN (L-5-HTP) IN MANIC-DEPRESSIVE PSYCHOSES. 

167919 01-09 
PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF CHRONIC 
MARIJUANA ADMINISTRATION IN MAN. 

BLOOD LEVEL PROFILE IN MAN FOLLOWING CHRONIC ORAL 
ADMINISTRATION OF FLURAZEPAM HYDROCHLORIDE. „„,^ ., ,, 

1 6981 7 01 -1 o 
PHARMACOKINETIC PROFILE OF DIAZEPAM IN MAN FOLLOWING SINGLE 
INTRAVENOUS AND ORAL AND CHRONIC ORAL ADMINISTRATION. 

1 70838 01-13 
INTERRESPONSE TIME CHANGES AS A FUNCTION OF DEPRIVATION AND 

AMPHETAMINE ADMINISTRATION. ,,,,^r„ ,,. 

171612 01-04 

ALTERATION OF MATERNAL BEHAVIOR IN MICE FOLLOWING 
ADMINISTRATION OF CYPROTERONE ACETATE. 

172374 01-04 



Subject Index 

QUANTITATIVE HISTOCHEMICAL STUDIES OF STRIATAL DOPAMINE 
DEPLETION FOLLOWING DL-ALPHA-METHYL-P-TYROSINE 
ADMINISTRATION ,72924 01-03 

DMT ADMINISTRATION TO HUMAN SUBJECTS (UNPUBLISHED PAPER). 

173522 01-12 
ELECTROENCEPHALOGRAPHIC MODIFICATIONS DURING ADMINISTRATION 

°f^'^"'^^- 174566 0,-09 

DELIRIOUS SYNDROME AFTER THE ADMINISTRATION OF HALOPERIDOL. 

174784 01-15 
RELATIONSHIP BETWEEN RESPONSE TO LOW PENTAMETHYLENETETRAZOL 

ADMINISTRATION AND PERSONALITY OF JUVENILE OFFENDERS AND 

THEIR REPEATED CRIMES. ,75072 02-17 

SHORT-TERM AND LONG-TERM LITHIUM ADMINISTRATION: EFFECTS ON 

THE BRAINS SEROTONERGIC BIOSYNTHETIC SYSTEMS. 

EFFECTS OF INTRAPERITONEAL AND INTRAVENTRICULAR D- 
AMPHETAMINE ADMINISTRATION ON ACTIVE AVOIDANCE 
PERFORMANCE IN THE RAT. ,75242 02-04 

BLOCKADE OF THE PROESTROUS LH SURGE IN CYCLIC RATS BY 
BARBITURATE ADMINISTRATION ON DIESTRUS. 

1 75650 02-03 
EFFECTS OF STIMULUS ASSOCIATED WITH AMOBARBITAL 
ADMINISTRATION ON AVOIDANCE BEHAVIOR. 

1 75877 02-04 

CYCLIC ADENOSINE MONOPHOSPHATE: SELECTIVE INCREASE IN CAUDATE 

NUCLEUS AFTER ADMINISTRATION OF L-DOPA. 

176254 02-13 
EFFECT OF CHRONIC ADMINISTRATION OF L-DOPA ON CATECHOL-O- 

METHYLTRANSFERASE IN RAT TISSUES. ^ ^^^^^ ^^^^ 

SUBACUTE TOXICITY OF 8-CHL0R0-6-PHENYL-4H-S- 

TRIAZOLOBENZODIAZEPINE (D-40TA) IN MALE AND FEMALE RATS: 
ORAL ADMINISTRATION FOR ONE MONTH. ^^ ^^ 

ADRENALINE NORADRENALINE AND DOPAMINE LEVELS IN BRAIN AND 
HEART AFTER ADMINISTRATION OF 6-HYDROXYDOPAMINE AND 
GUANETHIDINE TO NEWBORN MICE. ^^^^^^ ^^^^ 

EFFECTS OF OVERTRAINING AND PRETRIAL ADMINISTRATION OF 
DEXTROAMPHETAMINE ON REVERSAL LEARNING IN RATS. 

1 77533 02-04 
EFFECT OF ORAL ADMINISTRATION OF DELTA9- 

TETRAHYDROCANNABINOL ON MEMORY, SPEECH, AND PERCEPTION 
OF THERMAL STIMULATION: RESULTS WITH FOUR NORMAL HUMAN 
VOLUNTEER SUBJECTS. PRELIMINARY REPORT. 

177674 02-14 

THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 
DRUGS ON HUMAN SLEEP: IV. THE EFFECTS OF CHLORPROMAZINE. 

THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 
DRUGS ON HUMAN SLEEP: V. THE EFFECTS OF CHLORAL HYDRATE. 

177717 0214 

THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 
DRUGS ON HUMAN SLEEP: VI. THE EFFECTS OF CHLORDIAZEPOXIDE. 

THE EFFECT OF PROBENECID AND LARGE DOSE AMPHETAMINE 

ADMINISTRATION ON CEREBROSPINAL FLUID HOMOVANILLIC ACID. 

1 77826 02-13 

ACUTE LETHALITY FOR MICE FOLLOWING ADMINISTRATION OF 
CYCLOPHOSPHAMIDE WITH BARBITURATES. 

DREAM REPORTS AFTER RESERPINE ADMINISTRATION IN CHRONIC 
LOBOTOMIZED SCHIZOPHRENIC PATIENTS 

THE EFFECTS OF EARLY P-CHLOROPHENYLALANINE ADMINISTRATION 
AND POSTWEANING HOUSING CONDITIONS ON SEROTONIN AND 
BEHAVIOR IN RATS. ,78638 02-04 

PENTAZOCINE IN RHESUS MONKEY PLASMA AND BRAIN AFTER 
PARENTERAL AND ORAL ADMINISTRATION. 

178641 02-03 

DISSOCIATIVE CHANGE IN ANTIAGGRESSIVE AND MUSCLE RELAXANT 

ACTIONS OF S-TRIAZOLOBENZODIAZEPINE (D-40TA) BY REPEATED 

ADMINISTRATION AND PHENOBARBITAL PRETREATMENT, AND ITS 

RELATION TO METABOLISM. 

181654 02-04 

STUDIES ON CENTRAL REGULATING MECHANISM OF THE HYPOGLYCEMIA 
INDUCED BY INTRAVENTRICULAR ADMINISTRATION OF 
CHLORPROMAZINE. ,82093 02-03 

EFFECTS OF CONSECUTIVE ADMINISTRATION OF DIAZEPAM AND 
DOXEPIN ON BOTH APPROACH WITHDRAWAL AND APPROACH 
AVOIDANCE RESPONSES IN RATS. ^^^^^^ ^^^^ 



S-9 



Subject Index 



Psychopharmacology Abstracts 



EFFECTS OF SINGLE AND REPEATED ADMINISTRATION OF WATER 
SOLUBLE loDELTA9-TETRAHYDR0CANNABINOL (W THC) ON WEB- 
BUILDING OF SPIDERS. 

182193 02-04 
EEG CHANGES & MOTOR IMPAIRMENT AFTER DISULFIRAM 
ADMINISTRATION TO CATS. 

182248 03-03 
EFFECTS OF CHRONIC ADMINISTRATION OF AMPHETAMINE UPON THE 
CATECHOLAMINE CONTENT OF MOUSE BRAIN. 

182255 03-03 
A SMALL CONTROLLED STUDY TO DETERMINE THE TIME OF ONSET OF 
ACTION OF OXYPERTINE AFTER ORAL ADMINISTRATION IN NORMAL 
SUBJECTS. 

182763 03-14 
THE INFLUENCE OF CHRONIC ADMINISTRATION OF LITHIUM CARBONATE 
ON THE BRAIN NOREPINEPHRINE CONTENT IN RATS. 

182872 03-03 
BEHAVIORAL EFFECTS OF SEPARATE AND COMBINED ADMINISTRATION 
OF NALOXONE AND D-AMPHETAMINE. 

183892 03-04 
EFFECT OF CHRONIC METHADONE ADMINISTRATION ON PREGNANT RATS 
AND THEIR OFFSPRING. 

183894 03-03 
THE EFFECTS OF ACUTE ADMINISTRATION OF PROPRANOLOL AND 
PRACTOLOL ON THE UPTAKE, CONTENT, RELEASE AND TURNOVER OF 
NORADRENALINE IN THE RAT HEART IN VIVO. 

184232 03-03 
EFFECTS OF NEONATAL STRYCHNINE ADMINISTRATION ON ACTIVE 
AVOIDANCE IN RATS. 

184242 03-04 
THE CONCENTRATIONS OF DIAZEPAM AND ITS METABOLITES IN THE 
PLASMA AFTER AN ACUTE AND CHRONIC ADMINISTRATION. 

184978 03-13 
EFFECTS OF PROLONGED LSD-25 ADMINISTRATION UPON NEURONS OF 
SPINAL CORD GANGLIA TISSUE CULTURES. 

185112 03-03 
EFFECTS OF CONCURRENT BEHAVIOR MODIFICATION AND 

CHLORPROMAZINE ADMINISTRATION IN MENTALLY RETARDED 
WOMEN. (PH.D. DISSERTATION). 

185604 03-14 
A COMPARISON OF THE EFFECTS OF CHRONIC ADMINISTRATION OF 
ETHANOL AND ACETALDEHYDE TO MICE: EVIDENCE FOR A ROLE OF 
ACETALDEHYDE IN ETHANOL DEPENDENCE. 

185992 03-03 
PHARMACOLOGY OF NEUROLEPTICS UPON REPEATED ADMINISTRATION. 

186368 03-04 
ENHANCEMENT OF METHYLPHENIDATE INDUCED STEREOTYPIES BY 

REPEATED ADMINISTRATION OF NEUROLEPTICS. 

186369 03-04 
BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 5,6 

DIHYDROXYTRYPT AMINE ADMINISTRATION INTO BRAIN. 

186634 03-04 
EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF 
BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM 
RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT. 

186695 03-03 
THE ADMINISTRATION OF METHIONINE TO CHRONIC SCHIZOPHRENIC 
PATIENTS: A REVIEW OF TEN STUDIES. 

187113 03-08 
EFFECTS OF SHORT-TERM ADMINISTRATION OF N-NITROSO COMPOUNDS 
ON LIVER HISTOLOGY AND PENTOBARBITAL INDUCED SLEEPING TIME 
IN MICE. 

187575 04-04 
PERPHENAZINE CONCENTRATIONS IN HUMAN WHOLE BLOOD: A PILOT 
STUDY DURING ANTIPSYCHOTIC THERAPY USING DIFFERENT 
ADMINISTRATION FORMS. 

187639 04-16 
DELTA9-TETRAHYDR0CANNABIN0L: EFFECTS OF ROUTE OF 
ADMINISTRATION ON ONSET AND DURATION OF ACTIVITY AND 
TOLERANCE DEVELOPMENT. 

187928 04-03 
EFFECT OF PROLONGED CHLORPROMAZINE ADMINISTRATION ON THE 
SLEEP OF CHRONIC SCHIZOPHRENICS. 

188115 04-08 
REPEAT ADMINISTRATION OF MARIHUANA SMOKE TO HUMANS. 

188120 04-13 
EFFECT OF ORAL ADMINISTRATION OF METHADONE ON HEPATIC 
MICROSOMAL MIXED FUNCTION OXIDASE ACTIVITY IN MICE. 

188178 04-03 
CLINICAL EXPERIENCES WITH MESORIDAZINE (TPS-23): ITS 

ADMINISTRATION TO HOSPITALIZED SCHIZOPHRENIC PATIENTS. 

188934 04-08 
SELECTIVE RESERPINE RESISTANT ACCUMULATION OF CATECHOLAMINES 
IN CENTRAL DOPAMINE NEURONES AFTER DOPA ADMINISTRATION. 

189026 04-03 
CRUDE MARIHUANA EXTRACT: EEG AND BEHAVIORAL EFFECTS OF 
CHRONIC ORAL ADMINISTRATION IN RHESUS MONKEYS. 

189516 04-04 



EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND AGE ON 

VARIOUS NEUROTRANSMITTERS AND ASSOCIATED ENZYMES IN MALE 
FISCHER 344 RATS. 

189597 04-03 
CANNABINOIDS; NEUROCHEMICAL ASPECTS AFTER ORAL CHRONIC 
ADMINISTRATION TO RATS. 

1 89599 04-03 
PROPHYLACTIC EFFICACY OF LITHIUM CARBONATE IN MANIC- 
DEPRESSIVE ILLNESS: REPORT OF THE VETERANS ADMINISTRATION 
AND NATIONAL INSTITUTE OF MENTAL HEALTH (VA-NIMH) 
COLLABORATIVE STUDY GROUP. 

189735 04-09 
CHANGES IN ORIENTING AND HABITUATION IN THE RAT FOLLOWING 
ADMINISTRATION OF CHLORPROMAZINE. 

191211 04-04 
EFFECT OF SINGLE AND REPEATED ADMINISTRATION OF CLOZAPINE ON 
THE METABOLISM OF DOPAMINE AND NORADRENALINE IN THE BRAIN 
OF THE RAT. 

191418 04-03 
PHARMACOKINETICS AND DISTRIBUTION PROPERTIES OF 

PENTOBARBITAL IN HUMANS FOLLOWING ORAL AND INTRAVENOUS 
ADMINISTRATION. 

191444 04-13 
RELATIONSHIP OF CATECHOLAMINE NEURAL SYSTEMS TO THE 
BEHAVIORAL ALTERATIONS PRODUCED BY 6-HYDROXYDOPAMINE 
ADMINISTRATION INTO BRAIN. 

191518 04-03 
EFFECT OF PREGESTATIONAL MORPHINE ADMINISTRATION TO MICE ON 
BEHAVIOR OF THEIR OFFSPRING. 

191902 04-04 
SUBCELLULAR LOCALIZATION OF H3-DELTA9-TETRAHYDR0CANNABIN0L 
IN DOG BRAIN AFTER ACUTE OR CHRONIC ADMINISTRATION. 

191970 04-03 
EFFECTS OF CHRONIC METHYLPHENIDATE ADMINISTRATION ON 
LEARNING AND OFFSPRING BEHAVIOR. 

192116 04-04 
ADMITTED 

A DOUBLE-BLIND, COMPARATIVE CLINICAL TRIAL WITH LUDIOMIL (CIBA- 
34276-BA) AND AMITRIPTYLINE IN NEWLY ADMITTED DEPRESSED 
PATIENTS. 

167774 01-09 
SERUM PROLACTIN LEVELS IN NEWLY ADMITTED PSYCHIATRIC 
PATIENTS. 

191506 04-13 
ADOLESCENCE 

HYPERKINETIC, HYPOSCHOLASTIC BEHAVIOUR AND CHARACTER 
DISORDERS OF CHILDHOOD AND ADOLESCENCE: DIAGNOSIS AND 
PHARMACOTHERAPY. 

172800 01-11 
A SERIES OF MULTICENTRIC PILOT TRIALS WITH PIMOZIDE IN 
PSYCHIATRIC PRACTICE: II. PIMOZIDE IN THE TREATMENT OF 
BEHAVIOURAL DISORDERS IN CHILDHOOD AND ADOLESCENCE. 

183192 03-11 
ADOLESCENTS 

PIMOZIDE IN THE TREATMENT OF BEHAVIORAL DISORDERS OF 
HOSPITALIZED ADOLESCENTS. 

176109 02-14 
ACTION OF OPIPRAMOL (G-33040) IN DEPRESSIVE SYNDROMES IN 
CHILDREN AND ADOLESCENTS. 

182432 03- 10 
ANTIAGGRESSIVE EFFECT OF LITHIUM SALTS IN MENTALLY RETARDED 
ADOLESCENTS. 

182435 03-11 
THE EFFECT OF CHLORPROMAZINE AND AMYTAL SODIUM ON THE 
CONFORMITY OF ADOLESCENTS UNDER PSYCHIATRIC OBSERVATION. 

191776 04-14 
ADRENAL 

ONTOGENESIS OF CIRCADIAN PITUITARY ADRENAL PERIODICITY IN RATS 
AFFECTED BY NEONATAL TREATMENT WITH ACTH. 

181576 02-03 
EFFECTS OF CHRONICALLY ADMINISTERED DELTAl- 

TETRAHYDROCANNABINOL OF ADRENAL AND GONADAL ACTIVITY OF 
MALE RATS. 

183358 03-03 
A ROLE FOR NICOTINIC RECEPTORS IN THE REGULATION OF THE 
ADENYLATE CYCLASE OF ADRENAL MEDULLA. 

186675 03-03 
MECHANISM OF ADRENAL CATECHOLAMINE RELEASE BY DIVALENT 
MERCURY. 

189591 04-03 
INFLUENCE OF DIFFERENT ANIONS ON TYRAMINE AND AMPHETAMINE 
UPTAKE BY COW ADRENAL MEDULLA CHROMAFFIN VESICLES. 

190907 04-03 
ADRENALINE 

ADRENALINE, NORADRENALINE AND DOPAMINE LEVELS IN BRAIN AND 
HEART AFTER ADMINISTRATION OF 6-HYDROXYDOPAMINE AND 
GUANETHIDINE TO NEWBORN MICE. 

177338 02-03 



S-10 



VOLUME 12, SUBJECT INDEX 



'^""comparison of pharmacological responses to nicotine and 

RELEASE OF CATECHOLAMINES FROM THE ADRENALS IN DOGS AND 
MONKEYS. 188199 04-03 

*" aECTROCARDIOGRAPHIC CHANGES IN HYPERTHYROIDISM AFTER 
ADRENERGIC BLOCKADE WITH RESERPINE AND PROPRANOLOL 

i6746U Ul-l J 
EFFECT OF SUBSTITUTED TRYPTAMINES ON THE EFFLUX OF 

NORADRENALINE FROM ADRENERGIC NERVES IN RABBIT ATRIA 

1 60/4/ (J I -Uo 

TEMPERATURE DEPENDENT TOXICITY OF ADRENERGIC AGONISTS IN MICE 
AS A BASIS FOR TREATING D-AMPHETAMINE POISONING 

loVooo U I -Uj 

TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. {UNPUBLISHED PAPER). ^^^^^^ ^^^^ 

OSCILLATORY POTENTIALS OF THE CAT RETINA: EFFECTS OF ADRENERGIC 
^^^^^ 172916 01-03 

EFFECTS OF CHRONIC PRETREATMENT WITH SMALL DOSES OF RESERPINE 
UPON ADRENERGIC NERVE FUNCTION. 

1 77406 U2-UJ 

EFFECT OF ADRENERGIC SUBSTANCES ON OXYGEN CONSUMPTION OF 
RAT BRAIN TISSUE. ,80058 02-03 

EFFECTS OF CHOLINOMIMETICS ON ADRENERGIC TRANSMISSION. 

182088 02-03 
EVIDENCE FOR REDISTRIBUTION OF FILTRATE AMONG NEPHRONS AFTER 

BETA- ADRENERGIC STIMULATION AND BLOCKADE. 

1842/2 Uj-Uo 
POSSIBLE PERIPHERAL ADRENERGIC AND CHOLINERGIC MECHANISMS IN 

PSEUDOCONDITIONING. ,86575 03-03 

EFFECTS OF LITHIUM ON ADRENERGIC AMINE UPTAKE IN RAT BRAIN 

SYNAPTOSOMES. ,86633 03-03 

SPECIFICITY OF BLOCKADE OF THE NICOTINE INDUCED RELEASE OF 3H- 

NOREPINEPHRINE FROM ADRENERGIC NEURONS OF THE GUINEA-PIG 

HEART BY VARIOUS PHARMACOLOGICAL AGENTS. 

186676 03-03 
ABSENCE OF DEGENERATION OF ADRENERGIC NEURONS AFTER 

PROLONGED TREATMENT WITH DEBRISOQUIN. 

186677 03-03 
INFLUENCE OF ADRENERGIC BLOCKERS AND ANTILIPEMIC AGENTS ON 

PHARMACODYNAMIC ACTIONS OF MORPHINE IN CARBON 
TETRACHLORIDE TREATED RATS. ,88873 04-03 

THE EFFECT OF 5 7 DIHYDROXYTRYPT AMINE ON PERIPHERAL 
ADRENERGIC NERVES IN THE MOUSE. ^^^^^^ ^^^^ 

EFFECTS OF ADRENERGIC AGENTS, THEOPHYLLINE AND OTHER DRUGS 
ON DEXTRAN EDEMA AND HISTAMINE RELEASE IN RATS. 

189895 04-0o 

CHOLINERGIC AND ADRENERGIC BALANCE IN MANIA AND 

S^"'^°''"^^^"^- ,91530 04-09 

ADRENERGIC AND CHOLINERGIC FACTORS IN EXTRAPYRAMIDAL 

■^'SOR'^E''^- ,91533 04-11 

NEUROPHARMACOLOGICAL ANALYSIS OF CENTRAL ADRENERGIC AND 
CHOLINERGIC ANTAGONISM OF DELTA9-TETRAHYDR0CANNABm0L^^_^ 

THE RATE LIMITING CONTROL OF ENZYMES MONOAMINE OXIDASE AND 
CATECHOL-O-METHYLTRANSFERASE IN THE FETUS AND THE ADULT BY 
ADRENOCORTICOL HORMONES. ,78815 02-03 

INCREASED SYNTHESIS OF ADRENOMEDULLARY CATECHOLAMINES 

INDUCED BY CAFFEINE AND THEOPHYLLINE. ^^^^^^ ^^^^ 

^''^SIMULTANEOUS MASS FRAGMENTOGRAPHIC ASSAY OF NOREPINEPHRINE 
(NE) EPINEPHRINE (E) AND DOPAMINE (DA) IN RAT SYMPATHETIC 
GANGLION- EFFECTS OF DEXAMETHASONE IN NEWBORN AND ADULT 
RATS. (UNPUBLISHED PAPER). ,70747 01-03 

THE RATE LIMITING CONTROL OF ENZYMES MONOAMINE OXIDASE AND 
CATECHOL-O-METHYLTRANSFERASE IN THE FETUS AND THE ADULT BY 
ADRENOCORTICOL HORMONES. ,78815 02-03 

SEIZURE SUSCEPTIBILITY AND AVOIDANCE CONDITIONING IN ADULT 
RATS TREATED PRENATALLY WITH CHLORPROMAZINE. 

184371 03-04 



Subject Index 

PASSAGE OF TAURINE INTO ADULT MAMMALIAN BRAIN 

191331 04-03 

THE EFFECTS OF EARLY SALINE INJECTIONS AND PENTYLENETETRAZOL 
ON HEBB-WILLIAMS MAZE PERFORMANCE IN THE ADULT RAT. 

191378 04-04 

ADULTS 

THE USE OF PSYCHOACTIVE DRUGS BY ADULTS. 

1 67585 01-1/ 

CENTRAL NERVOUS STIMULANT INDUCED PHYSIOLOGICAL AND 
PERFORMANCE CHANGES IN ADULTS DURING SUSTAINED 
PSYCHOMOTOR TRACKING. ,79023 02-13 

ADVANCED 

CLINICAL EXPERIENCE WITH DIAMORPHINE IN ADVANCED MALIGNANT 

°'5^S^ ,91606 04-17 

ADVANTAGES 

A CRITICAL EVALUATION OF THE PRINCIPLES GOVERNING THE 
ADVANTAGES OF INTRAARTERIAL INFUSIONS. 

, 70 1 1 2 U I -Uo 

ADVERSE 

ACUTE ADVERSE REACTIONS TO PSYCHOACTIVE DRUGS, DRUG USAGE, 
AND PERSONALITY. (UNPUBLISHED PAPER). 

1 6/oJ2 U I - 10 

AVOIDANCE OF ADVERSE REACTIONS. 

180247 U2-13 

^''"features OF THE EFFECT OF SYMPATHOMIMETIC AMINES IN RADIATION 
^f^CTIONS. 191123 04-05 

TRAZODONE IN THE TREATMENT OF AFFECTIVE DISORDERS ^ ^ 

A COMPARISON OF LITHIUM CARBONATE IN THE PREVENTION OF MANIC 
AND DEPRESSIVE EPISODES IN RECURRENT AFFECTIVE ^ISORDE^R^^ ^ 

CATECHOLAMINE METABOLISM IN AFFECTIVE DISORDERS: RECENT 

STUDIES OF MHPG EXCRETION. ,6909101-13 

CHANGES IN SOMATOSENSORY EVOKED POTENTIALS PRODUCED BY 

DRUGS USED IN THE TREATMENT OF AFFECTIVE DISORDERS^ 

1 69092 1 "UV 
A COLLABORATIVE ASSESSMENT OF NOREPINEPHRINE METABOLISM IN 

AFFECTIVE DISORDERS. 169094 01-09 

THE USE OF LITHIUM IN AFFECTIVE DISORDERS, III: A DOUBLE-BLIND 

STUDY OF PROPHYLAXIS IN BIPOLAR ILLNESS ^^^^^^ ^^^ 

INFLUENCE OF AFFECTIVE STATES AND PSYCHOACTIVE DRUGS ON 

VERBAL LEARNING AND MEMORY ^^^^^^ ^^^ 

DRUGS AND PSYCHODYNAMIC SHIFTS IN AFFECTIVE ILLNESS. 

(UNPUBLISHED PAPER). ,70079 01-09 

BRAIN SEROTONIN, AFFECTIVE ILLNESS AND ANTIDEPRESSANT DRUGS: 

CEREBROSPINAL FLUID STUDIES WITH PROBENECID. (UNPUBLISHED 

^^^^^'>- 170084 01-09 

L-TRYPTOPHAN IN MANIA: CONTRIBUTION TO A PERMISSIVE 

HYPOTHESIS OF AFFECTIVE DISORDERS. ^^^^^^ ^^^^ 

LITHIUM CARBONATE AND SLEEP IN AFFECTIVE DISORDERS: FURTHER 

CONSIDERATIONS. ,7,503 01-09 

LITHIUM PROPHYLAXIS IN RECURRENT AFFECTIVE ILLNESS. ^^^^^^ ^^^^ 
LITHIUM PROPHYLAXIS IN AFFECTIVE DISORDERS: AN OPEN TRIAL WITH 

MATCHED CONTROLS. ,7240101-09 

LONG-TERM USE OF LITHIUM CARBONATE IN AFFECTIVE DISORDERS: A 

CLINICAL EVALUATION. ,74778 01-09 

LITHIUM DISTRIBUTION BETWEEN CEREBROSPINAL FLUID AND SERUM OF 

AFFECTIVE PSYCHOTIC PATIENTS TREATED WITH LITHIUM CARBONATE 

AND ITS CLINICAL RESPONSE. ,8030102-11 

CENTRAL DOPAMINE FUNCTION IN AFFECTIVE ILLNESS: EVIDENCE FROM 

PRECURSORS ENZYME INHIBITORS AND STUDIES OF CENTRAL 

DOPAMINE TURNOVER. (UNPUBLISHED PAPER). 

I o I 3jo Uz-UV 
A PSYCHOPHARMACOLOGICAL STUDY OF CATECHOLAMINES IN 

AFFECTIVE DISORDERS. ,84653 03-09 

L-TRYPTOPHAN IN AFFECTIVE DISORDERS: INDOLEAMINE CHANGES AND 

DIFFERENTIAL CLINICAL EFFECTS. ,85928 03-09 

THE EFFECT OF LITHIUM ON THYROID IODINE RELEASE IN PATIENTS 

WITH PRIMARY AFFECTIVE DISORDER ,86580 03-09 



s-n 



Subject Index 



Psychopharmacology Abstracts 



AFFECTIVF STATE AND THYROTROPIN AND PROLACTIN RESPONSES 
AFTER REPEATED INJECTIONS OF THYROTROPIN RELEASING HORMONE 
IN DEPRESSED PATIENTS. 

189076 04-09 
AFFECTIVE DISORDERS AND CHEMICAL DEPENDENCE: LITHIUM FOR 
ALCOHOL AND DRUG ADDICTION 

189775 04-09 
LITHIUM IN TREATMENT AND PREVENTION OF AFFECTIVE DISORDER: A 
VA-NIMH COLLABORATIVE STUDY. 

190381 04-09 
REBOUND PHENOMENON IN MANIC PATIENTS FOLLOWING 

PHYSOSTIGMINE: TOWARDS AN UNDERSTANDING OF AMINERGIC 
MECHANISMS UNDERLYING AFFECTIVE DISORDERS. 

191531 04-09 
AFFERENT 

THE EFFECT OF DIAZEPAM ON SOME CARDIOVASCULAR AND 

RESPIRATORY REFLEXES ELICITED BY AFFERENT ABDOMINAL VAGUS 
STIMULATION. 

178945 02-03 
EFFECT OF ANTICONVULSANT DRUGS ON THE NUMBER OF AFFERENT 
STIMULI NEEDED TO CAUSE A HIPPOCAMPAL SEIZURE DISCHARGE. 

189608 04-03 
5-HYDROXYTRYPTAMINE AND NORADRENALINE IN THE HIPPOCAMPAL 
REGION: EFFECT OF TRANSECTION OF AFFERENT PATHWAYS ON 
ENDOGENOUS LEVELS, HIGH AFFINITY UPTAKE AND SOME 
TRANSMITTER RELATED ENZYMES. 

191319 04-03 
AFFINITY 

STRIATAL TYROSINE HYDROXYLASES WITH HIGH AND LOW AFFINITY 
FOR TYROSINE: IMPLICATIONS FOR THE MULTIPLE POOL CONCEPT OF 
CATECHOLAMINES. 

167325 01-03 
DRUG-INDUCED ACTIVATION OF STRIATAL TYROiINt HYDROXYLASE: 
CHANGES IN THE AFFINITY FOR PTERIDINE COFACTORS. (UNPUBLISHED 
PAPER). 

173381 01-03 
ANTISCHIZOPHRENIC DRUGS AND BRAIN CHOLINERGIC RECEPTORS: 
AFFINITY FOR MUSCARINIC SITES PREDICTS EXTRAPYRAMIDAL 
EFFECTS. 

188114 04-15 
5-HYDROXYTRYPTAMINE AND NORADRENALINE IN THE HIPPOCAMPAL 
REGION: EFFECT OF TRANSECTION OF AFFERENT PATHWAYS ON 
ENDOGENOUS LEVELS, HIGH AFFINITY UPTAKE AND SOME 
TRANSMITTER RELATED ENZYMES. 

191319 04-03 
AFRODEX 

AFRODEX VS. PLACEBO IN THE TREATMENT OF MALE IMPOTENCE: 
STATISTICAL ANALYSIS OF TWO DOUBLE-BLIND CROSSOVER STUDIES. 

181959 02-14 
AFTERDISCHARGE 

THE ANTAGONISM OF HIPPOCAMPAL AND CORTICAL AFTERDISCHARGE 
BY SC-13504, A NEW ANTICONVULSANT. 

186632 03-03 
AFTEREFFECT 

EFFECT AND AFTEREFFECT OF DRUGS: ETHICAL CONSIDERATIONS ON THE 
USE OF PSYCHOTROPIC AGENTS (1). 

170847 01-17 
THE SPIRAL AFTEREFFECT (SAE) AS A MEASURE OF MOTION SICKNESS 
SUSCEPTIBILITY AND THE EFFECT ON THE SAE OF AN ANTIMOTION 
SICKNESS DRUG AND A CENTRAL NERVOUS SYSTEM DEPRESSANT. 

172780 01-03 
AGE 

L-DOPA IN 122 CASES OF PARKINSONS DISEASE AT AGE 70 OR OVER. A 
COMPARATIVE STUDY WITH A GROUP OF PATIENTS AGED 41 TO 69 
YEARS. 

168369 01-11 
PSYCHOPHARMACOLOGY OF OLD AGE. 

169945 01-17 
POLYMYALGIA RHEUMATICA IN A GERIATRIC DEPARTMENT: NINE 
PATIENTS WITH AN AVERAGE AGE OF 83 YEARS. 

187236 03-11 
EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND AGE ON 

VARIOUS NEUROTRANSMITTERS AND ASSOCIATED ENZYMES IN MALE 
FISCHER 344 RATS. 

189597 04-03 
AGED 

INFLUENCE OF TREATMENT ON SYMPTOMATOLOGY AND CORRELATED 
ELECTROENCEPHALOGRAPHIC (EEG) CHANGES IN THE AGED. 

167336 01-13 
L-DOPA IN 122 CASES OF PARKINSONS DISEASE AT AGE 70 OR OVER. A 
COMPARATIVE STUDY WITH A GROUP OF PATIENTS AGED 41 TO 69 
YEARS. 

168369 01-11 
MEGAVITAMIN TREATMENT, CULTURE AND TRANQUILIZERS, DRUGS FOR 
THE AGED: PROJECTS OF A CANADIAN GRANT. 

170293 01-11 



AN ERGOT ALKALOID PREPARATION (HYOERGINE) VERSUS PAPAVERINE 
IN TREATING COMMON COMPLAINTS OF THE AGED: DOUBLE-BLIND 
STUDY. 

173190 01-11 
PSYCHIATRIC PHARMACOLOGY OF THE AGED 

191693 04-17 
PHARMACOLOGY OF DEPRESSION IN THE AGED: EVALUATION OF 
GER0VITAL-H3 AS AN ANTIDEPRESSANT DRUG. 

192229 04-09 
AGGREGATED 

EFFECTS OF PSYCHOTROPIC DRUGS ON METHAMPHET AMINE INDUCED 
EXCITATIONS IN THE AGGREGATED MICE. 

182107 02-04 
AGGREGATION 

INFLUENCE OF VARIOUS SUBSTANCES WHICH INDUCE AND INHIBIT 
AGGREGATION ON THE UPTAKE OF DEOXYGLUCOSE BY HUMAN 
BLOOD PLATELETS. 

191770 04-13 
AGGRESSION 

EFFECT OF LITHIUM ON AGGRESSION, MANIA AND PERMSELECTIVE 
MEMBRANES. 

167448 01-09 
EFFECT OF DOPAMINERGIC STIMULATION OR BLOCKADE ON MORPHINE 
WITHDRAWAL AGGRESSION. 

171300 01-04 
DELTA9-TETRAHYDR0CANNABIN0L INDUCED INHIBITION OF PREDATORY 
AGGRESSION IN THE RAT. 

172745 01-04 
SELECTIVE BLOCKADE OF APOMORPHINE INDUCED AGGRESSION AND 
GNAWING FOLLOWING FENFLURAMINE OR RAPHE LESIONS IN THE 
RAT. 

182128 02-04 
EFFECTS OF (-)DELTA9-TRANS-TETRAHYDR0CANNABIN0L IN SEVERAL 
ANIMAL MODELS OF AGGRESSION. 

182188 02-04 
INHIBITION OF ISOLATION INDUCED AGGRESSION IN THE MOUSE BY 
ANTICHOLINERGIC COMPOUNDS. 

182239 03-04 
INHIBITION OF ISOLATION INDUCED AGGRESSION IN MICE BY 

ANTISEROTONERGIC DRUGS. 

182240 03-04 
THE NEUROPHARMACOLOGY OF AGGRESSION: A CRITICAL REVIEW. 

183615 03-14 
DRUG-INDUCED AGGRESSION IN CHICKS: DIFFERENTIAL INVOLVEMENT 
OF BIOGENIC AMINES. 

191977 04-04 
AGGRESSIVE 

STEREOTYPED AND AGGRESSIVE BEHAVIOR INDUCED BY SUSTAINED 
HIGH DOSE OF THEOPHYLLINE IN RATS. 

177019 02-04 
FURTHER ASPECTS OF AGGRESSIVE BEHAVIOR INDUCED BY SUSTAINED 

HIGH DOSE OF THEOPHYLLINE IN RATS. 

1 77020 02-04 
DEXTROAMPHETAMINE AND METHYLPHENIDATE IN THE TREATMENT OF 

HYPERACTIVE/AGGRESSIVE CHILDREN. 

177771 02-14 
PREDATION: SEPARATION OF AGGRESSIVE AND HUNGER MOTIVATION 
BY CONDITIONED AVERSION. 

185463 03-04 
BRAIN AMINES AND APOMORPHINE-INDUCED INTRASPECIFIC 
AGGRESSIVE BEHAVIOR IN THE RAT. 

186374 03-04 
DELTA9-TETRAHYDR0CANNABIN0L AND AGGRESSIVE BEHAVIOR IN 
RATS. 

189525 04-04 
NEUROCHEMICAL ANALYSIS OF AGGRESSIVE - DEFENSIVE BEHAVIOR 
ELICITED BY ELECTRICAL STIMULATION OF THE HYPOTHALAMUS AND 
CENTRAL GRAY MATTER. 

191784 04-02 
AGGRESSIVENESS 

THE EFFECT OF METHAMPHETAMINE ON BRAIN ACH CONSUMPTION AND 
AGGRESSIVENESS IN MICE STRESSED MILDLY BY LONG-TERM 
ISOLATION. 

182108 02-04 
INFLUENCE OF PSYCHOTROPIC DRUGS ON AGGRESSIVENESS EVOKED BY 

DESTRUCTION OF ISOLATED STRUCTURES OF THE FOREBRAIN. 

191788 04-04 
AGGRESSIVITY 

BEHAVIORAL CHANGES AND AGGRESSIVITY EVOKED BY DRUGS IN MICE. 

174604 01-04 
AGING 

PSYCHOPATHOLOGICAL IMPORTANCE AND THERAPEUTIC EFFECTS OF A 
COMBINATION OF HYDERGINE AND THIORIDAZINE IN PSYCHIATRIC 
SYNDROMES IN THE AGING. 

168976 01-14 
GER0VITAL-H3 IN THE TREATMENT OF THE DEPRESSED AGING PATIENT. 

177373 02-11 



S-12 



VOLUME 12, SUBJECT INDEX 



Subject index 



*°°PARKINS0N DISEASE TREATED WITH A SUSPECTED DOPAMINE RECEPTOR 

^'^°'^'^^- 186029 03-11 

METHODOLOGY FOR THE EVALUATION OF PENTAZOCINE, PROTOTYPE OF 
THE NEW MORPHINE AGONIST ANTAGONIST ANALGESICS. 

NALTREXONE AND NALOXONE: AGONIST AND ANTAGONIST EFFECTS ON 
KEY-PRESS RESPONDING OF PIGEONS MAINTAINED UNDER A MULTIPLE 
SCHEDULE OF FOOD PRESENTATION. ^^^^^^ ^^^^ 

DOPAMINE AGONIST INDUCED DISORIENTATION IN A RAT SWIMMING 

^*^'^- 192018 04-04 

THE EFFECTS OF CHLORDIAZEPOXIDE (LIBRIUM) ON THE INTENSITY AND 
HABITUATION OF AGONISTIC BEHAVIOR IN MALE SIAMESE FIGHTING 

'''^"- 177722 02-04 

INHIBITORY EFFECT OF DOXEPIN ON AGONISTIC BEHAVIOUR ELICITED BY 
HYPOTHALAMIC STIMULATION IN THE CAT. 

AGONISTS 

CENTRAL MONOAMINE METABOLISM IN MAN: EFFECT OF PUTATIVE 
DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS. 

169377 01-13 
TEMPERATURE DEPENDENT TOXICITY OF ADRENERGIC AGONISTS IN MICE 
AS A BASIS FOR TREATING D-AMPHETAMINE POISONING. 

169688 01-05 
PROGRESS REPORT ON THE USE OF THE DOG FOR ASSESSING MORPHINE- 
LIKE AND NALORPHINE-LIKE AGONISTS AS WELL AS DEPOT 
PREPARATIONS OF ANTAGONISTS. (UNPUBLISHED PAPER). 

176312 02-03 
A ROLE FOR THE AMYGDALA IN THE DEVELOPMENT OF THE CATALEPTIC 
AND STEREOTYPIC ACTIONS OF THE NARCOTIC AGONISTS AND 
ANTAGONISTS IN THE RAT. ,86577 03-03 

THE ANTAGONISM BETWEEN CHOLINOMIMETIC AGONISTS AND BETA- 
ADRENOCEPTOR STIMULANTS: THE DIFFERENTIATION BETWEEN 
BETWEEN FUNCTIONAL AND METAFFINOID ANTAGONISM. 

191420 04-03 
BEHAVIORAL EFFECTS OF DIRECT AND INDIRECT ACTING DOPAMINERGIC 

AGONISTS. „, „ „, 

191521 04-04 

SUPERSENSITIVITY TO DOPAMINERGIC AGONISTS FOLLOWING 

WITHDRAWAL OF A CHRONIC DIET CONTAINING HALOPERIDOL OR 

'"^°^"^^ 192012 04-04 

ONE CASE OF AGRYPNIA (4 MONTHS WITHOUT SLEEP) IN A MORVAN 
DISEASE- FAVORABLE ACTION OF 5-HYDROXYTRYPTOPHAN 

187237 03-14 

AID 

SERUM DOPAMINE-BETA-HYDROXYLASE: A POSSIBLE AID IN THE 
EVALUATION OF HYPERTENSION. 

AKATHISIA ^ 

IMIPRAMINE WITHDRAWAL: AN AKATHISIA LIKE SYNDROME. 

177710 02-15 

ALBINO 

THE EFFECT OF PSYCHOTROPIC AGENTS ON THE FORMATION OF 
AVOIDANCE REACTION IN ALBINO RATS DURING ELECTROPAIN 
STIMULATION OF ANOTHER RAT. 183206 03-04 

CONDITIONING OF AMPHETAMINE-INDUCED BEHAVIOUR IN THE ALBINO 

RAT 

185954 03-04 

EFFECTS OF NEUROLEPTIC AGENT ON CENTRAL NERVOUS SYSTEM OF 
"^^'^°^*^^- 1916,3 04-03 

BINDING OF DIAZOXIDE AND OTHER BENZOTHIADIAZINES TO HUMAN 

*^^^'^"^- 179987 02-13 

INFLUENCE OF VARIOUS DRUGS ON THE BINDING OF CHLORPROMAZINE 
TO ERYTHROCYTES AND ALBUMIN. ^^^^^^ ^^^^ 

INFLUENCE OF PH ON THE BENZODIAZEPINE HUMAN SERUM ALBUMIN 
COMPLEX: CIRCULAR DICHROISM STUDIES. 

189595 04-13 

ALCOHOL 

MESORIDAZINE AND CHLORPROMAZINE IN THE TREATMENT OF 
ALCOHOL WITHDRAWAL SYNDROME. 

168314 01-11 

PREVENTION OF ALCOHOL WITHDRAWAL SEIZURES: THE ROLES OF 
DIPHENYLHYDANTOIN AND CHLORDIAZEPOXIDE 

172275 01-11 



PSYCHOPHYSIOLOGICAL EFFECTS OF DIAZEPAM (VALIUM) COMBINED 
WITH A MODERATE DOSE OF ALCOHOL IN MAN. 

180699 02-14 

L-DOPA AND POTENTIATION OF ALCOHOL ANESTHESIA BY 

CHLORPROMAZINE. ^^^^^^ ^^^^ 

CHANGES IN THE NEUROEXCITABILITY OF ALCOHOL DEPENDENT RATS 
UNDERGOING WITHDRAWAL AS MEASURED BY THE 
PENTYLENETETRAZOL SEIZURE THRESHOLD. 

182348 03-03 
ACUTE EFFECTS OF ALCOHOL, DIAZEPAM, THIORIDAZINE, FLUPENTHIXOL 
AND ATROPINE ON PSYCHOMOTOR PERFORMANCE PROFILES. 

184848 03-14 
TEMPORAL DISORGANIZATION AND DELUSIONAL-LIKE IDEATION: 
PROCESSES INDUCED BY HASHISH AND ALCOHOL. 

185330 03-14 
PROPRANOLOL AND BEHAVIOR OF ALCOHOL ADDICTS AFTER ACUTE 
ALCOHOL INGESTION. ^^^ „ ,^ 

187257 04-14 

THE EFFECT OF MEDAZEPAM AND ALCOHOL ON COGNITIVE AND MOTOR 
SKILLS USED IN CAR DRIVING. ,89408 04.14 

EFFECTS OF DIAZEPAM AND CODEINE, ALONE AND IN COMBINATION 
WITH ALCOHOL, ON SIMULATED DRIVING, 

189619 04-14 

AFFECTIVE DISORDERS AND CHEMICAL DEPENDENCE: LITHIUM FOR 
ALCOHOL AND DRUG ADDICTION ^^^^^^ ^^^^ 

INTERACTION BETWEEN ALCOHOL, MINOR TRANQUILIZERS AND 

'^°^^^'^^- 19,14104-04 

COMPARISON OF CODEINE AND ETHYL ALCOHOL SELF-ADMINISTRATION 
UNDER A VARIABLE INTERVAL (VI) SCHEDULE IN MONKEYS. 

191983 04 04 

ALCOHOLIC 

EXCRETION OF NOREPINEPHRINE AND DOPAMINE ALCOHOLIC 
METABOLITES AFTER 6-HYDROXYDOPAMINE. 

I /Woo Ut'UO 

DIURETIC ANTIDEPRESSANT COMBINATION IN ALCOHOLIC DEPRESSIVES. 

187866 04-1 1 

ALCOHOLICS 

RESPONSE TO INCREMENTAL DOSES OF DITRAN IN ABSTINENT 
ALCOHOLICS AND DRUG USERS. 

185875 03-1, 

ALCOHOLISM 

PSYCHOTHERAPEUTICS OF ALCOHOLISM. 

PSYCHOTIC COMPLICATIONS AFTER TETRAETHYLTHIURAMDISULFIDE 
USED IN THE TREATMENT OF ALCOHOLISM. 

STUDY OF THE USE OF DISULFIRAM IMPLANT IN THE TREATMENT OF 

^^""°^'^" 183030 03-11 

DOUBLE-BLIND COMPARISON OF THIOTHIXENE, TRIFLUOPERAZINE, AND 

PLACEBO IN CHRONIC ALCOHOLISM. ,88584 04-11 

DRUG MAINTENANCE IN THE OUTPATIENT TREATMENT OF CHRONIC 

^^^°^°^'^^- ,89926 04-1, 

ALCOHOLS 

CALCIUM REVERSAL OF NERVE BLOCKADE BY ALCOHOLS, ANESTHETICS, 
TRANQUILIZERS, AND BARBITURATES. 

THE IMPULSE BLOCKING CONCENTRATIONS OF ANESTHETICS, ALCOHOLS, 
ANTICONVULSANTS. BARBITURATES, AND NARCOTICS ON PHRENIC 
AND SCIATIC NERVES. ,87803 04-03 

ALDEHYDE 

PARTIAL PURIFICATION AND CHARACTERIZATION OF NADPH-LINKED 
ALDEHYDE REDUCTASE FROM MONKEY BRAIN. 

,75232 02-03 

THE INFLUENCE OF ALDOSTERONE OR METHAMPHETAMINE ON LIVER 
GLYCOGEN DEPOSITION OF MICE STRESSED BY LONG-TERM 

'^°^^'°^- ,82105 02-03 

EFFECTS OF CAFFEINE ON ALERTNESS IN SIMULATED AUTOMOBILE 

^«'^'^^- 190743 04-14 

ALGORITHMS 

SIMPLE ALGORITHMS FOR PREDICTING PSYCHOTROPIC DRUGS ASSIGNED 
TO PSYCHIATRIC INPATIENTS. ,. „n,-r 

1 76676 02- 1 / 

NORADRENALINE IN THE GUINEA-PIG ALIMENTARY CANAL: REGIONAL 
DISTRIBUTION AND SENSITIVITY TO DENERVATION AND RESERPINE 



S-13 



Subject Index 



Psychopharmacology Abstracts 



ALKALI 

EFFECTS OF ALKALI METALS ON SPONTANEOUS MOTOR ACTIVITIES OF 
MICE. 

182637 03-02 
ALKALOID 

AN ERGOT ALKALOID PREPARATION (HYDERGINE) VERSUS PAPAVERINE 
IN TREATING COMMON COMPLAINTS OF THE AGED: DOUBLE-BLIND 
STUDY. 

173190 01-n 
HYPOTHERMIA EVOKED BY A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE ALKALOID. 

182130 02-03 
IN VIVO INHIBITION OF NEURONAL UPTAKE OF A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE (TIQ) ALKALOID BY COCAINE AND BY 
DESMETHYLIMIPRAMINE (DMI). 

182150 02-03 
UPTAKE, STORAGE AND RELEASE IN VIVO OF A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE (TIQ) ALKALOID BY SYMPATHETIC NERVES 
OF THE IRIS. 

182204 02-03 
ALKALOID STUDIES. 9. PREPARATION OF 18-ACYLYOHIMBAN-l 7-ONES 
AND THEIR CONVERSION TO NEW HETEROCYCLIC YOHIMBANS. 

185033 03-04 
FURTHER EVIDENCE FOR A DOPAMINE RECEPTOR STIMULATING ACTION 
OF AN ERGOT ALKALOID 

188739 04-03 
ALKALOIDS 

TETRAHYDROISOQUINOLINE ALKALOIDS: IN VIVO METABOLITES OF L- 
DOPA IN MAN. 

168286 01-13 
PEYOTE AND RELATED ALKALOIDS XVI: SYNTHESIS OF 3,4,5 

TRIMETHOXYPHENYLALANINE, AN AMINO ANALOG OF MESCALINE. 

170839 01-06 
THE CHEMISTRY OF PEYOTE ALKALOIDS. 

192875 04-12 
BIOSYNTHESIS OF THE PEYOTE ALKALOIDS. 

192876 04-12 
CACTUS ALKALOIDS. XIX. CRYSTALLIZATION OF MESCALINE HCL AND 3- 

METHOXYTYRAMINE HCL FROM TRICHOCEREUS-PACHANOI. 

192878 04-01 
CACTUS ALKALOIDS. XXII. DOLICHOTHELE SURCULOSA AND OTHER 

DOLICHOTHELE SPECIES. 

192879 04-01 
CACTUS ALKALOIDS: XVIII. PHENOLIC BETA-PHENETHYLAMINES FROM 

MAMMILLARIA-ELONGATA. 

192882 04-01 
ALKYLAMINE 

STIMULATION OF BRAIN AROMATIC ALKYLAMINE N- 
METHYLTRANSFERASE ACTIVITY BY FAD AND METHYLCOBALAMIN. 

180020 02-03 
ALLERGIC 

OXAZEPAM IN ALLERGIC CONDITIONS. 

168923 01-11 
ALPHA 

MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND ITS 
HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD. 

186566 03-16 
EVIDENCE FOR A NORADRENERGIC AND DOPAMINERGIC MECHANISM IN 
THE HYPERACTIVITY PRODUCED BY 4,ALPHA DIMETHYL-M-TYRAMINE 
(H-77-77) IN RATS. 

190309 04-04 
ALPHA-ADRENERGIC 

ALPHA-ADRENERGIC RECEPTORS MEDIATE SUPPRESSION OF DRINKING 
INDUCED BY HYPOTHALAMIC AMPHETAMINE INJECTION. 

182216 03-03 
ALPHA-ADRENERGIC BLOCKING AGENTS: ANTINOCICEPTIVE ACTIVITY 
AND ENHANCEMENT OF MORPHINE-INDUCED ANALGESIA. 

183895 03-03 
TREATMENT OF ANXIETY NEUROSIS BY ALPHA-ADRENERGIC AND BETA- 
ADRENERGIC BLOCKING AGENTS. 

186780 03-10 
CENTRAL HYPOTHERMIA BY 2-DEOXY-D-GLUCOSE: ANTAGONISM BY 
ALPHA-ADRENERGIC ACTIVATION. 

188200 04-03 
ALPHA-ADRENOCEPTOR 

PARADOXICAL THERMOREGULATORY BEHAVIOUR IN RATS INDUCED BY 
(J AMPHETAMINE: BLOCKADE BY ALPHA-ADRENOCEPTOR OR 
DOPAMINE RECEPTOR BLOCKING AGENTS. 

183797 03-03 
ALPHA-ADRENORECEPTOR 

EFFECTS OF CLONIDINE AND SOME ALPHA-ADRENORECEPTOR BLOCKING 
AGENTS ON AVOIDANCE CONDITIONED REFLEXES IN RATS: THEIR 
INTERACTIONS AND ANTAGONISM BY ATROPINE. 

186576 03-04 
ALPHA-BLOCKERS 

1-AMINOTETRALINES - CNS AGENTS AND ALPHA-BLOCKERS. 

175762 02-17 



ALPHA-l-ACETYLMETHADOL 

ALPHA-L-ACETYLMETHADOL AND ITS N-DEMTHYLATED METABOLITES 
HAVE POTENT OPIATE ACTION IN THE GUINEA-PIG ISOLATED ILEUM. 

187130 03-03 
ALPHA-METHYl-M-TYRAMINE 

INTERACTION OF APOMORPHINE, NEUROLEPTICS AND STIMULANTS 
WITH ALPHA-METHYL-M-TYRAMINE, A FALSE DOPAMINERGIC 
TRANSMITTER. 

181809 02-03 
ALPHA-METHYL-P-TYROSINE 

CATALEPSY INDUCED BY ALPHA-METHYL-P-TYROSINE AND D- 
AMPHETAMINE: THE ROLE OF CATECHOLAMINE METABOLISM. 

185750 03-03 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS: 
I. EFFECT ON THE BEHAVIOURAL CHANGES INDUCED BY RESERPINE, 
ALPHA-METHYL-P-TYROSINE OR AMPHETAMINE. 

186587 03-04 
ALPHA-METHYL-P-TYROSINE INHIBITION OF SELF-ADMINISTERED 
INTRAVENOUS MORPHINE AND ORAL WATER IN RATS. 

191940 04-04 
ALPHA-METHYL-PARA-TYROSINE 

INTERACTIONS IN MAN OF DELTA9-TETRAHYDR0CANNABIN0L: I. ALPHA- 
METHYL-PARA-TYROSINE. 

174347 01-13 
ALPHA-METHYLDOPA 

POTENTIATION OF HALOPERIDOL BY ALPHA-METHYLDOPA IN THE 
TREATMENT OF SCHIZOPHRENIC PATIENTS. 

167343 01-08 
EFFECT OF ALPHA-METHYLDOPA ON THE METABOLISM OF DOPAMINE IN 
THE STRIATUM OF THE RAT. 

186694 03-03 
THE ACTION OF ALPHA-METHYLDOPA IN THE CERVEAU ISOLE 
PREPARATION. 

187075 03-03 
ALPHA-METHYLDOPAMINE 

ALPHA-METHYLDOPAMINE DERIVATIVES. SYNTHESIS AND 
PHARMACOLOGY. 

189177 04-02 
ALPHA-METHYLTRYPTAMINE 

ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN 

DIMETHYLAMINOPROPYLTHIOCINNAMANILIDE HYDROCHLORIDE), A 
SEROTONIN ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN (5-HTP) AND ALPHA-METHYLTRYPTAMINE. 

176861 02-04 
ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN, A SEROTONIN 
ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN AND ALPHA-METHYLTRYPTAMINE. 

1 76873 02-04 
ALPHA-METHYLTYROSINE 

INHIBITION OF ANTICHOLINERGIC DRUG-INDUCED LOCOMOTOR 
STIMULATION IN MICE BY ALPHA-METHYLTYROSINE. 

) 77840 02-03 
INFLUENCE OF ALPHA-METHYLTYROSINE ON ENHANCEMENT OF 
SHUTTLEBOX AVOIDANCE BY MARIJUANA AND PENTOBARBITAL. 

187572 04-04 
EFFECTS OF ALPHA-METHYLTYROSINE ON D-AMPHETAMINE INDUCED 
RELEASE OF ENDOGENOUSLY SYNTHESIZED AND EXOGENOUSLY 
ADMINISTERED CATECHOLAMINES FROM THE CAT BRAIN IN VIVO. 

189397 04-03 
THE EFFECT OF INCREASED GAMMA-AMINOBUTYRIC ACID ON ALPHA- 
METHYLTYROSINE INDUCED DECREASE IN CATECHOLAMINES IN RAT 
BRAIN. 

191988 04-03 
DIFFERENTIAL INCREASE OF BEHAVIORAL AND EXTRAPYRAMIDAL 
STIMULATING ACTIONS OF NEUROLEPTICS BY ALPHA- 
METHYLTYROSINE PRETREATMENT IN RATS. 

192016 04-04 
ALPHA-RECEPTORS 

INVOLVEMENT OF ALPHA-RECEPTORS IN CLONIDINE INDUCED INHIBITION 
OF TRANSMITTER RELEASE FROM CENTRAL MONOAMINE NEURONES. 

182345 03-03 
ALTERATION 

ALTERATION OF MATERNAL BEHAVIOR IN MICE FOLLOWING 
ADMINISTRATION OF CYPROTERONE ACETATE. 

172374 01-04 
ALTERATION OF 5-HYDR0XYTRYPTAMINE-14C EFFLUX BY NICOTINE IN 
RAT BRAIN AREA SLICES. 

172925 01-03 
ALTERATION OF SENSORY AND MOTOR EVOKED RESPONSES BY 
DIELDRIN. 

181818 02-03 
AMPHETAMINE-INDUCED ALTERATION OF BIOGENIC AMINES AND SELF- 
STIMULATION. 

182212 03-03 
ALTERATION OF ETHANOL-INDUCED CNS DEPRESSION: INEFFECTIVENESS 
OF DRUGS THAT MODIFY CHOLINERGIC TRANSMISSION. 

186375 03-03 



S-14 



BT* 



VOLUME 12, SUBJECT INDEX 



Subject Index 



AITERATION OF EVOKED POTENTIALS IN CAUDATE NUCLEUS OF FREELY 
MOVING RATS BY L-DOPA, RESERPINE, AND PENTOBARBITAL 

Io/o6z U4-Uo 

LONG-TERM ALTERATION OF SLEEP-WAKEFULNESS CYCLE DURING 

CHRONIC PENTOBARBITAL DOSING AND WITHDRAWAL IN^^AT^^ ^^^^ 

*''"p*HLOROPHENYLALANINE INDUCED ALTERATIONS IN THE BEHAVIORAL 
EFFECTS OF 5-HYDROXYTRYPTOPHAN. ^^^^^^ ^^^^ 

THE ONTOGENY OF AMPHETAMINE-INDUCED ALTERATIONS IN THERMAL 
REGULATION. 182246 03-03 

BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 5,6 
DIHYDROXYTRYPTAMINE ADMINISTRATION INTO BRAIN. 

186634 03-04 

LIPIDOSIS-LIKE ALTERATIONS IN DORSAL ROOT GANGLION CELLS OF 

RATS TREATED WITH TRICYCLIC ANTIDEPRESSANTS. 

189605 U4-UJ 
DOSE-RELATED ALTERATIONS IN METABOLISM OF LEVODOPA: POSSIBLE 

MECHANISM FOR HYPOTENSIVE EFFECT. ^^^^^^ ^^^ ^ 

PERMANENT ALTERATIONS IN 5-HYDROXYTRYPTAMINE METABOLISM IN 
DISCRETE AREAS OF RAT BRAIN FOLLOWING EXPOSURE TO DRUGS 
DURING THE PERIOD OF DEVELOPMENT. ^^^^^^ ^^^^ 

RELATIONSHIP OF CATECHOLAMINE NEURAL SYSTEMS TO THE 
BEHAVIORAL ALTERATIONS PRODUCED BY 6-HYDROXYDOPAMINE 
ADMINISTRATION INTO BRAIN. ^^^^^^ ^^^^ 

EFFECTS OF ALTERATIONS IN IMPULSE FLOW ON TRANSMITTER 
METABOLISM IN CENTRAL DOPAMINERGIC NEURONS. 

191519 04-03 

PHARMACOLOGICAL ALTERATIONS IN THE STIMULUS INDUCED RELEASE 
OF NOREPINEPHRINE FROM THE RABBIT SUPERIOR CERVICAL 

^'^^^^'"^ ,91896 04-03 

ALTERED 

ALTERED NOREPINEPHRINE SYNTHESIS OF SPLANCHNIC VESSELS IN 
NEUROGENIC HYPERTENSION. ,88,98 04-03 

INTERACTIVE EFFECTS OF CYCLOHEXIMIDE AND PUROMYCIN IN 

ALTERING BRAIN POLYRIBOSOMES AND NEURAL AND BEHAVIOURAL 
RESPONSES TO ELECTROSHOCK IN MICE. ^^^^^^ ^^^^ 

EFFECTS OF DELTA9-THC, LSD-25 AND SCOPOLAMINE ON CONTINUOUS, 

SPONTANEOUS ALTERNATION IN THE Y-MAZE. 

,7,306 0,-04 
THE EFFECT OF SOME CHOLINOLYTIC DRUGS ON A NUMBER OF 

BEHAVIOURAL PARAMETERS MEASURED IN THE T-MAZE ALTERNATION 

TEST: DOSE-RESPONSE RELATIONSHIPS. ,„-,..,„.„. 

187641 04-04 

EKG ALTERNATIONS IN INFUSION TREATMENT WITH TRICYCLIC 
ANTIDEPRESSIVE DRUGS. ,80063 02-15 

^"^a'cHEMOTHERAPEUTIC ALTERNATIVE TO THE ANTIANXIETY AGENTS FOR 
THE EXTENDED TREATMENT OF PSYCHONEUROSIS. 

I V^UOO \J*i' I U 

EFFECTS OF ALUMINUM SALTS ON CULTURED NEUROBLASTOMA CELLS. 

,9,313 04-03 

AMA 

AMA DRUG EVALUATIONS. ,9,048 04-17 

*** AMANTADINE HYDROCHLORIDE IN TREATMENT OF PARKINSONISM. 

169461 01-1 1 
HABITUATION OF BLINK REFLEXES IN PARKINSONIAN PATIENTS UNDER 
LEVODOPA AND AMANTADINE TREATMENT. „ „, ,, 

171794 Olio 
THE EFFECT OF DOPAMINE ANTAGONISTS AND AMANTADINE ON THE 
ACQUISITION OF THE CONDITIONED AVOIDANCE RESPONSE IN RATS. 

INHIBITION OF THE APOMORPHINE GNAWING COMPULSION BY 
^^^^^f^^^^^- 176879 02-04 

CENTRAL NERVOUS SYSTEM AND AUTONOMIC NERVOUS SYSTEM 

EFFECTS OF AMANTADINE AND OF SOME STANDARD ANTIPARKINSON 

''^^^^- 177729 02-13 

ON THE SPECIFICITY OF DOPAMINE RELEASE BY AMANTADINE. 

1 78557 0^-UJ 
AMANTADINE MAY STIMULATE DOPAMINE AND NORADRENALINE 

^^^^f^ORS. ,83868 03-03 



THE EFFECT OF AMANTADINE, L-DOPA, (_) AMPHETAMINE AND 
APOMORPHINE ON THE ACQUISITION OF THE CONDITIONED 
AVOIDANCE RESPONSE. ,86636 03-04 

COMPARISON OF AMANTADINE, PLACEBO, AND LEVODOPA IN 

PARKINSONS DISEASE. ,89502 04-11 

CLINICAL EVALUATION OF AMANTADINE THERAPY FOR PARKINSONISM 
AND THE SIDE-EFFECTS - IN CASES OF THALAMIC SURGERY AND L- 
^OPA^^^^^Py ,90095 04-11 

CLINICAL ASSAY OF LORAZEPAM WITH AMBULANT PATIENTS. 

1 83201 03- 1 I 

TRIAL OF OXAZEPAM IN AMBULATORY PSYCHONEUROTICS. 

170412 01-1 1 
THE USE OF TIMED RELEASE NEUROLEPTICS IN AMBULATORY 

PSYCHIATRIC PRACTICE. ,72977 01-11 

PIPERACETAZINE IN AMBULATORY CHRONIC SCHIZOPHRENIC PATIENTS^ 
nrci^v-i: ,77748 02-08 

HIGH DOSAGE PIPERACETAZINE (QUIDE-R) IN AMBULATORY 

SCHIZOPHRENIC PATIENTS: THERAPEUTIC EFFICACY AND TOXICITY. 

1 87869 04-08 

FUNCTIONAL EVALUATION OF PITUITARY RESERVE IN PATIENTS WITH 
THE AMENORRHEA GALACTORRHEA SYNDROME UTILIZING 
LUTEINIZING HORMONE RELEASING HORMONE (LH-RH), LDOPA AND 
CHLORPROMAZINE. ,75245 02-13 

*** THE EFFECTS OF PHENOTHIAZINES ON ENDOCRINE FUNCTION: I. 

PATIENTS WITH INAPPROPRIATE LACTATION AND AMENORRHOEA. 

184436 03-15 

EFFECTS OF AMITRIPTYLINE AND IMIPRAMINE ON AMINE METABOLITES 
IN THE CEREBROSPINAL FLUID OF DEPRESSED PATIENTS. 

174094 0,-09 

BRAIN BIOGENIC AMINE DEPLETION AND MOOD. ,,.„„. no , . 

174994 02-14 

STEREOCHEMICAL ASPECTS IN THE METABOLISM OF THE 

PSYCHOTOMIMETIC AMINE l-(2,5 DIMETH0XY-4-METHYLPHENYL)-2 

^^^»^^^^^^^ 175759 02-03 

EVIDENCE FOR PERSISTENT RESERPINE BINDING TO AMINE STORAGE 

VESICLE MEMBRANES. ,82234 03-03 

PHARAAACOLOGICAL ANALYSIS OF NOREPINEPHRINE AND 5- 

HYDROXYTRYPTAMINE REMOVAL FROM THE PULMONARY 

CIRCULATION: DIFFERENTIATION OF UPTAKE SITES FOR EACH AMINE^ 

1 8271 7 03-Uo 
THE INHIBITION OF (3H) BIOGENIC AMINE ACCUMULATION INTO RAT 

BRAIN TISSUE SLICES BY VARIOUS TRYPTAMINE DERIVATIVES. 

1 82723 OJ-Uo 
EFFECT OF ANTIDEPRESSANT AND ANTIMANIC DRUGS ON AMINE 

^P^'^^E'^'^^'^ 184654 03-13 

PHARMACOLOGICAL DISTINCTIONS BETWEEN ACTIVE AND PASSIVE 
AVOIDANCE MEMORY FORMATION AS SHOWN BY MANIPULATION OF 
BIOGENIC AMINE ACTIVE COMPOUNDS. ^^^^^^ ^^^^ 

EFFECTS OF LITHIUM ON ADRENERGIC AMINE UPTAKE IN RAT BRAIN 
SYNAPTOSOMES. 186633 03-03 

STUDIES OF CEREBROSPINAL FLUID AMINE METABOLITES IN DEPRESSED 
PATIENTS- CONCEPTUAL PROBLEMS AND THEORETICAL IMPLICATIONS. 
(UNPUBLISHED PAPER). ,87398 04-13 

PLASMA AND CEREBROSPINAL FLUID PROBENECID CONCENTRATIONS AS 
RELATED TO ACCUMULATION OF ACIDIC BIOGENIC AMINE 
METABOLITES IN MAN. ,87933 04-13 

CHEMICAL CONVERSION OF THE PSYCHOTOMIMETIC AMINE ,-(2,5 
DIMETHOXY-4-METHYLPHENYL) 2-AMINOPROPANE TO 5- 
HYDROXYDIMETHYUNOOLE. ^^^^^^ ^^ ^, 

THE EFFECT OF HYPOTHERMIC DOSES OF ,-DELTA9- 

TETRAHYDROCANNABINOL ON BIOGENIC AMINE METABOLISM IN 
SELECTED PARTS OF THE RAT BRAIN. ,8823,04-03 

A STUDY OF BIOGENIC AMINE METABOLITES IN THE CEREBROSPINAL 
FLUID AND URINE OF MONKEYS WITH CHLORPROMAZINE INDUCED 
■DYSKINESIA. ,89210 04-03 

STEREOCHEMICAL ASPECTS AND METABOLITE FORMATION IN THE IN 
VIVO METABOLISM OF THE PSYCHOTOMIMETIC AMINE, 1-2,5- 
(DIMETHOXY-4-METHYLPHENYL) 2 AMINOPROPANE. 



S-15 



Subject Index 



Psychopharmacology Abstracts 



THE USE OF SELECTIVE AND INHIBITOR DRUGS TO MODIFY AMINE 
METABOLISM IN BRAIN. 

191500 04-03 
CLINICAL INTIMATIONS OF AMINE BALANCE AND PERMISSION. 

191534 04-09 
AMINERGIC 

REBOUND PHENOMENON IN MANIC PATIENTS FOLLOWING 

PHYSOSTIGMINE: TOWARDS AN UNDERSTANDING OF AMINERGIC 
MECHANISMS UNDERLYING AFFECTIVE DISORDERS. 

191531 04-09 
CHOLINERGIC AMINERGIC INTERACTIONS IN LEAD INDUCED 
HYPERACTIVITY. 

191954 04-05 
AMINES 

L-DOPA: EFFECT ON ETHANOL NARCOSIS AND BRAIN BIOGENIC AMINES 
IN MICE. 

169782 01-03 
EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON ATTACK ELICITED BY 
HYPOTHALAMIC STIMULATION: RELATION TO BRAIN BIOGENIC 
AMINES. 

170162 01-04 
MEASUREMENT OF BIOGENIC AMINES AT THE PICOGRAM LEVEL. 
(UNPUBLISHED LEVEL). 

173382 01-03 
SIGNIFICANCE OF THE CENTRAL BIOGENIC AMINES FOR THE THRESHOLD 
IN ELECTRO AND PENTETRAZOLE SEIZURES. 

181469 02-03 
BRAIN AMINES IN PYRIDOXINE DEFICIENT RATS. 

182171 02-03 
AMPHETAMINE-INDUCED ALTERATION OF BIOGENIC AMINES AND SELF- 
STIMULATION. 

182212 03-03 
BRAIN AMINES AND APOMORPHINE-INDUCED INTRASPECIFIC 
AGGRESSIVE BEHAVIOR IN THE RAT. 

186374 03-04 
THE MONOAMINE OXIDASES OF BRAIN: SELECTIVE INHIBITION WITH 
DRUGS AND THE CONSEQUENCES FOR THE METABOLISM OF THE 
BIOGENIC AMINES. 

186668 03-03 
EFFECTS OF SOME METALLIC CATIONS ON CEREBRAL CORTICAL 
NEURONES AND THEIR INTERACTIONS WITH BIOGENIC AMINES. 

187806 04-03 
IN VIVO CHANGES OF CEREBRAL CYCLIC ADENOSINE 3,5 

MONOPHOSPHATE INDUCED BY BIOGENIC AMINES: ASSOCIATION 
WITH PHOSPHORYLASE ACTIVATION. 

188291 04-03 
INTRACEREBRAL INJECTION OF 6-HYDROXYDOPAMINE AND HYDROGEN 
PEROXIDE IN CATS: SPECIFIC AND NONSPECIFIC EFFECTS ON STRIATAL 
BIOGENIC AMINES. 

188426 04-03 
EFFECT OF A BUTYROPHENONE DERIVATIVE, U-32802A, ON BRAIN 
BIOGENIC AMINES. 

189584 04-02 
FEATURES OF THE EFFECT OF SYMPATHOMIMETIC AMINES IN RADIATION 
AFFECTIONS. 

191123 04-05 
DRUG-INDUCED AGGRESSION IN CHICKS: DIFFERENTIAL INVOLVEMENT 
OF BIOGENIC AMINES. 

191977 04-04 
AMINO 

PEYOTE AND RELATED ALKALOIDS XVI: SYNTHESIS OF 3,4,5 

TRIMETHOXYPHENYLALANINE, AN AMINO ANALOG OF MESCALINE. 

170839 01-06 
BRAIN AMINO ACIDS DURING CONVULSIONS. 

177135 02-03 
ACTION OF CONVULSANTS ON ROOT POTENTIALS AND AMINO ACID 
RESPONSES IN ISOLATED FROG SPINAL CORD. (UNPUBLISHED PAPER). 

1 77976 02-03 
EFFECTS OF CHLORPROMAZINE AND ACTINOMYCIN D ON UPTAKE AND 
INCORPORATION OF CERTAIN AMINO ACIDS, HYPOXANTHINE AND 
THYMIDINE IN CULTURES OF HUMAN SKIN EPITHELIAL CELLS. 

179989 02-13 
THE EFFECTS OF CHRONIC RESERPINE AND NIALAMIDE TREATMENT ON 
THE FREE AMINO ACID LEVELS OF RAT BRAIN. 

187645 04-03 
POTENTIAL INHIBITORS OF S-ADENOSYLMETHIONINE DEPENDENT 
METHYLTRANSFERASES: 1. MODIFICATION OF THE AMINO ACID 
PORTION OF S-ADENOSYLHOMOCYSTEINE. 

190716 04-01 
STUDIES ON CONVULSANTS IN THE ISOLATED FROG SPINAL CORD. I. 
ANTAGONISM OF AMINO ACID RESPONSES. (UNPUBLISHED PAPER) 

190727 04-03 
DIAZEPAM, CYCLIC NUCLEOTIDES AND AMINO ACID 

NEUROTRANSMITTERS IN RAT CEREBELLUM. (UNPUBLISHED PAPER). 

191764 04-03 



AMINOACYL 

MESCALINE INDUCED CHANGES OF BRAIN CORTEX RIBOSOMES: EFFECT 
OF MESCALINE ON THE BINDING OF AMINOACYL TRANSFER 
RIBONUCLEIC ACID TO RIBOSOMES OF BRAIN TISSUE. 

189582 04-05 
AMINOINOANS 

DISCRIMINANT ANALYSIS OF THE RELATIONSHIP BETWEEN PHYSICAL 
PROPERTIES AND THE INHIBITION OF MONOAMINE OXIDASE BY 
AMINOTETRALINS AND AMINOINDANS 

180096 02-03 
AMINOPROPANE 

STEREOCHEMICAL ASPECTS AND METABOLITE FORMATION IN THE IN 
VIVO METABOLISM OF THE PSYCHOTOMIMETIC AMINE, 1-2,5- 
(DIMETHOXY-4-METHYLPHENYL) 2 AMINOPROPANE. 

190718 04-03 
AMINOTETRALINS 

DISCRIMINANT ANALYSIS OF THE RELATIONSHIP BETWEEN PHYSICAL 
PROPERTIES AND THE INHIBITION OF MONOAMINE OXIDASE BY 
AMINOTETRALINS AND AMINOINDANS. 

180096 02-03 
AMITRIPTYUNE 

A DOUBLE-BLIND, COMPARATIVE CLINICAL TRIAL WITH LUDIOMIL (CIBA- 
34276-BA) AND AMITRIPTYLINE IN NEWLY ADMITTED DEPRESSED 
PATIENTS. 

167774 01-09 
CHLORDIAZEPOXIDE IN DEPRESSIVE NEUROSIS: AN OPEN LABEL 
CROSSOVER STUDY WITH AMITRIPTYLINE. 

168316 01-10 
AMITRIPTYLINE IN ANXIOUS DEPRESSED OUTPATIENTS: A CONTROLLED 
STUDY. ■^ 

172993 01-10 
EFFECTS OF AMITRIPTYLINE AND IMIPRAMINE ON AMINE METABOLITES 
IN THE CEREBROSPINAL FLUID OF DEPRESSED PATIENTS. 

174094 01-09 
GENERAL PRACTITIONER CLINICAL TRIALS. A LONG-ACTING 
AMITRIPTYLINE PREPARATION. 

175583 02-09 
QUALITATIVE AND QUANTITATIVE STUDIES ON THE DISPOSITION OF 
AMITRIPTYLINE AND OTHER TRICYCLIC ANTIDEPRESSANT DRUGS IN 
MAN AS IT RELATES TO THE MANAGEMENT OF THE OVERDOSED 
PATIENT. 

177395 02-15 
A DOUBLE-BLIND CONTROLLED STUDY COMPARING PROTRIPTYLINE AND 
AMITRIPTYLINE. 

177567 02-09 
AMITRIPTYLINE IN MAN: DECREASED FORMATION OF CENTRAL 5- 
HYDROXYINDOLEACETIC ACID. 

177736 02-13 
DOXEPIN AND AMITRIPTYLINE CHLORDIAZEPOXIDE COMBINATION IN 
NEUROTIC STATES: A COMPARATIVE DOUBLE-BLIND STUDY. 

180048 02-10 
CLOMIPRAMINE AND AMITRIPTYLINE IN DEPRESSED OUTPATIENTS: A 
CONTROLLED STUDY. 

185747 03-09 
TRYPTOPHAN AND AMITRIPTYLINE IN THE TREATMENT OF DEPRESSIONS. 

187536 04-09 
AMITRIPTYLINE IN THE PSYCHOTIC STATES OF DOWNS SYNDROME: THE 
COMPARISON OF TWO CASES. 

191192 04-11 
A CONTROLLED TRIAL OF MAPROTILINE (LUDIOMIL) AND AMITRIPTYLINE 
IN GENERAL PRACTICE. 

192510 04-09 
TRIAL OF SUSTAINED RELEASE AMITRIPTYLINE ON ENURESIS. 

192589 04-11 
AMIZYL 

CHANGES IN SHORT-TERM AND LONG-TERM MEMORY OF DOGS AND 
CATS UNDER THE EFFECTS OF AMIZYL (BENACTYZINE). 

183517 03-04 
AMNESIA 

RETROGRADE AMNESIA FROM HYPOTHERMIA INDUCED BRAIN SEIZURES. 

167398 01-04 
RECOVERY FROM ELECTROCONVULSIVE SHOCK-INDUCED AMNESIA BY 
EXPOSURE TO THE TRAINING ENVIRONMENT: PHARMACOLOGICAL 
ENHANCEMENT BY PIRACETAM. 

186704 03-04 
AMOBARBITAL 

EFFECTS OF STIMULUS ASSOCIATED WITH AMOBARBITAL 
ADMINISTRATION ON AVOIDANCE BEHAVIOR. 

175877 02-04 
GENERALIZED PENICILLIN EPILEPSY IN THE CAT: EFFECTS OF 

INTRACAROTID AND INTRAVERTEBRAL PENTYLENETETRAZOL AND 
AMOBARBITAL INJECTIONS. 

188374 04-03 
AMOXAPINE 

AMOXAPINE AND IMIPRAMINE: A DOUBLE-BLIND STUDY IN DEPRESSED 
PATIENTS. 

174138 01-09 



S-16 



VOLUME 12, SUBJECT INDEX 

AMP 

EFFECT OF ETHANOL ON CYCLIC AMP LEVELS IN THE RAT BRAIN. 

167326 01-03 
EFFECTS OF CENTRALLY ACTING DRUGS ON ADENYL CYCLASE ACTIVITY 
AND CYCLIC AMP LEVELS OF MOUSE BRAIN. (PH.D. DISSERTATION). 

172019 01-03 
EFFECTS OF NEUROLEPTICS AND THYMOLEPTICS ON 

PHOSPHODIESTERASE ACTIVITY AND ON CYCLIC 3,5 AMP LEVELS IN 
RAT BRAIN. 

181467 02-03 
A CENTRAL EFFECT OF LOCAL ANESTHETICS: PREVENTION AGAINST THE 
ACCUMULATION OF CYCLIC AMP IN BRAIN SLICES. 

182099 02-03 
EFFECTS OF DECAPITATION, ETHER AND PENTOBARBITAL ON CYCLIC 
AMP AND CYCLIC GMP LEVELS IN RAT TISSUES. 

182154 02-03 
INTERACTION OF CYCLIC AMP WITH NEUROPHARMACOLOGIC 

DEPRESSANT AGENTS. 

182155 02-03 
THE EFFECT OF DOPAMINE RECEPTOR STIMULATING AGENTS AND OF N,0 

DIBUTYRYL CYCLIC AMP ON C14-D0PAMINE SYNTHESIS IN STRIATAL 
SLICES OF RATS. 

182256 03-03 
NOREPINEPHRINE - AN ANTAGONIST OF DIBUTYRYL CYCLIC AMP IN THE 
REGULATION OF NARCOSIS IN THE RAT. 

183789 03-03 
BETA-ADRENERGIC EFFECTS ON RAT MYOMETRIUM: ROLE OF CYCLIC 
AMP. 

188915 04-03 
AMPHETAMINE 

AVERAGE EVOKED RESPONSES IN NORMAL AND MINIMALLY BRAIN 
DYSFUNCTIONED CHILDREN TREATED WITH AMPHETAMINE: A 
PRELIMINARY REPORT. 

169861 01-11 
THE ACTIVITY OF SOME NEUROLEPTIC DRUGS AND AMPHETAMINE IN 
NORMAL AND ISOLATED RATS. 

170126 01-04 
TOLERANCE AND CROSS-TOLERANCE TO THE ANOREXIGENIC EFFECT OF 
SOME AMPHETAMINE DERIVATIVES IN RATS. 

171602 01-03 
STUDY INTO THE MECHANISM OF THE ANORECTIC ACTION OF 
AMPHETAMINE AND ITS P-CHLORO ANALOGUE. 

171610 01-03 
INTERRESPONSE TIME CHANGES AS A FUNCTION OF DEPRIVATION AND 
AMPHETAMINE ADMINISTRATION. 

171612 01-04 
A DIFFERENTIAL INHIBITORY ACTION OF LSD AND AMPHETAMINE ON 
COPULATORY BEHAVIOR IN THE FEMALE RAT. 

171617 01-04 
AMPHETAMINE USE AND MISUSE WITH RECOMMENDATIONS FOR 
STIMULANT CONTROL POLICY. 

172109 01-17 
ON THE MECHANISM OF CENTRAL ACTION OF AMPHETAMINE: THE ROLE 
OF CATECHOLAMINES. 

172921 01-04 
MODIFICATION OF STIMULATION BOUND BEHAVIOR BY 
TRIFLUOPERAZINE AND AMPHETAMINE IN RATS. (PH.D. 
DISSERTATION). 

173158 01-04 
AN ANALYSIS OF TOLERANCE TO THE ANOREXIGENIC EFFECTS OF 
AMPHETAMINE. (PH.D. DISSERTATION). 

173775 01-03 
DRINKING BEHAVIOUR AND BRAIN DOPAMINE: ANTAGONISTIC EFFECT 
OF TWO NEUROLEPTIC DRUGS (PIMOZIDE AND SPIRAMIDE) UPON 
AMPHETAMINE OR APOMORPHINE-INDUCED HYPODIPSIA. 

174035 01-04 
THE EFFECTS OF AMPHETAMINE, 2-AMINOINDANE AND 2- 

AMINOTETRALIN ON THE CONCENTRATIONS OF WHOLE BRAIN 
NORADRENALINE, DOPAMINE, 5-HYDROXYTRYPTAMINE AND 5- 
HYDROXYINDOLEACETIC ACID IN THE MOUSE. 

174828 01-03 
EFFECTS OF AMPHETAMINE AND ITS HYDROXYLATED METABOLITES ON 
CENTRAL NORADRENERGIC MECHANISMS. (PH.D. DISSERTATION). 

174959 01-03 
AMPHETAMINE TRICYCLIC INTERACTIONS: ROLE OF THE 

HYDROXYLATION OF AMPHETAMINE IN ITS CENTRAL AND PERIPHERAL 
MODE OF ACTION. (PH.D. DISSERTATION). 

174963 01-03 
STEREOCHEMICAL ASPECTS IN THE METABOLISM OF THE 

PSYCHOTOMIMETIC AMINE l-{2,5 DIMETH0XY-4-METHYLPHENYL)-2 
AMPHETAMINE. 

175759 02-03 
EFFECTS OF AMPHETAMINE (A), LSD, PSILOCYBIN (P), AND DOM ON 
SCHEDULE-CONTROLLED BEHAVIOR IN THE RAT. 

1 76869 02-04 
INABILITY OF RAT BRAIN HOMOGENATE TO OXIDIZE AMPHETAMINE. 

1 77334 02-03 



Subject Index 

AMPHETAMINE IN HUMAN PLASMA: A SENSITIVE AND SPECIFIC 
ENZYMATIC ASSAY. 

177403 02-16 
THE THALAMIC RAT: GENERAL BEHAVIOR, OPERANT LEARNING WITH 
REWARDING HYPOTHALAMIC STIMULATION, AND EFFECTS OF 
AMPHETAMINE. 

177477 02-04 
THE EFFECT OF PROBENECID AND LARGE DOSE AMPHETAMINE 

ADMINISTRATION ON CEREBROSPINAL FLUID HOMOVANILLIC ACID. 

177826 02-13 
EFFECT OF CHRONIC INTOXICATION WITH (_) AMPHETAMINE ON ITS 
CONCENTRATION IN LIVER AND BRAIN AND ON (14C) LEUCINE 
INCORPORATION INTO MICROSOMAL AND CYTOPLASMIC PROTEINS OF 
RAT LIVER. 

180056 02-05 
STEREOTYPY WITH SELECTIVE STIMULATION OF CERTAIN ITEMS OF 
BEHAVIOUR OBSERVED IN AMPHETAMINE TREATED MONKEYS 
(CERCOPITHECUS). 

180061 02-04 
RELATIVE IMPORTANCE OF DOPAMINERGIC AND NORADRENERGIC 
NEURONAL SYSTEMS FOR THE STIMULATION OF LOCOMOTOR 
ACTIVITY INDUCED BY AMPHETAMINE AND OTHER DRUGS. 

182209 02-04 
ALPHA-ADRENERGIC RECEPTORS MEDIATE SUPPRESSION OF DRINKING 
INDUCED BY HYPOTHALAMIC AMPHETAMINE INJECTION. 

182216 03-03 
EFFECTS OF AMPHETAMINE ISOMERS ON NEUROMUSCULAR 

TRANSMISSION IN RAT PHRENIC NERVE DIAPHRAGM PREPARATION. 

182232 03-03 
AMPHETAMINE AND PENTOBARBITAL EFFECTS ON THE DISCRIMINATIVE 
RESPONSE CONTROL BY DEPRIVATION OF RAPID EYE MOVEMENT 
SLEEP (REM). 

1 82245 03-03 
EFFECTS OF CHRONIC ADMINISTRATION OF AMPHETAMINE UPON THE 
CATECHOLAMINE CONTENT OF MOUSE BRAIN 

182255 03-03 
PARADOXICAL THERMOREGULATORY BEHAVIOUR IN RATS INDUCED BY 
( ) AMPHETAMINE: BLOCKADE BY ALPHA-ADRENOCEPTOR OR 
DOPAMINE RECEPTOR BLOCKING AGENTS. 

183797 03-03 
AMPHETAMINE AND THERMOREGULATION: STUDIES IN THE 
UNRESTRAINED AND CURARIZED RAT. 

184227 03-03 
IN VIVO RELEASE OF NEWLY SYNTHESIZED CATECHOLAMINES FROM THE 
HYPOTHALAMUS BY AMPHETAMINE. 

184230 03-03 
EFFECTS OF AMPHETAMINE ON ELECTROSHOCK RESPONSES IN 
DEVELOPING RATS. 

184372 03-03 
BRAIN MECHANISMS UNDERLYING THE EFFECTS OF AMPHETAMINE ON 
FEEDING AND NONFEEDING BEHAVIORS: DISSOCIATION AND OVERLAP. 

184839 03-03 
INTRACRANIAL SELF-STIMULATION IN RATS AS A FUNCTION OF 

VARIOUS STIMULUS PARAMETERS: IV. INFLUENCE OF AMPHETAMINE 
ON MEDIAL FOREBRAIN BUNDLE STIMULATION WITH MONOPOLAR 
ELECTRODES. 

185961 03-04 
MODULATION OF REWARD AND AVERSION PROCESSES IN THE RAT 
DIENCEPHALON BY AMPHETAMINE. 

186164 03-04 
JOINT EFFECTS OF SODIUM AMYLOBARBITONE AND AMPHETAMINE 
SULPHATE ON RESISTANCE TO EXTINCTION OF A REWARDED RUNNING 
RESPONSE IN THE RAT. 

186573 03-04 
ROLE OF CATECHOLAMINES IN THE ANORECTIC EFFECTS OF 
AMPHETAMINE IN RATS. 

186582 03-03 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS: 
I EFFECT ON THE BEHAVIOURAL CHANGES INDUCED BY RESERPINE, 
ALPHA-METHYL-P-TYROSINE OR AMPHETAMINE. 

186587 03-04 
THE EFFECT OF AMANTADINE, L-OOPA, (_) AMPHETAMINE AND 
APOMORPHINE ON THE ACQUISITION OF THE CONDITIONED 
AVOIDANCE RESPONSE. 

186636 03-04 
A COMPARISON OF THE EFFECTS OF AMPHETAMINE AND ITS 
METABOLITES, P-HYDROXYAMPHETAMINE AND P- 
HYDROXYNOREPHEDRINE, ON UPTAKE, RELEASE AND CATABOLISM OF 
3H-N0REPINEPHRINE IN CEREBRAL CORTEX OF RAT BRAIN. 

1 86669 03-03 
COCAINE, PEMOLINE AND AMPHETAMINE ON LEARNING AND RETENTION 
OF A DISCRIMINATION TEST IN MICE. 

186705 03-04 
DOES LITHIUM BLOCK THE EFFECTS OF AMPHETAMINE? A REPORT OF 
THREE CASES. 

186745 03-13 
BEHAVIOR AND EEG ANALYSIS OF CHRONIC AMPHETAMINE EFFECT. 

187116 03-13 



S-17 



Subject Index 

CARDIOVASCULAR AND GROSS BEHAVIORAL EFFECTS OF 

AMPHETAMINE, 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPROPANE 
(DOM) AND 2-AMINO-l-(2,5 DIMETHOXY-A-METHYLPHENYL BUTANE 
(BL-3912A) IN THE CONSCIOUS DOG. 

187573 04-03 

BEHAVIORAL EFFECTS OF AMPHETAMINE IN RATS WITH LESIONS IN THE 
CORPUS-STRIATUM. 

187698 04-04 

AMPHETAMINE AND OPERANT BEHAVIOR IN RATS; RELATIONSHIP 
BETWEEN DRUG EFFECT AND CONTROL RESPONSE RATE. 

187699 04-04 
COMPARATIVE EFFECTS OF SCOPOLAMINE AND AMPHETAMINE UPON 

BEHAVIORAL REACTIVITY AND VISUAL EVOKED POTENTIALS TO 

FLASHES IN RATS. 

187700 04-04 

THE EFFECTS OF CHLORDIAZEPOXIDE, AMPHETAMINE AND COCAINE ON 
BAR-PRESS BEHAVIOR IN NORMAL AND GENETICALLY NERVOUS DOGS. 

187868 04-04 
AN INVESTIGATION OF THE BEHAVIOURAL NATURE OF THE 
PSYCHOMOTOR STIMULANT EFFECT OF AMPHETAMINE. 

188620 04-04 
INTERACTION OF LOW-DOSE AMPHETAMINE USE WITH SCHIZOPHRENIA 
IN OUTPATIENTS: THREE CASE REPORTS. 

189099 04-15 
ENHANCEMENT OF AMPHETAMINE ACTION AFTER INTERRUPTION OF 
ASCENDING SEROTONERGIC PATHWAYS. 

189398 04-03 
EFFECTS OF CATECHOLAMINE DEPLETING DRUGS AND AMPHETAMINE ON 
SELF-STIMULATION OF BRAIN FOLLOWING VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS. 

189515 04-04 
PSYCHOMOTOR TEST PERFORMANCE WITH A FENFLURAMINE 
AMPHETAMINE COMBINATION. 

190146 04-07 
INFLUENCE OF DIFFERENT ANIONS ON TYRAMINE AND AMPHETAMINE 
UPTAKE BY COW ADRENAL MEDULLA CHROMAFFIN VESICLES. 

190907 04-03 
BEHAVIORAL AND EEG CHANGES IN THE AMPHETAMINE MODEL OF 

PSYCHOSIS. 

191505 04-04 

AMPHETAMINE AND NA-,K_ - ATPASE IN THE BRAIN. 

191789 04-03 
AMPHETAMINE AND METHYLPHENIDATE INDUCED RELEASE OF STRIATAL 
DOPAMINE IN VIVO: DIFFERENTIAL EFFECTS ON NEWLY SYNTHESIZED 

AND STORED POOLS. 

191897 04-03 

THE EFFECTS OF AMPHETAMINE SULFATE ON THE DIURNAL RHYTHMS OF 
MIDBRAIN; CORTEX, NOREPINEPHRINE; SEROTONIN AND BLOOD 
GLUCOSE LEVELS IN THE MOUSE. 

191918 04-03 
PIMOZIDE, L-PROPRANOLOL AND PHENTOLAMINE EFFECTS ON 

AMPHETAMINE SELF-ADMINISTRATION BY THE RAT. 

191919 04-04 

THE 4-HYDROXYLATION OF AMPHETAMINE AND PHENTERMINE BY RAT 

LIVER MICROSOMES. 

191921 04-03 

A ROLE FOR DOPAMINE IN THE STIMULANT EFFECTS OF AMPHETAMINE 
ON LOCUS-COERULEUS SELF-STIMULATION. 

191984 04-03 

THE INFLUENCE OF IMIPRAMINE, DEXPHENMETRAZINE AND 

AMPHETAMINE SULPHATE ON THE COMPOSITION OF DIURNAL SLEEP 
OF NARCOLEPTICS. 

192419 04-11 

AMPHETAMINE-INDUCED 

AMPHETAMINE-INDUCED ALTERATION OF BIOGENIC AMINES AND SELF- 
STIMULATION, „„o„o 

182212 03-03 

THE ONTOGENY OF AMPHETAMINE-INDUCED ALTERATIONS IN THERMAL 

REGULATION. 

182246 03-03 

CONDITIONING OF AMPHETAMINE-INDUCED BEHAVIOUR IN THE ALBINO 

RAT 

185954 03-04 

THE ANTAGONISM OF AMPHETAMINE-INDUCED SYMPTOMATOLOGY BY 

A NEUROLEPTIC. 

186744 03-14 

AMPHETAMINES 

AMPHETAMINES: VALUABLE ADJUNCT IN TREATMENT OF 
PARKINSONISM. 

169220 01-11 

EFFECTS OF PSYCHOTOMIMETICS ON VASCULAR STRIPS: STUDIES OF 
METHOXYLATED AMPHETAMINES AND OPTICAL ISOMERS OF 2,5 
DIMETHOXY-4-METHYLAMPHETAMINE AND 2,5 DIMETHOXY-4- 

BROMOAMPHETAMINE. 

177734 02-03 

EFFECTS OF AMPHETAMINES ON REGIONAL TRYPTOPHAN HYDROXYLASE 
ACTIVITY AND SYNAPTOSOMAL CONVERSION OF TRYPTOPHAN TO 5- 
HYDROXYTRYPTAMINE IN RAT BRAIN. 

186674 03-03 



Psychopharmacology Abstracts 



AMPHETAMINES EFFECTS ON SELF-STIMULATION: DEVELOPMENT OF 
TOLERANCE AND POST-DRUG DEPRESSION. 

191914 04-04 
EFFECTS OF AMPHETAMINES ON MOLLUSCAN NEURONS. 

191995 04-03 

AMPLITUDE 

THE EFFECTS OF METHAMPHETAMINE AND SECOBARBITAL ON THE 
CONTINGENT NEGATIVE VARIATION AMPLITUDE. 

185932 03-13 

AMSTERDAM 

THE EFFECTS OF DALMANE (FLURAZEPAM HYDROCHLORIDE) ON THE 
CONTINGENT NEGATIVE VARIATION. (AMSTERDAM). 

177645 02-16 

AMYGDALA 

POSSIBLE INVOLVEMENT OF A NORADRENERGIC AREA OF THE 
AMYGDALA WITH STEREOTYPED BEHAVIOUR. 

1 76877 02-04 
A ROLE FOR THE AMYGDALA IN THE DEVELOPMENT OF THE CATALEPTIC 
AND STEREOTYPIC ACTIONS OF THE NARCOTIC AGONISTS AND 
ANTAGONISTS IN THE RAT. 

1 86577 03-03 

AMYLOBARBITONE 

INFLUENCE OF AMYLOBARBITONE ON OPERANT DEPRESSION AND 
ELATION EFFECTS IN THE RAT. 

168834 01-04 

SENSORY CONTINGENT BAR-PRESSING FOR FAMILIAR AND NOVEL 
CHANGE UNDER A DEXAMPHETAMINE AMYLOBARBITONE MIXTURE. 

181605 02-04 
SEDATIVE OR TRANQUILLIZER? A COMPARISON OF THE HYPNOTIC 
EFFECTS OF CHLORDIAZEPOXIDE AND AMYLOBARBITONE SODIUM. 

184438 03-14 
JOINT EFFECTS OF SODIUM AMYLOBARBITONE AND AMPHETAMINE 
SULPHATE ON RESISTANCE TO EXTINCTION OF A REWARDED RUNNING 

RESPONSE IN THE RAT. 

186573 03-04 

AMYOTROPHIC 

LEVODOPA INDUCED DYSKINESIAS: COMPARISON IN PARKINSONISM 
DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS. 

169376 01-15 

AMYTAL 

THE EFFECT OF CHLORPROMAZINE AND AMYTAL SODIUM ON THE 
CONFORMITY OF ADOLESCENTS UNDER PSYCHIATRIC OBSERVATION. 

191776 04-14 

ANAFRANIL 

EXPERIENCE IN THE USE OF AN ANTIDEPRESSIVE, CLOMIPRAMINE 
(ANAFRANIL), IN PSYCHIATRIC OUTPATIENTS. 

176475 02-09 

ANALEPTICS 

EFFECTS OF ANALEPTICS ON MAZE LEARNING IN MICE. 

173078 01-04 

ANALGESIA 

CHROMATIN TEMPLATE ACTIVITY DURING MORPHINE-INDUCED 
ANALGESIA AND THE DEVELOPMENT OF ANALGESIC TOLERANCE. 

182160 02-03 
EFFECT OF GAMMA-AMINOBUTYRIC ACID (GABA) ON MORPHINE 
ANALGESIA, TOLERANCE AND PHYSICAL DEPENDENCE. 

182231 03-03 
ALPHA-ADRENERGIC BLOCKING AGENTS: ANTINOCICEPTIVE ACTIVITY 
AND ENHANCEMENT OF MORPHINE-INDUCED ANALGESIA. 

183895 03-03 
THE EFFECTS OF P-CHLOROPHENYLALANINE ON MORPHINE ANALGESIA, 
TOLERANCE AND DEPENDENCE DEVELOPMENT IN TWO STRAINS OF 

RATS 

187930 04-04 

ANALGESIA AND HYPERREACTIVITY PRODUCED BY INTRACRANIAL 
MICROINJECTIONS OF MORPHINE INTO THE PERIAQUEDUCTAL GRAY 
MATTER OF THE RAT. 

191367 04-04 

EFFECT OF L-PHENYL-3-2-THIAZ0LYL 2-THIOUREA, A DOPAMINE-BETA- 

HYDROXYLASE INHIBITOR, ON MORPHINE ANALGESIA, TOLERANCE 

AND PHYSICAL DEPENDENCE. „ „ „. 

191769 04-03 

ANALGESIC 

ANALGESIC POTENCY OF SODIUM SALICYLATE, INDOMETHACIN, AND 
CHLORDIAZEPOXIDE AS MEASURED BY THE SPATIAL PREFERENCE 
TECHNIQUE IN THE RAT. 

171301 01-02 

INFLUENCES OF RESERPINE AND CHLORPROMAZINE ON THE ANALGESIC 
AND METABOLIC EFFECTS OF MORPHINE. 

CHROMATIN TEMPLATE ACTIVITY DURING MORPHINE-INDUCED 
ANALGESIA AND THE DEVELOPMENT OF ANALGESIC TOLERANCE. 

1 82160 02-03 
ANTIPYRETIC, ANALGESIC AND ANTIINFLAMMATORY ACTIVITY OF 
DELTA9-TETRAHYDR0CANNABIN0L IN THE RAT. 

182221 03-03 
COMPARISON OF PSYCHOEXPERIMENTAL PERFORMANCE UNDER THE 
INFLUENCE OF THE ANALGESIC PROPIRAM FUMARATE. 

184618 03-14 



S-18 



VOLUME 12, SUBJECT INDEX 



Subject Index 



ANALGESIC EFFECT OF DELTA9-TETRAHY0R0CANNABIN0L IN THE DOG. 

186585 03-03 
CONSIDERATIONS ON THE USE OF ANALGESIC DRUGS IN DIFFERENT 
STAGES OF NEOPLASTIC DISEASES, 

191604 04-17 
ANALGESICS 

EFFECTS OF NARCOTIC ANALGESICS ON ENZYMES OF ACETYLCHOLINE 
METABOLISM IN CULTURED CHICK BRAIN CELLS. 

182225 03-03 
ANALGESICS. I. SELECTED 5-SUBSTITUTED 5-PROPIONOXYBARBlTURIC 
ACIDS. 

187939 04-01 
PSYCHOTROPIC EFFECT OF ANALGESICS AND NEUROLEPTICS ON A 
MODEL OF INVESTIGATORY BEHAVIOR CHANGED BY PAIN. 

191120 04-04 
METHODOLOGY FOR THE EVALUATION OF PENTAZOCINE, PROTOTYPE OF 
THE NEW MORPHINE AGONIST ANTAGONIST ANALGESICS. 

191603 04-16 
ANALGETIC 

3-ARYL-3-HYDROXYQUINOLIZIDINES WITH POTENTIAL HYPOTENSIVE, 
ANTIDEPRESSANT, AND ANALGETIC ACTIVITY. 

187938 04-01 
ANALOG 

PEYOTE AND RELATED ALKALOIDS XVI: SYNTHESIS OF 3,4,5 
TRIMETHOXYPHENYLALANINE, AN AMINO ANALOG OF MESCALINE. 

170839 01-06 
ANALOGS 

THE ROLE OF HYDROPHOBICITY IN THE ANTISEROTONIN ACTIVITY OF 
LSD ANALOGS. 

174606 01-12 
QUINAZOLINES AND 1,4 BENZ0DIAZEPINES.64.C0MPARIS0N OF THE 
STEREOCHEMISTRY OF DIAZEPAM WITH THAT OF CLOSE ANALOGS 
WITH MARGINAL BIOLOGICAL ACTIVITY. 

185034 03-01 
SALIGENIN ANALOGS OF L-DOPA AND DL-ALPHA-METHYL-DOPA. 

187565 04-11 
APPLICATION OF THE SEQUENTIAL SIMPLEX METHOD IN DESIGNING 
DRUG ANALOGS. 

190714 04-01 
ANALOGS OF CHOLINE: SYNAPTOSOMAL METABOLISM, 

192000 04-03 
MESCALINE: THE CHEMISTRY AND PHARMACOLOGY OF ITS ANALOGS. 

192877 04-12 
ANALOGUE 

STUDY INTO THE MECHANISM OF THE ANORECTIC ACTION OF 
AMPHETAMINE AND ITS P-CHLORO ANALOGUE. 

171610 01-03 
MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND ITS 
HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD, 

186566 03-16 
ANALOGUES 

STRUCTURE-ACTIVITY RELATIONS FOR THE INHIBITION OF 5-HT UPTAKE 
INTO RAT HYPOTHALAMIC HOMOGENATES BY SEROTONIN AND 
TRYPTAMINE ANALOGUES, 

1 75233 02-03 
THE EFFECT OF PHENIRAMINE AND ITS STRUCTURAL ANALOGUES ON 5- 
HYDROXYTRYPTAMINE IN RAT AND MOUSE BRAIN, 

1 75240 02-03 
A FREQUENCY SHIFT IN THE HIPPOCAMPAL THETA ACTIVITY: AN 

ELECTRICAL CORRELATE OF CENTRAL ACTION OF ACTH ANALOGUES IN 
THE DOG 

188166 04-04 
INHIBITION OF CHOLINE UPTAKE INTO SYNAPTOSOMES BY CHOLINE 
ANALOGUES. 

191999 04-03 
ANALYSES 

THE ROLE OF RESEARCH IN DRUG ABUSE INTERVENTION: STREET DRUG 
ANALYSES, 

167382 01-17 
ANALYSIS 

NEUROPHARMACOLOGICAL ANALYSIS OF EFFECTS OF DOXEPIN IN 
RABBITS (PH,D. DISSERTATION), 

168130 01-03 
THE DESIGN OF THERAPEUTIC TRIALS: A CRITICAL ANALYSIS WITH 
ILLUSTRATIONS, PARTICULARLY FROM THE FIELD OF PSYCHOTROPIC 
DRUGS OR: WHY NO ONE CAN EVER DO A PROPER DRUG TRIAL, 

173307 01-16 
AN ANALYSIS OF TOLERANCE TO THE ANOREXIGENIC EFFECTS OF 
AMPHETAMINE, (PH,D, DISSERTATION), 

173775 01-03 
SEMI-QUANTITATIVE ANALYSIS OF BROMAZEPAM BY RING OVEN 
METHOD, 

174853 01-16 
SIMULTANEOUS ANALYSIS OF A 1,5 BENZODIAZEPINE AND ITS 
METABOLITE IN BLOOD AND URINE BY SPECTRODENSITOMETRY, 

176871 02-16 



MOTHER INFANT SEPARATION: BEHAVIORAL ANALYSIS OF AN ANIMAL 
MODEL OF DEPRESSION, (PH,D, DISSERTATION), 

1 78867 02-04 
GAS CHROMATOGRAPHIC ANALYSIS OF BENZODIAZEPINES. PART I: 
MEDAZEPAM AND ITS METABOLITES. 

1 78948 02-06 
AN ANALYSIS OF D-AMPHETAMINE PRODUCED FACILITATION OF 
AVOIDANCE ACQUISITION IN RATS AND PERFORMANCE CHANGES 
SUBSEQUENT TO DRUG TERMINATION. 

1 79990 02-04 
DISCRIMINANT ANALYSIS OF THE RELATIONSHIP BETWEEN PHYSICAL 
PROPERTIES AND THE INHIBITION OF MONOAMINE OXIDASE BY 
AMINOTETRALINS AND AMINOINDANS, 

180096 02-03 
AFRODEX VS. PLACEBO IN THE TREATMENT OF MALE IMPOTENCE: 
STATISTICAL ANALYSIS OF TWO DOUBLE-BLIND CROSSOVER STUDIES. 

181959 02-14 
AUTOMATIC RECORDING OF ANIMAL BEHAVIOR AND ITS ANALYSIS. 

182106 02-17 
PHARMACOLOGIC ANALYSIS OF THE CAUDATE SPINDLE IN CATS, 

182124 02-03 
ANALYSIS OF TREMORGENIC EFFECTS OF INTRACAUDATE D- 
AMPHETAMINE, 

182129 02-03 
ANALYSIS OF DRUG BLOCK OF LSD/5-HT/GABA BY MONITORING 
NEURONAL MEMBRANE CHANGES, 

182143 02-03 
PHARMACOLOGICAL ANALYSIS OF NOREPINEPHRINE AND 5- 
HYDROXYTRYPTAMINE REMOVAL FROM THE PULMONARY 
CIRCULATION: DIFFERENTIATION OF UPTAKE SITES FOR EACH AMINE, 

182717 03-03 
THE ANALYSIS OF THE POTENTIAL ACTION OF A MEDICATION, 

184963 03-14 
CHLORPROMAZINE AND AVOIDANCE: A GENETIC ANALYSIS, 

185751 03-03 
EFFECTS OF LSD ON AUDITORY PERCEPTION: A SIGNAL DETECTION 

ANALYSIS, 

185752 03-04 
MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND ITS 

HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD. 

186566 03-16 
A DETAILED ANALYSIS OF THE EFFECTS OF D-AMPHETAMINE ON 
BEHAVIOR UNDER FIXED-INTERVAL SCHEDULES. 

187066 03-04 
BEHAVIOR AND EEG ANALYSIS OF CHRONIC AMPHETAMINE EFFECT. 

18711603-13 
DISAGGREGATION OF BRAIN POLYSOMES AFTER L-DOPA: AN ANALYSIS. 

188433 04-03 
VOLTAGE CLAMP ANALYSIS OF PENTYLENETETRAZOL EFFECTS ON 
APLYSIA NEURONS. 

189032 04-03 
AN ANALYSIS OF THE FACILITATION OF AVOIDANCE ACQUISITION BY D- 
AMPHETAMINE AND SCOPOLAMINE. 

189521 04-04 
CONFORMATIONAL ANALYSIS OF ACRIDAN DERIVATIVES BY NUCLEAR 
MAGNETIC RESONANCE SPECTROSCOPY, A RELATIONSHIP BETWEEN 
CONFORMATION AND PHARMACOLOGICAL ACTIVITY, 

190715 04-01 
FLUORESCENCE AND ELECTRON MICROSCOPIC ANALYSIS OF 
CATECHOLAMINE CONTAINING FIBERS IN MUTANT MOUSE 
CEREBELLUM, (UNPUBLISHED PAPER), 

191762 04-03 
DIPSOGENIC ACTION OF DIAZOXIDE: A PHARMACOLOGIC ANALYSIS, 

191768 04-03 
NEUROCHEMICAL ANALYSIS OF AGGRESSIVE ■ DEFENSIVE BEHAVIOR 
ELICITED BY ELECTRICAL STIMULATION OF THE HYPOTHALAMUS AND 
CENTRAL GRAY MATTER, 

191784 04-02 
NEUROPHARMACOLOGICAL ANALYSIS OF R(-)-2,5 DIMETHOXY-4- 
METHYLAMPHETAMINE (R-DOM), 

191906 04-03 
NEUROPHARMACOLOGICAL ANALYSIS OF CENTRAL ADRENERGIC AND 
CHOLINERGIC ANTAGONISM OF DELTA9-TETRAHYDR0CANNABIN0L, 

191992 04-03 
ANALYSIS OF HYPOTHERMIC ACTION OF DELTA9- 
TETRAHYDROCANNABINOL (DELTA9-THC) IN MICE, 

191997 04-03 
ANALYTICAL 

CONSTITUENTS OF CANNABIS-SATIVA L, V,: STABILITY OF AN 

ANALYTICAL SAMPLE EXTRACTED WITH CHLOROFORM, (UNPUBLISHED 
PAPER), 

180670 02-01 
ANALYZED 

COMPARISON OF THE CLINICAL AND COMPUTER ANALYZED EEG EFFECTS 
OF MESORIDAZINE AND CHLORPROMAZINE. 

180064 02-10 



S-19 



Subject Index 



Psychopharmacology Abstracts 



ANALYZES 

THE COMPUTER ANALYZES TWO PSYCHOTHERAPEUTIC AGENTS IN 
ANXIETY/DEPRESSED STATES. 

167345 01-10 

ANALYZING 

A METHOD FOR ANALYZING CNS EFFECTS OF DRUGS AND BRAIN 
LESIONS ON PERMANENT GROUPS OF RATS. 

1 76867 02-06 
ANATENSOL 

ASSESSMENT OF ANATENSOL (FLUPHENAZINE ENANTHATE) INJECTABLE 
IN THE TREATMENT OF SCHIZOPHRENIA. 

172444 01-08 

ANATOMIC 

METHIOTHEPIN ELEVATION OF 5-HYDROXYINDOLEACETIC ACID LEVELS IN 
VARIOUS ANATOMIC REGIONS OF RAT BRAIN, 

187831 04-03 
ANDROGENIZATION 

FURTHER EVIDENCE ON THE INTRAHYPOTHALAMIC LOCUS FOR 
ANDROGENIZATION OF FEMALE RATS. 

187935 04-03 
ANESTHESIA 

SYNTHESIS OF ACETYLCHOLINE IN BRAIN NERVE TERMINALS DURING 
CONSCIOUSNESS AND BARBITURATE ANESTHESIA. 

171600 01-03 
L-DOPA AND POTENTIATION OF ALCOHOL ANESTHESIA BY 
CHLORPROMAZINE. 

182091 02-03 
MICROVASCULAR SMOOTH MUSCLE HYPERRESPONSIVENESS DURING 
HALOTHANE ANESTHESIA IN THE RAT. 

182185 02-03 
TURNOVER OF HISTAMINE IN RAT BRAIN AND ITS DECREASE UNDER 
BARBITURATE ANESTHESIA. 

189396 04-03 
ANESTHbSIOLOGIC 

THE PROBLEMS OF THE PSYCHOPHARMACOLOGICAL TREATMENT OF 
PSYCHOSOMATIC DISEASES - THE ANESTHESIOLOGIC APPROACH. 

177063 02-17 
ANESTHETIC 

OPERANT BEHAVIOR AND NEUROPHYSIOLOGICAL OBSERVATIONS OF 
NORMAL HUMAN VOLUNTEERS RECEIVING CL-1848C, A NEW 
DISSOCIATIVE ANESTHETIC. 

167334 01-07 
EFFECT OF ANESTHETIC AGENTS ON THE SYNTHESIS AND 

DISAPPEARANCE OF BRAIN DOPAMINE NORMALLY AND AFTER 
HALOPERIDOL, KCL OR AXOTOMY. 

189571 04-03 
EFFECT OF ANESTHETIC AGENTS ON PERIPHERAL SYMPATHETIC NERVOUS 
SYSTEM FUNCTION AS MONITORED BY ARTERIAL PLASMA 
CATECHOLAMINE LEVELS. (UNPUBLISHED PAPER 

191495 04-03 
ANESTHETICS 

DECREASED HISTAMINE SYNTHESIS IN THE RAT BRAIN BY HYPNOTICS 
AND ANESTHETICS. 

168750 01-03 
EFFECT OF GENERAL ANESTHETICS ON SYSTEMIC CATECHOLAMINE 
CONCENTRATION I: HALOTHANE. (UNPUBLISHED PAPER). 

168862 01-05 
A CENTRAL EFFECT OF LOCAL ANESTHETICS: PREVENTION AGAINST THE 
ACCUMULATION OF CYCLIC AMP IN BRAIN SLICES. 

182099 02-03 
EFFECTS OF NON-HYDROGEN-BONDING ANESTHETICS ON MEMORY IN 
THE CHICK. 

1 84380 03-04 
CALCIUM REVERSAL OF NERVE BLOCKADE BY ALCOHOLS, ANESTHETICS, 
TRANQUILIZERS, AND BARBITURATES. 

187802 04-03 
THE IMPULSE BLOCKING CONCENTRATIONS OF ANESTHETICS, ALCOHOLS, 

ANTICONVULSANTS, BARBITURATES, AND NARCOTICS ON PHRENIC 
AND SCIATIC NERVES. 

187803 04-03 

ANESTHETIZED 

CARDIOVASCULAR EFFECTS OF RESERPINE, YOHIMBINE, AND RESERPINE 
YOHIMBINE MIXTURES ON INTACT ANESTHETIZED DOG. 

167328 01-03 
CARDIOPULMONARY EFFECTS OF CANNABIDIOL IN ANESTHETIZED DOGS. 

191993 04-05 
ANHYDRIDE 

STUDIES ON BENZODIAZEPINOOXAZOLES. V. REACTIONS OF 

BENZODIAZEPINOOXAZOLE DERIVATIVES WITH ACETIC ANHYDRIDE. 

180489 02-01 
ANIMAL 

ANIMAL MODELS FOR AN ENZYMIC BLOOD-BRAIN BARRIER MECHANISM 
FOR THERAPEUTICALLY ADMINISTERED L-DOPA. 

167359 01-03 
MOTHER INFANT SEPARATION: BEHAVIORAL ANALYSIS OF AN ANIMAL 
MODEL OF DEPRESSION. (PH.D. DISSERTATION). 

178867 02 04 



EEG CHARACTERISTICS IN VARIOUS SPECIES CF ANIMAL AND THEIR 
RELATION TO THE CNS EFFECTS OF DRUGS. 

182096 02-03 
AUTOMATIC RECORDING OF ANIMAL BEHAVIOR AND ITS ANALYSIS. 

182106 02-17 
EFFECTS OF (-)DELTA9-TRANS-TETRAHYDR0CANNABIN0L IN SEVERAL 
ANIMAL MODELS OF AGGRESSION. 

182188 02-04 
RUBIDIUM SALTS - ANIMAL TOXICITY STUDIES 

182442 03-05 
LEAD INDUCED BEHAVIORAL DYSFUNCTION: AN ANIMAL MODEL OF 
HYPERACTIVITY. 

184953 03-04 
NEUROTOXICOLOGIC STUDIES OF TWO CARBAMATE PESTICIDES IN 
SUBACUTE ANIMAL EXPERIMENTS. 

188874 04-05 
ANIMALS 

THE SAFETY TEST OF 10-CHLORO-l lB-(2-CHL0R0PHENYL) 2,3,5,6,7,116 
HEXAHYDROBENZODIAZEPINOOXAZOL-6-ONE (CS-370): SECOND 
REPORT, EFFECT OF CS-370 UPON THE DEVELOPMENT OF PRENATAL 
AND POSTNATAL OFFSPRINGS OF EXPERIMENTAL ANIMALS. 

168498 01-05 
THE PHARMACOLOGICAL EVALUATION IN LABORATORY ANIMALS OF 
KABI-1702 - A NEW SEDATIVE HYPNOTIC DRUG. 

171632 01-03 
STUDIES ON METABOLISM OF BROMAZEPAM (II): COLORIMETRIC 
DETERMINATION AND METABOLIC FATE OF BROMAZEPAM IN 
ANIMALS. 

181593 02-03 
INHIBITION OF GROWTH IN ANIMALS TREATED WITH METHADONE. 

182164 02-03 
DISTRIBUTION OF 14C-PSIL0CIN IN THE BRAINS OF VARIOUS ANIMALS. 

192425 04-03 
ANIONS 

INFLUENCE OF DIFFERENT ANIONS ON TYRAMINE AND AMPHETAMINE 
UPTAKE BY COW ADRENAL MEDULLA CHROMAFFIN VESICLES. 

190907 04-03 
ANISOMYCIN 

ANISOMYCIN, LIKE OTHER INHIBITORS OF CEREBRAL PROTEIN 

SYNTHESIS, IMPAIRS LONG-TERM MEMORY OF A DISCRIMINATION 
TASK. 

1 88605 04-04 

ANORECTIC 

STUDY INTO THE MECHANISM OF THE ANORECTIC ACTION OF 
AMPHETAMINE AND ITS P-CHLORO ANALOGUE. 

171610 01-03 
ROLE OF CATECHOLAMINES IN THE ANORECTIC EFFECTS OF 
AMPHETAMINE IN RATS. 

186582 03-03 

ANOREXIA 

EFFECT OF A CARNITINE CYPROHEPTADINE COMBINATION ON ANOREXIA 
AND WEIGHT GAIN IN CHILDREN. 

178811 02-10 
DECREASED ANOREXIA, EXCITEMENT AND STEREOTYPY TO D- 
AMPHETAMINE AFTER LATERAL HYPOTHALAMIC 6- 
HYDROXYDOPAMINE (6-OHDA) INJECTIONS. 

182136 02-04 
EFFECTS OF 6-HYDROXYDOPAMINE ON ANOREXIA PRODUCED BY D- 
AMPHETAMINE AND RELATED PHENYLETHYLAMINES. 

191905 04-03 
ANOREXIA-NERVOSA 

PLASMA LEVELS OF LUTEINIZING HORMONE AND OF IMMUNOREACTIVE 
ESTROGENS (ESTRADIOL) IN ANOREXIA-NERVOSA: RESPONSE TO 
CLOMIPHENE CITRATE. 

183807 03-10 

ANOREXIC 

TIME SAMPLING OF RAT EXPLORATORY BEHAVIOUR: A RELIABLE 
SCREENING TEST FOR THE CNS EFFECTS OF ANOREXIC AGENTS. 

187925 04-04 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 

DERIVATIVE SE-780 IN RATS. 

187926 04-04 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 

METABOLITE, NORFENFLURAMINE: AN EVALUATION OF ITS ROLE IN 
THE ACTIONS OF FENFLURAMINE. 

190335 04-04 

ANOREXIGENIC 

TOLERANCE AND CROSS-TOLERANCE TO THE ANOREXIGENIC EFFECT OF 
SOME AMPHETAMINE DERIVATIVES IN RATS. 

171602 01-03 
AN ANALYSIS OF TOLERANCE TO THE ANOREXIGENIC EFFECTS OF 
AMPHETAMINE, (PH.D. DISSERTATION), 

173775 01-03 
STUDIES ON THE ANOREXIGENIC ACTION OF PHENTERMINE. 

182134 02-03 
DIFFERENTIAL CIRCULATORY EFFECTS OF VARIOUS ANOREXIGENIC 

DRUGS. 

182214 03-03 



S-20 



VOLUME 12, SUBJECT INDEX 



Subject Index 



ANSWERS 

THERAPEUTIC APPROACH TO THE APPROXIMATE ANSWERS OF A 
SCHIZOPHRENIC PATIENT. 

170637 01-08 
CEREBRAL STIMULANTS AND MINIMAL DYSFUNCTION: SOME 
QUESTIONS, SOME ANSWERS, AND SOME MORE QUESTIONS. 

180992 02- 11 
ANTAGONISM 

SELECTIVE ANTAGONISM OF CENTRAL NERVOUS SYSTEM DEPRESSANTS 
BY DH-524; A COMPARATIVE STUDY WITH BEMEGRIDE. 

171007 01-13 
THE EFFECT OF PIPRAOROL IN MICE AND ITS ANTAGONISM BY 
NEUROLEPTIC DRUGS. 

171607 01-04 
ANTAGONISM OF P-CHLOROAMPHETAMINE (PCA) INDUCED DEPLETION 
OF 5-HT FROM RAT BRAIN BY SOME THYMOLEPTICS AND OTHER 
PSYCHOTROPIC DRUGS. 

171628 01-03 
ANTAGONISM OF THE EFFECTS OF CHLORPROMAZINE AND MORPHINE 
ON DOPAMINE METABOLISM BY GABA. 

176870 02-03 
L-DOPA CHLORPROMAZINE ANTAGONISM ON RUNNING ACTIVITY IN 
MICE. 

177785 02-04 
METHYLPHENIDATE ANTAGONISM OF HALOPERIDOL, INTERACTION WITH 
CHOLINERGIC AND ANTICHOLINERGIC DRUGS. 

186370 03-04 
EFFECTS OF CLONIDINE AND SOME ALPHA-ADRENORECEPTOR BLOCKING 
AGENTS ON AVOIDANCE CONDITIONED REFLEXES IN RATS: THEIR 
INTERACTIONS AND ANTAGONISM BY ATROPINE. 

186576 03-04 
THE ANTAGONISM OF HIPPOCAMPAL AND CORTICAL AFTERDISCHARGE 
BY SC-13504, A NEW ANTICONVULSANT. 

1 86632 03-03 
THE ANTAGONISM OF AMPHETAMINE-INDUCED SYMPTOMATOLOGY BY 
A NEUROLEPTIC. 

186744 03-14 
NEUROLEPTIC ANTAGONISM OF CATECHOLAMINE INHIBITIONS IN RAT 
CEREBELLUM AND CAUDATE. (UNPUBLISHED PAPER). 

187496 04-03 
BIOCHEMICAL AND BEHAVIORAL ANTAGONISM BETWEEN 
FENFLURAMINE AND APOMORPHINE IN RATS. 

188196 04-03 
CENTRAL HYPOTHERMIA BY 2-DEOXY-D-GLUCOSE: ANTAGONISM BY 
ALPHA-ADRENERGIC ACTIVATION. 

188200 04-03 
PROPRANOLOL ANTAGONISM OF MORPHINE INFLUENCED BEHAVIOR. 

188760 04-04 
DIFFERENTIAL ANTAGONISM BY NALOXONE OF INHIBITORY EFFECTS OF 
HALOPERIDOL AND MORPHINE ON BRAIN SELF-STIMULATION. 

190306 04-03 
STUDIES ON CONVULSANTS IN THE ISOLATED FROG SPINAL CORD. I. 
ANTAGONISM OF AMINO ACID RESPONSES. (UNPUBLISHED PAPER) 

190727 04-03 
NEOMYCIN AND RUTHENIUM RED ANTAGONISM OF MONOAMINERGIC 
DEPRESSION OF CEREBRAL CORTICAL NEURONES. 

191380 04-03 
THE ANTAGONISM BETWEEN CHOLINOMIMETIC AGONISTS AND BETA- 
ADRENOCEPTOR STIMULANTS: THE DIFFERENTIATION BETWEEN 
BETWEEN FUNCTIONAL AND METAFFINOID ANTAGONISM. 

191420 04-03 
NEUROPHARMACOLOGICAL ANALYSIS OF CENTRAL ADRENERGIC AND 
CHOLINERGIC ANTAGONISM OF DELTA9-TETRAHYDR0CANNABIN0L. 

191992 04-03 
ANTAGONIST 

DIURETIC ACTIVITY OF A NEW NARCOTIC ANTAGONIST IN MAN 
(BRISTOL-COMPOUND-2605) (UNPUBLISHED PAPER). 

174473 01-13 
THE EFFECTS OF PHENITRONE, A REPORTED HASHISH ANTAGONIST, ON 
THE OVERT BEHAVIOR OF CATS. 

174607 01-04 
ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN 

OIMETHYLAMINOPROPYLTHIOCINNAMANILIDE HYDROCHLORIDE), A 
SEROTONIN ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN (5-HTP) AND ALPHA-METHYLTRYPTAMINE. 

176861 02-04 
ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN, A SEROTONIN 
ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN AND ALPHA-METHYLTRYPTAMINE. 

176873 02-04 
INTERACTION OF THE BEHAVIORALLY ACTIVE DRUG, PHENITRONE, A 
PURPORTED HASHISH AND LSD ANTAGONIST, WITH SEVERAL 
CENTRAL NEUROCHEMICAL SYSTEMS. 

182217 03-04 
NOREPINEPHRINE - AN ANTAGONIST OF OIBUTYRYL CYCLIC AMP IN THE 
REGULATION OF NARCOSIS IN THE RAT. 

183789 03-03 



LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 
ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 
COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25, AN IN 
INTACT MALE RATS. 

186683 03-04 

EFFECTS OF AN ESTROGEN ANTAGONIST, MER-25, ON MOUNTING 
BEHAVIOR AND LORDOSIS BEHAVIOR IN THE FEMALE RAT. 

186691 03-04 
STUDIES OF EN-1639A (NALTREXONE): A NEW NARCOTIC ANTAGONIST. 

189059 04-07 
METHODOLOGY FOR THE EVALUATION OF PENTAZOCINE, PROTOTYPE OF 
THE NEW MORPHINE AGONIST ANTAGONIST ANALGESICS 

191603 04-16 
NALTREXONE AND NALOXONE: AGONIST AND ANTAGONIST EFFECTS ON 
KEY-PRESS RESPONDING OF PIGEONS MAINTAINED UNDER A MULTIPLE 
SCHEDULE OF FOOD PRESENTATION. 

191926 04-04 
ANTAGONISTIC 

ANTAGONISTIC EFFECTS OF PHYSOSTIGMINE AND METHYLPHENIDATE IN 
MAN. 

172272 01-11 
DRINKING BEHAVIOUR AND BRAIN DOPAMINE: ANTAGONISTIC EFFECT 
OF TWO NEUROLEPTIC DRUGS (PIMOZIDE AND SPIRAMIDE) UPON 
AMPHETAMINE OR APOMORPHINE-INDUCED HYPODIPSIA 

174035 01-04 
CHEMOTHERAPY AND PSYCHOTHERAPY, ARE THEY COMPLEMENTARY OR 
ANTAGONISTIC?: A PERSONAL STUDY. 

184959 03-17 

ANTAGONISTS 

CENTRAL MONOAMINE METABOLISM IN MAN: EFFECT OF PUTATIVE 
DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS. 

169377 01 13 
THE EFFECT OF DOPAMINE ANTAGONISTS AND AMANTADINE ON THE 
ACQUISITION OF THE CONDITIONED AVOIDANCE RESPONSE IN RATS 

174829 01-04 
PROGRESS REPORT ON THE USE OF THE DOG FOR ASSESSING MORPHINE- 
LIKE AND NALORPHINE-LIKE AGONISTS AS WELL AS DEPOT 
PREPARATIONS OF ANTAGONISTS (UNPUBLISHED PAPER). 

176312 02-03 
NEGATIVE REINFORCING PROPERTIES OF MORPHINE ANTAGONISTS IN 
NAIVE RHESUS MONKEYS. 

177719 02-04 
BEHAVIORAL EFFECTS OF MORPHINE AND OPIOID ANTAGONISTS 

182859 03-04 
A ROLE FOR THE AMYGDALA IN THE DEVELOPMENT OF THE CATALEPTIC 
AND STEREOTYPIC ACTIONS OF THE NARCOTIC AGONISTS AND 
ANTAGONISTS IN THE RAT. 

186577 03-03 
TRYPTAMINE ANTAGONISTS AND PUNISHED BEHAVIOR 

1 86692 03-04 
NEW LONG LATENCY BULBOSPINAL EVOKED POTENTIALS BLOCKED BY 

SEROTONIN ANTAGONISTS. 

188751 04-03 
INTERACTION OF SEROTONIN ANTAGONISTS WITH 3,4-DICHL0R0-2-(2- 
IMIDAZOLIN-2-YL-THIO) 2 ACETOPHENONE HYDROBROMIDE (DITA) 
AND D-AMPHETAMINE HYDROBROMIDE (DITA) AND D-AMPHETAMINE 
ON CERTAIN BEHAVIORAL PARAMETERS OF MALE MICE. 

192014 04-04 
ANTIAGGRESSION 

TOWARD A MECHANISM OF THE ANTIAGGRESSION EFFECTS OF 
CHLORDIAZEPOXIDE IN RATS. 

185934 03-04 
ANTIAGGRESSIVE 

DISSOCIATIVE CHANGE IN ANTIAGGRESSIVE AND MUSCLE RELAXANT 
ACTIONS OF S-TRIAZOLOBENZODIAZEPINE (D-40TA) BY REPEATED 
ADMINISTRATION AND PHENOBARBITAL PRETREATMENT, AND ITS 
RELATION TO METABOLISM. 

181654 02-04 
ANTIAGGRESSIVE EFFECT OF LITHIUM SALTS IN MENTALLY RETARDED 
ADOLESCENTS. 

182435 03-11 
ANTIANXIETY 

ON THE ANTIANXIETY PROPERTIES OF A NEW BENZODIAZEPINE, ORF- 
8063. 

172485 01-10 
PERIPHERAL VERSUS CENTRAL MECHANISMS ACCOUNTING FOR 
ANTIANXIETY EFFECTS OF PROPRANOLOL. 

181072 02-10 
CROSS-NATIONAL STUDY OF THE EXTENT OF ANTIANXIETY SEDATIVE 
DRUG USE. 

181713 02-17 
ELECTROCLINICAL DISCREPANCIES IN ANTIANXIETY DRUGS. 

181918 02-13 
MANIFEST ANXIETY AND ANTIANXIETY DRUG EFFECTS IN NORMAL 
VOLUNTEERS. 

182118 02-14 
THE CONDITIONED EMOTIONAL RESPONSE (CER) AS A BASELINE FOR THE 
STUDY OF ANTIANXIETY DRUGS. 

183862 03-04 



5-21 



Subject Index 



Psychopharmacology Abstracts 



CLASSIFICATION AND INDICATION OF ANTIANXIETY AGENTS IN CLINICAL 

'''''''''■ ,84845 03-10 

THE SHORT-TERM ANTIANXIETY EFFECTS OF PROPRANOLOL HCL. 

185210 03-10 

A STUDY OF ANTIANXIETY EFFECTS OF WY-4036. 

185874 03-10 

PYRAZAPON (CI-683); A NEW ANTIANXIETY AGENT. 

186581 03-04 
EFFECTS OF CNS AGENTS ON NICOTINE EXTENSOR CONVULSIONS AND 
LETHALITY IN MICE AND THEIR SEDATIVE ANTIANXIETY EFFECTS IN 

'^^^- 191907 04-14 

A CHEMOTHERAPEUTIC ALTERNATIVE TO THE ANTIANXIETY AGENTS FOR 
THE EXTENDED TREATMENT OF PSYCHONEUROSIS. 

192083 04-10 

ANTIAPOMORPHINE 

THE PREDICTIVE VALUE OF THE ANTIAPOMORPHINE TEST IN DOGS FOR 
NEUROLEPTIC THERAPY IN MAN. 

192421 04-04 

ANTIBIOTICS 

DRUG ABSORPTION IN RATS PRETREATED WITH ANTIBIOTICS. 

182715 03-03 
ANTIBODY 

THE SPECIFICITY OF ANTIMESCALINE ANTIBODY PRODUCED IN RABBITS. 

182186 02-03 
ANTICHOLINERGIC 

INHIBITION OF ANTICHOLINERGIC DRUG-INDUCED LOCOMOTOR 
STIMULATION IN MICE BY ALPHA-METHYLTYROSINE. 

1 77840 02-03 
INHIBITION OF ISOLATION INDUCED AGGRESSION IN THE MOUSE BY 
ANTICHOLINERGIC COMPOUNDS. 

182239 03-04 

METHYLPHENIDATE ANTAGONISM OF HALOPERIDOL, INTERACTION WITH 
CHOLINERGIC AND ANTICHOLINERGIC DRUGS. 

186370 03-04 
CORRELATION BETWEEN THE TRANQUILIZING AND SEDATIVE ACTION OF 
NEUROLEPTICS, ANTIDEPRESSANTS AND ANTICHOLINERGIC DRUGS. 

191783 04-02 

ANTICHOLINERGICS 

ANTICHOLINERGICS: THEIR EFFECTS ON FEAR MOTIVATED BEHAVIOR, 
URINARY U-HYDROXYCORTICOSTEROIDS, URINARY VOLUME, AND 
HEART RATE IN THE DOG. 

178720 02-03 

ANTICONVUISANT 

SYNTHESIS OF SUBSTITUTED CINNAMIDES: RELATIONSHIP BETWEEN 
ANTICONVULSANT AND MONOAMINE OXIDASE INHIBITORY 
PROPERTIES. 

169818 01-01 

DEPENDENCE OF ANTICONVULSANT DRUG ACTION ON CENTRAL 

MONOAMINES. 

172923 01-03 

A STUDY OF THE RELATIVE ANTICONVULSANT AND TOXIC ACTIVITIES OF 
DELTA9-TETRAHYDR0CANNABIN0L AND ITS CONGENERS. 

174608 01-05 
THE ANTICONVULSANT ACTIVITY OF CANNABIDIOL AND CANNABINOL. 

175238 02-03 
COMPARISON OF ANTICONVULSANT EFFECTS OF CLORAZEPATE 

DIPOTASSIUM AND DIAZEPAM: FOUR WEEK ANTICONVULSANT STUDY 

IN RHESUS MONKEYS. 

176677 02-03 

ANTICONVULSANT ACTIVITY OF CLONAZEPAM AND RO-8-4192 AGAINST 
PENICILLIN AND LIDOCAINE INDUCED SEIZURES. 

178947 02-03 
INVESTIGATIONS ON THE FATE OF THE ANTICONVULSANT CLONAZEPAM 
IN THE ORGANISM OF MAN, RAT AND DOG. 

179022 02-13 
FIRST RESULTS OBTAINED WITH A NEW ANTICONVULSANT OF THE 
BENZODIAZEPINE SERIES (CLONAZEPAM) 

180672 02-11 
TREATMENT OF COMPULSIVE EATING DISTURBANCES WITH 
ANTICONVULSANT MEDICATION. 

181270 02-14 

SUBSTITUTED PIPERAZINOQUINAZOLONES: RELATIONSHIP BETWEEN 
SELECTIVE INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE 
DEPENDENT OXIDATIONS AND ANTICONVULSANT ACTIVITY. 

183598 03-02 
SUBSTITUTED BENZOXAZOLE/BENZTHIAZOLE-2-THIONES: 

INTERRELATIONSHIP BETWEEN ANTICONVULSANT ACTIVITY AND 
INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT 
OXIDATIONS AND MONOAMINE OXIDASE. 

183601 03-03 
SERUM ANTICONVULSANT CONCENTRATIONS IN EPILEPTIC PATIENTS 
WITH MENTAL SYMPTOMS: A PRELIMINARY REPORT. 

184439 03-15 
ANTICONVULSANT ACTIVITY OF SUBSTITUTED INDOLEALKYLAMINES. 

185035 03-01 



CALCIUM METABOLISM IN ELDERLY EPILEPTIC PATIENTS DURING 
ANTICONVULSANT THERAPY. 

185560 03-15 
ANTICONVULSANT ACTIVITY AND INHIBITION OF RESPIRATION IN RAT 
BRAIN HOMOGENATES BY SUBSTITUTED OXADIAZOLES. 

185980 03-01 
THE ANTAGONISM OF HIPPOCAMPAL AND CORTICAL AFTERDISCHARGE 
BY SC-13504, A NEW ANTICONVULSANT. 

186632 03-03 
ANTICONVULSANT ACTION OF VITAMIN-D IN EPILEPTIC PATIENTS? A 
CONTROLLED PILOT STUDY. 

188889 04-11 
CARBAMAZEPINE SOLE ANTICONVULSANT FOR FOCAL EPILEPSY OF 

CHILDHOOD. 

189174 04-11 

ANTICONVULSANT EFFECTS OF CANNABINOLS IN MICE: DRUG 
INTERACTIONS WITH CANNABINOIDS AND CANNABINOID 
INTERACTIONS WITH PHENYTOIN. 

189513 04-03 

EFFECT OF ANTICONVULSANT DRUGS ON THE NUMBER OF AFFERENT 
STIMULI NEEDED TO CAUSE A HIPPOCAMPAL SEIZURE DISCHARGE. 

189608 04-03 
EFFECT OF SEIZURES AND ANTICONVULSANT AGENTS ON HIPPOCAMPAL 

RNA CONCENTRATION. 

1 89609 04-03 
ANTICONVULSANT DRUG SERUM LEVELS IN PSYCHIATRIC PATIENTS 

WITH SEIZURE DISORDERS: EFFECTS OF CERTAIN PSYCHOTROPIC 
DRUGS. 

191096 04-13 

ANTICONVULSANT PROPERTIES OF CANNABIDIOL. 

191994 04-03 
CARBAMAZEPINE AS AN ANTICONVULSANT: A PILOT STUDY. 

192391 04-07 

ANTICONVULSANTS 

ANTICONVULSANTS AND POST-TETANIC POTENTIATION. 

182249 03-03 
THE IMPULSE BLOCKING CONCENTRATIONS OF ANESTHETICS, ALCOHOLS, 
ANTICONVULSANTS, BARBITURATES, AND NARCOTICS ON PHRENIC 
AND SCIATIC NERVES. 

187803 04-03 

ANTICONVULSIVE 

ANTICONVULSIVE ACTIVITY OF 8-CHLORO-6-PHENYL-4H-S- 

TRIAZOLOBENZODIAZEPINE (D-40TA) AND ITS EFFECT ON LIMBIC 

SYSTEM. 

1 77099 02-02 

ANTIDEPRESSANT 

COMBINATIONS OF ANTIDEPRESSANT DRUGS IN THE TREATMENT OF 
DEPRESSIVE ILLNESS. 

168317 01-09 

CLOMIPRAMINE HCL - A DOUBLE-BLIND STUDY OF A NEW 
ANTIDEPRESSANT DRUG. 

168318 01-09 

THE EFFECT OF LITHIUM AND OTHER ANTIDEPRESSANT MEDICATIONS ON 

THE AUTONOMIC NERVOUS SYSTEM. 

169635 01-15 
BRAIN SEROTONIN, AFFECTIVE ILLNESS AND ANTIDEPRESSANT DRUGS: 

CEREBROSPINAL FLUID STUDIES WITH PROBENECID. {UNPUBLISHED 

'^'''''- 170084 01-09 

MELANOCYTE STIMULATING HORMONE RELEASE INHIBITING HORMONE 

AS AN ANTIDEPRESSANT: A PILOT STUDY. 

171501 01-09 
EFFECTS OF ANTIDEPRESSANT AGENTS ON OPEN-FIELD BEHAVIOUR IN 

RATS. 

174038 01-04 

ANTIDEPRESSANT DRUGS, „ „ „o 

174760 01-03 

ANTIDEPRESSANT DRUGS. 

174851 01-09 
ANTIDEPRESSANT EFFECTS OF D-CHLORPHENIRAMINE - CLINICAL 
EVALUATION (FIRST REPORT). 

1 76889 02-09 
QUALITATIVE AND QUANTITATIVE STUDIES ON THE DISPOSITION OF 
AMITRIPTYLINE AND OTHER TRICYCLIC ANTIDEPRESSANT DRUGS IN 
MAN AS IT RELATES TO THE MANAGEMENT OF THE OVERDOSED 

PATIENT. „^,, 

177395 02- 1; 

THE FIRST LONG-ACTING (RETARD) THYMOANALEPTIC OR 
ANTIDEPRESSANT: THE TIME-RELEASED DIBENZEPINE WITH 
PROLONGED ACTION. ^^^^^^^^,, 

ANTIDEPRESSANT DRUGS. ,80297 02-0< 

INDICATIONS FOR ANTIDEPRESSANT TREATMENT WITH SPECIAL 
REFERENCE TO DEPRESSED PRESCHOOL CHILDREN. 

182428 03- 1( 
RUBIDIUM SALTS - TOXIC EFFECTS IN HUMANS AND CLINICAL EFFECTS 
AS AN ANTIDEPRESSANT DRUG. 

182443 03-0' 



S-22 



VOLUME 12, SUBJECT INDEX 

CLINICAL STUDY OF ANTIDEPRESSANT AGENT, NOVERIL. 

182551 03-10 
EXPERIMENTS IN ORAL AND INJECTABLE FORMS OF A NEW 
ANTIDEPRESSANT (DOXEPIN) ON FORTY PATIENTS, 

182900 03-11 
THE ABSORPTION AND DISTRIBUTION OF THE NEW ANTIDEPRESSANT 
AZAPHEN IN THE ORGANS. 

183519 03-03 
5-HYDROXYTRYPTOPHAN AS AN ANTIDEPRESSANT: THE PREDICTIVE 
VALUE OF THE PROBENECID TEST. 

184652 03-09 
EFFECT OF ANTIDEPRESSANT AND ANTIMANIC DRUGS ON AMINE 
UPTAKE IN MAN. 

184654 03-13 
A STUDY OF REFRACTORY CASES OF DEPRESSIVE ILLNESSES AND THEIR 
RESPONSE TO COMBINED ANTIDEPRESSANT TREATMENT. 

185078 03-10 
DIURETIC ANTIDEPRESSANT COMBINATION IN ALCOHOLIC DEPRESSIVES. 

187866 04-11 
3-ARYL-3-HYDROXYQUINOLIZIDiNES WITH POTENTIAL HYPOTENSIVE, 
ANTIDEPRESSANT, AND ANALGETIC ACTIVITY. 

187938 04-01 
HEAT DYSCONTROL SYNDROME IN PATIENTS RECEIVING 

ANTIPSYCHOTIC, ANTIDEPRESSANT AND ANTIPARKINSON DRUG 
THERAPY. 

188094 04-15 
CLINICAL EXPERIENCES WITH A NEW ANTIDEPRESSANT, MAPROTILINE. 

188893 04-09 
ANTIDEPRESSANT EFFECT OF LITHIUM. 

189793 04-09 
THE USE OF A TRICYCLIC ANTIDEPRESSANT IN EPILEPSY. 

190379 04-09 
THE EFFICACY OF ANTIDEPRESSANT DRUGS: A REVIEW OF RESEARCH 
(1958 TO 1972). 

191857 04-09 
PHARMACOLOGY OF DEPRESSION IN THE AGED; EVALUATION OF 
GER0VITAL-H3 AS AN ANTIDEPRESSANT DRUG. 

192229 04-09 
CORRELATION OF PHARMACOLOGICAL INVESTIGATIONS WITH THE 
CLINICAL EFFICACY OF ANTIDEPRESSANT DRUGS. 

192420 04-13 
ANTIDEPRESSANTS 

EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON ATTACK ELICITED BY 
HYPOTHALAMIC STIMULATION: RELATION TO BRAIN BIOGENIC 
AMINES. 

170162 01-04 
COMPARISON OF TRICYCLIC ANTIDEPRESSANTS AS TO THEIR 
CARDIOTOXIC ACTION IN CONSCIOUS RABBITS. 

171629 01-03 
AN ENZYME APPROACH IN APPRAISING THE MODE OF SOME 
TRANQUILIZERS AND ANTIDEPRESSANTS. 

174318 01-03 
A NEW MODIFICATION FOR STUDYING 5-HT UPTAKE BY BLOOD 
PLATELETS: A RE-EVALUATION OF TRICYCLIC ANTIDEPRESSANTS AS 
UPTAKE INHIBITORS. 

180055 02-06 
PRELIMINARY STUDIES OF CARPIPRAMINE: A COMPOUND SIMILAR TO 
BOTH ANTIDEPRESSANTS AND NEUROLEPTICS. 

180725 02-07 
BEHAVIORAL PHARMACOLOGICAL STUDIES ON TRICYCLIC 
ANTIDEPRESSANTS IN RATS. 

182116 02-04 
IMPORTANCE OF THE COOPERATION OF FAMILIES IN THE TREATMENT OF 
THE SICK: CONCERNING CHRONIC DELIRIUM TREATED WITH 
NEUROLEPTICS AND MELANCHOLY TREATED WITH ANTIDEPRESSANTS. 

182899 03-17 
SYNTHESIS AND SCREENING OF CYCLIC BENZYLHYDRAZINE CONGENERS 
AS ANTIDEPRESSANTS. 

183600 03-01 
COMPARISON OF TRICYCLIC ANTIDEPRESSANTS IN RABBITS: 
ANTINOCICEPTION AND POTENTIATION OF THE NORADRENALINE 
PRESSOR RESPONSES. 

186579 03-03 
LIPIDOSIS-LIKE ALTERATIONS IN DORSAL ROOT GANGLION CELLS OF 
RATS TREATED WITH TRICYCLIC ANTIDEPRESSANTS. 

189605 04-03 
SELF-EVALUATIONS OF ANTIDEPRESSANTS. 

190305 04-17 
EFFECT OF PHENOTHIAZINE NEUROLEPTIC DRUGS AND TRICYCLIC 
ANTIDEPRESSANTS ON PHOSPHODIESTERASE ACTIVITY IN RAT 
CEREBRAL CORTEX. 

190311 04-03 
INFLUENCE OF NEUROLEPTICS AND BENZODIAZEPINES ON METABOLISM 
OF TRICYCLIC ANTIDEPRESSANTS IN MAN. 

191026 04-09 
CORRELATION BETWEEN THE TRANQUILIZING AND SEDATIVE ACTION OF 
NEUROLEPTICS, ANTIDEPRESSANTS AND ANTICHOLINERGIC DRUGS. 

191783 04-02 



Subject Index 



NORADRENERGIC NEURONS: EFFECTS OF TRICYCLIC ANTIDEPRESSANTS 
ON SINGLE UNIT ACTIVITY. 

191931 04-03 
PLASMA LEVELS AND TRICYCLIC ANTIDEPRESSANTS. 

192872 04-10 
ANTIDEPRESSIVE 

EXPERIENCE IN THE USE OF AN ANTIDEPRESSIVE, CLOMIPRAMINE 
(ANAFRANIL), IN PSYCHIATRIC OUTPATIENTS. 

1 76475 02-09 
CLINICAL EXPERIENCES WITH AN ANTIDEPRESSIVE DRUG, NORITREN 
(NORTRIPTYLINE). 

1 76565 02-09 
EKG ALTERNATIONS IN INFUSION TREATMENT WITH TRICYCLIC 
ANTIDEPRESSIVE DRUGS. 

180063 02-15 
INFLUENCE OF ANTIDEPRESSIVE THERAPY ON THE DISTURBED TIME 
ESTIMATION OF DEPRESSIVES. 

182591 03-14 
LABORATORY ASSESSMENTS OF ANTIDEPRESSIVE ACTIVITY - THEIR 
VALUE FOR CLINICAL PSYCHIATRY AND THE UNDERSTANDING OF 
DEPRESSION. 

192422 04-09 
ANTIDEPRESSIVES 

COMBINED USE OF ECT AND PSYCHOTROPIC DRUGS: ANTIDEPRESSIVES 
AND ANTIPSYCHOTICS. 

177670 02-11 
ANTIEPILEPTIC 

PHARMACOLOGY AND TOXICOLOGY OF THE ANTIEPILEPTIC DRUG 
CLONAZEPAM. 

179021 02-05 
ANTIHISTAMINES 

EFFECTS OF PHENOTHIAZINES, ANTIHISTAMINES, BENZODIAZEPINES AND 
BUTYROPHENONES ON THE RHYTHMS OF WAKEFULNESS SLEEP CYCLE 
IN RATS. 

182553 03-04 
EFFECTS OF PHENOTHIAZINES, ANTIHISTAMINES, BENZODIAZEPINES AND 

BUTYROPHENONES ON ELECTROENCEPHALOGRAM AND FEEDING 
BEHAVIOR OF RATS. 

182554 03-04 
ANTIHISTAMINIC 

INTERACTIONS OF CHLORPHENIRAMINE ETHANOL COMBINATIONS: 
ACUTE TOXICITY AND ANTIHISTAMINIC ACTIVITY. 

188875 04-05 
ANTIHYPERTENSIVE 

ANTIHYPERTENSIVE AND CENTRAL NERVOUS SYSTEM DEPRESSANT 
PROPERTIES OF 3-(GAMMA-P-FLU0R0BENZ0YLPR0PYL) 2,3,4,4A,5,6 
HEXAHYDROPYRAZINOQUINOLINE HYDROCHLORIDE (COMPOUND-69- 
183, CENTPYRAQUIN). 

176881 02-03 
ANTIINFLAMMATORY 

ANTIPYRETIC, ANALGESIC AND ANTIINFLAMMATORY ACTIVITY OF 
DELTA9-TETRAHYDR0CANNABIN0L IN THE RAT 

182221 03-03 
ANTILIPEMIC 

INFLUENCE OF ADRENERGIC BLOCKERS AND ANTILIPEMIC AGENTS ON 
PHARMACODYNAMIC ACTIONS OF MORPHINE IN CARBON 
TETRACHLORIDE TREATED RATS. 

188873 04-03 
ANTIMANIC 

EFFECT OF ANTIDEPRESSANT AND ANTIMANIC DRUGS ON AMINE 
UPTAKE IN MAN. 

184654 03-13 
ANTIMESCALINE 

THE SPECIFICITY OF ANTIMESCALINE ANTIBODY PRODUCED IN RABBITS. 

182186 02-03 
ANTIMOTION 

THE SPIRAL AFTEREFFECT (SAE) AS A MEASURE OF MOTION SICKNESS 
SUSCEPTIBILITY AND THE EFFECT ON THE SAE OF AN ANTIMOTION 
SICKNESS DRUG AND A CENTRAL NERVOUS SYSTEM DEPRESSANT 

172780 01-03 
ANTINOCICEPTION 

EFFECT OF CHEMICAL SYMPATHECTOMY ON MORPHINE 
ANTINOCICEPTION AND TOLERANCE IN RATS. 

182159 02-03 
COMPARISON OF TRICYCLIC ANTIDEPRESSANTS IN RABBITS: 
ANTINOCICEPTION AND POTENTIATION OF THE NORADRENALINE 
PRESSOR RESPONSES. 

186579 03-03 
ANTINOCICEPTIVE 

ALPHA-ADRENERGIC BLOCKING AGENTS: ANTINOCICEPTIVE ACTIVITY 
AND ENHANCEMENT OF MORPHINE-INDUCED ANALGESIA. 

183895 03-03 
STUDIES ON THE POTENTIATION OF THE ANTINOCICEPTIVE EFFECT OF 
OXOTREMORINE BY TETRABENAZINE IN MICE. 

185933 03-03 
ANTIOVULATORY 

A STUDY OF ANTIOVULATORY ACTIVITY OF HALOPERIDOL IN RABBITS. 

177021 02-03 



S-23 



Subject Index 



Psychopharmacology Abstracts 



ANTIPAKKINSON 

ANTIPARKINSON DRUGS AS CAUSAL AGENTS IN TARDIVE DYSKINESIA. 

169140 01-15 
CENTRAL NERVOUS SYSTEM AND AUTONOMIC NERVOUS SYSTEM 

EFFECTS OF AMANTADINE AND OF SOME STANDARD ANTIPARKINSON 
DRUGS. 

177729 02-13 
HEAT DYSCONTROL SYNDROME IN PATIENTS RECEIVING 
ANTIPSYCHOTIC, ANTIDEPRESSANT AND ANTIPARKINSON DRUG 
THERAPY. 

188094 04-15 
ANTIPARKINSONIAN 

ANTIPARKINSONIAN AGENTS AND DEPOT PHENOTHIAZINE. 

173006 01-09 
SYNTHESIS OF HYDROXYAPORPHINES AS POTENTIAL ANTIPARKINSONIAN 
AGENTS. (PH.D. DISSERTATION). 

174967 02-01 
EFFECTS OF ANTIPARKINSONIAN DRUGS ON NEUROLEPTIC INDUCED 
EXTRAPYRAMIDAL SIGNS IN MONKEYS. 

183610 03-03 
THE ABRUPT WITHDRAWAL OF ANTIPARKINSONIAN DRUGS IN 
SCHIZOPHRENIC PATIENTS. 

185005 03-08 
ANTIPSYCHOTIC 

METIAPINE: THE EVALUATION OF THE ANTIPSYCHOTIC PROPERTIES OF A 
NEW NEUROLEPTIC. A PILOT STUDY. 

167342 01-08 
ANTIPSYCHOTIC AGENTS. 

169152 01-11 
CHANGES IN MENTAL FUNCTIONING ACCOMPANYING ANTIPSYCHOTIC 
DRUG THERAPY. 

17112401-10 
IS THERE A RELATIONSHIP BETWEEN THE INVOLVEMENT OF 
EXTRAPYRAMIDAL AND MESOLIMBIC BRAIN AREAS WITH THE 
CATALEPTIC ACTION OF NEUROLEPTIC AGENTS AND THEIR CLINICAL 
ANTIPSYCHOTIC EFFECT? 

171305 01-03 
PSYCHOLOGICAL EFFECTS OF SINGLE DOSE ANTIPSYCHOTIC 
MEDICATION. 

173402 01-08 
BASIC PRINCIPLES IN THE USE OF ANTIPSYCHOTIC AGENTS. 

173433 01-11 
SAFETY EVALUATION OF PENFLURIDOL, A NEW LONG-ACTING ORAL 
ANTIPSYCHOTIC AGENT. 

177319 02-07 
NEURONE BLOCKING ACTIONS OF ANTIPSYCHOTIC DRUGS. 

182127 02-03 
BEHAVIORAL EFFECTS OF EX-11-582A, A POTENTIAL ANTIPSYCHOTIC 
AGENT. 

182242 03-04 
ANTIPSYCHOTIC ACTION OF NEUROLEPTIC AGENTS AND THE FUNCTION 
OF BASAL GANGLIA (SURVEY OF LITERATURE). 

183521 03-17 
A COMPARATIVE STUDY OF THE ANTIPSYCHOTIC ACTION OF SOME 
NEUROLEPTICS BASED ON THE MODEL OF LSD PSYCHOSES. 

183682 03-03 
GUIDELINES FOR ANTIPSYCHOTIC DRUG USE. 

186191 03-09 
PERPHENAZINE CONCENTRATIONS IN HUMAN WHOLE BLOOD: A PILOT 
STUDY DURING ANTIPSYCHOTIC THERAPY USING DIFFERENT 
ADMINISTRATION FORMS. 

187639 04-16 
HEAT DYSCONTROL SYNDROME IN PATIENTS RECEIVING 
ANTIPSYCHOTIC, ANTIDEPRESSANT AND ANTIPARKINSON DRUG 
THERAPY. 

188094 04-15 
PENFLURIDOL: AN EFFICACIOUS LONG-ACTING ORAL ANTIPSYCHOTIC 
COMPOUND. 

189072 04-08 
RAPID DIGITALIZATION OF DECOMPENSATED SCHIZOPHRENIC PATIENTS 
WITH ANTIPSYCHOTIC AGENTS. 

189095 04-08 
ANTIPSYCHOTICS 

COMBINED USE OF ECT AND PSYCHOTROPIC DRUGS: ANTIDEPRESSIVES 
AND ANTIPSYCHOTICS. 

177670 02-11 
ANTIPYRETIC 

ANTIPYRETIC, ANALGESIC AND ANTIINFLAMMATORY ACTIVITY OF 
DELTA9-TETRAHYDR0CANNABIN0L IN THE RAT. 

182221 03-03 
ANTIRESERPINE 

EVALUATION OF CENTRAL ANTIRESERPINE EFFECT BY THE USE OF LIGHT 
BLINK REFLEX. 

169469 01-04 
SYNTHESIS AND ANTIRESERPINE ACTIVITY OF PEPTIDES OF L-DOPA. 

180097 02-03 



ANTISCHIZOPHRENIC 

A POSSIBLE MECHANISM FOR THE ANTISCHIZOPHRENIC ACTION OF 
CHLORPROMAZINE; INHIBITION OF THE FORMATION OF 
DIMETHYLTRYPTAMINE BY CHLORPROMAZINE METABOLITES. 

187576 04-03 
ANTISCHIZOPHRENIC DRUGS AND BRAIN CHOLINERGIC RECEPTORS: 
AFFINITY FOR MUSCARINIC SITES PREDICTS EXTRAPYRAMIDAL 
EFFECTS. 

188114 04-15 
ANTISEROTONERGIC 

INHIBITION OF ISOLATION INDUCED AGGRESSION IN MICE BY 
ANTISEROTONERGIC DRUGS. 

182240 03-04 
ANTISEROTONIN 

QUANTUM CHEMICAL STUDIES ON DRUG ACTIONS: IV. CORRELATION OF 
SUBSTITUENT STRUCTURES AND ANTISEROTONIN ACTIVITY IN 
LYSERGAMIDE SERIES. 

174605 0112 
THE ROLE OF HYDROPHOBICITY IN THE ANTISEROTONIN ACTIVITY OF 

LSD ANALOGS. 

174606 01-12 
ANTISUICIDAL 

USE OF CHEMOTHERAPY AS ANTISUICIDAL PROPHYLAXIS. 

191140 04-11 
ANXIETY 

CLORAZEPATE OIPOTASSIUM, DIAZEPAM AND PLACEBO IN CHRONIC 
ANXIETY. 

167339 01-10 
THE COMPUTER ANALYZES TWO PSYCHOTHERAPEUTIC AGENTS IN 
ANXIETY/DEPRESSED STATES. 

167345 01-10 
A MULTICENTER INVESTIGATION OF LORAZEPAM IN ANXIETY NEUROSIS. 

167346 01-10 
CHLORDIAZEPOXIDE AND DOTHIEPIN COMPARED IN 

ANXIETY/DEPRESSION IN GENERAL PRACTICE. 

167575 01-10 
BROMAZEPAM AND PHENOBARBITAL IN ANXIETY: A CONTROLLED 
STUDY. 

167773 01-10 
A STUDY OF THE CLINICAL EFFECTS OF PHENELZINE AND PLACEBO IN 
THE TREATMENT OF PHOBIC ANXIETY. 

168832 01-10 
LOW DOSAGE HALOPERIDOL AND INDUCED ANXIETY IN NORMAL 
VOLUNTEERS. 

169745 01-14 
THE PROBLEM OF ANXIETY IN A NON-WESTERN SOCIETY: A COMBINED 
CHEMOTHERAPEUTIC AND PSYCHOTHERAPEUTIC APPROACH 

171162 01-10 
A DOUBLE-BUND COMPARISON OF THIORIDAZINE (MELLARIL) VERSUS 
DIAZEPAM (VALIUM) IN PATIENTS WITH CHRONIC MIXED ANXIETY 
AND DEPRESSIVE SYMPTOMS. 

172486 01-10 
PILOT CLINICAL TRIAL OF PARENTERAL LORAZEPAM (TEMESTA) IN 
ANXIETY STATES. 

174044 01-11 
THE DIFFERENTIATION OF ANXIETY AND DEPRESSIVE DISORDERS: A 
PSYCHOPHARMACOLOGICAL APPROACH. 

175286 02-10 
LORAZEPAM IN THE TREATMENT OF ANXIETY. 

176286 02-10 
PREDICTING RELIEF FROM ANXIETY WITH PHENOBARBITAL. 

177376 02-10 
EFFECTS OF DIPHENYLHYDANTOIN ON ANXIETY AND HOSTILITY IN 
INSTITUTIONALIZED PRISONERS. 

177671 02-11 
TACITIN TREATMENT FOR THE PATIENT WITH ANXIETY. 

178038 02-10 
A DOUBLE-BLIND TRIAL OF TRIOXAZINE WITH PLACEBO IN ANXIETY 
STATES. 

180249 02-10 
MANIFEST ANXIETY AND ANTIANXIETY DRUG EFFECTS IN NORMAL 
VOLUNTEERS. 

182118 02-14 
SOME RECENT ADVANCES IN THE MANAGEMENT OF ANXIETY. 

182764 03-10 
A CONTROLLED TRIAL OF OXYPERTINE IN PATIENTS WITH ANXIETY. 

182766 03-10 
ANXIETY NEUROSIS IN GENERAL PRACTICE. 

182767 03-10 
MEASUREMENT OF ANXIETY IN GENERAL PRACTICE. 

182768 03-10 
A MULTICENTRE CLINICAL TRIAL OF OXYPERTINE IN ANXIETY NEUROSIS. 

182769 03-10 
CHLORMEZANONE IN ANXIETY: A DRUG REDISCOVERED? 

184175 03-10 
RELATIONSHIP OF PLASMA MEPERIDINE LEVELS TO CHANGES IN ANXIETY 
AND HOSTILITY. 

185881 03-14 



S-24 



rOLUME 12, SUBJECT INDEX 



Subject Index 



PLASMA LEVEL OF DIAZEPAM AS A THERAPEUTIC PREDICTOR IN 
ANXIETY STATES. 

186584 03-tO 
TREATMENT OF ANXIETY NEUROSIS BY ALPHA-ADRENERGIC AND BETA- 
ADRENERGIC BLOCKING AGENTS. 

186780 03-10 
RESPONSE TO PROPRANOLOL AND DIAZEPAM IN SOMATIC AND PSYCHIC 
ANXIETY. 

188887 04-10 
MIXED ANXIETY DEPRESSION; FACT OR MYTH? 

189919 04-10 
THE TREATMENT OF MIXED ANXIETY AND DEPRESSION WITH LOXAPINE; 
A CONTROLLED COMPARATIVE STUDY. 

190195 04-09 
A DOUBLE-BLIND CONTROLLED STUDY OF LOXAPINE SUCCINATE IN THE 

TREATMENT OF ANXIETY NEUROSES. 

190196 04-09 
NXIOLYTIC 

A CLINICAL EVALUATION OF A NEW ANXIOLYTIC DRUG 
(THIENODIAZEPINE DERIVATIVE Y-6047) IN NEUROTICS AND 
PSYCHOSOMATIC DISORDERS - A PRELIMINARY REPORT. 

181771 02-07 
PERCEPTUAL STYLE AND PAIN TOLERANCE - II. THE INFLUENCE OF AN 
ANXIOLYTIC AGENT. 

184291 03-14 
CLINICAL EVALUATION OF ANXIOLYTIC DRUGS. 

185350 03-17 
PLASMA CONCENTRATIONS OF DIAZEPAM AND OF ITS METABOLITE N- 
DESMETHYLDIAZEPAM IN RELATION TO ANXIOLYTIC EFFECT. 

186184 03-13 
THE COMPARATIVE ANXIOLYTIC EFFECTS OF PLACEBO, IMIPRAMINE AND 
CHLORIMIPRAMINE USING PSYCHIATRIC AND PSYCHOPHYSIOLOGICAL 
MEASUREMENTS. 

191137 04-14 
NXIOUS 

ORTHOGONAL FACTORS VS. INTERDEPENDENT VARIABLES AS 
PREDICTORS OF DRUG TREATMENT RESPONSE IN ANXIOUS 
OUTPATIENTS. 

171299 01-14 
AMITRIPTYLINE IN ANXIOUS DEPRESSED OUTPATIENTS: A CONTROLLED 
STUDY. 

172993 01-10 
THE EFFECT OF LORAZEPAM ON ANXIOUS INSOMNIACS SLEEP AS 
RECORDED IN THE HOME ENVIRONMENT. 

177318 02-14 
CHL0RDIA2EP0XIDE AND HOSTILITY IN ANXIOUS OUTPATIENTS. 

181273 02-10 
EFFECTS OF HYPNOTICS ON ANXIOUS PATIENTS. 

184445 03-10 
THIORIDAZINE IN NEUROTIC, ANXIOUS, AND DEPRESSED PATIENTS. 

192227 04-10 
PHRODISIAC 

APHRODISIAC EFFECT OF L-DOPA AND APOMORPHINE IN MALE 
SEXUALLY SLUGGISH RATS. 

188519 04-03 
PlYSIA 

VOLTAGE CLAMP ANALYSIS OF PENTYLENETETRAZOL EFFECTS ON 
APLYSIA NEURONS. 

189032 04-03 
.PNEA 

ECT, GLAUCO/WA, AND PROLONGED APNEA. 

187837 04-15 
>POMORPHINE 

PHARMACOLOGICALLY INDUCED BEHAVIOURAL SUPERSENSITIVITY TO 
APOMORPHINE. 

169120 01-03 
DEVELOPMENT OF TOLERANCE IN RATS TO THE HYPOTHERMIC EFFECTS 
OF D-AMPHET AMINE AND APOMORPHINE. 

174764 01-03 
APOMORPHINE INDUCED BITING AND FIGHTING BEHAVIOUR IN 
RESERPINIZED RATS AND AN APPROACH TO THE MECHANISM OF 
ACTION. 

174768 01-04 
INHIBITION OF THE APOMORPHINE GNAWING COMPULSION BY 
AMANTADINE. 

176879 02-04 
DRUG-INDUCED CATALEPSY AS INFLUENCED BY PSYCHOSTIMULANTS, 
APOMORPHINE, L-DOPA, AND YOHIMBINE. 

177730 02-13 
FLAVOR AVERSIONS PRODUCED BY CONTINGENT DRUG INJECTION; 
RELATIVE EFFECTIVENESS OF APOMORPHINE, EMETINE, AND LITHIUM. 

1 78502 02-04 
EXPERIMENTAL DEPRESSION CAUSED BY APOMORPHINE AND 
PHENOHARMANE. 

180062 02-10 
INTERACTION OF APOMORPHINE, NEUROLEPTICS AND STIMULANTS 
WITH ALPHA-METHYL-M-TYRAMINE, A FALSE DOPAMINERGIC 
TRANSMITTER. 

181809 02-03 



SELECTIVE BLOCKADE OF APOMORPHINE INDUCED AGGRESSION AND 
GNAWING FOLLOWING FENFLURAMINE OR RAPHE LESIONS IN THE 
RAT 

182128 02-04 
EFFECT OF MORPHINE, HALOPERIDOL, APOMORPHINE AND BENZTROPINE 
ON DOPAMINE TURNOVER IN RAT CORPUS-STRIATUM: EVIDENCE 
SHOWING MORPHINE-INDUCED REDUCTION IN CNS DOPAMINERGIC 
ACTIVITY. 

182230 03-03 
INVERSION BY APOMORPHINE OF THE TENDENCY OF FEMALE RATS TO 
BE DEFEATED BY MALES WHEN COMPETING FOR FOOD IN A STRAIGHT 
RUNWAY. 

184212 03-04 
INFLUENCE OF FLUPENTHIXOL AND FLUPENTHIXOL DECANOATE ON 
METHYLPHENIDATE AND APOMORPHINE INDUCED COMPULSIVE 
GNAWING IN MICE 

186371 03-04 
A COMPARISON OF EFFECTS OF APOMORPHINE AND ET-495 ON 
LOCOMOTOR ACTIVITY AND CIRCLING BEHAVIOUR IN MICE. 

186635 03-04 < 
THE EFFECT OF AMANTADINE, L-DOPA, (J AMPHETAMINE AND 

APOMORPHINE ON THE ACQUISITION OF THE CONDITIONED 
AVOIDANCE RESPONSE. 

186636 03-04 
EFFECTS OF APOMORPHINE ON SELF-STIMULATION BEHAVIOR 

187666 04-04 
BIOCHEMICAL AND BEHAVIORAL ANTAGONISM BETWEEN 
FENFLURAMINE AND APOMORPHINE IN RATS. 

188196 04-03 
APHRODISIAC EFFECT OF L-DOPA AND APOMORPHINE IN MALE 
SEXUALLY SLUGGISH RATS. 

188519 04-03 
EFFECTS OF NOMIFENSINE (HOE-984), D-AMPHETAMINE AND 

APOMORPHINE ON MOTOR ACTIVITY, CATECHOLAMINE TURNOVER 
AND CAMP CONCENTRATIONS IN RAT BRAIN. (UNPUBLISHED PAPER). 

191766 04-03 
POSITIVE REINFORCING EFFECTS OF APOMORPHINE, D-AMPHETAMINE 
AND MORPHINE; INTERACTION WITH HALOPERIDOL. 

191899 04-04 
APOMORPHINE-INDUCED 

DRINKING BEHAVIOUR AND BRAIN DOPAMINE; ANTAGONISTIC EFFECT 
OF TWO NEUROLEPTIC DRUGS (PIMOZIDE AND SPIRAMIDE) UPON 
AMPHETAMINE OR APOMORPHINE-INDUCED HYPODIPSIA. 

174035 01-04 
EFFECTS OF MORPHINE AND CHLORPROMAZINE ON APOMORPHINE- 
INDUCED STEREOTYPED BEHAVIOUR. 

185997 03-04 
BRAIN AMINES AND APOMORPHINE-INDUCED INTRASPECIFIC 
AGGRESSIVE BEHAVIOR IN THE RAT. 

186374 03-04 
DOPAMINERGIC NATURE OF APOMORPHINE-INDUCED PECKING IN 
PIGEONS. 

188204 04-03 
APPARATUS 

A NEW RECORDING APPARATUS FOR MEASUREMENT OF LOCOMOTOR 
ACTIVITY OF MICE. EXPERIMENTAL OBSERVATIONS ON ITS USE 

186377 03-06 
APPETITE 

DIFFERENTIAL SELF-INJECTION BEHAVIOR PRODUCED BY FENFLURAMINE 
VERSUS OTHER APPETITE INHIBITING DRUGS. 

182215 03-04 
APPRAISING 

AN ENZYME APPROACH IN APPRAISING THE MODE OF SOME 
TRANQUILIZERS AND ANTIDEPRESSANTS. 

174318 01-03 
APPRECIATION 

IN APPRECIATION OF BASIC BIOCHEMICAL RESEARCH IN MENTAL 
HEALTH. (UNPUBLISHED PAPER). 

187488 04- 17 
APPROACH 

THERAPEUTIC APPROACH TO THE APPROXIMATE ANSWERS OF A 
SCHIZOPHRENIC PATIENT. 

170637 01-08 
THE PROBLEM OF ANXIETY IN A NON-WESTERN SOCIETY; A COMBINED 
CHEMOTHERAPEUTIC AND PSYCHOTHERAPEUTIC APPROACH. 

171162 01-10 
THE NOOTROPIC APPROACH TO THE PHARMACOLOGY OF THE 
INTEGRATIVE ACTIVITY OF THE BRAIN. 

173495 01-02 
AN ENZYME APPROACH IN APPRAISING THE MODE OF SOME 
TRANQUILIZERS AND ANTIDEPRESSANTS. 

174318 01-03 
APOMORPHINE INDUCED BITING AND FIGHTING BEHAVIOUR IN 
RESERPINIZED RATS AND AN APPROACH TO THE MECHANISM OF 
ACTION. 

174768 01-04 
THE DIFFERENTIATION OF ANXIETY AND DEPRESSIVE DISORDERS; A 
PSYCHOPHARMACOLOGICAL APPROACH. 

175286 02- 10 



■!ll f 



i i .1 



S-25 



Subject Index 



Psychopharmacology Abstracts 



THE PROBLEMS OF THE PSYCHOPHARMACOLOGICAL TREATMENT OF 
PSYCHOSOMATIC DISEASES •■ THE ANESTHESIOLOGIC APPROACH. 

177063 02-17 
EFFECTS OF CONSECUTIVE ADMINISTRATION OF DIAZEPAM AND 
DOXEPIN ON BOTH APPROACH WITHDRAWAL AND APPROACH 
AVOIDANCE RESPONSES IN RATS. 

182117 02-04 

CLINICAL PHARMACOLOGY AS AN APPROACH TO THE STUDY OF 
BIOCHEMICAL SLEEP MECHANISMS: THE ACTION OF L-DOPA. 

186643 03-14 
INTERACTION BETWEEN NEUROLEPTIC THERAPY AND SOCIOTHERAPEUTIC 
APPROACH. AN INVESTIGATION WITH PENFLURIDOL AND 
HALOPERIDOL. „ „„ 

192431 04-08 

APPROACHES 

BIOCHEMICAL AND PHARMACOLOGICAL APPROACHES IN THE STUDY OF 
SYMPATHETIC NERVES. (UNPUBLISHED PAPER). 

170082 01-03 

NEW APPROACHES TO CONSCIOUSNESS. 

178064 02-12 

APPROXIMATE 

THERAPEUTIC APPROACH TO THE APPROXIMATE ANSWERS OF A 
SCHIZOPHRENIC PATIENT. 

170637 01-08 

APY-606 

EXPERIENCE IN THE APPLICATION OF DICEPLON CAPY-606) - COMPARED 
WITH FLOROPIPAMIDE. 

1 76447 02-08 

CLINICAL APPLICATION OF APY-606. 

176541 02-08 

ARCHITECTONICS 

THE ACTION OF NEMBUTAL ON THE ULTRA ARCHITECTONICS OF THE 
NEUROHYPOPHYSIS. 

183520 03-01 

ARGENTINA 

A COMPARISON OF CLINICALLY USED PSYCHOACTIVE DRUGS IN FOUR 
LATIN-AMERICAN COUNTRIES AND IN CANADA (ARGENTINA, COSTA- 
RICA, MEXICO AND PANAMA). 

191139 04-17 

AROMATIC 

STIMULATION OF BRAIN AROMATIC ALKYLAMINE N- 

METHYLTRANSFERASE ACTIVITY BY FAD AND METHYLCOBALAMIN. 

180020 02-03 

AROUSAL 

ONTOGENY OF SEROTONINERGIC INHIBITION OF BEHAVIORAL AROUSAL 

IN THE RAT. 

174860 01-04 

ARRHYTHMIAS 

FAILURE OF BETA-ADRENERGIC RECEPTOR BLOCKADE TO PREVENT 
ARRHYTHMIAS INDUCED BY SYMPATHETIC NERVE STIMULATION. 

187923 04-03 

ARTERIAL 

DIAZEPAM AND MEPERIDINE ON ARTERIAL BLOOD GASES IN HEALTHY 
VOLUNTEERS. 

190147 04-13 
EFFECT OF ANESTHETIC AGENTS ON PERIPHERAL SYMPATHETIC NERVOUS 
SYSTEM FUNCTION AS MONITORED BY ARTERIAL PLASMA 
CATECHOLAMINE LEVELS. (UNPUBLISHED PAPER 

191495 04-03 

ARTERIOSCLEROSIS 

TREATMENT OF THE CEREBRAL MANIFESTATIONS OF ARTERIOSCLEROSIS 
WITH CYCLANDELATE. 

185008 03-11 

ARTISTIC 

HALLUCINOGENIC DRUGS AND ARTISTIC CREATIVITY. 

186026 03-12 

ASAHIGAWA 

CURRENT SITUATION OF THE USE OF DRUGS IN ASAHIGAWA JIDO-IN. 

168302 01-17 

ASCENDING 

ENHANCEMENT OF AMPHETAMINE ACTION AFTER INTERRUPTION OF 
ASCENDING SEROTONERGIC PATHWAYS. 

189398 04-03 

INFLUENCE OF PHENOBARBITAL AND SEX HORMONES ON ENZYMES IN 
ASCORBIC ACID BIOSYNTHESIS IN MALE AND FEMALE RATS. (PH.D. 
DISSERTATION). 

172017 01-03 

ASPIRIN 

RELIEF OF MUSCULOSKELETAL AND ASSOCIATED PSYCHOPATHOLOGICAL 
SYMPTOMS WITH MEPR08AMATE AND ASPIRIN: A CONTROLLED 
STUDY. 

169632 01-10 

ASSAY 

SIMULTANEOUS MASS FRAGMENTOGRAPHIC ASSAY OF NOREPINEPHRINE 
(NE) EPINEPHRINE (E) AND DOPAMINE (DA) IN RAT SYMPATHETIC 
GANGLION: EFFECTS OF DEXAMETHASONE IN NEWBORN AND ADULT 
RATS. (UNPUBLISHED PAPER). 

170747 01-03 



STUDY ON THE PSYCHOPHARMACOLOGICAL ASSAY OF CENTRALLY 
ACTING DRUGS IN RATS. 

171260 01-06 
AMPHETAMINE IN HUMAN PLASMA: A SENSITIVE AND SPECIFIC 
ENZYMATIC ASSAY. 

177403 02-16 
CLINICAL ASSAY OF LORAZEPAM WITH AMBULANT PATIENTS. 

183201 03-11 
ASSAY PROCEDURES FOR THIORIDAZINE, TRIFLUOPERAZINE, AND THEIR 
SULFOXIDES AND DETERMINATION OF URINARY EXCRETION OF THESE 
COMPOUNDS IN MENTAL PATIENTS. 

183602 03-01 

ASSESSED 

SOME RECENT HYPNOTICS ASSESSED. 

189673 04-14 

ASSESSING 

PROGRESS REPORT ON THE USE OF THE DOG FOR ASSESSING MORPHINE- 
LIKE AND NALORPHINE-LIKE AGONISTS AS WELL AS DEPOT 
PREPARATIONS OF ANTAGONISTS. (UNPUBLISHED PAPER). 

176312 02-03 

ASSESSMENT 

A COLLABORATIVE ASSESSMENT OF NOREPINEPHRINE METABOLISM IN 

AFFECTIVE DISORDERS. 

169094 01-09 

ASSESSMENT OF ANATENSOL (FLUPHENAZINE ENANTHATE) INJECTABLE 
IN THE TREATMENT OF SCHIZOPHRENIA. 

172444 01-08 
A CRITICAL ASSESSMENT OF METHODS FOR THE DETERMINATION OF 
MONOAMINE SYNTHESIS AND TURNOVER RATES IN VIVO. 

191514 04-06 
COMPREHENSIVE BEHAVIORAL ASSESSMENT OF THE EFFECTS OF DELTA9- 
TETRAHYDROCANNABINOL IN RATS. 

191966 04-04 

ASSESSMENTS 

LABORATORY ASSESSMENTS OF ANTIDEPRESSIVE ACTIVITY - THEIR 
VALUE FOR CLINICAL PSYCHIATRY AND THE UNDERSTANDING OF 
DEPRESSION. 

192422 04-09 

ASSOCIATE 

THE EFFECT OF TRANYLCYPROMINE (PARNATE) ON EYELID CONDITIONING 
AND PAIRED ASSOCIATE LEARNING IN DEPRESSED PATIENTS. 

188107 04-09 

ASSOCIATION 

PARKINSONIAN SYNDROMES: TREATMENT BY ASSOCIATION OF L-DOPA 
PLUS DECARBOXYLASE INHIBITOR. 

188093 04-11 

IN VIVO CHANGES OF CEREBRAL CYCLIC ADENOSINE 3,5 

MONOPHOSPHATE INDUCED BY BIOGENIC AMINES: ASSOCIATION 
WITH PHOSPHORYLASE ACTIVATION. 

188291 04-03 

ASSOCIATIVE 

ROLE OF ASSOCIATIVE LEARNING IN FEEDING BEHAVIOR. 

178044 02-17 

THE EFFECTS OF PENTYLENETETRAZOL (METRAZOL) ON A LEARNED 
TASTE AVERSION PRODUCED BY LITHIUM CHLORIDE: THE ISSUE OF 
ASSOCIATIVE MEMORY VS. RETENTIVE MEMORY. (UNPUBLISHED 

''^''''- 188251 04-04 

ATOMIC 

DIRECT DETERMINATION OF LITHIUM IN SERUM BY ATOMIC 
ABSORPTION SPECTROSCOPY. 

181653 02-06 

ATP 

(3H) OUABAIN BINDING TO NA_-ATPASE AND K_-ATPASE: INHIBITION BY 
BETA, GAMMA METHYLENE ATP. 

182184 02-03 

DDT EFFECT ON 32P INCORPORATION FROM GAMMA-LABELLED ATP 
INTO PROTEINS FROM LOBSTER NERVE. 

191315 04-03 

ATPASE 

THE EFFECTS OF PSYCHIC STIMULANTS ON THE ACTIVITY OF POTASSIUM 
AND SODIUM ION STIMULATED ATPASE IN THE MICROSOMAL 
FRACTIONS OF THE BRAIN OF RATS. 

183518 03-01 

OUABAIN RECEPTOR INTERACTIONS IN (NA_ . K. ) ATPASE 

PREPARATIONS. 

189567 04-0; 

AMPHETAMINE AND NA_,K. - ATPASE IN THE BRAIN. 

191789 04-C; 

ATRIA 

EFFECT OF SUBSTITUTED TRYPTAMINES ON THE EFFLUX OF 

NORADRENALINE FROM ADRENERGIC NERVES IN RABBIT ATRIA. 

168747 Ol-O: 

ATROPINE 

EFFECTS OF ATROPINE ON EXPLORATION, LEARNING AND 
ELECTROCORTICAL ACTIVITY IN THE DEVELOPING RAT. 

169473 01-0' 



S-26 



DLUME 12, SUBJECT INDEX 



Subject Index 



INTERACTION BETWEEN ATROPINE AND OXOTREMORINE ON CORTICAL 
ACETYLCHOLINE AND MOTOR ACTIVITY. 

171606 01-03 
TREATMENT OF HALLUCINATORY DISORDERS IN SCHIZOPHRENIA BY 
ATROPINE COMAS. 

181778 02-08 
ACUTE EFFECTS OF ALCOHOL, DIAZEPAM, THIORIDAZINE, FLUPENTHIXOL 
AND ATROPINE ON PSYCHOMOTOR PERFORMANCE PROFILES. 

184848 03-14 
EFFECTS OF CLONIDINE AND SOME ALPHA-ADRENORECEPTOR BLOCKING 
AGENTS ON AVOIDANCE CONDITIONED REFLEXES IN RATS: THEIR 
INTERACTIONS AND ANTAGONISM BY ATROPINE. 

186576 03-04 
ACTIONS OF ATROPINE, HEMICHOLINIUM-3, AND PHYSOSTIGMINE ON 
CHLORPROMAZINE INDUCED CHANGES IN RAT BRAIN MONOAMINES. 

187800 04-03 
EFFECT OF ATROPINE SULFATE ON THE SLEEP RELATED EEG SPIKE 
ACTIVITY OF THE TORTOISE, GEOCHELONECARBONARIA. 

191389 04-03 
TACHED 
THE EFFECT OF CANNABINOIDS ON THE NUMBER OF NUCLEAR 
MEMBRANE ATTACHED RIBOSOMES IN INFANT RAT BRAIN. 

183228 03-03 
TACK 
EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON ATTACK ELICITED BY 
HYPOTHALAMIC STIMULATION: RELATION TO BRAIN BIOGENIC 
AMINES. 

170162 01-04 
CENTRAL CHOLINERGIC (MUSCARINIC) LINK IN THE ATTACK REFLEXIVE 
BITING MECHANISM OF CATS. 

182238 03-04 
ATTACK ON THE GATE THEORY OF PAIN. 

189610 04-17 
TENTION 
EFFECTS OF (-)DELTA9TRANS-TETRAHYDR0CANNABIN0L (DELTA9-THC) 
ON MEMORY, ATTENTION AND SUBJECTIVE STATE: A DOUBLE-BLIND 
STUDY. 

174043 01-14 
ACQUISITION AND PERFORMANCE OF AN ATTENTION TASK BY RATS 
SUBJECTED TO CHRONIC NICOTINE TREATMENT. 

176864 0204 
NEUROPSYCHOPHARMACOLOGICAL STUDIES OF ATTENTION. 

181402 02-04 
EFFECTS OF TWO LEVELS OF ATTENTION DEMAND ON VIGILANCE 
PERFORMANCE UNDER MARIHUANA. 

189359 04-14 
THE EFFECTS OF HOE-36801 ON MUSCLE ACTIVITY AND BLOOD 
PRESSURE, ON ATTENTION AND CONCENTRATION, ON TIME 
JUDGMENT AND SUBJECTIVE RESPONSES IN NEUROTICS AND 
NORMALS. 

192429 04-14 
TENUATED 

KETAMINE INDUCED POSTANESTHETIC DELIRIUM ATTENUATED BY 
TETRAHYDROAMINOACRIDINE. 

188689 04-05 
TENUATION 

ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN 

DIMETHYLAMINOPROPYLTHIOCINNAMANILIDE HYDROCHLORIDE), A 
SEROTONIN ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN {5-HTP) AND ALPHA-METHYLTRYPTAMINE. 

176861 02-04 
ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN, A SEROTONIN 
ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN AND ALPHA-METHYLTRYPTAMINE. 

176873 02-04 
HALLUCINOGENIC DRUG-INDUCED BEHAVIOR UNDER SENSORY 
ATTENUATION: PREDICTION OF RESPONSE TO PSILOCYBIN. 

189744 04- 12 
TITUDES 

PSYCHOLOGICAL STUDY ON ATTITUDES TOWARD TRANQUILIZERS. 

173502 01-08 
POPULAR ATTITUDES AND BELIEFS ABOUT TRANQUILIZERS. 

177699 021 7 
7RIBUTABLE 

THE CORRECTIVE EFFECT OF PRAXINOR ON HYPOTENSION ATTRIBUTABLE 
TO PSYCHIATRIC THERAPY. SIDE-EFFECTS. 

172980 01-1 1 
JDIOGENIC 

EFFECT OF D-AMPHETAMINE SULFATE ON SUSCEPTIBILITY TO 
AUDIOGENIC SEIZURES IN DBA/2J MICE. 

184235 03-03 
JDITORY 

PHENOTHIAZINE DOSAGE LEVELS AND AUDITORY SIGNAL DETECTION IN 
SCHIZOPHRENIA. 

167817 01-08 
EFFECTS OF LSD ON AUDITORY PERCEPTION: A SIGNAL DETECTION 
ANALYSIS. 

185752 03-04 



AUTISM 

ORAL 5-HTP IN PRIMARY AUTISM WITH 5-HT BINDING DEFECT. 

181392 02-13 
AUTOCRITICISM 

AUTOCRITICISM AND REAL PLACE OF THE SAME MEDICATION (VESPRIN). 

184964 03-11 
AUTOMATIC 

A RAPID AUTOMATIC METHOD FOR DETERMINING SHOCK SENSITIVITIES 
OF MICE 

171521 01-04 
AUTOAAATIC RECORDING OF ANIMAL BEHAVIOR AND ITS ANALYSIS. 

182106 0217 
AUTOMATIC DETERMINATION OF THE PAIN THRESHOLD TO 
ELECTROSHOCK AND THE EFFECTS OF DELTA9-THC. 

183363 03-03 
AUTOMOBILE 

EFFECTS OF CAFFEINE ON ALERTNESS IN SIMULATED AUTOMOBILE 
DRIVING. 

190743 04-14 
AUTONOMIC 

THE EFFECT OF LITHIUM AND OTHER ANTIDEPRESSANT MEDICATIONS ON 
THE AUTONOMIC NERVOUS SYSTEM. 

169635 01-15 
CENTRAL NERVOUS SYSTEM AND AUTONOMIC NERVOUS SYSTEM 

EFFECTS OF AMANTADINE AND OF SOME STANDARD ANTIPARKINSON 
DRUGS. 

177729 02-13 
WORD RECOGNITION OF SCHIZOPHRENICS AS A FUNCTION OF 
PHENOTHIAZINE LEVEL AND AUTONOMIC RESPONSIVITY (PH.D. 
DISSERTATION). 

182524 03-08 
ROLE OF THE CENTRAL AUTONOMIC NERVOUS SYSTEM IN THE 
HYPOTENSION AND BRADYCARDIA INDUCED BY (-) DELTA9- 
TETRAHYDROCANNABINOL. 

183795 03-03 
AUTOPSY 

AN AUTOPSY CASE OF SCHIZOPHRENIA COMPLICATED WITH 
PARKINSONISM INDUCED BY PERPHENAZINE. 

171275 01-15 
DETERMINATION OF DOXEPIN IN AUTOPSY MATERIAL. 

172398 01-16 
AUTORADIOGRAPHIC 

EVIDENCE FOR AN UNUSUAL DISTRIBUTION OF CHLORPHENTERMINE IN 
VIVO: AN AUTORADIOGRAPHIC STUDY IN MICE. 

184226 03-03 
AVERAGE 

COMPARABLE THERAPEUTIC EFFICACY OF TRYPTOPHAN AND 
IMIPRAMINE: AVERAGE THERAPEUTIC RATINGS VERSUS TRUE 
EQUIVALENCE. AN IMPORTANT DIFFERENCE. 

167344 01 09 
AVERAGE EVOKED RESPONSES IN NORMAL AND MINIMALLY BRAIN 
DYSFUNCTIONED CHILDREN TREATED WITH AMPHETAMINE: A 
PRELIMINARY REPORT. 

169861 01-11 
POLYMYALGIA RHEUMATICA IN A GERIATRIC DEPARTMENT: NINE 
PATIENTS WITH AN AVERAGE AGE OF 83 YEARS. 

187236 03-11 
AVERSION 

AN OBSESSIVE NEUROSIS FOLLOWING MORNING-GLORY SEED INGESTION 
TREATED BY AVERSION RELIEF. 

184259 03-15 
HIPPOCAMPAL LESIONS AND LEARNED TASTE AVERSION. 

184834 03-04 
PREDATION: SEPARATION OF AGGRESSIVE AND HUNGER MOTIVATION 
BY CONDITIONED AVERSION. 

185463 03-04 
MODULATION OF REWARD AND AVERSION PROCESSES IN THE RAT 
DIENCEPHALON BY AMPHETAMINE. 

186164 03-04 
THE EFFECTS OF PENTYLENETETRAZOL (METRAZOL) ON A LEARNED 
TASTE AVERSION PRODUCED BY LITHIUM CHLORIDE: THE ISSUE OF 
ASSOCIATIVE MEMORY VS. RETENTIVE MEMORY. (UNPUBLISHED 
PAPER). 

188251 04-04 
METRAZOL DISRUPTS CONDITIONED AVERSION PRODUCED BY LICL: A 
TIME DEPENDENT EFFECT. 

188412 04-04 
AVERSIONS 

FLAVOR AVERSIONS PRODUCED BY CONTINGENT DRUG INJECTION: 
RELATIVE EFFECTIVENESS OF APOMORPHINE, EMETINE, AND LITHIUM. 

1 78502 0204 
BACKWARD CONDITIONING OF TASTE AVERSIONS IN RATS USING 
CYCLOPHOSPHAMIDE AS THE US. 

190265 04-04 
AVERSIVE 

NALORPHINE AS AN AVERSIVE AGENT. (PH.D. DISSERTATION). 

185727 03-04 



;i: t 



!■" :l 



S-27 



Subject Index 

AVIAN 

LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND GAMMA-AMINOBUTYRIC 
ACID (GABA) INTERACTION ON SPONTANEOUS POTENTIALS AND THE 
EVOKED RESPONSE IN THE AVIAN TECTUM. 

169689 0) -03 

AVOIDANCE 

ACQUISITION AND RETENTION OF AVOIDANCE BEHAVIORS FOLLOWING 
SEPTAL LESIONS OR SCOPOLAMINE INJECTIONS IN RATS. 

167401 01-04 
EFFECT OF PRENATAL MATERNAL ADMINISTRATION OF D-AMPHET AMINE 
ON RAT OFFSPRING ACTIVITY AND PASSIVE AVOIDANCE LEARNING. 

167415 01-03 
THE EFFECTS OF AGENTS THAT MODIFY MUSCARINIC TONE UPON 
BEHAVIOR CONTROLLED BY AN AVOIDANCE SCHEDULE THAT 
EMPLOYS SIGNALED UNAVOIDABLE SHOCK. 

171302 01-04 
MULTITRIAL PASSIVE AVOIDANCE IN RATS: MESCALINE, SHOCK, AND ITI 
EFFECTS. (PH.D. DISSERTATION). 

173162 01-04 
THE EFFECTS OF INTRACAUDATE INJECTIONS OF CHLORPROMAZINE ON 
CONDITIONED AVOIDANCE AND SELF-STIMULATION BEHAVIOR. (PH.D. 
DISSERTATION). 

173749 01-04 
THE EFFECT OF DOPAMINE ANTAGONISTS AND AMANTADINE ON THE 
ACQUISITION OF THE CONDITIONED AVOIDANCE RESPONSE IN RATS 

174829 01-04 
THE EFFECT OF PHASE-SHIFT ON THE PASSIVE AVOIDANCE RESPONSE IN 

RATS, AND THE MODIFYING EFFECT OF CHLORDIAZEPOXIDE. 

174830 01-04 
EFFECTS OF INTRAPERITONEAL AND INTRAVENTRICULAR D- 

AMPHET AMINE ADMINISTRATION ON ACTIVE AVOIDANCE 
PERFORMANCE IN THE RAT. 

175242 02-04 

EFFECTS OF STIMULUS ASSOCIATED WITH AMOBARBITAL 
ADMINISTRATION ON AVOIDANCE BEHAVIOR. 

175877 02-04 
POSTTRIAL STRYCHNINE: LACK OF EFFECT ON CONDITIONED AVOIDANCE 

LEARNING. 

176866 02-04 

AN ANALYSIS OF D-AMPHETAMINE PRODUCED FACILITATION OF 
AVOIDANCE ACQUISITION IN RATS AND PERFORMANCE CHANGES 
SUBSEQUENT TO DRUG TERMINATION. 

179990 02-04 

AVOIDANCE OF ADVERSE REACTIONS. 

180247 02-15 
INCREASED GASTRIC ACID DURING SHOCK AVOIDANCE IN MAN. 

181879 02-13 
EFFECTS OF PSYCHOTROPIC DRUGS ON DISCRIMINATION AVOIDANCE 
CONDITIONING IN RATS WITH OLFACTORY BULB ABLATIONS. 

1821)5 02-04 
EFFECTS OF CONSECUTIVE ADMINISTRATION OF DIAZEPAM AND 
DOXEPIN ON BOTH APPROACH WITHDRAWAL AND APPROACH 
AVOIDANCE RESPONSES IN RATS. 

182117 02-04 
INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC), 
CAFFEINE, (C), NICOTINE (N), PHENOBARBITAL (P): EFFECTS ON 
CONDITIONED AVOIDANCE (CAR). 

182192 02-04 

THE EFFECT OF PSYCHOTROPIC AGENTS ON THE FORMATION OF 
AVOIDANCE REACTION IN ALBINO RATS DURING ELECTROPAIN 
STIMULATION OF ANOTHER RAT. 

183206 03-04 
FAILURE OF ACTH TO INFLUENCE AVOIDANCE EXTINCTION IN A ONE- 
WAY AVOIDANCE SITUATION. 

183470 03-04 

EFFECTS OF NEONATAL STRYCHNINE ADMINISTRATION ON ACTIVE 
AVOIDANCE IN RATS. 

184242 03-04 

SEIZURE SUSCEPTIBILITY AND AVOIDANCE CONDITIONING IN ADULT 
RATS TREATED PRENATALLY WITH CHLORPROMAZINE. 

184371 03-04 
THE EFFECTS OF CHLORPROMAZINE ON A REDEFINED PROCEDURE OF 
EXTINCTION OF SIDMAN AVOIDANCE BEHAVIOR (PH.D. 
DISSERTATION) 

185715 03-14 

CHLORPROMAZINE AND AVOIDANCE: A GENETIC ANALYSIS. 

)8575) 03-03 
PHARMACOLOGICAL DISTINCTIONS BETWEEN ACTIVE AND PASSIVE 
AVOIDANCE MEMORY FORMATION AS SHOWN BY MANIPULATION OF 
BIOGENIC AMINE ACTIVE COMPOUNDS. 

) 85927 03-04 
EFFECTS OF CLONIDINE AND SOME ALPHA-ADRENORECEPTOR BLOCKING 
AGENTS ON AVOIDANCE CONDITIONED REFLEXES IN RATS: THEIR 
INTERACTIONS AND ANTAGONISM BY ATROPINE. 

186576 03-04 
THE EFFECT OF IPRONIAZID AND TRANYLCYPROMINE STUDIED WITH A 
DARK AVOIDANCE CONDITIONED SCHEDULE. 

) 86590 03-04 



Psychopharmacology Abstracts 



THE EFFECT OF AMANTADINE, L-DOPA, {.) AMPHETAMINE AND 
APOMORPHINE ON THE ACQUISITION OF THE CONDITIONED 
AVOIDANCE RESPONSE. 

) 86636 03-04 

STRUCTURE-ACTIVITY RELATIONS OF SOME INDOLEALKYLAMINES IN 
COMPARISON TO PHENETHYLAMINES ON MOTOR ACTIVITY AND 
ACQUISITION OF AVOIDANCE BEHAVIOR. 

)86703 03-0i! 
INFLUENCE OF ALPHA-METHYLTYROSINE ON ENHANCEMENT OF 
SHUTTLEBOX AVOIDANCE BY MARIJUANA AND PENTOBARBITAL. 

) 87572 04-0^ 
LOCALIZED BEHAVIORAL EFFECTS OF VASOPRESSIN ON MAINTENANCE 
OF AN ACTIVE AVOIDANCE RESPONSE IN RATS. 

) 87697 04-0' 
INTERACTION AMONG GENOTYPE, UNCONDITIONED STIMULUS, D- 
AMPHETAMINE, AND ONE-WAY AVOIDANCE BEHAVIOR OF RATS. 

) 87702 04-0- 
EFFECTS OF CYCLOHEXIMIDE ON ACQUISITION AND RETENTION OF 
AVOIDANCE LEARNING IN THE RAT: RECOVERY OF MEMORY. 

) 892) 5 04-0- 
THE EFFECTS OF D-AMPHETAMINE ON THE INTERRESPONSE TIMES OF 
RATS AND GUINEA-PIGS ON A MODIFIED SIDMAN DISCRIMINATED 
AVOIDANCE SCHEDULE. 

)89519 04-0 
AN ANALYSIS OF THE FACILITATION OF AVOIDANCE ACQUISITION BY D- 
AMPHETAMINE AND SCOPOLAMINE. 

189521 04-0 
MESCALINE FACILITATES RETENTION OF PASSIVE AVOIDANCE IN RATS. 

190266 04-0 
EFFECTS OF NICOTINE AND ITS WITHDRAWAL ON THE PERFORMANCE 01 
RATS ON SIGNALLED AND UNSIGNALLED AVOIDANCE SCHEDULES. 

19033) 04-0 
EFFECTS OF NICOTINE ON THE OBSERVED BEHAVIOUR OF RATS DURING 
SIGNALLED AND UNSIGNALLED AVOIDANCE EXPERIMENTS. 

) 90332 04-0 
INTERACTION OF MESCALINE AND STRESS ON SHUTTLEBOX 
ESCAPE/AVOIDANCE IN RATS. 

) 9) 934 04-0 
INTERACTIONS BETWEEN R0-4-)284 AND D-AMPHETAMINE (DA) ON 
SHUTTLEBOX AVOIDANCE IN RATS. 

) 92009 04-0 
EFFECTS OF DELTA) -TETRAHYDROCANNABINOL ON SIDMAN 
DISCRIMINATED AVOIDANCE BEHAVIOR IN RATS. 

)924)3 04-C 

AXON 

NONCHOLINERGIC MECHANISM OF ACTION OF CHOLINERGIC DRUGS ON 
SQUID AXON MEMBRANES. 

) 86672 03-C 

AXOPLASMIC 

INCREASED AXOPLASMIC TRANSPORT OF H3-D0PAMINE IN NIGRO- 
NEOSTRIATAL NEURONS AFTER RESERPINE. 

)7524) 02-C 
EFFECT OF DRUGS UPON AXOPLASMIC TRANSPORT. 

) 82772 03-1 

AXOTOMY 

INFLUENCES OF DRUGS ON THE INCREASES IN BRAIN DOPAMINE 
PRODUCED BY AXOTOMY OF GAMMA-HYDROXYBUTYRIC ACID 
(GHBA). 

)71622 0)-( 

EFFECT OF ANESTHETIC AGENTS ON THE SYNTHESIS AND 

DISAPPEARANCE OF BRAIN DOPAMINE NORMALLY AND AFTER 
HALOPERIDOL, KCL OR AXOTOMY. 

)8957) 04-( 

AZAPHEN 

THE ABSORPTION AND DISTRIBUTION OF THE NEW ANTIDEPRESSANT 
AZAPHEN IN THE ORGANS. 

) 835) 9 03-1 

BABOONS 

THE COMPARATIVE EFFECTS OF PENTOBARBITAL AND D-AMPHETAMINE 
ON A SHORT-TERM MEMORY TASK IN BABOONS. 

)91917 04-1 

BACKWARD 

BACKWARD CONDITIONING OF TASTE AVERSIONS IN RATS USING 
CYCLOPHOSPHAMIDE AS THE US. 

190265 04-1 

BACTERIAL 

A BACTERIAL MODEL FOR EVALUATION OF BARBITURATES. 

191920 04- 

BALANCE 

NEGATIVE SODIUM BALANCE IN LITHIUM CARBONATE TOXICITY: 
EVIDENCE OF MINERALOCORTICOID BLOCKADE. 

169869 0)- 
BALANCE BETWEEN ACETYLCHOLINE, SEROTONIN, NOREPINEPHRINE, At 
DOPAMINE IN SELF-STIMULATION, 

) 9) 528 04- 

CHOLINERGIC AND ADRENERGIC BALANCE IN MANIA AND 
SCHIZOPHRENIA. 

) 9) 530 04- 



S-28 



VOLUME 12, SUBJECT INDEX 



Subject Index 



CLINICAL INTIMATIONS OF AMINE BALANCE AND PERMISSION. 

191534 04-09 
BALB 

DIFFERENTIAL EFFECTS OF ETHANOL AND PENTOBARBITAL ON SLEEP 
TIME IN C57BL AND BALB MICE. 

177733 02-03 
BAMETHAN 

TREATMENT OF CEREBROVASCULAR DISTURBANCES WITH 2- 

BUTYLAMINOl-P-HYDROXYPHENYL ETHANOL SULFATE (BAMETHAN). 

182790 03-11 
BAR-PRESS 

THE EFFECTS OF CHLORDIAZEPOXIDE, AMPHETAMINE AND COCAINE ON 
BAR-PRESS BEHAVIOR IN NORMAL AND GENETICALLY NERVOUS DOGS. 

187868 04-04 
BAR-PRESSING 

SENSORY CONTINGENT BAR-PRESSING FOR FAMILIAR AND NOVEL 
CHANGE UNDER A DEXAMPHETAMINE AMYLOBARBITONE MIXTURE. 

181605 02-04 
BARBITAL 

TOLERANCE TO HEXOBARBITAL AND SUPERSENSITIVITY TO PILOCARPINE 
INDUCED BY CHRONIC BARBITAL TREATMENT IN THE RAT. 

171601 01-03 
COMPARISON OF BARBITAL & PENTOBARBITAL PHYSICAL DEPENDENCE 
IN THE CAT. 

191953 04-04 
BARBITURATE 

SYNTHESIS OF ACETYLCHOLINE IN BRAIN NERVE TERMINALS DURING 
CONSCIOUSNESS AND BARBITURATE ANESTHESIA. 

171600 01-03 
BLOCKADE OF THE PROESTROUS LH SURGE IN CYCLIC RATS BY 
BARBITURATE ADMINISTRATION ON DIESTRUS. 

175650 02-03 
BARBITURATE DEPENDENCE IN MICE INDUCED BY A SIMPLE SHORT-TERM 
ORAL PROCEDURE. 

175895 02-03 
THE ELECTROENCEPHALOGRAPHIC CHANGES IN ACUTE BARBITURATE 
POISONING. 

180152 02-15 
POTENTIATION OF BARBITURATE HYPNOSIS BY 5-DIAZ0IMIDAZ0LE-4- 
CARBOXAMIDE AND ITS DERIVATIVES. 

182113 02-03 
PHARMACOLOGIC ACTIVITY AND BIOTRANSFORMATION OF R. AND S- 
BARBITURATE ENANTIOMERS IN MOUSE AND MAN. 

182156 02-03 
MECHANISMS UNDERLYING POTENTIATION OF BARBITURATE ACTION BY 
SODIUM NITRITE IN THE MOUSE: THE ROLE OF METHEMOGLOBIN 
INDUCED HYPOXIA. 

182721 03-03 
PGO WAVES IN THE LATERAL GENICULATE NUCLEUS TRIGGERED BY 
BARBITURATE. 

187835 04-03 
TURNOVER OF HISTAMINE IN RAT BRAIN AND ITS DECREASE UNDER 
BARBITURATE ANESTHESIA. 

189396 04-03 
ABSENCE OF REM REBOUND AFTER BARBITURATE WITHDRAWAL. 

189884 04-14 
BARBITURATES 

TURNOVER CHANGES IN CENTRAL MONOAMINE NEURON SYSTEMS 
AFTER MINOR TRANQUILLIZERS AND BARBITURATES. 

171604 01-03 
ARE THERE SAFER HYPNOTICS THAN BARBITURATES? 

174561 01-15 
ACUTE LETHALITY FOR MICE FOLLOWING ADMINISTRATION OF 
CYCLOPHOSPHAMIDE WITH BARBITURATES. 

177834 02-05 
UPTAKE AND RELEASE OF NORADRENALINE IN RAT CEREBRAL CORTEX IN 
VITRO: NO EFFECT OF BENZODIAZEPINES AND BARBITURATES. 

182347 03-03 
CALCIUM REVERSAL OF NERVE BLOCKADE BY ALCOHOLS, ANESTHETICS, 
TRANQUILIZERS, AND BARBITURATES. 

187802 04-03 
THE IMPULSE BLOCKING CONCENTRATIONS OF ANESTHETICS, ALCOHOLS, 

ANTICONVULSANTS, BARBITURATES, AND NARCOTICS ON PHRENIC 
AND SCIATIC NERVES. 

187803 04-03 
BENZODIAZEPINES AND BARBITURATES: TURNOVER CHANGES IN 

CENTRAL 5-HYDROXYTRYPTAMINE PATHWAYS. 

189611 04-03 
A BACTERIAL MODEL FOR EVALUATION OF BARBITURATES. 

191920 04-03 
BARBITURIC 

THE SITE OF ACTION ON THE OPTICAL ISOMERS OF l-METHYL-5-PHENYL- 
5-PROPYL BARBITURIC ACID. 

185901 03-03 
BARRIER 

ANIMAL MODELS FOR AN ENZYMIC BLOOD-BRAIN BARRIER MECHANISM 
FOR THERAPEUTICALLY ADMINISTERED L-DOPA. 

167359 01-03 



THE DEVELOPMENT OF A BLOOD-BRAIN BARRIER TO METHADONE IN THE 
NEWBORN RAT. * 

182165 02-03 
TRUE AND APPARENT NON-PENETRATION OF THE BLOOD-BRAIN BARRIER 
BY PSYCHOTROPIC DRUGS. 

192423 04-03 
BASAL 

ANTIPSYCHOTIC ACTION OF NEUROLEPTIC AGENTS AND THE FUNCTION 
OF BASAL GANGLIA (SURVEY OF LITERATURE). 

183521 03-17 
BASE 

POTENTIAL INHIBITORS OF S-ADENOSYLMETHIONINE DEPENDENT 

METHYLTRANSFERASES. 2. MODIFICATION OF THE BASE PORTION OF 
S-ADENOSYLHOMOCYSTEINE. 

190717 04-01 
BASELINE 

THE CONDITIONED EMOTIONAL RESPONSE (CER) AS A BASELINE FOR THE 
STUDY OF ANTIANXIETY DRUGS. 

1 83862 03-04 
BATRACHOTOXIN 

THE INHIBITION OF 3H-D0PAMINE UPTAKE INTO RAT STRIATAL BY 
VERATRIDINE AND BATRACHOTOXIN. (UNPUBLISHED PAPER). 

173380 01-03 
BDP 

PROTECTION PRODUCED BY BENZODIAZEPINES (BDP) AGAINST THE 
NEUROTOXIC AND CONFLICT BEHAVIOR EFFECTS OF 
HEXACHLOROPHENE (HCP) IN CATS. 

1 76863 02-04 
BED-WETTING 

DRUGS FOR BED-WETTING. 

189778 04-11 
BEHAVIOR 

OPERANT BEHAVIOR AND NEUROPHYSIOLOGICAL OBSERVATIONS OF 
NORMAL HUMAN VOLUNTEERS RECEIVING CL-1848C, A NEW 
DISSOCIATIVE ANESTHETIC. 

167334 01-07 
EFFECTS OF ACUTE AND CHRONIC ADMINISTRATION OF CANNABIS- 
SATIVA EXTRACT ON THE MOUSE-KILLING BEHAVIOR OF RATS. 

167362 01-04 
THE EFFECTS OF D- AND L-AMPHETAMINE ON FIXED-INTERVAL AND 
FIXED-RATIO BEHAVIOR IN TOLERANT AND NONTOLERANT RATS. 

168438 01-04 
STIMULATION OF BEHAVIOR IN THE RAT BY CYCLAZOCINE: EFFECTS OF 

NALOXONE. 

168439 01-04 
EFFECTS OF IMIPRAMINE ON COPULATORY BEHAVIOR OF MALE RATS. 

168718 01-04 
THE SOCIAL PLAY BEHAVIOR OF CHIMPANZEES ACCORDING TO A 
PSYCHOPHARMACOLOGICAL TEST/. 

168838 01-04 
THE RELATIONSHIP OF MARIHUANA AND SOCIAL BEHAVIOR. 

169084 01-13 
THE EFFECTS OF AGENTS THAT MODIFY MUSCARINIC TONE UPON 
BEHAVIOR CONTROLLED BY AN AVOIDANCE SCHEDULE THAT 
EMPLOYS SIGNALED UNAVOIDABLE SHOCK. 

171302 01-04 
IMPORTANCE OF CATECHOLAMINE RELEASE BY NERVE IMPULSES FOR 
FREE OPERANT BEHAVIOR. 

171611 01-04 
CHANGE OF ESTROGEN ACTIVATED BEHAVIOR BY CYCLOHEXIMIDE IN 
THE FEMALE RAT. 

171615 01-04 
ACTIVATION OF COPULATORY BEHAVIOR BY PILOCARPINE AND 
OXOTREMORINE IN THE FEMALE RAT, 

17161601-04 
A DIFFERENTIAL INHIBITORY ACTION OF LSD AND AMPHETAMINE ON 
COPULATORY BEHAVIOR IN THE FEMALE RAT. 

171617 01-04 
THE ROLE OF THE SEPTAL AREA OF THE BRAIN IN THE INHIBITORY 
MODULATION OF BEHAVIOR. (PH.D. DISSERTATION), 

172021 01-03 
ALTERATION OF MATERNAL BEHAVIOR IN MICE FOLLOWING 
ADMINISTRATION OF CYPROTERONE ACETATE, 

172374 01-04 
MODIFICATION OF STIMULATION BOUND BEHAVIOR BY 
TRIFLUOPERAZINE AND AMPHETAMINE IN RATS, (PH.D. 
DISSERTATION). 

173158 01-04 
BEHAVIOR AND SENSITIVITY TO EXPERIMENTAL HYPERTENSION: II LACK 
OF CORRELATION BETWEEN CERTAIN BEHAVIOR PATTERNS AND 
HYPERTENSION IN TWO NEW STRAINS OF RATS. 

173256 01-04 
THE EFFECTS OF INTRACAUDATE INJECTIONS OF CHLORPROMAZINE ON 
CONDITIONED AVOIDANCE AND SELF-STIMULATION BEHAVIOR, (PH.D. 
DISSERTATION). 

173749 01-04 



!i 1 



S-29 



Subject Index 

THE EFFECTS OF MESCALINE ADMINISTERED BEFORE OR DURING 
EMBRYOGENESIS UPON THE HATCHABiLITY AND BEHAVIOR OF THE 
CHICK. (PH.D. DISSERTATION). 

173791 01-04 
THE EFFECTS OF PHENITRONE, A REPORTED HASHISH ANTAGONIST, ON 
THE OVERT BEHAVIOR OF CATS. 

174607 01-04 
PHARMACOLOGICAL SUPPRESSION OF EATING BEHAVIOR IN RELATION 
TO DIENCEPHALIC NORADRENERGIC RECEPTORS. 

174763 01-04 
MARIHUANA AND SOCIAL BEHAVIOR. 

175003 02-14 
EFFECTS OF PSYCHOACTIVE DRUGS ON NONVERBAL COMMUNICATION 
AND GROUP SOCIAL BEHAVIOR OF MONKEYS. 

175317 02-04 
EFFECTS OF STIMULUS ASSOCIATED WITH AMOBARBITAL 
ADMINISTRATION ON AVOIDANCE BEHAVIOR. 

175877 02-04 
VOCALIZATION: A CHARACTERISTIC CANNABIS INDUCED BEHAVIOR IN 
THE RAT? 

175884 02-04 

ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN 

DIMETHYLAMINOPROPYLTHIOCINNAMANILIDE HYDROCHLORIDE), A 
SEROTONIN ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN {5-HTP) AND ALPHA-METHYLTRYPTAMINE. 

176861 02-04 
PROTECTION PRODUCED BY BENZODIAZEPINES (BOP) AGAINST THE 
NEUROTOXIC AND CONFLICT BEHAVIOR EFFECTS OF 
HEXACHLOROPHENE (HCP) IN CATS. 

176863 02-04 
EFFECTS OF AMPHETAMINE (A), LSD, PSILOCYBIN (P), AND DOM ON 
SCHEDULE-CONTROLLED BEHAVIOR IN THE RAT. 

1 76869 02-04 
ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN, A SEROTONIN 
ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN AND ALPHA-METHYLTRYPTAMINE. 

176873 02-04 
STEREOTYPED AND AGGRESSIVE BEHAVIOR INDUCED BY SUSTAINED 
HIGH DOSE OF THEOPHYLLINE IN RATS. 

177019 02-04 
FURTHER ASPECTS OF AGGRESSIVE BEHAVIOR INDUCED BY SUSTAINED 

HIGH DOSE OF THEOPHYLLINE IN RATS. 

177020 02-04 
NOREPINEPHRINE SENSITIVE ADENYLATE CYCLASES IN RAT BRAIN: 

RELATION TO BEHAVIOR AND TYROSINE HYDROXYLASE. 

177252 02-03 
THE THALAMIC RAT: GENERAL BEHAVIOR, OPERANT LEARNING WITH 
REWARDING HYPOTHALAMIC STIMULATION, AND EFFECTS OF 
AMPHETAMINE. 

177477 02-04 
THE EFFECTS OF CHLORDIAZEPOXIDE (LIBRIUM) ON THE INTENSITY AND 
HABITUATION OF AGONISTIC BEHAVIOR IN MALE SIAMESE FIGHTING 
FISH. 

177722 02-04 

EFFECTS OF CHLORPROMAZINE, CHLORDIAZEPOXIDE AND 

PENTOBARBITAL ON NEURONAL EXCITABILITY IN THE MEDIAL 
FOREBRAIN BUNDLE DURING SELF-STIMULATION BEHAVIOR. 

177837 02-04 
ROLE OF ASSOCIATIVE LEARNING IN FEEDING BEHAVIOR. 

178044 02-17 
THE EFFECTS OF EARLY P-CHLOROPHENYLALANINE ADMINISTRATION 
AND POSTWEANING HOUSING CONDITIONS ON SEROTONIN AND 
BEHAVIOR IN RATS. 

1 78638 02-04 
ANTICHOLINERGICS: THEIR EFFECTS ON FEAR MOTIVATED BEHAVIOR, 
URINARY 11-HYDROXYCORTICOSTEROIDS, URINARY VOLUME, AND 
HEART RATE IN THE DOG. 

178720 02-03 
OPEN-FIELD BEHAVIOR AND ACQUISITION OF DISCRIMINATIVE RESPONSE 
CONTROL IN DELTA9-THC TOLERANT RATS. 

178813 02-04 
COMPARISON OF CLOPENTHIXOL AND PERPHENAZINE IN BEHAVIOR AND 
EEG OF UNANESTHETIZED CATS. 

181386 02-04 
DRUGS ON EEG CORRELATES OF BEHAVIOR. 

181396 02-04 
BASIC TYPES OF EFFECTS OF DRUGS ON BEHAVIOR. 

181399 02-04 
EFFECTS OF PSYCHOPHARMACOLOGIC AGENTS ON BEHAVIOR. 

181403 02-04 
DETERMINANTS OF DRUG EFFECTS ON PUNISHED BEHAVIOR. 

181405 02-04 
AUTOMATIC RECORDING OF ANIMAL BEHAVIOR AND ITS ANALYSIS. 

182106 02-17 
EFFECTS OF CNS STIMULANTS ON OPERANT BEHAVIOR 

182110 02-04 
EFFECTS OF CYPROHEPTADINE ON THE EATING BEHAVIOR OF RATS AND 

CATS. 

182111 02-04 



Psychopharmacology Abstracts 



EFFECTS OF PSYCHOTROPIC DRUGS ON ABNORMAL BEHAVIOR INDUCED 
BY DELTA9-TETRAHYDR0CANNABIN0L. 

182114 0204 
DISPOSITION OF NORAPOMORPHINE AND N,N PROPYLNORAPOMORPHINE 
IN MOUSE BRAIN AND ITS CORRELATION WITH STEREOTYPED 
GNAWING BEHAVIOR. 

182131 02-04 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON THE DOMINANCE 
BEHAVIOR OF THE RAT. 

182189 02-04 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L AND METHYSERGIDE ON 

DEFENSIVE BEHAVIOR IN RATS. 

182190 0204 
DIFFERENTIAL SELF-INJECTION BEHAVIOR PRODUCED BY FENFLURAMINE 

VERSUS OTHER APPETITE INHIBITING DRUGS. 

182215 03-04 
DRUGS, BEHAVIOR AND CHOLINE ACETYLTRANSFERASE. 

182237 03-04 
THE USE OF BIOCHEMICAL CORRELATES FOR THE PREDICTION OF 
MURICIDAL BEHAVIOR IN THE WILD RAT. 

182241 03-04 
EFFECTS OF PHENOTHIAZINES, ANTIHISTAMINES, BENZODIAZEPINES AND 
BUTYROPHENONES ON ELECTROENCEPHALOGRAM AND FEEDING 
BEHAVIOR OF RATS. 

182554 03-04 
THE EFFECT OF PAIN RELIEVING DRUGS ADMINISTERED DURING LABOR 
AND DELIVERY ON THE BEHAVIOR OF THE NEWBORN: A REVIEW. 

183706 03-17 
REDUCTION IN COPULATORY BEHAVIOR OF MALE RATS FOLLOWING 
HASHISH INJECTIONS. 

183790 03-04 
MODIFICATION OF THE EFFECTS OF CHLORPROMAZINE ON BEHAVIOR IN 
THE CHIMPANZEE. 

183889 03-04 
BEHAVIOR AS A STIMULUS: JOINT EFFECTS OF D-AMPHETAMINE AND 

PENTOBARBITAL. 

183890 03-04 
DIAZEPAM-INDUCED PLAY BEHAVIOR IN CATS DURING PREY KILLING. 

184979 03-04 
AN INVESTIGATION OF INTERACTIONS AMONG LSD, 

DEXTROAMPHETAMINE, AND VERBAL BEHAVIOR IN MONOLOGUES 
AND DIALOGUES. (PH.D. DISSERTATION). 

185600 03-14 
EFFECTS OF CONCURRENT BEHAVIOR MODIFICATION AND 

CHLORPROMAZINE ADMINISTRATION IN MENTALLY RETARDED 
WOMEN. (PH.D. DISSERTATION). 

185604 03-14 
NEURAL AND CHEMICAL MECHANISMS OF FEMALE SEXUAL BEHAVIOR IN 
THE RAT. (PH.D. DISSERTATION). 

185705 03-04 
THE EFFECTS OF CHLORPROMAZINE ON A REDEFINED PROCEDURE OF 
EXTINCTION OF SIDMAN AVOIDANCE BEHAVIOR. (PH.D. 
DISSERTATION). 

185715 03-14 
TESTS OF EMOTIONAL BEHAVIOR IN RATS FOLLOWING DEPLETION OF 
NOREPINEPHRINE, OF SEROTONIN, OR OF BOTH. 

185753 03-04 
DOSE DEPENDENT SELECTIVE FACILITATION OF RESPONSE CONTINGENT 
LIGHT ONSET BEHAVIOR BY D-AMPHETAMINE. 

185955 03-04 
BRAIN AMINES AND APOMORPHINE-INDUCED INTRASPECIFIC 
AGGRESSIVE BEHAVIOR IN THE RAT. 

186374 03-04 
ADAPTATION TO NITROGEN NARCOSIS MANIFESTED BY TIMING 
BEHAVIOR IN THE RAT. 

186630 03-04 

LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 
ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 
COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25, AN IN 
INTACT MALE RATS. 

1 86683 03-04 

EFFECTS OF AN ESTROGEN ANTAGONIST, MER-25, ON MOUNTING 
BEHAVIOR AND LORDOSIS BEHAVIOR IN THE FEMALE RAT. 

186691 03-04 
TRYPTAMINE ANTAGONISTS AND PUNISHED BEHAVIOR. 

186692 03-04 
STRUCTURE-ACTIVITY RELATIONS OF SOME INDOLEALKYLAMINES IN 

COMPARISON TO PHENETHYLAMINES ON MOTOR ACTIVITY AND 
ACQUISITION OF AVOIDANCE BEHAVIOR. 

1 86703 03-04 
A DETAILED ANALYSIS OF THE EFFECTS OF D-AMPHETAMINE ON 
BEHAVIOR UNDER FIXED-INTERVAL SCHEDULES. 

187066 03-04 
BEHAVIOR AND EEG ANALYSIS OF CHRONIC AMPHETAMINE EFFECT. 

187116 03-13 
PROPRANOLOL AND BEHAVIOR OF ALCOHOL ADDICTS AFTER ACUTE 
ALCOHOL INGESTION. 

187257 04-14 



S-30 



VOLUME 12, SUBJECT INDEX 



Subject Index 



EFFECTS OF LOCUS-COERULEUS STIMULATION ON HIPPOCAMPAL UNIT 
ACTIVITY AND ON BEHAVIOR IN UNRESTRAINED RATS. (UNPUBLISHED 
PAPER). 

187499 04-04 
EFFECTS OF (-) DELTA9-TRANS-TETRAHYDR0CANNABIN0L ON SOCIAL 
BEHAVIOR OF SQUIRREL MONKEY DYADS IN A WATER COMPETITION 
SITUATION. 

187640 04-04 
EFFECTS OF APOMORPHINE ON SELF-STIMULATION BEHAVIOR. 

187666 04-04 
AMPHETAMINE AND OPERANT BEHAVIOR IN RATS: RELATIONSHIP 
BETWEEN DRUG EFFECT AND CONTROL RESPONSE RATE. 

187699 04-04 
INTERACTION AMONG GENOTYPE, UNCONDITIONED STIMULUS, D- 
AMPHET AMINE, AND ONE-WAY AVOIDANCE BEHAVIOR OF RATS. 

187702 04-04 
THE EFFECTS OF CHLORDIAZEPOXIDE, AMPHETAMINE AND COCAINE ON 
BAR-PRESS BEHAVIOR IN NORMAL AND GENETICALLY NERVOUS DOGS. 

187868 04-04 
EFFECTS OF LSD AND MONOAMINE SYNTHESIS INHIBITORS ON 

HORMONE ACTIVATED COPULATORY BEHAVIOR IN THE FEMALE RAT. 

188611 04-04 
PROPRANOLOL ANTAGONISM OF MORPHINE INFLUENCED BEHAVIOR. 

188760 04-04 
DELTA9-TETRAHYDR0CANNABIN0L AND AGGRESSIVE BEHAVIOR IN 
RATS. 

189525 04-04 
HALLUCINOGENIC DRUG-INDUCED BEHAVIOR UNDER SENSORY 
ATTENUATION: PREDICTION OF RESPONSE TO PSILOCYBIN. 

189744 04-12 
DIAZEPAM ON DEMAND: DRUG SEEKING BEHAVIOR IN PSYCHIATRIC 
INPATIENTS. 

189924 04-17 
THE CONTROL OF DEVIANT SEXUAL BEHAVIOR BY DRUGS: A DOUBLE- 
BLIND CONTROLLED STUDY OF BENPERIDOL, CHLORPROMAZINE, AND 
PLACEBO. 

190061 04-11 
EFFECTS OF NICOTINE ON THE SHUTTLEBOX BEHAVIOR OF TRAINED 
GUINEA-PIGS. 

190333 04-04 
PSYCHOTROPIC EFFECT OF ANALGESICS AND NEUROLEPTICS ON A 
MODEL OF INVESTIGATORY BEHAVIOR CHANGED BY PAIN. 

191120 04-04 
PSYCHOENDOCRINE INVESTIGATION IN SCHIZOPHRENIA: RELATIONSHIP 
BETWEEN PITUITARY GONADAL FUNCTION AND BEHAVIOR. 

191190 04-14 
DRUG-INDUCED STEREOTYPED BEHAVIOR: SIMILARITIES AND 
DIFFERENCES. 

191504 04-04 
THE EFFECTS OF COMT INHIBITORS ON BEHAVIOR AND DOPAMINE 
METABOLISM. 

191517 04-03 
ROLE OF ACETYLCHOLINE AND DOPAMINE IN MANIC BEHAVIOR. 

191532 04-09 
NEUROCHEMICAL ANALYSIS OF AGGRESSIVE - DEFENSIVE BEHAVIOR 
ELICITED BY ELECTRICAL STIMULATION OF THE HYPOTHALAMUS AND 
CENTRAL GRAY MATTER. 

191784 04-02 
EFFECT OF PREGESTATIONAL MORPHINE ADMINISTRATION TO MICE ON 
BEHAVIOR OF THEIR OFFSPRING. 

191902 04-04 
CORRELATION BETWEEN BRAIN N,N DIMETHYLTRYPT AMINE (DMT) 
LEVELS AND BAR PRESSING BEHAVIOR IN RATS: EFFECT OF MAO 
INHIBITION. 

191935 04-04 
DISCRIMINATIVE CONTROL OF BEHAVIOR BY ELECTRICAL STIMULATION 
OF THE DORSAL RAPHE NUCLEUS: GENERALIZATION TO LYSERGIC 
ACID DIETHYLAMIDE (LSD). 

191944 04-04 
COMPARATIVE EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9- 
THC), CANNABIDIOL (CBD), AND CANNABINOL (CBN) ON TIMING 
BEHAVIOR IN RATS. 

191967 04-04 
EFFECTS OF PHENCYCLIDINE AND KETAMINE ON FOOD MAINTAINED 
BEHAVIOR IN THE PIGEON. 

191973 04-04 
EFFECTS OF CHLORPROMAZINE (CPZ) AND THIORIDAZINE PERFORMANCE 

AND STIMULUS CONTROL BEHAVIOR. 

191974 0404 
EFFECTS OF MORPHINE SULFATE ON POSITIVELY AND NEGATIVELY 

REINFORCED BEHAVIOR IN TWO STRAINS OF RATS. 

191975 04-04 
COMPARATIVE EFFECTS OF SOME CNS ACTIVE DRUGS ON LEARNED AND 

UNLEARNED BEHAVIOR IN THE HAMSTER. 

191976 04-04 
EFFECTS OF CHRONIC METHYLPHENIDATE ADMINISTRATION ON 

LEARNING AND OFFSPRING BEHAVIOR. 

192116 04-04 



EFFECTS OF DELTAl -TETRAHYDROCANNABINOL ON SIDMAN 
DISCRIMINATED AVOIDANCE BEHAVIOR IN RATS. 

192413 04-03 
BEHAVIORAL 

BEHAVIORAL PHARMACOLOGY. 

168272 01-17 
BEHAVIORAL EFFECT OF TRICYCLIC THYMOLEPTICS AND 

CHLORPHENIRAMINE IN MICE AFTER PRETREATMENT WITH 5 
HYDROXYTRYPTOPHAN (5-HTP). 

171609 01-04 
HYDROXYLAMINE INTERFERES WITH THE BEHAVIORAL RESPONSE TO 
MORPHINE DEPENDENCE IN MICE. 

171905 01-04 
EFFECTS OF MOLINDONE ON CNS STRUCTURES: NEUROPHYSIOLOGICAL 
AND BEHAVIORAL CORRELATIONS. 

172749 01-03 
EFFECTS OF SCOPOLAMINE UPON BEHAVIORAL REACTIVITY AND 
VISUALLY EVOKED POTENTIAL TO FLASHES IN RATS. 

173032 01-04 
BEHAVIORAL PARAMETERS OF DRUG ACTION: SIGNALED AND RESPONSE 
INDEPENDENT REINFORCEMENT. 

174008 01-04 
P-CHLOROPHENYLALANINE INDUCED ALTERATIONS IN THE BEHAVIORAL 
EFFECTS OF 5-HYDROXYTRYPTOPHAN. 

174034 01-04 
BEHAVIORAL EFFECTS OF A NEW DOPAMINE-BETA-HYDROXYLASE 
INHIBITOR (FUSARIC ACID) IN MAN. (UNPUBLISHED PAPER 

174329 01-09 
BEHAVIORAL CHANGES AND AGGRESSIVITY EVOKED BY DRUGS IN MICE. 

174604 01-04 
BEHAVIORAL AND ELECTROENCEPHALOGRAPHIC STUDIES ON 
THIOSEMICARBAZIDE INDUCED SEIZURE IN RABBITS. 

174855 01-05 
ONTOGENY OF SEROTONINERGIC INHIBITION OF BEHAVIORAL AROUSAL 
IN THE RAT. 

174860 01-04 
PIMOZIDE IN THE TREATMENT OF BEHAVIORAL DISORDERS OF 
HOSPITALIZED ADOLESCENTS. 

176109 02-14 
REPEATED ACQUISITION OF BEHAVIORAL CHAINS UNDER CHRONIC DRUG 
CONDITIONS. 

1 77408 02-04 
EFFECTS OF LORAZEPAM ON CNS STRUCTURES: NEUROPHYSIOLOGICAL 
AND BEHAVIORAL CORRELATIONS. 

1 77749 02-03 
MOTHER INFANT SEPARATION: BEHAVIORAL ANALYSIS OF AN ANIMAL 
MODEL OF DEPRESSION. (PH.D. DISSERTATION). 

1 78867 02-04 
BEHAVIORAL EVIDENCE FOR DOPAMINERGIC SUPERSENSITIVITY AFTER 
CHRONIC HALOPERIDOL. 

180021 02-04 
BEHAVIORAL PHARMACOLOGY OF BROMAZEPAM (RO-5-3350), A NEW 
BENZODIAZEPINE DERIVATIVE. 

181384 02-04 
PROGRAM IN BEHAVIORAL PHARMACOLOGY. 

181394 02-14 
BEHAVIORAL EFFECTS OF DRUGS IN MACACA-MULATTA. 

181401 02-04 
MECHANISMS OF DRUG-INDUCED BEHAVIORAL TOLERANCE. 

181406 02-0/: 
INFLUENCES OF LITHIUM ON THE BEHAVIORAL ACTION OF 
METHAMPHETAMINE AND TETRABENAZINE. 

182109 02-04 
BEHAVIORAL PHARMACOLOGICAL STUDIES ON TRICYCLIC 
ANTIDEPRESSANTS IN RATS. 

182116 02-04 
BEHAVIORAL EFFECTS OF SIMULTANEOUS DEPLETION OF BRAIN 
NOREPINEPHRINE AND SEROTONIN. 

182211 03-04 
BEHAVIORAL EFFECTS OF EX-11-582A, A POTENTIAL ANTIPSYCHOTIC 
AGENT. 

182242 03-04 
BEHAVIORAL AND PHYSIOLOGICAL ACTIVITY OF DEAMINATED 
METABOLITES OF MESCALINE. 

182244 03-03 
BEHAVIORAL EFFECTS OF MORPHINE AND OPIOID ANTAGONISTS. 

182859 03-04 
BEHAVIORAL EFFECTS OF SEPARATE AND COMBINED ADMINISTRATION 
OF NALOXONE AND D-AMPHETAMINE. 

183892 03-04 
DELTA9-TETRAHYDR0CANNABIN0L AND 11-HYDR0XY-DELTA9- 

TETRAHYDROCANNABINOL: BEHAVIORAL EFFECTS AND TOLERANCE 
DEVELOPMENT. 

183893 03-04 
TOLERANCE TO THE BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF 

HALOPERIDOL AND MORPHINE IN RATS CHRONICALLY TREATED WITH 
MORPHINE OR HALOPERIDOL. 

184225 03-03 



S-31 



Subject Index 



Psychopharmacology Abstracts 



LEAD INDUCED BEHAVIORAL DYSFUNCTION: AN ANIMAL MODEL OF 

"^^^^^^^'^'^^ ,84953 03-04 

REDUCED BEHAVIORAL EFFECTS OF PILOCARPINE DURING CHRONIC 

TREATMENT WITH DFP. ,85265 03-04 

DOSE EFFECTS OF METHYLPHENIDATE ON BEHAVIORAL INHIBITION AND 

ACTIVATION IN HYPERACTIVE CHILDREN. (PH.D. DISSERTATION). 

185676 03-14 
EFFECTS OF CHLORPROMAZINE AND THREE METABOLITES ON 

BEHAVIORAL RESPONSES IN RATS. ,85748 03-04 

BEHAVIORAL EFFECTS OF PROFADOL IN THE RAT. 

186373 03-04 
BEHAVIORAL AND VISUAL EVOKED POTENTIAL INVESTIGATIONS DURING 
TRIHEXYPHENIDYL AND THIOTHIXENE TREATMENT IN PSYCHOTIC 

ROYS 

187115 03-09 

A STUDY OF THE BEHAVIORAL DISRUPTION OF MICE INDUCED BY L- 
METHIONINE AND RELATED COMPOUNDS. 

187260 04-04 
ON THE BEHAVIORAL AND NEUROCHEMICAL ACTIONS OF 6- 
HYDROXYDOPA AND 5,6 DIHYDROXYTRYPTAMINE IN RATS. 

187380 04-03 
CARDIOVASCULAR AND GROSS BEHAVIORAL EFFECTS OF 

AMPHETAMINE, 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPROPANE 
(DOM) AND 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPHENYL BUTANE 
(BL-3912A) IN THE CONSCIOUS DOG. 

187573 04-03 
LOCALIZED BEHAVIORAL EFFECTS OF VASOPRESSIN ON MAINTENANCE 
OF AN ACTIVE AVOIDANCE RESPONSE IN RATS. 

187697 04-04 
BEHAVIORAL EFFECTS OF AMPHETAMINE IN RATS WITH LESIONS IN THE 

CORPUS-STRIATUM. 

187698 04-04 
COMPARATIVE EFFECTS OF SCOPOLAMINE AND AMPHETAMINE UPON 

BEHAVIORAL REACTIVITY AND VISUAL EVOKED POTENTIALS TO 
FLASHES IN RATS. 

187700 04-04 
A NEW PROLONGED ACTING TYPE OF CHLORPROMAZINE: BEHAVIORAL 
EFFECTS AND PROLONGED ACTIONS ON NERVE MEMBRANES. 

187805 04-01 
THE EFFECT OF PRETREATMENT WITH IPRONIAZID ON THE BEHAVIORAL 
ACTIVITIES OF BETA-PHENYLETHYLAMINE IN RATS. 

187932 04-04 
BIOCHEMICAL AND BEHAVIORAL ANTAGONISM BETWEEN 
FENFLURAMINE AND APOMORPHINE IN RATS. 

188196 04-03 
BEHAVIORAL AND ELECTROCORTICOGRAPHIC DOSE-RESPONSE 
RELATIONSHIPS WITH METRAZOL. (UNPUBLISHED PAPER). 

188248 04-04 
THE EFFECT OF BUTYLATED HYDROXYANISOLE AND BUTYLATED 
HYDROXYTOLUENE ON BEHAVIORAL DEVELOPMENT OF MICE. 

188637 04-04 

PARADOXICAL EFFECTS OF D-AMPHETAMINE ON BEHAVIORAL 
THERMOREGULATION: POSSIBLE MEDIATION BY BRAIN DOPAMINE. 

189399 04-04 
CRUDE MARIHUANA EXTRACT: EEG AND BEHAVIORAL EFFECTS OF 
CHRONIC ORAL ADMINISTRATION IN RHESUS MONKEYS. 

189516 04-04 
BEHAVIORAL AND EEG CHANGES IN THE AMPHETAMINE MODEL OF 

^^^^"°^'^ 191505 04-04 

RELATIONSHIP OF CATECHOLAMINE NEURAL SYSTEMS TO THE 
BEHAVIORAL ALTERATIONS PRODUCED BY 6-HYDROXYDOPAMINE 
ADMINISTRATION INTO BRAIN. 

191 51 o U4-UJ 

BEHAVIORAL EFFECTS OF DIRECT AND INDIRECT ACTING DOPAMINERGIC 

*^°^'^^^ ,91521 04-04 

BEHAVIORAL EFFECTS OF COCAINE COMPARED UNDER TWO SCHEDULES 
OF FOOD PRESENTATION IN THE SQUIRREL MONKEY. 

191916 04-04 

COMPREHENSIVE BEHAVIORAL ASSESSMENT OF THE EFFECTS OF DELTA9- 

TETRAHYDROCANNABINOL IN RATS. „ „ „, 

191966 04-04 

INTERACTION OF SEROTONIN ANTAGONISTS WITH 3.4-DICHLORO-2-(2- 
IMIDAZOLIN-2-YL-THIO) 2 ACETOPHENONE HYDROBROMIDE (DITA) 
AND D-AMPHETAMINE HYDROBROMIDE (DITA) AND D-AMPHETAMINE 
ON CERTAIN BEHAVIORAL PARAMETERS OF MALE MICE. 

192014 04-04 
DIFFERENTIAL INCREASE OF BEHAVIORAL AND EXTRAPYRAMIDAL 
STIMULATING ACTIONS OF NEUROLEPTICS BY ALPHA- 
METHYLTYROSINE PRETREATMENT IN RATS. 

192016 04-04 

BEHAVIORAllY ^. ,^, 

SAFETY AND EFFECTIVENESS OF HALOPERIDOL FOR MENTALLY 

RETARDED BEHAVIORALLY DISORDERED AND HYPERKINETIC PATIENTS. 

169634 01-11 



INTERACTION OF THE BEHAVIORALLY ACTIVE DRUG, PHENITRONE, A 
PURPORTED HASHISH AND LSD ANTAGONIST. WITH SEVERAL 
CENTRAL NEUROCHEMICAL SYSTEMS. 

,82217 03-04 

BEHAVIORS 

ACQUISITION AND RETENTION OF AVOIDANCE BEHAVIORS FOLLOWING 
SEPTAL LESIONS OR SCOPOLAMINE INJECTIONS IN RATS. 

167401 01-04 
PSYCHOTROPIC DRUGS AND PHENOTYPICAL BEHAVIORS. 

,8,407 02-05 
BRAIN MECHANISMS UNDERLYING THE EFFECTS OF AMPHETAMINE ON 
FEEDING AND NONFEEDING BEHAVIORS: DISSOCIATION AND OVERLAP. 

,84839 03-03 
THE EFFECTS ON INGESTIVE BEHAVIORS OF DAMAGE TO CENTRAL 
DOPAMINE CONTAINING NEURONS. 

191520 04-04 

BEHAVIOUR 

THE EFFECTS OF SCOPOLAMINE ON FIXED-INTERVAL BEHAVIOUR IN THE 
RAT: A RATE-DEPENDENCY EFFECT. 

168833 0,-04 

INHIBITION OF MOUSE-KILLING BEHAVIOUR IN RATS BY SOME 

THYMOLEPTIC DRUGS. ,,,^„^ „, „_, 

,7,608 0,-04 

EFFECTS OF TETRABENAZINE ON LORDOSIS BEHAVIOUR AND ON BRAIN 

MONOAMINES IN THE FEMALE RAT. 

,716,4 0,-04 

HYPERKINETIC, HYPOSCHOLASTIC BEHAVIOUR AND CHARACTER 
DISORDERS OF CHILDHOOD AND ADOLESCENCE: DIAGNOSIS AND 
PHARMACOTHERAPY. , ,^„^„ „, , , 

172800 0,-,, 

DRINKING BEHAVIOUR AND BRAIN DOPAMINE: ANTAGONISTIC EFFECT 
OF TWO NEUROLEPTIC DRUGS (PIMOZIDE AND SPIRAMIDE) UPON 
AMPHETAMINE OR APOMORPHINE-INDUCED HYPODIPSIA. 

,74035 0,-04 

EFFECTS OF ANTIDEPRESSANT AGENTS ON OPEN-FIELD BEHAVIOUR IN 

RATS 

,74038 01-04 

APOMORPHINE INDUCED BITING AND FIGHTING BEHAVIOUR IN 
RESERPINIZED RATS AND AN APPROACH TO THE MECHANISM OF 

*^™'- 174768 01-04 

POSSIBLE INVOLVEMENT OF A NORADRENERGIC AREA OF THE 

AMYGDALA WITH STEREOTYPED BEHAVIOUR. 

176877 02-04 
INHIBITORY EFFECT OF DOXEPIN ON AGONISTIC BEHAVIOUR ELICITED BY 

HYPOTHALAMIC STIMULATION IN THE CAT. 

STEREOTYPY WITH SELECTIVE STIMULATION OF CERTAIN ITEMS OF 
BEHAVIOUR OBSERVED IN AMPHETAMINE TREATED MONKEYS 

OXYPERTINE AND PRIMATE BEHAVIOUR. 

182762 03-04 

CATALEPSY AND STEREOTYPED BEHAVIOUR IN RATS TREATED 
CHRONICALLY WITH METHADONE: RELATION TO BRAIN 
HOMOVANILLIC ACID CONTENT. 

183606 03-04 

PARADOXICAL THERMOREGULATORY BEHAVIOUR IN RATS INDUCED BY 
( ) AMPHETAMINE: BLOCKADE BY ALPHA-ADRENOCEPTOR OR 
d'oPAMINE receptor BLOCKING AGENTS. 

183797 03-03 

THE EFFECT OF SULTHIAME ON DISTURBED BEHAVIOUR IN MENTALLY 
SUBNORMAL PATIENTS. ,85,9, 03-,4 

CONDITIONING OF AMPHETAMINE-INDUCED BEHAVIOUR IN THE ALBINO 

RAT 

,85954 03-04 

EFFECTS OF MORPHINE AND CHLORPROMAZINE ON APOMORPHINE- 
INDUCED STEREOTYPED BEHAVIOUR. ^ 

A COMPARISON OF EFFECTS OF APOMORPHINE AND ET-495 ON 
LOCOMOTOR ACTIVITY AND CIRCLING BEHAVIOUR IN MICE. 

loooo!) Uo"U4 

EFFECTS OF PHYSOSTIGMINE ON THE MAINTENANCE OF 
DISCRIMINATION BEHAVIOUR IN RATS. 

THE INFLUENCE OF 3-QUINUCLIDINYLBENZILATE ON THE BEHAVIOUR OF 

RATS IN A CIRCULAR RUNWAY. 

,87259 04-04 

TIME SAMPLING OF RAT EXPLORATORY BEHAVIOUR: A RELIABLE 
SCREENING TEST FOR THE CNS EFFECTS OF ANOREXIC AGENTS. 

,87925 04-W 
EFFECTS OF NICOTINE ON THE OBSERVED BEHAVIOUR OF RATS DURING 
SIGNALLED AND UNSIGNALLED AVOIDANCE EXPERIMENTS. 

,90332 04-0<! 

THE EFFECTS OF PSILOCYBIN ON EEG AND BEHAVIOUR IN MONKEYS. 

,92415 04-0^ 



S-32 



VOLUME 12, SUBJECT INDEX 



Subject Index 



THE EFFECT OF OCTOCLOTHEPIN AND PERPHENAZINE ON BEHAVIOUR IN 
RATS WITH DIFFERENT EXPLORATION AND DEFECATION RATES. 

192430 04-04 
BEHAVIOURAL 

BEHAVIOURAL STATE CYCLES IN ABNORMAL INFANTS. 

168523 01-14 
PHARMACOLOGICALLY INDUCED BEHAVIOURAL SUPERSENSITIVITY TO 
APOMORPHINE. 

169120 01-03 
INTERACTIVE EFFECTS OF CYCLOHEXIMIDE AND PUROMYCIN IN 
ALTERING BRAIN POLYRIBOSOMES AND NEURAL AND BEHAVIOURAL 
RESPONSES TO ELECTROSHOCK IN MICE. 

175230 02-03 
BEHAVIOURAL EFFECTS OF YOHIMBINE ADMINISTERED 
INTRAVENTRICULARLY IN THE RAT. 

177721 02-04 
BEHAVIOURAL EVALUATION OF PEPTIDES RELATED TO SCOTOPHOBIN. 

177836 02-04 
A SERIES OF MULTICENTRIC PILOT TRIALS WITH PIMOZIDE IN 
PSYCHIATRIC PRACTICE: II. PIMOZIDE IN THE TREATMENT OF 
BEHAVIOURAL DISORDERS IN CHILDHOOD AND ADOLESCENCE. 

183192 03-11 
BEHAVIOURAL AND BIOCHEMICAL EFFECTS OF 6-HYDROXYDOPA IN 
RATS. 

186571 03-04 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS; 
I. EFFECT ON THE BEHAVIOURAL CHANGES INDUCED BY RESERPINE, 
ALPHA-METHYL-P-TYROSINE OR AMPHETAMINE. 

186587 03-04 
BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 5,6 
DIHYDROXYTRYPTAMINE ADMINISTRATION INTO BRAIN. 

186634 03-04 
THE EFFECT OF SOME CHOLINOLYTIC DRUGS ON A NUMBER OF 

BEHAVIOURAL PARAMETERS MEASURED IN THE T-MAZE ALTERNATION 
TEST: DOSE-RESPONSE RELATIONSHIPS. 

187641 04-04 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 
DERIVATIVE SE-780 IN RATS. 

187926 04-04 
AN INVESTIGATION OF THE BEHAVIOURAL NATURE OF THE 
PSYCHOMOTOR STIMULANT EFFECT OF AMPHETAMINE. 

188620 04-04 
EFFECTS OF CHLORDIAZEPOXIDE ON HEART RATE AND BEHAVIOURAL 
SUPPRESSION IN PIGS SUBJECTED TO OPERANT CONDITIONING 
PROCEDURES. 

189409 04-04 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 
METABOLITE, NORFENFLURAMINE: AN EVALUATION OF ITS ROLE IN 
THE ACTIONS OF FENFLURAMINE. 

190335 04-04 
EFFECT OF CHRONIC TREATMENT WITH CENTRAL STIMULANTS ON BRAIN 
MONOAMINES AND SOME BEHAVIOURAL AND PHYSIOLOGICAL 
FUNCTIONS IN RATS, GUINEA-PIGS, AND RABBITS. 

191503 04-03 
BELIEFS 

POPULAR ATTITUDES AND BELIEFS ABOUT TRANQUILIZERS. 

177699 02-17 
BELLADONNA 

CAUDATE NUCLEUS EFFECTS ON GERIATRIC SENILITY: EFFECT OF 

BELLADONNA ON LEARNING AND MEMORY OF GERIATRIC PATIENTS. 

170744 01-11 
BEMEGRIDE 

SELECTIVE ANTAGONISM OF CENTRAL NERVOUS SYSTEM DEPRESSANTS 
BY DH-524, A COMPARATIVE STUDY WITH BEMEGRIDE. 

171007 01-13 
BENACTYZINE 

CHANGES IN SHORT-TERM AND LONG-TERM MEMORY OF DOGS AND 
CATS UNDER THE EFFECTS OF AMIZYL (BENACTYZINE). 

183517 03-04 
BENPERIDOL 

THE CONTROL OF DEVIANT SEXUAL BEHAVIOR BY DRUGS: A DOUBLE- 
BLIND CONTROLLED STUDY OF BENPERIDOL, CHLORPROMAZINE, AND 
PLACEBO. 

190061 04-11 
BENZALIN 

ISOLATION AND IDENTIFICATION OF HYPNOTICS (8): ISOLATION AND 
IDENTIFICATION OF BENZALIN AND CERCINE BY THIN-LAYER 
CHROMATOGRAPHY IN VITRO. 

182626 03-01 
BENZENE 

THE LACK OF EFFECTS OF PRETREATMENT WITH PHENOBARBITAL AND 
CHLORPROMAZINE ON THE ACUTE TOXICITY OF BENZENE IN RATS. 

189600 04-05 
BENZOATE 

LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 
ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 
COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25, AN IN 
INTACT MALE RATS, 

186683 03-04 



SUPPRESSION OF LORDOSIS IN GUINEA-PIGS BY ETHAMOXYTRIPHETOL 
(MER-25) GIVEN AT LONG INTERVALS (36-46 HR) AFTER ESTRADIOL 
BENZOATE TREATMENT. 

186686 03-04 
BENZOCT AMINE 

BENZOCTAMINE IN PSYCHIATRY: A 30-CASE STUDY. 

182901 03-11 
BENZODIAZEPIN-2-ONE5 

3-ONIUM DERIVATIVES OF 1,4 BENZODIAZEPIN-2-ONES WITH TERTIARY 
ORGANIC BASES. 

187942 04-01 
BENZODIAZEPINE 

CLINICAL EXPERIMENTATION WITH A NEW BENZODIAZEPINE IN THE 
MANAGEMENT OF PHOBIC AND OBSESSIVE SYMPTOMS. 

167594 01-10 
LORAZEPAM: CLINICAL TRIAL WITH A NEW BENZODIAZEPINE. 

169297 01-07 
METABOLITES OF BROMAZEPAM, A BENZODIAZEPINE, IN THE HUMAN, 
DOG, RAT, AND MOUSE 

170837 01-03 
ON THE ANTIANXIETY PROPERTIES OF A NEW BENZODIAZEPINE, ORF- 
8063. 

172485 01-10 
SIMULTANEOUS ANALYSIS OF A 1,5 BENZODIAZEPINE AND ITS 
METABOLITE IN BLOOD AND URINE BY SPECTRODENSITOMETRY. 

176871 02-16 
TRIAZOLAM: A SLEEP LABORATORY STUDY OF A NEW BENZODIAZEPINE 
HYPNOTIC. 

1 77747 02-07 
CHARACTERISTICS OF BENZODIAZEPINE TRANQUILIZERS. 

180307 02-17 
FIRST RESULTS OBTAINED WITH A NEW ANTICONVULSANT OF THE 
BENZODIAZEPINE SERIES (CLONAZEPAM). 

180672 02-11 
BEHAVIORAL PHARMACOLOGY OF BROMAZEPAM (RO-5-3350), A NEW 
BENZODIAZEPINE DERIVATIVE. 

181384 02-04 
CENTRAL NERVOUS ACTION OF BROMAZEPAM, A NEW BENZODIAZEPINE 
DERIVATIVE. 

181650 02-03 
CENTRAL NERVOUS ACTION OF FLURAZEPAM, A NEW BENZODIAZEPINE 
DERIVATIVE. 

182549 03-03 
CONTROL OF INSOMNIA WITH A NEW BENZODIAZEPINE: THE 

FLUNITRAZEPAM OR RO-5-4200 (FIRST INVESTIGATIONS OF PHASE I 
AND CONTROLLED INVESTIGATIONS OF PHASE II). 

183198 03-11 
THE EFFECT OF A NEW BENZODIAZEPINE DERIVATIVE NIMETAZEPAM ON 
THE SLEEP CYCLE IN MAN. 

188501 04-07 
INVESTIGATION OF PHYSICAL DEPENDENCE ON A NEW BENZODIAZEPINE 
DERIVATIVE, BROMAZEPAM. 

189209 04-05 
INFLUENCE OF PH ON THE BENZODIAZEPINE HUMAN SERUM ALBUMIN 
COMPLEX: CIRCULAR DICHROISM STUDIES. 

189595 04-13 
BENZODIAZEPINES 

SHOULD WE PUT BENZODIAZEPINES IN OUR DRINKING WATER 

168361 01-17 
PROTECTION PRODUCED BY BENZODIAZEPINES (BDP) AGAINST THE 
NEUROTOXIC AND CONFLICT BEHAVIOR EFFECTS OF 
HEXACHLORGPHENE (HCP) IN CATS. 

1 76863 02-04 
GAS CHROMATOGRAPHIC ANALYSIS OF BENZODIAZEPINES. PART I: 
MEDAZEPAM AND ITS METABOLITES 

1 78948 02-06 
REGIONAL CYCLIC NUCLEOTIDES PHOSPHODIESTERASE ACTIVITY IN CAT 
CENTRAL NERVOUS SYSTEM: EFFECTS OF BENZODIAZEPINES. 

181575 02-03 
EFFECTS OF BENZODIAZEPINES ON SPINAL REFLEXES IN CATS. 

182097 02-03 
PENTYLENETETRAZOL CONVULSIONS AND BRAIN CATECHOLAMINE 
TURNOVER RATE IN RATS AND MICE RECEIVING DIPHENYLHYDANTOIN 
OR BENZODIAZEPINES 

182344 03-03 
UPTAKE AND RELEASE OF NORADRENALINE IN RAT CEREBRAL CORTEX IN 
VITRO: NO EFFECT OF BENZODIAZEPINES AND BARBITURATES. 

182347 03-03 
EFFECTS OF PHENOTHIAZINES, ANTIHISTAMINES, BENZODIAZEPINES AND 
BUTYROPHENONES ON THE RHYTHMS OF WAKEFULNESS SLEEP CYCLE 
IN RATS. 

182553 03-04 
EFFECTS OF PHENOTHIAZINES, ANTIHISTAMINES, BENZODIAZEPINES AND 

BUTYROPHENONES ON ELECTROENCEPHALOGRAM AND FEEDING 
BEHAVIOR OF RATS 

182554 03-04 
RECENT DEVELOPMENTS IN THE PHARMACOLOGY OF THE 

BENZODIAZEPINES. 

182771 03-17 



S-33 



Subject Index 

BENZODIAZEPINES. 4.20XYAMIN0-5-PHENYLBENZ0DIAZEPINES. 

185032 03-01 
QUINAZOLINES AND 1,4 BENZ0DIAZEPINES.64.C0MPARIS0N OF THE 
STEREOCHEMISTRY OF DIAZEPAM WITH THAT OF CLOSE ANALOGS 
WITH MARGINAL BIOLOGICAL ACTIVITY. 

185034 03-01 
BENZODIAZEPINES AND BARBITURATES: TURNOVER CHANGES IN 
CENTRAL 5-HYDROXYTRYPTAMINE PATHWAYS. 

189611 04-03 
INFLUENCE OF NEUROLEPTICS AND BENZODIAZEPINES ON METABOLISM 
OF TRICYCLIC ANTIDEPRESSANTS IN MAN. 

191026 04-09 

BENZODIAZEPINOOXAZOLE 

STUDIES ON BENZODIAZEPINOOXAZOLES. III. REACTIONS AND 
REARRANGEMENTS OF BENZODIAZEPINOOXAZOLE DERIVATIVES. 

180487 02-01 
STUDIES ON BENZODIAZEPINOOXAZOLES. IV. THE FORMATION OF 

QUINOLONES BY THE RING CONTRACTION OF A 
BENZODIAZEPINOOXAZOLE DERIVATIVE. 

180488 02-01 
STUDIES ON BENZODIAZEPINOOXAZOLES. V. REACTIONS OF 

BENZODIAZEPINOOXAZOLE DERIVATIVES WITH ACETIC ANHYDRIDE. 

180489 02-01 
BENZODIAZEPINOOXAZOLES 

STUDIES ON BENZODIAZEPINOOXAZOLES. III. REACTIONS AND 
REARRANGEMENTS OF BENZODIAZEPINOOXAZOLE DERIVATIVES. 

180487 02-01 
STUDIES ON BENZODIAZEPINOOXAZOLES. IV. THE FORMATION OF 

QUINOLONES BY THE RING CONTRACTION OF A 
BENZODIAZEPINOOXAZOLE DERIVATIVE. 

180488 02-01 
STUDIES ON BENZODIAZEPINOOXAZOLES. V. REACTIONS OF 

BENZODIAZEPINOOXAZOLE DERIVATIVES WITH ACETIC ANHYDRIDE. 

180489 02-01 
STUDIES ON BENZODIAZEPINOOXAZOLES. VI. SYNTHESIS AND 

PHARMACOLOGY OF IIB-PYRIDYL AND IIB-THIENYL DERIVATIVES OF 
BENZODIAZEPINOOXAZOLES. 

180490 02-02 

BENZOIC 

A NOVEL SPASMOLYTIC AND CNS ACTIVE AGENT: 3-(2- 

BENZYLMETHYLAMINOETHYL) BENZOIC ACID METHYL ESTER 
HYDROCHLORIDE. 

184581 03-02 

BENZOQUINOLINES 

SYNTHETIC STUDIES LEADING TOWARD THE PREPARATION OF LINEAR 
BENZOQUINOLINES. (PH.D. DISSERTATION). 

180739 02-01 
BENZOTHIADIAZINES 

BINDING OF DIAZOXIDE AND OTHER BENZOTHIADIAZINES TO HUMAN 
ALBUMIN. 

179987 02-13 

BENZOXAZOLE 

SUBSTITUTED BENZOXAZOLE/BENZTHIAZOLE-2-THIONES: 

INTERRELATIONSHIP BETWEEN ANTICONVULSANT ACTIVITY AND 
INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT 
OXIDATIONS AND MONOAMINE OXIDASE. 

183601 03-03 

BENZTHIAZOlE-2-THIONES 

SUBSTITUTED BENZOXAZOLE/BENZTHIAZOLE-2-THIONES: 

INTERRELATIONSHIP BETWEEN ANTICONVULSANT ACTIVITY AND 
INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT 
OXIDATIONS AND MONOAMINE OXIDASE. 

183601 03-03 

BENZTROPINE 

BENZTROPINE PSYCHOSIS. 

168319 01-15 
EFFECT OF MORPHINE, HALOPERIDOL, APOMORPHINE AND BENZTROPINE 
ON DOPAMINE TURNOVER IN RAT CORPUS-STRIATUM: EVIDENCE 
SHOWING MORPHINE-INDUCED REDUCTION IN CNS DOPAMINERGIC 
ACTIVITY. 

182230 03-03 

BENZYLHYORAZINE 

SYNTHESIS AND SCREENING OF CYCLIC BENZYLHYORAZINE CONGENERS 
AS ANTIDEPRESSANTS. 

183600 03-01 

BEREAVED 

PSYCHOPHARMACOLOGICAL AGENTS FOR THE TERMINALLY ILL AND 

BEREAVED. 

188149 04-17 

BETA-ADRENERGIC 

TREATMENT OF ANXIETY NEUROSIS BY ALPHA-ADRENERGIC AND BETA- 
ADRENERGIC BLOCKING AGENTS. 

186780 03-10 

FAILURE OF BETA-ADRENERGIC RECEPTOR BLOCKADE TO PREVENT 
ARRHYTHMIAS INDUCED BY SYMPATHETIC NERVE STIMULATION. 

187923 04-03 
BETA-ADRENERGIC EFFECTS ON RAT MYOMETRIUM: ROLE OF CYCLIC 

AMP. 

188915 04-03 



Psychopharmacology Abstracts 



BETA-ADRENOCEPTOR 

THE INHIBITION BY BETA-ADRENOCEPTOR BLOCKING AGENTS OF 

CALCIUM UPTAKE INTO AND EFFLUX FROM ISOLATED SARCOPLASMIC 
VESICLES. 

184223 03-03 
THE ANTAGONISM BETWEEN CHOLINOMIMETIC AGONISTS AND BETA- 
ADRENOCEPTOR STIMULANTS: THE DIFFERENTIATION BETWEEN 
BETWEEN FUNCTIONAL AND METAFFINOID ANTAGONISM. 

191420 04-03 
BETA-BLOCKING 

BETA-BLOCKING AGENTS IN THE TREATMENT OF CATECHOLAMINE 
INDUCED SYMPTOMS IN MUSICIANS. 

192527 04-11 

BETA-DIKETONES 

EFFECT OF SELECTED BETA-DIKETONES ON LITHIUM FLUXES OF BOVINE 
RED BLOOD CELLS. 

171792 01-05 

BETA-HYDROXYMESCAUNE 

PHYSIOLOGICAL DISPOSITION OF BETA-PHENYLETHYLAMINE, 2,4,5 
TRIMETHOXYPHENYLETHYLAMINE, 2,3,4,5,6 

PENTAMETHOXYPHENYLETHYLAMINE AND BETA-HYDROXYMESCALINE 
IN RAT BRAIN, LIVER AND PLASMA. 

1 86706 03-03 

BETA-MEIANOCYTE 

INFLUENCE OF TETRACOSACTRIN (T) AND BETA-MELANOCYTE 

STIMULATING HORMONE (MSH) ON DEPRESSION OF THE SEGMENTAL 
REFLEX BY MORPHINE (MS). (UNPUBLISHED PAPER). 

183324 03-03 

BETA-PHENETHYLAMINES 

CACTUS ALKALOIDS: XVIII. PHENOLIC BETA-PHENETHYLAMINES FROM 
MAMMILLARIA-ELONGATA. 

192882 04-01 

BETA-PHENYl-GABA 

THE ACTION OF BETA-PHENYL-GABA DERIVATIVES ON NEURONES OF THE 
CAT CEREBRAL CORTEX. 

189750 04-03 

BETA-PHENYLETHYLAMINE 

BETA-PHENYLETHYLAMINE: A SPECIFIC SUBSTRATE FOR TYPE B 
MONOAMINE OXIDASE OF BRAIN. 

168437 01-03 

PHYSIOLOGICAL DISPOSITION OF BETA-PHENYLETHYLAMINE, 2,4,5 
TRIMETHOXYPHENYLETHYLAMINE, 2,3,4,5,6 

PENTAMETHOXYPHENYLETHYLAMINE AND BETA-HYDROXYMESCALINE 
IN RAT BRAIN, LIVER AND PLASMA 

186706 03-03 
THE EFFECT OF PRETREATMENT WITH IPRONIAZID ON THE BEHAVIORAL 
ACTIVITIES OF BETA-PHENYLETHYLAMINE IN RATS. 

187932 04-04 

BILIRUBIN 

NONSEDATING DOSAGES OF DIAZEPAM AND PHENOBARBITAL IN THE 
REDUCTION OF NEONATAL BILIRUBIN LEVELS. 

191607 04-17 

BINDING 

PLASMA BINDING OF IMIPRAMINE AND CLINICAL OUTCOME. 

172271 01-13 
BINDING OF DIAZOXIDE AND OTHER BENZOTHIADIAZINES TO HUMAN 
ALBUMIN. 

179987 02-13 

ORAL 5-HTP IN PRIMARY AUTISM WITH 5-HT BINDING DEFECT. 

181392 02-13 
INFLUENCE OF VARIOUS DRUGS ON THE BINDING OF CHLORPROMAZINE 
TO ERYTHROCYTES AND ALBUMIN. 

181470 02-03 

ON THE NATURE OF THE SEROTONIN BINDING AFTER LSD. 

182168 02-03 
(3H) OUABAIN BINDING TO NA.-ATPASE AND K.-ATPASE: INHIBITION BY 
BETA, GAMMA METHYLENE ATP. 

182184 02-03 

BINDING OF MORPHINE BY SERUM PROTEINS OF MORPHINE TREATED 

RABBITS. 

182187 02-03 

EVIDENCE FOR PERSISTENT RESERPINE BINDING TO AMINE STORAGE 

VESICLE MEMBRANES. 

182234 03-03 

ENHANCED BINDING OF CHLORPROMAZINE TO CHOLESTEROL DEPLETED 
SYNAPTOSOME FRACTIONS. 

187801 04-03 
PHYSIOCHEMICAL PROPERTIES, SOLUBILITY, AND PROTEIN BINDING OF 
DELTA9-TETRAHYDR0CANNABIN0L. (UNPUBLISHED PAPER). 

188256 04-01 

IN VITRO BINDING OF (4-14C) DIPHENYLHYDANTOIN TO RAT BRAIN 

MICROSOMES. 

1 88404 04-03 

THE NERVE IMPULSE BLOCKING ACTIONS OF TRANQUILIZERS AND THE 
BINDING OF NEUROLEPTICS TO SYNAPTOSOME MEMBRANES. 

189400 04-03 



S-34 



VOLUME 12, SUBJECT INDEX 



Subject Index 



MESCALINE INDUCED CHANGES OF BRAIN CORTEX RI80S0MES: EFFECT 
OF MESCALINE ON THE BINDING OF AMINOACYL TRANSFER 
RIBONUCLEIC ACID TO RIBOSOMES OF BRAIN TISSUE. 

189582 04-05 
PHYLOGENETIC DISTRIBUTION OF OPIATE RECEPTOR BINDING. 

190476 04-03 
SERUM TRYPTOPHAN BINDING IN CHLORPROMAZINE TREATED CHRONIC 
SCHIZOPHRENICS. 

191320 04-08 
BIOASSAY 

THE ORAL HYPNOTIC BIOASSAY OF HYDROXYZINE AND PENTOBARBITAL 
FOR NIGHTTIME SEDATION. 

177320 02-11 
BIOAVAILABILITY 

RELATIONSHIP BETWEEN BIOAVAILABILITY AND DISSOLUTION RATE OF 
OXAZEPAM. 

171630 01-16 
BIOCHEMICAL 

TOWARDS A BIOCHEMICAL TYPOLOGY OF DEPRESSION. 

169095 01-09 
BIOCHEMICAL AND PHARMACOLOGICAL APPROACHES IN THE STUDY OF 
SYMPATHETIC NERVES. (UNPUBLISHED PAPER). 

170082 01-03 
THE USE OF BIOCHEMICAL CORRELATES FOR THE PREDICTION OF 
MURICIDAL BEHAVIOR IN THE WILD RAT 

182241 03-04 
BEHAVIOURAL AND BIOCHEMICAL EFFECTS OF 6-HYDROXYDOPA IN 
RATS. 

186571 03-04 
BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 5,6 
DIHYDROXYTRYPTAMINE ADMINISTRATION INTO BRAIN. 

186634 03-04 
CLINICAL PHARMACOLOGY AS AN APPROACH TO THE STUDY OF 
BIOCHEMICAL SLEEP MECHANISMS: THE ACTION OF L-DOPA. 

186643 03-14 
IN APPRECIATION OF BASIC BIOCHEMICAL RESEARCH IN MENTAL 
HEALTH. (UNPUBLISHED PAPER). 

187488 04-17 
BIOCHEMICAL AND BEHAVIORAL ANTAGONISM BETWEEN 
FENFLURAMINE AND APOMORPHINE IN RATS. 

188196 04-03 
PHARMACOLOGICAL AND BIOCHEMICAL ACTIONS OF THE HEMOLYTIC 
AGENTS ACETYLPHENYLHYDRAZINE AND PHENYLHYDRAZINE ON 
MONOAMINE OXIDASE IN THE RAT. 

188769 04-03 
BIOCHEMISTRY 

BIOCHEMISTRY AND PSYCHIATRY WITH SPECIAL REFERENCE TO 
PSYCHOPHARMACOLOGY. 

189331 04-17 
BIOELECTRICAl 

CHANGES IN RHYTHMS OF BIOELECTRICAL ACTIVITY OF THE CEREBRAL 
CORTEX IN HUMANS UNDER THE INFLUENCE OF ETHYMISOL. 

191790 04-07 
BIOEQUIVALENCY 

BIOEQUIVALENCY OF GENERIC AND BRAND-NAMED CHLORPROMAZINE. 

187255 03-08 
BIOGENIC 

L-DOPA: EFFECT ON ETHANOL NARCOSIS AND BRAIN BIOGENIC AMINES 
IN MICE, 

169782 01-03 
EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON ATTACK ELICITED BY 
HYPOTHALAMIC STIMULATION: RELATION TO BRAIN BIOGENIC 
AMINES. 

170162 01-04 
MEASUREMENT OF BIOGENIC AMINES AT THE PICOGRAM LEVEL. 
(UNPUBLISHED LEVEL). 

173382 01-03 
BRAIN BIOGENIC AMINE DEPLETION AND MOOD. 

174994 02-14 
SIGNIFICANCE OF THE CENTRAL BIOGENIC AMINES FOR THE THRESHOLD 
IN ELECTRO AND PENTETRAZOLE SEIZURES. 

181469 02-03 
AMPHETAMINE-INDUCED ALTERATION OF BIOGENIC AMINES AND SELF- 
STIMULATION. 

182212 03-03 
THE INHIBITION OF (3H) BIOGENIC AMINE ACCUMULATION INTO RAT 
BRAIN TISSUE SLICES BY VARIOUS TRYPTAMINE DERIVATIVES. 

182723 03-03 
PHARMACOLOGICAL DISTINCTIONS BETWEEN ACTIVE AND PASSIVE 
AVOIDANCE MEMORY FORMATION AS SHOWN BY MANIPULATION OF 
BIOGENIC AMINE ACTIVE COMPOUNDS 

185927 03-04 
THE MONOAMINE OXIDASES OF BRAIN: SELECTIVE INHIBITION WITH 
DRUGS AND THE CONSEQUENCES FOR THE METABOLISM OF THE 
BIOGENIC AMINES. 

186668 03-03 
EFFECTS OF SOME METALLIC CATIONS ON CEREBRAL CORTICAL 
NEURONES AND THEIR INTERACTIONS WITH BIOGENIC AMINES. 

187806 04-03 



PLASMA AND CEREBROSPINAL FLUID PROBENECID CONCENTRATIONS AS 
RELATED TO ACCUMULATION OF ACIDIC BIOGENIC AMINE 
METABOLITES IN MAN. 

187933 04-13 
THE EFFECT OF HYPOTHERMIC DOSES OF 1-DELTA9- 

TETRAHYDROCANNABINOL ON BIOGENIC AMINE METABOLISM IN 
SELECTED PARTS OF THE RAT BRAIN. 

188231 04-03 
IN VIVO CHANGES OF CEREBRAL CYCLIC ADENOSINE 3,5 

MONOPHOSPHATE INDUCED BY BIOGENIC AMINES: ASSOCIATION 
WITH PHOSPHORYLASE ACTIVATION. 

188291 04-03 
INTRACEREBRAL INJECTION OF 6-HYDROXYDOPAMINE AND HYDROGEN 
PEROXIDE IN CATS: SPECIFIC AND NONSPECIFIC EFFECTS ON STRIATAL 
BIOGENIC AMINES. 

188426 04-03 
A STUDY OF BIOGENIC AMINE METABOLITES IN THE CEREBROSPINAL 
FLUID AND URINE OF MONKEYS WITH CHLORPROMAZINE INDUCED 
DYSKINESIA. 

189210 04-03 
EFFECT OF A BUTYROPHENONE DERIVATIVE, U-32802A, ON BRAIN 
BIOGENIC AMINES. 

1 89584 04-02 
DRUG-INDUCED AGGRESSION IN CHICKS: DIFFERENTIAL INVOLVEMENT 
OF BIOGENIC AMINES. 

191977 04-04 
BIOLOGICAL 

RADIOIMMUNOASSAY FOR LYSERGIDE (LSD) IN ILLICIT DRUGS AND 
BIOLOGICAL FLUIDS. 

170840 01-06 
DETERMINATION OF DRUG TRANSFER ACROSS BIOLOGICAL MEMBRANES: 
COMPARATIVE STUDY ON THE PASSAGE OF DRUGS INTO THE 
CENTRAL NERVOUS SYSTEM AND THEIR PLACENTAL TRANSFER AND 
FETAL LOCALIZATION IN THE PREGNANT RAT. (PH.D. DISSERTATION). 

172018 01-03 
THE BIOLOGICAL BASIS OF PSYCHOTICISM: A STUDY OF INDIVIDUAL 
DIFFERENCES IN RESPONSE TO DEXAMPHETAMINE. 

175219 02-13 
BIOLOGICAL INTERVENTIONS IN PSYCHOSES OF CHILDHOOD. 

175872 02-17 
QUINAZOLINES AND 1,4 BENZ0DIAZEPINES.64.C0MPARIS0N OF THE 
STEREOCHEMISTRY OF DIAZEPAM WITH THAT OF CLOSE ANALOGS 
WITH MARGINAL BIOLOGICAL ACTIVITY. 

185034 03-01 
VALIDITY OF SCREENING METHODS FOR DRUGS OF ABUSE IN 
BIOLOGICAL FLUIDS. II. HEROIN IN PLASMA AND SALIVA. 

187256 03-15 
BIOPOTENTIALS 

PREDICTION OF NEUROLEPTIC EFFECTS OF CI-686 BASED ON 
QUANTITATIVE PHARMACOELECTROENCEPHALOGRAPHY: DRUG 
PROFILES AND DOSE RESPONSE CURVES BASED ON COMPUTERIZED 
CEREBRAL BIOPOTENTIALS. 

181958 02-13 
BIOSYNTHESIS 

INFLUENCE OF PHENOBARBITAL AND SEX HORMONES ON ENZYMES IN 
ASCORBIC ACID BIOSYNTHESIS IN MALE AND FEMALE RATS. (PH.D. 
DISSERTATION). 

172017 01-03 
EFFECTS OF SOME TETRAHYDROCANNABINOLS ON THE BIOSYNTHESIS 
AND UTILIZATION OF CATECHOLAMINES IN THE RAT BRAIN. 

172917 01-03 
THE BIOSYNTHESIS OF THE CO-NEUROTRANSMITTER OCTOPAMINE IN 
COMPARISON WITH THE NEUROTRANSMITTER NORADRENALINE. 

181468 02-03 
DIMETHYLTRYPTAMINE: ITS BIOSYNTHESIS AND POSSIBLE ROLE IN 
MENTAL DISEASE. 

191535 04-12 
BIOSYNTHESIS OF THE PEYOTE ALKALOIDS. 

192876 04-12 
BIOSYNTHETIC 

SHORT-TERM AND LONG-TERM LITHIUM ADMINISTRATION: EFFECTS ON 
THE BRAINS SEROTONERGIC BIOSYNTHETIC SYSTEMS 

175149 02-13 
BIOTRANSFORMATION 

PHARMACOLOGIC ACTIVITY AND BIOTRANSFORMATION OF R_ AND S- 
BARBITURATE ENANTIOMERS IN MOUSE AND MAN. 

182156 02-03 
BIPOLAR 

THE USE OF LITHIUM IN AFFECTIVE DISORDERS, III: A DOUBLE-BLIND 
STUDY OF PROPHYLAXIS IN BIPOLAR ILLNESS. 

169495 01-09 
FACTORS ASSOCIATED WITH LITHIUM RESPONSE IN THE PROPHYLACTIC 
TREATMENT OF BIPOLAR MANIC-DEPRESSIVE ILLNESS. 

186188 03-09 
BISMUTH 

MENTAL ILLNESS OR METAL ILLNESS? BISMUTH SUBGALLATE. 

191215 04-15 



S-35 



Subject Index 



Psychopharmacology Abstracts 



APOMORPHINE INDUCED BITING AND FIGHTING BEHAVIOUR IN 

RESERPINIZED RATS AND AN APPROACH TO THE MECHANISM OF 

ACTION. 

174768 01-04 

CENTRAL CHOLINERGIC (MUSCARINIC) LINK IN THE ATTACK REFLEXIVE 
BITING MECHANISM OF CATS. 

182238 03-04 

BL-3912A 

CARDIOVASCULAR AND GROSS BEHAVIORAL EFFECTS OF 

AMPHETAMINE, 2-AMIN01-(2,5 DIMETHOXY-4-METHYLPROPANE 
(DOM) AND 2-AMIN0-l-(2,5 DIMETHOXY-4-METHYLPHENYL BUTANE 
(BL-3912A) IN THE CONSCIOUS DOG. 

187573 04-03 

BUNK 

EVALUATION OF CENTRAL ANTIRESERPINE EFFECT BY THE USE OF LIGHT 

BLINK REFLEX. 

169469 01-04 

HABITUATION OF BLINK REFLEXES IN PARKINSONIAN PATIENTS UNDER 
LEVODOPA AND AMANTADINE TREATMENT. 

171794 01-13 

BLOCK 

ANALYSIS OF DRUG BLOCK OF LSD/5-HT/GABA BY MONITORING 
NEURONAL MEMBRANE CHANGES. 

182143 02-03 
DOES LITHIUM BLOCK THE EFFECTS OF AMPHETAMINE? A REPORT OF 
THREE CASES. 

186745 03-13 

BLOCKADE 

EFFECTS OF DOPAMINE RECEPTOR STIMULATION AND BLOCKADE ON RO- 
4-1284 INDUCED ENHANCEMENT OF ELECTROSHOCK SEIZURE. 

167287 01-03 
ELECTROCARDIOGRAPHIC CHANGES IN HYPERTHYROIDISM AFTER 
ADRENERGIC BLOCKADE WITH RESERPINE AND PROPRANOLOL. 

167460 01-13 
PARADOXICAL BLOCKADE BY P-CHLOROPHENYLALANINE OF 5- 

HYDROXYTRYPTOPHAN FACILITATORY ACTIONS ON SPINAL REFLEXES. 

168436 01-03 
NEGATIVE SODIUM BALANCE IN LITHIUM CARBONATE TOXICITY: 
EVIDENCE OF MINERALOCORTICOID BLOCKADE. 

169869 01-15 
EFFECT OF DOPAMINERGIC STIMULATION OR BLOCKADE ON MORPHINE 
WITHDRAWAL AGGRESSION. 

171300 01-04 
BLOCKADE OF THE PROESTROUS LH SURGE IN CYCLIC RATS BY 
BARBITURATE ADMINISTRATION ON DIESTRUS. 

1 75650 02-03 
SELECTIVE BLOCKADE OF APOMORPHINE INDUCED AGGRESSION AND 
GNAWING FOLLOWING FENFLURAMINE OR RAPHE LESIONS IN THE 
RAT 

182128 02-04 

PARADOXICAL THERMOREGULATORY BEHAVIOUR IN RATS INDUCED BY 
( ) AMPHETAMINE: BLOCKADE BY ALPHA-ADRENOCEPTOR OR 
DOPAMINE RECEPTOR BLOCKING AGENTS. 

183797 03-03 
EVIDENCE FOR REDISTRIBUTION OF FILTRATE AMONG NEPHRONS AFTER 
BETA- ADRENERGIC STIMULATION AND BLOCKADE. 

184222 03-03 
SPECIFICITY OF BLOCKADE OF THE NICOTINE INDUCED RELEASE OF 3H- 
NOREPINEPHRINE FROM ADRENERGIC NEURONS OF THE GUINEA-PIG 
HEART BY VARIOUS PHARMACOLOGICAL AGENTS. 

186676 03-03 
FEAR REDUCTION IN THE RAT FOLLOWING CENTRAL CHOLINERGIC 

BLOCKADE. 

187703 04-04 
CALCIUM REVERSAL OF NERVE BLOCKADE BY ALCOHOLS, ANESTHETICS, 
TRANQUILIZERS, AND BARBITURATES. 

187802 04-03 
FAILURE OF BETA-ADRENERGIC RECEPTOR BLOCKADE TO PREVENT 
ARRHYTHMIAS INDUCED BY SYMPATHETIC NERVE STIMULATION. 

187923 04-03 
BLOCKADE OF INSULIN RELEASE BY CERTAIN PHENOTHIAZINES. 

189583 04-05 
BLOCKADE OF EXCITATORY 5-HT SYNAPSE BY LSD. 

191950 04-03 

BLOCKED 

NEW LONG LATENCY BULBOSPINAL EVOKED POTENTIALS BLOCKED BY 
SEROTONIN ANTAGONISTS. 

188751 04-03 

BLOCKERS 

INFLUENCE OF ADRENERGIC BLOCKERS AND ANTILIPEMIC AGENTS ON 
PHARMACODYNAMIC ACTIONS OF MORPHINE IN CARBON 
TETRACHLORIDE TREATED RATS. 

188873 04-03 

BLOCKING 

THE CURARIZED RAT AND HEART RATE CONDITIONING: A 
CONSIDERATION OF RESPIRATION PARAMETERS AND 



NEUROMUSCULAR BLOCKING AGENTS IN A CLASSICAL CONDITIONING 
PARADIGM. (PH.D. DISSERTATION). 

173133 01-03 
NEURONE BLOCKING ACTIONS OF ANTIPSYCHOTIC DRUGS. 

182127 02-03 
PARADOXICAL THERMOREGULATORY BEHAVIOUR IN RATS INDUCED BY 
( ) AMPHETAMINE; BLOCKADE BY ALPHA-ADRENOCEPTOR OR 
DOPAMINE RECEPTOR BLOCKING AGENTS. 

183797 03-03 
ALPHA-ADRENERGIC BLOCKING AGENTS: ANTINOCICEPTIVE ACTIVITY 
AND ENHANCEMENT OF MORPHINE-INDUCED ANALGESIA. 

183895 03-03 
THE INHIBITION BY BETA-ADRENOCEPTOR BLOCKING AGENTS OF 

CALCIUM UPTAKE INTO AND EFFLUX FROM ISOLATED SARCOPLASMIC 
VESICLES. 

184223 03-03 
EFFECTS OF CLONIDINE AND SOME ALPHA-ADRENORECEPTOR BLOCKING 
AGENTS ON AVOIDANCE CONDITIONED REFLEXES IN RATS: THEIR 
INTERACTIONS AND ANTAGONISM BY ATROPINE. 

186576 03-04 
TREATMENT OF ANXIETY NEUROSIS BY ALPHA-ADRENERGIC AND BETA- 
ADRENERGIC BLOCKING AGENTS. 

186780 03-10 
BLOCKING OF THE EFFECT OF A DELTAl-TETRAHYDROCANNABINOL 
(DELTAl-THC) ON SPONTANEOUS MOTOR ACTIVITY IN THE RAT BY 
IMMUNIZATION WITH A PROTEIN CONJUGATE OF DELTAl-THC 

187129 03-04 
THE IMPULSE BLOCKING CONCENTRATIONS OF ANESTHETICS, ALCOHOLS, 
ANTICONVULSANTS, BARBITURATES, AND NARCOTICS ON PHRENIC 
AND SCIATIC NERVES. 

187803 04-03 
THE NERVE IMPULSE BLOCKING ACTIONS OF TRANQUILIZERS AND THE 
BINDING OF NEUROLEPTICS TO SYNAPTOSOME MEMBRANES, 

189400 04-03 
DOPAMINERGIC INHIBITION OF STRIATAL CHOLINERGIC NEURONS: 
SYNERGISTIC BLOCKING ACTION OF GAMMA-BUTYROLACTONE AND 

NEUROLEPTIC DRUGS. 

189602 04-03 

BLOOD 

BLOOD LEVEL PROFILE IN MAN FOLLOWING CHRONIC ORAL 
ADMINISTRATION OF FLURAZEPAM HYDROCHLORIDE. 

169817 01-13 
EFFECT OF SELECTED BETA-DIKETONES ON LITHIUM FLUXES OF BOVINE 

RED BLOOD CELLS. 

171792 01-05 
SIMULTANEOUS ANALYSIS OF A 1,5 BENZODIAZEPINE AND ITS 
METABOLITE IN BLOOD AND URINE BY SPECTRODENSITOMETRY. 

176871 02-M 
BLOOD AND BRAIN LEVELS OF DELTAl-TETRAHYDROCANNABINOL IN 
MICE - THE EFFECT OF 7-HYDROXY-DELTAl- 
TETRAHYDROCANNABINOL. 

1 77333 02-0: 
A NEW MODIFICATION FOR STUDYING 5-HT UPTAKE BY BLOOD 
PLATELETS: A RE-EVALUATION OF TRICYCLIC ANTIDEPRESSANTS AS 
UPTAKE INHIBITORS. 

180055 02-0< 
EXPERIENCE IN THE TREATMENT OF CEREBRAL INSUFFICIENCY AND 
PERIPHERAL BLOOD CIRCULATION DISORDERS USING THE EP- 50-100 
EXPERIMENTAL DRUG. 

180676 02- r 
BLOOD LEVEL AND URINARY EXCRETION OF BROMAZEPAM IN MAN. 

182556 03-1: 
QUANTITATIVE DETERMINATION OF IMIPRAMINE AND DESIPRAMINE IN 
HUMAN BLOOD PLASMA BY DIRECT DENSITOMETRY OF THIN-LAYER 
CHROMATOGRAMS. 

183603 03-1: 

PERPHENAZINE CONCENTRATIONS IN HUMAN WHOLE BLOOD: A PILOT 
STUDY DURING ANTIPSYCHOTIC THERAPY USING DIFFERENT 
ADMINISTRATION FORMS. 

187639 04-11 
CONTROL OF NOREPINEPHRINE SYNTHESIS IN BLOOD VESSELS AND THE 
EFFECTS OF MONOAMINE OXIDASE INHIBITION. 

189390 04-0 
DIAZEPAM AND MEPERIDINE ON ARTERIAL BLOOD GASES IN HEALTHY 
VOLUNTEERS. 

190147 04-1 

COMPARATIVE PROPERTIES OF SOLUBLE AND PARTICULATE CATECHOL- 
O-METHYLTRANSFERASE FROM RAT RED BLOOD CELL: PRELIMINARY 
OBSERVATIONS. 

191523 04-0 

INFLUENCE OF VARIOUS SUBSTANCES WHICH INDUCE AND INHIBIT 
AGGREGATION ON THE UPTAKE OF DEOXYGLUCOSE BY HUMAN 

BLOOD PLATELETS. 

191770 04-1 

THE EFFECTS OF AMPHETAMINE SULFATE ON THE DIURNAL RHYTHMS 
MIDBRAIN; CORTEX. NOREPINEPHRINE; SEROTONIN AND BLOOD 
GLUCOSE LEVELS IN THE MOUSE. 

191918 04-0 



S-36 



VOLUME 12, SUBJECT INDEX 



Subject Index 



THE EFFECTS OF HOE-36801 ON MUSCLE ACTIVITY AND BLOOD 
PRESSURE, ON ATTENTION AND CONCENTRATION, ON TIME 
JUDGMENT AND SUBJECTIVE RESPONSES IN NEUROTICS AND 
NORMALS. 

192429 04-14 
BLOOD-BRAIN 

ANIMAL MODELS FOR AN ENZYMIC BLOOD-BRAIN BARRIER MECHANISM 
FOR THERAPEUTICALLY ADMINISTERED L-DOPA. 

167359 01-03 
THE DEVELOPMENT OF A BLOOD-BRAIN BARRIER TO METHADONE IN THE 
NEWBORN RAT. 

182165 02-03 
TRUE AND APPARENT NON-PENETRATION OF THE BLOOD-BRAIN BARRIER 
BY PSYCHOTROPIC DRUGS. 

192423 04-03 
BODY 

THE EFFECT OF LOWERED BODY TEMPERATURE ON LIFESPAN AND 
IMMUNE AND NONIMMUNE PROCESSES. 

169675 01-03 
METABOLIC CONTROL OF BODY TEMPERATURE IN MAN. 

174134 01-08 
POTENTIAL NEUROTRANSMITTERS AND RECEPTOR MECHANISMS 
INVOLVED IN THE CENTRAL CONTROL OF BODY TEMPERATURE IN 
HAMSTERS. (PH.D. DISSERTATION). 

174962 01-03 
DAILY RHYTHM IN BODY TEMPERATURE OF MENTAL PATIENTS: 
APPLICATION OF COSINOR METHOD - FIRST REPORT. 

191685 04-17 
DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) IMIPRAMINE 
INTERACTION ON MOUSE BODY TEMPERATURE. 

191996 04-03 
BODYWEIGHT 

INFLUENCE OF DIBENCYCLADINE AND IMIPRAMINE ON CALORIE INTAKE 
AND BODYWEIGHT. 

183359 03-03 
THE EFFECTS OF CHRONIC TREATMENT WITH D-AMPHETAMINE ON FOOD 
INTAKE, BODYWEIGHT, LOCOMOTOR ACTIVITY AND SUBCELLULAR 
DISTRIBUTION OF THE DRUG IN RAT BRAIN. 

185931 03-03 
INDEPENDENCE OF THE EFFECTS OF D-AMPHETAMINE AND FOOD 
DEPRIVATION OR BODYWEIGHT ON THE FOOD CONSUMPTION OF 
RATS. 

186376 03-06 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON BODYWEIGHT AND 
BRAIN ELECTROLYTES IN THE CHICKEN. 

186570 03-03 

189903 04-13 

189101 04-12 



BONICA 

JOHN J. BONICA ON PAIN MANAGEMENT. 

BOTANY 

THE BOTANY AND CHEMISTRY OF HALLUCINOGENS. 

BOUND 

MODIFICATION OF STIMULATION BOUND BEHAVIOR BY 
TRIFLUOPERAZINE AND AMPHETAMINE IN RATS. (PH.D. 
DISSERTATION). 

173158 01-04 
BOVINE 

EFFECT OF SELECTED BETA-DIKETONES ON LITHIUM FLUXES OF BOVINE 
RED BLOOD CELLS. 

171792 01-05 
STUDIES OF MONOAMINE OXIDASES: PROPERTIES OF THE ENZYME IN 
BOVINE AND RABBIT BRAIN MITOCHONDRIA. 

191300 04-03 
THE PRESENCE OF MAO IN SYNAPTIC MEMBRANES OF BOVINE BRAIN. 

191956 04-03 
BOYS 

IMIPRAMINE AND METHYLPHENIDATE TREATMENTS OF HYPERACTIVE 
BOYS: A DOUBLE-BLIND COMPARISON. 

185324 03-14 
BEHAVIORAL AND VISUAL EVOKED POTENTIAL INVESTIGATIONS DURING 
TRIHEXYPHENIDYL AND THIOTHIXENE TREATMENT IN PSYCHOTIC 
BOYS. 

187115 03-09 
ELECTRODERMAL ACTIVITY IN HYPERACTIVE BOYS WHO ARE 
METHYLPHENIDATE RESPONDERS. 

191400 04-14 
BRADYCARDIA 

ROLE OF THE CENTRAL AUTONOMIC NERVOUS SYSTEM IN THE 
HYPOTENSION AND BRADYCARDIA INDUCED BY (-) DELTA9- 
TETRAHYDROCANNABINOL. 

183795 03-03 
BRAIN 

EFFECT OF ETHANOL ON CYCLIC AMP LEVELS IN THE RAT BRAIN. 

167326 01-03 
RETROGRADE AMNESIA FROM HYPOTHERMIA INDUCED BRAIN SEIZURES. 

167398 01-04 



THE UPTAKE, RETENTION AND METABOLISM Of 3H-5- 

HYDROXYTRYPTAMINE IN BRAIN SLICES AND ILEUM FROM THE RAT: 
EFFECTS OF COCAINE, DESMETHYLIMIPRAMINE AND RESERPINE. (PH.D. 
DISSERTATION). 

168131 01-03 
BRAIN TO SERUM DISTRIBUTION OF RADIOACTIVITY OF INJECTED 3H-D- 
AMPHETAMINE IN DIFFERENTIALLY HOUSED MICE, 

168418 01-03 
BETA-PHENYLETHYLAMINE: A SPECIFIC SUBSTRATE FOR TYPE B 
MONOAMINE OXIDASE OF BRAIN. 

168437 01-03 
THE EFFECT OF D- AND L-P-CHLOROPHENYLALANINE ON THE 
METABOLISM OF 5-HYDROXYTRYPTAMINE IN BRAIN. 

168748 01-03 
DECREASED HISTAMINE SYNTHESIS IN THE RAT BRAIN BY HYPNOTICS 
AND ANESTHETICS. 

168750 01-03 
TRAZODONE IN THE TREATMENT OF ORGANIC BRAIN SYNDROMES, WITH 
SPECIAL REFERENCE TO PSYCHOGERIATRICS. 

168805 01-11 
EFFECT OF CHRONIC LITHIUM TREATMENT ON MONOAMINE 
METABOLISM IN RAT BRAIN. 

168839 01-03 
CHEMOTHERAPY IN CHRONIC ORGANIC BRAIN SYNDROME - A REVIEW 
OF THE LITERATURE. 

169065 01-11 
IMIPRAMINE IN THE TREATMENT OF MINIMAL BRAIN DYSFUNCTION IN 
CHILDREN. 

169295 01-11 
LITHIUM INDUCED DIABETES-INSIPIDUS: MANIC SYMPTOMS, BRAIN AND 
ELECTROLYTE CORRELATES, AND CHLOROTHIAZIDE TREATMENT. 

169486 01-15 
L-DOPA: EFFECT ON ETHANOL NARCOSIS AND BRAIN BIOGENIC AMINES 
IN MICE. 

169782 01-03 
AVERAGE EVOKED RESPONSES IN NORMAL AND MINIMALLY BRAIN 
DYSFUNCTIONED CHILDREN TREATED WITH AMPHETAMINE: A 
PRELIMINARY REPORT. 

169861 01-11 
BRAIN SEROTONIN, AFFECTIVE ILLNESS AND ANTIDEPRESSANT DRUGS: 
CEREBROSPINAL FLUID STUDIES WITH PROBENECID. (UNPUBLISHED 
PAPER). 

170084 01-09 
EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON ATTACK ELICITED BY 
HYPOTHALAMIC STIMULATION: RELATION TO BRAIN BIOGENIC 
AMINES. 

170162 01-04 
IS THERE A RELATIONSHIP BETWEEN THE INVOLVEMENT OF 
EXTRAPYRAMIDAL AND MESOLIMBIC BRAIN AREAS WITH THE 
CATALEPTIC ACTION OF NEUROLEPTIC AGENTS AND THEIR CLINICAL 
ANTIPSYCHOTIC EFFECT? 

171305 01-03 
THE UPTAKE OF DOPAMINE AND SEROTONIN IN RAT BRAIN DURING 
PROGESTERONE DECLINE. 

171307 01-03 
SYNTHESIS OF ACETYLCHOLINE IN BRAIN NERVE TERMINALS DURING 
CONSCIOUSNESS AND BARBITURATE ANESTHESIA. 

171600 01-03 
EFFECTS OF TETRABENAZINE ON LORDOSIS BEHAVIOUR AND ON BRAIN 
MONOAMINES IN THE FEMALE RAT. 

171614 01-04 
INFLUENCES OF DRUGS ON THE INCREASES IN BRAIN DOPAMINE 
PRODUCED BY AXOTOMY OF GAMMA-HYDROXYBUTYRIC ACID 
(GHBA). 

171622 01-03 
EFFECT OF IMIPRAMINE ON THE TURNOVER OF BRAIN 5-HT IN 
POSTNATAL RATS. 

171624 01-03 
LEVELS OF HVA IN MOUSE BRAIN FOLLOWING TREATMENT WITH 
METABOLITES OF CHLORPROMAZINE. 

171626 01-03 
THE EFFECT OF PROTRIPTYLINE ON THE METABOLISM OF LABELLED 

DOPAMINE AND NORADRENALINE IN THE RAT BRAIN 

171627 01-03 
ANTAGONISM OF P-CHLOROAMPHETAMINE (PCA) INDUCED DEPLETION 

OF 5-HT FROM RAT BRAIN BY SOME THYMOLEPTICS AND OTHER 
PSYCHOTROPIC DRUGS. 

171628 01-03 
A SENSITIVE GAS CHROMATOGRAPHIC PROCEDURE FOR THE 

ESTIMATION OF NORADRENALINE, DOPAMINE AND 5- 
HYDROXYTRYPTAMINE IN RAT BRAIN. 

171971 01-01 
EFFECTS OF CENTRALLY ACTING DRUGS ON ADENYL CYCLASE ACTIVITY 
AND CYCLIC AMP LEVELS OF MOUSE BRAIN. (PH.D. DISSERTATION). 

172019 01-03 
THE ROLE OF THE SEPTAL AREA OF THE BRAIN IN THE INHIBITORY 
MODULATION OF BEHAVIOR. (PH.D. DISSERTATION). 

172021 01-03 



S-37 



Subject Index 



Psychopharmacology Abstracts 



THE DISTRIBUTION OF DELTAl-TETRAHYDROCANNABINOL AND 7- 
HYDROXY-DELTAloTETRAHYDROCANNABINOL IN THE MOUSE BRAIN 
AFTER INTRAVENTRICULAR INJECTION. 

172596 01-03 
EFFECTS OF SOME TETRAHYDROCANNABINOLS ON THE BIOSYNTHESIS 
AND UTILIZATION OF CATECHOLAMINES IN THE RAT BRAIN. 

172917 01-03 
ALTERATION OF 5-HYDR0XYTRYPTAMINE-14C EFFLUX BY NICOTINE IN 
RAT BRAIN AREA SLICES. 

172925 01-03 
THE NOOTROPIC APPROACH TO THE PHARMACOLOGY OF THE 
INTEGRATIVE ACTIVITY OF THE BRAIN. 

173495 01-02 
DRINKING BEHAVIOUR AND BRAIN DOPAMINE: ANTAGONISTIC EFFECT 
OF TWO NEUROLEPTIC DRUGS (PIMOZIDE AND SPIRAMIDE) UPON 
AMPHETAMINE OR APOMORPHINE-INDUCED HYPODIPSIA. 

174035 01-04 
EXCITANT AND DEPRESSANT DRUGS MODULATE EFFECTS OF 

ENVIRONMENT ON BRAIN WEIGHT AND CHOLINESTERASES. 

174036 01-03 
THE EFFECTS OF AMPHETAMINE, 2-AMINOINDANE AND 2- 

AMINOTETRALIN ON THE CONCENTRATIONS OF WHOLE BRAIN 
NORADRENALINE, DOPAMINE, 5-HYDROXYTRYPTAMINE AND 5- 
HYDROXYINDOLEACETIC ACID IN THE MOUSE. 

174828 01-03 
BRAIN BIOGENIC AMINE DEPLETION AND MOOD. 

174994 02-14 
INTERACTIVE EFFECTS OF CYCLOHEXIMIDE AND PUROMYCIN IN 
ALTERING BRAIN POLYRIBOSOMES AND NEURAL AND BEHAVIOURAL 
RESPONSES TO ELECTROSHOCK IN MICE. 

1 75230 02-03 
PARTIAL PURIFICATION AND CHARACTERIZATION OF NADPH-LINKED 
ALDEHYDE REDUCTASE FROM MONKEY BRAIN. 

175232 02-03 
THE EFFECT OF PHENIRAMINE AND ITS STRUCTURAL ANALOGUES ON 5- 
HYDROXYTRYPTAMINE IN RAT AND MOUSE BRAIN. 

175240 02-03 
A METHOD FOR ANALYZING CNS EFFECTS OF DRUGS AND BRAIN 
LESIONS ON PERMANENT GROUPS OF RATS. 

176867 02-06 
SPECIFIC FACILITATION OF MAZE LEARNING BY A PEPTIDE EXTRACTED 

FROM TRAINED MOUSE BRAIN. 

176868 02-04 

RELATIVE POTENCIES OF D- AND L-AMPHETAMINE ON THE RELEASE OF 
DOPAMINE FROM CAT BRAIN IN VIVO. 

176874 02-03 
STUDIES ON MONOAMINE OXIDASE - REPORT 22; EFFECTS OF NAN02 
AND NH20H ON MITOCHONDRIAL MAO IN RAT BRAIN. 

1 77022 02-03 
DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: 
ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE 
MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY. 

177131 02-03 
BRAIN AMINO ACIDS DURING CONVULSIONS. 

177135 02-03 
NOREPINEPHRINE SENSITIVE ADENYLATE CYCLASES IN RAT BRAIN: 
RELATION TO BEHAVIOR AND TYROSINE HYDROXYLASE. 

177252 02-03 
INHIBITION OF LUNG, LIVER AND BRAIN MONOAMINE OXIDASE BY 
IMIPRAMINE AND DESIPRAMINE. 

1 77332 02-03 
BLOOD AND BRAIN LEVELS OF DELTAl-TETRAHYDROCANNABINOL IN 

MICE - THE EFFECT OF 7-HYDROXY-DELTAl- 
TETRAHYDROCANNABINOL. 

177333 02-03 
INABILITY OF RAT BRAIN HOMOGENATE TO OXIDIZE AMPHETAMINE. 

177334 02-03 
ADRENALINE, NORADRENALINE AND DOPAMINE LEVELS IN BRAIN AND 

HEART AFTER ADMINISTRATION OF 6-HYDROXYDOPAMINE AND 
GUANETHIDINE TO NEWBORN MICE. 

1 77338 02-03 
BRAIN RIBOSOMAL RNA SYNTHESIS INHIBITED BY CHLORPROMAZINE. 

177835 02-03 
PENTAZOCINE IN RHESUS MONKEY PLASMA AND BRAIN AFTER 
PARENTERAL AND ORAL ADMINISTRATION. 

178641 02-03 
STRUCTURAL FUNCTIONAL ORGANIZATION OF THE HUMAN BRAIN AND 
THE PATHOPHYSIOLOGY OF THE PARKINSONIAN TYPE HYPERKINESES. 

178787 02-13 
CHANGES IN BRAIN ACETYLCHOLINESTERASE ACTIVITY OF YOUNG RATS 
AFTER CHRONIC TREATMENT WITH TREMORINE. 

178814 02-03 

STIMULATION OF BRAIN AROMATIC ALKYLAMINE N- 

METHYLTRANSFERASE ACTIVITY BY FAD AND METHYLCOBALAMIN. 

180020 02-03 
LONG-TERM EFFECTS OF 5,7 DIHYDROXYTRYPTAMINE ON BRAIN 
MONOAMINES. 

180022 02-03 



EFFECT OF CHRONIC INTOXICATION WITH (_) AMPHETAMINE ON ITS 
CONCENTRATION IN LIVER AND BRAIN AND ON (14C) LEUCINE 
INCORPORATION INTO MICROSOMAL AND CYTOPLASMIC PROTEINS OF 
RAT LIVER. 

180056 02-05 

EFFECT OF ADRENERGIC SUBSTANCES ON OXYGEN CONSUMPTION OF 
RAT BRAIN TISSUE. 

180058 02-03 
EFFECTS OF PHENOXYBENZAMINE, ACEPERONE AND CLONIDINE ON THE 

LEVEL OF 3-METH0XY-4-HYDR0XYPHENYLGLYC0L, (MOPEG) IN RAT 
BRAIN. 

180059 02-03 
EFFECT OF CHLORPROMAZINE AND SOME OF ITS METABOLITES ON THE 

DOPAMINE SENSITIVE ADENYLATE CYCLASE OF RAT BRAIN STRIATUM, 

180060 02-03 
SOLUBILIZATION AND PURIFICATION OF BRAIN RNA POLYMERASE. 

180537 02-06 
ACETYLCHOLINE TURNOVER IN BRAIN OF MICE AND RATS: EFFECTS OF 
VARIOUS DOSE REGIMENS OF MORPHINE. (UNPUBLISHED PAPER). 

180582 02-03 
EFFECTS OF NEUROLEPTICS AND THYMOLEPTICS ON 

PHOSPHODIESTERASE ACTIVITY AND ON CYCLIC 3,5 AMP LEVELS IN 
RAT BRAIN. 

181467 02-03 
CATECHOLAMINE TURNOVER IN THE RAT BRAIN: DIFFERENT RESULTS 
OBTAINED IN DIFFERENT EXPERIMENTAL CONDITIONS. 

181471 02-03 
SUBCELLULAR DISTRIBUTION OF DELTA9-TETRAHYDR0CANNABIN0L IN 
RAT BRAIN. 

181810 02-03 
EFFECTS OF L-DELTA9-TETRAHYDR0CANNABIN0L, DL-AMPHETAMINE 
AND PENTOBARBITAL ON OXYGEN CONSUMPTION BY MOUSE BRAIN 
AND HEART HOMOGENATES. 

181813 02-03 
CONVULSION PRODUCING PROPERTY OF THE DIALYZABLE GLYCOPEPTIDE 
PREPARATION FROM WHOLE RAT BRAIN. 

181815 02-0; 
COMPARISON OF THE CHRONIC AND ACUTE EFFECTS OF D-LYSERGIC 
ACID DIETHYLAMIDE (LSD) TREATMENT ON RAT BRAIN SEROTONIN 
AND NOREPINEPHRINE. 

181945 02-0: 
A CENTRAL EFFECT OF LOCAL ANESTHETICS: PREVENTION AGAINST THE 
ACCUMULATION OF CYCLIC AMP IN BRAIN SLICES. 

182099 02-0; 
THE EFFECT OF METHAMPHETAMINE ON BRAIN ACH CONSUMPTION AND 
AGGRESSIVENESS IN MICE STRESSED MILDLY BY LONG-TERM 
ISOLATION. 

182108 02-0' 
DISPOSITION OF NORAPOMORPHINE AND N,N PROPYLNORAPOMORPHINE 
IN MOUSE BRAIN AND ITS CORRELATION WITH STEREOTYPED 
GNAWING BEHAVIOR. 

182131 02-0' 
EFFECTS OF SELECTED CENTRALLY ACTING AGENTS ON ADENYL CYCLASE 
ACTIVITY IN MOUSE BRAIN. 

182153 02-0; 
CONVERSION OF CHLORAL HYDRATE TO TRICHLOROETHANOL IN BRAIN 
AND LIVER. 

182157 02-0: 

LSD TOLERANCE AND BRAIN SEROTONIN METABOLISM. 

182167 02-0: 
INHIBITION OF C14-ACH UPTAKE IN RAT BRAIN SLICES BY 
DESMETHYLIMIPRAMINE. 

182170 02-0: 
BRAIN AMINES IN PYRIDOXINE DEFICIENT RATS. 

182171 02-0: 
BEHAVIORAL EFFECTS OF SIMULTANEOUS DEPLETION OF BRAIN 

NOREPINEPHRINE AND SEROTONIN. 

182211 03-0 
REGIONAL AND SUBCELLULAR DISTRIBUTION OF CHOLINE 
ACETYLTRANSFERASE IN THE BRAIN OF NORMAL AND MORPHINE 
TREATED RATS. 

1 82224 03-0 
EFFECTS OF NARCOTIC ANALGESICS ON ENZYMES OF ACETYLCHOLINE 

METABOLISM IN CULTURED CHICK BRAIN CELLS. 

182225 03-0 
EFFECT OF ACUTE AND CHRONIC MORPHINE ON SPECIFIC 

RADIOACTIVITIES OF CHOLINE AND ACETYLCHOLINE IN MOUSE BRAIN 

182226 030 
EFFECTS OF MORPHINE, NALORPHINE AND NALOXONE ON RAT BRAIN 

RELEASE OF ACETYLCHOLINE. 

182227 03-0 
STUDIES ON THE EFFECT OF ACUTE AND CHRONIC MORPHINE 

TREATMENT ON CATECHOLAMINE LEVELS AND TURNOVER IN 
DISCRETE BRAIN AREAS OF RATS. 

182228 03-0 
EFFECTS OF METHADONE ON ACTIVITY AND ON BRAIN MONOAMINES Ih 

TWO MOUSE STRAINS. 

182229 03-0 



S-38 



VOLUME 12, SUBJECT INDEX 



Subject Index 



EFFECT OF 2-ARYLALANINES, 2-ARYLSERINES, TETRAPHENYLBORON AND 
1 2 DL(2,4 DICHLOROPHENYL) ETHANOLAMINE ON LEVELS OF 
SEROTONIN (5-HT), NOREPINEPHRINE (NE) AND DOPAMINE (DM) IN 
WHOLE BRAIN OF MICE. 

182254 03-03 
EFFECTS OF CHRONIC ADMINISTRATION OF AMPHETAMINE UPON THE 

CATECHOLAMINE CONTENT OF MOUSE BRAIN. 

182255 03-03 
PENTYLENETETRAZOL CONVULSIONS AND BRAIN CATECHOLAMINE 

TURNOVER RATE IN RATS AND MICE RECEIVING DIPHENYLHYDANTOIN 
OR BENZODIAZEPINES. 

182344 03-03 
THE INHIBITION OF (3H) BIOGENIC AMINE ACCUMULATION INTO RAT 
BRAIN TISSUE SLICES BY VARIOUS TRYPTAMINE DERIVATIVES. 

182723 03-03 
NON-SPECIFICITY OF 5-HYDROXYTRYPTOPHAN IN REPLETING BRAIN 
SEROTONIN IN RATS WITH MFB LESIONS. 

182725 03-03 
THE INFLUENCE OF CHRONIC ADMINISTRATION OF LITHIUM CARBONATE 
ON THE BRAIN NOREPINEPHRINE CONTENT IN RATS. 

182872 03-03 
THE INFLUENCE OF NEUROTROPIC DRUGS ON MONOAMINE OXIDASE 
(MAO) AND 5-OXYTRYPTOPHANE DECARBOXYLASE (5-OTD) ACTIVITY 
IN THE BRAIN. 

183142 03-13 
THE EFFECT OF CANNABINOIDS ON THE NUMBER OF NUCLEAR 
MEMBRANE ATTACHED RIBOSOMES IN INFANT RAT BRAIN. 

183228 03-03 
EVALUATION OF EEG AND CLINICAL CHANGES ASSOCIATED WITH 
PAVABID THERAPY IN CHRONIC BRAIN SYNDROME. 

183402 03-13 
THE EFFECTS OF PSYCHIC STIMULANTS ON THE ACTIVITY OF POTASSIUM 
AND SODIUM ION STIMULATED ATPASE IN THE MICROSOMAL 
FRACTIONS OF THE BRAIN OF RATS. 

183518 03-01 
IMIPRAMINE AND ITS METABOLITES IN HUMAN BRAIN. 

183604 03-13 
CATALEPSY AND STEREOTYPED BEHAVIOUR IN RATS TREATED 
CHRONICALLY WITH METHADONE: RELATION TO BRAIN 
HOMOVANILLIC ACID CONTENT. 

183606 03-04 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON THE METABOLISM OF 
3H-5-HYDROXYTRYPTAMINE AND 3H-N0REPINEPHRINE IN THE RAT 
BRAIN. 

183787 03-03 
LONG-TERM EFFECTS OF 4-CHLOROAMPHETAMINE ON BRAIN 5- 
HYDROXYINDOLE METABOLISM IN RATS. 

183869 03-03 
A COMPARISON OF PSYCHOTOMIMETIC DRUG EFFECTS ON RAT BRAIN 
NOREPINEPHRINE METABOLISM. 

183891 03-03 
FORMATION OF NORADRENALINE IN THE RAT BRAIN FROM THE FOUR 
STEREOISOMERS OF 3,4 DIHYDROXYPHENYLSERINE. 

184229 03-03 
DOPAMINE IN BRAIN FUNCTION. 

184329 03-03 
EFFECTS OF VARIOUS MORPHINE TREATMENT SCHEDULES ON 
ACETYLCHOLINE TURNOVER RATE IN RAT BRAIN PARTS. 

184553 03-03 
BRAIN MECHANISMS UNDERLYING THE EFFECTS OF AMPHETAMINE ON 
FEEDING AND NONFEEDING BEHAVIORS: DISSOCIATION AND OVERLAP. 

184839 03-03 
EFFECT OF LSD-25 AND 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE ON 
RAT BRAIN AND PLATELET SEROTONIN LEVELS. 

184975 03-03 
HISTO-AUTORADIOGRAPHIC INVESTIGATIONS ON THE DISTRIBUTION OF 
INJECTED 5-HYDROXYTRYPTAMINE (SEROTONIN) IN THE BRAIN AND 
THE PITUITARY OF MICE. 

185900 03-03 
THE EFFECTS OF CHRONIC TREATMENT WITH D-AMPHETAMINE ON FOOD 
INTAKE, BODYWEIGHT, LOCOMOTOR ACTIVITY AND SUBCELLULAR 
DISTRIBUTION OF THE DRUG IN RAT BRAIN. 

185931 03-03 
ANTICONVULSANT ACTIVITY AND INHIBITION OF RESPIRATION IN RAT 
BRAIN HOMOGENATES BY SUBSTITUTED OXADIAZOLES. 

185980 03-01 
THE POSSIBLE ROLE OF TRYPTAMINE IN BRAIN FUNCTION AND ITS 
RELATIONSHIP TO THE ACTIONS OF LSD-LIKE HALLUCINOGENS. 

186024 03-12 
BRAIN AMINES AND APOMORPHINE-INDUCED INTRASPECIFIC 
AGGRESSIVE BEHAVIOR IN THE RAT. 

186374 03-04 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON BODYWEIGHT AND 
BRAIN ELECTROLYTES IN THE CHICKEN. 

186570 03-03 
THE ISOLATED PERFUSED RAT BRAIN AS A MODEL FOR STUDYING 
DRUGS ACTING ON THE CNS. 

186589 03-06 



EFFECTS OF LITHIUM ON ADRENERGIC AMINE UPTAKE IN RAT BRAIN 
SYNAPTOSOMES. 

186633 03-03 
BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 5,6 

DIHYDROXYTRYPTAMINE ADMINISTRATION INTO BRAIN. 

1 86634 03-04 
THE MONOAMINE OXIDASES OF BRAIN: SELECTIVE INHIBITION WITH 

DRUGS AND THE CONSEQUENCES FOR THE METABOLISM OF THE 
BIOGENIC AMINES. 

1 86668 03-03 
A COMPARISON OF THE EFFECTS OF AMPHETAMINE AND ITS 

METABOLITES, P-HYDROXYAMPHETAMINE AND P- 
HYDROXYNOREPHEDRINE, ON UPTAKE, RELEASE AND CATABOLISM OF 
3HN0REPINEPHRINE IN CEREBRAL CORTEX OF RAT BRAIN. 

186669 03-03 
EFFECTS OF AMPHETAMINES ON REGIONAL TRYPTOPHAN HYDROXYLASE 

ACTIVITY AND SYNAPTOSOMAL CONVERSION OF TRYPTOPHAN TO 5- 
HYDROXYTRYPTAMINE IN RAT BRAIN. 

186674 03-03 
EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF 
BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM 
RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT. 

186695 03-03 
DIFFERENTIAL EFFECTS OF PILOCARPINE AND SCOPOLAMINE ON THE 
PERFORMANCE OF A LIGHT DARK DISCRIMINATION MAINTAINED BY 
ELECTRICAL STIMULATION OF THE BRAIN. 

186701 03-03 
PHYSIOLOGICAL DISPOSITION OF BETA-PHENYLETHYLAMINE, 2,4,5 
TRIMETHOXYPHENYLETHYLAMINE, 2,3,4,5,6 

PENTAMETHOXYPHENYLETHYLAMINE AND BETA-HYDROXYMESCALINE 
IN RAT BRAIN, LIVER AND PLASMA. 

186706 03-03 
EFFECT OF MORPHINE ON REGIONAL LEVELS OF GAMMA- 
HYDROXYBUTYRATE IN MOUSE BRAIN. 

187077 03-03 
THE EFFECT OF LITHIUM ON HORMONE SENSITIVE ADENYLATE CYCLASE 
FROM VARIOUS REGIONS OF THE RAT BRAIN. 

187110 03-03 
THE INFLUENCE OF PSYCHOTROPIC DRUGS ON THE LEVELS OF 
ENDOGENOUS 2-PHENYLETHYLAMINE IN RABBIT BRAIN. 

187112 03-03 
LEARNING IMPAIRMENT IN RATS AFTER 6-HYDROXYDOPAMINE INDUCED 
DEPLETION OF BRAIN CATECHOLAMINES. 

187420 04-04 
PENTOBARBITAL AND IN VIVO TURNOVER RATE OF ACETYLCHOLINE IN 
MOUSE BRAIN AND IN REGIONS OF RAT BRAIN. (UNPUBLISHED 
PAPER). 

187526 04-03 
REGULATION OF BRAIN DOPAMINE TURNOVER RATE; 

PHARMACOLOGICAL IMPLICATIONS. (UNPUBLISHED PAPER). 

187527 04-03 
DEVELOPMENT OF LOCOMOTION AND BRAIN CATECHOLAMINES. 

187551 04-04 
EFFECT OF SKF-525-A ON THE METABOLISM OF (-) DELTA9- 
TETRAHYDROCANNABINOL IN THE RAT BRAIN AND LIVER 

187578 04-03 
THE EFFECTS OF CHRONIC RESERPINE AND NIALAMIDE TREATMENT ON 
THE FREE AMINO ACID LEVELS OF RAT BRAIN. 

187645 04-03 
ACTIONS OF ATROPINE, HEMICHOLINIUM-3, AND PHYSOSTIGMINE ON 
CHLORPROMAZINE INDUCED CHANGES IN RAT BRAIN MONOAMINES. 

187800 04-03 
METHIOTHEPIN ELEVATION OF 5-HYDROXYINDOLEACETIC ACID LEVELS IN 
VARIOUS ANATOMIC REGIONS OF RAT BRAIN. 

187831 04-03 
ANTISCHIZOPHRENIC DRUGS AND BRAIN CHOLINERGIC RECEPTORS: 
AFFINITY FOR MUSCARINIC SITES PREDICTS EXTRAPYRAMIDAL 
EFFECTS. 

188114 04-15 
EFFECTS OF LSD ON SYNTHESIS AND RELEASE OF 5-HT IN RAT BRAIN 
SLICES. 

188164 04-03 
EFFECT OF TETRAHYDROCANNABINOLS ON BRAIN ACETYLCHOLINE. 

188167 04-03 
THE EFFECT OF HYPOTHERMIC DOSES OF 1-DELTA9 

TETRAHYDROCANNABINOL ON BIOGENIC AMINE METABOLISM IN 
SELECTED PARTS OF THE RAT BRAIN. 

188231 04-03 
DEPLETION OF TRYPTOPHAN HYDROXYLASE BY 5,6 

DIHYDROXYTRYPTAMINE IN RAT BRAIN -- TIME COURSE AND 
REGIONAL DIFFERENCES 

188287 04-03 
IN VITRO BINDING OF (4-14C) DIPHENYLHYDANTOIN TO RAT BRAIN 
MICROSOMES. 

1 88404 04-03 
DISAGGREGATION OF BRAIN POLYSOMES AFTER LDOPA: AN ANALYSIS 

1 88433 04-03 



S-39 



Subject Index 

INVOLVEMENT OF BRAIN CHOLINERGIC MECHANISMS IN THE ACTION OF 
CHLORPROMAZINE. 

188891 04-03 
ESTIMATION OF THE RATE OF 5-HT SYNTHESIS IN THE MOUSE BRAIN BY 
VARIOUS METHODS. 

188976 04-03 
EFFECT OF PENTOBARBITAL ON UPTAKE AND RELEASE OF (3H)GABA AND 
(UOGLUTAMATE BY BRAIN SLICES. 

189031 04-03 
TURNOVER OF HISTAMINE IN RAT BRAIN AND ITS DECREASE UNDER 
BARBITURATE ANESTHESIA. 

189396 04-03 
EFFECTS OF ALPHA-METHYLTYROSINE ON D-AMPHETAMINE INDUCED 

RELEASE OF ENDOGENOUSLY SYNTHESIZED AND EXOGENOUSLY 
ADMINISTERED CATECHOLAMINES FROM THE CAT BRAIN IN VIVO. 

189397 04-03 
PARADOXICAL EFFECTS OF D-AMPHETAMINE ON BEHAVIORAL 

THERMOREGULATION: POSSIBLE MEDIATION BY BRAIN DOPAMINE. 

189399 04-04 
EFFECTS OF CATECHOLAMINE DEPLETING DRUGS AND AMPHETAMINE ON 
SELF-STIMULATION OF BRAIN FOLLOWING VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS. 

189515 04-04 
EFFECTS OF PERINATAL EXPOSURE TO METHYL MERCURY ON 
FUNCTIONAL BRAIN DEVELOPMENT AND NEUROCHEMISTRY. 

189564 04-05 
INFLUENCE OF MORPHINE AND NALOXONE ON THE RELEASE OF 
NORADRENALINE FROM RAT BRAIN CORTEX SLICES. 

189568 04-03 
INFLUENCE OF FENTANYL, LEVORPHANOL AND PETHIDINE ON THE 

RELEASE OF NORADRENALINE FROM RAT BRAIN CORTEX SLICES. 

189569 04-03 
EFFECT OF ANESTHETIC AGENTS ON THE SYNTHESIS AND 

DISAPPEARANCE OF BRAIN DOPAMINE NORMALLY AND AFTER 
HALOPERIDOL, KCL OR AXOTOMY. 

189571 04-03 
MESCALINE INDUCED CHANGES OF BRAIN CORTEX RIBOSOMES: EFFECT 
OF MESCALINE ON THE BINDING OF AMINOACYL TRANSFER 
RIBONUCLEIC ACID TO RIBOSOMES OF BRAIN TISSUE. 

189582 04-05 
EFFECT OF A BUTYROPHENONE DERIVATIVE, U-32802A, ON BRAIN 

BIOGENIC AMINES. 

189584 04-02 
EFFECT OF MORPHINE ON THE TURNOVER AND SYNTHESIS OF (LEU-3H) 
PROTEIN AND (CH-14C) PHOSPHATIDYLCHOLINE IN DISCRETE REGIONS 
OF THE RAT BRAIN. 

189586 04-03 
DIHYDROPTERIDINE REDUCTASE IN RAT BRAIN: REGIONAL DISTRIBUTION 
AND THE EFFECT OF CATECHOLAMINE DEPLETING DRUGS. 

189752 04-03 
EFFECT OF OXOTREMORINE AND PHYSOSTIGMINE ON CHOLINE LEVELS IN 
MOUSE WHOLE BRAIN, SPLEEN AND CEREBELLUM. 

189893 04-03 
DIFFERENTIAL ANTAGONISM BY NALOXONE OF INHIBITORY EFFECTS OF 
HALOPERIDOL AND MORPHINE ON BRAIN SELF-STIMULATION. 

190306 04-03 
THE INFLUENCE OF PSYCHOSTIMULANTS ON K42 MEMBRANE 
PERMEABILITY IN VARIOUS PORTIONS OF RAT BRAIN. 

191122 04-03 
PHOTIC RESPONSES IN MINIMAL BRAIN DYSFUNCTION. 

191188 04-15 
STUDIES OF MONOAMINE OXIDASES: PROPERTIES OF THE ENZYME IN 
BOVINE AND RABBIT BRAIN MITOCHONDRIA. 

191300 04-03 
EFFECTS OF LIDOCAINE ON RABBIT BRAIN MICROTUBULAR PROTEIN. 

191324 04-03 
PASSAGE OF TAURINE INTO ADULT MAMMALIAN BRAIN. 

191331 04-03 
PERMANENT ALTERATIONS IN 5-HYDROXYTRYPTAMINE METABOLISM IN 
DISCRETE AREAS OF RAT BRAIN FOLLOWING EXPOSURE TO DRUGS 
DURING THE PERIOD OF DEVELOPMENT 

191383 04-03 
THE MODE OF MORPHINE UPTAKE INTO BRAIN SLICES. 

191413 04-03 
EFFECT OF SINGLE AND REPEATED ADMINISTRATION OF CLOZAPINE ON 
THE METABOLISM OF DOPAMINE AND NORADRENALINE IN THE BRAIN 

OF THE RAT. 

191418 04-03 
EFFECT OF PIRIBEDIL AND ONE OF ITS METABOLITES ON THE 
CONCENTRATION OF HOMOVANILLIC ACID IN THE RAT BRAIN. 

191422 04-03 
EFFECT OF DIAZEPAM ON MOUSE WHOLE BRAIN AND BRAIN AREA 

ACETYLCHOLINE AND CHOLINE LEVELS 

191423 04-03 
SOME INTERRELATED PROPERTIES OF BRAIN MONOAMINE OXIDASE 

191498 04-01 
THE USE OF SELECTIVE AND INHIBITOR DRUGS TO MODIFY AMINE 
METABOLISM IN BRAIN. 

191500 04-03 



Psychopharmacology Abstracts 

EFFECT OF CHRONIC TREATMENT WITH CENTRAL STIMULANTS ON BRAIN 
MONOAMINES AND SOME BEHAVIOURAL AND PHYSIOLOGICAL 
FUNCTIONS IN RATS, GUINEA-PIGS, AND RABBITS. 

191503 04-03 
RELATIONSHIP OF CATECHOLAMINE NEURAL SYSTEMS TO THE 
BEHAVIORAL ALTERATIONS PRODUCED BY 6-HYDROXYDOPAMINE 
ADMINISTRATION INTO BRAIN. 

191518 04-03 
POST-MORTEM MEASUREMENT OF ENZYMES IN HUMAN BRAIN: 
EVIDENCE OF A CENTRAL NORADRENERGIC DEFICIT IN 
SCHIZOPHRENIA. 

191529 04-13 
EFFECTS OF NOMIFENSINE (HOE-984), D-AMPHETAMINE AND 

APOMORPHINE ON MOTOR ACTIVITY, CATECHOLAMINE TURNOVER 
AND CAMP CONCENTRATIONS IN RAT BRAIN. (UNPUBLISHED PAPER) 

191766 04-03 
ACTION OF HALOPERIDOL AND TRIFLUOPERAZINE ON THE MOTOR 
RESPONSES ELICITED BY ELECTRICAL STIMULATION OF THE BRAIN IN 
RABBITS. 

191787 04-02 

AMPHETAMINE AND NA.,K_ - ATPASE IN THE BRAIN. 

191789 04-03 
METABOLISM OF D-AMPHETAMINE BY RAT BRAIN IN VIVO AND IN 
VITRO. 

191922 04-03 
CORRELATION BETWEEN BRAIN N,N DIMETHYLTRYPTAMINE (DMT) 
LEVELS AND BAR PRESSING BEHAVIOR IN RATS: EFFECT OF MAO 
INHIBITION. 

191935 04-04 
ADENOSINE ACTION ON SYNAPTIC TRANSMISSION IN BRAIN SLICES. 

191945 04-03 
NORADRENERGIC REGULATION OF BRAIN SEROTONERGIC NEURONS: 
EVIDENCE FROM SINGLE UNIT STUDIES WITH CLONIDINE. 

191948 04-03 
EFFECT OF LILLY-1 10140, 3-(P-TRIFLU0R0METHYLPHEN0XY) N METHYL-3- 
PHENYLPROPYLAMINE ON SYNTHESIS OF 3HSER0T0NIN FROM 3H- 
TRYPTOPHAN IN RAT BRAIN. 

191951 04-03 
THE PRESENCE OF MAO IN SYNAPTIC MEMBRANES OF BOVINE BRAIN. 

191956 04-03 
INCREASED BRAIN NOREPINEPHRINE TURNOVER IN LEAD EXPOSED 

HYPERACTIVE RATS. 

191957 04-05 

DISPOSITION OF H3-DELTA9-TETRAHYDR0CANNABIN0L IN BRAIN OF 
PREGNANT DOGS AND THEIR FETUSES. 

191968 04-03 
SUBCELLULAR LOCALIZATION OF H3-DELTA9-TETRAHYDR0CANNABIN0L 
IN DOG BRAIN AFTER ACUTE OR CHRONIC ADMINISTRATION. 

191970 04-03 
MORPHINE TOLERANCE, DEPENDENCE AND WITHDRAWAL AND BRAIN 
ACETYLCHOLINE. 

191985 04-03 
THE EFFECT OF INCREASED GAMMA-AMI NOBUTYRIC ACID ON ALPHA- 
METHYLTYROSINE INDUCED DECREASE IN CATECHOLAMINES IN RAT 
BRAIN. 

191988 04-03 
TETRAHYDROCANNABINOLS: INHIBITION IN ACETYLCHOLINE SYNTHESIS 
IN REGIONAL RAT BRAIN SLICES. 

191998 04-03 
INHIBITION IN VIVO OF ACETYLCHOLINE SYNTHESIS IN MOUSE BRAIN BY 
INHIBITORS OF CHOLINE ACETYLTRANSFERASE. 

192001 04-03 
INCORPORATION OF 14C-DIHYDR0PHENYLALANINE AND 14C-CH0LINE 
INTO RAT BRAIN SUBCELLULAR PARTICLES AND THE EFFECT OF 
PSYCHOACTIVE DRUGS 

192426 04-02 

BRAINS 

THE EFFECT OF PSYCHOTROPIC AGENTS ON SOME ASPECTS OF 
ACETYLCHOLINE METABOLISM IN CAT BRAINS. 

174257 01-0: 
SHORT-TERM AND LONG-TERM LITHIUM ADMINISTRATION: EFFECTS ON 
THE BRAINS SEROTONERGIC BIOSYNTHETIC SYSTEMS. 

175149 02-1; 
DISTRIBUTION OF 14C-PSIL0CIN IN THE BRAINS OF VARIOUS ANIMALS. 

192425 04-0; 
BRANCHING 

MUSCLE ABNORMALITIES IN PSYCHOTIC PATIENTS: II. SERUM CPK 
ACTIVITY, FIBER ABNORMALITIES, AND BRANCHING AND SPROUTING 
OF SUBTERMINAL NERVES. 

187114 03-0^ 

BRAND-NAMED 

BIOEQUIVALENCY OF GENERIC AND BRAND-NAMED CHLORPROMAZINE. 

1 87255 03-0i 

BRETYLIUM 

TREMOR INDUCTION BY INTRACAUDATE INJECTIONS OF BRETYLIUM, 
TETRABENAZINE, OR MESCALINE: FUNCTIONAL DEFICITS IN CAUDATE 
DOPAMINE. 

167329 01-0: 



S-40 



VOLUME 12, SUBJECT INDEX 



Subject Index 



BRISTOl-COMPOUND-2605 

DIURETIC ACTIVITY OF A NEW NARCOTIC ANTAGONIST IN MAN 
(8RISTOL-COMPOUND-2605). (UNPUBLISHED PAPER). 

174473 01-13 
BROMAZEPAM 

BROMAZEPAM AND PHENOBARBITAL IN ANXIETY: A CONTROLLED 
STUDY. 

167773 01-10 
METABOLITES OF BROMAZEPAM, A BENZODIAZEPINE, IN THE HUMAN, 
DOG, RAT, AND MOUSE. 

170837 01-03 
A TRIAL ON BROMAZEPAM (LEXOTAN) AND PLACEBO IN THE 
TREATMENT OF PSYCHOPHYSIOLOGICAL DISORDERS. 

17115001-11 
SEMI-QUANTITATIVE ANALYSIS OF BROMAZEPAM BY RING OVEN 
METHOD. 

174853 01-16 
CLINICAL PHARMACOLOGICAL STUDY OF BROMAZEPAM IN THE FIELD OF 
INTERNAL MEDICINE. 

176473 02-10 
PHARMACOLOGICAL STUDIES ON BROMAZEPAM. 

178725 02-03 
BEHAVIORAL PHARMACOLOGY OF BROMAZEPAM (RO-5-3350), A NEW 
BENZODIAZEPINE DERIVATIVE. 

181384 02-04 
STUDIES ON METABOLISM OF BROMAZEPAM (III): ABSORPTION, 
EXCRETION, AND METABOLISM OF BROMAZEPAM IN MAN. 

181588 02-13 
STUDIES ON METABOLISM OF BROMAZEPAM (II): COLORIMETRIC 
DETERMINATION AND METABOLIC FATE OF BROMAZEPAM IN 
ANIMALS. 

181593 02-03 
CENTRAL NERVOUS ACTION OF BROMAZEPAM, A NEW BENZODIAZEPINE 
DERIVATIVE. 

181650 02-03 
ABSORPTION, DISTRIBUTION, EXCRETION AND METABOLISM OF 
BROMAZEPAM IN RABBIT. 

182555 03-03 
BLOOD LEVEL AND URINARY EXCRETION OF BROMAZEPAM IN MAN. 

182556 03-13 
DOUBLE-BLIND CROSSOVER COMPARISON OF BROMAZEPAM AND 

DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION. 

182624 03-11 
INVESTIGATION OF PHYSICAL DEPENDENCE ON A NEW BENZODIAZEPINE 
DERIVATIVE, BROMAZEPAM. 

189209 04-05 
BROMOMETHOXYAMPHET AMINES 

POTENTIAL PSYCHOTOMIMETICS: BROMOMETHOXY AMPHETAMINES AND 
STRUCTURAL CONGENERS OF LYSERGIC ACID. (PH.D. DISSERTATION). 

173588 01-03 
BROTOPON 

USE OF HALOPERIDOL (BROTOPON) IN THE TREATMENT OF 
SCHIZOPHRENIA. 

191686 04-08 
BUFOTENINE 

EVIDENCE FOR THE ACTION OF D-LYSERGIC ACID DIETHYLAMIDE, 

MESCALINE AND BUFOTENINE ON 5-HYDROXYTRYPTAMINE RECEPTORS 
IN UMBILICAL VASCULATURE. 

182716 03-03 
EFFECTS OF BUFOTENINE AND P-CHLOROPHENYLALANINE ON REACTIVITY 
TO FOOTSHOCK. 

184838 03-04 
BULB 

EFFECTS OF PSYCHOTROPIC DRUGS ON DISCRIMINATION AVOIDANCE 
CONDITIONING IN RATS WITH OLFACTORY BULB ABLATIONS. 

182115 02-04 
BULBOSPINAL 

NEW LONG LATENCY BULBOSPINAL EVOKED POTENTIALS BLOCKED BY 
SEROTONIN ANTAGONISTS. 

188751 04-03 
BULLFROG 

DIAZEPAM INHIBITION OF POST-TETANIC POTENTIATION IN BULLFROG 
SYMPATHETIC GANGLIA: POSSIBLE ROLE OF PROSTAGLANDINS. 

186673 03-03 
BUNDLE 

EFFECTS OF CHLORPROMAZINE, CHLORDIAZEPOXIDE AND 

PENTOBARBITAL ON NEURONAL EXCITABILITY IN THE MEDIAL 
FOREBRAIN BUNDLE DURING SELF-STIMULATION BEHAVIOR. 

1 77837 02-04 
INTRACRANIAL SELF-STIMULATION IN RATS AS A FUNCTION OF 
VARIOUS STIMULUS PARAMETERS: IV. INFLUENCE OF AMPHETAMINE 
ON MEDIAL FOREBRAIN BUNDLE STIMULATION WITH MONOPOLAR 
ELECTRODES. 

185961 03-04 
BURDEN 

ROLE OF FLUPHENAZINE DECANOATE IN LESSENING THE BURDEN OF 
CHRONIC SCHIZOPHRENICS ON THE COMMUNITY. 

169438 01-08 



BUTANE 

CARDIOVASCULAR AND GROSS BEHAVIORAL EFFECTS OF 

AMPHETAMINE, 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPROPANE 
(DOM) AND 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPHENYL BUTANE 
(BL-3912A) IN THE CONSCIOUS DOG. 

187573 04-03 
BUTANEDIOL 

PHARMACOLOGICAL AND TOXICOLOGICAL STUDIES ON 1.4 BUTANEDIOL. 

187381 04-03 
BUTANOLAMIDE 

EFFECT OF LSD-25 AND 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE ON 
RAT BRAIN AND PLATELET SEROTONIN LEVELS. 

184975 03-03 
BUTAPERAZINE 

THE EFFECT OF CONJUGATED ESTROGENS ON PLASMA BUTAPERAZINE 
LEVELS IN WOMEN. 

191959 04-15 
BUTOBARBITONE 

BUTOBARBITONE METABOLISM IN MAN: IDENTIFICATION OF 3- 
KETOBUTOBARBITONE. 

183793 03-13 
BUTYLATED 

THE EFFECT OF BUTYLATED HYDROXYANISOLE AND BUTYLATED 
HYDROXYTOLUENE ON BEHAVIORAL DEVELOPMENT OF MICE. 

188637 04-04 
BUTYLBARBITAL 

THE METABOLISM OF l-N-BUTYL-5,5 DIETHYLBARBITURIC ACID (N-N 
BUTYLBARBITAL) IN THE RAT. 

191057 04-03 
BUTYROPHENONE 

EFFECT OF A BUTYROPHENONE DERIVATIVE, U-32802A, ON BRAIN 
BIOGENIC AMINES. 

189584 04-02 

BUTYROPHENONES 

HALOPERIDOL AND THE BUTYROPHENONES. 

169296 01-09 
EFFECTS OF PHENOTHIAZINES, ANTIHISTAMINES, BENZODIAZEPINES AND 

BUTYROPHENONES ON THE RHYTHMS OF WAKEFULNESS SLEEP CYCLE 

IN RATS. 

182553 03-04 
EFFECTS OF PHENOTHIAZINES, ANTIHISTAMINES, BENZODIAZEPINES AND 

BUTYROPHENONES ON ELECTROENCEPHALOGRAM AND FEEDING 
BEHAVIOR OF RATS. 

182554 03-04 

C-FIBER 

THE EFFECT OF L-TRYPTOPHAN (TP) ON CUTANEOUS C-FIBER (CFR) AND 
POLYSYNAPTIC (PSR) REFLEXES IN ACUTE DECEREBRATE SPINAL CATS 
AND THE EFFECT OF PRETREATMENT WITH P-CHLOROPHENYLALANINE 
(PCPA) ON THE ACTION OF TP. (UNPUBLISHED PAPER). 

170874 01-03 
THE EFFECT IN THE CAT OF TRYPTAMINE (T) AND LSD ON CUTANEOUS C- 
FIBER (CFR) AND POLYSYNAPTIC (PSR) SPINAL REFLEXES. 
(UNPUBLISHED PAPER). 

174480 01-12 

C-NITROSO 

METABOLISM OF CHLORPHENTERMINE AND PHENTERMINE IN MAN TO 
YIELD HYDROXYLAMINO, C-NITROSO AND NITRO COMPOUNDS. 

183796 03-13 
C-200 

A CLINICAL STUDY OF L-TETRAHYDROPALMATINE (C-200) IN A 
NEUROPSYCHIATRIC CLINIC. 

182902 03-09 

CACTUS 

CACTUS ALKALOIDS. XIX. CRYSTALLIZATION OF MESCALINE HCL AfJD 3- 
METHOXYTYRAMINE HCL FROM TRICHOCEREUS-PACHANOI. 

192878 04-01 
CACTUS ALKALOIDS. XXII. DOLICHOTHELE SURCULOSA AND OTHER 

DOLICHOTHELE SPECIES. 

192879 04-01 
CACTUS ALKALOIDS: XVIII. PHENOLIC BETA-PHENETHYLAMINES FROM 

MAMMILLARIA-ELONGATA. 

192882 04-01 
CAFFEINE 

INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC), 
CAFFEINE, (C), NICOTINE (N), PHENOBARBITAL (P): EFFECTS ON 
CONDITIONED AVOIDANCE (CAR). 

182192 02-04 
INCREASED SYNTHESIS OF ADRENOMEDULLARY CATECHOLAMINES 
INDUCED BY CAFFEINE AND THEOPHYLLINE. 

184201 03-03 
THE EFFECT OF CAFFEINE, NITRAZEPAM AND CIGARETTE SMOKING ON 
THE CONTINGENT NEGATIVE VARIATION IN MAN. 

187350 04-13 
EFFECTS OF CAFFEINE ON ALERTNESS IN SIMULATED AUTOMOBILE 
DRIVING. 

190743 04-14 



S-41 



Subject Index 



Psychopharmacology Abstracts 



CALCIUM 

THE INHIBITION BY BETA-ADRENOCEPTOR BLOCKING AGENTS OF 

CALCIUM UPTAKE INTO AND EFFLUX FROM ISOLATED SARCOPLASMIC 
VESICLES. 

184223 03-03 
CALCIUM METABOLISM IN ELDERLY EPILEPTIC PATIENTS DURING 
ANTICONVULSANT THERAPY. 

185560 03-15 
EFFECT OF 5-METHOXYTRYPTAMINE ON SERUM CALCIUM AND 
PHOSPHATE IN RATS. 

186678 03-03 
CALCIUM REVERSAL OF NERVE BLOCKADE BY ALCOHOLS, ANESTHETICS, 
TRANQUILIZERS, AND BARBITURATES. 

187802 04-03 
CALIFORNIA 

COMPARATIVE SURVEY OF PSYCHIATRISTS TREATMENT PREFERENCES: 
CALIFORNIA AND NEW-YORK. 

185877 03-08 
CALMPOSE 

DIAZEPAM (CALMPOSE) IN ECLAMPSIA: A PRELIMINARY REPORT OF 16 
CASES. 

169633 01-11 
CALORIE 

INFLUENCE OF DIBENCYCLADINE AND IMIPRAMINE ON CALORIE INTAKE 
AND BODYWEIGHT. 

183359 03-03 
CAMBODIA 

PSYCHOTROPIC DRUGS IN CAMBODIA. 

178109 02-17 
CAMP 

TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. (UNPUBLISHED PAPER). 

170876 01-03 
EFFECTS OF NOMIFENSINE (HOE-984), D-AMPHETAMINE AND 

APOMORPHINE ON MOTOR ACTIVITY, CATECHOLAMINE TURNOVER 
AND CAMP CONCENTRATIONS IN RAT BRAIN. (UNPUBLISHED PAPER). 

191766 04-03 
CANADA 

A COMPARISON OF CLINICALLY USED PSYCHOACTIVE DRUGS IN FOUR 
LATIN-AMERICAN COUNTRIES AND IN CANADA (ARGENTINA, COSTA- 
RICA, MEXICO AND PANAMA). 

191139 04-17 
CANADIAN 

MEGAVITAMIN TREATMENT, CULTURE AND TRANQUILIZERS, DRUGS FOR 
THE AGED: PROJECTS OF A CANADIAN GRANT. 

170293 01-11 
CANAL 

NORADRENALINE IN THE GUINEA-PIG ALIMENTARY CANAL: REGIONAL 
DISTRIBUTION AND SENSITIVITY TO DENERVATION AND RESERPINE. 

191326 04-03 
CANINE 

EFFECTS OF PROSTAGLANDINS Bl AND B2 ON VASOCONSTRICTOR 
RESPONSES OF THE CANINE HINDPAW. 

189395 04-03 
CANNABIDIOL 

THE EFFECT OF CANNABIDIOL ON MAXIMAL ELECTROSHOCK SEIZURES IN 
RATS. 

168749 01-03 
PHARMACOLOGICAL INTERACTION BETWEEN CANNABIDIOL AND DELTA9- 
TETRAHYDROCANNABINOL. 

169472 01-03 
THE ANTICONVULSANT ACTIVITY OF CANNABIDIOL AND CANNABINOL. 

1 75238 02-03 
A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY IN MAN OF 
INTRAVENOUSLY ADMINISTERED DELTA9-TETRAHYDR0CANNABIN0L, 
CANNABINOL, AND CANNABIDIOL. 

1 76747 02-03 
INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L AND CANNABIDIOL 
ON INTESTINAL MOTILITY IN MICE. 

180057 02-03 
CANNABIDIOL AND CANNABIS-SATIVA EXTRACT PROTECT MICE AND 
RATS AGAINST CONVULSIVE AGENTS. 

183609 03-03 
CANNABIDIOL INTERACTION WITH DELTA9-TETRAHYDR0CANNABIN0L. 

183788 03-03 
COMPARATIVE EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9- 
THC), CANNABIDIOL (CBD), AND CANNABINOL (CBN) ON TIMING 
BEHAVIOR IN RATS. 

191967 04-04 
CARDIOPULMONARY EFFECTS OF CANNABIDIOL IN ANESTHETIZED DOGS. 

191993 04-05 
ANTICONVULSANT PROPERTIES OF CANNABIDIOL. 

191994 04-03 



CANNABINOID 

ANTICONVULSANT EFFECTS OF CANNABINOLS IN MICE: DRUG 
INTERACTIONS WITH CANNABINOIDS AND CANNABINOID 
INTERACTIONS WITH PHENYTOIN. 

189513 04-03 
THE EFFECT OF CANNABINOID MIXTURES ON THE RESPONSE TO 
STIMULANT DRUGS IN MICE. 

191991 04-04 
COMMON CANNABINOID PHENOTYPES IN 350 STOCKS OF CANNABIS. 

192787 04-17 
CANNABINOIDS 

PSYCHOPHARMACOLOGY OF THE CANNABINOIDS. 

181152 02-14 
THE EFFECT OF CANNABINOIDS ON THE NUMBER OF NUCLEAR 
MEMBRANE ATTACHED RIBOSOMES IN INFANT RAT BRAIN. 

183228 03-03 
ANTICONVULSANT EFFECTS OF CANNABINOLS IN MICE: DRUG 
INTERACTIONS WITH CANNABINOIDS AND CANNABINOID 
INTERACTIONS WITH PHENYTOIN. 

189513 04-03 
CANNABINOIDS AND HEXOBARBITAL INDUCED LOSS OF RIGHTING 
REFLEXES. 

189573 04-04 
CANNABINOIDS: NEUROCHEMICAL ASPECTS AFTER ORAL CHRONIC 
ADMINISTRATION TO RATS. 

189599 04-03 
CANNABINOL 

THE ANTICONVULSANT ACTIVITY OF CANNABIDIOL AND CANNABINOL. 

1 75238 02-03 
A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY IN MAN OF 
INTRAVENOUSLY ADMINISTERED DELTA9-TETRAHYDR0CANNABIN0L, 
CANNABINOL, AND CANNABIDIOL. 

1 76747 02-03 
COMPARATIVE EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9- 
THC), CANNABIDIOL (CBD), AND CANNABINOL (CBN) ON TIMING 
BEHAVIOR IN RATS. 

191967 04-04 
CANNABINOLS 

ANTICONVULSANT EFFECTS OF CANNABINOLS IN MICE: DRUG 
INTERACTIONS WITH CANNABINOIDS AND CANNABINOID 
INTERACTIONS WITH PHENYTOIN. 

189513 04-03 
CANNABIS 

PROSTAGLANDINS AND CANNABIS: A POSSIBLE MODE OF ACTION FOR 
THC. 

169067 01-03 
EEC, HEART RATE, AND MOOD CHANGE (HIGH) AFTER CANNABIS. 

169068 01-13 
VOCALIZATION: A CHARACTERISTIC CANNABIS INDUCED BEHAVIOR IN 

THE RAT? 

175884 02-04 
EFFECT OF CANNABIS ON PENTOBARBITAL INDUCED SLEEPING TIME AND 
PENTOBARBITAL METABOLISM IN THE RAT. 

179985 02-03 
CANNABIS PSYCHOSIS. 

180155 02-14 
CLINICAL PHARMACOLOGY OF CANNABIS. 

182741 03-14 
COMMON CANNABINOID PHENOTYPES IN 350 STOCKS OF CANNABIS. 

192787 04-17 
CANNABI^-INDICA 

CMh.NABIS-INDICA IN 19TH-CENTURY PSYCHIATRY. 

192059 04-17 
CANNABIS-SATIVA 

EFFECTS OF ACUTE AND CHRONIC ADMINISTRATION OF CANNABIS- 
SATIVA EXTRACT ON THE MOUSE-KILLING BEHAVIOR OF RATS 

167362 01-04 
CONSTITUENTS OF CANNABIS-SATIVA L. V.: STABILITY OF AN 

ANALYTICAL SAMPLE EXTRACTED WITH CHLOROFORM. (UNPUBLISHED 
PAPER). 

180670 02-01 
CANNABIDIOL AND CANNABIS-SATIVA EXTRACT PROTECT MICE AND 
RATS AGAINST CONVULSIVE AGENTS. 

183609 03-03 
CAPABILITY 

EVALUATION OF REINFORCING CAPABILITY OF DELTA9- 
TETRAHYDROCANNABINOL IN RHESUS MONKEYS. 

1 87638 04-04 
CAPSULE 

MOLINDONE: A CROSSOVER EVALUATION OF CAPSULE AND TABLET 
FORMULATIONS IN SEVERELY ILL SCHIZOPHRENIC PATIENTS. 

174137 01-08 



CAR 



INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC), 
CAFFEINE, (C), NICOTINE (N), PHENOBARBITAL (P): EFFECTS ON 
CONDITIONED AVOIDANCE (CAR). 

182192 02-04 



S-42 



VOLUME 12, SUBJECT INDEX 



Subject Index 



THE EFFECT OF MEDAZEPAM AND ALCOHOL ON COGNITIVE AND MOTOR 
SKILLS USED IN CAR DRIVING. 

189408 04-14 
CARBAMATE 

NEUROTOXICOLOGIC STUDIES OF TWO CARBAMATE PESTICIDES IN 
SUBACUTE ANIMAL EXPERIMENTS. 

188874 04-05 
CENTRALLY ACTING MUSCLE RELAXANTS. ISOMERIC 9,10 

DIHYDROXYOCTAHYDROPHENANTHRENES AND THEIR CARBAMATE 
ESTERS. 

190719 04-02 
CARBAMAZEPINE 

CARBAMAZEPINE SOLE ANTICONVULSANT FOR FOCAL EPILEPSY OF 
CHILDHOOD. 

189174 04-11 
CARBAMAZEPINE AS AN ANTICONVULSANT: A PILOT STUDY. 

192391 04-07 
CARBIDOPA 

LEVODOPA, CARBIDOPA, AND PYRIDOXINE IN PARKINSON DISEASE. 

187877 04-13 
CARBON 

REDUCTION BY PRETREATMENT WITH DIBENAMINE OF HEPATOTOXICITY 
INDUCED BY CARBON TETRACHLORIDE, THIOACETAMINDE OR 
DIMETHYLNITROSAMINE. 

188865 04-05 
INFLUENCE OF ADRENERGIC BLOCKERS AND ANTILIPEMIC AGENTS ON 
PHARMACODYNAMIC ACTIONS OF MORPHINE IN CARBON 
TETRACHLORIDE TREATED RATS. 

188873 04-03 
CARBONATE 

CLINICAL EFFECTS OF LITHIUM CARBONATE ON DEPRESSION. 

167917 01-09 
LITHIUM CARBONATE TREATMENT IN MANIC PSYCHOSIS. 

167918 01-09 
LITHIUM CARBONATE TOXICITY. 

168505 01-15 
A COMPARISON OF LITHIUM CARBONATE IN THE PREVENTION OF MANIC 
AND DEPRESSIVE EPISODES IN RECURRENT AFFECTIVE DISORDER. 

169090 01-09 
NEGATIVE SODIUM BALANCE IN LITHIUM CARBONATE TOXICITY: 
EVIDENCE OF MINERALOCORTICOID BLOCKADE. 

169869 01-15 
LITHIUM CARBONATE AND SLEEP IN AFFECTIVE DISORDERS: FURTHER 
CONSIDERATIONS. 

171503 01-09 
CLINICAL FACTORS IN LITHIUM CARBONATE PROPHYLAXIS FAILURE. 

174093 01-09 
LONG-TERM USE OF LITHIUM CARBONATE IN AFFECTIVE DISORDERS: A 
CLINICAL EVALUATION. 

174778 01-09 
DIFFERENTIAL EFFECTS OF D- AND L-AMPHETAMINE ON THE SLEEP OF 
DEPRESSED PSYCHIATRIC PATIENTS ON AND OFF LITHIUM CARBONATE 
TREATMENT. (UNPUBLISHED PAPER). 

1 78432 02-09 
LITHIUM DISTRIBUTION BETWEEN CEREBROSPINAL FLUID AND SERUM OF 
AFFECTIVE PSYCHOTIC PATIENTS TREATED WITH LITHIUM CARBONATE 
AND ITS CLINICAL RESPONSE. 

180301 02-11 
THE INFLUENCE OF CHRONIC ADMINISTRATION OF LITHIUM CARBONATE 
ON THE BRAIN NOREPINEPHRINE CONTENT IN RATS. 

182872 03-03 
LITHIUM CARBONATE IN MANIC-DEPRESSIVE PSYCHOSIS. 

187477 04-09 
LITHIUM CARBONATE: PSYCHIATRIC INDICATIONS AND MEDICAL 
COMPLICATIONS. 

187786 04-15 
HUNTINGTONS CHOREA TREATED WITH LITHIUM CARBONATE. 

187985 04-11 
PROPHYLACTIC EFFICACY OF LITHIUM CARBONATE IN MANIC- 
DEPRESSIVE ILLNESS: REPORT OF THE VETERANS ADMINISTRATION 
AND NATIONAL INSTITUTE OF MENTAL HEALTH (VA-NIMH) 
COLLABORATIVE STUDY GROUP. 

189735 04-09 
EXPERIMENT WITH LITHIUM CARBONATE ON THE TREATMENT OF MANIC 
STATE. 

191670 04-09 
CARDIOPULMONARY 

CARDIOPULMONARY EFFECTS OF CANNABIDIOL IN ANESTHETIZED DOGS. 

191993 04-05 
CARDIOTOXIC 

COMPARISON OF TRICYCLIC ANTIDEPRESSANTS AS TO THEIR 
CARDIOTOXIC ACTION IN CONSCIOUS RABBITS. 

171629 01-03 
CARDIOVASCULAR 

CARDIOVASCULAR EFFECTS OF RESERPINE, YOHIMBINE, AND RESERPINE 
YOHIMBINE MIXTURES ON INTACT ANESTHETIZED DOG. 

167328 01-03 



EEG AND CARDIOVASCULAR EFFECTS OF TRYPTAMINE (T) AND LSD IN 
THE ENCEPHALE ISOLE CAT. (UNPUBLISHED PAPER) 

174496 01-12 
CARDIOVASCULAR PHARMACOLOGY OF DELTA9- 
TETRAHYDROCANNABINOL, (PH.D. DISSERTATION). 

174964 01-03 
THE EFFECT OF DIAZEPAM ON SOME CARDIOVASCULAR AND 

RESPIRATORY REFLEXES ELICITED BY AFFERENT ABDOMINAL VAGUS 
STIMULATION. 

178945 02-03 
THE INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L (THC), 
PENTOBARBITAL AND SKF-525-A WITH THE CARDIOVASCULAR 
SYSTEM OF THE RAT. 

182218 03-03 
CARDIOVASCULAR AND GROSS BEHAVIORAL EFFECTS OF 

AMPHETAMINE, 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPROPANE 
(DOM) AND 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPHENYL BUTANE 
(BL-3912A) IN THE CONSCIOUS DOG. 

187573 04-03 
CARDIOVASCULAR REACTIVITY IN THE DOG AFTER CHEMICAL 
SYMPATHECTOMY WITH 6-HYDROXYDOPAMINE. 

187807 04-03 
CARDIOVASCULAR EFFECTS OF MARIHUANA IN MAN. 

187812 04-13 
CASE AGAINST THE USE OF D-TUBOCURARINE IN OPERANT STUDIES OF 
THE CARDIOVASCULAR SYSTEM. 

189425 04-03 
CARDIOVASCULAR EFFECTS OF DELTA8-THC AND DELTA9- 
TETRAHYDROCANNABINOL IN RATS. 

191971 04-03 
CARE 

MESORIDAZINE IN THE CARE OF DISTURBED MENTALLY RETARDED 
PATIENTS. 

168315 01-11 
PSYCHIATRIC CARE: DRUGS, THERAPIST, COMMUNITY. 

178189 02-17 
MEDICATION GROUPS FOR CONTINUING CARE. 

189640 04-17 
CARNITINE 

EFFECT OF A CARNITINE CYPROHEPTADINE COMBINATION ON ANOREXIA 
AND WEIGHT GAIN IN CHILDREN. 

178811 02-10 
CARPIPRAMINE 

EXPERIENCE IN THE USE OF A LOW DOSAGE OF CARPIPRAMINE 
(DEFEKTON). 

176472 02-08 
COMPARISON OF THE EFFECTS OF Y-4153 AND CARPIPRAMINE ON 
SCHIZOPHRENIA BY A DOUBLE-BUND METHOD. 

1 78053 02-08 
PRELIMINARY STUDIES OF CARPIPRAMINE: A COMPOUND SIMILAR TO 
BOTH ANTIDEPRESSANTS AND NEUROLEPTICS. 

180725 02-07 
A DOUBLE-BLIND COMPARISON OF PIMOZIDE WITH CARPIPRAMINE IN 
SCHIZOPHRENIC PATIENTS. 

183195 03-08 
CARRIER 

LITHIUM THERAPY AND ERYTHROCYTE MEMBRANE CATION CARRIER. 

187644 04-15 
CASE 

SLEEP STUDIES AND THERAPEUTIC TRIAL WITH L-DOPA IN A CASE OF 
STIFF-MAN SYNDROME. 

17113401-13 
AN AUTOPSY CASE OF SCHIZOPHRENIA COMPLICATED WITH 
PARKINSONISM INDUCED BY PERPHENAZINE. 

171275 01-15 
A CASE OF ENCEPHALITIS WITH PSYCHOTIC COMPLICATIONS. 

174783 01-11 
A CASE OF WERNERS SYNDROME WITH SCHIZOPHRENIA-LIKE 
SYMPTOMS. 

175120 02-09 
ACUTE CEREBELLAR DISTURBANCE ASSOCIATED WITH DIAZEPAM 
THERAPY - A CASE REPORT AND FURTHER INVESTIGATION. 

177392 02-15 
TIC DE GILLES-DE-LA-TOURETTE: CASE REPORT AND BRIEF DISCUSSION. 

181158 02-09 
SHORT-TERM PSYCHOTHERAPY WITH LSD: A CASE STUDY. 

181461 02-12 
A CASE OF KLEINE-LEVINE SYNDROME. 

183418 03-14 
LITHIUM IN THE TREATMENT OF PERIODIC CATATONIA: A CASE REPORT. 

183648 03-09 
A CASE OF TARDIVE DYSKINESIA APPEARING PRECOCIOUSLY UNDER 
NEUROLEPTICS. 

184961 03-17 
A CASE OF PERIODIC SOMNOLENCE IMPROVED BY THE CO-MEDICATION 
OF L-DOPA AND METHYLPHENIDATE. 

185241 03-14 



S-43 



Subject Index 

THYROTOXICOSIS DEVELOPING DURING LITHIUM TREATMENT; CASE 
REPORT. 

186473 03-15 
PSYCHEDELIC (LSD) PSYCHOTHERAPY: A CASE REPORT. 

186994 03-08 
ONE CASE OF AGRYPNIA (4 MONTHS WITHOUT SLEEP) IN A MORVAN 
DISEASE: FAVORABLE ACTION OF 5-HYDROXYTRYPTOPHAN. 

187237 03-14 
A CASE OF A NONSPECIFIC MENTAL ILLNESS WITH PSYCHOMOTOR 
VARIANT. 

188517 04-09 
STEROID PSYCHOSIS: A CASE REPORT. 

189042 04-15 
INTERACTION OF LOW-DOSE AMPHETAMINE USE WITH SCHIZOPHRENIA 
IN OUTPATIENTS: THREE CASE REPORTS. 

189099 04-15 
CASE AGAINST THE USE OF D-TUBOCURARINE IN OPERANT STUDIES OF 
THE CARDIOVASCULAR SYSTEM. 

189425 04-03 
CASTRATED 

MONOAMINES AND COPULATORY ACTIVATION IN THE CASTRATED MALE 
RAT 

171618 01-04 
LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 
ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 
COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25, AN IN 
INTACT MALE RATS. 

186683 03-04 



Psychopharmacology Abstracts 



CAT 



OSCILLATORY POTENTIALS OF THE CAT RETINA: EFFECTS OF ADRENERGIC 
DRUGS. 

172916 01-03 
INHIBITION BY MORPHINE OF REPETITIVE ACTIVATION OF CAT SPINAL 
MOTONEURONES. 

172926 01-03 
THE EFFECT OF PSYCHOTROPIC AGENTS ON SOME ASPECTS OF 
ACETYLCHOLINE METABOLISM IN CAT BRAINS. 

174257 01-03 
THE EFFECT IN THE CAT OF TRYPTAMINE (T) AND LSD ON CUTANEOUS C- 
FIBER (CFR) AND POLYSYNAPTIC (PSR) SPINAL REFLEXES. 
(UNPUBLISHED PAPER). 

174480 01-12 
EEG AND CARDIOVASCULAR EFFECTS OF TRYPTAMINE (T) AND LSD IN 
THE ENCEPHALE ISOLE CAT. (UNPUBLISHED PAPER) 

174496 01-12 
RELATIVE POTENCIES OF D- AND L-AMPHETAMINE ON THE RELEASE OF 
DOPAMINE FROM CAT BRAIN IN VIVO. 

176874 02-03 
INHIBITORY EFFECT OF DOXEPIN ON AGONISTIC BEHAVIOUR ELICITED BY 
HYPOTHALAMIC STIMULATION IN THE CAT. 

180044 02-04 
REGIONAL CYCLIC NUCLEOTIDES PHOSPHODIESTERASE ACTIVITY IN CAT 
CENTRAL NERVOUS SYSTEM: EFFECTS OF BENZODIAZEPINES. 

181575 02-03 
A COMPARISON OF SOMATIC REFLEX EFFECTS OF THREE PSYCHOTROPIC 
AGENTS IN THE CHLORALOSE CAT. 

182126 02-03 
THE ACTIONS OF SEVERAL PSYCHOACTIVE AGENTS UPON THE 
MUSCARINIC MECHANISMS IN THE SUPERIOR CERVICAL GANGLION OF 
THE CAT. 

183866 03-03 
THE EFFECTS OF 5-HYDROXYTRYPTAMINE AND SOME RELATED 
COMPOUNDS ON THE CAT SUPERIOR CERVICAL GANGLION IN SITU. 

184197 03-03 
THE EFFECTS OF VARIOUS NICOTINE-LIKE AGENTS IN THE CAT SUPERIOR 
CERVICAL GANGLION IN SITU. 

184202 03-03 
GENERALIZED PENICILLIN EPILEPSY IN THE CAT: EFFECTS OF 

INTRACAROTID AND INTRAVERTEBRAL PENTYLENETETRAZOL AND 
AMOBARBITAL INJECTIONS. 

188374 04-03 
EFFECTS OF INTRACEREBRAL INJECTION OF 5,6-HYDROXYTRYPTAMINE 
ON CEREBRAL MONOAMINES AND SLEEP STATES IN THE CAT/. 

189023 04-02 
EFFECTS OF ALPHA-METHYLTYROSINE ON D-AMPHETAMINE INDUCED 
RELEASE OF ENDOGENOUSLY SYNTHESIZED AND EXOGENOUSLY 
ADMINISTERED CATECHOLAMINES FROM THE CAT BRAIN IN VIVO. 

189397 04-03 
THE ACTION OF BETA-PHENYL-GABA DERIVATIVES ON NEURONES OF THE 
CAT CEREBRAL CORTEX. 

189750 04-03 
EXCITABILITY CHANGES DURING THE GRADUAL DEVELOPMENT OF AND 
RECOVERY FROM PENTYLENETETRAZOL AND STRYCHNINE INDUCED 
CONVULSIONS IN THE CAT. 

191927 04-03 
LONG-TERM ALTERATION OF SLEEP-WAKEFULNESS CYCLE DURING 
CHRONIC PENTOBARBITAL DOSING AND WITHDRAWAL IN CAT. 

191952 04-04 



COMPARISON OF BARBITAL & PENTOBARBITAL PHYSICAL DEPENDENCE 
IN THE CAT. 

191953 04-04 
CATABOUSM 

A COMPARISON OF THE EFFECTS OF AMPHETAMINE AND ITS 
METABOLITES, P-HYDROXYAMPHETAMINE AND P- 
HYDROXYNOREPHEDRINE, ON UPTAKE, RELEASE AND CATABOLISM OF 
3H-N0REPINEPHRINE IN CEREBRAL CORTEX OF RAT BRAIN. 

186669 03-03 
CATAHOUIA 

PSYCHOPHARMACOLOGIC FACILITATION OF OPERANT CONDITIONING OF 
GENETICALLY NERVOUS CATAHOULA AND POINTER DOGS. 

190696 04-04 
CATALEPSY 

DRUG-INDUCED CATALEPSY AS INFLUENCED BY PSYCHOSTIMULANTS, 
APOMORPHINE, L-DOPA, AND YOHIMBINE. 

177730 02-13 
CATALEPSY AND STEREOTYPED BEHAVIOUR IN RATS TREATED 
CHRONICALLY WITH METHADONE: RELATION TO BRAIN 
HOMOVANILLIC ACID CONTENT. 

183606 03-04 
CATALEPSY INDUCED BY ALPHA-METHYL-P-TYROSINE AND D- 
AMPHETAAAINE: THE ROLE OF CATECHOLAMINE METABOLISM. 

185750 03-03 
ON CATALEPSY AND CATATONIA AND THE PREDICTABILITY OF THE 
CATALEPSY TEST FOR NEUROLEPTIC ACTIVITY. 

185958 OS-O-i 
CATALEPSY AND STEREOTYPIES IN RATS TREATED WITH METHADONE; 
RELATION TO STRIATAL DOPAMINE. 

191421 04-0; 
CATALEPTIC 

IS THERE A RELATIONSHIP BETWEEN THE INVOLVEMENT OF 
EXTRAPYRAAAIDAL AND MESOLIMBIC BRAIN AREAS WITH THE 
CATALEPTIC ACTION OF NEUROLEPTIC AGENTS AND THEIR CLINICAL 
ANTIPSYCHOTIC EFFECT? 

171305 01 -o; 

A ROLE FOR THE AMYGDALA IN THE DEVELOPMENT OF THE CATALEPTIC 
AND STEREOTYPIC ACTIONS OF THE NARCOTIC AGONISTS AND 
ANTAGONISTS IN THE RAT. 

186577 03-0; 
CATATONIA 

EXPERIMENTAL CATATONIA AND PSYCHOPHARMACOLOGY. 

180724 02-0- 
LITHIUM IN THE TREATMENT OF PERIODIC CATATONIA: A CASE REPORT. 

183648 03-0< 
ON CATALEPSY AND CATATONIA AND THE PREDICTABILITY OF THE 
CATALEPSY TEST FOR NEUROLEPTIC ACTIVITY. 

185958 03-a 
CATECHOL-O-METHYLTRANSFERASE 

EFFECT OF CHRONIC ADMINISTRATION OF L-DOPA ON CATECHOL-O- 
METHYLTRANSFERASE IN RAT TISSUES. 

176936 02-0: 
THE RATE LIMITING CONTROL OF ENZYMES MONOAMINE OXIDASE AND 
CATECHOL-O-METHYLTRANSFERASE IN THE FETUS AND THE ADULT BY 
ADRENOCORTICOL HORMONES. 

1 7881 5 02-0: 
NICOTINIC ACID AND CATECHOL-O-METHYLTRANSFERASE ACTIVITY IN 
SCHIZOPHRENIA. 

183360 03-1: 
COMPARATIVE PROPERTIES OF SOLUBLE AND PARTICULATE CATECHOL- 
O-METHYLTRANSFERASE FROM RAT RED BLOOD CELL: PRELIMINARY 
OBSERVATIONS. 

191523 04-0 
CATECHOLAMINE 

EFFECT OF GENERAL ANESTHETICS ON SYSTEMIC CATECHOLAMINE 
CONCENTRATION I: HALOTHANE. (UNPUBLISHED PAPER). 

168862 01-0 
CATECHOLAMINE METABOLISM IN AFFECTIVE DISORDERS: RECENT 
STUDIES OF MHPG EXCRETION. 

169091 01-1 
THE EFFECTS OF CHRONIC TREATMENT WITH DELTA9- 

TETRAHYDROCANNABINOL ON CATECHOLAMINE SYNTHESIS IN THE 
RAT 

169471 01-0 
IMPORTANCE OF CATECHOLAMINE RELEASE BY NERVE IMPULSES FOR 
FREE OPERANT BEHAVIOR. 

171611 01-0 
CATECHOLAMINE TURNOVER IN THE RAT BRAIN: DIFFERENT RESULTS 
OBTAINED IN DIFFERENT EXPERIMENTAL CONDITIONS. 

181471 02-0 
THE EFFECTS OF DRUGS ON THE RELEASE OF CATECHOLAMINE. 

182089 02-0 
STUDIES ON THE EFFECT OF ACUTE AND CHRONIC MORPHINE 
TREATMENT ON CATECHOLAMINE LEVELS AND TURNOVER IN 
DISCRETE BRAIN AREAS OF RATS. 

182228 03-0 
EFFECTS OF CHRONIC ADMINISTRATION OF AMPHETAMINE UPON THE 
CATECHOLAMINE CONTENT OF MOUSE BRAIN. 

182255 03-0 



S-44 



VOLUME 12, SUBJECT INDEX 

PENTYLENETETRAZOL CONVULSIONS AND BRAIN CATECHOLAMINE 

TURNOVER RATE IN RATS AND MICE RECEIVING DIPHENYLHYDANTOIN 
OR BENZODIAZEPINES. 

182344 03-03 
CATALEPSY INDUCED BY ALPHA-METHYL-P-TYROSINE AND D- 
AMPHETAMINE: THE ROLE OF CATECHOLAMINE METABOLISM. 

185750 03-03 
COMPARATIVE EFFECTS OF DL-P-METHOXY AMPHETAMINE AND D- 
AMPHETAMINE ON CATECHOLAMINE RELEASE AND REUPTAKE IN 
VITRO. 

186671 03-03 
NEUROLEPTIC ANTAGONISM OF CATECHOLAMINE INHIBITIONS IN RAT 
CEREBELLUM AND CAUDATE. (UNPUBLISHED PAPER). 

187496 04-03 
SELF-STIMULATION AND CATECHOLAMINES: DRUG-INDUCED 

MOBILIZATION OF THE RESERVE POOL RE-ESTABLISHES RESPONDING 
IN CATECHOLAMINE DEPLETED RATS. 

189025 04-04 
HYDROCORTISONE INDUCED INCREASE IN THE HISTOCHEMICALLY 
DEMONSTRABLE CATECHOLAMINE CONTENT OF SYMPATHETIC 
NEURONS OF THE NEWBORN RAT. 

189027 04-03 
EFFECTS OF CATECHOLAMINE DEPLETING DRUGS AND AMPHETAMINE ON 
SELF-STIMULATION OF BRAIN FOLLOWING VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS. 

189515 04-04 
MECHANISM OF ADRENAL CATECHOLAMINE RELEASE BY DIVALENT 
MERCURY. 

189591 04-03 
DIHYDROPTERIDINE REDUCTASE IN RAT BRAIN: REGIONAL DISTRIBUTION 
AND THE EFFECT OF CATECHOLAMINE DEPLETING DRUGS. 

189752 04-03 
EFFECT OF ANESTHETIC AGENTS ON PERIPHERAL SYMPATHETIC NERVOUS 
SYSTEM FUNCTION AS MONITORED BY ARTERIAL PLASMA 
CATECHOLAMINE LEVELS. (UNPUBLISHED PAPER 

191495 04-03 
RELATIONSHIP OF CATECHOLAMINE NEURAL SYSTEMS TO THE 
BEHAVIORAL ALTERATIONS PRODUCED BY 6-HYDROXYDOPAMINE 
ADMINISTRATION INTO BRAIN. 

191518 04-03 
FLUORESCENCE AND ELECTRON MICROSCOPIC ANALYSIS OF 
CATECHOLAMINE CONTAINING FIBERS IN MUTANT MOUSE 
CEREBELLUM. (UNPUBLISHED PAPER). 

191762 04-03 
EFFECTS OF NOMIFENSINE (HOE-984), D-AMPHETAMINE AND 

APOMORPHINE ON MOTOR ACTIVITY, CATECHOLAMINE TURNOVER 
AND CAMP CONCENTRATIONS IN RAT BRAIN. (UNPUBLISHED PAPER). 

191766 04-03 
NONSPONTANEOUS CONVULSIONS IN MICE ELICITED BY SOME 
CATECHOLAMINE RELEASERS AND 6,7 
DIHYDROXYTETRAHYDROISOQUINOLINE(TIQ). 

192013 04-05 
THE EFFECTS OF HOE-36801 ON CATECHOLAMINE EXCRETION, HEART 
RATE AND PSYCHOMOTOR PERFORMANCE IN NEUROTICS AND 
NORMALS. 

192428 04-13 
BETA-BLOCKING AGENTS IN THE TREATMENT OF CATECHOLAMINE 
INDUCED SYMPTOMS IN MUSICIANS. 

192527 04-11 
CATECHOLAMINES 

STRIATAL TYROSINE HYDROXYLASES WITH HIGH AND LOW AFFINITY 
FOR TYROSINE: IMPLICATIONS FOR THE MULTIPLE POOL CONCEPT OF 
CATECHOLAMINES. 

167325 01-03 
EFFECTS OF SOME TETRAHYDROCANNABINOLS ON THE BIOSYNTHESIS 
AND UTILIZATION OF CATECHOLAMINES IN THE RAT BRAIN. 

172917 01-03 
ON THE MECHANISM OF CENTRAL ACTION OF AMPHETAMINE: THE ROLE 
OF CATECHOLAMINES. 

172921 01-04 
TECHNICAL STRATEGIES FOR THE STUDY OF CATECHOLAMINES IN MAN. 
(UNPUBLISHED PAPER). 

173387 01-03 
STUDIES ON THE URINARY EXCRETION OF CATECHOLAMINES AND 17- 
KETOSTEROID IN MANIC-DEPRESSIVE PSYCHOSIS. 

178623 02-09 
THE EFFECTS OF INTRAVENTRICULARLY ADMINISTERED 

CATECHOLAMINES AND SEROTONIN ON THE RESERPINE INDUCED 
SPIKE WAVES RECORDED FROM THE MEDICAL NUCLEUS TRAPEZOIDES 
IN THE RABBIT. 

182094 02-03 
THE EFFECT OF CATECHOLAMINES, ACETYLCHOLINE AND SEROTONIN ON 
THE MORPHINE TOLERANT LONGITUDINAL MUSCLE STRIP OF THE 
GUINEA-PIG ILEUM. 

182161 02-03 
RECOVERY OF FEEDING AFTER 6-HYDROXYDOPAMINE (6-HDA) OR 
LATERAL HYPOTHALAMIC LESIONS: THE ROLE OF CATECHOLAMINES, 

182213 03-03 



Subject Index 



COMPARATIVE EFFECTS OF DL-P-METHOXYAMPHETAMINE AND D- 
AMPHETAMINE ON CENTRAL CATECHOLAMINES AND LOCOMOTOR 
ACTIVITY. 

182253 03-04 
INCREASED SYNTHESIS OF ADRENOMEDULLARY CATECHOLAMINES 
INDUCED BY CAFFEINE AND THEOPHYLLINE. 

184201 03-03 
IN VIVO RELEASE OF NEWLY SYNTHESIZED CATECHOLAMINES FROM THE 
HYPOTHALAMUS BY AMPHETAMINE. 

184230 03-03 
A PSYCHOPHARMACOLOGICAL STUDY OF CATECHOLAMINES IN 
AFFECTIVE DISORDERS. 

184653 03-09 
ROLE OF CATECHOLAMINES IN THE ANORECTIC EFFECTS OF 
AMPHETAMINE IN RATS. 

186582 03-03 
LEARNING IMPAIRMENT IN RATS AFTER 6-HYDROXYDOPAMINE INDUCED 
DEPLETION OF BRAIN CATECHOLAMINES. 

187420 04-04 
DEVELOPMENT OF LOCOMOTION AND BRAIN CATECHOLAMINES. 

187551 04-04 
EVIDENCE FOR AN INHIBITORY ROLE FOR ACETYLCHOLINE, 

CATECHOLAMINES, AND SEROTONIN ON THE CEREBRAL CORTEX. 

187552 04-03 
COMPARISON OF PHARMACOLOGICAL RESPONSES TO NICOTINE AND 

RELEASE OF CATECHOLAMINES FROM THE ADRENALS IN DOGS AND 
MONKEYS. 

188199 04-03 
SELF-STIMULATION AND CATECHOLAMINES: DRUG-INDUCED 

MOBILIZATION OF THE RESERVE POOL RE-ESTABLISHES RESPONDING 
IN CATECHOLAMINE DEPLETED RATS. 

189025 04-04 
SELECTIVE RESERPINE RESISTANT ACCUMULATION OF CATECHOLAMINES 

IN CENTRAL DOPAMINE NEURONES AFTER DOPA ADMINISTRATION. 

189026 04-03 
EFFECTS OF ALPHA-METHYLTYROSINE ON D-AMPHETAMINE INDUCED 

RELEASE OF ENDOGENOUSLY SYNTHESIZED AND EXOGENOUSLY 
ADMINISTERED CATECHOLAMINES FROM THE CAT BRAIN IN VIVO. 

189397 04-03 
THE EFFECT OF INCREASED GAMMA-AMINOBUTYRIC ACID ON ALPHA- 
METHYLTYROSINE INDUCED DECREASE IN CATECHOLAMINES IN RAT 
BRAIN. 

191988 04-03 

CATION 

LITHIUM THERAPY AND ERYTHROCYTE MEMBRANE CATION CARRIER. 

187644 04-15 
CATIONS 

EFFECTS OF SOME METALLIC CATIONS ON CEREBRAL CORTICAL 
NEURONES AND THEIR INTERACTIONS WITH BIOGENIC AMINES. 

187806 04-03 
EFFECT OF DIVALENT CATIONS ON ACH CONTRACTURES OF 
DEPOLARIZED DENERVATED RAT MUSCLES. 

188914 04-03 



CATS 



THE EFFECT OF L-TRYPTOPHAN (TP) ON CUTANEOUS C-FIBER (CFR) AND 
POLYSYNAPTIC (PSR) REFLEXES IN ACUTE DECEREBRATE SPINAL CATS 
AND THE EFFECT OF PRETREATMENT WITH P-CHLOROPHENYLALANINE 
(PCPA) ON THE ACTION OF TP. (UNPUBLISHED PAPER). 

170874 01-03 
FAILURE OF N,N DIMETHYLTRYPTAMINE TO EVOKE TOLERANCE IN CATS. 

173398 01-03 
THE EFFECTS OF PHENITRONE, A REPORTED HASHISH ANTAGONIST, ON 
THE OVERT BEHAVIOR OF CATS. 

174607 01-04 
PROTECTION PRODUCED BY BENZODIAZEPINES (BDP) AGAINST THE 
NEUROTOXIC AND CONFLICT BEHAVIOR EFFECTS OF 
HEXACHLOROPHENE (HCP) IN CATS. 

176863 02-04 
COMPARISON OF CLOPENTHIXOL AND PERPHENAZINE IN BEHAVIOR AND 
EEG OF UNANESTHETIZED CATS. 

181386 02-04 
EFFECT OF 8-CHL0R0-6-PHENYL-4H-S-TRIAZ0L0BENZ0DIAZEPINE (D-40TA) 
ON THE DAYTIME SLEEP-WAKEFULNESS PATTERNS IN NORMAL AND P- 
CHLOROPHENYLALANINE INSOMNIAC CATS. 

181658 02-02 
EFFECTS OF BENZODIAZEPINES ON SPINAL REFLEXES IN CATS. 

182097 02-03 
EFFECTS OF CYPROHEPTADINE ON THE EATING BEHAVIOR OF RATS AND 
CATS. 

182111 02-04 
PHARAAACOLOGIC ANALYSIS OF THE CAUDATE SPINDLE IN CATS. 

182124 02-03 
CENTRAL CHOLINERGIC (MUSCARINIC) LINK IN THE ATTACK REFLEXIVE 
BITING MECHANISM OF CATS. 

182238 03-04 
EEG CHANGES & MOTOR IMPAIRMENT AFTER DISULFIRAM 
ADMINISTRATION TO CATS. 

182248 03-03 



S-45 



Subject Index 



Psychopharmacology Abstracts 



CHANGES IN SHORT-TERM AND LONG-TERM MEMORY OF DOGS AND 
CATS UNDER THE EFFECTS OF AMIZYL (BENACTYZINE). 

183517 03-04 
DIAZEPAM-INDUCED PLAY BEHAVIOR IN CATS DURING PREY KILLING. 

1 84979 03-04 
NEUROLOGICAL CHANGES IN CATS FOLLOWING LONG-TERM DIET OF 
MERCURY CONTAMINATED TUNA. 

186476 03-05 
HYPERTHERMIC EFFECT OF PALMITATE SODIUM, STEARATE SODIUM AND 
OLEATE SODIUM INJECTED INTO THE CEREBRAL VENTRICLES OF 
CONSCIOUS CATS. 

186640 03-03 
THE TRANSSYNAPTIC RELATIONSHIP BETWEEN DOPAMINE AND 
SEROTONIN IN THE CAUDATE NUCLEUS OF CATS. 

186700 03-04 
INTESTINAL EFFECTS OF 5-HYDROXYTRYPTAMINE AND MORPHINE IN 
GUINEA-PIGS, DOGS, CATS AND MONKEYS. 

188202 04-03 
INTRACEREBRAL INJECTION OF 6-HYDROXYDOPAMINE AND HYDROGEN 
PEROXIDE IN CATS: SPECIFIC AND NONSPECIFIC EFFECTS ON STRIATAL 
BIOGENIC AMINES. 

188426 04-03 
THE EFFECTS OF ACETYLCHOLINE AND OF SYNAPTIC STIMULATION ON 
THE SENSORIMOTOR CORTEX OF CATS. I. NEURONAL RESPONSES TO 
STIMULATION OF THE RETICULAR FORMATION. 

189855 04-03 
THE EFFECTS OF ACETYLCHOLINE AND OF SYNAPTIC STIMULATION ON 

THE SENSORIMOTOR CORTEX OF CATS. II. COMPARISON OF THE 
NEURONAL RESPONSES TO RETICULAR AND OTHER STIMULI. 

189856 04-03 
CAUDATE 

TREMOR INDUCTION BY INTRACAUDATE INJECTIONS OF BRETYLIUM, 
TETRABENAZINE, OR MESCALINE: FUNCTIONAL DEFICITS IN CAUDATE 
DOPAMINE. 

167329 01-03 
CAUDATE NUCLEUS EFFECTS ON GERIATRIC SENILITY: EFFECT OF 

BELLADONNA ON LEARNING AND MEMORY OF GERIATRIC PATIENTS. 

170744 01-11 
CYCLIC ADENOSINE MONOPHOSPHATE: SELECTIVE INCREASE IN CAUDATE 
NUCLEUS AFTER ADMINISTRATION OF L-DOPA. 

176254 02-13 
PHARMACOLOGIC ANALYSIS OF THE CAUDATE SPINDLE IN CATS. 

182124 02-03 
EFFECTS OF DOPAMINERGIC STIMULANTS ON THE CAUDATE SPINDLE. 

182125 02-03 
THE ACTION OF D-AMPHETAMINE ON SPONTANEOUS ACTIVITY IN THE 

CAUDATE NUCLEUS AND RETICULAR FORMATION OF THE RAT. 

185264 03-03 
DIFFERENTIAL RECOVERY OF FUNCTION FOLLOWING CAUDATE, 
HIPPOCAMPAL, AND SEPTAL LESIONS IN MICE. 

186620 03-04 
THE TRANSSYNAPTIC RELATIONSHIP BETWEEN DOPAMINE AND 
SEROTONIN IN THE CAUDATE NUCLEUS OF CATS. 

186700 03-04 
ALTERATION OF EVOKED POTENTIALS IN CAUDATE NUCLEUS OF FREELY 
MOVING RATS BY L-DOPA, RESERPINE, AND PENTOBARBITAL. 

187362 04-03 
NEUROLEPTIC ANTAGONISM OF CATECHOLAMINE INHIBITIONS IN RAT 
CEREBELLUM AND CAUDATE. (UNPUBLISHED PAPER). 

187496 04-03 
CAUSAL 

ANTIPARKINSON DRUGS AS CAUSAL AGENTS IN TARDIVE DYSKINESIA. 

169140 01-15 



CBD 



COMPARATIVE EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9- 
THC), CANNABIDIOL (CBD), AND CANNABINOL (CBN) ON TIMING 
BEHAVIOR IN RATS. 

191967 04-04 
CBN 

COMPARATIVE EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9- 
THC), CANNABIDIOL (CBD), AND CANNABINOL (CBN) ON TIMING 
BEHAVIOR IN RATS. 

191967 04-04 
CDP-CHOUNE 

ELECTROPHYSIOLOGICAL STUDIES OF THE EFFECTS OF CDP-CHOLINE ON 
THE CENTRAL NERVOUS SYSTEM. 

182547 03-03 



CELL 



SELF-STIMULATION OF NORADRENERGIC CELL GROUP (A6) IN LOCUS- 
COERULEUS OF RATS. 

173029 01-03 
COMPARATIVE PROPERTIES OF SOLUBLE AND PARTICULATE CATECHOL- 
0-METHYLTRANSFERASE FROM RAT RED BLOOD CELL: PRELIMINARY 
OBSERVATIONS. 

191523 04-01 



CELLS 

EFFECTS OF PCHLOROPHENYLALANINE ON DIFFERENTIATION OF 
SEROTONINERGIC RECEPTIVE CELLS DURING EMBRYOGENESIS. 
(UNPUBLISHED PAPER). 

168817 01-03 
EFFECT OF SELECTED BETA-DIKETONES ON LITHIUM FLUXES OF BOVINE 
RED BLOOD CELLS. 

171792 01-05 
EFFECTS OF CHLORPROMAZINE AND ACTINOMYCIN D ON UPTAKE AND 
INCORPORATION OF CERTAIN AMINO ACIDS, HYPOXANTHINE AND 
THYMIDINE IN CULTURES OF HUMAN SKIN EPITHELIAL CELLS. 

179989 02-13 
A COMPARISON OF EFFECTS OF D-LYSERGIC ACID DIETHYLAMIDE (LSD) 
AND SEROTONIN ON PRE- AND POSTSYNAPTIC CELLS IN THE 
SEROTONIN SYSTEM. 

182141 02-03 
EFFECTS OF NARCOTIC ANALGESICS ON ENZYMES OF ACETYLCHOLINE 
METABOLISM IN CULTURED CHICK BRAIN CELLS. 

182225 03-03 
THE EFFECTS OF MORPHINE, ETORPHINE AND SINOMENINE ON THE 
CHEMICAL SENSITIVITY AND SYNAPTIC RESPONSES OF RENSHAW 
CELLS AND OTHER SPINAL NEURONES IN THE RAT. 

188201 04-03 
EFFECT OF IMIPRAMINE ON CULTURED RAT HEART CELLS. 

188864 04-03 
LIPIDOSIS-LIKE ALTERATIONS IN DORSAL ROOT GANGLION CELLS OF 
RATS TREATED WITH TRICYCLIC ANTIDEPRESSANTS. 

189605 04-03 
EFFECTS OF ALUMINUM SALTS ON CULTURED NEUROBLASTOMA CELLS. 

191313 04-03 
CELLULAR 

KINETICS AND CELLULAR CONTROL MECHANISMS FOR IMIPRAMINE 
METABOLISM IN THE ISOLATED PERFUSED RAT LIVER. (PH.D. 
DISSERTATION). 

173601 01-03 
CELLULAR EFFECTS OF METHAQUALONE ON DRUG METABOLIZING 
ENZYMES. 

191942 04-03 
CENTERS 

INTERNATIONAL REFERENCE CENTERS NETWORK FOR PSYCHOTROPIC 
DRUGS. 

167706 01-17 
THE ACTION OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTOR 
CENTERS OF EMOTIONS IN THE HYPOTHALAMUS. 

191785 04-02 
CENTPYRAQUIN 

ANTIHYPERTENSIVE AND CENTRAL NERVOUS SYSTEM DEPRESSANT 
PROPERTIES OF 3-(GAMMA-P-FLU0ROBENZOYLPROPYL) 2,3,4,4A,5,6 
HtXAHYDROPYRAZINOQUINOLINE HYDROCHLORIDE (COMPOUND-69- 
183, CENTPYRAQUIN). 

176881 02-03 
CENTRAL 

CENTRAL MONOAMINE METABOLISM IN MAN: EFFECT OF PUTATIVE 
DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS. 

169377 01-13 
EVALUATION OF CENTRAL ANTIRESERPINE EFFECT BY THE USE OF LIGHT 
BLINK REFLEX. 

169469 01-04 
SELECTIVE ANTAGONISM OF CENTRAL NERVOUS SYSTEM DEPRESSANTS 
BY DH-524; A COMPARATIVE STUDY WITH BEMEGRIDE. 

171007 01-13 
THE EFFECT OF PANAX GINSENG SAPONIN ON THE CENTRAL NERVOUS 
SYSTEM IN RAT: THE PSYCHOPHARMACOLOGICAL EFFECT OF 
GINSENG. 

171599 01-04 
TURNOVER CHANGES IN CENTRAL MONOAMINE NEURON SYSTEMS 
AFTER MINOR TRANQUILLIZERS AND BARBITURATES. 

171604 01-03 
EFFECT OF TETRAHYDROCANNABINOLS ON CENTRAL MONOAMINE 

NEURONS. 

171605 01-03 
SEROTONINERGIC MECHANISMS IN THE CENTRAL ACTION OF 

PSYCHOTROPIC DRUGS. (PH.D. DISSERTATION). 

172015 01-03 
DETERMINATION OF DRUG TRANSFER ACROSS BIOLOGICAL MEMBRANES: 
COMPARATIVE STUDY ON THE PASSAGE OF DRUGS INTO THE 
CENTRAL NERVOUS SYSTEM AND THEIR PLACENTAL TRANSFER AND 
FETAL LOCALIZATION IN THE PREGNANT RAT. (PH.D. DISSERTATION). 

172018 01-03 
THE SPIRAL AFTEREFFECT (SAE) AS A MEASURE OF MOTION SICKNESS 
SUSCEPTIBILITY AND THE EFFECT ON THE SAE OF AN ANTIMOTION 
SICKNESS DRUG AND A CENTRAL NERVOUS SYSTEM DEPRESSANT. 

172780 01-03 
ON THE MECHANISM OF CENTRAL ACTION OF AMPHETAMINE: THE ROLE 
OF CATECHOLAMINES. 

172921 01-04 
DEPENDENCE OF ANTICONVULSANT DRUG ACTION ON CENTRAL 
MONOAMINES. 

172923 01-03 



S-46 



VOLUME 12, SUBJECT INDEX 



Subject Index 



CENTRAL MONOAMINES AND THE ACOUSTIC STARTLE REACTION IN 
RATS. (PH.D. DISSERTATION). 

173136 01-04 
EFFECT OF A NEW PSYCHOTROPIC DRUG, CS-370 (10-CHLORO-l lB-(2- 
CHLOROPHENYL)-2.3,5,6,7,l IB HEXAHYDROBENZODIAZEPINOOXAZOL- 
6-ONE) UPON THE CENTRAL NERVOUS SYSTEM. 

174603 01-03 
EFFECTS OF AMPHETAMINE AND ITS HYDROXYLATED METABOLITES ON 
CENTRAL NORADRENERGIC MECHANISMS. (PH.D. DISSERTATION). 

174959 01-03 
POTENTIAL NEUROTRANSMITTERS AND RECEPTOR MECHANISMS 
INVOLVED IN THE CENTRAL CONTROL OF BODY TEMPERATURE IN 
HAMSTERS. (PH.D. DISSERTATION). 

174962 01-03 
AMPHETAMINE TRICYCLIC INTERACTIONS: ROLE OF THE 

HYDROXYLATION OF AMPHETAMINE IN ITS CENTRAL AND PERIPHERAL 
MODE OF ACTION. (PH.D. DISSERTATION). 

174963 01-03 
ANTIHYPERTENSIVE AND CENTRAL NERVOUS SYSTEM DEPRESSANT 

PROPERTIES OF 3-(GAMMA-P-FLU0R0BENZ0YLPR0PYL) 2,3,4,4A,5,6 
HEXAHYDROPYRAZINOQUINOLINE HYDROCHLORIDE (COMPOUND-69- 
183, CENTPYRAQUIN). 

176881 02-03 
CENTRAL NERVOUS SYSTEM AND AUTONOMIC NERVOUS SYSTEM 

EFFECTS OF AMANTADINE AND OF SOME STANDARD ANTIPARKINSON 
DRUGS. 

177729 02-13 

AMITRIPTYLINE IN MAN: DECREASED FORMATION OF CENTRAL 5- 
HYDROXYINDOLEACETIC ACID. 

177736 02-13 
INFLUENCE OF Nl-2-HYDROXYETHYL SUBSTITUTION ON CENTRAL 
ACTIVITY OF OXAZEPAM AND LORAZEPAM. 

178756 02-04 
CENTRAL NERVOUS STIMULANT INDUCED PHYSIOLOGICAL AND 
PERFORMANCE CHANGES IN ADULTS DURING SUSTAINED 
PSYCHOMOTOR TRACKING. 

179023 02-13 
PERIPHERAL VERSUS CENTRAL MECHANISMS ACCOUNTING FOR 
ANTIANXIETY EFFECTS OF PROPRANOLOL. 

181072 02-10 
CENTRAL DOPAMINE FUNCTION IN AFFECTIVE ILLNESS: EVIDENCE FROM 
PRECURSORS, ENZYME INHIBITORS AND STUDIES OF CENTRAL 
DOPAMINE TURNOVER. (UNPUBLISHED PAPER). 

181358 02-09 
SIGNIFICANCE OF THE CENTRAL BIOGENIC AMINES FOR THE THRESHOLD 
IN ELECTRO AND PENTETRAZOLE SEIZURES. 

181469 02-03 
REGIONAL CYCLIC NUCLEOTIDES PHOSPHODIESTERASE ACTIVITY IN CAT 
CENTRAL NERVOUS SYSTEM: EFFECTS OF BENZODIAZEPINES. 

181575 02-03 
CENTRAL NERVOUS ACTION OF BROMAZEPAM, A NEW BENZODIAZEPINE 
DERIVATIVE. 

181650 02-03 
OXIDATIVE METABOLISM OF MESCALINE IN THE CENTRAL NERVOUS 
SYSTEM - IV: IN VIVO METABOLISM OF MESCALINE AND 2,3,4 
TRIMETHOXY-BETA-PHENYLETHYLAMINE. 

181944 02-03 
STUDIES ON CENTRAL REGULATING MECHANISM OF THE HYPOGLYCEMIA 
INDUCED BY INTRAVENTRICULAR ADMINISTRATION OF 
CHLORPROMAZINE. 

182093 02-03 
A CENTRAL EFFECT OF LOCAL ANESTHETICS: PREVENTION AGAINST THE 
ACCUMULATION OF CYCLIC AMP IN BRAIN SLICES. 

182099 02-03 
EFFECTS OF LICL ON THE CENTRAL NERVOUS SYSTEM. 

182112 02-04 
INTERACTION OF THE BEHAVIORALLY ACTIVE DRUG, PHENITRONE, A 
PURPORTED HASHISH AND LSD ANTAGONIST, WITH SEVERAL 
CENTRAL NEUROCHEMICAL SYSTEMS. 

182217 03-04 

THE EFFECTS OF DELTAl -TETRAHYDROCANNABINOL (DELTAl-THC OR 
DELTA9-THC) AND ETHANOL ON MONOSYNAPTIC AND POLYSYNAPTIC 
TRANSMISSION IN THE CENTRAL NERVOUS SYSTEM. 

182222 03-03 
CENTRAL CHOLINERGIC (MUSCARINIC) LINK IN THE ATTACK REFLEXIVE 
BITING MECHANISM OF CATS. 

182238 03-04 
COMPARATIVE EFFECTS OF DL-P-METHOXYAMPHETAMINE AND D- 
AMPHETAMINE ON CENTRAL CATECHOLAMINES AND LOCOMOTOR 
ACTIVITY. 

182253 03-04 
INVOLVEMENT OF ALPHA-RECEPTORS IN CLONIDINE INDUCED INHIBITION 
OF TRANSMITTER RELEASE FROM CENTRAL MONOAMINE NEURONES. 

182345 03-03 
ELECTROPHYSIOLOGICAL STUDIES OF THE EFFECTS OF CDP-CHOLINE ON 
THE CENTRAL NERVOUS SYSTEM. 

182547 03-03 



CENTRAL NERVOUS ACTION OF FLURAZEPAM, A NEW BENZODIAZEPINE 
DERIVATIVE. 

182549 03-03 
CENTRAL NERVOUS DEPRESSANT XV: SYNTHESIS AND 

PHARMACOLOGICAL SCREENING OF SOME TRIMETHOXYAZLACTONES. 

182828 03-02 
DRUGS ACTING ON THE CENTRAL NERVOUS SYSTEM. 

182835 03-17 
ROLE OF THE CENTRAL AUTONOMIC NERVOUS SYSTEM IN THE 
HYPOTENSION AND BRADYCARDIA INDUCED BY (■) DELTA9- 
TETRAHYDROCANNABINOL. 

183795 03-03 
L-DOPA EFFECTS ON MOTOR AND CENTRAL PROGRAMMING DEFICITS IN 
PARKINSONISM. 

184976 03-14 
FEAR REDUCTION IN THE RAT FOLLOWING CENTRAL CHOLINERGIC 
BLOCKADE. 

187703 04-04 
A FREQUENCY SHIFT IN THE HIPPOCAMPAL THETA ACTIVITY: AN 

ELECTRICAL CORRELATE OF CENTRAL ACTION OF ACTH ANALOGUES IN 
THE DOG 

188166 04-04 

CENTRAL HYPOTHERMIA BY 2-DEOXY-D-GLUCOSE: ANTAGONISM BY 
ALPHA-ADRENERGIC ACTIVATION. 

188200 04-03 
SELECTIVE RESERPINE RESISTANT ACCUMULATION OF CATECHOLAMINES 
IN CENTRAL DOPAMINE NEURONES AFTER DOPA ADMINISTRATION. 

189026 04-03 
SYNTHESIS AND CENTRAL NERVOUS SYSTEM ACTIVITY OF 1,2,3,4- 
TETRAHYDRO-l-AMINO-4-PHENYLNAPHTHALENES. 

189178 04-02 
BENZODIAZEPINES AND BARBITURATES: TURNOVER CHANGES IN 
CENTRAL 5-HYDROXYTRYPTAMINE PATHWAYS. 

189611 04-03 
INTERACTION OF D-AMPHETAMINE WITH CENTRAL NERVOUS SYSTEM 
DEPRESSANTS ON FOOD INTAKE AND SPONTANEOUS MOTOR 
ACTIVITY OF MICE. 

189613 04-04 

EFFECT OF LITHIUM ON CENTRAL METABOLISM OF 5- 
HYDROXYTRYPTAMINE. 

190337 04-03 
PHYSICOCHEMICAL PROPERTIES, DEVELOPMENT, AND REGULATION OF 
CENTRAL AND PERIPHERAL MONOAMINE OXIDASE ACTIVITY. 

191497 04-03 
EFFECT OF CHRONIC TREATMENT WITH CENTRAL STIMULANTS ON BRAIN 
MONOAMINES AND SOME BEHAVIOURAL AND PHYSIOLOGICAL 
FUNCTIONS IN RATS, GUINEA-PIGS, AND RABBITS 

191503 04-03 
EFFECTS OF ALTERATIONS IN IMPULSE FLOW ON TRANSMITTER 
METABOLISM IN CENTRAL DOPAMINERGIC NEURONS. 

191519 04-03 
THE EFFECTS ON INGESTIVE BEHAVIORS OF DAMAGE TO CENTRAL 

DOPAMINE CONTAINING NEURONS. 

191520 04-04 
POST-MORTEM MEASUREMENT OF ENZYMES IN HUMAN BRAIN: 

EVIDENCE OF A CENTRAL NORADRENERGIC DEFICIT IN 
SCHIZOPHRENIA. 

191529 04-13 
EFFECTS OF NEUROLEPTIC AGENT ON CENTRAL NERVOUS SYSTEM OF 
ALBINO RATS. 

191613 04-03 
NEUROCHEMICAL ANALYSIS OF AGGRESSIVE - DEFENSIVE BEHAVIOR 
ELICITED BY ELECTRICAL STIMULATION OF THE HYPOTHALAMUS AND 
CENTRAL GRAY MATTER. 

191784 04-02 
EVIDENCE FOR CHOLINERGICALLY MEDIATED EFFECT OF 

METHYLPHENIDATE HYDROCHLORIDE IN THE CENTRAL NERVOUS 
SYSTEM. 

191946 04-03 
NEUROPHARMACOLOGICAL ANALYSIS OF CENTRAL ADRENERGIC AND 
CHOLINERGIC ANTAGONISM OF DELTA9-TETRAHYDR0CANNABIN0L 

191992 04-03 
ESTIMATION OF THE CONTRIBUTION OF PERIPHERAL AND CENTRAL 
NORADRENERGIC NEURONES TO URINARY 3-METH0XY-4- 
HYDROXYPHENYLGLYCOL IN THE RAT. 

192335 04-03 
CENTRALLY 

STUDY ON THE PSYCHOPHARMACOLOGICAL ASSAY OF CENTRALLY 
ACTING DRUGS IN RATS. 

171260 01-06 
EFFECTS OF CENTRALLY ACTING DRUGS ON ADENYL CYCLASE ACTIVITY 
AND CYCLIC AMP LEVELS OF MOUSE BRAIN. (PH.D. DISSERTATION). 

172019 01-03 
INTERACTION OF CENTRALLY ADMINISTERED OUABAIN WITH AGENTS 
AFFECTING SYMPATHETIC FUNCTION. 

1 78640 02-03 
EFFECTS OF SELECTED CENTRALLY ACTING AGENTS ON ADENYL CYCLASE 
ACTIVITY IN MOUSE BRAIN. 

182153 02-03 



S-47 



Subject Index 



Psychopharmacology Abstracts 



EFFECTS OF CENTRALLY APPLIED DRUGS ON PRESSOR RESPONSES TO 
HYPOTHALAMIC STIMULATION. 

185902 03-03 
CENTRALLY ACTING MUSCLE RELAXANTS, ISOMERIC 9,10 

DIHYDROXYOCTAHYDROPHENANTHRENES AND THEIR CARBAMATE 
ESTERS. 

190719 04-02 

CER 

THE CONDITIONED EMOTIONAL RESPONSE (CER) AS A BASELINE FOR THE 
STUDY OF ANTIANXIETY DRUGS. 

183862 03-04 
CERCINE 

ISOLATION AND IDENTIFICATION OF HYPNOTICS (8): ISOLATION AND 
IDENTIFICATION OF BENZALIN AND CERCINE BY THIN-LAYER 
CHROMATOGRAPHY IN VITRO. 

182626 03-01 
CERCOPITHECUS 

STEREOTYPY WITH SELECTIVE STIMULATION OF CERTAIN ITEMS OF 
BEHAVIOUR OBSERVED IN AMPHETAMINE TREATED MONKEYS 
(CERCOPITHECUS). 

180061 02-04 
CEREBELLAR 

ACUTE CEREBELLAR DISTURBANCE ASSOCIATED WITH DIAZEPAM 
THERAPY - A CASE REPORT AND FURTHER INVESTIGATION. 

177392 02-15 
CEREBELLUM 

NEUROLEPTIC ANTAGONISM OF CATECHOLAMINE INHIBITIONS IN RAT 
CEREBELLUM AND CAUDATE. (UNPUBLISHED PAPER). 

187496 04-03 
EFFECT OF OXOTREMORINE AND PHYSOSTIGMINE ON CHOLINE LEVELS IN 
MOUSE WHOLE BRAIN, SPLEEN AND CEREBELLUM. 

189893 04-03 
FLUORESCENCE AND ELECTRON MICROSCOPIC ANALYSIS OF 
CATECHOLAMINE CONTAINING FIBERS IN MUTANT MOUSE 
CEREBELLUM. (UNPUBLISHED PAPER). 

191762 04-03 
DIAZEPAM, CYCLIC NUCLEOTIDES AND AMINO ACID 

NEUROTRANSMITTERS IN RAT CEREBELLUM. (UNPUBLISHED PAPER). 

191764 04-03 
CEREBRAL 

ONGOING INVESTIGATIONS OF CEREBRAL GLUTAMINE EXCRETION 
SCHIZOPHRENICS DURING TREATMENT WITH NEUROLEPTIC. 

174101 01-08 
TRANSPORT OF SYNAPTOSOMAL TRYPTOPHAN AND CEREBRAL 
TYROSINE: INCREASE IN THE SPEED OF UPTAKE OF RESERPINE OR THE 
INHIBITION OF MONOAMINE OXIDASE. 

179988 02-13 
EXPERIENCE IN THE TREATMENT OF CEREBRAL INSUFFICIENCY AND 
PERIPHERAL BLOOD CIRCULATION DISORDERS USING THE EP-50-100 
EXPERIMENTAL DRUG 

180676 02-11 
CEREBRAL STIMULANTS AND MINIMAL DYSFUNCTION: SOME 
QUESTIONS, SOME ANSWERS, AND SOME MORE QUESTIONS. 

180992 02-11 
EFFECTS OF LITHIUM ON CEREBRAL RNA METABOLISM IN VITRO AND IN 
VIVO. 

181942 02-03 
PREDICTION OF NEUROLEPTIC EFFECTS OF CI-686 BASED ON 
QUANTITATIVE PHARMACOELECTROENCEPHALOGRAPHY: DRUG 
PROFILES AND DOSE RESPONSE CURVES BASED ON COMPUTERIZED 
CEREBRAL BIOPOTENTIALS. 

181958 02-13 
UPTAKE AND RELEASE OF NORADRENALINE IN RAT CEREBRAL CORTEX IN 
VITRO: NO EFFECT OF BENZODIAZEPINES AND BARBITURATES. 

182347 03-03 
TREATMENT OF THE CEREBRAL MANIFESTATIONS OF ARTERIOSCLEROSIS 
WITH CYCLANDELATE. 

185008 03-11 
HYPERTHERMIC EFFECT OF PALMITATE SODIUM, STEARATE SODIUM AND 
OLEATE SODIUM INJECTED INTO THE CEREBRAL VENTRICLES OF 
CONSCIOUS CATS. 

186640 03-03 
A COMPARISON OF THE EFFECTS OF AMPHETAMINE AND ITS 
METABOLITES, P-HYDROXYAMPHETAMINE AND P- 
HYDROXYNOREPHEDRINE, ON UPTAKE, RELEASE AND CATABOLISM OF 
3H-N0REPINEPHRINE IN CEREBRAL CORTEX OF RAT BRAIN. 

186669 03-03 
ON THE CEREBRAL ACCUMULATION OF KETAMINE AND THE 
RELATIONSHIP BETWEEN METABOLISM OF THE DRUG AND ITS 
PHARMACOLOGICAL EFFECTS. 

186693 03-03 
EVIDENCE FOR AN INHIBITORY ROLE FOR ACETYLCHOLINE, 

CATECHOLAMINES, AND SEROTONIN ON THE CEREBRAL CORTEX. 

187552 04-03 
EFFECTS OF SOME METALLIC CATIONS ON CEREBRAL CORTICAL 
NEURONES AND THEIR INTERACTIONS WITH BIOGENIC AMINES. 

187806 04-03 



IN VIVO CHANGES OF CEREBRAL CYCLIC ADENOSINE 3,5 

MONOPHOSPHATE INDUCED BY BIOGENIC AMINES: ASSOCIATION 
WITH PHOSPHORYLASE ACTIVATION. 

188291 04-03 
ANISOMYCIN, LIKE OTHER INHIBITORS OF CEREBRAL PROTEIN 

SYNTHESIS, IMPAIRS LONG-TERM MEMORY OF A DISCRIMINATION 
TASK. 

188605 04-04 
EVIDENCE FOR A SPECIFIC UPTAKE OF DOPAMINE BY DOPAMINERGIC 
TERMINALS OF THE RAT CEREBRAL CORTEX. 

188978 04-03 
EFFECTS OF INTRACEREBRAL INJECTION OF 5,6-HYDROXYTRYPTAMINE 
ON CEREBRAL MONOAMINES AND SLEEP STATES IN THE CAT/. 

189023 04-02 
THE ACTION OF BETA-PHENYL-GABA DERIVATIVES ON NEURONES OF THE 
CAT CEREBRAL CORTEX. 

189750 04-03 
EFFECT OF PHENOTHIAZINE NEUROLEPTIC DRUGS AND TRICYCLIC 
ANTIDEPRESSANTS ON PHOSPHODIESTERASE ACTIVITY IN RAT 
CEREBRAL CORTEX. 

190311 04-03 
NEOMYCIN AND RUTHENIUM RED ANTAGONISM OF MONOAMINERGIC 
DEPRESSION OF CEREBRAL CORTICAL NEURONES. 

191380 04-03 
THE EFFECT OF CHOLINOMIMETIC DRUGS ON POTASSIUM TRANSPORT IN 
RAT CEREBRAL CORTEX. 

191411 04-03 
CHANGES IN RHYTHMS OF BIOELECTRICAL ACTIVITY OF THE CEREBRAL 
CORTEX IN HUMANS UNDER THE INFLUENCE OF ETHYMISOL. 

191790 04-07 
ENDURING LEARNING DEFICITS AND CEREBRAL SYNAPTIC 

MALFORMATION FROM EXPOSURE TO 10 PARTS OF HALOTHANE PER 
MILLION. 

192565 04-04 
CEREBROSPINAL 

BRAIN SEROTONIN, AFFECTIVE ILLNESS AND ANTIDEPRESSANT DRUGS: 
CEREBROSPINAL FLUID STUDIES WITH PROBENECID. (UNPUBLISHED 
PAPER). 

170084 01-09 
ELECTROLYTES IN CEREBROSPINAL FLUID IN ENDOGENOUS DEPRESSION. 

172402 01-09 
EFFECTS OF AMITRIPTYLINE AND IMIPRAMINE ON AMINE METABOLITES 
IN THE CEREBROSPINAL FLUID OF DEPRESSED PATIENTS. 

174094 01-09 
THE EFFECT OF PROBENECID AND LARGE DOSE AMPHETAMINE 

ADMINISTRATION ON CEREBROSPINAL FLUID HOMOVANILLIC ACID. 

177826 02-13 
CHOLINE ACETYLTRANSFERASE ACTIVITY IN THE CEREBROSPINAL FLUID 
OF PSYCHIATRIC PATIENTS. 

180047 02-13 
LITHIUM DISTRIBUTION BETWEEN CEREBROSPINAL FLUID AND SERUM OF 
AFFECTIVE PSYCHOTIC PATIENTS TREATED WITH LITHIUM CARBONATE 
AND ITS CLINICAL RESPONSE. 

180301 02-11 
THE ELIMINATION OF 5-HYDROXYINDOLEACETIC ACID FROM 

CEREBROSPINAL FLUID: CHARACTERISTICS OF THE ACID TRANSPORT 
SYSTEM OF THE CHOROID PLEXUS. 

182718 03-03 
THE EFFECT OF CHLORPROMAZINE ON HOMOVANILLIC ACID LEVELS IN 
CEREBROSPINAL FLUID OF SCHIZOPHRENIC PATIENTS. 

186565 03-08 
MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND ITS 

HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD. 

186566 03-16 
STUDIES OF CEREBROSPINAL FLUID AMINE METABOLITES IN DEPRESSED 

PATIENTS: CONCEPTUAL PROBLEMS AND THEORETICAL IMPLICATIONS. 
(UNPUBLISHED PAPER). 

187398 04-13 
PLASMA AND CEREBROSPINAL FLUID PROBENECID CONCENTRATIONS AS 
RELATED TO ACCUMULATION OF ACIDIC BIOGENIC AMINE 
METABOLITES IN MAN. 

187933 04-13 
A STUDY OF BIOGENIC AMINE METABOLITES IN THE CEREBROSPINAL 
FLUID AND URINE OF MONKEYS WITH CHLORPROMAZINE INDUCED 
DYSKINESIA. 

189210 04-03 
CEREBROVASCULAR 

TREATMENT OF CEREBROVASCULAR DISTURBANCES WITH 2- 

BUTYLAMINO-1-P-HYDROXYPHENYL ETHANOL SULFATE (BAMETHAN). 

182790 03-11 
CERULOPLASMIN 

INTERACTION OF PHENOTHIAZINE DERIVATIVES WITH HUMAN 
CERULOPLASMIN. 

177335 02-13 
CERVEAU 

THE ACTION OF ALPHA-METHYLDOPA IN THE CERVEAU ISOLE 
PREPARATION. 

187075 03-03 



S-48 



VOLUME 12, SUBJECT INDEX 



Subject Index 



CERVICAL 

THE ACTIONS OF SEVERAL PSYCHOACTIVE AGENTS UPON THE 

MUSCARINIC MECHANISMS IN THE SUPERIOR CERVICAL GANGLION OF 
THE CAT. 

183866 03-03 
THE EFFECTS OF 5-HYDROXYTRYPTAMINE AND SOME RELATED 
COMPOUNDS ON THE CAT SUPERIOR CERVICAL GANGLION IN SITU. 

184197 03-03 
THE EFFECTS OF VARIOUS NICOTINE-LIKE AGENTS IN THE CAT SUPERIOR 
CERVICAL GANGLION IN SITU. 

T84202 03-03 
THE EFFECTS OF LITHIUM ON HIGH ENERGY PHOSPHATE AND GLUCOSE 
LEVELS IN THE RAT SUPERIOR CERVICAL GANGLION. 

187677 04-03 
PHARMACOLOGICAL ALTERATIONS IN THE STIMULUS INDUCED RELEASE 
OF NOREPINEPHRINE FROM THE RABBIT SUPERIOR CERVICAL 
GANGLION. 

191896 04-03 

CFR 

THE EFFECT OF L-TRYPTOPHAN (IP) ON CUTANEOUS C-FIBER (CFR) AND 
POLYSYNAPTIC (PSR) REFLEXES IN ACUTE DECEREBRATE SPINAL CATS 
AND THE EFFECT OF PRETREATMENT WITH P-CHLOROPHENYLALANINE 
(PCPA) ON THE ACTION OF TP. (UNPUBLISHED PAPER). 

170874 01-03 
THE EFFECT IN THE CAT OF TRYPTAMINE (T) AND LSD ON CUTANEOUS C- 
FIBER (CFR) AND POLYSYNAPTIC (PSR) SPINAL REFLEXES. 
(UNPUBLISHED PAPER). 

174480 01-12 

CHAINS 

REPEATED ACQUISITION OF BEHAVIORAL CHAINS UNDER CHRONIC DRUG 
CONDITIONS. 

177408 02-04 

CHANGE 

DRUG ENHANCED SENSORY CONTINGENT BAR PRESSING: COMPARING 
THE EFFECT OF CONTINGENT AND NONCONTINGENT SENSORY 
CHANGE. 

168837 01-04 
EEG, HEART RATE, AND MOOD CHANGE (HIGH) AFTER CANNABIS. 

169068 01-13 
CHANGE OF ESTROGEN ACTIVATED BEHAVIOR BY CYCLOHEXIMIDE IN 
THE FEMALE RAT. 

171615 01-04 
SENSORY CONTINGENT BAR-PRESSING FOR FAMILIAR AND NOVEL 
CHANGE UNDER A DEXAMPHETAMINE AMYLOBARBITONE MIXTURE. 

181605 02-04 
DISSOCIATIVE CHANGE IN ANTIAGGRESSIVE AND MUSCLE RELAXANT 
ACTIONS OF S-TRIAZOLOBENZODIAZEPINE (D-40TA) BY REPEATED 
ADMINISTRATION AND PHENOBARBITAL PRETREATMENT, AND ITS 
RELATION TO METABOLISM. 

181654 02-04 

CHANGED 

PSYCHOTROPIC EFFECT OF ANALGESICS AND NEUROLEPTICS ON A 
MODEL OF INVESTIGATORY BEHAVIOR CHANGED BY PAIN. 

191120 04-04 
CHANGES 

INFLUENCE OF TREATMENT ON SYMPTOMATOLOGY AND CORRELATED 
ELECTROENCEPHALOGRAPHIC (EEG) CHANGES IN THE AGED. 

167336 01-13 
ELECTROCARDIOGRAPHIC CHANGES IN HYPERTHYROIDISM AFTER 
ADRENERGIC BLOCKADE WITH RESERPINE AND PROPRANOLOL. 

167460 01-13 
CHANGES IN SOMATOSENSORY EVOKED POTENTIALS PRODUCED BY 
DRUGS USED IN THE TREATMENT OF AFFECTIVE DISORDERS. 

169092 01-09 
LIPID INDUCED CHANGES OF PENTOBARBITAL DISTRIBUTION AND 
METABOLISM. 

170072 01-03 
CHANGES IN MENTAL FUNCTIONING ACCOMPANYING ANTIPSYCHOTIC 
DRUG THERAPY. 

171124 01-10 
TURNOVER CHANGES IN CENTRAL MONOAMINE NEURON SYSTEMS 
AFTER MINOR TRANQUILLIZERS AND BARBITURATES. 

171604 01-03 
INTERRESPONSE TIME CHANGES AS A FUNCTION OF DEPRIVATION AND 
AMPHETAMINE ADMINISTRATION. 

171612 01-04 
DRUG-INDUCED ACTIVATION OF STRIATAL TYROSINE HYDROXYLASE: 
CHANGES IN THE AFFINITY FOR PTERIDINE COFACTORS. (UNPUBLISHED 
PAPER). 

173381 01-03 
BEHAVIORAL CHANGES AND AGGRESSIVITY EVOKED BY DRUGS IN MICE. 

174604 01-04 
SLEEP CHANGES IN CHRONIC SCHIZOPHRENICS: EFFECTS OF 5- 
HYDROXYTRYPTOPHAN (5-HTP). (UNPUBLISHED PAPER 

178578 02-08 
CHANGES IN BRAIN ACETYLCHOLINESTERASE ACTIVITY OF YOUNG RATS 
AFTER CHRONIC TREATMENT WITH TREMORINE. 

178814 02-03 



CENTRAL NERVOUS STIMULANT INDUCED PHYSIOLOGICAL AND 
PERFORMANCE CHANGES IN ADULTS DURING SUSTAINED 
PSYCHOMOTOR TRACKING. 

179023 02-13 
AN ANALYSIS OF D-AMPHETAMINE PRODUCED FACILITATION OF 
AVOIDANCE ACQUISITION IN RATS AND PERFORMANCE CHANGES 
SUBSEQUENT TO DRUG TERMINATION. 

1 79990 02-04 
ELECTROENCEPHALOGRAPHIC CHANGES IN ACUTE PHENOBARBITONE 
POISONING. 

180149 02-15 
THE ELECTROENCEPHALOGRAPHIC CHANGES IN ACUTE BARBITURATE 

POISONING. 

180152 021 5 
ANALYSIS OF DRUG BLOCK OF LSD/5-HT/GABA BY MONITORING 
NEURONAL MEMBRANE CHANGES. 

182143 02-03 
EEG CHANGES & MOTOR IMPAIRMENT AFTER DISULFIRAM 
ADMINISTRATION TO CATS. 

182248 0303 
CHANGES IN THE NEUROEXCITABILITY OF ALCOHOL DEPENDENT RATS 
UNDERGOING WITHDRAWAL AS MEASURED BY THE 
PENTYLENETETRAZOL SEIZURE THRESHOLD. 

182348 03-03 
TREATMENT PROCESS OF DEPRESSION AND CHANGES IN 
MICROVIBRATION. 

182620 03-09 

EVALUATION OF EEG AND CLINICAL CHANGES ASSOCIATED WITH 
PAVABID THERAPY IN CHRONIC BRAIN SYNDROME. 

183402 03-13 
CHANGES IN SHORT-TERM AND LONG-TERM MEMORY OF DOGS AND 
CATS UNDER THE EFFECTS OF AMIZYL (BENACTYZINE). 

183517 03-04 
LONG-RANGE MOTOR PERFORMANCE CHANGES IN LEVODOPA TREATED 
PATIENTS WITH PARKINSONS DISEASE. 

184195 03-11 
RELATIONSHIP OF PLASMA MEPERIDINE LEVELS TO CHANGES IN ANXIETY 
AND HOSTILITY. 

185881 03-14 
REGIONAL CHANGES IN MONOAMINE LEVELS AND IN THE RATE OF 
TYROSINE AND TRYPTOPHAN HYDROXYLATION IN 4 WEEK OLD 
OFFSPRING OF NURSING MOTHERS TREATED WITH THE NEUROLEPTIC 
DRUG PENFLURIDOL. 

185899 03-03 
L-TRYPTOPHAN IN AFFECTIVE DISORDERS: INDOLEAMINE CHANGES AND 
DIFFERENTIAL CLINICAL EFFECTS. 

185928 03-09 
NEUROLOGICAL CHANGES IN CATS FOLLOWING LONG-TERM DIET OF 
MERCURY CONTAMINATED TUNA. 

186476 03-05 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS: 
I EFFECT ON THE BEHAVIOURAL CHANGES INDUCED BY RESERPINE, 
ALPHA-METHYL-P-TYROSINE OR AMPHETAMINE. 

186587 03-04 
ACTIONS OF ATROPINE, HEMICHOLINIUM-3, AND PHYSOSTIGMINE ON 
CHLORPROMAZINE INDUCED CHANGES IN RAT BRAIN MONOAMINES. 

187800 04-03 
PERSISTENT ELECTROENCEPHALOGRAPHIC CHANGES IN RHESUS 
MONKEYS AFTER SINGLE DOSES OF PENTOBARBITAL, NITRAZEPAM 
AND IMIPRAMINE. 

187931 04-03 
IN VIVO CHANGES OF CEREBRAL CYCLIC ADENOSINE 3,5 

MONOPHOSPHATE INDUCED BY BIOGENIC AMINES: ASSOCIATION 
WITH PHOSPHORYLASE ACTIVATION. 

188291 04-03 
MENTAL CHANGES IN PARKINSONISM. 

188886 04-15 
MESCALINE INDUCED CHANGES OF BRAIN CORTEX RIBOSOMES: EFFECT 
OF MESCALINE ON THE BINDING OF AMINOACYL TRANSFER 
RIBONUCLEIC ACID TO RIBOSOMES OF BRAIN TISSUE. 

189582 04-05 
BENZODIAZEPINES AND BARBITURATES: TURNOVER CHANGES IN 
CENTRAL 5-HYDROXYTRYPTAMINE PATHWAYS. 

189611 04-03 
CHANGES IN ORIENTING AND HABITUATION IN THE RAT FOLLOWING 
ADMINISTRATION OF CHLORPROMAZINE. 

191211 04-04 
BEHAVIORAL AND EEG CHANGES IN THE AMPHETAMINE MODEL OF 
PSYCHOSIS. 

191505 04-04 
CHANGES IN RHYTHMS OF BIOELECTRICAL ACTIVITY OF THE CEREBRAL 
CORTEX IN HUMANS UNDER THE INFLUENCE OF ETHYMISOL. 

191790 04-07 
EXCITABILITY CHANGES DURING THE GRADUAL DEVELOPMENT OF AND 
RECOVERY FROM PENTYLENETETRAZOL AND STRYCHNINE INDUCED 
CONVULSIONS IN THE CAT. 

191927 04-03 



S-49 



Subject Index 



Psychopharmacology Abstracts 



CHANGING 

CHANGING DEATHS PERSPECTIVE. 

169138 01-11 
CHARACTER 

HYPERKINETIC, HYPOSCHOLASTIC BEHAVIOUR AND CHARACTER 
DISORDERS OF CHILDHOOD AND ADOLESCENCE: DIAGNOSIS AND 
PHARMACOTHERAPY. 

172800 01-11 
CHARACTERISTIC 

VOCALIZATION: A CHARACTERISTIC CANNABIS INDUCED BEHAVIOR IN 
THE RAT? 

175884 02-04 
CHARACTERISTICS 

CHARACTERISTICS OF BENZODIAZEPINE TRANQUILIZERS. 

180307 02-17 
EEG CHARACTERISTICS IN VARIOUS SPECIES OF ANIMAL AND THEIR 
RELATION TO THE CNS EFFECTS OF DRUGS. 

182096 02-03 
THE ELIMINATION OF 5-HYDROXYINDOLEACETIC ACID FROM 

CEREBROSPINAL FLUID: CHARACTERISTICS OF THE ACID TRANSPORT 
SYSTEM OF THE CHOROID PLEXUS. 

182718 03-03 
MONOAMINE OXIDASE IN MAN: ENZYME CHARACTERISTICS IN HUMAN 
PLATELETS, PLASMA, AND OTHER HUMAN TISSUES. 

191502 04-13 
CHARACTERIZATION 

PARTIAL PURIFICATION AND CHARACTERIZATION OF NADPH-LINKED 
ALDEHYDE REDUCTASE FROM MONKEY BRAIN. 

175232 02-03 
THE LOCALIZATION AND CHARACTERIZATION OF 

PHENYLETHANOLAMINE-N-METHYLTRANSFERASE ACTIVITY IN SPECIFIC 
REGIONS OF THE CNS. 

191932 04-03 
CHELATION 

METAL CHELATION OF CHLORPROMAZINES. 

176763 02-06 
CHEMICAL 

QUANTUM CHEMICAL STUDIES ON DRUG ACTIONS: IV. CORRELATION OF 
SUBSTITUENT STRUCTURES AND ANTISEROTONIN ACTIVITY IN 
LYSERGAMIDE SERIES. 

174605 01-12 
EFFECT OF CHEMICAL SYMPATHECTOMY ON MORPHINE 
ANTINOCICEPTION AND TOLERANCE IN RATS. 

182159 02-03 
NIMH SPONSORED CHEMICAL SYNTHESIS PROGRAM. 

182444 03-01 
NEURAL AND CHEMICAL MECHANISMS OF FEMALE SEXUAL BEHAVIOR IN 
THE RAT. (PH.D. DISSERTATION). 

185705 03-04 
CARDIOVASCULAR REACTIVITY IN THE DOG AFTER CHEMICAL 
SYMPATHECTOMY WITH 6-HYDROXYDOPAMINE. 

187807 04-03 
CHEMICAL CONVERSION OF THE PSYCHOTOMIMETIC AMINE l-{2,5 
DIMETHOXY-4-METHYLPHENYL) 2-AMINOPROPANE TO 5- 
HYDROXYDIMETHYLINDOLE. 

187941 04-01 
THE EFFECTS OF MORPHINE, ETORPHINE AND SINOMENINE ON THE 
CHEMICAL SENSITIVITY AND SYNAPTIC RESPONSES OF RENSHAW 
CELLS AND OTHER SPINAL NEURONES IN THE RAT. 

188201 04-03 
AFFECTIVE DISORDERS AND CHEMICAL DEPENDENCE: LITHIUM FOR 
ALCOHOL AND DRUG ADDICTION 

189775 04-09 
CHEMISTRY 

CHEMISTRY OF TRAZODONE. 

THE BOTANY AND CHEMISTRY OF HALLUCINOGENS. 

THE CHEMISTRY OF PEYOTE ALKALOIDS. 

192875 04-12 
MESCALINE: THE CHEMISTRY AND PHARMACOLOGY OF ITS ANALOGS. 

192877 04-12 
CHEMOCONVULSIONS 

THRESHOLDS FOR ELECTROCONVULSIONS AND CHEMOCONVULSIONS IN 
MICE AFTER TERMINATION OF TREATMENT WITH PHENOBARBITAL. 

170073 01-03 
CHEMOTHERAPEUTIC 

THE PROBLEM OF ANXIETY IN A NON-WESTERN SOCIETY: A COMBINED 
CHEMOTHERAPEUTIC AND PSYCHOTHERAPEUTIC APPROACH. 

171162 01-10 
A CHEMOTHERAPEUTIC ALTERNATIVE TO THE ANTIANXIETY AGENTS FOR 
THE EXTENDED TREATMENT OF PSYCHONEUROSIS. 

192083 04-10 
CHEMOTHERAPY 

CHEMOTHERAPY IN CHRONIC ORGANIC BRAIN SYNDROME ■ A REVIEW 
OF THE LITERATURE. 

169065 01-11 



168801 01-01 
189101 04-12 



A NEW AGENT FOR CHEMOTHERAPY OF MIGRAINE HEADACHES: A 
CONTROLLED STUDY. 

169298 01-11 
THE ROLE OF CHEMOTHERAPY IN MANAGING POTENTIALLY SUICIDAL 
PATIENTS. 

178544 02-10 
ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY. 

179983 02-17 
CHEMOTHERAPY IN CHILDHOOD DEPRESSION. 

182430 03-09 
CHEMOTHERAPY AND PSYCHOTHERAPY, ARE THEY COMPLEMENTARY OR 
ANTAGONISTIC?: A PERSONAL STUDY. 

184959 03-17 
USE OF CHEMOTHERAPY AS ANTISUICIDAL PROPHYLAXIS. 

191140 04-11 
CHEMOTHERAPY OF DELIRIUM-TREMENS: A SURVEY OF PHYSICIANS 
PREFERENCES. 

192068 04-11 
CHICK 

THE EFFECTS OF MESCALINE ADMINISTERED BEFORE OR DURING 
EMBRYOGENESIS UPON THE HATCHABILITY AND BEHAVIOR OF THE 
CHICK. (PH.D. DISSERTATION). 

173791 01-04 
EFFECTS OF NARCOTIC ANALGESICS ON ENZYMES OF ACETYLCHOLINE 
METABOLISM IN CULTURED CHICK BRAIN CELLS. 

182225 03-03 
EFFECTS OF NON-HYDROGEN-BONDING ANESTHETICS ON MEMORY IN 
THE CHICK. 

184380 03-04 
CHICKEN 

EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON BODYWEIGHT AND 
BRAIN ELECTROLYTES IN THE CHICKEN. 

186570 03-03 
CHICKS 

DRUG-INDUCED AGGRESSION IN CHICKS: DIFFERENTIAL INVOLVEMENT 
OF BIOGENIC AMINES. 

191977 04-04 
CHILD 

CONTROL OF THE HYPERACTIVE CHILD VIA MEDICATION - AT WHAT 
COST TO PERSONALITY DEVELOPMENT; SOME PSYCHOLOGICAL 
IMPLICATIONS AND CLINICAL INTERVENTIONS. 

176810 02-11 
CHILDHOOD 

HYPERKINETIC, HYPOSCHOLASTIC BEHAVIOUR AND CHARACTER 
DISORDERS OF CHILDHOOD AND ADOLESCENCE: DIAGNOSIS AND 
PHARMACOTHERAPY. 

172800 01-11 
BIOLOGICAL INTERVENTIONS IN PSYCHOSES OF CHILDHOOD. 

175872 02-17 
CHEMOTHERAPY IN CHILDHOOD DEPRESSION. 

182430 03-09 
TREATMENT WITH PSYCHOPHARMACOLOGIC AGENTS IN CHILDHOOD 

DEPRESSIONS. 

182431 03-11 
PSYCHOTROPIC DRUGS IN CHILDHOOD DISTURBANCES. 

182890 03-11 
SOMATIC SIDE-EFFECTS OF PSYCHOTHERAPEUTIC DRUGS IN CHILDHOOD. 

183183 03-15 
A SERIES OF MULTICENTRIC PILOT TRIALS WITH PIMOZIDE IN 
PSYCHIATRIC PRACTICE: II. PIMOZIDE IN THE TREATMENT OF 
BEHAVIOURAL DISORDERS IN CHILDHOOD AND ADOLESCENCE. 

183192 03-11 
CARBAMAZEPINE SOLE ANTICONVULSANT FOR FOCAL EPILEPSY OF 
CHILDHOOD. 

189174 04-11 
CHILDREN 

IMIPRAMINE IN THE TREATMENT OF MINIMAL BRAIN DYSFUNCTION IN 
CHILDREN. 

169295 01-11 
HALOPERIDOL FOR PSYCHIATRIC DISORDERS IN CHILDREN. 

169457 01-14 
AVERAGE EVOKED RESPONSES IN NORMAL AND MINIMALLY BRAIN 
DYSFUNCTIONED CHILDREN TREATED WITH AMPHETAMINE: A 
PRELIMINARY REPORT. 

169861 01-11 
EFFECTS OF MEDICATION ON LEARNING IN HYPERACTIVE FOUR-YEAR- 
OLD CHILDREN. (ED.D DISSERTATION). 

172512 01-11 
TANTU-PASHAN AND LUCIDRIL THERAPY IN MENTALLY RETARDED 
CHILDREN. 

175628 02-11 
SIDE-EFFECTS OF DEXTROAMPHETAMINE THERAPY OF HYPERACTIVE 
CHILDREN. 

176238 02-15 
A DOUBLE-BLIND COMPARISON OF FLUPHENAZINE AND HALOPERIDOL IN 
OUTPATIENT SCHIZOPHRENIC CHILDREN. 

1 77754 02-08 



S-50 



VOLUME 12, SUBJECT INDEX 



Subject Index 



DEXTROAMPHETAMINE AND METHYLPHENIDATE IN THE TREATMENT OF 
HYPERACTIVE/AGGRESSIVE CHILDREN. 

177771 0214 
RESPONSE TO STIMULANT DRUG TREATMENT IN HYPERACTIVE 
CHILDREN PREDICTION FROM EEG AND NEUROLOGICAL FINDINGS. 

177778 02-11 
RITALIN FOR SCHOOL CHILDREN: THE TEACHERS PERSPECTIVE. 

178127 02-17 
EFFECT OF A CARNITINE CYPROHEPTADINE COMBINATION ON ANOREXIA 
AND WEIGHT GAIN IN CHILDREN. 

178811 02-10 
INDICATIONS FOR ANTIDEPRESSANT TREATMENT WITH SPECIAL 
REFERENCE TO DEPRESSED PRESCHOOL CHILDREN. 

182428 03-10 
DRUG THERAPY FOR DEPRESSION IN CHILDREN. INDICATIONS AND 

METHODS. 

182429 03-10 
ACTION OF OPIPRAMOL (G-33040) IN DEPRESSIVE SYNDROMES IN 

CHILDREN AND ADOLESCENTS. 

182432 03-10 
LITHIUM IN PSYCHIATRIC THERAPY AND PROPHYLAXIS. A REVIEW WITH 

SPECIAL REGARD TO ITS USE IN CHILDREN. 

182433 03-09 
LITHIUM TREATMENT OF PSYCHOTIC CHILDREN. A CONTROLLED 

CLINICAL TRIAL. 

182434 03-09 
DIAZEPAM TREATMENT FOR ACUTE CONVULSIONS IN CHILDREN: A 

REPORT OF 41 PATIENTS, THREE WITH PLASMA LEVELS. 

182595 03-11 
SOMNAMBULISM IN CHILDREN - CLINICAL COMMUNICATION. 

182870 03-17 
NEUROLOGICAL CONSEQUENCES OF PSYCHOTROPIC DRUG WITHDRAWAL 
IN SCHIZOPHRENIC CHILDREN. 

183275 03-08 
OUTPATIENT TREATMENT OF HYPERACTIVE SCHOOL CHILDREN WITH 
IMIPRAMINE. 

184174 03-11 
DOSE EFFECTS OF METHYLPHENIDATE ON BEHAVIORAL INHIBITION AND 
ACTIVATION IN HYPERACTIVE CHILDREN. (PH.D. DISSERTATION). 

185676 03-14 
A STUDY OF THE EFFECTS OF RITALIN INTERVENTION UPON THE 
PERCEPTUAL COMPETENCIES OF CHILDREN DIAGNOSED AS GIVING 
EVIDENCE OF PSYCHONEUROLOGICAL LEARNING DISABILITIES. (PH.D. 
DISSERTATION). 

186833 03-14 
METHYLPHENIDATE IN CHILDREN - EFFECT OF DOSAGE. 

187581 04-14 
IMIPRAMINE SIDE-EFFECTS IN CHILDREN. 

189512 04-15 
CHILDRENS 

EFFECTS OF METHYLPHENIDATE ON HYPERACTIVE CHILDRENS SLEEP. 

190321 04-14 
CHIMPANZEE 

MODIFICATION OF THE EFFECTS OF CHLORPROMAZINE ON BEHAVIOR IN 
THE CHIMPANZEE. 

183889 03-04 

CHIMPANZEES 

THE SOCIAL PLAY BEHAVIOR OF CHIMPANZEES ACCORDING TO A 
PSYCHOPHARMACOLOGICAL TEST/. 

168838 01-04 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON DELAYED MATCHING- 
TO-SAMPLE CHOICE SPEEDS IN CHIMPANZEES. 

171886 01-04 
EFFECTS OF CHRONIC EXPOSURE TO DELTA9-TETRAHYDR0CANNABIN0L 
ON DELAYED MATCHING-TO-SAMPLE IN CHIMPANZEES. 

189405 04-04 
CHLORAL 

THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 
DRUGS ON HUMAN SLEEP: V. THE EFFECTS OF CHLORAL HYDRATE 

177717 02-14 
CONVERSION OF CHLORAL HYDRATE TO TRICHLOROETHANOL IN BRAIN 
AND LIVER. 

182157 02-03 
CHLORALOSE 

A COMPARISON OF SOMATIC REFLEX EFFECTS OF THREE PSYCHOTROPIC 
AGENTS IN THE CHLORALOSE CAT. 

182126 02-03 
CHLORAMPHENICOL 

THE PRENATAL EFFECT OF CHLORAMPHENICOL ON THE POSTNATAL 
DEVELOPMENT OF MICE. 

187076 03-05 
CHLORDIAZEPOXIDE 

CHLORDIAZEPOXIDE AND DOTHIEPIN COMPARED IN 
ANXIETY/DEPRESSION IN GENERAL PRACTICE. 

167575 01-10 
CHLORDIAZEPOXIDE IN DEPRESSIVE NEUROSIS: AN OPEN LABEL 
CROSSOVER STUDY WITH AMITRIPTYLINE. 

168316 01-10 



EFFECTS OF CHLORPROMAZINE, MEPROBAMATE AND 
CHLORDIAZEPOXIDE ON THE MAZE LEARNING IN MICE. 

171259 01-04 
ANALGESIC POTENCY OF SODIUM SALICYLATE, INDOMETHACIN, AND 
CHLORDIAZEPOXIDE AS MEASURED BY THE SPATIAL PREFERENCE 
TECHNIQUE IN THE RAT. 

'71301 01-02 
PROPRANOLOL AND CHLORDIAZEPOXIDE ON EXPERIMENTAL ' INDUCED 
CONFLICT AND SHUTTLEBOX PERFORMANCE IN RODENTS 

171304 01-04 
PREVENTION OF ALCOHOL WITHDRAWAL SEIZURES: THE ROLES OF 
DIPHENYLHYDANTOIN AND CHLORDIAZEPOXIDE. 

172275 01-11 
THE EFFECT OF PHASE-SHIFT ON THE PASSIVE AVOIDANCE RESPONSE IN 
RATS, AND THE MODIFYING EFFECT OF CHLORDIAZEPOXIDE. 

174830 01-04 
CHLORDIAZEPOXIDE OVERDOSE: INTERPRETATION OF SERUM DRUG 
CONCENTRATIONS. 

177393 02-15 
THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 
DRUGS ON HUMAN SLEEP: VI. THE EFFECTS OF CHLORDIAZEPOXIDE. 

177718 02-14 
THE EFFECTS OF CHLORDIAZEPOXIDE (LIBRIUM) ON THE INTENSITY AND 
HABITUATION OF AGONISTIC BEHAVIOR IN MALE SIAMESE FIGHTING 
FISH. 

1 77722 02-04 
EFFECTS OF CHLORPROMAZINE, CHLORDIAZEPOXIDE AND 

PENTOBARBITAL ON NEURONAL EXCITABILITY IN THE MEDIAL 
FOREBRAIN BUNDLE DURING SELF-STIMULATION BEHAVIOR. 

1 77837 02-04 
DOXEPIN AND AMITRIPTYLINE CHLORDIAZEPOXIDE COMBINATION IN 
NEUROTIC STATES: A COMPARATIVE DOUBLE-BLIND STUDY. 

180048 02- 10 
CHLORDIAZEPOXIDE AND HOSTILITY IN ANXIOUS OUTPATIENTS. 

181273 02-10 
SIMILARITY OF CHRONIC CHLORDIAZEPOXIDE TREATMENT AND 
REMOVAL OF CONFLICT SITUATION. 

182258 03-04 
SOCIAL HIERARCHY IN MONKEYS (MACACA-MULATTA) MODIFIED BY 
CHLORDIAZEPOXIDE HYDROCHLORIDE. 

183863 03-04 
SEDATIVE OR TRANQUILLIZER? A COMPARISON OF THE HYPNOTIC 
EFFECTS OF CHLORDIAZEPOXIDE AND AMYLOBARBITONE SODIUM. 

184438 03-14 
TOWARD A MECHANISM OF THE ANTIAGGRESSION EFFECTS OF 
CHLORDIAZEPOXIDE IN RATS 

1 85934 03-04 
THE EFFECTS OF CHLORDIAZEPOXIDE, AMPHETAMINE AND COCAINE ON 
BAR-PRESS BEHAVIOR IN NORMAL AND GENETICALLY NERVOUS DOGS. 

187868 04-04 
EFFECTS OF CHLORDIAZEPOXIDE ON HEART RATE AND BEHAVIOURAL 
SUPPRESSION IN PIGS SUBJECTED TO OPERANT CONDITIONING 
PROCEDURES. 

189409 04-04 
CHLORDIAZEPOXIDE INDUCED BETA SPINDLE ACTIVITY IN RATS. 

192416 04-03 
CHLORIDE 

THE EFFECTS OF PENTYLENETETRAZOL (METRAZOL) ON A LEARNED 
TASTE AVERSION PRODUCED BY LITHIUM CHLORIDE: THE ISSUE OF 
ASSOCIATIVE MEMORY VS. RETENTIVE MEMORY. (UNPUBLISHED 
PAPER). 

188251 04-04 

CHLORIMIPR AMINE 

EFFECT OF CHLORIMIPRAMINE ON THE RATE OF TRYPTOPHAN 

HYDROXYLATION IN THE INTACT AND TRANSECTED SPINAL CORD. 

168751 01-03 
PHENOMENOLOGICAL - EXISTENTIAL STUDY OF PHOBIC - OBSESSIVE 
SYNDROMES TREATED WITH CHLORIMIPRAMINE. 

182788 03-09 
THE COMPARATIVE ANXIOLYTIC EFFECTS OF PLACEBO, IMIPRAMINE AND 
CHLORIMIPRAMINE USING PSYCHIATRIC AND PSYCHOPHYSIOLOGICAL 
MEASUREMENTS. 

191137 04-14 
CHLORIMIPRAMINE AND LSD: DIFFERENTIAL EFFECTS ON THE IN VIVO 
RELEASE OF 3H-5-HT. 

191949 04-03 
CHLORMEZANONE 

CHLORMEZANONE IN ANXIETY: A DRUG REDISCOVERED? 

184175 03-10 
CHLOROFORM 

CONSTITUENTS OF CANNABIS-SATIVA L. V.: STABILITY OF AN 

ANALYTICAL SAMPLE EXTRACTED WITH CHLOROFORM. (UNPUBLISHED 
PAPER). 

180670 02-01 
CHLOROFORM RESPONSES OF THE CHORDA TYMPANI NERVE IN THE 

RAT 

189219 04-03 



S-51 



Subject Index 



Psychopharmacology Abstracts 



CHLOROTHIAZIDE 

LITHIUM INDUCED DIABETES-INSIPIDUS: MANIC SYMPTOMS, BRAIN AND 
ELECTROLYTE CORRELATES, AND CHLOROTHIAZIDE TREATMENT. 

169486 01-15 
CHLORPHENIRAMINE 

BEHAVIORAL EFFECT OF TRICYCLIC THYMOLEPTICS AND 
CHLORPHENIRAMINE IN MICE AFTER PRETREATMENT WITH 5 
HYDROXYTRYPTOPHAN (5-HTP). 

171609 0104 
INTERACTIONS OF CHLORPHENIRAMINE ETHANOL COMBINATIONS: 
ACUTE TOXICITY AND ANTIHISTAMINIC ACTIVITY. 

188875 04-05 
CHLORPHENTERMINE 

METABOLISM OF CHLORPHENTERMINE AND PHENTERMINE IN MAN TO 
YIELD HYDROXYLAMINO, C-NITROSO AND NITRO COMPOUNDS. 

183796 03-13 
EVIDENCE FOR AN UNUSUAL DISTRIBUTION OF CHLORPHENTERMINE IN 
VIVO: AN AUTORADIOGRAPHIC STUDY IN MICE. 

184226 03-03 
CHLORPROMAZINE 

MESORIDAZINE AND CHLORPROMAZINE IN THE TREATMENT OF 
ALCOHOL WITHDRAWAL SYNDROME. 

168314 01-11 
EFFECT OF CHLORPROMAZINE (CPZ) ON INSULIN RELEASE IN VIVO AND 
IN VITRO IN THE RAT. 

168440 01-03 
THE POSSIBLE ROLE OF METABOLITES IN THERAPEUTIC RESPONSE TO 
CHLORPROMAZINE TREATMENT. 

168836 01-08 
EFFECTS OF CHLORPROMAZINE, MEPROBAMATE AND 
CHLORDIAZEPOXIDE ON THE MAZE LEARNING IN MICE. 

171259 01-04 
THE ELECTROCARDIOGRAPHIC ABNORMALITY INDUCED BY 
CHLORPROMAZINE. 

171296 01-15 
INTERACTION BETWEEN PRIOR EXPERIENCE AND THE EFFECTS OF 
CHLORPROMAZINE ON EXPLORATION IN THE RAT. 

171308 01-04 
LEVELS OF HVA IN MOUSE BRAIN FOLLOWING TREATMENT WITH 
METABOLITES OF CHLORPROMAZINE. 

171626 01-03 
THE EFFECTS OF INTRACAUDATE INJECTIONS OF CHLORPROMAZINE ON 
CONDITIONED AVOIDANCE AND SELF-STIMULATION BEHAVIOR. (PH.D. 
DISSERTATION). 

173749 01-04 
THE USE OF CHLORPROMAZINE IN SCHIZOPHRENIA. 

174059 01-08 
HIGH DOSES OF CHLORPROMAZINE AND TRIFLUOPERAZINE IN THE 
TREATMENT OF PATIENTS SUFFERING FROM SCHIZOPHRENIA. 

174589 01-08 
FUNCTIONAL EVALUATION OF PITUITARY RESERVE IN PATIENTS WITH 
THE AMENORRHEA GALACTORRHEA SYNDROME UTILIZING 
LUTEINIZING HORMONE RELEASING HORMONE (LH-RH), L-DOPA AND 
CHLORPROMAZINE. 

175245 02-13 
COMPARATIVE STUDIES OF SYNAPTIC MEMBRANE PROTEIN 
SOLUBILIZATION BY CHLORPROMAZINE AND SODIUM 
DODECYLSULFATE. 

176703 02-03 
ANTAGONISM OF THE EFFECTS OF CHLORPROMAZINE AND MORPHINE 
ON DOPAMINE METABOLISM BY GABA. 

176870 02-03 
EFFECTS OF LOW DOSES OF CHLORPROMAZINE ON A CONDITIONED 
EMOTIONAL RESPONSE IN THE RAT. 

176963 02-04 
RATE-DEPENDENT EFFECTS OF DRUGS. I. COMPARISONS OF 0- 
AMPHETAMINE, PENTOBARBITAL, AND CHLORPROMAZINE ON 
MULTIPLE AND MIXED SCHEDULES. 

177410 02-04 
THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 
DRUGS ON HUMAN SLEEP: IV. THE EFFECTS OF CHLORPROMAZINE. 

177716 02-14 
L-DOPA CHLORPROMAZINE ANTAGONISM ON RUNNING ACTIVITY IN 
MICE. 

177785 02-04 
BRAIN RIBOSOMAL RNA SYNTHESIS INHIBITED BY CHLORPROMAZINE. 

177835 02-03 
EFFECTS OF CHLORPROMAZINE, CHLORDIAZEPOXIDE AND 

PENTOBARBITAL ON NEURONAL EXCITABILITY IN THE MEDIAL 
FOREBRAIN BUNDLE DURING SELF-STIMULATION BEHAVIOR. 

177837 02-04 
EFFECTS OF CHLORPROMAZINE AND ACTINOMYCIN D ON UPTAKE AND 
INCORPORATION OF CERTAIN AMINO ACIDS, HYPOXANTHINE AND 
THYMIDINE IN CULTURES OF HUMAN SKIN EPITHELIAL CELLS. 

179989 02-13 
EFFECT OF CHLORPROMAZINE AND SOME OF ITS METABOLITES ON THE 
DOPAMINE SENSITIVE ADENYLATE CYCLASE OF RAT BRAIN STRIATUM. 

180060 02-03 



COMPARISON OF THE CLINICAL AND COMPUTER ANALYZED EEG EFFECTS 
OF MESORIDAZINE AND CHLORPROMAZINE. 

180064 02-10 
INFLUENCES OF RESERPINE AND CHLORPROMAZINE ON THE ANALGESIC 
AND METABOLIC EFFECTS OF MORPHINE. 

180507 02-03 
INFLUENCE OF VARIOUS DRUGS ON THE BINDING OF CHLORPROMAZINE 
TO ERYTHROCYTES AND ALBUMIN. 

181470 02-03 
L-DOPA AND POTENTIATION OF ALCOHOL ANESTHESIA BY 
CHLORPROMAZINE. 

182091 02-03 
STUDIES ON CENTRAL REGULATING MECHANISM OF THE HYPOGLYCEMIA 
INDUCED BY INTRAVENTRICULAR ADMINISTRATION OF 
CHLORPROMAZINE. 

182093 02-03 
PHARMACOLOGY OF MONO AND DISUBSTITUTED CHLORPROMAZINE 
METABOLITES. 

182243 03-03 
MODIFICATION OF THE EFFECTS OF CHLORPROMAZINE ON BEHAVIOR IN 
THE CHIMPANZEE. 

183889 03-04 
SEIZURE SUSCEPTIBILITY AND AVOIDANCE CONDITIONING IN ADULT 
RATS TREATED PRENATALLY WITH CHLORPROMAZINE. 

184371 03-04 
EFFECTS OF CONCURRENT BEHAVIOR MODIFICATION AND 

CHLORPROMAZINE ADMINISTRATION IN MENTALLY RETARDED 
WOMEN. (PH.D. DISSERTATION). 

185604 03-14 
THE EFFECTS OF CHLORPROMAZINE ON A REDEFINED PROCEDURE OF 
EXTINCTION OF SIDMAN AVOIDANCE BEHAVIOR. (PH.D. 
DISSERTATION). 

185715 03-14 
EFFECTS OF CHLORPROMAZINE AND THREE METABOLITES ON 
BEHAVIORAL RESPONSES IN RATS. 

185748 03-04 
CHLORPROMAZINE AND AVOIDANCE: A GENETIC ANALYSIS. 

185751 03-03 
EFFECTS OF MORPHINE AND CHLORPROMAZINE ON APOMORPHINE- 
INDUCED STEREOTYPED BEHAVIOUR. 

185997 03-04 
THE EFFECT OF CHLORPROMAZINE ON HOMOVANILLIC ACID LEVELS IN 
CEREBROSPINAL FLUID OF SCHIZOPHRENIC PATIENTS. 

186565 03-08 
BIOEQUIVALENCY OF GENERIC AND BRAND-NAMED CHLORPROMAZINE. 

187255 03-08 
CHLORPROMAZINE INDUCED HYPERPHAGIA. (UNPUBLISHED PAPER). 

187498 04-04 
A POSSIBLE MECHANISM FOR THE ANTISCHIZOPHRENIC ACTION OF 
CHLORPROMAZINE: INHIBITION OF THE FORMATION OF 
DIMETHYLTRYPTAMINE BY CHLORPROMAZINE METABOLITES. 

187576 04-03 
CHLORPROMAZINE CAUSING EXTRAPYRAMIDAL DYSFUNCTION IN 
NEWBORN INFANT OF PSYCHOTIC MOTHER. 

187787 04-15 
ACTIONS OF ATROPINE, HEMICHOLINIUM-3, AND PHYSOSTIGMINE ON 
CHLORPROMAZINE INDUCED CHANGES IN RAT BRAIN MONOAMINES. 

187800 04-03 
ENHANCED BINDING OF CHLORPROMAZINE TO CHOLESTEROL DEPLETED 

SYNAPTOSOME FRACTIONS. 

187801 04-03 
A NEW PROLONGED ACTING TYPE OF CHLORPROMAZINE: BEHAVIORAL 

EFFECTS AND PROLONGED ACTIONS ON NERVE MEMBRANES. 

187805 04-01 
EFFECT OF PROLONGED CHLORPROMAZINE ADMINISTRATION ON THE 
SLEEP OF CHRONIC SCHIZOPHRENICS. 

188115 04-08 
EFFECTS OF CHLORPROMAZINE PLASMA LEVELS ON 
ELECTROCARDIOGRAM. 

188838 04-13 
INVOLVEMENT OF BRAIN CHOLINERGIC MECHANISMS IN THE ACTION OF 
CHLORPROMAZINE. 

188891 04-03 
A STUDY OF BIOGENIC AMINE METABOLITES IN THE CEREBROSPINAL 
FLUID AND URINE OF MONKEYS WITH CHLORPROMAZINE INDUCED 
DYSKINESIA. 

189210 04-03 
THE ACTION OF CHLORPROMAZINE ON EXPLORATION IN PAIRS OF RATS. 

189514 04-04 
THE LACK OF EFFECTS OF PRETREATMENT WITH PHENOBARBITAL AND 
CHLORPROMAZINE ON THE ACUTE TOXICITY OF BENZENE IN RATS. 

189600 04-05 
THE CONTROL OF DEVIANT SEXUAL BEHAVIOR BY DRUGS: A DOUBLE- 
BLIND CONTROLLED STUDY OF BENPERIDOL, CHLORPROMAZINE, AND 
PLACEBO. 

190061 04-11 



S-52 



VOLUME 12, SUBJECT INDEX 



Subject Index 



A POLAROGRAPHIC METHOD FOR THE DETERMINATION OF THE N-OXIDE, 
NOXIDE-SULPHOXIDE AND SULPHOXIDE METABOLITES OF 
CHLORPROMAZINE. 

190902 04-06 
THE EFFECT OF CHLORPROMAZINE AND STELAZINE ON LYS050MES OF 
RAT LIVER DURING ACUTE INTOXICATION. 

191121 04-03 
CHANGES IN ORIENTING AND HABITUATION IN THE RAT FOLLOWING 
ADMINISTRATION OF CHLORPROMAZINE. 

191211 04-04 
SERUM TRYPTOPHAN BINDING IN CHLORPROMAZINE TREATED CHRONIC 
SCHIZOPHRENICS. 

191320 04-08 
EFFECTS OF D-AMPHETAMINE, MORPHINE AND CHLORPROMAZINE ON 
RESPONDING UNDER FIXED-INTERVAL SCHEDULES OF FOOD 
PRESENTATION OR ELECTRIC SHOCK PRESENTATION. 

191767 04-03 
THE EFFECT OF CHLORPROMAZINE AND AMYTAL SODIUM ON THE 
CONFORMITY OF ADOLESCENTS UNDER PSYCHIATRIC OBSERVATION 

191776 04-14 
ACTIVATION OF STRIATAL HYDROXYLASE BY HYDROXYLATED 
METABOLITES OF CHLORPROMAZINE. 

191908 04-03 
EFFECTS OF CHLORPROMAZINE (CPZ) AND THIORIDAZINE PERFORMANCE 
AND STIMULUS CONTROL BEHAVIOR. 

191974 04-04 
CHLORPROMAZINES 

SLEEP: A TOOL TO STUDY CHLORPROMAZINES ACTION. (UNPUBLISHED 
PAPER). 

173521 01-14 
METAL CHELATION OF CHLORPROMAZINES, 

176763 02-06 
CHOICE 

EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON DELAYED MATCHING- 
TO-SAMPLE CHOICE SPEEDS IN CHIMPANZEES. 

171886 01-04 
IMPROVING PSYCHIATRIC DRUG THERAPY: A MATTER OF DOSAGE AND 
CHOICE. 

190144 04-17 
CHOLESTEROL 

ENHANCED BINDING OF CHLORPROMAZINE TO CHOLESTEROL DEPLETED 
SYNAPTOSOME FRACTIONS. 

187801 04-03 
CHOLINE 

EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS. 

169467 01-03 
CHOLINE ACTIVATION OF LITHIUM TRANSPORT. 

178812 02-03 
CHOLINE ACETYLTRANSFERASE ACTIVITY IN THE CEREBROSPINAL FLUID 
OF PSYCHIATRIC PATIENTS. 

180047 02-13 
REGIONAL AND SUBCELLULAR DISTRIBUTION OF CHOLINE 
ACETYLTRANSFERASE IN THE BRAIN OF NORMAL AND MORPHINE 
TREATED RATS. 

182224 03-03 
EFFECT OF ACUTE AND CHRONIC MORPHINE ON SPECIFIC 

RADIOACTIVITIES OF CHOLINE AND ACETYLCHOLINE IN MOUSE BRAIN. 

182226 03-03 
DRUGS, BEHAVIOR AND CHOLINE ACETYLTRANSFERASE. 

182237 03-04 
TRANSSYNAPTIC INDUCTION OF CHOLINE ACETYLTRANSFERASE IN THE 
PREGANGLIONIC NEURON OF THE PERIPHERAL SYMPATHETIC NERVOUS 
SYSTEM. 

182720 03-03 
EFFECT OF OXOTREMORINE AND PHYSOSTIGMINE ON CHOLINE LEVELS IN 
MOUSE WHOLE BRAIN, SPLEEN AND CEREBELLUM. 

189893 04-03 
EFFECT OF DIAZEPAM ON MOUSE WHOLE BRAIN AND BRAIN AREA 
ACETYLCHOLINE AND CHOLINE LEVELS. 

191423 04-03 
INHIBITION OF CHOLINE UPTAKE INTO SYNAPTOSOMES BY CHOLINE 
ANALOGUES. 

191999 04-03 
ANALOGS OF CHOLINE: SYNAPTOSOMAL METABOLISM 

192000 04-03 
INHIBITION IN VIVO OF ACETYLCHOLINE SYNTHESIS IN MOUSE BRAIN BY 

INHIBITORS OF CHOLINE ACETYLTRANSFERASE. 

192001 04-03 
CHOLINERGIC 

TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. (UNPUBLISHED PAPER). 

170876 01-03 



CHOLINERGIC REVERSAL OF MANIC SYMPTOMS: A POSSIBLE 
EXPLANATION. (UNPUBLISHED PAPER). 

173520 01-09 
CENTRAL CHOLINERGIC (MUSCARINIC) LINK IN THE ATTACK REFLEXIVE 
BITING MECHANISM OF CATS. 

182238 03-04 
CHOLINERGIC MODIFICATION OF NALOXONE INDUCED JUMPING IN 
MORPHINE DEPENDENT MICE. 

184179 03-03 
ARE CHOLINERGIC MECHANISMS INVOLVED IN MORPHINE EFFECTS ON 
MOTILITY 

184198 03-03 
DOPAMINERGIC HYPERSENSITIVITY AND CHOLINERGIC HYPOFUNCTION 
IN THE PATHOPHYSIOLOGY OF TARDIVE DYSKINESIA. 

185929 03-11 
EFFECT OF SEVERAL DOPAMINERGIC DRUGS AND TRIHEXYPHENIDYL ON 
CHOLINERGIC PARAMETERS IN THE RAT STRIATUM. 

185995 03-03 
METHYLPHENIDATE ANTAGONISM OF HALOPERIDOL, INTERACTION WITH 
CHOLINERGIC AND ANTICHOLINERGIC DRUGS. 

186370 03-04 
ALTERATION OF ETHANOL-INDUCED CNS DEPRESSION: INEFFECTIVENESS 
OF DRUGS THAT MODIFY CHOLINERGIC TRANSMISSION. 

186375 03-03 
POSSIBLE PERIPHERAL ADRENERGIC AND CHOLINERGIC MECHANISMS IN 
PSEUDOCONDITIONING. 

186575 03-03 
NONCHOLINERGIC MECHANISM OF ACTION OF CHOLINERGIC DRUGS ON 
SQUID AXON MEMBRANES 

186672 03-03 
FEAR REDUCTION IN THE RAT FOLLOWING CENTRAL CHOLINERGIC 
BLOCKADE, 

187703 04-04 
ANTISCHIZOPHRENIC DRUGS AND BRAIN CHOLINERGIC RECEPTORS: 
AFFINITY FOR MUSCARINIC SITES PREDICTS EXTRAPYRAMIDAL 
EFFECTS. 

188114 04-15 
INVOLVEMENT OF BRAIN CHOLINERGIC MECHANISMS IN THE ACTION OF 
CHLORPROMAZINE. 

188891 04-03 
CHOLINERGIC SUPPRESSION OF TARDIVE DYSKINESIA. 

189403 04-11 
DOPAMINERGIC INHIBITION OF STRIATAL CHOLINERGIC NEURONS: 
SYNERGISTIC BLOCKING ACTION OF GAMMA-BUTYROLACTONE AND 
NEUROLEPTIC DRUGS. 

189602 04-03 
THE MOTIVATIONAL CONSEQUENCES OF CHOLINERGIC STIMULATION OF 
THE MEDIAL SEPTAL AREA. 

190260 04-04 
CHOLINERGIC SUPPRESSION OF TARDIVE DYSKINESIA. 

190314 04-13 
CHOLINERGIC AND ADRENERGIC BALANCE IN MANIA AND 
SCHIZOPHRENIA. 

191530 04-09 
ADRENERGIC AND CHOLINERGIC FACTORS IN EXTRAPYRAMIDAL 
DISORDERS. 

191533 04-11 
CHOLINERGIC AMINERGIC INTERACTIONS IN LEAD INDUCED 
HYPERACTIVITY. 

191954 04-05 
NEUROPHARMACOLOGICAL ANALYSIS OF CENTRAL ADRENERGIC AND 
CHOLINERGIC ANTAGONISM OF DELTA9-TETRAHYDR0CANNABIN0L. 

191992 04-03 
CHOLINERGICALLY 

EVIDENCE FOR CHOLINERGICALLY MEDIATED EFFECT OF 

METHYLPHENIDATE HYDROCHLORIDE IN THE CENTRAL NERVOUS 
SYSTEM. 

191946 04-03 
CHOLINESTE RASES 

EXCITANT AND DEPRESSANT DRUGS MODULATE EFFECTS OF 
ENVIRONMENT ON BRAIN WEIGHT AND CHOLINESTERASES. 

174036 01-03 
CHOLINOLYTIC 

THE EFFECT OF SOME CHOLINOLYTIC DRUGS ON A NUMBER OF 

BEHAVIOURAL PARAMETERS MEASURED IN THE T-MAZE ALTERNATION 
TEST: DOSE-RESPONSE RELATIONSHIPS 

187641 04-04 
CHOLINOMIMETIC 

THE EFFECT OF CHOLINOMIMETIC DRUGS ON POTASSIUM TRANSPORT IN 
RAT CEREBRAL CORTEX. 

191411 04-03 
THE ANTAGONISM BETWEEN CHOLINOMIMETIC AGONISTS AND BETA- 
ADRENOCEPTOR STIMULANTS: THE DIFFERENTIATION BETWEEN 
BETWEEN FUNCTIONAL AND METAFFINOID ANTAGONISM. 

191420 04-03 
CHOLINOMIMETICS 

EFFECTS OF CHOLINOMIMETICS ON ADRENERGIC TRANSMISSION 

182088 02-03 



S-53 



Subject Index 



Psychopharmacology Abstracts 



CHORDA 

CHLOROFORM RESPONSES OF THE CHORDA TYMPANI NERVE IN THE 

RAT 

189219 04-03 

CHOREA 

HUNTINGTONS CHOREA: THE RIGID FORM (WESTPHAL VARIANT) 
TREATED WITH LEVODOPA. 

187618 04-11 
HUNTINGTONS CHOREA TREATED WITH LITHIUM CARBONATE. 

187985 04-11 

CHOROID 

THE ELIMINATION OF 5-HYDROXYINDOLEACETIC ACID FROM 

CEREBROSPINAL FLUID: CHARACTERISTICS OF THE ACID TRANSPORT 
SYSTEM OF THE CHOROID PLEXUS. 

182718 03-03 

CHROMAFFIN 

INFLUENCE OF DIFFERENT ANIONS ON TYRAMINE AND AMPHETAMINE 
UPTAKE BY COW ADRENAL MEDULLA CHROMAFFIN VESICLES. 

190907 04-03 
CHROMATIN 

CHROMATIN TEMPLATE ACTIVITY DURING MORPHINE-INDUCED 
ANALGESIA AND THE DEVELOPMENT OF ANALGESIC TOLERANCE. 

182160 02-03 
CHROMATOGRAMS 

QUANTITATIVE DETERMINATION OF IMIPRAMINE AND DESIPRAMINE IN 
HUMAN BLOOD PLASMA BY DIRECT DENSITOMETRY OF THIN-LAYER 
CHROMATOGRAMS. 

183603 03-13 

CHROMATOGRAPHIC 

GAS CHROMATOGRAPHIC • MASS SPECTROMETRIC STUDIES ON 
TRICYCLIC PSYCHOTROPIC DRUGS. 

169073 01-01 
A SENSITIVE GAS CHROMATOGRAPHIC PROCEDURE FOR THE 
ESTIMATION OF NORADRENALINE, DOPAMINE AND 5- 
HYDROXYTRYPTAMINE IN RAT BRAIN. 

171971 01-01 
GAS CHROMATOGRAPHIC DETERMINATION OF METHAQUALONE IN 
SMALL AMOUNTS OF SERUM AFTER INGESTION OF THERAPEUTIC 
DOSES. 

172397 01-16 
GAS CHROMATOGRAPHIC ANALYSIS OF BENZODIAZEPINES, PART I: 
MEDAZEPAM AND ITS METABOLITES. 

178948 02-06 
A GAS CHROMATOGRAPHIC METHOD FOR THE QUANTITATIVE 
ESTIMATION OF N-HYDROXYPHENTERMINE. 

182203 02-06 
CHROMATOGRAPHY 

MEDICOLEGAL STUDIES ON ISOLATION AND IDENTIFICATION OF 
HYPNOTICS BY THIN-LAYER CHROMATOGRAPHY (TLC) - REPORT 1. 
THIN-LAYER CHROMATOGRAPHY OF HYPNOTICS AND TRANQUILIZERS. 

181315 02-16 
MEDICOLEGAL STUDIES ON ISOLATION AND IDENTIFICATION OF 
HYPNOTICS BY THIN-LAYER CHROMATOGRAPHY (TLC): REPORT 2 - 
ISOLATION AND IDENTIFICATION OF HYPNOTICS AND TRANQUILIZER 
IN VIVO. 

182623 03-06 

ISOLATION AND IDENTIFICATION OF HYPNOTICS (8): ISOLATION AND 
IDENTIFICATION OF BENZALIN AND CERCINE BY THIN-LAYER 
CHROMATOGRAPHY IN VITRO. 

182626 03-01 

CHROMOSOME 

LSD ..AN IN VIVO RETROSPECTIVE CHROMOSOME STUDY. 

181811 02-13 
CHROMOSOME EXAMINATIONS AFTER MEDICALLY ADMINISTERED 
LYSERGIC ACID DIETHYLAMIDE AND DEXTROAMPHETAMINE. 

192084 04-15 

CHROMOSOMES 

MUTAGENICITY EXPERIMENTS WITH THE TRANQUILLIZER MEPROBAMATE 
IN DROSOPHILA-MELANOGASTER AND IN HUMAN LEUKOCYTE 
CHROMOSOMES IN VITRO. 

184585 03-05 

CHRONIC 

CLORAZEPATE DIPOTASSIUM, DIAZEPAM AND PLACEBO IN CHRONIC 
ANXIETY. 

167339 01-10 

EFFECTS OF ACUTE AND CHRONIC ADMINISTRATION OF CANNABIS- 
SATIVA EXTRACT ON THE MOUSE-KILLING BEHAVIOR OF RATS. 

167362 01-04 
EFFECT OF CHRONIC POSTTRIAL SALINE INJECTIONS ON MAZE 

PERFORMANCE. „,„,„, 

167403 01-04 

POTENTIATION OF THERAPEUTIC EFFECTS OF NICOTINIC ACID BY 
PYRIDOXINE IN CHRONIC SCHIZOPHRENICS. 

168313 01-08 
CLINICAL EVALUATION OF FLUSPIRILENE AS A MAINTENANCE THERAPY 
IN CHRONIC SCHIZOPHRENIC PATIENTS. 

168320 01-08 



EFFECT OF CHRONIC LITHIUM TREATMENT ON MONOAMINE 
METABOLISM IN RAT BRAIN. 

168839 01-03 
CHEMOTHERAPY IN CHRONIC ORGANIC BRAIN SYNDROME - A REVIEW 
OF THE LITERATURE. 

169065 01-11 
PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF CHRONIC 
MARIJUANA ADMINISTRATION IN MAN. 

169070 01-13 
ROLE OF FLUPHENAZINE DECANOATE IN LESSENING THE BURDEN OF 
CHRONIC SCHIZOPHRENICS ON THE COMMUNITY. 

169438 01-08 
THE EFFECTS OF CHRONIC TREATMENT WITH DELTA9- 

TETRAHYDROCANNABINOL ON CATECHOLAMINE SYNTHESIS IN THE 
RAT 

169471 01-03 
BLOOD LEVEL PROFILE IN MAN FOLLOWING CHRONIC ORAL 
ADMINISTRATION OF FLURAZEPAM HYDROCHLORIDE. 

169817 01-13 
PHARAAACOKINETIC PROFILE OF DIAZEPAM IN MAN FOLLOWING SINGLE 
INTRAVENOUS AND ORAL AND CHRONIC ORAL ADMINISTRATION. 

170838 01-13 
DIPHENYLHYDANTOIN EFFECTIVENESS IN THE TREATMENT OF CHRONIC 
SCHIZOPHRENICS: A DOUBLE-BLIND CONTROLLED STUDY WITH A 
PLACEBO. 

171507 01-08 
TOLERANCE TO HEXOBARBITAL AND SUPERSENSITIVITY TO PILOCARPINE 
INDUCED BY CHRONIC BARBITAL TREATMENT IN THE RAT. 

171601 01-03 
CHRONIC HYPNOTIC DRUG USE: INEFFECTIVENESS, DRUG WITHDRAWAL 
INSOMNIA, AND DEPENDENCE. 

17211401-15 
A DOUBLE-BUND COMPARISON OF THIORIDAZINE (MELLARIL) VERSUS 
DIAZEPAM (VALIUM) IN PATIENTS WITH CHRONIC MIXED ANXIETY 
AND DEPRESSIVE SYMPTOMS. 

172486 01-10 
A COMPARATIVE TRIAL OF HALOPERIDOL AND THIORIDAZINE: 
MANAGEMENT OF CHRONIC SCHIZOPHRENIA. 

172741 01-08 
PHARAAACOTHERAPY IN CHRONIC SCHIZOPHRENIA. 

172831 01-08 
PRELIMINARY STUDY OF THE TREATMENT OF CHRONIC PSYCHOSES 
WITH FLUPENTHIXOL DECANOATE. 

172978 01-09 
HIGH AND LOW DOSE THIOTHIXENE TREATMENT IN CHRONIC 
SCHIZOPHRENIA. 

176673 02-08 
CLINICAL EXPERIENCES WITH NAVANE IN CHRONIC SCHIZOPHRENIA. 

176726 02-08 
CLINICAL EXPERIENCES WITH A PSYCHOTROPIC DRUG (OXYPERTINE) IN 

CHRONIC SCHIZOPHRENIA. 

176727 02-08 
ACQUISITION AND PERFORMANCE OF AN ATTENTION TASK BY RATS 

SUBJECTED TO CHRONIC NICOTINE TREATMENT. 

176864 02-04 
EFFECT OF CHRONIC ADMINISTRATION OF L-DOPA ON CATECHOL-0- 
METHYLTRANSFERASE IN RAT TISSUES. 

176936 02-03 

EFFECTS OF CHRONIC PRETREATMENT WITH SMALL DOSES OF RESERPINE 
UPON ADRENERGIC NERVE FUNCTION. 

1 77406 02-03 
REPEATED ACQUISITION OF BEHAVIORAL CHAINS UNDER CHRONIC DRUG 
CONDITIONS. 

177408 02-04 

THE EFFECTS OF PHYSOSTIGMINE IN PHENOTHIAZINE RESISTANT 
CHRONIC SCHIZOPHRENIC PATIENTS: PRELIMINARY OBSERVATIONS. 

1 77669 02-08 
PIPERACETAZINE IN AMBULATORY CHRONIC SCHIZOPHRENIC PATIENTS. 

177748 02-08 
EFFECTS OF AQUEOUS PINEAL EXTRACT IN CHRONIC SCHIZOPHRENIA. 

177818 02-08 
DREAM REPORTS AFTER RESERPINE ADMINISTRATION IN CHRONIC 
LOBOTOMIZED SCHIZOPHRENIC PATIENTS. 

178187 02-08 
PIMOZIDE (R-6238) IN CHRONIC SCHIZOPHRENIA: DOUBLE-BUND TRIAL. 

178255 02-08 
SLEEP CHANGES IN CHRONIC SCHIZOPHRENICS: EFFECTS OF 5- 
HYDROXYTRYPTOPHAN (5-HTP). (UNPUBLISHED PAPER 

1 78578 02-08 
CHANGES IN BRAIN ACETYLCHOLINESTERASE ACTIVITY OF YOUNG RATS 
AFTER CHRONIC TREATMENT WITH TREMORINE. 

178814 02-03 
BEHAVIORAL EVIDENCE FOR DOPAMINERGIC SUPERSENSITIVITY AFTER 
CHRONIC HALOPERIDOL. 

180021 02-04 

EFFECT OF CHRONIC INTOXICATION WITH (J AMPHETAMINE ON ITS 
CONCENTRATION IN LIVER AND BRAIN AND ON (14C) LEUCINE 



S-54 



-li *b«»' 



VOLUME 12, SUBJECT INDEX 



Subject Index 



INCORPORATION INTO MICROSOMAL AND CYTOPLASMIC PROTEINS OF 
RAT LIVER. 

180056 02-05 
EXPERIENCE GAINED IN THE TREATMENT OF CHRONIC SCHIZOPHRENIC 
PSYCHOSES WITH A THIORIDAZINE DERIVATIVE. 

180675 02-08 
CHRONIC MEPROBAMATE INTOXICATION AND PHOTOMYOCLONIC 
RESPONSE. 

181377 02-15 
COMPARISON OF THE CHRONIC AND ACUTE EFFECTS OF D-LYSERGIC 
ACID DIETHYLAMIDE (LSD) TREATMENT ON RAT BRAIN SEROTONIN 
AND NOREPINEPHRINE. 

181945 02-03 
EFFECT OF ACUTE AND CHRONIC MORPHINE ON SPECIFIC 

RADIOACTIVITIES OF CHOLINE AND ACETYLCHOLINE IN MOUSE BRAIN. 

182226 03-03 
STUDIES ON THE EFFECT OF ACUTE AND CHRONIC MORPHINE 
TREATMENT ON CATECHOLAMINE LEVELS AND TURNOVER IN 
DISCRETE BRAIN AREAS OF RATS. 

182228 03-03 
EFFECTS OF CHRONIC ADMINISTRATION OF AMPHETAMINE UPON THE 
CATECHOLAMINE CONTENT OF MOUSE BRAIN. 

182255 03-03 
SIMILARITY OF CHRONIC CHLORDIAZEPOXIDE TREATMENT AND 
REMOVAL Of CONFLICT SITUATION. 

182258 03-04 
CLINICAL STUDIES OF ACUTE PSYCHOSIS ON THE BASIS OF CHRONIC 
HYPNOTICA INTOXICATION - AN ABSTRACT REPORT. 

182755 03-15 
THE INFLUENCE OF CHRONIC ADMINISTRATION OF LITHIUM CARBONATE 
ON THE BRAIN NOREPINEPHRINE CONTENT IN RATS. 

182872 03-03 
IMPORTANCE OF THE COOPERATION OF FAMILIES IN THE TREATMENT OF 
THE SICK; CONCERNING CHRONIC DELIRIUM TREATED WITH 
NEUROLEPTICS AND MELANCHOLY TREATED WITH ANTIDEPRESSANTS. 

182899 03-17 
CLINICAL OBSERVATIONS ON THE USE OF PIMOZIDE IN THE TREATMENT 
OF CHRONIC SCHIZOPHRENICS. 

183196 03-08 
EVALUATION OF EEC AND CLINICAL CHANGES ASSOCIATED WITH 
PAVABID THERAPY IN CHRONIC BRAIN SYNDROME, 

183402 03-13 
EFFECT OF CHRONIC METHADONE ADMINISTRATION ON PREGNANT RATS 
AND THEIR OFFSPRING. 

183894 03-03 
ON THE DYNAMICS AND TREATMENT OF THE TENDENCY OF 
SCHIZOPHRENIC PSYCHOSIS TO BECOME CHRONIC. 

183957 03-08 
THE CONCENTRATIONS OF DIAZEPAM AND ITS METABOLITES IN THE 
PLASMA AFTER AN ACUTE AND CHRONIC ADMINISTRATION. 

184978 03-13 
REDUCED BEHAVIORAL EFFECTS OF PILOCARPINE DURING CHRONIC 
TREATMENT WITH DFP, 

185265 03-04 
THE EFFECTS OF CHRONIC TREATMENT WITH D-AMPHETAMINE ON FOOD 
INTAKE, BODYWEIGHT, LOCOMOTOR ACTIVITY AND SUBCELLULAR 
DISTRIBUTION OF THE DRUG IN RAT BRAIN. 

185931 03-03 
A COMPARISON OF THE EFFECTS OF CHRONIC ADMINISTRATION OF 
ETHANOL AND ACETALDEHYDE TO MICE: EVIDENCE FOR A ROLE OF 
ACETALDEHYDE IN ETHANOL DEPENDENCE. 

185992 03-03 
THE ADMINISTRATION OF METHIONINE TO CHRONIC SCHIZOPHRENIC 
PATIENTS: A REVIEW OF TEN STUDIES. 

187113 03-08 
BEHAVIOR AND EEG ANALYSIS OF CHRONIC AMPHETAMINE EFFECT. 

187116 03-13 
THE EFFECTS OF CHRONIC RESERPINE AND NIALAMIDE TREATMENT ON 
THE FREE AMINO ACID LEVELS OF RAT BRAIN. 

187645 04-03 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 
DERIVATIVE SE-780 IN RATS. 

187926 04-04 
EFFECT OF PROLONGED CHLORPROMAZINE ADMINISTRATION ON THE 
SLEEP OF CHRONIC SCHIZOPHRENICS. 

188115 04-08 
PLASMA DOPA AND FUNCTIONAL OSCILLATIONS AFTER CHRONIC 
TREATMENT OF PARKINSONS DISEASE. 

188421 04-13 
SENILITY AND CHRONIC MALNUTRITION. 

188446 04-11 
DOUBLE-BLIND COMPARISON OF THIOTHIXENE, TRIFLUOPERAZINE, AND 
PLACEBO IN CHRONIC ALCOHOLISM. 

188584 04-11 
EFFECTS OF CHRONIC EXPOSURE TO DELTA9-TETRAHYDR0CANNABIN0L 
ON DELAYED MATCHING-TO-SAMPLE IN CHIMPANZEES. 

189405 04-04 



CRUDE MARIHUANA EXTRACT: EEG AND BEHAVIORAL EFFECTS OF 
CHRONIC ORAL ADMINISTRATION IN RHESUS MONKEYS. 

189516 04-04 
EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND AGE ON 

VARIOUS NEUROTRANSMITTERS AND ASSOCIATED ENZYMES IN MALE 
FISCHER 344 RATS. 

189597 04-03 
CANNABINOIDS: NEUROCHEMICAL ASPECTS AFTER ORAL CHRONIC 
ADMINISTRATION TO RATS. 

189599 04-03 
DRUG MAINTENANCE IN THE OUTPATIENT TREATMENT OF CHRONIC 
ALCOHOLISM. 

189926 04-11 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 
METABOLITE, NORFENFLURAMINE: AN EVALUATION OF ITS ROLE IN 
THE ACTIONS OF FENFLURAMINE. 

190335 04-04 
DISSOCIATION OF GROWTH HORMONE AND PROLACTIN SECRETION IN 
PARKINSONS DISEASE FOLLOWING CHRONIC L-DOPA THERAPY. 

191233 04-13 
SERUM TRYPTOPHAN BINDING IN CHLORPROMAZINE TREATED CHRONIC 
SCHIZOPHRENICS. 

191320 04-08 
EFFECT OF CHRONIC TREATMENT WITH CENTRAL STIMULANTS ON BRAIN 
MONOAMINES AND SOME BEHAVIOURAL AND PHYSIOLOGICAL 
FUNCTIONS IN RATS, GUINEA-PIGS, AND RABBITS. 

191503 04-03 
EXPERIMENT WITH PENFLURIDOL {TLP-607) ON THE TREATMENT OF 
CHRONIC SCHIZOPHRENIA. 

191593 0408 
EFFECTS OF PHENETHYLAMINE (PEA) IN THE CHRONIC SPINAL DOG. 

191904 04-03 
LONG-TERM ALTERATION OF SLEEP-WAKEFULNESS CYCLE DURING 
CHRONIC PENTOBARBITAL DOSING AND WITHDRAWAL IN CAT. 

191952 04-04 
STUDIES OF THE IMMUNE RESPONSE IN CHRONIC MARIHUANA 
SMOKERS. 

191961 04-13 
SUBCELLULAR LOCALIZATION OF H3-DELTA9-TETRAHYDR0CANNABIN0L 
IN DOG BRAIN AFTER ACUTE OR CHRONIC ADMINISTRATION. 

191970 04-03 
EFFECT OF CHRONIC TREATMENT WITH DESIPRAMINE (DMI) AND 
IPRINDOLE (IP) ON THE NOREPINEPHRINE (NE) SENSITIVE ADENYLATE 
CYCLASE SYSTEM IN SLICES Of THE RAT LIMBIC FOREBRAIN. 

192003 04-03 
SUPERSENSITIVITY TO DOPAMINERGIC AGONISTS FOLLOWING 
WITHDRAWAL OF A CHRONIC DIET CONTAINING HALOPERIDOL OR 
PIMOZIDE. 

192012 04-04 
EFFECTS OF CHRONIC METHYLPHENIDATE ADMINISTRATION ON 
LEARNING AND OFFSPRING BEHAVIOR. 

192116 04-04 
CONDITIONING IN THE PREDICTION OF DRUG WITHDRAWAL EFFECTS IN 
CHRONIC SCHIZOPHRENIC PATIENTS. 

192412 04- 17 
CHRONICALLY 

END OF A BACK WARD: THE RAPID REHABILITATION AND RELEASE OF 
CHRONICALLY HOSPITALIZED PSYCHIATRIC PATIENTS. 

181153 02-08 
EFFECTS OF CHRONICALLY ADMINISTERED DELTAl- 
TETRAHYDROCANNABINOL OF ADRENAL AND GONADAL ACTIVITY OF 
MALE RATS. 

183358 03-03 
CATALEPSY AND STEREOTYPED BEHAVIOUR IN RATS TREATED 
CHRONICALLY WITH METHADONE: RELATION TO BRAIN 
HOMOVANILLIC ACID CONTENT. 

183606 03-04 
TOLERANCE TO THE BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF 
HALOPERIDOL AND MORPHINE IN RATS CHRONICALLY TREATED WITH 
MORPHINE OR HALOPERIDOL. 

184225 03-03 
CHRONOPHARMACOLOGY 

CHRONOPHARMACOLOGY OF DELTA9-TETRAHYDR0CANNABIN0L 
HYPOTHERMIA IN MICE. 

176880 02-03 
CHRONOTROPIC 

MECHANISM OF THE NEGATIVE CHRONOTROPIC AND INOTROPIC EFFECTS 
OF DELTAl -TETRAHYDROCANNABINOL (DELTAl-THC OR DELTA9-THC). 

182219 03-03 
CI-683 

PYRAZAPON (CI-683): A NEW ANTIANXIETY AGENT. 

186581 03-04 
CI-686 

PREDICTION OF NEUROLEPTIC EFFECTS OF CI-686 BASED ON 
QUANTITATIVE PHARMACOELECTROENCEPHALOGRAPHY: DRUG 
PROFILES AND DOSE RESPONSE CURVES BASED ON COMPUTERIZED 
CEREBRAL BIOPOTENTIALS. 

181958 02-13 



S-55 



Subject Index 



Psychopharmacology Abstracts 



^'"*a"oubu-blind comparative clinical trial with LUDIOMIL (CIBA- 

34276-BA) AND AMITRIPTYLINE IN NEWLY ADMITTED DEPRESSED 
P'^T'^^^^- 167774 01-09 

*^'°*THE EFFECT OF CAFFEINE, NITRAZEPAM AND CIGARETTE SMOKING ON 
THE CONTINGENT NEGATIVE VARIATION IN MAN. 

187350 04-13 

CINANSERIN 

ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN 

DIMETHYLAMINOPROPYLTHIOCINNAMANILIDE HYDROCHLORIDE), A 
SEROTONIN ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN (5-HTP) AND ALPHA-METHYLTRYPTAMINE. 

176861 02-04 

ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN, A SEROTONIN 
ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN AND ALPHA-METHYLTRYPTAMINE. 

SYNTHESIS OF SUBSTITUTED CINNAMIDES: RELATIONSHIP BETWEEN 
ANTICONVULSANT AND MONOAMINE OXIDASE INHIBITORY 
^^OP^^-^^^S. ,69818 01-01 

ORCADIAN 

ONTOGENESIS OF CIRCADIAN PITUITARY ADRENAL PERIODICITY IN RATS 
AFFECTED BY NEONATAL TREATMENT WITH ACTH. 

181576 02-03 

CIRCLING 

A COMPARISON OF EFFECTS OF APOMORPHINE AND ET-495 ON 
LOCOMOTOR ACTIVITY AND CIRCLING BEHAVIOUR IN MICE. 

186635 03-04 

THE INFLUENCE OF 3-QUINUCLIDINYLBENZILATE ON THE BEHAVIOUR OF 
RATS IN A CIRCULAR RUNWAY. ,87259 04-04 

INFLUENCE OF PH ON THE BENZODIAZEPINE HUMAN SERUM ALBUMIN 
COMPLEX: CIRCULAR DICHROISM STUDIES. 

loVjVj UA* I ^3 

CIRCULATION 

EXPERIENCE IN THE TREATMENT OF CEREBRAL INSUFFICIENCY AND 
PERIPHERAL BLOOD CIRCULATION DISORDERS USING THE EP-50-100 
EXPERIMENTAL DRUG. ,80676 02-11 

PHARMACOLOGICAL ANALYSIS OF NOREPINEPHRINE AND 5- 
HYDROXYTRYPTAMINE REMOVAL FROM THE PULMONARY 
CIRCULATION: DIFFERENTIATION OF UPTAKE SITES FOR EACH AMINE. 

lo2/I/ UJ*U»J 

DIFFERENTIAL CIRCULATORY EFFECTS OF VARIOUS ANOREXIGENIC 
■^"^^^ 182214 03-03 

PLASMA LEVELS OF LUTEINIZING HORMONE AND OF IMMUNOREACTIVE 
ESTROGENS (ESTRADIOL) IN ANOREXIA-NERVOSA: RESPONSE TO 
CLOMIPHENE CITRATE. ,83807 03-10 

CL-1848C 

OPERANT BEHAVIOR AND NEUROPHYSIOLOGICAL OBSERVATIONS OF 
NORMAL HUMAN VOLUNTEERS RECEIVING CL-1848C, A NEW 
DISSOCIATIVE ANESTHETIC. ,67334 01-07 

VOLTAGE CLAMP ANALYSIS OF PENTYLENETETRAZOL EFFECTS ON 
APLYSIA NEURONS. ,89032 04-03 

REHABILITATION OF LEARNING IN A HOSPITAL CLASS USING 
PSYCHOACTIVE DRUGS. ,7407101-11 

SPECIFIC INDICATIONS FOR DIFFERENT CLASSES OF PHENOTHIAZINES. 

171 505 1 -08 

THE CURARIZED RAT AND HEART RATE CONDITIONING: A 
CONSIDERATION OF RESPIRATION PARAMETERS AND 
NEUROMUSCULAR BLOCKING AGENTS IN A CLASSICAL CONDITIONING 
PARADIGM. (PH.D. DISSERTATION). ^^^^^^ ^^^^ 

CLASSIFICATION AND INDICATION OF ANTIANXIETY AGENTS IN CLINICAL 

''''^'^^'" 184845 03-10 

CLASSIFICATION OF DRUGS ACCORDING TO THEIR DISCRIMINABLE 

E"^^^S'^«*TS 188228 04-06 



ABSORPTION AND CLEARANCE OF SECOBARBITAL, HEPTABARBITAL, 
METHAQUALONE, AND ETHINAMATE. 

A PSYCHIATRIC CLINIC FOR DEPOT PHENOTHIAZINES. 

181192 02-08 
A CLINICAL STUDY OF L-TETRAHYDROPALMATINE (C-200) IN A 

NEUROPSYCHIATRY CLINIC. ,82902 03-09 

CLINICAL 

DOUBLE-BLIND CLINICAL EVALUATION OF MAZINDOL, 

DEXTROAMPHETAMINE, AND PLACEBO IN TREATMENT OF EXOGENOUS 

0"^'^ 167335 01-11 

CLINICAL EXPERIMENTATION WITH A NEW BENZODIAZEPINE IN THE 
MANAGEMENT OF PHOBIC AND OBSESSIVE SYMPTOMS. 

A DOUBLE-BUND, COMPARATIVE CLINICAL TRIAL WITH LUDIOMIL (CIBA- 
34276-BA) AND AMITRIPTYLINE IN NEWLY ADMITTED DEPRESSED 

'^'^''*'' 167774 01-09 

CLINICAL EFFECTS OF LITHIUM CARBONATE ON DEPRESSION. 

167917 01-09 
CLINICAL EVALUATION OF FLUSPIRILENE AS A MAINTENANCE THERAPY 
IN CHRONIC SCHIZOPHRENIC PATIENTS. ^^^^^^ ^^^ 

CLINICAL EXPERIENCE WITH A NEW PSYCHOTROPIC DRUG, TRAZODONE: 
A REVIEW OF LITERATURE. ,68803 01-11 

SYSTEMATIC CLINICAL STUDIES WITH TRAZODONE: METHODOLOGICAL 
'^^''^'■^^ 168804 01-16 

A STUDY OF THE CLINICAL EFFECTS OF PHENELZINE AND PLACEBO IN 
THE TREATMENT OF PHOBIC ANXIETY. ^^^^^ ^^^^ 

CLINICAL AND ELECTROMYOGRAPHIC RESEARCH CONCERNING 
TREATMENT OF PERIPHERAL NEUROPATHIES WITH NIVALASL 

1 68975 01" U 
MASS FRAGMENTOGRAPHY IN CLINICAL PSYCHOPHARMACOLOGY. 

169074 01-01 
MARIHUANA USE IN MAN: AN EXPERIMENTAL INQUIRY - CLINICAL 
PSYCHIATRIC IMPRESSIONS. 169085 01-14 

LORAZEPAM: CLINICAL TRIAL WITH A NEW BENZODIAZEPINE. 

169297 01-07 
CLINICAL TRIAL WITH DARTALANR, DJAKARTA, INDONESIA 

I iKjfJJ U I - I I 

CLINICAL RESEARCH ASPECTS OF PSYCHOTROPIC MEDICATION^ 

170754 01-1/ 

A CLINICAL EXPERIMENT WITH SULPIRIDE. ^^^^^^ ^^^^ 

CLINICAL TRIAL OF TRIFLUOPERAZINE (STELAZINE R) ON INDONESIAN 
PSYCHIATRIC PATIENTS. 17116101-09 

A DOUBLE-BUND CLINICAL TRIAL OF DOXEPIN HYDROCHLORIDE AND 
DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION 
IN THE FIELD OF INTERNAL MEDICINE. ^^^^^^ ^^^^ 

IS THERE A RELATIONSHIP BETWEEN THE INVOLVEMENT OF 
EXTRAPYRAMIDAL AND MESOLIMBIC BRAIN AREAS WITH THE 
CATALEPTIC ACTION OF NEUROLEPTIC AGENTS AND THEIR CLINICAL 
ANTIPSYCHOTIC EFFECT? ,7,305 01-03 

DIAZEPAM IN LABOUR: ITS METABOLISM AND EFFECT ON THE CLINICAL 
CONDITION AND THERMOGENESIS OF THE NEWBORN. 

171 73 1 01* I J 

PLASMA BINDING OF IMIPRAMINE AND CUNICAL OUTCOME. 

1 7227 1 !• I J 

ONE YEAR OF CLINICAL EXPERIENCE WITH LARGE DOSES OF 10 PERCENT 

FLUPENTHIXOL DECANOATE (LU-1705). ^^^^^^ ^^ ^. 

CLINICAL EXPERIENCE WITH MELITHRACENE IN THE TREATMENT OF 
DEPRESSIVE STATES. ,72979 01 -« 

CUNICAL STUDY OF THIOTHIXENE. ,73563 01-0. 

PILOT CLINICAL TRIAL OF PARENTERAL LORAZEPAM (TEMESTA) IN 
ANXIETY STATES. ,74044 01-1 

CUNICAL FACTORS IN LITHIUM CARBONATE PROPHYLAXIS FAILURE. 

1 74093 1 -U" 

LONG-TERM CLINICAL AND QUANTITATIVE EEG EFFECTS OF 

CLOPENTHIXOL IN SCHIZOPHRENICS: CLINICAL NEUROPHYSIOLOGICAL 
CORRELATIONS. ,^^,3, ^^^ 

CUNICAL RESULTS WITH PIZOTYLINE IN DEPRESSION. ^^^^^ ^^ ^ 



S-56 



VOLUME 12, SUBJECT INDEX 



Subject Index 



TRIFLUPERIDOL - A CONTROLLED CLINICAL TRIAL ON A GROUP OF 
SCHIZOPHRENIC PATIENTS. 

174587 01-08 
CLINICAL EXPERIENCES WITH FK-880 (SULPIRIDE). 

174681 01-08 
LONG-TERM USE OF LITHIUM CARBONATE IN AFFECTIVE DISORDERS: A 
CLINICAL EVALUATION. 

174778 01-09 
THE DOCUMENTATION OF CLINICAL PSYCHOTROPIC DRUG TRIALS. 

175332 02-16 
GENERAL PRACTITIONER CLINICAL TRIALS. A LONG-ACTING 
AMITRIPTYLINE PREPARATION. 

175583 02-09 
CLINICAL USE OF PSYCHOTHERAPEUTIC DRUGS. 

175914 02-17 
CLINICAL TRIAL OF PERAZINE (TAXILAN) IN TREATMENT OF 
SCHIZOPHRENIA. 

176446 02-08 
CLINICAL EFFECT OF A NEW PSYCHOTROPIC DRUG, ZISEPRON, IN 
TREATMENT OF PSYCHIATRIC DISEASES IN COMPARISON WITH 
THIORIDAZINE. 

1 76467 02-08 
CLINICAL EFFECTS OF DICEPLON. A PSYCHOTROPIC DRUG. 

1 76470 02-08 
CLINICAL PHARMACOLOGICAL STUDY OF BROMAZEPAM IN THE FIELD OF 
INTERNAL MEDICINE. 

176473 02-10 
CLINICAL APPLICATION OF APY-606. 

176541 02-08 
CLINICAL EXPERIENCES WITH A NEW PSYCHOTROPIC DRUG, R-6238 
(PIMOZIDE). 

176564 02-11 
CLINICAL EXPERIENCES WITH AN ANTIDEPRESSIVE DRUG, NORITREN 

(NORTRIPTYLINE). 

176565 02-09 
CLINICAL TRIAL WITH NOZINAN-R. AT SEVERAL MENTAL HOSPITALS IN 

JAVA. 

176582 02-11 
CLINICAL STUDY OF DP-181 (OXYPERTINE). 

176722 02-08 
CLINICAL EXPERIENCES WITH NAVANE IN CHRONIC SCHIZOPHRENIA. 

176726 02-08 
CLINICAL EXPERIENCES WITH A PSYCHOTROPIC DRUG (OXYPERTINE) IN 

CHRONIC SCHIZOPHRENIA. 

176727 02-08 
CONTROL OF THE HYPERACTIVE CHILD VIA MEDICATION - AT WHAT 

COST TO PERSONALITY DEVELOPMENT; SOME PSYCHOLOGICAL 
IMPLICATIONS AND CLINICAL INTERVENTIONS. 

176810 02-11 
ANTIDEPRESSANT EFFECTS OF D-CHLORPHENIRAMINE - CLINICAL 
EVALUATION (FIRST REPORT). 

176889 02-09 
CLINICAL EFFECT OF A NEW PSYCHOTROPIC DRUG, DOXEPIN 
HYDROCHLORIDE, IN THE TREATMENT OF DEPRESSIVE STATES. 

177569 02-11 
CLINICAL EXPERIENCE WITH FLUPHENAZINE ENANTHATE. 

178021 02-08 
CLINICAL EXPERIENCES WITH FLUPENTHIXOL (FX-703). 

178224 02-08 
COMPARISON OF THE CLINICAL AND COMPUTER ANALYZED EEG EFFECTS 
OF MESORIDAZINE AND CHLORPROMAZINE. 

180064 02-10 
RESULTS OF CLINICAL RESEARCH IN PSYCHOTHERAPY WITH 
HALLUCINOGENS. 

180145 02-12 
THE DOCUMENTATION OF CLINICAL PSYCHOTROPIC DRUG TRIALS: 
SAMPLE OUTPUT PACKAGE. 

180256 02-16 
LITHIUM DISTRIBUTION BETWEEN CEREBROSPINAL FLUID AND SERUM OF 
AFFECTIVE PSYCHOTIC PATIENTS TREATED WITH LITHIUM CARBONATE 
AND ITS CLINICAL RESPONSE. 

180301 02-11 
A CLINICAL EVALUATION OF A NEW ANXIOLYTIC DRUG 
(THIENODIAZEPINE DERIVATIVE Y-6047) IN NEUROTICS AND 
PSYCHOSOMATIC DISORDERS - A PRELIMINARY REPORT. 

181771 02-07 
LITHIUM TREATMENT OF PSYCHOTIC CHILDREN. A CONTROLLED 
CLINICAL TRIAL. 

182434 03-09 
RUBIDIUM SALTS - TOXIC EFFECTS IN HUMANS AND CLINICAL EFFECTS 
AS AN ANTIDEPRESSANT DRUG. 

182443 03-09 
CLINICAL STUDY OF ANTIDEPRESSANT AGENT. NOVERIL. 

182551 03-10 
CLINICAL STUDY OF TRANQUILIZERS. 

182574 03-17 



CLINICAL EXPERIENCE WITH A NEW PSYCHOTROPIC DRUG: FK-880 
(SULPIRIDE), ITS EFFECT ON PATIENTS WITH PSYCHOSOMATIC 
DISEASES AND PSYCHONEUROSIS. 

182731 03-10 
CLINICAL PHARMACOLOGY OF CANNABIS. 

182741 03-14 
CLINICAL STUDIES OF ACUTE PSYCHOSIS ON THE BASIS OF CHRONIC 
HYPNOTICA INTOXICATION - AN ABSTRACT REPORT 

182755 03-15 
A MULTICENTRE CLINICAL TRIAL OF OXYPERTINE IN ANXIETY NEUROSIS. 

182769 03-10 
CLINICAL DATA AND SOCIOPSYCHIATRIC IMPLICATIONS OF OUTPATIENT 
TREATMENT WITH LONG-TERM PHENOTHIAZINES. 

182791 03-09 
SOMNAMBULISM IN CHILDREN - CLINICAL COMMUNICATION. 

182870 03-17 
A CLINICAL STUDY OF L-TETRAHYDROPALMATINE (C-200) IN A 
NEUROPSYCHIATRIC CLINIC. 

182902 03-09 
DOUBLE-BLIND CLINICAL TRIAL OF NOVERIL AND OF NOVERIL-TR 
(NOVERIL 240MG). 

183190 03-07 
CLINICAL OBSERVATIONS ON THE USE OF PIMOZIDE IN THE TREATMENT 
OF CHRONIC SCHIZOPHRENICS. 

183196 03-08 
CLINICAL EXPERIMENT WITH A LONG-ACTING NEUROLEPTIC: 
FLUSPIRILENE (R6218). 

183200 03-15 
CLINICAL ASSAY OF LORAZEPAM WITH AMBULANT PATIENTS. 

183201 03-11 
EVALUATION OF EEG AND CLINICAL CHANGES ASSOCIATED WITH 

PAVABID THERAPY IN CHRONIC BRAIN SYNDROME. 

183402 03-13 
A SUMMARY OF THE CLINICAL DOSSIER ON DEPAMIDE. 

183544 03-17 
CLINICAL STUDY ON THE EFFECTS OF THIOTHIXENE IN HOSPITALIZED 
PSYCHOTIC PATIENTS. 

183955 03-08 
CLASSIFICATION AND INDICATION OF ANTIANXIETY AGENTS IN CLINICAL 
PRACTICE. 

184845 03-10 
ON THE CLINICAL EFFECT OF FLUPHENAZINE ENANTHATE IN OUTPATIENT 
SCHIZOPHRENICS. 

185213 03-08 
CLINICAL EVALUATION OF ANXIOLYTIC DRUGS. 

185350 03-17 
L-TRYPTOPHAN IN AFFECTIVE DISORDERS: INDOLEAMINE CHANGES AND 
DIFFERENTIAL CLINICAL EFFECTS. 

185928 03-09 
THE CLINICAL EFFECTIVENESS OF LITHIUM: COMPARISONS WITH OTHER 
DRUGS. 

186189 03-09 
CLINICAL PHARMACOLOGY AS AN APPROACH TO THE STUDY OF 
BIOCHEMICAL SLEEP MECHANISMS: THE ACTION OF L-DOPA. 

186643 03-14 
INSTITUTE OF PSYCHIATRY CLINICAL PSYCHOPHARMACOLOGY 
RESEARCH TEAM. 

187022 03-17 
THE PROBLEMS OF THE CLINICAL USAGE OF NITRAZEPAM: SUPPRESSIVE 
EFFECTS ON THE PHARYNGEAL REFLEX AND THE COMA. USING OTHER 
TRANQUILIZERS AT THE SAME TIME. 

188450 04-15 
ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM: 
CLINICAL AND PHARMACOLOGIC CORRELATIONS AND THE EFFECT OF 
INTRAMUSCULAR PYRIDOXINE. 

188560 04-11 
CLINICAL EXPERIENCES WITH A NEW ANTIDEPRESSANT, MAPROTILINE. 

188893 04-09 
CLINICAL EXPERIENCES WITH MESORIDAZINE (TPS-23): ITS 

ADMINISTRATION TO HOSPITALIZED SCHIZOPHRENIC PATIENTS. 

188934 04-08 
CLINICAL EVALUATION OF AMANTADINE THERAPY FOR PARKINSONISM 
AND THE SIDE-EFFECTS -- IN CASES OF THALAMIC SURGERY AND L- 
DOPA THERAPY. 

190095 04-11 
CLINICAL STUDIES OF DOPAMINERGIC MECHANISMS. 

191524 04-13 
CLINICAL INTIMATIONS OF AMINE BALANCE AND PERMISSION. 

191534 04-09 
CLINICAL EXPERIENCE WITH DIAMORPHINE IN ADVANCED MALIGNANT 
DISEASE. 

191606 04-17 
CLINICAL EFFECTS OF IMIPRAMINE-N-OXIDE ON DEPRESSION. 

191716 04-09 
CLINICAL USE OF LUVATREN (METHYLPERIDOL) FOR THE TREATMENT OF 
SCHIZOPHRENIA. 

191720 04-08 
CLINICAL EFFECTS OF MARIHUANA SECOBARBITAL COMBINATION. 

191989 04-14 



S-57 



Subject Index 



Psychopharmacology Abstracts 



CLINICAL EFFECTS OF MARIHUANA DEXTROAMPHETAMINE 

COMBINATION. 

19)990 04-14 

THE TRANYLCYPROMINE ISOMERS: A CONTROLLED CLINICAL TRIAL. 

192065 04-13 
HALOPERIDOL VERSUS THIORIDAZINE FOR THE TREATMENT OF 
PSYCHOGERIATRIC PATIENTS: A DOUBLE-BLIND CLINICAL STUDY. 

192231 04-09 
CORRELATION OF PHARMACOLOGICAL INVESTIGATIONS WITH THE 
CLINICAL EFFICACY OF ANTIDEPRESSANT DRUGS. 

192420 04-13 
LABORATORY ASSESSMENTS OF ANTIDEPRESSIVE ACTIVITY - THEIR 
VALUE FOR CLINICAL PSYCHIATRY AND THE UNDERSTANDING OF 
DEPRESSION. 

192422 04-09 
PLASMA NORTRIPTYLINE LEVELS - RELATIONSHIP TO CLINICAL EFFECTS. 

192873 04-09 

CLINICALLY 

A COMPARISON OF CLINICALLY USED PSYCHOACTIVE DRUGS IN FOUR 
LATIN-AMERICAN COUNTRIES AND IN CANADA (ARGENTINA, COSTA- 
RICA, MEXICO AND PANAMA). 

191139 04-17 

CLOMIPHENE 

PLASMA LEVELS OF LUTEINIZING HORMONE AND OF IMMUNOREACTIVE 
ESTROGENS (ESTRADIOL) IN ANOREXIA-NERVOSA: RESPONSE TO 
CLOMIPHENE CITRATE. 

183807 03-10 

CLOMIPRAMINE 

DEPRESSIVE FORMS OF SCHIZOPHRENIA AND EXPERIMENTAL 
TREATMENT BY CLOMIPRAMINE. 

167676 01-08 

CLOMIPRAMINE HCL - A DOUBLE-BLIND STUDY OF A NEW 
ANTIDEPRESSANT DRUG. 

168318 01-09 

EXPERIENCE IN THE USE OF AN ANTIDEPRESSIVE, CLOMIPRAMINE 
(ANAFRANIL), IN PSYCHIATRIC OUTPATIENTS. 

176475 02-09 
CLOMIPRAMINE AND AMITRIPTYLINE IN DEPRESSED OUTPATIENTS: A 

CONTROLLED STUDY. 

185747 03-09 

CLONAZEPAM 

ANTICONVULSANT ACTIVITY OF CLONAZEPAM AND RO-8-4192 AGAINST 
PENICILLIN AND LIDOCAINE INDUCED SEIZURES. 

178947 02-03 
PHARMACOLOGY AND TOXICOLOGY OF THE ANTIEPILEPTIC DRUG 

CLONAZEPAM. 

179021 02-05 

INVESTIGATIONS ON THE FATE OF THE ANTICONVULSANT CLONAZEPAM 
IN THE ORGANISM OF MAN, RAT AND DOG. 

179022 02-13 

FIRST RESULTS OBTAINED WITH A NEW ANTICONVULSANT OF THE 
BENZODIAZEPINE SERIES (CLONAZEPAM). 

180672 02-11 

CLONIDINE 

EFFECTS OF PHENOXYBENZAMINE, ACEPERONE AND CLONIDINE ON THE 
LEVEL OF 3-METH0XY-4-HYDR0XYPHENYLGLYC0L, (MOPEG) IN RAT 

^"^"^ 180059 02-03 

INVOLVEMENT OF ALPHA-RECEPTORS IN CLONIDINE INDUCED INHIBITION 
OF TRANSMITTER RELEASE FROM CENTRAL MONOAMINE NEURONES. 

182345 03-03 
EFFECTS OF CLONIDINE AND SOME ALPHA-ADRENORECEPTOR BLOCKING 
AGENTS ON AVOIDANCE CONDITIONED REFLEXES IN RATS: THEIR 
INTERACTIONS AND ANTAGONISM BY ATROPINE. 

186576 03-04 

NORADRENERGIC REGULATION OF BRAIN SEROTONERGIC NEURONS: 
EVIDENCE FROM SINGLE UNIT STUDIES WITH CLONIDINE. 

191948 04-03 

CLOPENTHIXOL 

LONG-TERM CLINICAL AND QUANTITATIVE EEG EFFECTS OF 

CLOPENTHIXOL IN SCHIZOPHRENICS: CLINICAL NEUROPHYSIOLOGICAL 

^°^«^^^^'°^^- 17413101-08 

OBSERVATIONS ON THE THERAPEUTIC ACTIVITY OF CLOPENTHIXOL IN 

PSYCHIATRY. 

175540 02-11 

COMPARISON OF CLOPENTHIXOL AND PERPHENAZINE IN BEHAVIOR AND 

EEG OF UNANESTHETIZED CATS. 

181386 02-04 

CLORAZEPATE 

CLORAZEPATE DIPOTASSIUM, DIAZEPAM AND PLACEBO IN CHRONIC 

^^^'^^'- 167339 01-10 

COMPARISON OF ANTICONVULSANT EFFECTS OF CLORAZEPATE 

DIPOTASSIUM AND DIAZEPAM: FOUR WEEK ANTICONVULSANT STUDY 
IN RHESUS MONKEYS. 

1 76677 02-03 



CLOZAPINE 

LONG-TERM APPLICATION OF CLOZAPINE (W-801) IN SCHIZOPHRENIC 

PATIENTS. 

174680 01-08 
A DOUBLE-BUND COMPARISON OF CLOZAPINE WITH THIORIDAZINE ON 
SCHIZOPHRENIA. 

175119 02-08 
EFFECT OF SINGLE AND REPEATED ADMINISTRATION OF CLOZAPINE ON 
THE METABOLISM OF DOPAMINE AND NORADRENALINE IN THE BRAIN 
OF THE RAT. 

191418 04-03 

CNS 

EFFECTS OF MOLINDONE ON CNS STRUCTURES: NEUROPHYSIOLOGICAL 
AND BEHAVIORAL CORRELATIONS. 

172749 01-03 
CNS DEPRESSION IN THE ABSENCE OF PROLACTIN RELEASE FOLLOWING 
INTRAARTERIAL INJECTIONS OF SODIUM PENTOTHAL IN THE 
PROESTROUS RAT. 

173257 01-03 

1-AMINOTETRALINES - CNS AGENTS AND ALPHA-BLOCKERS. 

175762 02-17 
ULTRASTRUCTURE OF CNS IN LITHIUM INTOXICATION. 

1 76476 02-05 
A METHOD FOR ANALYZING CNS EFFECTS OF DRUGS AND BRAIN 
LESIONS ON PERMANENT GROUPS OF RATS. 

1 76867 02-06 
EFFECTS OF LORAZEPAM ON CNS STRUCTURES: NEUROPHYSIOLOGICAL 
AND BEHAVIORAL CORRELATIONS. 

1 77749 02-03 

EEG CHARACTERISTICS IN VARIOUS SPECIES OF ANIMAL AND THEIR 
RELATION TO THE CNS EFFECTS OF DRUGS. 

182096 02-03 

EFFECTS OF CNS STIMULANTS ON OPERANT BEHAVIOR. 

182110 02-04 

EFFECT OF MORPHINE, HALOPERIDOL, APOMORPHINE AND BENZTROPINE 
ON DOPAMINE TURNOVER IN RAT CORPUS-STRIATUM: EVIDENCE 
SHOWING MORPHINE-INDUCED REDUCTION IN CNS DOPAMINERGIC 

^^^'^'^^ 182230 03-03 

A NOVEL SPASMOLYTIC AND CNS ACTIVE AGENT: 3-{2- 

BENZYLMETHYLAMINOETHYL) BENZOIC ACID METHYL ESTER 

HYDROCHLORIDE. „, „, „o 

184581 03-02 

SYNTHESIS AND CNS ACTIVITY OF 3-SUBSTITUTED 7-CHL0R0-5- 
PHENYLBENZOTRIAZEPIN-2-ONES. 

185978 03-01 
ALTERATION OF ETHANOL-INDUCED CNS DEPRESSION: INEFFECTIVENESS 
OF DRUGS THAT MODIFY CHOLINERGIC TRANSMISSION. 

186375 03-03 
THE ISOLATED PERFUSED RAT BRAIN AS A MODEL FOR STUDYING 
DRUGS ACTING ON THE CNS. 

186589 03-06 

TIME SAMPLING OF RAT EXPLORATORY BEHAVIOUR: A RELIABLE 
SCREENING TEST FOR THE CNS EFFECTS OF ANOREXIC AGENTS. 

187925 04-04 
EFFECTS OF DOPAMINE-LIKE DRUGS ON RAT STRIATAL ADENYL CYCLASE 
HAVE IMPLICATIONS FOR CNS DOPAMINE RECEPTOR TOPOGRAPHY. 

190545 04-03 
EFFECTS OF CNS AGENTS ON NICOTINE EXTENSOR CONVULSIONS AND 
LETHALITY IN MICE AND THEIR SEDATIVE ANTIANXIETY EFFECTS IN 

'^'^^ 191907 04-14 

THE LOCALIZATION AND CHARACTERIZATION OF 

PHENYLETHANOLAMINE-N-METHYLTRANSFERASE ACTIVITY IN SPECIFIC 

REGIONS OF THE CNS. ^„ „ ^^ 

191932 04-03 

COMPARATIVE EFFECTS OF SOME CNS ACTIVE DRUGS ON LEARNED AND 
UNLEARNED BEHAVIOR IN THE HAMSTER. 

191976 04-04 

CO-MEDICATION 

A CASE OF PERIODIC SOMNOLENCE IMPROVED BY THE CO-MEDICATION 
OF L-DOPA AND METHYLPHENIDATE. 

CO-NEUROTRANSMITTER 

THE BIOSYNTHESIS OF THE CO-NEUROTRANSMITTER OCTOPAMINE IN 
COMPARISON WITH THE NEUROTRANSMITTER NORADRENALINE. 

181468 02-03 

DIFFERENTIAL EFFECTS OF PENTYLENETETRAZOL ON REM SLEEP IN NAIVE 
AND COBALT EPILEPTIC RATS. ,89407 04-0. 

COCAINE 

THE UPTAKE, RETENTION AND METABOLISM OF 3H-5- 

HYDROXYTRYPTAMINE IN BRAIN SLICES AND ILEUM FROM THE RAT: 
EFFECTS OF COCAINE, DESMETHYLIMIPRAMINE AND RESERPINE. (PH.D 

^'s^^^^^^'^'^' 16813. oi-o: 



S-58 



VOLUME 12, SUBJECT INDEX 



Subject Index 



IN VIVO INHIBITION OF NEURONAL UPTAKE OF A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE (TIQ) ALKALOID BY COCAINE AND BY 
DESMETHYLIMIPRAMINE (DMI). 

182150 02-03 
THE EFFECTS OF COCAINE ON DEPRESSED PATIENTS. 

184160 03-09 
COCAINE, PEMOLINE AND AMPHETAMINE ON LEARNING AND RETENTION 
OF A DISCRIMINATION TEST IN MICE. 

186705 03-04 
THE EFFECT OF ORALLY ADMINISTERED COCAINE ON SLEEP OF 
DEPRESSED PATIENTS. 

187642 04-14 
THE EFFECTS OF CHLORDIAZEPOXIDE, AMPHETAMINE AND COCAINE ON 
BAR-PRESS BEHAVIOR IN NORMAL AND GENETICALLY NERVOUS DOGS. 

187868 04-04 
BEHAVIORAL EFFECTS OF COCAINE COMPARED UNDER TWO SCHEDULES 
OF FOOD PRESENTATION IN THE SQUIRREL MONKEY. 

191916 04-04 
CODEINE 

EFFECTS OF MORPHINE, CODEINE AND NALOXONE ON FOOD AND 
CODEINE REINFORCED RESPONDING IN THE RHESUS MONKEY. 

182195 02-04 
EFFECTS OF DIAZEPAM AND CODEINE, ALONE AND IN COMBINATION 
WITH ALCOHOL, ON SIMULATED DRIVING. 

189619 04-14 
COMPARISON OF CODEINE AND ETHYL ALCOHOL SELF-ADMINISTRATION 
UNDER A VARIABLE INTERVAL (VI) SCHEDULE IN MONKEYS. 

191983 04-04 
COEXISTENCE 

ON THE COEXISTENCE OF PARKINSONISM AND TARDIVE DYSKINESIA. 

190380 04-11 
COFACTORS 

DRUG-INDUCED ACTIVATION OF STRIATAL TYROSINE HYDROXYLASE: 
CHANGES IN THE AFFINITY FOR PTERIDINE COFACTORS. (UNPUBLISHED 
PAPER). 

173381 01-03 
COGNITIVE 

THE EFFECT OF MEDAZEPAM AND ALCOHOL ON COGNITIVE AND MOTOR 
SKILLS USED IN CAR DRIVING. 

189408 04-14 
COLLABORATIVE 

A COLLABORATIVE ASSESSMENT OF NOREPINEPHRINE METABOLISM IN 
AFFECTIVE DISORDERS. 

169094 01-09 
DEPRESSION SUBTYPES AND RESPONSE TO PHENELZINE, DIAZEPAM, AND 
A PLACEBO: RESULTS OF A NINE HOSPITAL COLLABORATIVE STUDY. 

171502 01-09 
PROPHYLACTIC TREATMENT OF RECURRENT DEPRESSION: OBSERVATIONS 
FROM A MULTIHOSPITAL COLLABORATIVE STUDY. 

186190 03-09 
PROPHYLACTIC EFFICACY OF LITHIUM CARBONATE IN MANIC- 
DEPRESSIVE ILLNESS: REPORT OF THE VETERANS ADMINISTRATION 
AND NATIONAL INSTITUTE OF MENTAL HEALTH (VA-NIMH) 
COLLABORATIVE STUDY GROUP. 

189735 04-09 
LITHIUM IN TREATMENT AND PREVENTION OF AFFECTIVE DISORDER: A 
VA-NIMH COLLABORATIVE STUDY. 

190381 04-09 
COIORIMETRIC 

STUDIES ON METABOLISM OF BROMAZEPAM (II): COLORIMETRIC 
DETERMINATION AND METABOLIC FATE OF BROMAZEPAM IN 
ANIMALS. 

181593 02-03 
COMA 

THE PROBLEMS OF THE CLINICAL USAGE OF NITRAZEPAM: SUPPRESSIVE 
EFFECTS ON THE PHARYNGEAL REFLEX AND THE COMA, USING OTHER 
TRANQUILIZERS AT THE SAME TIME. 

188450 04-15 
COMAS 

TREATMENT OF HALLUCINATORY DISORDERS IN SCHIZOPHRENIA BY 
ATROPINE COMAS. 

181778 02-08 
COMBINATION 

PSYCHOPATHOLOGICAL IMPORTANCE AND THERAPEUTIC EFFECTS OF A 
COMBINATION OF HYDERGINE AND THIORIDAZINE IN PSYCHIATRIC 
SYNDROMES IN THE AGING. 

168976 01-14 
COMBINATION OF L-DOPA, DESIPRAMINE, AND A DECARBOXYLASE 
INHIBITOR IN THE TREATMENT OF DEPRESSION. 

169468 01-09 
POSSIBLE MUTUAL THERAPEUTIC COMBINATION OF 
PSYCHOPHARMACEUTICALS. 

178029 02-17 
EFFECT OF A CARNITINE CYPROHEPTADINE COMBINATION ON ANOREXIA 
AND WEIGHT GAIN IN CHILDREN. 

178811 02-10 
DOXEPIN AND AMITRIPTYLINE CHLORDIAZEPOXIDE COMBINATION IN 
NEUROTIC STATES: A COMPARATIVE DOUBLE-BLIND STUDY. 

180048 02-10 



PRELIMINARY EXPERIENCES WITH THE TREATMENT OF SOME MENTAL 
CASES UTILIZING AN ENZYME COMBINATION, 

180298 02-17 
LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 
ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 
COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25, AN IN 
INTACT MALE RATS. 

186683 03-04 
DIURETIC ANTIDEPRESSANT COMBINATION IN ALCOHOLIC DEPRESSIVES. 

187866 04-11 
EFFECTS OF DIAZEPAM AND CODEINE, ALONE AND IN COMBINATION 
WITH ALCOHOL, ON SIMULATED DRIVING. 

189619 04-14 
PSYCHOMOTOR TEST PERFORMANCE WITH A FENFLURAMINE 
AMPHETAMINE COMBINATION 

190146 04-07 
THE METHOHEXITAL METHYLPHENIDATE INTERVIEW: A PROPOSED NEW 
DRUG COMBINATION FOR NARCOTHERAPY. 

190242 04-07 
CLINICAL EFFECTS OF MARIHUANA SECOBARBITAL COMBINATION. 

191989 04-14 
CLINICAL EFFECTS OF MARIHUANA DEXTROAMPHETAMINE 

COMBINATION. 

191990 04-14 
COMBINATIONS 

COMBINATIONS OF ANTIDEPRESSANT DRUGS IN THE TREATMENT OF 
DEPRESSIVE ILLNESS, 

168317 01-09 
POLYPHARMACY IN PSYCHIATRY: A MULTI-STATE COMPARISON OF 
PSYCHOTROPIC DRUG COMBINATIONS. 

187840 04-17 
INTERACTIONS OF CHLORPHENIRAMINE ETHANOL COMBINATIONS: 
ACUTE TOXICITY AND ANTIHISTAMINE ACTIVITY. 

188875 04-05 
THE USE OF PROPRANOLOL WITH VARIOUS DRUG COMBINATIONS IN 
THE TREATMENT OF ESSENTIAL HYPERTENSION 

192511 04-13 
COMBINED 

THE PROBLEM OF ANXIETY IN A NON-WESTERN SOCIETY: A COMBINED 
CHEMOTHERAPEUTIC AND PSYCHOTHERAPEUTIC APPROACH 

171162 01-10 
COMBINED USE OF ECT AND PSYCHOTROPIC DRUGS: ANTIDEPRESSIVES 
AND ANTIPSYCHOTICS. 

177670 02-11 
PSYCHOPHYSIOLOGICAL EFFECTS OF DIAZEPAM (VALIUM) COMBINED 
WITH A MODERATE DOSE OF ALCOHOL IN MAN. 

180699 02-14 
BEHAVIORAL EFFECTS OF SEPARATE AND COMBINED ADMINISTRATION 
OF NALOXONE AND D-AMPHETAMINE. 

1 83892 03-04 
A STUDY OF REFRACTORY CASES OF DEPRESSIVE ILLNESSES AND THEIR 
RESPONSE TO COMBINED ANTIDEPRESSANT TREATMENT. 

185078 03-10 
LEVODOPA COMBINED WITH MK-486 (L-ALPHA- 

METHYLDOPAHYDRAZINE) - A PERIPHERAL DECARBOXYLASE 
INHIBITOR IN PARKINSONS DISEASE. 

187615 04-11 
COMMUNICATION 

EFFECTS OF PSYCHOACTIVE DRUGS ON NONVERBAL COMMUNICATION 
AND GROUP SOCIAL BEHAVIOR OF MONKEYS. 

175317 02-04 
SOMNAMBULISM IN CHILDREN - CLINICAL COMMUNICATION. 

182870 03-17 
COMMUNITY 

ROLE OF FLUPHENAZINE DECANOATE IN LESSENING THE BURDEN OF 
CHRONIC SCHIZOPHRENICS ON THE COMMUNITY. 

169438 01-08 
PSYCHIATRIC CARE: DRUGS, THERAPIST, COMMUNITY. 

178189 02-17 
COMPARABLE 

COMPARABLE THERAPEUTIC EFFICACY OF TRYPTOPHAN AND 
IMIPRAMINE: AVERAGE THERAPEUTIC RATINGS VERSUS TRUE 
EQUIVALENCE. AN IMPORTANT DIFFERENCE. 

167344 01-09 
COMPARED 

CHLORDIAZEPOXIDE AND DOTHIEPIN COMPARED IN 
ANXIETY/DEPRESSION IN GENERAL PRACTICE. 

167575 01-10 
EXPERIENCE IN THE APPLICATION OF DICEPLON (APY-606) - COMPARED 
WITH FLOROPIPAMIDE 

176447 02-08 
DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) DOSE EFFECTS 
COMPARED ON THREE SCHEDULES OF FOOD REINFORCED OPERANT 
PERFORMANCE. 

182191 02-04 
SELECTIVE RESPIRATORY STIMULATING ACTION OF DOXAPRAM 
COMPARED TO PENTYLENETETRAZOL. 

183887 03-03 



S-59 



Subject Index 

BEHAVIORAL EFFECTS OF COCAINE COMPARED UNDER TWO SCHEDULES 
OF FOOD PRESENTATION IN THE SQUIRREL MONKEY. 

191916 04-04 

^°**DRUgTnHANCED SENSORY CONTINGENT BAR PRESSING: COMPARING 
THE EFFECT OF CONTINGENT AND NONCONTINGENT SENSORY 

^'^^'^^ 168837 01-04 

A DOUBLE-BLIND CONTROLLED STUDY COMPARING PROTRIPTYLINE AND 

'^^'^•^'"^^''^ 177567 02-09 

SEQUENTIAL TRIAL COMPARING TWO PLASMA LEVELS OF 

^0^^^^''^^^^'- 187582 04-10 

PREANESTHETIC MEDICATION IN ELECTIVE SURGERY: COMPARISON OF 
INTRAVENOUS DIAZEPAM WITH MEPERIDINE. 

167338 01-11 
A COMPARISON OF LITHIUM CARBONATE IN THE PREVENTION OF MANIC 
AND DEPRESSIVE EPISODES IN RECURRENT AFFECTIVE DISORDER. 

169090 01-09 
LEVODOPA INDUCED DYSKINESIAS: COMPARISON IN PARKINSONISM 
DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS. 

169376 01-15 
COMPARISON OF THIORIDAZINE AND DIAZEPAM IN THE CONTROL OF 
NONPSYCHOTIC SYMPTOMS ASSOCIATED WITH SENILITY: DOUBLE- 
BLIND STUDY. ,„,oo«, ,, 

170129 01-11 

COMPARISON OF TRICYCLIC ANTIDEPRESSANTS AS TO THEIR 
CARDIOTOXIC ACTION IN CONSCIOUS RABBITS. 

171629 01-03 
A DOUBLE-BLIND COMPARISON OF THIORIDAZINE (MELLARIL) VERSUS 
DIAZEPAM (VALIUM) IN PATIENTS WITH CHRONK MIXED ANXIETY 
AND DEPRESSIVE SYMPTOMS. 

172486 01-10 
A DOUBLE-BLIND COMPARISON OF CLOZAPINE WITH THIORIDAZINE ON 

SCHIZOPHRENIA. 

175119 02-08 

CLINICAL EFFECT OF A NEW PSYCHOTROPIC DRUG, ZISEPRON, IN 
TREATMENT OF PSYCHIATRIC DISEASES IN COMPARISON WITH 
THIORIDAZINE. „„ „„ 

176467 02-08 

COMPARISON OF ANTICONVULSANT EFFECTS OF CLORAZEPATE 

DIPOTASSIUM AND DIAZEPAM: FOUR WEEK ANTICONVULSANT STUDY 

IN RHESUS MONKEYS. _ „^ 

176677 02-03 

A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY IN MAN OF 
INTRAVENOUSLY ADMINISTERED DELTA9-TETRAHYDR0CANNABIN0L, 
CANNABINOL, AND CANNABIDIOL. 

176747 02-03 
LYSERGIC ACID DIETHYLAMIDE AND SEROTONIN: A COMPARISON OF 
EFFECTS ON SEROTONERGIC NEURONS AND NEURONS RECEIVING A 
SEROTONERGIC INPUT. „, „^ ,o 

177407 02-12 
A DOUBLE-BLIND COMPARISON OF FLUPHENAZINE AND HALOPERIDOL IN 
OUTPATIENT SCHIZOPHRENIC CHILDREN. 

177754 02-08 

COMPARISON OF THE EFFECTS OF Y-4153 AND CARPIPRAMINE ON 
SCHIZOPHRENIA BY A DOUBLE-BLIND METHOD. 

COMPARISON OF THE CLINICAL AND COMPUTER ANALYZED EEG EFFECTS 
OF MESORIDAZINE AND CHLORPROMAZINE. 

180064 02-10 

STUDY WITH RADIOTRACERS OF THE DISTRIBUTION OF A NEW 
PSYCHOTROPE IN MICE: L-2-PYRROLIDONE-5-CARBOXYLATE 
DIMETHYLAMINOETHANOL. I. COMPARISON WITH L-GLUTAMIC AND L- 
2-PYRROLIDONE-5-CARBOXYLICACID ,80723 02-03 

THE COMPARISON OF THERAPEUTIC EFFECTS OF FK-880 (SULPIRIDE) AND 
PERPHENAZINE IN SCHIZOPHRENIA BY A DOUBLE-BLIND CONTROLLED 

'''''■ 181378 02-08 

COMPARISON OF CLOPENTHIXOL AND PERPHENAZINE IN BEHAVIOR AND 

EEGOFUNANESTHETIZEDCATS. ,8,386 02-04 

THE BIOSYNTHESIS OF THE CO-NEUROTRANSMITTER OCTOPAMINE IN 

COMPARISON WITH THE NEUROTRANSMITTER NORADRENALINE. 

181468 02-03 
COMPARISON OF THE CHRONIC AND ACUTE EFFECTS OF D-LYSERGIC 

ACID DIETHYLAMIDE (LSD) TREATMENT ON RAT BRAIN SEROTONIN 

AND NOREPINEPHRINE. ,81945 02-03 

A COMPARISON OF SOMATIC REFLEX EFFECTS OF THREE PSYCHOTROPIC 

AGENTS IN THE CHLORALOSE CAT. 

182126 02-03 

A COMPARISON OF EFFECTS OF D-LYSERGIC ACID DIETHYLAMIDE (LSD) 
AND SEROTONIN ON PRE- AND POSTSYNAPTIC CELLS IN THE 
SEROTONIN SYSTEM. ,8214102-03 



Psychopharmacology Abstracts 



COMPARISON OF INTRAVENOUSLY ADMINISTERED METHADONE (ME), 
MORPHINE (MO), HEROIN (H) AND PLACEBO (P). 

182163 02-03 
A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY OF DELTA9- 
TETRAHYDROCANNABINOL AND ITS MONOHYDROXYLATEO 
METABOLITES IN MAN. 

182223 03-03 
DOUBLE-BLIND CROSSOVER COMPARISON OF BROMAZEPAM AND 

DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION. 

182624 03-11 
A DOUBLE-BLIND COMPARISON OF PIMOZIDE WITH CARPIPRAMINE IN 
SCHIZOPHRENIC PATIENTS. 

183195 03-08 
A COMPARISON OF PSYCHOTOMIMETIC DRUG EFFECTS ON RAT BRAIN 
NOREPINEPHRINE METABOLISM. 

183891 03-03 
A CONTROLLED COMPARISON OF THE PSYCHOTROPIC EFFECTS OF 
PROPANIDID AND METHOHEXITONE. 

184082 03-14 
SEDATIVE OR TRANQUILLIZER? A COMPARISON OF THE HYPNOTIC 
EFFECTS OF CHLORDIAZEPOXIDE AND AMYLOBARBITONE SODIUM. 

184438 03-14 
COMPARISON OF PSYCHOEXPERIMENTAL PERFORMANCE UNDER THE 
INFLUENCE OF THE ANALGESIC PROPIRAM FUMARATE. 

184618 03-14 
TRIFLUOPERAZINE: A COMPARISON BETWEEN REGULAR AND HIGH 

^°^^^- 184977 03-08 

QUINAZOLINES AND 1,4 BENZ00IAZEPINES.64. COMPARISON OF THE 
STEREOCHEMISTRY OF DIAZEPAM WITH THAT OF CLOSE ANALOGS 
WITH MARGINAL BIOLOGICAL ACTIVITY. 

185034 03-01 
IMIPRAMINE AND METHYLPHENIDATE TREATMENTS OF HYPERACTIVE 
BOYS- A DOUBLE-BLIND COMPARISON. 

185324 03-14 

AN IMPROVED METHOD FOR STUDYING THE PSYCHOGALVANIC 
REACTION IN MICE AND ITS INHIBITION BY PSYCHOLEPTIC DRUGS, 
COMPARISON WITH THE EFFECTS OF OTHER PHARMACOLOGICAL 

^'''^''- 185749 03-06 

A COMPARISON OF THE EFFECTS OF CHRONIC ADMINISTRATION OF 
ETHANOL AND ACETALDEHYDE TO MICE: EVIDENCE FOR A ROLE OF 
ACETALDEHYDE IN ETHANOL DEPENDENCE. 

COMPARISON OF TRICYCLIC ANTIDEPRESSANTS IN RABBITS: 
ANTINOCICEPTION AND POTENTIATION OF THE NORADRENALINE 
PRESSOR RESPONSES. ,86579 03-03 

A COMPARISON OF EFFECTS OF APOMORPHINE AND ET-495 ON 
LOCOMOTOR ACTIVITY AND CIRCLING BEHAVIOUR IN MICE. 

186635 03-04 

A COMPARISON OF THE EFFECTS OF AMPHETAMINE AND ITS 
METABOLITES, P-HYDROXY AMPHETAMINE AND P- 
HYDROXYNOREPHEDRINE, ON UPTAKE, RELEASE AND CATABOLISM OF 
3H-N0REPINEPHRINE IN CEREBRAL CORTEX OF RAT BRAIN. 

1 86669 03-UJ 

COMPARISON OF TYROSINE HYDROXYLASE AND DOPAMINE-BETA- 
HYDROXYLASE INHIBITION WITH THE EFFECTS OF VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS ON D-AMPHETAMINE INDUCED 

MOTOR ACTIVITY. 

186699 03-03 

STRUCTURE-ACTIVITY RELATIONS OF SOME INDOLEALKYLAMINES IN 

COMPARISON TO PHENETHYLAMINES ON MOTOR ACTIVITY AND 

ACQUISITION OF AVOIDANCE BEHAVIOR. 

1 86703 03-04 
COMPARISON OF THE LOCOMOTOR STIMULANT MECHANISMS OF 

ACTION OF D-AMPHETAMINE AND D-AMPHETAMINE PLUS L-DOPA: 

POSSIBLE INVOLVEMENT OF SEROTONIN. 

COMPARISON OF GRADED SINGLE INTRAMUSCULAR DOSES OF 
MORPHINE AND PENTOBARBITAL IN MAN. 

1 87254 uJ- 1 J 
POLYPHARMACY IN PSYCHIATRY: A MULTI-STATE COMPARISON OF 

PSYCHOTROPIC DRUG COMBINATIONS, „ „,. 17 

1 87840 04* 1 7 

ARE NEUROTIC PATIENTS IN PSYCHOTROPIC DRUG TRIALS 

REPRESENTATIVE? A COMPARISON OF STUDY AND NON-STUDY 
PATIENTS IN FOUR FAMILY PRACTICES. 

188144 04-10 

COMPARISON OF PHARMACOLOGICAL RESPONSES TO NICOTINE AND 
RELEASE OF CATECHOLAMINES FROM THE ADRENALS IN DOGS AND 

'^O^'^E^^ 188199 04-03 

DOUBLE-BLIND COMPARISON OF THIOTHIXENE, TRIFLUOPERAZINE, AND 
PLACEBO IN CHRONIC ALCOHOLISM. 

1 885o4 04- 1 I 

COMPARISON OF AMANTADINE, PLACEBO, AND LEVODOPA IN 

PARKINSONS DISEASE. ,89502 04-11 



S-60 



VOLUME 12, SUBJECT INDEX 



Subject Index 



THE EFFECTS OF ACETYLCHOLINE AND OF SYNAPTIC STIMULATION ON 
THE SENSORIMOTOR CORTEX OF CATS. II. COMPARISON OF THE 
NEURONAL RESPONSES TO RETICULAR AND OTHER STIMULI. 

189856 04-03 
TREATMENT OF PHOBIAS BY SYSTEMATIC DESENSITIZATION: 
COMPARISON OF STANDARD VS METHOHEXITAL AIDED 
DESENSITIZATION. 

189916 04-10 
A COMPARISON OF CLINICALLY USED PSYCHOACTIVE DRUGS IN FOUR 
LATIN-AMERICAN COUNTRIES AND IN CANADA (ARGENTINA, COSTA- 
RICA, MEXICO AND PANAMA). 

191139 04-17 
AMITRIPTYLINE IN THE PSYCHOTIC STATES OF DOWNS SYNDROME: THE 
COMPARISON OF TWO CASES. 

191192 04-11 
COMPARISON OF BARBITAL 8. PENTOBARBITAL PHYSICAL DEPENDENCE 
IN THE CAT. 

191953 04-04 
COMPARISON OF CODEINE AND ETHYL ALCOHOL SELF-ADMINISTRATION 
UNDER A VARIABLE INTERVAL (VI) SCHEDULE IN MONKEYS. 

191983 04-04 
COMPARISONS 

RATE-DEPENDENT EFFECTS OF DRUGS. 1. COMPARISONS OF D- 
AMPHETAMINE, PENTOBARBITAL, AND CHLORPROMAZINE ON 
MULTIPLE AND MIXED SCHEDULES. 

177410 02-04 
THE CLINICAL EFFECTIVENESS OF LITHIUM: COMPARISONS WITH OTHER 
DRUGS. 

186189 03-09 
COMPETENCIES 

A STUDY OF THE EFFECTS OF RITALIN INTERVENTION UPON THE 
PERCEPTUAL COMPETENCIES OF CHILDREN DIAGNOSED AS GIVING 
EVIDENCE OF PSYCHONEUROLOGICAL LEARNING DISABILITIES. (PH.D. 
DISSERTATION). 

186833 03-14 
COMPETING 

INVERSION BY APOMORPHINE OF THE TENDENCY OF FEMALE RATS TO 
BE DEFEATED BY MALES WHEN COMPETING FOR FOOD IN A STRAIGHT 
RUNWAY. 

184212 03-04 
COMPETITION 

EFFECTS OF (-) DELTA9-TRANS-TETRAHYDR0CANNABIN0L ON SOCIAL 
BEHAVIOR OF SQUIRREL MONKEY DYADS IN A WATER COMPETITION 
SITUATION. 

187640 04-04 
COMPLAINTS 

AN ERGOT ALKALOID PREPARATION (HYDERGINE) VERSUS PAPAVERINE 
IN TREATING COMMON COMPLAINTS OF THE AGED: DOUBLE-BLIND 
STUDY. 

173190 01-11 
COMPLEMENTAL 

COMPLEMENTAL PHARMACOLOGICAL STUDY OF DI-N-PROPYLACETAMIDE 
OR DEPAMIDE. 

180722 02-07 
COMPLEMENTARY 

CHEMOTHERAPY AND PSYCHOTHERAPY, ARE THEY COMPLEMENTARY OR 
ANTAGONISTIC?: A PERSONAL STUDY. 

184959 03-17 
COMPLEX 

INFLUENCE OF PH ON THE BENZODIAZEPINE HUMAN SERUM ALBUMIN 
COMPLEX: CIRCULAR DICHROISM STUDIES. 

189595 04-13 
COMPLICATED 

AN AUTOPSY CASE OF SCHIZOPHRENIA COMPLICATED WITH 
PARKINSONISM INDUCED BY PERPHENAZINE. 

171275 01-15 
COMPLICATIONS 

A CASE OF ENCEPHALITIS WITH PSYCHOTIC COMPLICATIONS. 

174783 01-11 
PSYCHOTIC COMPLICATIONS AFTER TETRAETHYLTHIURAMDISULFIDE 
USED IN THE TREATMENT OF ALCOHOLISM. 

175047 02-11 
COMPLICATIONS OF METHAQUALONE DIPHENHYDRAMINE (MANDRAX) 
ABUSE. 

177452 02-15 
THE OCULAR COMPLICATIONS BY MASSIVE DOSE OF PSYCHOTROPIC 
DRUGS. 

182552 03-15 
MYOCARDIOPATHIC COMPLICATIONS INDUCED BY IMIPRAMINE AND 
TRICYCLIC THYMOLEPTICS. 

182898 03-15 
PSYCHIATRIC COMPLICATIONS OF EVERYDAY DRUGS. 

186092 03-15 
LITHIUM CARBONATE: PSYCHIATRIC INDICATIONS AND MEDICAL 
COMPLICATIONS. 

187786 04-15 



COMPOSITION 

THE INFLUENCE OF IMIPRAMINE, DEXPHENMETRAZINE AND 

AMPHETAMINE SULPHATE ON THE COMPOSITION OF DIURNAL SLEEP 
OF NARCOLEPTICS. 

192419 04-11 
COMPOUND-69-183 

ANTIHYPERTENSIVE AND CENTRAL NERVOUS SYSTEM DEPRESSANT 
PROPERTIES OF 3-(GAMMA-P-FLU0R0BENZ0YLPR0PYL) 2,3,4,4A,5,6 
HEXAHYDROPYRAZINOQUINOLINE HYDROCHLORIDE (COMPOUND-69- 
183, CENTPYRAQUIN). 

176881 02-03 
COMPREHENSIVE 

COMPREHENSIVE BEHAVIORAL ASSESSMENT OF THE EFFECTS OF DELTA9- 
TETRAHYDROCANNABINOL IN RATS. 

191966 04-04 
COMPULSION 

INHIBITION OF THE APOMORPHINE GNAWING COMPULSION BY 
AMANTADINE. 

1 76879 02-04 
COMPULSIVE 

TREATMENT OF COMPULSIVE EATING DISTURBANCES WITH 
ANTICONVULSANT MEDICATION. 

181270 02-14 
INFLUENCE OF FLUPENTHIXOL AND FLUPENTHIXOL DECANOATE ON 
METHYLPHENIDATE AND APOMORPHINE INDUCED COMPULSIVE 
GNAWING IN MICE. 

186371 03-04 
COMPUTER 

THE COMPUTER ANALYZES TWO PSYCHOTHERAPEUTIC AGENTS IN 
ANXIETY/DEPRESSED STATES. 

167345 01-10 
COMPARISON OF THE CLINICAL AND COMPUTER ANALYZED EEG EFFECTS 
OF MESORIDAZINE AND CHLORPROMAZINE. 

180064 02-10 
COMPUTERIZED 

PREDICTION OF NEUROLEPTIC EFFECTS OF CI-686 BASED ON 
QUANTITATIVE PHARMACOELECTROENCEPHALOGRAPHY: DRUG 
PROFILES AND DOSE RESPONSE CURVES BASED ON COMPUTERIZED 
CEREBRAL BIOPOTENTIALS. 

181958 02-13 
COMT 

THE EFFECTS OF COMT INHIBITORS ON BEHAVIOR AND DOPAMINE 
METABOLISM. 

191517 04-03 
CONCENTRATION 

INFLUENCE OF CONCENTRATION AND MOTOR PERFORMANCE ON 
TARDIVE DYSKINESIA AND RABBIT SYNDROME. 

167587 01-15 
EFFECT OF GENERAL ANESTHETICS ON SYSTEMIC CATECHOLAMINE 
CONCENTRATION I: HALOTHANE. (UNPUBLISHED PAPER), 

168862 01-05 
INCREASE IN THE PLASMA CONCENTRATION OF FREE TRYPTOPHAN 
CAUSED BY PROBENECID IN HUMANS. 

169470 01-13 
EFFECT OF CHRONIC INTOXICATION WITH (J AMPHETAMINE ON ITS 
CONCENTRATION IN LIVER AND BRAIN AND ON (14C) LEUCINE 
INCORPORATION INTO MICROSOMAL AND CYTOPLASMIC PROTEINS OF 
RAT LIVER. 

180056 02-05 
EFFECT OF SEIZURES AND ANTICONVULSANT AGENTS ON HIPPOCAMPAL 
RNA CONCENTRATION. 

189609 04-03 
EFFECT OF PIRIBEDIL AND ONE OF ITS METABOLITES ON THE 
CONCENTRATION OF HOMOVANILLIC ACID IN THE RAT BRAIN. 

191422 04-03 
THE EFFECTS OF HOE- 36801 ON MUSCLE ACTIVITY AND BLOOD 
PRESSURE, ON ATTENTION AND CONCENTRATION, ON TIME 
JUDGMENT AND SUBJECTIVE RESPONSES IN NEUROTICS AND 
NORMALS. 

192429 04-14 
CONCENTRATION EFFECT RELATIONSHIPS WITH MAJOR AND MINOR 
TRANQUILIZERS. 

192871 04-14 
CONCENTRATIONS 

TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. (UNPUBLISHED PAPER). 

170876 01-03 
THE EFFECTS OF AMPHETAMINE, 2-AMINOINDANE AND 2- 

AMINOTETRALIN ON THE CONCENTRATIONS OF WHOLE BRAIN 
NORADRENALINE, DOPAMINE, 5-HYDROXYTRYPTAMINE AND 5- 
HYDROXYINDOLEACETIC ACID IN THE MOUSE. 

174828 01-03 
CHLORDIAZEPOXIDE OVERDOSE: INTERPRETATION OF SERUM DRUG 
CONCENTRATIONS 

177393 02-15 



:! I' 



S-61 



Subject Index 

METHYPRYLON OVERDOSE. INTERPRETATION OF SERUM DRUG 

CONCENTRATIONS. ^^^^^^^^^^ 

SERUM ANTICONVULSANT CONCENTRATIONS IN EPILEPTIC PATIENTS 
WITH MENTAL SYMPTOMS: A PRELIMINARY REPORT. 

184439 03-15 
THE CONCENTRATIONS OF DIAZEPAM AND ITS METABOLITES IN THE 
PLASMA AFTER AN ACUTE AND CHRONIC ADMINISTRATION. 

184978 03- 13 
PLASMA CONCENTRATIONS OF DIAZEPAM AND OF ITS METABOLITE N- 
DESMETHYLDIAZEPAM IN RELATION TO ANXIOLYTIC EFFECT. 

186184 03-13 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS: 
II EFFECT ON DOPAMINE AND NORADRENALINE CONCENTRATIONS 

AND TURNOVERS. 

186588 03-04 

PERPHENAZINE CONCENTRATIONS IN HUMAN WHOLE BLOOD: A PILOT 
STUDY DURING ANTIPSYCHOTIC THERAPY USING DIFFERENT 
ADMINISTRATION FORMS. 

187639 04-16 

THE IMPULSE BLOCKING CONCENTRATIONS OF ANESTHETICS, ALCOHOLS, 
ANTICONVULSANTS, BARBITURATES, AND NARCOTICS ON PHRENIC 
AND SCIATIC NERVES. ^ „^ 

187803 04-03 
PLASMA AND CEREBROSPINAL FLUID PROBENECID CONCENTRATIONS AS 
RELATED TO ACCUMULATION OF ACIDIC BIOGENIC AMINE 
METABOLITES IN MAN. 

187933 04-13 
EFFECTS OF NOMIFENSINE (HOE-984), D-AMPHETAMINE AND 

APOMORPHINE ON MOTOR ACTIVITY, CATECHOLAMINE TURNOVER 
AND CAMP CONCENTRATIONS IN RAT BRAIN. (UNPUBLISHED PAPER). 

191766 04-03 

CONCEPT 

STRIATAL TYROSINE HYDROXYLASES WITH HIGH AND LOW AFFINITY 
FOR TYROSINE: IMPLICATIONS FOR THE MULTIPLE POOL CONCEPT OF 
CATECHOLAMINES. 

167325 01-03 

CONCEPTUAL ,,^^ 

STUDIES OF CEREBROSPINAL FLUID AMINE METABOLITES IN DEPRESSED 
PATIENTS: CONCEPTUAL PROBLEMS AND THEORETICAL IMPLICATIONS. 
(UNPUBLISHED PAPER). 

187398 04-13 

CONDITION 

DIAZEPAM IN LABOUR: ITS METABOLISM AND EFFECT ON THE CLINICAL 
CONDITION AND THERMOGENESIS OF THE NEWBORN. 

171731 01-13 
INABILITY TO CONDITION A PERIPHERAL ACTIVATING DRUG. 

190698 04-04 

CONDITIONED , _ „„ 

THE EFFECTS OF INTRACAUDATE INJECTIONS OF CHLORPROMAZINE ON 
CONDITIONED AVOIDANCE AND SELF-STIMULATION BEHAVIOR. (PH.D. 

DISSERTATION). 

173749 01-04 

THE EFFECT OF DOPAMINE ANTAGONISTS AND AMANTADINE ON THE 
ACQUISITION OF THE CONDITIONED AVOIDANCE RESPONSE IN RATS. 

174829 01-04 
CONDITIONED HYPOGLYCEMIA: A MECHANISM FOR SACCHARIN 
INDUCED SENSITIVITY TO INSULIN IN THE RAT. 

174877 01-03 
POSTTRIAL STRYCHNINE: LACK OF EFFECT ON CONDITIONED AVOIDANCE 

LEARNING. 

176866 02-04 

EFFECTS OF LOW DOSES OF CHLORPROMAZINE ON A CONDITIONED 
EMOTIONAL RESPONSE IN THE RAT. 

176963 02-04 

INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L (0ELTA9-THC), 
CAFFEINE, (C), NICOTINE (N), PHENOBARBITAL (P): EFFECTS ON 
CONDITIONED AVOIDANCE (CAR). 

182192 02-04 

THE CONDITIONED EMOTIONAL RESPONSE (CER) AS A BASELINE FOR THE 
STUDY OF ANTIANXIETY DRUGS. 

183862 03-04 

PREDATION- SEPARATION OF AGGRESSIVE AND HUNGER MOTIVATION 

BY CONDITIONED AVERSION. ,85463 03-04 

EFFECTS OF CLONIDINE AND SOME ALPHA-ADRENORECEPTOR BLOCKING 
AGENTS ON AVOIDANCE CONDITIONED REFLEXES IN RATS: THEIR 
INTERACTIONS AND ANTAGONISM BY ATROPINE. 

186576 03-04 
THE EFFECT OF IPRONIAZID AND TRANYLCYPROMINE STUDIED WITH A 
DARK AVOIDANCE CONDITIONED SCHEDULE. 

186590 03-04 

THE EFFECT OF AMANTADINE, L-DOPA, (J AMPHETAMINE AND 

APOMORPHINE ON THE ACQUISITION OF THE CONDITIONED 

AVOIDANCE RESPONSE. 

186636 03-04 

METRAZOL DISRUPTS CONDITIONED AVERSION PRODUCED BY LICL: A 
TIME DEPENDENT EFFECT. „„,„„,„. 

188412 04-04 



Psychopharmacology Abstracts 



CONDITIONING 

THE CURARIZED RAT AND HEART RATE CONDITIONING: A 
CONSIDERATION OF RESPIRATION PARAMETERS AND 
NEUROMUSCULAR BLOCKING AGENTS IN A CLASSICAL CONDITIONING 
PARADIGM. (PH.D. DISSERTATION). 

173133 01-03 
EFFECTS OF PSYCHOTROPIC DRUGS ON DISCRIMINATION AVOIDANCE 
CONDITIONING IN RATS WITH OLFACTORY BULB ABLATIONS. 

182115 02-04 
SEIZURE SUSCEPTIBILITY AND AVOIDANCE CONDITIONING IN ADULT 
RATS TREATED PRENATALLY WITH CHLORPROMAZINE. 

184371 03-04 
CONDITIONING OF AMPHETAMINE-INDUCED BEHAVIOUR IN THE ALBINO 

185954 03-04 
EFFECTS OF METHAMPHETAMINE, PIPRADROL, AND METHYLPHENIDATE 
ON INSTRUMENTAL CONDITIONING AND SPONTANEOUS MOTOR 
ACTIVITY IN THE IMMATURE RAT. 

186568 03-04 
THE EFFECT OF TRANYLCYPROMINE (PARNATE) ON EYELID CONDITIONING 
AND PAIRED ASSOCIATE LEARNING IN DEPRESSED PATIENTS. 

188107 04-09 
EFFECTS OF CHLORDIAZEPQXIDE ON HEART RATE AND BEHAVIOURAL 
SUPPRESSION IN PIGS SUBJECTED TO OPERANT CONDITIONING 

PROCEDURES. „ „ „ 

1 89409 04-04 

DISSOCIATION BETWEEN SCOPOLAMINE AND MECAMYLAMINE DURING 

FEAR CONDITIONING IN RATS. 

190264 04-04 

BACKWARD CONDITIONING OF TASTE AVERSIONS IN RATS USING 
CYCLOPHOSPHAMIDE AS THE US. 

190265 04-04 

PSYCHOPHARMACOLOGIC FACILITATION OF OPERANT CONDITIONING OF 
GENETICALLY NERVOUS CATAHOULA AND POINTER DOGS. 

190696 04-04 
CONDITIONING IN THE PREDICTION OF DRUG WITHDRAWAL EFFECTS IN 
CHRONIC SCHIZOPHRENIC PATIENTS. 

192412 04-17 

CONDITIONS 

THE EFFECTS OF L-DELTA9-TRANS-TETRAHYDR0CANNABIN0L ON LOW 
AND HIGH RESPONSE RATES GENERATED UNDER TWO SIMILAR 
CONDITIONS (PH.D. DISSERTATION). ,68230 01-04 

OXAZEPAM IN ALLERGIC CONDITIONS. 

168923 01-11 
DRUGS COMMONLY USED IN MENTAL CONDITIONS. 

171257 01-17 

REPEATED ACQUISITION OF BEHAVIORAL CHAINS UNDER CHRONIC DRUG 

CONDITIONS. „, 

1 77408 02-04 

THE EFFECTS OF EARLY P-CHLOROPHENYLALANINE ADMINISTRATION 

AND POSTWEANING HOUSING CONDITIONS ON SEROTONIN AND 

BEHAVIOR IN RATS. „,o„ oo ^. 

178638 02-04 

DOUBLE-BLIND PSYCHOMETRIC EVALUATION OF PIMOZIDE AND 
HALOPERIDOL VERSUS PLACEBO IN EMOTIONALLY LABILE 
VOLUNTEERS UNDER TWO DIFFERENT WORK LOAD CONDITIONS. 

180065 02-14 
CATECHOLAMINE TURNOVER IN THE RAT BRAIN: DIFFERENT RESULTS 
OBTAINED IN DIFFERENT EXPERIMENTAL CONDITIONS. 

181471 02-03 
PSYCHOLOGICAL EXPERIMENTATION ON THE EFFECTS OF PROPIRAM 
FUMARATE AND PROMETHAZINE UNDER NORMAL AND STRESS 

CONDITIONS. ,„..,,„,„, 

184617 03-07 

CONDUCTION 

NERVE CONDUCTION VELOCITY IN PATIENTS ON LONG-TERM 
DIPHENYLHYDANTOIN THERAPY. 

189173 04-15 

PROPRANOLOL AND CHLORDIAZEPOXIDE ON EXPERIMENTALLY INDUCED 
CONFLICT AND SHUTTLEBOX PERFORMANCE IN RODENTS. 

171304 01-04 

ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN 

DIMETHYLAMINOPROPYLTHIOCINNAMANILIDE HYDROCHLORIDE), A 
SEROTONIN ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN (5-HTP) AND ALPHA-METHYLTRYPTAMINE. 

176861 02-04 

PROTECTION PRODUCED BY BENZODIAZEPINES (BDP) AGAINST THE 
NEUROTOXIC AND CONFLICT BEHAVIOR EFFECTS OF 
HEXACHLOROPHENE(HCP)INCATS. ,76863 02-04 

ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN, A SEROTONIN 
ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN AND ALPHA-METHYLTRYPTAMINE. 

176873 0204 

SIMILARITY OF CHRONIC CHLORDIAZEPOXIDE TREATMENT AND 

REMOVAL OF CONFLICT SITUATION. ,82258 03-04 



S-62 



VOLUME 12, SUBJECT INDEX 



Subject Index 



CONFORMATION 

MOLECULAR ORBITAL STUDIES ON THE CONFORMATION OF 

HALLUCINOGENIC INDOLEALKYLAMINES AND RELATED COMPOUNDS. 
THE ISOLATED MOLECULES AND THE SOLVENT EFFECT. 

183406 03-01 
CONFORMATIONAL ANALYSIS OF ACRIDAN DERIVATIVES BY NUCLEAR 
MAGNETIC RESONANCE SPECTROSCOPY. A RELATIONSHIP BETWEEN 
CONFORMATION AND PHARMACOLOGICAL ACTIVITY. 

190715 04-01 
CONFORMATIONAL 

CONFORMATIONAL ANALYSIS OF ACRIDAN DERIVATIVES BY NUCLEAR 
MAGNETIC RESONANCE SPECTROSCOPY. A RELATIONSHIP BETWEEN 
CONFORMATION AND PHARMACOLOGICAL ACTIVITY. 

190715 0401 
CONFORMITY 

THE EFFECT OF CHLORPROMAZINE AND AMYTAL SODIUM ON THE 
CONFORMITY OF ADOLESCENTS UNDER PSYCHIATRIC OBSERVATION. 

191776 04-14 
CONGENERS 

POTENTIAL PSYCHOTOMIMETICS: BROMOMETHOXY AMPHETAMINES AND 
STRUCTURAL CONGENERS OF LYSERGIC ACID. (PH.D. DISSERTATION). 

173588 01-03 
A STUDY OF THE RELATIVE ANTICONVULSANT AND TOXIC ACTIVITIES OF 
DELTA9-TETRAHYDR0CANNABIN0L AND ITS CONGENERS. 

174608 01-05 
SYNTHESIS AND SCREENING OF CYCLIC BENZYLHYDRAZINE CONGENERS 
AS ANTIDEPRESSANTS. 

183600 03-01 
CONJUGATE 

BLOCKING OF THE EFFECT OF A DELTAl-TETRAHYDROCANNABINOL 
(DELTAl-THC) ON SPONTANEOUS MOTOR ACTIVITY IN THE RAT BY 
IMMUNIZATION WITH A PROTEIN CONJUGATE OF DELTAl-THC. 

187129 03-04 
CONJUGATED 

THE EFFECT OF CONJUGATED ESTROGENS ON PLASMA BUTAPERAZINE 
LEVELS IN WOMEN. 

191959 04-15 
CONSCIOUS 

COMPARISON OF TRICYCLIC ANTIDEPRESSANTS AS TO THEIR 
CARDIOTOXIC ACTION IN CONSCIOUS RABBITS. 

171629 01-03 
HYPERTHERMIC EFFECT OF PALMITATE SODIUM, STEARATE SODIUM AND 
OLEATE SODIUM INJECTED INTO THE CEREBRAL VENTRICLES OF 
CONSCIOUS CATS. 

186640 03-03 
CARDIOVASCULAR AND GROSS BEHAVIORAL EFFECTS OF 

AMPHETAMINE, 2-AMIN0-l-(2,5 DIMETHOXY-4-METHYLPROPANE 
(DOM) AND 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPHENYL BUTANE 
(BL-3912A) IN THE CONSCIOUS DOG. 

187573 04-03 
CONSCIOUSNESS 

SYNTHESIS OF ACETYLCHOLINE IN BRAIN NERVE TERMINALS DURING 
CONSCIOUSNESS AND BARBITURATE ANESTHESIA. 

171600 01-03 
NEW APPROACHES TO CONSCIOUSNESS. 

178064 02-12 
CREATIVITY AND THE STATE OF CONSCIOUSNESS. 

186025 03-12 
THE USE OF ETHYMISOL (ETHYLNORANTIPHEIN) IN PATIENTS WITH 
PROLONGED DISTURBANCES OF CONSCIOUSNESS. 

191777 04-07 
CONSECUTIVE 

EFFECTS OF CONSECUTIVE ADMINISTRATION OF DIAZEPAM AND 
DOXEPIN ON BOTH APPROACH WITHDRAWAL AND APPROACH 
AVOIDANCE RESPONSES IN RATS. 

182117 02-04 
CONSTITUENTS 

CONSTITUENTS OF CANNABIS-SATIVA L. V.: STABILITY OF AN 
ANALYTICAL SAMPLE EXTRACTED WITH CHLOROFORM. (UNPUBLISHED 
PAPER). 

180670 02-01 
CONSUMPTION 

EFFECT OF ADRENERGIC SUBSTANCES ON OXYGEN CONSUMPTION OF 
RAT BRAIN TISSUE. 

180058 02-03 
EFFECTS OF L-DELTA9-TETRAHYDR0CANNA8IN0L, OL-AMPHETAMINE 
AND PENTOBARBITAL ON OXYGEN CONSUMPTION BY MOUSE BRAIN 
AND HEART HOMOGENATES. 

181813 02-03 
THE EFFECT OF METHAMPHETAMINE ON BRAIN ACH CONSUMPTION AND 
AGGRESSIVENESS IN MICE STRESSED MILDLY BY LONG-TERM 
ISOLATION. 

182108 02-04 
INDEPENDENCE OF THE EFFECTS OF D-AMPHETAMINE AND FOOD 
DEPRIVATION OR BODYWEIGHT ON THE FOOD CONSUMPTION OF 
RATS. 

186376 03-06 



RELUCTANCE OF RATS TO DRINK HASHISH SUSPENSIONS: FREE-CHOICE 
AND FORCED CONSUMPTION, AND THE EFFECTS OF HYPOTHALAMIC 
STIMULATION. 

186586 03-04 
CONTAMINATED 

NEUROLOGICAL CHANGES IN CATS FOLLOWING LONG-TERM DIET OF 
MERCURY CONTAMINATED TUNA. 

186476 03-05 
CONTINGENT 

DRUG ENHANCED SENSORY CONTINGENT BAR PRESSING: COMPARING 
THE EFFECT OF CONTINGENT AND NONCONTINGENT SENSORY 
CHANGE. 

168837 01-04 
THE EFFECTS OF DALMANE (FLURAZEPAM HYDROCHLORIDE) ON THE 
CONTINGENT NEGATIVE VARIATION (AMSTERDAM). 

177645 02-16 
FLAVOR AVERSIONS PRODUCED BY CONTINGENT DRUG INJECTION: 
RELATIVE EFFECTIVENESS OF APOMORPHINE, EMETINE, AND LITHIUM. 

1 78502 02-04 
SENSORY CONTINGENT BAR-PRESSING FOR FAMILIAR AND NOVEL 
CHANGE UNDER A DEXAMPHETAMINE AMYLOBARBITONE MIXTURE. 

181605 02-04 
THE EFFECTS OF METHAMPHETAMINE AND SECOBARBITAL ON THE 
CONTINGENT NEGATIVE VARIATION AMPLITUDE. 

185932 03-13 
DOSE DEPENDENT SELECTIVE FACILITATION OF RESPONSE CONTINGENT 
LIGHT ONSET BEHAVIOR BY D-AMPHETAMINE. 

185955 03-04 
THE EFFECT OF CAFFEINE, NITRAZEPAM AND CIGARETTE SMOKING ON 
THE CONTINGENT NEGATIVE VARIATION IN MAN. 

187350 04-13 
CONTINUING 

MEDICATION GROUPS FOR CONTINUING CARE. 

189640 04-17 
CONTRACTION 

STUDIES ON BENZODIAZEPINOOXAZOLES. IV. THE FORMATION OF 
QUINOLONES BY THE RING CONTRACTION OF A 
BENZODIAZEPINOOXAZOLE DERIVATIVE 

180488 02-01 
CONTRACTURES 

EFFECT OF DIVALENT CATIONS ON ACH CONTRACTURES OF 
DEPOLARIZED DENERVATED RAT MUSCLES. 

188914 04-03 
CONTRAINDICATEO 

PHENOTHIAZINES CONTRAINDICATEO FOR THE UNDERFAT. (DR.P.H. 
DISSERTATION). 

174966 01-15 
CONTROL 

COMPARISON OF THIORIDAZINE AND DIAZEPAM IN THE CONTROL OF 
NONPSYCHOTIC SYMPTOMS ASSOCIATED WITH SENILITY: DOUBLE- 
BLIND STUDY. 

170129 01-11 
RAPID CONTROL OF PSYCHOTIC EXCITEMENT STATES WITH 
INTRAMUSCULAR HALOPERIDOL. 

170627 01-09 
AMPHETAMINE USE AND MISUSE WITH RECOMMENDATIONS FOR 
STIMULANT CONTROL POLICY. 

172109 01-17 
SOME ASPECTS OF RESPIRATORY CONTROL IN NEUROLEPTOANALGESIA. 

172835 01-03 
KINETICS AND CELLULAR CONTROL MECHANISMS FOR IMIPRAMINE 
METABOLISM IN THE ISOLATED PERFUSED RAT LIVER. (PH.D. 
DISSERTATION). 

173601 01-03 
METABOLIC CONTROL OF BODY TEMPERATURE IN MAN. 

174134 01-08 
POTENTIAL NEUROTRANSMITTERS AND RECEPTOR MECHANISMS 
INVOLVED IN THE CENTRAL CONTROL OF BODY TEMPERATURE IN 
HAMSTERS. (PHD DISSERTATION). 

174962 01-03 
CONTROL OF THE HYPERACTIVE CHILD VIA MEDICATION - AT WHAT 
COST TO PERSONALITY DEVELOPMENT; SOME PSYCHOLOGICAL 
IMPLICATIONS AND CLINICAL INTERVENTIONS. 

176810 02-11 
PARENTERAL HALOPERIDOL FOR RAPID CONTROL OF SEVERE, 
DISRUPTIVE SYMPTOMS OF ACUTE SCHIZOPHRENIA. 

1 78545 02-08 
OPEN-FIELD BEHAVIOR AND ACQUISITION OF DISCRIMINATIVE RESPONSE 
CONTROL IN DELTA9-THC TOLERANT RATS. 

178813 02-04 
THE RATE LIMITING CONTROL OF ENZYMES MONOAMINE OXIDASE AND 
CATECHOL-0-METHYLTRANSFERASE IN THE FETUS AND THE ADULT BY 
ADRENOCORTICOL HORMONES. 

178815 02-03 
PSYCHOACTIVE DRUG CONTROL: ISSUES AND RECOMMENDATIONS. 

181638 02-17 



S-63 



Subject Index 



Psychopharmacology Abstracts 



AMPHETAMINE AND PENTOBARBITAL EFFECTS ON THE DISCRIMINATIVE 
RESPONSE CONTROL BY DEPRIVATION OF RAPID EYE MOVEMENT 
SLEEP (REM). 182245 03-03 

CONTROL OF INSOMNIA WITH A NEW BENZODIAZEPINE: THE 

FLUNITRAZEPAM OR RO-5-4200 (FIRST INVESTIGATIONS OF PHASE I 
AND CONTROLLED INVESTIGATIONS OF PHASE II). ^^^^^^ ^^^ ^ 

CONTROL OF MENTAL ACTIVITIES. ^^^^^^ ^^^^ 

AMPHETAMINE AND OPERANT BEHAVIOR IN RATS: RELATIONSHIP 

BETWEEN DRUG EFFECT AND CONTROL RESPONSE RATE. ^^^^^^ ^^^^ 

LONG-TERM TREATMENT OF ENDOGENOUS DEPRESSION WITH 

NORTRIPTYLINE WITH CONTROL OF PLASMA LEVELS. ^^^^^^ ^^^^ 

CONTROL OF NOREPINEPHRINE SYNTHESIS IN BLOOD VESSELS AND THE 
EFFECTS OF MONOAMINE OXIDASE INHIBITION ^^^^^^ ^^^^ 

THE CONTROL OF DEVIANT SEXUAL BEHAVIOR BY DRUGS: A DOUBLE- 
BLIND CONTROLLED STUDY OF BENPERIDOL, CHLORPROMAZINE, AND 
PLACEBO. ,9006104-11 

SHORT-TERM CONTROL OF TYROSINE HYDROXYLASE. 

191513 04-0 J 

DISCRIMINATIVE CONTROL OF BEHAVIOR BY ELECTRICAL STIMULATION 
OF THE DORSAL RAPHE NUCLEUS: GENERALIZATION TO LYSERGIC 
ACID DIETHYLAMIDE (LSD). 191944 04-04 

EFFECTS OF CHLORPROMAZINE (CPZ) AND THIORIDAZINE PERFORMANCE 

AND STIMULUS CONTROL BEHAVIOR. 

191974 04-04 

'^BROMAZEPAM AND PHENOBARBITAL IN ANXIETY: A CONTROLLED 

^^^^'' 167773 01-10 

A CONTROLLED STUDY OF SINGLE DOSE ADMINISTRATION OF 

IMIPRAMINE PAMOATE IN ENDOGENOUS DEPRESSION. ^^^^^^ ^^ ^ 

A NEW AGENT FOR CHEMOTHERAPY OF MIGRAINE HEADACHES: A 

CONTROLLED STUDY. ,69298 01-11 

RELIEF OF MUSCULOSKELETAL AND ASSOCIATED PSYCHOPATHOLOGICAL 
SYMPTOMS WITH MEPROBAMATE AND ASPIRIN: A CONTROLLED 

^^'^'^^ 169632 01-10 

THE EFFECTS OF AGENTS THAT MODIFY MUSCARINIC TONE UPON 
BEHAVIOR CONTROLLED BY AN AVOIDANCE SCHEDULE THAT 
EMPLOYS SIGNALED UNAVOIDABLE SHOCK. ^^^^^^ ^^^^ 

DIPHENYLHYDANTOIN EFFECTIVENESS IN THE TREATMENT OF CHRONIC 
SCHIZOPHRENICS- A DOUBLE-BLIND CONTROLLED STUDY WITH A 
PLACEBO. ,7,507 01-08 

AMITRIPTYLINE IN ANXIOUS DEPRESSED OUTPATIENTS: A CONTROLLED 
STUDY. ,72993 01-10 

TRIFLUPERIDOL - A CONTROLLED CLINICAL TRIAL ON A GROUP OF 

SCHIZOPHRENIC PATIENTS. ,74587 01-08 

PIPRADROL IN MILD DEPRESSION: A CONTROLLED STUDY. 

I 76 lU/ Uz- lU 
A DOUBLE-BLIND CONTROLLED STUDY COMPARING PROTRIPTYLINE AND 

AMITRIPTYLINE. ,77567 02-09 

THE COMPARISON OF THERAPEUTIC EFFECTS OF FK-880 (SULPIRIDE) AND 

PERPHENAZINE IN SCHIZOPHRENIA BY A DOUBLE-BLIND CONTROLLED 

^^LJDY. ,81378 02-08 

LITHIUM TREATMENT OF PSYCHOTIC CHILDREN. A CONTROLLED 

CLINICAL TRIAL. ,82434 03-09 

A SMALL CONTROLLED STUDY TO DETERMINE THE TIME OF ONSET OF 

ACTION OF OXYPERTINE AFTER ORAL ADMINISTRATION IN NORMAL 

^^^J^*^^^ 182763 03-14 

A CONTROLLED TRIAL OF OXYPERTINE IN PATIENTS WITH ANXIE_Tr ^^^^ 

CONTROL OF INSOMNIA WITH A NEW BENZODIAZEPINE: THE 

FLUNITRAZEPAM OR RO-5-4200 (FIRST INVESTIGATIONS OF PHASE I 
AND CONTROLLED INVESTIGATIONS OF PHASE II). ^^^^^^ ^^^ ^ 

A CONTROLLED COMPARISON OF THE PSYCHOTROPIC EFFECTS OF 

PROPANIDID AND METHOHEXITONE. ^^^^^^ ^^^^ 

DISULFIRAM IMPLANT: A CONTROLLED TRIAL. ^^^^^^ ^^^ ^ 



A CONTROLLED EVALUATION OF LITHIUM IN THE PREMENSTRUAL 

TENSION SYNDROME. 185192 03-11 

CLOMIPRAMINE AND AMITRIPTYLINE IN DEPRESSED OUTPATIENTS: A 
CONTROLLED STUDY. ,85747 03-09 

A CONTROLLED TRIAL OF IMIPRAMINE HYDROCHLORIDE ON ENURESIS 

1 86553 03-1 1 

EPISODIC DYSCONTROL: A CONTROLLED REPLICATION. 

1 87839 04-09 
ANTICONVULSANT ACTION OF VITAMIN-D IN EPILEPTIC PATIENTS? A 
CONTROLLED PILOT STUDY. ,88889 04-11 

THE USE OF DRUGS IN PSYCHIATRIC INTERVIEWS: SOME 
INTERPRETATIONS BASED ON CONTROLLED EXPERIMENTS 

189074 04- 1/ 

THE CONTROL OF DEVIANT SEXUAL BEHAVIOR BY DRUGS: A DOUBLE- 
BLIND CONTROLLED STUDY OF BENPERIDOL, CHLORPROMAZINE, AND 
PLACEBO. ,9006104-11 

THE TREATMENT OF MIXED ANXIETY AND DEPRESSION WITH LOXAPINE: 
A CONTROLLED COMPARATIVE STUDY. ^^^^^^ ^^^ 

A DOUBLE-BLIND CONTROLLED STUDY OF LOXAPINE SUCCINATE IN THE 
TREATMENT OF ANXIETY NEUROSES. ^^^^^^ ^^^ 

THE TRANYLCYPROMINE ISOMERS: A CONTROLLED CLINICAL TRIAL. 
A CONTROLLED TRIAL OF MAPROTILINE (LUDIOMIL) AND AMITRIPTYLINE 
IN GENERAL PRACTICE. ,92510 04-09 

^°'^LITHIUM PROPHYLAXIS IN AFFECTIVE DISORDERS: AN OPEN TRIAL WITH 
MATCHED CONTROLS. ,7240101-09 

METHYLTESTOSTERONE WITH IMIPRAMINE IN MEN: CONVERSION OF 
DEPRESSION TO PARANOID REACTION. ^^^^^ ^^^^ 

CONVERSION OF CHLORAL HYDRATE TO TRICHLOROETHANOL IN BRAIN 
AND LIVER. ,32157 02-03 

ALKALOID STUDIES 9. PREPARATION OF 18-ACYLYOHIMBAN-17-ONES 
AND THEIR CONVERSION TO NEW HETEROCYCLIC YOHIMBANS^_^ ^^^^ 

EFFECTS OF AMPHETAMINES ON REGIONAL TRYPTOPHAN HYDROXYLASE 
ACTIVITY AND SYNAPTOSOMAL CONVERSION OF TRYPTOPHAN TO 5- 
HYDROXYTRYPTAMINE IN RAT BRAIN. ^^^^^^ ^^^^ 

CHEMICAL CONVERSION OF THE PSYCHOTOMIMETIC AMINE 1(2,5 
DIMETHOXY-4-METHYLPHENYL) 2-AMINOPROPANE TO 5- 
HYDROXYDIMETHYLINDOLE. ^^^^^^ ^^^^ 

'^°'^ACTfoToF CONVULSANTS ON ROOT POTENTIALS AND AMINO ACID 

RESPONSES IN ISOLATED FROG SPINAL CORD. (UNPUBLISHE_^D^PAPER)^_^ 

STUDIES ON CONVULSANTS IN THE ISOLATED FROG SPINAL C(DRD J 
ANTAGONISM OF AMINO ACID RESPONSES. 'UNPUBLISHED^PAPER)^ ^^ 

*^°'^CONVULSION PRODUCING PROPERTY OF THE DIALYZABLE GLYCOPEPTIDE 
PREPARATION FROM WHOLE RAT BRAIN ^^^^^^ ^^^^ 

'^°'^CONTINUOUS INFUSION OF DIAZEPAM IN INFANTS WERE SEVERE 

RECURRENT CONVULSIONS. ,74568 01-11 

BRAIN AMINO ACIDS DURING CONVULSIONS. ^^^^^^ ^^^^ 

PENTYLENETETRAZOL CONVULSIONS AND BRAIN CATECHOLAMINE 
TURNOVER RATE IN RATS AND MICE RECEIVING DIPHENYLHYDANTOIN 
OR BENZODIAZEPINES. ,82344 03-03 

DIAZEPAM TREATMENT FOR ACUTE CONVULSIONS IN CHILDREN: A 
REPORT OF 41 PATIENTS, THREE WITH PLASMA LEVELS. ^^^^^^ ^^^ ^ 

EFFECTS OF CNS AGENTS ON NICOTINE EXTENSOR CONVULSIONS AND 
LETHALITY IN MICE AND THEIR SEDATIVE ANTIANXIETY EFFECTS IN 
WAN. ,9,9Q7 Q4.,4 

EXCITABILITY CHANGES DURING THE GRADUAL DEVELOPMENT OF AND 
RECOVERY FROM PENTYLENETETRAZOL AND STRYCHNINE INDUCED 
CONVULSIONS IN THE CAT. 191927 04-03 

NONSPONTANEOUS CONVULSIONS IN MICE ELICITED BY SOME 
CATECHOLAMINE RELEASERS AND 6,7 
DIHYDROXYTETRAHYDROISOQUINOLINE (TIQ). 



S-64 



VOLUME 12, SUBJECT INDEX 

CONVULSIVE 

CANNA8IDI0L AND CANNABIS-SATIVA EXTRACT PROTECT MICE AND 
RATS AGAINST CONVULSIVE AGENTS. 

1 83609 03-03 
COOPERATION 

IMPORTANCE OF THE COOPERATION OF FAMILIES IN THE TREATMENT OF 
THE SICK: CONCERNING CHRONIC DELIRIUM TREATED WITH 
NEUROLEPTICS AND MELANCHOLY TREATED WITH ANTIDEPRESSANTS. 

182899 03-17 
COPUIATORY 

EFFECTS OF IMIPRAMINE ON COPULATORY BEHAVIOR OF MALE RATS. 

168718 01-04 
ACTIVATION OF COPULATORY BEHAVIOR BY PILOCARPINE AND 
OXOTREMORINE IN THE FEMALE RAT. 

171616 01-04 
A DIFFERENTIAL INHIBITORY ACTION OF LSD AND AMPHETAMINE ON 

COPULATORY BEHAVIOR IN THE FEMALE RAT. 

171617 01-04 
MONOAMINES AND COPULATORY ACTIVATION IN THE CASTRATED MALE 

RAT. 

171618 01-04 
REDUCTION IN COPULATORY BEHAVIOR OF MALE RATS FOLLOWING 

HASHISH INJECTIONS. 

183790 03-04 
EFFECTS OF LSD AND MONOAMINE SYNTHESIS INHIBITORS ON 

HORMONE ACTIVATED COPULATORY BEHAVIOR IN THE FEMALE RAT. 

188611 04-04 
CORD 

EFFECT OF CHLORIMIPRAMINE ON THE RATE OF TRYPTOPHAN 

HYDROXYLATION IN THE INTACT AND TRANSECTED SPINAL CORD. 

168751 01-03 
EFFECTS OF P-CHLOROPHENYLALANINE (PCPA) AND NIALAMIDE ON 5- 
HYDROXYTRYPTAMINE (5-HT) IN THE TRANSECTED SPINAL CORD. 

171623 01-03 
ACTION OF CONVULSANTS ON ROOT POTENTIALS AND AMINO ACID 
RESPONSES IN ISOLATED FROG SPINAL CORD. (UNPUBLISHED PAPER). 

177976 02-03 
EFFECTS OF PROLONGED LSD-25 ADMINISTRATION UPON NEURONS OF 
SPINAL CORD GANGLIA TISSUE CULTURES. 

185112 03-03 
STUDIES ON CONVULSANTS IN THE ISOLATED FROG SPINAL CORD I 
ANTAGONISM OF AMINO ACID RESPONSES. (UNPUBLISHED PAPER) 

190727 04-03 
CORPORA-STRIATA 

EVIDENCE THAT MORPHINE INCREASES DOPAMINE UTILIZATION IN 
CORPORA-STRIATA OF RATS. 

176746 02-03 
CORPUS-STRIATUM 

EFFECT OF MORPHINE, HALOPERIDOL, APOMORPHINE AND BENZTROPINE 
ON DOPAMINE TURNOVER IN RAT CORPUS-STRIATUM: EVIDENCE 
SHOWING MORPHINE-INDUCED REDUCTION IN CNS DOPAMINERGIC 
ACTIVITY. 

182230 03-03 
BEHAVIORAL EFFECTS OF AMPHETAMINE IN RATS WITH LESIONS IN THE 
CORPUS-STRIATUM. 

187698 04-04 
THE EFFECTS OF DELTA9-THC AND A WATER SOLUBLE DERIVATIVE ON 
PGEI SYNTHESIS IN THE CORPUS-STRIATUM. 

191964 04-03 
CORRECTIVE 

THE CORRECTIVE EFFECT OF PRAXINOR ON HYPOTENSION ATTRIBUTABLE 
TO PSYCHIATRIC THERAPY SIDE-EFFECTS. 

172980 01-11 
CORRELATE 

A FREQUENCY SHIFT IN THE HIPPOCAMPAL THETA ACTIVITY: AN 

ELECTRICAL CORRELATE OF CENTRAL ACTION OF ACTH ANALOGUES IN 
THE DOG 

188166 04-04 
CORRELATED 

INFLUENCE OF TREATMENT ON SYMPTOMATOLOGY AND CORRELATED 
ELECTROENCEPHALOGRAPHIC (EEG) CHANGES IN THE AGED. 

167336 01-13 
CORRELATES 

LITHIUM INDUCED DIABETES-INSIPIDUS: MANIC SYMPTOMS, BRAIN AND 
ELECTROLYTE CORRELATES, AND CHLOROTHIAZIDE TREATMENT. 

169486 01-15 
DRUGS ON EEG CORRELATES OF BEHAVIOR. 

181396 02-04 
THE USE OF BIOCHEMICAL CORRELATES FOR THE PREDICTION OF 
MURICIDAL BEHAVIOR IN THE WILD RAT 

182241 03-04 
CORRELATION 

BEHAVIOR AND SENSITIVITY TO EXPERIMENTAL HYPERTENSION: II. LACK 
OF CORRELATION BETWEEN CERTAIN BEHAVIOR PATTERNS AND 
HYPERTENSION IN TWO NEW STRAINS OF RATS. 

173256 01-04 



Subject Index 

QUANTUM CHEMICAL STUDIES ON DRUG ACTIONS: IV. CORRELATION OF 
SUBSTITUENT STRUCTURES AND ANTISEROTONIN ACTIVITY IN 
LYSERGAMIDE SERIES 

174605 01-12 
DISPOSITION OF NORAPOMORPHINE AND N,N PROPYLNORAPOMORPHINE 
IN MOUSE BRAIN AND ITS CORRELATION WITH STEREOTYPED 
GNAWING BEHAVIOR. 

182131 02-04 
CORRELATION BETWEEN THE TRANQUILIZING AND SEDATIVE ACTION OF 
NEUROLEPTICS, ANTIDEPRESSANTS AND ANTICHOLINERGIC DRUGS. 

191783 04-02 
CORRELATION BETWEEN BRAIN N,N DIMETHYLTRYPTAMINE (DMT) 
LEVELS AND BAR PRESSING BEHAVIOR IN RATS: EFFECT OF MAO 
INHIBITION. 

191935 04-04 
CORRELATION OF PHARMACOLOGICAL INVESTIGATIONS WITH THE 
CLINICAL EFFICACY OF ANTIDEPRESSANT DRUGS, 

192420 04-13 
CORRELATIONS 

EFFECTS OF MOLINDONE ON CNS STRUCTURES: NEUROPHYSIOLOGICAL 
AND BEHAVIORAL CORRELATIONS. 

172749 01-03 
LONG-TERM CLINICAL AND QUANTITATIVE EEG EFFECTS OF 

CLOPENTHIXOL IN SCHIZOPHRENICS: CLINICAL NEUROPHYSIOLOGICAL 
CORRELATIONS 

174131 01-08 
EFFECTS OF LORAZEPAM ON CNS STRUCTURES: NEUROPHYSIOLOGICAL 
AND BEHAVIORAL CORRELATIONS. 

177749 02-03 
ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM: 
CLINICAL AND PHARMACOLOGIC CORRELATIONS AND THE EFFECT OF 
INTRAMUSCULAR PYRIDOXINE 

188560 04-11 
MULTIPLE FORMS OF MAO: SOME IN VIVO CORRELATIONS. 

191496 04-03 
CORTEX 

LSD EFFECTS ON SIGNAL-TO-NOISE RATIO AND LATERALIZATION OF 
VISUAL CORTEX AND LATERAL GENICULATE DURING PHOTIC 
STIMULATION. 

167449 01-03 
EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS. 

169467 01-03 
EFFECT OF PROCAINE. LIDOCAINE AND PENTOBARBITAL ON ELECTRICAL 
ACTIVITY OF GUINEA-PIG OLFACTORY CORTEX IN VITRO. 

182092 02-03 
UPTAKE AND RELEASE OF NORADRENALINE IN RAT CEREBRAL CORTEX IN 
VITRO: NO EFFECT OF BENZODIAZEPINES AND BARBITURATES. 

182347 03-03 
A COMPARISON OF THE EFFECTS OF AMPHETAMINE AND ITS 
METABOLITES, P-HYDROXYAMPHETAMINE AND P- 
HYDROXYNOREPHEDRINE, ON UPTAKE, RELEASE AND CATABOLISM OF 
3H-N0REPINEPHRINE IN CEREBRAL CORTEX OF RAT BRAIN. 

186669 03-03 
EVIDENCE FOR AN INHIBITORY ROLE FOR ACETYLCHOLINE, 

CATECHOLAMINES, AND SEROTONIN ON THE CEREBRAL CORTEX, 

187552 04-03 
EVIDENCE FOR A SPECIFIC UPTAKE OF DOPAMINE BY DOPAMINERGIC 
TERMINALS OF THE RAT CEREBRAL CORTEX 

188978 04-03 
INFLUENCE OF MORPHINE AND NALOXONE ON THE RELEASE OF 
NORADRENALINE FROM RAT BRAIN CORTEX SLICES. 

189568 04-03 
INFLUENCE OF FENTANYL, LEVORPHANOL AND PETHIDINE ON THE 

RELEASE OF NORADRENALINE FROM RAT BRAIN CORTEX SLICES. 

189569 04-03 
MESCALINE INDUCED CHANGES OF BRAIN CORTEX RIBOSOMES EFFECT 

OF MESCALINE ON THE BINDING OF AMINOACYL TRANSFER 
RIBONUCLEIC ACID TO RIBOSOMES OF BRAIN TISSUE. 

189582 04-05 
THE ACTION OF BETA-PHENYL-GABA DERIVATIVES ON NEURONES OF THE 
CAT CEREBRAL CORTEX. 

189750 04-03 
THE EFFECTS OF ACETYLCHOLINE AND OF SYNAPTIC STIMULATION ON 
THE SENSORIMOTOR CORTEX OF CATS. I. NEURONAL RESPONSES TO 
STIMULATION OF THE RETICULAR FORMATION 

189855 04-03 
THE EFFECTS OF ACETYLCHOLINE AND OF SYNAPTIC STIMULATION ON 

THE SENSORIMOTOR CORTEX OF CATS. II. COMPARISON OF THE 
NEURONAL RESPONSES TO RETICULAR AND OTHER STIMULI. 

189856 04-03 
EFFECT OF DESIPRAMINE ON RAT CORTEX SLICES INCUBATED WITH 3H- 

DOPAMINE. 

190310 04-03 



S-65 



Subject Index 



Psychopharmacology Abstracts 



EFFECT OF PHENOTHIAZINE NEUROLEPTIC DRUGS AND TRICYCLIC 
ANTIDEPRESSANTS ON PHOSPHODIESTERASE ACTIVITY IN RAT 
CEREBRAL CORTEX 19031104-03 

THE EFFECT OF CHOLINOMIMETIC DRUGS ON POTASSIUM TRANSPORT IN 
RAT CEREBRAL CORTEX. ,9141104-03 

CHANGES IN RHYTHMS OF BIOELECTRICAL ACTIVITY OF THE CEREBRAL 
CORTEX IN HUMANS UNDER THE INFLUENCE OF ETHYMISOL ^^^ ^^^^ 

THE EFFECTS OF AMPHETAMINE SULFATE ON THE DIURNAL RHYTHMS OF 
MIDBRAIN- CORTEX, NOREPINEPHRINE; SEROTONIN AND BLOOD 
GLUCOSE LEVELS IN THE MOUSE. 19,918 04-03 

*^°"nt*RACTION BETWEEN ATROPINE AND OXOTREMORINE ON CORTICAL 

ACETYLCHOLINE AND MOTOR ACTIVITY. ^_^^^^^ ^^^^ 

CORTICAL SYNAPTOSOMAL UPTAKE AND SUBSYNAPTOSOMAL 
DISTRIBUTION OF 3H-N0REPINEPHRINE AND 3H-AMPHETAMINE: 
MODIFICATION BY TRICYCLIC AND PSYCHOACTIVE AGENTS IN VITRO. 
(PH.D. DISSERTATION). ,72020 01-03 

THE ANTAGONISM OF HIPPOCAMPAL AND CORTICAL AFTERDISCHARGE 
BY SC-13504, A NEW ANTICONVULSANT. ^^^^^^ ^^^^ 

SHIFTING OF THE D-AMPHETAMINE DOSE-RESPONSE CURVE IN RATS 
WITH FRONTAL CORTICAL ABLATIONS. ^^^^^^ ^^ ^ 

EFFECTS OF SOME METALLIC CATIONS ON CEREBRAL CORTICAL 
NEURONES AND THEIR INTERACTIONS WITH BIOGENIC AMINES^ 

187806 04-UJ 

NEOMYCIN AND RUTHENIUM RED ANTAGONISM OF MONOAMINERGIC 
DEPRESSION OF CEREBRAL CORTICAL NEURONES. ^^^^^^ ^^^^ 

CORTICAL AND/OR SUBCORTICAL EFFECTS AS A FUNCTION OF 

HALLUCINOGENIC DRUG STRUCTURE ^^^^^^ ^^^^ 

^°"mODU?ATORySfFECTS OF CORTICOSTEROIDS ON EVOKED ACTIVITY IN 

THE HIPPOCAMPUS AND THALAMUS OF THE RAT. ^^^^ ^^ ^^^^ 

THE EFFECT OF MINOR TRANQUILIZERS ON STRESS INDUCED INCREASES 
IN RAT PLASMA CORTICOSTEROIDS. ,86578 03-03 

EFFECTS OF METHAMPHETAMINE ON DAILY RHYTHMS OF 
HYPOTHALAMIC NOREPINEPHRINE, SEROTONIN AND PLASMA 
CORTICOSTERONE LEVELS IN THE RAT. ^^^^^^ ^^^^ 

^°^'dAILY rhythm IN BODY TEMPERATURE OF MENTAL PATIENTS: 

APPLICATION OF COSINOR METHOD -- FIRST REPORT. ^^^^^^ ^^^^ 

*^°"cONTROL OF THE HYPERACTIVE CHILD VIA MEDICATION - AT WHAT 
COST TO PERSONALITY DEVELOPMENT, SOME PSYCHOLOGICAL 
IMPLICATIONS AND CLINICAL INTERVENTIONS. ^^^^^^ ^^^ ^ 

'^°"a*COMPARISON OF CLINICALLY USED PSYCHOACTIVE DRUGS IN FOUR 
LATIN-AMERICAN COUNTRIES AND IN CANADA (ARGENTINA, COSTA- 
RICA, MEXICO AND PANAMA). ^^^^^^ ^^^^ 

*^°"a"oMPARISON of CLINICALLY USED PSYCHOACTIVE DRUGS IN FOUR 
LATIN AMERICAN COUNTRIES AND IN CANADA (ARGENTINA, COSTA- 
RICA, MEXICO AND PANAMA). ^^^^^^ ^^^^ 

*^°ToufHOMEGACOLON INDUCED BY NEUROLEPTICS AMONG PSYCHIATRIC 
PATIENTS (MEMORANDUM COVERING 153 CASES). ^^^^^^ ^^^^ 

*^°*INFLUENCE OF DIFFERENT ANIONS ON TYRAMINE AND AMPHETAMINE 

UPTAKE BY COW ADRENAL MEDULLA CHROMAFFIN VESICL^E^S^^^ ^^^^ 



CREATIVITY AND THE STATE OF CONSCIOUSNESS 
HALLUCINOGENIC DRUGS AND ARTISTIC CREATIVITY. 

CRIME 

CRIME AND THE SEX DRIVE. 



CPK 



CPZ 



MUSCLE ABNORMALITIES IN PSYCHOTIC PATIENTS: II. SERUM CPK 
ACTlVITrFIBER ABNORMALITIES, AND BRANCHING AND SPROUTING 
OF SUBTERMINAL NERVES. ^^^^^^ ^^^ 

EFFECT OF CHLORPROMAZINE (CPZ) ON INSULIN RELEASE IN VIVO AND 
IN VITRO IN THE RAT. ,68440 01-03 

EFFECTS OF CHLORPROMAZINE (CPZ) AND THIORIDAZINE PERFORMANCE 
AND STIMULUS CONTROL BEHAVIOR. ^^^^^^ ^^^^ 



186025 03-12 

186026 03-12 

192410 04-17 



*^""*RELATIONSHIP BETWEEN RESPONSE TO LOW PENTAMETHYLENETETRAZOL 
ADMINISTRATION AND PERSONALITY OF JUVENILE OFFENDERS AND 
THEIR REPEATED CRIMES. ,75072 02-17 

"' CRISIS PSYCHOPHARMACOLOGY TECHNIQUES. ,74298 01-11 

DRUG THERAPIES IN CRISIS MANAGEMENT. ^^^^_^ ^^^^ 

'^"°"rOs's" AtIoNAL STUDY OF THE EXTENT OF ANTIANXIETY SEDATIVE 

DRUG USE. ,81713 02-17 

*^''°TOLE°RANCe'^AND CROSS-TOLERANCE TO THE ANOREXIGENIC EFFECT OF 

SOME AMPHETAMINE DERIVATIVES IN RATS. ^^^^^^ ^^^^ 

^"°"h°LORDIAZEPOXIDE in DEPRESSIVE NEUROSIS: AN OPEN LABEL 

CROSSOVER STUDY WITH AMITRIPTYLINE. ^^^^^^ ^^^^ 

MOLINDONE: A CROSSOVER EVALUATION OF CAPSULE AND TABLET 
FORMULATIONS IN SEVERELY ILL SCHIZOPHRENIC PATIENTS^^_^^ ^^^^ 

AFRODEX VS PLACEBO IN THE TREATMENT OF MALE IMPOTENCE: 

STATISTICAL ANALYSIS OF TWO DOUBLE-BLIND CROSSOVER^ STUDIES.^ 

nnilRIF BLIND CROSSOVER COMPARISON OF BROMAZEPAM AND 
%TaZEPAm'n PSYCHOSOMATIC DISEASE, NEUROSIS AND DER^^ESSION^ 

A DOUBLE-BLIND CROSSOVER SEQUENTIAL TRIAL OF ORAL THYROTROPIN 
RELEASING HORMONE IN DEPRESSION. ^^^^^^ ^^^ 

*^"" CRUDE MARIHUANA EXTRACT: EEG AND BEHAVIORAL EFFECTS OF 

CHRONIC ORAL ADMINISTRATION IN RHESUS MONKEYS. ^^^^^^ ^^^^ 

*^'"'"aCt"a°k''aLOIDS. XIX. CRYSTALLIZATION OF MESCALINE HCL AND 3- 
METHOXYTYRAMINE HCL FROM TRICHOCEREUS-PACHANOl^^^^^ ^^^^ 

"'^THE SAFETY TEST OF lO-CHLORO-1 lB-(2-CHL0R0PHENYL) 2,3,5,6,7,118 
HEXAHYDROBENZODIAZEPINOOXAZOL-6-ONE (CS-370). SECOND 
REPORT EFFECT OF CS-370 UPON THE DEVELOPMENT OF PRENATAL 
AND POSTNATAL OFFSPRINGS OF EXPERIMENTAL ANIMALS^^^^^ ^^^^ 

EFFECT OF A NEW PSYCHOTROPIC DRUG, CS-370 dO-CHLORO-l lB-(2- 
CHL0R0PHENYL)-2 3 5,6,7,118 HEXAHYDROBENZODIAZEPINOOXAZOL- 
6-ONE) UPON THE CENTRAL NERVOUS SYSTEM. ^^^^^ ^^^^ 

'^""mEGAVITAMIN TREATMENT, CULTURE AND TRANQUILIZERS, DRUGS FOR 
THE AGED: PROJECTS OF A CANADIAN GRANT. ^^^^^^ ^^^^ 

STIMULATION OF SEROTONIN N-ACETYLTRANSFERASE IN PINEAL ORGAN 
CULTURE BY DRUGS ,77128 02-03 

*^"TfFECTS of NARCOTIC ANALGESICS ON ENZYMES OF ACETYLCHOLINE 

METABOLISM IN CULTURED CHICK BRAIN CELLS ^^^^^^ ^^^^ 

EFFECT OF IMIPRAMINE ON CULTURED RAT HEART CELLS. ^^^^^ ^^^^ 

EFFECTS OF ALUMINUM SALTS ON CULTURED NEUR0BLAST(3MA Ca^L^S^_^ 

*^""e"f"fECTS OF CHLORPROMAZINE AND ACTINOMYCIN D ON UPTAKE AND 
INCORPORATION OF CERTAIN AMINO ACIDS, HYPOXANTHINE AND 
THYMIDINE IN CULTURES OF HUMAN SKIN EPITHELIAL CELLS^^^ ^^^, 

EFFECTS OF PROLONGED LSD-25 ADMINISTRATION UPON NEURONS OF 
SPINAL CORD GANGLIA TISSUE CULTURES. ^^^^^^ ^^ ^. 

*^""tHE^CURARIZED rat AND HEART RATE CONDITIONING: A 
rnwsinFRATION OF RESPIRATION PARAMETERS AND 
NEUROMUSCULAR BLOCKING AGENTS IN A CLASSICAL CONDITIONING 
PARADIGM (PH.D. DISSERTATION). ^^^^^^ ^^^ 



S-66 



VOLUME 12, SUBJECT INDEX 

AMPHETAMINE AND THERMOREGULATION: STUDIES IN THE 
UNRESTRAINED AND CURARIZED RAT. 

184227 03-03 
CURVE 

SHIFTING OF THE D-AMPHETAMINE DOSE-RESPONSE CURVE IN RATS 
WITH FRONTAL CORTICAL ABLATIONS. 

187261 04-04 
CURVES 

PREDICTION OF NEUROLEPTIC EFFECTS OF CI-686 BASED ON 
QUANTITATIVE PHARMACOELECTROENCEPHALOGRAPHY: DRUG 
PROFILES AND DOSE RESPONSE CURVES BASED ON COMPUTERIZED 
CEREBRAL BIOPOTENTIALS. 

181958 02-13 
CUTANEOUS 

THE EFFECT OF L-TRYPTOPHAN (TP) ON CUTANEOUS C-FIBER (CFR) AND 
POLYSYNAPTIC (PSR) REFLEXES IN ACUTE DECEREBRATE SPINAL CATS 
AND THE EFFECT OF PRETREATMENT WITH P-CHLOROPHENYLALANINE 
(PCPA) ON THE ACTION OF TP, (UNPUBLISHED PAPER). 

170874 01-03 
THE EFFECT IN THE CAT OF TRYPTAMINE (T) AND LSD ON CUTANEOUS C- 
FIBER (CFR) AND POLYSYNAPTIC (PSR) SPINAL REFLEXES. 
(UNPUBLISHED PAPER). 

174480 01-12 
CYCLANDELATE 

TREATMENT OF THE CEREBRAL MANIFESTATIONS OF ARTERIOSCLEROSIS 
WITH CYCLANDELATE. 

185008 03-11 
CYCLASE 

EFFECTS OF CENTRALLY ACTING DRUGS ON ADENYL CYCLASE ACTIVITY 
AND CYCLIC AMP LEVELS OF MOUSE BRAIN. (PH.D. DISSERTATION). 

172019 01-03 
DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: 

ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE 
MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY. 

177131 02-03 
EFFECT OF CHLORPROMAZINE AND SOME OF ITS METABOLITES ON THE 
DOPAMINE SENSITIVE ADENYLATE CYCLASE OF RAT BRAIN STRIATUM. 

180060 02-03 
EFFECTS OF SELECTED CENTRALLY ACTING AGENTS ON ADENYL CYCLASE 
ACTIVITY IN MOUSE BRAIN. 

182153 02-03 
A ROLE FOR NICOTINIC RECEPTORS IN THE REGULATION OF THE 
ADENYLATE CYCLASE OF ADRENAL MEDULLA. 

186675 03-03 
THE EFFECT OF LITHIUM ON HORMONE SENSITIVE ADENYLATE CYCLASE 
FROM VARIOUS REGIONS OF THE RAT BRAIN. 

187110 03-03 
STIMULATION OF A DOPAMINE SENSITIVE ADENYLATE CYCLASE IN 
HOMOGENATES OF RAT STRIATUM BY A METABOLITE OF PIRIBEDIL 
(ET-495). 

189616 04-03 
EFFECTS OF DOPAMINE-LIKE DRUGS ON RAT STRIATAL ADENYL CYCLASE 
HAVE IMPLICATIONS FOR CNS DOPAMINE RECEPTOR TOPOGRAPHY. 

190545 04-03 
EFFECT OF CHRONIC TREATMENT WITH DESIPRAMINE (DMI) AND 
IPRINDOLE (IP) ON THE NOREPINEPHRINE (NE) SENSITIVE ADENYLATE 
CYCLASE SYSTEM IN SLICES OF THE RAT LIMBIC FOREBRAIN. 

192003 04-03 
CYCLASES 

NOREPINEPHRINE SENSITIVE ADENYLATE CYCLASES IN RAT BRAIN: 
RELATION TO BEHAVIOR AND TYROSINE HYDROXYLASE. 

177252 02-03 
CYCLAZOCrNE 

STIMULATION OF BEHAVIOR IN THE RAT BY CYCLAZOCINE- EFFECTS OF 
NALOXONE. 

168439 01-04 
CYCLE 

EFFECTS OF PHENOTHIAZINES, ANTIHISTAMINES, BENZODIAZEPINES AND 
BUTYROPHENONES ON THE RHYTHMS OF WAKEFULNESS SLEEP CYCLE 
IN RATS. 

182553 03-04 
FLUNITRAZEPAM (RO-5-4200) AND SLEEP CYCLE IN INSOMNIAC 
PATIENTS. 

186574 03-11 
THE EFFECT OF A NEW BENZODIAZEPINE DERIVATIVE NIMETAZEPAM ON 
THE SLEEP CYCLE IN MAN. 

188501 04-07 
LONG-TERM ALTERATION OF SLEEP-WAKEFULNESS CYCLE DURING 
CHRONIC PENTOBARBITAL DOSING AND WITHDRAWAL IN CAT. 

191952 04-04 
CYCLES 

BEHAVIOURAL STATE CYCLES IN ABNORMAL INFANTS. 

168523 01-14 
CYCLIC 

EFFECT OF ETHANOL ON CYCLIC AMP LEVELS IN THE RAT BRAIN. 

167326 01-03 



Subject Index 

POSSIBLE INVOLVEMENT OF CYCLIC NUCLEOTIDES IN THE STIMULATION 
OF PITUITARY FUNCTION ELICITED BY RESERPINE. (UNPUBLISHED 
PAPER). 

170086 01-03 
THE ROLE OF CYCLIC 3,5 ADENOSINE MONOPHOSPHATE IN 
NEUROMUSCULAR TRANSMISSION. 

170660 01-13 
TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. (UNPUBLISHED PAPER). 

170876 01-03 
EFFECTS OF CENTRALLY ACTING DRUGS ON ADENYL CYCLASE ACTIVITY 
AND CYCLIC AMP LEVELS OF MOUSE BRAIN. (PH.D. DISSERTATION). 

172019 01-03 
BLOCKADE OF THE PROESTROUS LH SURGE IN CYCLIC RATS BY 
BARBITURATE ADMINISTRATION ON DIESTRUS. 

1 75650 02-03 
CYCLIC ADENOSINE MONOPHOSPHATE: SELECTIVE INCREASE IN CAUDATE 
NUCLEUS AFTER ADMINISTRATION OF L-DOPA. 

176254 02-13 
EFFECTS OF NEUROLEPTICS AND THYMOLEPTICS ON 

PHOSPHODIESTERASE ACTIVITY AND ON CYCLIC 3,5 AMP LEVELS IN 
RAT BRAIN. 

181467 02-03 
REGIONAL CYCLIC NUCLEOTIDES PHOSPHODIESTERASE ACTIVITY IN CAT 
CENTRAL NERVOUS SYSTEM: EFFECTS OF BENZODIAZEPINES. 

181575 02-03 
A CENTRAL EFFECT OF LOCAL ANESTHETICS: PREVENTION AGAINST THE 
ACCUMULATION OF CYCLIC AMP IN BRAIN SLICES. 

182099 02-03 
EFFECTS OF DECAPITATION, ETHER AND PENTOBARBITAL ON CYCLIC 
AMP AND CYCLIC GMP LEVELS IN RAT TISSUES. 

182154 02-03 
INTERACTION OF CYCLIC AMP WITH NEUROPHARMACOLOGIC 

DEPRESSANT AGENTS. 

182155 02-03 
THE EFFECT OF DOPAMINE RECEPTOR STIMULATING AGENTS AND OF N,0 

DIBUTYRYL CYCLIC AMP ON C14-D0PAMINE SYNTHESIS IN STRIATAL 
SLICES OF RATS. 

182256 03-03 
SYNTHESIS AND SCREENING OF CYCLIC BENZYLHYDRAZINE CONGENERS 
AS ANTIDEPRESSANTS. 

183600 03-01 
NOREPINEPHRINE -- AN ANTAGONIST OF DIBUTYRYL CYCLIC AMP IN THE 
REGULATION OF NARCOSIS IN THE RAT, 

183789 03-03 
NEUROCHEMICAL ROLE OF ADENOSINE 3,5 CYCLIC MONOPHOSPHATE 
AND GUANOSINE 3,5 CYCLIC MONOPHOSPHATE AND THEIR RELATION 
TO NEUROTRANSMITTERS; EFFECT OF TETRAHYDROCANNABINOLS. 
(PH.D. DISSERTATION). 

185582 03-03 
IN VIVO CHANGES OF CEREBRAL CYCLIC ADENOSINE 3,5 

MONOPHOSPHATE INDUCED BY BIOGENIC AMINES: ASSOCIATION 
WITH PHOSPHORYLASE ACTIVATION. 

188291 04-03 
BETA-ADRENERGIC EFFECTS ON RAT MYOMETRIUM: ROLE OF CYCLIC 
AMP. 

188915 04-03 
DIAZEPAM, CYCLIC NUCLEOTIDES AND AMINO ACID 

NEUROTRANSMITTERS IN RAT CEREBELLUM, (UNPUBLISHED PAPER). 

191764 04-03 
CYCLOHEXIMIDE 

CHANGE OF ESTROGEN ACTIVATED BEHAVIOR BY CYCLOHEXIMIDE IN 
THE FEMALE RAT. 

171615 01-04 
INTERACTIVE EFFECTS OF CYCLOHEXIMIDE AND PUROMYCIN IN 
ALTERING BRAIN POLYRIBOSOMES AND NEURAL AND BEHAVIOURAL 
RESPONSES TO ELECTROSHOCK IN MICE. 

175230 02-03 
LACK OF EFFECTS OF CYCLOHEXIMIDE ON TOLERANCE DEVELOPMENT TO 
A STIMULATORY EFFECT OF MORPHINE ON MICE. 

182158 02-03 
EFFECTS OF CYCLOHEXIMIDE ON ACQUISITION AND RETENTION OF 
AVOIDANCE LEARNING IN THE RAT: RECOVERY OF MEMORY. 

189215 04-04 
CYCIOPHOSPHAAAIDE 

ACUTE LETHALITY FOR MICE FOLLOWING ADMINISTRATION OF 
CYCLOPHOSPHAMIDE WITH BARBITURATES. 

1 77834 0205 
BACKWARD CONDITIONING OF TASTE AVERSIONS IN RATS USING 
CYCLOPHOSPHAMIDE AS THE US. 

190265 04-04 
CYPROHEPTADINE 

EFFECT OF A CARNITINE CYPROHEPTADINE COMBINATION ON ANOREXIA 
AND WEIGHT GAIN IN CHILDREN. 

178811 02-10 



S-67 



Subject Index 



Psychopharmacology Abstracts 



EFFECTS OF CYPROHEPTADINE ON THE EATING BEHAVIOR OF RATS AND 
CATS 182111 02-04 

"'Tt" ATION OF MATERNAL BEHAVIOR IN MICE FOLLOWING 

ADMINISTRATION OF CYPROTERONE ACETATE. ^^^^^^ ^^ ^^ 

EFFECTS OF CYPROTERONE ACETATE IN THE MALE JAPANESE^QUAIL.^^ ^^ 

""TytSeTIC STUDIES IN THE OFFSPRING OF LSD USERS. ^^^^^^ ^^^^ 

^'''°plYcioTROPIC DRUGS AND CYTOGENIC EFFECTS. ^^^^^^ ^^^^ 

'''°D'?mOP°MENT OF A VACCINE AGAINST MENTAL RETARDATION CAUSED 
BY CYTOMEGALOVIRUS INFECTION IN UTERO. ^^^^^^ ^^^ ^ 

CYTOPLASMIC INTOXICATION WITH (.) AMPHETAMINE ON ITS 

rnMr?NTRATION IN IVER AND BRAIN AND ON (1 4C) LEUCINE 
SpORATION into MICROSOMAL AND CYTOPLASMIC PROTEINS OF 
RAT LIVER. 180056 02-05 

'^"'m^HmiTlON OF C14-ACH UPTAKE IN RAT BRAIN SLICES BY 

DESMETHYLIMIPRAMINE. 182170 02-03 

'^''''ruff^ln OF DOPAMINE RECEPTOR STIMULATING AGENTS AND OF N,0 
' DIBUTYRYL CY^'rC AMP ON C14-D0PAMINE SYNTHESIS IN STRIATAL 
SLICES OF RATS. 182256 03-03 

D-AMPHETAMINE ^^^ernAL ADMINISTRATION OF D-AMPHETAMINE 

"on RAT OFFSPRING^CTIVITY AND PASSIVE AVOIDANCE LE^A^NING. ^^ 

TEMPERATURE DEPENDENT TOXICITY OF ADRENERGIC AGONISTS IN MICE 
''as A BAsfs FOR TREATING D-AMPHETAMINE POISONING. ^^^^^^ ^^ ^^ 

INTERACTION BY FENFLURAMINE WITH THE METABOLISM OF D- 

AMPHETAMINE IN THE RAT. ^^^^^4 01-03 

INHIBITORY EFFECTS OF PRETEST AND POSTTEST D-AMPHETAMINE ON 
MOUSE KILLING BY RATS. (PH.D. DISSERTATION). ^^^^^^ ^^^^ 

EFFECTS AND INTERACTIONS OF SCOPOLAMINE AND D-AMPHETAMINE 
ON SCHEDULe'cONTROLLED RESPONDING IN RATS. (PH.D. 
DISSERTATION), 173748 01-04 

DEVELOPMENT OF TOLERANCE IN RATS TO THE HYPOTHERMIC EFFECTS 
OF D-AMPHETAMINE AND APOMORPHINE. ^^^^^^ ^^^^ 

EFFECTS OF INTRAPERITONEAL AND INTRAVENTRICULAR D- 
AMPHETAMINE ADiUlNISTRATION ON ACTIVE AVOIDANCE 
PERFORMANCE IN THE RAT. ^^^^42 02-04 

THE HYDROXYLATION OF D-AMPHETAMINE BY LIVER MICROSOMES OF 
THE MALE RAT. 177337 02-03 

SPATIAL AND PAW PREFERENCES IN RATS. THEIR RELATIONSHIP TO 

^rItE DEPENDENT EFFECTS OF D-AMPHETAMINE. ^^^^^ ^^^^ 

RATE-DEPENDENT EFFECTS OF DRUGS. I. COMPARISONS OF D- 
AMPHETAMINE, PENTOBARBITAL, AND CHLORPROMAZINE ON 
MULTIPLE AND MIXED SCHEDULES. ^^^^^^ ^2-04 

AM AK]AiY<;i<; OF D-AMPHETAMINE PRODUCED FACILITATION OF 
'^ aOoIdInCE AcSui^TION IN RATS AND PERFORMANCE CHANGES 

SUBSEQUENT TO DRUG TERMINATION. ^^^^^^ ^2-04 

ANALYSIS OF TREMORGENIC EFFECTS OF INTRACAUDATE D- 

AMPHETAMINE. 182129 02-03 

DECREASED ANOREXIA, EXCITEMENT AND STERE(3TYPY TO D- 

AMPHETAMINE AFTER LATERAL HYPOTHALAMIC 6- 

HYDROXYDOPAMINE (6-OHDA) INJECTIONS. ^^^^^^ ^^.04 

TOLERANCE TO THE ACTIVITY ENHANCING EFFECTS OF DAMPHETAMm^E^ 

EFFECT OF D-AMPHETAMINE (D-A) AND 2.5 DIMETH0XY^4- 
' METHYLAMPHETAMINE (DOM) ON THE IN V WO RE ASE OF 14C- 
NOREPINEPHRINE (NE) INTO THE LATERAL VENTRICLE OF RATS.^^ ^^^^ 

rn^APARATIVE EFFECTS OF DL-P-METHOXYAMPHETAMINE AND D- 
'amXaMINE ON CENTRAL CATECHOLAMINES AND LOCOMOTOR 
ACTIVITY. 182253 03-04 



BEHAVIOR AS A STIMULUS: JOINT EFFECTS OF D-AMPHETAMINE AND 
PENTOBARBITAL. 183890 03-04 

BEHAVIORAL EFFECTS OF SEPARATE AND COMBINED ADMINISTRATION 
OF NALOXONE AND D-AMPHETAMINE. ^^^^^^ ^^^^ 

EFFECT OF D-AMPHETAMINE SULFATE ON SUSCEPTIBILITY TO 

AUDIOGENIC SEIZURES IN DBA/2J MICE ^^^^^^ ^^^^ 

THE ACTION OF D-AMPHETAMINE ON SPONTANEOUS ACTIVITY IN THE 
'"cAUdTtE nucleus and RETICULAR FORMATION OF THE RAL^^ ^^^^ 
CATALEPSY INDUCED BY ALPHA-METHYL-P-TYROSINE AND D 
"aMPHETAMINE: the ROLE OF CATECHOLAMINE METABOLISM^^^ ^^^^ 

THE EFFECTS OF CHRONIC TREATMENT WITH D-AMPHETAMINE ON FOOD 
INTAKE BODYWEIGHT, LOCOMOTOR ACTIVITY AND SUBCELLULAR 
DISTRIBUTION OF THE DRUG IN RAT BRAIN. ^^^^^^ ^^^^ 

DOSE DEPENDENT SELECTIVE FACILITATION OF RESPONSE CONTINGENT 
LIGHT ONSET BEHAVIOR BY D-AMPHETAMINE. ^^^^^^ ^^^^ 

iMnFPFNDFNCE OF THE EFFECTS OF D-AMPHETAMINE AND FOOD 
"deprivation OR BODYWEIGHT ON THE FOOD CONSUMPTION OF 

RATS. 186376 03-06 

rr,»ADADATlVF FFFFCTS OF DL-P-METHOXYAMPHETAMINE AND D- 
'TmZtAMINE ON CATECHOLAMINE RELEASE AND REUPTAKE IN 

VITRO. ,86671 03-03 

COMPARISON OF TYROSINE HYDROXYLASE AND DOPAMINE-BETA- 
TyDROXYLASE INHIBITION WITH THE EFFECTS OF VARIOUS 6- 

HYDROXY^OPAMINE TREATMENTS ON D-AMPHETAMINE INDUCED 

MOTOR ACTIVITY. 186699 03-03 

A DETAILED ANALYSIS OF THE EFFECTS OF D-AMPHETAMINE ON 

BEHAVIOR UNDER FIXED-INTERVAL SCHEDULES. ^^^^^^ ^^^^ 

rOMPARISON OF THE LOCOMOTOR STIMULANT MECHANISMS OF 
TtW OF D-AMPHETAMINE AND D-AMPHETAMINE PLUS L-DOPA. 
POSSIBLE INVOLVEMENT OF SEROTONIN, ^^^^^^ ^^^^ 

SHIFTING OF THE D-AMPHETAMINE DOSE-RESPONSE CURVE IN RATS 
WITH FRONTAL CORTICAL ABLATIONS. ^^^^^^ ^^^^ 

.MTCDArTiniM AMONG GENOTYPE, UNCONDITIONED STIMULUS, D- 
"^ETAM^f ANd'oNE-WAY AVOIDANCE BEHAVIOR OF RATS- ^^^^ 

cfFFfTS OF ALPHA-METHYLTYROSINE ON D-AMPHETAMINE INDUCED 
RELEASE OF ENDOGENOUSLY SYNTHESIZED AND EX^^^^^^ 
AdStERED CATECHOLAMINES FROM THE CAT BRAIN jN^VIVO^^ ^^ 

PARADOXICAL EFFECTS OF D-AMPHETAMINE ON BEHAVIORAL 
^Cmo'rEGULATION.. POSSIBLE MEDIATION BY BRAIN DOPAMINE^^ ^^ 

TUF FFFFfTS OF D-AMPHETAMINE ON THE INTERRESPONSE TIMES OF 
Lis AND GUm^A PIGS ON A MODIFIED SIDMAN DISCRIMINATED 
AVOIDANCE SCHEDULE. 189519 04-0^ 

AN ANALYSIS OF THE FACILITATION OF AVOIDANCE ACQUISITION BY D- 
AMPHET AMINE AND SCOPOLAMINE. ^^^^^i 04.0- 

INTFRACTION OF D-AMPHETAMINE WITH CENTRAL NERVOUS SYSTEM 
DEPRESSANTS ON FOOD INTAKE AND SPONTANEOUS MOTOR 
ACTIVITY OF MICE 189613 04-0 

EFFECTS OF INTRAVENOUS D-AMPHETAMINE, L-AMPHETAMINE AND 
METHYLPHENIDATE IN SCHIZOPHRENICS. ^^^^^^ ^^ ^ 

ccccrTc nF MnAAIFFNSINE (HOE-984), D-AMPHETAMINE AND 

PRESENTATION OR ELECTRIC SHOCK PRESENTATION. ^^^^^^ ^^ ^ 

POSITIVE REINFORCING EFFECTS OF APOMORPHINE D-AMPHETAMINE 
AND MORPHINE: INTERACTION WITH HALOPERIDOL. ^^^^^^ ^^^ 

FFFFCTS OF 6-HYDROXYDOPAMINE ON ANOREXIA PRODUCED BY D- 
'"aMPHETAMINE AND RELATED PHENYLETHYLAMINES. ^^^^^^ ^^^ 

THE COMPARATIVE EFFECTS OF PENTOBARBITAL AND D-AMPHETAMINi 
ON A SHORT-TERM MEMORY TASK IN BABOONS. ^^^^^^ ^^ 

METABOLISM OF D-AMPHETAMINE BY RAT BRAIN IN VIVO AND IN 
VITRO. 191922 04- 



S-68 



VOLUME 12, SUBJECT INDEX 

INTERACTIONS BETWEEN RO-4-1284 AND D-AMPHETAMINE (DA) ON 
SHUTTLEBOX AVOIDANCE IN RATS. 

192009 04-04 
INTERACTION OF SEROTONIN ANTAGONISTS WITH 3,4-DICHL0R0-2-(2- 
IMIDAZOLIN-2-YL-THIO) 2 ACETOPHENONE HYDROBROMIDE (DITA) 
AND D-AMPHETAMINE HYDROBROMIDE (DITA) AND D-AMPHETAMINE 
ON CERTAIN BEHAVIORAL PARAMETERS OF MALE MICE. 

192014 04-04 
D-AMPHETAMINE-INDUCED 

THE GENERAL LOCUS OF D-AMPHETAMINE-INDUCED DISCRIMINATIVE 
STIMULI. (PH.D. DISSERTATION). 

185725 03-03 
SIGNIFICANCE OF DOPAMINE RECEPTOR ACTIVITY IN DL-P- 
METHOXYAMPHETAMINE AND D-AMPHETAMINE-INDUCED 
LOCOMOTOR ACTIVITY. 

186670 03-04 
D-CHLORPHENIRAMINE 

ANTIDEPRESSANT EFFECTS OF D-CHLORPHENIRAMINE - CLINICAL 
EVALUATION (FIRST REPORT). 

1 76889 02-09 
D-LYSERGIC 

STUDIES ON ENZYMATIC DEALKYLATION OF D-LYSERGIC ACID 
DIETHYLAMIDE (LSD). 

1 77336 02-03 
COMPARISON OF THE CHRONIC AND ACUTE EFFECTS OF D-LYSERGIC 
ACID DIETHYLAMIDE (LSD) TREATMENT ON RAT BRAIN SEROTONIN 
AND NOREPINEPHRINE. 

181945 02-03 
A COMPARISON OF EFFECTS OF D-LYSERGIC ACID DIETHYLAMIDE (LSD) 
AND SEROTONIN ON PRE- AND POSTSYNAPTIC CELLS IN THE 
SEROTONIN SYSTEM. 

182141 02-03 
EVIDENCE FOR THE ACTION OF D-LYSERGIC ACID DIETHYLAMIDE 

MESCALINE AND BUFOTENINE ON 5-HYDROXYTRYPTAMINE RECEPTORS 
IN UMBILICAL VASCULATURE. 

182716 03-03 
D-TUBOCURARINE 

CASE AGAINST THE USE OF D-TUBOCURARINE IN OPERANT STUDIES OF 
THE CARDIOVASCULAR SYSTEM. 

189425 04-03 
D-40TA 

ACUTE TOXICITY OF 8-CHL0R0-6-PHENYL-4H-S- 

TRIAZOLOBENZODIAZEPINE (D-40TA) IN MICE, RATS, RABBITS AND 
DOGS. 

173548 01-05 
SUBACUTE TOXICITY OF 8-CHL0R0-6-PHENYL-4H-S- 

TRIAZOLOBENZODIAZEPINE (D-40TA) IN MALE AND FEMALE RATS- 
ORAL ADMINISTRATION FOR ONE MONTH. 

1 77097 02-05 
ANTICONVULSIVE ACTIVITY OF 8-CHL0R0-6-PHENYL-4H-S- 

TRIAZOLOBENZODIAZEPINE (D-40TA) AND ITS EFFECT ON LIMBIC 
SYSTEM. 

1 77099 02-02 
DISSOCIATIVE CHANGE IN ANTIAGGRESSIVE AND MUSCLE RELAXANT 
ACTIONS OF S-TRIAZOLOBENZOOIAZEPINE (D-40TA) BY REPEATED 
ADMINISTRATION AND PHENOBARBITAL PRETREATMENT, AND ITS 
RELATION TO METABOLISM. 

181654 02-04 
EFFECT OF 8-CHL0R0-6-PHENYL-4H-S-TRIAZ0L0BENZ0DIAZEPINE (D-40TA) 
ON THE DAYTIME SLEEP-WAKEFULNESS PATTERNS IN MONKEYS. 

181657 02-02 
EFFECT OF 8-CHL0R0-6-PHENYL-4H-S-TRIAZ0L0BENZ0DIAZEPINE (D-40TA) 

ON THE DAYTIME SLEEP-WAKEFULNESS PATTERNS IN NORMAL AND P- 
CHLOROPHENYLALANINE INSOMNIAC CATS. 

181658 02-02 
DAILY 

THE TREATMENT OF DEPRESSION WITH A SINGLE DAILY DOSE OF 
IMIPRAMINE PAMOATE. 

169491 01-09 
SINGLE VERSUS DIVIDED DAILY DOSE OF TRIMIPRAMINE IN THE 
TREATMENT OF DEPRESSIVE ILLNESS. 

170622 01-09 
EFFECTS OF METHAMPHETAMINE ON DAILY RHYTHMS OF 
HYPOTHALAMIC NOREPINEPHRINE, SEROTONIN AND PLASMA 
CORTICOSTERONE LEVELS IN THE RAT. 

184178 03-03 
DAILY RHYTHM IN BODY TEMPERATURE OF MENTAL PATIENTS 
APPLICATION OF COSINOR METHOD - FIRST REPORT 

191685 04-17 
OOXEPIN: IS A SINGLE DAILY DOSE ENOUGH? 

192066 04-10 
OALMANE 

THE EFFECTS OF DALMANE (FLURAZEPAM HYDROCHLORIDE) ON THE 
CONTINGENT NEGATIVE VARIATION. (AMSTERDAM). 

177645 02-16 
DAMAGE 

LACK OF EFFECT OF RIBAMINOL, TCAP, AND MAGNESIUM PEMOLINE ON 
RECOVERY FROM NEOCEREBELLAR DAMAGE 

171904 01-03 



Subject Index 

THE EFFECTS ON INGESTIVE BEHAVIORS OF DAMAGE TO CENTRAL 
DOPAMINE CONTAINING NEURONS. 

191520 04-04 
DANTROLENE 

A COMPARATIVE STUDY OF DANTROLENE SODIUM AND OTHER 
SKELETAL MUSCLE RELAXANTS WITH THE STRAUB TAIL MOUSE. 

186638 03-04 
DARK 

EFFECT OF 6-HYDROXYDOPAMINE ON DARK ADAPTATION IN THE RAT 
RETINA. 

167358 01-03 
THE EFFECT OF IPRONIAZID AND TRANYLCYPROMINE STUDIED WITH A 
DARK AVOIDANCE CONDITIONED SCHEDULE 

186590 03-04 
DIFFERENTIAL EFFECTS OF PILOCARPINE AND SCOPOLAMINE ON THE 
PERFORMANCE OF A LIGHT DARK DISCRIMINATION MAINTAINED BY 
ELECTRICAL STIMULATION OF THE BRAIN. 

186701 03-03 
DARKNESS 

DETERMINANTS OF THE NORADRENERGIC SATIETY EFFECT 
ENVIRONMENTAL DARKNESS VS. THE FEEDING PATTERN. 

182133 0204 
DARTALANR 

CLINICAL TRIAL WITH DARTALANR, DJAKARTA, INDONESIA. 

170753 01-11 
DATA 

CLINICAL DATA AND SOCIOPSYCHIATRIC IMPLICATIONS OF OUTPATIENT 
TREATMENT WITH LONG-TERM PHENOTHIAZINES 

182791 03-09 
DAWN 

SCHIZOPHRENIA MANAGEMENT - THE DAWN OF A NEW ERA 

172435 01-08 
DAYS 

EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) 
ADMINISTERED SUBCUTANEOUSLY TO RABBITS FOR 28 DAYS. 

191965 04-03 
DAYTIME 

EFFECT OF 8-CHL0R0-6-PHENYL-4H-S-TRIAZ0L0BENZ0DIAZEPINE (D-40TA) 
ON THE DAYTIME SLEEP-WAKEFULNESS PATTERNS IN MONKEYS. 

181657 02-02 
EFFECT OF 8-CHL0R0-6-PHENYL-4H-S-TRIAZ0L0BENZ0DIAZEPINE (D-40TA) 

ON THE DAYTIME SLEEP-WAKEFULNESS PATTERNS IN NORMAL AND P- 
CHLOROPHENYLALANINE INSOMNIAC CATS. 

181658 02-02 
DB-2182 

EXPERIMENT WITH LOPRAMINE (DB-2182) ON THE TREATMENT OF 
DEPRESSION. 

191665 04-09 
DDT 

DDT EFFECT ON 32P INCORPORATION FROM GAMMA-LABELLED ATP 
INTO PROTEINS FROM LOBSTER NERVE. 

191315 04-03 
DEALKYLATION 

STUDIES ON ENZYMATIC DEALKYLATION OF D-LYSERGIC ACID 
DIETHYLAMIDE (LSD). 

177336 02-03 
DEAMINATED 

BEHAVIORAL AND PHYSIOLOGICAL ACTIVITY OF DEAMINATED 
METABOLITES OF MESCALINE. 

182244 03-03 
DEANOL 

DEANOL IN THE TREATMENT OF LEVODOPA INDUCED DYSKINESIAS 

184196 03-11 
DEATH 

A REVIEW OF THE USE OF LSD FOR THE PATIENT NEAR DEATH 

177681 02-12 
DEATHS 

CHANGING DEATHS PERSPECTIVE. 

169138 01-11 
OEBRISOQUIN 

ABSENCE OF DEGENERATION OF ADRENERGIC NEURONS AFTER 
PROLONGED TREATMENT WITH DEBRISOQUIN. 

186677 03-03 
DECANOATE 

ROLE OF FLUPHENAZINE DECANOATE IN LESSENING THE BURDEN OF 
CHRONIC SCHIZOPHRENICS ON THE COMMUNITY. 

169438 01-08 
ONE YEAR OF CLINICAL EXPERIENCE WITH LARGE DOSES OF 10 PERCENT 
FLUPENTHIXOL DECANOATE (LU-1705). 

172735 01-07 
PRELIMINARY STUDY OF THE TREATMENT OF CHRONIC PSYCHOSES 
WITH FLUPENTHIXOL DECANOATE. 

172978 01-09 
FEATURES OF THE THERAPEUTIC EFFECT OF FLUPHENAZINE DECANOATE 
IN SCHIZOPHRENIA. 

1 83683 03-08 
IMPLICATIONS OF SUSTAINED RELEASE PHENOTHIAZINES: A STUDY OF 
FLUPHENAZINE DECANOATE. 

185007 03-09 



i!: I 



S-69 



Subject Index 

FlUPENTHIXOL DECANOATE IN SCHIZOPHRENIA. ^^^^^^ ^^^^ 

iWFi llFNf E OF FLUPENTHIXOL AND FLUPENTHIXOL DECANOATE ON 
METHYLPHENIDATE AND APOMORPHINE INDUCED COMPULSIVE 
GNAWING IN MICE. ,g^3^, qj.q^ 

""ff'eCTS°0F DECAPITATION, ETHER AND PENTOBARBITAL ON CYCLIC 

'amp AND CYCLIC GMP LEVELS IN RAT TISSUES. ^^^^^^ ^^^^ 

""coSaTON of L-DOPA, DESIPRAMINE, AND A DECARBOXYLASE 

INHIBITOR IN THE TREATMENT OF DEPRESSION. ^^^^^^ ^^^ 

THE INFLUENCE OF NEUROTROPIC DRUGS ON MONOAMINE OXIDASE 
(MAO) AND 5-OXYTRYPTOPHANE DECARBOXYLASE (5-OTD) ACTIVITY 
IN THE BRAIN. ,83142 03-13 

LEVODOPA COMBINED WITH MK-486 (L-ALPHA- 

METHYLDOPAHYDRAZINE) -- A PERIPHERAL DECARBOXYLASE 
INHIBITOR IN PARKINSONS DISEASE. ^^^^^^ ^^^ ^ 

PARKINSONIAN SYNDROMES: TREATMENT BY ASSOCIATION OF L-DOPA 
PLUS DECARBOXYLASE INHIBITOR. ^^^^^^ ^^ , , 

"'"t'hE^EFf'eCT of L-TRYPTOPHAN (TP) on CUTANEOUS C-FIBER (CFR) AND 
POLYSYNAPTIC (PSR) REFLEXES IN ACUTE DECEREBRATE SPINAL CATS 
AND THE EFFECT OF PRETREATMENT WITH P-CHLOROPHENYLALANINE 
(PCPA) ON THE ACTION OF TP. (UNPUBLISHED PAPER). ^^^^^^ ^^ ^^ 

°^^" HE UPTAKE OF DOPAMINE AND SEROTONIN IN RAT BRAIN DURING 

PROGESTERONE DECLINE. ,71307 01-03 

''''^°RAPKrDKJlTALIZATION OF DECOMPENSATED SCHIZOPHRENIC PATIENTS 
WITH ANTIPSYCHOTIC AGENTS. ^^^^^^ ^^^^ 

DECOMPENSATION 

PHENOTHIAZINE INDUCED DECOMPENSATION. ^^^^^^ ^^^^ 

"""version by APOMORPHINE OF THE TENDENCY OF FEMALE RATS TO 

BE DEFEATED BY MALES WHEN COMPETING FOR FOOD IN A STRAIGHT 
RUNWAY. 184212 03-04 

"""Effect of octoclothepin and perphenazine on behaviour in 

RATS WITH different EXPLORATION AND DEFECATION RATES^^ ^^^^ 

°"^0RAL 5-HTP IN PRIMARY AUTISM WITH 5-HT BINDING DEFEa._^_^^ ^^^^ 

""TdOuVe-BLIND TRIAL OF LONG-TERM LITHIUM THERAPY IN MENTAL 

DEFECTIVES 185193 03-11 

"""pERIENCE IN THE USE OF A LOW DOSAGE OF CARPIPRAMINE 

(DEFEKTON). 176472 02-08 

''"TFFEaS OF DELTA9-TETRAHYDR0CANNABIN0L AND METHYSERGIDE ON 
DEFENSIVE BEHAVIOR IN RATS. ^^^,90 02-04 

NFIIROCHEMICAL ANALYSIS OF AGGRESSIVE - DEFENSIVE BEHAVIOR 
ELICITED BY ELECTRICAL STIMULATION OF THE HYPOTHALAMUS AND 
CENTRAL GRAY MATTER. ^^^ ^g^ q^_q2 

°"7oTlY^MENTAL DEFICIENCY AND SCHIZOPHRENIA. ^^^^^^ ^^^^ 

°"'^BRAIN AMINES IN PYRIDOXINE DEFICIENT RATS. ^^^^^^ ^^^^ 

"" TOST-MORTEM MEASUREMENT OF ENZYMES IN HUMAN BRAIN: 
EVIDENCE OF A CENTRAL NORADRENERGIC DEFICIT IN 
SCHIZOPHRENIA. 191529 04-13 

""mMOR INDUCTION BY INTRACAUDATE INJECTIONS OF BRETYLIUM^ 
TETRABENAZINE, OR MESCALINE: FUNCTIONAL DEFICITS IN CAUDATE 
DOPAMINE ,67329 01-03 

L-DOPA EFFECTS ON MOTOR AND CENTRAL PROGRAMMING DEFICITS IN 
PARKINSONISM. 184976 03-14 



Psychopharmacology Abstracts 



THE NATURE OF STORAGE DEFICITS AND STATE-DEPENDENT RETRIEVAL 
UNDER MARIHUANA. ,89406 04-14 

ENDURING LEARNING DEFICITS AND CEREBRAL SYNAPTIC 

MALFORMATION FROM EXPOSURE TO 10 PARTS OF HALOTHANE PER 
MILLION. ,92565 04-04 

"° ABs"eNCE°OF DEGENERATION OF ADRENERGIC NEURONS AFTER 

PROLONGED TREATMENT WITH DEBRISOQUIN. ^^^^^^ ^^^^ 

"^"^EF^FECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON DELAYED MATCHING- 
TO-SAMPLE CHOICE SPEEDS IN CHIMPANZEES. ^^^^^^ ^^^^ 

EFFECTS OF CHRONIC EXPOSURE TO DELTA9-TETRAHYDR0CANNABIN0L 
ON DELAYED MATCHING-TO-SAMPLE IN CHIMPANZEES. ^^^^^ ^^^^ 

"^"^SCOPOLAMINE EFFECTS ON TWO-TRIAL DELAYED-RESPONSE 

PERFORMANCE IN THE RAT. ,86372 03-04 

"""DfuRIOUS SYNDROME AFTER THE ADMINISTRATION OF HALOPE^RIOOL.^^ 

"^"Importance of the cooperation of families in the treatment of 
thf sick- concerning chronic delirium treated with 

NEURl'fLEPTO AND melancholy TREATED WITH ANTIDEP^RE^S^S^ANTS.^ 

KETAMINE INDUCED POSTANESTHETIC DELIRIUM ATTENUATED BY 

TETRAHYDROAMINOACRIDINE. ^^^^^^ ^^^^ 

"""c'SmRm OF DELIRIUM-TREMENS: A SURVEY OF PHYSICIANS 

PREFERENCES. ,92068 04-11 

"Th'e^FFECT of pain RELIEVING DRUGS ADMINISTERED DURING LABOR 

AND DELIVERY ON THE BEHAVIOR OF THE NEWBORN: A REVIEW. ^_^^^ 

THE FUTURE OF PHARMACOTHERAPY: NEW DRUG DELIVERY ^SYSTE^MS.^^ 

""tHE""ru™"orDaiA°TETRAHYDROCANNABINOL AND 7- 

HYDROXY-DELTAl -TETRAHYDROCANNABINOL IN THE MOUSE BRAIN 
AFTER INTRAVENTRICULAR INJECTION. ^^^^^^ ^^^ 

BLOOD AND BRAIN LEVELS OF DELTAl -TETRAHYDROCANNABINOL IN 

MICE - THE EFFECT OF 7-HYOROXY-DELTAl- 

TETRAHYDROCANNABINOL. ,77333 02-03 

RELATIVE PHARMACOLOGICAL POTENCY IN MICE OF OPTICAL ISOMERS 

OF DELTAl TETRAHYDROCANNABINOL. ^^^^^^ ^^ ^^ 

MECHANISM OF THE NEGATIVE CHRONOTROPIC AND INOTROPIC EFFECTS 
OF DELTAl TETRAHYDROCANNABINOL (DELTAl-THC OR DEaA9-^THa 

THF EFFECTS OF DELTAl -TETRAHYDROCANNABINOL (DELTAl-THC OR 
DELTA9-THC) AND eTHANOL ON MONOSYNAPTIC AND POLYSYNAPTIC 
TRANSMISSION IN THE CENTRAL NERVOUS SYSTEM. ^ ^^^^^ ^_^ ^, 

EFFECTS OF CHRONICALLY ADMINISTERED DELTAl^ ^,,,.,,^^ „. 

TETRAHYDROCANNABINOL OF ADRENAL AND GONADAL ACTIVITY OF 

MALE RATS. 183358 03-0 

RIOCKING OF THE EFFECT OF A DELTAl-TETRAHYDROCANNABINOL 
mELTAl-THC) ON SPONTANEOUS MOTOR ACTIVITY IN THE RAT BY 

Immunization with a protein conjugate of deltai^-thc^ ^^^ 

7 OXO-DELTAl-TETRAHYDROCANNABINOL: A NOVEL METABOLITE OF 
DELTAl -tetrahydrocannabinol. ^^^^^^ ^^^ 

METABOLISM OF DELTAl-TETRAHYDROCANNABINOL BY RATS TOLERAN 
TO MARIHUANA. 192020 04-C 

EFFECTS OF DELTAl-TETRAHYDROCANNABINOL ON SIDMAN 

DISCRIMINATED AVOIDANCE BEHAVIOR IN RATS. ^^^^^^ ^^ ^ 

■"'"mechanism OF THE NEGATIVE CHRONOTROPIC AND INOTROPIC EFFEC 
OF DELTAl-TETRAHYDROCANNABINOL (DELTAl-THC OR DELM9-JHC) 

THF FFFFCTS OF DELTAl-TETRAHYDROCANNABINOL (DELTAl-THC OR 
DELTA9THC) AND ETHANOL ON MONOSYNAPTIC AND POLYSYNAPTK 
TRANSMISSION IN THE CENTRAL NERVOUS SYSTEM. ^^^^^^ ^^ 



S-70 



w^\ 



VOLUME 12, SUBJECT INDEX 



BLOCKING OF THE EFFECT OF A DELTAl-TETRAHYDROCANNABINOL 
(DELTA! -THC) ON SPONTANEOUS MOTOR ACTIVITY IN THE RAT BY 
IMMUNIZATION WITH A PROTEIN CONJUGATE OF DELTAI-THC. 

187129 03-04 
DEITA8-THC 

EFFECTS OF DELTAS-THC AND DELTA9-TETRAHYDR0CANNABIN0L ON THE 
IMMUNE RESPONSE IN MICE. 

CARDIOVASCULAR EFFECTS OF DELTAS-THC AND DELTA9- "*° ^^ °"^ 
TETRAHYDROCANNABINOL IN RATS. 

191971 04-03 
DELTA9-TETRAHYDROCANNABINOL 

THE EFFECTS OF CHRONIC TREATMENT WITH DELTA9- 
TETRAHYDROCANNABINOL ON CATECHOLAMINE SYNTHESIS IN THE 
RAT. 

PHARMACOLOGICAL INTERACTION BETWEEN CANNABIDIOL AND DELTA9- 
TETRAHYDROCANNABINOL. 

EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON DELAYED MATCHING 
TO-SAMPLE CHOICE SPEEDS IN CHIMPANZEES. 

DELTA9-TETRAHYDR0CANNABIN0L INDUCED INHIBITION OF PREDATORY 
AGGRESSION IN THE RAT. 

INTERACTIONS IN MAN OF DELTA9-TETRAHYDR0CANNABIN0L- I ALPHA- 
METHYL-PARA-TYROSINE. ' ' 

A STUDY OF THE RELATIVE ANTICONVULSANT AND TOXIC ACTIVITIES OF 
DELTA9-TETRAHYDR0CANNABIN0L AND ITS CONGENERS. 

TOXICOLOGY OF DELTA9-TETRAHY0R0CANNABIN0L (PH D ''""^°^ °''°^ 
DISSERTATION). 

CARDIOVASCULAR PHARMACOLOGY OF DELTA9- ^^''''^^ °''°^ 

TETRAHYDROCANNABINOL. (PH.D. DISSERTATION). 

A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY IN MAn'oF °'"°^ 

r^M.yi,':!?,^^'-^ ADMINISTERED DELTA9-TETRAHYDR0CANNABIN0L 
CANNABINOL, AND CANNABIDIOL. 

CHRONOPHARMACOLOGY OF DELTA9-TETRAHYDR0CANNABIN0l''^ ^^ "^ 
HYPOTHERMIA IN MICE. 

EFFECT OF ORAL ADMINISTRATION OF DELTA9- '^'^^^° °^"°^ 

TETRAHYDROCANNABINOL ON MEMORY, SPEECH AND PERCEPTION 
OF THERMAL STIMULATION: RESULTS WITH FOUR NORMAL HUMAN 
VOLUNTEER SUBJECTS. PRELIMINARY REPORT. 

'"^ol^.l"-.^^'^^'^^^ ™^ ^ ''O'-E OF 2-PHENYLETHYLAMINE IN^HE IwODe'^ 

OF ACTION OF DELTA9-TETRAHYDR0CANNABIN0L. 

1 79992 02-03 
INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L AND CANNABIDIOL 

ON INTESTINAL MOTILITY IN MICE. ^«in™mdiuiul 

SUBCELLULAR DISTRIBUTION OF DELTA9-TETRAHYDR0CANNABIN0L IN°^ 
RAT BRAIN. 

ELECTROENCEPHALOGRAPHIC EFFECTS OF DELTA9- '^'^'° °^"°^ 

TETRAHYDROCANNABINOL, LSD-25, MESCALINE AND 2 5 DIMETHOXY- 
4-METHYLAMPHETAMINE IN THE RABBITS. 

182095 02-03 
EFFECTS OF PSYCHOTROPIC DRUGS ON ABNORMAL BEHAVIOR INDUCED 
BY DELTA9-TETRAHYDR0CANNABIN0L. 

EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON THE DOMINANCE 

BEHAVIOR OF THE RAT. 

1 fl9 1 ftp n9 C\A 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L AND METHYSERGIDE ON 

DEFENSIVE BEHAVIOR IN RATS 

DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) DOSE EFFECTS 

D?o^on?.^?.,5? ^^"^^ SCHEDULES OF FOOD REINFORCED OPERANT 
PERFORMANCE. 

INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) 
CAFFEINE, (C), NICOTINE (N), PHENOBARBITAL (P)- EFFECTS ON ' 
CONDITIONED AVOIDANCE (CAR). 

IRQ 10*7 CiO f\A 

THE INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L (THC) 

cvcl?.^*^.^'^*"- *^^ SKF-525-A WITH THE CARDIOVASCULAR 
irSTEM OF THE RAT, 

1 899 1 ft D*^ m 
HYPOTHERMIC ACTION OF DELTA9-TETRAHYDR0CANNABIN0L 11-OH- 
DELTA9-TETRAHYDR0CANNABIN0L AND 1 1-0H-DELTA8- 
IZ'^lZ^cZTa' '''''''■'''' "-0H-DELTA9-THC AND 1 1- 

182220 03-03 



Subject Index 

ANTIPYRETIC, ANALGESIC AND ANTIINFLAMMATORY ACTIVITY OF 
DELTA9-TETRAHYDR0CANNABIN0L IN THE RAT. 

A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY OF DiUM- ^^ °^ 
TETRAHYDROCANNABINOL AND ITS MONOHYDROXYLATED 
METABOLITES IN MAN 

1 ft997T O'X m 

DELTA9-TETRAHYDR0CANNABIN0L IN DEPRESSED PATIENTS 

EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON THE METABOLISM OF 
3H-5-HYDROXYTRYPTAMINE AND 3H.N0REPINEPHRINE IN THE RAT 
BRAIN. 

1 fi'?7ft7 m fT^ 
CANNABIDIOL INTERACTION WITH DELTA9-TETRAHYDR0CANNABIN0L. 

ROLE OF THE CENTRAL AUTONOMIC NERVOUS SYSTEM IN THE 
HYPOTENSION AND BRADYCARDIA INDUCED BY ( ) DELTA9. 
TETRAHYDROCANNABINOL. 

DELTA9-TETRAHYDR0CANNABIN0L AND 1 1 ■HYDR0XY-DELTA9- 

TETRAHYDROCANNABINOL: BEHAVIORAL EFFECTS AND TOLERANCE 
DEVELOPMENT. 

1 ft'^PQ'^ m c\A 
TEMPORALLY RELATED STIMULUS PROPERTIES OF DELTA9- 
TETRAHYDROCANNABINOL IN MONKEYS. 

EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON BODYWEIGHT AND 
BRAIN ELECTROLYTES IN THE CHICKEN. 

ANALGESIC EFFECT OF DELTA9-TETRAHYDR0CANNABIN0L IN THE DOg" 

EFFECTS OF ORAL DELTA9-TETRAHYDR0CANNABIN0L ON OPERANT 
REINFORCEMENT SCHEDULE PERFORMANCE IN RATS. 

EFFECT OF SKF-525-A ON THE METABOLISM OF {-) DELTA9- ^^"^ 

TETRAHYDROCANNABINOL IN THE RAT BRAIN AND LIVER 

EVALUATION OF REINFORCING CAPABILITY OF DELTA9- ^^ °'^ 

TETRAHYDROCANNABINOL IN RHESUS MONKEYS. 

DELTA9-TETRAHYDR0CANNABIN0L: EFFECTS OF ROUTE OF 
ADMINISTRATION ON ONSET AND DURATION OF ACTIVITY AND 
TOLERANCE DEVELOPMENT 

THE EFFECT OF DELTA9TETRAHYDR0CANNABIN0L ON SLEEP 

LONG-TERM USE OF MARIHUANA AND THE DEVELOPMENT OF 

TOLERANCE OR SENSITIVITY TO DELTA9-TETRAHYDR0CANNABm0L. 

PHYSIOCHEMICAL PROPERTIES, SOLUBILITY, AND PROTEIN BINDING ot'"' 
DELTA9-TETRAHYDR0CANNABIN0L. (UNPUBLISHED PAPER) 

ORAL AND INTRAVENOUS TOXICITY OF DELTA9- '^^^^"^ °'''°' 

TETRAHYDROCANNABINOL IN RHESUS MONKEYS 

lftftft79 r\A n^ 
INFLUENCE ON ACUTE PRETREATMENT WITH DEL1A9- 

TETRAHYDROCANNABINOL OF THE LD50 OF VARIOUS SUBSTANCES 

THAT ALTER NEUROHUMORAL TRANSMISSION 

EFFECTS OF CHRONIC EXPOSURE TO DELTA9-TETRAHYDR0CANNABIN0L 
ON DELAYED MATCHING-TO-SAMPLE IN CHIMPANZEES 

DELTA9-TETRAHYDR0CANNABIN0L AND AGGRESSIVE BEHAVIOR IN 
RATS. 

INHALATION, PARENTERAL AND ORAL LD50 VALUES OF DELTA9- 
TETRAHYDROCANNABINOL IN FISCHER RATS. 

EFFECTS OF PHENOBARBITAL AND SKF-525-A PRETREATMENT SEX LIVER 
INJURY, AND VEHICLE ON DELTA9-TETRAHYDR0CANNABIN0L ' 

I UAIL NY. 

EFFECTS OF DELTAS-THC AND DELTA9-TETRAHYDR0CANNABIN0L ON THE 
IMMUNE RESPONSE IN MICE. 

THE INFLUENCE OF DELTA9-TETRAHYDR0CANNABIN0L (THC) ON 
PILOCARPINE (PILO) INDUCED PAROTID SECRETIONS OF THE RAT 

RETARDATION OF lUMOR GROWTH BY DELTA9- 

TETRAHYDROCANNABINOL (DELTA9-THC) 

191963 04-03 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9.THC) 

ADMINISTERED SUBCUTANEOUSLY TO RABBITS FOR 28 DAYS. 

COMPREHENSIVE BEHAVIORAL ASSESSMENT OF THE EFFECTS OF DiUM 
TETRAHYDROCANNABINOL IN RATS. 

191966 04-04 



S-71 



Subject Index 

rOMPARATIVE EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9- 
THcTSnNABIDIOl (CBD), AND CANNABINOL (CBN) ON TIMING 
BEHAVIOR IN RATS. ,,,9^7 Q4.O4 

CARDIOVASCULAR EFFECTS OF DELTA8-THC AND DELTA9- 

TETRAHYDROCANNABINOL IN RATS. ^^^^^^ ^^^^ 

MPiipnPHARMACOLOGICAL ANALYSIS OF CENTRAL ADRENERGIC AND 
'^^HOLiNfRGIC ANTAGONISM OF DELTA9-TETRAHYDR0CANNABIN0L ^^ 

DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) IMIPRAMINE 

INTERACTION ON MOUSE BODY TEMPERATURE. ^^^^^^ ^^^^ 

ANALYSIS OF HYPOTHERMIC ACTION OF DELTA9- 

TETRAHYDROCANNABINOL (DELTA9-THC) IN MICE. ^^^^^^ ^^^^ 

""EF^a'^S OF DELTA9-THC, LSD-25 AND SCOPOLAMINE ON CONTINUOUS, 

SPONTANEOUS ALTERNATION IN THE Y-MAZE. ^^^^^^ ^^^ 

(-)DELTA9-THC AS AN HYPNOTX: AN EXPERIMENTAL STUDY OF THREE 
DOSE LEVELS. ,^404, 0M4 

EFFECTS OF (-)DELTA9.TRANS-TETRAHYDR0CANNAB1N0L (DELTA'-^rHC) 
ON MEMORY, ATTENTION AND SUBJECTIVE STATE: A DOUBLE-BLIND 
STUDY. 174043 01-14 

OPEN-FIELD BEHAVIOR AND ACQUISITION OF DISCRIMINATIVE RESPONSE 
CONTROL IN DELTA9-THC TOLERANT RATS. ^_^^^^^ ^^^ 

DELTA9TETRAHYDR0CANNABIN0L (DELTA9-THC) DOSE EFfECTS 
COMPARED ON THREE SCHEDULES OF FOOD REINFORCED OPERANT 
PERFORMANCE. ,32,9, o2-04 

INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC), 
CAFFEINE, (C), NICOTINE (N). PHENOBARBITAL (P): EFFECTS ON 
CONDITIONED AVOIDANCE (CAR). ^^^^^^ o2-04 

MECHANISM OF THE NEGATIVE CHRONOTROPIC AND INOTROPIC EFFECTS 
OF DELTAl -TETRAHYDROCANNABINOL (DELTAl-THC OR DEUA9-JHa^ 

HYPOTHERMIC ACTION OF DELTA9-TETRAHYDR0CANNABIN0L, 11-OH- 
DELTA9-TETRAHYDP-0CANNABIN0L AND 1 1 -0H-DELTA8- 
?ETRAHYDR0CANNABIN0L (DELTA9-THC, 1 1-0H-DELTA9-THC AND 11- 
0H-DELTA8-THC) IN MICE. 182220 03-03 

THF EFFECTS OF DELTAl -TETRAHYDROCANNABINOL (DELTAl-THC OR 
DELtS-THC) AND ETHANOL ON MONOSYNAPTIC AND POLYSYNAPTIC 
TRANSMISSION IN THE CENTRAL NERVOUS SYSTEM. ^^^^^^ ^^^^ 

AUTOMATIC DETERMINATION OF THE PAIN THRESHOLD TO 

ELECTROSHOCK AND THE EFFECTS OF DELTA9-THC. ^^^^^^ ^^^^ 

EFFECTS OF DELTA9-THC ON FOOD AND WATER INTAKE OF DEPRIVATION 
EXPERIENCED RATS. 191375 04-04 

RETARDATION OF TUMOR GROWTH BY DELTA9- 

TETRAHYDROCANNABINOL (DELTA9-THC). ^^^^^^ ^^^^ 

THE EFFECTS OF DELTA9-THC AND A WATER SOLUBLE DERIVATIVE ON 
PGEt SYNTHESIS IN THE CORPUS-STRIATUM. ^^^^^^ ^^^^ 

EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9^THC) 

ADMINISTERED SUBCUTANEOUSLY TO RABBITS FOR 28 DAYS^^^ ^^^^ 

COMPARATIVE EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9- 
THcf CANNABIDIOL (CBD), AND CANNABINOL (CBN) ON TIMING 
BEHAVIOR IN RATS. ,9,9^^ Q4.Q4 

DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) IMIPRAMINE 

INTERACTION ON MOUSE BODY TEMPERATURE ^^^^^^ ^^^^ 

ANALYSIS OF HYPOTHERMIC ACTION OF DELTA9- 

TETRAHYDROCANNABINOL (DELTA9-THC) IN MICE. ^^^^^^ ^^^^ 

"on MEMORY ATTENTION AND SUBJECTIVE STATE: A DOUBLE-BLIND 
STUDY. 174043 01-14 

EFFECTS OF (.)DELTA9-TRANS-TETRAHYDR0CANNABIN0L IN SEVERAL 
ANIMAL MODELS OF AGGRESSION. ^^^igs 02-04 

cfCfrT"; Of ( ) DELTA9-TRANS-TETRAHYDR0CANNABIN0L ON SOCIAL 

"behavior OF SQUIRREL MONKEY DYADS IN A WATER COMPETITION 
SITUATION. ,87640 04-04 



Psychopharmacology Abstracts 



"'"tEMPORAL^ISORGANIZATION AND DELUSIONAL-LIKE IDEATION: 

PROCESSES INDUCED BY HASHISH AND ALCOHOL. ^^^^^^ ^^^^ 

"^^tp^FECTS OF TWO LEVELS OF ATTENTION DEMAND ON VIGILANCE 

PERFORMANCE UNDER MARIHUANA. ^^^^^^ ^^^^ 

DIAZEPAM ON DEMAND: DRUG SEEKING BEHAVIOR IN PSYCHIATRIC 
INPATIENTS. 189924 04-17 

"^''t^VODOPA INDUCED DYSKINESIAS: COMPARISON IN PARKINSONISM 

DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS. ^^^^^^ ^^^^ 

PARKINSONISM DEMENTIA OF GUAM: TREATMENT WITH LEVODOPA 
AND L-ALPHA-METHYLDOPAHYDRAZINE. ^^^^^ ^^^^ 

""'"oEME^nMION OF N,N DIMETHYLAMPHETAMINES - EVIDENCE FOR A 

MULTIENZYME SYSTEM. ^^^923 q^ Q3 

"'^HYDROCORTISONE INDUCED INCREASE IN THE HISTOCHEMICALLY 
DEMONSTRABLE CATECHOLAMINE CONTENT OF SYMPATHETIC 
NEURONS OF THE NEWBORN RAT. ^^^^^7 04-03 

DENERVATED^ DIVALENT CATIONS ON ACH CONTRACTURES OF 

DEPOLARIZED DENERVATED RAT MUSCLES. ^ ^^^^ ^ ^^^^ 

"''ISrE^'nALINE in the GUINEA-PIG ALIMENTARY CANAL: REGIONAL 
'°DIS?RrTION AND SENSITIVITY TO DENERVATION AND RESERHN^E^ ^^ 

"" QUaStIVE DETERMINATION OF IMIPRAMINE AND DESIPRAMINE IN 
HUMAN BLOOD PLASMA BY DIRECT DENSITOMETRY OF THIN-LAYER 
CHROMATOGRAMS. 183603 03-13 

'''° InTluS OF VARIOUS SUBSTANCES WHICH INDUCE AND INHIBIT 
AG(^REGAT10N ON THE UPTAKE OF DEOXYGLUCOSE BY HUMAN 
BLOOD PLATELETS. 191770 04-13 

"' WMPLEMENTAL PHARMACOLOGICAL STUDY OF DI-N-PROPYLACETAMIDE 

ORDEPAMIDE. 180722 02-07 

A SUMMARY OF THE CLINICAL DOSSIER ON DEPAMIDE. ^^^^^^ ^^^^ 

"""pOLmTALGIA RHEUMATICA IN A GERIATRIC DEPARTMENT: NINE 

PATIENTS WITH AN AVERAGE AGE OF 83 YEARS. ^^^^^^ ^^^^ 

°^"nf°JfmPMFNT OF PHYSICAL DEPENDENCE ON MORPHINE IN RESPECT TO 
"'l^^MfAND DOSAGE AND QUANTIFICATION OF THE PRECIPITATED 
WITHDRAWAL SYNDROME IN RATS, ^^^^^^ ^^^. 

ABUSE POTENTIAL OF ETORPHINE (M99) I. SUBJECTIVE EFFECTS AND 
PHYSICAL DEPENDENCE. (UNPUBLISHED PAPER). ^^^^^^ ^^^ 

HYDROXYLAMINE INTERFERES WITH THE BEHAVIORAL RESPONSE TO 
MORPHINE DEPENDENCE IN MICE. ^^^^^^ ^^ ^ 

CHRONIC HYPNOTIC DRUG USE: INEFFECTIVENESS, DRUG WITHDRAWAL 
INSOMNIA, AND DEPENDENCE. ^^21,4 oi-l 

DEPENDENCE OF ANTICONVULSANT DRUG ACTION ON CENTRAL 

MONOAMINES. 172923 01-C 

MORPHINE PHYSICAL DEPENDENCE UNALTERED BY PREVIOUS 

DEPENDENCE ON MORPHINE. ^ ^^^^^ q, ^ 

DEPENDENCE LIABILITY OF SEVERAL SEDATIVE HYPNOTIC AGENTS 

EVALUATED IN MONKEYS. ^^^,25 01-( 

BARBITURATE DEPENDENCE IN MICE INDUCED BY A SIMPLE SHORT-TER 

ORAL PROCEDURE. 175895 02-1 

ATTEMPT TO EVALUATE THE PHYSICAL DEPENDENCE LIABILITY OF 

PSYCHOTROPIC DRUGS IN MICE. ^^^103 02- 

DRUG DEPENDENCE TEST OF PHENOBARBITAL AND MORPHINE IN RATS 

BY SPONTANEOUS INTAKE. ^g2l04 02- 



S-72 



VOLUME 12, SUBJECT INDEX 



SEPARATION OF THE DEPENDENCE PRODUCING ACTIONS FROM THE 
DIRECT ACTIONS OF NARCOTICS ON GUINEA-PIG ILEUM. 

182162 02-03 
EFFECT OF GAMMA-AMINOBUTYRIC ACID (GABA) ON MORPHINE 
ANALGESIA, TOLERANCE AND PHYSICAL DEPENDENCE. 

182231 03-03 
A COMPARISON OF THE EFFECTS OF CHRONIC ADMINISTRATION OF 
ETHANOL AND ACETALDEHYDE TO MICE: EVIDENCE FOR A ROLE OF 
ACETALDEHYDE IN ETHANOL DEPENDENCE 

185992 03-03 
AN EXPERIMENTAL INVESTIGATION OF DEPENDENCE LIABILITY OF 
METHAQUALONE IN RATS. 

186569 03-03 
MORPHINE PHYSICAL DEPENDENCE IN THE DOG. 

186665 03-03 
THE EFFECTS OF P-CHLOROPHENYLALANINE ON MORPHINE ANALGESIA 
TOLERANCE AND DEPENDENCE DEVELOPMENT IN TWO STRAINS OF 
RATS. 

187930 04-04 
INVESTIGATION OF PHYSICAL DEPENDENCE ON A NEW BENZODIAZEPINE 
DERIVATIVE, BROMAZEPAM. 

189209 04-05 
AFFECTIVE DISORDERS AND CHEMICAL DEPENDENCE: LITHIUM FOR 
ALCOHOL AND DRUG ADDICTION 

189775 04-09 
EFFECT OF L-PHENYL-3-2-THIAZOLYL 2-THIOUREA, A DOPAMINE-BETA- 
HYDROXYLASE INHIBITOR. ON MORPHINE ANALGESIA, TOLERANCE 
AND PHYSICAL DEPENDENCE. 

191769 04-03 
COMPARISON OF BARBITAL & PENTOBARBITAL PHYSICAL DEPENDENCE 
IN THE CAT. 

191953 04-04 
MORPHINE TOLERANCE, DEPENDENCE AND WITHDRAWAL AND BRAIN 
ACETYLCHOLINE. 

191985 04-03 
DEPENDENT 

TEMPERATURE DEPENDENT TOXICITY OF ADRENERGIC AGONISTS IN MICE 
AS A BASIS FOR TREATING D-AMPHETAMINE POISONING. 

CHANGES IN THE NEUROEXCITABILITY OF ALCOHOL DEPENDENT RATS 
UNDERGOING WITHDRAWAL AS MEASURED BY THE 
PENTYLENETETRAZOL SEIZURE THRESHOLD. 

SUBSTITUTED PIPERAZINOQUINAZOLONES: RELATIONSHIP BETWEEN 
SELECTIVE INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE 
DEPENDENT OXIDATIONS AND ANTICONVULSANT ACTIVITY. 

183598 03 02 
SUBSTITUTED BENZOXAZOLE/BENZTHIAZOLE-2-THIONES- 
INTERRELATIONSHIP BETWEEN ANTICONVULSANT ACTIVITY AND 
INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT 
OXIDATIONS AND MONOAMINE OXIDASE. 

183601 03-03 
THE STANDARDIZED VIDEOTAPE INTERVIEW AS AN OBJECTIVE 
DEPENDENT VARIABLE IN PSYCHOTROPIC DRUG RESEARCH. 

183635 03-17 
CHOLINERGIC MODIFICATION OF NALOXONE INDUCED JUMPING IN 
MORPHINE DEPENDENT MICE. 

184179 03-03 
DOSE DEPENDENT SELECTIVE FACILITATION OF RESPONSE CONTINGENT 
LIGHT ONSET BEHAVIOR BY D-AMPHETAMINE. 

DOSE DEPENDENT POTENTIATION OR INHIBITION BY RO-4-4602 OF 5-HTP 

HYPERTHERMIA IN RABBITS. 

18S99A 01-01 
METRAZOL DISRUPTS CONDITIONED AVERSION PRODUCED BY LICL A 

TIME DEPENDENT EFFECT. 

188412 04-04 
POTENTIAL INHIBITORS OF S-ADENOSYLMETHIONINE DEPENDENT 
METHYLTRANSFERASES: 1. MODIFICATION OF THE AMINO ACID 
PORTION OF S-ADENOSYLHOMOCYSTEINE. 

POTENTIAL INHIBITORS OF S-ADENOSYLMETHIONINE DEPENDENT 
METHYLTRANSFERASES. 2. MODIFICATION OF THE BASE PORTION OF 
S-ADENOSYLHOMOCYSTEINE 
«PUTED 190717 04-01 

EFFECT OF 3,4 DIMETHOXYPHENETHYLAMINE ON MONOAMINE DEPLETED 
RATS. 

ENHANCED BINDING OF CHLORPROMAZINE TO CHOLESTEROL DEPLETED 
SYNAPTOSOME FRACTIONS. 

„,,„ 18780104-03 

SELF-STIMULATION AND CATECHOLAMINES: DRUG-INDUCED 

MOBILIZATION OF THE RESERVE POOL RE-ESTABLISHES RESPONDING 

IN CATECHOLAMINE DEPLETED RATS. 

189025 04-04 



Subject Index 



DEPLETING 

EFFECTS OF CATECHOLAMINE DEPLETING DRUGS AND AMPHETAMINE ON 
SELF-STIMULATION OF BRAIN FOLLOWING VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS. 

DIHYDROPTERIDINE REDUCTASE IN RAT BRAIN: REGIONAL DISTRIBUTION 

AND THE EFFECT OF CATECHOLAMINE DEPLETING DRUGS 
DEPLETION 189752 04-03 

ANTAGONISM OF P-CHLOROAMPHETAMINE (PCA) INDUCED DEPLETION 

OF 5-HT FROM RAT BRAIN BY SOME THYMOLEPTICS AND OTHER 

PSYCHOTROPIC DRUGS. 

171 A9R m m 
QUANTITATIVE HISTOCHEMICAL STUDIES OF STRIATAL DOPAMINE 

DEPLETION FOLLOWING DL-ALPHA-METHYL-P-TYROSINE 

ADMINISTRATION. 

172924 01-03 
BRAIN BIOGENIC AMINE DEPLETION AND MOOD 

174994 02-14 
BEHAVIORAL EFFECTS OF SIMULTANEOUS DEPLETION OF BRAIN 
NOREPINEPHRINE AND SEROTONIN. 

iftQOi 1 m f\A 
TESTS OF EMOTIONAL BEHAVIOR IN RATS FOLLOWING DEPLETION OF 
NOREPINEPHRINE, OF SEROTONIN, OR OF BOTH. 

185753 03-04 
LEARNING IMPAIRMENT IN RATS AFTER 6-HYDROXYDOPAMINE INDUCED 
DEPLETION OF BRAIN CATECHOLAMINES 

187420 04-04 
DEPLETION OF TRYPTOPHAN HYDROXYLASE BY 5 6 

DIHYDROXYTRYPTAMINE IN RAT BRAIN - TIME COURSE AND 
REGIONAL DIFFERENCES. 

188287 04-03 
DEPOLARIZED 

EFFECT OF DIVALENT CATIONS ON ACH CONTRACTURES OF 
DEPOLARIZED DENERVATED RAT MUSCLES 

188914 04-03 
DEPOLARIZING 

ON THE MECHANISM OF RELEASE OF NOREPINEPHRINE FROM 

SYMPATHETIC NERVES INDUCED BY DEPOLARIZING AGENTS AND 

SYMPATHOMIMETIC DRUGS. (UNPUBLISHED PAPER). 

187397 04-03 
DEPOSITION 

THE INFLUENCE OF ALDOSTERONE OR METHAMPHETAMINE ON LIVER 
GLYCOGEN DEPOSITION OF MICE STRESSED BY LONG-TERM 
ISOLATION. 

.».»«, 182105 02-03 

DEPOT 

ANTIPARKINSONIAN AGENTS AND DEPOT PHENOTHIAZINE 

PROGRESS REPORT ON THE USE OF THE DOG FOR ASSESSING MORPHINE- 
LIKE AND NALORPHINE-LIKE AGONISTS AS WELL AS DEPOT 
PREPARATIONS OF ANTAGONISTS. (UNPUBLISHED PAPER). 

176312 02-03 

A PSYCHIATRIC CLINIC FOR DEPOT PHENOTHIAZINES 

181192 02-08 
SIDE-EFFECTS OF DEPOT FLUPHENAZINES. 

188312 04-15 
DEPRESSANT 

THE SPIRAL AFTEREFFECT (SAE) AS A MEASURE OF MOTION SICKNESS 
SUSCEPTIBILITY AND THE EFFECT ON THE SAE OF AN ANTIMOTION 
SICKNESS DRUG AND A CENTRAL NERVOUS SYSTEM DEPRESSANT. 

, ^ 172780 01-03 

EXCITANT AND DEPRESSANT DRUGS MODULATE EFFECTS OF 
ENVIRONMENT ON BRAIN WEIGHT AND CHOLINESTERASES. 

174036 01-03 

ANTIHYPERTENSIVE AND CENTRAL NERVOUS SYSTEM DEPRESSANT 
PROPERTIES OF 3-(GAMMA-P-FLU0R0BENZ0YLPR0PYL) 2 3 4 4A 5 6 
HEXAHYDROPYRAZINOQUINOLINE HYDROCHLORIDE (COMPOUND-69- 
183, CENTPYRAQUIN). 

1 7Afift 1 (19 m 
INTERACTION OF CYCLIC AMP WITH NEUROPHARMACOLOGIC 
DEPRESSANT AGENTS. 

182155 02-03 
CENTRAL NERVOUS DEPRESSANT XV: SYNTHESIS AND 

PHARMACOLOGICAL SCREENING OF SOME TRIMETHOXYAZLACTONES. 

182828 03-02 
MODIFICATION OF LEARNING AND MEMORY IN GOLDFISH THROUGH THE 
USE OF STIMULANT AND DEPRESSANT DRUGS 

^ 186583 0304 

DEPRESSANTS 

SELECTIVE ANTAGONISM OF CENTRAL NERVOUS SYSTEM DEPRESSANTS 
BY DH-524; A COMPARATIVE STUDY WITH BEMEGRIDE. 

171007 01-13 

INTERACTION OF D-AMPHETAMINE WITH CENTRAL NERVOUS SYSTEM 
DEPRESSANTS ON FOOD INTAKE AND SPONTANEOUS MOTOR 
ACTIVITY OF MICE. 

189613 04-04 



S-73 



Subject Index 



Psychopharmacology Abstracts 



""the WMPUTER ANALYZES TWO PSYCHOTHERAPEUTIC AGENTS IN 

ANXIETY/DEPRESSED STATES. ^^^^^^ ^^^^ 

A DOUBLE-BLIND, COMPARATIVE CLINICAL TRIAL WITH LUDIOMIL (CIBA- 
34276 BA) AND AMITRIPTYLINE IN NEWLY ADMITTED DEPRESSED 
PATIENTS. 167774 01-09 

DRUG TREATMENT OF DEPRESSED PATIENTS REFERRED FOR 

HOSPITALIZATION. ,^^^21 01-09 

AMITRIPTYLINE IN ANXIOUS DEPRESSED OUTPATIENTS: A CONTROLLED 
STUDY. 172993 01-10 

EFFECTS OF AMITRIPTYLINE AND IMIPRAMINE ON AMINE METABOLITES 
IN THE CEREBROSPINAL FLUID OF DEPRESSED PATIENTS. ^^^^^^ ^^^^ 

AMOXAPINE AND IMIPRAMINE: A DOUBLE-BLIND STUDY IN DEPRESSED 

PATIENTS. 174138 01-09 

GER0VITAL-H3 IN THE TREATMENT OF THE DEPRESSED ^GING PATIENT.^ ^ 

DIFFERENTIAL EFFECTS OF D- AND L-AMPHETAMINE ON THE SLEEP OF 
DEPRESSED PSYCHIATRIC PATIENTS ON AND OFF LITHIUM CARBONATE 
TREATMENT. (UNPUBLISHED PAPER). ^^^^^^ o2-09 

HIGH FREQUENCY OF DYSPHORIC REACTIONS TO 

TETRAHYDROCANNABINOL AMONG DEPRESSED PATIENTS.^^^^^^ ^^^^ 

INDICATIONS FOR ANTIDEPRESSANT TREATMENT WITH SPECIAL 
REFERENCE TO DEPRESSED PRESCHOOL CHILDREN. ^^^^^^ ^^^^ 

DELTA9-TETRAHYDR0CANNABIN0L IN DEPRESSED PATIENTS. 

183546 OJ-IU 
THE EFFECTS OF COCAINE ON DEPRESSED PATIENTS. ^^^^^^ ^^^ 

TREATMENT EFFECTS ON THE SOCIAL ADJUSTMENT OF DEPRESSED 
PATIENTS. ,35322 03.1O 

CLOMIPRAMINE AND AMITRIPTYLINE IN DEPRESSED OUTPATIENTS: A 
CONTROLLED STUDY. ^^^^^^ ^3 q, 

STUDIES OF CEREBROSPINAL FLUID AMINE METABOLITES IN DEPRESSED 
PATIENTS- CONCEPTUAL PROBLEMS AND THEORETICAL IMPLICATIONS. 
(UNPUBLISHED PAPER). ,87398 04-13 

THE EFFECT OF ORALLY ADMINISTERED COCAINE ON SLEEP OF 

DEPRESSED PATIENTS. ,^^^^2 04-14 

THE EFFECT OF TRANYLCYPROMINE (PARNATE) ON EYELID CONDITIONING 

■ AND PAIRED ASSOCIATE LEARNING IN DEPRESSED P^TIENTS^^^^ ^^^ 

AFFECTIVE STATE AND THYROTROPIN AND PROLACTIN RESPONSES 
AFTER REPEATED INJECTIONS OF THYROTROPIN RELEASING HORMONE 
IN DEPRESSED PATIENTS, ,89076 04-09 

DIFFERENTIAL EFFECTS OF TRAZODONE IN DEPRESSED, SCHIZOPHRENIC 
AND GERIATRIC PATIENTS. ,9,, 38 04-14 

THIORIDAZINE IN NEUROTIC, ANXIOUS, AND DEPRESSED PATIENJ-^S_^ ^^^^ 

""cHLORDIAZEPOXIDE AND DOTHIEPIN COMPARED IN 

ANXIETY/DEPRESSION IN GENERAL PRACTICE. ^^^^^^ ^^^^ 

THE ROLE OF DOPAMINE IN DEPRESSION. ^^^^^^ ^^^^ 

A CONTROLLED STUDY OF SINGLE DOSE ADMINISTRATION OF 

IMIPRAMINE PAMOATE IN ENDOGENOUS DEPRESSION. ^^^^^^ ^^^^ 

CLINICAL EFFECTS OF LITHIUM CARBONATE ON DEPRESSION^^^^^^ ^^^^ 

PENTOBARBITAL: SELECTIVE DEPRESSION OF EXCITATORY POSTSYNAPTIC 

POTENTIALS. ,68485 01-03 

INFLUENCE OF AMYLOBARBITONE ON OPERANT DEPRESSION AND 

ELATION EFFECTS IN THE RAT. ,68834 01-04 

LONG-TERM TREATMENT OF DEPRESSION WITH DRUGS AND 

PSYCHOTHERAPY. ,69087 01-09 

THE HETEROGENEITY OF DEPRESSION. ^^^^^^ ^^^^ 

TOWARDS A BIOCHEMICAL TYPOLOGY OF DEPRESSION. ^^^^^^ ^^^^ 

COMBINATION OF L-DOPA, DESIPRAMINE, AND A DECARBOXYLASE 
INHIBITOR IN THE TREATMENT OF DEPRESSION. ^^^^^^ ^^ ^^ 



THE TREATMENT OF DEPRESSION WITH A SINGLE DAILY DOSE OF 

IMIPRAMINE PAMOATE. ^^^^^, ^^^ 

A DOUBLE-BUND CLINICAL TRIAL OF DOXEPIN HYDROCHLORIDE AND 
DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION 
IN THE FIELD OF INTERNAL MEDICINE. ^^^^^^ ^^^^ 

DEPRESSION SUBTYPES AND RESPONSE TO PHENELZINE. DIAZEPAM, AND 
A pTaCEBO RESULTS OF A NINE HOSPITAL ^OLLABORATIVE^STUDY. ^^ 

TREATMENT OF DEPRESSION BY DRUGS AND PSYCHOTHERAPY^^^^ ^^^^ 

DRUGS AND GROUP PSYCHOTHERAPY IN NEUROTIC DEPRESSION.^^ ^^^^ 

ELECTROLYTES IN CEREBROSPINAL FLUID IN ENDOGENOUS '^[P^^^^'OI^q, 

METHYLTESTOSTERONE WITH IMIPRAMINE IN MEN: CONVERSION OF 
DEPRESSION TO PARANOID REACTION. ^^^^^^ ^^^^ 

CNS DEPRESSION IN THE ABSENCE OF PROLACTIN RELEASE FOLLOWING 
INTRAARTERIAL INJECTIONS OF SODIUM PENTOTHAL IN THE 
PROESTROUS RAT, ,73257 01-03 

CLINICAL RESULTS WITH PIZOTYLINE IN DEPRESSION. ^^^^^^ ^^^^ 

RAPID AND GENTLE PHARMACOTHERAPY OF DEPRESSION. ^^^^^^ ^^^^ 
PIPRADROL IN MILD DEPRESSION: A CONTROLLED STUDY. ^^^^^^ ^^^^ 

EXPERIENCE IN THE USE OF SINEQUAN (DOXEPIN HYDROCHLORIDE) IN 
TREATMENT OF NEUROSIS, DEPRESSION AND DEPI^ESSIVE STATES^^^^ 

INDUCTION OF SEVERE DEPRESSION BY PHYSOSTIGMINE IN MARIJUANA 
INTOXICATED INDIVIDUALS. ^^^^^^ ^^^^ 

MOTHER INFANT SEPARATION: BEHAVIORAL ANALYSIS OF AN ANIMAL 
MODEL OF DEPRESSION. (PH.D. DISSERTATION). ^^^^^^ ^^^^ 

EXPERIMENTAL DEPRESSION CAUSED BY APOMORPHINE AND 

PHENOHARMANE. ,80062 02-1 C 

DIAGNOSIS AND MANAGEMENT OF DEPRESSION IN GENERAL PRACTICE^^ 
DOUBLE-BLIND COMPARATIVE STUDY OF HF-1972/N0VERIL IN 

DEPRESSION. ,80986 02-l( 

A TRIAL OF GER0VITAL-H3 IN DEPRESSION DURING SENILITY.^^^^^ ^^^^ 
DRUG THERAPY FOR DEPRESSION IN CHILDREN. INDICATIONS AND 

METHODS. ,82429 03-11 

CHEMOTHERAPY IN CHILDHOOD DEPRESSION, ^^^^^ ^^^^ 

TREATMENT PROCESS OF DEPRESSION AND CHANGES IN 

MICROVIBRATION. ,82620 03-0 

DOUBLE-BLIND CROSSOVER COMPARISON OF BROMAZEPAM AND 

DIAZEPAM IN PSYCHOSOMATIC DISEASE. NEUROSIS AND D^E^P^P^SSION 

MASKED DEPRESSION. ,82829 03-1 

HYPERTENSION AND DEPRESSION AND THEIR TREATMENT. ^^^^^^ ^^ ^ 

INFLUENCE OF TETRACOSACTRIN (T) AND BETA-MELANOCYTE 

STIMULATING HORMONE (MSH) ON DEPRESSION OF THE SEGMENTAL 
REFLEX BY MORPHINE (MS). (UNPUBLISHED PAPER). ^^^^^^ ^^^ 

COMPARATIVE EVALUATION OF DIBENCYCLADINE (LUDIOMIL) AND 
IMIPRAMINE IN PSYCHOTIC DEPRESSION. ^^^^^^ ^^ ^ 

SO-CALLED MASKED DEPRESSION AND ITS TREATMENT. ^^^^^^ ^^ 

LITHIUM TREATMENT OF DEPRESSION. ^^^^^^ ^^ ^ 

PROPHYLACTIC TREATMENT OF RECURRENT DEPRESSION: OBSERVATIOI 
FROM A MULTIHOSPITAL COLLABORATIVE STUDY. ^^^^^^ ^^ 

ALTERATION OF ETHANOL-INDUCED CNS DEPRESSION: INEFFECTIVENESS 
OF DRUGS THAT MODIFY CHOLINERGIC TRANSMISSION. ^^^^^^ ^^ 

A DOUBLE-BLIND CROSSOVER SEQUENTIAL TRIAL OF ORAL THYROTROF 
RELEASING HORMONE IN DEPRESSION. ^^^^^^ ^^ 

ACETYLCHOLINE AND DEPRESSION. ^^^^^2 04. 

LONG-TERM TREATMENT OF ENDOGENOUS DEPRESSION WITH 

NORTRIPTYLINE WITH CONTROL OF PLASMA LEVELS, ^^^^^^ ^^ 



S-74 



189650 04-09 



VOLUME 12, SUBJECT INDEX 

RECENT ADVANCES IN THE TREATMENT OF DEPRESSION. 

MIXED ANXIETY DEPRESSION: FACT OR MYTH? 

189919 04-10 
THE TREATMENT OF MIXED ANXIETY AND DEPRESSION WITH LOXAPINE- 
A CONTROLLED COMPARATIVE STUDY. 

190195 04-09 
THIRTY-FIVE YEARS CONTINUOUS TREATMENT FOR RECURRENT 
DEPRESSION: FROM ECT TO DRUGS. 

191119 04-09 
NEOMYCIN AND RUTHENIUM RED ANTAGONISM OF MONOAMINERGIC 
DEPRESSION OF CEREBRAL CORTICAL NEURONES. 

191380 04-03 
EXPERIMENT WITH LOPRAMINE (DB-2182) ON THE TREATMENT OF 
DEPRESSION. 

191665 04-09 
CLINICAL EFFECTS OF IMIPRAMINE-N-OXIDE ON DEPRESSION. 

191716 04-09 
AMPHETAMINES EFFECTS ON SELF-STIMULATION: DEVELOPMENT OF 
TOLERANCE AND POST-DRUG DEPRESSION. 

191914 04-04 
WELLBATRIN IN THE TREATMENT OF DEPRESSION. 

191978 04-10 
PHARMACOLOGY OF DEPRESSION IN THE AGED: EVALUATION OF 
GER0VITAL-H3 AS AN ANTIDEPRESSANT DRUG. 

192229 04-09 
LABORATORY ASSESSMENTS OF ANTIDEPRESSIVE ACTIVITY -- THEIR 
VALUE FOR CLINICAL PSYCHIATRY AND THE UNDERSTANDING OF 
DEPRESSION. 

192422 04-09 
A PHARMACOLOGICAL MODEL WITH RHESUS MONKEYS FOR THE 
PREDICTION OF SELECTIVE DEPRESSION OF PSYCHIC FUNCTIONS. 

192424 04-04 
PHENYLALANINE FOR ENDOGENOUS DEPRESSION. 

192521 04-09 
THYROTROPHIN RELEASING HORMONE IN THE TREATMENT OF 
DEPRESSION. 

192577 04-09 
}EPRESSIONS 

EXPERIENCES WITH LAROXYL (R) IN THE TREATMENT OF DEPRESSIONS IN 
PRIVATE PSYCHIATRIC PRACTICE IN DJAKARTA. 

170413 01-11 
MEASURING THE PHARMACOLOGICAL ACTION OF IMIPRAMINE IN THE 
TREATMENT OF DEPRESSIONS. 

1 74995 02-09 
TREATMENT WITH PSYCHOPHARMACOLOGIC AGENTS IN CHILDHOOD 
DEPRESSIONS. 

182431 03-11 
TRYPTOPHAN AND AMITRIPTYLINE IN THE TREATMENT OF DEPRESSIONS. 

187536 04-09 
)EPRESSIVE 

DEPRESSIVE FORMS OF SCHIZOPHRENIA AND EXPERIMENTAL 
TREATMENT BY CLOMIPRAMINE. 

167676 01-08 
CHLORDIAZEPOXIDE IN DEPRESSIVE NEUROSIS: AN OPEN LABEL 
CROSSOVER STUDY WITH AMITRIPTYLINE. 

168316 01-10 
COMBINATIONS OF ANTIDEPRESSANT DRUGS IN THE TREATMENT OF 

DEPRESSIVE ILLNESS. 

168317 01-09 
IMIPRAMINE, DIAZEPAM AND GROUP PSYCHOTHERAPY IN LONG-TERM 

TREATMENT OF DEPRESSIVE NEUROTICS. 

169089 01-10 
A COMPARISON OF LITHIUM CARBONATE IN THE PREVENTION OF MANIC 

AND DEPRESSIVE EPISODES IN RECURRENT AFFECTIVE DISORDER. 

169090 01-09 
SINGLE VERSUS DIVIDED DAILY DOSE OF TRIMIPRAMINE IN THE 

TREATMENT OF DEPRESSIVE ILLNESS 

170622 01-09 
A DOUBLE-BLIND INVESTIGATION OF DIMETHACRINE VERSUS 
IMIPRAMINE IN HOSPITALIZED DEPRESSIVE STATES. 

171695 01-09 
A GUIDE FOR DRUG USE IN DEPRESSIVE DISORDERS. 

171923 01-09 
A DOUBLE-BLIND COMPARISON OF THIORIDAZINE (MELLARIL) VERSUS 
DIAZEPAM (VALIUM) IN PATIENTS WITH CHRONIC MIXED ANXIETY 
AND DEPRESSIVE SYMPTOMS. 

172486 01-10 
CLINICAL EXPERIENCE WITH MELITHRACENE IN THE TREATMENT OF 
DEPRESSIVE STATES. 

172979 01-09 
THE DIFFERENTIATION OF ANXIETY AND DEPRESSIVE DISORDERS A 
PSYCHOPHARMACOLOGICAL APPROACH. 

175286 02-10 
EXPERIMENT WITH DOXEPIN (SINEQUAN) IN TREATMENT OF DEPRESSIVE 
STATES. 

176454 02-11 



Subject Index 



EXPERIENCE IN THE USE OF SINEQUAN (DOXEPIN HYDROCHLORIDE) IN 
TREATMENT OF NEUROSIS, DEPRESSION AND DEPRESSIVE STATES. 

176471 02-11 
CLINICAL EFFECT OF A NEW PSYCHOTROPIC DRUG, DOXEPIN 
HYDROCHLORIDE. IN THE TREATMENT OF DEPRESSIVE STATES. 

177569 02-11 
ACTION OF OPIPRAMOL (G- 33040) IN DEPRESSIVE SYNDROMES IN 
CHILDREN AND ADOLESCENTS. 

182432 03-10 
THE USE OF LOW DOSES OF MONOCHLORIMIPRAMINE IN THE THERAPY 
OF NEUROTIC DEPRESSIVE SYNDROMES. 

182789 03-10 
A PRELIMINARY STUDY ON THE ACTION OF THYROTROPINE RELEASING 
HORMONE OR TRH IN DEPRESSIVE STATES. 

184962 03-09 
A STUDY OF REFRACTORY CASES OF DEPRESSIVE ILLNESSES AND THEIR 
RESPONSE TO COMBINED ANTIDEPRESSANT TREATMENT. 

185078 03-10 
DEPRESSIVES 

DRUG THERAPY AND MARITAL THERAPY IN OUTPATIENT DEPRESSIVES. 

169088 01-09 
A DOUBLE-BLIND TRIAL OF IPRINDOLE AND IMIPRAMINE IN DEPRESSIVES 
AND RESPONSE TO ECT IN REFRACTORY CASES 

174376 01-09 
INFLUENCE OF ANTIDEPRESSIVE THERAPY ON THE DISTURBED TIME 
ESTIMATION OF DEPRESSIVES. 

182591 03-14 
DIURETIC ANTIDEPRESSANT COMBINATION IN ALCOHOLIC DEPRESSIVES 

187866 04-11 
DEPRIVATION 

EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS. 

169467 01-03 
INTERRESPONSE TIME CHANGES AS A FUNCTION OF DEPRIVATION AND 
AMPHETAMINE ADMINISTRATION. 

171612 01-04 
AMPHETAMINE AND PENTOBARBITAL EFFECTS ON THE DISCRIMINATIVE 
RESPONSE CONTROL BY DEPRIVATION OF RAPID EYE MOVEMENT 
SLEEP (REM). 

182245 03-03 
INDEPENDENCE OF THE EFFECTS OF D-AMPHETAMINE AND FOOD 
DEPRIVATION OR BODYWEIGHT ON THE FOOD CONSUMPTION OF 
RATS. 

186376 03-06 
EFFECTS OF DELTA9-THC ON FOOD AND WATER INTAKE OF DEPRIVATION 
EXPERIENCED RATS. 

191375 04-04 
DEPRIVED 

EFFECTS OF METHAMPHETAMINE ON FIXED-RATIO RESPONDING OF FOOD 
SATIATED AND FOOD DEPRIVED RATS. 

185957 03-04 
DERIVATIVE 

STUDIES ON BENZODIAZEPINOOXAZOLES. IV. THE FORMATION OF 
QUINOLONES BY THE RING CONTRACTION OF A 
BENZODIAZEPINOOXAZOLE DERIVATIVE 

180488 02-01 
EXPERIENCE GAINED IN THE TREATMENT OF CHRONIC SCHIZOPHRENIC 
PSYCHOSES WITH A THIORIDAZINE DERIVATIVE. 

180675 02-08 
BEHAVIORAL PHARMACOLOGY OF BROMAZEPAM (RO-5-3350) A NEW 
BENZODIAZEPINE DERIVATIVE. 

181384 02-04 
CENTRAL NERVOUS ACTION OF BROMAZEPAM, A NEW BENZODIAZEPINE 
DERIVATIVE 

181650 02-03 
A CLINICAL EVALUATION OF A NEW ANXIOLYTIC DRUG 
(THIENODIAZEPINE DERIVATIVE Y-6047) IN NEUROTICS AND 
PSYCHOSOMATIC DISORDERS - A PRELIMINARY REPORT 

181771 02-07 
CENTRAL NERVOUS ACTION OF FLURAZEPAM, A NEW BENZODIAZEPINE 
DERIVATIVE. 

182549 03-03 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 
DERIVATIVE SE-780 IN RATS. 

187926 04-04 
THE EFFECT OF A NEW BENZODIAZEPINE DERIVATIVE NIMETAZEPAM ON 
THE SLEEP CYCLE IN MAN. 

188501 04-07 
INVESTIGATION OF PHYSICAL DEPENDENCE ON A NEW BENZODIAZEPINE 
DERIVATIVE, BROMAZEPAM. 

189209 04-05 
EFFECT OF A BUTYROPHENONE DERIVATIVE, U-32802A ON BRAIN 
BIOGENIC AMINES. 

1 89584 04-02 
THE EFFECTS OF DELTA9-THC AND A WATER SOLUBLE DERIVATIVE ON 
PGEl SYNTHESIS IN THE CORPUS-STRIATUM. 

191964 04-03 



S-75 



Subject Index 

""'tolerance and cross-tolerance to the anorexigenic effect of 

SOME AMPHETAMINE DERIVATIVES IN RATS. ^^^^^^ ^^ ^^ 

STUDIES ON SIDE-EFFECTS AND WITHDRAWAL SYMPTOMS OF 

IMINODIBENZYL DERIVATIVES. ^^^080 01-15 

THE SYNTHESES OF 2,3 DIHYDROBENZOTHIAZINE DERIVATIVES. (PH.D. 
DISSERTATION). 173589 01-01 

PHARMACOKINETIC DISPOSITION OF NORAPOMORPHINE DERIVATIVES 
AND ITS INFLUENCE ON THE ELICITATION OF STEREOTYPICAL 
GNAWING. (PH.D. DISSERTATION). ^^^^^^ ^^ ^^ 

INTERACTION OF PHENOTHIAZINE DERIVATIVES WITH HUMAN 

CERULOPLASMIN. 177335 02-13 

SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF 

' OaAHYDROBENZOCYCLOHEPTATHIAZlNE DERIVATIVES. ^^^^^ ^^^^ 

«;TnniFS ON BENZODIAZEPINOOXAZOLES. 111. REACTIONS AND 
''reSng'eMENTS OF BENZODIAZEPINOOXAZOLE DERIVATIVES^ ^^^^ 

BENZODIAZEPINOOXAZOLES. ^^^^^^ ^2-02 

POTENTIATION OF BARBITURATE HYPNOSIS BY 5-DIAZ0IMIDAZ0LE-4- 
CARBOXAMIDE AND ITS DERIVATIVES. 182113 02-03 

INHIBITION OF THE SYNAPTOSOMAL UPTAKE MECHANISMS FOR L- 
NOREPINEPHRINE AND DOPAMINE BY N-ARYLALKYL DL-AMPHETAMINE 
DERIVATIVES. ,82250 03-03 

THE INHIBITION OF (3H) BIOGENIC AMINE ACCUMULATION INTO RAT 
'"BRAmTISSUE SLICES BY VARIOUS TRYPTAMINE DERIVATIVES.^^ ^^^^ 

3-ONIUM DERIVATIVES OF 1,4 BENZODIAZEPIN-2-ONES WITH TERTIARY 

ORGANIC BASES. ,87942 04-01 

ALPHA-METHYLDOPA/vONE DERIVATIVES. SYNTHESIS AND 

PHARMACOLOGY 189177 04-02 

THE ACTION OF BETA-PHENYL-GABA DERIVATIVES ON NEURONES OF THE 

CAT CEREBRAL CORTEX. 189750 04-03 

rONFORMATIONAL ANALYSIS OF ACRIDAN DERIVATIVES BY NUCLEAR 
'Ta^g'n^C REsiNTcE SPECTROSCOPY A RELATIONSHIP BETWEEN 

CONFORMATION AND PHARMACOLOGICAL ACTIVITY. ^^^^^ ^ ^^^^ 

""'hypothermia EVOKED BY A DOPAMINE DERIVED 

TETRAHYDROISOQUINOLINE ALKALOID. ^^^^^^ ^^.os 

.M ui\/n IWHIRITION OF NEURONAL UPTAKE OF A DOPAMINE DERIVED 
'\mArDROISOQSlNOLlNE (TIQ) ALKALOID BY COCAINE AND BY 
DESMETHYLIMIPRAMINE (DMI). ^^^150 02-03 

,,nTAi/c crriDArF AND RELEASE IN VIVO OF A DOPAMINE DERIVED 

" mRAHmOISOQCNOLINElTli^LKALOID BY SYMPATHETIC NERVES 

OF THE IRIS. 182204 02-03 

"' m'lS'oF PHOBIAS BY SYSTEMATIC DESENSITIZATION: 
COMPARISON OF STANDARD VS METHOHEXITAL AIDED 
DESENSITIZATION. 189916 04-10 

DRUGS or! WHY NO ONE CAN EVER DO A PROPER DRUG TRIAL ^^^^ 

SOME CONSIDERATIONS IN THE DESIGN OF SUBSTRATE AND TISSUE 
SPECIFIC INHIBITORS OF MAO. ^^,^9, q^ q, 

""'cOmTn'aTION of L-DOPA, DESIPRAMINE, AND A DECARBOXYLASE 

'"inhibitor IN THE TREATMENT OF DEPRESSION. ^^^^^^ ^^^^ 

INHIBITION OF LUNG. LIVER AND BRAIN MONOAMINE OXIDASE BY 

IMIPRAMINE AND DESIPRAMINE. 177332 02-03 

CHROMATOGRAMS. ,83,^03 03-13 



Psychopharmacology Abstracts 



EFFECT OF DESIPRAMINE ON RAT CORTEX SLICES INCUBATED WITH 3H- 
DOPAMINE. 190310 04-03 

FFFECT OF CHRONIC TREATMENT WITH DESIPRAMINE (DMI) AND 
PRmDOLE (IP) ON THE NOREPINEPHRINE (NE) SENSITIVE ADENYLATE 
CYCLASE SYsIeM IN SLICES OF THE RAT LIMBIC FOREBRAIN^^^ ^^^^ 

DESMETHYLIMIPRAMINE 

THF UPTAKE RETENTION AND METABOLISM OF 3H-5- ^ ,, ^..^ 

HYDROXYTRYPTAMINE in brain SLICES AND ILEUM FROM THE RAT: 
EFFEaS OF COCAINE, DESMETHYLIMIPRAMINE AND RESERPINE. (PH.D. 
DISSERTATION). ,^8131 01-03 

IN VIVO INHIBITION OF NEURONAL UPTAKE OF A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE (TIQ) ALKALOID BY COCAINE AND BY 
DESMETHYLIMIPRAMINE (DMI). ^^^iso 02-0' 

INHIBITION OF C14-ACH UPTAKE IN RAT BRAIN SLICES BY 

DESMETHYLIMIPRAMINE. 182170 02-0: 

'*"7n"fLUE°CE of PSYCHOTROPIC DRUGS ON AGGRESSIVENESS EVOKED BY 
" DESTRUC?I0n'0F ISOLATED STRUCTURES OF THE EOREBRAIN^^^ ^^^ 

""pHENOTHIAZINE DOSAGE LEVELS AND AUDITORY SIGNAL DETECTION IN 
SCHIZOPHRENIA. 167817 01-0 

EFFECTS OF LSD ON AUDITORY PERCEPTION: A SIGNAL DETECTION 
ANALYSIS. 185752 03-C 

""SSnTS of drug EFFECTS ON PUNISHED BEHAVIOR.^ ^^^^^ ^^ ^ 

DETERMINANTS OF THE NORADRENERGIC SATIETY EFFECT^ 

ENVIRONMENTAL DARKNESS VS. THE FEEDING PATTERN. ^^^^^^ ^^ ^ 

""SmTtION of drug TRANSFER across BIOLOGICAL MEMBRANE 
COMPARATIVE STUDY ON THE PASSAGE OF DRUGS INTO THE 
CENTRaVn RVOUS SYSTEM AND THEIR PLACENTAL TRANSFER AND 
FETAL LOCALIZATION IN THE PREGNANT RAT. (PH.D. DISSERTATION) 

TA-; THROMATOGRAPHIC DETERMINATION OF METHAQUALONE IN 
SMALL AMoSnTS OF SERUM AFTER INGESTION OF THERAPEUTIC 
DOSES. 172397 01 

DETERMINATION OF DOXEPIN IN AUTOPSY MATERIAL. ^ ^^^^^ ^^ 

STUDIES ON METABOLISM OF BROMAZEPAM dO^ COLORIMETRIC 
DETERMINATION AND METABOLIC FATE OF BROMAZEPAM IN 
ANIMALS. 181593 02 

DIRECT DETERMINATION OF LITHIUM IN SERUM BY ATOMIC 

ABSORPTION SPECTROSCOPY. ^ ^^ ^^3 ^^ 

AUTOMATIC DETERMINATION OF THE PAIN THRESHOLD TO 

ELECTROSHOCK AND THE EFFECTS OF DELTA9-THC. ^^_^^^^ ^, 

IDENTIFICATION AND QUANTITATIVE DETERMINATION OF ^^ 
PHENOTHIAZINE DRUGS IN URINE SAMPLES OF PSYCHIATRIC 
PATIENTS. 183599 0: 

ASSAY PROCEDURES FOR THIORIDAZINE, TRIFLUOPERAZINE, AND THI 
SU^FOX°DES AND DETERMINATION OF URINARY EXCRETION OF TBI 
COMPOUNDS IN MENTAL PATIENTS. ^^^^^ ^ 

niiAWTlTATIVE DETERMINATION OF IMIPRAMINE AND DESIPRAMINE 
"^'hUMAN BLOOD P^^^^^^ BY DIRECT DENSITOMETRY OF THIN-LAYE 

CHROMATOGRAMS. 183603 

GLC DETERMINATION OF MEPROBAMATE IN WATER, PLASMA AND 

URINE. 185977 C 

A POLAROGRAPHIC METHOD FOR THE DETERMINATION OF THE N-OX 

N-OXIDE-SULPHOXIDE AND SULPHOXIDE METABOLITES OF 

CHLORPROMAZINE 190902 ( 

A CRITICAL ASSESSMENT OF METHODS FOR THE DETERMINATION 01 
* SaMINE SYNTHESIS AND TURNOVER RATES IN VIVO.^^^^^^ ^ 

""!*^',!)?!i I CONTROLLED STUDY TO DETERMINE THE TIME OF ONSET ( 

^ laToN OF OXYPERTINE AFTER ORAL ADMINISTRATION IN NORM 

SUBJECTS. ,82763 



5-76 



VOLUME 12, SUBJECT INDEX 



Subject Index 



DETOXIFICATION 

USE OF PSYCHOTHERAPEUTIC DRUGS IN THE ACUTE DETOXIFICATION OF 
HEROIN ADDICTS. 

169746 01-11 
A ROLE OF THE DIETARY LIPID IN THE ABILITY OF PHENOBARBITAL TO 
STIMULATE DRUG DETOXIFICATION. 

175859 02-03 
DEVELOPING 

EFFECTS OF ATROPINE ON EXPLORATION, LEARNING AND 
ELECTROCORTICAL ACTIVITY IN THE DEVELOPING RAT. 

169473 01-04 
EFFECTS OF AMPHETAMINE ON ELECTROSHOCK RESPONSES IN 

DEVELOPING RATS. 

184372 03-03 
THYROTOXICOSIS DEVELOPING DURING LITHIUM TREATMENT: CASE 
REPORT. 

186473 03-15 
DEVELOPMENT 

THE SAFETY TEST OF 10-CHLORO-llB-(2-CHLOROPHENYL) 2,3,5,6,7,1 IB 
HEXAHYDROBENZODIAZEPINOOXAZOL-6-ONE (CS-370): SECOND 
REPORT, EFFECT OF CS-370 UPON THE DEVELOPMENT OF PRENATAL 
AND POSTNATAL OFFSPRINGS OF EXPERIMENTAL ANIMALS. 

168498 01-05 
DEVELOPMENT OF PHYSICAL DEPENDENCE ON MORPHINE IN RESPECT TO 
TIME AND DOSAGE AND QUANTIFICATION OF THE PRECIPITATED 
WITHDRAWAL SYNDROME IN RATS. 

169474 01-03 
DEVELOPMENT OF TOLERANCE IN RATS TO THE HYPOTHERMIC EFFECTS 

OF D-AMPHET AMINE AND APOMORPHINE. 

174764 01-03 
CONTROL OF THE HYPERACTIVE CHILD VIA MEDICATION - AT WHAT 
COST TO PERSONALITY DEVELOPMENT; SOME PSYCHOLOGICAL 
IMPLICATIONS AND CLINICAL INTERVENTIONS. 

176810 02-11 
DEVELOPMENT OF A VACCINE AGAINST MENTAL RETARDATION CAUSED 
BY CYTOMEGALOVIRUS INFECTION IN UTERO. 

178549 02-11 
LACK OF EFFECTS OF CYCLOHEXIMIDE ON TOLERANCE DEVELOPMENT TO 
A STIMULATORY EFFECT OF MORPHINE ON MICE. 

182158 02-03 
CHROMATIN TEMPLATE ACTIVITY DURING MORPHINE-INDUCED 
ANALGESIA AND THE DEVELOPMENT OF ANALGESIC TOLERANCE. 

182160 02-03 
THE DEVELOPMENT OF A BLOOD-BRAIN BARRIER TO METHADONE IN THE 
NEWBORN RAT. 

182165 02-03 
DELTA9-TETRAHYDR0CANNABIN0L AND 1 1-HYDR0XY-DELTA9- 

TETRAHYDROCANNABINOL: BEHAVIORAL EFFECTS AND TOLERANCE 
DEVELOPMENT. 

183893 03-04 
A ROLE FOR THE AMYGDALA IN THE DEVELOPMENT OF THE CATALEPTIC 
AND STEREOTYPIC ACTIONS OF THE NARCOTIC AGONISTS AND 
ANTAGONISTS IN THE RAT. 

186577 03-03 
EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF 
BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM 
RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT. 

186695 03-03 
THE PRENATAL EFFECT OF CHLORAMPHENICOL ON THE POSTNATAL 
DEVELOPMENT OF MICE. 

187076 03-05 
DEVELOPMENT OF LOCOMOTION AND BRAIN CATECHOLAMINES. 

187551 04-04 
DELTA9-TETRAHYDR0CANNABIN0L: EFFECTS OF ROUTE OF 
ADMINISTRATION ON ONSET AND DURATION OF ACTIVITY AND 
TOLERANCE DEVELOPMENT. 

187928 04-03 
THE EFFECTS OF P-CHLOROPHENYLALANINE ON MORPHINE ANALGESIA, 
TOLERANCE AND DEPENDENCE DEVELOPMENT IN TWO STRAINS OF 
RATS. 

187930 04-04 
LONG-TERM USE OF MARIHUANA AND THE DEVELOPMENT OF 

TOLERANCE OR SENSITIVITY TO DELTA9-TETRAHYDR0CANNABIN0L. 

188119 04-13 
THE EFFECT OF BUTYLATED HYDROXYANISOLE AND BUTYLATED 
HYDROXYTOLUENE ON BEHAVIORAL DEVELOPMENT OF MICE. 

188637 04-04 
EFFECTS OF PERINATAL EXPOSURE TO METHYL MERCURY ON 
FUNCTIONAL BRAIN DEVELOPMENT AND NEUROCHEMISTRY. 

189564 04-05 
PERMANENT ALTERATIONS IN 5-HYDROXYTRYPTAMINE METABOLISM IN 
DISCRETE AREAS OF RAT BRAIN FOLLOWING EXPOSURE TO DRUGS 
DURING THE PERIOD OF DEVELOPMENT. 

191383 04-03 
PHYSICOCHEMICAL PROPERTIES, DEVELOPMENT, AND REGULATION OF 
CENTRAL AND PERIPHERAL MONOAMINE OXIDASE ACTIVITY. 

191497 04-03 



AMPHETAMINES EFFECTS ON SELF-STIMULATION: DEVELOPMENT OF 
TOLERANCE AND POST-DRUG DEPRESSION. 

191914 04-04 
EXCITABILITY CHANGES DURING THE GRADUAL DEVELOPMENT OF AND 
RECOVERY FROM PENTYLENETETRAZOL AND STRYCHNINE INDUCED 
CONVULSIONS IN THE CAT. 

191927 04-03 
DEVELOPMENTS 

RECENT DEVELOPMENTS IN THE PHARMACOLOGY OF THE 
BENZODIAZEPINES. 

182771 03-17 
DEVIANT 

THE CONTROL OF DEVIANT SEXUAL BEHAVIOR BY DRUGS: A DOUBLE- 
BLIND CONTROLLED STUDY OF BENPERIDOL, CHLORPROMAZINE, AND 
PLACEBO. 

190061 04-11 
DEXAMETHASONE 

SIMULTANEOUS MASS FRAGMENTOGRAPHIC ASSAY OF NOREPINEPHRINE 
(NE), EPINEPHRINE (E) AND DOPAMINE (DA) IN RAT SYMPATHETIC 
GANGLION: EFFECTS OF DEXAMETHASONE IN NEWBORN AND ADULT 
RATS. (UNPUBLISHED PAPER). 

170747 01-03 
DEXAMPHETAMINE 

THE BIOLOGICAL BASIS OF PSYCHOTICISM: A STUDY OF INDIVIDUAL 
DIFFERENCES IN RESPONSE TO DEXAMPHETAMINE. 

175219 02-13 
SENSORY CONTINGENT BAR-PRESSING FOR FAMILIAR AND NOVEL 
CHANGE UNDER A DEXAMPHETAMINE AMYLOBARBITONE MIXTURE. 

181605 02-04 
DEXPHENMETRAZINE 

THE INFLUENCE OF IMIPRAMINE, DEXPHENMETRAZINE AND 

AMPHETAMINE SULPHATE ON THE COMPOSITION OF DIURNAL SLEEP 
OF NARCOLEPTICS. 

192419 04-11 
DEXTRAN 

EFFECTS OF ADRENERGIC AGENTS, THEOPHYLLINE AND OTHER DRUGS 
ON DEXTRAN EDEMA AND HISTAMINE RELEASE IN RATS 

189895 04-03 
DEXTROAMPHETAMINE 

DOUBLE-BLIND CLINICAL EVALUATION OF MAZINDOL, 

DEXTROAMPHETAMINE, AND PLACEBO IN TREATMENT OF EXOGENOUS 
OBESITY. 

167335 01-11 
EFFECTS OF LSD-25 AND DEXTROAMPHETAMINE ON SPEECH RHYTHMS 
IN PSYCHOTHERAPY DIALOGUES. 

168420 01-12 
SIDE-EFFECTS OF DEXTROAMPHETAMINE THERAPY OF HYPERACTIVE 
CHILDREN. 

176238 02-15 
EFFECTS OF OVERTRAINING AND PRETRIAL ADMINISTRATION OF 
DEXTROAMPHETAMINE ON REVERSAL LEARNING IN RATS. 

1 77533 02-04 
DEXTROAMPHETAMINE AND METHYLPHENIDATE IN THE TREATMENT OF 
HYPERACTIVE/AGGRESSIVE CHILDREN. 

177771 02-14 
AN INVESTIGATION OF INTERACTIONS AMONG LSD, 

DEXTROAMPHETAMINE, AND VERBAL BEHAVIOR IN MONOLOGUES 
AND DIALOGUES. (PH.D. DISSERTATION) 

185600 03-14 
THE STATE-DEPENDENT EFFECTS OF METHYLPHENIDATE AND 
DEXTROAMPHETAMINE. 

185861 03-14 
CLINICAL EFFECTS OF MARIHUANA DEXTROAMPHETAMINE 
COMBINATION. 

191990 04-14 
CHROMOSOME EXAMINATIONS AFTER MEDICALLY ADMINISTERED 
LYSERGIC ACID DIETHYLAMIDE AND DEXTROAMPHETAMINE. 

192084 04-15 
DFP 

REDUCED BEHAVIORAL EFFECTS OF PILOCARPINE DURING CHRONIC 
TREATMENT WITH DFP 

185265 03-04 
DH-S24 

SELECTIVE ANTAGONISM OF CENTRAL NERVOUS SYSTEM DEPRESSANTS 
BY DH-524; A COMPARATIVE STUDY WITH BEMEGRIDE. 

171007 01-13 
DI-N-PROPYLACETAMIDE 

COMPLEMENTAL PHARMACOLOGICAL STUDY OF DI-N-PROPYLACETAMIDE 
OR DEPAMIDE. 

180722 02-07 
DIABETES-INSIPIDUS 

LITHIUM INDUCED DIABETES-INSIPIDUS; MANIC SYMPTOMS, BRAIN AND 
ELECTROLYTE CORRELATES, AND CHLOROTHIAZIDE TREATMENT 

169486 01-15 
DIAGNOSED 

A STUDY OF THE EFFECTS OF RITALIN INTERVENTION UPON THE 
PERCEPTUAL COMPETENCIES OF CHILDREN DIAGNOSED AS GIVING 



S-77 



Subject Index 



Psychopharmacology Abstracts 



EVIDENCE OF PSYCHONEUROLOGICAL LEARNING DISABILITIES. (PH.D. 
°'^^^^^^^'°'' ,86833 03-14 

'"*°h'yPERKINETIC HYPOSCHOLASTIC behaviour AND CHARACTER 

DISORDERS OF CHILDHOOD AND ADOLESCENCE: DIAGNOSIS AND 
PHARMACOTHERAPY. ,72800 01-11 

DIAGNOSIS AND MANAGEMENT OF DEPRESSION IN GENERAL PRACTICE. 

180406 02-09 
MAINTENANCE TREATMENT OF SCHIZOPHRENIA IN THE LIGHT OF 

PROGNOSIS ORIENTED DIAGNOSIS. ,8608103-08 

DIALOGUES 

EFFECTS OF LSD-25 AND DEXTROAMPHETAMINE ON SPEECH RHYTHMS 
IN PSYCHOTHERAPY DIALOGUES. ,68420 01-12 

AN INVESTIGATION OF INTERACTIONS AMONG LSD, 

DEXTROAMPHETAMINE, AND VERBAL BEHAVIOR IN MONOLOGUES 
AND DIALOGUES. (PH.D. DISSERTATION). 

185600 03-14 

CONVULSION PRODUCING PROPERTY OF THE DIALYZABLE GLYCOPEPTIDE 
PREPARATION FROM WHOLE RAT BRAIN. 

181815 02-03 

CLINICAL EXPERIENCE WITH DIAMORPHINE IN ADVANCED MALIGNANT 

^'^^^^^- ,91606 04-17 

DIAPHRAGM 

EFFECTS OF AMPHETAMINE ISOMERS ON NEUROMUSCULAR 

TRANSMISSION IN RAT PHRENIC NERVE DIAPHRAGM PREPARATION. 

182232 03-03 

DIAZEPAM ,„., ^^ 

PREANESTHETIC MEDICATION IN ELECTIVE SURGERY: COMPARISON OF 
INTRAVENOUS DIAZEPAM WITH MEPERIDINE. 

167338 01-11 
CLORAZEPATE DIPOTASSIUM, DIAZEPAM AND PLACEBO IN CHRONIC 

^^^'^^^ 167339 01-10 

IMIPRAMINE, DIAZEPAM AND GROUP PSYCHOTHERAPY IN LONG-TERM 
TREATMENT OF DEPRESSIVE NEUROTICS. 

169089 01-10 

DIAZEPAM (CALMPOSE) IN ECLAMPSIA: A PRELIMINARY REPORT OF 16 

•-^^^^ ,69633 0,-11 

COMPARISON OF THIORIDAZINE AND DIAZEPAM IN THE CONTROL OF 
NONPSYCHOTIC SYMPTOMS ASSOCIATED WITH SENILITY: DOUBLE- 

«^'^^5^^^^ 170129 01-11 

DIAZEPAM AND POST-TETANIC POTENTIATION: POSSIBLE ROLE OF 

PROSTAGLANDINS. (UNPUBLISHED PAPER). 

170748 01-03 
PHARMACOKINETIC PROFILE OF DIAZEPAM IN MAN FOLLOWING SINGLE 

INTRAVENOUS AND ORAL AND CHRONIC ORAL ADMINISTRATION. 

170838 01-13 
A DOUBLE-BLIND CLINICAL TRIAL OF DOXEPIN HYDROCHLORIDE AND 

DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION 

IN THE FIELD OF INTERNAL MEDICINE. ^^ 

DEPRESSION SUBTYPES AND RESPONSE TO PHENELZINE, DIAZEPAM, AND 
A PLACEBO: RESULTS OF A NINE HOSPITAL COLLABORATIVE STUDY. 

INTERACTIONS OF DIAZEPAM AND HALOTHANE IN RATS. 

1 71 633 01-03 
DIAZEPAM IN LABOUR: ITS METABOLISM AND EFFECT ON THE CLINICAL 
CONDITION AND THERMOGENESIS OF THE NEWBORN. 

I / I /J I U I " I %J 

A DOUBLE-BLIND COMPARISON OF THIORIDAZINE (MELLARIL) VERSUS 
DIAZEPAM (VALIUM) IN PATIENTS WITH CHRONIC MIXED ANXIETY 
AND DEPRESSIVE SYMPTOMS, ,72486 01-10 

CONTINUOUS INFUSION OF DIAZEPAM IN INFANTS WERE SEVERE 

RECURRENT CONVULSIONS. ,,.czon, ,, 

1 74d6o U I - M 

DIAZEPAM USED INTRAVENOUSLY DURING REDUCTION OF FRACTURES 
AND DISLOCATIONS. ,74880 01-17 

COMPARISON OF ANTICONVULSANT EFFECTS OF CLORAZEPATE 

DIPOTASSIUM AND DIAZEPAM: FOUR WEEK ANTICONVULSANT STUDY 
IN RHESUS MONKEYS. ,76677 02-03 

ACUTE CEREBELLAR DISTURBANCE ASSOCIATED WITH DIAZEPAM 
THERAPY - A CASE REPORT AND FURTHER INVESTIGATION. 

FATAL INTOXICATION OF A YOUNG DRUG ADDICT WITH DIAZEPAM. 

178619 02-05 



THE EFFECT OF DIAZEPAM ON SOME CARDIOVASCULAR AND 

RESPIRATORY REFLEXES ELICITED BY AFFERENT ABDOMINAL VAGUS 

STIMULATION. „„ , 

1 78945 02-03 

A COMPARATIVE STUDY OF DIAZEPAM AND METHOCARBAMOL IN THE 
TREATMENT OF LOMBOSCIATALGIAS. 

,78950 02-1, 
PSYCHOPHYSIOLOGICAL EFFECTS OF DIAZEPAM (VALIUM) COMBINED 
WITH A MODERATE DOSE OF ALCOHOL IN MAN. 

180699 02-14 

EFFECTS OF CONSECUTIVE ADMINISTRATION OF DIAZEPAM AND 
DOXEPIN ON BOTH APPROACH WITHDRAWAL AND APPROACH 
AVOIDANCE RESPONSES IN RATS. 

182117 02-04 

DIAZEPAM TREATMENT FOR ACUTE CONVULSIONS IN CHILDREN: A 
REPORT OF 41 PATIENTS, THREE WITH PLASMA LEVELS. 

182595 03-11 
DOUBLE-BLIND CROSSOVER COMPARISON OF BROMAZEPAM AND 

DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION. 

182624 03-11 
THE EFFECT OF HYPOTHALAMIC STIMULATION ON ORAL INGESTION OF 

DIAZEPAM IN RATS. ,84238 03-04 

ACUTE EFFECTS OF ALCOHOL, DIAZEPAM, THIORIDAZINE, FLUPENTHIXOL 
AND ATROPINE ON PSYCHOMOTOR PERFORMANCE PROFILES 

184848 03-14 
THE CONCENTRATIONS OF DIAZEPAM AND ITS METABOLITES IN THE 
PLASMA AFTER AN ACUTE AND CHRONIC ADMINISTRATION. 

,84978 03-, 3 
QUINAZOLINES AND 1,4 BENZ0DIAZEPINES.64.C0MPARIS0N OF THE 
STEREOCHEMISTRY OF DIAZEPAM WITH THAT OF CLOSE ANALOGS 
WITH MARGINAL BIOLOGICAL ACTIVITY. 

PLASMA CONCENTRATIONS OF DIAZEPAM AND OF ITS METABOLITE N- 
DESMETHYLDIAZEPAM IN RELATION TO ANXIOLYTIC EFFECT 

1 861 84 03- 1 3 
PLASMA LEVEL OF DIAZEPAM AS A THERAPEUTIC PREDICTOR IN 

^^^^^''^'^'''- ,86584 03-,0 

DIAZEPAM INHIBITION OF POST-TETANIC POTENTIATION IN BULLFROG 
SYMPATHETIC GANGLIA: POSSIBLE ROLE OF PROSTAGLANDINS. 

1 86673 03-03 
RESPONSE TO PROPRANOLOL AND DIAZEPAM IN SOMATIC AND PSYCHIC 

^^^'"^- ,88887 04-,0 

EFFECTS OF DIAZEPAM AND CODEINE, ALONE AND IN COMBINATION 
WITH ALCOHOL, ON SIMULATED DRIVING. „„,,„„,,. 

189619 04-14 

DIAZEPAM ON DEMAND: DRUG SEEKING BEHAVIOR IN PSYCHIATRIC 

^^^^^^^^'^ ,89924 04-,7 

DIAZEPAM AND MEPERIDINE ON ARTERIAL BLOOD GASES IN HEALTHY 

^°^^^^"^^- 190147 04-13 

EFFECT OF DIAZEPAM ON MOUSE WHOLE BRAIN AND BRAIN AREA 

ACETYLCHOLINE AND CHOLINE LEVELS. 

191423 04-03 
NONSEDATING DOSAGES OF DIAZEPAM AND PHENOBARBITAL IN THE 

REDUCTION OF NEONATAL BILIRUBIN LEVELS. 

DIAZEPAM CYCLIC NUCLEOTIDES AND AMINO ACID 

NEUROTRANSMITTERS IN RAT CEREBELLUM. (UNPUBLISHED PAPER). 

1 9 1 764 04-03 

SOURCES OF VARIABILITY IN THE PHARMACODYNAMICS OF 14C- 
IMIPRAMINE INCLUDING INTERACTION WITH DIAZEPAM OR 
^^^OmAZmi. ,9,925 04-03 

DIAZEPAM-INOUCED 

DIAZEPAM-INDUCED PLAY BEHAVIOR IN CATS DURING PREY KILLING. 

, 84979 03-04 
DIAZEPAM-INDUCED EATING AND LEVER PRESSING FOR FOOD IN SATED 

'^^^ ,866,3 03-04 

BINDING OF DIAZOXIDE AND OTHER BENZOTHIADIAZINES TO HUMAN 

*^^^^'^- ,79987 02-,3 

DIPSOGENIC ACTION OF DIAZOXIDE: A PHARMACOLOGIC ANALYSIS. 

1 91 768 04-03 

REDUCTION BY PRETREATMENT WITH DIBENAMINE OF HEPATOTOXICITY 
INDUCED BY CARBON TETRACHLORIDE, THIOACETAMINDE OR 
DIMETHYLNITROSAMINE. ,88865 04-05 

INFLUENCE OF DIBENCYCLADINE AND IMIPRAMINE ON CALORIE INTAKE 
ANDBODYWEIGHT. ,83359 03-03 



S-78 



VOLUME 12, SUBJECT INDEX 



Subject Index 



COMPARATIVE EVALUATION OF DIBENCYCLADINE (LUDIOMIL) AND 
IMIPRAMINE IN PSYCHOTIC DEPRESSION. 

183361 03-09 
DIBENZEPINE 

THE FIRST LONG-ACTING (RETARD) THYMOANALEPTIC OR 
ANTIDEPRESSANT: THE TIME-RELEASED DIBENZEPINE WITH 
PROLONGED ACTION. 

178946 02-11 
OIBUTYRYL 

THE EFFECT OF DOPAMINE RECEPTOR STIMULATING AGENTS AND OF N,0 
DIBUTYRYL CYCLIC AMP ON C14-D0PAMINE SYNTHESIS IN STRIATAL 
SLICES OF RATS. 

182256 03-03 
NOREPINEPHRINE - AN ANTAGONIST OF DIBUTYRYL CYCLIC AMP IN THE 
REGULATION OF NARCOSIS IN THE RAT. 

183789 03-03 
DICEPLON 

EXPERIENCE IN THE APPLICATION OF DICEPLON (APY-606) - COMPARED 
WITH FLOROPIPAMIDE. 

176447 02-08 
CLINICAL EFFECTS OF DICEPLON, A PSYCHOTROPIC DRUG. 

176470 02-08 
DICHLOROPHENYL 

EFFECT OF 2-ARYLALANINES, 2-ARYLSERINES, TETRAPHENYLBORON AND 
1,2 DL(2,4 DICHLOROPHENYL) ETHANOLAMINE ON LEVELS OF 
SEROTONIN (5-HT), NOREPINEPHRINE (NE) AND DOPAMINE (DM) IN 
WHOLE BRAIN OF MICE. 

182254 03-03 
DICHROISM 

INFLUENCE OF PH ON THE BENZODIAZEPINE HUMAN SERUM ALBUMIN 
COMPLEX: CIRCULAR DICHROISM STUDIES. 

189595 04-13 
DIDEUTERO 

MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND ITS 
HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD. 

186566 03-16 
DIELDRIN 

ALTERATION OF SENSORY AND MOTOR EVOKED RESPONSES BY 
DIELDRIN. 

181818 02-03 
DIENCEPHALIC 

PHARMACOLOGICAL SUPPRESSION OF EATING BEHAVIOR IN RELATION 
TO DIENCEPHALIC NORADRENERGIC RECEPTORS. 

174763 01-04 
DIENCEPHALON 

MODULATION OF REWARD AND AVERSION PROCESSES IN THE RAT 
DIENCEPHALON BY AMPHETAMINE. 

186164 03-04 
DIESTRUS 

BLOCKADE OF THE PROESTROUS LH SURGE IN CYCLIC RATS BY 
BARBITURATE ADMINISTRATION ON DIESTRUS. 

175650 02-03 
DIET 

NEUROLOGICAL CHANGES IN CATS FOLLOWING LONG-TERM DIET OF 
MERCURY CONTAMINATED TUNA. 

186476 03-05 
SUPERSENSITIVITY TO DOPAMINERGIC AGONISTS FOLLOWING 
WITHDRAWAL OF A CHRONIC DIET CONTAINING HALOPERIDOL OR 
PIMOZIDE. 

192012 04-04 
DIETARY 

A ROLE OF THE DIETARY LIPID IN THE ABILITY OF PHENOBARBITAL TO 
STIMULATE DRUG DETOXIFICATION. 

175859 02-03 
DIETHYLAMIDE 

LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND GAMMA-AMINOBUTYRIC 
ACID (GABA) INTERACTION ON SPONTANEOUS POTENTIALS AND THE 
EVOKED RESPONSE IN THE AVIAN TECTUM. 

169689 01-03 
STUDIES ON ENZYMATIC DEALKYLATION OF D-LYSERGIC ACID 
DIETHYLAMIDE (LSD). 

177336 02-03 
LYSERGIC ACID DIETHYLAMIDE AND SEROTONIN: A COMPARISON OF 
EFFECTS ON SEROTONERGIC NEURONS AND NEURONS RECEIVING A 
SEROTONERGIC INPUT. 

177407 02-12 
COMPARISON OF THE CHRONIC AND ACUTE EFFECTS OF D-LYSERGIC 
ACID DIETHYLAMIDE (LSD) TREATMENT ON RAT BRAIN SEROTONIN 
AND NOREPINEPHRINE. 

181945 02-03 
A COMPARISON OF EFFECTS OF D-LYSERGIC ACID DIETHYLAMIDE (LSD) 
AND SEROTONIN ON PRE- AND POSTSYNAPTIC CELLS IN THE 
SEROTONIN SYSTEM. 

182141 02-03 
EVIDENCE FOR THE ACTION OF 0-LYSERGIC ACID DIETHYLAMIDE, 
MESCALINE AND BUFOTENINE ON 5-HYDROXYTRYPTAMINE RECEPTORS 
IN UMBILICAL VASCULATURE. 

182716 03-03 



DISCRIMINATIVE CONTROL OF BEHAVIOR BY ELECTRICAL STIMULATION 
OF THE DORSAL RAPHE NUCLEUS: GENERALIZATION TO LYSERGIC 
ACID DIETHYLAMIDE (LSD). 

191944 04-04 
CHROMOSOME EXAMINATIONS AFTER MEDICALLY ADMINISTERED 
LYSERGIC ACID DIETHYLAMIDE AND DEXTROAMPHETAMINE. 

192084 04-15 
DIETHYLBARBITURIC 

THE METABOLISM OF l-N-BUTYL-5,5 DIETHYLBARBITURIC ACID (N-N 
BUTYLBARBITAL) IN THE RAT. 

191057 04-03 
DIETHYLETHER 

INDUCTION OF A DIETHYLETHER WITHDRAWAL SYNDROME IN MICE BY 
EXPOSURE TO ETHER VAPOR. 

192006 04-03 
DIFFERENCE 

COMPARABLE THERAPEUTIC EFFICACY OF TRYPTOPHAN AND 
IMIPRAMINE: AVERAGE THERAPEUTIC RATINGS VERSUS TRUE 
EQUIVALENCE. AN IMPORTANT DIFFERENCE. 

167344 01-09 
DIFFERENTIAUY 

BRAIN TO SERUM DISTRIBUTION OF RADIOACTIVITY OF INJECTED 3H-D- 
AMPHETAMINE IN DIFFERENTIALLY HOUSED MICE. 

168418 01-03 
DIFFERENTIATING 

DIFFERENTIATING STIMULUS AND STORAGE HYPOTHESES OF STATE- 
DEPENDENT LEARNING. 

188226 04-14 
DIFFERENTIATION 

EFFECTS OF P-CHLOROPHENYLALANINE ON DIFFERENTIATION OF 
SEROTONINERGIC RECEPTIVE CELLS DURING EMBRYOGENESIS. 
(UNPUBLISHED PAPER). 

168817 01-03 
THE DIFFERENTIATION OF ANXIETY AND DEPRESSIVE DISORDERS: A 
PSYCHOPHARMACOLOGICAL APPROACH. 

175286 02-10 
PHARMACOLOGICAL ANALYSIS OF NOREPINEPHRINE AND 5- 
HYDROXYTRYPTAMINE REMOVAL FROM THE PULMONARY 
CIRCULATION: DIFFERENTIATION OF UPTAKE SITES FOR EACH AMINE. 

182717 03-03 
THE ANTAGONISM BETWEEN CHOLINOMIMETIC AGONISTS AND BETA- 
ADRENOCEPTOR STIMULANTS: THE DIFFERENTIATION BETWEEN 
BETWEEN FUNCTIONAL AND METAFFINOID ANTAGONISM. 

191420 04-03 
DIGITALIZATION 

RAPID DIGITALIZATION OF DECOMPENSATED SCHIZOPHRENIC PATIENTS 
WITH ANTIPSYCHOTIC AGENTS. 

189095 04-08 
DIHYDROBENZOTHIAZINE 

THE SYNTHESES OF 2,3 DIHYDROBENZOTHIAZINE DERIVATIVES. (PH.D. 
DISSERTATION). 

173589 01-01 
DIHYDRODIBENZOTHIEPINS 

D-(R)- AND L-(S) 3-ALKYLAMINOPYRROLIDINO-SUBSTITUTED 

DIHYDRODIBENZOTHIEPINS, XANTHENES, AND DIPHENYLMETHANES. 

187937 04-01 
DIHYDROPTERIDINE 

DIHYDROPTERIDINE REDUCTASE IN RAT BRAIN: REGIONAL DISTRIBUTION 
AND THE EFFECT OF CATECHOLAMINE DEPLETING DRUGS. 

189752 04-03 
DIHYDROXYOCTAHYDROPHENANTHRENES 

CENTRALLY ACTING MUSCLE RELAXANTS. ISOMERIC 9,10 

DIHYDROXYOCTAHYDROPHENANTHRENES AND THEIR CARBAMATE 
ESTERS. 

190719 04-02 
DIHYDROXYPHENYLSERINE 

THREO-3,4 DIHYDROXYPHENYLSERINE, A POOR SOURCE OF 
NORADRENALINE IN THE RAT. 

167445 01-03 
FORMATION OF NORADRENALINE IN THE RAT BRAIN FROM THE FOUR 
STEREOISOMERS OF 3,4 DIHYDROXYPHENYLSERINE. 

184229 03-03 
DIHYDROXYTETRAHYDROISOQUINOLINE 

NONSPONTANEOUS CONVULSIONS IN MICE ELICITED BY SOME 
CATECHOLAMINE RELEASERS AND 6,7 
DIHYDROXYTETRAHYDROISOQUINOLINE (TIQ). 

192013 04-05 
DIHYDROXYTRYPT AMINE 

LONG-TERM EFFECTS OF 5,7 DIHYDROXYTRYPTAMINE ON BRAIN 
MONOAMINES. 

180022 02-03 
BIOCHEMICAL AND BEHAVIOURAL ALTERATIONS FOLLOWING 5,6 
DIHYDROXYTRYPTAMINE ADMINISTRATION INTO BRAIN. 

186634 03-04 
ON THE BEHAVIORAL AND NEUROCHEMICAL ACTIONS OF 6- 
HYDROXYDOPA AND 5,6 DIHYDROXYTRYPTAMINE IN RATS. 

187380 04-03 



S-79 



Subject Index 

DEPLETION OF TRYPTOPHAN HYDROXYLASE BY 5,6 

DIHYDROXYTRYPT AMINE IN RAT BRAIN -- TIME COURSE AND 
REGIONAL DIFFERENCES. 

188287 04-03 

THE EFFECT OF 5,7 DIHYDROXYTRYPTAMINE ON PERIPHERAL 
ADRENERGIC NERVES IN THE MOUSE. 

188977 04-03 
EFFECTS OF VARIOUS DRUGS ON THE ACTIONS OF 5,7 
DIHYDROXYTRYPTAMINE. 

191955 04-03 

DIMETHACRINE 

A DOUBLE-BLIND INVESTIGATION OF DIMETHACRINE VERSUS 
IMIPRAMINE IN HOSPITALIZED DEPRESSIVE STATES. 

171695 01-09 
DIMETHOXY-4-BROMOAMPHETAMINE 

EFFECTS OF PSYCHOTOMIMETICS ON VASCULAR STRIPS: STUDIES OF 
METHOXYLATED AMPHETAMINES AND OPTICAL ISOMERS OF 2,5 
DIMETHOXY-4-METHYLAMPHETAMINE AND 2,5 DIMETHOXY-4- 
BROMOAMPHETAMINE. 

177734 02-03 

DIMETHOXY-4-ETHYLAMPHETAMINE 

STEREOSPECIFIC ACTIONS OF DOET (2,5 DIMETHOXY-4- 
ETHYLAMPHETAMINE) IN MAN. 

188121 04-12 
DIMETHOXY-4-METHYLAMPHETAMINE 

EFFECTS OF PSYCHOTOMIMETICS ON VASCULAR STRIPS: STUDIES OF 
METHOXYLATED AMPHETAMINES AND OPTICAL ISOMERS OF 2,5 
DIMETHOXY-4-METHYLAMPHETAMlNE AND 2,5 DIMETHOXY-4- 
BROMOAMPHETAMINE. 

177734 02-03 
ELECTROENCEPHALOGRAPHIC EFFECTS OF DELTA9- 

TETRAHYDROCANNABINOL, LSD-25, MESCALINE AND 2,5 DIMETHOXY- 
4-METHYLAMPHETAMINE IN THE RABBITS. 

182095 02-03 
EFFECT OF D-AMPHETAMINE (DA) AND 2,5 DIMETHOXY-4- 

METHYLAMPHETAMINE (DOM) ON THE IN VIVO RELEASE OF 14C- 
NOREPINEPHRINE (NE) INTO THE LATERAL VENTRICLE OF RATS. 

182251 03-03 
NEUROPHARMACOLOGICAL ANALYSIS OF R(-)-2,5 DIMETHOXY-4- 
METHYLAMPHETAMINE (R-DOM). 

191906 04-03 
DIMETHOXY-4-METHVlPHENYl 

STEREOCHEMICAL ASPECTS IN THE METABOLISM OF THE 

PSYCHOTOMIMETIC AMINE 1(2,5 DIMETH0XY-4-METHYLPHENYL)-2 
AMPHETAMINE. 

175759 02-03 

CARDIOVASCULAR AND GROSS BEHAVIORAL EFFECTS OF 

AMPHETAMINE, 2-AMIN0-l-(2,5 DIMETHOXY-4-METHYLPROPANE 
(DOM) AND 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPHENYL BUTANE 
(BL-3912A) IN THE CONSCIOUS DOG. 

187573 04-03 
CHEMICAL CONVERSION OF THE PSYCHOTOMIMETIC AMINE l-(2,5 
DIMETHOXY-4-METHYLPHENYL) 2-AMINOPROPANE TO 5- 
HYDROXYDIMETHYLINDOLE. 

187941 04-01 

STEREOCHEMICAL ASPECTS AND METABOLITE FORMATION IN THE IN 
VIVO METABOLISM OF THE PSYCHOTOMIMETIC AMINE, 1-2,5- 
(DtMETHOXY-4-METHYLPHENYL) 2 AMINOPROPANE. 

190718 04-03 

DIMETHOXY-4.METHYLPROPANE 

CARDIOVASCULAR AND GROSS BEHAVIORAL EFFECTS OF 

AMPHETAMINE, 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPROPANE 
(DOM) AND 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPHENYL BUTANE 
(BL-3912A) IN THE CONSCIOUS DOG. 

187573 04-03 
DIMETHOXYMETHYl-PHENOBARBITAl 

THE METABOLIC FATE OF N,N DIMETHOXYMETHYL-PHENOBARBITAL IN 

THE RAT. 

177731 02-03 

DIMETHOXYPHENETHYLAMINE 

EFFECT OF 3,4 DIMETHOXYPHENETHYLAMINE ON MONOAMINE DEPLETED 

RATS. 

183608 03-03 

DIMETHOXYPHENYLETHYLAMINE 

THE EFFECTS OF 3,4 DIMETHOXYPHENYLETHYLAMINE IN RATS TRAINED 
WITH MESCALINE AS A DISCRIMINATIVE STIMULUS. 

186667 03-04 

DIMETHYl-M-TYRAMINE 

EVIDENCE FOR A NORADRENERGIC AND DOPAMINERGIC MECHANISM IN 
THE HYPERACTIVITY PRODUCED BY 4,ALPHA DIMETHYL-M-TYRAMINE 

(H-77-77) IN RATS. 

190309 04-04 

DIMETHYLAMINOETHANOL 

STUDY WITH RADIOTRACERS OF THE DISTRIBUTION OF A NEW 
PSYCHOTROPE IN MICE: L-2-PYRROLIDONE-5-CARBOXYLATE 
DIMETHYLAMINOETHANOL. I. COMPARISON WITH L-GLUTAMIC AND L- 
2-PYRROLIDONE-5-CARBOXYLIC ACID. 

180723 02-03 



Psychopharmacology Abstracts 



DIMETHYLAMINOPROPYLTHIOCINNAMANIUDE 

ATTENUATION OF CONFLICT BEHAVIOR WITH CINANSERIN 

DIMETHYLAMINOPROPYLTHIOCINNAMANILIDE HYDROCHLORIDE), A 
SEROTONIN ANTAGONIST: REVERSAL OF THE EFFECT WITH 5- 
HYDROXYTRYPTOPHAN (5-HTP) AND ALPHA-METHYLTRYPT AMINE. 

176861 02-04 
DIMETHYLAMPHET AMINES 

DEMETHYLATION OF N,N DIMETHYLAMPHET AMINES - EVIDENCE FOR A 
MULTIENZYME SYSTEM. 

191923 04-03 
DIMETHYLNITROSAMINE 

REDUCTION BY PRETREATMENT WITH DIBENAMINE OF HEPATOTOXICITY 
INDUCED BY CARBON TETRACHLORIDE, THIOACETAMINDE OR 
DIMETHYLNITROSAMINE. 

188865 04-05 

OIMETHYLTRYPTAMINE 

FAILURE OF N,N OIMETHYLTRYPTAMINE TO EVOKE TOLERANCE IN CATS, 

173398 01-03 
A POSSIBLE MECHANISM FOR THE ANTISCHIZOPHRENIC ACTION OF 
CHLORPROMAZINE: INHIBITION OF THE FORMATION OF 
OIMETHYLTRYPTAMINE BY CHLORPROMAZINE METABOLITES. 

187576 04-03 
OIMETHYLTRYPTAMINE: ITS BIOSYNTHESIS AND POSSIBLE ROLE IN 
MENTAL DISEASE. 

191535 04-12 
CORRELATION BETWEEN BRAIN N,N OIMETHYLTRYPTAMINE (DMT) 
LEVELS AND BAR PRESSING BEHAVIOR IN RATS: EFFECT OF MAO 
INHIBITION. 

191935 04-04 

DIMINISHES 

MARIJUANA DIMINISHES GSR ACTIVATION PEAKING. 

181887 02-13 

DINUCLEOTIDE 

SUBSTITUTED PIPERAZINOQUINAZOLONES: RELATIONSHIP BETWEEN 
SELECTIVE INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE 
DEPENDENT OXIDATIONS AND ANTICONVULSANT ACTIVITY. 

183598 03-02 
SUBSTITUTED BENZOXAZOLE/BENZTHIAZOLE-2-THIONES: 

INTERRELATIONSHIP BETWEEN ANTICONVULSANT ACTIVITY AND 
INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT 
OXIDATIONS AND MONOAMINE OXIDASE. 

183601 03-03 

DIPHENHYDRAMINE 

COMPLICATIONS OF METHAQUALONE DIPHENHYDRAMINE (MANDRAX) 

ABUSE. 

177452 02-1; 

AN ELECTROENCEPHALOGRAPHIC STUDY ON THE TOLERANCE OF THE 
VARIOUS PSYCHIATRIC AND NEUROLOGICAL PATIENTS TO THE 
HYPNOTIC EFFECTS OF DIPHENHYDRAMINE - MEASURED BY THE 
AMOUNTS OF SLEEP EEG AS AN INDICATOR. 

182550 03-11 

DIPHENYLHYDANTOIN 

DIPHENYLHYDANTOIN EFFECTIVENESS IN THE TREATMENT OF CHRONIC 

SCHIZOPHRENICS: A DOUBLE-BUND CONTROLLED STUDY WITH A 

PLACEBO. 

171507 01-01 

PREVENTION OF ALCOHOL WITHDRAWAL SEIZURES: THE ROLES OF 
DIPHENYLHYDANTOIN AND CHLORDIAZEPOXIDE. 

172275 01-r 
EFFECTS OF DIPHENYLHYDANTOIN ON ANXIETY AND HOSTILITY IN 
INSTITUTIONALIZED PRISONERS. 

177671 02- 1 

PENTYLENETETRAZOL CONVULSIONS AND BRAIN CATECHOLAMINE 
TURNOVER RATE IN RATS AND MICE RECEIVING DIPHENYLHYDANTOIN 
OR BENZODIAZEPINES. 

182344 03-0: 

IN VITRO BINDING OF (4-14C) DIPHENYLHYDANTOIN TO RAT BRAIN 

MICROSOMES. 

188404 04-0: 

NERVE CONDUCTION VELOCITY IN PATIENTS ON LONG-TERM 
- DIPHENYLHYDANTOIN THERAPY. 

189173 04-1: 

DIPHENYIMETHANES 

D-(R)- AND L-(S) 3-ALKYLAMINOPYRROLIDINO-SUBSTITUTED 

DIHYDRODIBENZOTHIEPINS, XANTHENES, AND DIPHENYLMETHANES. 

187937 04-0 

DIPOTASSIUM „ ^ 

CLORAZEPATE DIPOTASSIUM, DIAZEPAM AND PLACEBO IN CHRONIC 

ANXIETY. 

167339 01-1 

COMPARISON OF ANTICONVULSANT EFFECTS OF CLORAZEPATE 

DIPOTASSIUM AND DIAZEPAM: FOUR WEEK ANTICONVULSANT STUD' 
IN RHESUS MONKEYS. 

1 76677 02-0 

DIPSOGENIC 

DIPSOGENIC ACTION OF DIAZOXIDE: A PHARMACOLOGIC ANALYSIS. 

191768 04-0 



S-80 



VOLUME 12, SUBJECT INDEX 



Subject Index 



DIRECT 

DIRECT DETERMINATION OF LITHIUM IN SERUM BY ATOMIC 
ABSORPTION SPECTROSCOPY, 

181653 02-06 
SEPARATION OF THE DEPENDENCE PRODUCING ACTIONS FROM THE 
DIRECT ACTIONS OF NARCOTICS ON GUINEA-PIG ILEUM. 

182162 02-03 
QUANTITATIVE DETERMINATION OF IMIPRAMINE AND DESIPRAMINE IN 
HUMAN BLOOD PLASMA BY DIRECT DENSITOMETRY OF THIN-LAYER 
CHROMATOGRAMS. 

183603 03-13 
BEHAVIORAL EFFECTS OF DIRECT AND INDIRECT ACTING DOPAMINERGIC 
AGONISTS. 

191521 04-04 
DISABILITIES 

A STUDY OF THE EFFECTS OF RITALIN INTERVENTION UPON THE 
PERCEPTUAL COMPETENCIES OF CHILDREN DIAGNOSED AS GIVING 
EVIDENCE OF PSYCHONEUROLOGICAL LEARNING DISABILITIES. (PH.D. 
DISSERTATION). 

186833 03-14 
DISAGGREGATION 

DISAGGREGATION OF BRAIN POLYSOMES AFTER L-DOPA: AN ANALYSIS. 

188433 04-03 
DISCHARGE 

EFFECT OF ANTICONVULSANT DRUGS ON THE NUMBER OF AFFERENT 
STIMULI NEEDED TO CAUSE A HIPPOCAMPAL SEIZURE DISCHARGE. 

189608 04-03 
DISCHARGED 

THE DISCHARGED PATIENTS DRUG TREATMENT. 

185195 03-17 
DISCIPLINE 

AN ACCOUNT OF THE USE OF FLUPHENAZINE SINCE THE ESTABLISHMENT 
OF PSYCHIATRY AS A SEPARATE DISCIPLINE. 

176431 02-11 
DISCREPANCIES 

ELECTROCLINICAL DISCREPANCIES IN ANTIANXIETY DRUGS. 

181918 02-13 
DISCRIMINABLE 

CLASSIFICATION OF DRUGS ACCORDING TO THEIR DISCRIMINABLE 
EFFECTS IN RATS. 

188228 04-06 
DISCRIMINANT 

DISCRIMINANT ANALYSIS OF THE RELATIONSHIP BETWEEN PHYSICAL 
PROPERTIES AND THE INHIBITION OF MONOAMINE OXIDASE BY 
AMINOTETRALINS AND AMINOINDANS. 

180096 02-03 
DISCRIMINATED 

THE EFFECTS OF D-AMPHETAMINE ON THE INTERRESPONSE TIMES OF 
RATS AND GUINEA-PIGS ON A MODIFIED SIDMAN DISCRIMINATED 
AVOIDANCE SCHEDULE. 

189519 04-04 
EFFECTS OF DELTA1-TETRAHYDR0CANNA8IN0L ON SIDMAN 
DISCRIMINATED AVOIDANCE BEHAVIOR IN RATS. 

192413 04-03 
DISCRIMINATION 

EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS. 

169467 01-03 
EFFECTS OF PSYCHOTROPIC DRUGS ON DISCRIMINATION AVOIDANCE 
CONDITIONING IN RATS WITH OLFACTORY BULB ABLATIONS. 

182115 02-04 
EFFECTS OF PHYSOSTIGMINE ON THE MAINTENANCE OF 
DISCRIMINATION BEHAVIOUR IN RATS. 

186637 03-04 
DIFFERENTIAL EFFECTS OF PILOCARPINE AND SCOPOLAMINE ON THE 
PERFORMANCE OF A LIGHT DARK DISCRIMINATION MAINTAINED BY 
ELECTRICAL STIMULATION OF THE BRAIN. 

186701 03-03 
COCAINE, PEMOLINE AND AMPHETAMINE ON LEARNING AND RETENTION 
OF A DISCRIMINATION TEST IN MICE. 

186705 03-04 
ANISOMYCIN, LIKE OTHER INHIBITORS OF CEREBRAL PROTEIN 

SYNTHESIS, IMPAIRS LONG-TERM MEMORY OF A DISCRIMINATION 
TASK. 

188605 04-04 
DISCRIMINATIVE 

OPEN-FIELD BEHAVIOR AND ACQUISITION OF DISCRIMINATIVE RESPONSE 
CONTROL IN DELTA9-THC TOLERANT RATS. 

178813 02-04 
AMPHETAMINE AND PENTOBARBITAL EFFECTS ON THE DISCRIMINATIVE 
RESPONSE CONTROL BY DEPRIVATION OF RAPID EYE MOVEMENT 
SLEEP (REM). 

182245 03-03 
THE GENERAL LOCUS OF D-AMPHETAMINE-INOUCED DISCRIMINATIVE 
STIMULI. (PH.D. DISSERTATION). 

185725 03-03 



THE EFFECTS OF 3,4 DIMETHOXYPHENYLETHYLAMINE IN RATS TRAINED 
WITH MESCALINE AS A DISCRIMINATIVE STIMULUS. 

186667 03-04 
HALLUCINOGENS AS DISCRIMINATIVE STIMULI. 

188229 04-12 
DISCRIMINATIVE CONTROL OF BEHAVIOR BY ELECTRICAL STIMULATION 
OF THE DORSAL RAPHE NUCLEUS: GENERALIZATION TO LYSERGIC 
ACID DIETHYLAMIDE (LSD). 

191944 04-04 
DISEASE 

L-DOPA IN 122 CASES OF PARKINSONS DISEASE AT AGE 70 OR OVER. A 
COMPARATIVE STUDY WITH A GROUP OF PATIENTS AGED 41 TO 69 
YEARS. 

168369 01-11 
VESTA VARIANT OF TOURETTES DISEASE: TREATMENT WITH 
HALOPERIDOL. 

169286 01-10 
A DOUBLE-BLIND CLINICAL TRIAL OF DOXEPIN HYDROCHLORIDE AND 
DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION 
IN THE FIELD OF INTERNAL MEDICINE. 

17128201-11 
SOME PROBLEMS IN THE PSYCHOPHARMACOLOGICAL TREATMENT OF 
PSYCHOSOMATIC DISEASE. 

177066 02-17 
L-DOPA AND THE TREATMENT OF EXTRAPYRAMIDAL DISEASE. 
(UNPUBLISHED PAPER). 

177975 02-11 
DOUBLE-BLIND CROSSOVER COMPARISON OF BROMAZEPAM AND 

DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION 

182624 03-11 
LONG-RANGE MOTOR PERFORMANCE CHANGES IN LEVODOPA TREATED 
PATIENTS WITH PARKINSONS DISEASE. 

184195 03-11 
PARKINSON DISEASE TREATED WITH A SUSPECTED DOPAMINE RECEPTOR 
AGONIST. 

186029 03-11 
ONE CASE OF AGRYPNIA (4 MONTHS WITHOUT SLEEP) IN A MORVAN 
DISEASE: FAVORABLE ACTION OF 5-HYDROXYTRYPTOPHAN 

187237 03-14 
LEVODOPA COMBINED WITH MK-486 (L-ALPHA- 

METHYLDOPAHYDRAZINE) - A PERIPHERAL DECARBOXYLASE 
INHIBITOR IN PARKINSONS DISEASE. 

187615 04-11 
LEVODOPA, CARBIDOPA, AND PYRIDOXINE IN PARKINSON DISEASE. 

187877 04-13 
PLASMA DOPA AND FUNCTIONAL OSCILLATIONS AFTER CHRONIC 
TREATMENT OF PARKINSONS DISEASE. 

188421 04-13 
PHARAAACOGENETICS AND MENTAL DISEASE. 

188826 04-11 
COMPARISON OF AMANTADINE, PLACEBO, AND LEVODOPA IN 
PARKINSONS DISEASE. 

189502 04-11 
DISSOCIATION OF GROWTH HORMONE AND PROLACTIN SECRETION IN 
PARKINSONS DISEASE FOLLOWING CHRONIC L-DOPA THERAPY. 

191233 04-13 
EFFECTS OF PIRIBEDIL (ET-495) - A DOPAMINERGIC RECEPTOR 
STIMULATING AGENT IN PARKINSONS DISEASE. 

191522 04-13 
DIMETHYLTRYPTAMINE: ITS BIOSYNTHESIS AND POSSIBLE ROLE IN 
MENTAL DISEASE. 

191535 04-12 
CLINICAL EXPERIENCE WITH DIAMORPHINE IN ADVANCED MALIGNANT 
DISEASE. 

191606 04-17 
DISEASES 

CLINICAL EFFECT OF A NEW PSYCHOTROPIC DRUG, ZISEPRON, IN 
TREATMENT OF PSYCHIATRIC DISEASES IN COMPARISON WITH 
THIORIDAZINE. 

1 76467 02-08 
THE PROBLEMS OF THE PSYCHOPHARMACOLOGICAL TREATMENT OF 
PSYCHOSOMATIC DISEASES - THE ANESTHESIOLOGIC APPROACH. 

177063 02-17 
CLINICAL EXPERIENCE WITH A NEW PSYCHOTROPIC DRUG: FK-880 
(SULPIRIDE), ITS EFFECT ON PATIENTS WITH PSYCHOSOMATIC 
DISEASES AND PSYCHONEUROSIS. 

182731 03-10 
CONSIDERATIONS ON THE USE OF ANALGESIC DRUGS IN DIFFERENT 
STAGES OF NEOPLASTIC DISEASES. 

191604 04-17 
DISLOCATIONS 

DIAZEPAM USED INTRAVENOUSLY DURING REDUCTION OF FRACTURES 
AND DISLOCATIONS. 

174880 01-17 
DISORDER 

A COMPARISON OF LITHIUM CARBONATE IN THE PREVENTION OF MANIC 
AND DEPRESSIVE EPISODES IN RECURRENT AFFECTIVE DISORDER. 

169090 01-09 



S-81 



Subject Index 



Psychopharmacology Abstracts 



THE EFFECT OF LITHIUM ON THYROID IODINE RELEASE IN PATIENTS 
WITH PRIMARY AFFECTIVE DISORDER. 

186580 03-09 
LITHIUM IN TREATMENT AND PREVENTION OF AFFECTIVE DISORDER: A 
VA-NIMH COLLABORATIVE STUDY. 

190381 04-09 

DISORDERED 

SAFETY AND EFFECTIVENESS OF HALOPERIDOL FOR MENTALLY 

RETARDED BEHAVIORALLY DISORDERED AND HYPERKINETIC PATIENTS. 

169634 01-11 

DISORDERS 

TRAZODONE IN THE TREATMENT OF AFFECTIVE DISORDERS. 

168807 01 -n 
CATECHOLAMINE METABOLISM IN AFFECTIVE DISORDERS: RECENT 
STUDIES OF MHPG EXCRETION. 

169091 01-13 

CHANGES IN SOMATOSENSORY EVOKED POTENTIALS PRODUCED BY 
DRUGS USED IN THE TREATMENT OF AFFECTIVE DISORDERS. 

169092 01-09 

A COLLABORATIVE ASSESSMENT OF NOREPINEPHRINE METABOLISM IN 

AFFECTIVE DISORDERS. 

169094 01-09 

HALOPERIDOL FOR PSYCHIATRIC DISORDERS IN CHILDREN. 

169457 01-14 
THE USE OF LITHIUM IN AFFECTIVE DISORDERS, III: A DOUBLE-BLIND 
STUDY OF PROPHYLAXIS IN BIPOLAR ILLNESS. 

169495 01-09 
A TRIAL ON BROMAZEPAM (LEXOTAN) AND PLACEBO IN THE 
TREATMENT OF PSYCHOPHYSIOLOGICAL DISORDERS. 

17115001-11 
L-TRYPTOPHAN IN MANIA: CONTRIBUTION TO A PERMISSIVE 
HYPOTHESIS OF AFFECTIVE DISORDERS. 

171500 01-09 
LITHIUM CARBONATE AND SLEEP IN AFFECTIVE DISORDERS: FURTHER 
CONSIDERATIONS. 

171503 01-09 
A GUIDE FOR DRUG USE IN DEPRESSIVE DISORDERS. 

171923 01-09 
LITHIUM PROPHYLAXIS IN AFFECTIVE DISORDERS: AN OPEN TRIAL WITH 
MATCHED CONTROLS. 

172401 01-09 
HYPERKINETIC, HYPOSCHOLASTIC BEHAVIOUR AND CHARACTER 
DISORDERS OF CHILDHOOD AND ADOLESCENCE: DIAGNOSIS AND 
PHARMACOTHERAPY. 

172800 01-11 

L-TRYPTOPHAN IN THE TREATMENT OF LEVODOPA INDUCED 
PSYCHIATRIC DISORDERS. 

174297 01-15 

LONG-TERM USE OF LITHIUM CARBONATE IN AFFECTIVE DISORDERS: A 
CLINICAL EVALUATION. 

174778 01-09 

THE DIFFERENTIATION OF ANXIETY AND DEPRESSIVE DISORDERS: A 
PSYCHOPHARMACOLOGICAL APPROACH. 

175286 02-10 
PIMOZIDE IN THE TREATMENT OF BEHAVIORAL DISORDERS OF 
HOSPITALIZED ADOLESCENTS. 

176109 02-14 

NEUROPHARMACOLOGICAL STUDIES OF MOOD DISORDERS. 

178114 02-09 
EXPERIENCE IN THE TREATMENT OF CEREBRAL INSUFFICIENCY AND 
PERIPHERAL BLOOD CIRCULATION DISORDERS USING THE EP- 50-100 
EXPERIMENTAL DRUG. 

180676 02-11 

A CLINICAL EVALUATION OF A NEW ANXIOLYTIC DRUG 
(THIENODIAZEPINE DERIVATIVE Y-6047) IN NEUROTICS AND 
PSYCHOSOMATIC DISORDERS - A PRELIMINARY REPORT. 

181771 02-07 

TREATMENT OF HALLUCINATORY DISORDERS IN SCHIZOPHRENIA BY 

ATROPINE COMAS. 

181778 02-08 

A SERIES OF MULTICENTRIC PILOT TRIALS WITH PIMOZIDE IN 
PSYCHIATRIC PRACTICE: I. PIMOZIDE IN THE TREATMENT OF 
PERSONALITY DISORDERS. 

183191 03-11 

A SERIES OF MULTICENTRIC PILOT TRIALS WITH PIMOZIDE IN 
PSYCHIATRIC PRACTICE: II. PIMOZIDE IN THE TREATMENT OF 
BEHAVIOURAL DISORDERS IN CHILDHOOD AND ADOLESCENCE. 

183192 03-11 
A SERIES OF MULTICENTRIC PILOT TRIALS WITH PIMOZIDE IN 

PSYCHIATRIC PRACTICE: III. PIMOZIDE IN THE TREATMENT OF STRESS 
INDUCED PSYCHIC AND FUNCTIONAL DISORDERS. 

183193 03-11 

A PSYCHOPHARMACOLOGICAL STUDY OF CATECHOLAMINES IN 

AFFECTIVE DISORDERS. 

184653 03-09 

TREATMENT OF MENTAL DISORDERS. 

185182 03-17 



L-TRYPTOPHAN IN AFFECTIVE DISORDERS: INDOLEAMINE CHANGES AND 
DIFFERENTIAL CLINICAL EFFECTS. 

185928 03-09 
AFFECTIVE DISORDERS AND CHEMICAL DEPENDENCE: LITHIUM FOR 
ALCOHOL AND DRUG ADDICTION 

1 89775 04-09 
A FEW REMARKS ON THE USE OF PSYCHOACTIVE AGENTS IN THE 
TREATMENT OF EMOTIONAL DISORDERS. 

190241 04-09 
ANTICONVULSANT DRUG SERUM LEVELS IN PSYCHIATRIC PATIENTS 
WITH SEIZURE DISORDERS: EFFECTS OF CERTAIN PSYCHOTROPIC 

DRUGS. 

191096 04-13 

REBOUND PHENOMENON IN MANIC PATIENTS FOLLOWING 

PHYSOSTIGMINE: TOWARDS AN UNDERSTANDING OF AMINERGIC 
MECHANISMS UNDERLYING AFFECTIVE DISORDERS. 

191531 04-09 

ADRENERGIC AND CHOLINERGIC FACTORS IN EXTRAPYRAMIDAL 

DISORDERS. 

191533 04-11 

DISORGANIZATION 

TEMPORAL DISORGANIZATION AND DELUSIONAL-LIKE IDEATION: 
PROCESSES INDUCED BY HASHISH AND ALCOHOL. 

185330 03-14 

DISORIENTATION 

PAROXYSMAL RIGHT LEFT DISORIENTATION IN AN EPILEPTIC PATIENT. 

17124601-11 
DOPAMINE AGONIST INDUCED DISORIENTATION IN A RAT SWIMMING 

TASK. 

192018 04-04 

DISPOSITION 

PHARMACOKINETIC DISPOSITION OF NORAPOMORPHINE DERIVATIVES 
AND ITS INFLUENCE ON THE ELICITATION OF STEREOTYPICAL 
GNAWING. (PH.D. DISSERTATION). 

174960 01-03 
QUALITATIVE AND QUANTITATIVE STUDIES ON THE DISPOSITION OF 
AMITRIPTYLINE AND OTHER TRICYCLIC ANTIDEPRESSANT DRUGS IN 
MAN AS IT RELATES TO THE MANAGEMENT OF THE OVERDOSED 
PATIENT. „„ _ 

177395 02- 15 

DISPOSITION OF NORAPOMORPHINE AND N,N PROPYLNORAPOMORPHINE 
IN MOUSE BRAIN AND ITS CORRELATION WITH STEREOTYPED 
GNAWING BEHAVIOR. 

182131 02-04 
PHYSIOLOGICAL DISPOSITION OF BETA-PHENYLETHYLAMINE, 2,4,5 
TRIMETHOXYPHENYLETHYLAMINE, 2,3,4,5,6 

PENTAMETHOXYPHENYLETHYLAMINE AND BETA-HYDROXYMESCALINE 
IN RAT BRAIN, LIVER AND PLASMA. 

186706 03-03 
DISPOSITION OF H3-DELTA9-TETRAHYDR0CANNABIN0L IN BRAIN OF 
PREGNANT DOGS AND THEIR FETUSES. 

191968 04-03 

DISRUPTION 

A STUDY OF THE BEHAVIORAL DISRUPTION OF MICE INDUCED BY L- 
METHIONINE AND RELATED COMPOUNDS. 

187260 04-04 

DISRUPTIVE 

PARENTERAL HALOPERIDOL FOR RAPID CONTROL OF SEVERE, 
DISRUPTIVE SYMPTOMS OF ACUTE SCHIZOPHRENIA. 

178545 02-08 

DISRUPTS 

METRAZOL DISRUPTS CONDITIONED AVERSION PRODUCED BY LICL: A 
TIME DEPENDENT EFFECT. 

188412 04-04 

DISSOCIATION 

DISSOCIATION OF STIMULATORY AND SYNTHETIC PHASES IN THE 
INDUCTION OF TYROSINE HYDROXYLASE. 

171785 01-0; 
BRAIN MECHANISMS UNDERLYING THE EFFECTS OF AMPHETAMINE ON 
FEEDING AND NONFEEDING BEHAVIORS: DISSOCIATION AND OVERLAP. 

184839 03-0: 
TEMPORAL ASPECTS OF SCOPOLAMINE INDUCED ONE-WAY MEMORY 
DISSOCIATION IN MICE. 

187701 04-0^ 

DISSOCIATION BETWEEN SCOPOLAMINE AND MECAMYLAMINE DURING 

FEAR CONDITIONING IN RATS. 

1 90264 04-0' 

DISSOCIATION OF GROWTH HORMONE AND PROLACTIN SECRETION IN 
PARKINSONS DISEASE FOLLOWING CHRONIC L-DOPA THERAPY. 

191233 04-1: 

DISSOCIATIVE 

OPERANT BEHAVIOR AND NEUROPHYSIOLOGICAL OBSERVATIONS OF 
NORMAL HUMAN VOLUNTEERS RECEIVING CL-1848C, A NEW 
DISSOCIATIVE ANESTHETIC. ^^^^^^ ^, ^. 

DISSOCIATIVE CHANGE IN ANTIAGGRESSIVE AND MUSCLE RELAXANT 
ACTIONS OF S-TRIAZOLOBENZODIAZEPINE (D-40TA) BY REPEATED 



S-82 






VOLUME 12, SUBJECT INDEX 



Subject Index 



ADMINISTRATION AND PHENOBARBITAL PRETREATMENT, AND ITS 
RELATION TO METABOLISM. 

181654 02-04 
ISSOLUTION 

RELATIONSHIP BETWEEN BIOAVAILABILITY AND DISSOLUTION RATE OF 
OXAZEPAM. 

171630 01-16 
ISTINCTIONS 

PHARMACOLOGICAL DISTINCTIONS BETWEEN ACTIVE AND PASSIVE 
AVOIDANCE MEMORY FORMATION AS SHOWN BY MANIPULATION OF 
BIOGENIC AMINE ACTIVE COMPOUNDS. 

185927 03-04 
ISTRIBUTION 

BRAIN TO SERUM DISTRIBUTION OF RADIOACTIVITY OF INJECTED 3H-D- 
AMPHETAMINE IN DIFFERENTIALLY HOUSED MICE. 

168418 01-03 
LIPID INDUCED CHANGES OF PENTOBARBITAL DISTRIBUTION AND 
METABOLISM. 

170072 01-03 
CORTICAL SYNAPTOSOMAL UPTAKE AND SUBSYNAPTOSOMAL 
DISTRIBUTION OF 3H-N0REPINEPHRINE AND 3H-AMPHETAMINE-. 
MODIFICATION BY TRICYCLIC AND PSYCHOACTIVE AGENTS IN VITRO. 
(PH.D. DISSERTATION). 

172020 01-03 
THE DISTRIBUTION OF DELTAl TETRAHYDROCANNABINOL AND 7- 
HYDROXY-DELTAl-TETRAHYDROCANNABINOL IN THE MOUSE BRAIN 
AFTER INTRAVENTRICULAR INJECTION. 

172596 01-03 
LITHIUM DISTRIBUTION BETWEEN CEREBROSPINAL FLUID AND SERUM OF 
AFFECTIVE PSYCHOTIC PATIENTS TREATED WITH LITHIUM CARBONATE 
AND ITS CLINICAL RESPONSE. 

180301 02-11 
STUDY WITH RADIOTRACERS OF THE DISTRIBUTION OF A NEW 
PSYCHOTROPE IN MICE: L-2-PYRROLIDONE-5-CARBOXYLATE 
DIMETHYLAMINOETHANOL. I. COMPARISON WITH L-GLUTAMIC AND L- 
2-PYRROLIDONE-5-CARBOXYLIC ACID. 

180723 02-03 
SUBCELLULAR DISTRIBUTION OF DELTA9-TETRAHYDR0CANNABIN0L IN 
RAT BRAIN. 

181810 02-03 
REGIONAL AND SUBCELLULAR DISTRIBUTION OF CHOLINE 
ACETYLTRANSFERASE IN THE BRAIN OF NORMAL AND MORPHINE 
TREATED RATS. 

182224 03-03 
ABSORPTION, DISTRIBUTION, EXCRETION AND METABOLISM OF 
BROMAZEPAM IN RABBIT. 

182555 03-03 
THE ABSORPTION AND DISTRIBUTION OF THE NEW ANTIDEPRESSANT 
AZAPHEN IN THE ORGANS. 

183519 03-03 
EVIDENCE FOR AN UNUSUAL DISTRIBUTION OF CHLORPHENTERMINE IN 
VIVO: AN AUTORADIOGRAPHIC STUDY IN MICE. 

184226 03-03 
HISTO-AUTORADIOGRAPHIC INVESTIGATIONS ON THE DISTRIBUTION OF 
INJECTED 5-HYDROXYTRYPTAMINE (SEROTONIN) IN THE BRAIN AND 
THE PITUITARY OF MICE. 

185900 03-03 
THE EFFECTS OF CHRONIC TREATMENT WITH D-AMPHET AMINE ON FOOD 
INTAKE, BODYWEIGHT, LOCOMOTOR ACTIVITY AND SUBCELLULAR 
DISTRIBUTION OF THE DRUG IN RAT BRAIN. 

185931 03-03 
DIHYDROPTERIDINE REDUCTASE IN RAT BRAIN: REGIONAL DISTRIBUTION 
AND THE EFFECT OF CATECHOLAMINE DEPLETING DRUGS, 

189752 04-03 
PHYLOGENETIC DISTRIBUTION OF OPIATE RECEPTOR BINDING. 

190476 04-03 
NORADRENALINE IN THE GUINEA-PIG ALIMENTARY CANAL: REGIONAL 
DISTRIBUTION AND SENSITIVITY TO DENERVATION AND RESERPINE. 

191326 04-03 
PHARMACOKINETICS AND DISTRIBUTION PROPERTIES OF 

PENTOBARBITAL IN HUMANS FOLLOWING ORAL AND INTRAVENOUS 
ADMINISTRATION. 

191444 04-13 
DISTRIBUTION OF 14C-DELTA9-THC IN MALE AND FEMALE RATS. 

191969 04-03 
DISTRIBUTION OF 14C-PSIL0CIN IN THE BRAINS OF VARIOUS ANIMALS. 

192425 04-03 
)ISTURBANCE 

ACUTE CEREBELLAR DISTURBANCE ASSOCIATED WITH DIAZEPAM 
THERAPY - A CASE REPORT AND FURTHER INVESTIGATION. 

177392 02-15 
IISTURBANCES 

EXTRAPYRAMIDAL DISTURBANCES BROUGHT ON BY NEUROLEPTICS. 

180070 02-15 
TREATMENT OF COMPULSIVE EATING DISTURBANCES WITH 
ANTICONVULSANT MEDICATION. 

181270 02-14 



TREATMENT OF CEREBROVASCULAR DISTURBANCES WITH 2- 

BUTYLAMINO-1-P-HYDROXYPHENYL ETHANOL SULFATE (BAMETHAN). 

182790 03-11 
PSYCHOTROPIC DRUGS IN CHILDHOOD DISTURBANCES. 

182890 03- 11 
THE USE OF ETHYMISOL (ETHYLNORANTIPHEIN) IN PATIENTS WITH 
PROLONGED DISTURBANCES OF CONSCIOUSNESS. 

191777 04-07 
DISTURBED 

MESORIDAZINE IN THE CARE OF DISTURBED MENTALLY RETARDED 
PATIENTS. 

168315 0111 
INFLUENCE OF ANTIDEPRESSIVE THERAPY ON THE DISTURBED TIME 
ESTIMATION OF DEPRESSIVES. 

182591 03-14 
THE EFFECT OF SULTHIAME ON DISTURBED BEHAVIOUR IN MENTALLY 
SUBNORMAL PATIENTS. 

185191 03-14 
DISUBSTITUTED 

PHARMACOLOGY OF MONO AND DISUBSTITUTED CHLORPROMAZINE 
METABOLITES. 

182243 03-03 
DISULFIRAM 

EEG CHANGES & MOTOR IMPAIRMENT AFTER DISULFIRAM 
ADMINISTRATION TO CATS. 

182248 0303 
STUDY OF THE USE OF DISULFIRAM IMPLANT IN THE TREATMENT OF 
ALCOHOLISM. 

183030 03-11 
DISULFIRAM IMPLANT: A CONTROLLED TRIAL. 

185190 03-11 
DITA 

INTERACTION OF SEROTONIN ANTAGONISTS WITH 3,4-DICHL0R0-2-(2- 
IMIDAZOLIN-2-YL-THIO) 2 ACETOPHENONE HYDROBROMIDE (DITA) 
AND D-AMPHETAMINE HYDROBROMIDE (DITA) AND D-AMPHETAMINE 
ON CERTAIN BEHAVIORAL PARAMETERS OF MALE MICE 

192014 04-04 
DITRAN 

RESPONSE TO INCREMENTAL DOSES OF DITRAN IN ABSTINENT 
ALCOHOLICS AND DRUG USERS. 

185875 03-11 
DIURESIS 

ENHANCED RENAL TUBULAR SECRETION OF MEPROBAMATE: ROLE OF 
SALINE FUROSEMIDE DIURESIS. 

184243 03-03 
DIURETIC 

DIURETIC ACTIVITY OF A NEW NARCOTIC ANTAGONIST IN MAN 
(BRISTOL-COMPOUND-2605). (UNPUBLISHED PAPER) 

174473 01-13 
DIURETIC ANTIDEPRESSANT COMBINATION IN ALCOHOLIC DEPRESSIVES. 

187866 04-11 
DIURNAL 

THE EFFECTS OF AMPHETAMINE SULFATE ON THE DIURNAL RHYTHMS OF 
MIDBRAIN; CORTEX, NOREPINEPHRINE; SEROTONIN AND BLOOD 
GLUCOSE LEVELS IN THE MOUSE. 

191918 04-03 
THE INFLUENCE OF IMIPRAMINE, DEXPHENMETRAZINE AND 

AMPHETAMINE SULPHATE ON THE COMPOSITION OF DIURNAL SLEEP 
OF NARCOLEPTICS. 

192419 04-11 
DIVALENT 

EFFECT OF DIVALENT CATIONS ON ACH CONTRACTURES OF 
DEPOLARIZED DENERVATED RAT MUSCLES. 

188914 04-03 
MECHANISM OF ADRENAL CATECHOLAMINE RELEASE BY DIVALENT 
MERCURY. 

189591 04-03 
DIVIDED 

SINGLE VERSUS DIVIDED DAILY DOSE OF TRIMIPRAMINE IN THE 
TREATMENT OF DEPRESSIVE ILLNESS. 

170622 01-09 
DJAKARTA 

EXPERIENCES WITH LAROXYL (R) IN THE TREATMENT OF DEPRESSIONS IN 
PRIVATE PSYCHIATRIC PRACTICE IN DJAKARTA. 

170413 oi-n 
PRELIMINARY EXPERIENCES WITH NOBRIUM IN PRIVATE PSYCHIATRIC 

PRACTICE IN DJAKARTA. 

170414 01-11 
CLINICAL TRIAL WITH DARTALANR, DJAKARTA, INDONESIA. 

170753 01-11 
DL-ALPHA-METHYL-DOPA 

SALIGENIN ANALOGS OF L-DOPA AND DL-ALPHA-METHYL-DOPA. 

187565 04-11 
DL-ALPHA-METHYL-P-TYROSINE 

QUANTITATIVE HISTOCHEMICAL STUDIES OF STRIATAL DOPAMINE 
DEPLETION FOLLOWING DL-ALPHA-METHYL-P-TYROSINE 
ADMINISTRATION. 

172924 01-03 



S-83 



Subject Index 



Psychopharmacology Abstracts 



DL-AMPHET AMINE 

EFFECTS OF L-DELTA9-TETRAHYDR0CANNABIN0L, DL-AMPHET AMINE 
AND PENTOBARBITAL ON OXYGEN CONSUMPTION BY MOUSE BRAIN 
AND HEART HOMOGENATES. ,81813 02-03 

INHIBITION OF THE SYNAPTOSOMAL UPTAKE MECHANISMS FOR L- 
NOREPINEPHRINE AND DOPAMINE BY N-ARYLALKYL DL-AMPHETAMINE 

^^""^^^'^^^ 182250 03-03 

Dl-P-METHOXY AMPHETAMINE 

COMPARATIVE EFFECTS OF DL-PMETHOXY AMPHETAMINE AND D- 
AMPHETAMINE ON CENTRAL CATECHOLAMINES AND LOCOMOTOR 

'^^^'^'^^ 182253 03-04 

SIGNIFICANCE OF DOPAMINE RECEPTOR ACTIVITY IN DL-P- 
METHOXY AMPHETAMINE AND D-AMPHETAMINE-INDUCED 
LOCOMOTOR ACTIVITY. ,86670 03-04 

COMPARATIVE EFFECTS OF DLP-METHOXYAMPHETAMINE AND D- 
AMPHETAMINE ON CATECHOLAMINE RELEASE AND REUPTAKE IN 

^'^''O- 186671 03-03 



DMI 



IN VIVO INHIBITION OF NEURONAL UPTAKE OF A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE (TIQ) ALKALOID BY COCAINE AND BY 
DESMETHYLIMIPRAMINE (DMI). ^^^^^^ ^^^^ 

EFFECT OF CHRONIC TREATMENT WITH DESIPRAMINE (DMI) AND 
IPRINDOLE (IP) ON THE NOREPINEPHRINE (NE) SENSITIVE ADENYLATE 
CYCLASE SYSTEM IN SLICES OF THE RAT LIMBIC FOREBRAIN. 

192003 04-03 

DMT 

DMT ADMINISTRATION TO HUMAN SUBJECTS. (UNPUBLISHED PAPER). 

173522 01-12 
ATTEMPTS TO EVOKE TOLERANCE TO DMT IN MAN. (UNPUBLISHED 

'^''''^- 176480 02-12 

CORRELATION BETWEEN BRAIN N,N DIMETHYLTRYPTAMINE (DMT) 

LEVELS AND BAR PRESSING BEHAVIOR IN RATS: EFFECT OF MAO 

INHIBITION. 

191935 04-04 

DOCUMENTATION 

THE DOCUMENTATION OF CLINICAL PSYCHOTROPIC DRUG TRIALS. 

175332 02-16 
THE DOCUMENTATION OF CLINICAL PSYCHOTROPIC DRUG TRIALS: 

SAMPLE OUTPUT PACKAGE. ,80256 02-16 

DODECYISULFATE 

COMPARATIVE STUDIES OF SYNAPTIC MEMBRANE PROTEIN 
SOLUBILIZATION BY CHLORPROMAZINE AND SODIUM 
DODECYLSULFATE. ,76703 02-03 

DOET 

STEREOSPECIFIC ACTIONS OF DOET (2,5 DIMETHOXY-4- 

ETHYLAMPHETAMINE) IN MAN. ^^^^^^ ^^^^ 



DOG 



CARDIOVASCULAR EFFECTS OF RESERPINE, YOHIMBINE, AND RESERPINE 
YOHIMBINE MIXTURES ON INTACT ANESTHETIZED DOG. 

167328 01-03 

METABOLITES OF BROMAZEPAM, A BENZODIAZEPINE, IN THE HUMAN, 
DOG, RAT, AND MOUSE. ,70837 01-03 

PROGRESS REPORT ON THE USE OF THE DOG FOR ASSESSING MORPHINE- 
LIKE AND NALORPHINE-LIKE AGONISTS AS WELL AS DEPOT 
PREPARATIONS OF ANTAGONISTS. (UNPUBLISHED PAPER). 

1 7631 2 02-03 

ANTICHOLINERGICS: THEIR EFFECTS ON FEAR MOTIVATED BEHAVIOR, 
URINARY ll-HYDROXYCORTICOSTEROIDS, URINARY VOLUME, AND 
HEART RATE IN THE DOG. ,78720 02-03 

INVESTIGATIONS ON THE FATE OF THE ANTICONVULSANT CLONAZEPAM 
IN THE ORGANISM OF MAN. RAT AND DOG. 

ANALGESIC EFFECT OF DELTA9-TETRAHYDR0CANNABIN0L IN THE DOG. 

186585 03-03 

MORPHINE PHYSICAL DEPENDENCE IN THE DOG. 

186665 03-03 

CARDIOVASCULAR AND GROSS BEHAVIORAL EFFECTS OF 

AMPHETAMINE, 2-AMINO-l-(2,5 DIMETHOXY-4-METHYLPROPANE 
(DOM) AND 2-AMIN0-l-(2,5 DIMETHOXY-4-METHYLPHENYL BUTANE 
(BL-3912A) IN THE CONSCIOUS DOG. ,87573 04-03 

CARDIOVASCULAR REACTIVITY IN THE DOG AFTER CHEMICAL 
SYMPATHECTOMY WITH 6-HYDROXYDOPAMINE. 

187807 04-03 



A FREQUENCY SHIFT IN THE HIPPOCAMPAL THETA ACTIVITY: AN 

ELECTRICAL CORRELATE OF CENTRAL ACTION OF ACTH ANALOGUES IN 

THE DOG 

188166 04-04 

COMPARATIVE METABOLISM OF TRIAZOLAM. A NEW SEDATIVE 
HYPNOTIC, IN RAT, DOG AND MAN. 

191900 04-02 

EFFECTS OF PHENETHYLAMINE (PEA) IN THE CHRONIC SPINAL DOG. 

191904 04-03 
SUBCELLULAR LOCALIZATION OF H3-DELTA9-TETRAHYDR0CANNABIN0L 
IN DOG BRAIN AFTER ACUTE OR CHRONIC ADMINISTRATION. 

191970 04-03 

DOGS 

ACUTE TOXICITY OF 8-CHL0R0-6-PHENYL-4H-S- 

TRIAZOLOBENZODIAZEPINE (D-40TA) IN MICE, RATS, RABBITS AND 

DOGS. 

173548 01-05 

CHANGES IN SHORT-TERM AND LONG-TERM MEMORY OF DOGS AND 
CATS UNDER THE EFFECTS OF AMIZYL (BENACTYZINE). 

183517 03-04 
THE EFFECTS OF CHLORDIAZEPOXIDE, AMPHETAMINE AND COCAINE ON 
BAR-PRESS BEHAVIOR IN NORMAL AND GENETICALLY NERVOUS DOGS. 

1 87868 04-04 
COMPARISON OF PHARMACOLOGICAL RESPONSES TO NICOTINE AND 
RELEASE OF CATECHOLAMINES FROM THE ADRENALS IN DOGS AND 

^O^"^^^^- ,88199 04-03 

INTESTINAL EFFECTS OF 5-HYDROXYTRYPTAMINE AND MORPHINE IN 
GUINEA-PIGS, DOGS. CATS AND MONKEYS. ^^^^^^ ^^ ^^ 

PSYCHOPHARMACOLOGIC FACILITATION OF OPERANT CONDITIONING OF 
GENETICALLY NERVOUS CATAHOULA AND POINTER DOGS. 

190696 04-04 

DISPOSITION OF H3-DELTA9-TETRAHYDR0CANNABIN0L IN BRAIN OF 
PREGNANT DOGS AND THEIR FETUSES. o o ft 04 • 

CARDIOPULMONARY EFFECTS OF CANNABIDIOL IN ANESTHETIZED DOGS. 

191993 04-0; 
THE PREDICTIVE VALUE OF THE ANTIAPOMORPHINE TEST IN DOGS FOR 
NEUROLEPTIC THERAPY IN MAN. 

192421 04-0' 

DOLICHOMEGACOLON INDUCED BY NEUROLEPTICS AMONG PSYCHIATRIC 
PATIENTS (MEMORANDUM COVERING 153 CASES). 

176432 02-1! 

CACTUS ALKALOIDS. XXII. DOLICHOTHELE SURCULOSA AND OTHER 
DOLICHOTHELE SPECIES. ^^^^^^^^^ 

EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON THE DOMINANCE 
BEHAVIOR OF THE RAT. ,^2^^, ^2.^ 

DOPA 

PLASMA DOPA AND FUNCTIONAL OSCILLATIONS AFTER CHRONIC 
TREATMENT OF PARKINSONS DISEASE. 

188421 04-1 

SELECTIVE RESERPINE RESISTANT ACCUMULATION OF CATECHOLAMINES 
IN CENTRAL DOPAMINE NEURONES AFTER DOPA ADMINISTRATION. 

189026 04-0 

EFFECTS OF DOPAMINE RECEPTOR STIMULATION AND BLOCKADE ON RC 
4-1284 INDUCED ENHANCEMENT OF ELECTROSHOCK SEIZURE. 

16728/ Ul-U 

TREMOR INDUCTION BY INTRACAUDATE INJECTIONS OF BRETYLIUM. 
TETRABENAZINE. OR MESCALINE: FUNCTIONAL DEFICITS IN CAUDATE 

^Of"^^"^^- 167329 Ol-C 

THE ROLE OF DOPAMINE IN DEPRESSION. 

167584 01-1 

CENTRAL MONOAMINE METABOLISM IN MAN: EFFECT OF PUTATIVE 
DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS. 

1 69377 1 ■ I 
DOPAMINE AND 5-HYDROXYTRYPTAMINE INHIBIT FEEDING IN RATS. 

170177 01-( 
SIMULTANEOUS MASS FRAGMENTOGRAPHIC ASSAY OF NOREPINEPHRIN 
(NE) EPINEPHRINE (E) AND DOPAMINE (DA) IN RAT SYMPATHETIC 
GANGLION: EFFECTS OF DEXAMETHASONE IN NEWBORN AND ADULT 

RATS. (UNPUBLISHED PAPER). 

170747 OI-( 

THE UPTAKE OF DOPAMINE AND SEROTONIN IN RAT BRAIN DURING 

PROGESTERONE DECLINE. ,^,3^^^,, 

INFLUENCES OF DRUGS ON THE INCREASES IN BRAIN DOPAMINE 
PRODUCED BY AXOTOMY OF GAMMA-HYDROXYBUTYRIC ACID 
(GHBA). 171622 01-1 



S-84 



VOLUME 12, SUBJECT INDEX 



Subject Index 



THE EFFECT OF PROTRIPTYLINE ON THE METABOLISM OF LABELLED 
DOPAMINE AND NORADRENALINE IN THE RAT BRAIN. 

171627 01-03 
A SENSITIVE GAS CHROMATOGRAPHIC PROCEDURE FOR THE 
ESTIMATION OF NORADRENALINE, DOPAMINE AND 5- 
HYDROXYTRYPTAMINE IN RAT BRAIN. 

171971 01-01 
QUANTITATIVE HISTOCHEMICAL STUDIES OF STRIATAL DOPAMINE 
DEPLETION FOLLOWING DL-ALPHA-METHYL-P-TYROSINE 
ADMINISTRATION. 

172924 01-03 
DRINKING BEHAVIOUR AND BRAIN DOPAMINE: ANTAGONISTIC EFFECT 
OF TWO NEUROLEPTIC DRUGS (PIMOZIDE AND SPIRAMIDE) UPON 
AMPHETAMINE OR APOMORPHINE-INDUCED HYPODIPSIA. 

174035 01-04 
THE EFFECTS OF AMPHETAMINE, 2-AMINOINDANE AND 2- 
AMINOTETRALIN ON THE CONCENTRATIONS OF WHOLE BRAIN 
NORADRENALINE, DOPAMINE, 5-HYDROXYTRYPTAMINE AND 5- 
HYDROXYINDOLEACETIC ACID IN THE MOUSE. 

174828 01-03 
THE EFFECT OF DOPAMINE ANTAGONISTS AND AMANTADINE ON THE 

ACQUISITION OF THE CONDITIONED AVOIDANCE RESPONSE IN RATS. 

174829 01-04 
EVIDENCE THAT MORPHINE INCREASES DOPAMINE UTILIZATION IN 

CORPORA-STRIATA OF RATS. 

176746 02-03 
ANTAGONISM OF THE EFFECTS OF CHLORPROMAZINE AND MORPHINE 
ON DOPAMINE METABOLISM BY GABA. 

176870 02-03 
RELATIVE POTENCIES OF D- AND L-AMPHETAMINE ON THE RELEASE OF 
DOPAMINE FROM CAT BRAIN IN VIVO. 

176874 02-03 
DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: 

ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE 
MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY. 

177131 02-03 
ADRENALINE, NORADRENALINE AND DOPAMINE LEVELS IN BRAIN AND 
HEART AFTER ADMINISTRATION OF 6-HYDROXYDOPAMINE AND 
GUANETHIDINE TO NEWBORN MICE. 

177338 02-03 
ON THE SPECIFICITY OF DOPAMINE RELEASE BY AMANTADINE. 

178557 02-03 
EXCRETION OF NOREPINEPHRINE AND DOPAMINE ALCOHOLIC 
METABOLITES AFTER 6-HYDROXYDOPAMINE. 

1 79986 02-03 
EFFECT OF CHLORPROMAZINE AND SOME OF ITS METABOLITES ON THE 
DOPAMINE SENSITIVE ADENYLATE CYCLASE OF RAT BRAIN STRIATUM. 

180060 02-03 
CENTRAL DOPAMINE FUNCTION IN AFFECTIVE ILLNESS: EVIDENCE FROM 
PRECURSORS, ENZYME INHIBITORS AND STUDIES OF CENTRAL 
DOPAMINE TURNOVER. (UNPUBLISHED PAPER). 

181358 02-09 
HYPOTHERMIA EVOKED BY A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE ALKALOID. 

182130 02-03 
IN VIVO INHIBITION OF NEURONAL UPTAKE OF A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE (TIQ) ALKALOID BY COCAINE AND BY 
DESMETHYLIMIPRAMINE (DMI). 

182150 02-03 
UPTAKE, STORAGE AND RELEASE IN VIVO OF A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE (TIQ) ALKALOID BY SYMPATHETIC NERVES 
OF THE IRIS. 

182204 02-03 
EFFECT OF MORPHINE, HALOPERIDOL, APOMORPHINE AND BENZTROPINE 
ON DOPAMINE TURNOVER IN RAT CORPUS-STRIATUM: EVIDENCE 
SHOWING MORPHINE-INDUCED REDUCTION IN CNS DOPAMINERGIC 
ACTIVITY. 

182230 03-03 
INHIBITION OF THE SYNAPTOSOMAL UPTAKE MECHANISMS FOR L- 
NOREPINEPHRINE AND DOPAMINE BY N-ARYLALKYL DL-AMPHETAMINE 
DERIVATIVES. 

182250 03-03 
EFFECT OF 2-ARYLALANINES, 2-ARYLSERINES, TETRAPHENYLBORON AND 
1,2 DL(2,4 DICHLOROPHENYL) ETHANOLAMINE ON LEVELS OF 
SEROTONIN (5-HT), NOREPINEPHRINE (NE) AND DOPAMINE (DM) IN 
WHOLE BRAIN OF MICE. 

182254 03-03 
THE EFFECT OF DOPAMINE RECEPTOR STIMULATING AGENTS AND OF N,0 
DIBUTYRYL CYCLIC AMP ON C14-D0PAMINE SYNTHESIS IN STRIATAL 
SLICES OF RATS. 

182256 03-03 
PARADOXICAL THERMOREGULATORY BEHAVIOUR IN RATS INDUCED BY 
(J AMPHETAMINE: BLOCKADE BY ALPHA-ADRENOCEPTOR OR 
DOPAMINE RECEPTOR BLOCKING AGENTS. 

183797 03-03 
AMANTADINE MAY STIMULATE DOPAMINE AND NORADRENALINE 
RECEPTORS. 

183868 03-03 



DOPAMINE IN BRAIN FUNCTION. 

184329 03-03 
PARKINSON DISEASE TREATED WITH A SUSPECTED DOPAMINE RECEPTOR 
AGONIST. 

186029 03-11 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS: 
II. EFFECT ON DOPAMINE AND NORADRENALINE CONCENTRATIONS 
AND TURNOVERS. 

186588 03-04 
SIGNIFICANCE OF DOPAMINE RECEPTOR ACTIVITY IN DL-P- 
METHOXYAMPHETAMINE AND D-AMPHETAMINE-INDUCED 
LOCOMOTOR ACTIVITY. 

186670 03-04 
EFFECT OF ALPHAMETHYLDOPA ON THE METABOLISM OF DOPAMINE IN 
THE STRIATUM OF THE RAT. 

186694 03-03 
THE TRANSSYNAPTIC RELATIONSHIP BETWEEN DOPAMINE AND 
SEROTONIN IN THE CAUDATE NUCLEUS OF CATS. 

186700 03-04 
REGULATION OF BRAIN DOPAMINE TURNOVER RATE: 

PHARMACOLOGICAL IMPLICATIONS. (UNPUBLISHED PAPER). 

187527 04-03 
THE ADDITIVE EFFECTS OF TRANQUILIZERS AND DOPAMINE ON SMOOTH 
MUSCLE. 

187804 04-03 
DOPAMINE AND GILLES-DE-LA-TOURETTES SYNDROME. 

188431 04-11 
FURTHER EVIDENCE FOR A DOPAMINE RECEPTOR STIMULATING ACTION 
OF AN ERGOT ALKALOID. 

188739 04-03 
EVIDENCE FOR A SPECIFIC UPTAKE OF DOPAMINE BY DOPAMINERGIC 
TERMINALS OF THE RAT CEREBRAL CORTEX. 

188978 04-03 
SELECTIVE RESERPINE RESISTANT ACCUMULATION OF CATECHOLAMINES 
IN CENTRAL DOPAMINE NEURONES AFTER DOPA ADMINISTRATION 

189026 04-03 
PARADOXICAL EFFECTS OF D-AMPHETAMINE ON BEHAVIORAL 

THERMOREGULATION: POSSIBLE MEDIATION BY BRAIN DOPAMINE. 

1 89399 04-04 
THE DOPAMINE RELEASING ACTIONS OF NEUROLEPTICS AND ETHANOL. 

189401 04-03 
EFFECT OF ANESTHETIC AGENTS ON THE SYNTHESIS AND 

DISAPPEARANCE OF BRAIN DOPAMINE NORMALLY AND AFTER 
HALOPERIDOL, KCL OR AXOTOMY. 

189571 04-03 
STIMULATION OF A DOPAMINE SENSITIVE ADENYLATE CYCLASE IN 
HOMOGENATES OF RAT STRIATUM BY A METABOLITE OF PIRIBEDIL 
(ET-495). 

189616 04-03 
EFFECTS OF DOPAMINE-LIKE DRUGS ON RAT STRIATAL ADENYL CYCLASE 
HAVE IMPLICATIONS FOR CNS DOPAMINE RECEPTOR TOPOGRAPHY. 

190545 0403 
EFFECT OF SINGLE AND REPEATED ADMINISTRATION OF CLOZAPINE ON 
THE METABOLISM OF DOPAMINE AND NORADRENALINE IN THE BRAIN 
OF THE RAT. 

191418 04-03 
CATALEPSY AND STEREOTYPIES IN RATS TREATED WITH METHADONE, 
RELATION TO STRIATAL DOPAMINE. 

191421 04-03 
DOPAMINE AND PSYCHIATRIC STATES: PRELIMINARY REMARKS 

191507 04-13 
THE EFFECTS OF COMT INHIBITORS ON BEHAVIOR AND DOPAMINE 
METABOLISM. 

191517 04-03 
THE EFFECTS ON INGESTIVE BEHAVIORS OF DAMAGE TO CENTRAL 
DOPAMINE CONTAINING NEURONS. 

191520 04-04 
ROLE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN IN 
INTRACRANIAL REWARD. 

191527 04-04 
BALANCE BETWEEN ACETYLCHOLINE, SEROTONIN, NOREPINEPHRINE, AND 

DOPAMINE IN SELF-STIMULATION. 

191528 04-04 
ROLE OF ACETYLCHOLINE AND DOPAMINE IN MANIC BEHAVIOR. 

191532 04-09 
AMPHETAMINE AND METHYLPHENIDATE INDUCED RELEASE OF STRIATAL 
DOPAMINE IN VIVO: DIFFERENTIAL EFFECTS ON NEWLY SYNTHESIZED 
AND STORED POOLS. 

191897 04-03 
A ROLE FOR DOPAMINE IN THE STIMULANT EFFECTS OF AMPHETAMINE 
ON LOCUS-COERULEUS SELF-STIMULATION. 

191984 04-03 
DOPAMINE AGONIST INDUCED DISORIENTATION IN A RAT SWIMMING 
TASK. 

192018 04-04 



S-85 



Subject Index 



Psychopharmacology Abstracts 



OOPAMINE-BETA-HYDROXYLASE 

SELECTIVE INHIBITION OF NOREPINEPHRINE SYNTHESIS IN MANIC- 
DEPRESSIVE PATIENTS WITH A DOPAMINE-BETA-HYDROXYLASE 
INHIBITOR. (UNPUBLISHED PAPER). 

170083 01-03 
BEHAVIORAL EFFECTS OF A NEW DOPAMINE-BETA-HYDROXYLASE 
INHIBITOR (FUSARIC ACID) IN MAN. (UNPUBLISHED PAPER 

174329 01-09 
COMPARISON OF TYROSINE HYDROXYLASE AND DOPAMINE-BETA- 
HYDROXYLASE INHIBITION WITH THE EFFECTS OF VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS ON D-AMPHETAMINE INDUCED 
MOTOR ACTIVITY. 

186699 03-03 
DOPAMINE-BETA-HYDROXYLASE AND THE REGULATION OF THE 
NORADRENERGIC NEURON. 

191509 04-03 
HUMAN SERUM DOPAMINE-BETA-HYDROXYLASE: RELATIONSHIP TO 

SYMPATHETIC ACTIVITY IN PHYSIOLOGICAL AND PATHOLOGICAL 

STATES. 

191510 04-13 

AN EVALUATION OF SERUM DOPAMINE-BETA-HYDROXYLASE AS AN 
INDEX OF SYMPATHETIC NERVE ACTIVITY IN MAN. 

191511 04-13 
SERUM DOPAMINE-BETA-HYDROXYLASE; A POSSIBLE AID IN THE 

EVALUATION OF HYPERTENSION. 

191512 04-13 
EFFECT OF L-PHENYL-3-2-THIAZOLYL 2-THIOUREA, A DOPAMINE-BETA- 
HYDROXYLASE INHIBITOR, ON MORPHINE ANALGESIA, TOLERANCE 
AND PHYSICAL DEPENDENCE. 

191769 04-03 

DOPAMINE-LIKE 

EFFECTS OF DOPAMINE-LIKE DRUGS ON RAT STRIATAL ADENYL CYCLASE 
HAVE IMPLICATIONS FOR CNS DOPAMINE RECEPTOR TOPOGRAPHY. 

190545 04-03 
DOPAMINERGIC 

EFFECT OF DOPAMINERGIC STIMULATION OR BLOCKADE ON MORPHINE 
WITHDRAWAL AGGRESSION. 

171300 01-04 
BEHAVIORAL EVIDENCE FOR DOPAMINERGIC SUPERSENSITIVITY AFTER 
CHRONIC HALOPERIDOL. 

180021 02-04 
INTERACTION OF APOMORPHINE, NEUROLEPTICS AND STIMULANTS 
WITH ALPHA-METHYL-M-TYRAMINE, A FALSE DOPAMINERGIC 
TRANSMITTER. 

181809 02-03 
EFFECTS OF DOPAMINERGIC STIMULANTS ON THE CAUDATE SPINDLE. 

182125 02-03 
RELATIVE IMPORTANCE OF DOPAMINERGIC AND NORADRENERGIC 
NEURONAL SYSTEMS FOR THE STIMULATION OF LOCOMOTOR 
ACTIVITY INDUCED BY AMPHETAMINE AND OTHER DRUGS. 

182209 02-04 
EFFECT OF MORPHINE, HALOPERIDOL, APOMORPHINE AND BENZTROPINE 
ON DOPAMINE TURNOVER IN RAT CORPUS-STRIATUM: EVIDENCE 
SHOWING MORPHINE-INDUCED REDUCTION IN CNS DOPAMINERGIC 
ACTIVITY. 

182230 03-03 

IN VIVO ESTIMATION OF TYROSINE HYDROXYLATION IN THE 
DOPAMINERGIC TERMINALS OF THE RAT NEOSTRIATUM. 

183794 03-03 
DOPAMINERGIC HYPERSENSITIVITY AND CHOLINERGIC HYPOFUNCTION 
IN THE PATHOPHYSIOLOGY OF TARDIVE DYSKINESIA. 

185929 03-11 
EFFECT OF SEVERAL DOPAMINERGIC DRUGS AND TRIHEXYPHENIDYL ON 
CHOLINERGIC PARAMETERS IN THE RAT STRIATUM. 

185995 03-03 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS; 

I EFFECT ON THE BEHAVIOURAL CHANGES INDUCED BY RESERPINE, 
ALPHA-METHYL-P-TYROSINE OR AMPHETAMINE. 

186587 03-04 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS: 

II EFFECT ON DOPAMINE AND NORADRENALINE CONCENTRATIONS 
AND TURNOVERS. 

186588 03-04 

DOPAMINERGIC NATURE OF APOMORPHINE-INDUCED PECKING IN 

PIGEONS. 

188204 04-03 

INHIBITORY EFFECT OF DOPAMINERGIC STIMULATION ON GH RELEASE IN 
ACROMEGALY. 

188350 04-13 
ROLE OF DOPAMINERGIC MECHANISMS IN REGULATION OF GROWTH 
HORMONE AND PROLACTIN SECRETION IN MAN. 

188428 04-13 
EVIDENCE FOR A SPECIFIC UPTAKE OF DOPAMINE BY DOPAMINERGIC 
TERMINALS OF THE RAT CEREBRAL CORTEX. 

188978 04-03 
DOPAMINERGIC INHIBITION OF STRIATAL CHOLINERGIC NEURONS: 
SYNERGISTIC BLOCKING ACTION OF GAMMA-BUTYROLACTONE AND 
NEUROLEPTIC DRUGS. 

189602 04-03 



EVIDENCE FOR A NORADRENERGIC AND DOPAMINERGIC MECHANISM IN 
THE HYPERACTIVITY PRODUCED BY 4,ALPHA DIMETHYL-M-TYRAMINE 
(H-77-77) IN RATS. 

190309 04-04 
EFFECTS OF ALTERATIONS IN IMPULSE FLOW ON TRANSMITTER 
METABOLISM IN CENTRAL DOPAMINERGIC NEURONS. 

191519 04-03 
BEHAVIORAL EFFECTS OF DIRECT AND INDIRECT ACTING DOPAMINERGIC 
AGONISTS. 

191521 04-04 
EFFECTS OF PIRIBEDIL (ET-495) - A DOPAMINERGIC RECEPTOR 

STIMULATING AGENT IN PARKINSONS DISEASE. 

191522 04-13 
CLINICAL STUDIES OF DOPAMINERGIC MECHANISMS. 

191524 04-13 
EVIDENCE FOR A DOPAMINERGIC INVOLVEMENT IN THE MAINTENANCE 
OF SELF-STIMULATION. 

191526 04-03 
SUPERSENSITIVITY TO DOPAMINERGIC AGONISTS FOLLOWING 
WITHDRAWAL OF A CHRONIC DIET CONTAINING HALOPERIDOL OR 
PIMOZIDE. 

192012 04-04 

DORSAL 

EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS. 

169467 01-03 

LIPIDOSIS-LIKE ALTERATIONS IN DORSAL ROOT GANGLION CELLS OF 
RATS TREATED WITH TRICYCLIC ANTIDEPRESSANTS. 

189605 04-03 
THE ROLE OF GAMMA-AMINOBUTYRIC ACID AS A MEDIATOR OF 
POSITIVE DORSAL ROOT POTENTIALS 

189832 04-03 
DISCRIMINATIVE CONTROL OF BEHAVIOR BY ELECTRICAL STIMULATION 
OF THE DORSAL RAPHE NUCLEUS: GENERALIZATION TO LYSERGIC 
ACID DIETHYLAMIDE (LSD). 

191944 04-04 

DOSAGE 

PHENOTHIAZINE DOSAGE LEVELS AND AUDITORY SIGNAL DETECTION IN 
SCHIZOPHRENIA. 

167817 01-08 
DEVELOPMENT OF PHYSICAL DEPENDENCE ON MORPHINE IN RESPECT TO 
TIME AND DOSAGE AND QUANTIFICATION OF THE PRECIPITATED 
WITHDRAWAL SYNDROME IN RATS. 

169474 01-03 
LOW DOSAGE HALOPERIDOL AND INDUCED ANXIETY IN NORMAL 
VOLUNTEERS. 

169745 01-14 
EXPERIENCE IN THE USE OF A LOW DOSAGE OF CARPIPRAMINE 
(DEFEKTON). 

1 76472 02-08 
INDICATIONS AND DOSAGE FOR MAXIMAL ACTIVITY OF ORNITHINE- 
CARBAMYL-TRANSFERASE IN THE PSYCHIATRIC ENVIRONMENT. 

184955 03- n 

DRUG DOSAGE IN ACUTE PHASE SCHIZOPHRENIA. 

185898 03-17 
^ METHYLPHENIDATE IN CHILDREN - EFFECT OF DOSAGE. 

187581 04-1^ 
HIGH DOSAGE PIPERACETAZINE (QUIDE-R) IN AMBULATORY 

SCHIZOPHRENIC PATIENTS: THERAPEUTIC EFFICACY AND TOXICITY. 

187869 04-OJ 
IMPROVING PSYCHIATRIC DRUG THERAPY: A MATTER OF DOSAGE AND 

CHOICE. „ ,. 

190144 04-1, 

DOSAGES 

NONSEDATING DOSAGES OF DIAZEPAM AND PHENOBARBITAL IN THE 
REDUCTION OF NEONATAL BILIRUBIN LEVELS. 

191607 04-1; 

DOSE 

A CONTROLLED STUDY OF SINGLE DOSE ADMINISTRATION OF 
IMIPRAMINE PAMOATE IN ENDOGENOUS DEPRESSION. 

167775 010< 
THE TREATMENT OF DEPRESSION WITH A SINGLE DAILY DOSE OF 
IMIPRAMINE PAMOATE. 

169491 Ol-C 

SINGLE VERSUS DIVIDED DAILY DOSE OF TRIMIPRAMINE IN THE 
TREATMENT OF DEPRESSIVE ILLNESS. 

170622 01-0' 
PSYCHOLOGICAL EFFECTS OF SINGLE DOSE ANTIPSYCHOTIC 

MEDICATION. 

173402 01-01 

(-)DELTA9-THC AS AN HYPNOTIC; AN EXPERIMENTAL STUDY OF THREE 

DOSE LEVELS. „ , „, , 

174041 01-1' 

HIGH AND LOW DOSE THIOTHIXENE TREATMENT IN CHRONIC 

SCHIZOPHRENIA. ^ „„ „, 

1 76673 02-0 



S-86 



OLUME 12, SUBJECT INDEX 



Subject Index 



STEREOTYPED AND AGGRESSIVE BEHAVIOR INDUCED BY SUSTAINED 
HIGH DOSE OF THEOPHYLLINE IN RATS. 

177019 02-04 
FURTHER ASPECTS OF AGGRESSIVE BEHAVIOR INDUCED BY SUSTAINED 

HIGH DOSE OF THEOPHYLLINE IN RATS. 

177020 02-04 
THE EFFECT OF PROBENECID AND LARGE DOSE AMPHETAMINE 

ADMINISTRATION ON CEREBROSPINAL FLUID HOMOVANILLIC ACID. 

177826 02-13 
ACETYLCHOLINE TURNOVER IN BRAIN OF MICE AND RATS: EFFECTS OF 
VARIOUS DOSE REGIMENS OF MORPHINE. (UNPUBLISHED PAPER). 

180582 02-03 
PSYCHOPHYSIOLOGICAL EFFECTS OF DIAZEPAM (VALIUM) COMBINED 
WITH A MODERATE DOSE OF ALCOHOL IN MAN. 

180699 02-14 
PREDICTION OF NEUROLEPTIC EFFECTS OF CI-686 BASED ON 
QUANTITATIVE PHARMACOELECTROENCEPHALOGRAPHY: DRUG 
PROFILES AND DOSE RESPONSE CURVES BASED ON COMPUTERIZED 
CEREBRAL BIOPOTENTIALS. 

181958 02-13 
DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) DOSE EFFECTS 
COMPARED ON THREE SCHEDULES OF FOOD REINFORCED OPERANT 
PERFORMANCE. 

182191 02-04 
THE OCULAR COMPLICATIONS BY MASSIVE DOSE OF PSYCHOTROPIC 
DRUGS. 

182552 03-15 
DOSE EFFECTS OF METHYLPHENIDATE ON BEHAVIORAL INHIBITION AND 
ACTIVATION IN HYPERACTIVE CHILDREN. (PH.D. DISSERTATION). 

185676 03-14 
DOSE DEPENDENT SELECTIVE FACILITATION OF RESPONSE CONTINGENT 
LIGHT ONSET BEHAVIOR BY D-AMPHETAMINE. 

185955 03-04 
DOSE DEPENDENT POTENTIATION OR INHIBITION BY RO-4-4602 OF 5-HTP 
HYPERTHERMIA IN RABBITS. 

185996 03-03 
DOXEPIN: IS A SINGLE DAILY DOSE ENOUGH? 

192066 04-10 
OSE-RELATED 

DOSE-RELATED ALTERATIONS IN METABOLISM OF LEVODOPA: POSSIBLE 
MECHANISM FOR HYPOTENSIVE EFFECT. 

190194 04-11 
OSE-RESPONSE 

SHIFTING OF THE D-AMPHETAMINE DOSE-RESPONSE CURVE IN RATS 
WITH FRONTAL CORTICAL ABLATIONS. 

187261 04-04 
THE EFFECT OF SOME CHOLINOLYTIC DRUGS ON A NUMBER OF 

BEHAVIOURAL PARAMETERS MEASURED IN THE T-MAZE ALTERNATION 
TEST: DOSE-RESPONSE RELATIONSHIPS. 

187641 04-04 
BEHAVIORAL AND ELECTROCORTICOGRAPHIC DOSE-RESPONSE 
RELATIONSHIPS WITH METRAZOL. (UNPUBLISHED PAPER). 

188248 04-04 
OSES 

GAS CHROMATOGRAPHIC DETERMINATION OF METHAQUALONE IN 
SMALL AMOUNTS OF SERUM AFTER INGESTION OF THERAPEUTIC 
DOSES. 

172397 01-16 
ONE YEAR OF CLINICAL EXPERIENCE WITH LARGE DOSES OF 10 PERCENT 
FLUPENTHIXOL DECANOATE (LU-1705). 

172735 01-07 
HIGH DOSES OF CHLORPROMAZINE AND TRIFLUOPERAZINE IN THE 
TREATMENT OF PATIENTS SUFFERING FROM SCHIZOPHRENIA. 

174589 01-08 
EFFECTS OF LOW DOSES OF CHLORPROMAZINE ON A CONDITIONED 
EMOTIONAL RESPONSE IN THE RAT. 

176963 02-04 
EFFECTS OF CHRONIC PRETREATMENT WITH SMALL DOSES OF RESERPINE 
UPON ADRENERGIC NERVE FUNCTION. 

1 77406 02-03 
THE USE OF LOW DOSES OF MONOCHLORIMIPRAMINE IN THE THERAPY 
OF NEUROTIC DEPRESSIVE SYNDROMES. 

182789 03-10 
TRIFLUOPERAZINE: A COMPARISON BETWEEN REGULAR AND HIGH 
DOSES. 

184977 03-08 
RESPONSE TO INCREMENTAL DOSES OF DITRAN IN ABSTINENT 
ALCOHOLICS AND DRUG USERS. 

185875 03-11 
COMPARISON OF GRADED SINGLE INTRAMUSCULAR DOSES OF 
MORPHINE AND PENTOBARBITAL IN MAN 

187254 03-15 
PERSISTENT ELECTROENCEPHALOGRAPHIC CHANGES IN RHESUS 
MONKEYS AFTER SINGLE DOSES OF PENTOBARBITAL, NITRAZEPAM 
AND IMIPRAMINE. 

187931 04-03 



THE EFFECT OF HYPOTHERMIC DOSES OF 1-DELTA9- 

TETRAHYOROCANNABINOL ON BIOGENIC AMINE METABOLISM IN 
SELECTED PARTS OF THE RAT BRAIN. 

188231 04-03 
DOSING 

LONG-TERM ALTERATION OF SLEEP-WAKEFULNESS CYCLE DURING 
CHRONIC PENTOBARBITAL DOSING AND WITHDRAWAL IN CAT. 

191952 04-04 
DOSSIER 

A SUMMARY OF THE CLINICAL DOSSIER ON DEPAMIDE. 

183544 03-17 
DOTHIEPIN 

CHLORDIAZEPOXIDE AND DOTHIEPIN COMPARED IN 
ANXIETY/DEPRESSION IN GENERAL PRACTICE. 

167575 01-10 
DOUBLE 

EFFECTS OF INTRACISTERNAL 6-HYDROXYDOPAMINE TREATMENT ON 
ACQUISITION AND PERFORMANCE OF RATS IN A DOUBLE T-MAZE. 

1 87696 04-04 
DOUBLE-BUND 

DOUBLE-BLIND CLINICAL EVALUATION OF MAZINDOL, 

DEXTROAMPHETAMINE, AND PLACEBO IN TREATMENT OF EXOGENOUS 
OBESITY. 

167335 01-11 
A DOUBLE-BUND, COMPARATIVE CLINICAL TRIAL WITH LUDIOMIL (CIBA- 
34276-BA) AND AMITRIPTYLINE IN NEWLY ADMITTED DEPRESSED 
PATIENTS 

167774 01-09 
CLOMIPRAMINE HCL - A DOUBLE-BLIND STUDY OF A NEW 
ANTIDEPRESSANT DRUG. 

168318 01-09 
TRAZODONE IN THE TREATMENT OF PSYCHONEUROSES: A DOUBLE-BLIND 
STUDY. 

168809 01-11 
THE USE OF LITHIUM IN AFFECTIVE DISORDERS, III: A DOUBLE-BLIND 
STUDY OF PROPHYLAXIS IN BIPOLAR ILLNESS. 

169495 01-09 
COMPARISON OF THIORIDAZINE AND DIAZEPAM IN THE CONTROL OF 
NONPSYCHOTIC SYMPTOMS ASSOCIATED WITH SENILITY: DOUBLE- 
BLIND STUDY. 

170129 01-11 
A DOUBLE-BUND CLINICAL TRIAL OF DOXEPIN HYDROCHLORIDE AND 
DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION 
IN THE FIELD OF INTERNAL MEDICINE. 

171282 01-11 
DIPHENYLHYDANTOIN EFFECTIVENESS IN THE TREATMENT OF CHRONIC 
SCHIZOPHRENICS: A DOUBLE-BLIND CONTROLLED STUDY WITH A 
PLACEBO. 

171507 01-08 
A DOUBLE-BUND INVESTIGATION OF DIMETHACRINE VERSUS 
IMIPRAMINE IN HOSPITAUZED DEPRESSIVE STATES. 

171695 01-09 
A DOUBLE-BLIND COMPARISON OF THIORIDAZINE (MELLARIL) VERSUS 
DIAZEPAM (VALIUM) IN PATIENTS WITH CHRONIC MIXED ANXIETY 
AND DEPRESSIVE SYMPTOMS. 

172486 01-10 
AN ERGOT ALKALOID PREPARATION (HYDERGINE) VERSUS PAPAVERINE 
IN TREATING COMMON COMPLAINTS OF THE AGED: DOUBLE-BLIND 
STUDY. 

173190 01-11 
EFFECTS OF (-)DELTA9-TRANS-TETRAHYDR0CANNABIN0L (DELTA9-THC) 
ON MEMORY, ATTENTION AND SUBJECTIVE STATE: A DOUBLE-BLIND 
STUDY 

174043 01-14 
AMOXAPINE AND IMIPRAMINE: A DOUBLE-BUND STUDY IN DEPRESSED 
PATIENTS. 

174138 01-09 
A DOUBLE-BUND TRIAL OF IPRINDOLE AND IMIPRAMINE IN DEPRESSIVES 
AND RESPONSE TO ECT IN REFRACTORY CASES. 

174376 01-09 
A DOUBLE-BUND COMPARISON OF CLOZAPINE WITH THIORIDAZINE ON 
SCHIZOPHRENIA. 

175119 02-08 
A DOUBLE-BLIND CONTROLLED STUDY COMPARING PROTRIPTYLINE AND 
AMITRIPTYLINE. 

1 77567 02-09 
A DOUBLE-BLIND COMPARISON OF FLUPHENAZINE AND HALOPERIDOL IN 
OUTPATIENT SCHIZOPHRENIC CHILDREN. 

177754 02-08 
COMPARISON OF THE EFFECTS OF Y-4I53 AND CARPIPRAMINE ON 
SCHIZOPHRENIA BY A DOUBLE-BLIND METHOD. 

178053 02-08 
PIMOZIDE (R-6238) IN CHRONIC SCHIZOPHRENIA: DOUBLE-BLIND TRIAL. 

1 78255 02-08 
DOXEPIN AND AMITRIPTYLINE CHLORDIAZEPOXIDE COMBINATION IN 
NEUROTIC STATES: A COMPARATIVE DOUBLE-BLIND STUDY. 

180048 02-10 



S-87 



Subject Index 

DOUBLE-BLIND PSYCHOMETRIC EVALUATION OF PIMOZIDE AND 
HALOPERIDOL VERSUS PLACEBO IN EMOTIONALLY LABILE 
VOLUNTEERS UNDER TWO DIFFERENT WORK LOAD CONDITIONS. 

180065 02-14 
A DOUBLE-BLIND TRIAL OF TRIOXAZINE WITH PLACEBO IN ANXIETY 
STATES. 

180249 02-10 
DOUBLE-BLIND COMPARATIVE STUDY OF HF-1972/N0VERIL IN 
DEPRESSION. 

180986 02-10 
THE COMPARISON OF THERAPEUTIC EFFECTS OF FK-880 (SULPIRIDE) AND 
PERPHENAZINE IN SCHIZOPHRENIA BY A DOUBLE-BLIND CONTROLLED 
STUDY. 

181378 02-08 
AFRODEX VS. PLACEBO IN THE TREATMENT OF MALE IMPOTENCE: 
STATISTICAL ANALYSIS OF TWO DOUBLE-BLIND CROSSOVER STUDIES. 

181959 02-14 
DOUBLE-BLIND CROSSOVER COMPARISON OF BROMAZEPAM AND 

DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION. 

182624 03-11 
DOUBLE-BLIND CLINICAL TRIAL OF NOVERIL AND OF NOVERIL-TR 
(NOVERIL 240MG). 

183190 03-07 
A DOUBLE-BLIND COMPARISON OF PIMOZIDE WITH CARPIPRAMINE IN 
SCHIZOPHRENIC PATIENTS. 

183195 03-08 
A DOUBLE-BLIND TRIAL OF LONG-TERM LITHIUM THERAPY IN MENTAL 
DEFECTIVES. 

185193 03-11 
IMIPRAMINE AND METHYLPHENIDATE TREATMENTS OF HYPERACTIVE 
BOYS; A DOUBLE-BLIND COMPARISON. 

185324 03-14 
A DOUBLE-BLIND CROSSOVER SEQUENTIAL TRIAL OF ORAL THYROTROPIN 
RELEASING HORMONE IN DEPRESSION. 

188348 04-09 
DOUBLE-BLIND COMPARISON OF THIOTHIXENE, TRIFLUOPERAZINE, AND 
PLACEBO IN CHRONIC ALCOHOLISM. 

188584 04-11 
THE CONTROL OF DEVIANT SEXUAL BEHAVIOR BY DRUGS: A DOUBLE- 
BLIND CONTROLLED STUDY OF BENPERIDOL, CHLORPROMAZINE, AND 
PLACEBO. 

190061 04-11 
A DOUBLE-BLIND CONTROLLED STUDY OF LOXAPINE SUCCINATE IN THE 
TREATMENT OF ANXIETY NEUROSES. 

190196 04-09 
HALOPERIDOL VERSUS THIORIDAZINE FOR THE TREATMENT OF 
PSYCHOGERIATRIC PATIENTS: A DOUBLE-BLIND CLINICAL STUDY. 

192231 04-09 
DOWNS 

MYOCLONIC SEIZURES IN DOWNS SYNDROME. 

173205 01-11 
AMITRIPTYLINE IN THE PSYCHOTIC STATES OF DOWNS SYNDROME: THE 
COMPARISON OF TWO CASES. 

191192 04-11 
DOXAPRAM 

SELECTIVE RESPIRATORY STIMULATING ACTION OF DOXAPRAM 
COMPARED TO PENTYLENETETRAZOL. 

183887 03-03 
DOXEPIN 

NEUROPHARMACOLOGICAL ANALYSIS OF EFFECTS OF DOXEPIN IN 
RABBITS (PH.D. DISSERTATION). 

168130 01-03 
A DOUBLE-BLIND CLINICAL TRIAL OF DOXEPIN HYDROCHLORIDE AND 
DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION 
IN THE FIELD OF INTERNAL MEDICINE. 

171282 01-11 
DETERMINATION OF DOXEPIN IN AUTOPSY MATERIAL. 

172398 01-16 
EXPERIMENT WITH DOXEPIN (SINEQUAN) IN TREATMENT OF DEPRESSIVE 
STATES. 

176454 02-11 
EXPERIENCE IN THE USE OF SINEQUAN (DOXEPIN HYDROCHLORIDE) IN 
TREATMENT OF NEUROSIS, DEPRESSION AND DEPRESSIVE STATES. 

176471 02-11 
EXPERIENCE IN THE USE OF SINEQUAN (DOXEPIN HYDROCHLORIDE). 

176474 02-10 
CLINICAL EFFECT OF A NEW PSYCHOTROPIC DRUG, DOXEPIN 
HYDROCHLORIDE, IN THE TREATMENT OF DEPRESSIVE STATES. 

177569 02-11 
INHIBITORY EFFECT OF DOXEPIN ON AGONISTIC BEHAVIOUR ELICITED BY 
HYPOTHALAMIC STIMULATION IN THE CAT. 

180044 02-04 
DOXEPIN AND AMITRIPTYLINE CHLORDIAZEPOXIDE COMBINATION IN 
NEUROTIC STATES; A COMPARATIVE DOUBLE-BLIND STUDY. 

180048 02-10 
EFFECTS OF CONSECUTIVE ADMINISTRATION OF DIAZEPAM AND 
DOXEPIN ON BOTH APPROACH WITHDRAWAL AND APPROACH 
AVOIDANCE RESPONSES IN RATS. 

182117 02-04 



Psychopharmacology Abstracts 



EXPERIMENTS IN ORAL AND INJECTABLE FORMS OF A NEW 
ANTIDEPRESSANT (DOXEPIN) ON FORTY PATIENTS. 

DOXEPIN: IS A SINGLE DAILY DOSE ENOUGH? 

DP-I8I 

EXPERIENCE IN THE APPLICATION OF A NEW DRUG, DP-181 
(OXYPERTINE), IN TREATMENT OF SCHIZOPHRENIA. 



182900 03-11 
192066 04-10 



CLINICAL STUDY OF DP-181 (OXYPERTINE). 



1 76468 02-08 

176722 02-08 
DREAM 

DREAM REPORTS AFTER RESERPINE ADMINISTRATION IN CHRONIC 
LOBOTOMIZED SCHIZOPHRENIC PATIENTS. 

178187 02-08 
SLEEPING PILLS AND DREAM CONTENT. 

189043 04-14 
DRINK 

RELUCTANCE OF RATS TO DRINK HASHISH SUSPENSIONS; FREE-CHOICE 
AND FORCED CONSUMPTION, AND THE EFFECTS OF HYPOTHALAMIC 
STIMULATION. 

186586 03-04 

DRINKING 

SHOULD WE PUT BENZODIAZEPINES IN OUR DRINKING WATER 

168361 01-17 
RECOVERY OF FEEDING AND DRINKING BY RATS AFTER 
INTRAVENTRICULAR 6-HYDROXYDOPAMINE OR LATERAL 
HYPOTHALAMIC LESIONS. 

168484 01 03 
DRINKING BEHAVIOUR AND BRAIN DOPAMINE: ANTAGONISTIC EFFECT 
OF TWO NEUROLEPTIC DRUGS (PIMOZIDE AND SPIRAMIDE) UPON 
AMPHETAMINE OR APOMORPHINE-INDUCEO HYPODIPSIA. 

174035 01-04 
ALPHA-ADRENERGIC RECEPTORS MEDIATE SUPPRESSION OF DRINKING 
INDUCED BY HYPOTHALAMIC AMPHETAMINE INJECTION. 

182216 03-03 
DRIVE 

CRIME AND THE SEX DRIVE. 

192410 04-17 

DRIVES 

THOUGHTS ON TREATMENT BY PRIVATE PHYSICIANS OF ABNORMAL SEX 
DRIVES. 

180674 02-11 

DRIVING 

EEG DRIVING RESPONSES AS A FUNCTION OF MONOAMINE OXIDASE. 

187149 03-13 
THE EFFECT OF MEDAZEPAM AND ALCOHOL ON COGNITIVE AND MOTOR 
SKILLS USED IN CAR DRIVING. 

189408 04-14 
EFFECTS OF DIAZEPAM AND CODEINE, ALONE AND IN COMBINATION 
WITH ALCOHOL, ON SIMULATED DRIVING. 

189619 04-14 
EFFECTS OF CAFFEINE ON ALERTNESS IN SIMULATED AUTOMOBILE 
DRIVING. 

190743 04-14 

DROPERIDOl 

DROPERIDOL - A PREFERRED NEUROLEPTIC IN NARCOANALYSIS. 

169462 01-14 
THE USE OF ORAL DROPERIDOL IN PSYCHIATRIC THERAPY. 

184965 03-07 
DROSOPHILA-MELANOGASTER 

MUTAGENICITY EXPERIMENTS WITH THE TRANQUILLIZER MEPROBAMATE 
IN DROSOPHILA-MELANOGASTER AND IN HUMAN LEUKOCYTE 
CHROMOSOMES IN VITRO, 

184585 03-05 

DRUG 

THE ROLE OF RESEARCH IN DRUG ABUSE INTERVENTION: STREET DRUG 
ANALYSES. 

167382 0117 
ACUTE ADVERSE REACTIONS TO PSYCHOACTIVE DRUGS, DRUG USAGE, 
AND PERSONALITY. (UNPUBLISHED PAPER). 

167832 01-15 
CLOMIPRAMINE HCL - A DOUBLE-BLIND STUDY OF A NEW 
ANTIDEPRESSANT DRUG. 

168318 01-09 
CLINICAL EXPERIENCE WITH A NEW PSYCHOTROPIC DRUG, TRAZODONE: 
A REVIEW OF LITERATURE. 

168803 01 11 
DRUG ENHANCED SENSORY CONTINGENT BAR PRESSING; COMPARING 
THE EFFECT OF CONTINGENT AND NONCONTINGENT SENSORY 
CHANGE. 

168837 01-04 
DRUG THERAPY AND MARITAL THERAPY IN OUTPATIENT DEPRESSIVES. 

169088 01-09 
PSYCHOTHERAPEUTIC DRUG TRIALS AMONG ENGLISH GENERAL 
PRACTITIONERS. 

170292 01-11 



S-88 



WB^' 



/OLUME 12, SUBJECT INDEX 



Subject Index 



DRUG TREATMENT Of DEPRESSED PATIENTS REFERRED FOR 
HOSPITALIZATION. 

170621 01-09 
CHANGES IN MENTAL FUNCTIONING ACCOMPANYING ANTIPSYCHOTIC 
DRUG THERAPY. 

171124 0110 
ORTHOGONAL FACTORS VS. INTERDEPENDENT VARIABLES AS 
PREDICTORS OF DRUG TREATMENT RESPONSE IN ANXIOUS 
OUTPATIENTS. 

171299 01-14 
THE PHARMACOLOGICAL EVALUATION IN LABORATORY ANIMALS OF 
KABI-1702 - A NEW SEDATIVE HYPNOTIC DRUG. 

171632 01-03 
A GUIDE FOR DRUG USE IN DEPRESSIVE DISORDERS. 

171923 01-09 
DETERMINATION OF DRUG TRANSFER ACROSS BIOLOGICAL MEMBRANES: 
COMPARATIVE STUDY ON THE PASSAGE OF DRUGS INTO THE 
CENTRAL NERVOUS SYSTEM AND THEIR PLACENTAL TRANSFER AND 
FETAL LOCALIZATION IN THE PREGNANT RAT. (PH.D. DISSERTATION). 

172018 01-03 
CHRONIC HYPNOTIC DRUG USE: INEFFECTIVENESS, DRUG WITHDRAWAL 
INSOMNIA, AND DEPENDENCE. 

17211401-15 
THE SPIRAL AFTEREFFECT (SAE) AS A MEASURE OF MOTION SICKNESS 
SUSCEPTIBILITY AND THE EFFECT ON THE SAE OF AN ANTIMOTION 
SICKNESS DRUG AND A CENTRAL NERVOUS SYSTEM DEPRESSANT. 

172780 01-03 
DEPENDENCE OF ANTICONVULSANT DRUG ACTION ON CENTRAL 
MONOAMINES. 

172923 01-03 
THE DESIGN OF THERAPEUTIC TRIALS: A CRITICAL ANALYSIS WITH 
ILLUSTRATIONS, PARTICULARLY FROM THE FIELD OF PSYCHOTROPIC 
DRUGS OR: WHY NO ONE CAN EVER DO A PROPER DRUG TRIAL. 

173307 01-16 
BEHAVIORAL PARAMETERS OF DRUG ACTION: SIGNALED AND RESPONSE 
INDEPENDENT REINFORCEMENT. 

174008 01-04 
DRUGS AND PLACEBOS: DRUG GUESSING BY NORMAL VOLUNTEERS. 

174210 01-14 
EFFECT OF A NEW PSYCHOTROPIC DRUG, CS-370 {10-CHLORO-11B-(2- 
CHLOROPHENYL)-2,3,5,6,7,l IB HEXAHYDR0BENZ0DIAZEPIN00XA20L- 
6-ONE) UPON THE CENTRAL NERVOUS SYSTEM. 

174603 01-03 
QUANTUM CHEMICAL STUDIES ON DRUG ACTIONS: IV. CORRELATION OF 
SUBSTITUENT STRUCTURES AND ANTISEROTONIN ACTIVITY IN 
LYSERGAMIDE SERIES. 

174605 01-12 
THE DOCUMENTATION OF CLINICAL PSYCHOTROPIC DRUG TRIALS. 

175332 02-16 
A ROLE OF THE DIETARY LIPID IN THE ABILITY OF PHENOBARBITAl TO 
STIMULATE DRUG DETOXIFICATION. 

175859 02-03 
DRUG EFFECTS ON GASTRIC ULCERATION RATE IN THE RAT. 
(UNPUBLISHED PAPER), 

176307 02-03 
CLINICAL EFFECT Of A NEW PSYCHOTROPIC DRUG, ZISEPRON, IN 
TREATMENT OF PSYCHIATRIC DISEASES IN COMPARISON WITH 
THIORIDAZINE. 

176467 02-08 
EXPERIENCE IN THE APPLICATION OF A NEW DRUG, DP-181 
(OXYPERTINE), IN TREATMENT OF SCHIZOPHRENIA. 

1764^8 02-08 
CLINICAL EFFECTS OF DICEPLON, A PSYCHOTROPIC DRUG. 

176470 02-08 
EXPERIENCE IN THE DRUG HORIZON AND PSYCHIATRIC INTERVIEW. 

176542 02-11 
CLINICAL EXPERIENCES WITH A NEW PSYCHOTROPIC DRUG, R-6238 
(PIMOZIDE). 

176564 02-11 
CLINICAL EXPERIENCES WITH AN ANTIDEPRESSIVE DRUG, NORITREN 

(NORTRIPTYLINE). 

176565 02-09 
CLINICAL EXPERIENCES WITH A PSYCHOTROPIC DRUG (OXYPERTINE) IN 

CHRONIC SCHIZOPHRENIA. 

176727 02-08 
CHLORDIAZEPOXIDE OVERDOSE: INTERPRETATION OF SERUM DRUG 
CONCENTRATIONS. 

177393 02-15 
METHYPRYLON OVERDOSE: INTERPRETATION OF SERUM DRUG 

CONCENTRATIONS. 

177394 02-15 
REPEATED ACQUISITION OF BEHAVIORAL CHAINS UNDER CHRONIC DRUG 

CONDITIONS. 

177408 02-04 
CLINICAL EffECT Of A NEW PSYCHOTROPIC DRUG, DOXEPIN 
HYDROCHLORIDE, IN THE TREATMENT Of DEPRESSIVE STATES. 

177569 02-11 



RESPONSE TO STIMULANT DRUG TREATMENT IN HYPERACTIVE 
CHILDREN: PREDICTION fROM EEG AND NEUROLOGICAL fINDINGS. 

177778 02-11 
FLAVOR AVERSIONS PRODUCED BY CONTINGENT DRUG INJECTION: 
RELATIVE EffECTIVENESS Of APOMORPHINE, EMETINE, AND LITHIUM. 

1 78502 02-04 
fATAL INTOXICATION OF A YOUNG DRUG ADDICT WITH DIAZEPAM. 

178619 02-05 
MARIHUANA - A PSYCHEDELIC DRUG? 

178695 02-17 
PHARAAACOLOGY AND TOXICOLOGY OF THE ANTIEPILEPTIC DRUG 
CLONAZEPAM. 

179021 02-05 
AN ANALYSIS OF D-AMPHETAMINE PRODUCED FACILITATION OF 
AVOIDANCE ACQUISITION IN RATS AND PERFORMANCE CHANGES 
SUBSEQUENT TO DRUG TERMINATION. 

179990 02-04 
DRUG ABUSE - OVERDOSE AND RECOVERY. 

180147 02-15 
THE DOCUMENTATION OF CLINICAL PSYCHOTROPIC DRUG TRIALS: 
SAMPLE OUTPUT PACKAGE. 

180256 02-16 
EXPERIENCE IN THE TREATMENT OF CEREBRAL INSUFFICIENCY AND 
PERIPHERAL BLOOD CIRCULATION DISORDERS USING THE EP- 50-100 
EXPERIMENTAL DRUG. 

180676 02-11 
PSYCHOPHARMACOLOGIC AGENTS: EFFECT ON DRUG METABOLISM. 

181398 02-13 
DRUG EFFECTS ON LEARNING AND MEMORY. 

181404 02-04 
DETERMINANTS OF DRUG EFFECTS ON PUNISHED BEHAVIOR.^ 

181405 02-04 
PSYCHOACTIVE DRUG CONTROL: ISSUES AND RECOMMENDATIONS. 

181638 02-17 
CROSS-NATIONAL STUDY OF THE EXTENT OF ANTIANXIETY SEDATIVE 
DRUG USE. 

181713 02-17 
A CLINICAL EVALUATION OF A NEW ANXIOLYTIC DRUG 
(THIENODIAZEPINE DERIVATIVE Y-6047) IN NEUROTICS AND 
PSYCHOSOMATIC DISORDERS - A PRELIMINARY REPORT. 

181771 0207 
PREDICTION OF NEUROLEPTIC EFFECTS OF CI-686 BASED ON 
QUANTITATIVE PHARMACOELECTROENCEPHALOGRAPHY: DRUG 
PROFILES AND DOSE RESPONSE CURVES BASED ON COMPUTERIZED 
CEREBRAL BIOPOTENTIALS. 

181958 02-13 
DRUG DEPENDENCE TEST OF PHENOBARBITAL AND MORPHINE IN RATS 
BY SPONTANEOUS INTAKE. 

182104 02-04 
MANIFEST ANXIETY AND ANTIANXIETY DRUG EFFECTS IN NORMAL 
VOLUNTEERS. 

182118 02-14 
ANALYSIS OF DRUG BLOCK OF LSD/5-HT/GABA BY MONITORING 
NEURONAL MEMBRANE CHANGES. 

182143 02-03 
INTERACTION OF THE BEHAVIORALLY ACTIVE DRUG. PHENITRONE, A 
PURPORTED HASHISH AND LSD ANTAGONIST, WITH SEVERAL 
CENTRAL NEUROCHEMICAL SYSTEMS. 

182217 03-04 
DRUG THERAPY FOR DEPRESSION IN CHILDREN. INDICATIONS AND 
METHODS. 

182429 03-10 
RUBIDIUM SALTS - TOXIC EFFECTS IN HUMANS AND CLINICAL EFFECTS 
AS AN ANTIDEPRESSANT DRUG. 

182443 03-09 
DRUG ABSORPTION IN RATS PRETREATED WITH ANTIBIOTICS. 

182715 03-03 
INDUCTION OF HEPATIC DRUG METABOLIZING ENZYMES BY LITHIUM 
TREATMENT. 

182727 03-03 
CLINICAL EXPERIENCE WITH A NEW PSYCHOTROPIC DRUG: FK-880 
(SULPIRIDE), ITS EFFECT ON PATIENTS WITH PSYCHOSOMATIC 
DISEASES AND PSYCHONEUROSIS. 

182731 03-10 
PSYCHIC FATIGABILITY, ITS FEATURES AND DRUG THERAPY. 

183197 03-11 
NEUROLOGICAL CONSEQUENCES OF PSYCHOTROPIC DRUG WITHDRAWAL 
IN SCHIZOPHRENIC CHILDREN. 

183275 03-08 
THE STANDARDIZED VIDEOTAPE INTERVIEW AS AN OBJECTIVE 
DEPENDENT VARIABLE IN PSYCHOTROPIC DRUG RESEARCH. 

183635 03-17 
A COMPARISON OF PSYCHOTOMIMETIC DRUG EFFECTS ON RAT BRAIN 
NOREPINEPHRINE METABOLISM. 

183891 03-03 
CHLORMEZANONE IN ANXIETY: A DRUG REDISCOVERED? 

184175 03-10 



S-89 



Subject Index 



Psychopharmacology Abstracts 



DECREASED EFFECT OF PHENOBARBITAL TREATMENT ON MICROSOMAL 
DRUG METABOLIZING ENZYME ACTIVITY DURING GESTATION. 

184228 03-03 
THE DISCHARGED PATIENTS DRUG TREATMENT. 

185195 03-17 
FURTHER STUDIES ON THE INHIBITION OF DRUG METABOLISM BY 
PREGNANOLONE AND RELATED STEROIDS. 

185866 03-03 
RESPONSE TO INCREMENTAL DOSES OF DITRAN IN ABSTINENT 
ALCOHOLICS AND DRUG USERS. 

185875 03-11 
DRUG DOSAGE IN ACUTE PHASE SCHIZOPHRENIA. 

185898 03-17 
REGIONAL CHANGES IN MONOAMINE LEVELS AND IN THE RATE OF 

TYROSINE AND TRYPTOPHAN HYDROXYLATION IN 4 WEEK OLD 
OFFSPRING OF NURSING MOTHERS TREATED WITH THE NEUROLEPTIC 
DRUG PENFLURIDOL. 

185899 03-03 
THE EFFECTS OF CHRONIC TREATMENT WITH D-AMPHETAMINE ON FOOD 

INTAKE, BODYWEIGHT, LOCOMOTOR ACTIVITY AND SUBCELLULAR 
DISTRIBUTION OF THE DRUG IN RAT BRAIN. 

185931 03-03 
DRUG LEVEL OF D- AND L-AMPHETAMINE DURING INTRAVENOUS SELF- 
ADMINISTRATION. 

185960 03-04 
GUIDELINES FOR ANTIPSYCHOTIC DRUG USE. 

186191 03-09 
SEXUAL DYSFUNCTION RESULTING FROM DRUG SIDE-EFFECTS. 

186204 03-15 
ON THE CEREBRAL ACCUMULATION OF KETAMINE AND THE 
RELATIONSHIP BETWEEN METABOLISM OF THE DRUG AND ITS 
PHARMACOLOGICAL EFFECTS. 

186693 03-03 
AMPHETAMINE AND OPERANT BEHAVIOR IN RATS: RELATIONSHIP 
BETWEEN DRUG EFFECT AND CONTROL RESPONSE RATE. 

187699 04-04 
POLYPHARMACY IN PSYCHIATRY: A MULTI-STATE COMPARISON OF 
PSYCHOTROPIC DRUG COMBINATIONS. 

187840 04-17 
HEAT DYSCONTROL SYNDROME IN PATIENTS RECEIVING 

ANTIPSYCHOTIC, ANTIDEPRESSANT AND ANTIPARKINSON DRUG 
THERAPY. 

188094 04-15 
ARE NEUROTIC PATIENTS IN PSYCHOTROPIC DRUG TRIALS 

REPRESENTATIVE? A COMPARISON OF STUDY AND NON-STUDY 
PATIENTS IN FOUR FAMILY PRACTICES. 

188144 04-10 
DRUG EFFECTS AND HYPOTHALAMIC ANTERIOR PITUITARY FUNCTION. 

188393 04-03 
DRUG THERAPIES IN CRISIS MANAGEMENT. 

189297 04-17 
ANTICONVULSANT EFFECTS OF CANNABINOLS IN MICE: DRUG 
INTERACTIONS WITH CANNABINOIDS AND CANNABINOID 
INTERACTIONS WITH PHENYTOIN. 

189513 04-03 
AFFECTIVE DISORDERS AND CHEMICAL DEPENDENCE: LITHIUM FOR 
ALCOHOL AND DRUG ADDICTION 

189775 04-09 
TARDIVE DYSKINESIA AND DRUG THERAPY IN GERIATRIC PATIENTS. 

189923 04-13 
DIAZEPAM ON DEMAND: DRUG SEEKING BEHAVIOR IN PSYCHIATRIC 

INPATIENTS. 

189924 04-17 

DRUG MAINTENANCE IN THE OUTPATIENT TREATMENT OF CHRONIC 

ALCOHOLISM. 

189926 04-11 

IMPROVING PSYCHIATRIC DRUG THERAPY: A MATTER OF DOSAGE AND 

CHOICE. 

190144 04-17 
THE METHOHEXITAL METHYLPHENIDATE INTERVIEW: A PROPOSED NEW 
DRUG COMBINATION FOR NARCOTHERAPY. 

190242 04-07 
DRUG INTERACTIONS. 

190258 04-15 
INABILITY TO CONDITION A PERIPHERAL ACTIVATING DRUG. 

190698 04-04 
APPLICATION OF THE SEQUENTIAL SIMPLEX METHOD IN DESIGNING 
DRUG ANALOGS. 

190714 04-01 
THE FUTURE OF PHARMACOTHERAPY: NEW DRUG DELIVERY SYSTEMS. 

191044 04-08 

AMA DRUG EVALUATIONS. 

191048 04-17 

ANTICONVULSANT DRUG SERUM LEVELS IN PSYCHIATRIC PATIENTS 
WITH SEIZURE DISORDERS: EFFECTS OF CERTAIN PSYCHOTROPIC 
DRUGS. 

191096 04-13 



CORTICAL AND/OR SUBCORTICAL EFFECTS AS A FUNCTION OF 
HALLUCINOGENIC DRUG STRUCTURE 

191936 04-03 
CELLULAR EFFECTS OF METHAQUALONE ON DRUG METABOLIZING 
ENZYMES. 

191942 04-0; 
PHARAAACOLOGY OF DEPRESSION IN THE AGED: EVALUATION OF 
GER0VITAL-H3 AS AN ANTIDEPRESSANT DRUG. 

192229 04-0< 
CONDITIONING IN THE PREDICTION OF DRUG WITHDRAWAL EFFECTS IN 
CHRONIC SCHIZOPHRENIC PATIENTS. 

192412 04- 1; 
THE USE OF PROPRANOLOL WITH VARIOUS DRUG COMBINATIONS IN 
THE TREATMENT OF ESSENTIAL HYPERTENSION. 

192511 04- 1: 
DRUG NAME FAMILIARITY AND THE PLACEBO EFFECT. 

192704 04-1: 
DRUG-INDUCED 

ACUTE DRUG-INDUCED EXTRAPYRAMIDAL SYNDROMES. 

167572 Ol-l: 
DRUG-INDUCED ACTIVATION OF STRIATAL TYROSINE HYDROXYLASE: 
CHANGES IN THE AFFINITY FOR PTERIDINE COFACTORS. (UNPUBLISHEl 
PAPER). 

173381 01-0 
DRUG-INDUCED CATALEPSY AS INFLUENCED BY PSYCHOSTIMULANTS, 
APOMORPHINE, L-DOPA, AND YOHIMBINE. 

177730 02-1: 
INHIBITION OF ANTICHOLINERGIC DRUG-INDUCED LOCOMOTOR 
STIMULATION IN MICE BY ALPHA-METHYLTYROSINE. 

1 77840 02-0 
MECHANISMS OF DRUG-INDUCED BEHAVIORAL TOLERANCE. 

181406 02-0 
SELF-STIMULATION AND CATECHOLAMINES: DRUG-INDUCED 

MOBILIZATION OF THE RESERVE POOL RE-ESTABLISHES RESPONDING 
IN CATECHOLAMINE DEPLETED RATS. 

189025 04-0 
HALLUCINOGENIC DRUG-INDUCED BEHAVIOR UNDER SENSORY 
ATTENUATION: PREDICTION OF RESPONSE TO PSILOCYBIN. 

189744 04-1 
DRUG-INDUCED STEREOTYPED BEHAVIOR: SIMILARITIES AND 
DIFFERENCES. 

191504 04-0 
DRUG-INDUCED AGGRESSION IN CHICKS: DIFFERENTIAL INVOLVEMENT 

OF BIOGENIC AMINES. 

191977 04-0 
A METHOD FOR TESTING DRUG-INDUCED PARKINSONIAN-LIKE EFFECT. 

191982 04-1 
DRUGS 

THE USE OF PSYCHOACTIVE DRUGS BY ADULTS. 

167585 01-1 
INTERNATIONAL REFERENCE CENTERS NETWORK FOR PSYCHOTROPIC 
DRUGS. 

167706 01-1 
IN THE SEARCH FOR NEW TRANQUILIZING DRUGS. 

167813 O1-0 
ACUTE ADVERSE REACTIONS TO PSYCHOACTIVE DRUGS. DRUG USAGE, 
AND PERSONALITY. (UNPUBLISHED PAPER). 

167832 01-1 
CURRENT SITUATION OF THE USE OF DRUGS IN ASAHIGAWA JIDO-IN. 

168302 01-1 
COMBINATIONS OF ANTIDEPRESSANT DRUGS IN THE TREATMENT OF 
DEPRESSIVE ILLNESS. 

168317 01-C 
THE EFFECT OF PLACEBO AND DRUGS ON HUMAN SLEEP. 

168419 01-1 
DYSTONIC REACTIONS TO DRUGS. 

168526 01-1 
STATE-DEPENDENT LEARNING PRODUCED BY ADDICTING DRUGS. 

169071 01-C 
GAS CHROMATOGRAPHIC - MASS SPECTROMETRY STUDIES ON 
TRICYCLIC PSYCHOTROPIC DRUGS. 

169073 01-C 
LONG-TERM TREATMENT OF DEPRESSION WITH DRUGS AND 
PSYCHOTHERAPY. 

169087 01-C 
CHANGES IN SOMATOSENSORY EVOKED POTENTIALS PRODUCED BY 
DRUGS USED IN THE TREATMENT OF AFFECTIVE DISORDERS. 

169092 01-C 
ANTIPARKINSON DRUGS AS CAUSAL AGENTS IN TARDIVE DYSKINESIA. 

169140 01-1 
INFLUENCE OF AFFECTIVE STATES AND PSYCHOACTIVE DRUGS ON 
VERBAL LEARNING AND MEMORY. 

169504 01-C 
USE OF PSYCHOTHERAPEUTIC DRUGS IN THE ACUTE DETOXIFICATION 01 
HEROIN ADDICTS. 

169746 01-1 
PSYCHOTROPIC DRUGS AS THERAPEUTIC AGENTS. 

169748 01-1 



S-90 



/OLUME 12, SUBJECT INDEX 



Subject Index 



DRUGS AND PSYCHODYNAMIC SHIFTS IN AFFECTIVE ILLNESS. 

(UNPUBLISHED PAPER). 

170079 01-09 
BRAIN SEROTONIN, AFFECTIVE ILLNESS AND ANTIDEPRESSANT DRUGS: 

CEREBROSPINAL FLUID STUDIES WITH PROBENECID. (UNPUBLISHED 

'^''^^ 170084 01-09 

THE ACTIVITY OF SOME NEUROLEPTIC DRUGS AND AMPHETAMINE IN 
NORMAL AND ISOLATED RATS. 

170126 01-04 
MEGAVITAMIN TREATMENT, CULTURE AND TRANQUILIZERS, DRUGS FOR 
THE AGED: PROJECTS OF A CANADIAN GRANT. 

170293 01-11 
THE ELECTROCARDIOGRAPHIC ABNORMALITIES INDUCED BY 
PSYCHOTROPIC DRUGS. 

170638 01-13 
RADIOIMMUNOASSAY FOR LYSERGIDE (LSD) IN ILLICIT DRUGS AND 
BIOLOGICAL FLUIDS. 

170840 01-06 
EFFECT AND AFTEREFFECT OF DRUGS: ETHICAL CONSIDERATIONS ON THE 
USE OF PSYCHOTROPIC AGENTS (1). 

170847 01-17 
TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. (UNPUBLISHED PAPER). 

170876 01-03 
DRUGS AND PSYCHIATRIC READAPTATION. 

171121 01-17 
ABOUT THE PSYOHOTROPIC DRUGS. 

171159 01-17 
DRUGS COMMONLY USED IN MENTAL CONDITIONS. 

171257 01-17 
STUDY ON THE PSYCHOPHARMACOLOGICAL ASSAY OF CENTRALLY 
ACTING DRUGS IN RATS. 

171260 01-06 
PSYCHOTROPIC DRUGS IN MEDICAL PRACTICE. 

171485 01-17 
COMMON PSYCHOTROPIC DRUGS. 

171568 01-17 
THE EFFECT OF PIPRADROL IN MICE AND ITS ANTAGONISM BY 
NEUROLEPTIC DRUGS. 

171607 01-04 

INHIBITION OF MOUSE-KILLING BEHAVIOUR IN RATS BY SOME 
THYMOLEPTIC DRUGS. 

171608 01-04 
INFLUENCES OF DRUGS ON THE INCREASES IN BRAIN DOPAMINE 

PRODUCED BY AXOTOMY OF GAMMA-HYDROXYBUTYRIC ACID 
(GHBA). 

171622 01-03 
ANTAGONISM OF P-CHLOROAMPHETAMINE (PCA) INDUCED DEPLETION 
OF 5-HT FROM RAT BRAIN BY SOME THYMOLEPTICS AND OTHER 
PSYCHOTROPIC DRUGS. 

171628 01-03 
TREATMENT OF DEPRESSION BY DRUGS AND PSYCHOTHERAPY. 

171924 01-10 
DRUGS AND GROUP PSYCHOTHERAPY IN NEUROTIC DEPRESSION. 

171925 01-10 
SEROTONINERGIC MECHANISMS IN THE CENTRAL ACTION OF 

PSYCHOTROPIC DRUGS. (PH.D. DISSERTATION). 

172015 01-03 
DETERMINATION OF DRUG TRANSFER ACROSS BIOLOGICAL MEMBRANES: 
COMPARATIVE STUDY ON THE PASSAGE OF DRUGS INTO THE 
CENTRAL NERVOUS SYSTEM AND THEIR PLACENTAL TRANSFER AND 
FETAL LOCALIZATION IN THE PREGNANT RAT. (PH.D. DISSERTATION). 

172018 01-03 
EFFECTS OF CENTRALLY ACTING DRUGS ON ADENYL CYCLASE ACTIVITY 

AND CYCLIC AMP LEVELS OF MOUSE BRAIN. (PH.D. DISSERTATION). 

172019 01-03 
SOME ASPECTS OF PSYCHOTOGENIC DRUGS. 

172809 01-17 
OSCILLATORY POTENTIALS OF THE CAT RETINA: EFFECTS OF ADRENERGIC 
DRUGS. 

172916 01-03 
THE EEG OF SLEEP AND PSYCHOTROPIC DRUGS. 

172972 01-13 
THE DESIGN OF THERAPEUTIC TRIALS: A CRITICAL ANALYSIS WITH 
ILLUSTRATIONS, PARTICULARLY FROM THE FIELD OF PSYCHOTROPIC 
DRUGS OR: WHY NO ONE CAN EVER DO A PROPER DRUG TRIAL. 

173307 01-16 
PSYCHOACTIVE DRUGS: IMMUNOASSAY AND LOCALIZATION. 

173536 01-06 
THE PSYCHIATRIC SIDE-EFFECTS OF DRUGS. 

173866 01-15 
DRINKING BEHAVIOUR AND BRAIN DOPAMINE: ANTAGONISTIC EFFECT 
OF TWO NEUROLEPTIC DRUGS (PIMOZIDE AND SPIRAMIDE) UPON 
AMPHETAMINE OR APOMORPHINE-INDUCED HYPODIPSIA. 

174035 01-04 



EXCITANT AND DEPRESSANT DRUGS MODULATE EFFECTS OF 
ENVIRONMENT ON BRAIN WEIGHT AND CHOLINESTERASES. 

174036 01-03 
REHABILITATION OF LEARNING IN A HOSPITAL CLASS USING 
PSYCHOACTIVE DRUGS. 

174071 01-11 
DRUGS AND PLACEBOS: DRUG GUESSING BY NORMAL VOLUNTEERS. 

174210 01-14 
BEHAVIORAL CHANGES AND AGGRESSIVITY EVOKED BY DRUGS IN MICE. 

174604 01-04 
ANTIDEPRESSANT DRUGS, 

174760 01-03 
ANTIDEPRESSANT DRUGS. 

174851 01-09 
PSYCHIATRISTS REACTIONS TO THEIR PATIENTS REFUSAL OF DRUGS, 

175251 02-17 
EFFECTS OF PSYCHOACTIVE DRUGS ON NONVERBAL COMMUNICATION 
AND GROUP SOCIAL BEHAVIOR OF MONKEYS. 

175317 02-04 
MANUAL OF INTOXICATING DRUGS. 

175537 02-17 

USE AND ABUSE OF DRUGS IN PSYCHIATRY. 

175620 02-17 
WITHDRAWAL OF MAINTENANCE DRUGS WITH LONG-TERM 
HOSPITALIZED MENTAL PATIENTS: A CRITICAL REVIEW. 

175862 02-17 
CLINICAL USE OF PSYCHOTHERAPEUTIC DRUGS. 

175914 02-17 

OVERDOSE OF PSYCHOTROPIC DRUGS. 

175935 02-15 
HYPOTENSION FROM DRUGS: INCIDENCE, PERIOD, PREVENTION. 

176674 02-15 
SIMPLE ALGORITHMS FOR PREDICTING PSYCHOTROPIC DRUGS ASSIGNED 
TO PSYCHIATRIC INPATIENTS. 

176676 02-17 
A METHOD FOR ANALYZING CNS EFFECTS OF DRUGS AND BRAIN 
LESIONS ON PERMANENT GROUPS OF RATS. 

1 76867 02-06 
STIMULATION OF SEROTONIN N-ACETYLTRANSFERASE IN PINEAL ORGAN 
CULTURE BY DRUGS. 

177128 02-03 
DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: 
ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE 
MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY. 

177131 02-03 
QUALITATIVE AND QUANTITATIVE STUDIES ON THE DISPOSITION OF 
AMITRIPTYLINE AND OTHER TRICYCLIC ANTIDEPRESSANT DRUGS IN 
MAN AS IT RELATES TO THE MANAGEMENT OF THE OVERDOSED 
PATIENT. 

177395 02-15 
RATE-DEPENDENT EFFECTS OF DRUGS. I. COMPARISONS OF D- 
AMPHETAMINE, PENTOBARBITAL, AND CHLORPROMAZINE ON 
MULTIPLE AND MIXED SCHEDULES. 

177410 02-04 
COMBINED USE OF ECT AND PSYCHOTROPIC DRUGS: ANTIDEPRESSIVES 
AND ANTIPSYCHOTICS. 

177670 02-11 
THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 
DRUGS ON HUMAN SLEEP: IV. THE EFFECTS OF CHLORPROMAZINE. 

177716 02-14 
THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 

DRUGS ON HUMAN SLEEP: V. THE EFFECTS OF CHLORAL HYDRATE. 

177717 02-14 
THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 

DRUGS ON HUMAN SLEEP: VI. THE EFFECTS OF CHLORDIAZEPOXIDE. 

177718 02-14 
CENTRAL NERVOUS SYSTEM AND AUTONOMIC NERVOUS SYSTEM 

EFFECTS OF AMANTADINE AND OF SOME STANDARD ANTIPARKINSON 
DRUGS. 

177729 02-13 
PHARAAACOLOGIC BASIS FOR USE OF PSYCHOTROPIC DRUGS: AN 
OVERVIEW. 

177782 02-17 

PSYCHOTROPIC DRUGS. 

178002 02-17 

PSYCHOTROPIC DRUGS IN CAMBODIA. 

178109 02-17 
PSYCHIATRIC CARE: DRUGS, THERAPIST, COMMUNITY. 

178189 02-17 
ROLE OF 5-HT IN THE ACTION OF SOME DRUGS AFFECTING 
EXTRAPYRAMIDAL SYSTEM. 

178757 02-04 
EKG ALTERNATIONS IN INFUSION TREATMENT WITH TRICYCLIC 
ANTIDEPRESSIVE DRUGS. 

180063 02-15 

ANTIDEPRESSANT DRUGS. 

180297 02-09 

EFFECTS OF DRUGS ON SLEEP. 

181393 02-14 



S-91 



Subject Index 

PSYCHOTROPIC DRUGS AND CYTOGENIC EFFECTS. 
DRUGS ON EEG CORRELATES OF BEHAVIOR. 
BASIC TYPES OF EFFECTS OF DRUGS ON BEHAVIOR. 
BEHAVIORAL EFFECTS OF DRUGS IN MACACA-MULATTA. 
PSYCHOTROPIC DRUGS AND PHENOTYPICAL BEHAVIORS. 
MODIFICATION OF THE FRUSTRATION EFFECT WITH DRUGS. 



181395 02-15 

181396 02-04 
181399 02-04 
181401 02-04 
181407 02-05 



181408 02-04 

INFLUENCE OF VARIOUS DRUGS ON THE BINDING OF CHLORPROMAZINE 
TO ERYTHROCYTES AND ALBUMIN. 

181470 02-03 
ELECTROCLINICAL DISCREPANCIES IN ANTIANXIETY DRUGS. 

181918 02-13 
THE EFFECTS OF DRUGS ON THE RELEASE OF CATECHOLAMINE. 

182089 02-03 
EEG CHARACTERISTICS IN VARIOUS SPECIES OF ANIMAL AND THEIR 
RELATION TO THE CNS EFFECTS OF DRUGS. 

182096 02-03 
ATTEMPT TO EVALUATE THE PHYSICAL DEPENDENCE LIABILITY OF 
PSYCHOTROPIC DRUGS IN MICE. 

182103 02-04 
EFFECTS OF PSYCHOTROPIC DRUGS ON METHAMPHETAMINE INDUCED 
EXCITATIONS IN THE AGGREGATED MICE. 

182107 02-04 
EFFECTS OF PSYCHOTROPIC DRUGS ON ABNORMAL BEHAVIOR INDUCED 
BY DELTA9-TETRAHYDR0CANNABIN0L. 

182114 02-04 
EFFECTS OF PSYCHOTROPIC DRUGS ON DISCRIMINATION AVOIDANCE 

CONDITIONING IN RATS WITH OLFACTORY BULB ABLATIONS. 

182115 02-04 
NEURONE BLOCKING ACTIONS OF ANTIPSYCHOTIC DRUGS. 

182127 02-03 
RELATIVE IMPORTANCE OF DOPAMINERGIC AND NORADRENERGIC 
NEURONAL SYSTEMS FOR THE STIMULATION OF LOCOMOTOR 
ACTIVITY INDUCED BY AMPHETAMINE AND OTHER DRUGS. 

182209 02-04 
DIFFERENTIAL CIRCULATORY EFFECTS OF VARIOUS ANOREXIGENIC 
DRUGS. 

182214 03-03 
DIFFERENTIAL SELF-INJECTION BEHAVIOR PRODUCED BY FENFLURAMINE 

VERSUS OTHER APPETITE INHIBITING DRUGS. 

182215 03-04 
DRUGS, BEHAVIOR AND CHOLINE ACETYLTRANSFERASE. 

182237 03-04 
INHIBITION OF ISOLATION INDUCED AGGRESSION IN MICE BY 
ANTISEROTONERGIC DRUGS. 

182240 03-04 
THE OCULAR COMPLICATIONS BY MASSIVE DOSE OF PSYCHOTROPIC 
DRUGS. 

182552 03-15 
THE USE OF TRANQUILIZING DRUGS IN CASES OF SCHIZOPHRENIA. 

182581 03-08 
SOCIAL IMPLICATIONS OF PSYCHOTROPIC DRUGS. 

182770 03-17 
EFFECT OF DRUGS UPON AXOPLASMIC TRANSPORT. 

182772 03-17 
DRUGS ACTING ON THE CENTRAL NERVOUS SYSTEM. 

182835 03-17 
PSYCHOTROPIC DRUGS IN CHILDHOOD DISTURBANCES. 

182890 03-11 
THE INFLUENCE OF NEUROTROPIC DRUGS ON MONOAMINE OXIDASE 
(MAO) AND 5-OXYTRYPTOPHANE DECARBOXYLASE (5-OTD) ACTIVITY 
IN THE BRAIN. 

183142 03-13 
SOMATIC SIDE-EFFECTS OF PSYCHOTHERAPEUTIC DRUGS IN CHILDHOOD. 

183183 03-15 
IDENTIFICATION AND QUANTITATIVE DETERMINATION OF 
PHENOTHIAZINE DRUGS IN URINE SAMPLES OF PSYCHIATRIC 
PATIENTS. 

183599 03-02 
EFFECTS OF ANTIPARKINSONIAN DRUGS ON NEUROLEPTIC INDUCED 
EXTRAPYRAMIDAL SIGNS IN MONKEYS. 

183610 03-03 
THE EFFECT OF PAIN RELIEVING DRUGS ADMINISTERED DURING LABOR 
AND DELIVERY ON THE BEHAVIOR OF THE NEWBORN: A REVIEW. 

183706 03-17 
SIDE-EFFECTS OF NEUROLEPTIC DRUGS. 

183749 03-15 
SIDE-EFFECTS OF DRUGS. 

183812 03-15 
THE CONDITIONED EMOTIONAL RESPONSE (CER) AS A BASELINE FOR THE 
STUDY OF ANTIANXIETY DRUGS. 

183862 03-04 
IMPACT OF PSYCHOACTIVE DRUGS ON HYPNOTIZABILITY. 

184021 03-12 



Psychopharmacology Abstracts 

INFLUENCE OF METHAMPHETAMINE AND NEUROLEPTIC DRUGS ON 
TYROSINE HYDROXYLASE ACTIVITY. 

184180 03-03 
EFFECT OF ANTIDEPRESSANT AND ANTIMANIC DRUGS ON AMINE 
UPTAKE IN MAN. 

184654 03-13 
THE ABRUPT WITHDRAWAL OF ANTIPARKINSONIAN DRUGS IN 
SCHIZOPHRENIC PATIENTS. 

185005 03-06 
CLINICAL EVALUATION OF ANXIOLYTIC DRUGS. 

185350 03-1/ 
AN IMPROVED METHOD FOR STUDYING THE PSYCHOGALVANIC 
REACTION IN MICE AND ITS INHIBITION BY PSYCHOLEPTIC DRUGS. 
COMPARISON WITH THE EFFECTS OF OTHER PHARMACOLOGICAL 
AGENTS. 

185749 03-0< 
EFFECTS OF CENTRALLY APPLIED DRUGS ON PRESSOR RESPONSES TO 
HYPOTHALAMIC STIMULATION. 

185902 03-0: 
EFFECT OF SEVERAL DOPAMINERGIC DRUGS AND TRIHEXYPHENIDYL ON 
CHOLINERGIC PARAMETERS IN THE RAT STRIATUM. 

185995 03-0; 
HALLUCINOGENIC DRUGS AND ARTISTIC CREATIVITY. 

186026 03-1; 
PSYCHIATRIC COMPLICATIONS OF EVERYDAY DRUGS. 

186092 03- 1; 
THE CLINICAL EFFECTIVENESS OF LITHIUM: COMPARISONS WITH OTHER 
DRUGS. 

186189 03-0S 
METHYLPHENIDATE ANTAGONISM OF HALOPERIDOL, INTERACTION WITH 
CHOLINERGIC AND ANTICHOLINERGIC DRUGS. 

186370 03-0^ 
ALTERATION OF ETHANOL-INDUCED CNS DEPRESSION: INEFFECTIVENESS 
OF DRUGS THAT MODIFY CHOLINERGIC TRANSMISSION. 

186375 03-0; 
DRUGS TO TREAT PAIN. 

186395 03-1' 
MODIFICATION OF LEARNING AND MEMORY IN GOLDFISH THROUGH THE 
USE OF STIMULANT AND DEPRESSANT DRUGS. 

186583 03-0- 
THE ISOLATED PERFUSED RAT BRAIN AS A MODEL FOR STUDYING 
DRUGS ACTING ON THE CNS. 

186589 03-0< 
THE EFFECTS OF SOME DRUGS ON AN EVOKED RESPONSE SENSITIVE TO 
TETRAHYDROCANNABINOLS. 

186666 03-0; 
THE MONOAMINE OXIDASES OF BRAIN: SELECTIVE INHIBITION WITH 
DRUGS AND THE CONSEQUENCES FOR THE METABOLISM OF THE 
BIOGENIC AMINES. 

186668 03-0: 
NONCHOLINERGIC MECHANISM OF ACTION OF CHOLINERGIC DRUGS ON 
SQUID AXON MEMBRANES. 

186672 03-0; 
THE INFLUENCE OF PSYCHOTROPIC DRUGS ON THE LEVELS OF 
ENDOGENOUS 2-PHENYLETHYLAMINE IN RABBIT BRAIN. 

187112 03-0; 
VALIDITY OF SCREENING METHODS FOR DRUGS OF ABUSE IN 
BIOLOGICAL FLUIDS. II. HEROIN IN PLASMA AND SALIVA. 

187256 03-1! 
ON THE MECHANISM OF RELEASE OF NOREPINEPHRINE FROM 
SYMPATHETIC NERVES INDUCED BY DEPOLARIZING AGENTS AND 
SYMPATHOMIMETIC DRUGS. (UNPUBLISHED PAPER). 

187397 04-0; 
THE EFFECT OF SOME CHOLINOLYTIC DRUGS ON A NUMBER OF 

BEHAVIOURAL PARAMETERS MEASURED IN THE T-MAZE ALTERNATIO^ 
TEST: DOSE-RESPONSE RELATIONSHIPS. 

187641 04-0- 
ANTISCHIZOPHRENIC DRUGS AND BRAIN CHOLINERGIC RECEPTORS: 
AFFINITY FOR MUSCARINIC SITES PREDICTS EXTRAPYRAMIDAL 
EFFECTS. 

188114 04-1! 
CLASSIFICATION OF DRUGS ACCORDING TO THEIR DISCRIMINABLE 
EFFECTS IN RATS. 

188228 04-0< 
A LOOK AT RESTRAINING PRACTICES AND THE USE OF PSYCHOTROPIC 
DRUGS. 

188533 04-1: 
THE USE OF DRUGS IN PSYCHIATRIC INTERVIEWS: SOME 
INTERPRETATIONS BASED ON CONTROLLED EXPERIMENTS. 

189074 04-1; 
EFFECTS OF CATECHOLAMINE DEPLETING DRUGS AND AMPHETAMINE Oh 
SELF-STIMULATION OF BRAIN FOLLOWING VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS. 

189515 04-0- 
DOPAMINERGIC INHIBITION OF STRIATAL CHOLINERGIC NEURONS: 
SYNERGISTIC BLOCKING ACTION OF GAMMA-BUTYROLACTONE AND 
NEUROLEPTIC DRUGS. 

189602 04-0: 



S-92 



VOLUME 12, SUBJECT INDEX 

EFFECT OF ANTICONVULSANT DRUGS ON THE NUMBER OF AFFERENT 
STIMULI NEEDED TO CAUSE A HIPPOCAMPAL SEIZURE DISCHARGE. 

189608 04-03 
DIHYDROPTERIDINE REDUCTASE IN RAT BRAIN: REGIONAL DISTRIBUTION 
AND THE EFFECT OF CATECHOLAMINE DEPLETING DRUGS. 

189752 04-03 

DRUGS FOR BED-WETTING. 

189778 04-11 
EFFECTS OF ADRENERGIC AGENTS, THEOPHYLLINE AND OTHER DRUGS 
ON DEXTRAN EDEMA AND HISTAMINE RELEASE IN RATS. 

189895 04-03 
THE CONTROL OF DEVIANT SEXUAL BEHAVIOR BY DRUGS: A DOUBLE- 
BLIND CONTROLLED STUDY OF BENPERIDOL, CHLORPROMAZINE, AND 
PLACEBO. 

190061 04-11 
PSYCHOTROPIC DRUGS - HARM OR HELP. 

190138 04-11 
HOW TO PRESCRIBE PSYCHOACTIVE DRUGS. 

190236 04-17 
THE USES AND RELATIVE HAZARD POTENTIAL OF PSYCHOACTIVE 

DRUGS. 

190237 04-17 
EFFECT OF PHENOTHIAZINE NEUROLEPTIC DRUGS AND TRICYCLIC 

ANTIDEPRESSANTS ON PHOSPHODIESTERASE ACTIVITY IN RAT 
CEREBRAL CORTEX. 

19031 1 04-03 
EFFECTS OF DOPAMINE-LIKE DRUGS ON RAT STRIATAL ADENYL CYCLASE 
HAVE IMPLICATIONS FOR CNS DOPAMINE RECEPTOR TOPOGRAPHY. 

190545 04-03 
ANTICONVULSANT DRUG SERUM LEVELS IN PSYCHIATRIC PATIENTS 
WITH SEIZURE DISORDERS: EFFECTS OF CERTAIN PSYCHOTROPIC 
DRUGS. 

191096 04-13 
THIRTY-FIVE YEARS CONTINUOUS TREATMENT FOR RECURRENT 
DEPRESSION: FROM ECT TO DRUGS. 

19111904-09 
A COMPARISON OF CLINICALLY USED PSYCHOACTIVE DRUGS IN FOUR 
LATIN-AMERICAN COUNTRIES AND IN CANADA (ARGENTINA, COSTA- 
RICA, MEXICO AND PANAMA). 

191139 04-17 
DRUGS, NEUROTRANSMITTERS, AND SCHIZOPHRENIA. 

191290 04-08 
PERMANENT ALTERATIONS IN 5-HYDROXYTRYPT AMINE METABOLISM IN 
DISCRETE AREAS OF RAT BRAIN FOLLOWING EXPOSURE TO DRUGS 
DURING THE PERIOD OF DEVELOPMENT. 

191383 04-03 
THE EFFECT OF CHOLINOMIMETIC DRUGS ON POTASSIUM TRANSPORT IN 
RAT CEREBRAL CORTEX. 

191411 04-03 
THE USE OF SELECTIVE AND INHIBITOR DRUGS TO MODIFY AMINE 
METABOLISM IN BRAIN. 

191500 04-03 
CONSIDERATIONS ON THE USE OF ANALGESIC DRUGS IN DIFFERENT 
STAGES OF NEOPLASTIC DISEASES. 

191604 04-17 
PSYCHOTROPIC DRUGS AND ELECTROENCEPHALOGRAPHY - FIRST 
REPORT. 

191625 04-13 
PSYCHOTROPIC DRUGS AND ELECTROENCEPHALOGRAPHY - SECOND 
REPORT. 

191667 04-13 
INDICATION AND PROBLEMS OF PSYCHOTROPIC DRUGS IN GENERAL 
PRACTICE. 

191677 04-17 
CORRELATION BETWEEN THE TRANQUILIZING AND SEDATIVE ACTION OF 
NEUROLEPTICS, ANTIDEPRESSANTS AND ANTICHOLINERGIC DRUGS. 

191783 04-02 
INFLUENCE OF PSYCHOTROPIC DRUGS ON AGGRESSIVENESS EVOKED BY 
DESTRUCTION OF ISOLATED STRUCTURES OF THE FOREBRAIN. 

191788 04-04 
THE EFFICACY OF ANTIDEPRESSANT DRUGS: A REVIEW OF RESEARCH 
(1958 TO 1972). 

191857 04-09 
INTERACTIONS OF PSYCHOTROPIC DRUGS AND MESCALINE IN VITRO. 

191933 04-03 
INTRAGASTRIC SELF-ADMINISTRATION OF PSYCHOACTIVE DRUGS IN THE 
RHESUS MONKEY. 

191939 04-04 
EFFECTS OF VARIOUS DRUGS ON THE ACTIONS OF 5,7 
DIHYDROXYTRYPT AMINE. 

191955 04-03 
COMPARATIVE EFFECTS OF SOME CNS ACTIVE DRUGS ON LEARNED AND 
UNLEARNED BEHAVIOR IN THE HAMSTER. 

191976 04-04 
THE EFFECT OF CANNABINOID MIXTURES ON THE RESPONSE TO 
STIMULANT DRUGS IN MICE. 

191991 04-04 
LSD AND THE INSANITY DRUGS, PART XXXI. 

192092 04-17 



Subject Index 

RATIONAL USE OF PSYCHOTROPIC DRUGS: I. HYPNOTICS. 

192190 04-14 
CORRELATION OF PHARAAACOLOGICAL INVESTIGATIONS WITH THE 
CLINICAL EFFICACY OF ANTIDEPRESSANT DRUGS. 

192420 04-13 
TRUE AND APPARENT NON-PENETRATION OF THE BLOOD-BRAIN BARRIER 
BY PSYCHOTROPIC DRUGS. 

192423 04-03 
INCORPORATION OF 14C-DIHYDR0PHENYLALANINE AND 14C -CHOLINE 
INTO RAT BRAIN SUBCELLULAR PARTICLES AND THE EFFECT OF 
PSYCHOACTIVE DRUGS. 

192426 04-03 
PSYCHIATRIC SYMPTOMS PRODUCED BY DRUGS. 

192513 04-15 
DURATION 

EFFECT OF 6-HYDROXYDOPAMINE ON THE DURATION OF HEXOBARBITAL 
SLEEP IN RATS. 

178558 02-03 
DELTA9-TETRAHYDR0CANNABIN0L: EFFECTS OF ROUTE OF 

ADMINISTRATION ON ONSET AND DURATION OF ACTIVITY AND 
TOLERANCE DEVELOPMENT. 

187928 04-03 
DYADIC 

FIGHTING IN MICE: DYADIC ESCALATION AND WHAT IS LEARNED. 

173039 01-04 
DYADS 

EFFECTS OF (-) DELTA9-TRANS-TETRAHYDR0CANNABIN0L ON SOCIAL 
BEHAVIOR OF SQUIRREL MONKEY DYADS IN A WATER COMPETITION 
SITUATION. 

187640 04-04 
DYNAMICS 

THE DYNAMICS OF A GROUP IN PSYCHOTHERAPY. 

180140 02-12 
ON THE DYNAMICS AND TREATMENT OF THE TENDENCY OF 
SCHIZOPHRENIC PSYCHOSIS TO BECOME CHRONIC. 

183957 03-08 
DYSCONTROl 

EPISODIC DYSCONTROL: A CONTROLLED REPLICATION. 

187839 04-09 
HEAT DYSCONTROL SYNDROME IN PATIENTS RECEIVING 
ANTIPSYCHOTIC, ANTIDEPRESSANT AND ANTIPARKINSON DRUG 
THERAPY. 

188094 04-15 
DYSFUNCTION 

IMIPRAMINE IN THE TREATMENT OF MINIMAL BRAIN DYSFUNCTION IN 
CHILDREN. 

169295 01-11 
CEREBRAL STIMULANTS AND MINIMAL DYSFUNCTION: SOME 
QUESTIONS, SOME ANSWERS, AND SOME MORE QUESTIONS. 

180992 02-11 
LEAD INDUCED BEHAVIORAL DYSFUNCTION: AN ANIMAL MODEL OF 
HYPERACTIVITY. 

184953 03-04 
SEXUAL DYSFUNCTION RESULTING FROM DRUG SIDE-EFFECTS. 

186204 03-15 
CHLORPROMAZINE CAUSING EXTRAPYRAMIDAL DYSFUNCTION IN 
NEWBORN INFANT OF PSYCHOTIC MOTHER. 

187787 04-15 
PHOTIC RESPONSES IN MINIMAL BRAIN DYSFUNCTION. 

191188 04-15 
DYSFUNCTIONED 

AVERAGE EVOKED RESPONSES IN NORMAL AND MINIMALLY BRAIN 
DYSFUNCTIONED CHILDREN TREATED WITH AMPHETAMINE: A 
PRELIMINARY REPORT. 

169861 01-11 
DYSKINESIA 

INFLUENCE OF CONCENTRATION AND MOTOR PERFORMANCE ON 
TARDIVE DYSKINESIA AND RABBIT SYNDROME. 

167587 01-15 
ANTIPARKINSON DRUGS AS CAUSAL AGENTS IN TARDIVE DYSKINESIA. 

169140 01-15 
PSEUDOPARKINSONISM AND TARDIVE DYSKINESIA. 

171974 01-15 
STUDY OF THE EFFECT OF CERTAIN PHARMACOLOGICAL AGENTS ON 
TARDIVE DYSKINESIA AND THE RABBIT SYNDROME. 

178193 02-11 
A CASE OF TARDIVE DYSKINESIA APPEARING PRECOCIOUSLY UNDER 
NEUROLEPTICS. 

184961 03-17 
DOPAMINERGIC HYPERSENSITIVITY AND CHOLINERGIC HYPOFUNCTION 
IN THE PATHOPHYSIOLOGY OF TARDIVE DYSKINESIA. 

185929 03-11 
STUDIES ON THE ACTION OF CERTAIN PHARMACOLOGICAL AGENTS ON 
TARDIVE DYSKINESIA AND ON THE RABBIT SYNDROME. 

188406 04-03 
A STUDY OF BIOGENIC AMINE METABOLITES IN THE CEREBROSPINAL 
FLUID AND URINE OF MONKEYS WITH CHLORPROMAZINE INDUCED 
DYSKINESIA. / 

189210 04-03 



S-93 



Subject Index 

CHOLINERGIC SUPPRESSION OF TARDIVE DYSKINESIA. 

189403 04- n 
IMPAIRMENT OF OPTOKINETIC NYSTAGMUS IN PATIENTS WITH TARDIVE 
DYSKINESIA. 

189734 04- 13 
TARDIVE DYSKINESIA AND DRUG THERAPY IN GERIATRIC PATIENTS. 

189923 04-13 
CHOLINERGIC SUPPRESSION OF TARDIVE DYSKINESIA. 

190314 04-13 
ON THE COEXISTENCE OF PARKINSONISM AND TARDIVE DYSKINESIA. 

190380 04-11 
TARDIVE AND WITHDRAWAL DYSKINESIA ASSOCIATED WITH 
HALOPERIDOL. 

191035 04-15 
DYSKINESIAS 

LEVODOPA INDUCED DYSKINESIAS: COMPARISON IN PARKINSONISM 
DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS. 

169376 01-15 
DEANOL IN THE TREATMENT OF LEVODOPA INDUCED DYSKINESIAS. 

184196 03-11 
DYSPHORIC 

HIGH FREQUENCY OF DYSPHORIC REACTIONS TO 

TETRAHYDROCANNABINOL AMONG DEPRESSED PATIENTS. 

181274 02-09 
DYSTONIC 

DYSTONIC REACTIONS TO DRUGS. 

168526 01-15 
EATING 

PHARMACOLOGICAL SUPPRESSION OF EATING BEHAVIOR IN RELATION 
TO DIENCEPHALIC NORADRENERGIC RECEPTORS. 

174763 01-04 
TREATMENT OF COMPULSIVE EATING DISTURBANCES WITH 
ANTICONVULSANT MEDICATION. 

181270 02-14 
EFFECTS OF CYPROHEPTADINE ON THE EATING BEHAVIOR OF RATS AND 
CATS. 

182111 02-04 
DIAZEPAM-INDUCED EATING AND LEVER PRESSING FOR FOOD IN SATED 
RATS. 

186613 03-04 
ECLAMPSIA 

DIAZEPAM (CALMPOSE) IN ECLAMPSIA: A PRELIMINARY REPORT OF 16 
CASES. 

169633 01-11 
ECT 

A DOUBLE-BLIND TRIAL OF IPRINDOLE AND IMIPRAMINE IN DEPRESSIVES 
AND RESPONSE TO ECT IN REFRACTORY CASES. 

174376 01-09 
COMBINED USE OF ECT AND PSYCHOTROPIC DRUGS: ANTIDEPRESSIVES 
AND ANTIPSYCHOTICS. 

177670 02-11 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS: 

I. EFFECT ON THE BEHAVIOURAL CHANGES INDUCED BY RESERPINE, 
ALPHA-METHYL-P-TYROSINE OR AMPHETAMINE. 

186587 03-04 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS: 

II. EFFECT ON DOPAMINE AND NORADRENALINE CONCENTRATIONS 
AND TURNOVERS. 

186588 03-04 
ECT, GLAUCOMA, AND PROLONGED APNEA. 

187837 04-15 
THIRTY-FIVE YEARS CONTINUOUS TREATMENT FOR RECURRENT 
DEPRESSION: FROM ECT TO DRUGS. 

191119 04-09 
EDEMA 

EFFECTS OF ADRENERGIC AGENTS, THEOPHYLLINE AND OTHER DRUGS 
ON DEXTRAN EDEMA AND HISTAMINE RELEASE IN RATS. 

189895 04-03 



Psychopharmacology Abstracts 



EEC 



INFLUENCE OF TREATMENT ON SYMPTOMATOLOGY AND CORRELATED 
ELECTROENCEPHALOGRAPHIC (EEG) CHANGES IN THE AGED. 

167336 01-13 
EEG, HEART RATE, AND MOOD CHANGE (HIGH) AFTER CANNABIS. 

169068 01-13 
THE EEG OF SLEEP AND PSYCHOTROPIC DRUGS. 

172972 01-13 
LONG-TERM CLINICAL AND QUANTITATIVE EEG EFFECTS OF 

CLOPENTHIXOL IN SCHIZOPHRENICS: CLINICAL NEUROPHYSIOLOGICAL 
CORRELATIONS. 

174131 01-08 
A METHOD OF QUANTIFYING EEG FOR PSYCHOPHARMACOLOGICAL 
RESEARCH. 

174135 01-16 
EEG AND CARDIOVASCULAR EFFECTS OF TRYPTAMINE (T) AND LSD IN 
THE ENCEPHALE ISOLE CAT. (UNPUBLISHED PAPER) 

174496 01-12 
RESPONSE TO STIMULANT DRUG TREATMENT IN HYPERACTIVE 
CHILDREN: PREDICTION FROM EEG AND NEUROLOGICAL FINDINGS. 

177778 02-11 



COMPARISON OF THE CLINICAL AND COMPUTER ANALYZED EEG EFFECTS 
OF MESORIDAZINE AND CHLORPROMAZINE. 

180064 02- 1( 
COMPARISON OF CLOPENTHIXOL AND PERPHENAZINE IN BEHAVIOR AND 
EEG OF UNANESTHETIZED CATS. 

181386 02-0^ 
DRUGS ON EEG CORRELATES OF BEHAVIOR. 

181396 02-0^ 
EEG CHARACTERISTICS IN VARIOUS SPECIES OF ANIMAL AND THEIR 
RELATION TO THE CNS EFFECTS OF DRUGS. 

182096 02-0: 
EEG CHANGES & MOTOR IMPAIRMENT AFTER DISULFIRAM 
ADMINISTRATION TO CATS. 

182248 03-0; 
AN ELECTROENCEPHALOGRAPHIC STUDY ON THE TOLERANCE OF THE 
VARIOUS PSYCHIATRIC AND NEUROLOGICAL PATIENTS TO THE 
HYPNOTIC EFFECTS OF DIPHENHYDRAMINE - MEASURED BY THE 
AMOUNTS OF SLEEP EEG AS AN INDICATOR. 

182550 03-1 
EVALUATION OF EEG AND CLINICAL CHANGES ASSOCIATED WITH 
PAVABID THERAPY IN CHRONIC BRAIN SYNDROME. 

183402 03-1: 
BEHAVIOR AND EEG ANALYSIS OF CHRONIC AMPHETAMINE EFFECT. 

187116 03-1: 
EEG DRIVING RESPONSES AS A FUNCTION OF MONOAMINE OXIDASE. 

187149 03-1: 
CRUDE MARIHUANA EXTRACT: EEG AND BEHAVIORAL EFFECTS OF 
CHRONIC ORAL ADMINISTRATION IN RHESUS MONKEYS. 

189516 04-0 
EFFECT OF ATROPINE SULFATE ON THE SLEEP RELATED EEG SPIKE 
ACTIVITY OF THE TORTOISE, GEOCHELONE-CARBONARIA. 

191389 04-0 
BEHAVIORAL AND EEG CHANGES IN THE AMPHETAMINE MODEL OF 
PSYCHOSIS. 

191505 04-0 
THE EFFECTS OF PSILOCYBIN ON EEG AND BEHAVIOUR IN MONKEYS. 

192415 04-0 
EFFECTIVENESS 

RELATIONSHIP BETWEEN THE EFFECTIVENESS OF LITHIUM THERAPY AND 
FAMILY HISTORY. 

169494 01-0 
SAFETY AND EFFECTIVENESS OF HALOPERIDOL FOR MENTALLY 

RETARDED BEHAVIORALLY DISORDERED AND HYPERKINETIC PATIENTS 

169634 01-1 
DIPHENYLHYDANTOIN EFFECTIVENESS IN THE TREATMENT OF CHRONIC 
SCHIZOPHRENICS: A DOUBLE-BLIND CONTROLLED STUDY WITH A 
PLACEBO. 

171507 01-0 
FLAVOR AVERSIONS PRODUCED BY CONTINGENT DRUG INJECTION: 
RELATIVE EFFECTIVENESS OF APOMORPHINE, EMETINE, AND LITHIUM. 

1 78502 02-0 
THE CLINICAL EFFECTIVENESS OF LITHIUM: COMPARISONS WITH OTHER 
DRUGS. 

186189 03-0 
EFFECTOR 

THE ACTION OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTOR 
CENTERS OF EMOTIONS IN THE HYPOTHALAMUS. 

191785 04-0 
EFFICACIOUS 

PENFLURIDOL: AN EFFICACIOUS LONG-ACTING ORAL ANTIPSYCHOTIC 
COMPOUND. 

189072 04-0 
EFFLUX 

EFFECT OF SUBSTITUTED TRYPTAMINES ON THE EFFLUX OF 

NORADRENALINE FROM ADRENERGIC NERVES IN RABBIT ATRIA. 

168747 01-0 
ALTERATION OF 5-HYDR0XYTRYPTAMINE-14C EFFLUX BY NICOTINE IN 
RAT BRAIN AREA SLICES. 

172925 01-0 
THE INHIBITION BY BETA-ADRENOCEPTOR BLOCKING AGENTS OF 

CALCIUM UPTAKE INTO AND EFFLUX FROM ISOLATED SARCOPLASMIC 
VESICLES. 

184223 03-0 
EKG 

EKG ALTERNATIONS IN INFUSION TREATMENT WITH TRICYCLIC 
ANTIDEPRESSIVE DRUGS. 

180063 02-1 
ELATION 

INFLUENCE OF AMYL0BAR8IT0NE ON OPERANT DEPRESSION AND 
ELATION EFFECTS IN THE RAT. 

168834 01-0 
ELDERLY 

CALCIUM METABOLISM IN ELDERLY EPILEPTIC PATIENTS DURING 
ANTICONVULSANT THERAPY. 

185560 03-1 
ELECTIVE 

PREANESTHETIC MEDICATION IN ELECTIVE SURGERY: COMPARISON OF 
INTRAVENOUS DIAZEPAM WITH MEPERIDINE. 

167338 01-1 



S-94 



VOLUME 12, SUBJECT INDEX 



Subject Index 



EFFECTS OF D-AMPHETAMINE, MORPHINE AND CHLORPROMAZINE ON 
RESPONDING UNDER FIXED-INTERVAL SCHEDULES OF FOOD 
PRESENTATION OR ELECTRIC SHOCK PRESENTATION. 

191767 04-03 

EFFECT OF PROCAINE, LIDOCAINE AND PENTOBARBITAL ON ELECTRICAL 
ACTIVITY OF GUINEA-PIG OLFACTORY CORTEX IN VITRO. 

182092 02-03 
DIFFERENTIAL EFFECTS OF PILOCARPINE AND SCOPOLAMINE ON THE 
PERFORMANCE OF A LIGHT DARK DISCRIMINATION MAINTAINED BY 
ELECTRICAL STIMULATION OF THE BRAIN. 

186701 03-03 
A FREQUENCY SHIFT IN THE HIPPOCAMPAL THETA ACTIVITY: AN 

ELECTRICAL CORRELATE OF CENTRAL ACTION OF ACTH ANALOGUES IN 

THE DOG 

188166 04-04 

NEUROCHEMICAL ANALYSIS OF AGGRESSIVE - DEFENSIVE BEHAVIOR 
ELICITED BY ELECTRICAL STIMULATION OF THE HYPOTHALAMUS AND 
CENTRAL GRAY MATTER. 

191784 04-02 

INFLUENCE OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTS OF 
ELECTRICAL STIMULATION AND MICROINJECTION OF ACETYLCHOLINE, 
SEROTONIN AND NORADRENALINE INTO THE MESENCEPHALON. 

191786 04-02 
ACTION OF HALOPERIDOL AND TRIFLUOPERAZINE ON THE MOTOR 

RESPONSES ELICITED BY ELECTRICAL STIMULATION OF THE BRAIN IN 

RABBITS. 

191787 04-02 

DISCRIMINATIVE CONTROL OF BEHAVIOR BY ELECTRICAL STIMULATION 
OF THE DORSAL RAPHE NUCLEUS: GENERALIZATION TO LYSERGIC 
ACID DIETHYLAMIDE (LSD). 

191944 04-04 

ELECTRO 

SIGNIFICANCE OF THE CENTRAL BIOGENIC AMINES FOR THE THRESHOLD 
IN ELECTRO AND PENTETRAZOLE SEIZURES. 

181469 02-03 

ELECTROCARDIOGRAM 

EFFECTS OF CHLORPROMAZINE PLASMA LEVELS ON 
ELECTROCARDIOGRAM. 

188838 04-13 

ELECTROCARDIOGRAPHIC 

ELECTROCARDIOGRAPHIC CHANGES IN HYPERTHYROIDISM AFTER 
ADRENERGIC BLOCKADE WITH RESERPINE AND PROPRANOLOL. 

167460 01-13 
THE ELECTROCARDIOGRAPHIC ABNORMALITIES INDUCED BY 
PSYCHOTROPIC DRUGS. 

170638 01-13 

THE ELECTROCARDIOGRAPHIC ABNORMALITY INDUCED BY 
CHLORPROMAZINE. 

171296 01-15 

ELECTROCLINICAL 

ELECTROCLINICAL ASPECT OF INSIDON TREATMENT IN PATIENTS WITH 
NEUROTIC SYMPTOMS. 

174777 01-10 

ELECTROCLINICAL DISCREPANCIES IN ANTIANXIETY DRUGS. 

181918 02-13 
ELECTROCONVULSIONS 

THRESHOLDS FOR ELECTROCONVULSIONS AND CHEMOCONVULSIONS IN 
MICE AFTER TERMINATION OF TREATMENT WITH PHENOBARBITAL. 

170073 01-03 

ELECTROCONVULSIVE 

RECOVERY FROM ELECTROCONVULSIVE SHOCK-INDUCED AMNESIA BY 
EXPOSURE TO THE TRAINING ENVIRONMENT: PHARMACOLOGICAL 
ENHANCEMENT BY PIRACETAM. 

186704 03-04 

ELECTROCORTICAL 

EFFECTS OF ATROPINE ON EXPLORATION, LEARNING AND 
ELECTROCORTICAL ACTIVITY IN THE DEVELOPING RAT. 

169473 01-04 

ElECTROCORTICOGRAPHIC 

BEHAVIORAL AND ELECTROCORTICOGRAPHIC DOSE-RESPONSE 
RELATIONSHIPS WITH METRAZOL. (UNPUBLISHED PAPER). 

188248 04-04 

ELECTRODERMAL 

ELECTRODERMAL ACTIVITY IN HYPERACTIVE BOYS WHO ARE 
METHYLPHENIDATE RESPONDERS. 

191400 04-14 

ELECTRODES 

INTRACRANIAL SELF-STIMULATION IN RATS AS A FUNCTION OF 
VARIOUS STIMULUS PARAMETERS: IV. INFLUENCE OF AMPHETAMINE 
ON MEDIAL FOREBRAIN BUNDLE STIMULATION WITH MONOPOLAR 
ELECTRODES. 

185961 03-04 

ELECTROENCEPHALOGRAM 

ELECTROENCEPHALOGRAM OF HYSTERIC PATIENTS. 

175069 02-09 



ON THE STUPOROUS AND HYPOMANIC EPISODES ASSOCIATED WITH 

SPIKE AND WAVE IN ELECTROENCEPHALOGRAM. 

181388 02-11 
EFFECTS OF PHENOTHIAZINES, ANTIHISTAMINES, BENZODIAZEPINES AND 

BUTYROPHENONES ON ELECTROENCEPHALOGRAM AND FEEDING 

BEHAVIOR OF RATS. 

182554 03-04 

ELECTROENCEPHALOGRAPHIC 

INFLUENCE OF TREATMENT ON SYMPTOMATOLOGY AND CORRELATED 
ELECTROENCEPHALOGRAPHIC (EEG) CHANGES IN THE AGED. 

167336 01-13 
ELECTROENCEPHALOGRAPHIC RESPONSES TO LITHIUM. 

174132 01-14 

EFFECTS OF MEBUTAMATE ON THE ELECTROENCEPHALOGRAPHIC SLEEP 

PROFILE. 

174348 01-14 

ELECTROENCEPHALOGRAPHIC MODIFICATIONS DURING ADMINISTRATION 

OF LITHIUM. 

174566 01-09 

BEHAVIORAL AND ELECTROENCEPHALOGRAPHIC STUDIES ON 

THIOSEMICARBAZIDE INDUCED SEIZURE IN RABBITS. 

174855 01-05 
ACUTE NITRAZEPAM (MOGADON) POISONING: AN 

ELECTROENCEPHALOGRAPHIC STUDY. 

180148 02-15 
ELECTROENCEPHALOGRAPHIC CHANGES IN ACUTE PHENOBARBITONE 

POISONING. 

180149 02-15 

THE ELECTROENCEPHALOGRAPHIC CHANGES IN ACUTE BARBITURATE 

POISONING. 

180152 02-15 

ELECTROENCEPHALOGRAPHIC EFFECTS OF DELTA9- 

TETRAHYDROCANNABINOL, LSD-25, MESCALINE AND 2,5 DIMETHOXY- 
4-METHYLAMPHETAMINE IN THE RABBITS. 

182095 02-03 
AN ELECTROENCEPHALOGRAPHIC STUDY ON THE TOLERANCE OF THE 
VARIOUS PSYCHIATRIC AND NEUROLOGICAL PATIENTS TO THE 
HYPNOTIC EFFECTS OF DIPHENHYDRAMINE - MEASURED BY THE 
AMOUNTS OF SLEEP EEG AS AN INDICATOR. 

182550 03-11 
PERSISTENT ELECTROENCEPHALOGRAPHIC CHANGES IN RHESUS 
MONKEYS AFTER SINGLE DOSES OF PENTOBARBITAL, NITRAZEPAM 
AND IMIPRAMINE. 

187931 04-03 
ELECTROENCEPHALOGRAPHY • 

PSYCHOTROPIC DRUGS AND ELECTROENCEPHALOGRAPHY - FIRST 
REPORT. 

191625 04-13 
PSYCHOTROPIC DRUGS AND ELECTROENCEPHALOGRAPHY - SECOND 
REPORT. 

191667 04-13 

ELECTROLYTE 

LITHIUM INDUCED DIABETES-INSIPIDUS: MANIC SYMPTOMS, BRAIN AND 
ELECTROLYTE CORRELATES, AND CHLOROTHIAZIDE TREATMENT. 

169486 01-15 

ELECTROLYTES 

ELECTROLYTES IN CEREBROSPINAL FLUID IN ENDOGENOUS DEPRESSION. 

172402 01-09 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON BODYWEIGHT AND 
BRAIN ELECTROLYTES IN THE CHICKEN. 

186570 03-03 

ELECTROMYOGRAPHIC 

CLINICAL AND ELECTROMYOGRAPHIC RESEARCH CONCERNING 
TREATMENT OF PERIPHERAL NEUROPATHIES WITH NIVALASI. 

168975 01-13 

ELECTRON 

FLUORESCENCE AND ELECTRON MICROSCOPIC ANALYSIS OF 
CATECHOLAMINE CONTAINING FIBERS IN MUTANT MOUSE 
CEREBELLUM. (UNPUBLISHED PAPER). 

191762 04-03 

ELECTROPAIN 

THE EFFECT OF PSYCHOTROPIC AGENTS ON THE FORMATION OF 
AVOIDANCE REACTION IN ALBINO RATS DURING ELECTROPAIN 
STIMULATION OF ANOTHER RAT. 

183206 03-04 

ELECTROPHYSIOLOGICAL 

ELECTROPHYSIOLOGICAL STUDIES OF THE EFFECTS OF CDP-CHOLINE ON 
THE CENTRAL NERVOUS SYSTEM. 

182547 03-03 

ELECTRORETINOGRAM 

REFLECTION OF SHORT-TERM LIGHT ADAPTATION EFFECT IN THE 
ELECTRORETINOGRAM. 

180591 02-04 

ELECTROSHOCK 

EFFECTS OF DOPAMINE RECEPTOR STIMULATION AND BLOCKADE ON RO- 
4-1284 INDUCED ENHANCEMENT OF ELECTROSHOCK SEIZURE. 

167287 01-03 



r^^^y 



S-95 



Subject Index 



Psychopharmacology Abstracts 



THE EFFECT OF CANNABIDIOL ON MAXIMAL ELECTROSHOCK SEIZURES IN 
RATS. 

168749 01-03 
INTERACTIVE EFFECTS OF CYCLOHEXIMIDE AND PUROMYCIN IN 
ALTERING BRAIN POLYRIBOSOMES AND NEURAL AND BEHAVIOURAL 
RESPONSES TO ELECTROSHOCK IN MICE. 

175230 02-03 
AUTOMATIC DETERMINATION OF THE PAIN THRESHOLD TO 
ELECTROSHOCK AND THE EFFECTS OF DELTA9-THC. 

183363 03-03 
EFFECTS OF AMPHETAMINE ON ELECTROSHOCK RESPONSES IN 
DEVELOPING RATS. 

184372 03-03 
ELEPHANT 

MEDICATION AND/OR PSYCHOTHERAPY V\/ITH SCHIZOPHRENICS: WHICH 
PART OF THE ELEPHANT HAVE YOU TOUCHED 

173534 01-08 
ELEVATION 

EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF 
BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM 
RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT. 

186695 03-03 
METHIOTHEPIN ELEVATION OF 5-HYDROXYINDOLEACETIC ACID LEVELS IN 
VARIOUS ANATOMIC REGIONS OF RAT BRAIN. 

187831 04-03 
ELICITATION 

PHARMACOKINETIC DISPOSITION OF NORAPOMORPHINE DERIVATIVES 
AND ITS INFLUENCE ON THE ELICITATION OF STEREOTYPICAL 
GNAWING. (PH.D. DISSERTATION). 

174960 01-03 
ELIMINATION 

THE ELIMINATION OF 5-HYDROXYINDOLEACETIC ACID FROM 

CEREBROSPINAL FLUID: CHARACTERISTICS OF THE ACID TRANSPORT 
SYSTEM OF THE CHOROID PLEXUS. 

182718 03-03 
EMBRYOGENESIS 

EFFECTS OF P-CHLOROPHENYLALANINE ON DIFFERENTIATION OF 
SEROTONINERGIC RECEPTIVE CELLS DURING EMBRYOGENESIS. 
(UNPUBLISHED PAPER). 

168817 01-03 
THE EFFECTS OF MESCALINE ADMINISTERED BEFORE OR DURING 
EMBRYOGENESIS UPON THE HATCHABILITY AND BEHAVIOR OF THE 
CHICK. (PH.D. DISSERTATION). 

173791 01-04 
EMBRYONIC 

EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF 
BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM 
RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT. 

186695 03-03 
EMERGENCY 

EMERGENCY TREATMENT OF AN ACUTE STATE OF MENTAL ABERRATION. 

191723 04-09 
EMETINE 

FLAVOR AVERSIONS PRODUCED BY CONTINGENT DRUG INJECTION: 
RELATIVE EFFECTIVENESS OF APOMORPHINE. EMETINE, AND LITHIUM. 

178502 02-04 
EMOTION 

PAIN AND EMOTION. 

181590 02-11 
EMOTIONAL 

EMOTIONAL FUNCTIONS IN SHORT-TERM VS. LONG-TERM L-DOPA 
THERAPY IN PARKINSONISM. 

168619 01-15 
EFFECTS OF LOW DOSES OF CHLORPROMAZINE ON A CONDITIONED 
EMOTIONAL RESPONSE IN THE RAT. 

176963 02-04 
THE CONDITIONED EMOTIONAL RESPONSE (CER) AS A BASELINE FOR THE 
STUDY OF ANTIANXIETY DRUGS. 

183862 03-04 
TESTS OF EMOTIONAL BEHAVIOR IN RATS FOLLOWING DEPLETION OF 
NOREPINEPHRINE, OF SEROTONIN, OR OF BOTH. 

185753 03-04 
A FEW REMARKS ON THE USE OF PSYCHOACTIVE AGENTS IN THE 
TREATMENT OF EMOTIONAL DISORDERS. 

190241 04-09 
EMOTIONALLY 

DOUBLE-BLIND PSYCHOMETRIC EVALUATION OF PIMOZIDE AND 
HALOPERIDOL VERSUS PLACEBO IN EMOTIONALLY LABILE 
VOLUNTEERS UNDER TWO DIFFERENT WORK LOAD CONDITIONS. 

180065 02-14 
EMOTIONS 

CONTRIBUTION OF PSYCHOPHARMACOLOGY TO THE 
PSYCHOPHYSIOLOGICAL THEORY OF EMOTIONS. 

178817 02-13 
THE ACTION OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTOR 
CENTERS OF EMOTIONS IN THE HYPOTHALAMUS. 

191785 04-02 



EMPLOYS 

THE EFFECTS OF AGENTS THAT MODIFY MUSCARINIC TONE UPON 
BEHAVIOR CONTROLLED BY AN AVOIDANCE SCHEDULE THAT 
EMPLOYS SIGNALED UNAVOIDABLE SHOCK. 

171302 01-04 
EN-1639A 

STUDIES OF EN-1639A (NALTREXONE): A NEW NARCOTIC ANTAGONIST. 

189059 04-07 
ENANTHATE 

EXPERIENCES WITH FLUPHENAZINE ENANTHATE IN LONG-STAY 
HOSPITALISED SCHIZOPHRENICS. 

171985 01-08 
ASSESSMENT OF ANATENSOL (FLUPHENAZINE ENANTHATE) INJECTABLE 
IN THE TREATMENT OF SCHIZOPHRENIA. 

172444 01-08 
EXAMINATION OF THE METHODS OF USING FLUPHENAZINE ENANTHATE. 

1 76469 02-08 
CLINICAL EXPERIENCE WITH FLUPHENAZINE ENANTHATE. 

178021 02-08 
FURTHER EXPERIENCE WITH FLUPHENAZINE ENANTHATE INJECTION. 

180153 02-08 
EXPERIENCES WITH FLUPHENAZINE ENANTHATE IN LONG-STAY 

HOSPITALIZED SCHIZOPHRENICS. 

180154 02-08 
PHARAAACOLOGICAL DIFFERENCES BETWEEN FLUPHENAZINE ENANTHATE 

AND ITS HYDROCHLORIDE. 

182634 03-02 
ON THE CLINICAL EFFECT OF FLUPHENAZINE ENANTHATE IN OUTPATIENT 
SCHIZOPHRENICS. 

185213 03-08 
ENANTIOMERS 

PHARAAACOLOGIC ACTIVITY AND BIOTRANSFORMATION OF R. AND S- 
BARBITURATE ENANTIOMERS IN MOUSE AND MAN. 

182156 02-03 
ENCEPHALE 

EEG AND CARDIOVASCULAR EFFECTS OF TRYPTAMINE (T) AND LSD IN 
THE ENCEPHALE ISOLE CAT. (UNPUBLISHED PAPER) 

174496 01-12 
ENCEPHAUTIS 

A CASE OF ENCEPHALITIS WITH PSYCHOTIC COMPLICATIONS. 

174783 01-11 
ENDOCRINE 

THE EFFECTS OF PHENOTHIAZINES ON ENDOCRINE FUNCTION: I. 
PATIENTS WITH INAPPROPRIATE LACTATION AND AMENORRHOEA. 

184436 03-15 
THE EFFECTS OF PHENOTHIAZINES ON ENDOCRINE FUNCTION: II. EFFECTS 

IN MEN AND POSTMENOPAUSAL WOMEN. 

184437 03-13 
ENDOGENOUS 

A CONTROLLED STUDY OF SINGLE DOSE ADMINISTRATION OF 
IMIPRAMINE PAMOATE IN ENDOGENOUS DEPRESSION. 

167775 01-09 
ELECTROLYTES IN CEREBROSPINAL FLUID IN ENDOGENOUS DEPRESSION. 

172402 01-09 
DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: 

ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE 
MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY. 

177131 02-03 
THE INFLUENCE OF PSYCHOTROPIC DRUGS ON THE LEVELS OF 
ENDOGENOUS 2-PHENYLETHYLAMINE IN RABBIT BRAIN. 

187112 03-03 
LONG-TERM TREATMENT OF ENDOGENOUS DEPRESSION WITH 
NORTRIPTYLINE WITH CONTROL OF PLASMA LEVELS. 

188832 04-09 
5-HYDROXYTRYPTAMINE AND NORADRENALINE IN THE HIPPOCAMPAL 
REGION: EFFECT OF TRANSECTION OF AFFERENT PATHWAYS ON 
ENDOGENOUS LEVELS, HIGH AFFINITY UPTAKE AND SOME 
TRANSMITTER RELATED ENZYMES. 

191319 04-03 
PHENYLALANINE FOR ENDOGENOUS DEPRESSION. 

192521 04-09 
ENDOGENOUSLY 

EFFECTS OF ALPHA-METHYLTYROSINE ON D-AMPHETAMINE INDUCED 
RELEASE OF ENDOGENOUSLY SYNTHESIZED AND EXOGENOUSLY 
ADMINISTERED CATECHOLAMINES FROM THE CAT BRAIN IN VIVO. 

189397 04-03 
ENDURING 

ENDURING LEARNING DEFICITS AND CEREBRAL SYNAPTIC 

MALFORMATION FROM EXPOSURE TO 10 PARTS OF HALOTHANE PER 
MILLION. 

192565 04-04 
ENERGY 

THE EFFECTS OF LITHIUM ON HIGH ENERGY PHOSPHATE AND GLUCOSE 
LEVELS IN THE RAT SUPERIOR CERVICAL GANGLION. 

187677 04-03 
ENGLISH 

PSYCHOTHERAPEUTIC DRUG TRIALS AMONG ENGLISH GENERAL 
PRACTITIONERS. 

170292 01-11 



S-96 



VOLUME 12, SUBJECT INDEX 



^"^"tpFECTS^OF DOPAMINE RECEPTOR STIMULATION AND BLOCKADE ON RO- 
4-1284 INDUCED ENHANCEMENT OF ELECTROSHOCK SEIZURE. 

167287 01-03 
ALPHA-ADRENERGIC BLOCKING AGENTS: ANTINOCICEPTIVE ACTIVITY 
AND ENHANCEMENT OF MORPHINE-INDUCED ANALGESIA. 

183895 03-03 
PROPRANOLOL ENHANCEMENT OF HYPOGLYCEMIC SWEATING. 

186187 03-13 
ENHANCEMENT OF METHYLPHENIDATE INDUCED STEREOTYPIES BY 
REPEATED ADMINISTRATION OF NEUROLEPTICS. 

186369 03-04 
RECOVERY FROM ELECTROCONVULSIVE SHOCK-INDUCED AMNESIA BY 
EXPOSURE TO THE TRAINING ENVIRONMENT: PHARMACOLOGICAL 
ENHANCEMENT BY PIRACETAM. 

186704 03-04 
INFLUENCE OF ALPHA-METHYLTYROSINE ON ENHANCEMENT OF 
SHUTTLEBOX AVOIDANCE BY MARIJUANA AND PENTOBARBITAL. 

187572 04-04 
ENHANCEMENT OF AMPHETAMINE ACTION AFTER INTERRUPTION OF 
ASCENDING SEROTONERGIC PATHWAYS. 

189398 04-03 
ENHANCEMENT OF NOCICEPTIVE REACTIONS BY NALOXONE IN MICE AND 

RATS. 

189517 04-05 

ENHANCEMENT OF PENTOBARBITAL AFTER MORPHINE ADDICTION. 

191898 04-03 
ENHANCING 

TOLERANCE TO THE ACTIVITY ENHANCING EFFECTS OF D-AMPHETAMINE. 

182208 02-04 

ENURESIS 

A CONTROLLED TRIAL OF IMIPRAMINE HYDROCHLORIDE ON ENURESIS. 

186553 03-11 
TRIAL OF SUSTAINED RELEASE AMITRIPTYLINE ON ENURESIS. 

192589 04-11 

ENVIRONMENT 

EXCITANT AND DEPRESSANT DRUGS MODULATE EFFECTS OF 
ENVIRONMENT ON BRAIN WEIGHT AND CHOLINESTERASES. 

174036 01-03 
THE EFFECT OF LORAZEPAM ON ANXIOUS INSOMNIACS SLEEP AS 
RECORDED IN THE HOME ENVIRONMENT. 

177318 02-14 
INDICATIONS AND DOSAGE FOR AAAXIMAL ACTIVITY OF ORNITHINE- 
CARBAMYL-TRANSFERASE IN THE PSYCHIATRIC ENVIRONMENT. 

184955 03-17 
RECOVERY FROM ELECTROCONVULSIVE SHOCK-INDUCED AMNESIA BY 
EXPOSURE TO THE TRAINING ENVIRONMENT: PHARMACOLOGICAL 
ENHANCEMENT BY PIRACETAM. 

186704 03-04 

ENVIRONMENTAL 

DETERMINANTS OF THE NORADRENERGIC SATIETY EFFECT: 
ENVIRONMENTAL DARKNESS VS. THE FEEDING PATTERN. 

182133 02-04 
THE EFFECT OF LOW ENVIRONMENTAL TEMPERATURE ON THE 
TRANYLCYPROMINE MEPERIDINE INTERACTION IN MICE. 

183897 03-03 

ENZYMATIC 

STUDIES ON ENZYMATIC DEALKYLATION OF D-LYSERGIC ACID 
DIETHYLAMIDE (LSD). 

177336 02-03 
AMPHETAMINE IN HUMAN PLASMA: A SENSITIVE AND SPECIFIC 
ENZYMATIC ASSAY. 

177403 02-16 

ENZYME 

AN ENZYME APPROACH IN APPRAISING THE MODE OF SOME 
TRANQUILIZERS AND ANTIDEPRESSANTS. 

174318 01-03 
PRELIMINARY EXPERIENCES WITH THE TREATMENT OF SOME MENTAL 
CASES UTILIZING AN ENZYME COMBINATION. 

180298 02-17 
CENTRAL DOPAMINE FUNCTION IN AFFECTIVE ILLNESS: EVIDENCE FROM 
PRECURSORS, ENZYME INHIBITORS AND STUDIES OF CENTRAL 
DOPAMINE TURNOVER. (UNPUBLISHED PAPER). 

181358 02-09 
DECREASED EFFECT OF PHENOBARBITAL TREATMENT ON MICROSOMAL 
DRUG METABOLIZING ENZYME ACTIVITY DURING GESTATION. 

184228 03-03 
STUDIES OF MONOAMINE OXIDASES: PROPERTIES OF THE ENZYME IN 
BOVINE AND RABBIT BRAIN MITOCHONDRIA. 

191300 04-03 
MONOAMINE OXIDASE IN MAN: ENZYME CHARACTERISTICS IN HUMAN 
PLATELETS, PLASMA, AND OTHER HUMAN TISSUES. 

191502 04-13 
ENZYMES 

INFLUENCE OF PHENOBARBITAL AND SEX HORMONES ON ENZYMES IN 
ASCORBIC ACID BIOSYNTHESIS IN MALE AND FEMALE RATS. (PH.D. 
DISSERTATION). 

172017 01-03 



Subject Index 

THE RATE LIMITING CONTROL OF ENZYMES MONOAMINE OXIDASE AND 
CATECHOL-O-METHYLTRANSFERASE IN THE FETUS AND THE ADULT BY 
ADRENOCORTICOL HORMONES. 

178815 02-03 
EFFECTS OF NARCOTIC ANALGESICS ON ENZYMES OF ACETYLCHOLINE 
METABOLISM IN CULTURED CHICK BRAIN CELLS. 

182225 03-03 
INDUCTION OF HEPATIC DRUG METABOLIZING ENZYMES BY LITHIUM 
TREATMENT. 

182727 03-03 
EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND AGE ON 

VARIOUS NEUROTRANSMITTERS AND ASSOCIATED ENZYMES IN MALE 
FISCHER 344 RATS. 

189597 04-03 
5-HYDROXYTRYPTAMINE AND NORADRENALINE IN THE HIPPOCAMPAL 
REGION- EFFECT OF TRANSECTION OF AFFERENT PATHWAYS ON 
ENDOGENOUS LEVELS, HIGH AFFINITY UPTAKE AND SOME 
TRANSMITTER RELATED ENZYMES. 

191319 04-03 
POST-MORTEM MEASUREMENT OF ENZYMES IN HUMAN BRAIN: 
EVIDENCE OF A CENTRAL NORADRENERGIC DEFICIT IN 
SCHIZOPHRENIA. 

191529 04-13 
CELLULAR EFFECTS OF METHAQUALONE ON DRUG METABOLIZING 

ENZYMES. 

191942 04-03 

ENZYMIC 

ANIMAL MODELS FOR AN ENZYMIC BLOOD-BRAIN BARRIER MECHANISM 
FOR THERAPEUTICALLY ADMINISTERED L-DOPA. 

167359 01-03 

EP-50-100 

EXPERIENCE IN THE TREATMENT OF CEREBRAL INSUFFICIENCY AND 
PERIPHERAL BLOOD CIRCULATION DISORDERS USING THE EP- 50-1 00 
EXPERIMENTAL DRUG. 

180676 02-11 

EPILEPSY 

STUDY OF THE PSYCHOTROPIC ACTION OF TEGRETOL IN PATIENTS WITH 
EPILEPSY. 

172439 01-11 

GENERALIZED PENICILLIN EPILEPSY IN THE CAT: EFFECTS OF 

INTRACAROTID AND INTRAVERTEBRAL PENTYLENETETRAZOL AND 
AMOBARBITAL INJECTIONS. 

1 88374 04-03 

IMIPRAMINE IN EXPERIMENTAL PETIT-MAL EPILEPSY. 

188424 04-03 
CARBAMAZEPINE SOLE ANTICONVULSANT FOR FOCAL EPILEPSY OF 

CHILDHOOD. 

189174 04-11 

THE USE OF A TRICYCLIC ANTIDEPRESSANT IN EPILEPSY. 

190379 04-09 

EPILEPTIC 

PAROXYSMAL RIGHT LEFT DISORIENTATION IN AN EPILEPTIC PATIENT. 

171246 01-11 
SERUM ANTICONVULSANT CONCENTRATIONS IN EPILEPTIC PATIENTS 
WITH MENTAL SYMPTOMS: A PRELIMINARY REPORT. 

184439 03-15 
CALCIUM METABOLISM IN ELDERLY EPILEPTIC PATIENTS DURING 
ANTICONVULSANT THERAPY. 

185560 03-15 
ANTICONVULSANT ACTION OF VITAMIN-D IN EPILEPTIC PATIENTS? A 
CONTROLLED PILOT STUDY. 

188889 04-11 
DIFFERENTIAL EFFECTS OF PENTYLENETETRAZOL ON REM SLEEP IN NAIVE 
AND COBALT EPILEPTIC RATS. 

189407 04-03 

EPINEPHRINE 

SIMULTANEOUS MASS FRAGMENTOGRAPHIC ASSAY OF NOREPINEPHRINE 
(NE) EPINEPHRINE (E) AND DOPAMINE (DA) IN RAT SYMPATHETIC 
GANGLION: EFFECTS OF DEXAMETHASONE IN NEWBORN AND ADULT 
RATS. (UNPUBLISHED PAPER). 

170747 01-03 

EPISODES 

A COMPARISON OF LITHIUM CARBONATE IN THE PREVENTION OF MANIC 
AND DEPRESSIVE EPISODES IN RECURRENT AFFECTIVE DISORDER. 

169090 01-09 
ON THE STUPOROUS AND HYPOMANIC EPISODES ASSOCIATED WITH 
SPIKE AND WAVE IN ELECTROENCEPHALOGRAM. 

181388 02-11 

EPISODIC 

EPISODIC DYSCONTROL: A CONTROLLED REPLICATION. 

1 87839 04-09 

EPISTEMIC 

A NOTE ON EPISTEMIC ORGANIZATION AND HALLUCINOGENS. 

190240 04-17 

EPITHELIAL 

EFFECTS OF CHLORPROMAZINE AND ACTINOMYCIN D ON UPTAKE AND 
INCORPORATION OF CERTAIN AMINO ACIDS, HYPOXANTHINE AND 
THYMIDINE IN CULTURES OF HUMAN SKIN EPITHELIAL CELLS. 

179989 02-13 



S-97 



Subject Index 



Psychopharmacology Abstracts 



EQUIVALENCE 

COMPARABLE THERAPEUTIC EFFICACY OF TRYPTOPHAN AND 
IMIPRAMINE: AVERAGE THERAPEUTIC RATINGS VERSUS TRUE 
EQUIVALENCE. AN IMPORTANT DIFFERENCE. 

167344 01-09 
ERGOT 

AN ERGOT ALKALOID PREPARATION (HYDERGINE) VERSUS PAPAVERINE 
IN TREATING COMMON COMPLAINTS OF THE AGED: DOUBLE-BLIND 
STUDY. 

173190 01-11 
FURTHER EVIDENCE FOR A DOPAMINE RECEPTOR STIMULATING ACTION 
OF AN ERGOT ALKALOID. 

188739 04-03 
ERYTHROCYTE 

LITHIUM THERAPY AND ERYTHROCYTE MEMBRANE CATION CARRIER. 

187644 04-15 
ERYTHROCYTES 

INFLUENCE OF VARIOUS DRUGS ON THE BINDING OF CHLORPROMAZINE 
TO ERYTHROCYTES AND ALBUMIN. 

181470 02-03 
ESCALATION 

FIGHTING IN MICE: DYADIC ESCALATION AND WHAT IS LEARNED. 

173039 01-04 
ESCAPE 

INTERACTION OF MESCALINE AND STRESS ON SHUTTLEBOX 
ESCAPE/AVOIDANCE IN RATS. 

191934 04-04 
ESTABLISHMENT 

AN ACCOUNT OF THE USE OF FLUPHENAZINE SINCE THE ESTABLISHMENT 
OF PSYCHIATRY AS A SEPARATE DISCIPLINE. 

176431 02-11 
ESTER 

A NOVEL SPASMOLYTIC AND CNS ACTIVE AGENT: 3-(2- 

BENZYLMETHYLAMINOETHYL) BENZOIC ACID METHYL ESTER 
HYDROCHLORIDE. 

184581 03-02 
ESTERASE 

EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS. 

169467 01-03 
ESTERS 

CENTRALLY ACTING MUSCLE RELAXANTS. ISOMERIC 9,10 

DIHYDROXYOCTAHYDROPHENANTHRENES AND THEIR CARBAMATE 
ESTERS. 

190719 04-02 
ESTIMATION 

A SENSITIVE GAS CHROMATOGRAPHIC PROCEDURE FOR THE 
ESTIMATION OF NORADRENALINE, DOPAMINE AND 5- 
HYDROXYTRYPTAMINE IN RAT BRAIN. 

171971 01-01 
A GAS CHROMATOGRAPHIC METHOD FOR THE QUANTITATIVE 
ESTIMATION OF N-HYDROXYPHENTERMINE. 

182203 02-06 
INFLUENCE OF ANTIDEPRESSIVE THERAPY ON THE DISTURBED TIME 
ESTIMATION OF DEPRESSIVES. 

182591 03-14 
IN VIVO ESTIMATION OF TYROSINE HYDROXYLATION IN THE 
DOPAMINERGIC TERMINALS OF THE RAT NEOSTRIATUM. 

183794 03-03 
ESTIMATION OF THE RATE OF 5-HT SYNTHESIS IN THE MOUSE BRAIN BY 
VARIOUS METHODS. 

188976 04-03 
ESTIMATION OF THE CONTRIBUTION OF PERIPHERAL AND CENTRAL 
NORADRENERGIC NEURONES TO URINARY 3-METH0XY-4- 
HYDROXYPHENYLGLYCOL IN THE RAT. 

192335 04-03 
ESTRADIOL 

PLASMA LEVELS OF LUTEINIZING HORMONE AND OF IMMUNOREACTIVE 
ESTROGENS (ESTRADIOL) IN ANOREXIA-NERVOSA: RESPONSE TO 
CLOMIPHENE CITRATE. 

183807 03-10 
LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 
ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 
COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25, AN IN 
INTACT MALE RATS. 

186683 03-04 
SUPPRESSION OF LORDOSIS IN GUINEA-PIGS BY ETHAMOXY-TRIPHETOL 
{MER-25) GIVEN AT LONG INTERVALS (36-46 HR) AFTER ESTRADIOL 
BENZOATE TREATMENT. 

186686 03-04 

ESTROGEN 

CHANGE OF ESTROGEN ACTIVATED BEHAVIOR BY CYCLOHEXIMIDE IN 

THE FEMALE RAT. 

171615 01-04 
LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 

ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 



COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25, AN IN 
INTACT MALE RATS. 

186683 03-04 
EFFECTS OF AN ESTROGEN ANTAGONIST, MER-25, ON MOUNTING 
BEHAVIOR AND LORDOSIS BEHAVIOR IN THE FEMALE RAT. 

186691 03-04 
ESTROGENS 

PLASMA LEVELS OF LUTEINIZING HORMONE AND OF IMMUNOREACTIVE 
ESTROGENS (ESTRADIOL) IN ANOREXIA-NERVOSA: RESPONSE TO 
CLOMIPHENE CITRATE. 

183807 03-10 
THE EFFECT OF CONJUGATED ESTROGENS ON PLASMA BUTAPERAZINE 
LEVELS IN WOMEN. 

191959 04-15 
ET-49S 

A COMPARISON OF EFFECTS OF APOMORPHINE AND ET-495 ON 
LOCOMOTOR ACTIVITY AND CIRCLING BEHAVIOUR IN MICE. 

186635 03-04 
STIMULATION OF A DOPAMINE SENSITIVE ADENYLATE CYCLASE IN 
HOMOGENATES OF RAT STRIATUM BY A METABOLITE OF PIRIBEDIL 
(ET-495). 

189616 04-03 
EFFECTS OF PIRIBEDIL (ET-495) - A DOPAMINERGIC RECEPTOR 
STIMULATING AGENT IN PARKINSONS DISEASE. 

191522 04-13 
ETHAMOXY-TRIPHETOL 

SUPPRESSION OF LORDOSIS IN GUINEA-PIGS BY ETHAMOXY-TRIPHETOL 
(MER-25) GIVEN AT LONG INTERVALS (36-46 HR) AFTER ESTRADIOL 
BENZOATE TREATMENT. 

186686 03-04 
ETHANOL 

EFFECT OF ETHANOL ON CYCLIC AMP LEVELS IN THE RAT BRAIN. 

167326 01-03 
L-DOPA: EFFECT ON ETHANOL NARCOSIS AND BRAIN BIOGENIC AMINES 
IN MICE. 

169782 01-03 
DIFFERENTIAL EFFECTS OF ETHANOL AND PENTOBARBITAL ON SLEEP 
TIME IN C57BL AND BALB MICE. 

1 77733 02-03 
THE EFFECTS OF DELTAl -TETRAHYDROCANNABINOL (DELTAl-THC OR 
DELTA9-THC) AND ETHANOL ON MONOSYNAPTIC AND POLYSYNAPTIC 
TRANSMISSION IN THE CENTRAL NERVOUS SYSTEM. 

182222 03-03 
TREATMENT OF CEREBROVASCULAR DISTURBANCES WITH 2- 

BUTYLAMINO-1-P-HYDROXYPHENYL ETHANOL SULFATE (BAMETHAN). 

182790 03-11 
A COMPARISON OF THE EFFECTS OF CHRONIC ADMINISTRATION OF 
ETHANOL AND ACETALDEHYDE TO MICE: EVIDENCE FOR A ROLE OF 
ACETALDEHYDE IN ETHANOL DEPENDENCE. 

185992 03-03 
INTERACTIONS OF CHLORPHENIRAMINE ETHANOL COMBINATIONS: 
ACUTE TOXICITY AND ANTIHISTAMINIC ACTIVITY. 

188875 04-05 
THE DOPAMINE RELEASING ACTIONS OF NEUROLEPTICS AND ETHANOL. 

189401 04-03 
LITHIUM TREATMENT DURING ETHANOL INGESTION AND WITHDRAWAL. 

192005 04-11 
ETHANOL-INDUCED 

ALTERATION OF ETHANOL-INDUCED CNS DEPRESSION: INEFFECTIVENESS 
OF DRUGS THAT MODIFY CHOLINERGIC TRANSMISSION. 

186375 03-03 
ETHANOLAMINE 

EFFECT OF 2-ARYLALANINES, 2-ARYLSERINES, TETRAPHENYLBORON AND 
1,2 DL(2,4 DICHLOROPHENYL) ETHANOLAMINE ON LEVELS OF 
SEROTONIN (5-HT), NOREPINEPHRINE (NE) AND DOPAMINE (DM) IN 
WHOLE BRAIN OF MICE. 

182254 03-03 
ETHER 

EFFECTS OF DECAPITATION, ETHER AND PENTOBARBITAL ON CYCLIC 
AMP AND CYCLIC GMP LEVELS IN RAT TISSUES. 

182154 02-03 
INDUCTION OF A DIETHYLETHER WITHDRAWAL SYNDROME IN MICE BY 
EXPOSURE TO ETHER VAPOR. 

192006 04-03 
ETHICAL 

EFFECT AND AFTEREFFECT OF DRUGS: ETHICAL CONSIDERATIONS ON THE 
USE OF PSYCHOTROPIC AGENTS (1). 

170847 01-17 

ETHINAAAATE 

ABSORPTION AND CLEARANCE OF SECOBARBITAL, HEPTABARBITAL, 
METHAQUALONE, AND ETHINAMATE. 

192575 04-13 

ETHYL 

COMPARISON OF CODEINE AND ETHYL ALCOHOL SELF-ADMINISTRATION 
UNDER A VARIABLE INTERVAL (VI) SCHEDULE IN MONKEYS. 

191983 04-04 



S-98 



VOLUME 12, SUBJECT INDEX 



ETHYINORANTIPHEIN 

THE USE OF ETHYMISOL (ETHYINORANTIPHEIN) IN PATIENTS WITH 
PROLONGED DISTURBANCES OF CONSCIOUSNESS. 

191777 04-07 

CTHYMISOl 

THE USE OF ETHYMISOL (ETHYLNORANTIPHEIN) IN PATIENTS WITH 
PROLONGED DISTURBANCES OF CONSCIOUSNESS. 

191777 04-07 
CHANGES IN RHYTHMS OF BIOELECTRICAL ACTIVITY OF THE CEREBRAL 
CORTEX IN HUMANS UNDER THE INFLUENCE OF ETHYMISOL. 

191790 04-07 

ETIOLOGY 

EXACERBATION OF PSYCHOPATHOLOGY DURING TREATMENT: ETIOLOGY. 

177676 02-17 

ETORPHINE 

ABUSE POTENTIAL OF ETORPHINE (M99) I. SUBJECTIVE EFFECTS AND 
PHYSICAL DEPENDENCE. (UNPUBLISHED PAPER). 

171241 01-14 
THE EFFECTS OF MORPHINE, ETORPHINE AND SINOMENINE ON THE 
CHEMICAL SENSITIVITY AND SYNAPTIC RESPONSES OF RENSHAW 
CELLS AND OTHER SPINAL NEURONES IN THE RAT. 

188201 04-03 

EUPHORIA 

LITHIUM (LI): LACK OF EFFECT ON MORPHINE (MS) EUPHORIA. 
(UNPUBLISHED PAPER). 

174479 01-14 

EVALUATE 

ATTEMPT TO EVALUATE THE PHYSICAL DEPENDENCE LIABILITY OF 
PSYCHOTROPIC DRUGS IN MICE. 

182103 02-04 

EVALUATED 

DEPENDENCE LIABILITY OF SEVERAL SEDATIVE HYPNOTIC AGENTS 
EVALUATED IN MONKEYS. 

174125 01-04 

EVALUATION 

DOUBLE-BLIND CLINICAL EVALUATION OF MAZINDOL, 

DEXTROAMPHETAMINE, AND PLACEBO IN TREATMENT OF EXOGENOUS 
OBESITY. 

167335 01-11 
METIAPINE: THE EVALUATION OF THE ANTIPSYCHOTIC PROPERTIES OF A 
NEW NEUROLEPTIC. A PILOT STUDY. 

167342 01-08 
CLINICAL EVALUATION OF FLUSPIRILENE AS A MAINTENANCE THERAPY 
IN CHRONIC SCHIZOPHRENIC PATIENTS. 

168320 01-08 
EVALUATION OF CENTRAL ANTIRESERPINE EFFECT BY THE USE OF LIGHT 
BLINK REFLEX. 

169469 01-04 

A CRITICAL EVALUATION OF THE PRINCIPLES GOVERNING THE 
ADVANTAGES OF INTRAARTERIAL INFUSIONS. 

170112 01-06 
EVALUATION OF THE HYPOTHERMIC ACTION OF 
TETRAHYDROCANNABINOLS IN MICE AND SQUIRREL MONKEYS. 

170163 01-03 
THE PHARMACOLOGICAL EVALUATION IN LABORATORY ANIMALS OF 
KABI-1702 - A NEW SEDATIVE HYPNOTIC DRUG. 

171632 01-03 
MOLINDONE: A CROSSOVER EVALUATION OF CAPSULE AND TABLET 
FORMULATIONS IN SEVERELY ILL SCHIZOPHRENIC PATIENTS. 

174137 01-08 
LONG-TERM USE OF LITHIUM CARBONATE IN AFFECTIVE DISORDERS: A 
CLINICAL EVALUATION. 

174778 01-09 
FUNCTIONAL EVALUATION OF PITUITARY RESERVE IN PATIENTS WITH 
THE AMENORRHEA GALACTORRHEA SYNDROME UTILIZING 
LUTEINIZING HORMONE RELEASING HORMONE (LH-RH), L-DOPA AND 
CHLORPROMAZINE. 

175245 02-13 
EFFICACY AND RESIDUAL EFFECT EVALUATION OF A NEW HYPNOTIC, 
TRIAZOLAM. 

176108 02-13 
ANTIDEPRESSANT EFFECTS OF D-CHLORPHENIRAMINE - CLINICAL 
EVALUATION (FIRST REPORT). 

176889 02-09 
SAFETY EVALUATION OF PENFLURIDOL, A NEW LONG-ACTING ORAL 
ANTIPSYCHOTIC AGENT. 

177319 02-07 

EVALUATION OF HYPNOTICS IN OUTPATIENTS WITH INSOMNIA USING A 
QUESTIONNAIRE AND A SELF-RATING TECHNIQUE. 

177735 02-06 
BEHAVIOURAL EVALUATION OF PEPTIDES RELATED TO SCOTOPHOBIN. 

177836 02-04 
DOUBLE-BLIND PSYCHOMETRIC EVALUATION OF PIMOZIDE AND 
HALOPERIDOL VERSUS PLACEBO IN EMOTIONALLY LABILE 
VOLUNTEERS UNDER TWO DIFFERENT WORK LOAD CONDITIONS. 

180065 02-14 



Subject Index 

A CLINICAL EVALUATION OF A NEW ANXIOLYTIC DRUG 
(THIENODIAZEPINE DERIVATIVE Y-6047) IN NEUROTICS AND 
PSYCHOSOMATIC DISORDERS - A PRELIMINARY REPORT. 

181771 02-07 
COMPARATIVE EVALUATION OF DIBENCYCLADINE (LUDIOMIL) AND 
IMIPRAMINE IN PSYCHOTIC DEPRESSION. 

'83361 03-09 
EVALUATION OF EEG AND CLINICAL CHANGES ASSOCIATED ITH 
PAVABID THERAPY IN CHRONIC BRAIN SYNDROME. 

183402 03-13 
A CONTROLLED EVALUATION OF LITHIUM IN THE PREMENSTRUAL 
TENSION SYNDROME. 

185192 03-11 
CLINICAL EVALUATION OF ANXIOLYTIC DRUGS. 

185350 03-17 
EVALUATION OF REINFORCING CAPABILITY OF DELTA9- 
TETRAHYDROCANNABINOL IN RHESUS MONKEYS. 

1 87638 04-04 
CLINICAL EVALUATION OF AMANTADINE THERAPY FOR PARKINSONISM 
AND THE SIDE-EFFECTS - IN CASES OF THALAMIC SURGERY AND L- 
DOPA THERAPY. 

190095 04-11 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 
METABOLITE, NORFENFLURAMINE: AN EVALUATION OF ITS ROLE IN 
THE ACTIONS OF FENFLURAMINE. 

190335 04-04 
AN EVALUATION OF SERUM DOPAMINE-BETA-HYDROXYLASE AS AN 
INDEX OF SYMPATHETIC NERVE ACTIVITY IN MAN. 

191511 04-13 
SERUM DOPAMINE-BETA-HYDROXYLASE: A POSSIBLE AID IN THE 

EVALUATION OF HYPERTENSION. 

191512 04-13 
METHODOLOGY FOR THE EVALUATION OF PENTAZOCINE, PROTOTYPE OF 

THE NEW MORPHINE AGONIST ANTAGONIST ANALGESICS. 

191603 04-16 
A BACTERIAL MODEL FOR EVALUATION OF BARBITURATES. 

191920 04-03 
PHARAAACOLOGY OF DEPRESSION IN THE AGED: EVALUATION OF 
GER0VITAL-H3 AS AN ANTIDEPRESSANT DRUG. 

192229 04-09 

EVALUATIONS 

AAAA DRUG EVALUATIONS. 

191048 04-17 

EVIDENCE 

NEGATIVE SODIUM BALANCE IN LITHIUM CARBONATE TOXICITY: 
EVIDENCE OF MINERALOCORTICOID BLOCKADE. 

169869 01-15 
EVIDENCE THAT MORPHINE INCREASES DOPAMINE UTILIZATION IN 
CORPORA-STRIATA OF RATS. 

1 76746 02-03 
FURTHER EVIDENCE FOR A ROLE OF 2-PHENYLETHYLAMINE IN THE MODE 
OF ACTION OF DELTA9-TETRAHYDR0CANNABIN0L. 

179992 02-03 
BEHAVIORAL EVIDENCE FOR DOPAMINERGIC SUPERSENSITIVITY AFTER 
CHRONIC HALOPERIDOL. 

180021 02-04 
CENTRAL DOPAMINE FUNCTION IN AFFECTIVE ILLNESS: EVIDENCE FROM 
PRECURSORS, ENZYME INHIBITORS AND STUDIES OF CENTRAL 
DOPAMINE TURNOVER. (UNPUBLISHED PAPER). 

181358 02-09 
EFFECT OF MORPHINE, HALOPERIDOL, APOMORPHINE AND BENZTROPINE 
ON DOPAMINE TURNOVER IN RAT CORPUS-STRIATUM: EVIDENCE 
SHOWING MORPHINE-INDUCED REDUCTION IN CNS DOPAMINERGIC 
ACTIVITY. 

182230 03-03 
EVIDENCE FOR PERSISTENT RESERPINE BINDING TO AMINE STORAGE 
VESICLE MEMBRANES. 

182234 03-03 
EVIDENCE FOR THE ACTION OF D-LYSERGIC ACID DIETHYLAMIDE, 

MESCALINE AND BUFOTENINE ON 5-HYDROXYTRYPTAMINE RECEPTORS 
IN UMBILICAL VASCULATURE. 

182716 03-03 
EVIDENCE FOR REDISTRIBUTION OF FILTRATE AMONG NEPHRONS AFTER 
BETA- ADRENERGIC STIMULATION AND BLOCKADE. 

184222 03-03 
EVIDENCE FOR AN UNUSUAL DISTRIBUTION OF CHLORPHENTERMINE IN 
VIVO: AN AUTORADIOGRAPHIC STUDY IN MICE. 

184226 03-03 
A COMPARISON OF THE EFFECTS OF CHRONIC ADMINISTRATION OF 
ETHANOL AND ACETALDEHYDE TO MICE: EVIDENCE FOR A ROLE OF 
ACETALDEHYDE IN ETHANOL DEPENDENCE. 

185992 03-03 
EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF 
BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM 
RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT. 

186695 03-03 
A STUDY OF THE EFFECTS OF RITALIN INTERVENTION UPON THE 
PERCEPTUAL COMPETENCIES OF CHILDREN DIAGNOSED AS GIVING 



S-99 



Subject Index 



Psychopharmacology Abstracts 



EVIDENCE OF PSYCHONEUROLOGICAL LEARNING DISABILITIES. (PH.D. 
DISSERTATION). 

186833 03-14 
EVIDENCE FOR AN INHIBITORY ROLE FOR ACETYLCHOLINE, 
CATECHOLAMINES, AND SEROTONIN ON THE CEREBRAL CORTEX. 

187552 04-03 
FURTHER EVIDENCE ON THE INTRAHYPOTHALAMIC LOCUS FOR 
ANDROGENIZATION OF FEMALE RATS. 

187935 04-03 
FURTHER EVIDENCE FOR A DOPAMINE RECEPTOR STIMULATING ACTION 
OF AN ERGOT ALKALOID. 

188739 04-03 
EVIDENCE FOR A SPECIFIC UPTAKE OF DOPAMINE BY DOPAMINERGIC 
TERMINALS OF THE RAT CEREBRAL CORTEX. 

188978 04-03 
EVIDENCE FOR A NORADRENERGIC AND DOPAMINERGIC MECHANISM IN 
THE HYPERACTIVITY PRODUCED BY 4.ALPHA DIMETHYL-M-TYRAMINE 
(H-77-77) IN RATS. 

190309 04-04 
EVIDENCE FOR A DOPAMINERGIC INVOLVEMENT IN THE MAINTENANCE 
OF SELF-STIMULATION. 

191526 04-03 
POST-MORTEM MEASUREMENT OF ENZYMES IN HUMAN BRAIN: 
EVIDENCE OF A CENTRAL NORADRENERGIC DEFICIT IN 
SCHIZOPHRENIA. 

191529 04-13 
DEMETHYLATION OF N,N DIMETHYLAMPHETAMINES - EVIDENCE FOR A 
MULTIENZYME SYSTEM. 

191923 04-03 
EVIDENCE FOR CHOLINERGICALLY MEDIATED EFFECT OF 

METHYLPHENIDATE HYDROCHLORIDE IN THE CENTRAL NERVOUS 
SYSTEM. 

191946 04-03 
NORADRENERGIC REGULATION OF BRAIN SEROTONERGIC NEURONS: 
EVIDENCE FROM SINGLE UNIT STUDIES WITH CLONIDINE. 

191948 04-03 
EVOKE 

FAILURE OF N,N DIMETHYLTRYPTAMINE TO EVOKE TOLERANCE IN CATS. 

173398 01-03 
ATTEMPTS TO EVOKE TOLERANCE TO DMT IN MAN. (UNPUBLISHED 
PAPER). 

176480 02-12 
EVOKED 

CHANGES IN SOMATOSENSORY EVOKED POTENTIALS PRODUCED BY 
DRUGS USED IN THE TREATMENT OF AFFECTIVE DISORDERS. 

169092 01-09 
LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND GAMMA-AMINOBUTYRIC 
ACID (GABA) INTERACTION ON SPONTANEOUS POTENTIALS AND THE 
EVOKED RESPONSE IN THE AVIAN TECTUM. 

169689 01-03 
AVERAGE EVOKED RESPONSES IN NORMAL AND MINIMALLY BRAIN 
DYSFUNCTIONED CHILDREN TREATED WITH AMPHETAMINE: A 
PRELIMINARY REPORT. 

169861 01-11 
EFFECTS OF SCOPOLAMINE UPON BEHAVIORAL REACTIVITY AND 
VISUALLY EVOKED POTENTIAL TO FLASHES IN RATS. 

173032 01-04 
REINVESTIGATION ON THE EFFECTS OF THIOPENTAL ON THE HUMAN 
SOMATOSENSORY EVOKED RESPONSE. 

174505 01-13 
BEHAVIORAL CHANGES AND AGGRESSIVITY EVOKED BY DRUGS IN MICE. 

174604 01-04 
ALTERATION OF SENSORY AND MOTOR EVOKED RESPONSES BY 
DIELDRIN. 

181818 02-03 
MODULATORY EFFECTS OF CORTICOSTEROIDS ON EVOKED ACTIVITY IN 
THE HIPPOCAMPUS AND THALAMUS OF THE RAT. 

182119 02-03 
5HYDR0XYTRYPTAMINE AND HISTAMINE EFFECTS ON 
RETICULOCEREBELLAR EVOKED POTENTIALS. 

182121 02-03 
HYPOTHERMIA EVOKED BY A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE ALKALOID. 

182130 02-03 
THE EFFECTS OF SOME DRUGS ON AN EVOKED RESPONSE SENSITIVE TO 
TETRAHYDROCANNABINOLS. 

186666 03-03 
BEHAVIORAL AND VISUAL EVOKED POTENTIAL INVESTIGATIONS DURING 
TRIHEXYPHENIDYL AND THIOTHIXENE TREATMENT IN PSYCHOTIC 
BOYS. 

187115 03-09 
ALTERATION OF EVOKED POTENTIALS IN CAUDATE NUCLEUS OF FREELY 
MOVING RATS BY L-DOPA, RESERPINE, AND PENTOBARBITAL. 

187362 04-03 
COMPARATIVE EFFECTS OF SCOPOLAMINE AND AMPHETAMINE UPON 
BEHAVIORAL REACTIVITY AND VISUAL EVOKED POTENTIALS TO 
FLASHES IN RATS. 

187700 04-04 



NEW LONG LATENCY BULBOSPINAL EVOKED POTENTIALS BLOCKED BY 
SEROTONIN ANTAGONISTS. 

188751 04-03 
INFLUENCE OF PSYCHOTROPIC DRUGS ON AGGRESSIVENESS EVOKED BY 
DESTRUCTION OF ISOLATED STRUCTURES OF THE FOREBRAIN. 

191788 04-04 
EWES 

EXCRETION OF THC AND ITS METABOLITES IN EWES MILK. 

189590 04-03 
EX-11-582A 

BEHAVIORAL EFFECTS OF EX-11-582A, A POTENTIAL ANTIPSYCHOTIC 
AGENT. 

182242 03-04 
EXACERBATION 

EXACERBATION OF PSYCHOPATHOLOGY DURING TREATMENT: ETIOLOGY. 

177676 02-17 
EXAMINATION 

TRANQUILIZERS AND EXAMINATION STRESS. 

168901 0114 
EXAMINATION OF THE METHODS OF USING FLUPHENAZINE ENANTHATE. 

176469 02-08 
EXAMINATIONS 

CHROMOSOME EXAMINATIONS AFTER MEDICALLY ADMINISTERED 
LYSERGIC ACID DIETHYLAMIDE AND DEXTROAMPHETAMINE. 

192084 04-15 
EXCITABIUTY 

EFFECTS OF CHLORPROMAZINE, CHLORDIAZEPOXIDE AND 

PENTOBARBITAL ON NEURONAL EXCITABILITY IN THE MEDIAL 
FOREBRAIN BUNDLE DURING SELF-STIMULATION BEHAVIOR. 

1 77837 02-04 
EXCITABILITY CHANGES DURING THE GRADUAL DEVELOPMENT OF AND 
RECOVERY FROM PENTYLENETETRAZOL AND STRYCHNINE INDUCED 
CONVULSIONS IN THE CAT. 

191927 04-03 
EXCITANT 

EXCITANT AND DEPRESSANT DRUGS MODULATE EFFECTS OF 
ENVIRONMENT ON BRAIN WEIGHT AND CHOLINESTERASES. 

174036 01-03 
EXCITATIONS 

EFFECTS OF PSYCHOTROPIC DRUGS ON METHAMPHETAMINE INDUCED 
EXCITATIONS IN THE AGGREGATED MICE. 

182107 02-04 
EXCITATORY 

PENTOBARBITAL: SELECTIVE DEPRESSION OF EXCITATORY POSTSYNAPTIC 
POTENTIALS. 

168485 01-03 
BLOCKADE OF EXCITATORY 5-HT SYNAPSE BY LSD. 

191950 04-03 
EXCITEMENT 

RAPID CONTROL OF PSYCHOTIC EXCITEMENT STATES WITH 
INTRAMUSCULAR HALOPERIDOL. 

170627 01-09 
DECREASED ANOREXIA, EXCITEMENT AND STEREOTYPY TO D- 
AMPHETAMINE AFTER LATERAL HYPOTHALAMIC 6- 
HYDROXYOOPAMINE (6-OHDA) INJECTIONS. 

182136 02-04 
EXCRETION 

CATECHOLAMINE METABOLISM IN AFFECTIVE DISORDERS: RECENT 
STUDIES OF MHPG EXCRETION. 

169091 01-13 
ONGOING INVESTIGATIONS OF CEREBRAL GLUTAMINE EXCRETION 
SCHIZOPHRENICS DURING TREATMENT WITH NEUROLEPTIC. 

174101 01-08 
STUDIES ON THE URINARY EXCRETION OF CATECHOLAMINES AND 17- 
KETOSTEROID IN MANIC-DEPRESSIVE PSYCHOSIS. 

178623 02-09 
EXCRETION OF NOREPINEPHRINE AND DOPAMINE ALCOHOLIC 
METABOLITES AFTER 6-HYDROXYDOPAMINE. 

179986 02-03 
STUDIES ON METABOLISM OF BROMAZEPAM (III): ABSORPTION, 
EXCRETION, AND METABOLISM OF BROMAZEPAM IN MAN. 

18] 588 02-13 
ABSORPTION, DISTRIBUTION, EXCRETION AND METABOLISM OF 
BROMAZEPAM IN RABBIT. 

182555 03-03 
BLOOD LEVEL AND URINARY EXCRETION OF BROMAZEPAM IN MAN. 

182556 03-13 
ASSAY PROCEDURES FOR THIORIDAZINE, TRIFLUOPERAZINE, AND THEIR 

SULFOXIDES AND DETERMINATION OF URINARY EXCRETION OF THESE 
COMPOUNDS IN MENTAL PATIENTS. 

183602 03-01 
EXCRETION OF THC AND ITS METABOLITES IN EWES MILK. 

189590 04-03 
THE EFFECTS OF HOE-36801 ON CATECHOLAMINE EXCRETION, HEART 
RATE AND PSYCHOMOTOR PERFORMANCE IN NEUROTICS AND 
NORMALS. 

192428 04-13 



S-100 



/OLUME 12, SUBJECT INDEX 



Subject Index 



iXISTENTIAL 

PHENOMENOLOGICAL - EXISTENTIAL STUDY OF PHOBIC - OBSESSIVE 
SYNDROMES TREATED WITH CHLORIMIPRAMINE. 

182788 03-09 

■XOGENOUS 

DOUBLE-BLIND CLINICAL EVALUATION OF MAZINDOL, 

DEXTROAMPHETAMINE, AND PLACEBO IN TREATMENT OF EXOGENOUS 
OBESITY 

167335 01-11 
TREATMENT OF EXOGENOUS PSYCHOSIS BY THE USE OF FK-880 
(SULPIRIDE). 

191663 04-09 
SKELETAL MUSCLE: RESERVOIR FOR EXOGENOUS L-DOPA. 

191771 04-03 
iXOGENOUSLY 

EFFECTS OF ALPHA-METHYLTYROSINE ON D-AMPHETAMINE INDUCED 
RELEASE OF ENDOGENOUSLY SYNTHESIZED AND EXOGENOUSLY 
ADMINISTERED CATECHOLAMINES FROM THE CAT BRAIN IN VIVO. 

189397 04-03 
IXPERIENCE 

CLINICAL EXPERIENCE WITH A NEW PSYCHOTROPIC DRUG, TRAZODONE: 
A REVIEW OF LITERATURE. 

168803 01-11 
EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS, 

169467 01-03 
INTERACTION BETWEEN PRIOR EXPERIENCE AND THE EFFECTS OF 
CHLORPROMAZINE ON EXPLORATION IN THE RAT. 

171308 01-04 
ONE YEAR OF CLINICAL EXPERIENCE WITH LARGE DOSES OF 10 PERCENT 
FLUPENTHIXOL DECANOATE (LU-1705). 

172735 01-07 
OUR EXPERIENCE WITH LITHIUM. 

172976 01-09 
CLINICAL EXPERIENCE WITH MELITHRACENE IN THE TREATMENT OF 
DEPRESSIVE STATES. 

172979 01-09 
EXPERIENCE IN THE APPLICATION OF DICEPLON (APY-606) - COMPARED 
WITH FLOROPIPAMIDE. 

176447 02-08 
EXPERIENCE IN THE USE OF IMIPRAMINE. 

176448 02-10 
EXPERIENCE IN THE USE OF SERENAL (OXAZOLAM) IN THE FIELD OF 

PEDIATRICS. 

176456 02-11 
EXPERIENCE IN THE APPLICATION OF A NEW DRUG, DP-181 
(OXYPERTINE), IN TREATMENT OF SCHIZOPHRENIA. 

176468 02-08 
EXPERIENCE IN THE USE OF SINEQUAN (DOXEPIN HYDROCHLORIDE) IN 
TREATMENT OF NEUROSIS, DEPRESSION AND DEPRESSIVE STATES. 

176471 02-11 
EXPERIENCE IN THE USE OF A LOW DOSAGE OF CARPIPRAMINE 

(DEFEKTON). 

176472 02-08 
EXPERIENCE IN THE USE OF SINEQUAN (DOXEPIN HYDROCHLORIDE). 

176474 02-10 
EXPERIENCE IN THE USE OF AN ANTIDEPRESSIVE, CLOMIPRAMINE 

(ANAFRANIL), IN PSYCHIATRIC OUTPATIENTS. 

176475 02-09 
EXPERIENCE IN THE DRUG HORIZON AND PSYCHIATRIC INTERVIEW. 

176542 02-11 
EXPERIENCE IN THE USE OF FK-880 (SULPIRIDE) IN THE FIELD OF 
PSYCHIATRY. 

177568 02-08 
CLINICAL EXPERIENCE WITH FLUPHENAZINE ENANTHATE. 

178021 02-08 
LONG-TERM CONSEQUENCES OF EXPERIENCE, MEDICATION, AND 
PSYCHOTHERAPY FOR SCHIZOPHRENIC PATIENTS (UNPUBLISHED 
PAPER). 

178677 021 7 
FURTHER EXPERIENCE WITH FLUPHENAZINE ENANTHATE INJECTION. 

180153 02-08 
EXPERIENCE GAINED IN THE TREATMENT OF CHRONIC SCHIZOPHRENIC 
PSYCHOSES WITH A THIORIDAZINE DERIVATIVE. 

180675 02-08 
EXPERIENCE IN THE TREATMENT OF CEREBRAL INSUFFICIENCY AND 

PERIPHERAL BLOOD CIRCULATION DISORDERS USING THE EP- 50-100 
EXPERIMENTAL DRUG. 

180676 02-11 
CLINICAL EXPERIENCE WITH A NEW PSYCHOTROPIC DRUG: FK-880 

(SULPIRIDE), ITS EFFECT ON PATIENTS WITH PSYCHOSOMATIC 
DISEASES AND PSYCHONEUROSIS. 

182731 03-10 
CLINICAL EXPERIENCE WITH DIAMORPHINE IN ADVANCED MALIGNANT 
DISEASE. 

191606 04-17 



EXPERIENCED 

EFFECTS OF DELTA9-THC ON FOOD AND WATER INTAKE OF DEPRIVATION 
EXPERIENCED RATS. 

191375 04-04 
EXPERIENCES 

EXPERIENCES WITH LAROXYL (R) IN THE TREATMENT OF DEPRESSIONS IN 
PRIVATE PSYCHIATRIC PRACTICE IN DJAKARTA. 

170413 01-11 
PRELIMINARY EXPERIENCES WITH NOBRIUM IN PRIVATE PSYCHIATRIC 

PRACTICE IN DJAKARTA. 

170414 01-11 
EXPERIENCES WITH FLUPHENAZINE ENANTHATE IN LONG-STAY 

HOSPITALISED SCHIZOPHRENICS. 

171985 01-08 
CLINICAL EXPERIENCES WITH FK-880 (SULPIRIDE). 

174681 01-08 
CLINICAL EXPERIENCES WITH A NEW PSYCHOTROPIC DRUG, R-6238 
(PIMOZIDE). 

176564 02-11 
CLINICAL EXPERIENCES WITH AN ANTIDEPRESSIVE DRUG, NORITREN 

(NORTRIPTYLINE). 

176565 02-09 
CLINICAL EXPERIENCES WITH NAVANE IN CHRONIC SCHIZOPHRENIA. 

1 76726 02-08 
CLINICAL EXPERIENCES WITH A PSYCHOTROPIC DRUG (OXYPERTINE) IN 

CHRONIC SCHIZOPHRENIA. 

176727 02-08 
CLINICAL EXPERIENCES WITH FLUPENTHIXOL (FX-703). 

1 78224 02-08 
EXPERIENCES WITH FLUPHENAZINE ENANTHATE IN LONG-STAY 
HOSPITALIZED SCHIZOPHRENICS. 

180154 02-08 
PRELIMINARY EXPERIENCES WITH THE TREATMENT OF SOME MENTAL 
CASES UTILIZING AN ENZYME COMBINATION. 

180298 02-17 
CLINICAL EXPERIENCES WITH A NEW ANTIDEPRESSANT, MAPROTILINE 

188893 04-09 
CLINICAL EXPERIENCES WITH MESORIDAZINE (TPS-23): ITS 

ADMINISTRATION TO HOSPITALIZED SCHIZOPHRENIC PATIENTS. 

188934 04-08 
EXPERIMENT 

A CLINICAL EXPERIMENT WITH SULPIRIDE. 

171122 01-11 
EXPERIMENT WITH DOXEPIN (SINEQUAN) IN TREATMENT OF DEPRESSIVE 
STATES. 

176454 02-11 
CLINICAL EXPERIMENT WITH A LONG-ACTING NEUROLEPTIC: 
FLUSPIRILENE (R6218). 

183200 03-15 
EXPERIMENT WITH PENFLURIDOL (TLP-607) ON THE TREATMENT OF 
CHRONIC SCHIZOPHRENIA. 

191593 04-08 
EXPERIMENT WITH LOPRAMINE (DB-2182) ON THE TREATMENT OF 
DEPRESSION. 

191665 04-09 
EXPERIMENT WITH LITHIUM CARBONATE ON THE TREATMENT OF MANIC 
STATE. 

191670 04-09 
EXPERIMENTAL 

DEPRESSIVE FORMS OF SCHIZOPHRENIA AND EXPERIMENTAL 
TREATMENT BY CLOMIPRAMINE. 

167676 01-08 
THE SAFETY TEST OF lO-CHLORO-1 lB-(2-CHL0R0PHENYL) 2,3,5,6,7,116 
HEXAHYDROBENZODIAZEPINOOXAZOL-6-ONE (CS-370): SECOND 
REPORT, EFFECT OF CS-370 UPON THE DEVELOPMENT OF PRENATAL 
AND POSTNATAL OFFSPRINGS OF EXPERIMENTAL ANIMALS. 

168498 01-05 
MARIHUANA USE IN MAN: AN EXPERIMENTAL INQUIRY - CLINICAL 
PSYCHIATRIC IMPRESSIONS. 

169085 01-14 
THE EFFECT OF MARIJUANA ON HOSTILITY IN AN EXPERIMENTAL GROUP 

SETTING: PRELIMINARY OBSERVATIONS. 

169086 01-14 
BEHAVIOR AND SENSITIVITY TO EXPERIMENTAL HYPERTENSION: II. LACK 

OF CORRELATION BETWEEN CERTAIN BEHAVIOR PATTERNS AND 
HYPERTENSION IN TWO NEW STRAINS OF RATS. 

173256 01-04 
(-)DELTA9-THC AS AN HYPNOTIC: AN EXPERIMENTAL STUDY OF THREE 
DOSE LEVELS. 

174041 01-14 
EXPERIMENTAL DEPRESSION CAUSED BY APOMORPHINE AND 
PHENOHARMANE. 

180062 02-10 
EXPERIENCE IN THE TREATMENT OF CEREBRAL INSUFFICIENCY AND 
PERIPHERAL BLOOD CIRCULATION DISORDERS USING THE EP- 50-100 
EXPERIMENTAL DRUG. 

180676 02-11 
EXPERIMENTAL CATATONIA AND PSYCHOPHARMACOLOGY. 

180724 02-04 



S-101 



Subject Index 



Psychopharmacology Abstract 



EXPERIMENTAL STUDIES IN COMPARATIVE PSYCHOPHARMACOLOGY. 

181400 02-04 
CATECHOLAMINE TURNOVER IN THE RAT BRAIN: DIFFERENT RESULTS 
OBTAINED IN DIFFERENT EXPERIMENTAL CONDITIONS. 

181471 02-03 
A NEW RECORDING APPARATUS FOR MEASUREMENT OF LOCOMOTOR 
ACTIVITY OF MICE. EXPERIMENTAL OBSERVATIONS ON ITS USE. 

186377 03-06 
AN EXPERIMENTAL INVESTIGATION OF DEPENDENCE LIABILITY OF 
METHAQUALONE IN RATS. 

186569 03-03 
IMIPRAMINE IN EXPERIMENTAL PETIT-MAL EPILEPSY. 

188424 04-03 
MYTHICIZING ELEMENTS IN EXPERIMENTAL PSYCHOLYSIS. 

189754 04-12 
EXPERIMENTALLY 

PROPRANOLOL AND CHLORDIAZEPOXIDE ON EXPERIMENTALLY INDUCED 
CONFLICT AND SHUTTLEBOX PERFORMANCE IN RODENTS. 

171304 01-04 
EXPERIMENTATION 

CLINICAL EXPERIMENTATION WITH A NEW BENZODIAZEPINE IN THE 
MANAGEMENT OF PHOBIC AND OBSESSIVE SYMPTOMS. 

167594 01-10 
PSYCHOLOGICAL EXPERIMENTATION ON THE EFFECTS OF PROPIRAM 
FUMARATE AND PROMETHAZINE UNDER NORMAL AND STRESS 
CONDITIONS. 

184617 03-07 
EXPERIMENTS 

EXPERIMENTS IN ORAL AND INJECTABLE FORMS OF A NEW 
ANTIDEPRESSANT (DOXEPIN) ON FORTY PATIENTS. 

182900 03-11 
MUTAGENICITY EXPERIMENTS WITH THE TRANQUILLIZER MEPROBAMATE 
IN DROSOPHILA-MELANOGASTER AND IN HUMAN LEUKOCYTE 
CHROMOSOMES IN VITRO. 

184585 03-05 
NEUROTOXICOLOGIC STUDIES OF TWO CARBAMATE PESTICIDES IN 
SUBACUTE ANIMAL EXPERIMENTS. 

188874 04-05 
THE USE OF DRUGS IN PSYCHIATRIC INTERVIEWS: SOME 
INTERPRETATIONS BASED ON CONTROLLED EXPERIMENTS. 

189074 04-17 
EFFECTS OF NICOTINE ON THE OBSERVED BEHAVIOUR OF RATS DURING 
SIGNALLED AND UNSIGNALLED AVOIDANCE EXPERIMENTS. 

190332 04-04 
EXPLANATION 

CHOLINERGIC REVERSAL OF MANIC SYMPTOMS: A POSSIBLE 
EXPLANATION. (UNPUBLISHED PAPER). 

173520 01-09 
EXPLORATION 

EFFECTS OF ATROPINE ON EXPLORATION, LEARNING AND 
ELECTROCORTICAL ACTIVITY IN THE DEVELOPING RAT. 

169473 01-04 
INTERACTION BETWEEN PRIOR EXPERIENCE AND THE EFFECTS OF 
CHLORPROMAZINE ON EXPLORATION IN THE RAT. 

171308 01-04 
THE ACTION OF CHLORPROMAZINE ON EXPLORATION IN PAIRS OF RATS. 

189514 04-04 
THE EFFECT OF OCTOCLOTHEPIN AND PERPHENAZINE ON BEHAVIOUR IN 
RATS WITH DIFFERENT EXPLORATION AND DEFECATION RATES. 

192430 04-04 
EXPLORATORY 

TIME SAMPLING OF RAT EXPLORATORY BEHAVIOUR: A RELIABLE 
SCREENING TEST FOR THE CNS EFFECTS OF ANOREXIC AGENTS. 

187925 04-04 
EXPOSED 

INCREASED BRAIN NOREPINEPHRINE TURNOVER IN LEAD EXPOSED 
HYPERACTIVE RATS. 

191957 04-05 
EXPOSURE 

RECOVERY FROM ELECTROCONVULSIVE SHOCK-INDUCED AMNESIA BY 
EXPOSURE TO THE TRAINING ENVIRONMENT: PHARMACOLOGICAL 
ENHANCEMENT BY PIRACETAM. 

186704 03-04 
EFFECTS OF CHRONIC EXPOSURE TO DELTA9-TETRAHYDR0CANNABIN0L 
ON DELAYED MATCHING-TO-SAMPLE IN CHIMPANZEES. 

189405 04-04 
EFFECTS OF PERINATAL EXPOSURE TO METHYL MERCURY ON 
FUNCTIONAL BRAIN DEVELOPMENT AND NEUROCHEMISTRY. 

189564 04-05 
PERMANENT ALTERATIONS IN 5-HYOROXYTRYPTAMINE METABOLISM IN 
DISCRETE AREAS OF RAT BRAIN FOLLOWING EXPOSURE TO DRUGS 
DURING THE PERIOD OF DEVELOPMENT. 

191383 04-03 
INDUCTION OF A DIETHYLETHER WITHDRAWAL SYNDROME IN MICE BY 
EXPOSURE TO ETHER VAPOR. 

192006 04-03 



ENDURING LEARNING DEFICITS AND CEREBRAL SYNAPTIC 

MALFORMATION FROM EXPOSURE TO 10 PARTS OF HALOTHANE PER 
MILLION. 

192565 04-0 
EXTENSOR 

EFFECTS OF CNS AGENTS ON NICOTINE EXTENSOR CONVULSIONS AND 
LETHALITY IN MICE AND THEIR SEDATIVE ANTIANXIETY EFFECTS IN 
MAN 

191907 04-1 
EXTENT 

CROSS-NATIONAL STUDY OF THE EXTENT OF ANTIANXIETY SEDATIVE 
DRUG USE. 

181713 02-1 
EXTINCTION 

FAILURE OF ACTH TO INFLUENCE AVOIDANCE EXTINCTION IN A ONE- 
WAY AVOIDANCE SITUATION. 

183470 03-C 
THE EFFECTS OF CHLORPROMAZINE ON A REDEFINED PROCEDURE OF 
EXTINCTION OF SIDMAN AVOIDANCE BEHAVIOR. (PH.D. 
DISSERTATION). 

185715 03-1 
JOINT EFFECTS OF SODIUM AMYLOBARBITONE AND AMPHETAMINE 
SULPHATE ON RESISTANCE TO EXTINCTION OF A REWARDED RUNNINi 
RESPONSE IN THE RAT. 

186573 03-C 
EXTRACT 

EFFECTS OF ACUTE AND CHRONIC ADMINISTRATION OF CANNABIS- 
SATIVA EXTRACT ON THE MOUSE-KILLING BEHAVIOR OF RATS. 

167362 01 -C 
EFFECTS OF AQUEOUS PINEAL EXTRACT IN CHRONIC SCHIZOPHRENIA. 

177818 02-C 
CANNABIDIOL AND CANNABIS- SATIVA EXTRACT PROTECT MICE AND 
RATS AGAINST CONVULSIVE AGENTS. 

183609 O3-0 
CRUDE MARIHUANA EXTRACT: EEG AND BEHAVIORAL EFFECTS OF 

CHRONIC ORAL ADMINISTRATION IN RHESUS MONKEYS. 

189516 O4-0 
EXTRACTED 

SPECIFIC FACILITATION OF MAZE LEARNING BY A PEPTIDE EXTRACTED 
FROM TRAINED MOUSE BRAIN. 

1 76868 02-C 
CONSTITUENTS OF CANNABIS-SATIVA L. V.: STABILITY OF AN 

ANALYTICAL SAMPLE EXTRACTED WITH CHLOROFORM. (UNPUBLISHEI 
PAPER). 

180670 02-C 
EXTRANEURONAL 

EXTRANEURONAL REMOVAL, ACCUMULATION AND 0-METHYLATION OF 
ISOPRENALINE IN THE PERFUSED HEART. 

189604 04-0 
EXTRAPYRAMIDAL 

ACUTE DRUG-INDUCED EXTRAPYRAMIDAL SYNDROMES. 

167572 01-1 
PHYSOSTIGMINE EFFECTS ON PHENOTHIAZINE INDUCED 
EXTRAPYRAMIDAL REACTIONS. 

170662 01-1 
IS THERE A RELATIONSHIP BETWEEN THE INVOLVEMENT OF 
EXTRAPYRAMIDAL AND MESOLIMBIC BRAIN AREAS WITH THE 
CATALEPTIC ACTION OF NEUROLEPTIC AGENTS AND THEIR CLINICAL 
ANTIPSYCHOTIC EFFECT? 

171305 01-0 
L-DOPA AND THE TREATMENT OF EXTRAPYRAMIDAL DISEASE. 
(UNPUBLISHED PAPER). 

177975 02-1 
ROLE OF 5-HT IN THE ACTION OF SOME DRUGS AFFECTING 
EXTRAPYRAMIDAL SYSTEM. 

1 78757 02-0 
EXTRAPYRAMIDAL DISTURBANCES BROUGHT ON BY NEUROLEPTICS. 

180070 02-1 
TRIFLUPERIDOL - THERAPEUTIC RESPONSE AND EXTRAPYRAMIDAL 
SYMPTOMS. 

180248 02-1 
EFFECTS OF ANTIPARKINSONIAN DRUGS ON NEUROLEPTIC INDUCED 
EXTRAPYRAMIDAL SIGNS IN MONKEYS. 

183610 03-0 
CHLORPROMAZINE CAUSING EXTRAPYRAMIDAL DYSFUNCTION IN 

NEWBORN INFANT OF PSYCHOTIC MOTHER. 

187787 04-1 
ANTISCHIZOPHRENIC DRUGS AND BRAIN CHOLINERGIC RECEPTORS: 
AFFINITY FOR MUSCARINIC SITES PREDICTS EXTRAPYRAMIDAL 
EFFECTS. 

188114 04-1: 
ADRENERGIC AND CHOLINERGIC FACTORS IN EXTRAPYRAMIDAL 
DISORDERS. 

191533 04-1 
DIFFERENTIAL INCREASE OF BEHAVIORAL AND EXTRAPYRAMIDAL 
STIMULATING ACTIONS OF NEUROLEPTICS BY ALPHA- 
METHYLTYROSINE PRETREATMENT IN RATS. 

192016 04-0 



S-102 



/OLUME 12, SUBJECT INDEX 



Subject Index 



■YE 

ON THE TREATMENT OF RAPID EYE MOVEMENT NARCOLEPSY. 

17149601-11 
AMPHETAMINE AND PENTOBARBITAL EFFECTS ON THE DISCRIMINATIVE 
RESPONSE CONTROL BY DEPRIVATION OF RAPID EYE MOVEMENT 
SLEEP (REM). 

182245 03-03 

■YEIID 

THE EFFECT OF TRANYLCYPROMINE (PARNATE) ON EYELID CONDITIONING 
AND PAIRED ASSOCIATE LEARNING IN DEPRESSED PATIENTS. 

188107 04-09 
iACIllTATES 

MESCALINE FACILITATES RETENTION OF PASSIVE AVOIDANCE IN RATS. 

190266 04-04 
'ACIIITATION 

SPECIFIC FACILITATION OF MAZE LEARNING BY A PEPTIDE EXTRACTED 
FROM TRAINED MOUSE BRAIN. 

176868 02-04 
AN ANALYSIS OF D-AMPHETAMINE PRODUCED FACILITATION OF 
AVOIDANCE ACQUISITION IN RATS AND PERFORMANCE CHANGES 
SUBSEQUENT TO DRUG TERMINATION. 

1 79990 02-04 
DOSE DEPENDENT SELECTIVE FACILITATION OF RESPONSE CONTINGENT 
LIGHT ONSET BEHAVIOR BY D-AMPHETAMINE. 

185955 03-04 
AN ANALYSIS OF THE FACILITATION OF AVOIDANCE ACQUISITION BY D- 
AMPHETAMINE AND SCOPOLAMINE. 

189521 04-04 
PSYCHOPHARMACOLOGIC FACILITATION OF OPERANT CONDITIONING OF 
GENETICALLY NERVOUS CATAHOULA AND POINTER DOGS. 

190696 04-04 
:ACILITAT0RY 

PARADOXICAL BLOCKADE BY P-CHLOROPHENYLALANINE OF 5- 
HYDROXYTRYPTOPHAN FACILITATORY ACTIONS ON SPINAL REFLEXES. 

168436 01-03 
'ACT 

MIXED ANXIETY DEPRESSION: FACT OR MYTH? 

189919 04-10 
:AD 

STIMULATION OF BRAIN AROMATIC ALKYLAMINE N- 
METHYLTRANSFERASE ACTIVITY BY FAD AND METHYLCOBALAMIN. 

180020 02-03 
FAILURE 

FAILURE OF N,N DIMETHYLTRYPTAMINE TO EVOKE TOLERANCE IN CATS. 

173398 01-03 
CLINICAL FACTORS IN LITHIUM CARBONATE PROPHYLAXIS FAILURE. 

174093 01-09 
FAILURE OF ACTH TO INFLUENCE AVOIDANCE EXTINCTION IN A ONE- 
WAY AVOIDANCE SITUATION. 

183470 03-04 
FAILURE OF BETA-ADRENERGIC RECEPTOR BLOCKADE TO PREVENT 
ARRHYTHMIAS INDUCED BY SYMPATHETIC NERVE STIMULATION. 

187923 04-03 
FAILURES 

FAILURES OF L-DOPA. 

168777 01-13 
FAMILIAR 

SENSORY CONTINGENT BAR-PRESSING FOR FAMILIAR AND NOVEL 
CHANGE UNDER A DEXAMPHETAMINE AMYLOBARBITONE MIXTURE. 

181605 02-04 
FAMILIARITY 

DRUG NAME FAMILIARITY AND THE PLACEBO EFFECT. 

192704 04-17 
FAMILIES 

IMPORTANCE OF THE COOPERATION OF FAMILIES IN THE TREATMENT OF 
THE SICK, CONCERNING CHRONIC DELIRIUM TREATED WITH 
NEUROLEPTICS AND MELANCHOLY TREATED WITH ANTIDEPRESSANTS. 

182899 03-17 
FAMILY 

RELATIONSHIP BETWEEN THE EFFECTIVENESS OF LITHIUM THERAPY AND 
FAMILY HISTORY. 

169494 01-09 
ARE NEUROTIC PATIENTS IN PSYCHOTROPIC DRUG TRIALS 

REPRESENTATIVE? A COMPARISON OF STUDY AND NON-STUDY 
PATIENTS IN FOUR FAMILY PRACTICES. 

188144 04-10 
RESILIENCE OF FAMILY PROCESS: EFFECT OF SECOBARBITAL. 

189743 04-14 
FATAL 

FATAL INTOXICATION OF A YOUNG DRUG ADDICT WITH DIAZEPAM. 

178619 02-05 
FATAL SUICIDAL INGESTION OF THIORIDAZINE. 

189606 04-15 



FATE 



THE METABOLIC FATE OF N,N DIMETHOXYMETHYL-PHENOBARBITAL IN 
THE RAT. 

177731 02-03 
THE METABOLIC FATE OF HEXOBARBITAL IN THE RAT. 

1 77732 02-03 



INVESTIGATIONS ON THE FATE OF THE ANTICONVULSANT CLONAZEPAM 
IN THE ORGANISM OF MAN, RAT AND DOG. 

179022 02-13 
STUDIES ON METABOLISM OF BROMAZEPAM (II): COLORIMETRIC 
DETERMINATION AND METABOLIC FATE OF BROMAZEPAM IN 
ANIMALS. 

181593 02-03 
FATIGABILITY 

PSYCHIC FATIGABILITY, ITS FEATURES AND DRUG THERAPY. 

183197 03-11 
FAVORABLE 

ONE CASE OF AGRYPNIA (4 MONTHS WITHOUT SLEEP) IN A MORVAN 
DISEASE: FAVORABLE ACTION OF 5-HYDROXYTRYPTOPHAN. 

187237 03-14 
FEAR 

ANTICHOLINERGICS: THEIR EFFECTS ON FEAR MOTIVATED BEHAVIOR, 
URINARY It-HYDROXYCORTICOSTEROIDS, URINARY VOLUME, AND 
HEART RATE IN THE DOG. 

178720 02-03 
FEAR REDUCTION IN THE RAT FOLLOWING CENTRAL CHOLINERGIC 
BLOCKADE. 

187703 04-04 
DISSOCIATION BETWEEN SCOPOLAMINE AND MECAMYLAMINE DURING 
FEAR CONDITIONING IN RATS. 

190264 04-04 

FEEDING 

RECOVERY OF FEEDING AND DRINKING BY RATS AFTER 
INTRAVENTRICULAR 6-HYDROXYDOPAMINE OR LATERAL 
HYPOTHALAMIC LESIONS. 

168484 01-03 
DOPAMINE AND 5-HYDROXYTRYPTAMINE INHIBIT FEEDING IN RATS. 

170177 01-04 
ROLE OF ASSOCIATIVE LEARNING IN FEEDING BEHAVIOR. 

178044 02-17 
DETERMINANTS OF THE NORADRENERGIC SATIETY EFFECT: 
ENVIRONMENTAL DARKNESS VS. THE FEEDING PATTERN. 

182133 02-04 
RECOVERY OF FEEDING AFTER 6-HYDROXYDOPAMINE {6-HDA) OR 
LATERAL HYPOTHALAMIC LESIONS: THE ROLE OF CATECHOLAMINES. 

182213 03-03 
EFFECTS OF PHENOTHIAZINES, ANTIHISTAMINES, BENZODIAZEPINES AND 
BUTYROPHENONES ON ELECTROENCEPHALOGRAM AND FEEDING 
BEHAVIOR OF RATS. 

182554 03-04 
BRAIN MECHANISMS UNDERLYING THE EFFECTS OF AMPHETAMINE ON 
FEEDING AND NONFEEDING BEHAVIORS: DISSOCIATION AND OVERLAP. 

184839 03-03 
FEMALE 

EFFECTS OF TETRABENAZINE ON LORDOSIS BEHAVIOUR AND ON BRAIN 
MONOAMINES IN THE FEMALE RAT. 

171614 01-04 
CHANGE OF ESTROGEN ACTIVATED BEHAVIOR BY CYCLOHEXIMIDE IN 

THE FEMALE RAT. 

171615 01-04 
ACTIVATION OF COPULATORY BEHAVIOR BY PILOCARPINE AND 

OXOTREMORINE IN THE FEMALE RAT. 

171616 01-04 
A DIFFERENTIAL INHIBITORY ACTION OF LSD AND AMPHETAMINE ON 

COPULATORY BEHAVIOR IN THE FEMALE RAT. 

171617 01-04 
INFLUENCE OF PHENOBARBITAL AND SEX HORMONES ON ENZYMES IN 

ASCORBIC ACID BIOSYNTHESIS IN MALE AND FEMALE RATS. (PH.D. 
DISSERTATION). 

172017 01-03 
SUBACUTE TOXICITY OF 8-CHL0R0-6-PHENYL-4HS- 

TRIAZOLOBENZODIAZEPINE (D-40TA) IN MALE AND FEMALE RATS: 
ORAL ADMINISTRATION FOR ONE MONTH. 

1 77097 02-05 
INVERSION BY APOMORPHINE OF THE TENDENCY OF FEMALE RATS TO 
BE DEFEATED BY MALES WHEN COMPETING FOR FOOD IN A STRAIGHT 
RUNWAY. 

184212 03-04 
NEURAL AND CHEMICAL MECHANISMS OF FEMALE SEXUAL BEHAVIOR IN 
THE RAT. (PH.D. DISSERTATION). 

185705 03-04 
EFFECTS OF AN ESTROGEN ANTAGONIST, MER-25, ON MOUNTING 
BEHAVIOR AND LORDOSIS BEHAVIOR IN THE FEMALE RAT. 

186691 03-04 
FURTHER EVIDENCE ON THE INTRAHYPOTHALAMIC LOCUS FOR 
ANDROGENIZATION OF FEMALE RATS. 

187935 04-03 
EFFECTS OF LSD AND MONOAMINE SYNTHESIS INHIBITORS ON 

HORMONE ACTIVATED COPULATORY BEHAVIOR IN THE FEMALE RAT. 

1 8861 1 04-04 
DISTRIBUTION OF 1 4C-DELTA9-THC IN MALE AND FEMALE RATS. 

191969 04-03 



S-103 



Subject Index 



Psychopharmacology Abstracts 



FENFLURAMINE 

INTERACTION BY FENFLURAMINE WITH THE METABOLISM OF D- 
AMPHETAMINE IN THE RAT. 

171634 01-03 
SELECTIVE BLOCKADE OF APOMORPHINE INDUCED AGGRESSION AND 
GNAWING FOLLOWING FENFLURAMINE OR RAPHE LESIONS IN THE 
RAT. 

182128 02-04 
DIFFERENTIAL SELF-INJECTION BEHAVIOR PRODUCED BY FENFLURAMINE 
VERSUS OTHER APPETITE INHIBITING DRUGS. 

182215 03-04 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 
DERIVATIVE SE-780 IN RATS. 

187926 04-04 
BIOCHEMICAL AND BEHAVIORAL ANTAGONISM BETWEEN 
FENFLURAMINE AND APOMORPHINE IN RATS. 

188196 04-03 
PSYCHOMOTOR TEST PERFORMANCE WITH A FENFLURAMINE 
AMPHETAMINE COMBINATION. 

190146 04-07 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 
METABOLITE, NORFENFLURAMINE: AN EVALUATION OF ITS ROLE IN 
THE ACTIONS OF FENFLURAMINE. 

190335 04-04 
FENTANYL 

INFLUENCE OF FENTANYL, LEVORPHANOL AND PETHIDINE ON THE 
RELEASE OF NORADRENALINE FROM RAT BRAIN CORTEX SLICES. 

189569 04-03 
FETAL 

DETERMINATION OF DRUG TRANSFER ACROSS BIOLOGICAL MEMBRANES- 
COMPARATIVE STUDY ON THE PASSAGE OF DRUGS INTO THE 
CENTRAL NERVOUS SYSTEM AND THEIR PLACENTAL TRANSFER AND 
FETAL LOCALIZATION IN THE PREGNANT RAT. (PH.D. DISSERTATION). 

172018 01-03 
FETUS 

THE RATE LIMITING CONTROL OF ENZYMES MONOAMINE OXIDASE AND 
CATECHOL-O-METHYLTRANSFERASE IN THE FETUS AND THE ADULT BY 
ADRENOCORTICOL HORMONES. 

178815 02-03 
FETUSES 

DISPOSITION OF H3-DELTA9-TETRAHYDROCANNABINOL IN BRAIN OF 
PREGNANT DOGS AND THEIR FETUSES. 

191968 04-03 
FIBER 

MUSCLE ABNORMALITIES IN PSYCHOTIC PATIENTS: II. SERUM CPK 
ACTIVITY, FIBER ABNORMALITIES, AND BRANCHING AND SPROUTING 
OF SUBTERMINAL NERVES. 

187114 03-09 
FIBERS 

FLUORESCENCE AND ELECTRON MICROSCOPIC ANALYSIS OF 
CATECHOLAMINE CONTAINING FIBERS IN MUTANT MOUSE 
CEREBELLUM. (UNPUBLISHED PAPER). 

191762 04-03 
FIGHTING 

FIGHTING IN MICE: DYADIC ESCALATION AND WHAT IS LEARNED. 

173039 01-04 
APOMORPHINE INDUCED BITING AND FIGHTING BEHAVIOUR IN 
RESERPINIZED RATS AND AN APPROACH TO THE MECHANISM OF 
ACTION. 

174768 01-04 
THE EFFECTS OF CHLORDIAZEPOXIDE (LIBRIUM) ON THE INTENSITY AND 
HABITUATION OF AGONISTIC BEHAVIOR IN MALE SIAMESE FIGHTING 
FISH. 

177722 02-04 
FILTRATE 

EVIDENCE FOR REDISTRIBUTION OF FILTRATE AMONG NEPHRONS AFTER 
BETA- ADRENERGIC STIMULATION AND BLOCKADE. 

184222 03-03 
NRST-PASS 

ON THE FIRST-PASS EFFECT IN THE LIVER OF NORTRIPTYLINE, LIDOCAINE 
AND PROPRANOLOL. 

171631 01-03 
FISCHER 

INHALATION, PARENTERAL AND ORAL LD50 VALUES OF DELTA9- 
TETRAHYDROCANNABINOL IN FISCHER RATS. 

189588 04-05 
EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND AGE ON 
VARIOUS NEUROTRANSMITTERS AND ASSOCIATED ENZYMES IN MALE 
FISCHER 344 RATS. 

189597 04-03 
FISH 

THE EFFECTS OF CHLORDIAZEPOXIDE (LIBRIUM) ON THE INTENSITY AND 
HABITUATION OF AGONISTIC BEHAVIOR IN MALE SIAMESE FIGHTING 
FISH. 

1 77722 02-04 
FIXED-INTERVAL 

THE EFFECTS OF D- AND L-AMPHETAMINE ON FIXED-INTERVAL AND 
FIXED-RATIO BEHAVIOR IN TOLERANT AND NONTOLERANT RATS. 

168438 01-04 



THE EFFECTS OF SCOPOLAMINE ON FIXED-INTERVAL BEHAVIOUR IN THE 
RAT; A RATE-DEPENDENCY EFFECT. 

168833 01-04 
A DETAILED ANALYSIS OF THE EFFECTS OF D-AMPHET AMINE ON 
BEHAVIOR UNDER FIXED-INTERVAL SCHEDULES. 

187066 03-04 
EFFECTS OF D-AMPHETAMINE, MORPHINE AND CHLORPROMAZINE ON 
RESPONDING UNDER FIXED-INTERVAL SCHEDULES OF FOOD 
PRESENTATION OR ELECTRIC SHOCK PRESENTATION 

191767 04-03 
FIXED-RATIO 

THE EFFECTS OF D- AND L-AMPHETAMINE ON FIXED-INTERVAL AND 
FIXED-RATIO BEHAVIOR IN TOLERANT AND NONTOLERANT RATS. 

168438 01-04 
EFFECTS OF METHAMPHETAMINE ON FIXED-RATIO RESPONDING OF FOOD 
SATIATED AND FOOD DEPRIVED RATS. 

185957 03-04 
FK-880 

CLINICAL EXPERIENCES WITH FK-880 (SULPIRIDE). 

174681 01-08 
EXPERIENCE IN THE USE OF FK-880 (SULPIRIDE) IN THE FIELD OF 
PSYCHIATRY. 

1 77568 02-08 
THE COMPARISON OF THERAPEUTIC EFFECTS OF FK-880 (SULPIRIDE) AND 
PERPHENAZINE IN SCHIZOPHRENIA BY A DOUBLE-BLIND CONTROLLED 
STUDY. 

181378 02-08 
CLINICAL EXPERIENCE WITH A NEW PSYCHOTROPIC DRUG: FK-880 
(SULPIRIDE), ITS EFFECT ON PATIENTS WITH PSYCHOSOMATIC 
DISEASES AND PSYCHONEUROSIS. 

182731 03-10 
TREATMENT OF EXOGENOUS PSYCHOSIS BY THE USE OF FK-880 
(SULPIRIDE). 

191663 04-09 
FLASHES 

EFFECTS OF SCOPOLAMINE UPON BEHAVIORAL REACTIVITY AND 
VISUALLY EVOKED POTENTIAL TO FLASHES IN RATS. 

173032 01-04 
COMPARATIVE EFFECTS OF SCOPOLAMINE AND AMPHETAMINE UPON 
BEHAVIORAL REACTIVITY AND VISUAL EVOKED POTENTIALS TO 
FLASHES IN RATS. 

187700 04-04 
FLAVOR 

FLAVOR AVERSIONS PRODUCED BY CONTINGENT DRUG INJECTION: 
RELATIVE EFFECTIVENESS OF APOMORPHINE, EMETINE, AND LITHIUM. 

178502 02-04 
FUCKER 

EFFECTS OF SHORT-TERM VERSUS LONG-TERM L-DOPA THERAPY IN 
PARKINSONISM ON CRITICAL FLICKER FREQUENCY. 

177511 02-11 
FLOROPIPAMIDE 

EXPERIENCE IN THE APPLICATION OF DICEPLON (APY-606) - COMPARED 
WITH FLOROPIPAMIDE. 

176447 02-08 
FLOW 

EFFECTS OF ALTERATIONS IN IMPULSE FLOW ON TRANSMITTER 
METABOLISM IN CENTRAL DOPAMINERGIC NEURONS. 

191519 04-03 
FLUID 

BRAIN SEROTONIN, AFFECTIVE ILLNESS AND ANTIDEPRESSANT DRUGS: 
CEREBROSPINAL FLUID STUDIES WITH PROBENECID. (UNPUBLISHED 
PAPER). 

170084 01-09 
ELECTROLYTES IN CEREBROSPINAL FLUID IN ENDOGENOUS DEPRESSION. 

172402 01-09 
EFFECTS OF AMITRIPTYLINE AND IMIPRAMINE ON AMINE METABOLITES 
IN THE CEREBROSPINAL FLUID OF DEPRESSED PATIENTS. 

174094 01-09 
THE EFFECT OF PROBENECID AND LARGE DOSE AMPHETAMINE 

ADMINISTRATION ON CEREBROSPINAL FLUID HOMOVANILLIC ACID. 

177826 02-13 
CHOLINE ACETYLTRANSFERASE ACTIVITY IN THE CEREBROSPINAL FLUID 
OF PSYCHIATRIC PATIENTS. 

180047 02-13 
LITHIUM DISTRIBUTION BETWEEN CEREBROSPINAL FLUID AND SERUM OF 
AFFECTIVE PSYCHOTIC PATIENTS TREATED WITH LITHIUM CARBONATE 
AND ITS CLINICAL RESPONSE. 

180301 02-11 
THE ELIMINATION OF 5-HYDROXYINDOLEACETIC ACID FROM 
CEREBROSPINAL FLUID: CHARACTERISTICS OF THE ACID TRANSPORT 
SYSTEM OF THE CHOROID PLEXUS. 

182718 03-03 
THE EFFECT OF CHLORPROMAZINE ON HOMOVANILLIC ACID LEVELS IN 
CEREBROSPINAL FLUID OF SCHIZOPHRENIC PATIENTS. 

186565 03-08 
MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND ITS 

HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD. 

186566 03-16 



S-104 



VOLUME 12, SUBJECT INDEX 



Subject Index 



STUDIES OF CEREBROSPINAL FLUID AMINE METABOLITES IN DEPRESSED 
PATIENTS: CONCEPTUAL PROBLEMS AND THEORETICAL IMPLICATIONS. 
(UNPUBLISHED PAPER). 

187398 04- 13 
PLASMA AND CEREBROSPINAL FLUID PROBENECID CONCENTRATIONS AS 
RELATED TO ACCUMULATION OF ACIDIC BIOGENIC AMINE 
METABOLITES IN MAN. 

187933 04-13 
A STUDY OF BIOGENIC AMINE METABOLITES IN THE CEREBROSPINAL 
FLUID AND URINE OF MONKEYS WITH CHLORPROMAZINE INDUCED 
DYSKINESIA. 

189210 04-03 
FLUIDS 

RADIOIMMUNOASSAY FOR LYSERGIDE (LSD) IN ILLICIT DRUGS AND 
BIOLOGICAL FLUIDS. 

170840 01-06 
VALIDITY OF SCREENING METHODS FOR DRUGS OF ABUSE IN 
BIOLOGICAL FLUIDS. II. HEROIN IN PLASMA AND SALIVA. 

187256 03-15 
FLUNITRAZEPAM 

CONTROL OF INSOMNIA WITH A NEW BENZODIAZEPINE: THE 

FLUNITRAZEPAM OR R0-5-4200 (FIRST INVESTIGATIONS OF PHASE I 
AND CONTROLLED INVESTIGATIONS OF PHASE II). 

183198 03-11 
FLUNITRAZEPAM (RO-5-4200) AND SLEEP CYCLE IN INSOMNIAC 
PATIENTS. 

186574 03-11 
FLUORESCENCE 

FLUORESCENCE AND ELECTRON MICROSCOPIC ANALYSIS OF 
CATECHOLAMINE CONTAINING FIBERS IN MUTANT MOUSE 
CEREBELLUM. (UNPUBLISHED PAPER). 

191762 04-03 
FLUPENTHIXOL 

ONE YEAR OF CLINICAL EXPERIENCE WITH LARGE DOSES OF 10 PERCENT 
FLUPENTHIXOL DECANOATE (LU-1705). 

172735 01-07 
PRELIMINARY STUDY OF THE TREATMENT OF CHRONIC PSYCHOSES 
WITH FLUPENTHIXOL DECANOATE. 

172978 01-09 

175393 02-11 

175460 02-08 

178224 02-08 



FLUPENTHIXOL IN CERTAIN PSYCHIATRIC ILLNESSES. 
FLUPENTHIXOL IN SCHIZOPHRENIA. 
CLINICAL EXPERIENCES WITH FLUPENTHIXOL (FX-703). 
THE USE OF FLUPENTHIXOL IN THERAPY. 



183124 03-11 
ACUTE EFFECTS OF ALCOHOL, DIAZEPAM, THIORIDAZINE, FLUPENTHIXOL 
AND ATROPINE ON PSYCHOMOTOR PERFORMANCE PROFILES. 

184848 03-14 
FLUPENTHIXOL DECANOATE IN SCHIZOPHRENIA. 

185194 03-08 
INFLUENCE OF FLUPENTHIXOL AND FLUPENTHIXOL DECANOATE ON 
METHYLPHENIDATE AND APOMORPHINE INDUCED COMPULSIVE 
GNAWING IN MICE. 

186371 03-04 
FLUPHENAZINE 

ROLE OF FLUPHENAZINE DECANOATE IN LESSENING THE BURDEN OF 
CHRONIC SCHIZOPHRENICS ON THE COMMUNITY. 

169438 01-08 
EXPERIENCES WITH FLUPHENAZINE ENANTHATE IN LONG-STAY 
HOSPITALISED SCHIZOPHRENICS. 

171985 01-08 
ASSESSMENT OF ANATENSOL (FLUPHENAZINE ENANTHATE) INJECTABLE 
IN THE TREATMENT OF SCHIZOPHRENIA. 

172444 01-08 
AN ACCOUNT OF THE USE OF FLUPHENAZINE SINCE THE ESTABLISHMENT 
OF PSYCHIATRY AS A SEPARATE DISCIPLINE. 

176431 02-11 
EXAMINATION OF THE METHODS OF USING FLUPHENAZINE ENANTHATE. 

176469 02-08 
A DOUBLE-BLIND COMPARISON OF FLUPHENAZINE AND HALOPERIDOL IN 
OUTPATIENT SCHIZOPHRENIC CHILDREN. 

177754 02-08 
CLINICAL EXPERIENCE WITH FLUPHENAZINE ENANTHATE. 

178021 02-08 
FURTHER EXPERIENCE WITH FLUPHENAZINE ENANTHATE INJECTION. 

180153 02-08 
EXPERIENCES WITH FLUPHENAZINE ENANTHATE IN LONG-STAY 

HOSPITALIZED SCHIZOPHRENICS. 

180154 02-08 
PHARMACOLOGICAL DIFFERENCES BETWEEN FLUPHENAZINE ENANTHATE 

AND ITS HYDROCHLORIDE. 

182634 03-02 
FEATURES OF THE THERAPEUTIC EFFECT OF FLUPHENAZINE DECANOATE 
IN SCHIZOPHRENIA. 

183683 03-08 



IMPLICATIONS OF SUSTAINED RELEASE PHENOTHIAZINES: A STUDY OF 
FLUPHENAZINE DECANOATE. 

185007 03-09 
ON THE CLINICAL EFFECT OF FLUPHENAZINE ENANTHATE IN OUTPATIENT 
SCHIZOPHRENICS. 

185213 03-06 
FLUPHENAZINES 

SIDE-EFFECTS OF DEPOT FLUPHENAZINES. 

188312 04-15 
FLURAZEPAM 

THE RESIDUAL EFFECTS OF FLURAZEPAM. 

168831 01-14 
BLOOD LEVEL PROFILE IN MAN FOLLOWING CHRONIC ORAL 
ADMINISTRATION OF FLURAZEPAM HYDROCHLORIDE. 

169817 01-13 
THE EFFECTS OF DALMANE (FLURAZEPAM HYDROCHLORIDE) ON THE 
CONTINGENT NEGATIVE VARIATION. (AMSTERDAM). 

177645 02-16 
CENTRAL NERVOUS ACTION OF FLURAZEPAM, A NEW BENZODIAZEPINE 
DERIVATIVE. 

182549 03-03 
THE EFFECT OF FLURAZEPAM ON THE PHOTOPALPEBRAL REFLEX. 

184314 03-13 
FLUSPIRILENE 

CLINICAL EVALUATION OF FLUSPIRILENE AS A MAINTENANCE THERAPY 
IN CHRONIC SCHIZOPHRENIC PATIENTS. 

168320 01-08 
FLUSPIRILENE, A LONG-ACTING INJECTABLE NEUROLEPTIC. 

183199 03-11 
CLINICAL EXPERIMENT WITH A LONG-ACTING NEUROLEPTIC: 

FLUSPIRILENE (R6218). 

183200 03-15 
FLUXES 

EFFECT OF SELECTED BETA-DIKETONES ON LITHIUM FLUXES OF BOVINE 
RED BLOOD CELLS. 

171792 01-05 
FOCAL 

CARBAMAZEPINE SOLE ANTICONVULSANT FOR FOCAL EPILEPSY OF 
CHILDHOOD. 

189174 04-11 
FOLLICULITIS 

LITHIUM INDUCED FOLLICULITIS. 

169492 01-15 
FOOD 

EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS. 

169467 01-03 
DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) DOSE EFFECTS 
COMPARED ON THREE SCHEDULES OF FOOD REINFORCED OPERANT 
PERFORMANCE. 

182191 02-04 
EFFECTS OF MORPHINE, CODEINE AND NALOXONE ON FOOD AND 
CODEINE REINFORCED RESPONDING IN THE RHESUS MONKEY. 

182195 02-04 
INVERSION BY APOMORPHINE OF THE TENDENCY OF FEMALE RATS TO 
BE DEFEATED BY AAALES WHEN COMPETING FOR FOOD IN A STRAIGHT 
RUNWAY. 

184212 03-04 
THE EFFECTS OF CHRONIC TREATMENT WITH D-AMPHETAMINE ON FOOD 
INTAKE, BODYWEIGHT, LOCOMOTOR ACTIVITY AND SUBCELLULAR 
DISTRIBUTION OF THE DRUG IN RAT BRAIN. 

185931 03-03 
EFFECTS OF METHAMPHETAMINE ON FIXED-RATIO RESPONDING OF FOOD 
SATIATED AND FOOD DEPRIVED RATS. 

185957 03-04 
INDEPENDENCE OF THE EFFECTS OF D-AMPHETAMINE AND FOOD 
DEPRIVATION OR BODYWEIGHT ON THE FOOD CONSUMPTION OF 
RATS. 

186376 03-06 
DIAZEPAM-INDUCED EATING AND LEVER PRESSING FOR FOOD IN SATED 
RATS. 

186613 03-04 
INTERACTION OF D-AMPHETAMINE WITH CENTRAL NERVOUS SYSTEM 
DEPRESSANTS ON FOOD INTAKE AND SPONTANEOUS MOTOR 
ACTIVITY OF MICE. 

189613 04-04 
EFFECTS OF DELTA9-THC ON FOOD AND WATER INTAKE OF DEPRIVATION 
EXPERIENCED RATS. 

191375 04-04 
EFFECTS OF D-AMPHETAMINE, MORPHINE AND CHLORPROMAZINE ON 
RESPONDING UNDER FIXED-INTERVAL SCHEDULES OF FOOD 
PRESENTATION OR ELECTRIC SHOCK PRESENTATION. 

191767 04-03 
BEHAVIORAL EFFECTS OF COCAINE COMPARED UNDER TWO SCHEDULES 
OF FOOD PRESENTATION IN THE SQUIRREL MONKEY. 

191916 04-04 



S-105 



Subject Index 

NALTREXONE AND NALOXONE: AGONIST AND ANTAGONIST EFFECTS ON 
KEY-PRESS RESPONDING OF PIGEONS MAINTAINED UNDER A MULTIPLE 
SCHEDULE OF FOOD PRESENTATION. 

191926 04-04 
EFFECTS OF PHENCYCLIDINE AND KET AMINE ON FOOD MAINTAINED 
BEHAVIOR IN THE PIGEON. 

191973 04-04 
FOOTSHOCK 

EFFECTS OF BUFOTENINE AND P-CHLOROPHENYLALANINE ON REACTIVITY 
TO FOOTSHOCK. 

184838 03-04 

FORCED 

RELUCTANCE OF RATS TO DRINK HASHISH SUSPENSIONS: FREE-CHOICE 
AND FORCED CONSUMPTION, AND THE EFFECTS OF HYPOTHALAMIC 
STIMULATION. 

186586 03-04 

FOREBRAIN 

EFFECTS OF CHLORPROMAZINE, CHLORDIAZEPOXIDE AND 

PENTOBARBITAL ON NEURONAL EXCITABILITY IN THE MEDIAL 
FOREBRAIN BUNDLE DURING SELF-STIMULATION BEHAVIOR. 

1 77837 02-04 
INTRACRANIAL SELF-STIMULATION IN RATS AS A FUNCTION OF 
VARIOUS STIMULUS PARAMETERS: IV. INFLUENCE OF AMPHETAMINE 
ON MEDIAL FOREBRAIN BUNDLE STIMULATION WITH MONOPOLAR 
ELECTRODES. 

185961 03-04 
THE EFFECT OF P-CHLOROPHENYLALANINE ON FOREBRAIN TRYPTOPHAN 
HYDROXYLASE IN RATS WITH LESIONS IN THE RAPHE NUCLEUS. 

188750 04-03 
INFLUENCE OF PSYCHOTROPIC DRUGS ON AGGRESSIVENESS EVOKED BY 
DESTRUCTION OF ISOLATED STRUCTURES OF THE FOREBRAIN. 

191788 04-04 
EFFECT OF CHRONIC TREATMENT WITH DESIPRAMINE (DMI) AND 
IPRINDOLE (IP) ON THE NOREPINEPHRINE (NE) SENSITIVE ADENYLATE 
CYCLASE SYSTEM IN SLICES OF THE RAT LIMBIC FOREBRAIN. 

192003 04-03 
FORMATION 

AMITRIPTYLINE IN MAN: DECREASED FORMATION OF CENTRAL 5- 
HYDROXYINDOLEACETIC ACID. 

177736 02-13 
STUDIES ON BENZ0DIAZEPIN00XA20LES. IV. THE FORMATION OF 
QUINOLONES BY THE RING CONTRACTION OF A 
BENZODIAZEPINOOXAZOLE DERIVATIVE. 

180488 02-01 
THE EFFECT OF PSYCHOTROPIC AGENTS ON THE FORMATION OF 
AVOIDANCE REACTION IN ALBINO RATS DURING ELECTROPAIN 
STIMULATION OF ANOTHER RAT. 

183206 03-04 
FORMATION OF NORADRENALINE IN THE RAT BRAIN FROM THE FOUR 
STEREOISOMERS OF 3,4 DIHYDROXYPHENYLSERINE. 

184229 03-03 
THE ACTION OF D-AMPHETAMINE ON SPONTANEOUS ACTIVITY IN THE 
CAUDATE NUCLEUS AND RETICULAR FORMATION OF THE RAT. 

185264 03-03 
PHARMACOLOGICAL DISTINCTIONS BETWEEN ACTIVE AND PASSIVE 
AVOIDANCE MEMORY FORMATION AS SHOWN BY MANIPULATION OF 
BIOGENIC AMINE ACTIVE COMPOUNDS, 

185927 03-04 
A POSSIBLE MECHANISM FOR THE ANTISCHIZOPHRENIC ACTION OF 
CHLORPROMAZINE: INHIBITION OF THE FORMATION OF 
DIMETHYLTRYPTAMINE BY CHLORPROMAZINE METABOLITES. 

187576 04-03 
THE EFFECTS OF ACETYLCHOLINE AND OF SYNAPTIC STIMULATION ON 
THE SENSORIMOTOR CORTEX OF CATS. I. NEURONAL RESPONSES TO 
STIMULATION OF THE RETICULAR FORMATION. 

189855 04-03 
STEREOCHEMICAL ASPECTS AND METABOLITE FORMATION IN THE IN 
VIVO METABOLISM OF THE PSYCHOTOMIMETIC AMINE, 1-2,5- 
(DIMETHOXY-4-METHYLPHENYL) 2 AMINOPROPANE. 

190718 04-03 
FORMULATIONS 

MOLINDONE: A CROSSOVER EVALUATION OF CAPSULE AND TABLET 
FORMULATIONS IN SEVERELY ILL SCHIZOPHRENIC PATIENTS. 

174137 01-08 
FOUR-YEAR-OLD 

EFFECTS OF MEDICATION ON LEARNING IN HYPERACTIVE FOUR-YEAR- 
OLD CHILDREN. (ED.D DISSERTATION). 

172512 01-11 
FRACTIONS 

THE EFFECTS OF PSYCHIC STIMULANTS ON THE ACTIVITY OF POTASSIUM 
AND SODIUM ION STIMULATED ATPASE IN THE MICROSOMAL 
FRACTIONS OF THE BRAIN OF RATS. 

183518 03-01 
ENHANCED BINDING OF CHLORPROMAZINE TO CHOLESTEROL DEPLETED 
SYNAPTOSOME FRACTIONS. 

187801 04-03 



Psychopharmacology Abstract! 



FRACTURES 

DIAZEPAM USED INTRAVENOUSLY DURING REDUCTION OF FRACTURES 
AND DISLOCATIONS. 

174880 01-1 
FRAGMENTOGRAPHIC 

SIMULTANEOUS MASS FRAGMENTOGRAPHIC ASSAY OF NOREPINEPHRIN 
(NE), EPINEPHRINE (E) AND DOPAMINE (DA) IN RAT SYMPATHETIC 
GANGLION: EFFECTS OF DEXAMETHASONE IN NEWBORN AND ADULT 
RATS. (UNPUBLISHED PAPER). 

170747 Ol-C 
MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND IT 
HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD. 

186566 03-1 
FRAGMENTOGRAPHY 

MASS FRAGMENTOGRAPHY IN CLINICAL PSYCHOPHARMACOLOGY. 

169074 Ol-C 
FREE 

INCREASE IN THE PLASMA CONCENTRATION OF FREE TRYPTOPHAN 
CAUSED BY PROBENECID IN HUMANS. 

169470 01-1 
IMPORTANCE OF CATECHOLAMINE RELEASE BY NERVE IMPULSES FOR 
FREE OPERANT BEHAVIOR. 

171611 Ol-C 
THE EFFECTS OF CHRONIC RESERPINE AND NIALAMIDE TREATMENT ON 

THE FREE AMINO ACID LEVELS OF RAT BRAIN. 

187645 04-( 

FREE-CHOICE 

RELUCTANCE OF RATS TO DRINK HASHISH SUSPENSIONS: FREE-CHOICE 
AND FORCED CONSUMPTION, AND THE EFFECTS OF HYPOTHALAMIC 
STIMULATION. 

186586 03-( 
FREQUENCY 

EFFECTS OF SHORT-TERM VERSUS LONG-TERM L-DOPA THERAPY IN 
PARKINSONISM ON CRITICAL FLICKER FREQUENCY. 

177511 02- 
HIGH FREQUENCY OF DYSPHORIC REACTIONS TO 

TETRAHYDROCANNABINOL AMONG DEPRESSED PATIENTS. 

181274 02-( 
A FREQUENCY SHIFT IN THE HIPPOCAMPAL THETA ACTIVITY: AN 

ELECTRICAL CORRELATE OF CENTRAL ACTION OF ACTH ANALOGUES I 
THE DOG 

188166 04-( 

FROG 

ACTION OF CONVULSANTS ON ROOT POTENTIALS AND AMINO ACID 
RESPONSES IN ISOLATED FROG SPINAL CORD. (UNPUBLISHED PAPER) 

1 77976 02-1 
STUDIES ON CONVULSANTS IN THE ISOLATED FROG SPINAL CORD. I. 
ANTAGONISM OF AMINO ACID RESPONSES. (UNPUBLISHED PAPER) 

190727 04-( 
FRONTAL 

EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS. 

169467 01-1 
SHIFTING OF THE D-AMPHETAMINE DOSE-RESPONSE CURVE IN RATS 
WITH FRONTAL CORTICAL ABLATIONS. 

187261 04-1 
FRUSTRATION 

MODIFICATION OF THE FRUSTRATION EFFECT WITH DRUGS. 

181408 02-1 
FUMARATE 

PSYCHOLOGICAL EXPERIMENTATION ON THE EFFECTS OF PROPIRAM 
FUMARATE AND PROMETHAZINE UNDER NORMAL AND STRESS 
CONDITIONS. 

184617 03-1 
COMPARISON OF PSYCHOEXPERIMENTAL PERFORMANCE UNDER THE 

INFLUENCE OF THE ANALGESIC PROPIRAM FUMARATE. 

184618 03- 
FUNCTION 

POSSIBLE INVOLVEMENT OF CYCLIC NUCLEOTIDES IN THE STIMULATIOI 
OF PITUITARY FUNCTION ELICITED BY RESERPINE. (UNPUBLISHED 
PAPER). 

170086 01 J 

INTERRESPONSE TIME CHANGES AS A FUNCTION OF DEPRIVATION AND 
AMPHETAMINE ADMINISTRATION. 

171612 01-1 
EFFECTS OF CHRONIC PRETREATMENT WITH SMALL DOSES OF RESERPII 

UPON ADRENERGIC NERVE FUNCTION. 

1 77406 02- 
INTERACTION OF CENTRALLY ADMINISTERED OUABAIN WITH AGENTS 
AFFECTING SYMPATHETIC FUNCTION. 

1 78640 02-' 
CENTRAL DOPAMINE FUNCTION IN AFFECTIVE ILLNESS: EVIDENCE FRO^ 
PRECURSORS, ENZYME INHIBITORS AND STUDIES OF CENTRAL 
DOPAMINE TURNOVER. (UNPUBLISHED PAPER). 

181358 02- 



S-106 



w 



VOLUME 12, SUBJECT INDEX 

WORD RECOGNITION OF SCHIZOPHRENICS AS A FUNCTION OF 
PHENOTHIAZINE LEVEL AND AUTONOMIC RESPONSIVITY. (PH.D. 
DISSERTATION). „ _ „„ 

182524 03-08 

ANTIPSYCHOTIC ACTION OF NEUROLEPTIC AGENTS AND THE FUNCTION 
OF BASAL GANGLIA (SURVEY OF LITERATURE). 

183521 03-17 

DOPAMINE IN BRAIN FUNCTION. 

184329 03-03 
THE EFFECTS OF PHEN0THIA2INES ON ENDOCRINE FUNCTION: I. 
PATIENTS WITH INAPPROPRIATE LACTATION AND AMENORRHOEA. 

184436 03-15 
THE EFFECTS OF PHENOTHIAZINES ON ENDOCRINE FUNCTION: II. EFFECTS 

IN MEN AND POST-MENOPAUSAL WOMEN. 

184437 03-13 
INTRACRANIAL SELF-STIMULATION IN RATS AS A FUNCTION OF 

VARIOUS STIMULUS PARAMETERS: IV. INFLUENCE OF AMPHETAMINE 
ON MEDIAL FOREBRAIN BUNDLE STIMULATION WITH MONOPOLAR 
ELECTRODES. 

185961 03-04 
THE POSSIBLE ROLE OF TRYPTAMINE IN BRAIN FUNCTION AND ITS 
RELATIONSHIP TO THE ACTIONS OF LSD-LIKE HALLUCINOGENS. 

186024 03-12 
DIFFERENTIAL RECOVERY OF FUNCTION FOLLOWING CAUDATE, 
HIPPOCAMPAL, AND SEPTAL LESIONS IN MICE. 

186620 03-04 
EEC DRIVING RESPONSES AS A FUNCTION OF MONOAMINE OXIDASE. 

187149 03-13 
EFFECT OF ORAL ADMINISTRATION OF METHADONE ON HEPATIC 
MICROSOMAL MIXED FUNCTION OXIDASE ACTIVITY IN MICE. 

188178 04-03 
DRUG EFFECTS AND HYPOTHALAMIC ANTERIOR PITUITARY FUNCTION. 

188393 04-03 
PSYCHOENDOCRINE INVESTIGATION IN SCHIZOPHRENIA: RELATIONSHIP 
BETWEEN PITUITARY GONADAL FUNCTION AND BEHAVIOR. 

191190 04-14 
EFFECT OF ANESTHETIC AGENTS ON PERIPHERAL SYMPATHETIC NERVOUS 
SYSTEM FUNCTION AS MONITORED BY ARTERIAL PLASMA 
CATECHOLAMINE LEVELS. (UNPUBLISHED PAPER 

191495 04-03 
REGULATION OF FUNCTION OF TRYPTOPHAN HYDROXYLASE. 

191516 04-03 
CORTICAL AND/OR SUBCORTICAL EFFECTS AS A FUNCTION OF 
HALLUCINOGENIC DRUG STRUCTURE 

191936 04-03 

FUNCTIONAL 

TREMOR INDUCTION BY INTRACAUDATE INJECTIONS OF BRETYLIUM, 
TETRABENAZINE, OR MESCALINE: FUNCTIONAL DEFICITS IN CAUDATE 
DOPAMINE. 

167329 01-03 

FUNCTIONAL EVALUATION OF PITUITARY RESERVE IN PATIENTS WITH 
THE AMENORRHEA GALACTORRHEA SYNDROME UTILIZING 
LUTEINIZING HORMONE RELEASING HORMONE (LH-RH), L-DOPA AND 
CHLORPROMAZINE. 

175245 02-13 
STRUCTURAL FUNCTIONAL ORGANIZATION OF THE HUMAN BRAIN AND 
THE PATHOPHYSIOLOGY OF THE PARKINSONIAN TYPE HYPERKINESES. 

178787 02-13 
A SERIES OF MULTICENTRIC PILOT TRIALS WITH PIMOZIDE IN 

PSYCHIATRIC PRACTICE: III. PIMOZIDE IN THE TREATMENT OF STRESS 
INDUCED PSYCHIC AND FUNCTIONAL DISORDERS. 

183193 03-11 
PLASMA DOPA AND FUNCTIONAL OSCILLATIONS AFTER CHRONIC 
TREATMENT OF PARKINSONS DISEASE. 

188421 04-13 
EFFECTS OF PERINATAL EXPOSURE TO METHYL MERCURY ON 
FUNCTIONAL BRAIN DEVELOPMENT AND NEUROCHEMISTRY. 

189564 04-05 
THE ANTAGONISM BETWEEN CHOLINOMIMETIC AGONISTS AND BETA- 
ADRENOCEPTOR STIMULANTS: THE DIFFERENTIATION BETWEEN 
BETWEEN FUNCTIONAL AND METAFFINOID ANTAGONISM. 

191420 04-03 
FUNCTIONING 

CHANGES IN MENTAL FUNCTIONING ACCOMPANYING ANTIPSYCHOTIC 
DRUG THERAPY. 

171124 01-10 

FUNCTIONS 

EMOTIONAL FUNCTIONS IN SHORT-TERM VS. LONG-TERM L-DOPA 
THERAPY IN PARKINSONISM. 

168619 01-15 
EFFECT OF CHRONIC TREATMENT WITH CENTRAL STIMULANTS ON BRAIN 
MONOAMINES AND SOME BEHAVIOURAL AND PHYSIOLOGICAL 
FUNCTIONS IN RATS, GUINEA-PIGS, AND RABBITS. 

191503 04-03 
A PHARMACOLOGICAL MODEL WITH RHESUS MONKEYS FOR THE 
PREDICTION OF SELECTIVE DEPRESSION OF PSYCHIC FUNCTIONS. 

192424 04-04 



Subject Index 



FUROSEMIDE 

ENHANCED RENAL TUBULAR SECRETION OF MEPROBAMATE: ROLE OF 
SALINE FUROSEMIDE DIURESIS. 

184243 03-03 

FUROXANOBENZOFUROXAN 

FUROXANOBENZOFUROXAN, A SELECTIVE MONOAMINE OXIDASE 
INHIBITOR. 

188770 0401 

FUSARIC 

BEHAVIORAL EFFECTS OF A NEW DOPAMINE-BETA-HYDROXYLASE 
INHIBITOR (FUSARIC ACID) IN MAN. (UNPUBLISHED PAPER 

174329 01-09 

FX-703 

CLINICAL EXPERIENCES WITH FLUPENTHIXOL (FX-703). 

1 78224 02-08 
G-33040 

ACTION OF OPIPRAMOL (G- 33040) IN DEPRESSIVE SYNDROMES IN 
CHILDREN AND ADOLESCENTS. 

182432 03-10 

GABA 

LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND GAMMA-AMINOBUTYRIC 
ACID (GABA) INTERACTION ON SPONTANEOUS POTENTIALS AND THE 
EVOKED RESPONSE IN THE AVIAN TECTUM. 

169689 01-03 
ANTAGONISM OF THE EFFECTS OF CHLORPROMAZINE AND MORPHINE 
ON DOPAMINE METABOLISM BY GABA 

1 76870 02-03 
ANALYSIS OF DRUG BLOCK OF LSD/5-HT/GABA BY MONITORING 
NEURONAL MEMBRANE CHANGES. 

182143 02-03 
EFFECT OF GAMMA-AMINOBUTYRIC ACID (GABA) ON MORPHINE 
ANALGESIA, TOLERANCE AND PHYSICAL DEPENDENCE 

182231 03-03 
EFFECT OF PENTOBARBITAL ON UPTAKE AND RELEASE OF (3H)GABA AND 
(14C)GLUTAMATE BY BRAIN SLICES. 

189031 04-03 
GAIN 

WEIGHT GAIN IN LITHIUM TREATED RATS 

174133 01-04 
EFFECT OF A CARNITINE CYPROHEPTADINE COMBINATION ON ANOREXIA 
AND WEIGHT GAIN IN CHILDREN. 

178811 02-10 
GALACTORRHEA 

FUNCTIONAL EVALUATION OF PITUITARY RESERVE IN PATIENTS WITH 
THE AMENORRHEA GALACTORRHEA SYNDROME UTILIZING 
LUTEINIZING HORMONE RELEASING HORMONE (LH-RH). LDOPA AND 
CHLORPROMAZINE 

175245 02-13 

GALENIC 

A FEW GALENIC METHOD TO PROLONG THE ACTION OF LITHIUM 
SULFATE. 

180700 02-15 

GAMAAA 

(3H) OUABAIN BINDING TO NA.-ATPASE AND K.-ATPASE: INHIBITION BY 
BETA, GAMMA METHYLENE ATP 

182184 02-03 

GAMMA-AMINOBUTYRIC 

LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND GAMMA-AMINOBUTYRIC 
ACID (GABA) INTERACTION ON SPONTANEOUS POTENTIALS AND THE 
EVOKED RESPONSE IN THE AVIAN TECTUM. 

169689 01-03 
EFFECT OF GAMMA-AMINOBUTYRIC ACID (GABA) ON MORPHINE 
ANALGESIA, TOLERANCE AND PHYSICAL DEPENDENCE. 

182231 03-03 
THE ROLE OF GAMMA-AMINOBUTYRIC ACID AS A MEDIATOR OF 
POSITIVE DORSAL ROOT POTENTIALS. 

1 89832 04-03 
THE EFFECT OF INCREASED GAMMA-AMINOBUTYRIC ACID ON ALPHA- 
METHYLTYROSINE INDUCED DECREASE IN CATECHOLAMINES IN RAT 
BRAIN. 

191988 04-03 
GAMMA-BUTYROLACTONE 

DOPAMINERGIC INHIBITION OF STRIATAL CHOLINERGIC NEURONS: 
SYNERGISTIC BLOCKING ACTION OF GAMMA-BUTYROLACTONE AND 
NEUROLEPTIC DRUGS. 

189602 04-03 
GAAAMA-HYDROXYBUTYRATE 

EFFECT OF MORPHINE ON REGIONAL LEVELS OF GAMMA- 
HYDROXYBUTYRATE IN MOUSE BRAIN. 

187077 03-03 
GAMAAA-HYDROXYBUTYRIC 

INFLUENCES OF DRUGS ON THE INCREASES IN BRAIN DOPAMINE 
PRODUCED BY AXOTOMY OF GAMMA-HYDROXYBUTYRIC ACID 
(GHBA). 

171622 01-03 

GAMAAA-LABELLED 

DDT EFFECT ON 32P INCORPORATION FROM GAMMA-LABELLED ATP 
INTO PROTEINS FROM LOBSTER NERVE. 

191315 04-03 



S-107 



Subject Index 



Psychopharmacology Abstracts 



GAMMA-P-FLUOROBENZOYLPROPYl 

ANTIHYPERTENSIVE AND CENTRAL NERVOUS SYSTEM DEPRESSANT 
PROPERTIES OF 3-(GAMMA-P-FLU0R0BENZ0YLPR0PYL) 2,3,4,4A,5,6 
HEXAHYDROPYRAZINOQUINOLINE HYDROCHLORIDE (COMPOUND-69- 
183, CENTPYRAQUIN). 

176881 02-03 
GANGLIA 

TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. (UNPUBLISHED PAPER). 

170876 01-03 
ANTIPSYCHOTIC ACTION OF NEUROLEPTIC AGENTS AND THE FUNCTION 
OF BASAL GANGLIA (SURVEY OF LITERATURE). 

183521 03-17 
EFFECTS OF PROLONGED LSD-25 ADMINISTRATION UPON NEURONS OF 
SPINAL CORD GANGLIA TISSUE CULTURES. 

185112 03-03 
DIAZEPAM INHIBITION OF POST-TETANIC POTENTIATION IN BULLFROG 
SYMPATHETIC GANGLIA: POSSIBLE ROLE OF PROSTAGLANDINS. 

186673 03-03 
GANGLION 

SIMULTANEOUS MASS FRAGMENTOGRAPHIC ASSAY OF NOREPINEPHRINE 
(NE), EPINEPHRINE (E) AND DOPAMINE (DA) IN RAT SYMPATHETIC 
GANGLION: EFFECTS OF DEXAMETHASONE IN NEWBORN AND ADULT 
RATS. (UNPUBLISHED PAPER). 

170747 01-03 
THE ACTIONS OF SEVERAL PSYCHOACTIVE AGENTS UPON THE 

MUSCARINIC MECHANISMS IN THE SUPERIOR CERVICAL GANGLION OF 
THE CAT. 

183866 03-03 
THE EFFECTS OF 5-HYDROXYTRYPTAMINE AND SOMf RELATED 

COMPOUNDS ON THE CAT SUPERIOR CERVICAL GANGLION IN SITU. 

184197 03-03 
THE EFFECTS OF VARIOUS NICOTINE-LIKE AGENTS IN THE CAT SUPERIOR 
CERVICAL GANGLION IN SITU. 

184202 03-03 
THE EFFECTS OF LITHIUM ON HIGH ENERGY PHOSPHATE AND GLUCOSE 
LEVELS IN THE RAT SUPERIOR CERVICAL GANGLION. 

187677 04-03 
LIPIDOSISLIKE ALTERATIONS IN DORSAL ROOT GANGLION CELLS OF 
RATS TREATED WITH TRICYCLIC ANTIDEPRESSANTS. 

189605 04-03 
PHARMACOLOGICAL ALTERATIONS IN THE STIMULUS INDUCED RELEASE 
OF NOREPINEPHRINE FROM THE RABBIT SUPERIOR CERVICAL 
GANGLION. 

191896 04-03 
GAS 

GAS CHROMATOGRAPHIC - MASS SPECTROMETRIC STUDIES ON 
TRICYCLIC PSYCHOTROPIC DRUGS. 

169073 01-01 
A SENSITIVE GAS CHROMATOGRAPHIC PROCEDURE FOR THE 
ESTIMATION OF NORADRENALINE, DOPAMINE AND 5- 
HYDROXYTRYPTAMINE IN RAT BRAIN. 

171971 01-01 
GAS CHROMATOGRAPHIC DETERMINATION OF METHAQUALONE IN 
SMALL AMOUNTS OF SERUM AFTER INGESTION OF THERAPEUTIC 
DOSES. 

172397 01-16 
GAS CHROMATOGRAPHIC ANALYSIS OF BENZODIAZEPINES. PART I: 
MEDAZEPAM AND ITS METABOLITES. 

178948 02-06 
A GAS CHROMATOGRAPHIC METHOD FOR THE QUANTITATIVE 
ESTIMATION OF NHYDROXYPHENTERMINE. 

182203 02-06 
GASES 

DIAZEPAM AND MEPERIDINE ON ARTERIAL BLOOD GASES IN HEALTHY 
VOLUNTEERS. 

190147 04-13 
GASTRIC 

DRUG EFFECTS ON GASTRIC ULCERATION RATE IN THE RAT. 
(UNPUBLISHED PAPER). 

176307 02-03 
INCREASED GASTRIC ACID DURING SHOCK AVOIDANCE IN MAN. 

181879 02-13 
EFFECTS OF SCOPOLAMINE METHYLBROMIDE ON SHOCK-INDUCED 
GASTRIC LESIONS IN THE UNRESTRAINED RAT. 

189381 04-03 
GATE 

ATTACK ON THE GATE THEORY OF PAIN. 

189610 04-17 
GENERALIZATION 

DISCRIMINATIVE CONTROL Of BEHAVIOR BY ELECTRICAL STIMULATION 
OF THE DORSAL RAPHE NUCLEUS: GENERALIZATION TO LYSERGIC 
ACID DIETHYLAMIDE (LSD). 

191944 04-04 



GENERALIZED 

GENERALIZED PENICILLIN EPILEPSY IN THE CAT: EFFECTS OF 

INTRACAROTID AND INTRAVERTEBRAL PENTYLENETETRAZOL AND 
AMOBARBITAL INJECTIONS. 

188374 04-03 
GENERATED 

THE EFFECTS OF L-DELTA9-TRANS-TETRAHYDR0CANNABIN0L ON LOW 
AND HIGH RESPONSE RATES GENERATED UNDER TWO SIMILAR 
CONDITIONS (PH.D. DISSERTATION). 

168230 01-04 
GENERIC 

BIOEQUIVALENCY OF GENERIC AND BRAND-NAMED CHLORPROMAZINE. 

187255 03-08 
GENETIC 

GENETIC EFFECTS OF LSD. 

1 75043 02-04 
CHLORPROMAZINE AND AVOIDANCE: A GENETIC ANALYSIS. 

185751 03-03 
GENETICAUY 

THE EFFECTS OF CHLORDIAZEPOXIDE, AMPHETAMINE AND COCAINE ON 
BAR-PRESS BEHAVIOR IN NORMAL AND GENETICALLY NERVOUS DOGS. 

187868 04-04 
PSYCHOPHARMACOLOGIC FACILITATION OF OPERANT CONDITIONING OF 
GENETICALLY NERVOUS CATAHOULA AND POINTER DOGS. 

190696 04-04 
GENICULATE 

LSD EFFECTS ON SIGNAL-TO-NOISE RATIO AND LATERALIZATION OF 
VISUAL CORTEX AND LATERAL GENICULATE DURING PHOTIC 
STIMULATION. 

167449 01-03 
PGO WAVES IN THE LATERAL GENICULATE NUCLEUS TRIGGERED BY 
BARBITURATE. 

187835 04-03 
GENOTYPE 

INTERACTION AMONG GENOTYPE, UNCONDITIONED STIMULUS, D- 
AMPHETAMINE, AND ONE-WAY AVOIDANCE BEHAVIOR OF RATS. 

187702 04-04 
GENTLE 

RAPID AND GENTLE PHARMACOTHERAPY OF DEPRESSION. 

174495 01-10 
GEOCHELONE-CARBONARIA 

EFFECT OF ATROPINE SULFATE ON THE SLEEP RELATED EEG SPIKE 
ACTIVITY OF THE TORTOISE, GEOCHELONE-CARBONARIA. 

191389 04-03 
GEOMETRIC 

THE EFFECTS OF SCOPOLAMINE ON PERFORMANCE ON A GEOMETRIC 
PROGRESSIVE RATIO SCHEDULE. 

190334 04-04 
GERIATRIC 

LORAZEPAM VERSUS GLUTETHIMIDE AS A SLEEP INDUCING AGENT FOR 
THE GERIATRIC PATIENT. 

167496 01-11 
CAUDATE NUCLEUS EFFECTS ON GERIATRIC SENILITY: EFFECT OF 

BELLADONNA ON LEARNING AND MEMORY OF GERIATRIC PATIENTS. 

170744 01-11 
SAFETY AND EFFICACY OF ZINC SULFATE IN GERIATRIC PATIENTS. 

184177 03-11 
POLYMYALGIA RHEUMATICA IN A GERIATRIC DEPARTMENT: NINE 
PATIENTS WITH AN AVERAGE AGE OF 83 YEARS. 

187236 03-11 
TARDIVE DYSKINESIA AND DRUG THERAPY IN GERIATRIC PATIENTS. 

189923 04-13 
DIFFERENTIAL EFFECTS OF TRAZODONE IN DEPRESSED, SCHIZOPHRENIC 
AND GERIATRIC PATIENTS. 

191138 04-14 
GERIATRICS 

PSYCHOPHARMACOLOGY AND GERIATRICS. 

176438 02-17 
GEROVITAL-H3 

GER0VITAL-H3 IN THE TREATMENT OF THE DEPRESSED AGING PATIENT. 

177373 02-11 
A TRIAL OF GER0VITAL-H3 IN DEPRESSION DURING SENILITY. 

181957 02-10 
PROCAINE (GER0VITAL-H3) THERAPY: MECHANISM OF INHIBITION OF 
MONOAMINE OXIDASE. 

191281 04-03 
PHARMACOLOGY OF DEPRESSION IN THE AGED: EVALUATION OF 
GER0VITAL-H3 AS AN ANTIDEPRESSANT DRUG. 

192229 04-09 
GESTATION 

DECREASED EFFECT OF PHENOBARBITAL TREATMENT ON MICROSOMAL 
DRUG METABOLIZING ENZYME ACTIVITY DURING GESTATION. 

184228 03-03 
GHBA 

INFLUENCES OF DRUGS ON THE INCREASES IN BRAIN DOPAMINE 
PRODUCED BY AXOTOMY OF GAMMA-HYDROXYBUTYRIC ACID 
(GHBA). 

171622 01-03 



S-108 



VOLUME 12, SUBJECT INDEX 



Subject Index 



GIUES-OE-lA-TOUREnE 

TIC DE GILLES-OE-LA-TOURETTE: CASE REPORT AND BRIEF DISCUSSION. 

181158 02-09 
GIUES-DE-LA-TOUREnES 

DOPAMINE AND GILLES-DE-LA-TOURETTES SYNDROME. 

188431 04-11 
GINSENG 

THE EFFECT OF PANAX GINSENG SAPONIN ON THE CENTRAL NERVOUS 
SYSTEM IN RAT: THE PSYCHOPHARMACOLOGICAL EFFECT OF 
GINSENG. 

171599 01-04 

GLAUCOMA 

ECT, GLAUCOMA, AND PROLONGED APNEA. 

GLC 



187837 04-15 



GLC DETERMINATION OF MEPROBAMATE IN WATER, PLASMA AND 
URINE. 

185977 03-16 
GLUCOSE 

THE EFFECTS OF LITHIUM ON HIGH ENERGY PHOSPHATE AND GLUCOSE 
LEVELS IN THE RAT SUPERIOR CERVICAL GANGLION. 

187677 04-03 
THE EFFECTS OF AMPHETAMINE SULFATE ON THE DIURNAL RHYTHMS OF 
MIDBRAIN; CORTEX, NOREPINEPHRINE; SEROTONIN AND BLOOD 
GLUCOSE LEVELS IN THE MOUSE. 

191918 04-03 
GLUTAMATE 

EFFECT OF PENTOBARBITAL ON UPTAKE AND RELEASE OF (3H)GABA AND 
(MOGLUTAMATE BY BRAIN SLICES. 

189031 04-03 
GLUT AMINE 

ONGOING INVESTIGATIONS OF CEREBRAL GLUTAMINE EXCRETION 
SCHIZOPHRENICS DURING TREATMENT WITH NEUROLEPTIC. 

174101 01-08 
GLUTETHIMIDE 

LORAZEPAM VERSUS GLUTETHIMIDE AS A SLEEP INDUCING AGENT FOR 
THE GERIATRIC PATIENT. 

167496 01-11 
GLYCOGEN 

THE INFLUENCE OF ALDOSTERONE OR METHAMPHETAMINE ON LIVER 
GLYCOGEN DEPOSITION OF MICE STRESSED BY LONG-TERM 
ISOLATION. 

182105 02-03 
GLYCOPEPTIDE 

CONVULSION PRODUCING PROPERTY OF THE DIALYZABLE GLYCOPEPTIDE 
PREPARATION FROM WHOLE RAT BRAIN. 

181815 02-03 
GMP 

EFFECTS OF DECAPITATION, ETHER AND PENTOBARBITAL ON CYCLIC 
AMP AND CYCLIC GMP LEVELS IN RAT TISSUES. 

182154 02-03 
GNAWING 

PHARMACOKINETIC DISPOSITION OF NORAPOMORPHINE DERIVATIVES 
AND ITS INFLUENCE ON THE ELICITATION OF STEREOTYPICAL 
GNAWING. (PH.D. DISSERTATION). 

174960 01-03 
INHIBITION OF THE APOMORPHINE GNAWING COMPULSION BY 
AMANTADINE. 

176879 02-04 
SELECTIVE BLOCKADE OF APOMORPHINE INDUCED AGGRESSION AND 
GNAWING FOLLOWING FENFLURAMINE OR RAPHE LESIONS IN THE 
RAT 

182128 02-04 
DISPOSITION OF NORAPOMORPHINE AND N,N PROPYLNORAPOMORPHINE 
IN MOUSE BRAIN AND ITS CORRELATION WITH STEREOTYPED 
GNAWING BEHAVIOR. 

182131 02-04 
INFLUENCE OF FLUPENTHIXOL AND FLUPENTHIXOL DECANOATE ON 
METHYLPHENIDATE AND APOMORPHINE INDUCED COMPULSIVE 
GNAWING IN MICE. 

186371 03-04 
GOLDFISH 

MODIFICATION OF LEARNING AND MEMORY IN GOLDFISH THROUGH THE 
USE OF STIMULANT AND DEPRESSANT DRUGS. 

186583 03-04 
GONADAL 

EFFECTS OF CHRONICALLY ADMINISTERED DELTAl- 

TETRAHYDROCANNABINOL OF ADRENAL AND GONADAL ACTIVITY OF 
MALE RATS. 

183358 03-03 
PSYCHOENDOCRINE INVESTIGATION IN SCHIZOPHRENIA: RELATIONSHIP 
BETWEEN PITUITARY GONADAL FUNCTION AND BEHAVIOR. 

191190 04-14 
GRADED 

COMPARISON OF GRADED SINGLE INTRAMUSCULAR DOSES OF 
MORPHINE AND PENTOBARBITAL IN MAN. 

187254 03-15 



GRADUAL 

EXCITABILITY CHANGES DURING THE GRADUAL DEVELOPMENT OF AND 
RECOVERY FROM PENTYLENETETRAZOL AND STRYCHNINE INDUCED 
CONVULSIONS IN THE CAT. 

191927 04-03 
GRAY 

ANALGESIA AND HYPERREACTIVITY PRODUCED BY INTRACRANIAL 
MICROINJECTIONS OF MORPHINE INTO THE PERIAQUEDUCTAL GRAY 
MATTER OF THE RAT. 

191367 04-04 
NEUROCHEMICAL ANALYSIS OF AGGRESSIVE - DEFENSIVE BEHAVIOR 
ELICITED BY ELECTRICAL STIMULATION OF THE HYPOTHALAMUS AND 
CENTRAL GRAY MATTER. 

191784 04-02 
GROUP 

L-DOPA IN 122 CASES OF PARKINSONS DISEASE AT AGE 70 OR OVER. A 
COMPARATIVE STUDY WITH A GROUP OF PATIENTS AGED 41 TO 69 
YEARS. 

168369 01-11 
THE EFFECT OF MARIJUANA ON HOSTILITY IN AN EXPERIMENTAL GROUP 
SETTING: PRELIMINARY OBSERVATIONS. 

169086 01-14 
IMIPRAMINE, DIAZEPAM AND GROUP PSYCHOTHERAPY IN LONG-TERM 
TREATMENT OF DEPRESSIVE NEUROTICS. 

169089 01-10 
DRUGS AND GROUP PSYCHOTHERAPY IN NEUROTIC DEPRESSION. 

171925 01-10 
SELF-STIMULATION OF NORADRENERGIC CELL GROUP (A6) IN LOCUS- 
COERULEUS OF RATS. 

173029 01-03 
TRIFLUPERIDOL - A CONTROLLED CLINICAL TRIAL ON A GROUP OF 
SCHIZOPHRENIC PATIENTS. 

174587 01-08 
EFFECTS OF PSYCHOACTIVE DRUGS ON NONVERBAL COMMUNICATION 
AND GROUP SOCIAL BEHAVIOR OF MONKEYS. 

175317 02-04 
THE DYNAMICS OF A GROUP IN PSYCHOTHERAPY. 

180140 02-12 
THE USE OF HALLUCINOGENS IN GROUP PSYCHOTHERAPY 

180144 02-12 
PROPHYLACTIC EFFICACY OF LITHIUM CARBONATE IN MANIC- 
DEPRESSIVE ILLNESS: REPORT OF THE VETERANS ADMINISTRATION 
AND NATIONAL INSTITUTE OF MENTAL HEALTH (VA-NIMH) 
COLLABORATIVE STUDY GROUP. 

189735 04-09 
GROUPS 

A METHOD FOR ANALYZING CNS EFFECTS OF DRUGS AND BRAIN 
LESIONS ON PERMANENT GROUPS OF RATS. 

1 76867 02-06 
MEDICATION GROUPS FOR CONTINUING CARE. 

189640 04-17 
GROWTH 

GROWTH HORMONE RESPONSES TO ADMINISTRATION OF L-5- 

HYDROXYTRYPTOPHAN (L-5-HTP) IN MANIC-DEPRESSIVE PSYCHOSES. 

167919 01-09 
INHIBITION OF GROWTH IN ANIMALS TREATED WITH METHADONE. 

182164 02-03 
THE EFFECT OF ZINC N TETRACOSACTRIN ON GROWTH HORMONE 
RELEASE DURING SLEEP. 

183490 03-13 
ROLE OF DOPAMINERGIC MECHANISMS IN REGULATION OF GROWTH 
HORMONE AND PROLACTIN SECRETION IN MAN. 

188428 04-13 
INHIBITION OF THE SLEEP RELATED PEAK IN PHYSIOLOGIC HUMAN 
GROWTH HORMONE RELEASE BY SOMATOSTATIN. 

190104 04-13 
DISSOCIATION OF GROWTH HORMONE AND PROLACTIN SECRETION IN 
PARKINSONS DISEASE FOLLOWING CHRONIC L-DOPA THERAPY 

191233 04-13 
RETARDATION OF TUMOR GROWTH BY DELTA9- 
TETRAHYDROCANNABINOL (DELTA9-THC). 

191963 04-03 
GSR 

MARIJUANA DIMINISHES GSR ACTIVATION PEAKING 

181887 02-13 
GUAM 

PARKINSONISM DEMENTIA OF GUAM: TREATMENT WITH LEVODOPA 
AND L-ALPHA-METHYLDOPAHYDRAZINE. 

179996 02-13 
GUANETHIDINE 

ADRENALINE, NORADRENALINE AND DOPAMINE LEVELS IN BRAIN AND 
HEART AFTER ADMINISTRATION OF 6-HYDROXYDOPAMINE AND 
GUANETHIDINE TO NEWBORN MICE. 

1 77338 02-03 
EFFECTS OF GUANETHIDINE AND IMIDAZOLE ON HISTAMINE RESPONSE. 

187799 04-03 






S-109 



Subject Index 



Psychopharmacology Abstracts 



GUANOSINE 

NEUROCHEMICAL ROLE OF ADENOSINE 3,5 CYCLIC MONOPHOSPHATE 
AND GUANOSINE 3,5 CYCLIC MONOPHOSPHATE AND THEIR RELATION 
TO NEUROTRANSMITTERS; EFFECT OF TETRAHYDROCANNABINOLS. 
(PH.D. DISSERTATION). 

185582 03-03 
GUESSING 

DRUGS AND PLACEBOS: DRUG GUESSING BY NORMAL VOLUNTEERS. 

174210 01-14 
GUIDE 

A GUIDE FOR DRUG USE IN DEPRESSIVE DISORDERS. 

171923 01-09 
GUIDELINES 

GUIDELINES FOR ANTIPSYCHOTIC DRUG USE. 

186191 03-09 
GUINEA-PIG 

IN VIVO 3H-PR0CHL0RPERAZINE METABOLISM IN THE GUINEA-PIG AND 
RABBIT. 

173875 01-03 
EFFECT OF PROCAINE, LIDOCAINE AND PENTOBARBITAL ON ELECTRICAL 
ACTIVITY OF GUINEA-PIG OLFACTORY CORTEX IN VITRO. 

182092 02-03 
THE EFFECT OF CATECHOLAMINES, ACETYLCHOLINE AND SEROTONIN ON 
THE MORPHINE TOLERANT LONGITUDINAL MUSCLE STRIP OF THE 
GUINEA-PIG ILEUM. 

182161 02-03 
SEPARATION OF THE DEPENDENCE PRODUCING ACTIONS FROM THE 

DIRECT ACTIONS OF NARCOTICS ON GUINEA-PIG ILEUM. 

182162 02-03 
SPECIFICITY OF BLOCKADE OF THE NICOTINE INDUCED RELEASE OF 3H- 

NOREPINEPHRINE FROM ADRENERGIC NEURONS OF THE GUINEA-PIG 
HEART BY VARIOUS PHARMACOLOGICAL AGENTS. 

186676 03-03 
INTERACTION BETWEEN SEROTONIN AND MORPHINE IN THE GUINEA-PIG 
ILEUM. 

186698 03-03 
ALPHA-L-ACETYLMETHADOL AND ITS N-DEMTHYLATED METABOLITES 
HAVE POTENT OPIATE ACTION IN THE GUINEA-PIG ISOLATED ILEUM. 

187130 03-03 
NORADRENALINE IN THE GUINEA-PIG ALIMENTARY CANAL: REGIONAL 
DISTRIBUTION AND SENSITIVITY TO DENERVATION AND RESERPINE. 

191326 04-03 
GUINEA-PIGS 

SUPPRESSION OF LORDOSIS IN GUINEA-PIGS BY ETHAMOXY-TRIPHETOL 
(MER-25) GIVEN AT LONG INTERVALS (36-46 HR) AFTER ESTRADIOL 
BENZOATE TREATMENT. 

186686 03-04 
INTESTINAL EFFECTS OF S-HYDROXYTRYPTAMINE AND MORPHINE IN 
GUINEA-PIGS, DOGS, CATS AND MONKEYS. 

188202 04-03 
THE EFFECTS OF D-AMPHETAMINE ON THE INTERRESPONSE TIMES OF 
RATS AND GUINEA-PIGS ON A MODIFIED SIDMAN DISCRIMINATED 
AVOIDANCE SCHEDULE. 

189519 04-04 
EFFECTS OF NICOTINE ON THE SHUTTLEBOX BEHAVIOR OF TRAINED 
GUINEA-PIGS. 

190333 04-04 
EFFECT OF CHRONIC TREATMENT WITH CENTRAL STIMULANTS ON BRAIN 
MONOAMINES AND SOME BEHAVIOURAL AND PHYSIOLOGICAL 
FUNCTIONS IN RATS, GUINEA-PIGS, AND RABBITS. 

191503 04-03 
GUNN 

MORPHINE METABOLISM IN VIVO AND IN VITRO BY HOMOZYGOUS 
GUNN RATS. 

183899 03-03 
H-77-77 

EVIDENCE FOR A NORADRENERGIC AND DOPAMINERGIC MECHANISM IN 
THE HYPERACTIVITY PRODUCED BY 4,ALPHA DIMETHYL-M-TYRAMINE 
(H-77-77) IN RATS. 

190309 04-04 
HABITUATION 

HABITUATION OF BLINK REFLEXES IN PARKINSONIAN PATIENTS UNDER 
LEVODOPA AND AMANTADINE TREATMENT. 

171794 01-13 
THE EFFECTS OF CHLORDIAZEPOXIDE (LIBRIUM) ON THE INTENSITY AND 
HABITUATION OF AGONISTIC BEHAVIOR IN MALE SIAMESE FIGHTING 
FISH. 

177722 02-04 
CHANGES IN ORIENTING AND HABITUATION IN THE RAT FOLLOWING 
ADMINISTRATION OF CHLORPROMAZINE. 

191211 04-04 
HALLUCINATIONS 

MESCALINE HYPERREACTIVITY: HALLUCINATIONS IN RATS? 
(UNPUBLISHED PAPER). 

178575 02-04 

HALLUCINATORY 

TREATMENT OF HALLUCINATORY DISORDERS IN SCHIZOPHRENIA BY 
ATROPINE COMAS. 

181778 02-08 



HALLUCINOGENIC 

MOLECULAR ORBITAL STUDIES ON THE CONFORMATION OF 

HALLUCINOGENIC INDOLEALKYLAMINES AND RELATED COMPOUNDS. 
THE ISOLATED MOLECULES AND THE SOLVENT EFFECT. 

183406 03-01 
HALLUCINOGENIC DRUGS AND ARTISTIC CREATIVITY. 

186026 03-12 
HALLUCINOGENIC DRUG-INDUCED BEHAVIOR UNDER SENSORY 
ATTENUATION: PREDICTION OF RESPONSE TO PSILOCYBIN. 

189744 04-12 
CORTICAL AND/OR SUBCORTICAL EFFECTS AS A FUNCTION OF 
HALLUCINOGENIC DRUG STRUCTURE 



HALLUCINOGENS 

PSYCHOPHARMACOLOGY OF HALLUCINOGENS. 

PSYCHOTHERAPY WITH HALLUCINOGENS. 

A HISTORY OF THE USE OF HALLUCINOGENS. 

THE MECHANISMS OF ACTION OF HALLUCINOGENS. 

INDIVIDUAL PSYCHOTHERAPY WITH HALLUCINOGENS. 

THE USE OF HALLUCINOGENS IN GROUP PSYCHOTHERAPY. 



191936 04-03 

180123 02-12 
180139 02-12 

180141 02-12 

180142 02-12 

180143 02-12 

180144 02-12 



RESULTS OF CLINICAL RESEARCH IN PSYCHOTHERAPY WITH 
HALLUCINOGENS. 

180145 02-12 
THE POSSIBLE ROLE OF TRYPTAMINE IN BRAIN FUNCTION AND ITS 
RELATIONSHIP TO THE ACTIONS OF LSD-LIKE HALLUCINOGENS. 

186024 03-12 
HALLUCINOGENS AS DISCRIMINATIVE STIMULI. 

188229 04-12 
THE BOTANY AND CHEMISTRY OF HALLUCINOGENS. 

189101 0412 
A NOTE ON EPISTEMIC ORGANIZATION AND HALLUCINOGENS. 

190240 04-17 
HALLUCINOGENS, A RE-EVALUATION. 

191938 04-03 
HALOPERIDOL 

POTENTIATION OF HALOPERIDOL BY ALPHA-METHYLDOPA IN THE 
TREATMENT OF SCHIZOPHRENIC PATIENTS. 

167343 01-08 
VESTA VARIANT OF TOURETTES DISEASE: TREATMENT WITH 
HALOPERIDOL. 

169286 01-10 
HALOPERIDOL AND THE BUTYROPHENONES. 

169296 01-09 
HALOPERIDOL FOR PSYCHIATRIC DISORDERS IN CHILDREN. 

169457 01-14 
SAFETY AND EFFECTIVENESS OF HALOPERIDOL FOR MENTALLY 

RETARDED BEHAVIORALLY DISORDERED AND HYPERKINETIC PATIENTS. 

169634 01-11 
LOW DOSAGE HALOPERIDOL AND INDUCED ANXIETY IN NORMAL 
VOLUNTEERS. 

169745 01-14 
RAPID CONTROL OF PSYCHOTIC EXCITEMENT STATES WITH 
INTRAMUSCULAR HALOPERIDOL. 

170627 01-09 
HALOPERIDOL EFFECTS ON MORPHINE SELF-ADMINISTRATION: TESTING 
FOR PHARMACOLOGICAL MODIFICATION OF THE PRIMARY 
REINFORCEMENT MECHANISM. 

172454 01-04 
A COMPARATIVE TRIAL OF HALOPERIDOL AND THIORIDAZINE: 
MANAGEMENT OF CHRONIC SCHIZOPHRENIA. 

172741 01-08 
DELIRIOUS SYNDROME AFTER THE ADMINISTRATION OF HALOPERIDOL. 

174784 01-15 
MANAGEMENT OF HOSTILE, SUSPICIOUS PATIENTS. TRIFLUOPERAZINE 
VERSUS HALOPERIDOL. 

176675 02-14 
A STUDY OF ANTIOVULATORY ACTIVITY OF HALOPERIDOL IN RABBITS. 

177021 02-03 
A DOUBLE-BUND COMPARISON OF FLUPHENAZINE AND HALOPERIDOL IN 
OUTPATIENT SCHIZOPHRENIC CHILDREN. 

1 77754 02-08 
PARENTERAL HALOPERIDOL FOR RAPID CONTROL OF SEVERE, 
DISRUPTIVE SYMPTOMS OF ACUTE SCHIZOPHRENIA. 

1 78545 02-08 
BEHAVIORAL EVIDENCE FOR DOPAMINERGIC SUPERSENSITIVITY AFTER 
CHRONIC HALOPERIDOL. 

180021 02-04 
DOUBLE-BLIND PSYCHOMETRIC EVALUATION OF PIMOZIDE AND 
HALOPERIDOL VERSUS PLACEBO IN EMOTIONALLY LABILE 
VOLUNTEERS UNDER TWO DIFFERENT WORK LOAD CONDITIONS. 

180065 02-14 



S-110 



VOLUME 12, SUBJECT INDEX 



Subject Index 



HALOPERIDOL (JANSSEN) IN THE TREATMENT OF UNSELECTED 
INSTITUTIONALIZED PSYCHIATRIC PATIENTS. 

180299 02-11 
EFFECT OF MORPHINE, HALOPERIDOL, APOMORPHINE AND BENZTROPINE 
ON DOPAMINE TURNOVER IN RAT CORPUS-STRIATUM: EVIDENCE 
SHOWING MORPHINE-INDUCED REDUCTION IN CNS DOPAMINERGIC 
ACTIVITY. 

182230 03-03 
TOLERANCE TO THE BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF 
HALOPERIDOL AND MORPHINE IN RATS CHRONICALLY TREATED WITH 
MORPHINE OR HALOPERIDOL. 

184225 03-03 
METHYLPHENIDATE ANTAGONISM OF HALOPERIDOL, INTERACTION WITH 
CHOLINERGIC AND ANTICHOLINERGIC DRUGS. 

186370 03-04 
EFFECT OF ANESTHETIC AGENTS ON THE SYNTHESIS AND 

DISAPPEARANCE OF BRAIN DOPAMINE NORMALLY AND AFTER 
HALOPERIDOL, KCL OR AXOTOMY. 

189571 04-03 
DIFFERENTIAL ANTAGONISM BY NALOXONE OF INHIBITORY EFFECTS OF 
HALOPERIDOL AND MORPHINE ON BRAIN SELF-STIMULATION. 

190306 04-03 
TARDIVE AND WITHDRAWAL DYSKINESIA ASSOCIATED WITH 
HALOPERIDOL. 

191035 04-15 
USE OF HALOPERIDOL (BROTOPON) IN THE TREATMENT OF 
SCHIZOPHRENIA. 

191686 04-08 
ACTION OF HALOPERIDOL AND TRIFLUOPERAZINE ON THE MOTOR 
RESPONSES ELICITED BY ELECTRICAL STIMULATION OF THE BRAIN IN 
RABBITS. 

191787 04-02 
POSITIVE REINFORCING EFFECTS OF APOMORPHINE, D-AMPHETAMINE 
AND MORPHINE: INTERACTION WITH HALOPERIDOL. 

191899 04-04 
SUPERSENSITIVITY TO DOPAMINERGIC AGONISTS FOLLOWING 
WITHDRAWAL OF A CHRONIC DIET CONTAINING HALOPERIDOL OR 
PIMOZIDE. 

192012 04-04 
HALOPERIDOL VERSUS THIORIDAZINE FOR THE TREATMENT OF 
PSYCHOGERIATRIC PATIENTS: A DOUBLE-BUND CLINICAL STUDY. 

192231 04-09 
INTERACTION BETWEEN NEUROLEPTIC THERAPY AND SOCIOTHERAPEUTIC 
APPROACH. AN INVESTIGATION WITH PENFLURIDOL AND 
HALOPERIDOL. 

192431 04-08 
HALOTHANE 

EFFECT OF GENERAL ANESTHETICS ON SYSTEMIC CATECHOLAMINE 
CONCENTRATION I: HALOTHANE. (UNPUBLISHED PAPER). 

168862 01-05 
INTERACTIONS OF DIAZEPAM AND HALOTHANE IN RATS. 

171633 01-03 
MICROVASCULAR SMOOTH MUSCLE HYPERRESPONSIVENESS DURING 
HALOTHANE ANESTHESIA IN THE RAT 

182185 02-03 
ENDURING LEARNING DEFICITS AND CEREBRAL SYNAPTIC 
MALFORMATION FROM EXPOSURE TO 10 PARTS OF HALOTHANE PER 
MILLION. 

192565 04-04 
HAMSTER 

COMPARATIVE EFFECTS OF SOME CNS ACTIVE DRUGS ON LEARNED AND 
UNLEARNED BEHAVIOR IN THE HAMSTER. 

191976 04-04 
HAMSTERS 

POTENTIAL NEUROTRANSMITTERS AND RECEPTOR MECHANISMS 
INVOLVED IN THE CENTRAL CONTROL OF BODY TEMPERATURE IN 
HAMSTERS. (PH.D. DISSERTATION). 

174962 01-03 
HARM 

PSYCHOTROPIC DRUGS - HARM OR HELP. 

190138 04-11 
HASHISH 

THE EFFECTS OF PHENITRONE, A REPORTED HASHISH ANTAGONIST, ON 
THE OVERT BEHAVIOR OF CATS. 

174607 01-04 
INTERACTION OF THE BEHAVIORALLY ACTIVE DRUG, PHENITRONE, A 
PURPORTED HASHISH AND LSD ANTAGONIST, WITH SEVERAL 
CENTRAL NEUROCHEMICAL SYSTEMS. 

182217 03-04 
REDUCTION IN COPULATORY BEHAVIOR OF MALE RATS FOLLOWING 
HASHISH INJECTIONS. 

183790 03-04 
TEMPORAL DISORGANIZATION AND DELUSIONAL-LIKE IDEATION: 
PROCESSES INDUCED BY HASHISH AND ALCOHOL. 

185330 03-14 
RELUCTANCE OF RATS TO DRINK HASHISH SUSPENSIONS: FREE-CHOICE 
AND FORCED CONSUMPTION, AND THE EFFECTS OF HYPOTHALAMIC 
STIMULATION. 

186586 03-04 



HATCHABILITY 

THE EFFECTS OF MESCALINE ADMINISTERED BEFORE OR DURING 
EMBRYOGENESIS UPON THE HATCHABILITY AND BEHAVIOR OF THE 
CHICK. (PH.D. DISSERTATION). 

173791 01-04 
HAZARD 

THE USES AND RELATIVE HAZARD POTENTIAL OF PSYCHOACTIVE 
DRUGS. 

190237 04-17 
HAZARDS 

HAZARDS OF LITHIUM PROPHYLAXIS. 

191187 04-15 
HCP 

PROTECTION PRODUCED BY BENZODIAZEPINES (BDP) AGAINST THE 
NEUROTOXIC AND CONFLICT BEHAVIOR EFFECTS OF 
HEXACHLOROPHENE (HCP) IN CATS. 

1 76863 02-04 
HEADACHES 

A NEW AGENT FOR CHEMOTHERAPY OF MIGRAINE HEADACHES: A 
CONTROLLED STUDY. 

169298 01-11 
HEALTH 

LITHIUM AND MENTAL HEALTH. 

178113 02-09 
IN APPRECIATION OF BASIC BIOCHEMICAL RESEARCH IN MENTAL 
HEALTH. (UNPUBLISHED PAPER). 

187488 04-17 
FACTORS AFFECTING OUTCOME IN A SCHOOL MENTAL HEALTH SERVICE. 

188567 04-11 
PROPHYLACTIC EFFICACY OF LITHIUM CARBONATE IN MANIC- 
DEPRESSIVE ILLNESS: REPORT OF THE VETERANS ADMINISTRATION 
AND NATIONAL INSTITUTE OF MENTAL HEALTH (VA-NIMH) 
COLLABORATIVE STUDY GROUP. 

189735 04-09 
HEALTHY 

DIAZEPAM AND MEPERIDINE ON ARTERIAL BLOOD GASES IN HEALTHY 
VOLUNTEERS. 

190147 04-13 
HEART 

EEG, HEART RATE, AND MOOD CHANGE (HIGH) AFTER CANNABIS. 

169068 01-13 
THE CURARIZED RAT AND HEART RATE CONDITIONING: A 
CONSIDERATION OF RESPIRATION PARAMETERS AND 
NEUROMUSCULAR BLOCKING AGENTS IN A CLASSICAL CONDITIONING 
PARADIGM (PH.D. DISSERTATION). 

173133 01-03 
ADRENALINE, NORADRENALINE AND DOPAMINE LEVELS IN BRAIN AND 
HEART AFTER ADMINISTRATION OF 6-HYDROXYDOPAMINE AND 
GUANETHIDINE TO NEWBORN MICE. 

1 77338 02-03 
ANTICHOLINERGICS: THEIR EFFECTS ON FEAR MOTIVATED BEHAVIOR, 
URINARY 11-HYDROXYCORTICOSTEROIDS, URINARY VOLUME, AND 
HEART RATE IN THE DOG. 

1 78720 02-03 
EFFECTS OF L-DELTA9-TETRAHYDR0CANNABIN0L, DL-AMPHETAMINE 
AND PENTOBARBITAL ON OXYGEN CONSUMPTION BY MOUSE BRAIN 
AND HEART HOMOGENATES. 

181813 02-03 
THE EFFECTS OF ACUTE ADMINISTRATION OF PROPRANOLOL AND 
PRACTOLOL ON THE UPTAKE, CONTENT, RELEASE AND TURNOVER OF 
NORADRENALINE IN THE RAT HEART IN VIVO. 

184232 03-03 
SPECIFICITY OF BLOCKADE OF THE NICOTINE INDUCED RELEASE OF 3H- 
NOREPINEPHRINE FROM ADRENERGIC NEURONS OF THE GUINEA-PIG 
HEART BY VARIOUS PHARMACOLOGICAL AGENTS. 

186676 03-03 
EFFECT OF IMIPRAMINE ON CULTURED RAT HEART CELLS. 

188864 04-03 
EFFECTS OF CHLORDIAZEPOXIDE ON HEART RATE AND BEHAVIOURAL 
SUPPRESSION IN PIGS SUBJECTED TO OPERANT CONDITIONING 
PROCEDURES. 

1 89409 04-04 
EXTRANEURONAL REMOVAL, ACCUMULATION AND 0-METHYLATION OF 
ISOPRENALINE IN THE PERFUSED HEART. 

189604 04-03 
THE EFFECTS OF HOE-36801 ON CATECHOLAMINE EXCRETION. HEART 
RATE AND PSYCHOMOTOR PERFORMANCE IN NEUROTICS AND 
NORMALS. 

192428 04-13 
HEAT 

HEAT DYSCONTROL SYNDROME IN PATIENTS RECEIVING 

ANTIPSYCHOTIC, ANTIDEPRESSANT AND ANTIPARKINSON DRUG 
THERAPY. 

188094 04-15 
HEBB-WILLIAMS 

THE EFFECTS OF EARLY SALINE INJECTIONS AND PENTYLENETETRAZOL 
ON HEBB-WILLIAMS MAZE PERFORMANCE IN THE ADULT RAT. 

191378 04-04 



s-ni 



Subject Index 



Psychopharmacoiogy Abstracts 



HEMICHOLINIUM-3 

ACTIONS OF ATROPINE, HEMICHOLINIUM-3, AND PHYSOSTIGMINE ON 
CHLORPROMAZINE INDUCED CHANGES IN RAT BRAIN MONOAMINES. 

187800 04-03 
HEMOLYTIC 

PHARMACOLOGICAL AND BIOCHEMICAL ACTIONS OF THE HEMOLYTIC 
AGENTS ACETYLPHENYLHYDRAZINE AND PHENYLHYDRAZINE ON 
MONOAMINE OXIDASE IN THE RAT. 

188769 04-03 
HEPATIC 

INDUCTION OF HEPATIC DRUG METABOLIZING ENZYMES BY LITHIUM 
TREATMENT. 

182727 03-03 
EFFECT OF ORAL ADMINISTRATION OF METHADONE ON HEPATIC 
MICROSOMAL MIXED FUNCTION OXIDASE ACTIVITY IN MICE. 

188178 04-03 
HEPATOTOXICITY 

EFFECT OF PHENOBARBITAL AND 3-METHYLCHOLANTHRENE 

PRETREATMENT ON THE HEPATOTOXICITY OF 1,1,1 TRICHLOROETHANE 
AND 1,1,2 TRICHLOROETHANE. 

167361 01-05 
REDUCTION BY PRETREATMENT WITH DIBENAMINE OF HEPATOTOXICITY 
INDUCED BY CARBON TETRACHLORIDE, THIOACETAMINDE OR 
DIMETHYLNITROSAMINE. 

188865 04-05 
HEPTABARBITAl 

ABSORPTION AND CLEARANCE OF SECOBARBITAL, HEPTABARBITAL, 
METHAQUALONE, AND ETHINAMATE. 

192575 04-13 
HEROIN 

USE OF PSYCHOTHERAPEUTIC DRUGS IN THE ACUTE DETOXIFICATION OF 
HEROIN ADDICTS. 

169746 01-11 
COMPARISON OF INTRAVENOUSLY ADMINISTERED METHADONE (ME), 
MORPHINE (MO), HEROIN (H) AND PLACEBO (P). 

182163 02-03 
VALIDITY OF SCREENING METHODS FOR DRUGS OF ABUSE IN 
BIOLOGICAL FLUIDS. II. HEROIN IN PLASMA AND SALIVA. 

187256 03-15 
HETEROCYCIIC 

ALKALOID STUDIES. 9. PREPARATION OF 18-ACYLYOHIMBAN-17-ONES 
AND THEIR CONVERSION TO NEW HETEROCYCLIC YOHIMBANS. 

185033 03-04 
HETEROGENEITY 

THE HETEROGENEITY OF DEPRESSION. 

169093 01-09 
HEXACHLOROPHENE 

PROTECTION PRODUCED BY BENZODIAZEPINES (BDP) AGAINST THE 
NEUROTOXIC AND CONFLICT BEHAVIOR EFFECTS OF 
HEXACHLOROPHENE (HCP) IN CATS. 

176863 02-04 
HEXAHYDROBENZODIAZEPINOOXAZOL-6-ONE 

THE SAFETY TEST OF lO-CHLORO-1 1 B-(2-CHL0R0PHENYL) 2,3,5,6,7,116 
HEXAHYDROBENZODIAZEPINOOXAZOL-6-ONE (CS-370)t SECOND 
REPORT, EFFECT OF CS-370 UPON THE DEVELOPMENT OF PRENATAL 
AND POSTNATAL OFFSPRINGS OF EXPERIMENTAL ANIMALS. 

168498 01-05 
EFFECT OF A NEW PSYCHOTROPIC DRUG, CS-370 (10-CHLORO-l lB-{2- 
CHL0R0PHENYL)-2,3,5,6,7,11B HEXAHYDROBENZODIAZEPINOOXAZOL- 
6-ONE) UPON THE CENTRAL NERVOUS SYSTEM. 

174603 01-03 
HEXAHYDROPYRAZINOQUINOLINE 

ANTIHYPERTENSIVE AND CENTRAL NERVOUS SYSTEM DEPRESSANT 
PROPERTIES OF 3-(GAMMA-P-FLU0R0BENZ0YLPR0PYL) 2,3,4,4A,5,6 
HEXAHYDROPYRAZINOQUINOLINE HYDROCHLORIDE (COMPOUND-69- 
183, CENTPYRAQUIN). 

176881 02-03 
HEXOBARBITAl 

TOLERANCE TO HEXOBARBITAL AND SUPERSENSITIVITY TO PILOCARPINE 
INDUCED BY CHRONIC BARBITAL TREATMENT IN THE RAT. 

171601 01-03 
THE METABOLIC FATE OF HEXOBARBITAL IN THE RAT. 

1 77732 02-03 
EFFECT OF 6-HYDROXYDOPAMINE ON THE DURATION OF HEXOBARBITAL 
SLEEP IN RATS. 

178558 02-03 
ON THE MECHANISM OF THE SYNERGISTIC EFFECT OF PERAZINE AND 
HEXOBARBITAL. 

184199 03-03 
CANNABINOIDS AND HEXOBARBITAL INDUCED LOSS OF RIGHTING 
REFLEXES. 

189573 04-04 
HF-1972 

DOUBLE-BLIND COMPARATIVE STUDY OF HF-1972/NOVERIL IN 
DEPRESSION. 

180986 02-10 



HIERARCHY 

SOCIAL HIERARCHY IN MONKEYS (MACACA-MULATTA) MODIFIED BY 
CHLORDIAZEPOXIDE HYDROCHLORIDE. 

183863 03-04 
HINDPAW 

EFFECTS OF PROSTAGLANDINS 81 AND 82 ON VASOCONSTRICTOR 
RESPONSES OF THE CANINE HINDPAW, 

189395 04-03 
HIPPOCAMPAl 

HIPPOCAMPAL LESIONS AND LEARNED TASTE AVERSION. 

184834 03-04 
DIFFERENTIAL RECOVERY OF FUNCTION FOLLOWING CAUDATE, 
HIPPOCAMPAL, AND SEPTAL LESIONS IN MICE. 

186620 03-04 
THE ANTAGONISM OF HIPPOCAMPAL AND CORTICAL AFTERDISCHARGE 
BY SC-13504, A NEW ANTICONVULSANT. 

186632 03-03 
EFFECTS OF LOCUS-COERULEUS STIMULATION ON HIPPOCAMPAL UNIT 
ACTIVITY AND ON BEHAVIOR IN UNRESTRAINED RATS. (UNPUBLISHED 
PAPER). 

187499 04-04 
A FREQUENCY SHIFT IN THE HIPPOCAMPAL THETA ACTIVITY: AN 

ELECTRICAL CORRELATE OF CENTRAL ACTION OF ACTH ANALOGUES IN 
THE DOG 

188166 04-04 
EFFECT OF ANTICONVULSANT DRUGS ON THE NUMBER OF AFFERENT 
STIMULI NEEDED TO CAUSE A HIPPOCAMPAL SEIZURE DISCHARGE. 

189608 04-03 
EFFECT OF SEIZURES AND ANTICONVULSANT AGENTS ON HIPPOCAMPAL 

RNA CONCENTRATION. 

189609 04-03 
5-HYDROXYTRYPTAMINE AND NORADRENALINE IN THE HIPPOCAMPAL 

REGION: EFFECT OF TRANSECTION OF AFFERENT PATHWAYS ON 
ENDOGENOUS LEVELS, HIGH AFFINITY UPTAKE AND SOME 
TRANSMITTER RELATED ENZYMES. 

191319 04-03 
HIPPOCAMPUS 

EFFECTS OF FOOD DEPRIVATION, DISCRIMINATION EXPERIENCE AND 
PHYSOSTIGMINE ON CHOLINE ACETYLASE AND ACETYLCHOLINE 
ESTERASE IN THE DORSAL HIPPOCAMPUS AND FRONTAL CORTEX OF 
RATS. 

169467 01-03 
MODULATORY EFFECTS OF CORTICOSTEROIDS ON EVOKED ACTIVITY IN 
THE HIPPOCAMPUS AND THALAMUS OF THE RAT. 

182119 02-03 
IN VIVO MEASUREMENT OF THE RELEASE OF 5-HYDROXYTRYPTAMINE (5- 
HT) FROM THE HIPPOCAMPUS OF THE RAT: EFFECT OF RO-4-1284, 
PARGYLINE AND P-CHLOROAMPHETAMINE (PCA). 

182140 02-03 
LITHIUM AND THE MONOAMINE NEUROTRANSMITTERS IN THE RAT 
HIPPOCAMPUS. 

190829 04-03 
HISTAMINE 

DECREASED HISTAMINE SYNTHESIS IN THE RAT BRAIN BY HYPNOTICS 
AND ANESTHETICS. 

168750 01-03 
5-HYDROXYTRYPTAMINE AND HISTAMINE EFFECTS ON 
RETICULOCEREBELLAR EVOKED POTENTIALS. 

182121 02-03 
EFFECTS OF GUANETHIDINE AND IMIDAZOLE ON HISTAMINE RESPONSE. 

187799 04-03 
TURNOVER OF HISTAMINE IN RAT BRAIN AND ITS DECREASE UNDER 
BARBITURATE ANESTHESIA. 

189396 04-03 
EFFECTS OF ADRENERGIC AGENTS, THEOPHYLLINE AND OTHER DRUGS 

ON DEXTRAN EDEMA AND HISTAMINE RELEASE IN RATS. 

189895 04-03 
HISTO-AUTORAOIOGRAPHIC 

HISTO-AUTORADIOGRAPHIC INVESTIGATIONS ON THE DISTRIBUTION OF 
INJECTED 5-HYOROXYTRYPTAMINE (SEROTONIN) IN THE BRAIN AND 
THE PITUITARY OF MICE. 

185900 03-03 
HISTOCHEMICAL 

QUANTITATIVE HISTOCHEMICAL STUDIES OF STRIATAL DOPAMINE 
DEPLETION FOLLOWING DL-ALPHA-METHYL-P-TYROSINE 
ADMINISTRATION. 

172924 01-03 
HISTOCHEMICALLY 

HYDROCORTISONE INDUCED INCREASE IN THE HISTOCHEMICALLY 
DEMONSTRABLE CATECHOLAMINE CONTENT OF SYMPATHETIC 
NEURONS OF THE NEWBORN RAT. 

189027 04-03 
HISTOLOGY 

EFFECTS OF SHORT-TERM ADMINISTRATION OF N-NITROSO COMPOUNDS 
ON LIVER HISTOLOGY AND PENTOBARBITAL INDUCED SLEEPING TIME 
IN MICE. 

187575 04-04 



S-112 



VOLUME 12, SUBJECT INDEX 



Subject Index 



HISTORY 

RELATIONSHIP BETWEEN THE EFFECTIVENESS OF LITHIUM THERAPY AND 
FAMILY HISTORY. 

169494 01-09 
A HISTORY OF THE USE OF HALLUCINOGENS. 

180141 02-12 
HOE-36801 

THE EFFECTS OF HOE-36801 ON CATECHOLAMINE EXCRETION, HEART 
RATE AND PSYCHOMOTOR PERFORMANCE IN NEUROTICS AND 
NORMALS 

192428 04-13 
THE EFFECTS OF HOE-36801 ON MUSCLE ACTIVITY AND BLOOD 

PRESSURE, ON ATTENTION AND CONCENTRATION, ON TIME 
JUDGMENT AND SUBJECTIVE RESPONSES IN NEUROTICS AND 
NORMALS 

192429 04-14 
10E-984 

EFFECTS OF NOMIFENSINE (HOE-984), D-AMPHETAMINE AND 
APOMORPHINE ON MOTOR ACTIVITY, CATECHOLAMINE TURNOVER 
AND CAMP CONCENTRATIONS IN RAT BRAIN. (UNPUBLISHED PAPER). 

191766 04-03 
<OME 

THE EFFECT OF LORAZEPAM ON ANXIOUS INSOMNIACS SLEEP AS 
RECORDED IN THE HOME ENVIRONMENT. 

177318 02-14 
IOMEOSTA5IS 

EFFECTS ON HOMEOSTASIS OF INTRAVENTRICULAR INJECTIONS OF 6- 
HYDROXYDOPAMINE IN RATS. 

187695 04-03 
lOMOGENATE 

INABILITY OF RAT BRAIN HOMOGENATE TO OXIDIZE AMPHETAMINE. 

1 77334 02-03 
lOMOGENATES 

STRUCTURE-ACTIVITY RELATIONS FOR THE INHIBITION OF 5-HT UPTAKE 
INTO RAT HYPOTHALAMIC HOMOGENATES BY SEROTONIN AND 
TRYPTAMINE ANALOGUES. 

1 75233 02-03 
EFFECTS OF L-DELTA9-TETRAHY0R0CANNABIN0L, DL-AMPHETAMINE 
AND PENTOBARBITAL ON OXYGEN CONSUMPTION BY MOUSE BRAIN 
AND HEART HOMOGENATES 

181813 02-03 
ANTICONVULSANT ACTIVITY AND INHIBITION OF RESPIRATION IN RAT 
BRAIN HOMOGENATES BY SUBSTITUTED OXADIAZOLES. 

185980 03-01 
STIMULATION OF A DOPAMINE SENSITIVE ADENYLATE CYCLASE IN 
HOMOGENATES OF RAT STRIATUM BY A METABOLITE OF PIRIBEDIL 
(ET-495). 

189616 04-03 
lOMOISO 

MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND ITS 
HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD. 

186566 03-16 
lOMOVANILLIC 

THE EFFECT OF PROBENECID AND LARGE DOSE AMPHETAMINE 
ADMINISTRATION ON CEREBROSPINAL FLUID HOMOVANILLIC ACID. 

177826 02-13 
CATALEPSY AND STEREOTYPED BEHAVIOUR IN RATS TREATED 
CHRONICALLY WITH METHADONE: RELATION TO BRAIN 
HOMOVANILLIC ACID CONTENT. 

183606 03-04 
THE EFFECT OF CHLORPROMAZINE ON HOMOVANILLIC ACID LEVELS IN 
CEREBROSPINAL FLUID OF SCHIZOPHRENIC PATIENTS. 

186565 03-08 
MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND ITS 

HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD 

186566 03-16 
EFFECT OF PIRIBEDIL AND ONE OF ITS METABOLITES ON THE 

CONCENTRATION OF HOMOVANILLIC ACID IN THE RAT BRAIN. 

191422 04-03 
OMOZYGOUS 

MORPHINE METABOLISM IN VIVO AND IN VITRO BY HOMOZYGOUS 
GUNN RATS. 

183899 03-03 
ONG-KONG 

PSYCHOTROPIC MEDICATION IN HONG-KONG, 

180321 02-17 
ORIZON 

EXPERIENCE IN THE DRUG HORIZON AND PSYCHIATRIC INTERVIEW. 

176542 02- n 
ORIZONS 

NEW HORIZONS IN PSYCHOPHARMACOLOGY. 

176926 02-17 
ORMONE 

GROWTH HORMONE RESPONSES TO ADMINISTRATION OF L-5- 

HYDROXYTRYPTOPHAN (L-5-HTP) IN MANIC-DEPRESSIVE PSYCHOSES. 

167919 01-09 



MELANOCYTE STIMULATING HORMONE RELEASE INHIBITING HORMONE 
AS AN ANTIDEPRESSANT: A PILOT STUDY 

171501 01-09 
FUNCTIONAL EVALUATION OF PITUITARY RESERVE IN PATIENTS WITH 
THE AMENORRHEA GALACTORRHEA SYNDROME UTILIZING 
LUTEINIZING HORMONE RELEASING HORMONE (LH-RH), L-DOPA AND 
CHLORPROMAZINE. 

175245 02-13 
TESTOSTERONE AND LUTEINIZING HORMONE (LH) IN UNTREATED AND 
METHADONE MAINTAINED NARCOTIC ADDICTS. 

182166 02-13 
INFLUENCE OF TETRACOSACTRIN (T) AND BETA-MELANOCYTE 

STIMULATING HORMONE (MSH) ON DEPRESSION OF THE SEGMENTAL 
REFLEX BY MORPHINE (MS). (UNPUBLISHED PAPER). 

183324 03-03 
THE EFFECT OF ZINC N TETRACOSACTRIN ON GROWTH HORMONE 
RELEASE DURING SLEEP. 

183490 03-13 
PLASMA LEVELS OF LUTEINIZING HORMONE AND OF IMMUNOREACTIVE 
ESTROGENS (ESTRADIOL) IN ANOREXIA-NERVOSA: RESPONSE TO 
CLOMIPHENE CITRATE. 

183807 03-10 
A PRELIMINARY STUDY ON THE ACTION OF THYROTROPINE RELEASING 
HORMONE OR TRH IN DEPRESSIVE STATES. 

184962 03-09 
THE EFFECT OF LITHIUM ON HORMONE SENSITIVE ADENYLATE CYCLASE 
FROM VARIOUS REGIONS OF THE RAT BRAIN. 

187110 03-03 
A DOUBLE-BLIND CROSSOVER SEQUENTIAL TRIAL OF ORAL THYROTROPIN 
RELEASING HORMONE IN DEPRESSION. 

188348 04-09 
ROLE OF DOPAMINERGIC MECHANISMS IN REGULATION OF GROWTH 
HORMONE AND PROLACTIN SECRETION IN MAN 

188428 04-13 
EFFECTS OF LSD AND MONOAMINE SYNTHESIS INHIBITORS ON 

HORMONE ACTIVATED COPULATORY BEHAVIOR IN THE FEMALE RAT 

188611 04-04 
AFFECTIVE STATE AND THYROTROPIN AND PROLACTIN RESPONSES 
AFTER REPEATED INJECTIONS OF THYROTROPIN RELEASING HORMONE 
IN DEPRESSED PATIENTS. 

189076 04-09 
INHIBITION OF THE SLEEP RELATED PEAK IN PHYSIOLOGIC HUMAN 
GROWTH HORMONE RELEASE BY SOMATOSTATIN. 

190104 04-13 
DISSOCIATION OF GROWTH HORMONE AND PROLACTIN SECRETION IN 
PARKINSONS DISEASE FOLLOWING CHRONIC L-DOPA THERAPY. 

191233 04-13 
THYROTROPHIN RELEASING HORMONE IN THE TREATMENT OF 
DEPRESSION. 

192577 04-09 
HORMONES 

INFLUENCE OF PHENOBARBITAL AND SEX HORMONES ON ENZYMES IN 
ASCORBIC ACID BIOSYNTHESIS IN MALE AND FEMALE RATS (PH D 
DISSERTATION). 

172017 01-03 
THE RATE LIMITING CONTROL OF ENZYMES MONOAMINE OXIDASE AND 
CATECHOL-0-METHYLTRANSFERASE IN THE FETUS AND THE ADULT BY 
ADRENOCORTICOL HORMONES. 

178815 02-03 
HOSPITAL 

A PROGRAMME WHICH LED TO REDUCTION IN NIGHT SEDATION IN A 
MAJOR HOSPITAL. 

170802 01-17 
DEPRESSION SUBTYPES AND RESPONSE TO PHENELZINE, DIAZEPAM, AND 
A PLACEBO; RESULTS OF A NINE HOSPITAL COLLABORATIVE STUDY 

171502 01-09 
REHABILITATION OF LEARNING IN A HOSPITAL CLASS USING 
PSYCHOACTIVE DRUGS. 

174071 01-11 
HOSPITALISED 

EXPERIENCES WITH FLUPHENAZINE ENANTHATE IN LONG-STAY 
HOSPITALISED SCHIZOPHRENICS. 

171985 01-08 
HOSPITALIZATION 

DRUG TREATMENT OF DEPRESSED PATIENTS REFERRED FOR 
HOSPITALIZATION. 

170621 01-09 
HOSPITALIZED 

A DOUBLE-BLIND INVESTIGATION OF DIMETHACRINE VERSUS 
IMIPRAMINE IN HOSPITALIZED DEPRESSIVE STATES. 

171695 01-09 
WITHDRAWAL OF MAINTENANCE DRUGS WITH LONG-TERM 
HOSPITALIZED MENTAL PATIENTS: A CRITICAL REVIEW. 

175862 02-17 
PIMOZIDE IN THE TREATMENT OF BEHAVIORAL DISORDERS OF 
HOSPITALIZED ADOLESCENTS. 

176109 02-14 



.•■'••<.S£>'v';' 



Wmi^ 



S-113 



Subject Index 



Psychopharmacoiogy Abstracts 



EXPERIENCES WITH FLUPHENAZINE ENANTHATE IN LONG-STAY 
HOSPITALIZED SCHIZOPHRENICS. 

180154 02-08 
END OF A BACK WARD: THE RAPID REHABILITATION AND RELEASE OF 
CHRONICALLY HOSPITALIZED PSYCHIATRIC PATIENTS. 

181153 02-08 
CLINICAL STUDY ON THE EFFECTS OF THIOTHIXENE IN HOSPITALIZED 

PSYCHOTIC PATIENTS. 

183955 03-08 
CLINICAL EXPERIENCES WITH MESORIDAZINE (TPS-23): ITS 

ADMINISTRATION TO HOSPITALIZED SCHIZOPHRENIC PATIENTS. 

188934 04-08 

CLINICAL TRIAL WITH NOZINAN-R. AT SEVERAL MENTAL HOSPITALS IN 
-"^^^ 176582 02-11 

MANAGEMENT OF HOSTILE, SUSPICIOUS PATIENTS. TRIFLUOPERAZINE 

VERSUS HALOPERIDOL. 

176675 02-14 

THE EFFECT OF MARIJUANA ON HOSTILITY IN AN EXPERIMENTAL GROUP 
SETTING; PRELIMINARY OBSERVATIONS. 

169086 01-14 
EFFECTS OF DIPHENYLHYDANTOIN ON ANXIETY AND HOSTILITY IN 
INSTITUTIONALIZED PRISONERS. 

177671 02-11 
CHLORDIAZEPOXIDE AND HOSTILITY IN ANXIOUS OUTPATIENTS. 

181273 02-10 
RELATIONSHIP OF PLASMA MEPERIDINE LEVELS TO CHANGES IN ANXIETY 
AND HOSTILITY. 

185881 03-14 

HOUSED 

BRAIN TO SERUM DISTRIBUTION OF RADIOACTIVITY OF INJECTED 3H-D- 
AMPHETAMINE IN DIFFERENTIALLY HOUSED MICE. 

168418 01-03 

HOUSING 

THE EFFECTS OF EARLY P-CHLOROPHENYLALANINE ADMINISTRATION 
AND POSTWEANING HOUSING CONDITIONS ON SEROTONIN AND 
BEHAVIOR IN RATS. 

178638 02-04 

HUMAN 

OPERANT BEHAVIOR AND NEUROPHYSIOLOGICAL OBSERVATIONS OF 
NORMAL HUMAN VOLUNTEERS RECEIVING CL-1848C, A NEW 
DISSOCIATIVE ANESTHETIC. 

167334 01-07 

THE EFFECT OF PLACEBO AND DRUGS ON HUMAN SLEEP. 

168419 01-14 

METABOLITES OF BROMAZEPAM, A BENZODIAZEPINE, IN THE HUMAN, 

DOG, RAT, AND MOUSE. 

170837 01-03 

DMT ADMINISTRATION TO HUMAN SUBJECTS. (UNPUBLISHED PAPER). 

173522 01-12 
REINVESTIGATION ON THE EFFECTS OF THIOPENTAL ON THE HUMAN 
SOMATOSENSORY EVOKED RESPONSE. 

174505 01-13 

INTERACTION OF PHENOTHIAZINE DERIVATIVES WITH HUMAN 

^^^^^OPlASmU. ,77335 02-13 

AMPHETAMINE IN HUMAN PLASMA: A SENSITIVE AND SPECIFIC 

ENZYMATIC ASSAY. „, „o ,. 

177403 02-16 

EFFECT OF ORAL ADMINISTRATION OF DELTA9- 

TETRAHYDROCANNABINOL ON MEMORY, SPEECH, AND PERCEPTION 
OF THERMAL STIMULATION: RESULTS WITH FOUR NORMAL HUMAN 
VOLUNTEER SUBJECTS. PRELIMINARY REPORT. 

177674 02-14 

THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 
DRUGS ON HUMAN SLEEP: IV. THE EFFECTS OF CHLORPROMAZINE. 

177716 0214 
THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 

DRUGS ON HUMAN SLEEP: V. THE EFFECTS OF CHLORAL HYDRATE 

177717 02-14 
THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 

DRUGS ON HUMAN SLEEP: VI. THE EFFECTS OF CHLORDIAZEPOXIDE. 

177718 02-14 
STRUCTURAL FUNCTIONAL ORGANIZATION OF THE HUMAN BRAIN AND 

THE PATHOPHYSIOLOGY OF THE PARKINSONIAN TYPE HYPERKINESES. 

178787 02-13 
BINDING OF DIAZOXIDE AND OTHER BENZOTHIADIAZINES TO HUMAN 

*L^"'"'^- ,79987 02-13 

EFFECTS OF CHLORPROMAZINE AND ACTINOMYCIN D ON UPTAKE AND 
INCORPORATION OF CERTAIN AMINO ACIDS, HYPOXANTHINE AND 
THYMIDINE IN CULTURES OF HUMAN SKIN EPITHELIAL CELLS. 

179989 02-13 
ISOLATION OF A POSSIBLE NEW METABOLITE OF THIORIDAZINE AND 
MESORIDAZINE FROM HUMAN PLASMA. 

,82722 03-13 



QUANTITATIVE DETERMINATION OF IMIPRAMINE AND DESIPRAMINE IN 
HUMAN BLOOD PLASMA BY DIRECT DENSITOMETRY OF THIN-LAYER 
CHROMATOGRAMS. 

183603 03-13 

IMIPRAMINE AND ITS METABOLITES IN HUMAN BRAIN. 

183604 03-13 
MUTAGENICITY EXPERIMENTS WITH THE TRANQUILLIZER MEPROBAMATE 

IN DROSOPHILA-MELANOGASTER AND IN HUMAN LEUKOCYTE 
CHROMOSOMES IN VITRO 

1 84585 03-05 
PERPHENAZINE CONCENTRATIONS IN HUMAN WHOLE BLOOD: A PILOT 
STUDY DURING ANTIPSYCHOTIC THERAPY USING DIFFERENT 
ADMINISTRATION FORMS. 

187639 04-16 
INFLUENCE OF PH ON THE BENZODIAZEPINE HUMAN SERUM ALBUMIN 
COMPLEX: CIRCULAR DICHROISM STUDIES. 

189595 04-13 
INHIBITION OF THE SLEEP RELATED PEAK IN PHYSIOLOGIC HUMAN 
GROWTH HORMONE RELEASE BY SOMATOSTATIN. 

190104 04-13 
MONOAMINE OXIDASE IN MAN: ENZYME CHARACTERISTICS IN HUMAN 
PLATELETS, PLASMA, AND OTHER HUMAN TISSUES. 

191502 04-13 
HUMAN SERUM DOPAMINE-BETA-HYDROXYLASE: RELATIONSHIP TO 
SYMPATHETIC ACTIVITY IN PHYSIOLOGICAL AND PATHOLOGICAL 

STATES. 

191510 04-13 

POST-MORTEM MEASUREMENT OF ENZYMES IN HUMAN BRAIN: 
EVIDENCE OF A CENTRAL NORADRENERGIC DEFICIT IN 
SCHIZOPHRENIA. 

191529 04-13 

INFLUENCE OF VARIOUS SUBSTANCES WHICH INDUCE AND INHIBIT 
AGGREGATION ON THE UPTAKE OF DEOXYGLUCOSE BY HUMAN 

BLOOD PLATELETS. 

191770 04-13 

HUMANS 

INCREASE IN THE PLASMA CONCENTRATION OF FREE TRYPTOPHAN 
CAUSED BY PROBENECID IN HUMANS. 

169470 01-13 
RUBIDIUM SALTS - TOXIC EFFECTS IN HUMANS AND CLINICAL EFFECTS 
AS AN ANTIDEPRESSANT DRUG. 

182443 03-09 
REPEAT ADMINISTRATION OF MARIHUANA SMOKE TO HUMANS. 

188120 04-13 
PHARMACOKINETICS AND DISTRIBUTION PROPERTIES OF 

PENTOBARBITAL IN HUMANS FOLLOWING ORAL AND INTRAVENOUS 
ADMINISTRATION. „ ,„ 

191444 04-13 

CHANGES IN RHYTHMS OF BIOELECTRICAL ACTIVITY OF THE CEREBRAL 
CORTEX IN HUMANS UNDER THE INFLUENCE OF ETHYMISOL. 

191790 04-07 

PREDATION: SEPARATION OF AGGRESSIVE AND HUNGER MOTIVATION 
BY CONDITIONED AVERSION. 

185463 03-04 

HUNTINGTONS 

HUNTINGTONS CHOREA: THE RIGID FORM (WESTPHAL VARIANT) 

TREATED WITH LEVODOPA. „,,,„„,,, 

187618 04-11 

HUNTINGTONS CHOREA TREATED WITH LITHIUM CARBONATE. 

187985 04-11 

HVA 

LEVELS OF HVA IN MOUSE BRAIN FOLLOWING TREATMENT WITH 
METABOLITES OF CHLORPROMAZINE 

171626 01-02 

HYDE 

METHAQUALONE -- A DR. JEKYLL AND MR. HYDE? 

177396 02-1; 

PSYCHOPATHOLOGICAL IMPORTANCE AND THERAPEUTIC EFFECTS OF A 
COMBINATION OF HYDERGINE AND THIORIDAZINE IN PSYCHIATRIC 
SYNDROMES IN THE AGING. 

168976 01-1' 

AN ERGOT ALKALOID PREPARATION (HYDERGINE) VERSUS PAPAVERINE 
IN TREATING COMMON COMPLAINTS OF THE AGED: DOUBLE-BLIND 

S^^'^^- 173190 01-11 

HYDRATE 

THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 
DRUGS ON HUMAN SLEEP: V. THE EFFECTS OF CHLORAL HYDRATE. 

CONVERSION OF CHLORAL HYDRATE TO TRICHLOROETHANOL IN BRAIN 

AND LIVER. 

182157 02-0: 

HYDROCORTISONE 

HYDROCORTISONE INDUCED INCREASE IN THE HISTOCHEMICALLY 
DEMONSTRABLE CATECHOLAMINE CONTENT OF SYMPATHETIC 
NEURONS OF THE NEWBORN RAT 



S-114 



VOLUME 12, SUBJECT INDEX 



Subject Index 



HYDROGEN 

INTRACEREBRAL INJECTION OF 6-HYDROXYDOPAMINE AND HYDROGEN 
PEROXIDE IN CATS: SPECIFIC AND NONSPECIFIC EFFECTS ON STRIATAL 
BIOGENIC AMINES. 

188426 04-03 
HYDROPHOBICITY 

THE ROLE OF HYDROPHOBICITY IN THE ANTISEROTONIN ACTIVITY OF 
LSD ANALOGS. 

174606 01-12 
HYDROXYANISOLE 

THE EFFECT OF BUTYLATED HYDROXYANISOLE AND BUTYLATED 
HYDROXYTOLUENE ON BEHAVIORAL DEVELOPMENT OF MICE. 

188637 04-04 
HYDROXYAPORPHINES 

SYNTHESIS OF HYDROXYAPORPHINES AS POTENTIAL ANTIPARKINSONIAN 
AGENTS. (PH.D. DISSERTATION). 

174967 02-01 
HYDROXYLAMINE 

HYDROXYLAMINE INTERFERES WITH THE BEHAVIORAL RESPONSE TO 
MORPHINE DEPENDENCE IN MICE. 

171905 01-04 
HYDROXYLAAAINO 

METABOLISM OF CHLORPHENTERMINE AND PHENTERMINE IN MAN TO 
YIELD HYDROXYLAMINO, C-NITROSO AND NITRO COMPOUNDS. 

183796 03-13 
HYDROXYLASE 

SPECIFIC ACTIVATION OF STRIATAL TYROSINE HYDROXYLASE (TH) BY 
NEUROLEPTICS. (UNPUBLISHED PAPER). 

170755 01-03 
TYROSINE HYDROXYLASE (TH) ACTIVITY AND CYCLIC 3,5 ADENOSINE 
MONOPHOSPHATE (CAMP) CONCENTRATIONS IN SYMPATHETIC 
GANGLIA OF RATS: EFFECTS OF DRUGS ACTING AT CHOLINERGIC AND 
ADRENERGIC SYNAPSES. (UNPUBLISHED PAPER). 

170876 01-03 
DISSOCIATION OF STIMULATORY AND SYNTHETIC PHASES IN THE 
INDUCTION OF TYROSINE HYDROXYLASE. 

171785 01-03 
DRUG-INDUCED ACTIVATION OF STRIATAL TYROSINE HYDROXYLASE: 
CHANGES IN THE AFFINITY FOR PTERIDINE COFACTORS. (UNPUBLISHED 
PAPER). 

173381 01-03 
NOREPINEPHRINE SENSITIVE ADENYLATE CYCLASES IN RAT BRAIN: 
RELATION TO BEHAVIOR AND TYROSINE HYDROXYLASE. 

177252 02-03 
A SENSITIVE, SIMPLE METHOD FOR MEASUREMENT OF TYROSINE 
HYDROXYLASE AND TRYPTOPHAN-5-HYDROXYLASE ACTIVITIES. 

182178 02-06 
INFLUENCE OF METHAMPHETAMINE AND NEUROLEPTIC DRUGS ON 
TYROSINE HYDROXYLASE ACTIVITY. 

184180 03-03 
EFFECTS OF AMPHETAMINES ON REGIONAL TRYPTOPHAN HYDROXYLASE 
ACTIVITY AND SYNAPTOSOMAL CONVERSION OF TRYPTOPHAN TO 5- 
HYDROXYTRYPTAMINE IN RAT BRAIN. 

186674 03-03 
EVIDENCE FOR A CRITICAL PERIOD FOR POSTNATAL ELEVATION OF 
BRAIN TYROSINE HYDROXYLASE ACTIVITY RESULTING FROM 
RESERPINE ADMINISTRATION DURING EMBRYONIC DEVELOPMENT. 

186695 03-03 
COMPARISON OF TYROSINE HYDROXYLASE AND DOPAMINE-BETA- 
HYDROXYLASE INHIBITION WITH THE EFFECTS OF VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS ON D-AMPHETAMINE INDUCED 
MOTOR ACTIVITY. 

186699 03-03 
DEPLETION OF TRYPTOPHAN HYDROXYLASE BY 5,6 
DIHYDROXYTRYPTAMINE IN RAT BRAIN - TIME COURSE AND 
REGIONAL DIFFERENCES. 

188287 04-03 
THE EFFECT OF P-CHLOROPHENYLALANINE ON FOREBRAIN TRYPTOPHAN 
HYDROXYLASE IN RATS WITH LESIONS IN THE RAPHE NUCLEUS. 

188750 04-03 
SHORT-TERM CONTROL OF TYROSINE HYDROXYLASE. 

191513 04-03 
SHORT-TERM AND LONG-TERM REGULATION OF TYROSINE 
HYDROXYLASE. 

191515 04-03 
REGULATION OF FUNCTION OF TRYPTOPHAN HYDROXYLASE. 

191516 04-03 
ACTIVATION OF STRIATAL HYDROXYLASE BY HYDROXYLATED 

METABOLITES OF CHLORPROMAZINE. 

191908 04-03 
HYDROXYLASES 

STRIATAL TYROSINE HYDROXYLASES WITH HIGH AND LOW AFFINITY 
FOR TYROSINE: IMPLICATIONS FOR THE MULTIPLE POOL CONCEPT OF 
CATECHOLAMINES. 

167325 01-03 
HYDROXYLATED 

EFFECTS OF AMPHETAMINE AND ITS HYDROXYLATED METABOLITES ON 
CENTRAL NORADRENERGIC MECHANISMS. (PH.D. DISSERTATION). 

174959 01-03 



ACTIVATION OF STRIATAL HYDROXYLASE BY HYDROXYLATED 
METABOLITES OF CHLORPROMAZINE. 

191908 04-03 
HYDROXYLATION 

EFFECT OF CHLORIMIPRAMINE ON THE RATE OF TRYPTOPHAN 

HYDROXYLATION IN THE INTACT AND TRANSECTED SPINAL CORD. 

168751 01-03 
AMPHETAMINE TRICYCLIC INTERACTIONS: ROLE OF THE 

HYDROXYLATION OF AMPHETAMINE IN ITS CENTRAL AND PERIPHERAL 
MODE OF ACTION. (PH.D. DISSERTATION). 

174963 01-03 
THE HYDROXYLATION OF D-AMPHETAMINE BY LIVER MICROSOMES OF 
THE MALE RAT. 

177337 02-03 
IN VIVO ESTIMATION OF TYROSINE HYDROXYLATION IN THE 
DOPAMINERGIC TERMINALS OF THE RAT NEOSTRIATUM. 

183794 03-03 
REGIONAL CHANGES IN MONOAMINE LEVELS AND IN THE RATE OF 
TYROSINE AND TRYPTOPHAN HYDROXYLATION IN 4 WEEK OLD 
OFFSPRING OF NURSING MOTHERS TREATED WITH THE NEUROLEPTIC 
DRUG PENFLURIDOL. 

185899 03-03 
HYDROXYTOLUENE 

THE EFFECT OF BUTYLATED HYDROXYANISOLE AND BUTYLATED 
HYDROXYTOLUENE ON BEHAVIORAL DEVELOPMENT OF MICE. 

188637 04-04 
HYDROXYTRYPTOPHAN 

BEHAVIORAL EFFECT OF TRICYCLIC THYMOLEPTICS AND 

CHLORPHENIRAMINE IN MICE AFTER PRETREATMENT WITH 5 
HYDROXYTRYPTOPHAN (5-HTP). 

171609 01-04 
HYDROXYZINE 

THE ORAL HYPNOTIC BIOASSAY OF HYDROXYZINE AND PENTOBARBITAL 
FOR NIGHTTIME SEDATION. 

177320 02-11 
HYPERACTIVATING 

TOLERANCE TO THE HYPERACTIVATING EFFECTS OF 
METHYLAMPHETAMINE. 

186702 03-04 
HYPERACTIVE 

EFFECTS OF MEDICATION ON LEARNING IN HYPERACTIVE FOUR-YEAR- 
OLD CHILDREN. (ED.D DISSERTATION). 

172512 01-11 
SIDE-EFFECTS OF DEXTROAMPHETAMINE THERAPY OF HYPERACTIVE 
CHILDREN. 

176238 02-15 
CONTROL OF THE HYPERACTIVE CHILD VIA MEDICATION -- AT WHAT 
COST TO PERSONALITY DEVELOPMENT; SOME PSYCHOLOGICAL 
IMPLICATIONS AND CLINICAL INTERVENTIONS. 

176810 02-11 
DEXTROAMPHETAMINE AND METHYLPHENIDATE IN THE TREATMENT OF 
HYPERACTIVE/AGGRESSIVE CHILDREN. 

177771 02-14 
RESPONSE TO STIMULANT DRUG TREATMENT IN HYPERACTIVE 
CHILDREN: PREDICTION FROM EEG AND NEUROLOGICAL FINDINGS. 

177778 02-11 
OUTPATIENT TREATMENT OF HYPERACTIVE SCHOOL CHILDREN WITH 
IMIPRAMINE. 

184174 03-11 
IMIPRAMINE AND METHYLPHENIDATE TREATMENTS OF HYPERACTIVE 
BOYS: A DOUBLE-BLIND COMPARISON. 

185324 03-14 
DOSE EFFECTS OF METHYLPHENIDATE ON BEHAVIORAL INHIBITION AND 
ACTIVATION IN HYPERACTIVE CHILDREN. (PHD, DISSERTATION). 

185676 03-14 
EFFECTS OF METHYLPHENIDATE ON HYPERACTIVE CHILDRENS SLEEP. 

190321 04-14 
ELECTRODERMAL ACTIVITY IN HYPERACTIVE BOYS WHO ARE 
METHYLPHENIDATE RESPONDERS. 

191400 04-14 
INCREASED BRAIN NOREPINEPHRINE TURNOVER IN LEAD EXPOSED 
HYPERACTIVE RATS. 

191957 04-05 
HYPERACTIVES 

METHYLPHENIDATE AND THE ACTIVITY OF HYPERACTIVES IN THE 
INFORMAL SETTING. 

181853 02-14 
HYPERACTIVITY 

LEAD INDUCED BEHAVIORAL DYSFUNCTION: AN ANIMAL MODEL OF 
HYPERACTIVITY. 

184953 03-04 
EVIDENCE FOR A NORADRENERGIC AND DOPAMINERGIC MECHANISM IN 
THE HYPERACTIVITY PRODUCED BY 4,ALPHA DIMETHYL-M-TYRAMINE 
(H-77-77) IN RATS, 

190309 04-04 
CHOLINERGIC AMINERGIC INTERACTIONS IN LEAD INDUCED 
HYPERACTIVITY. 

191954 04-05 



{//.'■■/.•■■■■'•v. 



s-ns 



Subject Index 

HYPERKINESES 

STRUCTURAL FUNCTIONAL ORGANIZATION OF THE HUMAN BRAIN AND 
THE PATHOPHYSIOLOGY OF THE PARKINSONIAN TYPE HYPERKINESES. 

178787 02-13 

HYPERKINETIC 

SAFETY AND EFFECTIVENESS OF HALOPERIDOL FOR MENTALLY 

RETARDED BEHAVIORALLY DISORDERED AND HYPERKINETIC PATIENTS. 

169634 01-11 
HYPERKINETIC HYPOSCHOLASTIC BEHAVIOUR AND CHARACTER 
DISORDERS OF CHILDHOOD AND ADOLESCENCE: DIAGNOSIS AND 
PHARMACOTHERAPY. 

172800 01-11 

HYPERPHAGIA 

CHLORPROMAZINE INDUCED HYPERPHAGIA. {UNPUBLISHED PAPER). 

187498 04-04 

HYPERREACTIVITY 

MESCALINE HYPERREACTIVITY: HALLUCINATIONS IN RATS? 
(UNPUBLISHED PAPER). 

178575 02-04 
ANALGESIA AND HYPERREACTIVITY PRODUCED BY INTRACRANIAL 
MICROINJECTIONS OF MORPHINE INTO THE PERIAQUEDUCTAL GRAY 
MATTER OF THE RAT. 

191367 04-04 

HYPERRESPONSIVENESS 

MICROVASCULAR SMOOTH MUSCLE HYPERRESPONSIVENESS DURING 
HALOTHANE ANESTHESIA IN THE RAT. 

182185 02-03 

HYPERSENSITIVITY 

DOPAMINERGIC HYPERSENSITIVITY AND CHOLINERGIC HYPOFUNCTION 
IN THE PATHOPHYSIOLOGY OF TARDIVE DYSKINESIA. 

185929 03-11 
HYPERTENSION 

BEHAVIOR AND SENSITIVITY TO EXPERIMENTAL HYPERTENSION: II. LACK 
OF CORRELATION BETWEEN CERTAIN BEHAVIOR PATTERNS AND 
HYPERTENSION IN TWO NEW STRAINS OF RATS. 

173256 01-04 
HYPERTENSION AND DEPRESSION AND THEIR TREATMENT. 

183234 03-09 
ALTERED NOREPINEPHRINE SYNTHESIS OF SPLANCHNIC VESSELS IN 
NEUROGENIC HYPERTENSION. 

188198 04-03 
SERUM DOPAMINE-BETA-HYDROXYLASE: A POSSIBLE AID IN THE 
EVALUATION OF HYPERTENSION. 

191512 04-13 
THE USE OF PROPRANOLOL WITH VARIOUS DRUG COMBINATIONS IN 
THE TREATMENT OF ESSENTIAL HYPERTENSION. 

192511 04-13 
HYPERTHERMIA 

DOSE DEPENDENT POTENTIATION OR INHIBITION BY RO-4-4602 OF 5-HTP 
HYPERTHERMIA IN RABBITS. 

185996 03-03 

HYPERTHERMIC 

HYPERTHERMIC EFFECT OF PALMITATE SODIUM, STEARATE SODIUM AND 
OLEATE SODIUM INJECTED INTO THE CEREBRAL VENTRICLES OF 
CONSCIOUS CATS. 

186640 03-03 

HYPERTHYROIDISM 

ELECTROCARDIOGRAPHIC CHANGES IN HYPERTHYROIDISM AFTER 
ADRENERGIC BLOCKADE WITH RESERPINE AND PROPRANOLOL. 

167460 01-13 

HYPNOSIS 

POTENTIATION OF BARBITURATE HYPNOSIS BY 5-DIAZ0IMIDA20LE-4- 
CARBOXAMIDE AND ITS DERIVATIVES. 

182113 02-03 

HYPNOTIC 

THE PHARMACOLOGICAL EVALUATION IN LABORATORY ANIMALS OF 
KABI-1702 - A NEW SEDATIVE HYPNOTIC DRUG. 

171632 01-03 
CHRONIC HYPNOTIC DRUG USE: INEFFECTIVENESS, DRUG WITHDRAWAL 
INSOMNIA, AND DEPENDENCE. 

172114 01-15 
ON THE RECENTLY REPORTED PHYSIOLOGICAL AND PHARMACOLOGICAL 
REALITY OF THE HYPNOTIC STATE. 

173056 01-13 
(-)DELTA9-THC AS AN HYPNOTIC: AN EXPERIMENTAL STUDY OF THREE 

DOSE LEVELS. 

174041 01-14 

DEPENDENCE LIABILITY OF SEVERAL SEDATIVE HYPNOTIC AGENTS 
EVALUATED IN MONKEYS. 

174125 01-04 

EFFICACY AND RESIDUAL EFFECT EVALUATION OF A NEW HYPNOTIC, 

TRIAZOLAM. ,, 

1761C3 02-13 

THE ORAL HYPNOTIC BIOASSAY OF HYDROXYZINE AND PENTOBARBITAL 
FOR NIGHTTIME SEDATION. 

177320 02-11 
TRIAZOLAM: A SLEEP LABORATORY STUDY OF A NEW BENZODIAZEPINE 

HYPNOTIC. 

177747 02-07 



Psychopharmacology Abstracts 



AN ELECTROENCEPHALOGRAPHIC STUDY ON THE TOLERANCE OF THE 
VARIOUS PSYCHIATRIC AND NEUROLOGICAL PATIENTS TO THE 
HYPNOTIC EFFECTS OF DIPHENHYDRAMINE - MEASURED BY THE 
AMOUNTS OF SLEEP EEG AS AN INDICATOR. 

182550 03-11 
SEDATIVE OR TRANQUILLIZER? A COMPARISON OF THE HYPNOTIC 
EFFECTS OF CHLORDIAZEPOXIDE AND AMYLOBARBITONE SODIUM. 

184438 03-14 
METHAQUALONE: AN IRRATIONAL HYPNOTIC. 

189902 04- 15 
COMPARATIVE METABOLISM OF TRIAZOLAM, A NEW SEDATIVE 
HYPNOTIC, IN RAT, DOG AND MAN. 

191900 04-02 
A PREDICTABLE LABORATORY MODEL FOR SEDATIVE/HYPNOTIC 

ACTIVITY IN MAN. 

191943 04-14 

HYPNOTICA 

CLINICAL STUDIES OF ACUTE PSYCHOSIS ON THE BASIS OF CHRONIC 
HYPNOTICA INTOXICATION - AN ABSTRACT REPORT. 

182755 03-15 

HYPNOTICS 

DECREASED HISTAMINE SYNTHESIS IN THE RAT BRAIN BY HYPNOTICS 

AND ANESTHETICS. 

168750 01-03 

ARE THERE SAFER HYPNOTICS THAN BARBITURATES? 

174561 01-15 
EVALUATION OF HYPNOTICS IN OUTPATIENTS WITH INSOMNIA USING A 
QUESTIONNAIRE AND A SELF-RATING TECHNIQUE. 

1 77735 02-06 
MEDICOLEGAL STUDIES ON ISOLATION AND IDENTIFICATION OF 
HYPNOTICS BY THIN-LAYER CHROMATOGRAPHY (TLC) - REPORT 1. 
THIN-LAYER CHROMATOGRAPHY OF HYPNOTICS AND TRANQUILIZERS. 

181315 02-16 
MEDICOLEGAL STUDIES ON ISOLATION AND IDENTIFICATION OF 
HYPNOTICS BY THIN-LAYER CHROMATOGRAPHY (TLC): REPORT 2 - 
ISOLATION AND IDENTIFICATION OF HYPNOTICS AND TRANQUILIZER 

IN VIVO. 

182623 03-06 

ISOLATION AND IDENTIFICATION OF HYPNOTICS (8): ISOLATION AND 
IDENTIFICATION OF BENZALIN AND CERCINE BY THIN-LAYER 
CHROMATOGRAPHY IN VITRO. 

182626 03-01 

EFFECTS OF HYPNOTICS ON ANXIOUS PATIENTS. 

184445 03-10 

SOME RECENT HYPNOTICS ASSESSED. 

189673 04-14 

RATIONAL USE OF PSYCHOTROPIC DRUGS: I. HYPNOTICS. 

192190 04-14 

HYPNOTIZABILITY 

IMPACT OF PSYCHOACTIVE DRUGS ON HYPNOTIZABILITY. 

184021 03-12 

HYPODIPSIA 

DRINKING BEHAVIOUR AND BRAIN DOPAMINE: ANTAGONISTIC EFFECT 
OF TWO NEUROLEPTIC DRUGS (PIMOZIDE AND SPIRAMIDE) UPON 
AMPHETAMINE OR APOMORPHINE-INDUCED HYPODIPSIA. 

174035 01-04 

HYPOFUNCTION 

DOPAMINERGIC HYPERSENSITIVITY AND CHOLINERGIC HYPOFUNCTION 
IN THE PATHOPHYSIOLOGY OF TARDIVE DYSKINESIA. 

185929 03-11 

HYPOGLYCEMIA 

CONDITIONED HYPOGLYCEMIA: A MECHANISM FOR SACCHARIN 
INDUCED SENSITIVITY TO INSULIN IN THE RAT. 

174877 01-03 
STUDIES ON CENTRAL REGULATING MECHANISM OF THE HYPOGLYCEMIA 
INDUCED BY INTRAVENTRICULAR ADMINISTRATION OF 
CHLORPROMAZINE. 

182093 02-03 

HYPOGLYCEMIC 

PROPRANOLOL ENHANCEMENT OF HYPOGLYCEMIC SWEATING, 

186187 03-13 

HYPOMANIC 

ON THE STUPOROUS AND HYPOMANIC EPISODES ASSOCIATED WITH 
SPIKE AND WAVE IN ELECTROENCEPHALOGRAM. 

181388 02-11 

HYPOSCHOLASTIC 

HYPERKINETIC, HYPOSCHOLASTIC BEHAVIOUR AND CHARACTER 
DISORDERS OF CHILDHOOD AND ADOLESCENCE: DIAGNOSIS AND 

PHARMACOTHERAPY. „„ ^, ,, 

172800 01-11 

HYPOTENSION ^ „ ,. 

THE CORRECTIVE EFFECT OF PRAXINOR ON HYPOTENSION ATTRIBUTABLE 
TO PSYCHIATRIC THERAPY. SIDE-EFFECTS, 

172980 CM' 

HYPOTENSION FROM DRUGS: INCIDENCE, PERIOD, PREVENTION. 

176674 02-1; 



S-116 



" "'^*~ 



VOLUME 12, SUBJECT INDEX 

ROLE OF THE CENTRAL AUTONOMIC NERVOUS SYSTEM IN THE 
HYPOTENSION AND BRADYCARDIA INDUCED BY (-) DELTA9- 
TETRAHYDROCANNABINOL. 

183795 03-03 
HYPOTENSIVE 

3-ARYL-3-HYDROXYQUINOLIZIDINES WITH POTENTIAL HYPOTENSIVE 
ANTIDEPRESSANT, AND ANALGETIC ACTIVITY. 

187938 04-01 
DOSE-RELATED ALTERATIONS IN METABOLISM OF LEVODOPA- POSSIBLE 
MECHANISM FOR HYPOTENSIVE EFFECT. 

190194 04-11 
HYPOTHALAMIC 

RECOVERY OF FEEDING AND DRINKING BY RATS AFTER 
INTRAVENTRICULAR 6-HYDROXYDOPAMINE OR LATERAL 
HYPOTHALAMIC LESIONS. 

168484 01-03 

INFLUENCE OF MORPHINE ON LATERAL HYPOTHALAMIC SELF- 
STIMULATION IN THE RAT. 

168835 01-04 
EFFECTS OF TRICYCLIC ANTIDEPRESSANTS ON ATTACK ELICITED BY 
HYPOTHALAMIC STIMULATION: RELATION TO BRAIN BIOGENIC 
AMINES. 

170162 01-04 
STRUCTURE-ACTIVITY RELATIONS FOR THE INHIBITION OF 5-HT UPTAKE 
INTO RAT HYPOTHALAMIC HOMOGENATES BY SEROTONIN AND 
TRYPTAMINE ANALOGUES. 

1 75233 02-03 
THE THALAMIC RAT: GENERAL BEHAVIOR. OPERANT LEARNING WITH 
REWARDING HYPOTHALAMIC STIMULATION, AND EFFECTS OF 
AMPHETAMINE. 

1 77477 02-04 
INHIBITORY EFFECT OF DOXEPIN ON AGONISTIC BEHAVIOUR ELICITED BY 
HYPOTHALAMIC STIMULATION IN THE CAT. 

180044 02-04 
EFFECTS OF NEUROPHARMACOLOGICAL AGENTS ON HYPOTHALAMIC 
NEURONAL ACTIVITY: A MICROELECTROPHORETIC STUDY. 

182123 02-03 
DECREASED ANOREXIA, EXCITEMENT AND STEREOTYPY TO D- 
AMPHETAMINE AFTER LATERAL HYPOTHALAMIC 6- 
HYDROXYDOPAMINE (6-OHDA) INJECTIONS. 
„_„ 182136 02-04 

RECOVERY OF FEEDING AFTER 6-HYDROXYDOPAMINE (6-HDA) OR 
LATERAL HYPOTHALAMIC LESIONS: THE ROLE OF CATECHOLAMINES. 

182213 03-03 
ALPHA-ADRENERGIC RECEPTORS MEDIATE SUPPRESSION OF DRINKING 
INDUCED BY HYPOTHALAMIC AMPHETAMINE INJECTION. 

182216 03-03 
EFFECTS OF METHAMPHETAMINE ON DAILY RHYTHMS OF 
HYPOTHALAMIC NOREPINEPHRINE, SEROTONIN AND PLASMA 
CORTICOSTERONE LEVELS IN THE RAT. 

184178 03-03 
THE EFFECT OF HYPOTHALAMIC STIMULATION ON ORAL INGESTION OF 
DIAZEPAM IN RATS. 

184238 03-04 
EFFECTS OF CENTRALLY APPLIED DRUGS ON PRESSOR RESPONSES TO 
HYPOTHALAMIC STIMULATION. 

185902 03-03 
RELUCTANCE OF RATS TO DRINK HASHISH SUSPENSIONS FREE-CHOICE 
AND FORCED CONSUMPTION, AND THE EFFECTS OF HYPOTHALAMIC 
STIMULATION. 

186586 03-04 
DRUG EFFECTS AND HYPOTHALAMIC ANTERIOR PITUITARY FUNCTION. 

188393 04-03 
YPOTHALAMUS 

EFFECT OF MONOAMINE OXIDASE INHIBITORS ON METABOLISM AND IN 
VIVO RELEASE OF H3-N0REPINEPHRINE FROM THE HYPOTHALAMUS. 

171973 01-03 
IN VIVO RELEASE OF NEWLY SYNTHESIZED CATECHOLAMINES FROM THE 
HYPOTHALAMUS BY AMPHETAMINE. 

184230 03-03 
NEUROCHEMICAL ANALYSIS OF AGGRESSIVE - DEFENSIVE BEHAVIOR 
ELICITED BY ELECTRICAL STIMULATION OF THE HYPOTHALAMUS AND 
CENTRAL GRAY MATTER. 

T„r... « 191784 04-02 

THE ACTION OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTOR 
CENTERS OF EMOTIONS IN THE HYPOTHALAMUS. 

191785 04-02 
irPOTHERMIA 

RETROGRADE AMNESIA FROM HYPOTHERMIA INDUCED BRAIN SEIZURES. 
,,,„„ 167398 01-04 

CHRONOPHARMACOLOGY OF DELTA9TETRAHYDR0CANNABIN0L 
HYPOTHERMIA IN MICE. 

176880 02-03 
HYPOTHERMIA EVOKED BY A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE ALKALOID. 

1 ft9 1 '^0 no m 
CENTRAL HYPOTHERMIA BY 2-DEOXY-D-GLUCOSE: ANTAGONISM BY 
ALPHA-ADRENERGIC ACTIVATION. 

188200 04-03 



Subject Index 



HYPOTHERMIC 

EVALUATION OF THE HYPOTHERMIC ACTION OF 

TETRAHYDROCANNABINOLS IN MICE AND SQUIRREL MONKEYS 

170163 01-03 

DEVELOPMENT OF TOLERANCE IN RATS TO THE HYPOTHERMIC EFFECTS 
OF D-AMPHETAMINE AND APOMORPHINE. 

174764 01-03 

HYPOTHERMIC ACTION OF DELTA9-TETRAHYDR0CANNABIN0L 11-OH- 
0ELTA9-TETRAHYDR0CANNABIN0L AND ll-OHDELTAS- 
TETRAHYDR0CANNABIN0L(DELTA9-THC, 1 1-0HDELTA9THC AND 11- 
0H-DELTA8-THC) IN MICE. 

1 82220 03-03 
THE EFFECT OF HYPOTHERMIC DOSES OF 1-DELTA9- 

TETRAHYDROCANNABINOL ON BIOGENIC AMINE METABOLISM IN 
SELECTED PARTS OF THE RAT BRAIN. 

188231 04-03 
ANALYSIS OF HYPOTHERMIC ACTION OF DELTA9- 
TETRAHYDROCANNABINOL (DELTA9-THC) IN MICE. 

191997 04-03 
HYPOTHESES 

DIFFERENTIATING STIMULUS AND STORAGE HYPOTHESES OF STATE- 
DEPENDENT LEARNING. 

188226 04-14 
HYPOTHESIS 

L-TRYPTOPHAN IN MANIA: CONTRIBUTION TO A PERMISSIVE 
HYPOTHESIS OF AFFECTIVE DISORDERS. 

171500 01-09 
HYPOXANTHINE 

EFFECTS OF CHLORPROMAZINE AND ACTINOMYCIN D ON UPTAKE AND 
INCORPORATION OF CERTAIN AMINO ACIDS, HYPOXANTHINE AND 
THYMIDINE IN CULTURES OF HUMAN SKIN EPITHELIAL CELLS 

179989 02-13 
HYPOXIA 

MECHANISMS UNDERLYING POTENTIATION OF BARBITURATE ACTION BY 
SODIUM NITRITE IN THE MOUSE: THE ROLE OF METHEMOGLOBIN 
INDUCED HYPOXIA. 

182721 03-03 
HYSTERIC 

ELECTROENCEPHALOGRAM OF HYSTERIC PATIENTS. 

1 75069 02-09 
H3-DEITA9-TETRAHYDROCANNABINOL 

DISPOSITION OF H3-DELTA9-TETRAHYDR0CANNABIN0L IN BRAIN OF 

PREGNANT DOGS AND THEIR FETUSES. 

191968 04-03 
SUBCELLULAR LOCALIZATION OF H3-DELTA9-TETRAHYDR0CANNABIN0L 

IN DOG BRAIN AFTER ACUTE OR CHRONIC ADMINISTRATION. 

191970 04-03 
H3-DOPAMINE 

INCREASED AXOPLASMIC TRANSPORT OF H3-D0PAMINE IN NIGRO- 
NEOSTRIATAL NEURONS AFTER RESERPINE. 

175241 02-03 
H3-NOREPINEPHRINE 

EFFECT OF MONOAMINE OXIDASE INHIBITORS ON METABOLISM AND IN 

VIVO RELEASE OF H3-N0REPINEPHRINE FROM THE HYPOTHALAMUS 

171973 01-03 
IDEATION 

TEMPORAL DISORGANIZATION AND DELUSIONAL-LIKE IDEATION 
PROCESSES INDUCED BY HASHISH AND ALCOHOL. 

185330 03-14 
IDENTIFICATION 

MEDICOLEGAL STUDIES ON ISOLATION AND IDENTIFICATION OF 
HYPNOTICS BY THIN-LAYER CHROMATOGRAPHY (TLC) - REPORT 1 
THIN-LAYER CHROMATOGRAPHY OF HYPNOTICS AND TRANQUILIZERS. 

181315 02-16 

MEDICOLEGAL STUDIES ON ISOLATION AND IDENTIFICATION OF 
HYPNOTICS BY THIN-LAYER CHROMATOGRAPHY (TLC): REPORT 2 -- 
ISOLATION AND IDENTIFICATION OF HYPNOTICS AND TRANQUILIZER 
IN VIVO. 

182623 03-06 
ISOLATION AND IDENTIFICATION OF HYPNOTICS (8): ISOLATION AND 
IDENTIFICATION OF BENZALIN AND CERCINE BY THIN-LAYER 
CHROMATOGRAPHY IN VITRO. 

182626 03-01 
IDENTIFICATION AND QUANTITATIVE DETERMINATION OF 
PHENOTHIAZINE DRUGS IN URINE SAMPLES OF PSYCHIATRIC 
PATIENTS. 

183599 03-02 
BUTOBARBITONE METABOLISM IN MAN: IDENTIFICATION OF 3- 
KETOBUTOBARBITONE. 

183793 03-13 
ILEUM 

THE UPTAKE, RETENTION AND METABOLISM OF 3H-5- 

HYDROXYTRYPTAMINE IN BRAIN SLICES AND ILEUM FROM THE RAT- 
EFFECTS OF COCAINE, DESMETHYLIMIPRAMINE AND RESERPINE (PH D 
DISSERTATION). 

168131 01-03 







5-117 



Subject Index 



Psychopharmacology Abstracts 



THE EFFECT OF CATECHOLAMINES, ACETYLCHOLINE AND SEROTONIN ON 
THE MORPHINE TOLERANT LONGITUDINAL MUSCLE STRIP OF THE 

^^"^^*-^"^'^^^'^- ,8216,02-03 

SEPARATION OF THE DEPENDENCE PRODUCING ACTIONS FROM THE 

DIRECT ACTIONS OF NARCOTICS ON GUINEA-PIG ILEUM. 

,82,62 02-03 
INTERACTION BETWEEN SEROTONIN AND MORPHINE IN THE GUINEA-PIG 

'^^^^ ,86698 03-03 

ALPHA-L-ACETYLMETHADOL AND ITS N-DEMTHYLATED METABOLITES 
HAVE POTENT OPIATE ACTION IN THE GUINEA-PIG ISOLATED ILEUM. 

,87,30 03-03 



ILL 



MOLINDONE- A CROSSOVER EVALUATION OF CAPSULE AND TABLET 
FORMULATIONS IN SEVERELY ILL SCHIZOPHRENIC PATIENTS. 

,74137 01-08 
PSYCHOPHARMACOLOGICAL AGENTS FOR THE TERMINALLY ILL AND 

''^"'''°- ,88,49 04-,7 

RADIOIMMUNOASSAY FOR LYSERGIDE (LSD) IN ILLICIT DRUGS AND 

BIOLOGICAL FLUIDS. 

170840 0,-06 

COMBINATIONS OF ANTIDEPRESSANT DRUGS IN THE TREATMENT OF 

DEPRESSIVE ILLNESS. „,,.,„, ^ 

,683,7 0,-09 

THE USE OF LITHIUM IN AFFECTIVE DISORDERS, III: A DOUBLE-BLIND 
STUDY OF PROPHYLAXIS IN BIPOLAR ILLNESS. 

,69495 0,-09 
DRUGS AND PSYCHODYNAMIC SHIFTS IN AFFECTIVE ILLNESS. 

(UNPUBLISHED PAPER). 

,70079 0,-09 

BRAIN SEROTONIN, AFFECTIVE ILLNESS AND ANTIDEPRESSANT DRUGS: 

CEREBROSPINAL FLUID STUDIES WITH PROBENECID. (UNPUBLISHED 

'^''^'- ,70084 0,-09 

SINGLE VERSUS DIVIDED DAILY DOSE OF TRIMIPRAMINE IN THE 
TREATMENT OF DEPRESSIVE ILLNESS. 

,70622 01 09 

LITHIUM PROPHYLAXIS IN RECURRENT AFFECTIVE ILLNESS. 

,7,926 01-09 
CENTRAL DOPAMINE FUNCTION IN AFFECTIVE ILLNESS: EVIDENCE FROM 
PRECURSORS, ENZYME INHIBITORS AND STUDIES OF CENTRAL 
DOPAMINE TURNOVER. (UNPUBLISHED PAPER). 

181358 02-09 
FACTORS ASSOCIATED WITH LITHIUM RESPONSE IN THE PROPHYLACTIC 
TREATMENT OF BIPOLAR MANIC-DEPRESSIVE ILLNESS. 

186,88 03-09 
A CASE OF A NONSPECIFIC MENTAL ILLNESS WITH PSYCHOMOTOR 

VARIANT. 

,88517 04-09 

PROPHYLACTIC EFFICACY OF LITHIUM CARBONATE IN MANIC- 
DEPRESSIVE ILLNESS: REPORT OF THE VETERANS ADMINISTRATION 
AND NATIONAL INSTITUTE OF MENTAL HEALTH (VA-NIMH) 
COLLABORATIVE STUDY GROUP. 

189735 04-09 

MENTAL ILLNESS OR METAL ILLNESS? BISMUTH SUBGALLATE. 

19,215 04-15 

ILLNESSES 

FLUPENTHIXOL IN CERTAIN PSYCHIATRIC ILLNESSES. 

175393 02-11 
A STUDY OF REFRACTORY CASES OF DEPRESSIVE ILLNESSES AND THEIR 
RESPONSE TO COMBINED ANTIDEPRESSANT TREATMENT. 

185078 03-10 

ILLUSTRATIONS .,.,.,,.r., 

THE DESIGN OF THERAPEUTIC TRIALS: A CRITICAL ANALYSIS WITH 
ILLUSTRATIONS, PARTICULARLY FROM THE FIELD OF PSYCHOTROPIC 
DRUGS OR WHY NO ONE CAN EVER DO A PROPER DRUG TRIAL. 

173307 0,-16 

IMAO 

ARE THE IMAO OUTDATED? 

,83202 03-09 

EFFECTS OF GUANETHIDINE AND IMIDAZOLE ON HISTAMINE RESPONSE. 

,87799 04-03 

IMINODIBENZYL 

STUDIES ON SIDE-EFFECTS AND WITHDRAWAL SYMPTOMS OF 

IMINODIBENZYL DERIVATIVES. ,^ 

,73080 0,-15 

IMIPRAMINE 

COMPARABLE THERAPEUTIC EFFICACY OF TRYPTOPHAN AND 
IMIPRAMINE: AVERAGE THERAPEUTIC RATINGS VERSUS TRUE 
EQUIVALENCE. AN IMPORTANT DIFFERENCE. 

167344 01-09 

A CONTROLLED STUDY OF SINGLE DOSE ADMINISTRATION OF 
IMIPRAMINE PAMOATE IN ENDOGENOUS DEPRESSION. 

167775 01-09 



EFFECTS OF IMIPRAMINE ON COPULATORY BEHAVIOR OF MALE RATS. 

168718 0,-04 
IMIPRAMINE, DIAZEPAM AND GROUP PSYCHOTHERAPY IN LONG-TERM 
TREATMENT OF DEPRESSIVE NEUROTICS. 

,69089 0,-,0 
IMIPRAMINE IN THE TREATMENT OF MINIMAL BRAIN DYSFUNCTION IN 
CHILDREN. 

,69295 01-11 
THE TREATMENT OF DEPRESSION WITH A SINGLE DAILY DOSE OF 
IMIPRAMINE PAMOATE. 

169491 0,-09 

EFFECT OF IMIPRAMINE ON THE TURNOVER OF BRAIN 5-HT IN 
POSTNATAL RATS. 

,7,624 0,-03 

A DOUBLE-BLIND INVESTIGATION OF DIMETHACRINE VERSUS 
IMIPRAMINE IN HOSPITALIZED DEPRESSIVE STATES 

,7,695 01-09 
PLASMA BINDING OF IMIPRAMINE AND CLINICAL OUTCOME. 

172271 01-13 
METHYLTESTOSTERONE WITH IMIPRAMINE IN MEN: CONVERSION OF 
DEPRESSION TO PARANOID REACTION. 

172992 0,-15 
KINETICS AND CELLULAR CONTROL MECHANISMS FOR IMIPRAMINE 
METABOLISM IN THE ISOLATED PERFUSED RAT LIVER. (PH.D. 
DISSERTATION). 

173601 01-03 
EFFECTS OF AMITRIPTYLINE AND IMIPRAMINE ON AMINE METABOLITES 
IN THE CEREBROSPINAL FLUID OF DEPRESSED PATIENTS. 

,74094 01-09 
AMOXAPINE AND IMIPRAMINE: A DOUBLE-BUND STUDY IN DEPRESSED 

PATIENTS. ^„ „, „„ 

174138 01-09 

A DOUBLE-BLIND TRIAL OF IPRINDOLE AND IMIPRAMINE IN DEPRESSIVES 
AND RESPONSE TO ECT IN REFRACTORY CASES. 

,74376 01-09 

MEASURING THE PHARMACOLOGICAL ACTION OF IMIPRAMINE IN THE 
TREATMENT OF DEPRESSIONS. 

1 74995 02-09 

EXPERIENCE IN THE USE OF IMIPRAMINE. 

176448 02-10 
INHIBITION OF LUNG, LIVER AND BRAIN MONOAMINE OXIDASE BY 
IMIPRAMINE AND DESIPRAMINE. 

1 77332 02-03 

IMIPRAMINE WITHDRAWAL: AN AKATHISIA LIKE SYNDROME. 

177710 02-15 
MYOCARDIOPATHIC COMPLICATIONS INDUCED BY IMIPRAMINE AND 
TRICYCLIC THYMOLEPTICS. 

182898 03-15 

INFLUENCE OF DIBENCYCLADINE AND IMIPRAMINE ON CALORIE INTAKE 

AND BODYWEIGHT. ^ 

183359 03-03 

COMPARATIVE EVALUATION OF DIBENCYCLADINE (LUDIOMIL) AND 
IMIPRAMINE IN PSYCHOTIC DEPRESSION. 

18336, 03-W 

QUANTITATIVE DETERMINATION OF IMIPRAMINE AND DESIPRAMINE IN 
HUMAN BLOOD PLASMA BY DIRECT DENSITOMETRY OF THIN-LAYER 
CHROMATOGRAMS. ,83603 03-1: 

IMIPRAAAINE AND ITS METABOLITES IN HUMAN BRAIN. 

,83604 03-,: 
OUTPATIENT TREATMENT OF HYPERACTIVE SCHOOL CHILDREN WITH 

IMIPRAMINE. , „, ,, 

,84,74 03-1 

IMIPRAMINE AND METHYLPHENIDATE TREATMENTS OF HYPERACTIVE 
BOYS A DOUBLE-BLIND COMPARISON. 

185324 03-1' 
IMIPRAMINE MEDIATED EFFECTS ON LEVODOPA METABOLISM IN MAN. 

185998 03- 1: 
A CONTROLLED TRIAL OF IMIPRAMINE HYDROCHLORIDE ON ENURESIS. 

186553 03-1 
PERSISTENT ELECTROENCEPHALOGRAPHIC CHANGES IN RHESUS 
MONKEYS AFTER SINGLE DOSES OF PENTOBARBITAL, NITRAZEPAM 
AND IMIPRAMINE. ^^^^^^^^^^ 

IMIPRAMINE IN EXPERIMENTAL PETIT-MAL EPILEPSY. 

1 88424 04-0 

EFFECT OF IMIPRAMINE ON CULTURED RAT HEART CELLS. 

188864 04-0 

IMIPRAMINE SIDE-EFFECTS IN CHILDREN 

189512 041 

THE COMPARATIVE ANXIOLYTIC EFFECTS OF PLACEBO, IMIPRAMINE AN( 
CHLORIMIPRAMINE USING PSYCHIATRIC AND PSYCHOPHYSIOLOGICAL 
MEASUREMENTS. ^^,^3^^^, 

DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) IMIPRAMINE 
INTERACTION ON MOUSE BODY TEMPERATURE. 

191996 04-0 



5-118 



OLUME 12, SUBJECT INDEX 



THE INFLUENCE OF IMIPRAMINE, DEXPHENMETRAZINE AND 

AMPHETAMINE SULPHATE ON THE COMPOSITION OF DIURNAL SLEEP 
OF NARCOLEPTICS. 

192419 04-11 
IIPRAMINE-N-OXIDE 

CLINICAL EFFECTS OF IMIPRAMINE-N-OXIDE ON DEPRESSION 

191716 04-09 
MATURE 

EFFECTS OF METHAMPHETAMINE, PIPRADROL, AND METHYLPHENIDATE 
ON INSTRUMENTAL CONDITIONING AND SPONTANEOUS MOTOR 
ACTIVITY IN THE IMMATURE RAT. 

186568 03-04 
MUNE 
THE EFFECT OF LOWERED BODY TEMPERATURE ON LIFESPAN AND 
IMMUNE AND NONIMMUNE PROCESSES. 

169675 01-03 
EFFECTS OF DELTA8-THC AND DELTA9-TETRAHYDR0CANNABIN0L ON THE 
IMMUNE RESPONSE IN MICE. 

191960 04-03 
STUDIES OF THE IMMUNE RESPONSE IN CHRONIC MARIHUANA 

SMOKERS. 

191961 04-13 
MUNIZATION 

BLOCKING OF THE EFFECT OF A DELTAl-TETRAHYDROCANNABINOL 
(DELTAl-THC) ON SPONTANEOUS MOTOR ACTIVITY IN THE RAT BY 
IMMUNIZATION WITH A PROTEIN CONJUGATE OF DELTAl-THC. 

187129 03-04 
MUNOASSAY 

PSYCHOACTIVE DRUGS: IMMUNOASSAY AND LOCALIZATION. 

173536 01-06 
MUNOREACTIVE 

PLASMA LEVELS OF LUTEINIZING HORMONE AND OF IMMUNOREACTIVE 
ESTROGENS (ESTRADIOL) IN ANOREXIA-NERVOSA: RESPONSE TO 
CLOMIPHENE CITRATE. 

183807 03-10 
>ACT 

IMPACT OF PSYCHOACTIVE DRUGS ON HYPNOTIZABILITY. 

184021 03-12 
■AIRMENT 
EEG CHANGES 8. MOTOR IMPAIRMENT AFTER DISULFIRAM 
ADMINISTRATION TO CATS. 

182248 03-03 
LEARNING IMPAIRMENT IN RATS AFTER 6-HYDROXYDOPAMINE INDUCED 
DEPLETION OF BRAIN CATECHOLAMINES. 

187420 04-04 
IMPAIRMENT OF OPTOKINETIC NYSTAGMUS IN PATIENTS WITH TARDIVE 
DYSKINESIA. 

189734 04-13 
AIRS 

ANISOMYCIN, LIKE OTHER INHIBITORS OF CEREBRAL PROTEIN 

SYNTHESIS, IMPAIRS LONG-TERM MEMORY OF A DISCRIMINATION 
TASK. 

188605 04-04 
LANT 

STUDY OF THE USE OF DISULFIRAM IMPLANT IN THE TREATMENT OF 
ALCOHOLISM. 

183030 03-11 
DISULFIRAM IMPLANT: A CONTROLLED TRIAL. 

185190 03-11 
ORTANT 

COMPARABLE THERAPEUTIC EFFICACY OF TRYPTOPHAN AND 
IMIPRAMINE: AVERAGE THERAPEUTIC RATINGS VERSUS TRUE 
EQUIVALENCE. AN IMPORTANT DIFFERENCE. 

167344 01-09 
OTENCE 

AFRODEX VS. PLACEBO IN THE TREATMENT OF MALE IMPOTENCE- 
STATISTICAL ANALYSIS OF TWO DOUBLE-BLIND CROSSOVER STUDIES. 

181959 02-14 
RESSIONS 

MARIHUANA USE IN MAN: AN EXPERIMENTAL INQUIRY - CLINICAL 
PSYCHIATRIC IMPRESSIONS. 

169085 01-14 
IMPRESSIONS OF SCANDINAVIAN PSYCHIATRY - 1973. 

173452 01-17 
ROVING 

IMPROVING PSYCHIATRIC DRUG THERAPY: A MATTER OF DOSAGE AND 
CHOICE. 

190144 04-17 
UlSE 

THE IMPULSE BLOCKING CONCENTRATIONS OF ANESTHETICS ALCOHOLS 
ANTICONVULSANTS, BARBITURATES, AND NARCOTICS ON PHRENIC 
AND SCIATIC NERVES. 

187803 04-03 

THE NERVE IMPULSE BLOCKING ACTIONS OF TRANQUILIZERS AND THE 
BINDING OF NEUROLEPTICS TO SYNAPTOSOME MEMBRANES. 

crcrrrc ^ 189400 04-03 

EFFECTS OF ALTERATIONS IN IMPULSE FLOW ON TRANSMITTER 
METABOLISM IN CENTRAL DOPAMINERGIC NEURONS. 

191519 04-03 



Subject Index 

IMPULSES 

IMPORTANCE OF CATECHOLAMINE RELEASE BY NERVE IMPULSES FOR 
FREE OPERANT BEHAVIOR. 

171611 01-04 
INABILITY 

INABILITY OF RAT BRAIN HOMOGENATE TO OXIDIZE AMPHETAMINE. 

1 77334 02-03 
INABILITY TO CONDITION A PERIPHERAL ACTIVATING DRUG 

190698 04 04 
INAPPROPRIATE 

THE EFFECTS OF PHENOTHIAZINES ON ENDOCRINE FUNCTION- I 
PATIENTS WITH INAPPROPRIATE LACTATION AND AMENORRHOEA 

1 84436 03- 1 5 
INCIDENCE 

HYPOTENSION FROM DRUGS: INCIDENCE, PERIOD, PREVENTION. 

176674 02-15 
INCREASE 

INCREASE IN THE PLASMA CONCENTRATION OF FREE TRYPTOPHAN 
CAUSED BY PROBENECID IN HUMANS. 

169470 01-13 
CYCLIC ADENOSINE MONOPHOSPHATE: SELECTIVE INCREASE IN CAUDATE 
NUCLEUS AFTER ADMINISTRATION OF L-DOPA. 

176254 02-13 
TRANSPORT OF SYNAPTOSOMAL TRYPTOPHAN AND CEREBRAL 

TYROSINE: INCREASE IN THE SPEED OF UPTAKE OF RESERPINE OR THE 
INHIBITION OF MONOAMINE OXIDASE 

179988 02-13 
HYDROCORTISONE INDUCED INCREASE IN THE HISTOCHEMICALLY 
DEMONSTRABLE CATECHOLAMINE CONTENT OF SYMPATHETIC 
NEURONS OF THE NEWBORN RAT 

189027 04-03 
DIFFERENTIAL INCREASE OF BEHAVIORAL AND EXTRAPYRAMIDAL 
STIMULATING ACTIONS OF NEUROLEPTICS BY ALPHA- 
METHYLTYROSINE PRETREATMENT IN RATS. 

192016 04-04 
INCREASES 

INFLUENCES OF DRUGS ON THE INCREASES IN BRAIN DOPAMINE 
PRODUCED BY AXOTOMY OF GAMMA-HYDROXYBUTYRIC ACID 
(GHBA). 

171622 01-03 
EVIDENCE THAT MORPHINE INCREASES DOPAMINE UTILIZATION IN 
CORPORA-STRIATA OF RATS. 

1 76746 02-03 
THE EFFECT OF MINOR TRANQUILIZERS ON STRESS INDUCED INCREASES 
IN RAT PLASMA CORTICOSTEROIDS. 

186578 03-03 
INCREMENTAL 

RESPONSE TO INCREMENTAL DOSES OF DITRAN IN ABSTINENT 
ALCOHOLICS AND DRUG USERS. 

185875 03-11 
INCUBATED 

EFFECT OF DESIPRAMINE ON RAT CORTEX SLICES INCUBATED WITH 3H- 
DOPAMINE. 

190310 04-03 
INDANETHYLAMINES 

PREPARATION AND PHARMACOLOGICAL SCREENING OF 
INDANETHYLAMINES RELATED TO TRYPTAMINE. 

185979 03-01 
INDEPENDENCE 

INDEPENDENCE OF THE EFFECTS OF D-AMPHETAMINE AND FOOD 
DEPRIVATION OR BODYWEIGHT ON THE FOOD CONSUMPTION OF 
RATS. 

186376 03-06 
INDEPENDENT 

BEHAVIORAL PARAMETERS OF DRUG ACTION: SIGNALED AND RESPONSE 
INDEPENDENT REINFORCEMENT. 

174008 01-04 
INDICATION 

CLASSIFICATION AND INDICATION OF ANTIANXIETY AGENTS IN CLINICAL 

PRACTICE. 

184845 03-10 
INDICATION AND PROBLEMS OF PSYCHOTROPIC DRUGS IN GENERAL 

PRACTICE. 

191677 04-17 
INDICATOR 

AN ELECTROENCEPHALOGRAPHIC STUDY ON THE TOLERANCE OF THE 
VARIOUS PSYCHIATRIC AND NEUROLOGICAL PATIENTS TO THE 
HYPNOTIC EFFECTS OF DIPHENHYDRAMINE - MEASURED BY THE 
AMOUNTS OF SLEEP EEG AS AN INDICATOR. 

182550 03-11 
INDIRECT 

BEHAVIORAL EFFECTS OF DIRECT AND INDIRECT ACTING DOPAMINERGIC 
AGONISTS. 

191521 04-04 
INDIVIDUAL 

THE BIOLOGICAL BASIS OF PSYCHOTICISM: A STUDY OF INDIVIDUAL 
DIFFERENCES IN RESPONSE TO DEXAMPHETAMINE. 

175219 02-13 




5-119 



Subject Index 

INDIVIDUAL PSYCHOTHERAPY WITH HALLUCINOGENS. 

180143 02-12 

INDIVIDUALS 

INDUCTION OF SEVERE DEPRESSION BY PHYSOSTIGMINE IN MARIJUANA 

INTOXICATED INDIVIDUALS. 

177450 02-14 

INDOLEALKYIAMINES 

MOLECULAR ORBITAL STUDIES ON THE CONFORMATION OF 

HALLUCINOGENIC INDOLEALKYLAMINES AND RELATED COMPOUNDS. 
THE ISOLATED MOLECULES AND THE SOLVENT EFFECT. 

183406 03-01 
ANTICONVULSANT ACTIVITY OF SUBSTITUTED INDOLEALKYLAMINES. 

185035 03-01 
STRUCTURE-ACTIVITY RELATIONS OF SOME INDOLEALKYLAMINES IN 
COMPARISON TO PHENETHYLAMINES ON MOTOR ACTIVITY AND 
ACQUISITION OF AVOIDANCE BEHAVIOR. 

186703 03-04 

INDOLEAMINE 

L-TRYPTOPHAN IN AFFECTIVE DISORDERS: INDOLEAMINE CHANGES AND 

DIFFERENTIAL CLINICAL EFFECTS. 

185928 03-09 

INDOMETHACIN 

ANALGESIC POTENCY OF SODIUM SALICYLATE, INDOMETHACIN, AND 
CHLORDIAZEPOXIDE AS MEASURED BY THE SPATIAL PREFERENCE 
TECHNIQUE IN THE RAT. 

171301 01-02 

INDONESIA 

CLINICAL TRIAL WITH DARTALANR, DJAKARTA, INDONESIA. 

170753 01-11 
PSYCHOTROPIC MEDICATION IN INDONESIA (1970-1973). 

174618 01-17 

INDONESIAN 

CLINICAL TRIAL OF TRIFLUOPERAZINE (STELAZINE R) ON INDONESIAN 

PSYCHIATRIC PATIENTS. 

171161 01-09 

INDUCE 

INFLUENCE OF VARIOUS SUBSTANCES WHICH INDUCE AND INHIBIT 
AGGREGATION ON THE UPTAKE OF DEOXYGLUCOSE BY HUMAN 
BLOOD PLATELETS. 

191770 04-13 

INDUCED ^ „„ 

EFFECTS OF DOPAMINE RECEPTOR STIMULATION AND BLOCKADE ON RO- 
4-1284 INDUCED ENHANCEMENT OF ELECTROSHOCK SEIZURE. 

167287 01-03 
RETROGRADE AMNESIA FROM HYPOTHERMIA INDUCED BRAIN SEIZURES. 

167398 01-04 

PHARMACOLOGICALLY INDUCED BEHAVIOURAL SUPERSENSITIVITY TO 

APOMORPHINE. „ _ 

169120 01-03 

LEVODOPA INDUCED DYSKINESIAS; COMPARISON IN PARKINSONISM 
DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS. 

169376 01-15 
LITHIUM INDUCED DIABETES-INSIPIDUS: MANIC SYMPTOMS, BRAIN AND 
ELECTROLYTE CORRELATES, AND CHLOROTHIAZIDE TREATMENT. 

169486 01-15 

LITHIUM INDUCED FOLLICULITIS. 

169492 01-15 

LOW DOSAGE HALOPERIDOL AND INDUCED ANXIETY IN NORMAL 

VOLUNTEERS. 

169745 01-14 

LIPID INDUCED CHANGES OF PENTOBARBITAL DISTRIBUTION AND 

METABOLISM. __ „, „, 

170072 01-03 

THE ELECTROCARDIOGRAPHIC ABNORMALITIES INDUCED BY 

PSYCHOTROPIC DRUGS. ,70638 01-13 

PHYSOSTIGMINE EFFECTS ON PHENOTHIAZINE INDUCED 
EXTRAPYRAMIDAL REACTIONS. 

170662 01-13 

AN AUTOPSY CASE OF SCHIZOPHRENIA COMPLICATED WITH 
PARKINSONISM INDUCED BY PERPHENAZINE. 

171275 01-15 

THE ELECTROCARDIOGRAPHIC ABNORMALITY INDUCED BY 

CHLORPROMAZINE. ,7,296 01-15 

PROPRANOLOL AND CHLORDIAZEPOXIDE ON EXPERIMENTALLY INDUCED 
CONFLICT AND SHUTTLEBOX PERFORMANCE IN RODENTS. 

171304 01-04 

PHENOTHIAZINE INDUCED DECOMPENSATION. 

171506 01-15 
TOLERANCE TO HEXOBARBITAL AND SUPERSENSITIVITY TO PILOCARPINE 
INDUCED BY CHRONIC BARBITAL TREATMENT IN THE RAT. 

171601 01-03 
ANTAGONISM OF P-CHLOROAMPHETAMINE (PCA) INDUCED DEPLETION 
OF 5-HT FROM RAT BRAIN BY SOME THYMOLEPTICS AND OTHER 
PSYCHOTROPIC DRUGS. ,71628 01-03 



Psychopharmacology Abstract 

DELTA9-TETRAHYDR0CANNABIN0L INDUCED INHIBITION OF PREDATORY 
AGGRESSION IN THE RAT. 

172745 01-C 
P-CHLOROPHENYLALANINE INDUCED ALTERATIONS IN THE BEHAVIORAL 
EFFECTS OF 5-HYDROXYTRYPTOPHAN. 

174034 01-C 
L-TRYPTOPHAN IN THE TREATMENT OF LEVODOPA INDUCED 
PSYCHIATRIC DISORDERS 

174297 01-1 
APOMORPHINE INDUCED BITING AND FIGHTING BEHAVIOUR IN 
RESERPINIZED RATS AND AN APPROACH TO THE MECHANISM OF 
ACTION. 

174768 01 -( 
BEHAVIORAL AND ELECTROENCEPHALOGRAPHIC STUDIES ON 
THIOSEMICARBAZIDE INDUCED SEIZURE IN RABBITS. 

174855 01-1 
CONDITIONED HYPOGLYCEMIA: A MECHANISM FOR SACCHARIN 
INDUCED SENSITIVITY TO INSULIN IN THE RAT. 

174877 01-1 
VOCALIZATION: A CHARACTERISTIC CANNABIS INDUCED BEHAVIOR IN 

THE RAT? 

1 75884 02- 

BARBITURATE DEPENDENCE IN MICE INDUCED BY A SIMPLE SHORT-TER 

ORAL PROCEDURE. 

175895 02- 

DOLICHOMEGACOLON INDUCED BY NEUROLEPTICS AMONG PSYCHIATR 

PATIENTS (MEMORANDUM COVERING 153 CASES). 

1 76432 02- 
STEREOTYPED AND AGGRESSIVE BEHAVIOR INDUCED BY SUSTAINED 

HIGH DOSE OF THEOPHYLLINE IN RATS. 

177019 02- 
FURTHER ASPECTS OF AGGRESSIVE BEHAVIOR INDUCED BY SUSTAINED 

HIGH DOSE OF THEOPHYLLINE IN RATS. 

1 77020 02- 
EFFECTS OF PG-501 ON PARAPYRAMIDAL SYSTEM SYNDROME INDUCEI 

BY PSYCHOTROPICS. 

178019 02 
ANTICONVULSANT ACTIVITY OF CLONAZEPAM AND RO-8-4192 AGAIN! 
PENICILLIN AND LIDOCAINE INDUCED SEIZURES. 

178947 02 
CENTRAL NERVOUS STIMULANT INDUCED PHYSIOLOGICAL AND 
PERFORMANCE CHANGES IN ADULTS DURING SUSTAINED 
PSYCHOMOTOR TRACKING. 

179023 02 

EFFECT OF CANNABIS ON PENTOBARBITAL INDUCED SLEEPING TIME Al 
PENTOBARBITAL METABOLISM IN THE RAT. 

179985 02 

NICOTINIC ACID INDUCED SYSTEMIC LUPUS-ERYTHEMATOSUS. 

180243 02 

STUDIES ON CENTRAL REGULATING MECHANISM OF THE HYPOGLYCEA 
INDUCED BY INTRAVENTRICULAR ADMINISTRATION OF 
CHLORPROMAZINE. ^ 

182093 02 

THE EFFECTS OF INTRAVENTRICULARLY ADMINISTERED 

CATECHOLAMINES AND SEROTONIN ON THE RESERPINE INDUCED 
SPIKE WAVES RECORDED FROM THE MEDICAL NUCLEUS TRAPEZOID 

IN THE RABBIT. ,„„,^„.„. 

182094 02 

EFFECTS OF PSYCHOTROPIC DRUGS ON METHAMPHETAMINE INDUCED 
EXCITATIONS IN THE AGGREGATED MICE. 

182107 0: 
EFFECTS OF PSYCHOTROPIC DRUGS ON ABNORMAL BEHAVIOR INDUCI 
BY DELTA9-TETRAHYDR0CANNABIN0L. 

182114 0: 
SELECTIVE BLOCKADE OF APOMORPHINE INDUCED AGGRESSION AND 
GNAWING FOLLOWING FENFLURAMINE OR RAPHE LESIONS IN THE 

^^- 182128 0; 

SUBSTANTIAL ORAL MORPHINE INTAKE BY THE RAT USING SCHEDULI 
INDUCED POLYDIPSIA. 

182194 0: 

RELATIVE IMPORTANCE OF DOPAMINERGIC AND NORADRENERGIC 
NEURONAL SYSTEMS FOR THE STIMULATION OF LOCOMOTOR 
ACTIVITY INDUCED BY AMPHETAMINE AND OTHER DRUGS. 

182209 0: 

ALPHA-ADRENERGIC RECEPTORS MEDIATE SUPPRESSION OF DRINKINC 
INDUCED BY HYPOTHALAMIC AMPHETAMINE INJECTION. 

182216 0: 

INHIBITION OF ISOLATION INDUCED AGGRESSION IN THE MOUSE BY 
ANTICHOLINERGIC COMPOUNDS. ,82239 0' 

INHIBITION OF ISOLATION INDUCED AGGRESSION IN MICE BY 

ANTISEROTONERGIC DRUGS. ,82240 

INVOLVEMENT OF ALPHA-RECEPTORS IN CLONIDINE INDUCED INHIBIT 
OF TRANSMITTER RELEASE FROM CENTRAL MONOAMINE NEURONE 

1 82345 a 



S-120 



VOLUME 12, SUBJECT INDEX 

MECHANISMS UNDERLYING POTENTIATION OF BARBITURATE ACTION BY 
SODIUM NITRITE IN THE MOUSE: THE ROLE OF METHEMOGLOBIN 
INDUCED HYPOXIA. 

182721 03-03 
MYOCARDIOPATHIC COMPLICATIONS INDUCED BY IMIPRAMINE AND 
TRICYCLIC THYMOLEPTICS. 

182898 03-15 
A SERIES OF MULTICENTRIC PILOT TRIALS WITH PIMOZIDE IN 

PSYCHIATRIC PRACTICE; III. PIMOZIDE IN THE TREATMENT OF STRESS 
INDUCED PSYCHIC AND FUNCTIONAL DISORDERS. 

183193 03-11 
EFFECTS OF ANTIPARKINSONIAN DRUGS ON NEUROLEPTIC INDUCED 
EXTRAPYRAMIDAL SIGNS IN MONKEYS. 

183610 03-03 
ROLE OF THE CENTRAL AUTONOMIC NERVOUS SYSTEM IN THE 
HYPOTENSION AND BRADYCARDIA INDUCED BY (-) DELTA9- 
TETRAHYDROCANNABINOL. 

183795 03-03 
PARADOXICAL THERMOREGULATORY BEHAVIOUR IN RATS INDUCED BY 
(J AMPHETAMINE: BLOCKADE BY ALPHA-ADRENOCEPTOR OR 
DOPAMINE RECEPTOR BLOCKING AGENTS. 

183797 03-03 
CHOLINERGIC MODIFICATION OF NALOXONE INDUCED JUMPING IN 
MORPHINE DEPENDENT MICE. 

184179 03-03 
DEANOL IN THE TREATMENT OF LEVODOPA INDUCED DYSKINESIAS. 

184196 03-11 
INCREASED SYNTHESIS OF ADRENOMEDULLARY CATECHOLAMINES 
INDUCED BY CAFFEINE AND THEOPHYLLINE. 

184201 03-03 
LEAD INDUCED BEHAVIORAL DYSFUNCTION: AN ANIMAL MODEL OF 
HYPERACTIVITY. 

.r „« 184953 03-04 

TEMPORAL DISORGANIZATION AND DELUSIONAL-LIKE IDEATION- 
PROCESSES INDUCED BY HASHISH AND ALCOHOL. 

185330 03-14 
CATALEPSY INDUCED BY ALPHA-METHYL-P-TYROSINE AND D- 
AMPHETAMINE: THE ROLE OF CATECHOLAMINE METABOLISM. 

185750 03-03 
ENHANCEMENT OF METHYLPHENIDATE INDUCED STEREOTYPIES BY 
REPEATED ADMINISTRATION OF NEUROLEPTICS. 

186369 03-04 
INFLUENCE OF FLUPENTHIXOL AND FLUPENTHIXOL DECANOATE ON 
METHYLPHENIDATE AND APOMORPHINE INDUCED COMPULSIVE 
GNAWING IN MICE. 

186371 03-04 
THE EFFECT OF MINOR TRANQUILIZERS ON STRESS INDUCED INCREASES 
IN RAT PLASMA CORTICOSTEROIDS. 

186578 03-03 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS- 
I. EFFECT ON THE BEHAVIOURAL CHANGES INDUCED BY RESERPINE 
ALPHA-METHYL-P-TYROSINE OR AMPHETAMINE. 

186587 03-04 
SPECIFICITY OF BLOCKADE OF THE NICOTINE INDUCED RELEASE OF 3H- 
NOREPINEPHRINE FROM ADRENERGIC NEURONS OF THE GUINEA-PIG 
HEART BY VARIOUS PHARMACOLOGICAL AGENTS. 

186676 03-03 
COMPARISON OF TYROSINE HYDROXYLASE AND DOPAMINE-BETA- 
HYDROXYLASE INHIBITION WITH THE EFFECTS OF VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS ON DAMPHETAMINE INDUCED 
MOTOR ACTIVITY. 

186699 03-03 
A STUDY OF THE BEHAVIORAL DISRUPTION OF MICE INDUCED BY L- 
METHIONINE AND RELATED COMPOUNDS. 

187260 04-04 
ON THE MECHANISM OF RELEASE OF NOREPINEPHRINE FROM 
SYMPATHETIC NERVES INDUCED BY DEPOLARIZING AGENTS AND 
SYMPATHOMIMETIC DRUGS. (UNPUBLISHED PAPER). 

187397 04-03 
LEARNING IMPAIRMENT IN RATS AFTER 6-HYDROXYDOPAMINE INDUCED 

DEPLETION OF BRAIN CATECHOLAMINES. 
^...«„„ 187420 04-04 

CHLORPROMAZINE INDUCED HYPERPHAGIA. (UNPUBLISHED PAPER). 

187498 04-04 
EFFECTS OF SHORT-TERM ADMINISTRATION OF N-NITROSO COMPOUNDS 
ON LIVER HISTOLOGY AND PENTOBARBITAL INDUCED SLEEPING TIME 
IN MICE. 

Tr.,n« 187575 04-04 

TEMPORAL ASPECTS OF SCOPOLAMINE INDUCED ONE-WAY MEMORY 
DISSOCIATION IN MICE. 

187701 04-04 
ACTIONS OF ATROPINE, HEMICHOLINIUM-3, AND PHYSOSTIGMINE ON 
CHLORPROMAZINE INDUCED CHANGES IN RAT BRAIN MONOAMINES. 

187800 04-03 
FAILURE OF BETA-ADRENERGIC RECEPTOR BLOCKADE TO PREVENT 
ARRHYTHMIAS INDUCED BY SYMPATHETIC NERVE STIMULATION. 

187923 04-03 



Subject Index 

IN VIVO CHANGES OF CEREBRAL CYCLIC ADENOSINE 3 5 

MONOPHOSPHATE INDUCED BY BIOGENIC AMINES: ASSOCIATION 
WITH PHOSPHORYLASE ACTIVATION. 

188291 04-03 
KETAMINE INDUCED POSTANESTHETIC DELIRIUM ATTENUATED BY 
TETRAHYDROAMINOACRIDINE. 

188689 04-05 
REDUCTION BY PRETREATMENT WITH DIBENAMINE OF HEPATOTOXICITY 
INDUCED BY CARBON TETRACHLORIDE, THIOACETAMINDE OR 
DIMETHYLNITROSAMINE. 

188865 04-05 
HYDROCORTISONE INDUCED INCREASE IN THE HISTOCHEMICALLY 
DEMONSTRABLE CATECHOLAMINE CONTENT OF SYMPATHETIC 
NEURONS OF THE NEWBORN RAT. 

189027 04-03 
A STUDY OF BIOGENIC AMINE METABOLITES IN THE CEREBROSPINAL 
FLUID AND URINE OF MONKEYS WITH CHLORPROMAZINE INDUCED 
DYSKINESIA. 

189210 04-03 
EFFECTS OF ALPHAMETHYLTYROSINE ON DAMPHETAMINE INDUCED 
RELEASE OF ENDOGENOUSLY SYNTHESIZED AND EXOGENOUSLY 
ADMINISTERED CATECHOLAMINES FROM THE CAT BRAIN IN VIVO. 

189397 04-03 
CANNABINOIDS AND HEXOBARBITAL INDUCED LOSS OF RIGHTING 
REFLEXES. 

189573 04-04 
MESCALINE INDUCED CHANGES OF BRAIN CORTEX RIBOSOMES EFFECT 
OF MESCALINE ON THE BINDING OF AMINOACYL TRANSFER 
RIBONUCLEIC ACID TO RIBOSOMES OF BRAIN TISSUE. 

189582 04-05 
RATING OF PSYCHOLOGICAL EFFECTS INDUCED BY ORDINARY NOVERIL 
AND TIME-RELEASED NOVERIL. 

190312 04-14 
PHARAAACOLOGICAL ALTERATIONS IN THE STIMULUS INDUCED RELEASE 
OF NOREPINEPHRINE FROM THE RABBIT SUPERIOR CERVICAL 
GANGLION. 

191896 04-03 
AMPHETAMINE AND METHYLPHENIDATE INDUCED RELEASE OF STRIATAL 

DOPAMINE IN VIVO: DIFFERENTIAL EFFECTS ON NEWLY SYNTHESIZED 
AND STORED POOLS. 

191897 04-03 
EXCITABILITY CHANGES DURING THE GRADUAL DEVELOPMENT OF AND 

RECOVERY FROM PENTYLENETETRAZOL AND STRYCHNINE INDUCED 
CONVULSIONS IN THE CAT. 

191927 04-03 
CHOLINERGIC AMINERGIC INTERACTIONS IN LEAD INDUCED 
HYPERACTIVITY. 

191954 04-05 
THE INFLUENCE OF DELTA9-TETRAHYDR0CANNABIN0L (THC) ON 
PILOCARPINE (PILO) INDUCED PAROTID SECRETIONS OF THE RAT 

191962 04-03 
THE EFFECT OF INCREASED GAMMA-AMINOBUTYRIC ACID ON ALPHA- 
METHYLTYROSINE INDUCED DECREASE IN CATECHOLAMINES IN RAT 
BRAIN. 

191988 04-03 
DOPAMINE AGONIST INDUCED DISORIENTATION IN A RAT SWIMMING 
TASK. 

192018 04-04 
CHLOROIAZEPOXIDE INDUCED BETA SPINDLE ACTIVITY IN RATS 

192416 04-03 
BETA-BLOCKING AGENTS IN THE TREATMENT Of CATECHOLAMINE 
INDUCED SYMPTOMS IN MUSICIANS. 

192527 04-11 
INDUCING 

LORAZEPAM VERSUS GLUTETHIMIDE AS A SLEEP INDUCING AGENT FOR 
THE GERIATRIC PATIENT. 

167496 0)11 
INDUCTION 

TREMOR INDUCTION BY INTRACAUDATE INJECTIONS OF BRETYLIUM 
TETRABENAZINE. OR MESCALINE: FUNCTIONAL DEFICITS IN CAUDATE 
DOPAMINE 

167329 01-03 
DISSOCIATION OF STIMULATORY AND SYNTHETIC PHASES IN THE 

INDUCTION OF TYROSINE HYDROXYLASE. 

171785 01-03 
INDUCTION OF SEVERE DEPRESSION BY PHYSOSTIGMINE IN MARIJUANA 

INTOXICATED INDIVIDUALS. 
.,„ , 177450 02-14 

TRANSSYNAPTIC INDUCTION OF CHOLINE ACETYLTRANSFERASE IN THE 

PREGANGLIONIC NEURON OF THE PERIPHERAL SYMPATHETIC NERVOUS 

SYSTEM. 

182720 03-03 
INDUCTION OF HEPATIC DRUG METABOLIZING ENZYMES BY LITHIUM 
TREATMENT 

182727 03-03 
INDUCTION OF A DIETHYLETHER WITHDRAWAL SYNDROME IN MICE BY 
EXPOSURE TO ETHER VAPOR. 

192006 04-03 



^^■:'- 






^'/■l->-' 



S-121 



Subject Index 



INEFFECTIVENESS 

CHRONIC HYPNOTIC DRUG USE: INEFFECTIVENESS, DRUG WITHDRAWAL 
INSOMNIA, AND DEPENDENCE. 

17211401-15 
ALTERATION OF ETHANOL-INDUCED CNS DEPRESSION, INEFFECTIVENESS 
OF DRUGS THAT MODIFY CHOLINERGIC TRANSMISSION. 

186375 03-03 

INFANT 

MOTHER INFANT SEPARATION: BEHAVIORAL ANALYSIS OF AN ANIMAL 
MODEL OF DEPRESSION. (PH.D. DISSERTATION). 

178867 02-04 
THE EFFECT OF CANNABINOIDS ON THE NUMBER OF NUCLEAR 
MEMBRANE ATTACHED RIBOSOMES IN INFANT RAT BRAIN. 

183228 03-03 
CHLORPROMAZINE CAUSING EXTRAPYRAMIDAL DYSFUNCTION IN 
NEWBORN INFANT OF PSYCHOTIC MOTHER. 

187787 0415 

INFANTS 

BEHAVIOURAL STATE CYCLES IN ABNORMAL INFANTS. 

168523 01-14 
CONTINUOUS INFUSION OF DIAZEPAM IN INFANTS WERE SEVERE 
RECURRENT CONVULSIONS. 

174568 01 11 

INFECTION 

DEVELOPMENT OF A VACCINE AGAINST MENTAL RETARDATION CAUSED 
BY CYTOMEGALOVIRUS INFECTION IN UTERO. 

178549 02-11 

INFLUENCE 

INFLUENCE OF TREATMENT ON SYMPTOMATOLOGY AND CORRELATED 
ELECTROENCEPHALOGRAPHIC (EEG) CHANGES IN THE AGED. 

167336 01-13 
INFLUENCE OF CONCENTRATION AND MOTOR PERFORMANCE ON 
TARDIVE DYSKINESIA AND RABBIT SYNDROME. 

167587 01-15 
INFLUENCE OF AMYLOBARBITONE ON OPERANT DEPRESSION AND 
ELATION EFFECTS IN THE RAT. 

168834 01-04 

INFLUENCE OF MORPHINE ON LATERAL HYPOTHALAMIC SELF- 
STIMULATION IN THE RAT. 

168835 01-04 

INFLUENCE OF AFFECTIVE STATES AND PSYCHOACTIVE DRUGS ON 
VERBAL LEARNING AND MEMORY. 

169504 01-09 

INFLUENCE OF PHENOBARBITAL AND SEX HORMONES ON ENZYMES IN 
ASCORBIC ACID BIOSYNTHESIS IN MALE AND FEMALE RATS. (PH.D. 
DISSERTATION). 

172017 01-03 
PHARMACOKINETIC DISPOSITION OF NORAPOMORPHINE DERIVATIVES 
AND ITS INFLUENCE ON THE ELICITATION OF STEREOTYPICAL 
GNAWING. (PH.D. DISSERTATION). 

174960 01-03 
INFLUENCE OF N1-2-HYDR0XYETHYL SUBSTITUTION ON CENTRAL 
ACTIVITY OF OXAZEPAM AND LORAZEPAM. 

178756 02-04 
INFLUENCE OF VARIOUS DRUGS ON THE BINDING OF CHLORPROMAZINE 
TO ERYTHROCYTES AND ALBUMIN. 

181470 02-03 
THE INFLUENCE OF ALDOSTERONE OR METHAMPHETAMINE ON LIVER 
GLYCOGEN DEPOSITION OF MICE STRESSED BY LONG-TERM 
ISOLATION. 

182105 02-03 

INFLUENCE OF ANTIDEPRESSIVE THERAPY ON THE DISTURBED TIME 
ESTIMATION OF DEPRESSIVES. 

182591 03-14 
THE INFLUENCE OF CHRONIC ADMINISTRATION OF LITHIUM CARBONATE 
ON THE BRAIN NOREPINEPHRINE CONTENT IN RATS. 

182872 03-03 
THE INFLUENCE OF NEUROTROPIC DRUGS ON MONOAMINE OXIDASE 
(MAO) AND 5-OXYTRYPTOPHANE DECARBOXYLASE (5-OTD) ACTIVITY 
IN THE BRAIN. 

183142 03-13 
INFLUENCE OF TETRACOSACTRIN (T) AND BETA-MELANOCYTE 

STIMULATING HORMONE (MSH) ON DEPRESSION OF THE SEGMENTAL 
REFLEX BY MORPHINE (MS). (UNPUBLISHED PAPER). 

183324 03-03 
INFLUENCE OF DIBENCYCLADINE AND IMIPRAMINE ON CALORIE INTAKE 

AND BODYWEIGHT. 

183359 03-03 

FAILURE OF ACTH TO INFLUENCE AVOIDANCE EXTINCTION IN A ONE- 
WAY AVOIDANCE SITUATION. 

183470 03-04 

INFLUENCE OF METHAMPHETAMINE AND NEUROLEPTIC DRUGS ON 
TYROSINE HYDROXYLASE ACTIVITY. 

184180 03-03 

PERCEPTUAL STYLE AND PAIN TOLERANCE - II. THE INFLUENCE OF AN 

ANXIOLYTIC AGENT. 

184291 03-14 



Psychopharmacology Abstracts 

COMPARISON OF PSYCHOEXPERIMENTAL PERFORMANCE UNDER THE 
INFLUENCE OF THE ANALGESIC PROPIRAM FUMARATE. 

184618 03-1' 
INTRACRANIAL SELF-STIMULATION IN RATS AS A FUNCTION OF 

VARIOUS STIMULUS PARAMETERS: IV. INFLUENCE OF AMPHETAMINE 
ON MEDIAL FOREBRAIN BUNDLE STIMULATION WITH MONOPOLAR 
ELECTRODES. 

185961 03-0. 
INFLUENCE OF FLUPENTHIXOL AND FLUPENTHIXOL DECANOATE ON 
METHYLPHENIDATE AND APOMORPHINE INDUCED COMPULSIVE 
GNAWING IN MICE. 

186371 03-0 

THE INFLUENCE OF PSYCHOTROPIC DRUGS ON THE LEVELS OF 
ENDOGENOUS 2-PHENYLETHYLAMINE IN RABBIT BRAIN. 

187112 03-0 
THE INFLUENCE OF 3-QUINUCLIDINYLBENZILATE ON THE BEHAVIOUR OF 
RATS IN A CIRCULAR RUNWAY. 

187259 04-0 
INFLUENCE OF ALPHA-METHYLTYROSINE ON ENHANCEMENT OF 
SHUTTLEBOX AVOIDANCE BY MARIJUANA AND PENTOBARBITAL. 

187572 04-0 
INFLUENCE OF ADRENERGIC BLOCKERS AND ANTILIPEMIC AGENTS ON 
PHARMACODYNAMIC ACTIONS OF MORPHINE IN CARBON 
TETRACHLORIDE TREATED RATS. 

188873 04-C 
INFLUENCE ON ACUTE PRETREATMENT WITH DELTA9- 

TETRAHYDROCANNABINOL OF THE LD50 OF VARIOUS SUBSTANCES 
THAT ALTER NEUROHUMORAL TRANSMISSION. 

188876 04-C 
INFLUENCE OF MORPHINE AND NALOXONE ON THE RELEASE OF 
NORADRENALINE FROM RAT BRAIN CORTEX SLICES. 

189568 04-C 
INFLUENCE OF FENTANYL, LEVORPHANOL AND PETHIDINE ON THE 

RELEASE OF NORADRENALINE FROM RAT BRAIN CORTEX SLICES. 

189569 04-( 
INFLUENCE OF PH ON THE BENZODIAZEPINE HUMAN SERUM ALBUMIN 

COMPLEX: CIRCULAR DICHROISM STUDIES. 

189595 04-1 
INFLUENCE OF DIFFERENT ANIONS ON TYRAMINE AND AMPHETAMINE 
UPTAKE BY COW ADRENAL MEDULLA CHROMAFFIN VESICLES. 

190907 04-( 
INFLUENCE OF NEUROLEPTICS AND BENZODIAZEPINES ON METABOLISM 
OF TRICYCLIC ANTIDEPRESSANTS IN MAN. 

191026 04-1 

THE INFLUENCE OF PSYCHOSTIMULANTS ON K42 MEMBRANE 
PERMEABILITY IN VARIOUS PORTIONS OF RAT BRAIN. 

191122 04-1 

INFLUENCE OF VARIOUS SUBSTANCES WHICH INDUCE AND INHIBIT 
AGGREGATION ON THE UPTAKE OF DEOXYGLUCOSE BY HUMAN 

BLOOD PLATELETS. 

191770 04- 

INFLUENCE OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTS OF 
ELECTRICAL STIMULATION AND MICROINJECTION OF ACETYLCHOLINI 
SEROTONIN AND NORADRENALINE INTO THE MESENCEPHALON. 

191786 04-1 
INFLUENCE OF PSYCHOTROPIC DRUGS ON AGGRESSIVENESS EVOKED B^ 
DESTRUCTION OF ISOLATED STRUCTURES OF THE FOREBRAIN. 

191788 04-' 
CHANGES IN RHYTHMS OF BIOELECTRICAL ACTIVITY OF THE CEREBRAL 
CORTEX IN HUMANS UNDER THE INFLUENCE OF ETHYMISOL. 

191790 04- 
THE INFLUENCE OF DELTA9-TETRAHYDR0CANNABIN0L (THC) ON 
PILOCARPINE (PILO) INDUCED PAROTID SECRETIONS OF THE RAT. 

191962 04- 
THE INFLUENCE OF IMIPRAMINE, DEXPHENMETRAZINE AND 

AMPHETAMINE SULPHATE ON THE COMPOSITION OF DIURNAL SLEEP 
OF NARCOLEPTICS. 

192419 04- 

INFLUENCED 

DRUG-INDUCED CATALEPSY AS INFLUENCED BY PSYCHOSTIMULANTS, 
APOMORPHINE, L-DOPA, AND YOHIMBINE. 

177730 02- 
PROPRANOLOL ANTAGONISM OF MORPHINE INFLUENCED BEHAVIOR. 

188760 04- 

INFLUENCES 

INFLUENCES OF DRUGS ON THE INCREASES IN BRAIN DOPAMINE 
PRODUCED BY AXOTOMY OF GAMMA-HYDR0XY8UTYRIC ACID 

(GHBA). 

171622 01- 

INFLUENCES OF RESERPINE AND CHLORPROMAZINE ON THE ANALGESIC 
AND METABOLIC EFFECTS OF MORPHINE. 

180507 02- 
INFLUENCES OF LITHIUM ON THE BEHAVIORAL ACTION OF 
METHAMPHETAMINE AND TETRABENAZINE. 

182109 02- 

INFORMAL , ,. 

METHYLPHENIDATE AND THE ACTIVITY OF HYPERACTIVES IN THE 
INFORMAL SETTING. ^^,^^3^^. 



S-122 



LUME 12, SUBJECT INDEX 



SION 

CONTINUOUS INFUSION OF DIAZEPAM IN INFANTS WERE SEVERE 
RECURRENT CONVULSIONS. 

174568 01-1) 
EKG ALTERNATIONS IN INFUSION TREATMENT WITH TRICYCLIC 
ANTIDEPRESSIVE DRUGS. 

180063 02- 15 
SIONS 

\ CRITICAL EVALUATION OF THE PRINCIPLES GOVERNING THE 
ADVANTAGES OF INTRAARTERIAL INFUSIONS. 

170112 01-06 
STION 

3AS CHROMATOGRAPHIC DETERMINATION OF METHAQUALONE IN 
SMALL AMOUNTS OF SERUM AFTER INGESTION OF THERAPEUTIC 
DOSES. 

172397 01-16 
"HE EFFECT OF HYPOTHALAMIC STIMULATION ON ORAL INGESTION OF 
DIAZEPAM IN RATS. 

184238 03-04 
^N OBSESSIVE NEUROSIS FOLLOWING MORNING-GLORY SEED INGESTION 
TREATED BY AVERSION RELIEF. 

184259 03-15 
■ROPRANOLOL AND BEHAVIOR OF ALCOHOL ADDICTS AFTER ACUTE 
ALCOHOL INGESTION. 

187257 04-14 
ATAL SUICIDAL INGESTION OF THIORIDAZINE. 

189606 04-15 
ITHIUM TREATMENT DURING ETHANOL INGESTION AND WITHDRAWAL. 

192005 04-11 
iTIVE 

HE EFFECTS ON INGESTIVE BEHAVIORS OF DAMAGE TO CENTRAL 
DOPAMINE CONTAINING NEURONS. 

191520 04-04 
LATION 

'JHALATION, PARENTERAL AND ORAL LD50 VALUES OF DELTA9- 

TETRAHYDROCANNABINOL IN FISCHER RATS. 

189588 04-05 
IT 

OPAMINE AND 5-HYDROXYTRYPTAMINE INHIBIT FEEDING IN RATS. 

170177 01-04 
JFLUENCE OF VARIOUS SUBSTANCES WHICH INDUCE AND INHIBIT 

AGGREGATION ON THE UPTAKE OF DEOXYGLUCOSE BY HUMAN 

BLOOD PLATELETS. 

191770 04-13 
ITED 

RAIN RIBOSOMAL RNA SYNTHESIS INHIBITED BY CHLORPROMAZINE. 

1 77835 02-03 
ITING 

lELANOCYTE STIMULATING HORMONE RELEASE INHIBITING HORMONE 

AS AN ANTIDEPRESSANT: A PILOT STUDY. 

171501 01-09 
IFFERENTIAL SELF-INJECTION BEHAVIOR PRODUCED BY FENFLURAMINE 

VERSUS OTHER APPETITE INHIBITING DRUGS. 

182215 03-04 
ITION 

ELECTIVE INHIBITION OF NOREPINEPHRINE SYNTHESIS IN MANIC- 
DEPRESSIVE PATIENTS WITH A OOPAMINE-BETA-HYDROXYLASE 
INHIBITOR. (UNPUBLISHED PAPER). 

170083 01-03 
IHIBITION OF MOUSE-KILLING BEHAVIOUR IN RATS BY SOME 
THYMOLEPTIC DRUGS. 

171608 01-04 
ELTA9-TETRAHYDR0CANNABIN0L INDUCED INHIBITION OF PREDATORY 
AGGRESSION IN THE RAT. 

172745 01-04 
IHIBITION BY MORPHINE OF REPETITIVE ACTIVATION OF CAT SPINAL 
MOTONEURONES. 

172926 01-03 
HE INHIBITION OF 3H-D0PAMINE UPTAKE INTO RAT STRIATAL BY 
VERATRIDINE AND BATRACHOTOXIN. (UNPUBLISHED PAPER), 

173380 01-03 
nOGENY OF SEROTONINERGIC INHIBITION OF BEHAVIORAL AROUSAL 
IN THE RAT. 

174860 01-04 
■RUCTURE-ACTIVITY RELATIONS FOR THE INHIBITION OF 5-HT UPTAKE 
INTO RAT HYPOTHALAMIC HOMOGENATES BY SEROTONIN AND 
TRYPTAMINE ANALOGUES. 

175233 02-03 
HIBITION OF THE APOMORPHINE GNAWING COMPULSION BY 
AMANTADINE. 

1 76879 02-04 
HIBITION OF LUNG, LIVER AND BRAIN MONOAMINE OXIDASE BY 
IMIPRAMINE AND DESIPRAMINE. 

177332 02-03 
HIBITION OF ANTICHOLINERGIC DRUG-INDUCED LOCOMOTOR 
STIMULATION IN MICE BY ALPHA-METHYLTYROSINE. 

177840 02-03 



Subject Index 

TRANSPORT OF SYNAPTOSOMAL TRYPTOPHAN AND CEREBRAL 

TYROSINE: INCREASE IN THE SPEED OF UPTAKE OF RESERPINE OR THE 
INHIBITION OF MONOAMINE OXIDASE. 

179988 02-13 
DISCRIMINANT ANALYSIS OF THE RELATIONSHIP BETWEEN PHYSICAL 
PROPERTIES AND THE INHIBITION OF MONOAMINE OXIDASE BY 
AMINOTETRALINS AND AMINOINDANS. 

180096 02-03 
IN VIVO INHIBITION OF NEURONAL UPTAKE OF A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE (TIQ) ALKALOID BY COCAINE AND BY 
DESMETHYLIMIPRAMINE (DMI). 

182150 02-03 
INHIBITION OF GROWTH IN ANIMALS TREATED WITH METHADONE. 

182164 02-03 
INHIBITION OF C14-ACH UPTAKE IN RAT BRAIN SLICES BY 
DESMETHYLIMIPRAMINE. 

182170 02-03 
(3H) OUABAIN BINDING TO NA_-ATPASE AND K.-ATPASE: INHIBITION BY 
BETA, GAMMA METHYLENE ATP. 

182184 02-03 
INHIBITION OF ISOLATION INDUCED AGGRESSION IN THE MOUSE BY 
ANTICHOLINERGIC COMPOUNDS. 

182239 03-04 
INHIBITION OF ISOLATION INDUCED AGGRESSION IN MICE BY 

ANTISEROTONERGIC DRUGS. 

182240 03-04 
INHIBITION OF THE SYNAPTOSOMAL UPTAKE MECHANISMS FOR L- 

NOREPINEPHRINE AND DOPAMINE BY N-ARYLALKYL DL-AMPHETAMINE 
DERIVATIVES. 

182250 03-03 
INVOLVEMENT OF ALPHA-RECEPTORS IN CLONIOINE INDUCED INHIBITION 
OF TRANSMITTER RELEASE FROM CENTRAL MONOAMINE NEURONES. 

182345 03-03 
THE INHIBITION OF (3H) BIOGENIC AMINE ACCUMULATION INTO RAT 
BRAIN TISSUE SLICES BY VARIOUS TRYPTAMINE DERIVATIVES 

182723 03-03 
SUBSTITUTED PIPERAZINOQUINAZOLONES: RELATIONSHIP BETWEEN 
SELECTIVE INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE 
DEPENDENT OXIDATIONS AND ANTICONVULSANT ACTIVITY. 

183598 03-02 
SUBSTITUTED BENZOXAZOLE/BENZTHIAZOLE-2-THIONES: 

INTERRELATIONSHIP BETWEEN ANTICONVULSANT ACTIVITY AND 
INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT 
OXIDATIONS AND MONOAMINE OXIDASE. 

183601 03-03 
METHADONE INHIBITION OF 3H-5-HYDROXYTRYPTAMINE UPTAKE BY 
SYNAPTOSOMES. 

183896 03-03 
THE INHIBITION BY BETA-ADRENOCEPTOR BLOCKING AGENTS OF 

CALCIUM UPTAKE INTO AND EFFLUX FROM ISOLATED SARCOPLASMIC 
VESICLES. 

184223 03-03 
DOSE EFFECTS OF METHYLPHENIDATE ON BEHAVIORAL INHIBITION AND 
ACTIVATION IN HYPERACTIVE CHILDREN. (PH.D. DISSERTATION). 

185676 03-14 
AN IMPROVED METHOD FOR STUDYING THE PSYCHOGALVANIC 
REACTION IN MICE AND ITS INHIBITION BY PSYCHOLEPTIC DRUGS 
COMPARISON WITH THE EFFECTS OF OTHER PHARMACOLOGICAL 
AGENTS. 

185749 0306 
FURTHER STUDIES ON THE INHIBITION OF DRUG METABOLISM BY 
PREGNANOLONE AND RELATED STEROIDS. 

185866 03-03 
THE EFFECT OF P-CHLOROAMPHETAMINE ON MOTILITY IN RATS AFTER 
INHIBITION OF MONOAMINE SYNTHESIS, STORAGE, UPTAKE AND 
RECEPTOR INTERACTION. 

185959 03-04 
ANTICONVULSANT ACTIVITY AND INHIBITION OF RESPIRATION IN RAT 
BRAIN HOMOGENATES BY SUBSTITUTED OXADIAZOLES. 

185980 03-01 
DOSE DEPENDENT POTENTIATION OR INHIBITION BY R0-4-4602 OF 5-HTP 
HYPERTHERMIA IN RABBITS, 

185996 03-03 
ACETYLCHOLINESTERASE INHIBITION AND MYELINOGENESIS IN VITRO. 

186033 03-03 
THE MONOAMINE OXIDASES OF BRAIN: SELECTIVE INHIBITION WITH 
DRUGS AND THE CONSEQUENCES FOR THE METABOLISM OF THE 
BIOGENIC AMINES. 

1 86668 03-03 
DIAZEPAM INHIBITION OF POST-TETANIC POTENTIATION IN BULLFROG 
SYMPATHETIC GANGLIA: POSSIBLE ROLE OF PROSTAGLANDINS. 

186673 03-03 
COMPARISON OF TYROSINE HYDROXYLASE AND DOPAMINE-BETA- 
HYDROXYLASE INHIBITION WITH THE EFFECTS OF VARIOUS 6- 
HYDROXYDOPAMINE TREATMENTS ON D-AMPHETAMINE INDUCED 
MOTOR ACTIVITY. 

1 86699 03-03 



"^m 




M,':^ 



S-123 



Subject Index 

A POSSIBLE MECHANISM FOR THE ANTISCHIZOPHRENIC ACTION OF 
CHLORPROMAZINE: INHIBITION OF THE FORMATION OF 
DIMETHYLTRYPTAMINE BY CHLORPROMAZINE METABOLITES. 

187576 04-03 

CONTROL OF NOREPINEPHRINE SYNTHESIS IN BLOOD VESSELS AND THE 
EFFECTS OF MONOAMINE OXIDASE INHIBITION. 

189390 04-03 

DOPAMINERGIC INHIBITION OF STRIATAL CHOLINERGIC NEURONS: 
SYNERGISTIC BLOCKING ACTION OF GAMMA-BUTYROLACTONE AND 
NEUROLEPTIC DRUGS. ,89602 04-03 

INHIBITION OF THE SLEEP RELATED PEAK IN PHYSIOLOGIC HUMAN 
GROWTH HORMONE RELEASE BY SOMATOSTATIN. 

190104 04-13 

PROCAINE (GER0VITAL-H3) THERAPY: MECHANISM OF INHIBITION OF 
MONOAMINE OXIDASE. ,9128104-03 

CORRELATION BETWEEN BRAIN N,N DIMETHYLTRYPTAMINE (DMT) 

LEVELS AND BAR PRESSING BEHAVIOR IN RATS: EFFECT OF MAO 

INHIBITION. 

191935 04-04 

ALPHA-METHYL-P-TYROSINE INHIBITION OF SELF-ADMINISTERED 
INTRAVENOUS MORPHINE AND ORAL WATER IN RATS. 

191940 04-04 

TETRAHYDROCANNABINOLS: INHIBITION IN ACETYLCHOLINE SYNTHESIS 
IN REGIONAL RAT BRAIN SLICES. 

191998 04-03 

INHIBITION OF CHOLINE UPTAKE INTO SYNAPTOSOMES BY CHOLINE 

ANALOGUES. „ „ „, 

191999 04-03 

INHIBITION IN VIVO OF ACETYLCHOLINE SYNTHESIS IN MOUSE BRAIN BY 
INHIBITORS OF CHOLINE ACETYLTRANSFERASE. 

192001 04-03 

INHIBITIONS 

NEUROLEPTIC ANTAGONISM OF CATECHOLAMINE INHIBITIONS IN RAT 
CEREBELLUM AND CAUDATE. (UNPUBLISHED PAPER). 

187496 04-03 

INHIBITOR 

COMBINATION OF L-DOPA, DESIPRAMINE, AND A DECARBOXYLASE 
INHIBITOR IN THE TREATMENT OF DEPRESSION. 

169468 01-09 

SELECTIVE INHIBITION OF NOREPINEPHRINE SYNTHESIS IN MANIC- 
DEPRESSIVE PATIENTS WITH A DOPAMINE-BETA-HYDROXYLASE 
INHIBITOR. (UNPUBLISHED PAPER). 

170083 01-03 
BEHAVIORAL EFFECTS OF A NEW DOPAMINE-BETA-HYDROXYLASE 
INHIBITOR (FUSARIC ACID) IN MAN. (UNPUBLISHED PAPER 

174329 01-09 
THE MECHANISM OF ACTION OF THE MONOAMINE OXIDASE INHIBITOR 

PARGYLINE. „^ 

1 75239 02-03 

LEVODOPA COMBINED WITH MK-486 (L-ALPHA- 

METHYLDOPAHYDRAZINE) - A PERIPHERAL DECARBOXYLASE 
INHIBITOR IN PARKINSONS DISEASE. 

187615 04-11 

PARKINSONIAN SYNDROMES: TREATMENT BY ASSOCIATION OF L-DOPA 
PLUS DECARBOXYLASE INHIBITOR. ,88093 04-11 

FUROXANOBENZOFUROXAN, A SELECTIVE MONOAMINE OXIDASE 

INHIBITOR. „„,-,„„,„, 

188770 04-01 

THE USE OF SELECTIVE AND INHIBITOR DRUGS TO MODIFY AMINE 

METABOLISM IN BRAIN, ,9,500 04-03 

EFFECT OF L-PHENYL-3-2-THIAZOLYL 2-THIOUREA, A DOPAMINE-BETA- 
HYDROXYLASE INHIBITOR, ON MORPHINE ANALGESIA, TOLERANCE 
AND PHYSICAL DEPENDENCE. ,91769 04-03 

INHIBITORS 

EFFECT OF MONOAMINE OXIDASE INHIBITORS ON METABOLISM AND IN 
VIVO RELEASE OF H3-N0REPINEPHRINE FROM THE HYPOTHALAMUS. 

I / I T / O U I "UO 

A NEW MODIFICATION FOR STUDYING 5-HT UPTAKE BY BLOOD 

PLATELETS- A RE-EVALUATION OF TRICYCLIC ANTIDEPRESSANTS AS 
UPTAKE INHIBITORS. ,80055 02-06 

CENTRAL DOPAMINE FUNCTION IN AFFECTIVE ILLNESS: EVIDENCE FROM 
PRECURSORS, ENZYME INHIBITORS AND STUDIES OF CENTRAL 
DOPAMINE TURNOVER. (UNPUBLISHED PAPER). 

ANISOMYCIN, LIKE OTHER INHIBITORS OF CEREBRAL PROTEIN 

SYNTHESIS, IMPAIRS LONG-TERM MEMORY OF A DISCRIMINATION 

^^^'^- 188605 04-04 

EFFECTS OF LSD AND MONOAMINE SYNTHESIS INHIBITORS ON 

HORMONE ACTIVATED COPULATORY BEHAVIOR IN THE FEMALE RAT. 

188611 04-04 



Psychopharmacology Abstrac 



POTENTIAL INHIBITORS OF S-ADENOSYLMETHIONINE DEPENDENT 
METHYLTRANSFERASES: 1. MODIFICATION OF THE AMINO ACID 
PORTION OF S-ADENOSYLHOMOCYSTEINE. 

190716 04- 
POTENTIAL INHIBITORS OF S-ADENOSYLMETHIONINE DEPENDENT 

METHYLTRANSFERASES. 2. MODIFICATION OF THE BASE PORTION 01 
S-ADENOSYLHOMOCYSTEINE. 

190717 04 

SOME CONSIDERATIONS IN THE DESIGN OF SUBSTRATE AND TISSUE 
SPECIFIC INHIBITORS OF MAO. 

191499 04 

THE EFFECTS OF COMT INHIBITORS ON BEHAVIOR AND DOPAMINE 

METABOLISM, 

191517 04 

INHIBITION IN VIVO OF ACETYLCHOLINE SYNTHESIS IN MOUSE BRAIN 
INHIBITORS OF CHOLINE ACETYLTRANSFERASE. 

192001 04 

INHIBITORY 

SYNTHESIS OF SUBSTITUTED CINNAMIDES: RELATIONSHIP BETWEEN 

ANTICONVULSANT AND MONOAMINE OXIDASE INHIBITORY 

PROPERTIES. „„,„„, 

169818 01 

A DIFFERENTIAL INHIBITORY ACTION OF LSD AND AMPHETAMINE ON 
COPULATORY BEHAVIOR IN THE FEMALE RAT. 

17161701 
THE ROLE OF THE SEPTAL AREA OF THE BRAIN IN THE INHIBITORY 
MODULATION OF BEHAVIOR. (PH.D. DISSERTATION). 

172021 0' 
INHIBITORY EFFECTS OF PRETEST AND POSTTEST D-AMPHETAMINE 0^ 
MOUSE-KILLING BY RATS. (PH.D. DISSERTATION). 

173727 

INHIBITORY EFFECT OF DOXEPIN ON AGONISTIC BEHAVIOUR ELICITED 
HYPOTHALAMIC STIMULATION IN THE CAT. 

1 80044 o: 

EVIDENCE FOR AN INHIBITORY ROLE FOR ACETYLCHOLINE, 

CATECHOLAMINES, AND SEROTONIN ON THE CEREBRAL CORTEX. 

187552 
INHIBITORY EFFECT OF DOPAMINERGIC STIMULATION ON GH RELEAS 

ACROMEGALY, _,^„ „ 

188350 

EFFECTS OF SCOPOLAMINE ON INHIBITORY MECHANISMS. 

190275 
DIFFERENTIAL ANTAGONISM BY NALOXONE OF INHIBITORY EFFECTS ( 
HALOPERIDOL AND MORPHINE ON BRAIN SELF-STIMULATION. 

190306 

ASSESSMENT OF ANATENSOL (FLUPHENAZINE ENANTHATE) INJECTAB 
IN THE TREATMENT OF SCHIZOPHRENIA. 

1 72444 

EXPERIMENTS IN ORAL AND INJECTABLE FORMS OF A NEW 
ANTIDEPRESSANT (DOXEPIN) ON FORTY PATIENTS. 

1 82900 
FLUSPIRILENE, A LONG-ACTING INJECTABLE NEUROLEPTIC. 

183199 C 

BRAIN TO SERUM DISTRIBUTION OF RADIOACTIVITY OF INJECTED 3F 
AMPHETAMINE IN DIFFERENTIALLY HOUSED MICE. 

1 6841 8 C 
HISTO-AUTORADIOGRAPHIC INVESTIGATIONS ON THE DISTRIBUTION 
INJECTED 5-HYDROXYTRYPTAMINE (SEROTONIN) IN THE BRAIN AN 
THE PITUITARY OF MICE. 

1 85900 ( 

HYPERTHERMIC EFFECT OF PALMITATE SODIUM, STEARATE SODIUM 

OLEATE SODIUM INJECTED INTO THE CEREBRAL VENTRICLES OF 

CONSCIOUS CATS. ,„...„, 

186640 ( 

INJECTION ^ _,^ ^ 

THE DISTRIBUTION OF DELTAl-TETRAHYDROCANNABINOL AND 7- 
HYDROXY-DELTAl-TETRAHYDROCANNABINOL IN THE MOUSE BRAI 
AFTER INTRAVENTRICULAR INJECTION 

FLAVOR AVERSIONS PRODUCED BY CONTINGENT DRUG INJECTION: 
RELATIVE EFFECTIVENESS OF APOMORPHINE, EMETINE, AND LITHI 

1785021 
FURTHER EXPERIENCE WITH FLUPHENAZINE ENANTHATE INJECTION. 

1801531 
ALPHA-ADRENERGIC RECEPTORS MEDIATE SUPPRESSION OF DRINKIh 
INDUCED BY HYPOTHALAMIC AMPHETAMINE INJECTION. 

182216 

INTRACEREBRAL INJECTION OF 6-HYDROXYDOPAMINE AND HYDROG 

PEROXIDE IN CATS: SPECIFIC AND NONSPECIFIC EFFECTS ON STRI/ 

BIOGENIC AMINES. ^^^^^^ 

EFFECTS OF INTRACEREBRAL INJECTION OF 5,6-HYDROXYTRYPTAMII 
ON CEREBRAL MONOAMINES AND SLEEP STATES IN THE CAT/. 

1 8902 J 



S-124 



VOLUME 12, SUBJECT INDEX 

INJECTIONS 

TREMOR INDUCTION BY INTRACAUDATE INJECTIONS OF BRETYLIUM, 
TETRABENAZINE, OR MESCALINE; FUNCTIONAL DEFICITS IN CAUDATE 
DOPAMINE. 

167329 01-03 
ACQUISITION AND RETENTION OF AVOIDANCE BEHAVIORS FOLLOWING 
SEPTAL LESIONS OR SCOPOLAMINE INJECTIONS IN RATS. 

167401 01-04 
EFFECT OF CHRONIC POSTTRIAL SALINE INJECTIONS ON MAZE 
PERFORMANCE. 

167403 01-04 
CNS DEPRESSION IN THE ABSENCE OF PROLACTIN RELEASE FOLLOWING 
INTRAARTERIAL INJECTIONS OF SODIUM PENTOTHAL IN THE 
PROESTROUS RAT. 

173257 01-03 
THE EFFECTS OF INTRACAUDATE INJECTIONS OF CHLORPROMAZINE ON 
CONDITIONED AVOIDANCE AND SELF-STIMULATION BEHAVIOR. (PH D 
DISSERTATION). 

173749 01-04 
DECREASED ANOREXIA, EXCITEMENT AND STEREOTYPY TO D- 
AMPHETAMINE AFTER LATERAL HYPOTHALAMIC 6- 
HYDROXYDOPAMINE (6-OHDA) INJECTIONS. 

182136 02-04 
REDUCTION IN COPULATORY BEHAVIOR OF MALE RATS FOLLOWING 
HASHISH INJECTIONS. 

183790 03-04 
EFFECTS ON HOMEOSTASIS OF INTRAVENTRICULAR INJECTIONS OF 6- 
HYDROXYDOPAMINE IN RATS. 

187695 04-03 
GENERALIZED PENICILLIN EPILEPSY IN THE CAT; EFFECTS OF 

INTRACAROTID AND INTRAVERTEBRAL PENTYLENETETRAZOL AND 
AMOBARBITAL INJECTIONS. 

188374 04-03 
AFFECTIVE STATE AND THYROTROPIN AND PROLACTIN RESPONSES 
AFTER REPEATED INJECTIONS OF THYROTROPIN RELEASING HORMONE 
IN DEPRESSED PATIENTS. 

189076 04-09 
THE EFFECTS OF EARLY SALINE INJECTIONS AND PENTYLENETETRAZOL 
ON HEBB-WILLIAMS MAZE PERFORMANCE IN THE ADULT RAT. 

191378 04-04 
IJURY 

EFFECTS OF PHENOBARBITAL AND SKF-525-A PRETREATMENT, SEX LIVER 
INJURY, AND VEHICLE ON DELTA9-TETRAHYDR0CANNABIN0L 
TOXICITY. 

189598 04-05 
lOTROPIC 

MECHANISM OF THE NEGATIVE CHRONOTROPIC AND INOTROPIC EFFECTS 
OF DELTA] -TETRAHYDROCANNABINOL (DELTAl-THC OR DELTA9-THC). 

182219 03-03 
IPATIENTS 

SIMPLE ALGORITHMS FOR PREDICTING PSYCHOTROPIC DRUGS ASSIGNED 

TO PSYCHIATRIC INPATIENTS. 

176676 02-17 
DIAZEPAM ON DEMAND: DRUG SEEKING BEHAVIOR IN PSYCHIATRIC 

INPATIENTS. 

189924 04-17 
IPUT 

LYSERGIC ACID DIETHYLAMIDE AND SEROTONIN; A COMPARISON OF 
EFFECTS ON SEROTONERGIC NEURONS AND NEURONS RECEIVING A 
SEROTONERGIC INPUT. 

177407 02-12 
IQUIRY 

MARIHUANA USE IN MAN; AN EXPERIMENTAL INQUIRY - CLINICAL 
PSYCHIATRIC IMPRESSIONS. 

169085 01-14 
ISANITY 

LSD AND THE INSANITY DRUGS, PART XXXI. 

192092 04-17 
ISIDON 

ELECTROCLINICAL ASPECT OF INSIDON TREATMENT IN PATIENTS WITH 
NEUROTIC SYMPTOMS. 

174777 01-10 
ISOMNIA 

THE USE OF N-DEMETHYLDIA2EPAM IN OUTPATIENTS SUFFERING FROM 
INSOMNIA. 

167340 01-n 
CHRONIC HYPNOTIC DRUG USE; INEFFECTIVENESS, DRUG WITHDRAWAL 
INSOMNIA, AND DEPENDENCE. 

172114 01-15 
EVALUATION OF HYPNOTICS IN OUTPATIENTS WITH INSOMNIA USING A 
QUESTIONNAIRE AND A SELF-RATING TECHNIQUE. 

1 77735 02-06 
CONTROL OF INSOMNIA WITH A NEW BENZODIAZEPINE; THE 

FLUNITRAZEPAM OR RO-5-4200 (FIRST INVESTIGATIONS OF PHASE I 
AND CONTROLLED INVESTIGATIONS OF PHASE II). 

183198 03-11 



Subject Index 

INSOMNIAC 

EFFECT OF 8-CHL0R0-6-PHENYL-4H-S-TRIAZ0L0BENZ0DIAZEPINE (D-40TA) 
ON THE DAYTIME SLEEP-WAKEFULNESS PATTERNS IN NORMAL AND P- 
CHLOROPHENYLALANINE INSOMNIAC CATS. 

181658 02-02 
FLUNITRAZEPAM (RO-5-4200) AND SLEEP CYCLE IN INSOMNIAC 
PATIENTS. 

186574 03-11 
INSOMNIACS 

THE EFFECT OF LORAZEPAM ON ANXIOUS INSOMNIACS SLEEP AS 
RECORDED IN THE HOME ENVIRONMENT. 

177318 02-14 
INSTITUTE 

INSTITUTE OF PSYCHIATRY CLINICAL PSYCHOPHARMACOLOGY 
RESEARCH TEAM. 

187022 03-17 
PROPHYLACTIC EFFICACY OF LITHIUM CARBONATE IN MANIC- 
DEPRESSIVE ILLNESS; REPORT OF THE VETERANS ADMINISTRATION 
AND NATIONAL INSTITUTE OF MENTAL HEALTH (VA-NIMH) 
COLLABORATIVE STUDY GROUP. 

189735 04-09 
INSTITUTIONALIZED 

EFFECTS OF DIPHENYLHYDANTOIN ON ANXIETY AND HOSTILITY IN 
INSTITUTIONALIZED PRISONERS. 

177671 02-11 
HALOPERIDOL (JANSSEN) IN THE TREATMENT OF UNSELECTED 
INSTITUTIONALIZED PSYCHIATRIC PATIENTS. 

180299 02-11 
INSTRUMENTAL 

EFFECTS OF METHAMPHETAMINE, PIPRADROL, AND METHYLPHENIDATE 
ON INSTRUMENTAL CONDITIONING AND SPONTANEOUS MOTOR 
ACTIVITY IN THE IMMATURE RAT. 

186568 03-04 
INSUFFICIENCY 

EXPERIENCE IN THE TREATMENT OF CEREBRAL INSUFFICIENCY AND 
PERIPHERAL BLOOD CIRCULATION DISORDERS USING THE EP- 50-100 
EXPERIMENTAL DRUG. 

180676 02-11 
INSULIN 

EFFECT OF CHLORPROMAZINE (CPZ) ON INSULIN RELEASE IN VIVO AND 
IN VITRO IN THE RAT. 

168440 01-03 
CONDITIONED HYPOGLYCEMIA; A MECHANISM FOR SACCHARIN 
INDUCED SENSITIVITY TO INSULIN IN THE RAT. 

174877 01-03 
BLOCKADE OF INSULIN RELEASE BY CERTAIN PHENOTHIAZINES. 

189583 04-05 
INTACT 

CARDIOVASCULAR EFFECTS OF RESERPINE, YOHIMBINE, AND RESERPINE 
YOHIMBINE MIXTURES ON INTACT ANESTHETIZED DOG. 

167328 01-03 
EFFECT OF CHLORIMIPRAMINE ON THE RATE OF TRYPTOPHAN 
HYDROXYLATION IN THE INTACT AND TRANSECTED SPINAL CORD 

168751 01-03 
LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 
ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 
COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25 AN IN 
INTACT MALE RATS. 

186683 03-04 
INTAKE 

DRUG DEPENDENCE TEST OF PHENOBARBITAL AND MORPHINE IN RATS 
BY SPONTANEOUS INTAKE. 

182104 02-04 
SUBSTANTIAL ORAL MORPHINE INTAKE BY THE RAT USING SCHEDULE 
INDUCED POLYDIPSIA. 

182194 02-04 
INFLUENCE OF DIBENCYCLADINE AND IMIPRAMINE ON CALORIE INTAKE 
AND BODYWEIGHT. 

183359 03-03 
THE EFFECTS OF CHRONIC TREATMENT WITH D-AMPHETAMINE ON FOOD 
INTAKE, BODYWEIGHT, LOCOMOTOR ACTIVITY AND SUBCELLULAR 
DISTRIBUTION OF THE DRUG IN RAT BRAIN. 

185931 03-03 
INTERACTION OF D-AMPHETAMINE WITH CENTRAL NERVOUS SYSTEM 
DEPRESSANTS ON FOOD INTAKE AND SPONTANEOUS MOTOR 
ACTIVITY OF MICE. 

189613 04-04 
EFFECTS OF DELTA9-THC ON FOOD AND WATER INTAKE OF DEPRIVATION 
EXPERIENCED RATS 

191375 04-04 
INTEGRATIVE 

THE NOOTROPIC APPROACH TO THE PHARMACOLOGY OF THE 
INTEGRATIVE ACTIVITY OF THE BRAIN. 

173495 01-02 
INTELLIGENCE 

PARKINSONISM, L-DOPA, AND INTELLIGENCE. 

175426 02-11 



S-125 



Subject Index 



Psychopharmacology Abstracts 



"^"tHE^EFFECTS of CHLORDIAZEPOXIDE (LIBRIUM) ON THE INTENSITY AND 
HABITUATION OF AGONISTIC BEHAVIOR IN MALE SIAMESE FIGHTING 

""'^^ 177722 02-04 

"'^"hAR MACOLOGICAL INTERACTION BETWEEN CANNABIDIOL AND DELTA9- 
TETRAHYDROCANNABINOL. ,69472 01-03 

LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND GAMMA-AMINOBUTYRIC 
ACID (GABA) INTERACTION ON SPONTANEOUS POTENTIALS AND THE 
EVOKED RESPONSE IN THE AVIAN TECTUM. 

169689 01-03 

INTERACTION BETWEEN PRIOR EXPERIENCE AND THE EFFECTS OF 
CHLORPROMAZINE ON EXPLORATION IN THE RAT. 

171308 01-04 
INTERACTION BETWEEN ATROPINE AND OXOTREMORINE ON CORTICAL 
ACETYLCHOLINE AND MOTOR ACTIVITY. 

171606 01-03 

INTERACTION BY FENFLURAMINE WITH THE METABOLISM OF D- 

AMPHETAMINE IN THE RAT. ,71634 01-03 

INTERACTION OF PHENOTHIAZINE DERIVATIVES WITH HUMAN 

^^^^^OPlASmr^. ,77335 02-13 

INTERACTION OF CENTRALLY ADMINISTERED OUABAIN WITH AGENTS 

AFFECTING SYMPATHETIC FUNCTION. 

1 78640 02-03 
INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L AND CANNABIDIOL 

ON INTESTINAL MOTILITY IN MICE. 

180057 02-03 
INTERACTION OF APOMORPHINE, NEUROLEPTICS AND STIMULANTS 

WITH ALPHA-METHYL-M-TYRAMINE, A FALSE DOPAMINERGIC 

TRANSMITTER. 

181809 02-03 

INTERACTION OF CYCLIC AMP WITH NEUROPHARMACOLOGIC 

DEPRESSANT AGENTS. „, „ „n n, 

182155 02-03 

INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC), 
CAFFEINE, (C), NICOTINE (N), PHENOBARBITAL (P): EFFECTS ON 
CONDITIONED AVOIDANCE (CAR). 

182192 02-04 

INTERACTION OF THE BEHAVIORALLY ACTIVE DRUG, PHENITRONE, A 
PURPORTED HASHISH AND LSD ANTAGONIST, WITH SEVERAL 
CENTRAL NEUROCHEMICAL SYSTEMS. 

182217 03-04 

THE INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L (THC), 
PENTOBARBITAL AND SKF-525-A WITH THE CARDIOVASCULAR 

SYSTEM OF THE RAT. „^ „^ 

182218 03-03 

CANNABIDIOL INTERACTION WITH DELTA9-TETRAHYDR0CANNABIN0L. 

183788 03-03 
THE EFFECT OF LOW ENVIRONMENTAL TEMPERATURE ON THE 
TRANYLCYPROMINE MEPERIDINE INTERACTION IN MICE. 

183897 03-03 
THE EFFECT OF P-CHLOROAMPHETAMINE ON MOTILITY IN RATS AFTER 
INHIBITION OF MONOAMINE SYNTHESIS, STORAGE, UPTAKE AND 
RECEPTOR INTERACTION. ,85959 03-04 

METHYLPHENIDATE ANTAGONISM OF HALOPERIDOL, INTERACTION WITH 
CHOLINERGIC AND ANTICHOLINERGIC DRUGS. 

186370 03-04 

INTERACTION BETWEEN SEROTONIN AND MORPHINE IN THE GUINEA-PIG 

l^^^*^- 186698 03-03 

INTERACTION AMONG GENOTYPE, UNCONDITIONED STIMULUS, D- 

AMPHETAMINE AND ONE-WAY AVOIDANCE BEHAVIOR OF RATS. 

187702 04-04 
INTERACTION OF LOW-DOSE AMPHETAMINE USE WITH SCHIZOPHRENIA 

IN OUTPATIENTS: THREE CASE REPORTS. ^^^^^^ ^^^^ 

INTERACTION OF D-AMPHETAMINE WITH CENTRAL NERVOUS SYSTEM 
DEPRESSANTS ON FOOD INTAKE AND SPONTANEOUS MOTOR 
^^^^■'^Of^^^^- 189613 04-04 

INTERACTION BETWEEN ALCOHOL, MINOR TRANQUILIZERS AND 

'«°^''"'^^- ,9,14104-04 

POSITIVE REINFORCING EFFECTS OF APOMORPHINE, D-AMPHETAMINE 
AND MORPHINE: INTERACTION WITH HALOPERIDOL. 

,9,899 04-04 

SOURCES OF VARIABILITY IN THE PHARMACODYNAMICS OF ,4C- 
IMIPRAMINE INCLUDING INTERACTION WITH DIAZEPAM OR 

^"'°^"^*^"^^- ,91925 04-03 

INTERACTION OF MESCALINE AND STRESS ON SHUTTLEBOX 

ESCAPE/AVOIDANCE IN RATS. ,9,934 04-04 



DELTA9-TETRAHYDR0CANNABIN0L (DELTA9-THC) IMIPRAMINE \ 

INTERACTION ON MOUSE BODY TEMPERATURE. 

,91996 04-03 
INTERACTION OF SEROTONIN ANTAGONISTS WITH 3,4-DICHL0R0-2-(2- 
IMIDAZOLIN-2-YL-THIO) 2 ACETOPHENONE HYDROBROMIDE (DITA) 
AND D-AMPHETAMINE HYDROBROMIDE (DITA) AND D-AMPHETAMINE 
ON CERTAIN BEHAVIORAL PARAMETERS OF MALE MICE. 

1920,4 04-04 

INTERACTION BETWEEN NEUROLEPTIC THERAPY AND SOCIOTHERAPEUTIC 
APPROACH. AN INVESTIGATION WITH PENFLURIDOL AND 
HALOPERIDOL „ ^, „ „„ 

,9243, 04-08 

INTERACTIONS 

INTERACTIONS OF DIAZEPAM AND HALOTHANE IN RATS. 

17,633 0,-03 
EFFECTS AND INTERACTIONS OF SCOPOLAMINE AND D-AMPHETAMINE 
ON SCHEDULE-CONTROLLED RESPONDING IN RATS. (PH.D. 

^'^^^^^^^'°''- ,73748 01-04 

INTERACTIONS IN MAN OF 0ELTA9-TETRAHYDR0CANNABIN0L: I. ALPHA- 

METHYL-PARA-TYROSINE. ,74347 0,.,3 

AMPHETAMINE TRICYCLIC INTERACTIONS: ROLE OF THE 

HYDROXYLATION OF AMPHETAMINE IN ITS CENTRAL AND PERIPHERAL 
MODE OF ACTION. (PH.D. DISSERTATION). 

,74963 01-03 

AN INVESTIGATION OF INTERACTIONS AMONG LSD, 

DEXTROAMPHETAMINE, AND VERBAL BEHAVIOR IN MONOLOGUES 
AND DIALOGUES. (PH.D. DISSERTATION). ^^ 

EFFECTS OF CLONIDINE AND SOME ALPHA-ADRENORECEPTOR BLOCKING 
AGENTS ON AVOIDANCE CONDITIONED REFLEXES IN RATS: THEIR 
INTERACTIONS AND ANTAGONISM BY ATROPINE. 

EFFECTS OF SOME METALLIC CATIONS ON CEREBRAL CORTICAL 
NEURONES AND THEIR INTERACTIONS WITH BIOGENIC AMINES. 

187806 04-03 
INTERACTIONS OF CHLORPHENIRAMINE ETHANOL COMBINATIONS: 
ACUTE TOXICITY AND ANTIHISTAMINE ACTIVITY. 

188875 04-05 

ANTICONVULSANT EFFECTS OF CANNABINOLS IN MICE: DRUG 
INTERACTIONS WITH CANNABINOIDS AND CANNABINOID 
INTERACTIONS WITH PHENYTOIN. 

1895,3 04-03 

OUABAIN RECEPTOR INTERACTIONS IN (NA_ _ K. ) ATPASE 

•"^^P^'^'^^'O^^- ,89567 04-03 

DRUG INTERACTIONS. ^^^^^^ ^^ ,^ 

METABOLIC INTERACTIONS BETWEEN NORTRIPTYLINE AND 

THIORIDAZINE IN RATS. ,90346 04-03 

INTERACTIONS OF PSYCHOTROPIC DRUGS AND MESCALINE IN VITRO. 

,9,933 04-03 
CHOLINERGIC AMINERGIC INTERACTIONS IN LEAD INDUCED 

^^PE^^^T'^'^^ ,9,954 04-05 

INTERACTIONS BETWEEN RO-4-,284 AND D-AMPHETAMINE (DA) ON 
SHUTTLEBOX AVOIDANCE IN RATS. ^^^^^ ^^^^ 

INTERACTIVE 

INTERACTIVE EFFECTS OF CYCLOHEXIMIDE AND PUROMYCIN IN 

ALTERING BRAIN POLYRIBOSOMES AND NEURAL AND BEHAVIOURAL 
RESPONSES TO ELECTROSHOCK IN MICE. ^ ^^^^^ ^^^^ 

INTERDEPENDENT 

ORTHOGONAL FACTORS VS. INTERDEPENDENT VARIABLES AS 
PREDICTORS OF DRUG TREATMENT RESPONSE IN ANXIOUS 
OUTPATIENTS. ,7,299 0,-14 

HYDROXYLAMINE INTERFERES WITH THE BEHAVIORAL RESPONSE TO 
MORPHINE DEPENDENCE IN MICE. ^^^^^^ ^^^ 

A DOUBLE-BUND CLINICAL TRIAL OF DOXEPIN HYDROCHLORIDE AND 
DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION 
IN THE FIELD OF INTERNAL MEDICINE. 

1/1 Zo/ U I- 1 1 

CLINICAL PHARMACOLOGICAL STUDY OF BROMAZEPAM IN THE FIELD Of 
INTERNAL MEDICINE. ,76473 02-10 

MASS FRAGMENTOGRAPHIC ANALYSIS OF HOMOVANILLIC ACID AND ITS 
HOMOISO ANALOGUE IN CEREBROSPINAL FLUID USING THE ALPHA 
DIDEUTERO ACID AS INTERNAL STANDARD. 

,86566 UJ-lo 



S-126 



OLUME 12, SUBJECT INDEX 



Subject Index 



JTERNATIONAL 

INTERNATIONAL REFERENCE CENTERS NETWORK FOR PSYCHOTROPIC 
DRUGS. 

167706 01-17 
ITERPRETATION 

CHLORDIAZEPOXIDE OVERDOSE: INTERPRETATION OF SERUM DRUG 
CONCENTRATIONS. 

177393 02-15 
METHYPRYLON OVERDOSE: INTERPRETATION OF SERUM DRUG 

CONCENTRATIONS. 

177394 02-15 
ITERPRETATIONS 

THE USE OF DRUGS IN PSYCHIATRIC INTERVIEWS: SOME 
INTERPRETATIONS BASED ON CONTROLLED EXPERIMENTS. 

189074 04-17 
ITERRELATED 

SOME INTERRELATED PROPERTIES OF BRAIN MONOAMINE OXIDASE. 

191498 04-01 
TERREIATIONSHIP 

SUBSTITUTED BENZOXAZOLE/BENZTHIAZOLE-2-THIONES: 
INTERRELATIONSHIP BETWEEN ANTICONVULSANT ACTIVITY AND 
INHIBITION OF NICOTINAMIDE ADENINE DINUCLEOTIDE DEPENDENT 
OXIDATIONS AND MONOAMINE OXIDASE. 

183601 03-03 
TERRESPONSE 

INTERRESPONSE TIME CHANGES AS A FUNCTION OF DEPRIVATION AND 
AMPHETAMINE ADMINISTRATION. 

171612 01-04 
THE EFFECTS OF D-AMPHETAMINE ON THE INTERRESPONSE TIMES OF 
RATS AND GUINEA-PIGS ON A MODIFIED SIDMAN DISCRIMINATED 
AVOIDANCE SCHEDULE. 

189519 04-04 
TERRUPTION 

ENHANCEMENT OF AMPHETAMINE ACTION AFTER INTERRUPTION OF 
ASCENDING SEROTONERGIC PATHWAYS. 

189398 04-03 
TERVAL 

COMPARISON OF CODEINE AND ETHYL ALCOHOL SELF-ADMINISTRATION 
UNDER A VARIABLE INTERVAL (VI) SCHEDULE IN MONKEYS. 

191983 04-04 
TERVALS 

SUPPRESSION OF LORDOSIS IN GUINEA-PIGS BY ETHAMOXY-TRIPHETOL 
(MER-25) GIVEN AT LONG INTERVALS (36-46 HR) AFTER ESTRADIOL 
BENZOATE TREATMENT. 

186686 03-04 
TERVENTION 
THE ROLE OF RESEARCH IN DRUG ABUSE INTERVENTION: STREET DRUG 
ANALYSES. 

167382 01-17 
A STUDY OF THE EFFECTS OF RITALIN INTERVENTION UPON THE 
PERCEPTUAL COMPETENCIES OF CHILDREN DIAGNOSED AS GIVING 
EVIDENCE OF PSYCHONEUROLOGICAL LEARNING DISABILITIES. (PH.D. 
DISSERTATION). 

186833 03-14 
TERVENTIONS 
BIOLOGICAL INTERVENTIONS IN PSYCHOSES OF CHILDHOOD. 

175872 02-17 
CONTROL OF THE HYPERACTIVE CHILD VIA MEDICATION - AT WHAT 
COST TO PERSONALITY DEVELOPMENT; SOME PSYCHOLOGICAL 
IMPLICATIONS AND CLINICAL INTERVENTIONS. 

176810 02-11 
FERVIEW 
EXPERIENCE IN THE DRUG HORIZON AND PSYCHIATRIC INTERVIEW. 

176542 02-11 
THE STANDARDIZED VIDEOTAPE INTERVIEW AS AN OBJECTIVE 
DEPENDENT VARIABLE IN PSYCHOTROPIC DRUG RESEARCH. 

183635 03-17 
THE METHOHEXITAL METHYLPHENIDATE INTERVIEW: A PROPOSED NEW 
DRUG COMBINATION FOR NARCOTHERAPY. 

190242 04-07 
rERVIEWS 
THE USE OF DRUGS IN PSYCHIATRIC INTERVIEWS: SOME 
INTERPRETATIONS BASED ON CONTROLLED EXPERIMENTS. 

189074 04-17 
rESTINAL 
INTERACTION OF DELTA9-TETRAHYDR0CANNABIN0L AND CANNABIDIOL 
ON INTESTINAL MOTILITY IN MICE. 

180057 02-03 
INTESTINAL EFFECTS OF 5-HYDROXYTRYPTAMINE AND MORPHINE IN 
GUINEA-PIGS, DOGS, CATS AND MONKEYS. 

188202 04-03 
riMATIONS 
CLINICAL INTIMATIONS OF AMINE BALANCE AND PERMISSION. 

191534 04-09 
rOXICATED 
INDUCTION OF SEVERE DEPRESSION BY PHYSOSTIGMINE IN MARIJUANA 
INTOXICATED INDIVIDUALS. 

177450 02-14 



INTOXICATING 

MANUAL OF INTOXICATING DRUGS. 

175537 02-17 
INTOXICATION 

ULTRASTRUCTURE OF CNS IN LITHIUM INTOXICATION. 

1 76476 02-05 
FATAL INTOXICATION OF A YOUNG DRUG ADDICT WITH DIAZEPAM. 

178619 02-05 
EFFECT OF CHRONIC INTOXICATION WITH (J AMPHETAMINE ON ITS 
CONCENTRATION IN LIVER AND BRAIN AND ON (140 LEUCINE 
INCORPORATION INTO MICROSOMAL AND CYTOPLASMIC PROTEINS OF 
RAT LIVER. 

180056 02-05 
CHRONIC MEPROBAMATE INTOXICATION AND PHOTOMYOCLONIC 
RESPONSE. 

181377 02-15 
CLINICAL STUDIES OF ACUTE PSYCHOSIS ON THE BASIS OF CHRONIC 
HYPNOTICA INTOXICATION - AN ABSTRACT REPORT. 

182755 03-15 
THE EFFECT OF CHLORPROMAZINE AND STELAZINE ON LYSOSOMES OF 
RAT LIVER DURING ACUTE INTOXICATION. 

191121 04-03 
INTRAARTERIAL 

A CRITICAL EVALUATION OF THE PRINCIPLES GOVERNING THE 
ADVANTAGES OF INTRAARTERIAL INFUSIONS. 

170112 01-06 
CNS DEPRESSION IN THE ABSENCE OF PROLACTIN RELEASE FOLLOWING 
INTRAARTERIAL INJECTIONS OF SODIUM PENTOTHAL IN THE 
PROESTROUS RAT. 

173257 01-03 
INTRACAROTID 

GENERALIZED PENICILLIN EPILEPSY IN THE CAT: EFFECTS OF 

INTRACAROTID AND INTRAVERTEBRAL PENTYLENETETRAZOL AND 
AMOBARBITAL INJECTIONS. 

188374 04-03 
INTRACAUDATE 

TREMOR INDUCTION BY INTRACAUDATE INJECTIONS OF BRETYLIUM, 
TETRABENAZINE, OR MESCALINE: FUNCTIONAL DEFICITS IN CAUDATE 
DOPAMINE. 

167329 01-03 
THE EFFECTS OF INTRACAUDATE INJECTIONS OF CHLORPROMAZINE ON 
CONDITIONED AVOIDANCE AND SELF-STIMULATION BEHAVIOR. (PH.D. 
DISSERTATION). 

173749 01-04 
ANALYSIS OF TREMORGENIC EFFECTS OF INTRACAUDATE D- 
AMPHETAMINE. 

182129 02-03 
INTRACEREBRAL 

INTRACEREBRAL INJECTION OF 6-HYDROXYDOPAMINE AND HYDROGEN 
PEROXIDE IN CATS: SPECIFIC AND NONSPECIFIC EFFECTS ON STRIATAL 
BIOGENIC AMINES. 

188426 04-03 
EFFECTS OF INTRACEREBRAL INJECTION OF 5,6-HYDROXYTRYPTAMINE 
ON CEREBRAL MONOAMINES AND SLEEP STATES IN THE CAT/. 

189023 04-02 
INTRACISTERNAL 

EFFECTS OF INTRACISTERNAL 6-HYDROXYDOPAMINE TREATMENT ON 
ACQUISITION AND PERFORMANCE OF RATS IN A DOUBLE T-MAZE. 

187696 04-04 
INTRACRANIAL 

INTRACRANIAL SELF-STIMULATION IN RATS AS A FUNCTION OF 
VARIOUS STIMULUS PARAMETERS: IV. INFLUENCE OF AMPHETAMINE 
ON MEDIAL FOREBRAIN BUNDLE STIMULATION WITH MONOPOLAR 
ELECTRODES. 

185961 03-04 
NEGATIVE AND POSITIVE INTRACRANIAL REINFORCEMENT THRESHOLDS- 
EFFECTS OF MORPHINE. 

190330 04-04 
ANALGESIA AND HYPERREACTIVITY PRODUCED BY INTRACRANIAL 
MICROINJECTIONS OF MORPHINE INTO THE PERIAQUEDUCTAL GRAY 
MATTER OF THE RAT. 

191367 04-04 
ROLE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN IN 
INTRACRANIAL REWARD. 

191527 04-04 
INTRAGASTRIC 

INTRAGASTRIC SELF-ADMINISTRATION OF PSYCHOACTIVE DRUGS IN THE 
RHESUS MONKEY. 

191939 04-04 
INTRAHYPOTHALAMIC 

FURTHER EVIDENCE ON THE INTRAHYPOTHALAMIC LOCUS FOR 
ANDROGENIZATION OF FEMALE RATS. 

187935 04-03 
INTRAMUSCULAR 

RAPID CONTROL OF PSYCHOTIC EXCITEMENT STATES WITH 
INTRAMUSCULAR HALOPERIDOL. 

170627 01-09 



■'>:-^'y 



S-127 



Subject Index 

COMPARISON OF GRADED SINGLE INTRAMUSCULAR DOSES OF 
MORPHINE AND PENTOBARBITAL IN MAN. 

187254 03-15 
ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM: 
CLINICAL AND PHARMACOLOGIC CORRELATIONS AND THE EFFECT OF 
INTRAMUSCULAR PYRIDOXINE. „„.,„„ ,, 

188560 04-11 

INTRAPERITONEAL 

EFFECTS OF INTRAPERITONEAL AND INTRAVENTRICULAR D- 
AMPHETAMINE ADMINISTRATION ON ACTIVE AVOIDANCE 
PERFORMANCE IN THE RAT. 

1 75242 02-04 

INTRASPECIFIC 

BRAIN AMINES AND APOMORPHINE-INDUCED INTRASPECIFIC 
AGGRESSIVE BEHAVIOR IN THE RAT. 

186374 03-04 

INTRAVENOUS 

PREANESTHETIC MEDICATION IN ELECTIVE SURGERY: COMPARISON OF 
INTRAVENOUS DIAZEPAM WITH MEPERIDINE. 

167338 01-11 
PHARMACOKINETIC PROFILE OF DIAZEPAM IN MAN FOLLOWING SINGLE 
INTRAVENOUS AND ORAL AND CHRONIC ORAL ADMINISTRATION. 

170838 01-13 
DRUG LEVEL OF D- AND L-AMPHETAMINE DURING INTRAVENOUS SELF- 
ADMINISTRATION. 

185960 03-04 

ORAL AND INTRAVENOUS TOXICITY OF DELTA9- 
TETRAHYDROCANNABINOL IN RHESUS MONKEYS. 

188872 04-05 
PHARMACOKINETICS AND DISTRIBUTION PROPERTIES OF 

PENTOBARBITAL IN HUMANS FOLLOWING ORAL AND INTRAVENOUS 
ADMINISTRATION. 

191444 04-13 
EFFECTS OF INTRAVENOUS D-AMPHETAMINE, L-AMPHETAMINE AND 
METHYLPHENIDATE IN SCHIZOPHRENICS. 

191508 04-08 
ALPHA-METHYL-P-TYROSINE INHIBITION OF SELF-ADMINISTERED 
INTRAVENOUS MORPHINE AND ORAL WATER IN RATS. 

191940 04-04 

INTRAVENOUSLY 

DIAZEPAM USED INTRAVENOUSLY DURING REDUCTION OF FRACTURES 

AND DISLOCATIONS, 

174880 01-17 

A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY IN MAN OF 
INTRAVENOUSLY ADMINISTERED DELTA9-TETRAHYDR0CANNABIN0L, 
CANNABINOL, AND CANNABIDIOL. 

176747 02-03 
COMPARISON OF INTRAVENOUSLY ADMINISTERED METHADONE (ME), 
MORPHINE (MO). HEROIN (H) AND PLACEBO (P). 

182163 02-03 

INTRAVENTRICULAR 

RECOVERY OF FEEDING AND DRINKING BY RATS AFTER 
INTRAVENTRICULAR 6-HYDROXYDOPAMINE OR LATERAL 
HYPOTHALAMIC LESIONS. 

168484 01-03 
THE DISTRIBUTION OF DELTAl -TETRAHYDROCANNABINOL AND 7- 
HYDROXY-DELTAl -TETRAHYDROCANNABINOL IN THE MOUSE BRAIN 
AFTER INTRAVENTRICULAR INJECTION. 

172596 01-03 

EFFECTS OF INTRAPERITONEAL AND INTRAVENTRICULAR D- 
AMPHETAMINE ADMINISTRATION ON ACTIVE AVOIDANCE 
PERFORMANCE IN THE RAT. 

175242 02-04 

STUDIES ON CENTRAL REGULATING MECHANISM OF THE HYPOGLYCEMIA 
INDUCED BY INTRAVENTRICULAR ADMINISTRATION OF 
CHLORPROMAZINE. 

182093 02-03 

EFFECTS ON HOMEOSTASIS OF INTRAVENTRICULAR INJECTIONS OF 6- 

HYDROXYDOPAMINE IN RATS. 

187695 04-03 

INTRAVENTRICULARLY 

BEHAVIOURAL EFFECTS OF YOHIMBINE ADMINISTERED 
INTRAVENTRICULARLY IN THE RAT. 

177721 02-04 

THE EFFECTS OF INTRAVENTRICULARLY ADMINISTERED 

CATECHOLAMINES AND SEROTONIN ON THE RESERPINE INDUCED 
SPIKE WAVES RECORDED FROM THE MEDICAL NUCLEUS TRAPEZOIDES 

IN THE RABBIT. „„ „, 

182094 02-03 

INTRAVERTEBRAL 

GENERALIZED PENICILLIN EPILEPSY IN THE CAT: EFFECTS OF 

INTRACAROTID AND INTRAVERTEBRAL PENTYLENETETRAZOL AND 
AMOBARBITAL INJECTIONS. 

188374 04-03 

INVERSION 

INVERSION BY APOMORPHINE OF THE TENDENCY OF FEMALE RATS TO 
BE DEFEATED BY MALES WHEN COMPETING FOR FOOD IN A STRAIGHT 

^^^^^' 184212 03-04 



Psychopharmacology Abstracts 



INVESTIGATION 

A MULTICENTER INVESTIGATION OF LORAZEPAM IN ANXIETY NEUROSIS. 

167346 01-10 
A DOUBLE-BUND INVESTIGATION OF DIMETHACRINE VERSUS 
IMIPRAMINE IN HOSPITALIZED DEPRESSIVE STATES. 

171695 01-09 
ACUTE CEREBELLAR DISTURBANCE ASSOCIATED WITH DIAZEPAM 
THERAPY - A CASE REPORT AND FURTHER INVESTIGATION. 

177392 02-15 
AN INVESTIGATION OF INTERACTIONS AMONG LSD, 

DEXTROAMPHETAMINE, AND VERBAL BEHAVIOR IN MONOLOGUES 
AND DIALOGUES. (PH.D. DISSERTATION). 

185600 03-14 
AN EXPERIMENTAL INVESTIGATION OF DEPENDENCE LIABILITY OF 
METHAQUALONE IN RATS. 

186569 03-03 

AN INVESTIGATION OF THE BEHAVIOURAL NATURE OF THE 
PSYCHOMOTOR STIMULANT EFFECT OF AMPHETAMINE. 

188620 04-04 
INVESTIGATION OF PHYSICAL DEPENDENCE ON A NEW BENZODIAZEPINE 
DERIVATIVE, BROMAZEPAM. 

189209 04-05 
PSYCHOENDOCRINE INVESTIGATION IN SCHIZOPHRENIA: RELATIONSHIP 
BETWEEN PITUITARY GONADAL FUNCTION AND BEHAVIOR. 

191190 04-14 
INTERACTION BETWEEN NEUROLEPTIC THERAPY AND SOCIOTHERAPEUTIC 
APPROACH. AN INVESTIGATION WITH PENFLURIDOL AND 
HALOPERIDOL. 

192431 04-08 

INVESTIGATIONS 

PSYCHOMETRIC INVESTIGATIONS IN PARKINSONS SYNDROME DURING 
TREATMENT WITH L-DOPA AND RELEVANCE OF SOME PSYCHOLOGICAL 

PHENOMENA. 

168578 01-13 

ONGOING INVESTIGATIONS OF CEREBRAL GLUTAMINE EXCRETION 
SCHIZOPHRENICS DURING TREATMENT WITH NEUROLEPTIC. 

174101 01-08 
INVESTIGATIONS ON THE FATE OF THE ANTICONVULSANT CLONAZEPAM 
IN THE ORGANISM OF AAAN, RAT AND DOG. 

179022 02-13 

CONTROL OF INSOMNIA WITH A NEW BENZODIAZEPINE: THE 

FLUNITRAZEPAM OR RO-5-4200 (FIRST INVESTIGATIONS OF PHASE I 
AND CONTROLLED INVESTIGATIONS OF PHASE II). 

183198 03-11 
HISTO-AUTORADIOGRAPHIC INVESTIGATIONS ON THE DISTRIBUTION OF 
INJECTED 5-HYDROXYTRYPTAMINE (SEROTONIN) IN THE BRAIN AND 

THE PITUITARY OF MICE. 

185900 03-03 

BEHAVIORAL AND VISUAL EVOKED POTENTIAL INVESTIGATIONS DURING 
TRIHEXYPHENIDYL AND THIOTHIXENE TREATMENT IN PSYCHOTIC 

^°^^' 187115 03-09 

CORRELATION OF PHARMACOLOGICAL INVESTIGATIONS WITH THE 
CLINICAL EFFICACY OF ANTIDEPRESSANT DRUGS. 

192420 04-13 

INVESTIGATORY 

PSYCHOTROPIC EFFECT OF ANALGESICS AND NEUROLEPTICS ON A 
MODEL OF INVESTIGATORY BEHAVIOR CHANGED BY PAIN. 

191120 04-04 

INVOLUNTARY 

THE SUPPRESSION OF INVOLUNTARY MOVEMENTS WITH 

TETRABENAZINE. ,,„.,o«o,, 

178618 02-11 

INVOLVED 

POTENTIAL NEUROTRANSMITTERS AND RECEPTOR MECHANISMS 
INVOLVED IN THE CENTRAL CONTROL OF BODY TEMPERATURE IN 
HAMSTERS. (PH.D. DISSERTATION). 

174962 01-03 

ARE CHOLINERGIC MECHANISMS INVOLVED IN MORPHINE EFFECTS ON 

MOTILITY ^^ 

184198 03-02 

INVOLVEMENT 

POSSIBLE INVOLVEMENT OF CYCLIC NUCLEOTIDES IN THE STIMULATION 
OF PITUITARY FUNCTION ELICITED BY RESERPINE. (UNPUBLISHED 

''*''^'" 170086 01-0: 

IS THERE A RELATIONSHIP BETWEEN THE INVOLVEMENT OF 
EXTRAPYRAMIDAL AND MESOLIMBIC BRAIN AREAS WITH THE 
CATALEPTIC ACTION OF NEUROLEPTIC AGENTS AND THEIR CLINICAL 
ANTIPSYCHOTIC EFFECT? umsO^^ 

POSSIBLE INVOLVEMENT OF A NORADRENERGIC AREA OF THE 
AMYGDALA WITH STEREOTYPED BEHAVIOUR. 

1 76877 02-0i 

INVOLVEMENT OF ALPHA-RECEPTORS IN CLONIDINE INDUCED INHIBITION 
OF TRANSMITTER RELEASE FROM CENTRAL MONOAMINE NEURONES. 

182345 03-a 



S-128 



rOLUME 12, SUBJECT INDEX 



Subject Index 



COMPARISON OF THE LOCOMOTOR STIMULANT MECHANISMS OF 
ACTION OF D-AMPHETAMINE AND D-AMPHETAMINE PLUS L-DOPA: 
POSSIBLE INVOLVEMENT OF SEROTONIN. 

187119 03-04 
INVOLVEMENT OF BRAIN CHOLINERGIC MECHANISMS IN THE ACTION OF 
CHLORPROMAZINE. 

188891 04-03 
EVIDENCE FOR A DOPAMINERGIC INVOLVEMENT IN THE MAINTENANCE 
OF SELF-STIMULATION. 

191526 04-03 
DRUG-INDUCED AGGRESSION IN CHICKS: DIFFERENTIAL INVOLVEMENT 
OF BIOGENIC AMINES. 

191977 04-04 
>DINE 

THE EFFECT OF LITHIUM ON THYROID IODINE RELEASE IN PATIENTS 
WITH PRIMARY AFFECTIVE DISORDER. 

186580 03-09 
>N 

THE EFFECTS OF PSYCHIC STIMULANTS ON THE ACTIVITY OF POTASSIUM 
AND SODIUM ION STIMULATED ATPASE IN THE MICROSOMAL 
FRACTIONS OF THE BRAIN OF RATS. 

183518 03-01 
)NTOPHORESIS 

TO SPRITZ OR NOT TO SPRITZ: THE DOUBTFUL VALUE OF AIMLESS 
IONTOPHORESIS. 

187132 03-06 
RINDOLE 

A DOUBLE-BLIND TRIAL OF IPRINDOLE AND IMIPRAMINE IN DEPRESSIVES 
AND RESPONSE TO ECT IN REFRACTORY CASES. 

174376 01-09 
EFFECT OF CHRONIC TREATMENT WITH DESIPRAMINE (DMI) AND 
IPRINDOLE (IP) ON THE NOREPINEPHRINE (NE) SENSITIVE ADENYLATE 
CYCLASE SYSTEM IN SLICES OF THE RAT LIMBIC FOREBRAIN. 

192003 04-03 
RONIAZID 

THE EFFECT OF IPRONIAZID AND TRANYLCYPROMINE STUDIED WITH A 
DARK AVOIDANCE CONDITIONED SCHEDULE. 

186590 03-04 
THE EFFECT OF PRETREATMENT WITH IPRONIAZID ON THE BEHAVIORAL 
ACTIVITIES OF BETA-PHENYLETHYLAMINE IN RATS. 

187932 04-04 
IS 

UPTAKE, STORAGE AND RELEASE IN VIVO OF A DOPAMINE DERIVED 
TETRAHYDROISOQUINOLINE (TIQ) ALKALOID BY SYMPATHETIC NERVES 
OF THE IRIS. 

182204 02-03 
RATIONAL 

METHAQUALONEt AN IRRATIONAL HYPNOTIC. 

189902 04-15 
OLATEO 

THE ACTIVITY OF SOME NEUROLEPTIC DRUGS AND AMPHETAMINE IN 
NORMAL AND ISOLATED RATS. 

170126 01-04 
KINETICS AND CELLULAR CONTROL MECHANISMS FOR IMIPRAMINE 
METABOLISM IN THE ISOLATED PERFUSED RAT LIVER. (PH.D. 
DISSERTATION). 

173601 01-03 
ACTION OF CONVULSANTS ON ROOT POTENTIALS AND AMINO ACID 
RESPONSES IN ISOLATED FROG SPINAL CORD. (UNPUBLISHED PAPER). 

177976 02-03 
MOLECULAR ORBITAL STUDIES ON THE CONFORMATION OF 

HALLUCINOGENIC INDOLEALKYLAMINES AND RELATED COMPOUNDS. 
THE ISOLATED MOLECULES AND THE SOLVENT EFFECT. 

183406 03-01 
THE INHIBITION BY BETA-ADRENOCEPTOR BLOCKING AGENTS OF 

CALCIUM UPTAKE INTO AND EFFLUX FROM ISOLATED SARCOPLASMIC 
VESICLES. 

184223 03-03 
THE ISOLATED PERFUSED RAT BRAIN AS A MODEL FOR STUDYING 
DRUGS ACTING ON THE CNS. 

186589 03-06 
ALPHA-L-ACETYLMETHADOL AND ITS N-DEMTHYLATED METABOLITES 
HAVE POTENT OPIATE ACTION IN THE GUINEA-PIG ISOLATED ILEUM. 

187130 03-03 
STUDIES ON CONVULSANTS IN THE ISOLATED FROG SPINAL CORD. I. 
ANTAGONISM OF AMINO ACID RESPONSES. (UNPUBLISHED PAPER) 

190727 04-03 
INFLUENCE OF PSYCHOTROPIC DRUGS ON AGGRESSIVENESS EVOKED BY 
DESTRUCTION OF ISOLATED STRUCTURES OF THE FOREBRAIN. 

191788 04-04 
OLATION 

MEDICOLEGAL STUDIES ON ISOLATION AND IDENTIFICATION OF 
HYPNOTICS BY THIN-LAYER CHROMATOGRAPHY (TLC) - REPORT 1. 
THIN-LAYER CHROMATOGRAPHY OF HYPNOTICS AND TRANQUILIZERS. 

181315 02-16 
THE INFLUENCE OF ALDOSTERONE OR METHAMPHETAMINE ON LIVER 
GLYCOGEN DEPOSITION OF MICE STRESSED BY LONG-TERM 
ISOLATION. 

182105 02-03 



THE EFFECT OF METHAMPHETAMINE ON BRAIN ACH CONSUMPTION AND 
AGGRESSIVENESS IN MICE STRESSED MILDLY BY LONG-TERM 
ISOLATION. 

182108 02-04 

INHIBITION OF ISOLATION INDUCED AGGRESSION IN THE MOUSE BY 
ANTICHOLINERGIC COMPOUNDS. 

182239 03-04 
INHIBITION OF ISOLATION INDUCED AGGRESSION IN MICE BY 

ANTISEROTONERGIC DRUGS. 

182240 03-04 
MEDICOLEGAL STUDIES ON ISOLATION AND IDENTIFICATION OF 

HYPNOTICS BY THIN-LAYER CHROMATOGRAPHY (TLC): REPORT 2 - 
ISOLATION AND IDENTIFICATION OF HYPNOTICS AND TRANQUILIZER 
IN VIVO. 

182623 03-06 
ISOLATION AND IDENTIFICATION OF HYPNOTICS (8): ISOLATION AND 
IDENTIFICATION OF BENZALIN AND CERCINE BY THIN-LAYER 
CHROMATOGRAPHY IN VITRO. 

182626 03-01 
ISOLATION OF A POSSIBLE NEW METABOLITE OF THIORIDAZINE AND 
MESORIDAZINE FROM HUMAN PLASMA. 

182722 03-13 
ISOLE 

EEG AND CARDIOVASCULAR EFFECTS OF TRYPTAMINE (T) AND LSD IN 
THE ENCEPHALE ISOLE CAT. (UNPUBLISHED PAPER) 

174496 0112 
THE ACTION OF ALPHA-METHYLDOPA IN THE CERVEAU ISOLE 
PREPARATION. 

187075 03-03 
ISOMERIC 

CENTRALLY ACTING MUSCLE RELAXANTS. ISOMERIC 9,10 

OIHYDROXYOCTAHYDROPHENANTHRENES AND THEIR CARBAMATE 
ESTERS. 

190719 04-02 
ISOMERS 

EFFECTS OF PSYCHOTOMIMETICS ON VASCULAR STRIPS: STUDIES OF 
METHOXYLATED AMPHETAMINES AND OPTICAL ISOMERS OF 2,5 
DIMETHOXY-4-METHYLAMPHETAMINE AND 2,5 DIMETHOXY-4- 
BROMOAMPHETAMINE. 

I 77734 02-03 
RELATIVE PHARMACOLOGICAL POTENCY IN MICE OF OPTICAL ISOMERS 
OF DELTAl-TETRAHYDROCANNABINOL. 

181941 02-03 
EFFECTS OF AMPHETAMINE ISOMERS ON NEUROMUSCULAR 

TRANSMISSION IN RAT PHRENIC NERVE DIAPHRAGM PREPARATION. 

182232 03-03 
THE SITE OF ACTION ON THE OPTICAL ISOMERS OF l-METHYL-5-PHENYL- 
5-PROPYL BARBITURIC ACID 

185901 03-03 
THE TRANYLCYPROMINE ISOMERS: A CONTROLLED CLINICAL TRIAL. 

192065 04-13 
ISOPRENAUNE 

EXTRANEURONAL REMOVAL, ACCUMULATION AND 0-METHYLATION OF 
ISOPRENALINE IN THE PERFUSED HEART. 

189604 04-03 
ITEMS 

STEREOTYPY WITH SELECTIVE STIMULATION OF CERTAIN ITEMS OF 
BEHAVIOUR OBSERVED IN AMPHETAMINE TREATED MONKEYS 
(CERCOPITHECUS). 

180061 02-04 
III 

MULTITRIAL PASSIVE AVOIDANCE IN RATS: MESCALINE, SHOCK, AND ITI 
EFFECTS. (PH.D. DISSERTATION). 

173162 01-04 
JANSSEN 

HALOPERIDOL (JANSSEN) IN THE TREATMENT OF UNSELECTED 
INSTITUTIONALIZED PSYCHIATRIC PATIENTS. 

180299 02-11 
JAPAN 

PSYCHOTROPIC MEDICATION IN JAPAN. 

180319 0208 
JAPANESE 

EFFECTS OF CYPROTERONE ACETATE IN THE MALE JAPANESE QUAIL. 

186681 03-03 
JAVA 

CLINICAL TRIAL WITH NOZINAN-R. AT SEVERAL MENTAL HOSPITALS IN 
JAVA. 

176582 02-11 
JEKYLL 

METHAQUALONE - A DR. JEKYLL AND MR. HYDE? 

177396 02-15 
JIDO-IN 

CURRENT SITUATION OF THE USE OF DRUGS IN ASAHIGAWA JIDO-IN. 

168302 01-17 
JUDGMENT 

THE EFFECTS OF HOE- 36801 ON MUSCLE ACTIVITY AND BLOOD 
PRESSURE, ON ATTENTION AND CONCENTRATION, ON TIME 






S-129 



Subject Index 



Psychopharmacology Abstracts 



JUDGMENT AND SUBJECTIVE RESPONSES IN NEUROTICS AND 

NORMALS. 

192429 04- 14 

JUMPING 

CHOLINERGIC MODIFICATION OF NALOXONE INDUCED JUMPING IN 
MORPHINE DEPENDENT MICE. 

184179 03-03 

JUVENILE 

RELATIONSHIP BETWEEN RESPONSE TO LOW PENTAMETHYLENETETRAZOL 
ADMINISTRATION AND PERSONALITY OF JUVENILE OFFENDERS AND 
THEIR REPEATED CRIMES. 

175072 02-17 



OUABAIN RECEPTOR INTERACTIONS IN (NA_ . K_ ) ATPASE 
PREPARATIONS. 

AMPHETAMINE AND NA_,K- - ATPASE IN THE BRAIN. 



189567 04-03 

191789 04-03 
K.-ATPASE 

(3H) OUABAIN BINDING TO NA.-ATPASE AND K.-ATPASE: INHIBITION BY 
BETA, GAMMA METHYLENE ATP. 

182184 02-03 

KABI-1702 

THE PHARMACOLOGICAL EVALUATION IN LABORATORY ANIMALS OF 
KABI-1702 - A NEW SEDATIVE HYPNOTIC DRUG. 

171632 01-03 

KCL 

EFFECT OF ANESTHETIC AGENTS ON THE SYNTHESIS AND 

DISAPPEARANCE OF BRAIN DOPAMINE NORMALLY AND AFTER 
HALOPERIDOL, KCL OR AXOTOMY. 

189571 04-03 

KET AMINE 

THE USE OF KET AMINE IN PSYCHIATRY. 

175282 02-07 
ON THE CEREBRAL ACCUMULATION OF KET AMINE AND THE 
RELATIONSHIP BETWEEN METABOLISM OF THE DRUG AND ITS 
PHARMACOLOGICAL EFFECTS. 

186693 03-03 
KETAMINE INDUCED POSTANESTHETIC DELIRIUM ATTENUATED BY 
TETRAHYDROAMINOACRIDINE. 

188689 04-05 
EFFECTS OF PHENCYCLIDINE AND KETAMINE ON FOOD MAINTAINED 
BEHAVIOR IN THE PIGEON. 

191973 04-04 

KEY-PRESS 

NALTREXONE AND NALOXONE: AGONIST AND ANTAGONIST EFFECTS ON 
KEY-PRESS RESPONDING OF PIGEONS MAINTAINED UNDER A MULTIPLE 
SCHEDULE OF FOOD PRESENTATION. 

191926 04-04 

KILLING 

DIAZEPAM-INDUCED PLAY BEHAVIOR IN CATS DURING PREY KILLING. 

184979 03-04 

KINETICS 

KINETICS AND CELLULAR CONTROL MECHANISMS FOR IMIPRAMINE 
METABOLISM IN THE ISOLATED PERFUSED RAT LIVER. (PH.D. 
DISSERTATION). 

173601 01-03 

KLEINE-LEVINE 

A CASE OF KLEINE-LEVINE SYNDROME. 

K42 



183418 03-14 



THE INFLUENCE OF PSYCHOSTIMULANTS ON K42 MEMBRANE 
PERMEABILITY IN VARIOUS PORTIONS OF RAT BRAIN. 

191122 04-03 
L-ALPHA-METHYLDOPAHYDRAZINE 

PARKINSONISM DEMENTIA OF GUAM: TREATMENT WITH LEVODOPA 
AND L-ALPHA-METHYLDOPAHYDRAZINE. 

179996 02-13 
LEVODOPA COMBINED WITH MK-486 (L-ALPHA- 
METHYLDOPAHYDRAZINE) - A PERIPHERAL DECARBOXYLASE 
INHIBITOR IN PARKINSONS DISEASE. 

187615 04-11 

L-AMPHETAMINE 

THE EFFECTS OF D- AND L-AMPHETAMINE ON FIXED-INTERVAL AND 
FIXED-RATIO BEHAVIOR IN TOLERANT AND NONTOLERANT RATS. 

168438 01-04 
RELATIVE POTENCIES OF D- AND L-AMPHETAMINE ON THE RELEASE OF 
DOPAMINE FROM CAT BRAIN IN VIVO. 

1 76874 02-03 
DIFFERENTIAL EFFECTS OF D- AND L-AMPHETAMINE ON THE SLEEP OF 
DEPRESSED PSYCHIATRIC PATIENTS ON AND OFF LITHIUM CARBONATE 
TREATMENT (UNPUBLISHED PAPER). 

178432 02-09 

DRUG LEVEL OF D- AND L-AMPHETAMINE DURING INTRAVENOUS SELF- 
ADMINISTRATION. 

1 85960 03-04 
EFFECTS OF INTRAVENOUS D-AMPHETAMINE, L-AMPHETAMINE AND 
METHYLPHENIDATE IN SCHIZOPHRENICS. 

191508 04-08 



l-ASPARAGINASE 

EFFECT OF L-ASPARAGINASE ON RETENTION OF MAZE LEARNING IN 
MICE. 

167324 01-04 

L-DELTA9-TETRAHYDROCANNABINOL 

EFFECTS OF L-DELTA9TETRAHYDR0CANNABIN0L, DL-AMPHETAMINE 
AND PENTOBARBITAL ON OXYGEN CONSUMPTION BY MOUSE BRAIN 
AND HEART HOMOGENATES. 

181813 02-03 
L-DELTA9-TRANS-TETRAHYDROCANNABINOL 

THE EFFECTS OF L-DELTA9-TRANS-TETRAHYDR0CANNABIN0L ON LOW 
AND HIGH RESPONSE RATES GENERATED UNDER TWO SIMILAR 
CONDITIONS (PH.D. DISSERTATION). 

168230 01-04 

L-DOPA 

ANIMAL MODELS FOR AN ENZYMIC BLOOD-BRAIN BARRIER MECHANISM 
FOR THERAPEUTICALLY ADMINISTERED L-DOPA. 

167359 01-03 
EFFECTS OF L-DOPA ON NATURAL NIGHT SLEEP AND ON REBOUND OF 
REM SLEEP. 

167921 01-14 
TETRAHYDROISOQUINOLINE ALKALOIDS: IN VIVO METABOLITES OF L- 
DOPA IN MAN. 

168286 01-13 

L-DOPA IN 122 CASES OF PARKINSONS DISEASE AT AGE 70 OR OVER. A 
COMPARATIVE STUDY WITH A GROUP OF PATIENTS AGED 41 TO 69 
YEARS. 

168369 01-11 

PSYCHOMETRIC INVESTIGATIONS IN PARKINSONS SYNDROME DURING 
TREATMENT WITH L-DOPA AND RELEVANCE OF SOME PSYCHOLOGICAL 
PHENOMENA. 

168578 01-13 
EMOTIONAL FUNCTIONS IN SHORT-TERM VS. LONG-TERM L-DOPA 
THERAPY IN PARKINSONISM. 

168619 01-15 

FAILURES OF L-DOPA. 

168777 01-13 
COMBINATION OF L-DOPA, DESIPRAMINE, AND A DECARBOXYLASE 
INHIBITOR IN THE TREATMENT OF DEPRESSION. 

169468 01-09 

L-DOPA: EFFECT ON ETHANOL NARCOSIS AND BRAIN BIOGENIC AMINES 

IN MICE. 

169782 01-03 

SLEEP STUDIES AND THERAPEUTIC TRIAL WITH L-DOPA IN A CASE OF 
STIFF-MAN SYNDROME. 

171134 01-13 

EFFECTS OF L-DOPA ON SCHIZOPHRENIA. 

171245 01-08 
FUNCTIONAL EVALUATION OF PITUITARY RESERVE IN PATIENTS WITH 
THE AMENORRHEA GALACTORRHEA SYNDROME UTILIZING 
LUTEINIZING HORMONE RELEASING HORMONE (LH-RH), L-DOPA AND 
CHLORPROMAZINE. 

175245 02- 13 

PARKINSONISM, L-DOPA, AND INTELLIGENCE. 

175426 02-11 
THE PATIENTS VIEW OF L-DOPA AFTER ONE YEARS THERAPY. 

175459 02-15 
THREE CASES OF SCHIZOPHRENIA TREATED WITH L-DOPA. 

175550 02-08 
CYCLIC ADENOSINE MONOPHOSPHATE: SELECTIVE INCREASE IN CAUDATE 
NUCLEUS AFTER ADMINISTRATION OF L-DOPA. 

176254 02-13 
EFFECT OF CHRONIC ADMINISTRATION OF L-DOPA ON CATECHOL-0- 
METHYLTRANSFERASE IN RAT TISSUES. 

176936 02-03 
EFFECTS OF SHORT-TERM VERSUS LONG-TERM L-DOPA THERAPY IN 
PARKINSONISM ON CRITICAL FLICKER FREQUENCY. 

177511 02-11 
DRUG-INDUCED CATALEPSY AS INFLUENCED BY PSYCHOSTIMULANTS. 
APOMORPHINE, L-DOPA, AND YOHIMBINE. 

177730 02-13 
L-DOPA CHLORPROMAZINE ANTAGONISM ON RUNNING ACTIVITY IN 

MICE. 

177785 02-04 

L-DOPA AND THE TREATMENT OF EXTRAPYRAMIDAL DISEASE. 

(UNPUBLISHED PAPER) 

177975 02-11 

SYNTHESIS AND ANTIRESERPINE ACTIVITY OF PEPTIDES OF L-DOPA 

180097 02-03 

L-DOPA AND POTENTIATION OF ALCOHOL ANESTHESIA BY 
CHLORPROMAZINE. 

182091 0203 

L-DOPA EFFECTS ON MOTOR AND CENTRAL PROGRAMMING DEFICITS IN 

PARKINSONISM. 

184976 03-14 

A CASE OF PERIODIC SOMNOLENCE IMPROVED BY THE CO-MEDICATION 
OF L-DOPA AND METHYLPHENIDATE. 

185241 03-14 



S-130 



HUME 12, SUBJECT INDEX 

EFFECT OF L-DOPA IN 54 MN INCORPORATION BY TISSUES. 

185993 03-03 
THE EFFECT OF AMANTADINE, L-DOPA, (J AMPHETAMINE AND 
APOMORPHINE ON THE ACQUISITION OF THE CONDITIONED 
AVOIDANCE RESPONSE. 

186636 03-04 
CLINICAL PHARMACOLOGY AS AN APPROACH TO THE STUDY OF 
BIOCHEMICAL SLEEP MECHANISMS: THE ACTION OF L-DOPA. 

186643 03-14 
COMPARISON OF THE LOCOMOTOR STIMULANT MECHANISMS OF 
ACTION OF D-AMPHETAMINE AND D-AMPHETAMINE PLUS L-DOPA: 
POSSIBLE INVOLVEMENT OF SEROTONIN. 

187119 03-04 
ALTERATION OF EVOKED POTENTIALS IN CAUDATE NUCLEUS OF FREELY 
MOVING RATS BY L-DOPA, RESERPINE, AND PENTOBARBITAL. 

187362 04-03 
SALIGENIN ANALOGS OF L-DOPA AND DL-ALPHA-METHYL-DOPA. 

187565 04-11 
PARKINSONIAN SYNDROMES: TREATMENT BY ASSOCIATION OF L-DOPA 
PLUS DECARBOXYLASE INHIBITOR. 

188093 04-11 
DISAGGREGATION OF BRAIN POLYSOMES AFTER L-DOPA: AN ANALYSIS. 

188433 04-03 
APHRODISIAC EFFECT OF L-DOPA AND APOMORPHINE IN MALE 
SEXUALLY SLUGGISH RATS. 

188519 04-03 
THE ACUTE TOXICITY OF L-DOPA. 

189587 04-05 
CLINICAL EVALUATION OF AMANTADINE THERAPY FOR PARKINSONISM 
AND THE SIDE-EFFECTS -■ IN CASES OF THALAMIC SURGERY AND L- 
DOPA THERAPY. 

190095 04-11 
DISSOCIATION OF GROWTH HORMONE AND PROLACTIN SECRETION IN 
PARKINSONS DISEASE FOLLOWING CHRONIC L-DOPA THERAPY. 

19)233 04-13 
SKELETAL MUSCLE: RESERVOIR FOR EXOGENOUS L-DOPA. 

191771 04-03 
LUTAMIC 
STUDY WITH RADIOTRACERS OF THE DISTRIBUTION OF A NEW 
PSYCHOTROPE IN MICE: L-2-PYRROLIDONE-5-CARBOXYLATE 
DIMETHYLAMINOETHANOL. I. COMPARISON WITH L-GLUTAMIC AND L- 
2-PYRR0LID0NE-5-CARB0XYLIC ACID. 

180723 02-03 
ETHIONINE 

A STUDY OF THE BEHAVIORAL DISRUPTION OF MICE INDUCED BY L- 
METHIONINE AND RELATED COMPOUNDS. 

187260 04-04 
OREPINEPHRINE 
INHIBITION OF THE SYNAPTOSOMAL UPTAKE MECHANISMS FOR L- 
NOREPINEPHRINE AND DOPAMINE BY N-ARYLALKYL DL-AMPHETAMINE 
DERIVATIVES. 

182250 03-03 
CHLOROPHENYLALANINE 

THE EFFECT OF D- AND L-P-CHLOROPHENYLALANINE ON THE 
METABOLISM OF 5-HYDROXYTRYPT AMINE IN BRAIN 

168748 01-03 
1ENYL-3-2-THIAZOLYI 
EFFECT OF L-PHENYL-3-2-THIAZ0LYL 2-THIOUREA, A DOPAMINE-BETA- 
HYDROXYLASE INHIBITOR, ON MORPHINE ANALGESIA, TOLERANCE 
AND PHYSICAL DEPENDENCE. 

191769 04-03 
tOPRANOLOL 
PIMOZIDE, L-PROPRANOLOL AND PHENTOLAMINE EFFECTS ON 
AMPHETAMINE SELF-ADMINISTRATION BY THE RAT. 

191919 04-04 
ITRAHYDROPAIMATINE 

A CLINICAL STUDY OF L-TETRAHYDROPALMATINE (C-200) IN A 
NEUROPSYCHIATRY CLINIC. 

182902 03-09 
lYPTOPHAN 
THE EFFECT OF L-TRYPTOPHAN (TP) ON CUTANEOUS C-FIBER (CFR) AND 
POLYSYNAPTIC (PSR) REFLEXES IN ACUTE DECEREBRATE SPINAL CATS 
AND THE EFFECT OF PRETREATMENT WITH P-CHLOROPHENYLALANINE 
(PCPA) ON THE ACTION OF TP. {UNPUBLISHED PAPER). 

170874 01-03 
L-TRYPTOPHAN IN MANIA: CONTRIBUTION TO A PERMISSIVE 
HYPOTHESIS OF AFFECTIVE DISORDERS. 

171500 01-09 
L-TRYPTOPHAN IN THE TREATMENT OF LEVODOPA INDUCED 
PSYCHIATRIC DISORDERS. 

174297 01-15 
L-TRYPTOPHAN IN AFFECTIVE DISORDERS: INDOLEAMINE CHANGES AND 
DIFFERENTIAL CLINICAL EFFECTS, 

185928 03-09 
PYRROLIDONE-S-CARBOXYLATE 

STUDY WITH RADIOTRACERS OF THE DISTRIBUTION OF A NEW 
PSYCHOTROPE IN MICE: L-2-PYRROLIDONE-5-CARBOXYLATE 



Subject Index 



DIMETHYLAMINOETHANOL. I. COMPARISON WITH L-GLUTAMIC AND L- 
2-PYRROLIDONE-5-CARBOXYLIC ACID. 

180723 02-03 
L-2-PYRROUDONE-5-CARBOXYLIC 

STUDY WITH RADIOTRACERS OF THE DISTRIBUTION OF A NEW 
PSYCHOTROPE IN MICE: L-2-PYRROLIDONE-5-CARBOXYLATE 
DIMETHYLAMINOETHANOL. I. COMPARISON WITH L-GLUTAMIC AND L- 
2-PYRROLIDONE-5-CARBOXYLIC ACID. 

180723 02-03 
1-5-HTP 

GROWTH HORMONE RESPONSES TO ADMINISTRATION OF L-5- 

HYDROXYTRYPTOPHAN (L-5-HTP) IN MANIC-DEPRESSIVE PSYCHOSES. 

167919 01-09 
l-5-HYDROXYTRYPTOPHAN 

GROWTH HORMONE RESPONSES TO ADMINISTRATION OF L-5- 

HYDROXYTRYPTOPHAN (L-5-HTP) IN MANIC-DEPRESSIVE PSYCHOSES. 

167919 01-09 
TREATMENT OF ACTION MYOCLONUS WITH L-5-HYDROXYTRYPTOPHAN. 

188429 04-11 
LABEL 

CHLORDIAZEPOXIDE IN DEPRESSIVE NEUROSIS: AN OPEN LABEL 
CROSSOVER STUDY WITH AMITRIPTYLINE. 

168316 01-10 
LABELLED 

THE EFFECT OF PROTRIPTYLINE ON THE METABOLISM OF LABELLED 
DOPAMINE AND NORADRENALINE IN THE RAT BRAIN. 

171627 01-03 
LABILE 

DOUBLE-BLIND PSYCHOMETRIC EVALUATION OF PIMOZIDE AND 
HALOPERIDOL VERSUS PLACEBO IN EMOTIONALLY LABILE 
VOLUNTEERS UNDER TWO DIFFERENT WORK LOAD CONDITIONS. 

180065 02-14 
LABOR 

THE EFFECT OF PAIN RELIEVING DRUGS ADMINISTERED DURING LABOR 
AND DELIVERY ON THE BEHAVIOR OF THE NEWBORN: A REVIEW. 

183706 03-17 
LABORATORY 

RESEARCH ON SUPERSENSITIVE LABORATORY METHODS IN SWEDEN. 

170302 01-06 
THE PHARMACOLOGICAL EVALUATION IN LABORATORY ANIMALS OF 
KABI-1702 - A NEW SEDATIVE HYPNOTIC DRUG. 

171632 01-03 
TRIAZOLAM: A SLEEP LABORATORY STUDY OF A NEW BENZODIAZEPINE 
HYPNOTIC. 

177747 02-07 
LABORATORY STUDIES FOR EVERY MEDICATED OUTPATIENT: ARE THEY 
REALLY NECESSARY?. 

189075 04-13 
A PREDICTABLE LABORATORY MODEL FOR SEDATIVE/HYPNOTIC 
ACTIVITY IN MAN. 

191943 04-14 
LABORATORY ASSESSMENTS OF ANTIDEPRESSIVE ACTIVITY -- THEIR 
VALUE FOR CLINICAL PSYCHIATRY AND THE UNDERSTANDING OF 
DEPRESSION 

192422 04-09 
LABOUR 

DIAZEPAM IN LABOUR: ITS METABOLISM AND EFFECT ON THE CLINICAL 
CONDITION AND THERMOGENESIS OF THE NEWBORN. 

171731 01-13 
LACTATION 

THE EFFECTS OF PHENOTHIAZINES ON ENDOCRINE FUNCTION: I. 
PATIENTS WITH INAPPROPRIATE LACTATION AND AMENORRHOEA. 

184436 03-15 
LAROXYL 

EXPERIENCES WITH LAROXYL (R) IN THE TREATMENT OF DEPRESSIONS IN 
PRIVATE PSYCHIATRIC PRACTICE IN DJAKARTA. 

170413 01-11 
LATENCY 

NEW LONG LATENCY BULBOSPINAL EVOKED POTENTIALS BLOCKED BY 
SEROTONIN ANTAGONISTS. 

188751 04-03 
LATERAL 

LSD EFFECTS ON SIGNAL-TO-NOISE RATIO AND LATERALIZATION OF 
VISUAL CORTEX AND LATERAL GENICULATE DURING PHOTIC 
STIMULATION. 

167449 01-03 
RECOVERY OF FEEDING AND DRINKING BY RATS AFTER 
INTRAVENTRICULAR 6-HYDROXYDOPAMINE OR LATERAL 
HYPOTHALAMIC LESIONS. 

168484 01-03 
INFLUENCE OF MORPHINE ON LATERAL HYPOTHALAMIC SELF- 
STIMULATION IN THE RAT. 

168835 01-04 
PRESENCE OF OSMORECEPTORS FOR THIRST IN THE LATERAL PREOPTIC 
NUCLEUS. 

168859 01-03 
LEVODOPA INDUCED DYSKINESIAS: COMPARISON IN PARKINSONISM 
DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS. 

169376 01-15 



//'A'M 



S-131 



Subject Index 



DECREASED ANOREXIA, EXCITEMENT AND STEREOTYPY TO D- 
AMPHET AMINE AFTER LATERAL HYPOTHALAMIC 6- 
HYDROXYDOPAMINE (6-OHDA) INJECTIONS. 

182136 02-04 
RECOVERY OF FEEDING AFTER 6-HYDROXYDOPAMINE (6-HDA) OR 
LATERAL HYPOTHALAMIC LESIONS: THE ROLE OF CATECHOLAMINES. 

182213 03-03 
EFFECT OF DAMPHETAMINE (D-A) AND 2,5 DIMETHOXY-4- 

METHYLAMPHET AMINE (DOM) ON THE IN VIVO RELEASE OF 14C- 
NOREPINEPHRINE (NE) INTO THE LATERAL VENTRICLE OF RATS. 

182251 03-03 
PGO WAVES IN THE LATERAL GENICULATE NUCLEUS TRIGGERED BY 

BARBITURATE. 

187835 04-03 

LATERALIZATION 

LSD EFFECTS ON SIGNAL-TO-NOISE RATIO AND LATERALIZATION OF 
VISUAL CORTEX AND LATERAL GENICULATE DURING PHOTIC 
STIMULATION. 

167449 01-03 

LATIN-AMERICAN 

A COMPARISON OF CLINICALLY USED PSYCHOACTIVE DRUGS IN FOUR 
LATIN-AMERICAN COUNTRIES AND IN CANADA (ARGENTINA, COSTA- 
RICA. MEXICO AND PANAMA). 

191139 04-17 

LDSO 

INFLUENCE ON ACUTE PRETREATMENT WITH DELTA9- 

TETRAHYDROCANNABINOL OF THE LDSO OF VARIOUS SUBSTANCES 
THAT ALTER NEUROHUMORAL TRANSMISSION. 

188876 04-05 
INHALATION, PARENTERAL AND ORAL LDSO VALUES OF DELTA9- 
TETRAHYDROCANNABINOL IN FISCHER RATS. 

189588 04-05 

LEAD 

LEAD INDUCED BEHAVIORAL DYSFUNCTION: AN ANIMAL MODEL OF 
HYPERACTIVITY. 

184953 03-04 

CHOLINERGIC AMINERGIC INTERACTIONS IN LEAD INDUCED 
HYPERACTIVITY. 

191954 04-05 
INCREASED BRAIN NOREPINEPHRINE TURNOVER IN LEAD EXPOSED 
HYPERACTIVE RATS. 

191957 04-05 

LEADING 

SYNTHETIC STUDIES LEADING TOWARD THE PREPARATION OF LINEAR 
BENZOQUINOLINES. (PH.D. DISSERTATION). 

180739 02-01 

LEARNED 

FIGHTING IN MICE: DYADIC ESCALATION AND WHAT IS LEARNED. 

173039 01-04 

HIPPOCAMPAL LESIONS AND LEARNED TASTE AVERSION. 

184834 03-04 

THE EFFECTS OF PENTYLENETETRAZOL (METRAZOL) ON A LEARNED 
TASTE AVERSION PRODUCED BY LITHIUM CHLORIDE: THE ISSUE OF 
ASSOCIATIVE MEMORY VS. RETENTIVE MEMORY. (UNPUBLISHED 

PAPER). 

188251 04-04 

COMPARATIVE EFFECTS OF SOME CNS ACTIVE DRUGS ON LEARNED AND 
UNLEARNED BEHAVIOR IN THE HAMSTER. 

191976 04-04 

LEARNING 

EFFECT OF L-ASPARAGINASE ON RETENTION OF MAZE LEARNING IN 

^'" 167324 01-04 

EFFECT OF PRENATAL MATERNAL ADMINISTRATION OF DAMPHETAMINE 
ON RAT OFFSPRING ACTIVITY AND PASSIVE AVOIDANCE LEARNING. 

167415 01-03 
STATE-DEPENDENT LEARNING PRODUCED BY ADDICTING DRUGS. 

169071 01-03 
EFFECTS OF ATROPINE ON EXPLORATION, LEARNING AND 
ELECTROCORTICAL ACTIVITY IN THE DEVELOPING RAT. 

169473 01-04 
INFLUENCE OF AFFECTIVE STATES AND PSYCHOACTIVE DRUGS ON 
VERBAL LEARNING AND MEMORY. 

CAUDATE NUCLEUS EFFECTS ON GERIATRIC SENILITY: EFFECT OF 

BELLADONNA ON LEARNING AND MEMORY OF GERIATRIC PATIENTS. 

170744 01-11 
EFFECTS OF CHLORPROMAZINE, MEPROBAMATE AND 
CHLORDIAZEPOXIDE ON THE MAZE LEARNING IN MICE. 

171259 01-04 

EFFECTS OF MEDICATION ON LEARNING IN HYPERACTIVE FOUR-YEAR- 
OLD CHILDREN. (EDO DISSERTATION). 

172512 01-11 

EFFECTS OF ANALEPTICS ON MAZE LEARNING IN MICE. 

173078 01-04 

REHABILITATION OF LEARNING IN A HOSPITAL CLASS USING 

PSYCHOACTIVE DRUGS. 

174071 01-11 



Psychopharmacology Abstracts 

POSTTRIAL STRYCHNINE: LACK OF EFFECT ON CONDITIONED AVOIDANCE 
LEARNING. 

1 76866 02-0i 
SPECIFIC FACILITATION OF MAZE LEARNING BY A PEPTIDE EXTRACTED 
FROM TRAINED MOUSE BRAIN. 

176868 02-0' 
THE THALAMIC RAT: GENERAL BEHAVIOR, OPERANT LEARNING WITH 
REWARDING HYPOTHALAMIC STIMULATION, AND EFFECTS OF 
AMPHETAMINE. 

177477 02-0- 
EFFECTS OF OVERTRAINING AND PRETRIAL ADMINISTRATION OF 
DEXTROAMPHETAMINE ON REVERSAL LEARNING IN RATS. 

1 77533 02-a 
ROLE OF ASSOCIATIVE LEARNING IN FEEDING BEHAVIOR. 

178044 02-1 

DRUG EFFECTS ON LEARNING AND MEMORY. 

181404 02-0 
LEARNING AND MEMORY AFTER 6-HYDROXYDOPAMINE (6-OHDA). 

182210 02-0 
STRYCHNINE SULFATE AND PIRACETAM: LACK OF EFFECT ON LEARNING 

IN THE RAT. 

184980 03-0 
MODIFICATION OF LEARNING AND MEMORY IN GOLDFISH THROUGH TH 
USE OF STIMULANT AND DEPRESSANT DRUGS. 

1 86583 03-0 
COCAINE, PEMOLINE AND AMPHETAMINE ON LEARNING AND RETENTIOf 
OF A DISCRIMINATION TEST IN MICE. 

186705 O3-0 
A STUDY OF THE EFFECTS OF RITALIN INTERVENTION UPON THE 
PERCEPTUAL COMPETENCIES OF CHILDREN DIAGNOSED AS GIVING 
EVIDENCE OF PSYCHONEUROLOGICAL LEARNING DISABILITIES. (PH.D. 
DISSERTATION). 

186833 03-1 
LEARNING IMPAIRMENT IN RATS AFTER 6-HYDROXYDOPAMINE INDUCEI 
DEPLETION OF BRAIN CATECHOLAMINES. 

187420 04-C 
THE EFFECT OF TRANYLCYPROMINE (PARNATE) ON EYELID CONDITIONIN 
AND PAIRED ASSOCIATE LEARNING IN DEPRESSED PATIENTS. 

188107 04-( 
, DIFFERENTIATING STIMULUS AND STORAGE HYPOTHESES OF STATE- 
DEPENDENT LEARNING. 

188226 04-1 

EFFECTS OF CYCLOHEXIMIDE ON ACQUISITION AND RETENTION OF 
AVOIDANCE LEARNING IN THE RAT: RECOVERY OF MEMORY. 

189215 04-( 
PERFORMANCE ON A VERBAL LEARNING TASK BY SUBJECTS OF HEAVY 
PAST MARIJUANA USAGE. 

190308 04- 

EFFECTS OF CHRONIC METHYLPHENIDATE ADMINISTRATION ON 
LEARNING AND OFFSPRING BEHAVIOR. 

192116 04-1 

ENDURING LEARNING DEFICITS AND CEREBRAL SYNAPTIC 

MALFORMATION FROM EXPOSURE TO 10 PARTS OF HALOTHANE PER 

MILLION. 

192565 04-1 

LEFT 

PAROXYSMAL RIGHT LEFT DISORIENTATION IN AN EPILEPTIC PATIENT. 

171246 01- 

ACQUISITION AND RETENTION OF AVOIDANCE BEHAVIORS FOLLOWING 
SEPTAL LESIONS OR SCOPOLAMINE INJECTIONS IN RATS. 

167401 01- 
RECOVERY OF FEEDING AND DRINKING BY RATS AFTER 
INTRAVENTRICULAR 6-HYDROXYDOPAMINE OR LATERAL 
HYPOTHALAMIC LESIONS. 

168484 01- 

A METHOD FOR ANALYZING CNS EFFECTS OF DRUGS AND BRAIN 

LESIONS ON PERMANENT GROUPS OF RATS. 

176867 02- 
SELECTIVE BLOCKADE OF APOMORPHINE INDUCED AGGRESSION AND 

GNAWING FOLLOWING FENFLURAMINE OR RAPHE LESIONS IN THE 

DAT 

182128 02- 
RECOVERY OF FEEDING AFTER 6-HYDROXYDOPAMINE (6-HDA) OR 
LATERAL HYPOTHALAMIC LESIONS: THE ROLE OF CATECHOLAMINES. 

182213 03- 
NON-SPECIFICITY OF 5-HYDROXYTRYPTOPHAN IN REPLETING BRAIN 
SEROTONIN IN RATS WITH MFB LESIONS 

182725 03- 

HIPPOCAMPAL LESIONS AND LEARNED TASTE AVERSION. 

1 84834 03- 

DIFFERENTIAL RECOVERY OF FUNCTION FOLLOWING CAUDATE, 

HIPPOCAMPAL, AND SEPTAL LESIONS IN MICE. 

1 86620 03- 
BEHAVIORAL EFFECTS OF AMPHETAMINE IN RATS WITH LESIONS IN ^^ 

CORPUS-STRIATUM. ^^^^^^^^ 



S-132 



3LUME 12, SUBJECT INDEX 



Subject Index 



THE EFFECT OF P-CHLOROPHENYLALANINE ON FOREBRAIN TRYPTOPHAN 
HYDROXYLASE IN RATS WITH LESIONS IN THE RAPHE NUCLEUS. 

188750 04-03 
EFFECTS OF SCOPOLAMINE METHYLBROMIDE ON SHOCK-INDUCED 
GASTRIC LESIONS IN THE UNRESTRAINED RAT. 

189381 04-03 
ISENING 
ROLE OF FLUPHENAZINE DECANOATE IN LESSENING THE BURDEN OF 
CHRONIC SCHIZOPHRENICS ON THE COMMUNITY. 

169438 01-08 
HAIITY 
ACUTE LETHALITY FOR MICE FOLLOWING ADMINISTRATION OF 
CYCLOPHOSPHAMIDE WITH BARBITURATES. 

177834 02-05 
EFFECTS OF CNS AGENTS ON NICOTINE EXTENSOR CONVULSIONS AND 
LETHALITY IN MICE AND THEIR SEDATIVE ANTIANXIETY EFFECTS IN 
MAN. 

191907 04-14 
J-3H 
EFFECT OF MORPHINE ON THE TURNOVER AND SYNTHESIS OF (LEU-3H) 
PROTEIN AND {CH-14C) PHOSPHATIDYLCHOLINE IN DISCRETE REGIONS 
OF THE RAT BRAIN. 

189586 04-03 
ICINE 
EFFECT OF CHRONIC INTOXICATION WITH (J AMPHETAMINE ON ITS 
CONCENTRATION IN LIVER AND BRAIN AND ON (14C) LEUCINE 
INCORPORATION INTO MICROSOMAL AND CYTOPLASMIC PROTEINS OF 
RAT LIVER. 

180056 02-05 
tKOCYTE 
MUTAGENICITY EXPERIMENTS WITH THE TRANQUILLIZER MEPROBAMATE 
IN DROSOPHILA-MELANOGASTER AND IN HUMAN LEUKOCYTE 
CHROMOSOMES IN VITRO. 

184585 03-05 
rEL 
BLOOD LEVEL PROFILE IN MAN FOLLOWING CHRONIC ORAL 
ADMINISTRATION OF FLURAZEPAM HYDROCHLORIDE. 

169817 01-13 
MEASUREMENT OF BIOGENIC AMINES AT THE PICOGRAM LEVEL. 
(UNPUBLISHED LEVEL). 

173382 01-03 
EFFECTS OF PHENOXYBENZAMINE, ACEPERONE AND CLONIDINE ON THE 
LEVEL OF 3-METH0XY-4-HYDR0XYPHENYLGLYC0L, (MOPEG) IN RAT 
BRAIN. 

180059 02-03 
WORD RECOGNITION OF SCHIZOPHRENICS AS A FUNCTION OF 
PHENOTHIAZINE LEVEL AND AUTONOMIC RESPONSIVITY. (PH.D. 
DISSERTATION). 

182524 03-08 
BLOOD LEVEL AND URINARY EXCRETION OF BROMAZEPAM IN MAN. 

182556 03-13 
DRUG LEVEL OF D- AND L-AMPHETAMINE DURING INTRAVENOUS SELF- 
ADMINISTRATION. 

185960 03-04 
PLASMA LEVEL OF DIAZEPAM AS A THERAPEUTIC PREDICTOR IN 
ANXIETY STATES. 

186584 03-10 
^ELS 
EFFECT OF ETHANOL ON CYCLIC AMP LEVELS IN THE RAT BRAIN. 

167326 01-03 
PHENOTHIAZINE DOSAGE LEVELS AND AUDITORY SIGNAL DETECTION IN 
SCHIZOPHRENIA. 

167817 01-08 
LEVELS OF HVA IN MOUSE BRAIN FOLLOWING TREATMENT WITH 
METABOLITES OF CHLORPROMAZINE. 

171626 01-03 
EFFECTS OF CENTRALLY ACTING DRUGS ON ADENYL CYCLASE ACTIVITY 
AND CYCLIC AMP LEVELS OF MOUSE BRAIN. (PH.D. DISSERTATION). 

172019 01-03 
(-)DELTA9-THC AS AN HYPNOTIC: AN EXPERIMENTAL STUDY OF THREE 
DOSE LEVELS. 

174041 01-14 
DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: 
ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE 
MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY. 

177131 02-03 
BLOOD AND BRAIN LEVELS OF DELTAl -TETRAHYDROCANNABINOL IN 
MICE - THE EFFECT OF 7HYDR0XY-DELTA1- 
TETRAHYDROCANNABINOL. 

1 77333 02-03 
ADRENALINE, NORADRENALINE AND DOPAMINE LEVELS IN BRAIN AND 
HEART AFTER ADMINISTRATION OF 6-HYDROXYDOPAMINE AND 
GUANETHIDINE TO NEWBORN MICE. 

177338 02-03 
EFFECTS OF NEUROLEPTICS AND THYMOLEPTICS ON 

PHOSPHODIESTERASE ACTIVITY AND ON CYCLIC 3,5 AMP LEVELS IN 
RAT BRAIN. 

181467 02-03 



EFFECTS OF DECAPITATION, ETHER AND PENTOBARBITAL ON CYCLIC 
AMP AND CYCLIC GMP LEVELS IN RAT TISSUES. 

182154 02-03 
STUDIES ON THE EFFECT OF ACUTE AND CHRONIC MORPHINE 
TREATMENT ON CATECHOLAMINE LEVELS AND TURNOVER IN 
DISCRETE BRAIN AREAS OF RATS. 

182228 03-03 
EFFECT OF 2-ARYLALANlNES, 2ARYLSERINES, TETRAPHENYLBORON AND 
1,2 DL(2,4 DICHLOROPHENYL) ETHANOLAMINE ON LEVELS OF 
SEROTONIN (5-HT), NOREPINEPHRINE (NE) AND DOPAMINE (DM) IN 
WHOLE BRAIN OF MICE. 

182254 03-03 
DIAZEPAM TREATMENT FOR ACUTE CONVULSIONS IN CHILDREN: A 
REPORT OF 41 PATIENTS, THREE WITH PLASMA LEVELS. 

182595 03-11 
EFFECT OF VARIOUS STEROIDS AND ACTH ON METHYPRYLON PLASMA 
LEVELS AND SLEEPING TIME IN RATS. 

183611 03-03 
PLASMA LEVELS OF LUTEINIZING HORMONE AND OF IMMUNOREACTIVE 
ESTROGENS (ESTRADIOL) IN ANOREXIA-NERVOSA: RESPONSE TO 
CLOMIPHENE CITRATE. 

183807 03-10 
EFFECTS OF METHAMPHETAMINE ON DAILY RHYTHMS OF 
HYPOTHALAMIC NOREPINEPHRINE, SEROTONIN AND PLASMA 
CORTICOSTERONE LEVELS IN THE RAT. 

184178 03-03 
EFFECT OF LSD-25 AND 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE ON 
RAT BRAIN AND PLATELET SEROTONIN LEVELS. 

184975 03-03 
RELATIONSHIP OF PLASMA MEPERIDINE LEVELS TO CHANGES IN ANXIETY 
AND HOSTILITY. 

185881 03-14 
REGIONAL CHANGES IN MONOAMINE LEVELS AND IN THE RATE OF 
TYROSINE AND TRYPTOPHAN HYDROXYLATION IN 4 WEEK OLD 
OFFSPRING OF NURSING MOTHERS TREATED WITH THE NEUROLEPTIC 
DRUG PENFLURIDOL 

185899 03-03 
THE EFFECT OF CHLORPROMAZINE ON HOMOVANILLIC ACID LEVELS IN 
CEREBROSPINAL FLUID OF SCHIZOPHRENIC PATIENTS 

186565 03-08 
EFFECT OF MORPHINE ON REGIONAL LEVELS OF GAMMA- 
HYDROXYBUTYRATE IN MOUSE BRAIN. 

187077 03-03 
THE INFLUENCE OF PSYCHOTROPIC DRUGS ON THE LEVELS OF 
ENDOGENOUS 2-PHENYLETHYLAMINE IN RABBIT BRAIN. 

187112 03-03 
SEQUENTIAL TRIAL COMPARING TWO PLASMA LEVELS OF 
NORTRIPTYLINE. 

187582 04-10 
THE EFFECTS OF CHRONIC RESERPINE AND NIALAMIDE TREATMENT ON 
THE FREE AMINO ACID LEVELS OF RAT BRAIN. 

187645 04-03 
THE EFFECTS OF LITHIUM ON HIGH ENERGY PHOSPHATE AND GLUCOSE 
LEVELS IN THE RAT SUPERIOR CERVICAL GANGLION. 

187677 04-03 
METHIOTHEPIN ELEVATION OF 5-HYDROXYINDOLEACETIC ACID LEVELS IN 
VARIOUS ANATOMIC REGIONS OF RAT BRAIN. 

187831 0403 
LONG-TERM TREATMENT OF ENDOGENOUS DEPRESSION WITH 
NORTRIPTYLINE WITH CONTROL OF PLASMA LEVELS. 

188832 04-09 
EFFECTS OF CHLORPROMAZINE PLASMA LEVELS ON 
ELECTROCARDIOGRAM. 

188838 04-13 
EFFECTS OF TWO LEVELS OF ATTENTION DEMAND ON VIGILANCE 
PERFORMANCE UNDER MARIHUANA. 

189359 04-14 
EFFECT OF OXOTREMORINE AND PHYSOSTIGMINE ON CHOLINE LEVELS IN 
MOUSE WHOLE BRAIN, SPLEEN AND CEREBELLUM. 

189893 04-03 
ANTICONVULSANT DRUG SERUM LEVELS IN PSYCHIATRIC PATIENTS 
WITH SEIZURE DISORDERS: EFFECTS OF CERTAIN PSYCHOTROPIC 
DRUGS. 

191096 04-13 
5-HYDROXYTRYPTAMINE AND NORADRENALINE IN THE HIPPOCAMPAL 
REGION: EFFECT OF TRANSECTION OF AFFERENT PATHWAYS ON 
ENDOGENOUS LEVELS, HIGH AFFINITY UPTAKE AND SOME 
TRANSMITTER RELATED ENZYMES. 

191319 04-03 
EFFECT OF DIAZEPAM ON MOUSE WHOLE BRAIN AND BRAIN AREA 
ACETYLCHOLINE AND CHOLINE LEVELS. 

191423 04-03 
EFFECT OF ANESTHETIC AGENTS ON PERIPHERAL SYMPATHETIC NERVOUS 
SYSTEM FUNCTION AS MONITORED BY ARTERIAL PLASMA 
CATECHOLAMINE LEVELS. (UNPUBLISHED PAPER 

191495 04-03 
SERUM PROLACTIN LEVELS IN NEWLY ADMITTED PSYCHIATRIC 
PATIENTS. 

191506 04-13 



S-133 



Subject Index 



Psychopharmacology Abstracts 



NONSEDATING DOSAGES OF DIAZEPAM AND PHENOBARBITAL IN THE 
REDUCTION OF NEONATAL BILIRUBIN LEVELS. 

191607 04-17 
THE EFFECTS OF AMPHETAMINE SULFATE ON THE DIURNAL RHYTHMS OF 
MIDBRAIN; CORTEX, NOREPINEPHRINE; SEROTONIN AND BLOOD 
GLUCOSE LEVELS IN THE MOUSE, 

191918 04-03 
PROTRIPTYLINE STEADY-STATE PLASMA LEVELS IN MAN. 

191924 04-13 
CORRELATION BETWEEN BRAIN N,N DIMETHYLTRYPT AMINE (DMT) 
LEVELS AND BAR PRESSING BEHAVIOR IN RATS: EFFECT OF MAO 
INHIBITION. 

191935 04-04 
THE EFFECT OF CONJUGATED ESTROGENS ON PLASMA BUTAPERAZINE 
LEVELS IN WOMEN. 

191959 04-15 
PLASMA LEVELS AND TRICYCLIC ANTIDEPRESSANTS. 

192872 04-10 
PLASMA NORTRIPTYLINE LEVELS - RELATIONSHIP TO CLINICAL EFFECTS. 

192873 04-09 
LEVER 

DIAZEPAM-INDUCED EATING AND LEVER PRESSING FOR FOOD IN SATED 
RATS. 

186613 03-04 

LEVODOPA 

LEVODOPA INDUCED DYSKINESIAS: COMPARISON IN PARKINSONISM 
DEMENTIA AND AMYOTROPHIC LATERAL SCLEROSIS. 

169376 01-15 
HABITUATION OF BLINK REFLEXES IN PARKINSONIAN PATIENTS UNDER 
LEVODOPA AND AMANTADINE TREATMENT. 

171794 01-13 
L-TRYPTOPHAN IN THE TREATMENT OF LEVODOPA INDUCED 
PSYCHIATRIC DISORDERS. 

174297 01-15 
PARKINSONISM DEMENTIA OF GUAM: TREATMENT WITH LEVODOPA 
AND L-ALPHA-METHYLDOPAHYDRAZINE. 

179996 02-13 
LONG-RANGE MOTOR PERFORMANCE CHANGES IN LEVODOPA TREATED 
PATIENTS WITH PARKINSONS DISEASE. 

184195 03-11 
DEANOL IN THE TREATMENT OF LEVODOPA INDUCED DYSKINESIAS. 

184196 03-11 
IMIPRAMINE MEDIATED EFFECTS ON LEVODOPA METABOLISM IN MAN. 

185998 03-13 
LEVODOPA COMBINED WITH MK-486 (L-ALPHA- 
METHYLDOPAHYDRAZINE) - A PERIPHERAL DECARBOXYLASE 
INHIBITOR IN PARKINSONS DISEASE. 

187615 04-11 
HUNTINGTONS CHOREA: THE RIGID FORM (WESTPHAL VARIANT) 
TREATED WITH LEVODOPA. 

187618 04-11 
LEVODOPA, CARBIDOPA, AND PYRIDOXINE IN PARKINSON DISEASE. 

187877 04-13 
LEVODOPA AND MELANOMA. 

188414 04-15 
ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM: 
CLINICAL AND PHARMACOLOGIC CORRELATIONS AND THE EFFECT OF 
INTRAMUSCULAR PYRIDOXINE. 

188560 04-11 
R0-4-4602 AND LEVODOPA IN THE TREATMENT OF PARKINSONISM. 

188561 04-11 
COMPARISON OF AMANTADINE, PLACEBO, AND LEVODOPA IN 

PARKINSONS DISEASE. 

189502 04-11 
DOSE-RELATED ALTERATIONS IN METABOLISM OF LEVODOPA: POSSIBLE 
MECHANISM FOR HYPOTENSIVE EFFECT. 

190194 04-11 
LONG-TERM TREATMENT WITH LEVODOPA. 

191614 04-11 
LEVOMEPROMAZINE 

THE ACTION OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTOR 
CENTERS OF EMOTIONS IN THE HYPOTHALAMUS. 

191785 04-02 
INFLUENCE OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTS OF 

ELECTRICAL STIMULATION AND MICROINJECTION OF ACETYLCHOLINE, 
SEROTONIN AND NORADRENALINE INTO THE MESENCEPHALON. 

191786 04-02 
LEVORPHANOl 

INFLUENCE OF FENTANYL, LEVORPHANOL AND PETHIDINE ON THE 
RELEASE OF NORADRENALINE FROM RAT BRAIN CORTEX SLICES. 

189569 04-03 
LEXOTAN 

A TRIAL ON BROMAZEPAM (LEXOTAN) AND PLACEBO IN THE 
TREATMENT OF PSYCHOPHYSIOLOGICAL DISORDERS. 

17115001-11 
LH-RH 

FUNCTIONAL EVALUATION OF PITUITARY RESERVE IN PATIENTS WITH 
THE AMENORRHEA GALACTORRHEA SYNDROME UTILIZING 



LUTEINIZING HORMONE RELEASING HORMONE (LH-RH), L-DOPA AND 
CHLORPROMAZINE. 

175245 02-13 
LIABILITY 

DEPENDENCE LIABILITY OF SEVERAL SEDATIVE HYPNOTIC AGENTS 
EVALUATED IN MONKEYS. 

174125 01-04 
ATTEMPT TO EVALUATE THE PHYSICAL DEPENDENCE LIABILITY OF 
PSYCHOTROPIC DRUGS IN MICE. 

182103 02-04 
AN EXPERIMENTAL INVESTIGATION OF DEPENDENCE LIABILITY OF 
METHAQUALONE IN RATS. 

186569 03-03 
LIBRIUM 

THE EFFECTS OF CHLORDIAZEPOXIDE (LIBRIUM) ON THE INTENSITY AND 
HABITUATION OF AGONISTIC BEHAVIOR IN MALE SIAMESE FIGHTING 
FISH. 

1 77722 02-04 
LICL 

EFFECTS OF LICL ON THE CENTRAL NERVOUS SYSTEM. 

182112 02-04 
METRAZOL DISRUPTS CONDITIONED AVERSION PRODUCED BY LICL: A 
TIME DEPENDENT EFFECT. 

188412 04-04 
LIDOCAINE 

ON THE FIRST-PASS EFFECT IN THE LIVER OF NORTRIPTYLINE, LIDOCAINE 
AND PROPRANOLOL. 

171631 01-03 
ANTICONVULSANT ACTIVITY OF CLONAZEPAM AND RO-8-4192 AGAINST 
PENICILLIN AND LIDOCAINE INDUCED SEIZURES. 

1 78947 02-03 
EFFECT OF PROCAINE, LIDOCAINE AND PENTOBARBITAL ON ELECTRICAL 
ACTIVITY OF GUINEA-PIG OLFACTORY CORTEX IN VITRO. 

182092 02-03 
EFFECTS OF LIDOCAINE ON RABBIT BRAIN MICROTUBULAR PROTEIN. 

191324 04-03 
LIFESPAN 

THE EFFECT OF LOWERED BODY TEMPERATURE ON LIFESPAN AND 
IMMUNE AND NONIMMUNE PROCESSES. 

169675 01-03 
LIGHT 

EVALUATION OF CENTRAL ANTIRESERPINE EFFECT BY THE USE OF LIGHT 
BLINK REFLEX. 

169469 Ol-O-i 
REFLECTION OF SHORT-TERM LIGHT ADAPTATION EFFECT IN THE 
ELECTRORETINOGRAM. 

180591 02-01 
DOSE DEPENDENT SELECTIVE FACILITATION OF RESPONSE CONTINGENT 
LIGHT ONSET BEHAVIOR BY D-AMPHETAMINE. 

185955 03-Oi 
MAINTENANCE TREATMENT OF SCHIZOPHRENIA IN THE LIGHT OF 
PROGNOSIS ORIENTED DIAGNOSIS. 

186081 03-Of 
DIFFERENTIAL EFFECTS OF PILOCARPINE AND SCOPOLAMINE ON THE 
PERFORMANCE OF A LIGHT DARK DISCRIMINATION MAINTAINED BY 
ELECTRICAL STIMULATION OF THE BRAIN. 

186701 03-0: 
LILLY-1 10140 

EFFECT OF LILLY-1 10140, 3-(P-TRIFLU0R0METHYLPHEN0XY) N METHYL-3- 
PHENYLPROPYLAMINE ON SYNTHESIS OF 3H-SER0T0NIN FROM 3H- 
TRYPTOPHAN IN RAT BRAIN. 

191951 04-0: 
LIMBIC 

ANTICONVULSIVE ACTIVITY OF 8-CHL0R0-6-PHENYL-4H-S- 

TRIAZOLOBENZODIAZEPINE (D-40TA) AND ITS EFFECT ON LIMBIC 
SYSTEM. 

177099 02-0; 
EFFECT OF CHRONIC TREATMENT WITH DESIPRAMINE (DMI) AND 
IPRINDOLE (IP) ON THE NOREPINEPHRINE (NE) SENSITIVE ADENYLATE 
CYCLASE SYSTEM IN SLICES OF THE RAT LIMBIC FOREBRAIN. 

192003 04-0: 
LIMITING 

THE RATE LIMITING CONTROL OF ENZYMES MONOAMINE OXIDASE AND 
CATECHOL-0-METHYLTRANSFERASE IN THE FETUS AND THE ADULT BY 
ADRENOCORTICOL HORMONES. 

178815 02-0; 

LINEAR 

SYNTHETIC STUDIES LEADING TOWARD THE PREPARATION OF LINEAR 
BENZOQUINOLINES. (PH.D. DISSERTATION). 

180739 02-0' 

LINK 

CENTRAL CHOLINERGIC (MUSCARINIC) LINK IN THE ATTACK REFLEXIVE 
BITING MECHANISM OF CATS. 

182238 03-0- 

LIPID 

LIPID INDUCED CHANGES OF PENTOBARBITAL DISTRIBUTION AND 
METABOLISM. 

170072 oi-o: 



S-134 



VOLUME 12, SUBJECT INDEX 



Subject Index 



A ROLE OF THE DIETARY LIPID IN THE ABILITY OF PHENOBARBITAL TO 
STIMULATE DRUG DETOXIFICATION. 

175859 02-03 
UPIDOSIS-UKE 

LIPIDOSISLIKE ALTERATIONS IN DORSAL ROOT GANGLION CELLS OF 
RATS TREATED WITH TRICYCLIC ANTIDEPRESSANTS. 

189605 04-03 
LITERATURE 

CLINICAL EXPERIENCE WITH A NEW PSYCHOTROPIC DRUG, TRAZODONE: 
A REVIEW OF LITERATURE. 

168803 01-n 
CHEMOTHERAPY IN CHRONIC ORGANIC BRAIN SYNDROME ■ A REVIEW 
OF THE LITERATURE. 

169065 01-11 
THE PROPERTIES OF 3.4 METHYLENEDIOXYAMPHETAMINE (MDA). I. A 
REVIEW OF THE LITERATURE. 

176597 02-17 
ANTIPSYCHOTIC ACTION OF NEUROLEPTIC AGENTS AND THE FUNCTION 
OF BASAL GANGLIA (SURVEY OF LITERATURE). 

183521 03-17 
.ITHIUM 

EFFECT OF LITHIUM ON AGGRESSION, MANIA AND PERMSELECTIVE 
MEMBRANES. 

167448 01-09 
LITHIUM IN PSYCHIATRY. 

167675 01-09 
CLINICAL EFFECTS OF LITHIUM CARBONATE ON DEPRESSION. 

167917 01-09 
LITHIUM CARBONATE TREATMENT IN MANIC PSYCHOSIS. 

167918 01-09 
LITHIUM CARBONATE TOXICITY. 

168505 01-15 
EFFECT OF CHRONIC LITHIUM TREATMENT ON MONOAMINE 
METABOLISM IN RAT BRAIN. 

168839 01-03 
A COMPARISON OF LITHIUM CARBONATE IN THE PREVENTION OF MANIC 
AND DEPRESSIVE EPISODES IN RECURRENT AFFECTIVE DISORDER. 

169090 01-09 
LITHIUM INDUCED DIABETES-INSIPIDUS: MANIC SYMPTOMS, BRAIN AND 
ELECTROLYTE CORRELATES, AND CHLOROTHIAZIDE TREATMENT. 

169486 01-15 
LITHIUM INDUCED FOLLICULITIS. 

169492 01-15 
RELATIONSHIP BETWEEN THE EFFECTIVENESS OF LITHIUM THERAPY AND 
FAMILY HISTORY. 

169494 01-09 
THE USE OF LITHIUM IN AFFECTIVE DISORDERS, III: A DOUBLE-BLIND 

STUDY OF PROPHYLAXIS IN BIPOLAR ILLNESS. 

169495 01-09 
THE EFFECT OF LITHIUM AND OTHER ANTIDEPRESSANT MEDICATIONS ON 

THE AUTONOMIC NERVOUS SYSTEM. 

169635 01-15 
NEGATIVE SODIUM BALANCE IN LITHIUM CARBONATE TOXICITY: 
EVIDENCE OF MINERALOCORTICOID BLOCKADE. 

169869 01-15 
LITHIUM CARBONATE AND SLEEP IN AFFECTIVE DISORDERS: FURTHER 
CONSIDERATIONS. 

171503 01-09 
EFFECT OF SELECTED BETA-DIKETONES ON LITHIUM FLUXES OF BOVINE 
RED BLOOD CELLS. 

171792 01-05 
LITHIUM PROPHYLAXIS IN RECURRENT AFFECTIVE ILLNESS. 

171926 01-09 
LITHIUM PROPHYLAXIS IN AFFECTIVE DISORDERS: AN OPEN TRIAL WITH 
MATCHED CONTROLS. 

172401 01-09 
OUR EXPERIENCE WITH LITHIUM. 

172976 01-09 
CLINICAL FACTORS IN LITHIUM CARBONATE PROPHYLAXIS FAILURE. 

174093 01-09 
ELECTROENCEPHALOGRAPHIC RESPONSES TO LITHIUM. 

174132 01-14 
WEIGHT GAIN IN LITHIUM TREATED RATS. 

174133 01-04 
LITHIUM (LI): LACK OF EFFECT ON MORPHINE (MS) EUPHORIA. 

(UNPUBLISHED PAPER). 

174479 01-14 
ELECTROENCEPHALOGRAPHIC MODIFICATIONS DURING ADMINISTRATION 
OF LITHIUM. 

174566 01-09 
LONG-TERM USE OF LITHIUM CARBONATE IN AFFECTIVE DISORDERS: A 
CLINICAL EVALUATION. 

174778 01-09 
SHORT-TERM AND LONG-TERM LITHIUM ADMINISTRATION: EFFECTS ON 
THE BRAINS SEROTONERGIC BIOSYNTHETIC SYSTEMS. 

175149 02-13 
ULTRASTRUCTURE OF CNS IN LITHIUM INTOXICATION. 

176476 02-05 



LITHIUM AND MENTAL HEALTH. 

178113 02-09 
DIFFERENTIAL EFFECTS OF 0- AND L-AMPHETAMINE ON THE SLEEP OF 
DEPRESSED PSYCHIATRIC PATIENTS ON AND OFF LITHIUM CARBONATE 
TREATMENT. (UNPUBLISHED PAPER). 

1 78432 02-09 
FLAVOR AVERSIONS PRODUCED BY CONTINGENT DRUG INJECTION: 
RELATIVE EFFECTIVENESS OF APOMORPHINE, EMETINE, AND LITHIUM. 

178502 02-04 
CHOLINE ACTIVATION OF LITHIUM TRANSPORT. 

178812 02-03 
LITHIUM IN THE TREATMENT OF SCHIZOPHRENIA. 

180046 02-08 
LITHIUM DISTRIBUTION BETWEEN CEREBROSPINAL FLUID AND SERUM OF 
AFFECTIVE PSYCHOTIC PATIENTS TREATED WITH LITHIUM CARBONATE 
AND ITS CLINICAL RESPONSE. 

180301 02-11 
A FEW GALENIC METHOD TO PROLONG THE ACTION OF LITHIUM 
SULFATE. 

180700 02-15 
DIRECT DETERMINATION OF LITHIUM IN SERUM BY ATOMIC 
ABSORPTION SPECTROSCOPY. 

181653 02-06 
EFFECTS OF LITHIUM ON CEREBRAL RNA METABOLISM IN VITRO AND IN 
VIVO. 

181942 02-03 
INFLUENCES OF LITHIUM ON THE BEHAVIORAL ACTION OF 
METHAMPHETAMINE AND TETRABENAZINE. 

182109 02-04 
LITHIUM IN PSYCHIATRIC THERAPY AND PROPHYLAXIS. A REVIEW WITH 
SPECIAL REGARD TO ITS USE IN CHILDREN. 

182433 03-09 
LITHIUM TREATMENT OF PSYCHOTIC CHILDREN. A CONTROLLED 

CLINICAL TRIAL. 

182434 03-09 
ANTIAGGRESSIVE EFFECT OF LITHIUM SALTS IN MENTALLY RETARDED 

ADOLESCENTS. 

182435 03-11 
INDUCTION OF HEPATIC DRUG METABOLIZING ENZYMES BY LITHIUM 

TREATMENT. 

182727 03-03 
THE INFLUENCE OF CHRONIC ADMINISTRATION OF LITHIUM CARBONATE 
ON THE BRAIN NOREPINEPHRINE CONTENT IN RATS. 

182872 03-03 
LITHIUM IN THE TREATMENT OF PERIODIC CATATONIA: A CASE REPORT. 

183648 03-09 
A CONTROLLED EVALUATION OF LITHIUM IN THE PREMENSTRUAL 
TENSION SYNDROME. 

185192 03-11 
A DOUBLE-BLIND TRIAL OF LONG-TERM LITHIUM THERAPY IN MENTAL 

DEFECTIVES. 

185193 03-11 
LITHIUM TREATMENT OF DEPRESSION 

185873 03-09 
FACTORS ASSOCIATED WITH LITHIUM RESPONSE IN THE PROPHYLACTIC 
TREATMENT OF BIPOLAR MANIC-DEPRESSIVE ILLNESS 

186188 03-09 
THE CLINICAL EFFECTIVENESS OF LITHIUM: COMPARISONS WITH OTHER 

DRUGS. 

186189 03-09 
THYROTOXICOSIS DEVELOPING DURING LITHIUM TREATMENT: CASE 

REPORT. 

186473 03-15 
THE EFFECT OF LITHIUM ON THYROID IODINE RELEASE IN PATIENTS 
WITH PRIMARY AFFECTIVE DISORDER. 

186580 03-09 
EFFECTS OF LITHIUM ON ADRENERGIC AMINE UPTAKE IN RAT BRAIN 
SYNAPTOSOMES. 

186633 03-03 
DOES LITHIUM BLOCK THE EFFECTS OF AMPHETAMINE? A REPORT OF 
THREE CASES 

186745 03-13 
LITHIUM: ITS ROLE IN PSYCHIATRIC RESEARCH AND TREATMENT. 

186920 03-09- 
THE EFFECT OF LITHIUM ON HORMONE SENSITIVE ADENYLATE CYCLASE 
FROM VARIOUS REGIONS OF THE RAT BRAIN. 

187110 03-03 
LITHIUM CARBONATE IN MANIC-DEPRESSIVE PSYCHOSIS 

187477 04-09 
LITHIUM THERAPY AND ERYTHROCYTE MEMBRANE CATION CARRIER. 

187644 04-15 
THE EFFECTS OF LITHIUM ON HIGH ENERGY PHOSPHATE AND GLUCOSE 
LEVELS IN THE RAT SUPERIOR CERVICAL GANGLION. 

187677 04-03 
LITHIUM CARBONATE: PSYCHIATRIC INDICATIONS AND MEDICAL 
COMPLICATIONS. 

187786 04-15 
HUNTINGTONS CHOREA TREATED WITH LITHIUM CARBONATE 

187985 04-11 



i' .■'.'■,•,'.■/,• 



S-135 



Subject Index 



Psychopharmacology Abstracts 



THE EFFECTS OF PENTYLENETETRAZOL (METRAZOL) ON A LEARNED 
TASTE AVERSION PRODUCED BY LITHIUM CHLORIDE: THE ISSUE OF 
ASSOCIATIVE MEMORY VS. RETENTIVE MEMORY. (UNPUBLISHED 
PAPER). 

188251 04-04 
PROPHYLACTIC EFFICACY OF LITHIUM CARBONATE IN MANIC- 
DEPRESSIVE ILLNESS: REPORT OF THE VETERANS ADMINISTRATION 
AND NATIONAL INSTITUTE OF MENTAL HEALTH (VA-NIMH) 
COLLABORATIVE STUDY GROUP 

189735 04-09 
AFFECTIVE DISORDERS AND CHEMICAL DEPENDENCE: LITHIUM FOR 
ALCOHOL AND DRUG ADDICTION 

189775 04-09 
ANTIDEPRESSANT EFFECT OF LITHIUM. 

189793 04-09 
EFFECT OF LITHIUM ON CENTRAL METABOLISM OF 5- 
HYDROXYTRYPT AMINE. 

190337 04-03 
LITHIUM IN TREATMENT AND PREVENTION OF AFFECTIVE DISORDER: A 
VA-NIMH COLLABORATIVE STUDY. 

190381 04-09 
LITHIUM AND THE MONOAMINE NEUROTRANSMITTERS IN THE RAT 
HIPPOCAMPUS. 

190829 04-03 
THE EFFECT OF LITHIUM ON THYROID IN MAN. 

191142 04-15 
HAZARDS OF LITHIUM PROPHYLAXIS. 

191187 04-15 
EXPERIMENT WITH LITHIUM CARBONATE ON THE TREATMENT OF MANIC 
STATE. 

191670 04-09 
LITHIUM TREATMENT DURING ETHANOL INGESTION AND WITHDRAWAL. 

192005 04-11 
LIVER 

ON THE FIRST-PASS EFFECT IN THE LIVER OF NORTRIPTYLINE, LIDOCAINE 
AND PROPRANOLOL. 

171631 01-03 
KINETICS AND CELLULAR CONTROL MECHANISMS FOR IMIPRAMINE 
METABOLISM IN THE ISOLATED PERFUSED RAT LIVER. (PH.D. 
DISSERTATION). 

173601 01-03 
INHIBITION OF LUNG, LIVER AND BRAIN MONOAMINE OXIDASE BY 
IMIPRAMINE AND DESIPRAMINE. 

1 77332 02-03 
THE HYDROXYLATION OF D-AMPHETAMINE BY LIVER MICROSOMES OF 
THE MALE RAT. 

177337 02-03 
EFFECT OF CHRONIC INTOXICATION WITH (J AMPHETAMINE ON ITS 
CONCENTRATION IN LIVER AND BRAIN AND ON (14C) LEUCINE 
INCORPORATION INTO MICROSOMAL AND CYTOPLASMIC PROTEINS OF 
RAT LIVER. 

180056 02-05 
THE INFLUENCE OF ALDOSTERONE OR METHAMPHETAMINE ON LIVER 
GLYCOGEN DEPOSITION OF MICE STRESSED BY LONG-TERM 
ISOLATION. 

182105 02-03 
CONVERSION OF CHLORAL HYDRATE TO TRICHLOROETHANOL IN BRAIN 
AND LIVER. 

182157 02-03 
PHYSIOLOGICAL DISPOSITION OF BETA-PHENYLETHYLAMINE, 2,4,5 
TRIMETHOXYPHENYLETHYLAMINE, 2,3,4,5,6 

PENTAMETHOXYPHENYLETHYLAMINE AND BETA-HYDROXYMESCALINE 
IN RAT BRAIN, LIVER AND PLASMA. 

186706 03-03 
EFFECTS OF SHORT-TERM ADMINISTRATION OF N-NITROSO COMPOUNDS 
ON LIVER HISTOLOGY AND PENTOBARBITAL INDUCED SLEEPING TIME 
IN MICE. 

187575 04-04 
EFFECT OF SKF-525-A ON THE METABOLISM OF (-) DELTA9- 
TETRAHYDROCANNABINOL IN THE RAT BRAIN AND LIVER. 

187578 04-03 
EFFECTS OF PHENOBARBITAL AND SKF-525-A PRETREATMENT, SEX, LIVER 
INJURY, AND VEHICLE ON DELTA9-TETRAHYDR0CANNABIN0L 
TOXICITY 

189598 04-05 
THE EFFECT OF CHLORPROMAZINE AND STELAZINE ON LYSOSOMES OF 
RAT LIVER DURING ACUTE INTOXICATION. 

191121 04-03 
THE 4-HYDROXYLATION OF AMPHETAMINE AND PHENTERMINE BY RAT 
LIVER MICROSOMES. 

191921 04-03 
LOAD 

DOUBLE-BLIND PSYCHOMETRIC EVALUATION OF PIMOZIDE AND 
HALOPERIOOL VERSUS PLACEBO IN EMOTIONALLY LABILE 
VOLUNTEERS UNDER TWO DIFFERENT WORK LOAD CONDITIONS. 

180065 02-14 



LOBOTOMIZED 

DREAM REPORTS AFTER RESERPINE ADMINISTRATION IN CHRONIC 
LOBOTOMIZED SCHIZOPHRENIC PATIENTS. 

178187 02-08 
LOBSTER 

DDT EFFECT ON 32P INCORPORATION FROM GAMMA-LABELLED ATP 
INTO PROTEINS FROM LOBSTER NERVE. 

191315 04-03 
LOCAL 

A CENTRAL EFFECT OF LOCAL ANESTHETICS: PREVENTION AGAINST THE 
ACCUMULATION OF CYCLIC AMP IN BRAIN SLICES. 

182099 0203 
LOCALIZATION ' 

DETERMINATION OF DRUG TRANSFER ACROSS BIOLOGICAL MEMBRANES: 
COMPARATIVE STUDY ON THE PASSAGE OF DRUGS INTO THE 
CENTRAL NERVOUS SYSTEM AND THEIR PLACENTAL TRANSFER AND 
FETAL LOCALIZATION IN THE PREGNANT RAT. (PH.D. DISSERTATION). 

172018 0103 
PSYCHOACTIVE DRUGS: IMMUNOASSAY AND LOCALIZATION. 

173536 01-06 
TISSUE LOCALIZATION OF 7- AND 8-HYDROXYCHLORPROMAZINES. 

189589 04-03 
THE LOCALIZATION AND CHARACTERIZATION OF 

PHENYLETHANOLAMINE-N-METHYLTRANSFERASE ACTIVITY IN SPECIFIC 
REGIONS OF THE CNS 

191932 0403 
SUBCELLULAR LOCALIZATION OF H3-DELTA9-TETRAHYDR0CANNABIN0L 
IN DOG BRAIN AFTER ACUTE OR CHRONIC ADMINISTRATION. 

191970 04-03 
LOCALIZED 

LOCALIZED BEHAVIORAL EFFECTS OF VASOPRESSIN ON MAINTENANCE 
OF AN ACTIVE AVOIDANCE RESPONSE IN RATS. 

187697 04-04 
LOCOMOTION 

DEVELOPMENT OF LOCOMOTION AND BRAIN CATECHOLAMINES. 

187551 04-04 
LOCOMOTOR 

INHIBITION OF ANTICHOLINERGIC DRUG-INDUCED LOCOMOTOR 
STIMULATION IN MICE BY ALPHA-METHYLTYROSINE. 

177840 02-03 
RELATIVE IMPORTANCE OF DOPAMINERGIC AND NORADRENERGIC 
NEURONAL SYSTEMS FOR THE STIMULATION OF LOCOMOTOR 
ACTIVITY INDUCED BY AMPHETAMINE AND OTHER DRUGS. 

182209 02-04 
COMPARATIVE EFFECTS OF DL-P-METHOXYAMPHETAMINE AND D- 
AMPHETAMINE ON CENTRAL CATECHOLAMINES AND LOCOMOTOR 
ACTIVITY. 

182253 03-04 
THE EFFECTS OF CHRONIC TREATMENT WITH D-AMPHETAMINE ON FOOD 
INTAKE, BODYWEIGHT, LOCOMOTOR ACTIVITY AND SUBCELLULAR 
DISTRIBUTION OF THE DRUG IN RAT BRAIN. 

185931 03-03 
A NEW RECORDING APPARATUS FOR MEASUREMENT OF LOCOMOTOR 
ACTIVITY OF MICE. EXPERIMENTAL OBSERVATIONS ON ITS USE. 

186377 03-06 
A COMPARISON OF EFFECTS OF APOMORPHINE AND ET-495 ON 
LOCOMOTOR ACTIVITY AND CIRCLING BEHAVIOUR IN MICE. 

186635 03-04 
SIGNIFICANCE OF DOPAMINE RECEPTOR ACTIVITY IN DL-P- 
METHOXYAMPHETAMINE AND D-AMPHETAMINE-INDUCED 
LOCOMOTOR ACTIVITY. 

186670 03-04 
COMPARISON OF THE LOCOMOTOR STIMULANT MECHANISMS OF 
ACTION OF D-AMPHETAMINE AND D-AMPHETAMINE PLUS L-DOPA: 
POSSIBLE INVOLVEMENT OF SEROTONIN. 

187119 03-04 
LOCUS 

THE GENERAL LOCUS OF D-AMPHETAMINE-INDUCED DISCRIMINATIVE 
STIMULI. (PH.D. DISSERTATION). 

185725 03-03 
FURTHER EVIDENCE ON THE INTRAHYPOTHALAMIC LOCUS FOR 
ANDROGENIZATION OF FEMALE RATS. 

187935 04-03 
LOCUS-COERULEUS 

SELF-STIMULATION OF NORADRENERGIC CELL GROUP (A6) IN LOCUS- 
COERULEUS OF RATS. 

173029 01-03 
EFFECTS OF LOCUS-COERULEUS STIMULATION ON HIPPOCAMPAL UNIT 
ACTIVITY AND ON BEHAVIOR IN UNRESTRAINED RATS. (UNPUBLISHED 
PAPER). 

187499 04-04 
A ROLE FOR DOPAMINE IN THE STIMULANT EFFECTS OF AMPHETAMINE 
ON LOCUS-COERULEUS SELF-STIMULATION. 

191984 04-03 
LOMBOSCIATALGIAS 

A COMPARATIVE STUDY OF DIAZEPAM AND METHOCARBAMOL IN THE 
TREATMENT OF LOMBOSCIATALGIAS. 

178950 02-11 



S-136 



VOLUME 12, SUBJECT INDEX 



Subject Index 



LONG 

SUPPRESSION OF LORDOSIS IN GUINEA-PIGS BY ETHAMOXY-TRIPHETOL 
(MER-25) GIVEN AT LONG INTERVALS (36-46 HR) AFTER ESTRADIOL 
BENZOATE TREATMENT. 

186686 03-04 
NEW LONG LATENCY BULBOSPINAL EVOKED POTENTIALS BLOCKED BY 
SEROTONIN ANTAGONISTS. 

188751 04-03 
LONG-ACTING 

GENERAL PRACTITIONER CLINICAL TRIALS. A LONG-ACTING 
AMITRIPTYLINE PREPARATION 

175583 02-09 
SAFETY EVALUATION OF PENFLURIDOL, A NEW LONG-ACTING ORAL 
ANTIPSYCHOTIC AGENT. 

177319 02-07 
THE FIRST LONG-ACTING (RETARD) THYMOANALEPTIC OR 
ANTIDEPRESSANT: THE TIME-RELEASED DIBENZEPINE WITH 
PROLONGED ACTION. 

178946 02-11 
FLUSPIRILENE, A LONG-ACTING INJECTABLE NEUROLEPTIC. 

183199 03-11 
CLINICAL EXPERIMENT WITH A LONG-ACTING NEUROLEPTIC: 

FLUSPIRILENE (R6218). 

183200 03-15 
LONG-ACTING PHENOTHIAZINES AND SCHIZOPHRENIA. 

186288 03-08 
PENFLURIDOL: AN EFFICACIOUS LONG-ACTING ORAL ANTIPSYCHOTIC 
COMPOUND. 

189072 04-08 
LONG-RANGE 

LONG-RANGE MOTOR PERFORMANCE CHANGES IN LEVODOPA TREATED 
PATIENTS WITH PARKINSONS DISEASE. 

184195 03-11 
LONG-STAY 

EXPERIENCES WITH FLUPHENAZINE ENANTHATE IN LONG-STAY 
HOSPITALISED SCHIZOPHRENICS. 

171985 01-08 
EXPERIENCES WITH FLUPHENAZINE ENANTHATE IN LONG-STAY 
HOSPITALIZED SCHIZOPHRENICS. 

180154 02-08 
LONG-TERM 

EMOTIONAL FUNCTIONS IN SHORT-TERM VS. LONG-TERM L-DOPA 
THERAPY IN PARKINSONISM. 

168619 01-15 
LONG-TERM TREATMENT OF DEPRESSION WITH DRUGS AND 
PSYCHOTHERAPY. 

169087 01-09 
IMIPRAMINE, DIAZEPAM AND GROUP PSYCHOTHERAPY IN LONG-TERM 
TREATMENT OF DEPRESSIVE NEUROTICS. 

169089 01-10 
LONG-TERM CLINICAL AND QUANTITATIVE EEG EFFECTS OF 
CLOPENTHIXOL IN SCHIZOPHRENICS: CLINICAL NEUROPHYSIOLOGICAL 
CORRELATIONS. 

174131 01-08 
LONG-TERM APPLICATION OF CLOZAPINE (W-801) IN SCHIZOPHRENIC 
PATIENTS. 

174680 01-08 
LONG-TERM USE OF LITHIUM CARBONATE IN AFFECTIVE DISORDERS: A 
CLINICAL EVALUATION. 

174778 01-09 
SHORT-TERM AND LONG-TERM LITHIUM ADMINISTRATION: EFFECTS ON 
THE BRAINS SEROTONERGIC BIOSYNTHETIC SYSTEMS. 

175149 02-13 
WITHDRAWAL OF MAINTENANCE DRUGS WITH LONG-TERM 
HOSPITALIZED MENTAL PATIENTS: A CRITICAL REVIEW. 

175862 02-17 
EFFECTS OF SHORT-TERM VERSUS LONG-TERM L-DOPA THERAPY IN 
PARKINSONISM ON CRITICAL FLICKER FREQUENCY. 

177511 02-11 
THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 
DRUGS ON HUMAN SLEEP: IV. THE EFFECTS OF CHLORPROMAZINE. 

177716 02-14 
THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 

DRUGS ON HUMAN SLEEP: V. THE EFFECTS OF CHLORAL HYDRATE. 

177717 02-14 
THE EFFECTS OF LONG-TERM ADMINISTRATION OF PSYCHOTROPIC 

DRUGS ON HUMAN SLEEP: VI. THE EFFECTS OF CHLORDIAZEPOXIDE. 

177718 02-14 
LONG-TERM CONSEQUENCES OF EXPERIENCE, MEDICATION, AND 

PSYCHOTHERAPY FOR SCHIZOPHRENIC PATIENTS. (UNPUBLISHED 
PAPER). 

178677 02-17 
LONG-TERM EFFECTS OF 5,7 DIHYDROXYTRYPTAMINE ON BRAIN 
MONOAMINES. 

180022 02-03 
THE INFLUENCE OF ALDOSTERONE OR METHAMPHETAMINE ON LIVER 
GLYCOGEN DEPOSITION OF MICE STRESSED BY LONG-TERM 
ISOLATION. 

182105 02-03 



THE EFFECT OF METHAMPHETAMINE ON BRAIN ACH CONSUMPTION AND 
AGGRESSIVENESS IN MICE STRESSED MILDLY BY LONG-TERM 
ISOLATION. 

182108 02-04 
CLINICAL DATA AND SOCIOPSYCHIATRIC IMPLICATIONS OF OUTPATIENT 
TREATMENT WITH LONG-TERM PHENOTHIAZINES. 

182791 03-09 
CHANGES IN SHORT-TERM AND LONG-TERM MEMORY OF DOGS AND 
CATS UNDER THE EFFECTS OF AMIZYL (BENACTYZINE). 

183517 03-04 
LONG-TERM EFFECTS OF 4-CHLOROAMPHETAMINE ON BRAIN 5- 
HYDROXYINDOLE METABOLISM IN RATS. 

183869 03-03 
A DOUBLE-BLIND TRIAL OF LONG-TERM LITHIUM THERAPY IN MENTAL 
DEFECTIVES. 

185193 03-11 
NEUROLOGICAL CHANGES IN CATS FOLLOWING LONG-TERM DIET OF 
MERCURY CONTAMINATED TUNA. 

186476 03-05 
LONG-TERM USE OF MARIHUANA AND THE DEVELOPMENT OF 

TOLERANCE OR SENSITIVITY TO DELTA9-TETRAHYDR0CANNABIN0L 

188119 04-13 
ANISOMYCIN, LIKE OTHER INHIBITORS OF CEREBRAL PROTEIN 

SYNTHESIS, IMPAIRS LONG-TERM MEMORY OF A DISCRIMINATION 
TASK. 

188605 04-04 
LONG-TERM TREATMENT OF ENDOGENOUS DEPRESSION WITH 
NORTRIPTYLINE WITH CONTROL OF PLASMA LEVELS. 

188832 04-09 
NERVE CONDUCTION VELOCITY IN PATIENTS ON LONG-TERM 
DIPHENYLHYDANTOIN THERAPY. 

189173 04-15 
SHORT-TERM AND LONG-TERM REGULATION OF TYROSINE 
HYDROXYLASE. 

191515 04-03 
LONG-TERM TREATMENT WITH LEVODOPA. 

191614 04-11 
LONG-TERM ALTERATION OF SLEEP-WAKEFULNESS CYCLE DURING 
CHRONIC PENTOBARBITAL DOSING AND WITHDRAWAL IN CAT. 

191952 04-04 
LONGITUDINAL 

THE EFFECT OF CATECHOLAMINES, ACETYLCHOLINE AND SEROTONIN ON 
THE MORPHINE TOLERANT LONGITUDINAL MUSCLE STRIP OF THE 
GUINEA-PIG ILEUM. 

182161 02-03 
LOPRAMINE 

EXPERIMENT WITH LOPRAMINE (DB-2182) ON THE TREATMENT OF 
DEPRESSION. 

191665 04-09 
LORAZEPAM 

A MULTICENTER INVESTIGATION OF LORAZEPAM IN ANXIETY NEUROSIS. 

167346 01-10 
LORAZEPAM VERSUS GLUTETHIMIDE AS A SLEEP INDUCING AGENT FOR 
THE GERIATRIC PATIENT. 

167496 01-11 
LORAZEPAM: CLINICAL TRIAL WITH A NEW BENZODIAZEPINE. 

169297 01-07 
PILOT CLINICAL TRIAL OF PARENTERAL LORAZEPAM (TEMESTA) IN 
ANXIETY STATES. 

174044 01-11 
USE OF LORAZEPAM IN TREATING PATIENTS WITH NEUROTIC AND 
SOMATIZED PSYCHOVEGETATIVE SYMPTOMS. 

174136 01-09 
LORAZEPAM IN THE TREATMENT OF ANXIETY. 

176286 02-10 
THE EFFECT OF LORAZEPAM ON ANXIOUS INSOMNIACS SLEEP AS 
RECORDED IN THE HOME ENVIRONMENT. 

177318 02-14 
EFFECTS OF LORAZEPAM ON CNS STRUCTURES: NEUROPHYSIOLOGICAL 
AND BEHAVIORAL CORRELATIONS. 

1 77749 02-03 
INFLUENCE OF Nl-2-HYDROXYETHYL SUBSTITUTION ON CENTRAL 
ACTIVITY OF OXAZEPAM AND LORAZEPAM. 

178756 02-04 
WY-4036 (LORAZEPAM) - A NEW TRANQUILIZER. 

180146 02-10 
CLINICAL ASSAY OF LORAZEPAM WITH AMBULANT PATIENTS. 

183201 03-11 
LORDOSIS 

EFFECTS OF TETRABENAZINE ON LORDOSIS BEHAVIOUR AND ON BRAIN 
MONOAMINES IN THE FEMALE RAT. 

171614 01-04 
LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 
ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 
COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25, AN IN 
INTACT MALE RATS. 

186683 03-04 






S-137 



Subfect Index 

SUPPRESSION OF LORDOSIS IN GUINEA-PIGS BY ETHAMOXY-TRIPHETOL 
(MER-25) GIVEN AT LONG INTERVALS (36-46 HR) AFTER ESTRADIOL 
BEN20ATE TREATMENT. 

186686 03-04 
EFFECTS OF AN ESTROGEN ANTAGONIST, MER-25, ON MOUNTING 
BEHAVIOR AND LORDOSIS BEHAVIOR IN THE FEMALE RAT. 

186691 03-04 
LOSS 

CANNABINOIDS AND HEXOBARBITAL INDUCED LOSS OF RIGHTING 
REFLEXES. 

189573 04-04 
LOW-DOSE 

INTERACTION OF LOW-DOSE AMPHETAMINE USE WITH SCHIZOPHRENIA 
IN OUTPATIENTS: THREE CASE REPORTS. 

189099 04-15 
LOWERED 

THE EFFECT OF LOWERED BODY TEMPERATURE ON LIFESPAN AND 
IMMUNE AND NONIMMUNE PROCESSES. 

169675 01-03 
LOXAPINE 

THE TREATMENT OF MIXED ANXIETY AND DEPRESSION WITH LOXAPINE- 
A CONTROLLED COMPARATIVE STUDY. 

190195 04-09 
A DOUBLE-BLIND CONTROLLED STUDY OF LOXAPINE SUCCINATE IN THE 

TREATMENT OF ANXIETY NEUROSES. 

190196 04-09 



Psychopharmacology Abstract; 



LSD 



LSD EFFECTS ON SIGNAL-TO-NOISE RATIO AND LATERALIZATION OF 
VISUAL CORTEX AND LATERAL GENICULATE DURING PHOTIC 
STIMULATION. 

167449 01-03 
RADIOIMMUNOASSAY FOR LYSERGIDE (LSD) IN ILLICIT DRUGS AND 
BIOLOGICAL FLUIDS. 

170840 01-06 
A DIFFERENTIAL INHIBITORY ACTION OF LSD AND AMPHETAMINE ON 
COPULATORY BEHAVIOR IN THE FEMALE RAT. 

17161701-04 
THE EFFECT IN THE CAT OF TRYPTAMINE (T) AND LSD ON CUTANEOUS C- 
FIBER (CFR) AND POLYSYNAPTIC (PSR) SPINAL REFLEXES 
(UNPUBLISHED PAPER). 

174480 01-12 
EEG AND CARDIOVASCULAR EFFECTS OF TRYPTAMINE (T) AND LSD IN 
THE ENCEPHALE ISOLE CAT. (UNPUBLISHED PAPER) 

174496 01-12 
THE ROLE OF HYDROPHOBICITY IN THE ANTISEROTONIN ACTIVITY OF 
LSD ANALOGS. 

174606 01-12 
GENETIC EFFECTS OF LSD. 

1 75043 02-04 
EFFECTS OF AMPHETAMINE (A), LSD, PSILOCYBIN (P), AND DOM ON 
SCHEDULE-CONTROLLED BEHAVIOR IN THE RAT. 

176869 02-04 
STUDIES ON ENZYMATIC DEALKYLATION OF D-LYSERGIC ACID 
DIETHYLAMIDE (LSD). 

177336 02-03 
A REVIEW OF THE USE OF LSD FOR THE PATIENT NEAR DEATH. 

177681 02-12 
SHORT-TERM PSYCHOTHERAPY WITH LSD: A CASE STUDY. 

181461 02-12 
LSD ...AN IN VIVO RETROSPECTIVE CHROMOSOME STUDY. 

181811 02-13 
COMPARISON OF THE CHRONIC AND ACUTE EFFECTS OF D-LYSERGIC 
ACID DIETHYLAMIDE (LSD) TREATMENT ON RAT BRAIN SEROTONIN 
AND NOREPINEPHRINE. 

181945 02-03 
A COMPARISON OF EFFECTS OF D-LYSERGIC ACID DIETHYLAMIDE (LSD) 
AND SEROTONIN ON PRE- AND POSTSYNAPTIC CELLS IN THE 
SEROTONIN SYSTEM. 

182141 02-03 
ANALYSIS OF DRUG BLOCK OF LSD/5-HT/GABA BY MONITORING 
NEURONAL MEMBRANE CHANGES. 

182143 02-03 
LSD TOLERANCE AND BRAIN SEROTONIN METABOLISM. 

182167 02-03 
ON THE NATURE OF THE SEROTONIN BINDING AFTER LSD. 

182168 02-03 
INTERACTION OF THE BEHAVIORALLY ACTIVE DRUG, PHENITRONE, A 

PURPORTED HASHISH AND LSD ANTAGONIST, WITH SEVERAL 
CENTRAL NEUROCHEMICAL SYSTEMS. 

182217 03-04 
A COMPARATIVE STUDY OF THE ANTIPSYCHOTIC ACTION OF SOME 
NEUROLEPTICS BASED ON THE MODEL OF LSD PSYCHOSES. 

183682 03-03 
CYTOGENETIC STUDIES IN THE OFFSPRING OF LSD USERS. 

185083 03-12 
AN INVESTIGATION OF INTERACTIONS AMONG LSD 

DEXTROAMPHETAMINE, AND VERBAL BEHAVIOR IN MONOLOGUES 
AND DIALOGUES. (PH.D. DISSERTATION). 

185600 03-14 



EFFECTS OF LSD ON AUDITORY PERCEPTION: A SIGNAL DETECTION 
ANALYSIS. 

185752 03-0' 
PSYCHEDELIC (LSD) PSYCHOTHERAPY: A CASE REPORT. 

1 86994 03-0{ 
EFFECTS OF LSD ON SYNTHESIS AND RELEASE OF 5-HT IN RAT BRAIN 
SLICES. 

188164 04-0; 
EFFECTS OF LSD AND MONOAMINE SYNTHESIS INHIBITORS ON 

HORMONE ACTIVATED COPULATORY BEHAVIOR IN THE FEMALE RAT. 

188611 04-0^ 
EFFECTS OF LSD, MESCALINE, AND PSILOCYBIN ON SYMPATHETIC 
PREGANGLIONIC NEURONS. 

191937 04-0: 
DISCRIMINATIVE CONTROL OF BEHAVIOR BY ELECTRICAL STIMULATION 
OF THE DORSAL RAPHE NUCLEUS: GENERALIZATION TO LYSERGIC 
ACID DIETHYLAMIDE (LSD). 

191944 04-0i( 
CHLORIMIPRAMINE AND LSD: DIFFERENTIAL EFFECTS ON THE IN VIVO 
RELEASE OF 3H-5-HT. 

191949 04-03 
BLOCKADE OF EXCITATORY 5-HT SYNAPSE BY LSD. 

191950 04-03 
LSD AND THE INSANITY DRUGS, PART XXXI. 

192092 04-17 
LSD-LIKE 

THE POSSIBLE ROLE OF TRYPTAMINE IN BRAIN FUNCTION AND ITS 
RELATIONSHIP TO THE ACTIONS OF LSD-LIKE HALLUCINOGENS. 

186024 03-12 
LSD-25 

EFFECTS OF LSD-25 AND DEXTROAMPHETAMINE ON SPEECH RHYTHMS 
IN PSYCHOTHERAPY DIALOGUES. 

168420 01-12 
LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND GAMMA-AMINOBUTYRIC 
ACID (GABA) INTERACTION ON SPONTANEOUS POTENTIALS AND THE 
EVOKED RESPONSE IN THE AVIAN TECTUM. 

169689 01-03 
EFFECTS OF DELTA9-THC, LSD-25 AND SCOPOLAMINE ON CONTINUOUS, 
SPONTANEOUS ALTERNATION IN THE Y-MAZE. 

171306 01-04 
ELECTROENCEPHALOGRAPHIC EFFECTS OF DELTA9- 

TETRAHYDROCANNABINOL, LSD-25, MESCALINE AND 2,5 DIMETHOXY- 
4-METHYLAMPHETAMINE IN THE RABBITS. 

182095 02-03 
EFFECT OF LSD-25 AND 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE ON 
RAT BRAIN AND PLATELET SEROTONIN LEVELS. 

184975 03-03 
EFFECTS OF PROLONGED LSD-25 ADMINISTRATION UPON NEURONS OF 
SPINAL CORD GANGLIA TISSUE CULTURES. 

185112 03-03 
LU-1705 

ONE YEAR OF CLINICAL EXPERIENCE WITH LARGE DOSES OF 10 PERCENT 
FLUPENTHIXOL DECANOATE (LU-1705). 

172735 01-07 
LUCIDRIL 

TANTU-PASHAN AND LUCIDRIL THERAPY IN MENTALLY RETARDED 
CHILDREN. 

175628 02-11 
lUDIOMIL 

A DOUBLE-BLIND, COMPARATIVE CLINICAL TRIAL WITH LUDIOMIL (CIBA- 
34276-BA) AND AMITRIPTYLINE IN NEWLY ADMITTED DEPRESSED 
PATIENTS. 

167774 01-09 
COMPARATIVE EVALUATION OF DIBENCYCLADINE (LUDIOMIL) AND 
IMIPRAMINE IN PSYCHOTIC DEPRESSION. 

183361 03-09 
A CONTROLLED TRIAL OF MAPROTILINE (LUDIOMIL) AND AMITRIPTYLINE 
IN GENERAL PRACTICE. 

192510 04-09 
LUNG 

INHIBITION OF LUNG, LIVER AND BRAIN MONOAMINE OXIDASE BY 
IMIPRAMINE AND DESIPRAMINE. 

177332 02-03 
LUPUS-ERYTHEMATOSUS 

NICOTINIC ACID INDUCED SYSTEMIC LUPUS-ERYTHEMATOSUS. 

180243 02-15 
LUTEINIZING 

FUNCTIONAL EVALUATION OF PITUITARY RESERVE IN PATIENTS WITH 
THE AMENORRHEA GALACTORRHEA SYNDROME UTILIZING 
LUTEINIZING HORMONE RELEASING HORMONE (LH-RH), L-DOPA AND 
CHLORPROMAZINE. 

175245 02-13 
TESTOSTERONE AND LUTEINIZING HORMONE (LH) IN UNTREATED AND 
METHADONE MAINTAINED NARCOTIC ADDICTS. 

182166 02-13 
PLASMA LEVELS OF LUTEINIZING HORMONE AND OF IMMUNOREACTIVE 
ESTROGENS (ESTRADIOL) IN ANOREXIA-NERVOSA: RESPONSE TO 
CLOMIPHENE CITRATE. 

183807 03-10 



S-138 



rOLUME 12, SUBJECT INDEX 



Subject Index 



JVATREN 

CLINICAL USE OF LUVATREN (METHYLPERIDOL) FOR THE TREATMENT OF 
SCHIZOPHRENIA. 

191720 04-08 
rSERGAMIDE 

QUANTUM CHEMICAL STUDIES ON DRUG ACTIONS; IV. CORRELATION OF 
SUBSTITUENT STRUCTURES AND ANTISEROTONIN ACTIVITY IN 
LYSERGAMIDE SERIES. 

174605 01-12 
rSERGIC 

LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND GAMMA-AMINOBUTYRIC 
ACID (GABA) INTERACTION ON SPONTANEOUS POTENTIALS AND THE 
EVOKED RESPONSE IN THE AVIAN TECTUM. 

169689 01-03 
POTENTIAL PSYCHOTOMIMETICS; BROMOMETHOXYAMPHETAMINES AND 
STRUCTURAL CONGENERS OF LYSERGIC ACID. (PH.D. DISSERTATION). 

173588 01-03 
LYSERGIC ACID DIETHYLAMIDE AND SEROTONIN: A COMPARISON OF 
EFFECTS ON SEROTONERGIC NEURONS AND NEURONS RECEIVING A 
SEROTONERGIC INPUT. 

177407 02-12 
SYNTHESIS OF COMPOUNDS RELATED TO LYSERGIC ACID. 

182445 03-01 
DISCRIMINATIVE CONTROL OF BEHAVIOR BY ELECTRICAL STIMULATION 
OF THE DORSAL RAPHE NUCLEUS: GENERALIZATION TO LYSERGIC 
ACID DIETHYLAMIDE (LSD). 

191944 04-04 
CHROMOSOME EXAMINATIONS AFTER MEDICALLY ADMINISTERED 
LYSERGIC ACID DIETHYLAMIDE AND DEXTROAMPHETAMINE. 

192084 04-15 
SERGIDE 

RADIOIMMUNOASSAY FOR LYSERGIDE (LSD) IN ILLICIT DRUGS AND 
BIOLOGICAL FLUIDS. 

170840 01-06 
'SOSOMES 

THE EFFECT OF CHLORPROMAZINE AND STELAZINE ON LYSOSOMES OF 
RAT LIVER DURING ACUTE INTOXICATION. 

191121 04-03 
ACACA-MULATTA 

BEHAVIORAL EFFECTS OF DRUGS IN MACACA-MULATTA. 

181401 02-04 
SOCIAL HIERARCHY IN MONKEYS (MACACA-MULATTA) MODIFIED BY 
CHLORDIAZEPOXIDE HYDROCHLORIDE. 

183863 03-04 
AGNESIUM 

LACK OF EFFECT OF RIBAMINOL, TCAP, AND MAGNESIUM PEMOLINE ON 
RECOVERY FROM NEOCEREBELLAR DAMAGE. 

171904 01-03 
AGNETIC 

CONFORMATIONAL ANALYSIS OF ACRIDAN DERIVATIVES BY NUCLEAR 
MAGNETIC RESONANCE SPECTROSCOPY. A RELATIONSHIP BETWEEN 
CONFORMATION AND PHARMACOLOGICAL ACTIVITY. 

190715 04-01 
AINTAINED 

TESTOSTERONE AND LUTEINIZING HORMONE (LH) IN UNTREATED AND 
METHADONE MAINTAINED NARCOTIC ADDICTS. 

182166 02-13 
DIFFERENTIAL EFFECTS OF PILOCARPINE AND SCOPOLAMINE ON THE 
PERFORMANCE OF A LIGHT DARK DISCRIMINATION MAINTAINED BY 
ELECTRICAL STIMULATION OF THE BRAIN. 

186701 03-03 
NALTREXONE AND NALOXONE: AGONIST AND ANTAGONIST EFFECTS ON 
KEY-PRESS RESPONDING OF PIGEONS MAINTAINED UNDER A MULTIPLE 
SCHEDULE OF FOOD PRESENTATION. 

191926 04-04 
EFFECTS OF PHENCYCLIDINE AND KETAMINE ON FOOD MAINTAINED 
BEHAVIOR IN THE PIGEON. 

191973 04-04 
AINTENANCE 

CLINICAL EVALUATION OF FLUSPIRILENE AS A MAINTENANCE THERAPY 
IN CHRONIC SCHIZOPHRENIC PATIENTS. 

168320 01-08 
THE MAINTENANCE TREATMENT OF SCHIZOPHRENIA. 

172963 01-08 
WITHDRAWAL OF MAINTENANCE DRUGS WITH LONG-TERM 
HOSPITALIZED MENTAL PATIENTS: A CRITICAL REVIEW. 

175862 02-17 
MAINTENANCE TREATMENT OF SCHIZOPHRENIA IN THE LIGHT OF 
PROGNOSIS ORIENTED DIAGNOSIS. 

186081 03-08 
EFFECTS OF PHYSOSTIGMINE ON THE MAINTENANCE OF 
DISCRIMINATION BEHAVIOUR IN RATS. 

186637 03-04 
LOCALIZED BEHAVIORAL EFFECTS OF VASOPRESSIN ON MAINTENANCE 
OF AN ACTIVE AVOIDANCE RESPONSE IN RATS. 

187697 04-04 
DRUG MAINTENANCE IN THE OUTPATIENT TREATMENT OF CHRONIC 
ALCOHOLISM. 

189926 04-11 



EVIDENCE FOR A DOPAMINERGIC INVOLVEMENT IN THE MAINTENANCE 
OF SELF-STIMULATION. 

191526 04-03 
MAJOR 

A PROGRAMME WHICH LED TO REDUCTION IN NIGHT SEDATION IN A 
MAJOR HOSPITAL. 

170802 01-17 
CONCENTRATION EFFECT RELATIONSHIPS WITH MAJOR AND MINOR 
TRANQUILIZERS. 

192871 04-14 
MALE 

EFFECTS OF IMIPRAMINE ON COPULATORY BEHAVIOR OF MALE RATS. 

168718 01-04 
MONOAMINES AND COPULATORY ACTIVATION IN THE CASTRATED MALE 
RAT 

171618 01-04 
INFLUENCE OF PHENOBARBITAL AND SEX HORMONES ON ENZYMES IN 
ASCORBIC ACID BIOSYNTHESIS IN MALE AND FEMALE RATS. (PH.D. 
DISSERTATION). 

172017 01-03 
SUBACUTE TOXICITY OF 8-CHL0R0-6-PHENYL-4H-S- 

TRIAZOLOBENZODIAZEPINE (D-40TA) IN MALE AND FEMALE RATS: 
ORAL ADMINISTRATION FOR ONE MONTH. 

177097 02-05 
THE HYDROXYLATION OF D-AMPHETAMINE BY LIVER MICROSOMES OF 
THE MALE RAT. 

177337 02-03 
THE EFFECTS OF CHLORDIAZEPOXIDE (LIBRIUM) ON THE INTENSITY AND 
HABITUATION OF AGONISTIC BEHAVIOR IN MALE SIAMESE FIGHTING 
FISH. 

177722 02-04 
AFRODEX VS. PLACEBO IN THE TREATMENT OF MALE IMPOTENCE: 
STATISTICAL ANALYSIS OF TWO DOUBLE-BLIND CROSSOVER STUDIES. 

181959 0214 
EFFECTS OF CHRONICALLY ADMINISTERED DELTAl- 
TETRAHYDROCANNABINOL OF ADRENAL AND GONADAL ACTIVITY OF 
MALE RATS. 

183358 03-03 
REDUCTION IN COPULATORY BEHAVIOR OF MALE RATS FOLLOWING 
HASHISH INJECTIONS. 

183790 03-04 
EFFECTS OF CYPROTERONE ACETATE IN THE MALE JAPANESE QUAIL. 

186681 03-03 
LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 
ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 
COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25, AN IN 
INTACT MALE RATS. 

186683 03-04 
APHRODISIAC EFFECT OF L-DOPA AND APOMORPHINE IN MALE 
SEXUALLY SLUGGISH RATS. 

188519 04-03 
EFFECTS OF CHRONIC NICOTINE ADMINISTRATION AND AGE ON 
VARIOUS NEUROTRANSMITTERS AND ASSOCIATED ENZYMES IN MALE 
FISCHER 344 RATS. 

189597 04-03 
DISTRIBUTION OF 14C-DELTA9-THC IN MALE AND FEMALE RATS. 

191969 04-03 
INTERACTION OF SEROTONIN ANTAGONISTS WITH 3,4-0ICHL0R0-2-(2- 
IMIDAZOLIN-2-YL-THIO) 2 ACETOPHENONE HYDROBROMIDE (DITA) 
AND D-AMPHETAMINE HYDROBROMIDE (DITA) AND D-AMPHETAMINE 
ON CERTAIN BEHAVIORAL PARAMETERS OF MALE MICE. 

192014 04-04 
MALES 

INVERSION BY APOMORPHINE OF THE TENDENCY OF FEMALE RATS TO 
BE DEFEATED BY MALES WHEN COMPETING FOR FOOD IN A STRAIGHT 
RUNWAY. 

184212 03-04 
MALFORMATION 

ENDURING LEARNING DEFICITS AND CEREBRAL SYNAPTIC 
MALFORMATION FROM EXPOSURE TO 10 PARTS OF HALOTHANE PER 
MILLION. 

192565 04-04 
MALIGNANT 

CLINICAL EXPERIENCE WITH DIAMORPHINE IN ADVANCED MALIGNANT 
DISEASE. 

191606 04-17 
MALNUTRITION 

SENILITY AND CHRONIC MALNUTRITION. 

188446 04-11 
MAMMALIAN 

PASSAGE OF TAURINE INTO ADULT MAMMALIAN BRAIN. 

191331 04-03 
MAMMILLARIA-ELONGATA 

CACTUS ALKALOIDS: XVIII. PHENOLIC BETA-PHENETHYLAMINES FROM 
MAMMILLARIA-ELONGATA. 

192882 04-01 









&■;;>;.•/;■'■,.■.'.•:• 



S-139 



Subject Index 



Psychopharmacology Abstrac 



MAN 



TETRAHYDROISOQUINOLINE ALKALOIDS: IN VIVO METABOLITES OF L- 
DOPA IN MAN. 

168286 01-13 
PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF CHRONIC 
MARIJUANA ADMINISTRATION IN MAN. 

169070 01-13 
MARIHUANA USE IN MAN: AN EXPERIMENTAL INQUIRY - CLINICAL 
PSYCHIATRIC IMPRESSIONS. 

169085 01-14 
CENTRAL MONOAMINE METABOLISM IN MAN: EFFECT OF PUTATIVE 
DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS. 

169377 01-13 
BLOOD LEVEL PROFILE IN MAN FOLLOWING CHRONIC ORAL 
ADMINISTRATION OF FLURAZEPAM HYDROCHLORIDE. 

169817 01-13 
PHARMACOKINETIC PROFILE OF DIAZEPAM IN MAN FOLLOWING SINGLE 
INTRAVENOUS AND ORAL AND CHRONIC ORAL ADMINISTRATION. 

170838 01-13 
ANTAGONISTIC EFFECTS OF PHYSOSTIGMINE AND METHYLPHENIDATE IN 
MAN. 

172272 01-11 
TECHNICAL STRATEGIES FOR THE STUDY OF CATECHOLAMINES IN MAN. 
(UNPUBLISHED PAPER). 

173387 01-03 
METABOLIC CONTROL OF BODY TEMPERATURE IN MAN. 

174134 01-08 
BEHAVIORAL EFFECTS OF A NEW DOPAMINE-BETA-HYDROXYLASE 
INHIBITOR (FUSARIC ACID) IN MAN. (UNPUBLISHED PAPER 

174329 01-09 
INTERACTIONS IN MAN OF DELTA9-TETRAHYDR0CANNABIN0L: I. ALPHA- 
METHYL-PARA-TYROSINE. 

174347 01-13 
DIURETIC ACTIVITY OF A NEW NARCOTIC ANTAGONIST IN MAN 
(BRISTOL-COMPOUND-2605). (UNPUBLISHED PAPER). 

174473 01-13 
ATTEMPTS TO EVOKE TOLERANCE TO DMT IN MAN. (UNPUBLISHED 
PAPER). 

176480 02-12 
A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY IN MAN OF 
INTRAVENOUSLY ADMINISTERED DELTA9-TETRAHYDR0CANNABIN0L, 
CANNABINOL, AND CANNABIDIOL. 

176747 02-03 
QUALITATIVE AND QUANTITATIVE STUDIES ON THE DISPOSITION OF 
AMITRIPTYLINE AND OTHER TRICYCLIC ANTIDEPRESSANT DRUGS IN 
MAN AS IT RELATES TO THE MANAGEMENT OF THE OVERDOSED 
PATIENT. 

177395 02-15 
AMITRIPTYLINE IN MAN: DECREASED FORMATION OF CENTRAL 5- 
HYDROXYINDOLEACETIC ACID. 

177736 02-13 
INVESTIGATIONS ON THE FATE OF THE ANTICONVULSANT CLONAZEPAM 
IN THE ORGANISM OF MAN, RAT AND DOG. 

179022 02-13 
PSYCHOPHYSIOLOGICAL EFFECTS OF DIAZEPAM (VALIUM) COMBINED 
WITH A MODERATE DOSE OF ALCOHOL IN MAN. 

180699 02-14 
STUDIES ON METABOLISM OF BROMAZEPAM (III): ABSORPTION, 
EXCRETION, AND METABOLISM OF BROMAZEPAM IN MAN. 

181588 02-13 
INCREASED GASTRIC ACID DURING SHOCK AVOIDANCE IN MAN. 

181879 02-13 
PHARMACOLOGIC ACTIVITY AND BIOTRANSFORMATION OF R. AND S- 
BARBITURATE ENANTIOMERS IN MOUSE AND MAN. 

182156 02-03 
A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY OF DELTA9- 
TETRAHYDROCANNABINOL AND ITS MONOHYDROXYLATED 
METABOLITES IN MAN. 

182223 03-03 
BLOOD LEVEL AND URINARY EXCRETION OF BROMAZEPAM IN MAN. 

182556 03-13 
BUTOBARBITONE METABOLISM IN MAN: IDENTIFICATION OF 3- 
KETOBUTOBARBITONE. 

183793 03-13 
METABOLISM OF CHLORPHENTERMINE AND PHENTERMINE IN MAN TO 
YIELD HYDROXYLAMINO, C-NITROSO AND NITRO COMPOUNDS. 

183796 03-13 
EFFECT OF ANTIDEPRESSANT AND ANTIMANIC DRUGS ON AMINE 
UPTAKE IN MAN. 

184654 03-13 
IMIPRAMINE MEDIATED EFFECTS ON LEVODOPA METABOLISM IN MAN. 

185998 03-13 
MAN AND HIS MEDICINES. 

186474 03-17 
COMPARISON OF GRADED SINGLE INTRAMUSCULAR DOSES OF 
MORPHINE AND PENTOBARBITAL IN MAN. 

187254 03-15 



THE EFFECT OF CAFFEINE, NITRAZEPAM AND CIGARETTE SMOKING ON 
THE CONTINGENT NEGATIVE VARIATION IN MAN. 

187350 04- 
N-(2-DIETHYLAMIN0ETHYL) 2 (P-HYDROXYPHENOXY) ACET AMIDE, A 
METABOLITE OF MEFEXAMIDE IN MAN. 

187577 04- 
CARDIOVASCULAR EFFECTS OF MARIHUANA IN MAN. 

187812 04- 
PLASMA AND CEREBROSPINAL FLUID PROBENECID CONCENTRATIONS A 
RELATED TO ACCUMULATION OF ACIDIC BIOGENIC AMINE 
METABOLITES IN MAN. 

187933 04- 
STEREOSPECIFIC ACTIONS OF DOET (2,5 DIMETHOXY-4- 
ETHYLAMPHETAMINE) IN MAN, 

188121 04- 
ROLE OF DOPAMINERGIC MECHANISMS IN REGULATION OF GROWTH 
HORMONE AND PROLACTIN SECRETION IN MAN. 

188428 04- 
THE EFFECT OF A NEW BENZODIAZEPINE DERIVATIVE NIMETAZEPAM 
THE SLEEP CYCLE IN MAN. 

188501 04- 
INFLUENCE OF NEUROLEPTICS AND BENZODIAZEPINES ON METABOLIS^ 
OF TRICYCLIC ANTIDEPRESSANTS IN MAN. 

191026 04- 
THE EFFECT OF LITHIUM ON THYROID IN MAN. 

191142 04- 
MONOAMINE OXIDASE IN MAN; ENZYME CHARACTERISTICS IN HUMAh 
PLATELETS, PLASMA, AND OTHER HUMAN TISSUES. 

191502 04- 
AN EVALUATION OF SERUM DOPAMINE-BETA-HYDROXYLASE AS AN 
INDEX OF SYMPATHETIC NERVE ACTIVITY IN MAN. 

191511 04- 
COMPARATIVE METABOLISM OF TRIAZOLAM, A NEW SEDATIVE 
HYPNOTIC, IN RAT, DOG AND MAN. 

191900 04- 
EFFECTS OF CNS AGENTS ON NICOTINE EXTENSOR CONVULSIONS AND 
LETHALITY IN MICE AND THEIR SEDATIVE ANTIANXIETY EFFECTS IN 
MAN. 

191907 04- 
PROTRIPTYLINE STEADY-STATE PLASMA LEVELS IN MAN. 

191924 04- 
A PREDICTABLE LABORATORY MODEL FOR SEDATIVE/HYPNOTIC 
ACTIVITY IN MAN. 

191943 04- 
THE PREDICTIVE VALUE OF THE ANTIAPOMORPHINE TEST IN DOGS FOR 
NEUROLEPTIC THERAPY IN MAN. 

192421 04- 
MANAGEMENT 

CLINICAL EXPERIMENTATION WITH A NEW BENZODIAZEPINE IN THE 
MANAGEMENT OF PHOBIC AND OBSESSIVE SYMPTOMS. 

167594 01- 
SCHIZOPHRENIA MANAGEMENT - THE DAWN OF A NEW ERA. 

172435 01- 
A COMPARATIVE TRIAL OF HALOPERIDOL AND THIORIDAZINE: 
MANAGEMENT OF CHRONIC SCHIZOPHRENIA. 

172741 01- 
MANAGEMENT OF HOSTILE, SUSPICIOUS PATIENTS. TRIFLUOPERAZINE 
VERSUS HALOPERIDOL. 

1 76675 02- 
QUALITATIVE AND QUANTITATIVE STUDIES ON THE DISPOSITION OF 
AMITRIPTYLINE AND OTHER TRICYCLIC ANTIDEPRESSANT DRUGS IN 
MAN AS IT RELATES TO THE MANAGEMENT OF THE OVERDOSED 
PATIENT. 

177395 02- 
DIAGNOSIS AND MANAGEMENT OF DEPRESSION IN GENERAL PRACTICE 

180406 02- 
SOME RECENT ADVANCES IN THE MANAGEMENT OF ANXIETY. 

182764 03- 
DRUG THERAPIES IN CRISIS AAANAGEMENT. 

189297 04- 
JOHN J. BONICA ON PAIN MANAGEMENT. 

189903 04- 
MANAGING 

THE ROLE OF CHEMOTHERAPY IN MANAGING POTENTIALLY SUICIDAL 
PATIENTS. 

178544 02- 
MANDRAX 

COMPLICATIONS OF METHAQUALONE DIPHENHYDRAMINE (MANDRAX) 
ABUSE. 

177452 02- 
MANIA 

EFFECT OF LITHIUM ON AGGRESSION, MANIA AND PERMSELECTIVE 
MEMBRANES. 

167448 01-1 
L-TRYPTOPHAN IN MANIA: CONTRIBUTION TO A PERMISSIVE 
HYPOTHESIS OF AFFECTIVE DISORDERS. 

171500 01-1 



S-140 



rOLUME 12, SUBJECT INDEX 

CHOLINERGIC AND ADRENERGIC BALANCE IN MANIA AND 
SCHIZOPHRENIA. 



Subject Index 



191530 04-09 



lANIC 

LITHIUM CARBONATE TREATMENT IN MANIC PSYCHOSIS. 

167918 01-09 
A COMPARISON OF LITHIUM CARBONATE IN THE PREVENTION OF MANIC 

AND DEPRESSIVE EPISODES IN RECURRENT AFFECTIVE DISORDER. 

169090 01-09 
LITHIUM INDUCED DIABETES-INSIPIDUS: MANIC SYMPTOMS, BRAIN AND 
ELECTROLYTE CORRELATES, AND CHLOROTHIAZIDE TREATMENT. 

169486 01-15 
CHOLINERGIC REVERSAL OF MANIC SYMPTOMS: A POSSIBLE 
EXPLANATION. (UNPUBLISHED PAPER). 

173520 01-09 
PRESENT TREATMENT OF MANIC STATES. 

183189 03-09 
REBOUND PHENOMENON IN MANIC PATIENTS FOLLOWING 

PHYSOSTIGMINE: TOWARDS AN UNDERSTANDING OF AMINERGIC 
MECHANISMS UNDERLYING AFFECTIVE DISORDERS. 

191531 04-09 
ROLE OF ACETYLCHOLINE AND DOPAMINE IN MANIC BEHAVIOR. 

191532 04-09 
EXPERIMENT WITH LITHIUM CARBONATE ON THE TREATMENT OF MANIC 

STATE. 

191670 04-09 

lANIC-DEPRESSIVE 

GROWTH HORMONE RESPONSES TO ADMINISTRATION OF L-5- 

HYDROXYTRYPTOPHAN (L-5-HTP) IN MANIC-DEPRESSIVE PSYCHOSES. 

167919 01-09 
SELECTIVE INHIBITION OF NOREPINEPHRINE SYNTHESIS IN MANIC- 
DEPRESSIVE PATIENTS WITH A DOPAMINE-BETA-HYDROXYLASE 
INHIBITOR. (UNPUBLISHED PAPER). 

170083 01-03 
STUDIES ON THE URINARY EXCRETION OF CATECHOLAMINES AND 17- 
KETOSTEROID IN MANIC-DEPRESSIVE PSYCHOSIS. 

178623 02-09 
FACTORS ASSOCIATED WITH LITHIUM RESPONSE IN THE PROPHYLACTIC 
TREATMENT OF BIPOLAR MANIC-DEPRESSIVE ILLNESS. 

186188 03-09 
LITHIUM CARBONATE IN MANIC-DEPRESSIVE PSYCHOSIS. 

187477 04-09 
PROPHYLACTIC EFFICACY OF LITHIUM CARBONATE IN MANIC- 
DEPRESSIVE ILLNESS: REPORT OF THE VETERANS ADMINISTRATION 
AND NATIONAL INSTITUTE OF MENTAL HEALTH (VA-NIMH) 
COLLABORATIVE STUDY GROUP. 

189735 04-09 
lANIFESTATIONS 

TREATMENT OF THE CEREBRAL MANIFESTATIONS OF ARTERIOSCLEROSIS 
WITH CYCLANDELATE. 

185008 03-11 
UVNIFESTED 

ADAPTATION TO NITROGEN NARCOSIS MANIFESTED BY TIMING 
BEHAVIOR IN THE RAT. 

186630 03-04 

AANIPULATION 

PHARMACOLOGICAL DISTINCTIONS BETWEEN ACTIVE AND PASSIVE 
AVOIDANCE MEMORY FORMATION AS SHOWN BY MANIPULATION OF 
BIOGENIC AMINE ACTIVE COMPOUNDS. 

185927 03-04 
MANUAL 

MANUAL OF INTOXICATING DRUGS. 

175537 02-17 
AAO 

STUDIES ON MONOAMINE OXIDASE - REPORT 22: EFFECTS OF NAN02 
AND NH20H ON MITOCHONDRIAL MAO IN RAT BRAIN. 

177022 02-03 
THE INFLUENCE OF NEUROTROPIC DRUGS ON MONOAMINE OXIDASE 
(MAO) AND 5-OXYTRYPTOPHANE DECARBOXYLASE (5-OTD) ACTIVITY 
IN THE BRAIN. 

183142 03-13 
MULTIPLE FORMS OF MAO: SOME IN VIVO CORRELATIONS. 

191496 04-03 
SOME CONSIDERATIONS IN THE DESIGN OF SUBSTRATE AND TISSUE 
SPECIFIC INHIBITORS OF MAO. 

191499 04-01 
CORRELATION BETWEEN BRAIN N,N DIMETHYLTRYPTAMINE (DMT) 
LEVELS AND BAR PRESSING BEHAVIOR IN RATS: EFFECT OF MAO 
INHIBITION. 

191935 04-04 
THE PRESENCE OF MAO IN SYNAPTIC MEMBRANES OF BOVINE BRAIN. 

191956 04-03 
MAPROTIIINE 

CLINICAL EXPERIENCES WITH A NEW ANTIDEPRESSANT, MAPROTILINE. 

188893 04-09 
A CONTROLLED TRIAL OF MAPROTILINE (LUDIOMIL) AND AMITRIPTYLINE 
IN GENERAL PRACTICE. 

192510 04-09 



MARGINAL 

QUINAZOLINES AND 1,4 BENZ0DIAZEPINES.64.C0MPARIS0N OF THE 
STEREOCHEMISTRY OF DIAZEPAM WITH THAT OF CLOSE ANALOGS 
WITH MARGINAL BIOLOGICAL ACTIVITY. 

185034 03-01 
MARIHUANA 

THE RELATIONSHIP OF MARIHUANA AND SOCIAL BEHAVIOR. 

169084 01-13 
MARIHUANA USE IN MAN: AN EXPERIMENTAL INQUIRY - CLINICAL 

PSYCHIATRIC IMPRESSIONS. 

169085 01-14 
TOXIC EFFECTS OF MARIHUANA TAR ON MOUSE SKIN. 

170464 01-05 
MARIHUANA AND SOCIAL BEHAVIOR. 

175003 02-14 
THE EFFECT OF MARIHUANA ON TRACKING TASK PERFORMANCE. 

177720 02-14 
MARIHUANA - A PSYCHEDELIC DRUG? 

178695 02-17 
MARIHUANA AND PAIN. 

182719 03-13 
CARDIOVASCULAR EFFECTS OF MARIHUANA IN MAN. 

187812 04-13 
LONG-TERM USE OF MARIHUANA AND THE DEVELOPMENT OF 

TOLERANCE OR SENSITIVITY TO DELTA9-TETRAHYDR0CANNABIN0L. 

188119 04-13 
REPEAT ADMINISTRATION OF MARIHUANA SMOKE TO HUMANS. 

188120 04-13 
EFFECT OF MARIHUANA ON THE PSYCHOLOGICAL REFRACTORY PERIOD. 

189358 04-14 
EFFECTS OF TWO LEVELS OF ATTENTION DEMAND ON VIGILANCE 

PERFORMANCE UNDER MARIHUANA. 

189359 04-14 
THE NATURE OF STORAGE DEFICITS AND STATE-DEPENDENT RETRIEVAL 

UNDER MARIHUANA. 

189406 04-14 
CRUDE MARIHUANA EXTRACT: EEG AND BEHAVIORAL EFFECTS OF 
CHRONIC ORAL ADMINISTRATION IN RHESUS MONKEYS. 

189516 04-04 
STUDIES OF THE IMMUNE RESPONSE IN CHRONIC MARIHUANA 
SMOKERS. 

191961 04-13 
CLINICAL EFFECTS OF MARIHUANA SECOBARBITAL COMBINATION. 

191989 04-14 
CLINICAL EFFECTS OF MARIHUANA DEXTROAMPHETAMINE 

COMBINATION. 

191990 04-14 
METABOLISM OF DELTAl -TETRAHYDROCANNABINOL BY RATS TOLERANT 

TO AAARIHUANA. 

192020 04-03 
MARIJUANA 

PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF CHRONIC 
MARIJUANA ADMINISTRATION IN MAN. 

169070 01-13 
THE EFFECT OF MARIJUANA ON HOSTILITY IN AN EXPERIMENTAL GROUP 
SETTING: PRELIMINARY OBSERVATIONS. 

169086 01-14 
INDUCTION OF SEVERE DEPRESSION BY PHYSOSTIGMINE IN MARIJUANA 
INTOXICATED INDIVIDUALS. 

177450 02-14 
MARIJUANA DIMINISHES GSR ACTIVATION PEAKING. 

181887 02-13 
INFLUENCE OF ALPHA-METHYLTYROSINE ON ENHANCEMENT OF 
SHUTTLEBOX AVOIDANCE BY MARIJUANA AND PENTOBARBITAL. 

187572 04-04 
PERFORMANCE ON A VERBAL LEARNING TASK BY SUBJECTS OF HEAVY 
PAST MARIJUANA USAGE. 

190308 04-14 
MARITAL 

DRUG THERAPY AND MARITAL THERAPY IN OUTPATIENT DEPRESSIVES. 

169088 01-09 
MASKED 

MASKED DEPRESSION. 

182829 03-10 
SO-CALLED MASKED DEPRESSION AND ITS TREATMENT. 

183369 03-10 
MASSIVE 

THE OCULAR COMPLICATIONS BY MASSIVE DOSE OF PSYCHOTROPIC 
DRUGS. 

182552 03-15 

MATCHED 

LITHIUM PROPHYLAXIS IN AFFECTIVE DISORDERS: AN OPEN TRIAL WITH 
MATCHED CONTROLS. 

172401 01-09 
MATCHING-TO-SAMPU 

EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON DELAYED MATCHING- 
TO-SAMPLE CHOICE SPEEDS IN CHIMPANZEES. 

171886 01-04 



■■>> 



mm 



S-141 



Subject Index 



Psychopharmacology Abstrac 



EFFECTS OF CHRONIC EXPOSURE TO DELTA9-TETRAHYDR0CANNABIN0L 
ON DELAYED MATCHING-TO-SAMPLE IN CHIMPANZEES. 

189405 04-04 
MATERNAL 

EFFECT OF PRENATAL MATERNAL ADMINISTRATION OF D-AMPHETAMINE 
ON RAT OFFSPRING ACTIVITY AND PASSIVE AVOIDANCE LEARNING. 

167415 01-03 
ALTERATION OF MATERNAL BEHAVIOR IN MICE FOLLOWING 
ADMINISTRATION OF CYPROTERONE ACETATE. 

172374 01-04 
MAHER 

IMPROVING PSYCHIATRIC DRUG THERAPY: A MATTER OF DOSAGE AND 
CHOICE. 

190144 04-17 
ANALGESIA AND HYPERREACTIVITY PRODUCED BY INTRACRANIAL 
MICROINJECTIONS OF MORPHINE INTO THE PERIAQUEDUCTAL GRAY 
MATTER OF THE RAT. 

191367 04-04 
NEUROCHEMICAL ANALYSIS OF AGGRESSIVE - DEFENSIVE BEHAVIOR 
ELICITED BY ELECTRICAL STIMULATION OF THE HYPOTHALAMUS AND 
CENTRAL GRAY MATTER. 

191784 04-02 
MAXIMAL 

THE EFFECT OF CANNABIDIOL ON MAXIMAL ELECTROSHOCK SEIZURES IN 
RATS. 

168749 01-03 
INDICATIONS AND DOSAGE FOR MAXIMAL ACTIVITY OF ORNITHINE- 
CARBAMYL-TRANSFERASE IN THE PSYCHIATRIC ENVIRONMENT. 

184955 03-17 
MAZE 

EFFECT OF L-ASPARAGINASE ON RETENTION OF MAZE LEARNING IN 
MICE. 

167324 01-04 
EFFECT OF CHRONIC POSTTRIAL SALINE INJECTIONS ON MAZE 
PERFORMANCE. 

167403 01-04 
EFFECTS OF CHLORPROMAZINE, MEPROBAMATE AND 
CHLORDIAZEPOXIDE ON THE MAZE LEARNING IN MICE. 

171259 01-04 
EFFECTS OF ANALEPTICS ON MAZE LEARNING IN MICE. 

173078 01-04 
SPECIFIC FACILITATION OF MAZE LEARNING BY A PEPTIDE EXTRACTED 
FROM TRAINED MOUSE BRAIN. 

176868 02-04 
THE EFFECTS OF EARLY SALINE INJECTIONS AND PENTYLENETETRAZOL 
ON HEBB-WILLIAMS MAZE PERFORMANCE IN THE ADULT RAT. 

191378 04-04 
MAZINDOL 

DOUBLE-BLIND CLINICAL EVALUATION OF MAZINDOL, 

DEXTROAMPHETAMINE, AND PLACEBO IN TREATMENT OF EXOGENOUS 
OBESITY. 

167335 01-11 
MDA 

THE PROPERTIES OF 3,4 METHYLENEDIOXYAMPHET AMINE (MDA). I. A 
REVIEW OF THE LITERATURE. 

176597 02-17 
MEASURE 

THE SPIRAL AFTEREFFECT (SAE) AS A MEASURE OF MOTION SICKNESS 
SUSCEPTIBILITY AND THE EFFECT ON THE SAE OF AN ANTIMOTION 
SICKNESS DRUG AND A CENTRAL NERVOUS SYSTEM DEPRESSANT. 

172780 01-03 
MEASURED 

ANALGESIC POTENCY OF SODIUM SALICYLATE, INDOMETHACIN, AND 
CHLORDIAZEPOXIDE AS MEASURED BY THE SPATIAL PREFERENCE 
TECHNIQUE IN THE RAT. 

171301 01-02 
CHANGES IN THE NEUROEXCITABILITY OF ALCOHOL DEPENDENT RATS 
UNDERGOING WITHDRAWAL AS MEASURED BY THE 
PENTYLENETETRAZOL SEIZURE THRESHOLD. 

182348 03-03 
AN ELECTROENCEPHALOGRAPHIC STUDY ON THE TOLERANCE OF THE 
VARIOUS PSYCHIATRIC AND NEUROLOGICAL PATIENTS TO THE 
HYPNOTIC EFFECTS OF DIPHENHYDRAMINE - MEASURED BY THE 
AMOUNTS OF SLEEP EEG AS AN INDICATOR. 

182550 03-11 
THE EFFECT OF SOME CHOLINOLYTIC DRUGS ON A NUMBER OF 

BEHAVIOURAL PARAMETERS MEASURED IN THE T-MAZE ALTERNATION 
TEST: DOSE-RESPONSE RELATIONSHIPS. 

187641 04-04 
MEASUREMENT 

MEASUREMENT OF BIOGENIC AMINES AT THE PICOGRAM LEVEL. 
(UNPUBLISHED LEVEL). 

173382 01-03 
IN VIVO MEASUREMENT OF THE RELEASE OF 5-HYDROXYTRYPTAMINE (5- 
HT) FROM THE HIPPOCAMPUS OF THE RAT: EFFECT OF RO-4-1284, 
PARGYLINE AND P-CHLOROAMPHETAMINE (PCA). 

182140 02-03 



A SENSITIVE, SIMPLE METHOD FOR MEASUREMENT OF TYROSINE 
HYDROXYLASE AND TRYPTOPHAN-5-HYDROXYLASE ACTIVITIES. 

182178 02- 
MEASUREMENT OF ANXIETY IN GENERAL PRACTICE. 

182768 03- 
A NEW RECORDING APPARATUS FOR MEASUREMENT OF LOCOMOTOR 
ACTIVITY OF MICE. EXPERIMENTAL OBSERVATIONS ON ITS USE. 

186377 03- 
POST-MORTEM MEASUREMENT OF ENZYMES IN HUMAN BRAIN 
EVIDENCE OF A CENTRAL NORADRENERGIC DEFICIT IN 
SCHIZOPHRENIA. 

191529 04- 
MEASUREMENTS 

THE COMPARATIVE ANXIOLYTIC EFFECTS OF PLACEBO, IMIPRAMINE Ah 
CHLORIMIPRAMINE USING PSYCHIATRIC AND PSYCHOPHYSIOLOGIC^ 
MEASUREMENTS. 

191137 04- 
MEASURING 

MEASURING THE PHARMACOLOGICAL ACTION OF IMIPRAMINE IN THE 
TREATMENT OF DEPRESSIONS. 

174995 02- 
MEBUTAMATE 

EFFECTS OF MEBUTAMATE ON THE ELECTROENCEPHALOGRAPHIC SLEEP 
PROFILE. 

174348 01- 
MECAMYLAMINE 

DISSOCIATION BETWEEN SCOPOLAMINE AND MECAMYLAMINE DURING 
FEAR CONDITIONING IN RATS. 

190264 04- 
MECHANISM 

ANIMAL MODELS FOR AN ENZYMIC BLOOD-BRAIN BARRIER MECHANIS, 
FOR THERAPEUTICALLY ADMINISTERED L-DOPA. 

167359 01-1 
STUDY INTO THE MECHANISM OF THE ANORECTIC ACTION OF 
AMPHETAMINE AND ITS P-CHLORO ANALOGUE. 

171610 01-1 
HALOPERIDOL EFFECTS ON MORPHINE SELF-ADMINISTRATION: TESTING 
FOR PHARMACOLOGICAL MODIFICATION OF THE PRIMARY 
REINFORCEMENT MECHANISM. 

172454 01-1 
ON THE MECHANISM OF CENTRAL ACTION OF AMPHETAMINE: THE ROL 
OF CATECHOLAMINES. 

172921 01-( 
APOMORPHINE INDUCED BITING AND FIGHTING BEHAVIOUR IN 
RESERPINIZED RATS AND AN APPROACH TO THE MECHANISM OF 
ACTION. 

174768 01 -( 
CONDITIONED HYPOGLYCEMIA: A MECHANISM FOR SACCHARIN 
INDUCED SENSITIVITY TO INSULIN IN THE RAT. 

174877 01-( 
THE MECHANISM OF ACTION OF THE MONOAMINE OXIDASE INHIBITOR 
PARGYLINE. 

1 75239 02-( 
DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: 

ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE 
MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY 

177131 02-C 
MECHANISM OF RELEASE AT NORADRENERGIC NERVE TERMINALS BY 
RESERPINE AND SEVERAL SYMPATHOMIMETIC AGENTS. (UNPUBLISHE 
PAPER). 

1 78747 02-C 
STUDIES ON CENTRAL REGULATING MECHANISM OF THE HYPOGLYCEML 
INDUCED BY INTRAVENTRICULAR ADMINISTRATION OF 
CHLORPROMAZINE. 

182093 02-0 

MECHANISM OF THE NEGATIVE CHRONOTROPIC AND INOTROPIC EFFECT 

OF DELTAl-TETRAHYDROCANNABINOL (DELTAl-THC OR DELTA9-THC). 

182219 03-0 
CENTRAL CHOLINERGIC (MUSCARINIC) LINK IN THE ATTACK REFLEXIVE 
BITING MECHANISM OF CATS. 

182238 03-0 
ON THE MECHANISM OF THE SYNERGISTIC EFFECT OF PERAZINE AND 
HEXOBARBITAL. 

184199 03-0 
MECHANISM OF ACTION OF SUBSTANCE-P. 

184200 03-0 
TOWARD A MECHANISM OF THE ANTIAGGRESSION EFFECTS OF 

CHLORDIAZEPOXIDE IN RATS. 

185934 03-0 
NONCHOLINERGIC MECHANISM OF ACTION OF CHOLINERGIC DRUGS ON 
SQUID AXON MEMBRANES. 

186672 03-0: 
ON THE MECHANISM OF RELEASE OF NOREPINEPHRINE FROM 
SYMPATHETIC NERVES INDUCED BY DEPOLARIZING AGENTS AND 
SYMPATHOMIMETIC DRUGS. (UNPUBLISHED PAPER). 

187397 04-0: 



S-142 



VOLUME 12, SUBJECT INDEX 

A POSSIBLE MECHANISM FOR THE ANTISCHIZOPHRENIC ACTION OF 
CHLORPROMAZINE: INHIBITION OF THE FORMATION OF 
DIMETHYLTRYPT AMINE BY CHLORPROMAZINE METABOLITES. 

187576 04-03 
MECHANISM OF THE VASOCONSTRICTOR ACTION OF PROSTAGLANDIN B. 

189394 04-03 
MECHANISM OF ADRENAL CATECHOLAMINE RELEASE BY DIVALENT 

MERCURY. 

189591 04-03 
DOSE-RELATED ALTERATIONS IN METABOLISM OF LEVODOPA; POSSIBLE 
MECHANISM FOR HYPOTENSIVE EFFECT. 

190194 04-11 
EVIDENCE FOR A NORADRENERGIC AND DOPAMINERGIC MECHANISM IN 
THE HYPERACTIVITY PRODUCED BY 4,ALPHA DIMETHYL-M-TYRAMINE 
(H-77-77) IN RATS. 

190309 04-04 
PROCAINE (GER0VITAL-H3) THERAPY: MECHANISM OF INHIBITION OF 
MONOAMINE OXIDASE. 

191281 04-03 
MECHANISMS 

SEROTONINERGIC MECHANISMS IN THE CENTRAL ACTION OF 
PSYCHOTROPIC DRUGS. (PH.D. DISSERTATION). 

172015 01-03 
KINETICS AND CELLULAR CONTROL MECHANISMS FOR IMIPRAMINE 
METABOLISM IN THE ISOLATED PERFUSED RAT LIVER. (PH.D. 
DISSERTATION). 

173601 01-03 
EFFECTS OF AMPHETAMINE AND ITS HYDROXYLATED METABOLITES ON 
CENTRAL NORADRENERGIC MECHANISMS. (PH.D. DISSERTATION). 

174959 01-03 
POTENTIAL NEUROTRANSMITTERS AND RECEPTOR MECHANISMS 
INVOLVED IN THE CENTRAL CONTROL OF BODY TEMPERATURE IN 
HAMSTERS. (PH.D. DISSERTATION). 

174962 01-03 
THE MECHANISMS OF ACTION OF HALLUCINOGENS. 

180142 02-12 
PERIPHERAL VERSUS CENTRAL MECHANISMS ACCOUNTING FOR 
ANTIANXIETY EFFECTS OF PROPRANOLOL. 

181072 02 10 
MECHANISMS OF DRUG-INDUCED BEHAVIORAL TOLERANCE. 

181406 02-04 
INHIBITION OF THE SYNAPTOSOMAL UPTAKE MECHANISMS FOR L- 
NOREPINEPHRINE AND DOPAMINE BY N-ARYLALKYL DL-AMPHETAMINE 
DERIVATIVES. 

182250 03-03 
RUBIDIUM SALTS: BASIC MECHANISMS OF ACTION 

182441 03-03 
MECHANISMS UNDERLYING POTENTIATION OF BARBITURATE ACTION BY 
SODIUM NITRITE IN THE MOUSE: THE ROLE OF METHEMOGLOBIN 
INDUCED HYPOXIA. 

182721 03-03 
THE ACTIONS OF SEVERAL PSYCHOACTIVE AGENTS UPON THE 
MUSCARINIC MECHANISMS IN THE SUPERIOR CERVICAL GANGLION OF 
THE CAT. 

183866 03-03 
ARE CHOLINERGIC MECHANISMS INVOLVED IN MORPHINE EFFECTS ON 
MOTILITY 

184198 03-03 
BRAIN MECHANISMS UNDERLYING THE EFFECTS OF AMPHETAMINE ON 
FEEDING AND NONFEEDING BEHAVIORS: DISSOCIATION AND OVERLAP. 

184839 03-03 
NEURAL AND CHEMICAL MECHANISMS OF FEMALE SEXUAL BEHAVIOR IN 
THE RAT. (PH.D. DISSERTATION). 

185705 03-04 
POSSIBLE PERIPHERAL ADRENERGIC AND CHOLINERGIC MECHANISMS IN 
PSEUDOCONDITIONING. 

186575 03-03 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS: 
I. EFFECT ON THE BEHAVIOURAL CHANGES INDUCED BY RESERPINE. 
ALPHA-METHYL-P-TYROSINE OR AMPHETAMINE. 

186587 03-04 
EFFECT OF ECT ON DOPAMINERGIC AND NORADRENERGIC MECHANISMS: 

II EFFECT ON DOPAMINE AND NORADRENALINE CONCENTRATIONS 
AND TURNOVERS. 

186588 03-04 
CLINICAL PHARMACOLOGY AS AN APPROACH TO THE STUDY OF 

BIOCHEMICAL SLEEP MECHANISMS: THE ACTION OF L-DOPA. 

186643 03-14 
COMPARISON OF THE LOCOMOTOR STIMULANT MECHANISMS OF 
ACTION OF D-AMPHETAMINE AND D-AMPHETAMINE PLUS L-DOPA: 
POSSIBLE INVOLVEMENT OF SEROTONIN. 

187119 03-04 
ROLE OF DOPAMINERGIC MECHANISMS IN REGULATION OF GROWTH 
HORMONE AND PROLACTIN SECRETION IN MAN. 

188428 04-13 
INVOLVEMENT OF BRAIN CHOLINERGIC MECHANISMS IN THE ACTION OF 
CHLORPROMAZINE. 

188891 04-03 



Subject Index 

EFFECTS OF SCOPOLAMINE ON INHIBITORY MECHANISMS. 

190275 04-04 
CLINICAL STUDIES OF DOPAMINERGIC MECHANISMS. 

191524 04-13 
REBOUND PHENOMENON IN MANIC PATIENTS FOLLOWING 

PHYSOSTIGMINE: TOWARDS AN UNDERSTANDING OF AMINERGIC 
MECHANISMS UNDERLYING AFFECTIVE DISORDERS. 

191531 04-09 
MEDAZEPAM 

GAS CHROMATOGRAPHIC ANALYSIS OF BENZODIAZEPINES. PART I: 
MEDAZEPAM AND ITS METABOLITES. 

1 78948 02-06 
THE EFFECT OF MEDAZEPAM AND ALCOHOL ON COGNITIVE AND MOTOR 
SKILLS USED IN CAR DRIVING. 

189408 04-14 

MEDIAL 

EFFECTS OF CHLORPROMAZINE, CHLORDIAZEPOXIDE AND 

PENTOBARBITAL ON NEURONAL EXCITABILITY IN THE MEDIAL 
FOREBRAIN BUNDLE DURING SELF-STIMULATION BEHAVIOR. 

177837 02-04 
INTRACRANIAL SELF-STIMULATION IN RATS AS A FUNCTION OF 

VARIOUS STIMULUS PARAMETERS: IV. INFLUENCE OF AMPHETAMINE 
ON MEDIAL FOREBRAIN BUNDLE STIMULATION WITH MONOPOLAR 
ELECTRODES. 

185961 03-04 
THE MOTIVATIONAL CONSEQUENCES OF CHOLINERGIC STIMULATION OF 
THE MEDIAL SEPTAL AREA. 

190260 04-04 
MEDIATE 

ALPHA-ADRENERGIC RECEPTORS MEDIATE SUPPRESSION OF DRINKING 
INDUCED BY HYPOTHALAMIC AMPHETAMINE INJECTION. 

182216 03-03 
MEDIATED 

IMIPRAMINE MEDIATED EFFECTS ON LEVODOPA METABOLISM IN MAN. 

185998 03-13 
EVIDENCE FOR CHOLINERGICALLY MEDIATED EFFECT OF 

METHYLPHENIDATE HYDROCHLORIDE IN THE CENTRAL NERVOUS 
SYSTEM. 

191946 04-03 

MEDIATION 

PARADOXICAL EFFECTS OF D-AMPHETAMINE ON BEHAVIORAL 

THERMOREGULATION: POSSIBLE MEDIATION BY BRAIN DOPAMINE. 

189399 04-04 

MEDIATOR 

THE ROLE OF GAMMA-AMINOBUTYRIC ACID AS A MEDIATOR OF 
POSITIVE DORSAL ROOT POTENTIALS. 

189832 04-03 

MEDICAL 

PSYCHOTROPIC DRUGS IN MEDICAL PRACTICE. 

171485 01-17 
THE EFFECTS OF INTRAVENTRICULARLY ADMINISTERED 

CATECHOLAMINES AND SEROTONIN ON THE RESERPINE INDUCED 
SPIKE WAVES RECORDED FROM THE MEDICAL NUCLEUS TRAPEZOIDES 
IN THE RABBIT. 

182094 02-03 
LITHIUM CARBONATE: PSYCHIATRIC INDICATIONS AND MEDICAL 
COMPLICATIONS. 

187786 04-15 

MEDICALLY 

CHROMOSOME EXAMINATIONS AFTER MEDICALLY ADMINISTERED 
LYSERGIC ACID DIETHYLAMIDE AND DEXTROAMPHETAMINE. 

192084 04-15 
MEDICATED 

LABORATORY STUDIES FOR EVERY MEDICATED OUTPATIENT: ARE THEY 
REALLY NECESSARY?. 

189075 04-13 
MEDICATION 

PREANESTHETIC MEDICATION IN ELECTIVE SURGERY: COMPARISON OF 
INTRAVENOUS DIAZEPAM WITH MEPERIDINE. 

167338 01-11 
ON PHARMACO-PSYCHOTHERAPY; THE ROLE OF THE 

PSYCHOTHERAPEUTIC SITUATION IN PSYCHOTROPIC MEDICATION. 

170415 01-11 
CLINICAL RESEARCH ASPECTS OF PSYCHOTROPIC MEDICATION. 

170754 01-17 
EFFECTS OF MEDICATION ON LEARNING IN HYPERACTIVE FOUR-YEAR- 
OLD CHILDREN. (ED.D DISSERTATION). 

172512 01-11 
PSYCHOLOGICAL EFFECTS OF SINGLE DOSE ANTIPSYCHOTIC 
MEDICATION. 

173402 01-08 
MEDICATION AND/OR PSYCHOTHERAPY WITH SCHIZOPHRENICS: WHICH 
PART OF THE ELEPHANT HAVE YOU TOUCHED 

173534 01-08 
PSYCHOTROPIC MEDICATION IN INDONESIA (1970-1973). 

174618 01-17 




S-143 



Subject Index 



Psychopharmacology Abstracts 



CONTROL OF THE HYPERACTIVE CHILD VIA MEDICATION -- AT WHAT 
COST TO PERSONALITY DEVELOPMENT; SOME PSYCHOLOGICAL 
IMPLICATIONS AND CLINICAL INTERVENTIONS. 

176810 02-11 
LONG-TERM CONSEQUENCES OF EXPERIENCE, MEDICATION, AND 
PSYCHOTHERAPY FOR SCHIZOPHRENIC PATIENTS (UNPUBLISHED 
PAPER). 

178677 02-17 
PSYCHOTROPIC MEDICATION IN JAPAN. 

180319 02-08 
STATUS OF PSYCHOTROPIC MEDICATION IN VIET-NAM. 

180320 02-17 
PSYCHOTROPIC MEDICATION IN HONG-KONG. 

180321 02-17 
TREATMENT OF COMPULSIVE EATING DISTURBANCES WITH 

ANTICONVULSANT MEDICATION. 

181270 02-14 
THE ANALYSIS OF THE POTENTIAL ACTION OF A MEDICATION. 

184963 03-14 
AUTOCRITICISM AND REAL PLACE OF THE SAME MEDICATION (VESPRIN). 

184964 03-11 
RECONSTRUCTIVE MEDICATION. 

188447 04-11 
MEDICATION GROUPS FOR CONTINUING CARE. 

189640 04-17 
MEDICATIONS 

THE EFFECT OF LITHIUM AND OTHER ANTIDEPRESSANT MEDICATIONS ON 
THE AUTONOMIC NERVOUS SYSTEM. 

169635 01-15 
MEDICINE 

TRAZODONE AND PSYCHOSOMATIC MEDICINE. 

168808 01-11 
A DOUBLE-BLIND CLINICAL TRIAL OF DOXEPIN HYDROCHLORIDE AND 
DIAZEPAM IN PSYCHOSOMATIC DISEASE, NEUROSIS AND DEPRESSION 
IN THE FIELD OF INTERNAL MEDICINE. 

171282 01-11 
CLINICAL PHARMACOLOGICAL STUDY OF BROMAZEPAM IN THE FIELD OF 
INTERNAL MEDICINE. 

176473 02-10 
TOPICS IN PSYCHIATRY: PSYCHOTROPIC MEDICINE. 

177190 02-17 
MEDICINES 

MAN AND HIS MEDICINES. 

186474 03-17 
MEDICOLEGAL 

MEDICOLEGAL STUDIES ON ISOLATION AND IDENTIFICATION OF 
HYPNOTICS BY THIN-LAYER CHROMATOGRAPHY (TLC) - REPORT 1. 
THIN-LAYER CHROMATOGRAPHY OF HYPNOTICS AND TRANQUILIZERS. 

181315 02-16 
MEDICOLEGAL STUDIES ON ISOLATION AND IDENTIFICATION OF 
HYPNOTICS BY THIN-LAYER CHROMATOGRAPHY (TLC): REPORT 2 ~ 
ISOLATION AND IDENTIFICATION OF HYPNOTICS AND TRANQUILIZER 
IN VIVO. 

182623 03-06 
MEDULLA 

A ROLE FOR NICOTINIC RECEPTORS IN THE REGULATION OF THE 
ADENYLATE CYCLASE OF ADRENAL MEDULLA. 

186675 03-03 
INFLUENCE OF DIFFERENT ANIONS ON TYRAMINE AND AMPHETAMINE 
UPTAKE BY COW ADRENAL MEDULLA CHROMAFFIN VESICLES. 

190907 04-03 
MEFEXAMIDE 

N-(2-DIETHYLAMIN0ETHYL) 2 (P-HYDROXYPHENOXY) ACET AMIDE, A 
METABOLITE OF MEFEXAMIDE IN MAN. 

187577 04-01 
ME6AVITAMIN 

MEGAVITAMIN TREATMENT, CULTURE AND TRANQUILIZERS, DRUGS FOR 
THE AGED: PROJECTS OF A CANADIAN GRANT. 

170293 01 -U 
MELANCHOLY 

IMPORTANCE OF THE COOPERATION OF FAMILIES IN THE TREATMENT OF 
THE SICK: CONCERNING CHRONIC DELIRIUM TREATED WITH 
NEUROLEPTICS AND MELANCHOLY TREATED WITH ANTIDEPRESSANTS. 

182899 03-17 
MELANOCYTE 

MELANOCYTE STIMULATING HORMONE RELEASE INHIBITING HORMONE 
AS AN ANTIDEPRESSANT: A PILOT STUDY. 

171501 01-09 
MELANOMA 

LEVODOPA AND MELANOMA. 

188414 04-15 
MEIITHRACENE 

CLINICAL EXPERIENCE WITH MELITHRACENE IN THE TREATMENT OF 
DEPRESSIVE STATES. 

172979 01-09 



MELLARIL 

A DOUBLE-BLIND COMPARISON OF THIORIDAZINE (MELLARIL) VERSUS 
DIAZEPAM (VALIUM) IN PATIENTS WITH CHRONIC MIXED ANXIETY 
AND DEPRESSIVE SYMPTOMS. 

172486 01-lC 
MEMBRANE 

COMPARATIVE STUDIES OF SYNAPTIC MEMBRANE PROTEIN 
SOLUBILIZATION BY CHLORPROMAZINE AND SODIUM 
DODECYLSULFATE. 

1 76703 02-0: 
ANALYSIS OF DRUG BLOCK OF LSD/5-HT/GABA BY MONITORING 
NEURONAL MEMBRANE CHANGES. 

182143 02-0; 
THE EFFECT OF CANNABINOIDS ON THE NUMBER OF NUCLEAR 
MEMBRANE ATTACHED RIBOSOMES IN INFANT RAT BRAIN. 

183228 03-0- 
LITHIUM THERAPY AND ERYTHROCYTE MEMBRANE CATION CARRIER. 

187644 04- If 
PHENOLS: EFFECTS ON MEMBRANE PERMEABILITY OF MOLLUSCAN 
NEURONS. 

189033 04-0- 
THE INFLUENCE OF PSYCHOSTIMULANTS ON K42 MEMBRANE 
PERMEABILITY IN VARIOUS PORTIONS OF RAT BRAIN. 

191122 04-0; 
MEMBRANES 

EFFECT OF LITHIUM ON AGGRESSION, MANIA AND PERMSELECTIVE 
MEMBRANES. 

167448 01-0? 
DETERMINATION OF DRUG TRANSFER ACROSS BIOLOGICAL MEMBRANES 
COMPARATIVE STUDY ON THE PASSAGE OF DRUGS INTO THE 
CENTRAL NERVOUS SYSTEM AND THEIR PLACENTAL TRANSFER AND 
FETAL LOCALIZATION IN THE PREGNANT RAT. (PH.D. DISSERTATION). 

172018 01-0; 
EVIDENCE FOR PERSISTENT RESERPINE BINDING TO AMINE STORAGE 
VESICLE MEMBRANES. 

182234 03-03 
NONCHOLINERGIC MECHANISM OF ACTION OF CHOLINERGIC DRUGS ON 
SQUID AXON MEMBRANES. 

186672 03-02 
A NEW PROLONGED ACTING TYPE OF CHLORPROAAAZINE: BEHAVIORAL 
EFFECTS AND PROLONGED ACTIONS ON NERVE MEMBRANES. 

187805 04-01 
THE NERVE IMPULSE BLOCKING ACTIONS OF TRANQUILIZERS AND THE 
BINDING OF NEUROLEPTICS TO SYNAPTOSOME MEMBRANES. 

189400 04-03 
THE PRESENCE OF MAO IN SYNAPTIC MEMBRANES OF BOVINE BRAIN. 

191956 04-03 
MEMORY 

INFLUENCE OF AFFECTIVE STATES AND PSYCHOACTIVE DRUGS ON 
VERBAL LEARNING AND MEMORY. 

169504 01-09 
CAUDATE NUCLEUS EFFECTS ON GERIATRIC SENILITY: EFFECT OF 

BELLADONNA ON LEARNING AND MEMORY OF GERIATRIC PATIENTS. 

170744 01-11 
EFFECTS OF (-)DELTA9-TRANS-TETRAHYDR0CANNABIN0L (DELTA9-THC) 
ON MEMORY, ATTENTION AND SUBJECTIVE STATE: A DOUBLE-BLIND 
STUDY. 

174043 01-14 
EFFECT OF ORAL ADMINISTRATION OF DELTA9- 

TETRAHYDROCANNABINOL ON MEMORY, SPEECH, AND PERCEPTION 
OF THERMAL STIMULATION: RESULTS WITH FOUR NORMAL HUMAN 
VOLUNTEER SUBJECTS. PRELIMINARY REPORT. 

177674 02-14 
DRUG EFFECTS ON LEARNING AND MEMORY. 

181404 02-04 
LEARNING AND MEMORY AFTER 6-HYDROXYDOPAMINE (6-OHDA). 

182210 02-04 
CHANGES IN SHORT-TERM AND LONG-TERM MEMORY OF DOGS AND 
CATS UNDER THE EFFECTS OF AMIZYL (BENACTYZINE). 

183517 03-04 
EFFECTS OF NON-HYDROGEN-BONDING ANESTHETICS ON MEMORY IN 
THE CHICK. 

184380 03-04 
PHARAAACOLOGICAL DISTINCTIONS BETWEEN ACTIVE AND PASSIVE 
AVOIDANCE MEMORY FORMATION AS SHOWN BY MANIPULATION Of 
BIOGENIC AMINE ACTIVE COMPOUNDS. 

185927 03-04 
MODIFICATION OF LEARNING AND MEMORY IN GOLDFISH THROUGH THE 
USE OF STIMULANT AND DEPRESSANT DRUGS. 

186583 03-04 
TEMPORAL ASPECTS OF SCOPOLAMINE INDUCED ONE-WAY MEMORY 
DISSOCIATION IN MICE. 

187701 04-04 
THE EFFECTS OF PENTYLENETETRAZOL (METRAZOL) ON A LEARNED 
TASTE AVERSION PRODUCED BY LITHIUM CHLORIDE: THE ISSUE OF 
ASSOCIATIVE MEMORY VS. RETENTIVE MEMORY. (UNPUBLISHED 
PAPER). 

188251 04-04 



S-144 



VOLUME 12, SUBJECT INDEX 



Subject Index 



ANISOMYCIN, LIKE OTHER INHIBITORS OF CEREBRAL PROTEIN 

SYNTHESIS, IMPAIRS LONG-TERM MEMORY OF A DISCRIMINATION 

^*^'^ 188605 04-04 

EFFECTS OF CYCLOHEXIMIDE ON ACQUISITION AND RETENTION OF 
AVOIDANCE LEARNING IN THE RAT: RECOVERY OF MEMORY. 

189215 04-04 
THE COMPARATIVE EFFECTS OF PENTOBARBITAL AND D-AMPHETAMINE 
ON A SHORT-TERM MEMORY TASK IN BABOONS. 

191917 04-04 

MEN 

METHYLTESTOSTERONE WITH IMIPRAMINE IN MEN: CONVERSION OF 
DEPRESSION TO PARANOID REACTION. 

172992 01-15 
THE EFFECTS OF PHENOTHIAZINES ON ENDOCRINE FUNCTION: II. EFFECTS 
IN MEN AND POST-MENOPAUSAL WOMEN. 

184437 03-13 

MENTAL 

CHANGES IN MENTAL FUNCTIONING ACCOMPANYING ANTIPSYCHOTIC 
DRUG THERAPY. 

171124 01-10 
DRUGS COMMONLY USED IN MENTAL CONDITIONS. 

171257 01-17 
POLLY: MENTAL DEFICIENCY AND SCHIZOPHRENIA. 

174641 01-17 
WITHDRAWAL OF MAINTENANCE DRUGS WITH LONG-TERM 
HOSPITALIZED MENTAL PATIENTS: A CRITICAL REVIEW. 

175862 02-17 
CLINICAL TRIAL WITH NOZINAN-R. AT SEVERAL MENTAL HOSPITALS IN 
JAVA. 

176582 02-11 

LITHIUM AND MENTAL HEALTH. 

178113 02-09 
DEVELOPMENT OF A VACCINE AGAINST MENTAL RETARDATION CAUSED 
BY CYTOMEGALOVIRUS INFECTION IN UTERO. 

178549 02-11 
PRELIMINARY EXPERIENCES WITH THE TREATMENT OF SOME MENTAL 
CASES UTILIZING AN ENZYME COMBINATION. 

180298 02-17 
ASSAY PROCEDURES FOR THIORIDAZINE, TRIFLUOPERAZINE, AND THEIR 
SULFOXIDES AND DETERMINATION OF URINARY EXCRETION OF THESE 
COMPOUNDS IN MENTAL PATIENTS. 

183602 03-01 
SERUM ANTICONVULSANT CONCENTRATIONS IN EPILEPTIC PATIENTS 
WITH MENTAL SYMPTOMS: A PRELIMINARY REPORT. 

184439 03-15 
TREATMENT OF MENTAL DISORDERS. 

185182 03-17 
A DOUBLE-BLIND TRIAL OF LONG-TERM LITHIUM THERAPY IN MENTAL 
DEFECTIVES. 

185193 03-11 

CONTROL OF MENTAL ACTIVITIES. 

185235 03-17 
IN APPRECIATION OF BASIC BIOCHEMICAL RESEARCH IN MENTAL 
HEALTH. (UNPUBLISHED PAPER). 

187488 04-17 
A CASE OF A NONSPECIFIC MENTAL ILLNESS WITH PSYCHOMOTOR 
VARIANT. 

188517 04-09 

FACTORS AFFECTING OUTCOME IN A SCHOOL MENTAL HEALTH SERVICE. 

188567 04-11 
PHARMACOGENETICS AND MENTAL DISEASE. 

188826 04-11 

MENTAL CHANGES IN PARKINSONISM. 

188886 04-15 
PROPHYLACTIC EFFICACY OF LITHIUM CARBONATE IN MANIC- 
DEPRESSIVE ILLNESS: REPORT OF THE VETERANS ADMINISTRATION 
AND NATIONAL INSTITUTE OF MENTAL HEALTH (VA-NIMH) 
COLLABORATIVE STUDY GROUP. 

189735 04-09 

MENTAL ILLNESS OR METAL ILLNESS? BISMUTH SUBGALLATE. 

191215 04-15 
DIMETHYLTRYPTAMINE: ITS BIOSYNTHESIS AND POSSIBLE ROLE IN 
MENTAL DISEASE. 

191535 04-12 

DAILY RHYTHM IN BODY TEMPERATURE OF MENTAL PATIENTS: 
APPLICATION OF COSINOR METHOD - FIRST REPORT. 

191685 04-17 
EMERGENCY TREATMENT OF AN ACUTE STATE OF MENTAL ABERRATION. 

191723 04-09 
MENTALLY 

MESORIDAZINE IN THE CARE OF DISTURBED MENTALLY RETARDED 
PATIENTS. 

168315 01-11 
SAFETY AND EFFECTIVENESS OF HALOPERIDOL FOR MENTALLY 

RETARDED BEHAVIORALLY DISORDERED AND HYPERKINETIC PATIENTS. 

169634 01-11 



TANTU-PASHAN AND LUCIDRIL THERAPY IN MENTALLY RETARDED 
CHILDREN. 

175628 02-11 
ANTIAGGRESSIVE EFFECT OF LITHIUM SALTS IN MENTALLY RETARDED 
ADOLESCENTS. 

182435 03-11 
THE EFFECT OF SULTHIAME ON DISTURBED BEHAVIOUR IN MENTALLY 

SUBNORMAL PATIENTS. 

185191 03-14 

EFFECTS OF CONCURRENT BEHAVIOR MODIFICATION AND 

CHLORPROMAZINE ADMINISTRATION IN MENTALLY RETARDED 
WOMEN. (PH.D. DISSERTATION). 

185604 03-14 

MEPERIDINE 

PREANESTHETIC MEDICATION IN ELECTIVE SURGERY: COMPARISON OF 
INTRAVENOUS DIAZEPAM WITH MEPERIDINE. 

167338 01-11 
THE EFFECT OF LOW ENVIRONMENTAL TEMPERATURE ON THE 
TRANYLCYPROMINE MEPERIDINE INTERACTION IN MICE. 

183897 03-03 
RELATIONSHIP OF PLASMA MEPERIDINE LEVELS TO CHANGES IN ANXIETY 
AND HOSTILITY. 

185881 03-14 
DIAZEPAM AND MEPERIDINE ON ARTERIAL BLOOD GASES IN HEALTHY 
VOLUNTEERS. 

190147 04-13 

MEPROBAMATE 

RELIEF OF MUSCULOSKELETAL AND ASSOCIATED PSYCHOPATHOLOGICAL 
SYMPTOMS WITH MEPROBAMATE AND ASPIRIN: A CONTROLLED 
STUDY. 

169632 01-10 

EFFECTS OF CHLORPROMAZINE, MEPROBAMATE AND 
CHLORDIAZEPOXIDE ON THE MAZE LEARNING IN MICE. 

171259 01-04 
CHRONIC MEPROBAMATE INTOXICATION AND PHOTOMYOCLONIC 
RESPONSE. 

181377 02-15 
ENHANCED RENAL TUBULAR SECRETION OF MEPROBAMATE: ROLE OF 
SALINE FUROSEMIDE DIURESIS. 

184243 03-03 
MUTAGENICITY EXPERIMENTS WITH THE TRANQUILLIZER MEPROBAMATE 
IN DROSOPHILA-MELANOGASTER AND IN HUMAN LEUKOCYTE 
CHROMOSOMES IN VITRO. 

184585 03-05 
GLC DETERMINATION OF MEPROBAMATE IN WATER, PLASMA AND 

URINE. 

185977 03-16 

MER-25 

LORDOSIS BEHAVIOR IN CASTRATED MALE MICE TREATED WITH 
ESTRADIOL BENZOATE OR TESTOSTERONE PROPIONATE IN 
COMBINATION WITH AN ESTROGEN ANTAGONIST, MER-25, AN IN 
INTACT MALE RATS. 

186683 03-04 

SUPPRESSION OF LORDOSIS IN GUINEA-PIGS BY ETHAMOXY-TRIPHETOL 
(MER-25) GIVEN AT LONG INTERVALS (36-46 HR) AFTER ESTRADIOL 
BENZOATE TREATMENT. 

186686 03-04 
EFFECTS OF AN ESTROGEN ANTAGONIST, MER-25, ON MOUNTING 
BEHAVIOR AND LORDOSIS BEHAVIOR IN THE FEMALE RAT. 

186691 03-04 
MERCURY 

NEUROLOGICAL CHANGES IN CATS FOLLOWING LONG-TERM DIET OF 
MERCURY CONTAMINATED TUNA. 

186476 03-05 
EFFECTS OF PERINATAL EXPOSURE TO METHYL MERCURY ON 
FUNCTIONAL BRAIN DEVELOPMENT AND NEUROCHEMISTRY. 

189564 04-05 
MECHANISM OF ADRENAL CATECHOLAMINE RELEASE BY DIVALENT 
MERCURY. 

189591 04-03 

MESCAUNE 

TREMOR INDUCTION BY INTRACAUDATE INJECTIONS OF BRETYLIUM, 
TETRABENAZINE, OR MESCALINE: FUNCTIONAL DEFICITS IN CAUDATE 
DOPAMINE. 

167329 01 03 

PEYOTE AND RELATED ALKALOIDS XVI: SYNTHESIS OF 3,4,5 

TRIMETHOXYPHENYLALANINE, AN AMINO ANALOG OF MESCALINE. 

170839 01-06 
MULTITRIAL PASSIVE AVOIDANCE IN RATS: MESCALINE, SHOCK, AND IT! 
EFFECTS. (PH.D. DISSERTATION). 

173162 01-04 
THE EFFECTS OF MESCALINE ADMINISTERED BEFORE OR DURING 
EMBRYOGENESIS UPON THE HATCHABILITY AND BEHAVIOR OF THE 
CHICK. (PH.D. DISSERTATION). 

173791 01-04 
MESCALINE HYPERREACTIVITY: HALLUCINATIONS IN RATS? 
(UNPUBLISHED PAPER). 

178575 02-04 



S-145 



Subject Index 



Psychopharmacology Abstracts 



OXIDATIVE METABOLISM OF MESCALINE IN THE CENTRAL NERVOUS 
SYSTEM a- IV: IN VIVO METABOLISM OF MESCALINE AND 2,3,4 
TRIMETHOXY-BETA-PHENYLETHYLAMINE. 

181944 02-03 
ELECTROENCEPHALOGRAPHIC EFFECTS OF DELTA9- 
TETRAHYDROCANNABINOL, LSD-25, MESCALINE AND 2,5 DIMETHOXY- 
4-METHYLAMPHETAMINE IN THE RABBITS. 

182095 02-03 
BEHAVIORAL AND PHYSIOLOGICAL ACTIVITY OF DEAMINATED 
METABOLITES OF MESCALINE. 

182244 03-03 
EVIDENCE FOR THE ACTION OF D-LYSERGIC ACID DIETHYLAMIDE, 
MESCALINE AND BUFOTENINE ON 5-HYDROXYTRYPTAMINE RECEPTORS 
IN UMBILICAL VASCULATURE. 

182716 03-03 
THE EFFECTS OF 3,4 DIMETHOXYPHENYLETHYLAMINE IN RATS TRAINED 
WITH MESCALINE AS A DISCRIMINATIVE STIMULUS. 

186667 03-04 
MESCALINE INDUCED CHANGES OF BRAIN CORTEX RIBOSOMES: EFFECT 
OF MESCALINE ON THE BINDING OF AMINOACYL TRANSFER 
RIBONUCLEIC ACID TO RIBOSOMES OF BRAIN TISSUE. 

189582 04-05 
MESCALINE FACILITATES RETENTION OF PASSIVE AVOIDANCE IN RATS. 

190266 04-04 
INTERACTIONS OF PSYCHOTROPIC DRUGS AND MESCALINE IN VITRO. 

191933 04-03 
INTERACTION OF MESCALINE AND STRESS ON SHUTTLEBOX 

ESCAPE/AVOIDANCE IN RATS. 

191934 04-04 
EFFECTS OF LSD, MESCALINE, AND PSILOCYBIN ON SYMPATHETIC 

PREGANGLIONIC NEURONS. 

191937 04-03 
MESCALINE: THE CHEMISTRY AND PHARMACOLOGY OF ITS ANALOGS. 

192877 04-12 
CACTUS ALKALOIDS. XIX. CRYSTALLIZATION OF MESCALINE HCL AND 3- 

METHOXYTYRAMINE HCL FROM TRICHOCEREUS-PACHANOI. 

192878 04-01 
MESENCEPHALON 

INFLUENCE OF LEVOMEPROMAZINE AND TRIMEPRIMINE ON EFFECTS OF 
ELECTRICAL STIMULATION AND MICROINJECTION OF ACETYLCHOLINE, 
SEROTONIN AND NORADRENALINE INTO THE MESENCEPHALON. 

191786 04-02 
MESOUMBIC 

IS THERE A RELATIONSHIP BETWEEN THE INVOLVEMENT OF 
EXTRAPYRAMIDAL AND MESOLIMBIC BRAIN AREAS WITH THE 
CATALEPTIC ACTION OF NEUROLEPTIC AGENTS AND THEIR CLINICAL 
ANTIPSYCHOTIC EFFECT? 

171305 01-03 
DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: 
ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE 
MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY, 

177131 02-03 
MESORIDAZINE 

MESORIDAZINE AND CHLORPROMAZINE IN THE TREATMENT OF 
ALCOHOL WITHDRAWAL SYNDROME. 

168314 01-11 
MESORIDAZINE IN THE CARE OF DISTURBED MENTALLY RETARDED 

PATIENTS. 

168315 01-11 
COMPARISON OF THE CLINICAL AND COMPUTER ANALYZED EEG EFFECTS 

OF MESORIDAZINE AND CHLORPROMAZINE. 

180064 02-10 
ISOLATION OF A POSSIBLE NEW METABOLITE OF THIORIDAZINE AND 
MESORIDAZINE FROM HUMAN PLASMA. 

182722 03-13 
SIMULTANEOUS MESORIDAZINE AND PSYCHODRAMA IN NEUROTICS. 

183362 03-10 
MESORIDAZINE (TPS-23 SANDOZ) IN ACUTE PSYCHOTIC STATES. 

187958 04-11 
CLINICAL EXPERIENCES WITH MESORIDAZINE (TPS-23): ITS 
ADMINISTRATION TO HOSPITALIZED SCHIZOPHRENIC PATIENTS. 

188934 04-08 
META-SUBSITUTEO 

STRUCTURAL RELATIONSHIP BETWEEN META-SUBSITUTED N- 
ETHYLAMPHETAMINES AND SELF-ADMINISTRATION IN RHESUS 
MONKEYS. 

191915 04-04 
METABOLIC 

METABOLIC CONTROL OF BODY TEMPERATURE IN MAN. 

174134 01 08 
THE METABOLIC FATE OF N,N DIMETHOXYMETHYL-PHENOBARBITAL IN 
THE RAT. 

177731 02-03 
THE METABOLIC FATE OF HEXOBARBITAL IN THE RAT. 

177732 02-03 
INFLUENCES OF RESERPINE AND CHLORPROMAZINE ON THE ANALGESIC 

AND METABOLIC EFFECTS OF MORPHINE. 

180507 02-03 



STUDIES ON METABOLISM OF BROMAZEPAM (11): COLORIMETRIC 
DETERMINATION AND METABOLIC FATE OF BROMAZEPAM IN 
ANIMALS. 

181593 02-03 

METABOLIC INTERACTIONS BETWEEN NORTRIPTYLINE AND 
THIORIDAZINE IN RATS. 

190346 04-03 
METABOLISM 

THE UPTAKE, RETENTION AND METABOLISM OF 3H-5- 

HYDROXYTRYPTAMINE IN BRAIN SLICES AND ILEUM FROM THE RAT: 
EFFECTS OF COCAINE, DESMETHYLIMIPRAMINE AND RESERPINE. (PH D 
DISSERTATION). 

168131 01-03 
THE EFFECT OF D- AND L-P-CHLOROPHENYLALANINE ON THE 
METABOLISM OF 5-HYDROXYTRYPTAMINE IN BRAIN. 

168748 01-03 
EFFECT OF CHRONIC LITHIUM TREATMENT ON MONOAMINE 
METABOLISM IN RAT BRAIN. 

168839 01-03 
CATECHOLAMINE METABOLISM IN AFFECTIVE DISORDERS: RECENT 
STUDIES OF MHPG EXCRETION 

169091 01-13 
A COLLABORATIVE ASSESSMENT OF NOREPINEPHRINE METABOLISM IN 
AFFECTIVE DISORDERS. 

169094 01-09 
CENTRAL MONOAMINE METABOLISM IN MAN: EFFECT OF PUTATIVE 
DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS. 

169377 01-13 
LIPID INDUCED CHANGES OF PENTOBARBITAL DISTRIBUTION AND 
METABOLISM. 

170072 01-03 
THE EFFECT OF PROTRIPTYLINE ON THE METABOLISM OF LABELLED 
DOPAMINE AND NORADRENALINE IN THE RAT BRAIN. 

171627 01-03 
INTERACTION BY FENFLURAMINE WITH THE METABOLISM OF D- 
AMPHETAMINE IN THE RAT. 

171634 01-03 
DIAZEPAM IN LABOUR: ITS METABOLISM AND EFFECT ON THE CLINICAL 
CONDITION AND THERMOGENESIS OF THE NEWBORN. 

171731 01-13 
EFFECT OF MONOAMINE OXIDASE INHIBITORS ON METABOLISM AND IN 
VIVO RELEASE OF H3-N0REPINEPHRINE FROM THE HYPOTHALAMUS. 

171973 01-03 
THC: METABOLISM AND SUBJECTIVE EFFECTS OF STRESS. (UNPUBLISHED 
PAPER). 

173516 01-14 
KINETICS AND CELLULAR CONTROL MECHANISMS FOR IMIPRAMINE 
METABOLISM IN THE ISOLATED PERFUSED RAT LIVER. (PH.D. 
DISSERTATION). 

173601 01-03 
IN VIVO 3H-PR0CHL0RPERAZINE METABOLISM IN THE GUINEA-PIG AND 
RABBIT. 

173875 01-03 
THE EFFECT OF PSYCHOTROPIC AGENTS ON SOME ASPECTS OF 
ACETYLCHOLINE METABOLISM IN CAT BRAINS. 

174257 01-03 
3H-DELTA9-TETRAHYDR0CANNABIN0L (THC) METABOLISM IN RHESUS 
AND SQUIRREL MONKEYS. 

175751 02-03 
STEREOCHEMICAL ASPECTS IN THE METABOLISM OF THE 

PSYCHOTOMIMETIC AMINE l-(2,5 DIMETH0XY-4-METHYLPHENYL)-2 
AMPHETAMINE. 

1 75759 02-03 
ANTAGONISM OF THE EFFECTS OF CHLORPROMAZINE AND MORPHINE 
ON DOPAMINE METABOLISM BY GABA. 

1 76870 02-03 
EFFECT OF CANNABIS ON PENTOBARBITAL INDUCED SLEEPING TIME AND 
PENTOBARBITAL METABOLISM IN THE RAT. 

179985 02-03 
PSYCHOPHARMACOLOGIC AGENTS: EFFECT ON DRUG METABOLISM. 

1 81 398 02-13 
STUDIES ON METABOLISM OF BROMAZEPAM (III): ABSORPTION, 
EXCRETION, AND METABOLISM OF BROMAZEPAM IN MAN. 

181588 02-13 
STUDIES ON METABOLISM OF BROMAZEPAM (II): COLORIMETRIC 
DETERMINATION AND METABOLIC FATE OF BROMAZEPAM IN 
ANIMALS. 

181593 02-03 
DISSOCIATIVE CHANGE IN ANTIAGGRESSIVE AND MUSCLE RELAXANT 
ACTIONS OF S-TRIAZOLOBENZODIAZEPINE (D-40TA) BY REPEATED 
ADMINISTRATION AND PHENOBARBITAL PRETREATMENT, AND ITS 
RELATION TO METABOLISM. 

181654 02-04 
EFFECTS OF LITHIUM ON CEREBRAL RNA METABOLISM IN VITRO AND IN 
VIVO. 

181942 02-03 



S-146 



VOLUME 12, SUBJECT INDEX 



Subject Index 



OXIDATIVE METABOLISM OF MESCALINE IN THE CENTRAL NERVOUS 
SYSTEM - IV: IN VIVO METABOLISM OF MESCALINE AND 2,3,4 
TRIMETHOXY-BETA-PHENYLETHYLAMINE. 

181944 02-03 
LSD TOLERANCE AND BRAIN SEROTONIN METABOLISM. 

182167 02-03 
EFFECTS OF NARCOTIC ANALGESICS ON ENZYMES OF ACETYLCHOLINE 
METABOLISM IN CULTURED CHICK BRAIN CELLS. 

182225 03-03 
ABSORPTION, DISTRIBUTION, EXCRETION AND METABOLISM OF 
BROMAZEPAM IN RABBIT. 

182555 03-03 
THE METABOLISM OF THE TETRAHYDROCANNABINOLS. 

182773 03-17 
EFFECTS OF DELTA9-TETRAHYDR0CANNABIN0L ON THE METABOLISM OF 
3H-5-HYDROXYTRYPTAMINE AND 3H-N0REPINEPHRINE IN THE RAT 
BRAIN. 

183787 03-03 
BUTOBARBITONE METABOLISM IN MAN: IDENTIFICATION OF 3- 
KETOBUTOBARBITONE. 

183793 03-13 
METABOLISM OF CHLORPHENTERMINE AND PHENTERMINE IN MAN TO 
YIELD HYDROXYLAMINO, C-NITROSO AND NITRO COMPOUNDS. 

183796 03-13 
LONG-TERM EFFECTS OF 4-CHLOROAMPHET AMINE ON BRAIN 5- 
HYDROXYINDOLE METABOLISM IN RATS. 

183869 03-03 
A COMPARISON OF PSYCHOTOMIMETIC DRUG EFFECTS ON RAT BRAIN 
NOREPINEPHRINE METABOLISM. 

183891 03-03 
MORPHINE METABOLISM IN VIVO AND IN VITRO BY HOMOZYGOUS 
GUNN RATS. 

183899 03-03 
CALCIUM METABOLISM IN ELDERLY EPILEPTIC PATIENTS DURING 
ANTICONVULSANT THERAPY. 

185560 03-15 
CATALEPSY INDUCED BY ALPHA-METHYL-P-TYROSINE AND D- 
AMPHETAMINE: THE ROLE OF CATECHOLAMINE METABOLISM. 

185750 03-03 
FURTHER STUDIES ON THE INHIBITION OF DRUG METABOLISM BY 
PREGNANOLONE AND RELATED STEROIDS. 

185866 03-03 
IMIPRAMINE MEDIATED EFFECTS ON LEVODOPA METABOLISM IN MAN. 

185998 03-13 
THE MONOAMINE OXIDASES OF BRAIN: SELECTIVE INHIBITION WITH 
DRUGS AND THE CONSEQUENCES FOR THE METABOLISM OF THE 
BIOGENIC AMINES. 

186668 03-03 
ON THE CEREBRAL ACCUMULATION OF KETAMINE AND THE 
RELATIONSHIP BETWEEN METABOLISM OF THE DRUG AND ITS 
PHARMACOLOGICAL EFFECTS. 

186693 03-03 
EFFECT OF ALPHA-METHYLDOPA ON THE METABOLISM OF DOPAMINE IN 

THE STRIATUM OF THE RAT. 

186694 03-03 
EFFECT OF SKF-525-A ON THE METABOLISM OF (-) DELTA9- 

TETRAHYDROCANNABINOL IN THE RAT BRAIN AND LIVER. 

187578 04-03 
THE EFFECT OF HYPOTHERMIC DOSES OF 1-DELTA9- 

TETRAHYDROCANNABINOL ON BIOGENIC AMINE METABOLISM IN 
SELECTED PARTS OF THE RAT BRAIN. 

188231 04-03 
DOSE-RELATED ALTERATIONS IN METABOLISM OF LEVODOPA: POSSIBLE 
MECHANISM FOR HYPOTENSIVE EFFECT. 

190194 04-11 
EFFECT OF LITHIUM ON CENTRAL METABOLISM OF 5- 
HYDROXYTRYPTAMINE. 

190337 04-03 
STEREOCHEMICAL ASPECTS AND METABOLITE FORMATION IN THE IN 
VIVO METABOLISM OF THE PSYCHOTOMIMETIC AMINE, 1-2,5- 
(DIMETHOXY-4-METHYLPHENYL) 2 AMINOPROPANE. 

190718 04-03 
INFLUENCE OF NEUROLEPTICS AND BENZODIAZEPINES ON METABOLISM 
OF TRICYCLIC ANTIDEPRESSANTS IN MAN. 

191026 04-09 
THE METABOLISM OF l-N-BUTYL-5,5 DIETHYLBARBITURIC ACID (N-N 
BUTYLBARBITAL) IN THE RAT. 

191057 04-03 
PERMANENT ALTERATIONS IN 5-HYDROXYTRYPTAMINE METABOLISM IN 
DISCRETE AREAS OF RAT BRAIN FOLLOWING EXPOSURE TO DRUGS 
DURING THE PERIOD OF DEVELOPMENT. 

191383 04-03 
EFFECT OF SINGLE AND REPEATED ADMINISTRATION OF CLOZAPINE ON 
THE METABOLISM OF DOPAMINE AND NORADRENALINE IN THE BRAIN 
OF THE RAT. 

191418 04-03 
THE USE OF SELECTIVE AND INHIBITOR DRUGS TO MODIFY AMINE 
METABOLISM IN BRAIN. 

191500 04-03 



THE EFFECTS OF COMT INHIBITORS ON BEHAVIOR AND DOPAMINE 
METABOLISM. 

191517 04-03 
EFFECTS OF ALTERATIONS IN IMPULSE FLOW ON TRANSMITTER 
METABOLISM IN CENTRAL DOPAMINERGIC NEURONS. 

191519 04-03 
COMPARATIVE METABOLISM OF TRIAZOLAM, A NEW SEDAT!\/E 
HYPNOTIC, IN RAT, DOG AND MAN. 

1, 1900 04-02 
METABOLISM OF D-AMPHETAMINE BY RAT BRAIN IN VIVO AND IN 

VITRO. 

191922 04-03 

ANALOGS OF CHOLINE: SYNAPTOSOMAL METABOLISM. 

192000 04-03 
METABOLISM OF DELTAl-TETRAHYDROCANNABINOL BY RATS TOLERANT 
TO MARIHUANA. 

192020 04-03 

METABOLITE 

SIMULTANEOUS ANALYSIS OF A 1,5 BENZODIAZEPINE AND ITS 
METABOLITE IN BLOOD AND URINE BY SPECTRODENSITOMETRY. 

176871 02-16 
ISOLATION OF A POSSIBLE NEW METABOLITE OF THIORIDAZINE AND 
MESORIDAZINE FROM HUMAN PLASMA. 

182722 03-13 
PLASAAA CONCENTRATIONS OF DIAZEPAM AND OF ITS METABOLITE N- 
DESMETHYLDIAZEPAM IN RELATION TO ANXIOLYTIC EFFECT. 

186184 03-13 
7-OXO-DELTAl-TETRAHYDROCANNABINOL: A NOVEL METABOLITE OF 
DELTAl-TETRAHYDROCANNABINOL. 

187574 04-01 
N-(2-DIETHYLAMIN0ETHYL) 2 (P-HYDROXYPHENOXY) ACETAMIDE, A 
METABOLITE OF MEFEXAMIDE IN MAN. 

187577 04-01 
STIMULATION OF A DOPAMINE SENSITIVE ADENYLATE CYCLASE IN 
HOMOGENATES OF RAT STRIATUM BY A METABOLITE OF PIRIBEDIL 
(ET-495). 

189616 04-03 
CHRONIC ANOREXIC AND BEHAVIOURAL EFFECTS OF THE FENFLURAMINE 
METABOLITE, NORFENFLURAMINE: AN EVALUATION OF ITS ROLE IN 
THE ACTIONS OF FENFLURAMINE. 

190335 04-04 
STEREOCHEMICAL ASPECTS AND METABOLITE FORMATION IN THE IN 
VIVO METABOLISM OF THE PSYCHOTOMIMETIC AMINE, 1-2,5- 
(DIMETHOXY-4-METHYLPHENYL) 2 AMINOPROPANE. 

190718 04-03 
METABOUTES 

TETRAHYDROISOQUINOLINE ALKALOIDS: IN VIVO METABOLITES OF L- 
DOPA IN MAN. 

168286 01-13 
THE POSSIBLE ROLE OF METABOLITES IN THERAPEUTIC RESPONSE TO 
CHLORPROMAZINE TREATMENT. 

168836 01-08 
METABOLITES OF BROMAZEPAM, A BENZODIAZEPINE, IN THE HUMAN, 
DOG, RAT, AND MOUSE. 

170837 01-03 
LEVELS OF HVA IN MOUSE BRAIN FOLLOWING TREATMENT WITH 
METABOLITES OF CHLORPROMAZINE. 

171626 01-03 
EFFECTS OF AMITRIPTYLINE AND IMIPRAMINE ON AMINE METABOLITES 
IN THE CEREBROSPINAL FLUID OF DEPRESSED PATIENTS. 

174094 01-09 
EFFECTS OF AMPHETAMINE AND ITS HYDROXYLATED METABOLITES ON 
CENTRAL NORADRENERGIC MECHANISMS. (PH.D. DISSERTATION). 

174959 01-03 
GAS CHROMATOGRAPHIC ANALYSIS OF BENZODIAZEPINES. PART h 
MEDAZEPAM AND ITS METABOLITES. 

178948 02-06 
EXCRETION OF NOREPINEPHRINE AND DOPAMINE ALCOHOLIC 
METABOLITES AFTER 6-HYDROXYDOPAMINE. 

1 79986 02-03 
EFFECT OF CHLORPROMAZINE AND SOME OF ITS METABOLITES ON THE 
DOPAMINE SENSITIVE ADENYLATE CYCLASE OF RAT BRAIN STRIATUM. 

180060 02-03 
A COMPARISON OF THE PHARMACOLOGICAL ACTIVITY OF DELTA9- 
TETRAHYDROCANNABINOL AND ITS MONOHYDROXYLATED 
METABOLITES IN MAN. 

182223 03-03 
PHARMACOLOGY OF MONO AND DISUBSTITUTED CHLORPROMAZINE 
METABOLITES. 

182243 03-03 
BEHAVIORAL AND PHYSIOLOGICAL ACTIVITY OF DEAMINATED 

METABOLITES OF MESCALINE. 

182244 03-03 
IMIPRAMINE AND ITS METABOLITES IN HUMAN BRAIN. 

183604 03-13 
THE CONCENTRATIONS OF DIAZEPAM AND ITS METABOLITES IN THE 
PLASMA AFTER AN ACUTE AND CHRONIC ADMINISTRATION. 

184978 03-13 




S-147 



Subject Index 



EFFECTS OF CHLORPROMAZINE AND THREE METABOLITES ON 
BEHAVIORAL RESPONSES IN RATS. 

185748 03-04 
A COMPARISON OF THE EFFECTS OF AMPHETAMINE AND ITS 
METABOLITES, PHYDROXYAMPHETAMINE AND P- 
HYDROXYNOREPHEDRINE, ON UPTAKE, RELEASE AND CATABOLISM OF 
3H-N0REPINEPHRINE IN CEREBRAL CORTEX OF RAT BRAIN. 

186669 0303 
ALPHA-L-ACETYLMETHADOL AND ITS N-DEMTHYLATED METABOLITES 
HAVE POTENT OPIATE ACTION IN THE GUINEA-PIG ISOLATED ILEUM. 

187130 03-03 
STUDIES OF CEREBROSPINAL FLUID AMINE METABOLITES IN DEPRESSED 
PATIENTS: CONCEPTUAL PROBLEMS AND THEORETICAL IMPLICATIONS 
(UNPUBLISHED PAPER). 

187398 04-13 
A POSSIBLE MECHANISM FOR THE ANTISCHIZOPHRENIC ACTION OF 
CHLORPROMAZINE: INHIBITION OF THE FORMATION OF 
DIMETHYLTRYPTAMINE BY CHLORPROMAZINE METABOLITES. 

187576 04-03 
PLASMA AND CEREBROSPINAL FLUID PROBENECID CONCENTRATIONS AS 
RELATED TO ACCUMULATION OF ACIDIC BIOGENIC A.MINE 
METABOLITES IN MAN. 

187933 04-13 
A STUDY OF BIOGENIC AMINE METABOLITES IN THE CEREBROSPINAL 
FLUID AND URINE OF MONKEYS WITH CHLORPROMAZINE INDUCED 
DYSKINESIA. 

189210 04-03 
EXCRETION OF THC AND ITS METABOLITES IN EWES MILK. 

189590 04-03 
A POLAROGRAPHIC METHOD FOR THE DETERMINATION OF THE N-OXIDE 
N-OXIDE-SULPHOXIDE AND SULPHOXIDE METABOLITES OF 
CHLORPROMAZINE. 

190902 04-06 
EFFECT OF PIRIBEDIL AND ONE OF ITS METABOLITES ON THE 
CONCENTRATION OF HOMOVANILLIC ACID IN THE RAT BRAIN. 

191422 04-03 
ABNORMALITIES IN TRYPTOPHAN METABOLITES IN SCHIZOPHRENIA. 

191536 04-13 
ACTIVATION OF STRIATAL HYDROXYLASE BY HYDROXYLATED 
METABOLITES OF CHLORPROMAZINE. 

191908 04-03 
METABOLIZING 

INDUCTION OF HEPATIC DRUG METABOLIZING ENZYMES BY LITHIUM 
TREATMENT. 

182727 03-03 
DECREASED EFFECT OF PHENOBARBITAL TREATMENT ON MICROSOMAL 
DRUG METABOLIZING ENZYME ACTIVITY DURING GESTATION. 

184228 03-03 
CELLULAR EFFECTS OF METHAQUALONE ON DRUG METABOLIZING 
ENZYMES. 

191942 04-03 
METAFFINOIO 

THE ANTAGONISM BETWEEN CHOLINOMIMETIC AGONISTS AND BETA- 
ADRENOCEPTOR STIMULANTS: THE DIFFERENTIATION BETWEEN 
BETWEEN FUNCTIONAL AND METAFFINOID ANTAGONISM. 

191420 04-03 
METAL 

METAL CHELATION OF CHLORPROMAZINES. 

176763 02-06 
MENTAL ILLNESS OR METAL ILLNESS? BISMUTH SUBGALLATE. 

191215 04-15 
METALLIC 

EFFECTS OF SOME METALLIC CATIONS ON CEREBRAL CORTICAL 
NEURONES AND THEIR INTERACTIONS WITH BIOGENIC AMINES. 

187806 04-03 
METALS 

EFFECTS OF ALKALI METALS ON SPONTANEOUS MOTOR ACTIVITIES OF 
MICE. 

182637 03-02 
METHADONE 

COMPARISON OF INTRAVENOUSLY ADMINISTERED METHADONE (ME), 
MORPHINE (MO), HEROIN (H) AND PLACEBO (P). 

182163 02-03 
INHIBITION OF GROWTH IN ANIMALS TREATED WITH METHADONE. 

182164 02-03 
THE DEVELOPMENT OF A BLOOD-BRAIN BARRIER TO METHADONE IN THE 

NEWBORN RAT. 

182165 02-03 
TESTOSTERONE AND LUTEINIZING HORMONE (LH) IN UNTREATED AND 

METHADONE MAINTAINED NARCOTIC ADDICTS. 

182166 02-13 
EFFECTS OF METHADONE ON ACTIVITY AND ON BRAIN MONOAMINES IN 

TWO MOUSE STRAINS. 

182229 03-03 
CATALEPSY AND STEREOTYPED BEHAVIOUR IN RATS TREATED 
CHRONICALLY WITH METHADONE: RELATION TO BRAIN 
HOMOVANILLIC ACID CONTENT. 

183606 03-04 



Psychopharmacology Abstracts 

EFFECT OF CHRONIC METHADONE ADMINISTRATION ON PREGNANT RATS 
AND THEIR OFFSPRING. 

183894 03-03 
METHADONE INHIBITION OF 3H-5-HYDR0XYTRYPTAMINE UPTAKE BY 
SYNAPTOSOMES. 

183896 03-03 
EFFECT OF ORAL ADMINISTRATION OF METHADONE ON HEPATIC 
MICROSOMAL MIXED FUNCTION OXIDASE ACTIVITY IN MICE. 

188178 04-03 
CATALEPSY AND STEREOTYPIES IN RATS TREATED WITH METHADONE- 
RELATION TO STRIATAL DOPAMINE. 

191421 04-03 
METHAMPHETAMINE 

THE INFLUENCE OF ALDOSTERONE OR METHAMPHETAMINE ON LIVER 
GLYCOGEN DEPOSITION OF MICE STRESSED BY LONG-TERM 
ISOLATION. 

182105 02-03 
EFFECTS OF PSYCHOTROPIC DRUGS ON METHAMPHETAMINE INDUCED 
EXCITATIONS IN THE AGGREGATED MICE. 

182107 02-04 
THE EFFECT OF METHAMPHETAMINE ON BRAIN ACH CONSUMPTION AND 

AGGRESSIVENESS IN MICE STRESSED MILDLY BY LONG-TERM 
ISOLATION. 

182108 02-04 
INFLUENCES OF LITHIUM ON THE BEHAVIORAL ACTION OF 

METHAMPHETAMINE AND TETRABENAZINE. 

182109 02-04 
EFFECTS OF METHAMPHETAMINE ON DAILY RHYTHMS OF 

HYPOTHALAMIC NOREPINEPHRINE, SEROTONIN AND PLASMA 
CORTICOSTERONE LEVELS IN THE RAT. 

184178 03-03 
INFLUENCE OF METHAMPHETAMINE AND NEUROLEPTIC DRUGS ON 
TYROSINE HYDROXYLASE ACTIVITY. 

184180 03-03 
THE EFFECTS OF METHAMPHETAMINE AND SECOBARBITAL ON THE 
CONTINGENT NEGATIVE VARIATION AMPLITUDE. 

185932 03-13 
EFFECTS OF METHAMPHETAMINE ON FIXED-RATIO RESPONDING OF FOOD 
SATIATED AND FOOD DEPRIVED RATS. 

185957 03-04 
EFFECTS OF METHAMPHETAMINE, PIPRADROL, AND METHYLPHENIDATE 
ON INSTRUMENTAL CONDITIONING AND SPONTANEOUS MOTOR 
ACTIVITY IN THE IMMATURE RAT. 

186568 03-04 
METHAQUALONE 

GAS CHROMATOGRAPHIC DETERMINATION OF METHAQUALONE IN 
SMALL AMOUNTS OF SERUM AFTER INGESTION OF THERAPEUTIC 
DOSES. 

172397 01-16 
METHAQUALONE - A DR. JEKYLL AND MR. HYDE? 

177396 02-15 
COMPLICATIONS OF METHAQUALONE DIPHENHYDRAMINE (MANDRAX) 
ABUSE. 

177452 02-15 
AN EXPERIMENTAL INVESTIGATION OF DEPENDENCE LIABILITY OF 
METHAQUALONE IN RATS. 

186569 03-03 
METHAQUALONE: AN IRRATIONAL HYPNOTIC. 

189902 04-15 
CELLULAR EFFECTS OF METHAQUALONE ON DRUG METABOLIZING 
ENZYMES. 

191942 04-03 
ABSORPTION AND CLEARANCE OF SECOBARBITAL, HEPTABARBITAL, 
METHAQUALONE, AND ETHINAAAATE. 

192575 04-13 
METHEMOGLOBIN 

MECHANISMS UNDERLYING POTENTIATION OF BARBITURATE ACTION BY 
SODIUM NITRITE IN THE MOUSE: THE ROLE OF METHEMOGLOBIN 
INDUCED HYPOXIA. 

182721 03-03 
METHIONINE 

THE ADMINISTRATION OF METHIONINE TO CHRONIC SCHIZOPHRENIC 
PATIENTS: A REVIEW OF TEN STUDIES. 

187113 03-08 
METHIOTHEPIN 

METHIOTHEPIN ELEVATION OF 5-HYDROXYINDOLEACETIC ACID LEVELS IN 
VARIOUS ANATOMIC REGIONS OF RAT BRAIN. 

187831 04-03 
METHOCARBAMOL 

A COMPARATIVE STUDY OF DIAZEPAM AND METHOCARBAMOL IN THE 
TREATMENT OF LOMBOSCIATALGIAS. 

178950 02-11 
METHOD 

A RAPID AUTOMATIC METHOD FOR DETERMINING SHOCK SENSITIVITIES 
OF MICE. 

171521 01-04 
A METHOD OF QUANTIFYING EEG FOR PSYCHOPHARMACOLOGICAL 
RESEARCH. 

174135 01-16 



S-148 



VOLUME 12, SUBJECT INDEX 



SEMI-QUANTITATIVE ANALYSIS OF BROMAZEPAM BY RING OVEN 

METHOD. 174853 01-16 

A METHOD FOR ANALYZING CNS EFFECTS OF DRUGS AND BRAIN 

LESIONS ON PERMANENT GROUPS OF RATS. ^^^^^^ ^^^^ 

COMPARISON OF THE EFFECTS OF Y-4153 AND CARPIPRAMINE ON 

SCHIZOPHRENIA BY A DOUBLE-BLIND METHOD ^^^^^^ ^^^^ 

A FEW GALENIC METHOD TO PROLONG THE ACTION OF LITHIUM 

SULFATE. 180700 02-15 

A ";FNSITIVE SIMPLE METHOD FOR MEASUREMENT OF TYROSINE 

" KxYLASrAND TRYPTOPHAN-5-HYDROXYLASE ACTIVITI^ES^^ ^^^ 

A GAS CHROMATOGRAPHIC METHOD FOR THE QUANTITATIVE 

ESTIMATION OF N-HYDROXYPHENTERMINE. ^^^^^^ ^^^^ 

AN IMPROVED METHOD FOR STUDYING THE PSYCHOGALVANIC 
REACTION IN MICE AND ITS INHIBITION BY PSYCHOLEPTIC DRUGS. 
COMPARISON WITH THE EFFECTS OF OTHER PHARMACOLOGICAL 

^^^^'^^ 185749 03-06 

APPLICATION OF THE SEQUENTIAL SIMPLEX METHOD IN DESIGNING 

DRUG ANALOGS. 190714 04-01 

A POLAROGRAPHIC METHOD FOR THE DETERMINATION OF THE N-OXIDE. 

N-OXIDE-SULPHOXIDE AND SULPHOXIDE METABOLITES OF 

CHLORPROMAZINE. ,,^^^2 04-06 

DAILY RHYTHM IN BODY TEMPERATURE OF MENTAL PATIENTS: 

APPLICATION OF COSINOR METHOD - FIRST REPORT. ^^^^^^ ^^^_^ 

A METHOD FOR TESTING DRUG-INDUCED PARKINSONIAN-LIKE^EFFECL^^ 

**"'s?ST°EM °TIC*CLINICAL STUDIES WITH TRAZODONE: METHODOLOGICAL 

'^^''^'^^^ 168804 01-16 

PSYCHOPHARMACOLOGICAL RESEARCH: SOME METHODOLOGICAL 

PROBLEMS. 169932 01-06 

**" METHODOLOGY FOR THE EVALUATION OF PENTAZOCINE. PROTOTYPE OF 
THE NEW MORPHINE AGONIST ANTAGONIST ANALGESICS.^^^^^^ ^^^^ 

**"SaRCH ON SUPERSENSITIVE LABORATORY METHODS IN SWEDE^N^^ ^^ 
EXAMINATION OF THE METHODS OF USING FLUPHENAZINE EN^NTHATE^^ 
DRUG THERAPY FOR DEPRESSION IN CHILDREN. INDICATIONS AND 

METHODS. 182429 03-10 

VALIDITY OF SCREENING METHODS FOR DRUGS OF ABUSE I